PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Azbill, RD; Mu, X; Springer, JE				Azbill, RD; Mu, X; Springer, JE			Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes	BRAIN RESEARCH			English	Article						riluzole; spinal cord; glutamate uptake; amyotrophic lateral sclerosis; excitotoxicity; G protein	TRAUMATIC BRAIN INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; FOCAL CEREBRAL-ISCHEMIA; EXCITATORY AMINO-ACIDS; TRANSPORTER GLT-1; XENOPUS-OOCYTES; NMDA RECEPTORS; GRANULE CELLS; INHIBITION; MECHANISM	The purpose of this study was to examine the effect of the anti-convulsant agent, riluzole, on high-affinity glutamate uptake as measured in rat spinal cord synaptosomes. The rate of glutamate uptake was significantly increased in the presence of 0.1 mu M and 1.0 mu M riluzole, but not at the higher concentrations examined. Kinetics analysis demonstrated that riluzole (0.1 mu M) decreased the apparent K-m by 21% and increased the V-max by 31%. Glutamate uptake also was significantly increased in spinal cord synaptosomes obtained from rats treated with 8 mg/kg (i.p.) of riluzole and sacrificed 4 h later. The increase in glutamate uptake in vitro was not affected by pretreatment either with H7, an inhibitor of PKA and PKC, or with the PKC activating phorbol ester, 12-O-tetradecanoylphorbol 13-acetate. Previous studies have shown that some of the actions of riluzole are mediated by G proteins sensitive to pertussis toxin. Surprisingly, treatment of synaptosomes with pertussis toxin alone increased the rate of glutamate uptake, while having no effect on uptake in the presence of riluzole. However, pretreatment with cholera toxin was found to completely block the effects of riluzole on glutamate uptake. These results reveal an additional mechanism by which riluzole can affect glutamatergic neurotransmission, and provides further support that riluzole may prove beneficial in the treatment of traumatic central nervous system injuries involving the excitotoxic actions of glutamate. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Kentucky, Med Ctr, Spinal Cord & Brain Injury Res Ctr, Dept Neurobiol & Anat, Lexington, KY 40536 USA		Springer, JE (corresponding author), Univ Kentucky, Med Ctr, Spinal Cord & Brain Injury Res Ctr, Dept Neurobiol & Anat, Lexington, KY 40536 USA.			Azbill, David/0000-0001-7989-1771	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30248] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030248] Funding Source: NIH RePORTER		Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Barneoud P, 1996, NEUROSCIENCE, V74, P971, DOI 10.1016/0306-4522(96)00249-7; BENOIT E, 1991, PFLUG ARCH EUR J PHY, V419, P603, DOI 10.1007/BF00370302; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; CASADO M, 1991, J NEUROCHEM, V57, P1185, DOI 10.1111/j.1471-4159.1991.tb08278.x; CASADO M, 1993, J BIOL CHEM, V268, P27313; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHERAMY A, 1992, NEUROSCI LETT, V147, P209, DOI 10.1016/0304-3940(92)90597-Z; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Conradt M, 1997, J NEUROCHEM, V68, P1244, DOI 10.1046/j.1471-4159.1997.68031244.x; DEBONO MW, 1993, EUR J PHARMACOL, V235, P283, DOI 10.1016/0014-2999(93)90147-A; DOBLE A, 1992, NEUROSCI LETT, V140, P251, DOI 10.1016/0304-3940(92)90114-M; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; Dowd LA, 1996, MOL PHARMACOL, V49, P465; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; HEBERT T, 1994, MOL PHARMACOL, V45, P1055; HUBERT JP, 1994, BRIT J PHARMACOL, V113, P261, DOI 10.1111/j.1476-5381.1994.tb16203.x; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LEVY LM, 1995, EUR J NEUROSCI, V7, P2036, DOI 10.1111/j.1460-9568.1995.tb00626.x; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; MALGOURIS C, 1989, J NEUROSCI, V9, P3720; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; Pisano P, 1996, NEUROPHARMACOLOGY, V35, P541, DOI 10.1016/0028-3908(96)84624-7; PRATT J, 1992, NEUROSCI LETT, V140, P225, DOI 10.1016/0304-3940(92)90108-J; Rao VLR, 1998, J NEUROCHEM, V70, P2020; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Springer JE, 1997, J NEUROCHEM, V68, P2469; Stutzmann JM, 1996, NEUROREPORT, V7, P387, DOI 10.1097/00001756-199601310-00003; TORP R, 1995, EXP BRAIN RES, V103, P51; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; VOLTERRA A, 1994, ANN NY ACAD SCI, V738, P153; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; WAHL F, 1993, EUR J PHARMACOL, V230, P209, DOI 10.1016/0014-2999(93)90804-Q; Wokke J, 1996, LANCET, V348, P795, DOI 10.1016/S0140-6736(96)03181-9; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	38	127	131	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 21	2000	871	2					175	180		10.1016/S0006-8993(00)02430-6			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	337TG	WOS:000088377300002	10899284				2022-02-06	
J	Perlesz, A; Kinsella, G; Crowe, S				Perlesz, A; Kinsella, G; Crowe, S			Psychological distress and family satisfaction following traumatic brain injury: Injured individuals and their primary, secondary, and tertiary carers	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							SEVERE HEAD-INJURY; RELATIVES; CHILDREN; PARENTS; IMPACT; SYMPTOMS; PATIENT; STRESS	Objective: To assess family psychosocial outcome following traumatic brain injury (TBI) in all family members, including relatives more peripheral to the person with the injury Design: A cross-sectional design was used to gather outcome data from individuals with TBI and primary secondary and tertiary carers, 19.3 months posttrauma. Multivariate analyses of variance (ANOVAs) ascertained differences in levels of psychological distress and family satisfaction within families. Setting and participants: Sevenh-nine families (65 individuals with TBI, 72 primary carers, 43 secondary carers, and 22 tertiary carers) were drawn from a sample of outpatients of three metropolitan, acute rehabilitation hospitals over a 12-month period. Outcome measures: in addition to using the Family Satisfaction Scale (FSS), measures of psychological distress included the Beck Depression Inventory (BDI), State Anxiety inventory (SAI), and Profile of Mood States (POMS). Results: Although it was noted that a significant proportion of family members were not psychologically distressed and reported good family satisfaction, people with TBI remain at greater risk of poor psychosocial outcome than do their relatives. Of other family members, primary carers-particularly wives-are at greatest risk of poor psychosocial outcome, and a number of secondary and tertiary carers also displayed high levels of psychological distress. Conclusions: Male relatives (the majority of whom were secondary or tertiary carers) may report their distress in terms of anger and fatigue, rather than as depression and anxiety. Future research could develop TBI-specific measures of anger and fatigue as screening instruments to identify peripheral family members requiring assistance in adapting to TBI. Many families-despite their initial traumatic experience-eventually cope well, encouraging researchers and clinicians to focus future research efforts on those families who have made good adjustments to TBI.	La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3083, Australia; La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3083, Australia		Perlesz, A (corresponding author), Bouverie Ctr, 50 Flemington St, Flemington, Vic 3031, Australia.	a.perlesz@latrobe.edu.au	Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934; Crowe, Simon/0000-0002-4407-8542			ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; Beck AT, 1987, BECK DEPRESSION INVE; BRAITHWAITE V, 1990, BOUND CARE; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Brown E.W., 1985, FAMILY SYSTEMS MED, V3, P440, DOI 10.1037/h0089672; CAMPLAIR P, 1990, COMMUNITY INTEGRATIO; CHRISTENSEN BK, 1998, J INT NEUROPSYCH SOC, V1, P122; CHRISTENSEN BK, 1995, J INT NEUROPSYCH SOC, V1, P370; Daniel A., 1983, POWER PRIVILEGE PRES; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; GARSKE GG, 1992, REHABIL COUNS BULL, V36, P44; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; *HEADW, 1994, HEADW BRAIN INJ INF; Henry P. W., 1985, FAMILY SYSTEMS MED, V3, P427; *HLTH DEP VICT ACC, 1991, ACQ BRAIN DAM DAT BA, V2; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JACOBS HE, 1989, NEUROPSYCHOLOGICAL T; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1990, REHABILITATION ADULT; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KAY T, 1992, HEAD INJURY FAMILY I; KAY T, 1991, HEAD INJURY FAMILY M; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McNair D., 1981, MANUAL PROFILE MOOD; MINTZ MC, 1995, BRAIN INJURY, V9, P173, DOI 10.3109/02699059509008190; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; NAGLE TK, 1989, NARIC Q, V2, P6; Olson D.H., 1983, FAMILIES WHAT MAKES; OLSON DH, 1982, FAMILY SATISFACTION; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; Panting A, 1972, REHABILITATION, V38, P33; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; PERLESZ A, 1997, THESIS LA TROBE U ME; PERLESZ A, 1989, RECOVERY BRIN INJURY; PERLESZ A, 1996, HEADW VICT C BRAIN I; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; RIDLEY B, 1989, SOC SCI MED, V29, P555, DOI 10.1016/0277-9536(89)90201-3; RIMEL RW, 1990, REHABILITATION ADULT; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; ROSENTHAL M, 1984, BEHAV ASSESSMENT REH; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SACHS PR, 1991, TREATING FAMILIES BR; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; SAWYER MG, 1988, J MARITAL FAM THER, V14, P287, DOI 10.1111/j.1752-0606.1988.tb00748.x; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; Smith LM, 1995, FAMILY SUPPORT PROGR; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; URBACH JR, 1994, J NEUROPSYCH CLIN N, V6, P289; Willer B., 1990, CANADIAN J REHABILIT, V3, P167; WILLER B, 1990, NEUROBEHAVIOURAL SEQ; WILLIAMS J, 1991, HEAD INJURY FAMILY M; ZARSKI JJ, 1991, HEAD INJURY FAMILY M; ZIMOSTRAD SW, 1989, COGNITIVE REHABI MAY, P26; [No title captured], DOI DOI 10.1080/09602019108520164	79	127	133	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2000	15	3					909	929		10.1097/00001199-200006000-00005			21	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	321FL	WOS:000087445400005	10785622				2022-02-06	
J	Friedman, SD; Brooks, WM; Jung, RE; Chiulli, SJ; Sloan, JH; Montoya, BT; Hart, BL; Yeol, RA				Friedman, SD; Brooks, WM; Jung, RE; Chiulli, SJ; Sloan, JH; Montoya, BT; Hart, BL; Yeol, RA			Quantitative proton MRS predicts outcome after traumatic brain injury	NEUROLOGY			English	Article							CLOSED-HEAD-INJURY; MAGNETIC-RESONANCE SPECTROSCOPY; AXONAL INJURY; LESIONS; HUMANS	Objective: To determine whether proton MRS (H-1-MRS) neurochemical measurements predict neuropsychological outcome of patients with traumatic brain injury (TBI). Background: Although clinical indices and conventional imaging techniques provide critical information for TBI patient triage and acute care, none accurately predicts individual patient outcome, Methods: The authors studied 14 patients with TBI soon after injury (45 +/- 21 days postinjury) and again at 6 months (172 +/- 43 days) and 14 age-, sex;, and education-matched control subjects. N-acetylaspartate (NAA), creatine, and choline were measured in normal-appearing occipitoparietal white and gray matter using quantitative H-1-NIRS. Outcome was assessed with the Glasgow Outcome Scale (GOS) and a battery of neuropsychological tests. A composite measure of neuropsychological function was calculated from individual test z-scores probing the major functional domains commonly impaired after head trauma. Results: Early NAA concentrations in gray matter predicted overall neuropsychological performance (r = 0.74, p = 0.01) and GOS (F = 11.93, p = 0.007). Other metabolite measures were not related to behavioral function at outcome. Conclusion: H-1-MRS provides a rapid, noninvasive tool to assess the extent of diffuse injury after head trauma, a component of injury that may be the most critical factor in evaluating resultant neuropsychological dysfunction. H-1-MRS can be added to conventional MR examinations with minimal additional time, and may prove useful in assessing injury severity, golding patient care, and predicting patient outcome.	Univ New Mexico, Clin & Magnet Resonance Res Ctr, Ctr Hlth Sci, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Radiol, Albuquerque, NM 87131 USA; St Josephs Rehabil Hosp, Albuquerque, NM USA		Brooks, WM (corresponding author), Univ New Mexico, Clin & Magnet Resonance Res Ctr, Ctr Hlth Sci, 1201 Yale Blvd NE, Albuquerque, NM 87131 USA.			brooks, william/0000-0001-6227-7636; friedman, seth/0000-0001-8785-7215; Jung, Rex/0000-0003-3718-0597			BARKER PB, 1994, RADIOLOGY, V192, P723, DOI 10.1148/radiology.192.3.8058940; BARKER PB, 1993, NMR BIOMED, V6, P89, DOI 10.1002/nbm.1940060114; BIGLER ED, 1996, NEUROIMAGING, V2, P261; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; BRENNER RE, 1993, MAGNET RESON MED, V29, P737, DOI 10.1002/mrm.1910290605; Brooks WM, 1997, J RHEUMATOL, V24, P2323; Brooks WM, 1999, MAGNET RESON MED, V41, P193, DOI 10.1002/(SICI)1522-2594(199901)41:1<193::AID-MRM27>3.3.CO;2-G; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; Feldman Z., 1996, NEUROTRAUMA, P43; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GENTRY LR, 1994, RADIOLOGY, V191, P1; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; PIJNAPPEL WWF, 1992, J MAGN RESON, V97, P122, DOI 10.1016/0022-2364(92)90241-X; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; ROSS B, 1994, MAGN RESON QUART, V10, P191; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; STACHNIAK J, 1994, J CLIN ANESTH, V6, P437, DOI 10.1016/S0952-8180(05)80020-0; TEASDALE G, 1974, LANCET, V2, P81; VANDENBOOGAART A, 1994, MAGNET RESON MED, V31, P347, DOI 10.1002/mrm.1910310402; VOLLMER DG, 1993, HEAD INJURY, P533; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WEBB PG, 1994, MAGNET RESON MED, V31, P365, DOI 10.1002/mrm.1910310404; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; Zampolini M, 1997, EUR J NEUROL, V4, P246, DOI 10.1111/j.1468-1331.1997.tb00343.x; [No title captured]	40	127	132	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	APR 22	1999	52	7					1384	1391		10.1212/WNL.52.7.1384			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	189KG	WOS:000079903200014	10227622				2022-02-06	
J	Kyrkanides, S; Olschowka, JA; Williams, JP; Hansen, JT; O'Banion, MK				Kyrkanides, S; Olschowka, JA; Williams, JP; Hansen, JT; O'Banion, MK			TNF alpha and IL-1 beta mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury	JOURNAL OF NEUROIMMUNOLOGY			English	Article						intercellular adhesion molecule-1; ionizing radiation; mouse; brain; astrocytes; microglia	CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; CEREBRAL-ARTERY OCCLUSION; CLOSED-HEAD INJURY; CELLS IN-VITRO; RAT-BRAIN; ENDOTHELIAL-CELLS; GENE-EXPRESSION; CYTOKINE PRODUCTION	Radiation injury to the central nervous system (CNS) results in glial activation accompanied by expression of pro-inflammatory cytokines and adhesion molecules. In this study we demonstrate intercellular adhesion molecule-1 (ICAM-1) induction in the irradiated mouse brain at the mRNA and protein levels. Immunocytochemical analysis revealed that ICAM-1 protein was primarily expressed in endothelial cells and microglia. In vitro, ionizing radiation significantly induces TNF alpha, IL-1 beta and ICAM-1 mRNA in primary microglia cultures. Interestingly, although ionizing radiation activated primary astrocyte cultures, it did not induce ICAM-1 expression. However, exposure of astrocytes to conditioned medium collected from irradiated microglia resulted in ICAM-1 induction, which was abrogated when the conditioned medium was pre-incubated with neutralizing antibodies raised against murine TNF alpha and IL-1 beta. These results indicate that pro-inflammatory cytokines may be necessary for ICAM-1 expression in astrocytes in CNS radiation injury. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Radiat Oncol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA		O'Banion, MK (corresponding author), 601 Elmwood Ave,Box 603, Rochester, NY 14642 USA.			O'Banion, M. Kerry/0000-0003-1246-3363	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA011051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS033553, R01NS033553] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA11051] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 33553] Funding Source: Medline		ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; BALLESTAS ME, 1995, GLIA, V14, P267, DOI 10.1002/glia.440140404; BASALINGAM V, 1994, J NEUROSCI, V14, P846; BLUETHMANN H, 1994, J LEUKOCYTE BIOL, V56, P565, DOI 10.1002/jlb.56.5.565; BORRIELLO F, 1995, BIOTECHNIQUES, V19, P580; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; CHIANG CS, 1991, BRAIN RES, V566, P265, DOI 10.1016/0006-8993(91)91707-8; CHIANG CS, 1993, RADIOTHER ONCOL, V29, P60, DOI 10.1016/0167-8140(93)90174-7; Chiang CS, 1997, INT J RADIAT BIOL, V72, P45; Chopp M, 1996, J CEREBR BLOOD F MET, V16, P578, DOI 10.1097/00004647-199607000-00007; CLARK WM, 1991, J NEUROSURG, V75, P623, DOI 10.3171/jns.1991.75.4.0623; Clark WM, 1996, CNS DRUGS, V6, P90, DOI 10.2165/00023210-199606020-00002; DAVELLA D, 1994, J NEUROSURG, V81, P774, DOI 10.3171/jns.1994.81.5.0774; DECKERTSCHLUTER M, 1994, J NEUROPATH EXP NEUR, V53, P457, DOI 10.1097/00005072-199409000-00005; DEVRIES HE, 1994, J NEUROIMMUNOL, V52, P1, DOI 10.1016/0165-5728(94)90155-4; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DIXIT V, 1987, BIOMATER ARTIF CELL, V15, P559, DOI 10.3109/10731198709117553; ENGELHARDT B, 1994, J NEUROIMMUNOL, V51, P199, DOI 10.1016/0165-5728(94)90082-5; EPSTEIN BE, 1993, CANCER, V71, P1362, DOI 10.1002/1097-0142(19930215)71:4<1362::AID-CNCR2820710431>3.0.CO;2-5; Eralinna JP, 1996, J NEUROIMMUNOL, V66, P103, DOI 10.1016/0165-5728(96)00031-8; Fan Lei, 1995, Molecular Brain Research, V30, P125, DOI 10.1016/0169-328X(94)00287-O; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fiebich BL, 1997, J NEUROCHEM, V68, P704; FIKE JR, 1988, INT J RADIAT ONCOL, V14, P63, DOI 10.1016/0360-3016(88)90052-1; FULTON DS, 1992, J NEURO-ONCOL, V14, P63; Gaugler MH, 1997, INT J RADIAT BIOL, V72, P201; GIULIAN D, 1993, ADV NEUROL, V59, P315; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3; GIULIAN D, 1986, J CELL BIOL, V102, P803, DOI 10.1083/jcb.102.3.803; GUILIAN D, 1988, J NEUROSCI, V8, P2485; Hallahan DE, 1997, P NATL ACAD SCI USA, V94, P6432, DOI 10.1073/pnas.94.12.6432; Heckmann M, 1998, EXP CELL RES, V238, P148, DOI 10.1006/excr.1997.3826; HERY C, 1995, J NEUROIMMUNOL, V57, P101, DOI 10.1016/0165-5728(94)00168-N; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Kamiryo T, 1996, ACTA NEUROCHIR, V138, P451, DOI 10.1007/BF01420308; Kato H, 1996, BRAIN RES, V734, P203, DOI 10.1016/0006-8993(96)00636-1; Kawana A, 1997, RADIAT RES, V147, P431, DOI 10.2307/3579499; Kim JS, 1996, J NEUROL SCI, V137, P69, DOI 10.1016/0022-510X(95)00338-3; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Leon LR, 1997, ANN NY ACAD SCI, V813, P244, DOI 10.1111/j.1749-6632.1997.tb51702.x; Lou JN, 1997, NEUROREPORT, V8, P629, DOI 10.1097/00001756-199702100-00010; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; MATTAMMAL MB, 1995, J NEUROCHEM, V64, P1645; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; OBanion MK, 1996, J NEUROCHEM, V66, P2532; OBANION MK, 1992, P NATL ACAD SCI USA, V89, P4888, DOI 10.1073/pnas.89.11.4888; Oka A, 1997, NEUROREPORT, V8, P1161, DOI 10.1097/00001756-199703240-00020; Olschowka JA, 1997, BRAIN BEHAV IMMUN, V11, P273, DOI 10.1006/brbi.1997.0506; Portanova JP, 1996, J EXP MED, V184, P883, DOI 10.1084/jem.184.3.883; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; RUBIN P, 1994, RADIOTHER ONCOL, V31, P51, DOI 10.1016/0167-8140(94)90413-8; SATOH J, 1991, J NEUROSCI RES, V29, P1, DOI 10.1002/jnr.490290102; SCHMIDLEY JW, 1992, PROSTAG LEUKOTR ESS, V47, P105, DOI 10.1016/0952-3278(92)90145-9; SCHULTHEISS TE, 1995, INT J RADIAT ONCOL, V31, P1093, DOI 10.1016/0360-3016(94)00655-5; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; SHRIKANT P, 1994, J NEUROIMMUNOL, V51, P209, DOI 10.1016/0165-5728(94)90083-3; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tocco G, 1997, EXP NEUROL, V144, P339, DOI 10.1006/exnr.1997.6429; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; ZHANG RL, 1995, STROKE, V26, P1438, DOI 10.1161/01.STR.26.8.1438; Zuckerman SH, 1998, INFLAMMATION, V22, P95, DOI 10.1023/A:1022351908951	70	127	132	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728			J NEUROIMMUNOL	J. Neuroimmunol.	MAR 1	1999	95	1-2					95	106		10.1016/S0165-5728(98)00270-7			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	183JT	WOS:000079551000010	10229119				2022-02-06	
J	Andrews, TK; Rose, FD; Johnson, DA				Andrews, TK; Rose, FD; Johnson, DA			Social and behavioural effects of traumatic brain injury in children	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; RECOVERY	Traumatic brain injury (TBI) is the leading cause of death and permanent disability in children and adolescents. Although cognitive and behavioural effects have now been reported for all degrees of TBI severity in children, other aspects of functioning which might be related (such as psychosocial adjustment), have been neglected. In the present study the social and behavioural effects of TBI were assessed by comparing 27 TBI children with 27 controls. TBI children demonstrated significantly lower levels of self-esteem and adaptive behaviour, and higher levels of loneliness, maladaptive behaviour and aggressive/antisocial behaviour. These findings confirm the previously demonstrated detrimental effects of TBI on children's behavioural functioning and offer new evidence for the detrimental effects of TBI on children's social functioning.	Univ E London, Dept Psychol, London E15 4LZ, England; Astley Ainslie Hosp, Dept Neuropsychol, Edinburgh EH9 2HL, Midlothian, Scotland		Andrews, TK (corresponding author), Univ E London, Dept Psychol, London E15 4LZ, England.						ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASHER SR, 1984, CHILD DEV, V55, P1456, DOI 10.2307/1130015; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Coopersmith S., 1981, SEI SELF ESTEEM INVE; DeBlois C.S., 1988, RES COMMUNICATIONS P, V5, P303; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; JOHNSON DA, 1987, BRIT J CLIN PSYCHOL, V26, P289, DOI 10.1111/j.2044-8260.1987.tb01362.x; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; KOLB B, 1995, BRAIN PLASTICITY BEH, P37; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Osberg JS, 1997, BRAIN INJURY, V11, P11; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; RUBIN KH, 1988, CLIN IMPLICATIONS AT; SOKOL DK, 1996, BRAIN INJURY, V10, P429; TEASDALE G, 1974, LANCET, V2, P81; TYERMAN AD, 1984, INT J REHABILITATION, V4, P11; Webb C, 1996, BRAIN INJURY, V10, P303, DOI 10.1080/026990596124476	21	127	127	1	29	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1998	12	2					133	138		10.1080/026990598122755			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YV073	WOS:000071786900003	9492960				2022-02-06	
J	Mikawa, S; Kinouchi, H; Kamii, H; Gobbel, GT; Chen, SF; Carlson, E; Epstein, CJ; Chan, PH				Mikawa, S; Kinouchi, H; Kamii, H; Gobbel, GT; Chen, SF; Carlson, E; Epstein, CJ; Chan, PH			Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; oxygen free radicals; blood-brain barrier; motor dysfunction; copper, zinc-superoxide dismutase; transgenic mouse	EXPERIMENTAL HEAD-INJURY; CEREBRAL-ISCHEMIA; FREE-RADICALS; AMINO-ACIDS; EDEMA; RATS; PEROXYNITRITE; INFARCTION; RESPONSES; CATS	To elucidate the role of oxygen-derived free radicals and superoxide dismutase in traumatic brain injury (TBI), blood-brain barrier (BBB) permeability, brain edema, behavioral function, and necrotic cavity volume (CV) were evaluated after TBI using nontransgenic (nTg) mice and heterozygous and homozygous transgenic (Tg) mice with a 1.5-(Tg1.5x), 3.1-(Tg3.1x) and five-(Tg5x) fold increase in human copper, zinc-superoxide dismutase (CuZn-SOD) activity. Traumatic brain injury was produced by the weight-drop method. Evans blue dye leakage 4 hours after injury was attenuated in a CuZn-SOD dose-dependent manner with decreases of 18.6%, 40.9%, and 48.8%, in the Tg1.5x, Tg3.1x, and Tg5x groups, respectively. The water content 6 hours after injury in the TE3.1x (79.64%) and Tg5x (79.45%) groups was significantly lower than in nTg mice (81.37%). There was an initial decrease in body weight and in motor performance, as measured by beam walk and beam balance tasks undertaken 1 day after TBI. However, the average reduction in beam balance and beam walk performance deficits and changes in body weight postinjury were significantly ameliorated in Tg mice. The CV was significantly smaller in Tg mice than in nTg mice (p < 0.01). These results indicate that superoxide radicals play a deleterious role following TRI. Furthermore, Tg mice provide a useful model for demonstrating the beneficial role of an antioxidant enzyme in TBI without the confounding effect of pharmacokinetics, toxicity, and BBB per meability associated with exogenous agents.	UNIV CALIF SAN FRANCISCO,DEPT NEUROL SURG,SCH MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT NEUROL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PEDIAT,SAN FRANCISCO,CA 94143; TOHOKU UNIV,SCH MED,DEPT NEUROSURG,SENDAI,MIYAGI 980,JAPAN						NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-08938] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-14543, NS-25372] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS014543, P50NS014543, R01NS025372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG008938] Funding Source: NIH RePORTER		BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BETZ AL, 1985, J NEUROCHEM, V44, P574, DOI 10.1111/j.1471-4159.1985.tb05451.x; BRAUGHLER JM, 1987, J NEUROSURG, V67, P102, DOI 10.3171/jns.1987.67.1.0102; Chan P.H., 1988, CELLULAR ANTIOXIDANT, V3, P89; CHAN PH, 1983, BRAIN RES, V277, P329, DOI 10.1016/0006-8993(83)90941-1; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; CHAN PH, 1990, STROKE, V21, P180; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CUEVAS P, 1990, ACTA ANAT, V4137, P303; DEMOPOULOS HB, 1982, PATHOLOGY OXYGEN, P127; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; IKEDA Y, 1989, NEUROSURGERY, V24, P679, DOI 10.1227/00006123-198905000-00004; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; SHI YP, 1994, MAMM GENOME, V5, P337, DOI 10.1007/BF00356551; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; VINK R, 1988, J BIOL CHEM, V263, P757; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Young W, 1987, Cent Nerv Syst Trauma, V4, P27	43	127	128	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	1996	85	5					885	891		10.3171/jns.1996.85.5.0885			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	VP489	WOS:A1996VP48900020	8893728				2022-02-06	
J	FAN, L; YOUNG, PR; BARONE, FC; FEUERSTEIN, GZ; SMITH, DH; MCINTOSH, TK				FAN, L; YOUNG, PR; BARONE, FC; FEUERSTEIN, GZ; SMITH, DH; MCINTOSH, TK			EXPERIMENTAL BRAIN INJURY INDUCES EXPRESSION OF INTERLEUKIN-1-BETA MESSENGER-RNA IN THE RAT-BRAIN	MOLECULAR BRAIN RESEARCH			English	Article						INTERLEUKIN-1-BETA; MESSENGER-RNA; NORTHERN BLOT; CORTEX; INJURY; FLUID PERCUSSION	NERVE GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; MESSENGER-RNA; INDUCTION; IL-6; MACROPHAGES; ASTROCYTES; MECHANISMS; MICROGLIA; CULTURES	Cytokines have been shown to be induced following a variety of central nervous system (CNS) insults, and may play a role in the pathophysiological sequelae of CNS injury. In the present study, we characterized the regional expression of interleukin-IB (IL-1 beta) mRNA in specific brain regions following experimental lateral fluid-percussion traumatic brain injury (TBI) in rats. Adult Sprague-Dawley rats (n = 42) were anesthetized with sodium pentobarbital (60 mg/kg, i.p.) and subjected to lateral fluid-percussion brain injury of moderate severity (2.4 atm.) centered over the left parietal cortex, or 'sham' treatment (anesthesia and surgery without injury). Animals were sacrificed at 1, 6 and 24 h post injury, brains were removed, and tissue samples of left (injured) parietal cortex (LC)I corresponding area in the contralateral right cortex (RC), cortex adjacent to injured parietal cortex (LA), corresponding adjacent area in the right cortex (RA), left hippocampus (LH) and right hippocampus (RH) were prepared. Total RNA was isolated and Northern blot hybridization was performed and the quantity of brain tissue IL-1 beta mRNA is presented as percent relative radioactivity of IL-1 beta positive macrophage RNA which was loaded on same gel. At 1 h following brain injury, a marked and significant increase in expression of IL-1 beta mRNA was observed in LC (20.0 +/- 0.7% of positive control, n = 6, P < 0.05 compared with sham animal), LH (24.5 +/- 0.9%, p < 0.05) and LA (21.5 +/- 3.1%, P < 0.05) in the injured hemisphere, which remained elevated up to 6 h post injury in the LC (4.0 +/- 0.4%, n = 6, P < 0.05) and LH (5.0 +/- 1.3%, P < 0.05). In sham or naive animals, no expression of IL-1 beta mRNA was observed in any of the respective brain areas. These results indicate that following TBI, the temporal expression of IL-1 beta mRNA is regionally stimulated in specific brain regions. These regional changes in cytokines, such as IL-1 beta may play a role in the post-traumatic pathologic or regenerative sequelae of brain injury.	UNIV PENN, DEPT NEUROSURG, DIV NEUROSURG, PHILADELPHIA, PA 19104 USA; SMITHKLINE BEECHAM PHARMACEUT, DEPT MOLEC GENET, KING OF PRUSSIA, PA 19406 USA				smith, douglas/A-1321-2007		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803, NS26818] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818, P50NS008803, R55NS026818, P01NS008803] Funding Source: NIH RePORTER		Abraham E, 1991, Methods Achiev Exp Pathol, V14, P45; BERKENBOSCH F, 1991, NEUR CONT B, V6, P131; BUTTINI M, 1994, MOL BRAIN RES, V23, P126, DOI 10.1016/0169-328X(94)90218-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; COCEANI F, 1988, BRAIN RES, V446, P245, DOI 10.1016/0006-8993(88)90883-9; FARRAR WL, 1987, IMMUNOL REV, V100, P361, DOI 10.1111/j.1600-065X.1987.tb00539.x; FONTANA A, 1984, J IMMUNOL, V133, P1696; FONTANA A, 1982, J IMMUNOL, V129, P2413; FRIEDMAN WJ, 1992, J NEUROSCI RES, V33, P37, DOI 10.1002/jnr.490330106; GIULIAN D, 1988, J NEUROSCI, V8, P709; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; HIGGINS GA, 1991, MOL BRAIN RES, V9, P143, DOI 10.1016/0169-328X(91)90139-O; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; LIU T, 1993, STROKE, V24, P1746, DOI 10.1161/01.STR.24.11.1746; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MINAMI M, 1990, BIOCHEM BIOPH RES CO, V171, P832, DOI 10.1016/0006-291X(90)91221-D; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; MINAMI M, 1992, J NEUROCHEM, V58, P390, DOI 10.1111/j.1471-4159.1992.tb09324.x; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; ROTHWELL NJ, 1991, TRENDS PHARMACOL SCI, V12, P430, DOI 10.1016/0165-6147(91)90623-Z; SPRANGER M, 1990, EUR J NEUROSCI, V2, P69, DOI 10.1111/j.1460-9568.1990.tb00382.x; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; VANDAM AM, 1992, BRAIN RES, V588, P291, DOI 10.1016/0006-8993(92)91588-6; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131	31	127	128	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	MAY	1995	30	1					125	130					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QV326	WOS:A1995QV32600014	7609633				2022-02-06	
J	GRAHAM, DI; GENTLEMAN, SM; LYNCH, A; ROBERTS, GW				GRAHAM, DI; GENTLEMAN, SM; LYNCH, A; ROBERTS, GW			DISTRIBUTION OF BETA-AMYLOID PROTEIN IN THE BRAIN FOLLOWING SEVERE HEAD-INJURY	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						BETA-AMYLOID PROTEIN; HEAD INJURY	ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; NEUROFIBRILLARY TANGLES; DEMENTIA-PUGILISTICA; AXONAL INJURY; DAMAGE; ALLELE; APP; PATHOLOGY; TRAUMA	Deposits of beta-amyloid protein (beta AP) can be found in the brains of 30% of fatally head-injured patients; they have been found in children and after survival times of only 4 h. The principal aims of this study were to map the distribution of beta AP in 14 patients aged 65 years or less in whom it was known that the protein had been deposited, and to correlate its distribution with the pathologies of traumatic brain injury. The results show that beta AP is widely distributed, and that there is no correlation between its presence and cerebral contusions, intracranial haematoma, axonal injury, ischaemic brain damage, brain swelling or the pathology of raised intracranial pressure, These findings suggest that the deposition of beta AP is a consequence of the acute phase response of nerve cells to stress in susceptible individuals. Further studies will be required to establish the possible relationship between the deposition of beta AP following head injury and the molecular neuropathology of Alzheimer's disease.	CHARING CROSS & WESTMINSTER MED SCH,DEPT PSYCHIAT & ANAT,LONDON,ENGLAND; SMITHKLINE BEECHAM PHARMACEUT,DEPT MOLEC NEUROPATHOL,HARLOW CM19 5AD,ESSEX,ENGLAND		GRAHAM, DI (corresponding author), UNIV GLASGOW,SO GEN HOSP,INST NEUROL SCI,DEPT NEUROPATHOL,GLASGOW G51 4TF,LANARK,SCOTLAND.						ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; ALLSOP D, 1990, AM J PATHOL, V136, P255; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; COLE G, 1993, ACTA NEUROPATHOL, V85, P542; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; GENTLEMAN SM, 1989, HISTOCHEMISTRY, V92, P355, DOI 10.1007/BF00500553; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1991, BRIT MED J, V304, P118; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; Huber A., 1993, J NEUROTRAUMA S1, V10, pS180; KALARIA RN, 1991, BRAIN RES, V631, P151; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; MORTIMER JA, 1991, INT J EPIDEMIOL S, V20, pS4; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; ROBERTS GW, 1988, LANCET, V11, P1546; ROYSTON MC, 1992, TRENDS PHARMACOL SCI, V13, P131; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCOTT J, 1993, LANCET, V342, P696, DOI 10.1016/0140-6736(93)91704-P; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977	30	127	127	0	2	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0305-1846			NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	FEB	1995	21	1					27	34		10.1111/j.1365-2990.1995.tb01025.x			8	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	QH609	WOS:A1995QH60900005	7770117				2022-02-06	
J	ARMSTEAD, WM; KURTH, CD				ARMSTEAD, WM; KURTH, CD			DIFFERENT CEREBRAL HEMODYNAMIC-RESPONSES FOLLOWING FLUID PERCUSSION BRAIN INJURY IN THE NEWBORN AND JUVENILE PIG	JOURNAL OF NEUROTRAUMA			English	Article							BLOOD-FLOW; HEAD-INJURY; METABOLISM; CHILDREN; CATS; CIRCULATION; OPIOIDS; PIGLETS; TRAUMA; DAMAGE	The present study was designed to characterize the influence of early developmental changes on the relationship among systemic arterial pressure, cerebral hemodynamics, and cerebral oxygenation during the first 3 h following percussion brain injury. Anesthetized newborn (1-5 days old) and juvenile (3-4 weeks old) pigs equipped with a closed cranial window were connected to a percussion device consisting of a saline-filled cylindrical reservoir with a metal pendulum. Brain injury of moderate severity (1.9-2.3 atm) was produced by allowing the pendulum to strike a piston on the cylinder. Mean arterial blood pressure increased after brain injury in juveniles (68 +/- 4 to 93 +/- 2 mm Hg within 3 min, n = 6), whereas it decreased after injury in newborns (70 +/- 3 to 51 +/- 3 mm Hg within 3 min, n = 6). Fluid percussion brain injury decreased pial artery diameter more in newborns (132 +/- 5 to 110 +/- 5 mu m within 10 min, n = 5) than in juveniles (141 +/- 3 to 133 +/- 3 mu m within 10 min, n = 5). Pial arterioles constricted to a greater extent than small pial arteries following brain injury in both age groups. Within 30 sec, brain injury produced a transient increase in cerebral hemoglobin O-2 saturation (27 +/- 4%, n = 5) that was reversed to a profound decrease in cerebral hemoglobin O-2 saturation (45 +/- 2%, n = 5) in the newborn as measured by near infrared spectroscopy. In contrast, brain injury produced modest increases in hemoglobin O-2 saturation (10 +/- 1%, n = 5), followed by mild desaturation (4 +/- 1%, n = 5) in juveniles. Additionally, regional cerebral blood flow was reduced within 10 min of injury in both newborn and juvenile pigs and remained depressed for 180 min in newborns. In contrast, cerebral blood flow returned to control values within 180 min in juveniles. These data show that the effects of comparable brain injury level were very different in newborn and juvenile pigs. Further, these data suggest that reductions in cerebral blood flow following brain injury are more dependent on changes in reactivity of arterioles. Finally, these data suggest that the decrease in cerebral oxygenation, an index of metabolism, coupled with reduced cerebral blood flow, could result in profound hypoperfusion after brain injury.	UNIV PENN, DEPT ANESTHESIA, PHILADELPHIA, PA 19104 USA; UNIV PENN, DEPT PHARMACOL, PHILADELPHIA, PA 19104 USA; UNIV PENN, DEPT PHYSIOL, PHILADELPHIA, PA 19104 USA		ARMSTEAD, WM (corresponding author), CHILDRENS HOSP, DEPT ANESTHESIA, 34TH & CIV CTR BLVD, PHILADELPHIA, PA 19104 USA.						ARMSTEAD WM, 1991, J CEREBR BLOOD F MET, V11, P380, DOI 10.1038/jcbfm.1991.78; COLOMBANI PM, 1985, J PEDIATR SURG, V20, P8, DOI 10.1016/S0022-3468(85)80382-1; CROCKARD HA, 1977, SURG NEUROL, V7, P281; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DOBBING J, 1991, SCI FDN PAEDIAT, P744; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; KUHL DE, 1980, J NEUROSURG, V52, P309, DOI 10.3171/jns.1980.52.3.0309; KURTH CD, 1993, J CLIN MONITOR, V9, P163, DOI 10.1007/BF01617023; LAPTOOK AR, 1983, BRAIN RES, V276, P51, DOI 10.1016/0006-8993(83)90547-4; LEFFLER CW, 1985, PEDIATR RES, V19, P1160, DOI 10.1203/00006450-198511000-00009; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YUAN XQ, 1993, FASEB J, V7, pA853	28	127	127	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	1994	11	5					487	497		10.1089/neu.1994.11.487			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PR237	WOS:A1994PR23700003	7861442				2022-02-06	
J	KLONOFF, H; CLARK, C; KLONOFF, PS				KLONOFF, H; CLARK, C; KLONOFF, PS			LONG-TERM OUTCOME OF HEAD-INJURIES - A 23 YEAR FOLLOW-UP-STUDY OF CHILDREN WITH HEAD-INJURIES	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							BRAIN INJURY; TRAUMA; SEQUELAE; SYMPTOMS; ADULTS; COMA	The purpose of the 23 year follow up study was to determine the relationship between trauma variables including measures of head injury and very long-term sequelae. The study included 159 individuals with a mean age 31.40 years, of whom approximately 90% were admitted to hospital with a mild head injury during childhood (mean age 7.96). Extent of head injury was determined by unconsciousness, neurological status, skull fracture, EEG, post-traumatic seizures and a composite measure. The composite measure of neurological variables was the best predictor of long-term outcome. In addition, IQ recorded in the post-acute phase was a reliable predictor of long-term outcome. Of the sample, 32.7% reported physical complaints and 17.6% reported current psychological/psychiatric problems unrelated to the head injury. Subjective sequelae (physical, intellectual and emotional) specified as due to the head injury were reported by 31% of the sample, and the sequelae were found to be related to the extent of the head injury and initial IQ. There were no discernible relationships between attribute variables including premorbid status and age with subjective sequelae. There were, however, significant relationships between subjective sequelae and objective, psychosocial measures of adaptation including educational lag, unemployment, current psychological/psychiatric problems and relationships with family members. Finally, there appeared to be continuity of complaints elicited during the five year follow up of the original project and current sequelae. The severity of the head injury was identified as the primary contributory factor in the reconstitution process and in the prediction of long term outcomes.	ST JOSEPHS HOSP,BARROW NEUROL INST,PHOENIX,AZ 85013		KLONOFF, H (corresponding author), UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,FAIRMONT MED BLDG,706-750 W BROADWAY,VANCOUVER V5Z 1H6,BC,CANADA.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Annegers J. F., 1983, PEDIATRIC HEAD TRAUM, P1; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; FABIAN AA, 1947, AM J ORTHOPSYCHIAT, V17, P68, DOI 10.1111/j.1939-0025.1947.tb04977.x; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; KLONOFF H, 1971, AM J PUBLIC HEALTH N, V61, P2405, DOI 10.2105/AJPH.61.12.2405; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Levin H.S., 1989, MILD HEAD INJURY; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Paris R., 1974, CLIN NEUROPSYCHOLOGY, P179; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1983, REHABILITATION HEAD, P9; SALCIDO R, 1991, AM J PHYS MED REHAB, V70, P215, DOI 10.1097/00002060-199108000-00011; SEIDEL HM, 1991, MOSBYS GUIDE PHYSICA; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260	35	127	130	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	1993	56	4					410	415		10.1136/jnnp.56.4.410			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	KW665	WOS:A1993KW66500015	8482963	Green Published, Bronze			2022-02-06	
J	FREEMAN, LW; WRIGHT, TW				FREEMAN, LW; WRIGHT, TW			EXPERIMENTAL OBSERVATIONS OF CONCUSSION AND CONTUSION OF THE SPINAL CORD	ANNALS OF SURGERY			English	Article																	Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Bastian H C, 1890, Med Chir Trans, V73, P151; BERENGARIUS C, 1728, FRACTURA CRANI LIBER; Bodian D, 1936, ANAT REC, V65, P89, DOI 10.1002/ar.1090650110; BRUNS L, 1898, ARCH PSYCHIAT, V31, P128; Burrell H.L., 1887, BOSTON M SURG J, V117, P169; Celsus AC, 1935, MEDICINA; CLINE HJ, 1815, NEW ENGLAND J MED SU, V4, P1; COOPER S, 1932, J PHYSL, V77, pP18; Crutchfield WG, 1933, S SURG, V2, P156; CUSHING H, 1905, J HOPKINS HOSP B, V16, P77; Elsberg CA, 1911, AM J MED SCI, V142, P636; HEAD H, 1920, STUDIES NEUROLOGY; Hippocrates, 1849, GENUINE WORKS HIPPOC; KANAVEL AB, 1918, SURG GYNECOL OBSTET, V26, P601; KELLOGG WN, 1946, J EXP PSYCHOL, V36, P366, DOI 10.1037/h0055933; KIMBROUGH JC, 1946, J UROLOGY, V55, P179, DOI 10.1016/S0022-5347(17)69896-3; KIRGIS HD, 1949, J NEUROSURG, V6, P368, DOI 10.3171/jns.1949.6.5.0368; MATHIJSEN A, 1852, BIJDRAGE TOT MILITAI; MCCRAVEY A, 1945, JAMA-J AM MED ASSOC, V129, P152; PARE A, 1840, OUEVRES COMPLETES AM; Paul of Aegina, 1844, 7 BOOKS P AEGINETA; Putnam TJ, 1934, ARCH NEURO PSYCHIATR, V32, P1189, DOI 10.1001/archneurpsyc.1934.02250120066006; Ramon y Cajal, 1928, DEGENERATION REGENER; SCHIEFFERDECKER P, 1876, VIRCHOWS ARCH, V67, P542; Sherrington CS, 1906, INTEGRATIVE ACTION N; Taylor AS, 1929, ANN SURG, V90, P321; Walker AE, 1951, HIST NEUROLOGICAL SU	28	127	139	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0003-4932			ANN SURG	Ann. Surg.		1953	137	4					433	443		10.1097/00000658-195304000-00001			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	UE745	WOS:A1953UE74500001	13031478	Green Published			2022-02-06	
J	Henry, LC; Elbin, RJ; Collins, MW; Marchetti, G; Kontos, AP				Henry, Luke C.; Elbin, R. J.; Collins, Michael W.; Marchetti, Gregory; Kontos, Anthony P.			Examining Recovery Trajectories After Sport-Related Concussion With a Multimodal Clinical Assessment Approach	NEUROSURGERY			English	Article						Comprehensive assessment; Recovery time; Sport-related concussion	TEST-RETEST RELIABILITY; ERROR SCORING SYSTEM; PREDICT PROTRACTED RECOVERY; HIGH-SCHOOL; POST-CONCUSSION; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PROLONGED RECOVERY; SEX-DIFFERENCES	BACKGROUND:Previous research estimates that the majority of athletes with sport-related concussion (SRC) will recover between 7 and 10 days after injury. This short temporal window of recovery is based predominately on symptom resolution and cognitive improvement and does not accurately reflect recent advances in the clinical assessment model.OBJECTIVE:To characterize SRC recovery at 1-week postinjury time intervals on symptom, neurocognitive, and vestibular-oculomotor outcomes and to examine sex differences in SRC recovery time.METHODS:A prospective, repeated-measures design was used to examine the temporal resolution of neurocognitive, symptom, and vestibular-oculomotor impairment in 66 subjects (age, 16.5 1.9 years; range, 14-23 years; 64% male) with SRC.RESULTS:Recovery time across all outcomes was between 21 and 28 days after SRC for most athletes. Symptoms demonstrated the greatest improvement in the first 2 weeks, although neurocognitive impairment lingered across various domains up to 28 days after SRC. Vestibular-oculomotor decrements also resolved between 1 and 3 weeks after injury. There were no sex differences in neurocognitive recovery. Male subjects were more likely to be asymptomatic by the fourth week and reported less vestibular-oculomotor impairment than female subjects at weeks 1 and 2.CONCLUSION:When the recommended comprehensive approach is used for concussion assessment, recovery time for SRC is approximately 3 to 4 weeks, which is longer than the commonly reported 7 to 14 days. Sports medicine clinicians should use a variety of complementing assessment tools to capture the heterogeneity of SRC.ABBREVIATIONS:BESS, Balance Error Scoring SystemCI, confidence intervalDHI, Dizziness Handicap InventoryES, effect sizeImPACT, Immediate Post-Concussion Assessment and Cognitive TestPCSS, Post-Concussion Symptom ScaleSAC, Standard Assessment of ConcussionSRC, sport-related concussion	[Henry, Luke C.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Marchetti, Gregory] Duquesne Univ, Rangos Sch Hlth Sci, Dept Phys Therapy, Pittsburgh, PA 15219 USA		Henry, LC (corresponding author), 3200 S Water St, Pittsburgh, PA 15203 USA.	lch32@pitt.edu		Kontos, Anthony/0000-0002-3749-4310	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; University of PittsburghUniversity of Pittsburgh; ElMindA, Ltd (Israel); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by grants to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to Dr Kontos and through a research contract between the University of Pittsburgh and ElMindA, Ltd (Israel) with Dr Kontos. Dr Collins is a codeveloper and board member of ImPACT Applications. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Balaban CD, 2001, J ANXIETY DISORD, V15, P27, DOI 10.1016/S0887-6185(00)00041-4; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; Pardini D., 2004, BR J SPORTS MED, V38, P661; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; Reynolds E, 2014, PROG NEUROL SURG, V28, P128, DOI 10.1159/000358770; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	59	126	126	0	44	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2016	78	2					232	241		10.1227/NEU.0000000000001041			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DB5WY	WOS:000368585600009	26445375	Green Accepted			2022-02-06	
J	Akhtar, A				Akhtar, Aysha			The Flaws and Human Harms of Animal Experimentation	CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS			English	Article						animal research; medical testing; human health; human ethics; drug development; animal ethics	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CLINICAL-TRIALS; POSTMENOPAUSAL WOMEN; ALZHEIMERS-DISEASE; MODELS; STROKE; MOUSE; DRUGS; TRANSLATION	Nonhuman animal ("animal") experimentation is typically defended by arguments that it is reliable, that animals provide sufficiently good models of human biology and diseases to yield relevant information, and that, consequently, its use provides major human health benefits. I demonstrate that a growing body of scientific literature critically assessing the validity of animal experimentation generally (and animal modeling specifically) raises important concerns about its reliability and predictive value for human outcomes and for understanding human physiology. The unreliability of animal experimentation across a wide range of areas undermines scientific arguments in favor of the practice. Additionally, I show how animal experimentation often significantly harms humans through misleading safety studies, potential abandonment of effective therapeutics, and direction of resources away from more effective testing methods. The resulting evidence suggests that the collective harms and costs to humans from animal experimentation outweigh potential benefits and that resources would be better invested in developing human-based testing methods.	Oxford Ctr Anim Eth, Oxford, England		Akhtar, A (corresponding author), Oxford Ctr Anim Eth, Oxford, England.						Akhtar A, 2012, ANIMALS PUBLIC HLTH; Akhtar AZ, 2008, REV NEUROSCIENCE, V19, P47; Akhtar AZ, 2009, ATLA-ALTERN LAB ANIM, V37, P43, DOI 10.1177/026119290903700108; Allen A., 2006, SLATE; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], 2003, NAT REV DRUG DISCOV, V2, P167; Attarwala H, 2010, J Young Pharm, V2, P332, DOI 10.4103/0975-1483.66810; Bailey J, 2008, ATLA-ALTERN LAB ANIM, V36, P381, DOI 10.1177/026119290803600403; Bailey Jarrod, 2005, Biogenic Amines, V19, P235, DOI 10.1163/156939105774647385; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Baldwin A, 2007, NEW SCI, V194, P24, DOI 10.1016/S0262-4079(07)61358-X; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Cavanaugh S, 2014, ALTEX; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Curry SH, 2003, ANN NY ACAD SCI, V993, P69, DOI 10.1111/j.1749-6632.2003.tb07512.x; DeGrazia D, 1996, TAKING ANIMALS SERIO, P116; Degryse AL, 2011, AM J MED SCI, V341, P444, DOI 10.1097/MAJ.0b013e31821aa000; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Farber N, DRUG DEV BRAIN INJUR; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; FLETCHER AP, 1978, J ROY SOC MED, V71, P693, DOI 10.1177/014107687807100915; Flow BL, 1997, CONTEMP TOP LAB ANIM, V36, P65; Gawrylewski A, 2007, SCIENTIST, V21, P44; Godlee F., 2014, BMJ-BRIT MED J, V348, pg3719, DOI DOI 10.1136/BMJ.G3719; Greek R, 2000, JAMA-J AM MED ASSOC, V283, P743, DOI 10.1001/jama.283.6.743; Greek Ray, 2010, Philos Ethics Humanit Med, V5, P14, DOI 10.1186/1747-5341-5-14; Guttman-Yassky E, 2007, BRIT J DERMATOL, V157, P1103, DOI 10.1111/j.1365-2133.2007.08135.x; Harding A., 2004, SCIENTIST; Hart PC, 2010, NEUROSCI RES PROG SE, P71; Hartung T, 2012, ALTEX-ALTERN ANIM EX, V29, P251, DOI 10.14573/altex.2012.3.251; Hartung T, 2009, ATLA-ALTERN LAB ANIM, V37, P45, DOI 10.1177/026119290903702S10; HEYWOOD R, 1981, TOXICOL LETT, V8, P349, DOI 10.1016/0378-4274(81)90125-9; Hogan RJ, 2006, PLOS MED, V3, P1656, DOI 10.1371/journal.pmed.0030411; Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012; Institute of Medicine, 2013, IMPR UT TRANSL AN MO; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; KOPPANYI T, 1966, CLIN PHARMACOL THER, V7, P250; LaFollette H., 2011, OXFORD HDB ANIMAL ET, P812; Lane E, 2008, PSYCHOPHARMACOLOGY, V199, P303, DOI 10.1007/s00213-007-0931-8; Leist M, 2013, ARCH TOXICOL, V87, P563, DOI 10.1007/s00204-013-1038-0; Lemere CA, 2009, PROG BRAIN RES, V175, P83, DOI 10.1016/S0079-6123(09)17506-4; Lemon R, 2005, BMJ-BRIT MED J, V330, P977, DOI 10.1136/bmj.330.7498.977; Lonjon N, 2009, J NEUROSCI RES, V87, P403, DOI 10.1002/jnr.21871; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Matthews RAJ, 2008, J ROY SOC MED, V101, P95, DOI 10.1258/jrsm.2007.070164; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Monastersky R., 2008, CHRON HIGHER EDUC, P54; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; O'Neil BJ, 1999, ACAD EMERG MED, V6, P75, DOI 10.1111/j.1553-2712.1999.tb00099.x; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Palfreyman MG, 2002, DRUG DISCOVERY W FAL, P33; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Pippin JJ., 2013, S TEX L REV, V54, P469; Pound P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3387; Roberts I, 2002, BRIT MED J, V324, P474, DOI 10.1136/bmj.324.7335.474; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sams-Dodd F, 2006, DRUG DISCOV TODAY, V11, P355, DOI 10.1016/j.drudis.2006.02.005; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; SCHNEIERSON SS, 1956, P SOC EXP BIOL MED, V91, P229, DOI 10.3181/00379727-91-22221; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shanks Niall, 2009, Philos Ethics Humanit Med, V4, P2, DOI 10.1186/1747-5341-4-2; Sinha G, 2013, NAT BIOTECHNOL, V31, P185; Suckow MA, 2006, LAB RAT, P323; Tator CH, 2012, J NEUROSURG-SPINE, V17, P157, DOI 10.3171/2012.5.AOSPINE12116; Taylor K, 2008, ATLA-ALTERN LAB ANIM, V36, P327, DOI 10.1177/026119290803600310; Tonks A, 2007, BMJ-BRIT MED J, V334, P1346, DOI 10.1136/bmj.39240.416968.AD; Traynor BJ, 2006, NEUROLOGY, V67, P20, DOI 10.1212/01.wnl.0000223353.34006.54; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wadman, 2012, NATURE NEWS BLOG; Wall RJ, 2008, THERIOGENOLOGY, V69, P2, DOI 10.1016/j.theriogenology.2007.09.030; Wang MM, 2013, TRANSL STROKE RES, V4, P3, DOI 10.1007/s12975-012-0219-0; WIEBERS DO, 1990, STROKE, V21, P1; Wilkins HM, 2011, HORIZONS NEUROSC RES, V5, P1; Woodroofe A, 2007, GENETIC ENG BIOTECHN, V27, P18; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zurlo J, 2012, HASTINGS CENT REP, V42, pS23, DOI 10.1002/hast.104	85	126	127	20	143	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0963-1801	1469-2147		CAMB Q HEALTHC ETHIC	Camb. Q. Healthc. Ethics	OCT	2015	24	4					407	419		10.1017/S0963180115000079			13	Health Care Sciences & Services; Health Policy & Services; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Biomedical Social Sciences	CR7YX	WOS:000361569300004	26364776	Green Published, hybrid	Y	N	2022-02-06	
J	Kroshus, E; Baugh, CM; Daneshvar, DH; Viswanath, K				Kroshus, Emily; Baugh, Christine M.; Daneshvar, Daniel H.; Viswanath, Kasisomayajula			Understanding Concussion Reporting Using a Model Based on the Theory of Planned Behavior	JOURNAL OF ADOLESCENT HEALTH			English	Article						Adolescent; Brain concussion; Sports; Education	FOOTBALL PLAYERS; INJURY; SPORT; EDUCATION; KNOWLEDGE; COLLEGE; HOCKEY; RETURN; BRAIN; RISK	Purpose: Athlete's report of concussion symptoms to coaching or medical personnel is an important component of concussion risk reduction. This study applies a model based on the Theory of Planned Behavior (TPB) to the prediction of concussive symptom underreporting among late adolescent and young adult male ice hockey players. Methods: Participants were members of an American Tier III Junior A ice hockey league (ages 18-21 years; male; n - 256). Twelve of 14 league teams and 97% of players within these teams agreed to participate. Written survey items assessed symptom reporting behavior, intention, perceived norms, self-efficacy, perceived outcomes of reporting, and concussion knowledge. Structural equation modeling was used to assess the significance of relationships hypothesized by the TPB-based model and the overall model fit. Data were collected in January 2013. Results: Results supported the fit of the TPB-based model in explaining reporting behavior; all model pathways were significant in the hypothesized direction. Of the perceived reporting outcomes assessed, those related to athletic performance were identified as most strongly associated with reporting intention. Conclusions: Results of this study suggest the importance of considering factors such as perceived outcomes of reporting, perceived norms, and self-efficacy, in addition to knowledge, when analyzing concussion underreporting among adolescent athletes. As concussion education for athletes becomes increasingly mandated, testing and applying psychosocial theories such as TPB may help increase program efficacy. (C) 2014 Society for Adolescent Health and Medicine. All rights reserved.	[Kroshus, Emily; Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Baugh, Christine M.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Baugh, Christine M.; Daneshvar, Daniel H.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Viswanath, Kasisomayajula] Dana Farber Canc Inst, Boston, MA 02115 USA		Kroshus, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 677 Huntington Ave,Kresge Bldg 172, Boston, MA 02115 USA.	emk329@mail.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513			Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bandura A., 1980, SOCIAL FOUNDATIONS O; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Borkan J, 1999, DOING QUALITATIVE RE; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Gielen AC, 2003, EPIDEMIOL REV, V25, P65, DOI 10.1093/epirev/mxg004; Glanz K, 2008, HEALTH BEHAVIOR AND; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kroshus E, 2013, BR J SPORTS MED; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Marar M, 2012, AM J SPORTS MED, V20, P1; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; National Collegiate Athletic Association, 2011, 2011 12 NCAA SPORTS; National Federation of state high school associations, HIGH SCHOOL SPORTS P; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Provvidenza C, 2013, BRIT J SPORT MED, V47, P1; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Richmond SA, 2013, BR J SPORTS MED; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sarris CE, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12224; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	40	126	126	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	MAR	2014	54	3					269	+		10.1016/j.jadohealth.2013.11.011			8	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	AB3XF	WOS:000331722800006	24560034				2022-02-06	
J	Cobb, BR; Urban, JE; Davenport, EM; Rowson, S; Duma, SM; Maldjian, JA; Whitlow, CT; Powers, AK; Stitzel, JD				Cobb, Bryan R.; Urban, Jillian E.; Davenport, Elizabeth M.; Rowson, Steven; Duma, Stefan M.; Maldjian, Joseph A.; Whitlow, Christopher T.; Powers, Alexander K.; Stitzel, Joel D.			Head Impact Exposure in Youth Football: Elementary School Ages 9-12 Years and the Effect of Practice Structure	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Brain injury; Biomechanics; Helmet; Linear; Rotational; Acceleration; Pediatrics; Children; Sports	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; HELMET IMPACTS; CONCUSSION; COLLEGIATE; PLAYERS; ACCELERATION; LOCATION; GAME; EPIDEMIOLOGY	Head impact exposure in youth football has not been well-documented, despite children under the age of 14 accounting for 70% of all football players in the United States. The objective of this study was to quantify the head impact exposure of youth football players, age 9-12, for all practices and games over the course of single season. A total of 50 players (age = 11.0 +/- A 1.1 years) on three teams were equipped with helmet mounted accelerometer arrays, which monitored each impact players sustained during practices and games. During the season, 11,978 impacts were recorded for this age group. Players averaged 240 +/- A 147 impacts for the season with linear and rotational 95th percentile magnitudes of 43 +/- A 7 g and 2034 +/- A 361 rad/s(2). Overall, practice and game sessions involved similar impact frequencies and magnitudes. One of the three teams however, had substantially fewer impacts per practice and lower 95th percentile magnitudes in practices due to a concerted effort to limit contact in practices. The same team also participated in fewer practices, further reducing the number of impacts each player experienced in practice. Head impact exposures in games showed no statistical difference. While the acceleration magnitudes among 9-12 year old players tended to be lower than those reported for older players, some recorded high magnitude impacts were similar to those seen at the high school and college level. Head impact exposure in youth football may be appreciably reduced by limiting contact in practices. Further research is required to assess whether such a reduction in head impact exposure will result in a reduction in concussion incidence.	[Cobb, Bryan R.; Rowson, Steven; Duma, Stefan M.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [Urban, Jillian E.; Davenport, Elizabeth M.; Maldjian, Joseph A.; Stitzel, Joel D.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27157 USA; [Urban, Jillian E.; Davenport, Elizabeth M.] Wake Forest Sch Med, Winston Salem, NC 27157 USA; [Maldjian, Joseph A.; Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol Neuroradiol, Winston Salem, NC 27157 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Translat Sci Inst, Winston Salem, NC 27157 USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC 27157 USA; [Powers, Alexander K.; Stitzel, Joel D.] Wake Forest Sch Med, Childress Inst Pediat Trauma, Winston Salem, NC 27157 USA		Rowson, S (corresponding author), Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, 440 ICTAS Bldg,Stanger St, Blacksburg, VA 24061 USA.	srowson@vt.edu	Cobb, Bryan/J-8647-2014; Duma, Stefan/A-8368-2012; Rowson, Steven/B-1270-2012; Stitzel, Joel/B-4045-2012	Cobb, Bryan/0000-0003-1785-3774; Rowson, Steven/0000-0002-3227-0596; Stitzel, Joel/0000-0001-9762-3033; Maldjian, Joseph/0000-0002-6384-1072	Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center; National Highway Traffic Safety Administration	The authors would like to thank the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center and the National Highway Traffic Safety Administration for providing support for this study as well as Elizabeth Lillie, Matt Bennett, Amanda Dunn, and the South Fork Panthers and Blacksburg youth football programs for their involvement.	Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1	33	126	126	2	40	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2013	41	12					2463	2473		10.1007/s10439-013-0867-6			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	249UN	WOS:000326803700001	23881111	Green Published, hybrid			2022-02-06	
J	Burgos, KL; Javaherian, A; Bomprezzi, R; Ghaffari, L; Rhodes, S; Courtright, A; Tembe, W; Kim, S; Metpally, R; Van Keuren-Jensen, K				Burgos, Kasandra Lovette; Javaherian, Ashkan; Bomprezzi, Roberto; Ghaffari, Layla; Rhodes, Susan; Courtright, Amanda; Tembe, Waibhav; Kim, Seungchan; Metpally, Raghu; Van Keuren-Jensen, Kendall			Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing	RNA			English	Article						next-generation sequencing; NGS; small RNA; RNA isolation; TruSeq; cerebrospinal fluid; miRNA	MICRORNAS; BIOMARKERS; CANCER; GENES; BRAIN; CSF	There has been a growing interest in using next-generation sequencing (NGS) to profile extracellular small RNAs from the blood and cerebrospinal fluid (CSF) of patients with neurological diseases, CNS tumors, or traumatic brain injury for biomarker discovery. Small sample volumes and samples with low RNA abundance create challenges for downstream small RNA sequencing assays. Plasma, serum, and CSF contain low amounts of total RNA, of which small RNAs make up a fraction. The purpose of this study was to maximize RNA isolation from RNA-limited samples and apply these methods to profile the miRNA in human CSF by small RNA deep sequencing. We systematically tested RNA isolation efficiency using ten commercially available kits and compared their performance on human plasma samples. We used RiboGreen to quantify total RNA yield and custom TaqMan assays to determine the efficiency of small RNA isolation for each of the kits. We significantly increased the recovery of small RNA by repeating the aqueous extraction during the phenol-chloroform purification in the top performing kits. We subsequently used the methods with the highest small RNA yield to purify RNA from CSF and serum samples from the same individual. We then prepared small RNA sequencing libraries using Illumina's TruSeq sample preparation kit and sequenced the samples on the HiSeq 2000. Not surprisingly, we found that the miRNA expression profile of CSF is substantially different from that of serum. To our knowledge, this is the first time that the small RNA fraction from CSF has been profiled using next-generation sequencing.	[Burgos, Kasandra Lovette; Javaherian, Ashkan; Ghaffari, Layla; Courtright, Amanda; Tembe, Waibhav; Kim, Seungchan; Metpally, Raghu; Van Keuren-Jensen, Kendall] Translat Genom Res Inst, Phoenix, AZ 85003 USA; [Bomprezzi, Roberto; Rhodes, Susan] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA		Van Keuren-Jensen, K (corresponding author), Translat Genom Res Inst, Phoenix, AZ 85003 USA.	kjensen@tgen.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10RR25056-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR025056] Funding Source: NIH RePORTER	We thank Sonal Das and the Michael J. Fox Foundation for Parkinson's Research for inspiring these experiments. We also thank the TGen sequencing core for their expert advice, especially Lori Phillips, Rebecca Reiman, and Winnie Liang. We also thank the following: Madison Levine, Stephen Villa, and Benjamin Rakela for their input on the manuscript and the Network and Computing Systems division of the Translational Genomics Research Institute (TGen) for making available the data storage and computing infrastructure including the Saguaro2 supercomputing resources funded by the NIH grant #1S10RR25056-01.	Aldridge Sarah, 2012, Methods Mol Biol, V822, P19, DOI 10.1007/978-1-61779-427-8_2; Baraniskin A, 2011, BLOOD, V117, P3140, DOI 10.1182/blood-2010-09-308684; Casalini P, 2009, J BUON, V14, pS17; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fang ZD, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-26; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Haghikia A, 2012, NEUROLOGY, V79, P2166, DOI 10.1212/WNL.0b013e3182759621; Hua DS, 2012, OMICS, V16, P690, DOI 10.1089/omi.2012.0069; Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Rosa A, 2009, CELL CYCLE, V8, P3513, DOI 10.4161/cc.8.21.9847; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Van Nieuwerburgh F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026969	22	126	130	2	44	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	MAY	2013	19	5					712	722		10.1261/rna.036863.112			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	126AS	WOS:000317584100012	23525801	Bronze, Green Published			2022-02-06	
J	Pandit, AS; Expert, P; Lambiotte, R; Bonnelle, V; Leech, R; Turkheimer, FE; Sharp, DJ				Pandit, Anand S.; Expert, Paul; Lambiotte, Renaud; Bonnelle, Valerie; Leech, Robert; Turkheimer, Federico E.; Sharp, David J.			Traumatic brain injury impairs small-world topology	NEUROLOGY			English	Article							STRUCTURAL CONNECTIVITY; AXONAL INJURY; HEAD-INJURY; NETWORK; STATE; DISRUPTION; ATTENTION; RECOVERY; TIME	Objective: We test the hypothesis that brain networks associated with cognitive function shift away from a "small-world" organization following traumatic brain injury (TBI). Methods: We investigated 20 TBI patients and 21 age-matched controls. Resting-state functional MRI was used to study functional connectivity. Graph theoretical analysis was then applied to partial correlation matrices derived from these data. The presence of white matter damage was quantified using diffusion tensor imaging. Results: Patients showed characteristic cognitive impairments as well as evidence of damage to white matter tracts. Compared to controls, the graph analysis showed reduced overall connectivity, longer average path lengths, and reduced network efficiency. A particular impact of TBI is seen on a major network hub, the posterior cingulate cortex. Taken together, these results confirm that a network critical to cognitive function shows a shift away from small-world characteristics. Conclusions: We provide evidence that key brain networks involved in supporting cognitive function become less small-world in their organization after TBI. This is likely to be the result of diffuse white matter damage, and may be an important factor in producing cognitive impairment after TBI.	[Pandit, Anand S.; Bonnelle, Valerie; Leech, Robert; Sharp, David J.] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Computat Cognit & Clin Neuroimaging Lab, London, England; [Expert, Paul; Turkheimer, Federico E.] Inst Psychiat, Ctr Neuroimaging Sci, London, England; [Leech, Robert] Univ Namur, Dept Math Naxys, Namur, Belgium		Sharp, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Computat Cognit & Clin Neuroimaging Lab, Hammersmith Hosp Campus, London, England.	david.sharp@imperial.ac.uk	Expert, Paul/E-7697-2012; Leech, Robert/AAE-8254-2019; Turkheimer, Federico E/B-9485-2012; Sharp, David J/A-2119-2013; Expert, Paul/AAX-6356-2020	Leech, Robert/0000-0002-5801-6318; Turkheimer, Federico E/0000-0002-3766-3815; Expert, Paul/0000-0002-5016-4623; Lambiotte, Renaud/0000-0002-0583-4595	Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Imperial College Healthcare Charity; RCUKUK Research & Innovation (UKRI); EPSRC grantUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/E049451/1]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/E049451/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0701951, G1100809] Funding Source: UKRI; Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/E049451/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701951, G1100809] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-011-048] Funding Source: researchfish	Supported by The Medical Research Council (UK) (to D.J.S., F.E.T., and P.E.), The Imperial College Healthcare Charity (to D.J.S.), a fellowship from the RCUK (to R.L.), and EPSRC grant EP/E049451/1.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lowenstein Daniel H, 2009, Ann Neurol, V66, pA7, DOI 10.1002/ana.21876; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	39	126	132	1	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAY	2013	80	20					1826	1833		10.1212/WNL.0b013e3182929f38			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	148NI	WOS:000319251000007	23596068	Green Published			2022-02-06	
J	Badri, S; Chen, J; Barber, J; Temkin, NR; Dikmen, SS; Chesnut, RM; Deem, S; Yanez, ND; Treggiari, MM				Badri, Shide; Chen, Jasper; Barber, Jason; Temkin, Nancy R.; Dikmen, Sureyya S.; Chesnut, Randall M.; Deem, Steven; Yanez, N. David; Treggiari, Miriam M.			Mortality and long-term functional outcome associated with intracranial pressure after traumatic brain injury	INTENSIVE CARE MEDICINE			English	Article						Intracranial pressure; Intracranial hypertension; Traumatic brain injury; Neuropsychological tests; Functional outcome; Critical care	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; MANAGEMENT; HYPERTENSION; EXPERIENCE; ICP	Elevated intracranial pressure (ICP) has been associated with increased mortality in patients with severe traumatic brain injury (TBI). We have examined whether raised ICP is independently associated with mortality, functional status and neuropsychological functioning in adult TBI patients. Data from a randomized trial of 499 participants were secondarily analyzed. The primary endpoints were mortality and a composite measure of functional status and neuropsychological function (memory, speed of information processing, executive function) over a 6-month period. The area under the curve of the ICP profile (average ICP) during the first 48 h of monitoring was the main predictor of interest. Multivariable regression was used to adjust for a priori defined confounders: age, Glasgow Coma Score, Abbreviated Injury Scale-head and hypoxia. Of the participants, 365 patients had complete 48-h ICP data. The overall 6-month mortality was 18 %. The adjusted odds ratio of mortality comparing 10-mmHg increases in average ICP was 3.12 (95 % confidence interval 1.79, 5.44; p < 0.01). Overall, higher average ICP was associated with decreased functional status and neuropsychological functioning (p < 0.01). Importantly, among survivors, increasing average ICP was not independently associated with worse performance on neuropsychological testing (p = 0.46). Average ICP in the first 48 h of monitoring was an independent predictor of mortality and of a composite endpoint of functional and neuropsychological outcome at the 6-month follow-up in moderate or severe TBI patients. However, there was no association between average ICP and neuropsychological functioning among survivors.	[Badri, Shide; Deem, Steven; Treggiari, Miriam M.] Univ Washington, Sch Med, Harborview Anesthesiol Res Ctr, Dept Anesthesiol & Pain Med,Harborview Med Ctr, Seattle, WA 98104 USA; [Badri, Shide] Amarex Clin Res, Safety Compliance & Coding Dept, Germantown, MD USA; [Chen, Jasper] Kaiser Permanente, Dept Anesthesiol, Redwood City, CA USA; [Barber, Jason; Temkin, Nancy R.; Dikmen, Sureyya S.; Chesnut, Randall M.; Treggiari, Miriam M.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Sch Med, Dept Orthoped Surg, Seattle, WA 98104 USA; [Temkin, Nancy R.; Yanez, N. David] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Temkin, Nancy R.; Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Deem, Steven] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; [Treggiari, Miriam M.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Harborview Med Ctr, Seattle, WA 98104 USA		Treggiari, MM (corresponding author), Univ Washington, Sch Med, Harborview Anesthesiol Res Ctr, Dept Anesthesiol & Pain Med,Harborview Med Ctr, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	treggmm@u.washington.edu		Chesnut, Randall/0000-0001-6377-3666	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS19643]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER	The study was supported by departmental funds. The original data were collected under NIH/NINDS grant R01 NS19643.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; BUXTON RL, 1970, LANCET, V2, P498; DAVIS RA, 1984, SURG GYNECOL OBSTET, V159, P597; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Marmarou A, 2005, ACT NEUR S, V95, P277; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Ross A M, 1992, J Neurosci Nurs, V24, P88; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; TROUPP J, 1965, J Trauma, V5, P373; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630	25	126	129	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	NOV	2012	38	11					1800	1809		10.1007/s00134-012-2655-4			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CN	WOS:000310250500009	23011528				2022-02-06	
J	Siemionow, MZ; Papay, F; Djohan, R; Bernard, S; Gordon, CR; Alam, D; Hendrickson, M; Lohman, R; Eghtesad, B; Fung, J				Siemionow, Maria Z.; Papay, Frank; Djohan, Risal; Bernard, Steven; Gordon, Chad R.; Alam, Daniel; Hendrickson, Mark; Lohman, Robert; Eghtesad, Bijan; Fung, John			First US Near-Total Human Face Transplantation: A Paradigm Shift for Massive Complex Injuries	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article; Proceedings Paper	88th Annual Meeting of the American-Association-of-Plastic-Surgeons	MAR 21-25, 2009	Rancho Mirage, CA	Amer Assoc Plast Surg			FACIAL ALLOGRAFT TRANSPLANTATION; TOLERANCE; CADAVER; ALLOTRANSPLANTATION; INDUCTION; ISSUES; MODEL	Background: Severe complex facial injuries are difficult to reconstruct and require multiple surgical procedures. The potential of performing complex craniofacial reconstruction in one surgical procedure is appealing, and composite face allograft transplantation may be considered an alternative option. The authors describe establishment of the Cleveland Clinic face transplantation program that led them to perform the first U. S. near-total face transplantation. Methods: In November of 2004, the authors received the world's first institutional review board approval to perform a face transplant in humans. In December of 2008, after a 22-hour operation, the authors performed the first near-total face transplantation in the United States, replacing 80 percent of the patient's traumatic facial deficit with a composite allograft from a brain-dead donor. This largest, and most complex, face allograft in the world included over 535 cm(2) of facial skin; functional units of full nose with nasal lining and bony skeleton; lower eyelids and upper lip; underlying muscles and bones, including orbital floor, zygoma, maxilla, alveolus with teeth, hard palate, and parotid glands; and pertinent nerves, arteries, and veins. Immunosuppressive treatment consisted of thymoglobulin, tacrolimus, mycophenolate mofetil, and prednisone. Results: The patient tolerated the procedure and immunosuppression well. At day 47 after transplantation, routine biopsy showed rejection of the graft mucosa without clinical evidence of skin or graft rejection. The patient's physical and psychological recovery went well. The functional outcome has been excellent, including optimal return of breathing through the nose, smelling, tasting, speaking, drinking from a cup, and eating solid foods. Conclusion: The functional outcome thus far at 8 months is rewarding and confirms the feasibility of performing complex reconstruction of severely disfigured patients in a single surgical procedure of facial allotransplantation. (Plast. Reconstr. Surg. 125: 111, 2010.)	[Siemionow, Maria Z.; Papay, Frank; Djohan, Risal; Bernard, Steven; Gordon, Chad R.; Alam, Daniel; Hendrickson, Mark; Lohman, Robert; Eghtesad, Bijan; Fung, John] Cleveland Clin, Dept Plast & Reconstruct Surg, Cleveland, OH 44195 USA		Siemionow, MZ (corresponding author), Cleveland Clin, Dept Plast & Reconstruct Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA.	siemiom@ccf.org	Fung, John/A-2679-2012	Fung, John/0000-0002-3038-0441			Breidenbach WC, 2008, J HAND SURG-AM, V33A, P1039, DOI 10.1016/j.jhsa.2008.02.015; Chenggang Y, 2008, AM J TRANSPLANT, V8, P2169, DOI 10.1111/j.1600-6143.2008.02352.x; Demir Y, 2004, PLAST RECONSTR SURG, V114, P1790, DOI 10.1097/01.PRS.0000142414.92308.AB; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; Gazarian A, 2008, ANN CHIR PLAST ESTH, V144, P424; Guo SZ, 2008, LANCET, V372, P631, DOI 10.1016/S0140-6736(08)61276-3; Lantieri L, 2008, LANCET, V372, P639, DOI 10.1016/S0140-6736(08)61277-5; Lengele BG, 2009, CLIN PLAST SURG, V36, P507, DOI 10.1016/j.cps.2009.02.006; Meningaud JP, 2008, PLAST RECONSTR SURG, V122, P1383, DOI 10.1097/PRS.0b013e3181882146; Morris P, 2007, TRANSPLANTATION, V83, P109, DOI 10.1097/01.tp.0000254201.89012.ae; *MSNBC, BOST HOSP PERF FAC T; *MSNBC, SURG NEWS WORLDS 6 F; *MSNBC, FAC AND HANDS TRANSP; Ravindra KV, 2008, SURGERY, V144, P638, DOI 10.1016/j.surg.2008.06.025; Siemionow M, 2006, PLAST RECONSTR SURG, V117, P876, DOI 10.1097/01.prs.0000204876.27481.fc; Siemionow M, 2006, PLAST RECONSTR SURG, V117, P864, DOI 10.1097/01.prs.0000204875.10333.56; Siemionow M, 2005, TRANSPLANTATION, V79, P558, DOI 10.1097/01.TP.0000152799.16035.B7; Siemionow M, 2003, TRANSPLANTATION, V75, P1607, DOI 10.1097/01.TP.0000068870.71053.29; Siemionow M, 2002, TRANSPLANTATION, V74, P1211, DOI 10.1097/00007890-200211150-00002; Siemionow M, 2006, J RECONSTR MICROSURG, V22, P399, DOI 10.1055/s-2006-947693; Siemionow M, 2006, J RECONSTR MICROSURG, V22, P329, DOI 10.1055/s-2006-946709; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Ulusal BG, 2003, PLAST RECONSTR SURG, V112, P1302, DOI 10.1097/01.PRS.0000079823.84984.BB; Unal S, 2005, ANN PLAS SURG, V55, P297, DOI 10.1097/01.sap.0000168693.25306.79; Yazici I, 2007, ANN PLAS SURG, V58, P338, DOI 10.1097/01.sap.0000237683.72676.12; Yazici I, 2006, PLAST RECONSTR SURG, V118, P1321, DOI 10.1097/01.prs.0000239452.31605.b3; WORLDS 5 FACE TRANSP; WASHINGTON TIME 0616; CHINESE FACE TRANSPL	30	126	127	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	JAN	2010	125	1					111	122		10.1097/PRS.0b013e3181c15c4c			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	541LK	WOS:000273417000014	19770815				2022-02-06	
J	Berry, C; Ley, EJ; Tillou, A; Cryer, G; Margulies, DR; Salim, A				Berry, Cherisse; Ley, Eric J.; Tillou, Areti; Cryer, Gil; Margulies, Daniel R.; Salim, Ali			The Effect of Gender on Patients With Moderate to Severe Head Injuries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Trauma; Traumatic brain injury; Gender; Outcome; Mortality	TRAUMATIC BRAIN-INJURY; PROGESTERONE; RATS; ESTROGEN; WOMEN; SHOCK; DIMORPHISM; MECHANISM; OUTCOMES; FEMALES	Background: Male and female nervous systems respond differently to traumatic brain injury (TBI) and in vivo research relates this difference to neuroprotection from female sex hormones. Attempts to replicate female sex hormone-related neuroprotection in clinical studies have been unsuccessful. The objective of this study was to determine whether gender or menopausal status affects mortality in patients with moderate to severe TBI. Methods: A retrospective review of all patients with isolated moderate to severe TBI was undertaken using data from the National Trauma Database version 6.2 (2000-2005). Isolated TBI was defined as head Abbreviated Injury Score >= 3 in patients without significant extracranial injuries (Abbreviated Injury Score <3 for other anatomic regions). Demographics. Injury Severity Score, and outcomes (mortality, intensive care unit and hospital length of stay, and complications) were compared. The population was stratified into age subgroups: 14 to 45 years (premenopausal), 46 to 55 years (perimenopausal), and older than 55 years (postmenopausal). Logistic regression analysis was used to determine the relationship among female gender, mortality, and development of complications after moderate to severe TBI. Results: A total of 72,294 patients with moderate to severe TBI were evaluated. Females showed a significantly lower risk in both mortality (adjusted odds ratios [AOR], 0.82; 95% confidence intervals [CI], 0.77-0.87; p < 0.0001) and in developing any type of complications (AOR, 0.88; 95% CI, 0.84-0.93; p < 0.0001) than the male population after adjusting for differences in patient characteristics. After age stratification, perimenopausal women (46-55 years) and postmenopausal women (older than 55 years) showed a significantly lower risk in mortality (AOR, 0.76 95% CI 0.63-0.92; p < 0.0044 and AOR, 0.79: 95% CI, 0.73-0.86; p < 0.0001. respectively). There was no difference in mortality in premenopausal women compared with their male age-matched counterparts (AOR, 1.09: 95% CI, 0.99-1.21; p = 0.0917). Conclusions: Female gender is independently associated with reduced mortality and decreased complications after TBI. As peri- and postmenopausal women demonstrated improved survival, and premenopausal women did not, estrogen unlikely confers neuroprotection in women after TBI. Future TBI treatment may benefit with Further research focused on why peri- and postmenopausal women show decreased mortality after TBI.	[Berry, Cherisse; Ley, Eric J.; Margulies, Daniel R.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Tillou, Areti; Cryer, Gil] Univ Calif Los Angeles, Div Trauma, Dept Surg, Los Angeles, CA USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020				Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Haider AH, 2007, ARCH SURG-CHICAGO, V142, P875, DOI 10.1001/archsurg.142.9.875; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Jarrar D, 2000, SURGERY, V128, P246, DOI 10.1067/msy.2000.107376; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; OCONNOR CA, 2005, PHARM RES, V52, P119; Phelan HA, 2007, J TRAUMA, V63, P1127, DOI 10.1097/TA.0b013e318154c1b8; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10	18	126	131	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2009	67	5					950	953		10.1097/TA.0b013e3181ba3354			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	518XO	WOS:000271729500009	19901653				2022-02-06	
J	Sharma, HS; Ali, SF; Hussain, SM; Schlager, JJ; Sharma, A				Sharma, Hari S.; Ali, Syed F.; Hussain, Saber M.; Schlager, John J.; Sharma, Aruna			Influence of Engineered Nanoparticles from Metals on the Blood-Brain Barrier Permeability, Cerebral Blood Flow, Brain Edema and Neurotoxicity. An Experimental Study in the Rat and Mice Using Biochemical and Morphological Approaches	JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY			English	Article; Proceedings Paper	1st International Symposium on Nanoneuroscience - Nanoeuroprotection and Nanoeurotoxicity	AUG 20-26, 2007	Killithea, GREECE			Engineered Nanoparticles; Silver; Copper; Aluminum; Blood-Brain Barrier; Brain Edema; Cerebral Blood Flow; Neuropathology; Astrocytes; Myelin; Evans Blue	SPINAL CORD BARRIER; CARBON-NANOTUBES; TRAUMATIC INJURY; OXIDATIVE STRESS; HEAT-STRESS; METHAMPHETAMINE INTOXICATION; TISSUE DISTRIBUTION; PYROLYSIS PRODUCTS; DRUG-DELIVERY; HEALTH-RISKS	Influence of nanoparticles on brain function following in vivo exposures is not well known. Depending on the magnitude and intensity of nanoparticle exposure from the environment, food and/or water source, neuronal function could be affected and may lead to neurotoxicity and neuropathology. This hypothesis was examined in present investigation using systemic or intracerebroventricular administration of engineered nanoparticles from metals, i.e., Al, Ag and Cu (approximate to 50 to 60 nm) on neurotoxicity in rats and mice. Intraperitoneal (50 mg/kg), intravenous (30 mg/kg), intracarotid (2.5 mg/kg) or intracerebroventricular administration (20 mu g) of nanoparticles significantly altered the blood-brain barrier (BBB) function to Evans blue and radioiodine in several regions of the brain and spinal cord at 24 h after their administration. Marked decreases in local cerebral blood flow (CBF) and pronounced brain edema was seen in regional areas associated with BBB leakage. Neuronal cell injuries, glial cell activation, heat shock protein (HSP) upregulation and loss of myelinated fibers are quite common in effected brain areas. The observed pathological changes were most pronounced in mice compared to rats. Exposures to Cu and Ag nanoparticles showed most marked effects on brain pathology when administered into systemic circulation or into the brain ventricular spaces as compared to Al nanoparticles. Our results are the first to show that nanoparticles from metals are able to induce selective and specific neurotoxicity that depends on the type of metals, route of administration and the species used.	[Sharma, Hari S.; Sharma, Aruna] Uppsala Univ, Univ Hosp, Lab Cerebrovasc Res Anesthesiol & Intens Care, SE-75185 Uppsala, Sweden; [Ali, Syed F.] US FDA, Neurochem Lab, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Hussain, Saber M.; Schlager, John J.] USAF, Res Lab, Appl Biotechnol Branch, Human Effectiveness Directorate, Wright Patterson AFB, OH 45433 USA		Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Lab Cerebrovasc Res Anesthesiol & Intens Care, SE-75185 Uppsala, Sweden.		Sharma, Aruna/D-4430-2011				Amidi M, 2006, J CONTROL RELEASE, V111, P107, DOI 10.1016/j.jconrel.2005.11.014; Borm PJA, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-11; Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240; CAVAGNA G, 1961, Med Lav, V52, P251; COLEMAN WE, 1968, AM IND HYG ASSOC J, V29, P33, DOI 10.1080/00028896809342978; DEY P K, 1984, Indian Journal of Physiology and Pharmacology, V28, P177; Dunning MD, 2004, J NEUROSCI, V24, P9799, DOI 10.1523/JNEUROSCI.3126-04.2004; Euliss LE, 2006, CHEM SOC REV, V35, P1095, DOI 10.1039/b600913c; Fabian E, 2008, ARCH TOXICOL, V82, P151, DOI 10.1007/s00204-007-0253-y; Fang Jia-You, 2006, Chang Gung Med J, V29, P358; Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011; Fenoglio I, 2006, FREE RADICAL BIO MED, V40, P1227, DOI 10.1016/j.freeradbiomed.2005.11.010; Gordh T, 2006, PAIN, V124, P211, DOI 10.1016/j.pain.2006.05.020; GRIFFITH FD, 1973, AM IND HYG ASSOC J, V34, P176, DOI 10.1080/0002889738506828; He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457; Johnston CJ, 1996, TOXICOL APPL PHARM, V140, P154, DOI 10.1006/taap.1996.0208; Johnston CJ, 2000, TOXICOL APPL PHARM, V168, P208, DOI 10.1006/taap.2000.9037; Kim JS, 2006, TOXICOL SCI, V89, P338, DOI 10.1093/toxsci/kfj027; Kiyatkin EA, 2007, EUR J NEUROSCI, V26, P1242, DOI 10.1111/j.1460-9568.2007.05741.x; Koziara JM, 2006, J NANOSCI NANOTECHNO, V6, P2712, DOI 10.1166/jnn.2006.441; Kurbitz S, 2001, APPL PHYS B-LASERS O, V73, P333, DOI 10.1007/s003400100657; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Lanone S, 2006, CURR MOL MED, V6, P651, DOI 10.2174/156652406778195026; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Mertens H, 2006, NANO LETT, V6, P2622, DOI 10.1021/nl061494m; Mills NL, 2006, AM J RESP CRIT CARE, V173, P426, DOI 10.1164/rccm.200506-865OC; Moghimi S. Moein, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P553; Oberdorster G, 2000, Res Rep Health Eff Inst, P5; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Oberdorster G, 1996, PARTICLE OVERLOAD IN THE RAT LUNG AND LUNG CANCER, P73; Rapoport S. I., 1976, BLOOD BRAIN BARRIER; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P295, DOI 10.1196/annals.1403.022; Sharma H.S., 2009, HDB NEUROCHEM MOL NE, V24, P163; Sharma H. S., 2004, BLOOD SPINAL CORD BR, P437; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Sharma HS, 2008, EXPERT OPIN PHARMACO, V9, P2773, DOI 10.1517/14656566.9.16.2773 ; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P197, DOI 10.1196/annals.1403.014; Sharma HS, 2007, PROG BRAIN RES, V162, P173, DOI 10.1016/S0079-6123(06)62010-4; Sharma HS, 2007, PROG BRAIN RES, V162, P245, DOI 10.1016/S0079-6123(06)62013-X; Sharma HS, 2006, ANN NY ACAD SCI, V1074, P198, DOI 10.1196/annals.1369.020; Sharma HS, 2006, INDIAN J MED RES, V123, P629; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5073, DOI 10.1166/jnn.2009.GR10; SHARMA HS, 1995, NEUROSCI RES, V21, P241, DOI 10.1016/0168-0102(94)00855-A; SHARMA HS, 1990, BRAIN RES, V517, P215, DOI 10.1016/0006-8993(90)91029-G; Sharma HS, 2006, J NEURAL TRANSM, V113, P497, DOI 10.1007/s00702-005-0406-1; Sharma HS, 1998, PROG BRAIN RES, V115, P351; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHARMA HS, 1986, NEUROPHARMACOLOGY, V25, P161, DOI 10.1016/0028-3908(86)90037-7; SHARMA HS, 1987, NEUROPHARMACOLOGY, V26, P85, DOI 10.1016/0028-3908(87)90049-9; Sharma HS, 2002, AMINO ACIDS, V23, P261, DOI 10.1007/s00726-001-0137-z; SHARMA HS, 1990, NEUROSCIENCE, V36, P725, DOI 10.1016/0306-4522(90)90014-U; SHARMA HS, 1992, NEUROSCIENCE, V48, P889, DOI 10.1016/0306-4522(92)90277-9; SHARMA HS, 1993, ACTA NEUROPATHOL, V85, P145; SHARMA HS, 1990, ACTA NEUROPATHOL, V79, P604, DOI 10.1007/BF00294237; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P23, DOI 10.1023/B:BIRY.0000016347.35373.39; Teeguarden JG, 2007, TOXICOL SCI, V95, P300, DOI 10.1093/toxsci/kfl165; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Westman, 2004, BLOOD SPINAL CORD BR, P117; Williams David, 2006, Med Device Technol, V17, P8; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Zhang WW, 2003, J COLLOID INTERF SCI, V257, P237, DOI 10.1016/S0021-9797(02)00056-5; Zhu SQ, 2006, MAR ENVIRON RES, V62, pS5, DOI 10.1016/j.marenvres.2006.04.059	64	126	129	2	32	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1533-4880	1533-4899		J NANOSCI NANOTECHNO	J. Nanosci. Nanotechnol.	AUG	2009	9	8					5055	5072		10.1166/jnn.2009.GR09			18	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	470QO	WOS:000267994100071	19928185				2022-02-06	
J	Kumar, R; Husain, M; Gupta, RK; Hasan, KM; Haris, M; Agarwal, AK; Pandey, CM; Narayana, PA				Kumar, Raj; Husain, Mazhar; Gupta, Rakesh K.; Hasan, Khader M.; Haris, Mohammad; Agarwal, Atul K.; Pandey, C. M.; Narayana, Ponnada A.			Serial Changes in the White Matter Diffusion Tensor Imaging Metrics in Moderate Traumatic Brain Injury and Correlation with Neuro-Cognitive Function	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; diffusion tensor imaging; fractional anisotropy; neuropsychological test; traumatic brain injury; white matter	HUMAN CORPUS-CALLOSUM; AXONAL INJURY; HEAD-INJURY; HEPATIC-ENCEPHALOPATHY; FRACTIONAL ANISOTROPY; MRI; CHILDREN; ECHO; ATTENTION; REDUCTION	Diffuse axonal injury (DAI) that follows traumatic brain injury (TBI) is thought to be a major contributor to neurocognitive dysfunction that sometimes follows TBI. Conventional magnetic resonance imaging (MRI), diffusion tensor imaging (DTI) and neuropsychological tests (NPT) were performed on 38 TBI patients [hemorrhagic DAI (H-DAI, n = 8), non-hemorrhagic (Nh-DAI, n = 7), with no apparent DAI on conventional MRI (NA-DAI, n 23)] with a Glasgow Coma Scale score ranging between 9 and 13. The fractional anisotropy (FA) and mean diffusivity (MD) were quantified from different regions of the corpus callosum (CC), and peri-ventricular white matter (PWM) within 5-14 days and 6 months following TBI. Patients in all three groups showed decreased FA in the anterior limb of the internal capsule (ALIC) and the posterior limb of the internal capsule ( PLIC), while the genu of the CC showed a decrease in the H-DAI group during the early period following TBI that persisted 6 months later, which appeared to be consistent with axonopathy. In patients without abnormalities on conventional MRI and DTI in the initial phase, a significant decrease in FA and increase in MD were observed in a few regions of the CC at 6 months, which was suggestive of demyelination/gliosis. The changes in FA and MD in the CC and PWM at 6 months follow-up showed significant correlation with some of the NPT performed in the three groups. DTI demonstrates axonopathy in the acute stage, as well as at secondary stages, at 6 months post-injury in the CC and PWM in regions of normal-appearing white matter on conventional MRI.	[Gupta, Rakesh K.] Sanjay Gandhi Postgrad Inst Med Sci, MR Sect, Dept Radiodiag, Lucknow 226014, Uttar Pradesh, India; [Kumar, Raj; Husain, Mazhar] Chhatrapati Shahuji Maharaj Med Univ, Dept Neurosurg, Lucknow, Uttar Pradesh, India; [Agarwal, Atul K.] Chhatrapati Shahuji Maharaj Med Univ, Dept Neurol, Lucknow, Uttar Pradesh, India; [Pandey, C. M.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Biostat, Lucknow, Uttar Pradesh, India; [Hasan, Khader M.; Narayana, Ponnada A.] Univ Texas Houston, Sch Med, Dept Diagnost & Intervent Imaging, Houston, TX USA		Gupta, RK (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, MR Sect, Dept Radiodiag, Lucknow 226014, Uttar Pradesh, India.	rgupta@sgpgi.ac.in	Hasan, Khader M./ABB-5767-2020		Indian Council of Medical ResearchIndian Council of Medical Research (ICMR) [5/4-5/13/Neuro/2004-NCD-1]; Indian Council of Medical Research, New Delhi, IndiaIndian Council of Medical Research (ICMR); University Grant Commission, New Delhi, IndiaUniversity Grants Commission, India	This study was supported in part by the Indian Council of Medical Research (grant no. 5/4-5/13/Neuro/2004-NCD-1). Raj Kumar acknowledges the financial assistance from the Indian Council of Medical Research, New Delhi, India. Mohammad Haris acknowledges financial assistance from the University Grant Commission, New Delhi, India.	ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Batchelor PG, 2003, MAGN RESON MED, V49, P1143, DOI 10.1002/mrm.10491; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Conturo TE, 1995, NMR BIOMED, V8, P307, DOI 10.1002/nbm.1940080706; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; DHIMAN RK, 1995, J GASTROEN HEPATOL, V10, P14, DOI 10.1111/j.1440-1746.1995.tb01041.x; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giugni E, 2005, RADIOL MED, V109, P563; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; GREENWOOD R, 2002, J NEUROL NEUROSUR PS, V73, P8; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Hasan KM, 2005, J MAGN RESON IMAGING, V21, P735, DOI 10.1002/jmri.20296; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kinoshita T, 2005, EUR J RADIOL, V56, P5, DOI 10.1016/j.ejrad.2005.04.001; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Marr A., 2004, CENTRAL NERVOUS SYST; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Ramalingaswamy P., 1974, MANUAL INDIAN ADAPTA, P2; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; [No title captured]	61	126	132	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2009	26	4					481	495		10.1089/neu.2008.0461			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	430OV	WOS:000264999300002	19196176				2022-02-06	
J	Wilcock, DM; Lewis, MR; Van Nostrand, WE; Davis, J; Previti, ML; Gharkholonarehe, N; Vitek, MP; Colton, CA				Wilcock, Donna M.; Lewis, Matthew R.; Van Nostrand, William E.; Davis, Judianne; Previti, Mary Lou; Gharkholonarehe, Nastaran; Vitek, Michael P.; Colton, Carol A.			Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2	JOURNAL OF NEUROSCIENCE			English	Article						amyloid; tau; neurodegeneration; neuropeptide Y; cerebral amyloid angiopathy; Alzheimer's disease	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; NEUROPEPTIDE-Y; BETA-PROTEIN; NEUROFIBRILLARY DEGENERATION; MEMORY DEFICITS; PERITONEAL-MACROPHAGES; OXIDATIVE STRESS; CELL-SURVIVAL; EARLY-ONSET	Alzheimer's disease (AD) is characterized by three primary pathologies in the brain: amyloid plaques, neurofibrillary tangles, and neuron loss. Mouse models have been useful for studying components of AD but are limited in their ability to fully recapitulate all pathologies. We crossed the APPSwDI transgenic mouse, which develops amyloid beta(A beta)-protein deposits only, with a nitric oxide synthase 2 (NOS2) knock-out mouse, which develops no AD-like pathology. APPSwDI/NOS2(-/-) mice displayed impaired spatial memory compared with the APPSwDI mice, yet they have unaltered levels of A beta. APPSwDI mice do not show tau pathology, whereas APPSwDI/NOS2(-/-) mice displayed extensive tau pathology associated with regions of dense microvascular amyloid deposition. Also, APPSwDI mice do not have any neuron loss, whereas the APPSwDI/NOS2(-/-) mice have significant neuron loss in the hippocampus and subiculum. Neuropeptide Y neurons have been shown to be particularly vulnerable in AD. These neurons appear to be particularly vulnerable in the APPSwDI/NOS2(-/-) mice as we observe a dramatic reduction in the number of NPY neurons in the hippocampus and subiculum. These data show that removal of NOS2 from an APP transgenic mouse results in development of a much greater spectrum of AD-like pathology and behavioral impairments.	[Wilcock, Donna M.; Lewis, Matthew R.; Gharkholonarehe, Nastaran; Vitek, Michael P.; Colton, Carol A.] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA; [Van Nostrand, William E.; Davis, Judianne; Previti, Mary Lou] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA		Colton, CA (corresponding author), Duke Univ, Med Ctr, Div Neurol, Bryan Res Bldg,Box 2900,Res Dr, Durham, NC 27710 USA.	glia01@aol.com	Wilcock, Donna M/J-7517-2016	Colton, Carol/0000-0003-3305-370X; Vitek, Michael/0000-0001-8140-8048	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG019780, F32AG030942, R01AG019740] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F32 AG030942, F32 AG030942-01, R01 AG019740, R01 AG019740-04, R01 AG019780, AG030942, RF1 AG057895, AG19780, R01 AG019780-05, AG19740] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS055118, R01 NS055118-01A1, NS55118] Funding Source: Medline		Akassoglou K, 2005, MOL PHARMACOL, V68, P952, DOI 10.1124/mol.105.017277; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Brune B, 2005, ANTIOXID REDOX SIGN, V7, P497, DOI 10.1089/ars.2005.7.497; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Ciani E, 2002, J NEUROCHEM, V82, P1282, DOI 10.1046/j.1471-4159.2002.01080.x; Colton C, 1996, MOL CHEM NEUROPATHOL, V28, P15, DOI 10.1007/BF02815200; Colton CA, 2006, P NATL ACAD SCI USA, V103, P12867, DOI 10.1073/pnas.0601075103; Culmsee C, 2005, MOL PHARMACOL, V68, P1006, DOI 10.1124/mol.105.013086; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Dawson VL, 1998, PROG BRAIN RES, V118, P215; Diez M, 2003, NEUROBIOL DIS, V14, P579, DOI 10.1016/j.nbd.2003.08.003; Diez M, 2000, NEUROSCIENCE, V100, P259, DOI 10.1016/S0306-4522(00)00261-X; DUMONT Y, 1992, PROG NEUROBIOL, V38, P125, DOI 10.1016/0301-0082(92)90038-G; Duport S, 2005, NEUROSCIENCE, V135, P1155, DOI 10.1016/j.neuroscience.2005.06.035; EDVINSSON L, 1987, J CEREBR BLOOD F MET, V7, P45, DOI 10.1038/jcbfm.1987.7; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; FLOOD JF, 1987, BRAIN RES, V421, P280, DOI 10.1016/0006-8993(87)91297-2; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Goedert M, 2005, MOVEMENT DISORD, V20, pS45, DOI 10.1002/mds.20539; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hewett SJ, 2005, FREE RADICAL BIO MED, V39, P1478, DOI 10.1016/j.freeradbiomed.2005.07.007; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1998, EXP GERONTOL, V33, P883, DOI 10.1016/S0531-5565(98)00045-X; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang Y, 2006, CELL BIOCHEM BIOPHYS, V46, P35, DOI 10.1385/CBB:46:1:35; Iqbal K, 1997, MOL PSYCHIATR, V2, P178, DOI 10.1038/sj.mp.4000269; IQBAL K, 1994, MOL NEUROBIOL, V9, P119, DOI 10.1007/BF02816111; KOBARI M, 1993, BRAIN RES BULL, V31, P443, DOI 10.1016/0361-9230(93)90107-M; KOHLER C, 1986, J COMP NEUROL, V244, P384, DOI 10.1002/cne.902440310; KOWALL NW, 1988, ANN NEUROL, V23, P105, DOI 10.1002/ana.410230202; Kroncke KD, 2000, ANTIOXID REDOX SIGN, V2, P585, DOI 10.1089/15230860050192341; Kroncke KD, 2001, INT IMMUNOPHARMACOL, V1, P1407, DOI 10.1016/S1567-5769(01)00087-X; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; LeBlanc AC, 2003, PROG NEURO-PSYCHOPH, V27, P215, DOI 10.1016/S0278-5846(03)00017-4; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; MARTIGNONI E, 1992, J NEURAL TRANSM-PARK, V4, P191, DOI 10.1007/BF02260903; Miao J, 2005, AM J PATHOL, V167, P505, DOI 10.1016/S0002-9440(10)62993-8; Minthon L, 1990, J Neural Transm Suppl, V30, P57; MORRISSETTE DA, 2007, SOC NEUR ABSTR, V33, P888; Nagy Z, 1998, ALZ DIS ASSOC DIS, V12, P182, DOI 10.1097/00002093-199809000-00010; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oshima K, 2006, ACTA NEUROPATHOL, V111, P510, DOI 10.1007/s00401-006-0070-z; Pannu R, 2006, NEUROCHEM INT, V49, P170, DOI 10.1016/j.neuint.2006.04.010; Redrobe JP, 2004, J MOL NEUROSCI, V22, P159, DOI 10.1385/JMN:22:3:159; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schwab C, 2004, EXP NEUROL, V188, P52, DOI 10.1016/j.expneurol.2004.03.016; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Su JH, 2001, BRAIN RES, V898, P350, DOI 10.1016/S0006-8993(01)02018-2; SUZUKI Y, 1989, J CEREBR BLOOD F MET, V9, P268, DOI 10.1038/jcbfm.1989.44; Tang XQ, 2006, LIFE SCI, V79, P870, DOI 10.1016/j.lfs.2006.03.010; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Vitek MP, 2006, ANTIOXID REDOX SIGN, V8, P893, DOI 10.1089/ars.2006.8.893; WEINBERG JB, 1995, BLOOD, V86, P1184; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wink DA, 2001, ANTIOXID REDOX SIGN, V3, P203, DOI 10.1089/152308601300185179; Xu F, 2007, NEUROSCIENCE, V146, P98, DOI 10.1016/j.neuroscience.2007.01.043	67	126	127	0	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	FEB 13	2008	28	7					1537	1545		10.1523/JNEUROSCI.5066-07.2008			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	262LM	WOS:000253150000002	18272675	Green Published, Bronze, Green Accepted			2022-02-06	
J	Jin, W; Wang, HD; Yan, W; Xu, LZ; Wang, XL; Zhao, XN; Yang, XH; Chen, G; Ji, Y				Jin, Wei; Wang, Handong; Yan, Wei; Xu, Lizhi; Wang, Xiaoliang; Zhao, Xiaoning; Yang, Xiaohe; Chen, Gang; Ji, Yan			Disruption of Nrf2 Enhances Upregulation of Nuclear Factor-kappa B Activity, Proinflammatory Cytokines, and Intercellular Adhesion Molecule-1 in the Brain after Traumatic Brain Injury	MEDIATORS OF INFLAMMATION			English	Article							TRANSCRIPTION FACTOR; NRF2-DEFICIENT MICE; INFLAMMATION; SUSCEPTIBILITY; PATHWAY; EXPRESSION; INDUCTION; OXIDANTS; GENES; MODEL	Inflammatory response plays an important role in the pathogenesis of secondary brain injury after traumatic brain injury (TBI). Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor that plays a crucial role in cytoprotection against inflammation. The present study investigated the role of Nrf2 in the cerebral upregulation of NF-kappa B activity, proinflammatory cytokine, and ICAM-1 after TBI. Wild-type Nrf2 (+/+) and Nrf2 (-/-)-deficient mice were subjected to a moderately severe weight-drop impact head injury. Electrophoretic mobility shift assays (EMSAs) were performed to analyze the activation of nuclear factor kappa B (NF-kappa B). Enzyme-linked immunosorbent assays were performed to quantify the production of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6). Immunohistochemistry staining experiments were performed to detect the expression of intercellular adhesion molecule-1 (ICAM-1). Nrf2 (-/-) mice were shown to have more NF-kappa B activation, inflammatory cytokines TNF-alpha, IL-1 beta and IL-6 production, and ICAM-1 expression in brain after TBI compared with their wild-type Nrf2 (+/+) counterparts. The results suggest that Nrf2 plays an important protective role in limiting the cerebral upregulation of NF-kappa B activity, proinflammatory cytokine, and ICAM-1 after TBI. Copyright (c) 2008 Wei Jin et al.	[Jin, Wei; Wang, Handong; Wang, Xiaoliang; Chen, Gang] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China; [Yan, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China; [Xu, Lizhi; Zhao, Xiaoning; Yang, Xiaohe] Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210093, Jiangsu Prov, Peoples R China; [Ji, Yan] Nanjing Univ, Sch Med, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing 210008, Jiangsu Prov, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China.	hdwang_jw@yahoo.com.cn	wang, xl/Y-8251-2019	Yan, Wei/0000-0002-1123-0835	Jinling Hospital of China	This work was supported by grants from Jinling Hospital of China. The authors would like to thank Dr. Bo Wu and Dr. Geng-bao Feng for technical assistance.	Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; CARLOS TM, 1994, BLOOD, V84, P2068; Chen F, 1999, CLIN CHEM, V45, P7; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	30	126	131	0	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2008	2008								725174	10.1155/2008/725174			7	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	408YT	WOS:000263473400001	19190763	Green Published, gold, Green Submitted			2022-02-06	
J	Wen, L; Yang, XF; Liu, WG; Shen, G; Zheng, XS; Cao, F; Li, G				Wen Liang; Yang Xiaofeng; Liu Weiguo; Shen Gang; Zheng Xuesheng; Cao Fei; Li Gu			Cranioplasty of large cranial defect at an early stage after decompressive craniectomy performed for severe head trauma	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						cranioplasty; decompressive craniectomy; traumatic brain injury						jediwen@163.com						0	126	137	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAY	2007	18	3					526	532		10.1097/scs.0b013e3180534348			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	175BF	WOS:000246986300011	17538313				2022-02-06	
J	Popovic, V; Pekic, S; Pavlovic, D; Maric, N; Jasovic-Gasic, M; Djurovic, B; Medic-Stojanoska, M; Zivkovic, V; Stojanovic, M; Doknic, M; Milic, N; Djurovic, M; Dieguez, C; Casanueva, FF				Popovic, V; Pekic, S; Pavlovic, D; Maric, N; Jasovic-Gasic, M; Djurovic, B; Medic-Stojanoska, M; Zivkovic, V; Stojanovic, M; Doknic, M; Milic, N; Djurovic, M; Dieguez, C; Casanueva, FF			Hypopituitarism as a consequence of traumatic brain injury (TBI) and its possible relation with cognitive disabilities and mental distress	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						traumatic brain injury; hypopituitarism; GH deficiency; neuropsychological tests; psychiatric tests	GROWTH-HORMONE DEFICIENCY; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; GH DEFICIENCY; PREVALENCE; DIAGNOSIS; ARGININE; CHILDREN	Recent studies have demonstrated that hypopituitarism, in particular GH deficiency, is common among survivors of traumatic brain injury (TBI) tested several months or yr following head trauma. We present the results of endocrine, neurological, neuropsychological and psychiatric evaluation in a group of 67 patients who suffered TBI at least one yr ago. Our study shows that decreased endocrine function is either restricted to one or more anterior pituitary hormones and is present in 34% of patients with any pituitary hormone deficit, while multiple pituitary hormone deficiencies are found in 10% of patients. GH/IGF-I axis was evaluated by GHRH+GHRP-6 test and IGF-I measurement. Severe GHD is the most frequent deficiency present in 15% of TBI patients. Gonadotrophin deficiency was present in 9% of patients with TBI, while thyrotroph and corticotroph function seemed more refractory to impairment. Patients with moderate-to-severe trauma are not necessarily more likely to have hypopituitarism than those with mild injury. Neuropsychological testing revealed a significant positive correlation of peak GH levels after GHRH+GHJRP-6 test with verbal learning and verbal short term memory (RAVLT total score p=0.06, immediate free recall p=0.02 and delayed free recall p=0.04). Verbal and visual memory was significantly lower in elderly patients and in males. Visoconstructional abilities (RCF copy) were significantly lower in the elderly (p<0.01) and undereducated (p=0.02). Visual memory (free recall of complex figure after 30 min) significantly correlated with lower IGF-I levels (p=0.01). Gonadotrophins and testosterone correlated significantly with visoconstructional abilities. Simple and complex conceptual tracking (TMT A and B) was significantly more impaired in older TBI patients (p<0.01) and with longer time from trauma (TMT B only, p=0.03). The psychiatric evaluation by using two different scales showed depression, phobic anxiety and psychoticism to be more prominent in the TBI group. Paranoid ideation and somatization negatively correlated with the peak GH responses to GHRH+GHRP-6 test (p=0.04 and p=0.03, respectively). Depression scale showed that nearly half of patients suffered from mild to moderate depression. The benefits of hormone replacement therapy on cognitive functioning and mental distress in TBI patients are eagerly awaited. (C) 2004, Editrice Kurtis.	Univ Belgrade, Ctr Clin, Inst Endocrinol, YU-11000 Belgrade, Serbia Monteneg, Serbia; Univ Novi Sad, Inst Endocrinol, YU-21000 Novi Sad, Serbia Monteneg, Serbia; Univ Santiago de Compostela, Complejo Hosp, Dept Physiol, Santiago De Compostela, Spain; Univ Santiago de Compostela, Complejo Hosp, Endocrine Sect, Santiago De Compostela, Spain		Popovic, V (corresponding author), Univ Belgrade, Ctr Clin, Inst Endocrinol, Dr Subot 13, YU-11000 Belgrade, Serbia Monteneg, Serbia.	popver@Eunet.Yu	Pavlovic, Dragan/AAB-6998-2022; Maric, Nadja/AAP-2722-2020; Pekic, Sandra/S-7175-2016	Maric, Nadja/0000-0002-7051-853X; 			Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Barnett A, 2002, NEUROPEDIATRICS, V33, P242, DOI 10.1055/s-2002-36737; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bulow B, 2002, CLIN ENDOCRINOL, V56, P183, DOI 10.1046/j.0300-0664.2001.01461.x; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Burman P, 1996, CLIN ENDOCRINOL, V44, P319, DOI 10.1046/j.1365-2265.1996.617439.x; Christiansen JS, 2001, J CLIN ENDOCR METAB, V86, P1868; DANIEL PM, 1959, LANCET, V2, P927; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Deijen JB, 1998, PSYCHONEUROENDOCRINO, V23, P45, DOI 10.1016/S0306-4530(97)00092-9; EDWARDS OM, 1986, MEDICINE, V65, P281; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ghigo E, 2001, ENDOCRINE, V15, P29, DOI 10.1385/ENDO:15:1:029; Kadri Munaf, 2003, J Perinatol, V23, P181, DOI 10.1038/sj.jp.7210913; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kovacs K, 2003, LANCET, V361, P520, DOI 10.1016/S0140-6736(03)12490-7; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Nakajima W, 2000, J NEUROSCI, V20, P7994; Popovic V, 2003, CLIN ENDOCRINOL, V59, P251, DOI 10.1046/j.1365-2265.2003.01835.x; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; Shalet SM, 1998, ENDOCR REV, V19, P203, DOI 10.1210/er.19.2.203; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9	26	126	127	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0391-4097	1720-8386		J ENDOCRINOL INVEST	J. Endocrinol. Invest.	DEC	2004	27	11					1048	1054		10.1007/BF03345308			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	898LR	WOS:000227078800010	15754737				2022-02-06	
J	Spataro, LE; Sloane, EM; Milligan, ED; Wieseler-Frank, J; Schoeniger, D; Jekich, BM; Barrientos, RM; Maier, SF; Watkins, LR				Spataro, LE; Sloane, EM; Milligan, ED; Wieseler-Frank, J; Schoeniger, D; Jekich, BM; Barrientos, RM; Maier, SF; Watkins, LR			Spinal gap junctions: Potential involvement in pain facilitation	JOURNAL OF PAIN			English	Article						carbenoxolone; astrocytes; spinal cord; mechanical allodynia; thermal hyperalgesia	CENTRAL-NERVOUS-SYSTEM; HIV-1 ENVELOPE GLYCOPROTEIN; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; GLYCYRRHETINIC ACID; RAT-BRAIN; PROINFLAMMATORY CYTOKINES; PERIPHERAL MONONEUROPATHY; GLIAL INTERACTIONS; NEUROPATHIC PAIN; ASTROCYTES	Glia are now recognized as important contributors in pathological pain creation and maintenance. Spinal cord glia exhibit extensive gap junctional connectivity, raising the possibility that glia are involved in the contralateral spread of excitation resulting in mirror image pain. In the present experiments, the gap junction decoupler carbenoxolone was administered intrathecally after induction of neuropathic pain in response to sciatic nerve inflammation (sciatic inflammatory neuropathy) or partial nerve injury (chronic constriction injury). In both neuropathic pain models, a low dose of carbenoxolone reversed mirror image mechanical allodynia, while leaving ipsilateral mechanical allodynia unaffected. Ipsilateral thermal hyperalgesia was briefly attenuated. Critically, blockade of mechanical allodynia and thermal hyperalgesia was not observed in response to intrathecal glycyrrhizic acid, a compound similar to carbenoxolone in all respects but it does not decouple gap junctions. Thus, blockade of mechanical allodynia and thermal hyperalgesia by carbenoxolone does appear to reflect an effect on gap junctions. Examination of carbenoxolone's effects on intrathecal human immunodeficiency virus type 1 gp120 showed that blockade of pain facilitation might result, at least in part, via suppression of interleukin-1 and, in turn, interleukin-6. These data provide the first suggestion that spread of excitation via gap junctions might contribute importantly to inflammatory and traumatic neuropathic pain. Perspective: The current studies provide evidence for involvement of gap junctions in spinal cord pain facilitation. Intrathecal carbenoxolone, a gap junction decoupler, reversed neuropathy-induced mirror image pain and intrathecal gp120-induced allodynia. in addition, it decreased gp120-induced proinflammatory cytokines. This suggests gap junction activation might lead to proinflammatory cytokine release by distantly activated glia. (C) 2004 by the American Pain Society.	Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA		Watkins, LR (corresponding author), Univ Colorado, Dept Psychol, Muenzinger Psychol Bldg,Room D-244,Campus Box 345, Boulder, CO 80309 USA.	lwatkins@psych.colorado.edu	Barrientos, Ruth/P-4734-2019; Barrientos, Ruth/E-3244-2013	Barrientos, Ruth/0000-0001-7224-4109; Barrientos, Ruth/0000-0001-7224-4109	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [F32AI051093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K02DA015642] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [AI51093] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA015642] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH01558] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39020, NS340696] Funding Source: Medline		Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Baranauskas G, 1998, PROG NEUROBIOL, V54, P349, DOI 10.1016/S0301-0082(97)00067-1; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Blomstrand F, 1999, NEUROSCIENCE, V92, P255, DOI 10.1016/S0306-4522(98)00738-6; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; Chacur M, 2001, PAIN, V94, P231, DOI 10.1016/S0304-3959(01)00354-2; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; DAVIDSON JS, 1986, BIOCHEM BIOPH RES CO, V134, P29, DOI 10.1016/0006-291X(86)90522-X; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; DeLeo JA, 1999, CYTOKINES PAIN, P159; Dermietzel R, 1998, CELL BIOL INT, V22, P719, DOI 10.1006/cbir.1999.0393; Duax WL, 2000, VITAM HORM, V58, P121, DOI 10.1016/S0083-6729(00)58023-6; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Fu KY, 1999, BRAIN RES, V825, P59, DOI 10.1016/S0006-8993(99)01186-5; GARRISON CJ, 1994, EXP NEUROL, V129, P237, DOI 10.1006/exnr.1994.1165; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; HAJOS F, 1989, EXP BRAIN RES, V78, P164; Hansen MK, 2000, AUTON NEUROSCI-BASIC, V85, P119, DOI 10.1016/S1566-0702(00)00230-7; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HARVEY LO, 1986, BEHAV RES METH INSTR, V18, P623, DOI 10.3758/BF03201438; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; JELLINCK PH, 1993, J STEROID BIOCHEM, V46, P209, DOI 10.1016/0960-0760(93)90296-9; Laughlin TM, 2000, PAIN, V84, P159, DOI 10.1016/S0304-3959(99)00195-5; Li WEI, 2000, NEUROSCIENCE, V97, P113, DOI 10.1016/S0306-4522(00)00032-4; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Milligan ED, 1999, J NEUROSCI METH, V90, P81, DOI 10.1016/S0165-0270(99)00075-8; Milligan ED, 2000, BRAIN RES, V861, P105, DOI 10.1016/S0006-8993(00)02050-3; MILLIGAN ED, 2002, PAIN RES METHODS PRO, P67; MOISAN MP, 1990, ENDOCRINOLOGY, V127, P1450, DOI 10.1210/endo-127-3-1450; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; Naus CCG, 1998, CELL BIOL INT, V22, P751, DOI 10.1006/cbir.1998.0391; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; O'Connor KA, 2004, BRAIN BEHAV IMMUN, V18, P274, DOI 10.1016/j.bbi.2003.09.009; Ochalski PAY, 1997, NEUROSCIENCE, V76, P931; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasti L, 1997, J NEUROSCI, V17, P7817; Paulson PE, 2000, PAIN, V84, P233, DOI 10.1016/S0304-3959(99)00216-X; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; ROHLMANN A, 1994, NEUROREPORT, V5, P409, DOI 10.1097/00001756-199401120-00009; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Rozental R, 2001, METH MOL B, V154, P447; SCHOENIGER D, 2004, SPINAL INTERLEUKIN 6, P1; Schweitzer JS, 2000, J NEUROPHYSIOL, V84, P927, DOI 10.1152/jn.2000.84.2.927; STEWART PM, 1993, STEROIDS, V58, P614, DOI 10.1016/0039-128X(93)90104-U; Sweitzer S, 2001, NEUROSCIENCE, V103, P529, DOI 10.1016/S0306-4522(00)00574-1; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; vanHaarst AD, 1996, J NEUROENDOCRINOL, V8, P595, DOI 10.1046/j.1365-2826.1996.04944.x; Verkhratsky A, 1998, PHYSIOL REV, V78, P99, DOI 10.1152/physrev.1998.78.1.99; Vesce S, 1999, CELL MOL LIFE SCI, V56, P991, DOI 10.1007/s000180050488; Volknandt W, 2002, NEUROCHEM INT, V41, P301, DOI 10.1016/S0197-0186(02)00045-1; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; WATKINS LR, 2003, IN PRESS ADV PAIN RE; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	64	126	136	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	SEP	2004	5	7					392	405		10.1016/j.jpain.2004.06.006			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	865BX	WOS:000224678600005	15501197				2022-02-06	
J	Zhang, L; Plotkin, RC; Wang, G; Sandel, ME; Lee, S				Zhang, L; Plotkin, RC; Wang, G; Sandel, ME; Lee, S			Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						acetylcholine; brain injuries; cognition disorders; rehabilitation	ALZHEIMERS-DISEASE; DOUBLE-BLIND; ACETYLCHOLINE; SYSTEMS	Objective: To examine effects of donepezil on short-term memory and sustained attention in postacute patients with traumatic brain injury (TBI). Design: A 24-week, randomized, placebo-controlled, double-blind crossover trial. Setting: Outpatient clinics in 2 teaching hospitals. Participants: Eighteen postacute TBI patients with cognitive impairment. Intervention: Patients were randomly assigned to group A or group B. Patients in group A received donepezil for the first 10 weeks and then a placebo for another 10 weeks. The 2 treatment phases were separated by a washout period of 4 weeks. Patients in group B received the preparations in the opposite order. Main Outcome Measures: Short-term memory and sustained attention were assessed by 2 indexes (Auditory Immediate Index [All], Visual Immediate Index [VII]) of the Wechsler Memory Scale-III and the Paced Auditory Serial Addition Test (PASAT), at baseline, week 10, and week 24 of the trial. Results: Intragroup comparison of different phases of the trial in both groups showed that donepezil significantly increased the testing scores of the All and VII, as well as PASAT scores, compared with baseline. There was no significant change in the testing scores between assessment at baseline and the end of the placebo phase in group B. Intergroup comparison at the 10-week assessment showed significantly improved testing scores in group A with donepezil over group B with the placebo. The improved testing scores with donepezil in group A were sustained after the washout period and placebo phase, suggesting a carry-over effect of the medication. Conclusions: Donepezil increased neuropsychologic testing scores in short-term memory and sustained attention in post-acute TBI patients. Cholinergic augmentation may be a viable approach to restore memory and attention after TBI. (C) 2004 by the American Congress of Rehabilitation Medici. ne and the American Academy of Physical Medicine and Rehabilitation.	Univ Texas, Hlth Sci Ctr, Dept Rehabil Med, San Antonio, TX 78285 USA; Dept Vet Affairs Med Ctr, San Antonio, TX USA; Univ Penn, Ctr Med, Philadelphia, PA 19104 USA; SUNY Syracuse, Upstate Med Univ, Syracuse, NY 13210 USA; Kaiser Fdn Rehabil Ctr, Vallejo, CA USA		Zhang, L (corresponding author), San Antonio Brain & Spine Consultants, 19114 La Verita, San Antonio, TX 78258 USA.	neurorehab@yahoo.com					Brown H., 1999, APPL MIXED MODELS ME; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Cohen J, 1977, STAT POWER ANAL BEHA; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Kato K, 1999, NEUROSCI LETT, V260, P5, DOI 10.1016/S0304-3940(98)00943-4; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; Lawrence AD, 1998, NEUROCHEM RES, V23, P787, DOI 10.1023/A:1022419712453; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LEVIN HS, 1988, SCAND J REHABIL MED, P33; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; MYSIW WJ, 1997, PHYS MED REH CLIN N, V89, P781; *PSYCH CORP, 1997, WMS 3 ADM SCOR MAN; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Spreen O, 1991, COMPENDIUM NEUROPSYC; SQUIRE LR, 1988, TRENDS NEUROSCI, V11, P170, DOI 10.1016/0166-2236(88)90144-0; Staff RT, 2000, NUCL MED COMMUN, V21, P37, DOI 10.1097/00006231-200001000-00007; Taverni JP, 1998, BRAIN INJURY, V12, P77; TEASDALE G, 1974, LANCET, V2, P81; Tulsky DS, 2000, PSYCHOL ASSESSMENT, V12, P253, DOI [10.1037/1040-3590.12.3.253, 10.1037//1040-3590.12.3.253]; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003	38	126	129	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2004	85	7					1050	1055		10.1016/j.apmr.2003.10.014			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	835XU	WOS:000222519600002	15241749				2022-02-06	
J	Hamm, RJ				Hamm, RJ			Neurobehavioral assessment of outcome following traumatic brain injury in rats: An evaluation of selected measures	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cognitive function; reflex suppression; sensitivity measure; vestibulomotor function	WATER MAZE PERFORMANCE; METHYLPHENIDATE TREATMENT; AMANTADINE	Neurobehavioral assessment of outcome has played an integral part in traumatic brain injury (TBI) research. Given the fundamental role of neurobehavioral measurement, it is critical that the tasks used are of the highest psychometric quality. The purpose of this paper is to evaluate several, commonly used neurobehavioral measures along the dimensions of reliability, sensitivity, and validity. Using both the midline and lateral fluid-percussion injury models, nine neurobehavioral measures were evaluated that assessed three different neurobehavioral constructs. Reflex suppression was measured by the duration of the suppression of the pinna, corneal, and righting reflexes. Vestibulomotor function was assessed with the beam-balance, beam-walking, and rotorod tasks. Cognitive function was evaluated by three measures of Morris water maze performance (goal latency, path length, cumulative distance). The evaluation of the reliability of the nine neurobehavioral measures found that all had acceptably high reliability coefficients (0.79 or higher). The analysis of each measure's sensitivity to injury found that all measures were capable of detecting injury-induced impairments. However, there were some substantial differences in the sensitivity of the measures of vestibulomotor and maze performance: the rotorod was the most sensitive vestibulomotor measure and goal latency and path length were equally sensitive measures of maze performance. In the assessment of validity, the results of a factor analysis supported the convergent and discriminative validity of the measures. And in cases in which the preclinical and clinical research have assessed the same construct, the animal model neurobehavioral measures had predictive (or external) validity. Thus, according to the psychometric standards by which measurement instruments are evaluated, the results indicated that these measures provide a valid assessment of neurobehavioral function after fluid percussion TBI.	Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Hamm, RJ (corresponding author), Virginia Commonwealth Univ, Dept Psychol, POB 842018, Richmond, VA 23284 USA.	rhamm@vcu.edu					*AM PSYCH ASS, 1985, STAND ED PSYCH TEST; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1997, J NEUROTRAUM, V14, P159; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; LEVIN HS, 1991, J NEUROL SCI, V103, pS39; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mueller C., 1978, INTRO FACTOR ANAL; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Schneider WN, 1999, BRAIN INJURY, V13, P863; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259	15	126	129	3	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2001	18	11					1207	1216		10.1089/089771501317095241			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	491KC	WOS:000172106700002	11721739				2022-02-06	
J	Bloom, DR; Levin, HS; Ewing-Cobbs, L; Saunders, AE; Song, J; Fletcher, JM; Kowatch, RA				Bloom, DR; Levin, HS; Ewing-Cobbs, L; Saunders, AE; Song, J; Fletcher, JM; Kowatch, RA			Lifetime and novel psychiatric disorders after pediatric traumatic brain injury	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						traumatic brain injury; pediatric; attention-deficit/hyperactivity disorder; psychiatric disorders	DEPRESSIVE SYMPTOMATOLOGY IDS; CLOSED-HEAD-INJURY; DIAGNOSTIC INTERVIEW; CHILDREN; ADOLESCENTS; INVENTORY; PARENT	Objective: To assess lifetime and current psychiatric disorders at least 1 year after traumatic brain injury (TBI) in children and adolescents. Method: Forty-six youths who sustained a TBI between the ages of 6 through 15 years were evaluated at least 1 year post-TBI to identify the presence of lifetime and/or novel psychiatric disorders. Semistructured interviews of the parent and child and standardized parent self report rating instruments were used. Results: Attention-deficit/hyperactivity disorder and depressive disorders were the most common lifetime and novel diagnoses. A wide variety and high rate of never psychiatric disorders were identified; 74% of these disorders persisted in 48% of the injured children. Internalizing disorders were more likely to resolve than externalizing disorders; Both interviews and parent ratings were Sensitive to current externalizing behaviors; interviews more often detected internalizing disorders, whereas parent ratings also identified cognitive difficulties. Conclusions: Findings were generally consistent with previous research demonstrating the high rate of novel psychiatric disorders following pediatric TBI. Psychiatric interviews were Sensitive in identifying both lifetime and novel disorders.	Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77225 USA; Univ Texas, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Houston, TX 77225 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Univ Texas, SW Med Sch, Dept Psychiat & Behav Sci, Dallas, TX 75230 USA		Bloom, DR (corresponding author), Texas Childrens Hosp, 6621 Fannin,MC3-2340, Houston, TX 77030 USA.		Fletcher, Jack/AAX-2931-2020; fletcher, jack/Q-5975-2019		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		Barkley R.A., 1997, ADHD NATURE SELF CON; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Ewing-Cobbs L, 1999, COGNITIVE ASPECTS OF CHRONIC ILLNESS IN CHILDREN, P262; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; HERJANIC B, 1982, J ABNORM CHILD PSYCH, V10, P307, DOI 10.1007/BF00912324; Jennett B, 1981, MANAGEMENT HEAD INJU; KASHANI JH, 1985, J AM ACAD CHILD PSY, V24, P437, DOI 10.1016/S0002-7138(09)60561-6; Kovacs M., 1992, CHILDRENS DEPRESSION; LEHMKUHL G, 1990, BRAIN BEHAV CHILD PS, P267; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; RUSH AJ, 1986, PSYCHOPHARMACOL BULL, V22, P985; Shaffer D, 1975, Ciba Found Symp, P191; SYLVESTER CE, 1987, J AM ACAD CHILD PSY, V26, P668, DOI 10.1097/00004583-198709000-00010; TEASDALE G, 1974, LANCET, V2, P81; Wirt RD, 1990, MULTIDIMENSIONAL DES	29	126	126	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-8567	1527-5418		J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	MAY	2001	40	5					572	579		10.1097/00004583-200105000-00017			8	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	425UE	WOS:000168309400017	11349702				2022-02-06	
J	Biswas, AK; Scott, WA; Sommerauer, JF; Luckett, PM				Biswas, AK; Scott, WA; Sommerauer, JF; Luckett, PM			Heart rate variability after acute traumatic brain injury in children	CRITICAL CARE MEDICINE			English	Article						head trauma; head injury; trauma; children; heart rate variability; outcome; intracranial pressure; cerebral perfusion pressure; pentobarbital; autonomic nervous system; power spectral analysis; low-frequency power; high-frequency power; low-to high-frequency ratio	SPATIAL VELOCITY ELECTROCARDIOGRAM; SPECTRAL-ANALYSIS; SYMPATHOVAGAL INTERACTION; ARTERIAL-PRESSURE; NEURAL REGULATION; AUTONOMIC CONTROL; POWER SPECTRUM; PATTERNS; DEATH; ARRHYTHMIA	Objective: To evaluate heart rate variability (HRV) by power spectral analysis of heart rate and its relationship to intracranial pressure (ICP), cerebral perfusion pressure (CPP), and outcomes in children with acute traumatic head injury. Design: Prospective, case series. Setting: Pediatric intensive care unit in a level II trauma center/children's hospital. Subjects: Fifteen critically ill children with documented acute traumatic brain injury and four control subjects. Interventions: None. Measurements and Main Results: The normalized total power from 0.04 to 0.15 Hz was used to quantify low-frequency HRV and from 0.15 to 0.40 Hz to quantity high-frequency HRV. The ratio of low- to high-frequency (LF/HF) power was used as a measure of sympathetic modulation of heart rate. The power spectral data from the 5-min samples were averaged over each hour of data collection, and an hourly LF/HF ratio was obtained based on a 60-min electrocardiogram collection (twelve 5-min segments). The daily mean LF/HF ratio was calculated from the hourly LF/HF measurements. We found no linear correlation between the LF/HF ratio and either ICP or CPP (p = NS). There was a significant decrease in the LF/HF ratio when the intracranial pressure was >30 mm Hg (p < .001) or the cerebral perfusion pressure was <40 mm Hg (p < .001). Children with a Glasgow Coma Scale score of 3-4 had a lower LF/HF ratio compared with those who had a Glasgow Coma Scale score of 5-8 (p < .005). Patients who progressed to brain death had a markedly lower LF/HF ratio (p < .001), with a significant decrease after the first 4 hrs of hospitalization. Patients with more favorable outcomes had significantly higher LF/HF ratios. Conclusions: Our findings suggest that an ICP of >30 mm Hg or a CPP of <40 mm Hg may be associated with marked autonomic dysfunction and poor outcome. We speculate that HRV power spectral analysis may be a useful adjunct in determining the severity of neurologic insult and the prognosis for recovery in children. The LF/HF ratio may be helpful not only in identifying those patients who will progress to brain death but also in predicting which patients will have favorable outcomes.	Univ Texas, SW Med Ctr, Dept Pediat, Div Pediat Crit Care, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Cardiol, Dallas, TX USA; Childrens Med Ctr, Dallas, TX 75235 USA		Biswas, AK (corresponding author), Univ Texas, SW Med Ctr, Dept Pediat, Div Pediat Crit Care, 5323 Harry Hines Blvd, Dallas, TX USA.						AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; BERGER RD, 1986, IEEE T BIO-MED ENG, V33, P900, DOI 10.1109/TBME.1986.325789; Camm AJ, 1996, CIRCULATION, V93, P1043; CHORAODEAGUIAR AJ, 1979, J ELECTROCARDIOL, V12, P381, DOI 10.1016/S0022-0736(79)80007-2; EWING DJ, 1980, ANN INTERN MED, V92, P308, DOI 10.7326/0003-4819-92-2-308; FRANK JI, 1992, ARCH NEUROL-CHICAGO, V49, P1200, DOI 10.1001/archneur.1992.00530350122028; FURLAN R, 1990, CIRCULATION, V81, P537, DOI 10.1161/01.CIR.81.2.537; GALLETLY DC, 1994, BRIT J ANAESTH, V72, P177, DOI 10.1093/bja/72.2.177; Godin PJ, 1996, CRIT CARE MED, V24, P1117, DOI 10.1097/00003246-199607000-00009; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; GOLDBERGER JJ, 1994, AM J PHYSIOL, V266, pH2152, DOI 10.1152/ajpheart.1994.266.5.H2152; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; GOLDSTEIN B, 1995, CRIT CARE MED, V23, P1694, DOI 10.1097/00003246-199510000-00014; GOLDSTEIN B, 1994, PEDIATR RES, V36, P358, DOI 10.1203/00006450-199409000-00016; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; HALINEN MO, 1978, ACTA PHYSIOL SCAND, V104, P167, DOI 10.1111/j.1748-1716.1978.tb06263.x; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HON EH, 1969, MED RES ENG, V8, P14; JENNETT B, 1975, LANCET, V1, P480; KAWAMOTO M, 1995, ANAESTH INTENS CARE, V23, P464, DOI 10.1177/0310057X9502300409; KERO P, 1978, PEDIATRICS, V62, P307; King ML, 1997, BRAIN INJURY, V11, P445; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; KLUGE KA, 1988, PEDIATR RES, V24, P667, DOI 10.1203/00006450-198812000-00005; LACQUANITI LG, 1993, INT J CLIN MONIT COM, V10, P181, DOI 10.1007/BF01246453; LEIPZIG TJ, 1986, NEUROSURGERY, V19, P356, DOI 10.1227/00006123-198609000-00004; LOMBARDI F, 1987, AM J CARDIOL, V60, P1239, DOI 10.1016/0002-9149(87)90601-1; LOWENSOHN RI, 1977, LANCET, V1, P626; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; PAUL RH, 1975, AM J OBSTET GYNECOL, V123, P206, DOI 10.1016/0002-9378(75)90528-1; PHELAN JP, 1994, AM J OBSTET GYNECOL, V171, P424, DOI 10.1016/0002-9378(94)90278-X; PIA HW, 1986, ACTA NEUROCHIR, V82, P1, DOI 10.1007/BF01456312; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; RANDALL DC, 1991, AM J PHYSIOL, V260, pH985, DOI 10.1152/ajpheart.1991.260.3.H985; REIS DJ, 1994, J HYPERTENS, V12, pS159; RUDOLPH AJ, 1965, PEDIATRICS, V36, P551; SANO T, 1968, JPN HEART J, V9, P64; SANO T, 1967, JPN HEART J, V8, P301; SAUL JP, 1990, AM J PHYSIOL, V258, pH713, DOI 10.1152/ajpheart.1990.258.3.H713; SCHECHTMAN VL, 1988, SLEEP, V11, P413, DOI 10.1093/sleep/11.5.413; TEASDALE G, 1974, LANCET, V2, P81; VALKAMA JO, 1993, INT J CARDIOL, V38, P177, DOI 10.1016/0167-5273(93)90177-I; VALLBONA C, 1965, AM J CARDIOL, V16, P379, DOI 10.1016/0002-9149(65)90729-0; WHEELER T, 1973, BRIT MED J, V4, P584, DOI 10.1136/bmj.4.5892.584; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yang CCH, 1996, AM J PHYSIOL-HEART C, V270, pH575, DOI 10.1152/ajpheart.1996.270.2.H575; ZBILUT JP, 1988, CRIT CARE MED, V16, P64, DOI 10.1097/00003246-198801000-00014	50	126	129	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2000	28	12					3907	3912		10.1097/00003246-200012000-00030			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	388NB	WOS:000166186200021	11153634				2022-02-06	
J	Carroll, D; Joint, C; Maartens, N; Shlugman, D; Stein, J; Aziz, TZ				Carroll, D; Joint, C; Maartens, N; Shlugman, D; Stein, J; Aziz, TZ			Motor cortex stimulation for chronic neuropathic pain: a preliminary study of 10 cases	PAIN			English	Article						motor cortex stimulation; chronic neuropathic pain; pain relief; case reports	CENTRAL POSTSTROKE PAIN; THALAMIC PAIN; ELECTRICAL-STIMULATION; CORTICAL STIMULATION; THERAPY	There is growing evidence to support the use of motor cortex stimulation (MCS) in the management of patients with chronic neuropathic pain. A prospective audit of ten patients using a modified staged technique for motor cortex implantation provides further evidence for the analgesic effectiveness of this technique. Ten patients suffering from phantom limb pain (n = 3), post stroke pain (n = 5), post traumatic neuralgia secondary to gunshot injury to the brain stem (n = 1) and brachyalgia secondary to neuro-fibromatosis (n = 1) were treated between November 1995 and February 1998. All ten patients had failed to respond to previous multiple pain therapies. Patients were evaluated pre and post-operatively by an independent pain specialist. The overall response rate was 50%, with 5/10 patients reporting short term relief (> 50% pain relief) and long-term benefit in 4/5 of patients who initially responded to intermittent cortical stimulation (longest follow up 31 months after implantation). Of those patients who benefited two had post stroke pain, two phantom limb pain and one posttraumatic neuralgia. We conclude that motor cortex stimulation is an effective analgesic intervention in some patients with chronic neuropathic pain, but it is difficult if not impossible to predict those patients who may respond to treatment prior to implantation. Randomised controlled trials are now urgently needed to test the effectiveness of motor cortex stimulation under double-blind conditions. (C) 2000 International Association for the Study of Pain. Published by Elsevier Science B.V.	Radcliffe Infirm NHS Trust, Dept Neurosurg, Oxford OX2 6HE, England; Univ Oxford, Pain Res Unit, Oxford Radcliffe NHS Trust, Oxford OX3 7LJ, England; Radcliffe Infirm NHS Trust, Nuffield Dept Anaesthet, Oxford OX2 6EH, England; Univ Oxford, Dept Physiol, Oxford OX1 2JD, England		Aziz, TZ (corresponding author), Radcliffe Infirm NHS Trust, Dept Neurosurg, Oxford OX2 6HE, England.						ADAMS JE, 1974, J NEUROSURG, V41, P740, DOI 10.3171/jns.1974.41.6.0740; BOWSHER D, 1995, POSTGRAD MED J, V71, P598, DOI 10.1136/pgmj.71.840.598; CANAVERO S, 1995, J NEUROSURG, V83, P1117; CANAVERO S, 1998, 4 IMS C LUC, P36; DARIO A, 1997, REV NEUROBIOL, V43, P625; Ebel H, 1996, ACTA NEUROCHIR, V138, P1300, DOI 10.1007/BF01411059; FIELDS HL, 1974, BRAIN, V97, P169, DOI 10.1093/brain/97.1.169; Fujii M, 1997, NEUROL SURG TOKYO, V25, P315; Garcia-Larrea L, 1997, STEREOT FUNCT NEUROS, V68, P141, DOI 10.1159/000099915; GUYATT G, 1988, CAN MED ASSOC J, V139, P497; Herregodts P, 1995, ADV STER F, V11, P132; Hosobuchi Y, 1993, Adv Neurol, V63, P215; KATAYAMA Y, 1994, STEREOT FUNCT NEUROS, V62, P295, DOI 10.1159/000098635; KATAYAMA Y, 1991, PACE, V14, P116, DOI 10.1111/j.1540-8159.1991.tb04055.x; KELLER JL, 1988, SCAND J GASTROENTERO, V23, P22, DOI 10.3109/00365528809099154; MEYERSON BA, 1993, ACTA NEUROCHIR, P150; MIGITA K, 1995, NEUROSURGERY, V36, P1037, DOI 10.1227/00006123-199505000-00025; Namba S, 1988, Acta Neurochir Suppl (Wien), V42, P243; Nguyen JP, 1997, ADV STER F, V12, P54; Nguyen JP, 1998, MOVEMENT DISORD, V13, P84, DOI 10.1002/mds.870130118; NGUYEN JP, 1998, 4 IMS C LUC, P32; PEYRON R, 1995, PAIN, V62, P275, DOI 10.1016/0304-3959(94)00211-V; Rainov NG, 1997, CLIN NEUROL NEUROSUR, V99, P205, DOI 10.1016/S0303-8467(97)00017-6; Saitoh Y, 1999, LANCET, V353, P212, DOI 10.1016/S0140-6736(05)77223-8; TSUBOKAWA T, 1993, J NEUROSURG, V78, P393, DOI 10.3171/jns.1993.78.3.0393; Tsubokawa T, 1991, Acta Neurochir Suppl (Wien), V52, P137; TSUBOKAWA T, 1991, PACE, V14, P131, DOI 10.1111/j.1540-8159.1991.tb04058.x; TSUBOKAWA T, 1990, 6 WORLD PAIN C AD, pS491; TSUBOKAWA T, 1998, STEREOT FUNCT NEUROS, V156, P1547; Yamamoto T, 1997, PAIN, V72, P5, DOI 10.1016/S0304-3959(97)00028-6	30	126	131	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	FEB	2000	84	2-3					431	437		10.1016/S0304-3959(99)00245-6			7	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	282ZP	WOS:000085251900037	10666551				2022-02-06	
J	van der Naalt, J; Hew, JM; van Zomeren, AH; Sluiter, WJ; Minderhoud, JM				van der Naalt, J; Hew, JM; van Zomeren, AH; Sluiter, WJ; Minderhoud, JM			Computed tomography and magnetic resonance imaging in mild to moderate head injury: Early and late imaging related to outcome	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; COGNITIVE SEQUELAE; SCALE; MRI; CT; DISABILITY; LESIONS; DAMAGE	Serial magnetic resonance imaging (MRI) and computed tomographic (CT) studies were performed in mild to moderate head injury to evaluate whether early and late imaging have additional value in predicting outcome in this category of patients. During 1-year follow-up of a series of 67 patients, a CT scan on admission was performed together with MRI studies within 1 to 3 months and 6 to 12 months after injury. With CT, intracranial lesions were seen in 62% of patients compared with 44% with early and 19% with late MRT, located predominantly in the frontal and temporal regions. More than half of the lesions revealed with CT resulted in focal atrophy on MRI, Outcome was found to be worse in patients with edema and lesions on CT. Likewise, abnormalities detected with MRI were associated with poor outcome scores. In multiple regression analysis, only lesions in the frontal regions detected with early MRI were found to be predictive of outcome. With late MRI, only focal atrophy in the frontotemporal regions was found to be predictive of outcome. The findings in this study suggests that MRI studies may be valuable for predicting long-term outcome in patients with mild to moderate HI.	Univ Groningen Hosp, Dept Neurol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Radiol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Neuropsychol, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Endocrinol, NL-9700 RB Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen Hosp, Dept Neurol, POB 30-001, NL-9700 RB Groningen, Netherlands.			van der Naalt, Joukje/0000-0001-9873-2418			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; EIDE PK, 1992, ACTA NEUROL SCAND, V86, P194, DOI 10.1111/j.1600-0404.1992.tb05065.x; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; GANDY SE, 1984, ANN NEUROL, V16, P254, DOI 10.1002/ana.410160217; GENARELLI TA, 1982, J NEUROSURG, V56, P26; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Marshall LF, 1991, J NEUROSURG S, V75, P14; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WILSON JTL, 1993, J NEUROL NEUROSUR PS, V56, P198	41	126	126	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0364-5134			ANN NEUROL	Ann. Neurol.	JUL	1999	46	1					70	78		10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	212DG	WOS:000081200900010	10401782				2022-02-06	
J	Wade, SL; Taylor, HG; Drotar, D; Stancin, T; Yeates, KO				Wade, SL; Taylor, HG; Drotar, D; Stancin, T; Yeates, KO			Family burden and adaptation during the initial year after traumatic brain injury in children	PEDIATRICS			English	Article						traumatic brain injury; orthopedic injuries; burden; adaptation; family outcomes	PEDIATRIC HEAD-INJURY; ASSESSMENT DEVICE; RELATIVES; SEQUELAE; RELIABILITY; PREDICTORS; VALIDITY	Objective. Traumatic brain injury (TBI) often leads to long-term behavioral and cognitive deficits in children. However, little is known about the burden and psychosocial morbidity of pediatric TBI for families. The purpose of this study was to test the hypothesis that moderate and severe TBI in children has more adverse consequences than orthopedic trauma. Design. The sample was comprised of children between the ages of 6 and 12 recruited from hospital trauma and inpatient units including 53 with severe TBI, 56 with moderate TBI, and 80 with orthopedic injuries not involving central nervous system insult. Measures of injury-related burden, parental distress, and family functioning were administered to the child's primary caregiver at baseline assessment conducted soon after injury and at 6- and 12-month follow-ups. Multivariate repeated measures analysis of covariance was used to examine group differences in these outcomes over time. Results. Caregivers in the severe TBI group reported significantly higher levels of family burden, injury-related stress, and parental psychological symptoms than caregivers in the orthopedic injury group (ORTHO). The groups did not differ with respect to marital distress. Caregivers in the severe TBI group were significantly more likely than caregivers in the ORTHO group to exceed the clinical cutoff on the Brief Symptom Inventory and to report clinically significant levels of family dysfunction at follow-up. Conclusions. The findings suggest that severe TBI is a source of considerable caregiver morbidity, even when compared with other traumatic injuries. Caregivers in the severe TBI group had persistent stress associated with the child's injury, as well as the reactions of other family members, and a relative risk of clinically significant psychological symptoms nearly twice that of the ORTHO comparison group. These findings underscore the need for interventions that facilitate family adaptation after pediatric TBI.	Case Western Reserve Univ, Sch Med, Cleveland, OH USA; Metrohlth Med Ctr, Cleveland, OH USA; Case Western Reserve Univ, Sch Med, Columbus, OH USA; Ohio State Univ, Columbus, OH 43210 USA; Childrens Hosp, Columbus, OH 43205 USA; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA		Wade, SL (corresponding author), Injury Follow Up Program, 11400 Euclid Ave,Suite 290C, Cleveland, OH 44106 USA.		Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892			BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DEROGATIS LR, 1982, ADM PROCEDURES BSI M; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; FOLKMAN S, 1988, SOC SCI MED, V26, P309, DOI 10.1016/0277-9536(88)90395-4; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JENNETT B, 1975, LANCET, V1, P480; KRAUS JF, 1995, TRAUMATIC HEAD INJUR, P70; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOOS RH, 1988, SOC SCI MED, V27, P999, DOI 10.1016/0277-9536(88)90291-2; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; ROLLAND JS, 1987, FAM PROCESS, V26, P203, DOI 10.1111/j.1545-5300.1987.00203.x; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Spanier G. B., 1989, DYADIC ADJUSTMENT SC; Stein R, 1985, PACTS PAPERS AECOM T; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; STEVENSONHINDE J, 1995, FAM PROCESS, V34, P337, DOI 10.1111/j.1545-5300.1995.00337.x; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; WAALAND P, 1991, NEUROPSYCHOL REHABIL, V1, P19; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	37	126	126	0	9	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUL	1998	102	1					110	116		10.1542/peds.102.1.110			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	100CF	WOS:000074795800018	9651422				2022-02-06	
J	Geurts, ACH; Ribbers, GM; Knoop, JA; vanLimbeek, J				Geurts, ACH; Ribbers, GM; Knoop, JA; vanLimbeek, J			Identification of static and dynamic postural instability following traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CLOSED-HEAD-INJURY; BODY SWAY; QUANTIFICATION; PARAMETERS; BALANCE	Objective: Quantitative evaluation of static and dynamic aspects of postural instability as a long-term consequence of traumatic brain injury (TBI). Design: Experimental two-group design. Setting: Outpatient rehabilitation department. Patients and Other Participants: From a consecutive sample of TBI patients at least 6 months after trauma, 20 subjects were selected who complained of reduced gross motor skills but showed no sensorimotor impairments in a standard neurological examination (11 men, 9 women; mean age, 36.2 +/- 10.7 years). Thirteen patients had sustained mild, 2 moderate, and 5 severe TBI. Twenty healthy controls were matched for age and gender. Intervention: None. Main Outcome Measures: A dual-plate force platform recorded the amplitude and velocity of the center-of-pressure fluctuations in the anteroposterior (AP) and lateral (I,AT) sway directions during quiet standing. Also, the speed and fluency of weight shifting using visual feedback was registered. Both balance tasks were combined with an arithmetic task, whereas quiet standing was also tested with visual deprivation. Results: Compared to controls, TBI patients showed an increase of over 50% in AP and LAT sway, and a weight-shifting speed 20% lower. Dual-task interference was never significant. Visual deprivation was most detrimental for the TBI patients, particularly for LAT sway control. Conclusion: A long-term overall reduction in both static and dynamic control of posture can be present after TBI, even in patients without clear neurological deficits. Force-plate recordings can identify such (latent) balance problems. Visual deprivation during quiet standing appears a simple, sensitive test for postural instability related to sensory integration deficits. (C) 1996 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation	SINT MAARTENSKLIN,DEPT CLIN NEUROPSYCHOL,NIJMEGEN,NETHERLANDS; SINT MAARTENSKLIN,DEPT REHABIL MED,NIJMEGEN,NETHERLANDS; SINT MAARTENSKLIN,DEPT RES & DEV,NIJMEGEN,NETHERLANDS				Knoop, Hans/D-3264-2009; Ribbers, Gerard/N-3623-2019; Geurts, Alexander/H-8032-2014; Ribbers, Gerard M/C-1454-2014	Knoop, Hans/0000-0001-7763-3517; Geurts, Alexander/0000-0001-7478-1119; Ribbers, Gerard M/0000-0002-6114-349X			BERGER W, 1988, J NEUROL NEUROSUR PS, V51, P568, DOI 10.1136/jnnp.51.4.568; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bickerstaff ER, 1989, NEUROLOGICAL EXAMINA; BINDER LM, 1989, ASSESSMENT BEHAV CON, P37; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BOHNEN NIL, 1991, THESIS U LIMBURG; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; GEURTS ACH, 1994, J MOTOR BEHAV, V26, P162, DOI 10.1080/00222895.1994.9941670; HUFSCHMIDT A, 1980, ARCH PSYCHIAT NERVEN, V228, P135, DOI 10.1007/BF00365601; INGERSOLL CD, 1993, SPORTS MED, V16, P342, DOI 10.2165/00007256-199316050-00005; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; JACOBS A, 1994, J NUCL MED, V35, P942; Jennett B, 1981, MANAGEMENT HEAD INJU; KLEINBAUM DG, 1988, APPLIED REGRESSION A; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; MAYO NE, 1991, AM J PHYS MED REHAB, V70, P118, DOI 10.1097/00002060-199106000-00002; MIZRAHI J, 1989, MED BIOL ENG COMPUT, V27, P181, DOI 10.1007/BF02446228; Newton R, 1989, Brain Inj, V3, P335, DOI 10.3109/02699058909004558; PAULUS W, 1989, EXP BRAIN RES, V78, P243; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; SHIMBA T, 1984, J BIOMECH, V17, P53, DOI 10.1016/0021-9290(84)90080-0; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; STELMACH GE, 1990, DISORDERS POSTURE GA, P253; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE N, 1992, TUTORIALS MOTOR BEHA, V2, P917; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151	27	126	130	0	21	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	1996	77	7					639	644		10.1016/S0003-9993(96)90001-5			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	UY347	WOS:A1996UY34700002	8669988				2022-02-06	
J	SHAPIRA, Y; SETTON, D; ARTRU, AA; SHOHAMI, E				SHAPIRA, Y; SETTON, D; ARTRU, AA; SHOHAMI, E			BLOOD-BRAIN-BARRIER PERMEABILITY, CEREBRAL EDEMA, AND NEUROLOGIC FUNCTION AFTER CLOSED-HEAD INJURY IN RATS	ANESTHESIA AND ANALGESIA			English	Article							QUANTITATIVE-EVALUATION; VASCULAR-PERMEABILITY; ISCHEMIA; PROTEINS; DAMAGE	We previously described the time course of changes in neurologic status (as indicated by neurologic severity score [NSS]) and cerebral edema (as indicated by brain tissue specific gravity and water content) after closed head trauma in rats. The present study was designed to determine whether head trauma alters the integrity of the blood-brain barrier (BBB), the role of the BBB in edema formation and neurologic outcome, and the effect of MK-801 (a noncompetitive N-methyl-D-aspartate receptor antagonist) on BBB permeability. Rats in which cranial impact was delivered during ether anesthesia (n = 106) were killed at 15 min, 1, 2, 4, 10, and 24 h, and 2, 4, and 7 days. Control rats (n = 12) received no cranial impact. Subsets of head-injured rats killed at 4 and 24 h received MK-801 (3 mg/kg intraperitoneally) 1 h after injury. BBB permeability was assessed with intravenous injection of Evans Blue dye, cerebral edema was assessed by determining brain tissue specific gravity and water content, and neurologic status was assessed using NSS. Tissue extravasation of Evans Blue was maximal in the injured hemisphere 4 h after injury, but a residual BBB permeability defect was still evident as long as 4 days after the insult. In MK-801-treated rats, extravasation of Evans Blue in the injured hemisphere was not significantly different from that in the noninjured hemisphere. The time course of alteration of BBB permeability differed from that of cerebral edema (which was maximal at 24 h and then gradually resolved by 4-7 days) and from NSS (which was maximal at 1 h after injury, then decreased toward preinjury values at 10 h postinjury and thereafter). Our results indicate that this model of closed head trauma causes increased BBB permeability to Evans Blue and that the changes in BBB are not directly, temporally related to cerebral edema or NSS. Treatment with MK-801 did not prevent increased BBB permeability at 4 and 24 h after injury.	UNIV WASHINGTON,SCH MED,DEPT ANESTHESIOL,RN-10,SEATTLE,WA 98195; HANEGEU UNIV,SOROKA MED CTR,DEPT ANESTHESIOL,JERUSALEM,ISRAEL; SHAREI ZEDEK MED CTR,DEPT ANESTHESIOL,JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,DEPT PHARMACOL,JERUSALEM,ISRAEL								BARTH TM, 1990, STROKE, V21; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BODSCH W, 1982, BRAIN RES, V249, P111, DOI 10.1016/0006-8993(82)90175-5; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CLASEN RA, 1982, J NEUROPATH EXP NEUR, V41, P113, DOI 10.1097/00005072-198203000-00003; DIETRICH WD, 1991, ACTA NEUROPATHOL, V81, P615, DOI 10.1007/BF00296371; DOBBIN J, 1989, J CEREBR BLOOD F MET, V9, P71, DOI 10.1038/jcbfm.1989.10; GAZENDAM J, 1979, J NEUROSURG, V51, P70, DOI 10.3171/jns.1979.51.1.0070; HINDMAN BJ, 1990, ANESTHESIOLOGY, V73, P951, DOI 10.1097/00000542-199011000-00024; KAPASI MZ, 1991, J CEREB BLOOD FLOW S, V2, pS474; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1985, BRIT J ANAESTH, V57, P18, DOI 10.1093/bja/57.1.18; Klatzo I, 1967, BRAIN EDEMA, P554; KUCHIWAKI H, 1984, RECENT PROGR STUDY T, P459; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; KUROIWA T, 1985, ACTA NEUROPATHOL, V66, P3, DOI 10.1007/BF00698288; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MARMAROU A, 1984, RECENT PROGR STUDY T, P37; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; SCHIELKE GP, 1991, J CEREBR BLOOD F MET, V11, P466, DOI 10.1038/jcbfm.1991.89; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAPIRA Y, 1989, Neurological Research, V11, P169; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8	29	126	127	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0003-2999			ANESTH ANALG	Anesth. Analg.	JUL	1993	77	1					141	148					8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	LL119	WOS:A1993LL11900028	8317722				2022-02-06	
J	Cherry, JD; Tripodis, Y; Alvarez, VE; Huber, B; Kiernan, PT; Daneshvar, DH; Mez, J; Montenigro, PH; Solomon, TM; Alosco, ML; Stern, RA; Mckee, AC; Stein, TD				Cherry, Jonathan D.; Tripodis, Yorghos; Alvarez, Victor E.; Huber, Bertrand; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Montenigro, Philip H.; Solomon, Todd M.; Alosco, Michael L.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.			Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						CTE; Neuroinflammation; Microglia; Repetitive head impacts; Mild traumatic brain injury; American football	BETA-AMYLOID DEPOSITION; BRAIN-INJURY; ALZHEIMERS-DISEASE; AXONAL INJURY; PATHOLOGY; INFLAMMATION; NEURODEGENERATION; PLAYERS	The chronic effects of repetitive head impacts (RHI) on the development of neuroinflammation and its relationship to chronic traumatic encephalopathy (CTE) are unknown. Here we set out to determine the relationship between RHI exposure, neuroinflammation, and the development of hyperphosphorylated tau (ptau) pathology and dementia risk in CTE. We studied a cohort of 66 deceased American football athletes from the Boston University-Veteran's Affairs-Concussion Legacy Foundation Brain Bank as well as 16 non-athlete controls. Subjects with a neurodegenerative disease other than CTE were excluded. Counts of total and activated microglia, astrocytes, and ptau pathology were performed in the dorsolateral frontal cortex (DLF). Binary logistic and simultaneous equation regression models were used to test associations between RHI exposure, microglia, ptau pathology, and dementia. Duration of RHI exposure and the development and severity of CTE were associated with reactive microglial morphology and increased numbers of CD68 immunoreactive microglia in the DLF. A simultaneous equation regression model demonstrated that RHI exposure had a significant direct effect on CD68 cell density (p < 0.0001) and ptau pathology (p < 0.0001) independent of age at death. The effect of RHI on ptau pathology was partially mediated through increased CD68 positive cell density. A binary logistic regression demonstrated that a diagnosis of dementia was significantly predicted by CD68 cell density (OR = 1.010, p = 0.011) independent of age (OR = 1.055, p = 0.007), but this effect disappeared when ptau pathology was included in the model. In conclusion, RHI is associated with chronic activation of microglia, which may partially mediate the effect of RHI on the development of ptau pathology and dementia in CTE. Inflammatory molecules may be important diagnostic or predictive biomarkers as well as promising therapeutic targets in CTE.	[Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Montenigro, Philip H.; Solomon, Todd M.; Alosco, Michael L.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Alzheimers Dis, Boston, MA 02215 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Montenigro, Philip H.; Solomon, Todd M.; Alosco, Michael L.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand; Kiernan, Patrick T.; Mez, Jesse; Alosco, Michael L.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Montenigro, Philip H.; Stern, Robert A.; McKee, Ann C.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA		Stein, TD (corresponding author), Boston Univ, Alzheimers Dis, Boston, MA 02215 USA.; Stein, TD (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.; Stein, TD (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.; Stein, TD (corresponding author), VA Boston Healthcare Syst, Boston, MA 02130 USA.; Stein, TD (corresponding author), Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA.	tdstein@bu.edu	Lang, Steven/AAE-8102-2021; , Bob/ABA-8507-2020	Lang, Steven/0000-0003-1669-9146; Daneshvar, Daniel/0000-0003-3691-9513; Tripodis, Yorghos/0000-0003-2190-7608; Stein, Thor/0000-0001-6954-4477	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award [I01-CX001038]; Alzheimer's AssociationAlzheimer's Association [NIRG-305779]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1RF1AG054156-01]; Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS) Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering [U01NS086659-01]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP) [13267017]; National Heart, Lung, and Blood Institute, Framingham Heart Study (NHLBI/NIH) [N01-HC-25195, R01AG08122]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1F32NS096803-01]; Concussion Legacy Foundation; Andlinger Foundation; WWE; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, F32NS096803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG008122, P30AG013846, RF1AG054156, K23AG046377] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038); Alzheimer's Association (NIRG-305779); National Institute of Aging (1RF1AG054156-01); Veterans Affairs Biorepository (CSP 501); Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS) Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C); National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering (U01NS086659-01); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5); Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP #13267017); National Heart, Lung, and Blood Institute, Framingham Heart Study (NHLBI/NIH #N01-HC-25195 and R01AG08122); NINDS (1F32NS096803-01); Concussion Legacy Foundation. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We gratefully acknowledge the use of resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA) as well as all the individuals whose participation and contributions made this work possible.	Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cherry JD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00594; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Duncan G.K., 2004, RES HUM DEV, V1, P59, DOI DOI 10.1080/15427609.2004.9683330; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Intriligator, 1983, HDB ECONOMETRICS, V1, P391, DOI DOI 10.1016/S1573-4412(83)01011-9; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Maphis N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00196; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro P. H., 2016, J NEUROTRAUMA; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; RABINOWITZ SS, 1991, J EXP MED, V174, P827, DOI 10.1084/jem.174.4.827; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015	38	125	126	5	36	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	OCT 28	2016	4								112	10.1186/s40478-016-0382-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA2RN	WOS:000386442500001	27793189	gold, Green Published			2022-02-06	
J	Chin, EY; Nelson, LD; Barr, WB; McCrory, P; McCrea, MA				Chin, Esther Y.; Nelson, Lindsay D.; Barr, William B.; McCrory, Paul; McCrea, Michael A.			Reliability and Validity of the Sport Concussion Assessment Tool-3 (SCAT3) in High School and Collegiate Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head injuries; concussions; clinical assessments; grading scales; athletic training; Sport Concussion Assessment Tool-3 (SCAT3)	TRAUMATIC BRAIN-INJURY; LINE TEST-PERFORMANCE; BASE-LINE; NEUROPSYCHOLOGICAL ASSESSMENT; INTERNATIONAL-CONFERENCE; STANDARDIZED ASSESSMENT; NORMATIVE DATA; CONSENSUS STATEMENT; POSTURAL STABILITY; SYMPTOMS	Background: The Sport Concussion Assessment Tool-3 (SCAT3) facilitates sideline clinical assessments of concussed athletes. Yet, there is little published research on clinically relevant metrics for the SCAT3 as a whole. Purpose: We documented the psychometric properties of the major SCAT3 components (symptoms, cognition, balance) and derived clinical decision criteria (ie, reliable change score cutoffs and normative conversation tables) for clinicians to apply to cases with and without available preinjury baseline data. Study Design: Cohort study (diagnosis); Level of evidence, 2. Methods: High school and collegiate athletes (N = 2018) completed preseason baseline evaluations including the SCAT3. Re-evaluations of 166 injured athletes and 164 noninjured controls were performed within 24 hours of injury and at 8, 15, and 45 days after injury. Analyses focused on predictors of baseline performance, test-retest reliability, and sensitivity and specificity of the SCAT3 using either single postinjury cutoffs or reliable change index (RCI) criteria derived from this sample. Results: Athlete sex, level of competition, attention-deficit/hyperactivity disorder (ADHD), learning disability (LD), and estimated verbal intellectual ability (but not concussion history) were associated with baseline scores on 1 SCAT3 components (small to moderate effect sizes). Female sex, high school level of competition (vs college), and ADHD were associated with higher baseline symptom ratings (d = 0.25-0.32). Male sex, ADHD, and LD were associated with lower baseline Standardized Assessment of Concussion (SAC) scores (d = 0.28-0.68). Male sex, high school level of competition, ADHD, and LD were associated with poorer baseline Balance Error Scoring System (BESS) performance (d = 0.14-0.26). After injury, the symptom checklist manifested the largest effect size at the 24-hour assessment (d = 1.52), with group differences diminished but statistically significant at day 8 (d = 0.39) and nonsignificant at day 15. Effect sizes for the SAC and BESS were small to moderate at 24 hours (SAC: d = -0.36; modified BESS: d = 0.46; full BESS: d = 0.51) and became nonsignificant at day 8 (SAC) and day 15 (BESS). Receiver operating characteristic curve analyses demonstrated a stronger discrimination for symptoms (area under the curve [AUC] = 0.86) than cognitive and balance measures (AUCs = 0.58 and 0.62, respectively), with comparable discrimination of each SCAT3 component using postinjury scores alone versus baseline-adjusted scores (P = .71-.90). Normative conversion tables and RCI criteria were created to facilitate the use of the SCAT3 both with and without baseline test results. Conclusion: Individual predictors should be taken into account when interpreting the SCAT3. The normative conversion tables and RCIs presented can be used to help interpret concussed athletes' performance both with and without baseline data, given the comparability of the 2 interpretative approaches.	[Chin, Esther Y.; Nelson, Lindsay D.; Barr, William B.; McCrory, Paul; McCrea, Michael A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Chin, Esther Y.] AMITA Hlth, Alexian Bros Neurosci Inst, Elk Grove Village Hoffman Estates, Hoffman Estates, IL USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Planck Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Planck Rd, Milwaukee, WI 53226 USA; [Barr, William B.] NYU, Sch Med, Dept Neurol, New York, NY USA; [McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Planck Rd, Milwaukee, WI 53226 USA.; Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurol, 8701 West Watertown Planck Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu	McCrory, Paul/Q-8688-2019	McCrory, Paul/0000-0003-4850-0568; Barr, William/0000-0001-7711-7758	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; Clinical and Translational Science Institute [1UL1-RR031973(-01)]; National Center for Advancing Translational Sciences/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8UL1TR000055]; International Olympic Committee; Axon Sports (US); Cogstate Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER	This work was supported by the US Army Medical Research and Materiel Command under award number W81XWH-12-1-0004. This publication was also supported by the Clinical and Translational Science Institute grant 1UL1-RR031973(-01) and by the National Center for Advancing Translational Sciences/National Institutes of Health grant 8UL1TR000055. P.M. is a co-investigator, collaborator, or consultant on grants relating to mild traumatic brain injuries (TBIs) funded by several governmental organizations. He is directly employed by the National Health and Medical Research Council of Australia and is based at the Florey Institute of Neuroscience and Mental Health. He is a co-chair of the Australian Centre for Research into Injury in Sport and its Prevention, which is one of the Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. He is a co-chair of the International Concussion in Sport Group. He has a clinical and consulting practice in general and sports neurology. He receives book royalties from McGraw-Hill and was employed in an editorial capacity by the British Medical Journal Publishing Group (2001-2008). He has been reimbursed by the government, professional scientific bodies, and sporting bodies for travel costs related to presenting research on mild TBIs and sport-related concussions at meetings, scientific conferences, and symposiums. He received consultancy fees in 2010 from Axon Sports (US) for the development of educational material (which was not renewed) and has received research funding since 2001 from Cogstate Inc. He has not received any research funding, salary, or other monies from the Australian Football League (AFL), Federation Internationale de Football Association, or National Football League. The AFL funds research at the Florey Institute under a legal memorandum; P.M. does not receive any money from this industry-funded research. P.M. serves on the AFL Concussion Working Group in an honorary capacity. He is a co-founder and shareholder in 2 biomedical companies (involved in eHealth and compression garment technologies) but does not hold any individual shares in any company related to concussion or brain injury assessments or technologies. He did not receive any form of financial support directly related to this article.	[Anonymous], 2000, Am J Sports Med, V28, P440; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bruce JM, 2004, NEUROLOGY, V63, P1516; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Griffin LY, 2003, MED SCI SPORT EXER, V35, P1785; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Helmick K., 2006, DEFENSE VETERANS BRA; Herring SA, 2002, MED SCI SPORT EXER, V34, P1212; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Jerrell JM, 2015, EUR CHILD ADOLES PSY, V24, P65, DOI 10.1007/s00787-014-0541-z; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maassen GH, 2004, J INT NEUROPSYCH SOC, V10, P888, DOI 10.1017/S1355617704106097; Margari L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-198; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Parisi P, 2014, EPILEPSY BEHAV, V32, P72, DOI 10.1016/j.yebeh.2013.12.028; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Susco TM, 2004, J ATHL TRAINING, V39, P241; Zottoli TM, 2015, CLIN NEUROPSYCHOL, V29, P678, DOI 10.1080/13854046.2015.1062562; 2001, MED SCI SPORTS EXERC, V33, P846	58	125	125	0	43	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2016	44	9					2276	2285		10.1177/0363546516648141			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	DV6CU	WOS:000383019300016	27281276				2022-02-06	
J	Barrio, JR; Small, GW; Wong, KP; Huang, SC; Liu, J; Merrill, DA; Giza, CC; Fitzsimmons, RP; Omalu, B; Bailes, J; Kepe, V				Barrio, Jorge R.; Small, Gary W.; Wong, Koon-Pong; Huang, Sung-Cheng; Liu, Jie; Merrill, David A.; Giza, Christopher C.; Fitzsimmons, Robert P.; Omalu, Bennet; Bailes, Julian; Kepe, Vladimir			In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						traumatic brain injury; chronic traumatic encephalopathy; [F-18]FDDNP PET; tau imaging; concussions	INTRINSIC CONNECTIVITY; LIVING BRAIN; INJURY; TAU; NEUROPATHOLOGY; PATHOLOGY; DEGENERATION; VALIDATION; DISORDER; SPECTRUM	Chronic traumatic encephalopathy (CTE) is an acquired primary tauopathy with a variety of cognitive, behavioral, and motor symptoms linked to cumulative brain damage sustained from single, episodic, or repetitive traumatic brain injury (TBI). No definitive clinical diagnosis for this condition exists. In this work, we used [F-18]FDDNP PET to detect brain patterns of neuropathology distribution in retired professional American football players with suspected CTE (n = 14) and compared results with those of cognitively intact controls (n = 28) and patients with Alzheimer's dementia (AD) (n = 24), a disease that has been cognitively associated with CTE. [F-18]FDDNP PET imaging results in the retired players suggested the presence of neuropathological patterns consistent with models of concussion wherein brainstem white matter tracts undergo early axonal damage and cumulative axonal injuries along subcortical, limbic, and cortical brain circuitries supporting mood, emotions, and behavior. This deposition pattern is distinctively different from the progressive pattern of neuropathology [paired helical filament (PHF)-tau and amyloid-beta] in AD, which typically begins in the medial temporal lobe progressing along the cortical default mode network, with no or minimal involvement of subcortical structures. This particular [F-18]FDDNP PET imaging pattern in cases of suspected CTE also is primarily consistent with PHF-tau distribution observed at autopsy in subjects with a history of mild TBI and autopsy-confirmed diagnosis of CTE.	[Barrio, Jorge R.; Wong, Koon-Pong; Huang, Sung-Cheng; Liu, Jie; Kepe, Vladimir] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Small, Gary W.; Merrill, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Small, Gary W.; Merrill, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg & Pediat, Los Angeles, CA 90095 USA; [Fitzsimmons, Robert P.] Fitzsimmons Law Off, Wheeling, WV 26003 USA; [Omalu, Bennet] Univ Calif Davis, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA; [Bailes, Julian] NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL 60201 USA; [Bailes, Julian] Univ Chicago, Pritzker Sch Med, Evanston, IL 60201 USA		Barrio, JR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	jbarrio@mednet.ucla.edu; vkepe@mednet.ucla.edu	Wong, Koon-Pong/AAI-3780-2020	Wong, Koon-Pong/0000-0002-6095-4645	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-AG025831, M01-RR00865]; Toulmin Foundation; Robert and Marion Wilson; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG025831] Funding Source: NIH RePORTER	We thank Natacha Donoghue and Jacqueline Martinez for subject scheduling and management; John Williams, University of California, Los Angeles, Nuclear Medicine Clinic, for performing the PET scans; and Shelley West, Billy West, and Bus Cook for guidance with subject referral and for their helpful input. Funding from the National Institutes of Health (P01-AG025831 and M01-RR00865), the Toulmin Foundation, and Robert and Marion Wilson is highly appreciated. No company provided research funding for this study.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barrio JR, 2009, ACCOUNTS CHEM RES, V42, P842, DOI 10.1021/ar800189x; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Gardner RC, 2013, ANN NEUROL, V73, P603, DOI 10.1002/ana.23844; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Harada R, 2013, EUR J NUCL MED MOL I, V40, P125, DOI 10.1007/s00259-012-2261-2; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kepe V, 2006, METHOD ENZYMOL, V412, P144, DOI 10.1016/S0076-6879(06)12010-8; Kepe V, 2013, J ALZHEIMERS DIS, V36, P145, DOI 10.3233/JAD-130032; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Liu J, 2007, MOL IMAGING BIOL, V9, P6, DOI 10.1007/s11307-006-0061-4; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLachlan G, 1992, DISCRIMINANT ANAL ST; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; MINTUN MA, 1984, ANN NEUROL, V15, P217, DOI 10.1002/ana.410150302; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pannekoek JN, 2013, J AFFECT DISORDERS, V145, P29, DOI 10.1016/j.jad.2012.07.006; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Protas HD, 2012, NEUROIMAGE, V61, P749, DOI 10.1016/j.neuroimage.2012.02.056; Ramasubbu R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00017; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Smid LM, 2013, J ALZHEIMERS DIS, V36, P261, DOI 10.3233/JAD-122434; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; STRICH SJ, 1961, LANCET, V2, P443; Tantawy MN, 2009, NUCL MED BIOL, V36, P931, DOI 10.1016/j.nucmedbio.2009.06.007; US Pharmacopeial Convention, 2013, POS EM TOM DRUGS COM	54	125	126	4	53	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	APR 21	2015	112	16					E2039	E2047		10.1073/pnas.1409952112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG4FJ	WOS:000353239100012	25848027	hybrid, Green Published			2022-02-06	
J	Baillargeon, A; Lassonde, M; Leclerc, S; Ellemberg, D				Baillargeon, Annie; Lassonde, Maryse; Leclerc, Suzanne; Ellemberg, Dave			Neuropsychological and neurophysiological assessment of sport concussion in children, adolescents and adults	BRAIN INJURY			English	Article						Sport concussion; event-related potentials; neuropsychology; children	TRAUMATIC BRAIN-INJURY; EVENT-RELATED POTENTIALS; HIGH-SCHOOL; SEX-DIFFERENCES; HEAD-INJURY; COLLEGIATE; CHILDHOOD; RECOVERY; SYMPTOMS; STATEMENT	Objective: To determine whether age differences exist with respect to neuropsychological and electrophysiological functioning following a sport concussion. Design: Cross-sectional study. Participants: Ninety-six athletes (9-12 years, n = 32; 13-16 years, n = 34; adults, n = 30), half of whom had a sport concussion. Intervention: Cognitive functioning was assessed using standardized neuropsychological tests and event-related potentials elicited by a visual 3-stimulus oddball paradigm. The PCSS was used to assess symptoms experienced at the time of injury. Main outcome measurements: Neuropsychological assessment with an adaptation of the battery used by the National Hockey League. Latencies and amplitudes of the P3a and P3b were analysed in terms of group (concussed vs. control) and age. Results: All concussed athletes had significantly lower amplitude for the P3b component compared to their non-injured teammates (p > 0.05). Adolescents also showed persistent deficits in working memory (p > 0.05). Conclusions: These data suggest persistent neurophysiological deficits that are present at least 6 months following a concussion. Moreover, adolescents are more sensitive to the consequences of concussions than are children or adults.	[Leclerc, Suzanne; Ellemberg, Dave] Univ Montreal, Dept Kinesiol, Montreal, PQ H3T 1J4, Canada; [Baillargeon, Annie; Lassonde, Maryse] Univ Montreal, Dept Psychol, Montreal, PQ H3T 1J4, Canada; [Baillargeon, Annie; Lassonde, Maryse; Ellemberg, Dave] Ctr Rech Neuropsychol & Cognit Montreal, Montreal, PQ, Canada; [Baillargeon, Annie; Lassonde, Maryse; Ellemberg, Dave] Ctr Rech Hop Ste JustineMontreal, Montreal, PQ, Canada		Ellemberg, D (corresponding author), Univ Montreal, Dept Kinesiol, 2100 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	dave.ellemberg@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canada Foundation for InnovationCanada Foundation for InnovationCGIAR	This research was funded by a grant from the Canadian Institutes of Health Research to D.E. and M.L. and a grant from the Canada Foundation for Innovation to D.E.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; COURCHESNE E, 1978, ELECTROEN CLIN NEURO, V45, P468, DOI 10.1016/0013-4694(78)90291-2; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; GRATTON G, 1983, PSYCHOPHYSIOLOGY, V20, P443; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Holguin SR, 1999, ALCOHOL CLIN EXP RES, V23, P582, DOI 10.1097/00000374-199904000-00003; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kelly JP, 1997, NEUROLOGY, V48, P581; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; O'Hare ED, 2008, NEUROIMAGE, V42, P1678, DOI 10.1016/j.neuroimage.2008.05.057; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Sawaki R, 2007, PSYCHOPHYSIOLOGY, V44, pS51; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; van der Stelt O, 1998, ALCOHOL CLIN EXP RES, V22, P1877, DOI 10.1097/00000374-199812000-00001	44	125	126	0	60	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2012	26	3					211	220		10.3109/02699052.2012.654590			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	899XD	WOS:000300849100002	22372409				2022-02-06	
J	Mondello, S; Linnet, A; Buki, A; Robicsek, S; Gabrielli, A; Tepas, J; Papa, L; Brophy, GM; Tortella, F; Hayes, RL; Wang, KK				Mondello, Stefania; Linnet, Akinyi; Buki, Andras; Robicsek, Steven; Gabrielli, Andrea; Tepas, Joseph; Papa, Linda; Brophy, Gretchen M.; Tortella, Frank; Hayes, Ronald L.; Wang, Kevin K.			Clinical Utility of Serum Levels of Ubiquitin C-Terminal Hydrolase as a Biomarker for Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Biomarkers; Critical care; Diagnosis; Head injury; Outcome; Proteomics; UCH-L1	NEURON-SPECIFIC ENOLASE; SPECTRIN BREAKDOWN PRODUCTS; ALPHA-II-SPECTRIN; HEAD-INJURY; CEREBROSPINAL-FLUID; PROGNOSIS; PROTEIN; PROTEASOME; DIAGNOSIS; DAMAGE	BACKGROUND: Brain damage markers released in cerebrospinal fluid (CSF) and blood may provide valuable information about diagnosis and outcome prediction after traumatic brain injury (TBI). OBJECTIVE: To examine the concentrations of ubiquitin C-terminal hydrolase-L1 (UCH-L1), a novel brain injury biomarker, in CSF and serum of severe TBI patients and their association with clinical characteristics and outcome. METHODS: This case-control study enrolled 95 severe TBI subjects (Glasgow Coma Scale [GCS] score, 8). Using sensitive UCH-L1 sandwich ELISA, we studied the temporal profile of CSF and serum UCH-L1 levels over 7 days for severe TBI patients. RESULTS: Comparison of serum and CSF levels of UCH-L1 in TBI patients and control subjects shows a robust and significant elevation of UCH-L1 in the acute phase and over the 7-day study period. Serum and CSF UCH-L1 receiver-operating characteristic curves further confirm strong specificity and selectivity for diagnosing severe TBI vs controls, with area under the curve values in serum and CSF statistically significant at all time points up to 24 hours (P < .001). The first 12-hour levels of both serum and CSF UCH-L1 in patients with GCS score of 3 to 5 were also significantly higher than those with GCS score of 6 to 8. Furthermore, UCH-L1 levels in CSF and serum appear to distinguish severe TBI survivors from nonsurvivors within the study, with nonsurvivors having significantly higher and more persistent levels of serum and CSF UCH-L1. Cumulative serum UCH-L1 levels > 5.22 ng/mL predicted death (odds ratio, 4.8). CONCLUSION: Serum levels of UCH-L1 appear to have potential clinical utility in diagnosing TBI, including correlating to injury severity and survival outcome.	[Mondello, Stefania; Robicsek, Steven; Gabrielli, Andrea; Hayes, Ronald L.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Wang, Kevin K.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, McKnight Brain Inst, Gainesville, FL 32611 USA; [Mondello, Stefania; Hayes, Ronald L.] Banyan Biomarkers Inc, Clin Dept, Ctr Innovat Res, Alachua, FL 32615 USA; [Wang, Kevin K.] Banyan Biomarkers Inc, Diagnost Res & Dev Dept, Ctr Innovat Res, Alachua, FL 32615 USA; [Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Tepas, Joseph] Univ Florida, Dept Neurosurg, Jacksonville, FL USA; [Papa, Linda] Orlando Reg Med Ctr Inc, Orlando, FL USA; [Brophy, Gretchen M.] Virginia Commonwealth Univ, Richmond, VA USA; [Tortella, Frank] Walter Reed Army Inst Res, Dept Appl Neurobiol, Div Psychiat & Neurosci, Silver Spring, MD USA		Mondello, S (corresponding author), Banyan Biomarkers Inc, Dept Clin Programs, 13400 Progress Blvd, Alachua, FL 32615 USA.	stm_mondello@hotmail.com	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614; Brophy, Gretchen/0000-0002-4749-2693; Wang, Kevin/0000-0002-9343-6473	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS049175-01, R01-NS052831-01, R01 NS051431-01]; Department of DefenseUnited States Department of Defense [DAMD17-03-1-0772, DAMD17-03-1-0066]; University of FloridaUniversity of Florida [N00014-06-1-1029]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051431, R01NS049175, R01NS052831] Funding Source: NIH RePORTER	This study was supported in part by the National Institutes of Health (R01 NS049175-01, R01-NS052831-01, and R01 NS051431-01), supported in part by Department of Defense awards DAMD17-03-1-0772 and DAMD17-03-1-0066, National Institutes of Health awards, and Navy grant N00014-06-1-1029 (University of Florida). The opinions or assertions contained herein are the private views of the authors and are not to be construed as official, or as reflecting true views of Department of the Army or Department of Defense. Drs Mondello, Buki, Robicsek, Gabrielli, Brophy, and Papa are consultants for Banyan Biomarkers, Inc. L. Akinyi is an employee of Banyan Biomarkers, Inc. Drs Wang and Hayes own stock, receive royalties from, and are officers of Banyan Biomarkers Inc and thus may benefit financially as a result of the outcomes of this research or work reported in this publication. Dr Tortella reports no disclosures.	[Anonymous], 2000, J Head Trauma Rehabil, V15, P750; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Coleman MP, 2004, CNS NEUROL DISORD-DR, V3, P227, DOI 10.2174/1568007043337436; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Keller JN, 2000, J CEREBR BLOOD F MET, V20, P1467, DOI 10.1097/00004647-200010000-00008; Kesler SR, 2000, BRAIN INJURY, V14, P851; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Laser H, 2003, J NEUROSCI RES, V74, P906, DOI 10.1002/jnr.10806; Laskowitz D T, 1998, J Stroke Cerebrovasc Dis, V7, P234, DOI 10.1016/S1052-3057(98)80032-3; Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Martens P, 1996, ACAD EMERG MED, V3, P126, DOI 10.1111/j.1553-2712.1996.tb03399.x; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; USUI A, 1989, CLIN CHEM, V35, P1942; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	42	125	137	2	23	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2012	70	3					666	675		10.1227/NEU.0b013e318236a809			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	898ZU	WOS:000300781700024	21937927	Green Accepted, Bronze			2022-02-06	
J	Laker, SR				Laker, Scott R.			Epidemiology of Concussion and Mild Traumatic Brain Injury	PM&R			English	Article							EMERGENCY-DEPARTMENT VISITS; HIGH-SCHOOL SPORTS; UNITED-STATES; SEX-DIFFERENCES; SYMPTOMS; OUTCOMES; TRENDS; MECHANISM; IRAQ	Mild traumatic brain injury (mTBI) is a common public health concern that affects millions of people each year. The available epidemiology of mTBI may contain insights that can guide future identification, prevention, and treatment efforts. This article discusses epidemiology of both non sports-related mTBI and sports-related concussion. Specific occupational factors, emergency department data, and meta-analysis regarding mTBI are reviewed and discussed. With regard to sports concussion, the article will discuss data related to the sport played, the individual's position, level of play, and gender differences. Although males make up a larger percentage of cases than do females throughout the majority of reviewed non sports-related mTBI data, the sports literature indicates that rates are higher in women when similar sports are compared. Identifiable risk factors within sports include female gender, sport, and position played. Emerging trends across mTBI include increased incidence and decreased rate of hospitalization for mTBI. PM R 2011;3:S354-S358	Univ Colorado, Dept Phys Med & Rehabil, Aurora, CO 80045 USA		Laker, SR (corresponding author), Univ Colorado, Dept Phys Med & Rehabil, Mail Stop F493,12631 E 17th Ave,Room 2513, Aurora, CO 80045 USA.	scott.laker@ucdenver.edu	Laker, Scott/ABE-7455-2021				Adler RH, 2011, PM R, V3, pS472; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; [Anonymous], 2006, TRAUM BRAIN INJ US; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, TAK CONC OUT PLAY LE; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; National Federation of State High School Associations, 2010, 2009 10 HIGH SCH ATH; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	38	125	126	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S354	S358		10.1016/j.pmrj.2011.07.017			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	966YK	WOS:000305873100002	22035677				2022-02-06	
J	Mayes, SD; Calhoun, SL; Murray, MJ; Zahid, J				Mayes, Susan Dickerson; Calhoun, Susan L.; Murray, Michael J.; Zahid, Jahanara			Variables Associated with Anxiety and Depression in Children with Autism	JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES			English	Article						Anxiety; Depression; Autism; Age; IQ	PERVASIVE DEVELOPMENTAL DISORDERS; TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; ASPERGER-SYNDROME; SPECTRUM DISORDERS; GENDER-DIFFERENCES; PROCESSING SPEED; ADHD SUBTYPES; SYMPTOMS; ADOLESCENTS	Mothers of 627 children with autism (ages 1-17, IQs 16-146) completed the Pediatric Behavior Scale. Maternal ratings of anxiety and depression increased with age and IQ, but were unrelated to gender, parent occupation, and race. Anxiety and depression were highly correlated with each other and with autism severity, somatic complaints, mood disturbance, and social problems. Remaining correlations with behavior problems, attention deficit, hyperactivity, and sleep problems were small. The strongest combined predictors of anxiety and depression were autism severity, verbal IQ, and age, explaining 25% and 23% of the variance. Findings suggest that anxiety and depression have a direct link with autism (increasing with autism severity) and a developmental component (increasing with age and IQ). Anxiety is present in most children with autism and depression is present in about half. Therefore, all children with autism should be screened for anxiety and depression and treated if indicated. Controlled studies are needed to determine what interventions are effective in reducing anxiety and depression in autism.	[Mayes, Susan Dickerson] Penn State Univ Hosp, Milton S Hershey Med Ctr, Dept Psychiat H073, Hershey, PA 17033 USA; [Mayes, Susan Dickerson; Calhoun, Susan L.; Murray, Michael J.; Zahid, Jahanara] Penn State Coll Med, Dept Psychiat, Hershey, PA USA		Mayes, SD (corresponding author), Penn State Univ Hosp, Milton S Hershey Med Ctr, Dept Psychiat H073, 500 Univ Dr, Hershey, PA 17033 USA.	smayes@psu.edu					Bellini S., 2004, FOCUS AUTISM DEV DIS, V19, P78, DOI DOI 10.1177/10883576040190020201; BENJAMIN RS, 1990, J ANXIETY DISORD, V4, P293, DOI 10.1016/0887-6185(90)90027-7; Brereton AV, 2006, J AUTISM DEV DISORD, V36, P863, DOI 10.1007/s10803-006-0125-y; Chalfant AM, 2007, J AUTISM DEV DISORD, V37, P1842, DOI 10.1007/s10803-006-0318-4; Chaplin TM, 2009, J EARLY ADOLESCENCE, V29, P307, DOI 10.1177/0272431608320125; Compas BE, 1997, J CONSULT CLIN PSYCH, V65, P617, DOI 10.1037/0022-006X.65.4.617; Eisenmajer R, 1996, J AM ACAD CHILD PSY, V35, P1523, DOI 10.1097/00004583-199611000-00022; Frith U, 2004, J CHILD PSYCHOL PSYC, V45, P672, DOI 10.1111/j.1469-7610.2004.00262.x; Gadow KD, 2005, AUTISM, V9, P392, DOI 10.1177/1362361305056079; Gadow KD, 2008, J AUTISM DEV DISORD, V38, P1710, DOI 10.1007/s10803-008-0556-8; Ghaziuddin M, 1998, J INTELL DISABIL RES, V42, P279; Gillott A, 2001, AUTISM, V5, P277, DOI 10.1177/1362361301005003005; Gray C. A., 1993, FOCUS AUTISM OTHER D, V8, P1; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hartley SL, 2009, J AUTISM DEV DISORD, V39, P1715, DOI 10.1007/s10803-009-0810-8; Howlin P, 2003, J AUTISM DEV DISORD, V33, P3, DOI 10.1023/A:1022270118899; Hurtig T, 2009, AUTISM, V13, P583, DOI 10.1177/1362361309335719; Kanne SM, 2009, J AUTISM DEV DISORD, V39, P827, DOI 10.1007/s10803-008-0688-x; Kim JA., 2000, AUTISM, V4, P117, DOI [DOI 10.1177/1362361300004002002, 10.1177/1362361300004002002]; Lemstra M, 2008, CAN J PUBLIC HEALTH, V99, P125, DOI 10.1007/BF03405459; Lewinsohn PM, 1998, J ABNORM PSYCHOL, V107, P109, DOI 10.1037/0021-843X.107.1.109; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Macintosh KE, 2004, J CHILD PSYCHOL PSYC, V45, P421, DOI 10.1111/j.1469-7610.2004.00234.x; MacNeil BM, 2009, RES AUTISM SPECT DIS, V3, P1, DOI 10.1016/j.rasd.2008.06.001; MANJIVIONA J, 1995, J AUTISM DEV DISORD, V25, P23, DOI 10.1007/BF02178165; Matson JL, 2007, RES DEV DISABIL, V28, P341, DOI 10.1016/j.ridd.2005.12.004; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Mayes SD, 2003, LEARNING AND BEHAVIOR PROBLEMS IN ASPERGER SYNDROME, P15; Mayes SD, 2004, J DEV PHYS DISABIL, V16, P257, DOI 10.1023/B:JODD.0000032301.07550.0e; Mayes SD, 2001, J ABNORM CHILD PSYCH, V29, P263, DOI 10.1023/A:1010337916636; Mayes SD, 1999, INFANT YOUNG CHILD, V12, P90, DOI 10.1097/00001163-199910000-00011; Mayes SD, 2008, J DEV BEHAV PEDIATR, V29, P206, DOI 10.1097/DBP.0b013e31816d924f; Mayes SD, 2007, CHILD NEUROPSYCHOL, V13, P469, DOI 10.1080/09297040601112773; Mayes SD, 2011, RES AUTISM SPECT DIS, V5, P474, DOI 10.1016/j.rasd.2010.06.012; Mayes SD, 2009, J ATTEN DISORD, V12, P540, DOI 10.1177/1087054708320402; Mayes SD, 2009, J AUTISM DEV DISORD, V39, P1682, DOI 10.1007/s10803-009-0812-6; Mayes SD, 2009, SLEEP MED CLIN, V4, P19, DOI 10.1016/j.jsmc.2008.12.004; Mayes SD, 2009, RES AUTISM SPECT DIS, V3, P931, DOI 10.1016/j.rasd.2009.04.002; Mayes SD, 2009, J PEDIATR PSYCHOL, V34, P328, DOI 10.1093/jpepsy/jsn083; Miller JN, 2000, J ABNORM PSYCHOL, V109, P227, DOI 10.1037/0021-843X.109.2.227; Miller JN, 1997, J CHILD PSYCHOL PSYC, V38, P247; Miller JN., 2000, AUTISM, V4, P29, DOI DOI 10.1177/1362361300041003; Murray M. J., J AUTISM DE IN PRESS; Myhr G, 1998, CAN J PSYCHIAT, V43, P589, DOI 10.1177/070674379804300607; Nichols S, 2000, J PEDIATR PSYCHOL, V25, P545, DOI 10.1093/jpepsy/25.8.545; Posey DJ, 2006, J CHILD ADOL PSYCHOP, V16, P181, DOI 10.1089/cap.2006.16.181; Prinz R., 1987, ADV BEHAV ASSESSMENT, P57; Prior M, 1998, J CHILD PSYCHOL PSYC, V39, P893, DOI 10.1017/S0021963098002807; Russell E, 2005, AUST NZ J PSYCHIAT, V39, P633, DOI 10.1111/j.1440-1614.2005.01637.x; Schopler E, 1996, J AUTISM DEV DISORD, V26, P109, DOI 10.1007/BF02276238; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Sofronoff K, 2005, J CHILD PSYCHOL PSYC, V46, P1152, DOI 10.1111/j.1469-7610.2005.00411.x; Sukhodolsky DG, 2008, J ABNORM CHILD PSYCH, V36, P117, DOI 10.1007/s10802-007-9165-9; SZATMARI P, 1995, J AM ACAD CHILD PSY, V34, P1662, DOI 10.1097/00004583-199512000-00017; TRYON P. A., 2006, FOCUS AUTISM OTHER D, V21, P2, DOI DOI 10.1177/10883576060210010101; Twenge JM, 2002, J ABNORM PSYCHOL, V111, P578, DOI 10.1037//0021-843X.111.4.578; Vickerstaff S, 2007, J AUTISM DEV DISORD, V37, P1647, DOI 10.1007/s10803-006-0292-x; Weisbrot DM, 2005, J CHILD ADOL PSYCHOP, V15, P477, DOI 10.1089/cap.2005.15.477; West L, 2009, J SPEC PEDIATR NURS, V14, P183, DOI 10.1111/j.1744-6155.2009.00196.x; White SW, 2009, J AUTISM DEV DISORD, V39, P1006, DOI 10.1007/s10803-009-0713-8; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Wing Lorna, 1998, ASPERGER SYNDROME HI, P11; WOLRAICH ML, 1994, NEW ENGL J MED, V330, P301, DOI 10.1056/NEJM199402033300501; Wood JJ, 2009, J CHILD PSYCHOL PSYC, V50, P224, DOI 10.1111/j.1469-7610.2008.01948.x; [No title captured]	67	125	125	5	63	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1056-263X	1573-3580		J DEV PHYS DISABIL	J. Dev. Phys. Disabil.	AUG	2011	23	4					325	337		10.1007/s10882-011-9231-7			13	Education, Special; Psychology, Developmental; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Psychology; Rehabilitation	788LU	WOS:000292447200005					2022-02-06	
J	Silverberg, ND; Iverson, GL				Silverberg, Noah D.; Iverson, Grant L.			Etiology of the post-concussion syndrome: Physiogenesis and psychogenesis revisited	NEUROREHABILITATION			English	Article						Mild traumatic brain injury; etiology; rehabilitation	TRAUMATIC BRAIN-INJURY; ACUTE STRESS DISORDER; MILD HEAD-INJURY; RANDOMIZED CONTROLLED-TRIALS; SYMPTOMS FOLLOWING MILD; POSTCONCUSSION SYNDROME; PSYCHOLOGICAL TREATMENT; ILLNESS PERCEPTIONS; MISERABLE MINORITY; EARLY INTERVENTION	In his seminal article, Physiogenesis and Psychogenesis in the 'Post-Concussional Syndrome,' Lishman (1988) proposed that neurobiological factors account for the development of the post-concussion syndrome and psychological factors become primarily responsible for maintaining it in the chronic phase. Over the 20 years that followed, researchers have advanced our understanding of the etiology of the post-concussion syndrome. Our review of this evidence suggests that neurobiological and psychological factors play a causal role in post-concussion symptoms from the outset, and thus, Lishman's causal model should be updated. If we can clinically identify individuals on a trajectory of poor recovery in the acute post-injury stage, then we can direct secondary prevention towards modifiable risk factors.	[Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC V5Z 2G9, Canada; [Silverberg, Noah D.] Univ British Columbia, Dept Med, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Iverson, Grant/0000-0001-7348-9570	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Acarturk C, 2009, PSYCHOL MED, V39, P241, DOI 10.1017/S0033291708003590; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Allen EA, 2007, TRAUMA, V9, P181, DOI 10.1177/1460408607087717; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Beltman MW, 2010, BRIT J PSYCHIAT, V197, P11, DOI 10.1192/bjp.bp.109.064675; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Bortolotti B, 2008, GEN HOSP PSYCHIAT, V30, P293, DOI 10.1016/j.genhosppsych.2008.04.001; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Dhawan P, 2006, BCMJ, V9, P442; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donkin L, 2006, PSYCHOL HEALTH, V21, P421, DOI 10.1080/14768320500329292; Ekers D, 2008, PSYCHOL MED, V38, P611, DOI 10.1017/S0033291707001614; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Ferguson JM, 2003, INT CLIN PSYCHOPHARM, V18, P9, DOI 10.1097/00004850-200301000-00002; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Herrera-Guzman I, 2009, J PSYCHIATR RES, V43, P855, DOI 10.1016/j.jpsychires.2008.10.015; Hill O., 1970, MODERN TRENDS PSYCHO, P26; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hunot V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001848; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson G. L., PTSD MILD T IN PRESS; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kongsted A, 2008, EUR J PAIN, V12, P455, DOI 10.1016/j.ejpain.2007.07.008; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Levkovitz Y, 2002, BRAIN RES BULL, V58, P345, DOI 10.1016/S0361-9230(01)00780-8; Lidvall H F, 1974, Acta Neurol Scand Suppl, V56, P3; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McLean SA, 2005, PSYCHOSOM MED, V67, P783, DOI 10.1097/01.psy.0000181276.49204.bb; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Pampallona S, 2004, ARCH GEN PSYCHIAT, V61, P714, DOI 10.1001/archpsyc.61.7.714; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; SALKOVSKIS PM, 1986, BEHAV RES THER, V24, P597, DOI 10.1016/0005-7967(86)90041-0; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Snell D. L., BRAIN INJUR IN PRESS; Snell D. L., 2010, THESIS U OTAGO NZ; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; van Straten A., 2002, J PSYCHOSOM RES, VJournal of Psychosomatic Research, P23; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Zeitzer J.M., 2008, STAT ART SOTA	96	125	125	0	22	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2011	29	4					317	329		10.3233/NRE-2011-0708			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	870YW	WOS:000298705800001	22207058				2022-02-06	
J	Elbogen, EB; Wagner, HR; Fuller, SR; Calhoun, PS; Kinneer, PM; Beckham, JC				Elbogen, Eric B.; Wagner, H. Ryan; Fuller, Sara R.; Calhoun, Patrick S.; Kinneer, Patricia M.; Beckham, Jean C.		Mid-Atlantic Mental Illness Res Ed	Correlates of Anger and Hostility in Iraq and Afghanistan War Veterans	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; COMBAT VETERANS; VIETNAM VETERANS; ALCOHOL-USE; RISK-FACTORS; VIOLENCE; AGGRESSION; PTSD	Objective: As troops return from Iraq and Afghanistan to civilian life, clinicians are starting to grapple with how best to detect those at risk of postdeployment adjustment problems. Data reveal the presence of mental health problems in these soldiers, including posttraumatic stress disorder (PTSD), head injury, and alcohol abuse. Each of these conditions has been associated with elevated anger and hostility in veterans from previous conflicts. The authors sought to identify variables empirically related to anger and hostility in Iraq and Afghanistan veterans. Method: A total of 676 veterans who served since September 11, 2001, and who volunteered to participate in research studies were interviewed with instruments designed to collect information on psychiatric symptoms, health, and possible postdeployment adjustment issues. The primary outcome measures were variables measuring aggressive impulses or urges, difficulty managing anger, and perceived problems controlling violent behavior. Results: The three outcome measures were each significantly associated with PTSD hyperarousal symptoms. Other PTSD symptoms were less strongly and less consistently linked to anger and hostility. Traumatic brain injury and alcohol misuse were related to the outcome variables in bivariate but not multivariate analyses. Distinct sets of demographic, historical, and military-related variables were associated with the different facets of anger and hostility measured. Conclusions: The results underscore the need to tailor interventions individually to address anger and hostility effectively and to develop theoretically sophisticated, evidence-based knowledge to identify service members at risk of problematic postdeployment adjustment.	Univ N Carolina, Sch Med, Dept Psychiat, Forens Psychiat Program & Clin, Chapel Hill, NC 27599 USA; VISN Mental Illness Res Educ & Clin Ctr 6, Durham, NC USA; VA Med Ctr, Durham, NC USA; Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27706 USA		Elbogen, EB (corresponding author), Univ N Carolina, Sch Med, Dept Psychiat, Forens Psychiat Program, CB 7160, Chapel Hill, NC 27599 USA.	eric.elbogen@unc.edu			Mid-Atlantic Mental Illness Research, Education, and Clinical Center; VA Office of Research and Development Clinical Science; University of North Carolina-Chapel Hill; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH080988]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH080988] Funding Source: NIH RePORTER	Supported by the Mid-Atlantic Mental Illness Research, Education, and Clinical Center, the VA Office of Research and Development Clinical Science, a University of North Carolina-Chapel Hill Junior Faculty Development Award to Dr. Elbogen, and NIMH grant R01MH080988.	Beckham JC, 2000, AGGRESS VIOLENT BEH, V5, P451, DOI 10.1016/S1359-1789(98)00018-4; Beckham JC, 1997, J CLIN PSYCHOL, V53, P859, DOI 10.1002/(SICI)1097-4679(199712)53:8<859::AID-JCLP11>3.3.CO;2-U; Begic D, 2001, MIL MED, V166, P671, DOI 10.1093/milmed/166.8.671; Calhoun PS, 2008, J CLIN PSYCHIAT, V69, P1686, DOI 10.4088/JCP.v69n1103; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Fiellin DA, 2006, JAMA-J AM MED ASSOC, V296, P515, DOI 10.1001/jama.296.5.515; Freeman TW, 2001, J NERV MENT DIS, V189, P317, DOI 10.1097/00005053-200105000-00008; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Frueh BC, 2001, AGGRESS VIOLENT BEH, V6, P79, DOI 10.1016/S1359-1789(99)00012-9; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gerlock A A, 1994, Issues Ment Health Nurs, V15, P393, DOI 10.3109/01612849409006916; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grieger T. A., 2006, PRIM PSYCHIAT, V13, P45; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, JAMA-J AM MED ASSOC, V296, P574, DOI 10.1001/jama.296.5.574; Hutchinson J., 2006, PRIMARY PSYCHIAT, V13, P66; Institute of Medicine, 2008, GULF WAR HLTH, V7; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; LASKO NB, 1994, COMPR PSYCHIAT, V35, P373, DOI 10.1016/0010-440X(94)90278-X; McDonald SD, 2009, J ANXIETY DISORD, V23, P247, DOI 10.1016/j.janxdis.2008.07.007; McFall M, 1999, J TRAUMA STRESS, V12, P501, DOI 10.1023/A:1024771121189; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Newby JH, 2005, MIL MED, V170, P643, DOI 10.7205/MILMED.170.8.643; Orcutt HK, 2003, J TRAUMA STRESS, V16, P381, DOI 10.1023/A:1024470103325; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Savarese VW, 2001, J TRAUMA STRESS, V14, P717, DOI 10.1023/A:1013038021175; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Spitzer R, 1995, STRUCTURED CLIN INTE; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taft CT, 2005, J CONSULT CLIN PSYCH, V73, P151, DOI 10.1037/0022-006X.73.1.151; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Weathers FW, 1996, J TRAUMA STRESS, V9, P111, DOI 10.1007/BF02116837	40	125	127	0	15	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0002-953X			AM J PSYCHIAT	Am. J. Psychiat.	SEP	2010	167	9					1051	1058		10.1176/appi.ajp.2010.09050739			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	649SR	WOS:000281794200011	20551162	Green Accepted			2022-02-06	
J	Dohi, K; Ohtaki, H; Nakamachi, T; Yofu, S; Satoh, K; Miyamoto, K; Song, D; Tsunawaki, S; Shioda, S; Aruga, T				Dohi, Kenji; Ohtaki, Hirokazu; Nakamachi, Tomoya; Yofu, Sachiko; Satoh, Kazue; Miyamoto, Kazuyuki; Song, Dandan; Tsunawaki, Shohko; Shioda, Seiji; Aruga, Tohru			Gp91(phox) (NOX2) in classically activated microglia exacerbates traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article							NADPH-OXIDASE; OXIDATIVE STRESS; LIPID-PEROXIDATION; ALZHEIMERS-DISEASE; CELLS; DAMAGE; NEURONS; SYSTEM; MODEL; MICE	Background: We hypothesized that gp91(phox) (NOX2), a subunit of NADPH oxidase, generates superoxide anion (O-2(-)) and has a major causative role in traumatic brain injury (TBI). To evaluate the functional role of gp91(phox) and reactive oxygen species (ROS) on TBI, we carried out controlled cortical impact in gp91(phox) knockout mice (gp91(phox-/-)). We also used a microglial cell line to determine the activated cell phenotype that contributes to gp91(phox) generation. Methods: Unilateral TBI was induced in gp91(phox-/-) and wild-type (Wt) mice (C57/B6J) (25-30 g). The expression and roles of gp91(phox) after TBI were investigated using immunoblotting and staining techniques. Levels of O2-and peroxynitrite were determined in situ in the mouse brain. The activated phenotype in microglia that expressed gp91(phox) was determined in a microglial cell line, BV-2, in the presence of IFN gamma or IL-4. Results: Gp91(phox) expression increased mainly in amoeboid-shaped microglial cells of the ipsilateral hemisphere of Wt mice after TBI. The contusion area, number of TUNEL-positive cells, and amount of O-2(-) and peroxynitrite metabolites produced were less in gp91(phox-/-) mice than in Wt. In the presence of IFN gamma, BV-2 cells had increased inducible nitric oxide synthase and nitric oxide levels, consistent with a classical activated phenotype, and drastically increased expression of gp91(phox). Conclusions: Classical activated microglia promote ROS formation through gp91(phox) and have an important role in brain damage following TBI. Modulating gp91(phox) and gp91(phox)-derived ROS may provide a new therapeutic strategy in combating post-traumatic brain injury.	[Dohi, Kenji; Miyamoto, Kazuyuki; Aruga, Tohru] Showa Univ, Sch Med, Dept Emergency & Crit Care Med, Shinagawa Ku, Tokyo 1428555, Japan; [Ohtaki, Hirokazu; Nakamachi, Tomoya; Yofu, Sachiko; Satoh, Kazue; Song, Dandan; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Tokyo 1428555, Japan; [Tsunawaki, Shohko] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Setagaya Ku, Tokyo 1578535, Japan		Dohi, K (corresponding author), Showa Univ, Sch Med, Dept Emergency & Crit Care Med, Shinagawa Ku, Tokyo 1428555, Japan.	kdop@med.showa-u.ac.jp		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [20592128]; Japan Health Sciences Foundation	The authors thank Prof. Mary C. Dinauer for the supply the animals. The project was supported by a Showa University Grant-in-Aid for Innovative Collaborative Research Projects, by a Special Research Grant-in-Aid for the development of Characteristic education, and a Grant-in-Aid for Scientific Research (C) (No. 20592128, 2008) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (KD). This work was also supported in part by Research on Health Sciences focusing on Drug Innovation from The Japan Health Sciences Foundation (SS).	Abramov AY, 2005, PHILOS T R SOC B, V360, P2309, DOI 10.1098/rstb.2005.1766; Anantharam V, 2007, NEUROTOXICOLOGY, V28, P988, DOI 10.1016/j.neuro.2007.08.008; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dinauer MC, 1997, J IMMUNOL, V158, P5581; Dohi K, 2007, ANTIOXID REDOX SIGN, V9, P281, DOI 10.1089/ars.2007.9.281; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hilburger EW, 2005, NEUROSCI LETT, V377, P16, DOI 10.1016/j.neulet.2004.11.066; HUANG J, 2009, P NATL ACAD SCI US; Huh PW, 2000, EUR J PHARMACOL, V389, P79, DOI 10.1016/S0014-2999(99)00768-2; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kazama K, 2004, CIRC RES, V95, P1019, DOI 10.1161/01.RES.0000148637.85595.c5; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Liu SM, 2007, CAN J NEUROL SCI, V34, P356, DOI 10.1017/S031716710000682X; Lo W, 2007, NEUROSCI LETT, V414, P228, DOI 10.1016/j.neulet.2006.12.055; Miller AA, 2006, BRAIN RES, V1111, P111, DOI 10.1016/j.brainres.2006.06.082; MORIKAWA K, 2008, OPEN CRIT CARE MED J, V1, P33; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Qin B, 2006, NEUROBIOL AGING, V27, P1577, DOI 10.1016/j.neurobiolaging.2005.09.036; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Tang JP, 2005, J NEUROCHEM, V94, P1342, DOI 10.1111/j.1471-4159.2005.03292.x; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Yoshida LS, 1998, J BIOL CHEM, V273, P27879, DOI 10.1074/jbc.273.43.27879; Zekry D, 2003, IUBMB LIFE, V55, P307, DOI 10.1080/1521654031000153049	41	125	128	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUL 26	2010	7								41	10.1186/1742-2094-7-41			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	657AV	WOS:000282384200001	20659322	gold, Green Published			2022-02-06	
J	Gasparovic, C; Yeo, R; Mannell, M; Ling, J; Elgie, R; Phillips, J; Doezema, D; Mayer, AR				Gasparovic, Charles; Yeo, Ronald; Mannell, Maggie; Ling, Josef; Elgie, Robert; Phillips, John; Doezema, David; Mayer, Andrew R.			Neurometabolite Concentrations in Gray and White Matter in Mild Traumatic Brain Injury: An H-1-Magnetic Resonance Spectroscopy Study	JOURNAL OF NEUROTRAUMA			English	Article						cognitive; creatine; glutamate; mild traumatic brain injury; spectroscopy	PROTON MR SPECTROSCOPY; TEMPORAL WINDOW; N-ACETYLASPARTATE; GLUTAMATE RELEASE; CREATINE; CHOLINE; GLUTAMATE/GLUTAMINE; VULNERABILITY; METABOLITES; CHILDREN	Single-voxel proton magnetic resonance imaging (H-1-MRS) and proton MR spectroscopic imaging (H-1-MRSI) were used to compare brain metabolite levels in semi-acute mild traumatic brain injury (mTBI) patients (n = 10) and matched healthy controls (n = 9). The H-1-MRS voxel was positioned in the splenium, a region known to be susceptible to axonal injury in TBI, and a single H-1-MRSI slice was positioned above the lateral ventricles. To increase sensitivity to the glutamate (Glu) and the combined glutamate-glutamine (Glx) signal, an inter-pulse echo time shown to emphasize the major Glu signals was used along with an analysis method that reduces partial volume errors by using water as a concentration standard. Our preliminary findings indicate significantly lower levels of gray matter Glx and higher levels of white matter creatine-phosphocreatine (Cr) in mTBI subjects relative to healthy controls. Furthermore, Cr levels were predictive of executive function and emotional distress in the combined groups. These results suggest that perturbations in Cr, a critical component of the brain's energy metabolism, and Glu, the brain's major neurotransmitter, may occur following mTBI. Moreover, the different pattern of results for gray and white matter suggests tissue-specific metabolic responses to mTBI.	[Gasparovic, Charles; Yeo, Ronald; Mannell, Maggie; Ling, Josef; Phillips, John; Mayer, Andrew R.] Mind Res Network, Albuquerque, NM 87131 USA; [Gasparovic, Charles; Phillips, John; Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Elgie, Robert; Doezema, David] Univ New Mexico, Sch Med, Dept Emergency Med, Albuquerque, NM 87131 USA; [Yeo, Ronald] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Gasparovic, C (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall 1101 Yale Blvd NE, Albuquerque, NM 87131 USA.	chuck@unm.edu	Gasparovic, Charles/E-7289-2010		DOEUnited States Department of Energy (DOE) [DE-FG02-99ER62764]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24HD050836, R21-NS064464-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS064464] Funding Source: NIH RePORTER	This research was supported by grants from The Mind Research Network ( DOE grant no. DE-FG02-99ER62764), and from the National Institutes of Health ( grant R24HD050836 and R21-NS064464-01A1). Special thanks to Diana South and Cathy Smith for assistance with data collection.	Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Baslow MH, 2007, J MOL NEUROSCI, V32, P235, DOI 10.1007/s12031-007-0049-9; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Capizzano AA, 2007, J MAGN RESON IMAGING, V26, P1378, DOI 10.1002/jmri.21144; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Cimatti M, 2006, J Neurosurg Sci, V50, P83; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Di X, 1999, J NEUROTRAUM, V16, P195, DOI 10.1089/neu.1999.16.195; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Hattingen E, 2008, NEURORADIOLOGY, V50, P759, DOI 10.1007/s00234-008-0409-3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Inglese M, 2003, MAGNET RESON MED, V50, P190, DOI 10.1002/mrm.10481; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Koura SS, 1998, ACT NEUR S, V71, P244; KREIS R, 1993, J MAGN RESON SER B, V102, P9, DOI 10.1006/jmrb.1993.1056; Maniega SM, 2008, STROKE, V39, P2467, DOI 10.1161/STROKEAHA.107.507020; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mullins PG, 2008, MAGN RESON MED, V60, P964, DOI 10.1002/mrm.21696; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pouwels PJW, 1997, NMR BIOMED, V10, P73, DOI 10.1002/(SICI)1099-1492(199704)10:2<73::AID-NBM448>3.0.CO;2-4; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ramonet D, 2004, HIPPOCAMPUS, V14, P586, DOI 10.1002/hipo.10188; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Sakellaris G, 2008, ACTA PAEDIATR, V97, P31, DOI 10.1111/j.1651-2227.2007.00529.x; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Son BC, 2000, ACT NEUR S, V76, P13; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tayoshi S, 2009, SCHIZOPHR RES, V108, P69, DOI 10.1016/j.schres.2008.11.014; Thierry AGM, 2004, AM J NEURORADIOL, V25, P370; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vymazal J, 1999, RADIOLOGY, V211, P489, DOI 10.1148/radiology.211.2.r99ma53489; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Zauner A, 1996, ACT NEUR S, V67, P40	61	125	130	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2009	26	10					1635	1643		10.1089/neu.2009.0896			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	507CT	WOS:000270829200002	19355814	Green Published, Green Accepted			2022-02-06	
J	Vaishnavi, S; Rao, V; Fann, JR				Vaishnavi, Sandeep; Rao, Vani; Fann, Jesse R.			Neuropsychiatric Problems After Traumatic Brain Injury: Unraveling the Silent Epidemic	PSYCHOSOMATICS			English	Article							HEAD-INJURY; PSYCHIATRIC-ILLNESS; AXIS-I; DEPRESSION; RECOVERY; IMPACT; PSYCHOPATHOLOGY; METHYLPHENIDATE; REHABILITATION; INDIVIDUALS	Background: Traumatic brain injury (TBI) is a significant public health concern. According to the Centers for Disease Control and Prevention, about 1.4 million people in the United States sustain a TBI annually. Objective: This review places particular emphasis on the current knowledge of effective treatment of TBI symptoms, and proposes directions for future research. Results: Neuropsychiatric problems are more prevalent and longer-lasting in TBI patients than in the general population. About 40% of TBI victims suffer from two or more psychiatric disorders, and a similar percentage experience at least one unmet need for cognitive, emotional, or job assistance 1 year after injury. The entire spectrum of TBI severity, from mild to severe, is associated with an increase in psychiatric conditions. Conclusion: Despite the high incidence of severe consequences of TBI, there are scarce empirical data to guide psychiatric treatment. Some approaches that have been helpful include cognitive and behavioral therapy and pharmacologic treatment. The authors list specific research recommendations that could further identify useful therapeutic interventions. (Psychosomatics 2009; 50: 198-205)	[Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Johns Hopkins Sch Med, Div Geriatr Psychiat & Neuropsychiat, Seattle, WA 98195 USA; Univ Washington, Alexian Bros Behav Health, Alexian Bros Neurosci Inst, Seattle, WA 98195 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Fann, JR (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Johns Hopkins Sch Med, Div Geriatr Psychiat & Neuropsychiat, Box 356560, Seattle, WA 98195 USA.	fann@u.washington.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K23MH066894, R21HD053736]; NIDRR [H133G070016]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD053736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH066894] Funding Source: NIH RePORTER	Dr. Rao is supported by NIH Grant 5K23MH066894; Dr. Fann is supported by NIH Grants R21HD053736 and NIDRR Grant H133G070016.	Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BAKCHINE S, 1989, NEUROLOGY, V39, P777, DOI 10.1212/WNL.39.6.777; BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1080/j.1440-1614.2000.00758.x; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; DAMASIO H, 1994, SCIENCE, V265, P1159; Deb S, 1999, AM J PSYCHIAT, V156, P374; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Gennarelli T. A., 1987, HEAD INJURY, P108; Giles GM, 2007, BRAIN INJURY, V21, P505, DOI 10.1080/02699050701311729; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; HOGE CW, 2008, NEW ENGL J MED, V358, P525; Hornstein A, 1996, BRAIN INJURY, V10, P145, DOI 10.1080/026990596124647; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khouzam HR, 1998, GEN HOSP PSYCHIAT, V20, P62, DOI 10.1016/S0163-8343(97)00097-2; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Mcintosh TK, 1999, TRAUMATIC BRAIN INJU, P39; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; Umansky R, 2000, INT J NEUROPSYCHOPH, V3, P81, DOI 10.1017/S1461145700001723; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; [No title captured]	62	125	132	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	MAY-JUN	2009	50	3					198	205		10.1176/appi.psy.50.3.198			8	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	464VV	WOS:000267537700003	19567758				2022-02-06	
J	Belanger, HG; Uomoto, JM; Vanderploeg, RD				Belanger, Heather G.; Uomoto, Jay M.; Vanderploeg, Rodney D.			The Veterans Health Administration System of Care for Mild Traumatic Brain Injury: Costs, Benefits, and Controversies	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						screening; TBI; Veterans Health Administration	POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION-LIKE SYMPTOMS; OIF/OEF SERVICE MEMBERS; GULF-WAR VETERANS; MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL OUTCOMES; COGNITIVE PERFORMANCE; CLINICAL MANAGEMENT; EXPLOSION INJURIES; MAJOR DEPRESSION	The Veterans Health Administration's (VHA!s) Polytrauma System of Care, developed in response to a new cohort of patients back from Iraq and Afghanistan, is described with particular focus on the assessment and treatment of Mild traumatic bra-In Injury (mild TBI). The development of systemwide TBI screening within the VHA has been an ambitious and historic undertaking. As with any population-wide screening tool, there are benefits and costs associated with it. The purpose of this article is to identify and discuss the strengths and weaknesses of the VHA's TBI clinical reminder and subsequent evaluation and treatment processes. Complicating factors such as increased media attention and other contextual factors are discussed.	[Belanger, Heather G.; Vanderploeg, Rodney D.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Uomoto, Jay M.] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Uomoto, Jay M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA		Belanger, HG (corresponding author), James A Haley Vet Hosp, Dept Psychol, 13000 Bruce B Downs Blvd 117, Tampa, FL 33612 USA.	Heather.Belanger@va.gov	Uomoto, Jay/AAF-4809-2019		Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Health Administration (VHA)US Department of Veterans Affairs	The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration (VHA). Further support was provided by the James A. Haley Veterans' Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views of the Department of Veterans Affairs.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Belanger HG, 2005, J REHABIL RES DEV, V42, P403, DOI 10.1682/JRRD.2004.08.0095; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Binder LM, 1999, ARCH CLIN NEUROPSYCH, V14, P531, DOI 10.1016/S0887-6177(98)00047-X; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2008, ARCH CLIN NEUROPSYCH, V23, P731; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; *DEF VET BRAIN INJ, BLAST INJ FAQS; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; DICKER BG, 1992, J HEAD TRAUMA REHAB, V7, P83; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hunt SC, 2002, MIL MED, V167, P414; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johnston SC, 2005, NEUROLOGY, V65, P360; Kashida Hiroshi, 2006, Int J Clin Oncol, V11, P1, DOI 10.1007/s10147-005-0550-5; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lesho EP, 2005, MIL MED, V170, P243, DOI 10.7205/MILMED.170.3.243; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Mercado JM, 2008, ARCH CLIN NEUROPSYCH, V23, P731; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MITTENBERG W, 1997, J INT NEUROPSYCH SOC, V3, P13; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	62	125	125	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2009	24	1					4	13		10.1097/HTR.0b013e3181957032			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	427GT	WOS:000264768500003	19158591				2022-02-06	
J	Hildreth, AN; Mejia, VA; Maxwell, RA; Smith, PW; Dart, BW; Barker, DE				Hildreth, Amy N.; Mejia, Vicente A.; Maxwell, Robert A.; Smith, Philip W.; Dart, Benjamin W.; Barker, Donald E.			Adrenal suppression following a single dose of etomidate for rapid sequence induction: A prospective randomized study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	66th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 27-29, 2007	Las Vegas, NV	Amer Assoc Surg Trauma		adrenocortical insufficiency; etomidate; trauma	TRAUMATIC BRAIN-INJURY; ADRENOCORTICAL FUNCTION; SEPTIC SHOCK; CORTISOL; INHIBITION; RESPONSES; STEROIDOGENESIS; INSUFFICIENCY; EMERGENCY; MORTALITY	Background: The administration of etomidate for rapid sequence induction (RSI) has been linked to subsequent adrenocortical insufficiency in nontrauma patients. However, etomidate-related adrenocortical insufficiency has not been well studied in the trauma population. Purpose: We performed a prospective, randomized, controlled study to assess the effect of one dose of etomidate for RSI on adrenal function and its clinical significance during and after resuscitation in trauma patients. Methods: Adult trauma patients admitted to our Level I trauma center requiring RSI were randomized to receive etomidate 0.3 mg/kg and succinylcholine 1 mg/kg (E group) or fentanyl 100 mu g, midazolam 5 mg, and succinylcholine 1 mg/kg (FM group) for induction. A baseline serum cortisol level was drawn before RSI. Four to six hours after RSI, a postintubation serum cortisol level was drawn. An ACTH stimulation test was performed. Results: Thirty patients were enrolled: 18 E group patients and 12 FM group patients. No statistical difference was detected between the two groups with respect to age, injury severity score, and baseline serum cortisol. Mean serum cortisol levels were significantly lower in E group patients than in FM group patients 4 to 6 hours after intubation (18.2 vs. 27.8 mu g/dL, p < 0.05). Change in serum cortisol between baseline and postintubation levels was different (-12.8 mu g/dL +/- 9.6 mu g/dL vs. 1.1 mu g/dL +/- 7.6 mu g/dL, p < 0.01). Patients in the E group had an average increase in cortisol after ACTH administration of 4.2 mu g/dL +/- 4.9 mu g/dL vs. 11.2 mu g/dL +/- 6.1 mu g/dL in the FM group, p < 0.001. Patients in the E group required longer ICU lengths of stay (mean, 6.3 days vs. 1.5 days, p < 0.05), more ventilator days (mean, 28 days vs. 17 days, p < 0.01), and longer hospital lengths of stay (mean, 11.6 days vs. 6.4 days, p < 0.01). Conclusions:. The use of etomidate for RSI in trauma patients led to chemical evidence of adrenocortical insufficiency and may have contributed to increased hospital and ICU lengths of stay and increased ventilator days. Further studies should be considered to evaluate the safety profile of this drug in trauma patients.	[Hildreth, Amy N.; Mejia, Vicente A.; Maxwell, Robert A.; Smith, Philip W.; Dart, Benjamin W.; Barker, Donald E.] Univ Tennessee, Coll Med, Div Surg Crit Care, Dept Surg,Chattanooga Unit, Knoxville, TN 37996 USA		Hildreth, AN (corresponding author), Wake Forest Univ, Med Ctr, Dept Surg, Med Ctr Blvd, Winston Salem, NC 27157 USA.	ahildret@gmail.com	Barker, David JP/A-5671-2013; Hildreth, Amy/AAM-9196-2020				Absalom A, 1999, ANAESTHESIA, V54, P861; ALLOLIO B, 1984, KLIN WOCHENSCHR, V62, P1014, DOI 10.1007/BF01711723; ALLOLIO B, 1985, CLIN ENDOCRINOL, V22, P281, DOI 10.1111/j.1365-2265.1985.tb03241.x; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; BORNER U, 1985, DEUT MED WOCHENSCHR, V110, P750, DOI 10.1055/s-2008-1068899; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cotton BA, 2005, CRIT CARE MED, V33, pA46, DOI 10.1097/00003246-200512002-00170; CUNITZ G, 1978, CHILD BRAIN, V4, P205; DECOSTER R, 1985, ACTA ENDOCRINOL-COP, V110, P526, DOI 10.1530/acta.0.1100526; DEJONG FH, 1984, J CLIN ENDOCR METAB, V59, P1143, DOI 10.1210/jcem-59-6-1143; DIAGO MC, 1988, ANAESTHESIA, V43, P644, DOI 10.1111/j.1365-2044.1988.tb04148.x; DUTHIE DJR, 1985, BRIT J ANAESTH, V57, P156, DOI 10.1093/bja/57.2.156; Fellows I W, 1985, Eur J Anaesthesiol, V2, P285; FELLOWS IW, 1983, BRIT MED J, V287, P1835, DOI 10.1136/bmj.287.6408.1835; Fillinger MP, 2002, J CARDIOTHOR VASC AN, V16, P163, DOI 10.1053/jcan.2002.31057; FRAGEN RJ, 1984, ANESTHESIOLOGY, V61, P652, DOI 10.1097/00000542-198412000-00004; FRAGEN RJ, 1987, ANESTHESIOLOGY, V66, P839, DOI 10.1097/00000542-198706000-00026; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Ho JT, 2006, J CLIN ENDOCR METAB, V91, P105, DOI 10.1210/jc.2005-0265; Jameson P, 1997, ACTA ANAESTH SCAND, V41, P304, DOI 10.1111/j.1399-6576.1997.tb04683.x; LEDINGHAM IM, 1983, LANCET, V1, P1270; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; Mallios C, 1987, Ned Tijdschr Geneeskd, V131, P918; Mohammad Z, 2006, CRIT CARE, V10, DOI 10.1186/cc4979; Montalban C, 2001, ACTA ANAESTH SCAND, V45, P207, DOI 10.1034/j.1399-6576.2001.450212.x; Nicholson G, 2002, ANAESTHESIA, V57, P319, DOI 10.1046/j.1365-2044.2002.02450.x; Oglesby AJ, 2004, EMERG MED J, V21, P655, DOI 10.1136/emj.2003.009043; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Schulz-Stubner S, 2005, CRIT CARE MED, V33, P2723, DOI 10.1097/01.CCM.0000187093.71107.A8; SEAR J W, 1988, Acta Anaesthesiologica Belgica, V39, P87; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; WAGNER RL, 1984, ANESTHESIOLOGY, V61, P647, DOI 10.1097/00000542-198412000-00003; WATT I, 1984, ANAESTHESIA, V39, P973, DOI 10.1111/j.1365-2044.1984.tb08885.x; Zhang Y, 2000, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V22, P284	35	125	133	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2008	65	3					573	578		10.1097/TA.0b013e31818255e8			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	350BC	WOS:000259326400014	18784570				2022-02-06	
J	Lai, YC; Hickey, RW; Chen, YM; Bayir, H; Sullivan, ML; Chu, CT; Kochanek, PM; Dixon, CE; Jenkins, LW; Graham, SH; Watkins, SC; Clark, RSB				Lai, Yichen; Hickey, Robert W.; Chen, Yaming; Bayir, Huelya; Sullivan, Mara L.; Chu, Charleen T.; Kochanek, Patrick M.; Dixon, C. Edward; Jenkins, Larry W.; Graham, Steven H.; Watkins, Simon C.; Clark, Robert S. B.			Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						autophagosome; controlled cortical impact; GCEE; head injury; LC3; mitophagy	INDUCED OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; NEURONAL INJURY; TRANSGENIC MICE; DISEASE; RATS; MACROAUTOPHAGY; DEGENERATION; INVOLVEMENT; GLUTATHIONE	Autophagy is a homeostatic process for recycling of proteins and organelles, induced by nutrient deprivation and regulated by oxygen radicals. Whether autophagy is induced after traumatic brain injury (TBI) is not established. We show that TBI in mice results in increased ultrastructural and biochemical evidence of autophagy. Specifically, autophagosomal vacuoles and secondary lysosomes were frequently observed in cell processes and axons in ipsilateral brain regions by electron microscopy, and lipidated microtubule-associated protein light chain 3, a biochemical footprint of autophagy referred to as LC3 II, was increased at 2 and 24 h after TBI versus controls. Since oxygen radicals are believed to be important in the pathogenesis of TBI and are essential for the process of starvation-induced autophagy in vitro, we also sought to determine if treatment with the antioxidant gamma-glutamylcysteinyl ethyl ester (GCEE) reduced autophagy and influenced neurologic outcome after TBI in mice. Treatment with GCEE reduced oxidative stress and partially reduced LC3 II formation in injured brain at 24 h after TBI versus vehicle. Treatment with GCEE also led to partial improvement in behavioral and histologic outcome versus vehicle. Taken together, these data show that autophagy occurs after experimental TBI, and that oxidative stress contributes to overall neuropathology, in part by initiating or influencing autophagy.	[Lai, Yichen; Chen, Yaming; Bayir, Huelya; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Lai, Yichen; Chen, Yaming; Bayir, Huelya; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Hickey, Robert W.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Bayir, Huelya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Sullivan, Mara L.; Watkins, Simon C.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Dixon, C. Edward; Jenkins, Larry W.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Graham, Steven H.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA		Clark, RSB (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Watkins, Simon/ABG-2590-2021; Chu, Charleen T/B-1601-2008	Watkins, Simon/0000-0003-4092-1552; Chu, Charleen T/0000-0002-5052-8271; Kochanek, Patrick/0000-0002-2627-913X; Lai, Yi-Chen/0000-0002-9450-5506	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD040848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS038620] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08 HD 040848, T32 HD 40686, K08 HD040848] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS 30318, R01 NS 38620] Funding Source: Medline		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS68; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Clark RSB, 2007, J CEREBR BLOOD F MET, V27, P316, DOI 10.1038/sj.jcbfm.9600338; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Drake J, 2003, J NEUROSCI RES, V74, P917, DOI 10.1002/jnr.10810; Drake J, 2002, J NEUROSCI RES, V68, P776, DOI 10.1002/jnr.10266; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; JENKINS LW, 1981, ACTA NEUROPATHOL, V55, P205, DOI 10.1007/BF00691320; KALIMO H, 1982, J CEREBR BLOOD F MET, V2, pS19; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2006, AUTOPHAGY, V2, P302, DOI 10.4161/auto.2945; NEELY N, 1974, BIOCHEM BIOPH RES CO, V59, P680, DOI 10.1016/S0006-291X(74)80033-1; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	37	125	130	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2008	28	3					540	550		10.1038/sj.jcbfm.9600551			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	266DA	WOS:000253410400011	17786151	Bronze			2022-02-06	
J	Rotondi, AJ; Sinkule, J; Balzer, K; Harris, J; Moldovan, R				Rotondi, Armando J.; Sinkule, Jennifer; Balzer, Kathleen; Harris, Jeffrey; Moldovan, Rene			A qualitative needs assessment of persons who have experienced traumatic brain injury and their primary family caregivers	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						family needs; needs assessment; patient needs; person with TBI needs; traumatic brain injury	CRITICAL INCIDENT TECHNIQUE; CHRONIC ILLNESS; OF-LIFE; STROKE; RELATIVES; INTERVENTION; CONSEQUENCES; SERVICES; TBI	Objectives: To determine the expressed needs of persons with traumatic brain injury (TBI) and their primary family caregivers. Design: Semistructured interviews with content-analytic techniques to identify respondents' needs. Participants: Eighty persons with TBI, with an average time since their most severe TBI of 5.8 years, and 85 primary support persons. Results: Respondents described their needs via phases that paralleled transition's in settings, treatments, and responsibilities (ie, acute care, i.n-patient rehabilitation, return home, and living in the community). Prominent themes during in-patient phases included provider quality, emotional support, and understanding the injuries. Prominent themes during the latter 2 phases included guidance, life planning, community integration, and behavioral and emotional issues. Conclusions: Participants reported insufficient education and preparation for the future. Current methods of identifying needs may not be based on these populations' perceptions, and often miss the natural divisions of needs that occur over the course of treatment and rehabilitation. To meet their needs, services must be responsive to changes in needs over time, accessible to consumers of services for as long as they are required, and designed to be directed and customized by users.	Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; George Mason Univ, Dept Psychiat, Fairfax, VA USA		Rotondi, AJ (corresponding author), 612B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	rotondi@pitt.edu					Allen SM, 1997, MED CARE, V35, P1132, DOI 10.1097/00005650-199711000-00005; [Anonymous], 1998, NIH CONSENS STATEMEN, V16, P1; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; BRUZY S, 1977, SPECIALE, V26, P77; Bull M J, 1990, West J Nurs Res, V12, P758, DOI 10.1177/019394599001200605; Callan RJ, 1998, TOURISM MANAGE, V19, P93, DOI 10.1016/S0261-5177(97)00078-2; Campbell C H, 1988, Rehabil Nurs, V13, P320; CAMPLAIR PS, 1990, COMMUNITY INTEGRATIO, P207; CARNWATH TCM, 1987, BRIT MED J, V294, P409, DOI 10.1136/bmj.294.6569.409; Cleeland C S, 1986, J Pain Symptom Manage, V1, P209, DOI 10.1016/S0885-3924(86)80043-4; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Dixon L, 2001, PSYCHIAT SERV, V52, P903, DOI 10.1176/appi.ps.52.7.903; DRAPER BM, 1992, J AM GERIATR SOC, V40, P896, DOI 10.1111/j.1532-5415.1992.tb01986.x; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; GLASS TA, 1993, STROKE, V24, P64, DOI 10.1161/01.STR.24.1.64; Hallberg N, 1999, METHOD INFORM MED, V38, P66; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Mathis M, 1984, J Neurosurg Nurs, V16, P36; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCCUBBIN MA, 1996, HDB CHILD HLTH ASSES, P227; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; MOLTER NC, 1979, HEART LUNG, V8, P332; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Olvingson C, 2002, INT J MED INFORM, V68, P165, DOI 10.1016/S1386-5056(02)00074-6; Panting A, 1972, REHABILITATION, V38, P33; POULSHOCK SW, 1984, J GERONTOL, V39, P230, DOI 10.1093/geronj/39.2.230; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Rotondi AJ, 2002, J CRIT CARE, V17, P16, DOI 10.1053/jcrc.2002.33033; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Smith J E, 2000, Care Manag J, V2, P27; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Vadhan NP, 2001, J NERV MENT DIS, V189, P637, DOI 10.1097/00005053-200109000-00011; VOGT TM, 1992, J CLIN EPIDEMIOL, V45, P659, DOI 10.1016/0895-4356(92)90138-D; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WHYTE J, 1998, REHABILITATION MED P, P1191; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	46	125	128	1	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2007	22	1					14	25		10.1097/00001199-200701000-00002			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	130SX	WOS:000243820400002	17235227				2022-02-06	
J	Zurita, M; Vaquero, J				Zurita, Mercedes; Vaquero, Jesus			Bone marrow stromal cells can achieve cure of chronic paraplegic rats: Functional and morphological outcome one year after transplantation	NEUROSCIENCE LETTERS			English	Article						spinal cord injury; adult stem cells; paraplegia	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; INTRACEREBRAL TRANSPLANTATION; RECOVERY; TISSUE	Chronic paraplegia resulting from severe spinal cord injury (SCI) is considered to be an irreversible condition. Nevertheless, recent studies utilizing adult stem cells appear to offer promise in the treatment of this and other neurological diseases. Here, we show that progressive functional motor recovery is achieved over the course of the year following the administration of bone marrow stromal cells (BMSC) in traumatic central spinal cord cavities of adult rats with chronic paraplegia. At this time, functional recovery is almost complete and associated with evident nervous tissue regeneration in the previously injured spinal cord. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Univ Autonoma Madrid, Puerta Hierro Hosp, Neurosurg Serv, Mapfre Med Fdn,Neurosci Res Unit, Madrid 28035, Spain		Vaquero, J (corresponding author), Univ Autonoma Madrid, Puerta Hierro Hosp, Neurosurg Serv, Mapfre Med Fdn,Neurosci Res Unit, San Martin Porres 4, Madrid 28035, Spain.	jvaqueroc@telefonica.net					BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; Zurita M, 2000, SURG NEUROL, V54, P117, DOI 10.1016/S0090-3019(00)00287-1; Zurita M, 2001, SURG NEUROL, V55, P249, DOI 10.1016/S0090-3019(01)00442-6; Zurita M, 2004, NEUROREPORT, V15, P1105, DOI 10.1097/00001756-200405190-00004	14	125	153	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUL 10	2006	402	1-2					51	56		10.1016/j.neulet.2006.03.069			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	055FB	WOS:000238434300011	16713677				2022-02-06	
J	Chang, EF; Meeker, M; Holland, MC				Chang, EF; Meeker, M; Holland, MC			Acute traumatic intraparenchymal hemorrhage: Risk factors for progression in the early post-injury period	NEUROSURGERY			English	Article						computed tomography; contusion; intraparenchymal hematoma; progression; risk factors; traumatic brain injury	HEAD-INJURY; INTRACEREBRAL HEMATOMAS; SUBARACHNOID HEMORRHAGE; BRAIN-INJURY; BLOOD-FLOW; CT-SCAN; LESIONS; MANAGEMENT; CONTUSIONS; ISCHEMIA	OBJECTIVE: To characterize the natural course of traumatic intraparenchymal contusions and hematomas (IPHs) and to identify risk factors for IPH progression in the acute post-injury period. METHODS: A retrospective analysis was performed on a prospective observational database containing 113 head trauma patients exhibiting 229 initially nonoperated acute IPHs. The main outcome variable was radiographic evidence of IPH progression on serially obtained head computed tomographic (CT) scans. Secondary outcomes included the actual amount Of IPH growth and later surgical evacuation. Univariate and multivariate analyses (using a generalized estimate equation) were applied to both demographic and initial radiographic features to identify risk factors for IPH progression and surgery. RESULTS: Overall, 10 IPHs (4%) shrank, 133 (58%) remained unchanged, and 86 (38%) grew between the first and second heat! CT scan. IPH progression was independently associated with the presence of subarachnoid hemorrhage (odds ratio [OR], 1.6; 95% confidence interval [Cl], 1.12-2.3), presence of a subdural hematoma (OR, 1.1-3.43), and initial size (OR, 1.11; 95% Cl, 1.02-1.21, for each cm(3) 1.94; 95% Cl, volume). Size of initial IPH proportionately correlated with the amount of subsequent growth (linear regression, P < 0.001). Worsened Glasgow Coma Score between initial and follow-up head CT scan (OR, 8.6; 95% Cl, 1.5-50), IPH growth greater than 5 cm(3) (OR, 7.3; 95%, CI, 1.6-34), and effacement of basal cisterns on initial CT scan (OR, 9.0; 95% Cl, 1.5-52) were strongly associated with late surgical evacuation. CONCLUSION: A large proportion of IPHs progress in the acute post-injury period. IPHs associated with subarachnoid hemorrhage, a subdural hematoma, or large initial size should be monitored carefully for progression with repeat head CT imaging. Effacement of cisterns on the initial head CT scan was strongly predictive of failure of nonoperative management, thereby leading to surgical evacuation. These findings should be important factors in the understanding and management of IPH.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA		Chang, EF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,M 779, San Francisco, CA 94143 USA.	echang@itsa.ucsf.edu					BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Gean AD, 1994, IMAGING HEAD TRAUMA; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Naff NJ, 2001, NEUROSURGERY, V49, P614, DOI 10.1097/00006123-200109000-00015; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; PAPO I, 1980, NEUROSURGERY, V7, P337, DOI 10.1227/00006123-198010000-00005; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 2002, ACT NEUR S, V81, P81; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019	21	125	134	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2006	58	4					647	655		10.1227/01.NEU.0000197101.68538.E6			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	036BZ	WOS:000237047200020	16575328				2022-02-06	
J	Davis, DP; Idris, AH; Sise, MJ; Kennedy, F; Eastman, AB; Velky, T; Vilke, GM; Hoyt, DB				Davis, DP; Idris, AH; Sise, MJ; Kennedy, F; Eastman, AB; Velky, T; Vilke, GM; Hoyt, DB			Early ventilation and outcome in patients with moderate to severe traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; ventilation; intubation; resuscitation; head trauma; hyperventilation	SEVERE HEAD-INJURY; RAPID-SEQUENCE INTUBATION; CEREBRAL BLOOD-FLOW; RESPIRATORY-DISTRESS-SYNDROME; INDUCED LUNG INJURY; INTRACELLULAR CALCIUM-CONCENTRATION; KINASE-IV ACTIVITY; ENDOTRACHEAL INTUBATION; MECHANICAL VENTILATION; INTRACRANIAL-PRESSURE	Objectives: An increase in mortality has been reported with early intubation in severe traumatic brain injury, possibly due to suboptimal ventilation. This analysis explores the impact of early ventilation on outcome in moderate to severe traumatic brain injury. Design: Retrospective, registry-based analysis. Setting. This study was conducted in a large county trauma system that includes urban, suburban, and rural jurisdictions. Patients: Nonarrest trauma victims with a Head Abbreviated Injury Score of :3 were identified from our county trauma registry. Interventions. Intubated patients were stratified into 5 mm Hg arrival Pco(2) increments. Logistic regression was used to calculate odds ratios for each increment, adjusting for age, gender, mechanism of injury, year of injury, preadmission Glasgow Coma Scale score, hypotension, Head Abbreviated Injury Score, Injury Severity Score, POD and base deficit. Increments with the highest relative survival were used to define the optimal Pco(2), range. Outcomes for patients with arrival Pco(2) values inside and outside this optimal range were then explored for both intubated and nonintubated patients, adjusting for the same factors as defined previously. In addition, the independent outcome effect of hyperventilation and hypoventilation was assessed. Measurements and Main Results: A total of 890 intubated and 2,914 nonintubated patients were included. Improved survival was observed for the arrival Pco(2) range 30-49 mm Hg. Patients with arrival Pco(2) values inside this optimal range had improved survival and a higher incidence of good outcomes. Conversely, there was no improvement in outcomes for patients within this optimal Pco(2) range for nonintubated patients after adjusting for all of the factors defined previously. Both hyperventilation and hypoventilation were associated with worse outcomes in intubated but not nonintubated patients. The proportion of arrival Pco(2) values within the optimal range was lower for intubated vs. nonintubated patients. Conclusions. Arrival hypercapnia and hypocapnia are common and associated with worse outcomes in intubated but not spontaneously breathing patients with traumatic brain injury.	Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; Univ Texas SW, Div Trauma, Dallas, TX USA; Scripps Mercy Hosp, San Diego, CA 92103 USA; Sharp Mem Hosp & Rehabil Ctr, San Diego, CA 92123 USA; Scripps Mem Hosp, La Jolla, CA 92037 USA		Davis, DP (corresponding author), Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA.			Idris, Ahamed/0000-0001-7113-6499			Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Ausina A, 1998, ACT NEUR S, V71, P1; Bao Yinghui, 2000, Chin J Traumatol, V3, P210; Blomgren K, 2003, BIOCHEM BIOPH RES CO, V304, P551, DOI 10.1016/S0006-291X(03)00628-4; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bruehl C, 2003, J NEUROPHYSIOL, V89, P2489, DOI 10.1152/jn.01083.2002; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; COURNAND A, 1948, AM J PHYSIOL, V152, P162; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2003, J TRAUMA, V55, P713, DOI 10.1097/01.TA.0000037428.65987.12; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DAVIS DP, IN PRESS J TRAUMA; DAVIS DP, 2006, IN PRESS PREHOSP EME; di Bartolomeo S, 2003, EUR J EMERG MED, V10, P268, DOI 10.1097/01.mej.0000103466.32882.7b; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Falcone R E, 1996, Air Med J, V15, P163, DOI 10.1016/S1067-991X(96)90024-3; FEWELL JE, 1980, CIRC RES, V46, P125, DOI 10.1161/01.RES.46.1.125; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Fritz KI, 2004, NEUROCHEM RES, V29, P791, DOI 10.1023/B:NERE.0000018852.85899.85; Fritz KI, 2003, NEUROSCI LETT, V352, P211, DOI 10.1016/j.neulet.2003.08.049; Fritz KI, 2001, PEDIATR RES, V50, P586, DOI 10.1203/00006450-200111000-00009; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; HEDGES JR, 1988, ANN EMERG MED, V17, P469, DOI 10.1016/S0196-0644(88)80238-5; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; HENNING R, 1986, ANAESTH INTENS CARE, V14, P267, DOI 10.1177/0310057X8601400307; HURST JM, 1989, J TRAUMA, V29, P1637, DOI 10.1097/00005373-198912000-00008; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; Karch SB, 1996, AM J EMERG MED, V14, P617, DOI 10.1016/S0735-6757(96)90073-X; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Majima HJ, 1998, J BIOL CHEM, V273, P8217, DOI 10.1074/jbc.273.14.8217; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; MATTA B, 1994, J NEUROSURG ANESTH, V6, P280; MATTLE HP, 1995, NEUROLOGY, V45, P498, DOI 10.1212/WNL.45.3.498; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; OUYANG YB, 1994, EXP BRAIN RES, V101, P265, DOI 10.1007/BF00228746; OUYANG YB, 1994, BRAIN RES, V646, P65, DOI 10.1016/0006-8993(94)90058-2; Pace SA, 2000, ANN EMERG MED, V35, P568, DOI 10.1016/S0196-0644(00)70029-1; Pepe PE, 2003, J TRAUMA, V54, P1048, DOI 10.1097/01.TA.0000064280.05372.7C; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; PORTH CJM, 1984, HEART LUNG, V13, P507; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Potapenko E, 2004, NEUROCHEM RES, V29, P1659, DOI 10.1023/B:NERE.0000035800.65411.3e; Rosenthal RJ, 1998, J AM COLL SURGEONS, V187, P32, DOI 10.1016/S1072-7515(98)00126-4; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Schneider GH, 1998, ACT NEUR S, V71, P62; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Slutsky A S, 2000, Respir Res, V1, P73, DOI 10.1186/rr15; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; SYVERUD SA, 1988, ANN EMERG MED, V17, P236, DOI 10.1016/S0196-0644(88)80114-8; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Tobias JD, 1996, PEDIATR EMERG CARE, V12, P249, DOI 10.1097/00006565-199608000-00003; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tremblay LN, 2002, CRIT CARE MED, V30, P1693, DOI 10.1097/00003246-200208000-00003; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; VADEBONCOEUR TF, 2006, IN PRESS J EMERG MED; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vilke Gary M., 1994, Journal of Emergency Medicine, V12, P217, DOI 10.1016/0736-4679(94)90702-1; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wayne M A, 1999, Prehosp Emerg Care, V3, P107, DOI 10.1080/10903129908958916; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Zhang HB, 2002, ANESTHESIOLOGY, V97, P1426, DOI 10.1097/00000542-200212000-00014; Zornow MH, 2002, CRIT CARE MED, V30, P2774, DOI 10.1097/00003246-200212000-00026	81	125	129	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	APR	2006	34	4					1202	1208		10.1097/01.CCM.0000208359.74623.1C			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025YH	WOS:000236303000038	16484927				2022-02-06	
J	Zhao, J; Moore, AN; Clifton, GL; Dash, PK				Zhao, J; Moore, AN; Clifton, GL; Dash, PK			Sulforaphane enhances aquaporin-4 expression and decreases cerebral edema following traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						head trauma; intracranial pressure; Nrf2; phase II enzymes; vasogenic edema	CONTROLLED CORTICAL IMPACT; WATER CHANNELS; SPINAL-CORD; RAT-BRAIN; NULL MICE; MODEL; QUANTIFICATION; GLUTAMATE; RECEPTOR; IMMUNOREACTIVITY	Brain edema, the infiltration and accumulation of excess fluid causing an increase in brain tissue volume, often leads to a rise in intracranial pressure and is a key contributor to the morbidity and mortality associated with traumatic brain injury (TBI). The cellular and molecular mechanisms contributing to the development/ resolution of TBI-associated brain edema are poorly understood. Aquaporin-4 (AQP4) water channel is expressed at high levels in brain astrocytes, and the bidirectional transport of water through these channels is critical for the maintenance of brain water homeostasis. By using a rodent injury model, we show that TBI decreased AQP4 level in the injury core and modestly increased it in the penumbra region surrounding the core. Postinjury administration of sulforaphane (SUL), an isothiocyanate present in abundance in cruciferous vegetables such as broccoli, attenuated AQP4 loss in the injury core and further increased AQP4 levels in the penumbra region compared with injured animals receiving vehicle. These increases in AQP4 levels were accompanied by a significant reduction in brain edema (assessed by percentage water content) at 3 days post-injury. These findings suggest that the reduction of brain edema in response to SUL administration could be due, in part, to water clearance by AQP4 from the injured brain. (c) 2005 Wiley-Liss, Inc.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; Univ Texas, Sch Med, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049160, R01NS035457] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35457, NS049160] Funding Source: Medline		Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; ALFORD MF, 1994, J HISTOCHEM CYTOCHEM, V42, P283, DOI 10.1177/42.2.8288869; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Brus C, 2002, J CONTROL RELEASE, V84, P171, DOI 10.1016/S0168-3659(02)00295-X; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Kamuhabwa AAR, 2003, INT J ONCOL, V22, P933; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Khiabani KT, 2004, PLAST RECONSTR SURG, V114, P1846, DOI 10.1097/01.PRS.0000143580.45631.DD; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1994, ACTA NEUROCHIR, P3; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li Volti G, 2004, BIOCHEM BIOPH RES CO, V315, P517, DOI 10.1016/j.bbrc.2004.01.090; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P404, DOI 10.1097/00005072-199207000-00003; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nesic O, 2002, J NEUROSCI RES, V68, P406, DOI 10.1002/jnr.10171; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Redell JB, 2003, EXP BIOL MED, V228, P261, DOI 10.1177/153537020322800304; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; VERSCHURE PJ, 1994, J HISTOCHEM CYTOCHEM, V42, P765, DOI 10.1177/42.6.8189038	48	125	139	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV 15	2005	82	4					499	506		10.1002/jnr.20649			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	985QV	WOS:000233394100007	16211562				2022-02-06	
J	Leal-Cerro, A; Flores, JM; Rincon, M; Murillo, F; Pujol, M; Garcia-Pesquera, F; Dieguez, C; Casanueva, FF				Leal-Cerro, A; Flores, JM; Rincon, M; Murillo, F; Pujol, M; Garcia-Pesquera, F; Dieguez, C; Casanueva, FF			Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury	CLINICAL ENDOCRINOLOGY			English	Article							GH-RELEASING HORMONE; SEVERE HEAD-INJURY; POSTTRAUMATIC HYPOPITUITARISM; SUBARACHNOID HEMORRHAGE; DIAGNOSIS; REPRODUCIBILITY; HYPOTHYROIDISM; HYPOGONADISM; DYSFUNCTION; PEPTIDE-6	Objective Traumatic brain injury (TBI) has been associated with hypopituitarism and GH deficiency. However, TBI-mediated hypopituitarism may be more frequent than previously thought. The present work, performed in patients with severe TBI at least 1 year before, had three aims: (i) to evaluate the prevalence of hypopituitarism, (ii) in particular to evaluate the prevalence of GH deficiency, and (iii) to compare three different tests of GH reserve in this cohort. Design and patients From a nonselected group of 249 patients admitted to our Clinical Centre for severe TBI over the last 5 years, 200 of them answered a custom made questionnaire of symptoms of hypopituitarism enclosed in the invitation letter to participate in the study. A total of 170 (99 men and 14 women), accepted to participate in the study (study cohort); 57 had normal questionnaires and were not further studied, 14 discontinued the study, and 99 attended the hospital for dynamic tests of pituitary hormone deficiencies. From these, 44 subjects with IGF-I in the lower range were tested with GHRH+GHRP-6; ITT; and glucagon tests of GH reserve, on three different occasions. Measurements Pituitary hormones plus IGF-I and target gland hormones were analysed. Results With regard to the initial cohort of 170 subjects (100%), three (1.7%) showed diabetes insipidus; 10 (5.8%) TSH deficiency, 11 (6.4%) ACTH deficiency and 29 (17%) gonadotrophin deficiency. In 10 subjects (5.8%), GH deficiency was diagnosed by strict criteria. Finally, 15 (8.8%) showed combined deficit of several hormones. Conclusion After severe head trauma, gonadotrophin deficiency was the most common pituitary deficit. GH deficiency showed a prevalence similar to ACTH and TSH deficits, i.e. near 6% of the cohort. Taken together, 24.7% of the subjects studied showed any type of pituitary hormone deficiency.	Virgen Rocio Univ Hosp, Div Endocrinol, Seville, Spain; Virgen Rocio Univ Hosp, Intens Care Unit, Seville, Spain; Virgen Rocio Univ Hosp, Div Neurophysiol, Seville, Spain; Virgen Rocio Univ Hosp, Hormonal Lab, Seville, Spain; Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Dept Med, Endocrine Sect, Santiago De Compostela, Spain; Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Dept Physiol, Santiago De Compostela, Spain		Leal-Cerro, A (corresponding author), Virgen Rocio Hosp, Div Endocrinol, Seville 41013, Spain.	alfonso.leal@infonegocio.com					Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; BARRECA T, 1980, J CLIN ENDOCR METAB, V51, P1279, DOI 10.1210/jcem-51-6-1279; BASAVARAJU N, 1989, J AM GERIATR SOC, V37, P49, DOI 10.1111/j.1532-5415.1989.tb01568.x; Benvenga S, 1997, J ENDOCRINOL INVEST, V20, P675, DOI 10.1007/BF03348031; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Casanueva FF, 2005, ARCH PHYS MED REHAB, V86, P463, DOI 10.1016/j.apmr.2004.05.018; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; CASANUEVA FF, 2004, 10 YEARS KIMS, P91; CASTANER MF, 1981, MED CLIN, V78, P358; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Della Corte F, 1998, CRIT CARE MED, V26, P1419; EDWARDS OM, 1986, MEDICINE, V65, P281; EIHOLZER U, 1986, EUR J PEDIATR, V145, P128, DOI 10.1007/BF00441873; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; FISHER DA, 1998, QUEST DIAGNOSTIC MAN, P312; FLEISCHER AS, 1978, J NEUROSURG, V49, P650, DOI 10.3171/jns.1978.49.5.0650; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; GUNN IR, 1991, ANN CLIN BIOCHEM, V28, P327, DOI 10.1177/000456329102800402; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hoeck HC, 1999, GROWTH HORM IGF RES, V9, P18, DOI 10.1054/ghir.1998.0085; HOWLETT TA, 1997, DIAGNOSIS TREATMENT, P81; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lamberts SWJ, 1998, LANCET, V352, P127; Leal A, 2002, CLIN ENDOCRINOL, V57, P377, DOI 10.1046/j.1365-2265.2002.01623.x; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lieberman SA, 1996, J PEDIATR-US, V128, pS58, DOI 10.1016/S0022-3476(96)70013-6; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; McKenna SP, 1999, QUAL LIFE RES, V8, P373, DOI 10.1023/A:1008987922774; MONZANI F, 1993, CLIN INVESTIGATOR, V71, P367; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Popovic V, 2004, CLIN ENDOCRINOL, V60, P185, DOI 10.1046/j.1365-2265.2003.01955.x; POPOVIC V, 1995, J CLIN ENDOCR METAB, V80, P942, DOI 10.1210/jc.80.3.942; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Porter R. J., 1946, J NEUROL NEUROSUR PS, V11, P528; Rahim A, 1996, CLIN ENDOCRINOL, V45, P557; RUDMAN D, 1977, J CLIN ENDOCR METAB, V45, P747, DOI 10.1210/jcem-45-4-747; Segal-Lieberman G, 2000, Pituitary, V3, P181, DOI 10.1023/A:1011407910913; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; TOOGOOD AA, 1994, CLIN ENDOCRINOL, V41, P511, DOI 10.1111/j.1365-2265.1994.tb02583.x; WITTER M, 1957, FORTSCHR NEUROL PSYC, V25, P523	46	125	134	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	MAY	2005	62	5					525	532		10.1111/j.1365-2265.2005.02250.x			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	918PP	WOS:000228560400003	15853820				2022-02-06	
J	Bayir, H; Marion, DW; Puccio, AM; Wisniewski, SR; Janesko, KL; Clark, RSB; Kochanek, PM				Bayir, H; Marion, DW; Puccio, AM; Wisniewski, SR; Janesko, KL; Clark, RSB; Kochanek, PM			Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients	JOURNAL OF NEUROTRAUMA			English	Article						estrogen; female; F-2-isoprostane; free radical; head injury; women; oxidative stress	SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; TIRILAZAD MESYLATE; RADICAL PRODUCTS; FEMALE RATS; BLOOD-FLOW; BN 80933; PROGESTERONE; HYPOTHERMIA; ESTROGEN	Striking gender differences have been reported in the pathophysiology and outcome of acute neurological injury. Greater neuroprotection in females versus males may be due, in part, to direct and indirect sex hormone-mediated antioxidant mechanisms. Progesterone administration decreases brain levels of F-2-isoprostane, a marker of lipid peroxidation, after experimental traumatic brain injury (TBI) in male rats, and estrogen is neuroprotective in experimental neurological injury. In this study, we evaluated the effect of gender on lipid peroxidation, as assessed by cerebrospinal fluid (CSF) levels of F-2-isoprostane, after severe TBI in humans. Lipid peroxidation was assessed in CSF from 68 adults enrolled in two randomized controlled trials evaluating the effect of therapeutic hypothermia after severe TBI (Glasgow coma scale [GCS] score less than or equal to8). Patients treated with hypothermia (n = 41, 12 females, 29 males) were cooled to 32-33degreesC (within similar to6 h) for either 24 or 48 h and then re-warmed. F-2-isoprostane levels were assessed by ELISA in ventricular CSF samples (n = 199) on day 1, 2, and 3. The association between age, GCS score, time, gender, treatment, duration of treatment, core temperature at the time of CSF sampling, secondary hypoxemia, and CSF F-2-isoprostane level was assessed by multivariate and dichotomous analyses. F-2-isoprostane was similar to2-fold higher in males than females (145.8 +/- 39.6 versus 75.4 +/- 16.6 pg/mL, day 1p = 0.018). An effect of time after injury (p = 0.007) was reflected by a marked early peak in F-2-isoprostane (day 1). CSF F-2-isoprostane was also associated with hypoxemia (P = 0.04). Hypothermia tended to decrease F-2-isoprostane levels only in males on d1 after TBI. To our knowledge, this is the first study showing gender differences in lipid peroxidation after clinical TBI. Lipid peroxidation occurs early after severe TBI in adults and is more prominent in males vs females. These results established that gender is an important consideration in clinical trial design, particularly in the case of antioxidant strategies.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Epidemiol & Publ Hlth, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Marion, Donald/AAR-5749-2021; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, P50NS030318, P20NS030318] Funding Source: NIH RePORTER		Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bergeron R, 1996, J NEUROSCI, V16, P1193; BOCHICCHIO M, 1990, INTENS CARE MED, V16, P444, DOI 10.1007/BF01711223; Chabrier PE, 1999, P NATL ACAD SCI USA, V96, P10824, DOI 10.1073/pnas.96.19.10824; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Inder T, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000020088.11295.13; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KARIBE H, 1994, BRAIN RES, V649, P12, DOI 10.1016/0006-8993(94)91043-X; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Marin JG, 2000, NEUROREPORT, V11, P1357, DOI 10.1097/00001756-200004270-00041; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; MILVY P, 1973, ANN NY ACAD SCI, V222, P1102, DOI 10.1111/j.1749-6632.1973.tb15327.x; Montine TJ, 1999, NEUROLOGY, V52, P562, DOI 10.1212/WNL.52.3.562; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROOF RL, 1993, BEHAV BRAIN RES, V57, P41; Santizo R, 1999, J CEREBR BLOOD F MET, V19, P1061, DOI 10.1097/00004647-199910000-00001; SKORNYAKOV VJ, 1988, LAB DELO, V8, P14; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7	37	125	139	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2004	21	1					1	8		10.1089/089771504772695896			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	766GU	WOS:000188368700001	14987460				2022-02-06	
J	Erlanger, D; Feldman, D; Kutner, K; Kaushik, T; Kroger, H; Festa, J; Barth, J; Freeman, J; Broshek, D				Erlanger, D; Feldman, D; Kutner, K; Kaushik, T; Kroger, H; Festa, J; Barth, J; Freeman, J; Broshek, D			Development and validation of a web-based neuropsychological test protocol for sports-related return-to-play decision-making	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						sports concussion; return-to-play; Internet assessment; neuropsychology	MILD HEAD-INJURY; TEST-PERFORMANCE; CONCUSSION	The Concussion Resolution Index (CRI) is an online assessment tool designed to track resolution of symptoms following sports-related concussion. The CRI is composed of six subtests measuring reaction time, visual recognition, and speed of information processing. Three factors are derived from the subtests: Simple Reaction Time (SRT), Complex Reaction Time (CRT), and Processing Speed (PS). Multiple alternate forms within subtests afford simple, reliable, assessment of change, relative to a baseline test completed by an athlete. The test also assesses self-reported neurophysiological symptoms at the time of injury and tracks resolution of these symptoms. The data demonstrate the CRI is a valid and reliable measure of cognitive performance in a relatively heterogeneous group of athletes aged 13-35. Two methods of statistical analysis for assessing change from baseline were compared to establish a psychometric basis for retum-to-play decision-making: the Reliable Change Index (RCI) and multiple regression. Multiple regression was more accurate than the RCI in determining a decline in performance relative to the baseline. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd. All rights reserved.	HeadMinder Inc, New York, NY 10021 USA; Columbia Univ, New York, NY USA; Bergen Neuropsychol Grp, Hackensack, NJ USA; Weill Med Coll, New York, NY USA; Univ Virginia, Charlottesville, VA USA		Erlanger, D (corresponding author), HeadMinder Inc, Suite 5B,3 E 65th St, New York, NY 10021 USA.	david@headminder.com	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815			Baddeley A., 1992, SPEED CAPACITY LANGU; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 1989, MILD HEAD INJURY, P257; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Cantu, 1991, Adolesc Med, V2, P141; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Echemendia R. J., 1999, 107 ANN M AM PSYCH A; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JORDAN DD, 1994, P MILD BRAIN INJ SPO; KUTNER K, 1997, NFL PHYS SOC SPORTS; LANDRY G, 1994, P MILD BRAIN INJ SUM; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; McCrea M., 1997, STANDARDIZED ASSESSM; Sattler J. M., 1988, ASSESSMENT CHILDREN; Smith, 1973, SYMBOL DIGIT MODALIT; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Torg JS, 1982, ATHLETIC INJURIES HE; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	29	125	131	0	24	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2003	18	3					293	316	PII S0887-6177(02)00138-5	10.1016/S0887-6177(02)00138-5			24	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	666FJ	WOS:000182166200005	14591461	Bronze			2022-02-06	
J	Stancin, T; Drotar, D; Taylor, HG; Yeates, KO; Wade, SL; Minich, NM				Stancin, T; Drotar, D; Taylor, HG; Yeates, KO; Wade, SL; Minich, NM			Health-related quality of life of children and adolescents after traumatic brain injury	PEDIATRICS			English	Article						traumatic brain injury; health-related quality of life; functional outcomes	CLOSED-HEAD-INJURY; NEUROBEHAVIORAL SYMPTOMS; FAMILY BURDEN; SEVERITY; RECOVERY; RELIABILITY; PREDICTORS; SCALE	Objective. Relatively little is known about the longer-term impact of traumatic brain injury (TBI) on children's daily functioning, especially the broader outcome domain referred to as health-related quality of life (HRQL). The objective of the present study was to examine the nature and predictors of HRQL outcomes in children with moderate to severe TBI an average of 4 years postinjury. Methods. The study used a concurrent cohort-prospective design involving postinjury assessments of 3 groups of traumatically injured children and their families including 42 with severe TBI, 42 with moderate TBI, and 50 with orthopedic injuries only. Parent and child perceptions of HRQL and child adaptive behavior measures were obtained along with parent descriptions of the child's health problems and use of medical and mental health services. Predictors included indices of injury severity, social factors, and ratings of preinjury child behavior problems and school performance. Results. Based on parent report, adolescents who sustained severe TBI had lower HRQL related to overall psychosocial functioning and in the domains of behavior, mental health, general health, and family impact than adolescents who sustained orthopedic injuries only. Communication skills, daily living skills, and general adaptive functioning also were rated lower in the severe TBI group. In contrast to parent reports, adolescents with severe TBI did not rate their HRQL in most domains differently than did adolescents with orthopedic injuries. There were no group differences in frequency of persistent physical limitations. Sixty-seven percent of families of children with severe TBI used mental health counseling at some point after the injury. Risks for poorer HRQL outcomes were related to family social disadvantage and poorer preinjury child behavioral and academic functioning. Conclusions. Findings underscore the importance of using comprehensive measures of HRQL, along with traditional indicators of functional outcomes, when evaluating the longer-term impact of injuries in children. Identification of predictors suggests the need for close monitoring and intervention of high-risk children.	Metrohlth Med Ctr, Dept Pediat, Cleveland, OH 44109 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; Ohio State Univ, Columbus, OH 43210 USA; Columbus Childrens Hosp, Dept Pediat, Columbus, OH USA; Childrens Hosp Med Ctr, Dept Pediat Rehabil, Cincinnati, OH USA; Univ Cincinnati, Cincinnati, OH USA		Stancin, T (corresponding author), Metrohlth Med Ctr, Dept Pediat, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	tstancin@metrohealth.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36335] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ-390611] Funding Source: Medline		Achenbach, 1991, MANUAL TEACHERS REPO; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Drotar D, 1998, MEASURING HLTH RELAT; Ewing-Cobbs L, 1999, COGNITIVE ASPECTS OF CHRONIC ILLNESS IN CHILDREN, P262; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Hack M, 1999, Pediatrics, V103, P319; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1988, TRAUMATIC HEAD INJUR, P22; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; Landgraf JM, 1998, MEASURING HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS, P105; Landgraf JM, 1996, CHILD HLTH QUESTIONN; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MAYER T, 1984, J TRAUMA, V24, P31, DOI 10.1097/00005373-198401000-00004; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOOS RH, 1988, SOC SCI MED, V27, P999, DOI 10.1016/0277-9536(88)90291-2; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; RIVARA FP, 1991, PEDIATRICS, V88, P783; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Saigal S, 1998, MEASURING HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS, P151; Spieth LE, 1996, J PEDIATR PSYCHOL, V21, P175, DOI 10.1093/jpepsy/21.2.175; Spilker B, 1990, QUALITY LIFE ASSESSM; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; STEVENSONHINDE J, 1995, FAM PROCESS, V34, P337, DOI 10.1111/j.1545-5300.1995.00337.x; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TAYLOR HG, IN PRESS NEUROPSYCHO; TAYLOR HG, 2001, UNPUB REHABIL PSYCHO; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 1999, J DEV BEHAV PEDIATR, V20, P401, DOI 10.1097/00004703-199910000-00039; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Waters E, 1999, AMBULATORY CHILD HLT, V5, P131; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015; World Health Organization, 1948, CONS WHO; World Health Organization, 1980, INT CLASS IMP DIS HA; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; YEATES KO, 1998, J CLIN EXP NEUROPSYC, V19, P835	53	125	130	0	14	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	FEB	2002	109	2							e34	10.1542/peds.109.2.e34			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	517FV	WOS:000173601200016	11826244				2022-02-06	
J	Haigh, R; Tennant, A; Biering-Sorensen, F; Grimby, G; Marincek, C; Phillips, S; Ring, H; Tesio, L; Thonnard, JL				Haigh, R; Tennant, A; Biering-Sorensen, F; Grimby, G; Marincek, C; Phillips, S; Ring, H; Tesio, L; Thonnard, JL			The use of outcome measures in physical medicine and rehabilitation within Europe	JOURNAL OF REHABILITATION MEDICINE			English	Article						rehabilitation; outcome measure; cross-cultural; cross-diagnostic	HEALTH-STATUS; ARTHRITIS; INDEX; PAIN; DISABILITY; HIP	The aim of the study was to survey the use of outcome measures in rehabilitation within Europe. It was envisaged that this would provide the basis for further studies on the cross-cultural validity of outcome measures. A postal questionnaire was distributed in November 1998 to 866 units providing rehabilitation. In total, 418 questionnaires were returned, corresponding to a response rate of 48%. These 418 centres treated an estimated 113000 patients annually, undertaking 360000 assessments. The survey focused on nine diagnostic groups: hip and knee replacement, low back pain, lower limb amputees, multiple sclerosis, neuromuscular disorders, rheumatoid arthritis, spinal cord lesions, stroke and traumatic brain injury. It identified a relatively small number of dominant outcome assessments for each diagnostic group and some variation in the preference for measures across regions. A large number of measures, however, are being used in one or a small number of locations and with relatively few patients. For rehabilitation of orthopaedic patients the majority of assessments undertaken are at the impairment level. For patients with neurological disorders the emphasis is mostly upon measures of disability.	Univ Leeds, Rheumatol & Rehabil Res Unit, Res Sch Med, Leeds LS2 9NZ, W Yorkshire, England; Copenhagen Univ Hosp, Rigshosp, Ctr Neurosci, Clin Para & Tetraplegia, Copenhagen, Denmark; Sahlgrens Univ Hosp, Dept Rehabil Med, S-41345 Gothenburg, Sweden; Univ Ljubljana, Inst Rehabil, Ljubljana, Slovenia; Royal Natl Hosp Rheumat Dis, Bath Head Injury Neurorehabil Unit, Natl Hlth Serv Trust, Bath BA1 1RL, Avon, England; Tel Aviv Univ, Sch Med, Loewenstein Hosp, Rehabil Ctr, IL-69978 Tel Aviv, Israel; IRCCS, Dept Rehabil, Salvatore Maugeri Fdn, Pavia, Italy; Catholic Univ Louvain, Unite Readapt & Med Phys, Brussels, Belgium		Tennant, A (corresponding author), Univ Leeds, Rheumatol & Rehabil Res Unit, Res Sch Med, 36 Clarendon Rd, Leeds LS2 9NZ, W Yorkshire, England.		TESIO, Luigi/J-6202-2019; Grimby, Gunnar/AAB-3178-2019; TESIO, Luigi/A-1083-2008	TESIO, Luigi/0000-0003-0980-1587; TESIO, Luigi/0000-0003-0980-1587; Biering-Sorensen, Fin/0000-0002-2186-0144			American Spinal Injury Association, 2000, INT STAND NEUR CLASS; [Anonymous], 1985, Stroke, V16, P885; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Beck AT., 1979, COGNITIVE THERAPY DE; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; BERGNER M, 1976, INT J HEALTH SERV, V6, P393, DOI 10.2190/RHE0-GGH4-410W-LA17; Cohen ME, 2000, ARCH PHYS MED REHAB, V81, pS21, DOI 10.1053/apmr.2000.20620; Collen F M, 1991, Int Disabil Stud, V13, P50; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GREEN SB, 1977, EDUC PSYCHOL MEAS, V37, P827, DOI 10.1177/001316447703700403; HANTSON L, 1994, STROKE, V25, P2215, DOI 10.1161/01.STR.25.11.2215; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; KURTZKE JF, 1955, NEUROLOGY, V5, P580, DOI 10.1212/WNL.5.8.580; MAHONEY F I, 1965, Md State Med J, V14, P61; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Rasch Georg, 1980, PROBABILISTIC MODELS; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; TEASDALE G, 1974, LANCET, V2, P81; TurnerStokes L, 1997, CLIN REHABIL, V11, P306, DOI 10.1177/026921559701100407; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	31	125	127	0	18	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2001	33	6					273	278					6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	495RM	WOS:000172354200007	11766957				2022-02-06	
J	Curran, CA; Ponsford, JL; Crowe, S				Curran, CA; Ponsford, JL; Crowe, S			Coping strategies and emotional outcome following traumatic brain injury: A comparison with orthopedic patients	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						coping strategies; emotional outcome adjustment; traumatic brain injury	BLUNT HEAD-INJURY; PSYCHOSOCIAL ADJUSTMENT; MULTIPLE-SCLEROSIS; DEPRESSION; STRESS; REHABILITATION; INDIVIDUALS; PREDICTORS; APPRAISAL; SYMPTOMS	Objectives: To investigate coping strategies in relation to emotional adjustment in individuals with traumatic brain injury (TBI) 1-5 years postinjury and to compare these with a group of 40 participants who sustained serious orthopedic injuries. Design: Participants completed measures of handicap and coping strategies, and rated their levels of depression, anxiety and self-esteem on standardized questionnaires. Setting: Participants had received inpatient rehabilitation at Bethesda Hospital 1-5 years Drier to completing questionnaires. They were recruited from a list of consecutive admissions. Participants: 88 TBI individuals were compared with 40 participants who had sustained serious orthopedic injuries without damage to the central nervous system. They had all been involved in motor vehicle or work-related accidents. Outcome Measures: Beck Depression inventory (BDI) and State-Trait Anxiety inventory (STAI). Results: Consistent with previous studies; a significant proportion of the current sample displayed high levels of emotional distress. Results showed few differences between the TBI and orthopedic groups. Coping strategies characterized by worry, wishful thinking, and self-blame were associated with higher levels of depression and anxiety in both groups. Strategies focusing on problem solving and having a positive outlook were related to lower anxiety levels, but to a lesser degree. Conclusions: This study has provided further evidence that coping strategies are associated with emotional outcome in TBI individuals. There is now a growing empirical basis on which preliminary interventions can be based.	Epworth Med Fdn, Bethesda Rehabil Ctr, Dept Psychol, Richmond, Vic 3121, Australia; Monash Univ, Dept Psychol, Clayton, Vic 3168, Australia; La Trobe Univ, Dept Psychol Sci, Bundoora, Vic 3083, Australia		Curran, CA (corresponding author), Epworth Med Fdn, Bethesda Rehabil Ctr, Dept Psychol, Richmond, Vic 3121, Australia.	c.curran@bigpond.net.au		Crowe, Simon/0000-0002-4407-8542			Aikens JE, 1997, J BEHAV MED, V20, P433, DOI 10.1023/A:1025547431847; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P117; Band DA, 1998, BRIT J HEALTH PSYCH, V3, P245, DOI 10.1111/j.2044-8287.1998.tb00571.x; Beck A.T., 1987, MANUAL BECK DEPRESSI; BOMBARDIER CH, 1990, BEHAV RES THER, V28, P297, DOI 10.1016/0005-7967(90)90081-S; BROOKS C, 1992, J AM STUD, V26, P126, DOI 10.1017/S002187580003053X; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BRUDERMATTSON SF, 1990, J CLIN PSYCHOL, V46, P557, DOI 10.1002/1097-4679(199009)46:5<557::AID-JCLP2270460503>3.0.CO;2-1; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Crisp R., 1994, J APPL REHABILITATIO, V25, P16; DEGRAUW WP, 1989, J COLL STUDENT PSYCH, V4, P55; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Folkman S., 1984, STRESS; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Frydenberg E., 1996, COPING SCALE ADULTS; Frydenberg E., 1993, MANUAL ADOLESCENT CO; GARSKE GG, 1992, REHABIL COUNS BULL, V36, P44; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; HAGNEBO C, 1999, PSYCHOL HEALTH MED, V4, P17; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; HINKLEY BS, 1994, J PAIN SYMPTOM MANAG, V9, P175, DOI 10.1016/0885-3924(94)90128-7; Jean VM, 1999, J CLIN PSYCHOL, V55, P21, DOI 10.1002/(SICI)1097-4679(199901)55:1<21::AID-JCLP2>3.0.CO;2-B; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Knight RG, 1996, AUST PSYCHOL, V31, P48, DOI 10.1080/00050069608260176; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; KUYKEN W, 1994, COGNITIVE THER RES, V18, P403, DOI 10.1007/BF02357751; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; MALT U, 1992, PSYCHIAT MED, V3, P117; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; MOORE A, 1989, BRAIN INJURY, V4, P171; Moore A D, 1994, NeuroRehabilitation, V4, P122, DOI 10.3233/NRE-1994-4208; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; MOORE AD, 1994, CANADIAN J REHABILIT, V7, P193; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD J, 1996, INT PERSPECTIVES TRA, P434; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rosenberg M., 1965, SOC ADOLESCENT SELF; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; Siegel K, 1997, PSYCHOL REP, V81, P435, DOI 10.2466/pr0.1997.81.2.435; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Whatley SL, 1998, PSYCHOL REP, V83, P783; Wheeler G, 1996, SPINAL CORD, V34, P351, DOI 10.1038/sc.1996.64; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206	59	125	125	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2000	15	6					1256	1274		10.1097/00001199-200012000-00006			19	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	378ZX	WOS:000165617400006	11056407				2022-02-06	
J	Wurst, FM; Kempter, C; Seidl, S; Alt, A				Wurst, FM; Kempter, C; Seidl, S; Alt, A			Ethyl glucuronide - A marker of alcohol consumption and a relapse marker with clinical and forensic implications	ALCOHOL AND ALCOHOLISM			English	Article							SERUM	Ethyl glucuronide (EtG) is a non-volatile, water-soluble, direct metabolite of ethanol that can be detected in body fluids and hair. We investigated urine and serum samples from three patient groups: (1) 33 in-patients in acute alcohol withdrawal; (2) 30 detoxified in-patients (treated for at least 4 weeks) from a 'motivation station' and (3) 43 neuro-rehabilitation patients (non-alcoholics; most of them suffering from stroke, traumatic brain injury, Parkinson's disease etc.) using gas chromatography/ mass spectrometry (GC/MS) with deuterium-labelled EtG as the internal standard and additionally in the second group of patients using liquid chromatography (LC/MS-MS). We found no correlation between the concentration of EtG in urine at hospitalization and the blood-ethanol concentration (r = 0.17), the time frame of detection (r = 0.5) or the total amount of clomethiazole required for the treatment of withdrawal symptoms (r = 0.28). In four out of 30 in-patients from the 'motivation station' - where neither clinical impression nor routine laboratory findings gave indications of relapse - concentrations of EtG in urine ranged between 4.2 and 196.6 mg/l. EtG concentrations in urine of between 2.89 and 23.49 mg/l were found in seven out of 43 neuro-rehabilitation patients using GC/MS. The GC/MS and the LC/MS-MS results showed a correlation of 0.98 with Pearson's correlation test and 1.0 with Spearman's correlation test. We suggest that EtG is a marker of alcohol consumption that can be detected for an extended time period after the complete elimination of alcohol from the body. When used as a relapse marker with a specific time frame of detection intermediate between short- and long-term markers, EtG fills a clinically as well as forensically important gap. Its specificity and sensitivity exceed those of all other known ethanol markers.	Univ Ulm, Dept Psychiat 2, D-89312 Gunzburg, Germany; Univ Stuttgart, Dept Hydrochem & Hydrobiol, D-7000 Stuttgart, Germany; Univ Ulm, Dept Forens Med, Ulm, Germany		Wurst, FM (corresponding author), Univ Ulm, Dept Psychiat 2, Ludwig Heilmeyer Str 2, D-89312 Gunzburg, Germany.						Alt Andreas, 1997, Blutalkohol, V34, P360; BESSERER K, 1983, ZENTRALBLATT RECHTSM, V25, P369; HELANDER A, 1992, LIFE SCI, V50, P1207, DOI 10.1016/0024-3205(92)90320-O; HELANDER A, 1997, P 14 INT C ALC DRUGS, P223; HELANDER A, 1992, ALCOHOL CLIN EXP RES, V16, P607; JAAKONMAKI P. I., 1967, EUR J PHARMACOL, V1, P63, DOI 10.1016/0014-2999(67)90067-2; JOKELAINEN K, 1997, ALCOHOL ALCOHOLISM, V32, P342; KAMIL IA, 1952, BIOCHEM J, V51, P32; KOZU T, 1973, SHINZU IGAKU ZASSHI, V21, P595; MACHATA G, 1964, MIKROCHIM ICHOANAL, P262; MACHATA G, 1962, MIKROCHIM ACTA, P691; MALLACH HJ, 1987, ALKOHOLWIRKUNG BEIM, P13; Neubauer O, 1901, ARCH EXP PATHOL PHAR, V46, P133, DOI 10.1007/BF01977773; SACHS H, 1997, HAAR SPUR SPUREN HAA, P119; Schmitt G, 1997, J FORENSIC SCI, V42, P1099; SCHMITT G, 1995, J ANAL TOXICOL, V19, P91, DOI 10.1093/jat/19.2.91; Schmitt Georg, 1997, Blutalkohol, V34, P371; Seidl Stephan, 1998, Blutalkohol, V35, P174; SKOPP G, 1995, GTFCH S ARZN 1995 DI, P166; STICHT G, 1997, RECHTSMEDIZIN, V7, P184; THIERFELDER H, 1885, Z PHYSL CHEM, V9, P511; WURST FM, 1998, NERVENARZT, V69, P84; WURST FM, 1996, AKTUELLE PERSPEKTIVE, P378; WURST FM, 1996, J NEUROL, V243, P24; WURST FM, 1997, ALCOHOL ALCOHOLISM, V32, P327; WURST FM, 1995, ALCOHOL ALCOHOLISM, V30, P560	26	125	127	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0735-0414			ALCOHOL ALCOHOLISM	Alcohol Alcohol.	JAN-FEB	1999	34	1					71	77		10.1093/alcalc/34.1.71			7	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	167JR	WOS:000078629600012	10075405	Bronze			2022-02-06	
J	Galski, T; Tompkins, C; Johnston, MV				Galski, T; Tompkins, C; Johnston, MV			Competence in discourse as a measure of social integration and quality of life in persons with traumatic brain injury	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; LANGUAGE; DISORDERS; STROKE; ADULTS	Persisting difficulties in communication are a serious handicap faced by many after traumatic brain injury (TBI) and a major barrier to community reintegration. Conventional approaches to the study of communication problems after TBI have focused on the form of language production and expression, usually in terms of phonological, semantic and syntactical features. Most TBI patients, however, perform overall within normal ranges on these conventional indicators. More recently, attention was focused on language in its naturally-occurring form, that is, discourse, which is heavily influenced by linguistic, cognitive and social skills. Because most TBI patients are left with residual deficits in these areas, study of discourse abilities seem to be particularly suited to understanding their problems in communication and facilitating eventual reintegration into the community. This study was designed to determine if and how the conversational discourse of TBI patients differs from a matched non-TBI group and whether any identified variables are related to measures of outcome as measured by community integration and quality of life. Additionally, the study was designed to explore the relationship between TBI and features of discourse across conversational, narrative, procedural genres. TBI patients (n = 30) from an out-patient brain injury programme were compared to matched controls (n = 10) in the three discourse genres. Bivariate and multivariate analyses evaluated 23 measures of discourse efficiency, complexity, topic management, information and pragmatic behaviours in each genre as well as measures of psyshosocial adjustment, particularly social integration and quality of life. Results indicated that TBIs were significantly different from controls on several measures of discourse and psychosocial adjustment. A number of other features of discourse were found to correlate significantly with social integration and quality of life. Interestingly, discourse variables appeared to correlate with social integration more strongly than age, gender, education, and other conventional psychosocial factors. Contrary to prediction, features of conversational discourse did not correlate more strongly than other types of discourse with social integration and quality of life. Discussion centred on the apparent comorbidity of features in everyday discourse and psychosocial deteriminants that were associated with quality of life and social integration.	Kessler Inst Rehabil, E Orange, NJ 07018 USA; UMDNJ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Galski, T (corresponding author), Kessler Inst Rehabil, E Orange, NJ 07018 USA.						Astrom M, 1996, STROKE, V27, P270, DOI 10.1161/01.STR.27.2.270; ATEN JL, 1994, LANGUAGE INTERVENTIO, P300; Beck, 1978, BECK DEPRESSION INVE; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; BUTLER RB, 1994, TOP GERIATR REHABIL, V10, P71; COCHRANE R, 1984, J NEUROLOGICAL COMMU, V1, P4; COEHLO CA, 1994, WORKSH C MAN DISC PR; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Cohen NJ, 1996, J CLIN CHILD PSYCHOL, V25, P192, DOI 10.1207/s15374424jccp2502_8; DAHLSTROM WG, 1975, MMPI HDB, V1; DEBEAUGRANDE R, 1980, TEXT DISCOURSE PROCE; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Evans D, 1989, QUALITY LIFE QUESTIO; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GLOSSER G, 1988, J SPEECH HEAR DISORD, V53, P115, DOI 10.1044/jshd.5302.115; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HALLIDAY MAK, 1989, LANGUAGE CONTENT TEX; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hathaway S. R., 1982, MINNESOTA MULTIPHASI; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Hunt K. W., 1965, 3 NAT COUNC TEACH EN; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; MALKMUS D, 1980, REHABILITATION HEAD; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; Mattis S, 1988, DEMENTIA RATING SCAL; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Milton S. B., 1986, CLIN NEUROPSYCHOLOGY, P223, DOI [10.1007/978-1-4613-2291-7_11, DOI 10.1007/978-1-4613-2291-7_11]; MILTON SB, 1984, P CLIN APH C, P114; Montgomery K.M., 1983, INT NEUR SOC M MEX C; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Murray H.A., 1938, EXPLOR PERS; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P18; ROBINSON RG, 1993, DEPRESSION NEUROLOGI, P1; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SHADDEN BB, 1994, WORKSH C MAN DISC PR; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1997, BRAIN INJURY, V11, P409; *SPSS INC, 1997, SYSTAT 7 0 STAT; STERN RA, 1991, AM J PSYCHIAT, V148, P351; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	54	125	126	0	15	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	1998	12	9					769	782		10.1080/026990598122160			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	117ET	WOS:000075768500005	9755368				2022-02-06	
J	Trudeau, DL; Anderson, J; Hansen, LM; Shagalov, DN; Schmoller, J; Nugent, S; Barton, S				Trudeau, DL; Anderson, J; Hansen, LM; Shagalov, DN; Schmoller, J; Nugent, S; Barton, S			Findings of mild traumatic brain injury in combat veterans with PTSD and a history of blast concussion	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Neuronal-Regulation	SEP   19, 1996	MARCO ISLAND, FLORIDA	Soc Neuronal Regulat			DEFICIT HYPERACTIVITY DISORDER; HEAD-INJURY; ATTENTION	Veterans with chronic posttraumatic stress disorder were evaluated for a history of blast concussion, controlling for confounding conditions. Electroencephalograms were analyzed by discriminant function for traumatic brain injury. A difference was found in discriminant scores between veterans with and without blast concussion. More members of the blast group had attentional symptoms and attentional dysfunction. Combat veterans with a remote history of blast injury have persistent electroencephalographic features of traumatic brain injury as well as attentional problems. The authors hypothesize that these constitute a type of chronic postconcussive syndrome that has cognitive and mood symptoms overlapping those of posttraumatic stress disorder.	VAMC, Dept Psychiat, Minneapolis, MN 55417 USA; Univ Minnesota, Dept Psychiat, Minneapolis, MN USA; Univ Minnesota, Dept Family Med & Community Hlth, Minneapolis, MN USA; Univ Minnesota, Res Explorat Program, Minneapolis, MN USA		Trudeau, DL (corresponding author), VAMC, Dept Psychiat, 1 Vet Dr,116A4, Minneapolis, MN 55417 USA.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Braverman ER, 1996, CLIN ELECTROENCEPHAL, V27, P5, DOI 10.1177/1550059496027S0402; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUFFY FH, 1994, CLIN ELECTROENCEPHAL, V25, pR6, DOI 10.1177/155005949402500403; DUPUY TR, 1993, TOVA MANUAL; Epstein Richard S., 1994, P285; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; HOFFMAN DA, 1994, J NEUROPSYCH CLIN N, V6, P332; HUDSPETH WJ, 1994, NEUROREP QEEG ANAL R; Jennett B, 1981, MANAGEMENT HEAD INJU; LEVI L, 1990, ISRAEL J MED SCI, V26, P555; Lovell Mark R., 1994, P133; LUBAR JO, 1984, BIOFEEDBACK SELF-REG, V9, P1, DOI 10.1007/BF00998842; McAllister Thomas W., 1994, P357; PACKARD RC, 1994, SEMIN NEUROL, V14, P74, DOI 10.1055/s-2008-1041062; PENISTON EG, 1991, MED PSYCHOTHERAPY, V4, P1; Rattok J, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI 10.1097/00001199-199602000-00011; RUMPL E, 1993, ELECTROENCEPHALOGRAP, P383; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SPENCER T, 1995, ARCH GEN PSYCHIAT, V52, P434; Thatcher R. W., 1989, ELECTROENCEPHALOGR C, V73, DOI [10.1016/0013-4694(89)90188-0, DOI 10.1016/0013-4694(89)90188-0, https://doi.org/10.1016/0013-4694(89)90188-0]; Treadwell I, 1989, Nurs RSA, V4, P32; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; WARD MF, 1993, AM J PSYCHIAT, V150, P885	24	125	126	0	4	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	1998	10	3					308	313		10.1176/jnp.10.3.308			6	Clinical Neurology; Neurosciences; Psychiatry	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	106GJ	WOS:000075121300006	9706538				2022-02-06	
J	Murakami, K; Kondo, T; Epstein, CJ; Chan, PH				Murakami, K; Kondo, T; Epstein, CJ; Chan, PH			Overexpression of CuZn-superoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice	STROKE			English	Article						cerebral ischemia, global; superoxide dismutase; hippocampus; mice	TRANSIENT FOREBRAIN ISCHEMIA; DELAYED NEURONAL DEATH; FOCAL CEREBRAL-ISCHEMIA; APOPTOTIC CELL-DEATH; TRAUMATIC BRAIN INJURY; NITRIC-OXIDE SYNTHASE; RAT-BRAIN; NEUROTROPHIC FACTOR; DNA FRAGMENTATION; PROTEIN-SYNTHESIS	Background and Purpose The role of copper, zinc-superoxide dismutase (CuZn-SOD) in hippocampal injury after transient global ischemia was studied using transgenic (Tg) mice and wild-type littermates. Methods Global ischemia was induced by bilateral common carotid artery occlusion. The hemisphere with the hypoplastic posterior communicating artery was determined and then the hippocampus in this hemisphere was evaluated qualitatively using a score of 0 to 4 and quantitatively using an image analyzer. Results Hippocampal injury was reduced in Tg mice after both 5 and 10 minutes of ischemia. In the 5-minute ischemia group, the mean score of the injury was significantly lower in Tg than nontransgenic (nTg) mice at 3 days. In the 10-minute group, the hippocampal injury was reduced more in Tg than nTg mice at 1 day. Quantitative evaluation by an image analyzer confirmed the qualitative data. Neurons with fragmented DNA were also studied in the hippocampal injury. In the 5-minute group, despite the reduction of the injury in Tg mice, their neurons with fragmented DNA were relatively increased at 1 day. In the 10-minute group, this ratio was almost the same in both nTg and Tg mice. Conclusions CuZn-SOD plays a protective role in the pathogenesis of selective hippocampal injury after brief ischemia, whether the insult is relatively mild or intense. Furthermore, CuZn-SOD may reduce both necrotic and DNA fragmented neuronal death after global ischemia.	UNIV CALIF SAN FRANCISCO,SCH MED,CNS INJURY & EDEMA RES CTR,DEPT PEDIAT,SAN FRANCISCO,CA; UNIV CALIF SAN FRANCISCO,SCH MED,CNS INJURY & EDEMA RES CTR,DEPT NEUROL SURG & NEUROL,SAN FRANCISCO,CA						NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P-02-AG-68938] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-25372, P-56-NS-14543] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS014543, P01NS014543, R01NS025372] Funding Source: NIH RePORTER		ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; BECK T, 1994, J CEREBR BLOOD F MET, V14, P689, DOI 10.1038/jcbfm.1994.86; BERGA P, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1314; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; CHAN PH, 1990, STROKE, V21, P80; CHAN PH, 1993, NEUROREPORT, V5, P293, DOI 10.1097/00001756-199312000-00028; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Copin JC, 1996, J NEUROTRAUM, V13, P233, DOI 10.1089/neu.1996.13.233; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; ERDOGDU G, 1993, METAB BRAIN DIS, V8, P199, DOI 10.1007/BF01001061; FERRER I, 1995, ACTA NEUROPATHOL, V90, P504; FRANK L, 1993, EXP BRAIN RES, V95, P70; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HOSSMANN KA, 1993, RESUSCITATION, V26, P225, DOI 10.1016/0300-9572(93)90143-E; KAMEYAMA M, 1985, STROKE, V16, P489, DOI 10.1161/01.STR.16.3.489; Kamii H, 1996, J CEREBR BLOOD F MET, V16, P1153, DOI 10.1097/00004647-199611000-00009; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KITAGAWA K, 1990, NEUROSCIENCE, V35, P551, DOI 10.1016/0306-4522(90)90328-2; KOIDA M, 1989, JPN J PHARMACOL, V51, P273, DOI 10.1254/jjp.51.273; KONTOS HA, 1985, CIRC RES, V57, P508, DOI 10.1161/01.RES.57.4.508; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; LINNIK MD, 1995, MOL BRAIN RES, V32, P116, DOI 10.1016/0169-328X(95)00069-5; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MOLLER A, 1994, NEW STRATEGIES PREVE, P125; MURAKAMI K, 1995, SOC NEUR ABSTR, V53, P1730; NITATORI T, 1995, J NEUROSCI, V15, P1001; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Panahian N, 1996, NEUROSCIENCE, V72, P343, DOI 10.1016/0306-4522(95)00563-3; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; RINK A, 1995, AM J PATHOL, V147, P1575; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TAKEDA A, 1992, BRAIN RES, V569, P177, DOI 10.1016/0006-8993(92)90388-P; TAKEDA A, 1993, NEUROSCIENCE, V55, P23, DOI 10.1016/0306-4522(93)90451-K; TOSAKI A, 1985, STROKE, V16, P501, DOI 10.1161/01.STR.16.3.501; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; TRUELOVE D, 1994, FREE RADICAL BIO MED, V17, P445, DOI 10.1016/0891-5849(94)90171-6; TSUKAHARA T, 1994, NEUROSURGERY, V34, P323, DOI 10.1227/00006123-199402000-00016; WELSH FA, 1987, J NEUROCHEM, V49, P846, DOI 10.1111/j.1471-4159.1987.tb00971.x; WIDMANN R, 1991, J NEUROCHEM, V56, P789, DOI 10.1111/j.1471-4159.1991.tb01993.x; YAMAMOTO M, 1987, ARCH INT PHARMACOD T, V290, P16; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; ZINI I, 1992, NEUROSCI LETT, V138, P279, DOI 10.1016/0304-3940(92)90933-X	52	125	126	0	1	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0039-2499			STROKE	Stroke	SEP	1997	28	9					1797	1804		10.1161/01.STR.28.9.1797			8	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	XW442	WOS:A1997XW44200025	9303028				2022-02-06	
J	Powell, JH; AlAdawi, S; Morgan, J; Greenwood, RJ				Powell, JH; AlAdawi, S; Morgan, J; Greenwood, RJ			Motivational deficits after brain injury: Effects of bromocriptine in 11 patients	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						motivation; abulia; dopamine; bromocriptine	VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; PARKINSONS-DISEASE; DOPAMINE; RAT; REWARD; STIMULATION; DEPRESSION; DISORDERS; BEHAVIOR	Objective-To test the hypothesis that treatment with bromocriptine would ameliorate deficits in clinical motivation, responsiveness to reward, and frontal cognitive function after brain injury. Method-An open trial in six men and five women who had had either traumatic brain injury or subarachnoid haemorrhage between two months and five years previously. After repeated baseline assessments, bromocriptine was given in gradually increasing doses. Assessments were repeated at increasing doses, during maintenance, and after withdrawal. Novel structured instruments for quantifying motivation were developed; measures of anxiety and depression, and cognitive tests sensitive to motivation or frontal lobe involvement were also given. Results-Bromocriptine treatment was followed by improved scores on all measures other than mood. Improvement was maintained after bromocriptine withdrawal in eight of the patients. Conclusion-Poor motivation in patients with brain injury may result from dysfunction in the mesolimbic/mesocortical dopaminergic circuitry, giving rise to associated deficiencies in reward responsiveness and frontal cognitive function.	HOMERTON HOSP, REG NEUROL REHABIL UNIT, LONDON E9 6SR, ENGLAND; INST PSYCHIAT, DEPT PSYCHOL, LONDON SE5 8AF, ENGLAND		Powell, JH (corresponding author), UNIV LONDON GOLDSMITHS COLL, DEPT PSYCHOL, LEWISHAM WAY, LONDON SE14 6NW, ENGLAND.		Al-Adawi, Samir/A-9663-2016	Al-Adawi, Samir/0000-0002-9858-5582			BARRETT K, 1991, J NEUROL NEUROSUR PS, V54, P718, DOI 10.1136/jnnp.54.8.718; BENTON AL, 1986, NEUROPSYCHOLOGIA, V6, P63; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BOZARTH MA, 1981, LIFE SCI, V28, P551, DOI 10.1016/0024-3205(81)90148-X; BOZARTH MA, 1981, LIFE SCI, V29, P1881, DOI 10.1016/0024-3205(81)90519-1; BROWN AS, 1993, J NEURAL TRANSM-GEN, V91, P75, DOI 10.1007/BF01245227; BURGESS PW, 1990, COGNITIVE REHABILITA; BURTON K, 1984, NEUROL CLIN, V2, P461, DOI 10.1016/S0733-8619(18)31084-3; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; ECHIVERRI HC, 1988, PEDIATR NEUROL, V4, P228, DOI 10.1016/0887-8994(88)90036-7; FIORINO DF, 1993, BEHAV BRAIN RES, V55, P131, DOI 10.1016/0166-4328(93)90109-4; GOODWIN FK, 1974, NEUROPSYCHOPHARMACOL, P261; Huynh H., 1976, J EDUC STAT, V1, P69, DOI [10.3102/10769986001001069, DOI 10.3102/10769986001001069, 10.2307/1164736]; LEVIMINZI S, 1991, COMPR PSYCHIAT, V32, P210, DOI 10.1016/0010-440X(91)90041-A; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LIDDLE PF, 1993, BEHAV NEUROL, V6, P49, DOI 10.3233/BEN-1993-6108; LINDVALL O, 1978, BRAIN RES, V142, P1, DOI 10.1016/0006-8993(78)90173-7; MULLER U, 1994, PROG NEURO-PSYCHOPH, V18, P1103, DOI 10.1016/0278-5846(94)90114-7; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; PARKS RW, 1992, J NEUROPSYCH CLIN N, V4, P109; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; PORTIN R, 1980, PARKINSONS DISEASE C, P270; RICHARDS PM, 1989, J CONSULT CLIN PSYCH, V57, P396, DOI 10.1037/0022-006X.57.3.396; ROBERTSON A, 1978, CAN J PSYCHOL, V32, P67, DOI 10.1037/h0081677; ROSS ED, 1981, NEUROLOGY, V31, P1435, DOI 10.1212/WNL.31.11.1435; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; SHAKOW D, 1963, BEHAV SCI, V8, P275; THIERRY AM, 1976, NATURE, V263, P242, DOI 10.1038/263242a0; THORNER MO, 1989, BASIC CLIN ASPECTS N, V3, P19; VANPRAAG HM, 1975, PSYCHOL MED, V5, P138, DOI 10.1017/S0033291700056385; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Vikki Juhani, 1994, Journal of Clinical and Experimental Neuropsychology, V16, P325; Wechsler D., 1986, WECHSLER ADULT INTEL; WEDDELL RA, 1995, BEHAV PHARMACOL, V6, P81; WILNER P, 1991, MESOLIMBIC DOPAMINE, P387; WISE RA, 1978, BRAIN RES, V152, P215, DOI 10.1016/0006-8993(78)90253-6; Wise RA, 1982, NEURAL BASIS FEEDING, P445; YOSHIDA M, 1992, NEUROSCI LETT, V139, P73, DOI 10.1016/0304-3940(92)90861-Z; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	125	126	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	1996	60	4					416	421		10.1136/jnnp.60.4.416			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	UD872	WOS:A1996UD87200013	8774407	Bronze, Green Published			2022-02-06	
J	DIETRICH, AM; BOWMAN, MJ; GINNPEASE, ME; KOSNIK, E; KING, DR				DIETRICH, AM; BOWMAN, MJ; GINNPEASE, ME; KOSNIK, E; KING, DR			PEDIATRIC HEAD-INJURIES - CAN CLINICAL FACTORS RELIABLY PREDICT AN ABNORMALITY ON COMPUTED-TOMOGRAPHY	ANNALS OF EMERGENCY MEDICINE			English	Article								Study objective: To assess clinical features that might reliably predict the need for computed tomography (CT) imaging in pediatric head trauma. Design/setting/type of participant: Prospective cohort of 324 head CT scans performed on 322 consecutive trauma patients at an urban children's hospital. Results: Sixty-two percent of patients were male. The mean age was 7.1 years (10 days to 20.6 years); half were less than 5 years of age. The two most frequent mechanisms of injury were falls (32%) and motor vehicle accidents (25%). Abnormalities were detected in 74 scans. Intracranial injuries were apparent in 39 patients (12%); 16 had a concomitant fracture. An isolated cranial abnormality was observed on 35 scans (11%). Loss of consciousness, amnesia for the event, a Glasgow Coma Scale (GCS) of less than 15, and the presence of a neurologic deficit were more common in children with intracranial injury (P<.05). Vomiting, seizures, and headache were not discriminating clinical features. No single characteristic consistently identified the children with an intracranial injury. Of the 195 children who were neurologically intact (GCS, 15) at the time of presentation, 11 (5%) had evidence of intracranial pathology on CT scan. Conclusion: This study demonstrates a poor correlation between the clinical symptoms of significant traumatic brain injury and findings on CT.			DIETRICH, AM (corresponding author), CHILDRENS HOSP,DEPT PEDIAT,EMERGENCY MED SECT,700 CHILDRENS DR,COLUMBUS,OH 43205, USA.		Bowman, Mary/E-2790-2011					0	125	128	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	OCT	1993	22	10					1535	1540		10.1016/S0196-0644(05)81254-5			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LZ645	WOS:A1993LZ64500004	8214831				2022-02-06	
J	Waljas, M; Iverson, GL; Lange, RT; Hakulinen, U; Dastidar, P; Huhtala, H; Liimatainen, S; Hartikainen, K; Ohman, J				Waljas, Minna; Iverson, Grant L.; Lange, Rael T.; Hakulinen, Ullamari; Dastidar, Prasun; Huhtala, Heini; Liimatainen, Suvi; Hartikainen, Kaisa; Ohman, Juha			A Prospective Biopsychosocial Study of the Persistent Post-Concussion Symptoms following Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; cognitive function; diffusion tensor imaging; prospective study; outcome measures	TENSOR IMAGING FINDINGS; POSTTRAUMATIC-STRESS-DISORDER; MINOR HEAD-INJURY; DSM-IV CRITERIA; TASK-FORCE; POSTCONCUSSIONAL DISORDER; COLLABORATING-CENTER; WHITE-MATTER; DIAGNOSTIC-CRITERIA; AXONAL INJURY	This study examined multiple biopsychosocial factors relating to post-concussion symptom (PCS) reporting in patients with mild traumatic brain injuries (mTBI), including structural (computed tomography and magnetic resonance imaging [MRI]) and microstructural neuroimaging (diffusion tensor imaging [DTI]). Patients with mTBIs completed several questionnaires and cognitive testing at approximately one month (n=126) and one year (n=103) post-injury. At approximately three weeks post-injury, DTI was undertaken using a Siemens 3T scanner in a subgroup (n=71). Measures of fractional anisotropy were calculated for 16 regions of interest (ROIs) and measures of apparent diffusion coefficient were calculated for 10 ROIs. Patients were compared with healthy control subjects. Using International Classification of Diseases, Tenth Revision (ICD-10) PCS criteria and mild or greater symptom reporting, 59% of the mTBI sample met criteria at one month and 38% met criteria at one year. However, 31% of the healthy control sample also met criteria for the syndrome-illustrating a high false-positive rate. Significant predictors of ICD-10 PCS at one month were pre-injury mental health problems and the presence of extra-cranial bodily injuries. Being symptomatic at one month was a significant predictor of being symptomatic at one year, and depression was significantly related to PCS at both one month and one year. Intracranial abnormalities visible on MRI were present in 12.1% of this sample, and multifocal areas of unusual white matter as measured by DTI were present in 50.7% (compared with 12.4% of controls). Structural MRI abnormalities and microstructural white matter findings were not significantly associated with greater post-concussion symptom reporting. The personal experience and reporting of post-concussion symptoms is likely individualized, representing the cumulative effect of multiple variables, such as genetics, mental health history, current life stress, medical problems, chronic pain, depression, personality factors, and other psychosocial and environmental factors. The extent to which damage to the structure of the brain contributes to the persistence of post-concussion symptoms remains unclear.	[Waljas, Minna; Liimatainen, Suvi; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland; [Hakulinen, Ullamari; Dastidar, Prasun] Tampere Univ Hosp, Dept Radiol, Tampere, Finland; [Waljas, Minna; Dastidar, Prasun; Ohman, Juha] Univ Tampere Med Sch, Tampere, Finland; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Hakulinen, Ullamari] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Hartikainen, Kaisa] Pirkanmaa Hosp Dist, Behav Neurol Res Unit, Tampere, Finland		Waljas, M (corresponding author), Tampere Univ Hosp, Dept Neurosurg, POB 2000, FIN-3521 Tampere, Finland.	minna.waljas@pshp.fi		Iverson, Grant/0000-0001-7348-9570; Ohman, Juha/0000-0002-6592-1367; Hartikainen, Kaisa/0000-0001-7278-9635	Pirkanmaa Hospital District, Tampere University Hospital; University of Tampere; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]	This research was funded by Competitive Research Funding of the Pirkanmaa Hospital District, Tampere University Hospital and Research Funding of University of Tampere. This study was done as part of the first author's PhD thesis research program. Dr. Iverson notes that he was supported in part by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD). The authors thank Pasi Jolma (MD, PhD) for recruiting the patients and conducting neurological examinations and Annika Vuorinen (MSc) for assistance in recruitment and assessment of the control sample. Preliminary results of this study were presented at the International Neuropsychological Society, Boston, MA, in February 2011.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bay Esther H, 2009, Res Theory Nurs Pract, V23, P42; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Hakulinen U, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-30; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mitrushina M., 2005, NORMATIVE DATA NEURO; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson J. T. L, 1996, RECOVERY TRAUMATIC B, P29; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Wood RL, 2007, J NEUROL NEUROSUR PS, V78, P552, DOI 10.1136/jnnp.2006.113845; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	107	124	127	4	47	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2015	32	8					534	547		10.1089/neu.2014.3339			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CF2BS	WOS:000352352900003	25363626				2022-02-06	
J	Hillary, FG; Roman, CA; Venkatesan, U; Rajtmajer, SM; Bajo, R; Castellanos, ND				Hillary, Frank G.; Roman, Cristina A.; Venkatesan, Umesh; Rajtmajer, Sarah M.; Bajo, Ricardo; Castellanos, Nazareth D.			Hyperconnectivity is a Fundamental Response to Neurological Disruption	NEUROPSYCHOLOGY			English	Article						brain injury; Multiple Sclerosis; Alzheimer's Disease; connectivity; default mode network	MILD COGNITIVE IMPAIRMENT; DEFAULT-MODE NETWORK; ALTERED FUNCTIONAL CONNECTIVITY; RESTING-STATE NETWORKS; MULTIPLE-SCLEROSIS PATIENTS; TRAUMATIC BRAIN-INJURY; EARLY ALZHEIMERS-DISEASE; WORKING-MEMORY NETWORK; SHORT-TERM-MEMORY; PROCESSING SPEED	Objective: In the cognitive and clinical neurosciences, the past decade has been marked by dramatic growth in a literature examining brain "connectivity" using noninvasive methods. We offer a critical review of the blood oxygen level dependent functional MRI (BOLD fMRI) literature examining neural connectivity changes in neurological disorders with focus on brain injury and dementia. The goal is to demonstrate that there are identifiable shifts in local and large-scale network connectivity that can be predicted by the degree of pathology. We anticipate that the most common network response to neurological insult is hyperconnectivity but that this response depends upon demand and resource availability. Method: To examine this hypothesis, we initially reviewed the results from 1,426 studies examining functional brain connectivity in individuals diagnosed with multiple sclerosis, traumatic brain injury, mild cognitive impairment, and Alzheimer's disease. Based upon inclusionary criteria, 126 studies were included for detailed analysis. Results: Results from 126 studies examining local and whole brain connectivity demonstrated increased connectivity in traumatic brain injury and multiple sclerosis. This finding is juxtaposed with findings in mild cognitive impairment and Alzheimer's disease where there is a shift to diminished connectivity as degeneration progresses. Conclusion: This summary of the functional imaging literature using fMRI methods reveals that hyperconnectivity is a common response to neurological disruption and that it may be differentially observable across brain regions. We discuss the factors contributing to both hyper- and hypoconnectivity results after neurological disruption and the implications these findings have for network plasticity.	[Hillary, Frank G.; Roman, Cristina A.; Venkatesan, Umesh] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Rajtmajer, Sarah M.] Penn State Univ, Dept Math, University Pk, PA 16802 USA; [Bajo, Ricardo; Castellanos, Nazareth D.] Univ Complutense Madrid, Dept Phys, E-28040 Madrid, Spain		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.	fhillary@psu.edu; nazamadrid@yahoo.es	Castellanos, Nazareth/AAA-8812-2020; Bajo, Ricardo/AAA-5541-2019; Hillary, Frank/AAN-8622-2021	Bajo, Ricardo/0000-0003-0646-2962; Castellanos, Nazareth/0000-0002-3508-7316			Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Alves J, 2013, BRAIN IMAGING BEHAV, V7, P353, DOI 10.1007/s11682-013-9236-1; Arenivas A, 2014, BRAIN IMAGING BEHAV, V8, P407, DOI 10.1007/s11682-012-9191-2; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Bai F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024271; Bai F, 2011, J ALZHEIMERS DIS, V23, P87, DOI 10.3233/JAD-2010-101533; Bai F, 2011, BEHAV BRAIN RES, V216, P666, DOI 10.1016/j.bbr.2010.09.010; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; Balthazar MLF, 2014, HUM BRAIN MAPP, V35, P1237, DOI 10.1002/hbm.22248; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cader S, 2006, BRAIN, V129, P527, DOI 10.1093/brain/awh670; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Canuet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046289; Casanova B, 2003, J NEUROL, V250, P22, DOI 10.1007/s00415-003-0928-0; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Ceccarelli A, 2010, EUR J NEUROSCI, V31, P1273, DOI 10.1111/j.1460-9568.2010.07147.x; Cerasa A, 2012, EXP NEUROL, V237, P418, DOI 10.1016/j.expneurol.2012.07.020; Chawla D, 2000, NEURAL COMPUT, V12, P2805, DOI 10.1162/089976600300014737; Chawla D, 1999, NEURAL COMPUT, V11, P1389, DOI 10.1162/089976699300016287; Chen GY, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00456; Chhatwal JP, 2013, NEUROLOGY, V81, P736, DOI 10.1212/WNL.0b013e3182a1aafe; Ciftci K, 2011, ANN BIOMED ENG, V39, P1493, DOI 10.1007/s10439-011-0258-9; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Codeca C, 2010, MULT SCLER J, V16, P1308, DOI 10.1177/1352458510376957; Cole LJ, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.10.010; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P500, DOI 10.1001/archneur.1985.04060050102019; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Das SR, 2013, HIPPOCAMPUS, V23, P1, DOI 10.1002/hipo.22051; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Dogonowski AM, 2013, ACTA NEUROL SCAND, V128, P328, DOI 10.1111/ane.12121; Dogonowski AM, 2013, MULT SCLER J, V19, P559, DOI 10.1177/1352458512460416; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Dong L, 2012, CHINESE MED J-PEKING, V125, P604, DOI 10.3760/cma.j.issn.0366-6999.2012.04.009; Drzezga A, 2011, BRAIN, V134, P1635, DOI 10.1093/brain/awr066; Duong MVA, 2005, J CEREBR BLOOD F MET, V25, P1245, DOI 10.1038/sj.jcbfm.9600122; Duong MVA, 2005, NEUROIMAGE, V24, P533, DOI 10.1016/j.neuroimage.2004.08.038; Esposito R, 2013, PEERJ, V1, DOI 10.7717/peerj.135; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; Forn C, 2012, MULT SCLER J, V18, P153, DOI 10.1177/1352458511417744; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franciotti R, 2013, NEUROBIOL AGING, V34, P1148, DOI 10.1016/j.neurobiolaging.2012.09.015; Gallo A, 2012, NEUROLOGY, V79, P1458, DOI 10.1212/WNL.0b013e31826d5eea; Galvin JE, 2011, NEUROLOGY, V76, P1797, DOI 10.1212/WNL.0b013e31821ccc83; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; GAZZANIGA MS, 1984, BRAIN, V107, P145, DOI 10.1093/brain/107.1.145; GAZZANIGA MS, 1979, BRAIN, V102, P805, DOI 10.1093/brain/102.4.805; Genon S, 2013, CORTEX, V49, P1566, DOI 10.1016/j.cortex.2012.11.017; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Gour N, 2011, NEUROIMAGE, V58, P687, DOI 10.1016/j.neuroimage.2011.05.090; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Han SD, 2012, J INT NEUROPSYCH SOC, V18, P39, DOI 10.1017/S1355617711001299; Hardmeier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042087; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Helekar SA, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00219; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Huang SA, 2010, NEUROIMAGE, V50, P935, DOI 10.1016/j.neuroimage.2009.12.120; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jacobs HIL, 2012, NEUROLOGY, V78, P352, DOI 10.1212/WNL.0b013e318245287d; Jiang X., 2013, BRAIN IMAGING BEHAV; Jin MW, 2012, MAGN RESON IMAGING, V30, P48, DOI 10.1016/j.mri.2011.07.007; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Jones DT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039731, 10.1371/journal.pone.0044294]; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kim J, 2013, BRAIN RES, V1495, P18, DOI 10.1016/j.brainres.2012.12.011; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Leavitt VM, 2014, BRAIN IMAGING BEHAV, V8, P394, DOI 10.1007/s11682-012-9183-2; Leavitt VM, 2012, MULT SCLER J, V18, P409, DOI 10.1177/1352458511423651; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Li JJ, 2013, CEREB CORTEX, V23, P542, DOI [10.1093/cercor/bhs034, 10.1093/cercor/bhs410]; Li R, 2013, AM J NEURORADIOL, V34, P340, DOI 10.3174/ajnr.A3197; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082104; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Liang PP, 2012, J ALZHEIMERS DIS, V30, P475, DOI 10.3233/JAD-2012-111721; Liang PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022153; Liu ZY, 2012, IEEE ENG MED BIO, P5454, DOI 10.1109/EMBC.2012.6347228; Liu ZY, 2012, NMR BIOMED, V25, P1311, DOI 10.1002/nbm.2803; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Loitfelder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042862; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; LUCK SJ, 1989, NATURE, V342, P543, DOI 10.1038/342543a0; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Miao XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025546; Minati L, 2014, J ALZHEIMERS DIS, V40, P213, DOI 10.3233/JAD-131766; Morbelli S, 2012, NEUROBIOL AGING, V33, P2533, DOI 10.1016/j.neurobiolaging.2012.01.005; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Neufang S, 2014, HUM BRAIN MAPP, V35, P954, DOI 10.1002/hbm.22226; Neufang S, 2011, J ALZHEIMERS DIS, V25, P309, DOI 10.3233/JAD-2011-102154; Pagani M, 2009, PSYCHIAT RES-NEUROIM, V173, P8, DOI 10.1016/j.pscychresns.2008.07.016; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Parisi L., 2012, BRAIN IMAGI IN PRESS; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Prakash RS, 2011, J INT NEUROPSYCH SOC, V17, P986, DOI 10.1017/S1355617711001093; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ranganath C, 2005, J COGNITIVE NEUROSCI, V17, P994, DOI 10.1162/0898929054475118; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Richiardi J, 2012, NEUROIMAGE, V62, P2021, DOI 10.1016/j.neuroimage.2012.05.078; Ries ML, 2012, NEUROPSYCHOLOGIA, V50, P603, DOI 10.1016/j.neuropsychologia.2011.12.014; Rocca MA, 2007, NEUROLOGY, V69, P2136, DOI 10.1212/01.wnl.0000295504.92020.ca; Rocca MA, 2012, RADIOLOGY, V265, P864, DOI 10.1148/radiol.12120216; Rocca MA, 2012, NEUROLOGY, V79, P1449, DOI 10.1212/WNL.0b013e31826d5f10; Rocca MA, 2010, RADIOLOGY, V254, P541, DOI 10.1148/radiol.09090463; Rocca MA, 2009, HUM BRAIN MAPP, V30, P2412, DOI 10.1002/hbm.20679; Rocca MA, 2009, HUM BRAIN MAPP, V30, P276, DOI 10.1002/hbm.20504; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Roosendaal SD, 2010, RADIOLOGY, V255, P595, DOI 10.1148/radiol.10091433; Rosenbaum RS, 2010, NEUROBIOL AGING, V31, P780, DOI 10.1016/j.neurobiolaging.2008.06.002; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Rytsar R, 2011, NEUROIMAGE, V57, P1131, DOI 10.1016/j.neuroimage.2011.05.029; Saini S, 2004, J NEUROL NEUROSUR PS, V75, P840, DOI 10.1136/jnnp.2003.016782; SALTHOUSE TA, 1991, PSYCHOL AGING, V6, P118, DOI 10.1037/0882-7974.6.1.118; SALTHOUSE TA, 1993, J GERONTOL, V48, pP245, DOI 10.1093/geronj/48.5.P245; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Schoonheim MM, 2012, MULT SCLER J, V18, P164, DOI 10.1177/1352458511422245; Schwindt GC, 2013, CEREB CORTEX, V23, P1685, DOI 10.1093/cercor/bhs160; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; SEYMOUR SE, 1994, BRAIN, V117, P105, DOI 10.1093/brain/117.1.105; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Sole-Padulles C, 2013, J CLIN PSYCHOPHARM, V33, P199, DOI 10.1097/JCP.0b013e3182825bfd; Song JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063727; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tecchio F, 2008, BRAIN, V131, P1783, DOI 10.1093/brain/awn087; Tijms BM, 2013, NEUROBIOL AGING, V34, P2023, DOI 10.1016/j.neurobiolaging.2013.02.020; Tsirka V, 2011, INT J PSYCHOPHYSIOL, V79, P89, DOI 10.1016/j.ijpsycho.2010.09.006; Turner G. R., 2012, FRONTIERS SYSTEMS NE, V5, P9; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valsasina P, 2011, EUR J NEUROSCI, V33, P1256, DOI 10.1111/j.1460-9568.2011.07623.x; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Verdoorn TA, 2011, J ALZHEIMERS DIS, V26, P239, DOI 10.3233/JAD-2011-0056; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang L, 2013, RADIOLOGY, V268, P501, DOI 10.1148/radiol.13121573; Wang Y, 2013, J ALZHEIMERS DIS, V35, P751, DOI 10.3233/JAD-130080; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036838; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; Wang ZQ, 2011, J NEUROL SCI, V309, P79, DOI 10.1016/j.jns.2011.07.017; Wee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037828; Wen XY, 2013, BRAIN RES, V1509, P58, DOI 10.1016/j.brainres.2013.03.007; Werfel J, 2005, NEURAL COMPUT, V17, P2699, DOI 10.1162/089976605774320539; Wu X, 2011, HUM BRAIN MAPP, V32, P1868, DOI 10.1002/hbm.21153; Xia MR, 2014, J ALZHEIMERS DIS, V39, P527, DOI 10.3233/JAD-131583; Xie CM, 2013, NEUROIMAGE-CLIN, V3, P311, DOI 10.1016/j.nicl.2013.09.002; Xie CM, 2012, NEUROIMAGE, V63, P320, DOI 10.1016/j.neuroimage.2012.06.062; Yan H., 2010, J INT NEUROPSYCH SOC, V21, P1; Yao HX, 2013, EUR J RADIOL, V82, P1531, DOI 10.1016/j.ejrad.2013.03.019; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044758; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379; Zamboni G, 2013, BIOL PSYCHIAT, V74, P375, DOI 10.1016/j.biopsych.2013.04.015; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049; Zhao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033540; Zhou B, 2013, CURR ALZHEIMER RES, V10, P754, DOI 10.2174/15672050113109990146; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006; Zhu D., 2013, HUMAN BRAIN MAPPING; Zhu DC, 2013, J ALZHEIMERS DIS, V34, P969, DOI 10.3233/JAD-121879; [No title captured]	206	124	124	0	66	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2015	29	1					59	75		10.1037/neu0000110			17	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AX9OX	WOS:000347232800007	24933491	Green Submitted, Green Accepted			2022-02-06	
J	Hu, JZ; Huang, JH; Zeng, L; Wang, G; Cao, M; Lu, HB				Hu, Jian-Zhong; Huang, Jiang-Hu; Zeng, Lei; Wang, Guan; Cao, Min; Lu, Hong-Bin			Anti-Apoptotic Effect of MicroRNA-21 after Contusion Spinal Cord Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						antagomir-21; apoptosis; miRNA; SCI	TRAUMATIC BRAIN-INJURY; TUMOR-SUPPRESSOR PDCD4; EXPRESSION; MIR-21; PROTECTS; DEATH; INVOLVEMENT; PATHWAY; TARGETS; SYSTEM	Multiple cellular, molecular, and biochemical changes contribute to the etiology and treatment outcome of contusion spinal cord injury (SCI). Dysregulation of microRNAs (miRNAs) has been found following SCI in recent studies. However, little is known about the functional significance of the unique role of miRNAs in SCI. We analyzed the miRNA expression patterns 1 and 3 days following rat SCI using miRNA microarray. Microarray data revealed that nine miRNAs were upregulated and five miRNAs were downregulated 1 day post-injury, and that three miRNAs were upregulated and five miRNAs were downregulated 3 days post-injury, in the sites of contused when compared with sham rat spinal cords. Because miR-21 was one of the miRNAs being most significantly upregulated, we investigated its function. Knockdown of miR-21 by antagomir-21 led to attenuated recovery in hindlimb motor function, increased lesion size, and decreased tissue sparing in rats. Compared with the negative control group, treatment with antagomir-21 significantly increased apoptosis following SCI. Pro-apoptosis genes Fas ligand (FasL), phosphatase and tensin homolog (PTEN), and programmed cell death protein 4 (PDCD4) were proved to be direct targets of miR-21 in many diseases and cell types. In vivo treatment with antagomir-21 increased the expression of FasL and PTEN, but did not affect PDCD4. These results suggested that miR-21 played an important role in limiting secondary cell death following SCI, and that the protective effects of miR-21 might have been the result of its regulation on pro-apoptotic genes. Thus, miR-21 may play an important role in the pathophysiology of SCI.	[Hu, Jian-Zhong; Huang, Jiang-Hu; Zeng, Lei; Wang, Guan; Cao, Min] Cent S Univ, Dept Spine Surg, Res Ctr Sports Med, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Lu, Hong-Bin] Cent S Univ, Dept Sports Med, Res Ctr Sports Med, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China		Lu, HB (corresponding author), Cent S Univ, Dept Sports Med, Res Ctr Sports Med, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171698]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [09JJ3047]	This work is supported by the National Natural Science Foundation of China (No. 81171698) and the Hunan Provincial Natural Science Foundation of China (No. 09JJ3047).	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Benveniste E. N., 2004, BRAIN RES REV, V44, P65; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; He Q, 2013, MOL CARCINOGEN, V52, P286, DOI 10.1002/mc.21859; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Xu XL, 2012, KIDNEY INT, V82, P1167, DOI 10.1038/ki.2012.241; Yed D., 2010, J BIOL CHEM, V285, P20; Yoshino O, 2004, SPINE, V29, P1394, DOI 10.1097/01.BRS.0000129894.34550.48; Yunta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034534; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhang L, 2012, GLIA, V60, P1888, DOI 10.1002/glia.22404; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055	41	124	135	3	31	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	15					1349	1360		10.1089/neu.2012.2748			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	191WY	WOS:000322446800336	23647386	Green Published			2022-02-06	
J	Guo, DJ; Zeng, LH; Brody, DL; Wong, M				Guo, Dongjun; Zeng, Linghui; Brody, David L.; Wong, Michael			Rapamycin Attenuates the Development of Posttraumatic Epilepsy in a Mouse Model of Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; TEMPORAL-LOBE EPILEPSY; TUBEROUS SCLEROSIS COMPLEX; MAMMALIAN TARGET; STATUS EPILEPTICUS; SEIZURES; EPILEPTOGENESIS; THERAPY; INHIBITION; PREVENTION	Posttraumatic epilepsy is a major source of disability following traumatic brain injury (TBI) and a common cause of medically-intractable epilepsy. Previous attempts to prevent the development of posttraumatic epilepsy with treatments administered immediately following TBI have failed. Recently, the mammalian target of rapamycin complex 1 (mTORC1) pathway has been implicated in mechanisms of epileptogenesis and the mTORC1 inhibitor, rapamycin, has been proposed to have antiepileptogenic effects in preventing some types of epilepsy. In this study, we have tested the hypothesis that rapamycin has antiepileptogenic actions in preventing the development of posttraumatic epilepsy in an animal model of TBI. A detailed characterization of posttraumatic epilepsy in the mouse controlled cortical impact model was first performed using continuous video-EEG monitoring for 16 weeks following TBI. Controlled cortical impact injury caused immediate hyperactivation of the mTORC1 pathway lasting at least one week, which was reversed by rapamycin treatment. Rapamycin decreased neuronal degeneration and mossy fiber sprouting, although the effect on mossy fiber sprouting was reversible after stopping rapamycin and did not directly correlate with inhibition of epileptogenesis. Most posttraumatic seizures occurred greater than 10 weeks after TBI, and rapamycin treatment for one month after TBI decreased the seizure frequency and rate of developing posttraumatic epilepsy during the entire 16 week monitoring session. These results suggest that rapamycin may represent a rational treatment for preventing posttraumatic epilepsy in patients with TBI.	[Guo, Dongjun; Brody, David L.; Wong, Michael] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Guo, Dongjun; Brody, David L.; Wong, Michael] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Zeng, Linghui] Zhejiang Univ City Coll, Dept Pharm, Hangzhou 310003, Zhejiang, Peoples R China		Wong, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wong_m@wustl.edu	Ritter, Stefanie L/D-9312-2012		National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS056872, NS057105]; Pfizer Inc. (Washington University/Pfizer Biomedical Research Agreement); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056872, P30NS057105] Funding Source: NIH RePORTER	1) National Institutes of Health/National Institute of Neurological Disorders and Stroke: NS056872, NS057105. 2) Pfizer Inc. (Washington University/Pfizer Biomedical Research Agreement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Chachua T, 2012, EPILEPSIA, V53, P2015, DOI 10.1111/j.1528-1167.2012.03674.x; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Hartman AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045156; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Russo E, 2012, NEUROPHARM      1022; Sliwa A, 2012, NEUROSCI LETT, V509, P105, DOI 10.1016/j.neulet.2011.12.051; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; van Vliet EA, 2012, EPILEPSIA, V53, P1254, DOI 10.1111/j.1528-1167.2012.03513.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	42	124	135	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2013	8	5							e64078	10.1371/journal.pone.0064078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146RE	WOS:000319107400100	23691153	Green Published, gold, Green Submitted			2022-02-06	
J	Cifu, DX; Taylor, BC; Carne, WF; Bidelspach, D; Sayer, NA; Scholten, J; Campbell, EH				Cifu, David X.; Taylor, Brent C.; Carne, William F.; Bidelspach, Douglas; Sayer, Nina A.; Scholten, Joel; Campbell, Emily Hagel			Traumatic brain injury, posttraumatic stress disorder, and pain diagnoses in OIF/OEF/OND Veterans	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						military healthcare; military Veterans; Operation Enduring Freedom; Operation Iraqi Freedom; Operation New Dawn; pain; posttraumatic stress disorder; PTSD; TBI; traumatic brain injury	MENTAL-HEALTH; IRAQI FREEDOM; WAR; PREVALENCE; MILITARY; ACCURACY; PROGRAM; CARE	To identify the prevalence of traumatic brain injury (TBI), posttraumatic stress disorder (PTSD), and pain in Veterans from Operation Iraqi Freedom/Operation Enduring Freedom/Operation New Dawn (OIF/OEF/OND), Veterans who received any inpatient or outpatient care from Veterans Health Administration (VHA) facilities from 2009 to 2011 were studied. A subset of Veterans was identified who were diagnosed with TBI, PTSD, and/or pain (head, neck, or back) as determined by their International Classification of Diseases-9th Revision-Clinical Modification codes. Between fiscal years 2009 and 2011, 613,391 Veterans accessed VHA services at least once (age: 31.9 +/- 9.6 yr). TBI diagnosis in any 1 year was slightly less than 7%. When data from 3 years were pooled, 9.6% were diagnosed with TBI, 29.3% were diagnosed with PTSD, and 40.2% were diagnosed with pain. The full polytrauma triad expression (TBI, PTSD, and pain) was diagnosed in 6.0%. Results show that increasing numbers of Veterans from OIF/OEF/OND accessed VHA over a 3 year period. Among those with a TBI diagnosis, the majority also had a mental health disorder, with approximately half having both PTSD and pain. While the absolute number of Veterans increased by over 40% from 2009 to 2011, the proportion of Veterans diagnosed with TBI and the high rate of comorbid PTSD and pain in this population remained relatively stable.	[Cifu, David X.; Bidelspach, Douglas; Scholten, Joel] Dept Vet Affairs VA, Phys Med & Rehabil Program Off, Washington, DC USA; [Cifu, David X.; Carne, William F.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Cifu, David X.; Carne, William F.] Hunter Holmes McGuire VA Med Ctr VAMC, Richmond, VA USA; [Taylor, Brent C.; Sayer, Nina A.; Campbell, Emily Hagel] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Taylor, Brent C.; Sayer, Nina A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Carne, William F.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Bidelspach, Douglas] Lebanon VAMC, Rehabil & Prosthet Serv, Lebanon, PA USA; [Sayer, Nina A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Scholten, Joel] Washington VAMC, Dept Phys Med & Rehabil, Washington, DC USA; [Scholten, Joel] Georgetown Univ, Med Ctr, Dept Phys Med & Rehabil, Washington, DC 20007 USA		Cifu, DX (corresponding author), Dept Phys Med & Rehabil, 1223 East Marshall St, Richmond, VA 23298 USA.	dcifu@vcu.edu	Taylor, Brent C/A-8069-2009; Sayer, Nina/E-3249-2016	Taylor, Brent C/0000-0002-2140-8377; Cifu, David/0000-0003-1600-9387	VA Office of Research and Development Health Services Research and Development ServiceUS Department of Veterans Affairs [PLY 05-2010-2]; PTBRI QUERI; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This material was based on work supported by the VA Office of Research and Development Health Services Research and Development Service (grant PLY 05-2010-2) from the PTBRI QUERI and the Defense and Veterans Brain Injury Center. The funding source had no role in the study design, analysis, interpretation of the data, writing of the manuscript, or decision to submit the article for publication.	[Anonymous], 2012, QUERI POL BLAST REL; [Anonymous], 2011, QUERI POL BLAST REL; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bray R, 2009, DEP DEFENSE SURVEY H; Carlson KF, 2010, J REHABIL RES DEV, V47, P689, DOI 10.1682/JRRD.2009.08.0118; Cifu D, 2011, OVERCOMING POSTDEPLO; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Department of Veterans Affairs, 2013, VHA HDB; Friedman MJ, 2005, NEW ENGL J MED, V352, P1287, DOI 10.1056/NEJMp058028; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Independent Review Group on Rehabilitative Care and Administrative Processes at Walter Reed Army Medical Center and National Naval Medical Center, 2007, REB TRUST REP REH CA; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lorence Daniel, 2003, J Med Syst, V27, P435, DOI 10.1023/A:1025607805588; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McNaughton H, 2000, NEW ZEAL MED J, V113, P184; Reeves RR, 2005, J PSYCHOSOC NURS MEN, V43, P18, DOI 10.3928/02793695-20050701-06; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Roemer L, 1998, J TRAUMA STRESS, V11, P597, DOI 10.1023/A:1024469116047; Rosen CS, 2004, J TRAUMA STRESS, V17, P213, DOI 10.1023/B:JOTS.0000029264.23878.53; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Todd KH, 2005, EMERG MED CLIN N AM, V23, P285, DOI 10.1016/j.emc.2004.12.002; U.S. Health Care Financing Administration U.S. National Center for Health Statistics, 2006, ICM 9 CM INT CLASS D; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004	30	124	124	0	8	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	9					1169	1176		10.1682/JRRD.2013.01.0006			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	287IE	WOS:000329534500004	24458958	Bronze			2022-02-06	
J	Moser, RS; Glatts, C; Schatz, P				Moser, Rosemarie Scolaro; Glatts, Colette; Schatz, Philip			Efficacy of Immediate and Delayed Cognitive and Physical Rest for Treatment of Sports-Related Concussion	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; MANAGEMENT; REHABILITATION; STATEMENT; RECOVERY; SYMPTOMS; EXERCISE	Objectives To evaluate the efficacy of cognitive and physical rest for the treatment of concussion. Study design High school and collegiate athletes (N = 49) underwent post-concussion evaluations between April 2010 and September 2011 and were prescribed at least 1 week of cognitive and physical rest. Participants were assigned to groups on the basis of the time elapsed between sustaining a concussion and the onset of rest (1-7 days, 8-30 days, 31+ days). Main outcome measures included Concussion Symptom Scale ratings and scores on the 4 composite indices of the Immediate Post-Concussion Assessment and Cognitive Testing measure, both before and following rest. Mixed-factorial design ANOVA were used to compare changes on the dependent measures within and between groups. Results Participants showed significantly improved performance on Immediate Post-Concussion Assessment and Cognitive Testing and decreased symptom reporting following prescribed cognitive and physical rest (P < .001), regardless of the time between concussion and onset of rest (P = .44). Conclusion These preliminary data suggest that a period of cognitive and physical rest may be a useful means of treating concussion-related symptoms, whether applied soon after a concussion or weeks to months later. (J Pediatr 2012;161:922-6).	[Moser, Rosemarie Scolaro; Glatts, Colette; Schatz, Philip] Sports Concuss Ctr New Jersey, Lawrenceville, NJ 08648 USA; [Moser, Rosemarie Scolaro; Schatz, Philip] Int Brain Res Fdn, Secaucus, NJ USA; [Glatts, Colette; Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA		Moser, RS (corresponding author), Sports Concuss Ctr New Jersey, 3131 Princeton Pike,Bldg 5,Suite 110, Lawrenceville, NJ 08648 USA.	rmoser@SportsConcussionNJ.com		Schatz, Philip/0000-0002-6222-6545			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Andrasik Frank, 2010, Cleve Clin J Med, V77 Suppl 3, pS72, DOI 10.3949/ccjm.77.s3.13; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Giza CC, 2001, J ATHL TRAINING, V36, P228; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2000, NEUROSURGERY, V47, P69; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Thatcher R.W., 2009, EEG EVALUATION TRAUM; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4	27	124	124	0	51	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	NOV	2012	161	5					922	926		10.1016/j.jpeds.2012.04.012			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	027RJ	WOS:000310370600032	22622050				2022-02-06	
J	Muellenbach, RM; Kredel, M; Kunze, E; Kranke, P; Kuestermann, J; Brack, A; Gorski, A; Wunder, C; Roewer, N; Wurmb, T				Muellenbach, Ralf M.; Kredel, Markus; Kunze, Ekkehard; Kranke, Peter; Kuestermann, Julian; Brack, Alexander; Gorski, Armin; Wunder, Christian; Roewer, Norbert; Wurmb, Thomas			Prolonged heparin-free extracorporeal membrane oxygenation in multiple injured acute respiratory distress syndrome patients with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Acute respiratory distress syndrome; traumatic brain injury; extracorporeal membrane oxygenation; multiple trauma	LUNG INJURY; FAILURE; ECMO; CRANIOTOMY; THERAPY; SUPPORT; ARDS	BACKGROUND: Extracorporeal membrane oxygenation (ECMO) can be used as an "ultima ratio" strategy in multiple injured patients with severe thoracic trauma. However, systemic anticoagulation during ECMO is recommended and thus traumatic brain injury (TBI) and intracranial bleeding are well-accepted contraindications for ECMO therapy. METHODS: This report describes three cases of prolonged heparin-free venovenous ECMO in multiple injured acute respiratory distress syndrome patients with severe TBI failing conventional mechanical ventilation. RESULTS: Using this strategy, neither ECMO-associated bleeding nor clotting of the extracorporeal circuit occurred. All patients survived. CONCLUSIONS: Based on our experience, we recommend the use of heparin-free ECMO in multiple injured patients with pulmonary failure that is not successfully controlled by lung-protective ventilation even if severe TBI is present. (J Trauma. 2012;72: 1444-1447. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Muellenbach, Ralf M.; Kredel, Markus; Kranke, Peter; Kuestermann, Julian; Brack, Alexander; Wunder, Christian; Roewer, Norbert; Wurmb, Thomas] Univ Wurzburg, Dept Anaesthesia & Crit Care, D-97070 Wurzburg, Germany; [Kunze, Ekkehard] Univ Wurzburg, Dept Neurosurg, D-97070 Wurzburg, Germany; [Gorski, Armin] Univ Wurzburg, Dept Heart Lung & Vasc Surg, D-97070 Wurzburg, Germany		Muellenbach, RM (corresponding author), Univ Klinikum Wurzburg, Klin & Poliklin Anasthesiol, Zentrum Operat Med, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany.	muellenbac_r@klinik.uni-wuerzburg.de	Kunze, Ekkehard/AAE-6926-2019	Kredel, Markus/0000-0003-2183-033X			Arlt M, 2010, RESUSCITATION, V81, P804, DOI 10.1016/j.resuscitation.2010.02.020; Bui JD, 2002, J THORAC CARDIOV SUR, V124, P852, DOI 10.1067/mtc.2002.126038; Cordell-Smith JA, 2006, INJURY, V37, P29, DOI 10.1016/j.injury.2005.03.027; Friesenecker BE, 2005, ACTA NEUROCHIR, V147, P993, DOI 10.1007/s00701-005-0568-5; Kopp R, 2010, ARTIF ORGANS, V34, P13, DOI 10.1111/j.1525-1594.2009.00791.x; Madershahian N, 2007, J CARDIAC SURG, V22, P180, DOI 10.1111/j.1540-8191.2007.00381.x; Michaels AJ, 1999, J TRAUMA, V46, P638, DOI 10.1097/00005373-199904000-00013; Moller T, 2010, ANASTH INTENSIV NOTF, V45, P544, DOI 10.1055/s-0030-1265745; Muellenbach RM, 2011, ANAESTHESIST, V60, P647, DOI 10.1007/s00101-011-1872-5; Muller T, 2009, CRIT CARE, V13, DOI 10.1186/cc8213; Peek GJ, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14350; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; Yen TS, 2008, CLIN NEUROL NEUROSUR, V110, P295, DOI 10.1016/j.clineuro.2007.10.017; Young N, 2010, CURR OPIN CRIT CARE, V16, P45, DOI 10.1097/MCC.0b013e32833546fa	14	124	128	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1444	1447		10.1097/TA.0b013e31824d68e3			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	944JD	WOS:000304195100059	22673280				2022-02-06	
J	Chamoun, R; Suki, D; Gopinath, SP; Goodman, JC; Robertson, C				Chamoun, Roukoz; Suki, Dima; Gopinath, Shankar P.; Goodman, J. Clay; Robertson, Claudia			Role of extracellular glutamate measured by cerebral microdialysis in severe traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						Severe head injury; microdialysis; glutamate; outcome	EXCITATORY AMINO-ACIDS; INTRACEREBRAL MICRODIALYSIS; RELEASE	Object. Authors of several studies have implied a key role of glutamate, an excitatory amino acid, in the pathophysiology of traumatic brain injury (TBI). However, the place of glutamate measurement in clinical practice and its impact on the management of TBI has yet to be elucidated. The authors' objective in the present study was to evaluate glutamate levels in TBI, analyzing the factors affecting them and determining their prognostic value. Methods. A prospective study of patients with severe TBI was conducted with an inclusion criterion of a Glasgow Coma Scale score <= 8 within 48 hours of injury. Invasive monitoring included intracranial pressure measurements, brain tissue PO(2), jugular venous O(2) saturation, and cerebral microdialysis. Patients received standard care including mass evacuation when indicated and treatment of elevated intracranial pressure values. Demographic data, CT findings, and outcome at 6 months of follow-up were recorded. Results. One hundred sixty-five patients were included in the study. Initially high glutamate values were predictive of a poor outcome. The mortality rate was 30.3% among patients with glutamate levels > 20 mu mol/L, compared with 18% among those with levels <= 20 mu mol/L. Two general patterns were recognized: Pattern 1, glutamate levels tended to normalize over the monitoring period (120 hours): and Pattern 2, glutamate levels tended to increase with time or remain abnormally elevated. Patients showing Pattern 1 had a lower mortality rate (17.1 vs 39.6%) and a better 6-month functional outcome among survivors (41.2 vs 20.7%). Conclusions. Glutamate levels measured by microdialysis appear to have an important role in TBI. Data in this study suggest that glutamate levels are correlated with the mortality rate and 6-month functional outcome. (DOI: 10.3171/2009.12.JNS09689)	[Chamoun, Roukoz; Gopinath, Shankar P.; Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Goodman, J. Clay] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Suki, Dima] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA		Gopinath, SP (corresponding author), Baylor Coll Med, Dept Neurosurg, 1709 Dryden,Suite 750, Houston, TX 77030 USA.	shankarg@bcm.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1-NS38660]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health Grant No. PO1-NS38660.	BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHOI DW, 1987, J NEUROSCI, V7, P369; DUHAIME AC, 1994, PEDIATR NEUROSURG, V21, P117, DOI 10.1159/000120825; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; Hickenbottom SL, 1998, SEMIN NEUROL, V18, P485, DOI 10.1055/s-2008-1040901; Hillered L, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p695A; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Willis C, 2004, COCHRANE DB SYST REV	18	124	132	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2010	113	3					564	570		10.3171/2009.12.JNS09689			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	641FV	WOS:000281111100020	20113156	Green Accepted			2022-02-06	
J	Wafaisade, A; Lefering, R; Tjardes, T; Wutzler, S; Simanski, C; Paffrath, T; Fischer, P; Bouillon, B; Maegele, M				Wafaisade, Arasch; Lefering, Rolf; Tjardes, Thorsten; Wutzler, Sebastian; Simanski, Christian; Paffrath, Thomas; Fischer, Philipp; Bouillon, Bertil; Maegele, Marc		Trauma Registry DGU	Acute Coagulopathy in Isolated Blunt Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Coagulopathy; Outcome; Mortality; Pre-hospital care	SEVERE HEAD-INJURY; DISSEMINATED INTRAVASCULAR COAGULATION; MANAGEMENT; HEMORRHAGE; DISORDERS; MODERATE; REGISTRY; SURGERY; CARE	The role of acute coagulopathy after traumatic brain injury (TBI) on outcome has gained increasing appreciation over the recent years. This study was conducted to assess the frequency, outcome, and risk factors associated with this complication. Using the large, multi-center population-based Trauma Registry of the German Society for Trauma Surgery (TR-DGU), we retrospectively analyzed adult patients with isolated blunt TBI (intracranial AIS(HEAD) a parts per thousand yen 3 and extracranial AIS scores < 3) for the presence of acute post-traumatic coagulopathy upon emergency room (ER) arrival. Coagulopathy was defined as prothrombin time test (Quick's value) < 70% and/or platelets < 100,000/mu l. From a total of 3,114 eligible patients with isolated TBI, 706 (22.7%) presented with coagulopathy upon ER arrival. Coagulopathy was associated with higher rates of craniotomies (P = 0.02), of single and multiple organ failure and with less intubation-free days. In surviving patients, ICU length of stay and hospital length of stay were significantly longer, if coagulopathy had been present at admission. The overall hospital mortality was 50.4% (n = 356) in patients with coagulopathy vs. 17.3% (n = 417) in non-coagulopathic patients (all P < 0.001). Multivariate analysis identified AIS(HEAD) severity grade, GCS a parts per thousand currency sign 8 at scene, the presence of hypotension at scene and/or at ER, pre-hospital i.v.-fluids a parts per thousand yen2,000 ml and age a parts per thousand yen75 years as independent risk factors for coagulopathy after TBI. Acute coagulopathy in TBI had an adjusted odds ratio for hospital mortality of 2.97 (CI95: 2.30-3.85; P < 0.001). Coagulopathy upon ER admission is frequent after isolated blunt TBI and represents a powerful, independent predictor related to prognosis. Future research should aim to determine the beneficial effects of early treatment of TBI-associated coagulopathy.	[Wafaisade, Arasch; Tjardes, Thorsten; Simanski, Christian; Paffrath, Thomas; Bouillon, Bertil; Maegele, Marc] Univ Witten Herdecke, Dept Trauma & Orthoped Surg, Cologne Merheim Med Ctr CMMC, D-51109 Cologne, Germany; [Wafaisade, Arasch; Lefering, Rolf; Fischer, Philipp; Maegele, Marc] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne Merheim Med Ctr CMMC, D-51109 Cologne, Germany; [Wutzler, Sebastian] Goethe Univ Frankfurt, Dept Trauma Surg, Frankfurt, Germany; [Trauma Registry DGU] German Soc Trauma Surg DGU, Comm Emergency Med Intens & Trauma Care Sekt NIS, Berlin, Germany		Wafaisade, A (corresponding author), Univ Witten Herdecke, Dept Trauma & Orthoped Surg, Cologne Merheim Med Ctr CMMC, Ostmerheimerstr 200, D-51109 Cologne, Germany.	araschw@hotmail.com					Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL AIS 19; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARDENHEUE M, 1994, UNFALLCHIRURG, V97, P230; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Coats TJ, 2006, EMERG MED J, V23, P846, DOI 10.1136/emj.2006.036574; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; LUTZE G, USEFUL FACTS COAGULA; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Pathak A, 2005, Neurol India, V53, P178; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schreiber MA, 2004, CRIT CARE CLIN, V20, P101, DOI 10.1016/S0749-0704(03)00095-2; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; THOMAS L, 2000, LABOR DIAGNOSE INDIK, V5; WAGNER C, 2000, LABOR DIAGNOSE, P613; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	38	124	136	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2010	12	2					211	219		10.1007/s12028-009-9281-1			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	573IL	WOS:000275905800011	19806475				2022-02-06	
J	Aitken, ME; McCarthy, ML; Slomine, BS; Ding, R; Durbin, DR; Jaffe, KM; Paidas, CN; Dorsch, AM; Christensen, JR; MacKenzie, EJ				Aitken, Mary E.; McCarthy, Melissa L.; Slomine, Beth S.; Ding, Ru; Durbin, Dennis R.; Jaffe, Kenneth M.; Paidas, Charles N.; Dorsch, Andrea M.; Christensen, James R.; MacKenzie, Ellen J.		CHAT Study Grp	Family Burden After Traumatic Brain Injury in Children	PEDIATRICS			English	Article						traumatic brain injury; health-related quality of life; PedsQL; family burden	QUALITY-OF-LIFE; GENERIC CORE SCALES; PROBLEM-SOLVING INTERVENTION; PRELIMINARY EFFICACY; ASSESSMENT DEVICE; INITIAL YEAR; RELIABILITY; VALIDITY; PEDSQL(TM)-4.0; PREDICTORS	OBJECTIVE. Traumatic brain injury has a substantial impact on caregivers. This study describes the burden experienced by caregivers of children with traumatic brain injury and examines the relationship between child functioning and family burden during the first year after injury. PATIENTS AND METHODS. Children aged 5 to 15 years hospitalized for traumatic brain injury at 4 participating trauma centers were eligible. Caregivers completed baseline and 3- and 12-month telephone interviews measuring the child's health-related quality of life using the Pediatric Quality of Life Inventory. The emotional impact scale of the Child Health Questionnaire was used to identify caregivers with substantial distress, including general worry or interference with family routine. Caregiver perceptions of whether health care needs were met or unmet and days missed from work were also measured. RESULTS. A total of 330 subjects enrolled; follow-up was conducted with 312 at 3 months and 288 at 12 months. Most subjects were white (68%) and male (69%). Abnormal Pediatric Quality of Life Inventory subscores were related to substantial caregiver burden (either general worry or interference in routine). These abnormalities were reported by > 75% of patients at 3 months and persisted to 1 year in some patients. Parental perception of unmet health care needs was strongly related to family burden outcomes, with up to 69% of this subset of parents reporting substantial worry, and nearly one quarter reporting interference with daily routine/concentration 1 year after injury. Child dysfunction predicted parental burden at 3 and 12 months. Burden was greater when health care need was unmet. Abnormalities on the Pediatric Quality of Life Inventory predicted the amount of work missed by parents, especially in the presence of unmet needs. CONCLUSIONS. Caregivers are more likely to report family burden problems when child functioning is poorer and health care needs are unmet. Improved identification and provision of services is a potentially modifiable factor that may decrease family burden after pediatric traumatic brain injury. Pediatrics 2009;123:199-206	[Aitken, Mary E.] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Arkansas Childrens Hosp,Res Inst, Little Rock, AR 72202 USA; [McCarthy, Melissa L.; Ding, Ru] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Christensen, James R.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Christensen, James R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Slomine, Beth S.] Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD USA; [Durbin, Dennis R.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Jaffe, Kenneth M.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; [Dorsch, Andrea M.] Univ Washington, Childrens Hosp & Reg Med Ctr, Sch Med, Div Rehabil Psychol, Seattle, WA USA; [Paidas, Charles N.] Univ S Florida, Dept Surg, Tampa, FL 33620 USA; [MacKenzie, Ellen J.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA		Aitken, ME (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Pediat, 800 Marshall St,Slot 512-26, Little Rock, AR 72202 USA.	aitkenmarye@uams.edu	Durbin, Dennis/AAD-7829-2022; Aitken, Mary/ABG-6119-2021; ding, ru/B-1615-2009	Aitken, Mary/0000-0002-8318-9755	National Center for Injury Prevention and Control of the Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CCR319701]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR020146]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR020146] Funding Source: NIH RePORTER	We express our appreciation to the study coordinators who worked hard to successfully recruit of all of the injured children and families involved: Eileen Houseknecht, RN, BSN; Patricia Klotz, RN, BSN; Patricia Korehbandi, RN, MS, CHES; Vinita Misra Knight, MPH, CSTR; Donna Parnell, RN, MNSc; and Susan Ziegfeld, MSN, CRNP.	Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Bastiaansen D, 2004, QUAL LIFE RES, V13, P489, DOI 10.1023/B:QURE.0000018483.01526.ab; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Committee on Injury Scaling, 1990, ABBR INJ SCAL 1990 R; Eiser C, 2003, CHILD CARE HLTH DEV, V29, P95, DOI 10.1046/j.1365-2214.2003.00318.x; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Langlois JA, 2006, TRAUMATIC BRAIN INJU; MACKENZIE EJ, 1984, AM J EMERG MED, V2, P537, DOI 10.1016/0735-6757(84)90081-0; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Miller IW, 2000, FAM PROCESS, V39, P141, DOI 10.1111/j.1545-5300.2000.39112.x; Minkovitz CS, 2005, PEDIATRICS, V115, P306, DOI 10.1542/peds.2004-0341; Minkovitz CS, 2002, AMBUL PEDIATR, V2, P85, DOI 10.1367/1539-4409(2002)002<0085:ABMACH>2.0.CO;2; Mowbray CT, 2005, COMMUNITY MENT HLT J, V41, P687, DOI 10.1007/s10597-005-6425-4; Osberg JS, 1996, PEDIATRICS, V98, P890; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; SILLS MR, 2007, PEDIATRICS, V119; SLOMINE BS, 2006, PEDIATRICS, V117; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Varni JW, 2002, ARTHRITIS RHEUM, V46, P714, DOI 10.1002/art.10095; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Ware JE., 1996, CHQ USERS MANUAL	41	124	125	0	21	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JAN	2009	123	1					199	206		10.1542/peds.2008-0607			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	388UZ	WOS:000262046400034	19117883				2022-02-06	
J	Bilotta, F; Caramia, R; Cernak, I; Paoloni, FP; Doronzio, A; Cuzzone, V; Santoro, A; Rosa, G				Bilotta, Federico; Caramia, Remo; Cernak, Ibolja; Paoloni, Francesca Paola; Doronzio, Andrea; Cuzzone, Vincenzo; Santoro, Antonio; Rosa, Giovanni			Intensive insulin therapy after severe traumatic brain injury: A randomized clinical trial	NEUROCRITICAL CARE			English	Article						traumatic brain injury; intensive insulin infusion; hypoglycemia	PLASMA-GLUCOSE CONCENTRATIONS; CRITICALLY-ILL PATIENTS; LACTATE/PYRUVATE RATIO; ISCHEMIC-STROKE; HYPOGLYCEMIA; HYPERGLYCEMIA; MANAGEMENT; DAMAGE	Introduction To investigate the risks and possible benefits of routine versus intensive insulin therapy, assessed by the frequency of hypoglycemic events defined as a glucose concentration less than 80 mg/dl (< 4.44 mmol/l) in patients admitted to the intensive care unit (ICU) after severe traumatic brain injury (TBI). Methods and Results Ninety-seven patients admitted after severe TBI, were enrolled and randomly assigned to two groups of target glycemia. Insulin was infused at conventional rates when blood glucose levels exceeded 220 mg/dl (12.22 mmol/l) or at intensive rates, to maintain glycemia at 80-120 mg/dl (4.44-6.66 mmol/l). The following primary and outcome variables were measured during follow-up: hypoglycemic episodes, duration of ICU stay, infection rate, and 6-month mortality and neurologic outcome measured using the Glasgow Outcome Scale (GOS). Episodes of hypoglycemia (defined as blood glucose < 80 mg/dl or 4.44 mmol/l) were significantly higher in patients receiving intensive insulin therapy: median (min-max) conventional insulin therapy 7 (range 0-11) vs. intensive insulin therapy 15 (range 6-33); P < 0.0001. Duration of ICU stay was shorter in patients receiving intensive insulin therapy (7.3 vs. 10.0 days; P < 0.05); while infection rates during ICU stay (25.0% vs. 38.8%, P = 0.15), and GOS scores and mortality at 6 months were similar in the two groups. Conclusions Intensive insulin therapy significantly increases the risk of hypoglycemic episodes. Even though patients receiving intensive insulin therapy have shorter ICU stays and infection rates similar to those receiving conventional insulin therapy, both groups have similar follow-up mortality and neurologic outcome. Hence if intensive insulin therapy is to be used, great effort must be taken to avoid hypoglycemia.	[Bilotta, Federico; Caramia, Remo; Doronzio, Andrea; Cuzzone, Vincenzo; Rosa, Giovanni] Univ Roma La Sapienza, Dept Anesthesiol Crit Care & Pain Med, I-00199 Rome, Italy; [Cernak, Ibolja] Johns Hopkins Univ, Appl Phys Lab, Biomed Business Area, Laurel, MD USA; [Paoloni, Francesca Paola] GIMEMA Data Ctr, Rome, Italy; [Santoro, Antonio] Univ Roma La Sapienza, Dept Neurosurg, Rome, Italy		Bilotta, F (corresponding author), Univ Roma La Sapienza, Dept Anesthesiol Crit Care & Pain Med, Viale Somalia 81, I-00199 Rome, Italy.	bilotta@tiscali.it		Ibolja, Cernak/0000-0003-3214-698X; SANTORO, Antonio/0000-0002-0798-6816; Paoloni, Francesca/0000-0001-5527-981X			Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; BOYLE PJ, 1988, NEW ENGL J MED, V318, P1487, DOI 10.1056/NEJM198806093182302; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LI PA, 1994, NEUROSCI LETT, V177, P63, DOI 10.1016/0304-3940(94)90045-0; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; Mechanick JI, 2007, CURR OPIN CLIN NUTR, V10, P193, DOI 10.1097/MCO.0b013e32802b7016; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; Preiser JC, 2007, CRIT CARE MED, V35, pS503, DOI 10.1097/01.CCM.0000278046.24345.C7; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; SIEBER FE, 1992, CRIT CARE MED, V20, P104, DOI 10.1097/00003246-199201000-00022; Souba WW, 1997, NEW ENGL J MED, V336, P41, DOI 10.1056/NEJM199701023360107; Thomas G, 2007, NEPHROL DIAL TRANSPL, V22, P2849, DOI 10.1093/ndt/gfm401; Turina M, 2006, CRIT CARE MED, V34, pS291, DOI 10.1097/01.ccm.0000231887.84751.04; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; Wass CT, 1996, MAYO CLIN PROC, V71, P801; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; WIDOM B, 1990, ANN INTERN MED, V112, P904, DOI 10.7326/0003-4819-112-12-904; Yamada K, 2007, CRIT CARE, V11, DOI 10.1186/cc5953; 2006, APSF NEWSLETTER  SUM	35	124	135	0	11	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2008	9	2					159	166		10.1007/s12028-008-9084-9			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	351RC	WOS:000259441300001	18373223				2022-02-06	
J	Griesbach, GS; Gomez-Pinilla, F; Hovda, DA				Griesbach, Grace S.; Gomez-Pinilla, Fernando; Hovda, David A.			Time window for voluntary exercise-induced increases in hippocampal neuroplasticity molecules after traumatic brain injury is severity dependent	JOURNAL OF NEUROTRAUMA			English	Article						BDNF; CREB; exercise; rehabilitation; synapsin I	LATERAL FLUID PERCUSSION; CEREBRAL GLUCOSE-UTILIZATION; LONG-TERM POTENTIATION; SYNAPTIC-PLASTICITY; HEAD-INJURY; SYNAPSIN-I; NEUROTROPHIC FACTOR; NEUROTRANSMITTER RELEASE; SUSTAINED ACTIVATION; RAT HIPPOCAMPUS	We recently found that an exercise-induced increase in hippocampal brain-derived neurotrophic factor (BDNF) is dependent when exercise is initiated after traumatic brain injury (TBI). When voluntary exercise was delayed by 2 weeks after a mild fluid-percussion injury (FPI) in rats, an increase in BDNF and an improvement in behavioral outcome were observed. This suggests that following FPI there is a therapeutic window for the implementation of voluntary exercise. To determine if more severely injured animals require more time after TBI before voluntary exercise can increase neuroplasticity, adult male rats with a moderate lateral FPI or sham injury were housed with or without access to a running wheel from post-injury-day (PID) 0-6, 14-20 or 30-36. Rats with a mild injury only had access to the running wheel from PID 0-6 or 14-20. Rats were sacrificed at PID 7, 21, or 37. BDNF, synapsin I, and cyclic AMP response element binding protein ( CREB) were analyzed within the ipsilateral hippocampus. Whereas BDNF levels significantly increased with exercise in the mild FPI rats that were exercised from PID 14 to 20, the moderate FPI rats only showed significant increases in BDNF when exercised from PID 30 to 36. In addition, moderate FPI rats that were allowed to exercise from PID 30 to 36 also exhibited significant increases in synapsin I and CREB. These results indicate that the time window for exercise-induced increases in BDNF, synapsin I, and CREB is dependent on injury severity.	Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA		Griesbach, GS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neurosurg, 10833 Le Conte Ave,18-228 NPI,Box 957039, Los Angeles, CA 90095 USA.	ggriesbach@mednet.ucla.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27544, NS048535] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544, R21NS048535] Funding Source: NIH RePORTER		Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Finkbeiner S, 2000, CELL MOL LIFE SCI, V57, P394, DOI 10.1007/PL00000701; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; GRIESBACH GS, 2006, J NEUROTRAUMA, V23; GROSS PM, 1980, J APPL PHYSIOL, V48, P213, DOI 10.1152/jappl.1980.48.2.213; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HOVDA DA, 1994, SOC NEUR ABST; Ivanco TL, 2000, NEUROPHARMACOLOGY, V39, P765, DOI 10.1016/S0028-3908(00)00004-6; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; KOKAIA Z, 1994, EUR J NEUROSCI, V6, P587, DOI 10.1111/j.1460-9568.1994.tb00303.x; Kokaia Z, 1998, EXP NEUROL, V154, P289, DOI 10.1006/exnr.1998.6888; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MELLONI RH, 1994, NEUROSCIENCE, V58, P683, DOI 10.1016/0306-4522(94)90448-0; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; ORGOGOZO JM, 1979, SCIENCE, V206, P847, DOI 10.1126/science.493986; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Shen H, 2001, NEUROSCIENCE, V107, P219, DOI 10.1016/S0306-4522(01)00315-3; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Vissing J, 1996, J CEREBR BLOOD F MET, V16, P729, DOI 10.1097/00004647-199607000-00025; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	56	124	128	0	13	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2007	24	7					1161	1171		10.1089/neu.2006.0255			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	186DV	WOS:000247760200007	17610355				2022-02-06	
J	Bishop, GM; Dringen, R; Robinson, SR				Bishop, Glenda M.; Dringen, Ralf; Robinson, Stephen R.			Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						astrocyte; carmustine; epileptiform; glutathione reductase; hydrogen peroxide; ischemia; reactive oxygen species; stroke; traumatic brain injury; zinc	EXOGENOUS HYDROGEN-PEROXIDE; SYNAPTICALLY-RELEASED ZINC; CULTURED ASTROGLIAL CELLS; NEURONAL DEATH; BOVINE BRAIN; DETOXIFICATION; 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA; ACCUMULATION; PURIFICATION; PATHWAYS	The release of zinc (Zn) from glutamatergic synapses contributes to the neuropathology of ischemia, traumatic brain injury, and stroke. Astrocytes surround glutamatergic synapses, and are vulnerable to the toxicity of Zn, which impairs their antioxidative glutathione (GSH) system and elevates the production of reactive oxygen species (ROS). It is not known whether one or both of these actions are the primary cause of Zn-induced cell death in astrocytes. Using primary rat astrocyte cultures we have examined whether Zn-mediated impairment of GSH redox cycling is the main source of its toxicity. Zn acetate at concentrations of 100 mu M or greater were found to inactivate glutathione reductase (GR) via an NADPH-dependent mechanism, while concentrations of 150 mu M and above caused substantial cell death. Furthermore, Zn increased the ratio of GSSG:GSH in astrocytes, increased their export of GSSG, slowed their clearance of exogenous H2O2, and promoted the intracellular production of ROS. In contrast, the GR inhibitor, carmustine, did not induce cell death, cause the production of ROS, or alter the GSH thiol redox balance. Taken together these results indicate that Zn toxicity in astrocytes is primarily associated with the generation of intracellular ROS, rather than the inhibition of GR. (c) 2007 Elsevier Inc. All rights reserved.	Monash Univ, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3168, Australia; Univ Bremen, Fac Biol Chem 2, Ctr Biomol Interact, D-2800 Bremen 33, Germany		Bishop, GM (corresponding author), Monash Univ, Sch Psychol Psychiat & Psychol Med, Wellington Rd, Clayton, Vic 3168, Australia.	glenda.bishop@med.monash.edu.au	Robinson, Stephen R./AAU-3219-2021; Bishop, Glenda M/G-6031-2010; Robinson, Stephen R/B-7155-2013	Robinson, Stephen R./0000-0002-0987-0075; Dringen, Ralf/0000-0001-7869-1305; Bishop, Glenda/0000-0002-2736-0415			AKERBOOM TPM, 1989, METHOD ENZYMOL, V173, P523; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Bragadin M, 2004, ANN NY ACAD SCI, V1030, P348, DOI 10.1196/annals.1329.043; Brocardo PS, 2005, TOXICOLOGY, V207, P283, DOI 10.1016/j.tox.2004.09.012; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; COHEN MB, 1988, BIOCHEM PHARMACOL, V37, P3317, DOI 10.1016/0006-2952(88)90645-4; Dineley KE, 2000, NEUROBIOL DIS, V7, P310, DOI 10.1006/nbdi.2000.0303; Doroshenko N, 2003, EUR J PHARMACOL, V476, P185, DOI 10.1016/S0014-2999(03)02191-5; Dringen R, 2005, J NEUROSCI RES, V79, P157, DOI 10.1002/jnr.20280; Dringen R, 1997, BRAIN RES, V759, P67, DOI 10.1016/S0006-8993(97)00233-3; Dringen R, 1999, J NEUROCHEM, V72, P2523, DOI 10.1046/j.1471-4159.1999.0722523.x; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Dringen R, 2002, METHOD ENZYMOL, V348, P281, DOI 10.1016/S0076-6879(02)48646-6; Dringen R, 1998, BRAIN RES PROTOC, V2, P223, DOI 10.1016/S1385-299X(97)00047-0; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Gutterer JM, 1999, J NEUROCHEM, V73, P1422, DOI 10.1046/j.1471-4159.1999.0731422.x; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Hoepken HH, 2004, J NEUROCHEM, V88, P1194, DOI 10.1046/j.1471-4159.2003.02236.x; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; KARPLUS PA, 1988, EUR J BIOCHEM, V171, P193, DOI 10.1111/j.1432-1033.1988.tb13775.x; Keppler D, 1999, FREE RADICAL BIO MED, V27, P985, DOI 10.1016/S0891-5849(99)00171-9; Kim D, 2003, NEUROREPORT, V14, P187, DOI 10.1097/00001756-200302100-00005; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAY JM, 1982, J BIOL CHEM, V257, P4362; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; MIZE CE, 1962, J BIOL CHEM, V237, P1589; Noh KM, 2000, J NEUROSCI, V20; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Robinson SR, 2001, J NEUROSCI RES, V66, P972, DOI 10.1002/jnr.10057; Romero IA, 1996, TOXICOL APPL PHARM, V139, P94, DOI 10.1006/taap.1996.0146; Ryu JR, 2002, EXP BRAIN RES, V143, P257, DOI 10.1007/s00221-001-0991-7; Seefeldt T, 2005, J MED CHEM, V48, P5224, DOI 10.1021/jm050030i; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Walther UI, 2003, ARCH TOXICOL, V77, P131, DOI 10.1007/s00204-002-0421-z; Wilhelm B, 2001, ARCH TOXICOL, V75, P388	43	124	131	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	APR 15	2007	42	8					1222	1230		10.1016/j.freeradbiomed.2007.01.022			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	154NJ	WOS:000245514000010	17382203				2022-02-06	
J	Zweckberger, K; Eros, C; Zimmermann, R; Kim, SW; Engel, D; Plesnila, N				Zweckberger, Klaus; Eroes, Christian; Zimmermann, Ricarda; Kim, Seong-Woong; Engel, Doortje; Plesnila, Nikolaus			Effect of early and delayed decompressive craniectomy on secondary brain damage after controlled cortical impact in mice	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; craniectomy; early craniectomy; mice; neuroprotection controlled cortical impact; secondary brain damage; traumatic brain injury	SEVERE HEAD-INJURIES; CEREBRAL-BLOOD-FLOW; CNS INJURY; MANAGEMENT; EDEMA; APOPTOSIS; CONTUSION; PATHWAYS	The timing of decompressive craniectomy for the treatment of increased intracranial pressure (ICP) after traumatic brain injury (TBI) is a widely discussed clinical issue. Although we showed recently that early decompression is beneficial following experimental TBI, it remains unclear to what degree decompression craniectomy reduces secondary brain damage and if craniectomy is still beneficial when it is delayed by several hours as often inevitable during daily clinical practice. The aim of the current study was therefore to investigate the influence of craniectomy on secondary contusion expansion and brain edema formation and to determine the therapeutic window of craniectomy. Male C57/B16 mice were subjected to controlled cortical impact injury. Contusion volume, brain edema formation, and opening of the blood-brain barrier were investigated 2, 6, 12, and 24 h and 7 days after trauma. The effect of decompression craniectomy on secondary brain damage was studied in control mice (closed skull) and in animals craniotomized immediately or with a delay of 1, 3, or 8 It after trauma. Twenty-four hours after trauma:, the time point of maximal lesion expansion (+60% vs. 15 min after trauma) and brain edema formation (+3.0% water content vs. sham), contusion volume in craniotomized mice did not show any secondary expansion; that is, contusion volume was similar to that observed in mice sacrificed immediately after trauma (18.3 +/- 5.3 vs. 22.2 +/- 1.4 mm(3)). Furthermore, brain edema formation was reduced by 52% in craniotomized animals. The beneficial effect of craniectomy was still present even when treatment was delayed by up to 3 h after trauma (p < 0.05). The current study clearly demonstrates that early craniectomy prevents secondary brain damage and significantly reduces brain edema formation after experimental TBI. Evaluation of early craniectomy as a therapeutic option after TBI in humans may therefore be indicated.	Univ Munich, Med Ctr, Lab Expt Neurosurg, Dept Neurosurg, Munich, Germany; Univ Munich, Med Ctr, Inst Surg Res, Munich, Germany; Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands		Plesnila, N (corresponding author), Univ Munich, Med Ctr, Lab Expt Neurosurg, Dept Neurosurg, Marchioninistr 15, Munich, Germany.	plesnila@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019				Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Burkert W, 1989, Zentralbl Neurochir, V50, P106; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; GAAB M, 1979, CHILD BRAIN, V5, P484; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTLEMAN D, 1990, INJURY, V21, P305, DOI 10.1016/0020-1383(90)90047-X; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; JENNETT B, 1980, J NEUROL NEUROSUR PS, V43, P289, DOI 10.1136/jnnp.43.4.289; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kocher T., 1901, HIRNERSCHUTTERUNG HI, V3, P262; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maeda K, 2000, J CEREBR BLOOD F MET, V20, P10, DOI 10.1097/00004647-200001000-00003; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Ogawa M, 1974, Med J Osaka Univ, V25, P73; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; RIBAS GC, 1992, J NEUROTRAUM, V9, pS265; RINALDI A, 1990, ACT NEUR S, V51, P394; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Wilberger J, 1991, Neurosurg Clin N Am, V2, P341; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	32	124	125	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2006	23	7					1083	1093		10.1089/neu.2006.23.1083			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	069UG	WOS:000239473200004	16866621				2022-02-06	
J	Mandel, S; Weinreb, O; Amit, T; Youdim, MBH				Mandel, S; Weinreb, O; Amit, T; Youdim, MBH			Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives	BRAIN RESEARCH REVIEWS			English	Article; Proceedings Paper	OASI Workshop 2004	MAY 13-17, 2004	Troina, ITALY			Parkinson's disease; neuroprotection; rasagiline; propargylamine; ladostigil; PKC; Bcl-2; cell death; MAPK	PROTEIN-KINASE-C; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; CHOLINESTERASE INHIBITOR; SIGNAL-TRANSDUCTION; TERMINAL FRAGMENT; TEA POLYPHENOLS; PKC-EPSILON; B INHIBITOR; MAP KINASE	The mitochondria are directly involved in cell survival and death. Drugs that protect mitochondria viability and prevent apoptotic cascade mechanisms involved in mitochondrial permeability transition pore (MPTp) will be cytoprotective. Rasagiline (N-propargyl-1R-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO) B inhibitor, anti-Parkinson drug. Unlike selegiline, rasagiline is not derived from amphetamine, is not metabolized to neurotoxic I-methamphetamine derivative, nor does it have sympathomimetic activity. Rasagiline is effective as monotherapy or adjunct to L-dopa for patients with early and late Parkinson's disease (PD), and adverse events do not occur with greater frequency in subjects receiving rasagiline than those on placebo. Controlled studies indicate that it might have a disease-modifying effect in PD that may be related to neuroprotection. Its S-isomer, TVP 1022, is a relatively inactive MAO inhibitor. However, both drugs have similar neuroprotective activities in neuronal cell cultures in response to various neurotoxins and in vivo (global ischemia, neurotrauma, head injury, anoxia, etc.), indicating that MAO inhibition is not a pre-requisite for neuroprotection. Structure activity studies have shown that the neuroprotective activity is associated with the propargyl moiety of rasagiline, which protects mitochondrial viability and MPTp by activating Bel-2 and protein kinase C (PKC), and down regulating pro-apoptotic FAS and Bax. Rasagiline and its derivatives also process amyloid precursor protein (APP) to the neuroprotective-neurotrophic soluble APP alpha (sAPP alpha) by PKC and MAP kinase-dependent activation of alpha-secretase. The neuroprotective activity of propargylamine has led us to develop novel bifunctional neuroprotective iron-chelating MAO-inhibiting drugs possessing propargyl moiety for the treatment of other neurodegenerative diseases. (c) 2005 Elsevier B.V. All rights reserved.	Technion, Fac Med, Dept Pharmacol, IL-31096 Haifa, Israel		Youdim, MBH (corresponding author), Technion, Fac Med, Dept Pharmacol, POB 9697, IL-31096 Haifa, Israel.	Youdim@tx.technion.ac.il					ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Akao Y, 2002, NEUROSCI LETT, V326, P105, DOI 10.1016/S0304-3940(02)00332-4; Bar Am O, 2004, NEUROSCI LETT, V355, P169, DOI 10.1016/j.neulet.2003.10.067; Bar-Am O, 2004, J NEUROCHEM, V89, P1119, DOI 10.1111/j.1471-4159.2004.02425.x; Battaini F, 1999, EXP NEUROL, V159, P559, DOI 10.1006/exnr.1999.7151; Battaini F, 1997, TRENDS NEUROSCI, V20, P410, DOI 10.1016/S0166-2236(97)01084-9; Benussi L, 1998, NEUROSCI LETT, V240, P97, DOI 10.1016/S0304-3940(97)00894-X; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Caputi A, 1997, J NEUROCHEM, V68, P2523; Cassandras CG, 1999, APPL COMPUT CONT SIG, V1, P1; Farlow MR, 2003, NEUROLOGIST, V9, P230, DOI 10.1097/01.nrl.0000087724.73783.5f; Finberg JPM, 1998, NEUROREPORT, V9, P703; Furlan R, 2004, J NEUROIMMUNOL, V150, P10, DOI 10.1016/j.jneuroim.2004.01.004; Grinberg LN, 1997, BIOCHEM PHARMACOL, V54, P973, DOI 10.1016/S0006-2952(97)00155-X; Grunblatt E, 2004, J NEURAL TRANSM, V111, P367, DOI 10.1007/s00702-003-0030-x; Gsell W, 1995, J NEURAL TRANSM-SUPP, P271; Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; Huang W, 1999, EUR J PHARMACOL, V366, P127, DOI 10.1016/S0014-2999(98)00929-7; JELLINGER KA, 1991, J NEURAL TRANSM-SUPP, P1; Kimura T, 2000, NEUROREPORT, V11, P869, DOI 10.1097/00001756-200003200-00042; KINOUCHI T, 1995, FEBS LETT, V364, P203, DOI 10.1016/0014-5793(95)00392-M; KRIBBEN A, 1993, AM J PHYSIOL, V265, pC939, DOI 10.1152/ajpcell.1993.265.4.C939; Kumamoto M, 2001, BIOSCI BIOTECH BIOCH, V65, P126, DOI 10.1271/bbb.65.126; Levites Y, 2002, J BIOL CHEM, V277, P30574, DOI 10.1074/jbc.M202832200; Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x; Lin L, 1999, P NATL ACAD SCI USA, V96, P12108, DOI 10.1073/pnas.96.21.12108; LIN LW, 1995, DRUG AGING, V6, P136, DOI 10.2165/00002512-199506020-00006; Maher P, 2001, J NEUROSCI, V21, P2929, DOI 10.1523/JNEUROSCI.21-09-02929.2001; Mandel S, 2003, TRENDS PHARMACOL SCI, V24, P184, DOI 10.1016/S0165-6147(03)00067-1; Maruyama W, 2000, ADV RES NEURODEGENER, V8, P171; Maruyama W, 2001, J NEURAL TRANSM, V108, P11, DOI 10.1007/s007020170093; Maruyama W, 2001, J NEUROCHEM, V78, P727, DOI 10.1046/j.1471-4159.2001.00448.x; MARUYAMA W, 2000, ANN NY ACAD SCI, V939, P320; MASLIAH E, 1991, J NEUROSCI, V11, P2759; Matsushima H, 1996, J NEUROCHEM, V67, P317; McNamara RK, 1998, J COMP NEUROL, V397, P337; McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517; Mills J, 1999, J NEUROCHEM, V72, P443, DOI 10.1046/j.1471-4159.1999.0720443.x; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Montz H P, 1985, Brain Res, V355, P150; MUTISYA EM, 1994, J NEUROCHEM, V63, P2179; Naoi M, 2001, PARKINSONISM RELAT D, V8, P139, DOI 10.1016/S1353-8020(01)00028-1; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; PARKER WD, 1989, NEW ENGL J MED, V320, P1331, DOI 10.1056/NEJM198905183202007; Rafique R, 2004, FREE RADICAL RES, V38, P157, DOI 10.1080/10715760310001643311; Rogers JT, 2004, CURR DRUG TARGETS, V5, P535, DOI 10.2174/1389450043345272; Rossner S, 1997, EUR J NEUROSCI, V9, P2125, DOI 10.1111/j.1460-9568.1997.tb01379.x; ROTH GS, 1995, TRENDS NEUROSCI, V18, P203, DOI 10.1016/0166-2236(95)93902-A; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Sagi Y, 2003, J NEUROCHEM, V86, P290, DOI 10.1046/j.1471-4159.2003.01801.x; SAITOH T, 1993, ANN NY ACAD SCI, V695, P34, DOI 10.1111/j.1749-6632.1993.tb23023.x; SAURA J, 1994, NEUROSCIENCE, V62, P15, DOI 10.1016/0306-4522(94)90311-5; SHIMOHAMA S, 1993, NEUROLOGY, V43, P1407, DOI 10.1212/WNL.43.7.1407; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561; SLACK BE, 1993, J BIOL CHEM, V268, P21097; Sterling J, 2002, J MED CHEM, V45, P5260, DOI 10.1021/jm020120c; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; Vianna MRM, 2000, PSYCHOPHARMACOLOGY, V150, P77, DOI 10.1007/s002130000396; WANG HY, 1994, NEUROBIOL AGING, V15, P293, DOI 10.1016/0197-4580(94)90023-X; WEINREB O, 2004, FASEB J; Weinstock M, 2002, PSYCHOPHARMACOLOGY, V160, P318, DOI 10.1007/s00213-001-0978-x; Weinstock M, 2001, ANN NY ACAD SCI, V939, P148; Weinstock M, 2000, ADV RES NEURODEGENER, V8, P157; WEINSTOCK M, 2003, NEUROPSYCHOPHARMACOL, V27, P556; Wenk GL, 2004, J NEUROCHEM, V89, P484, DOI 10.1111/j.1471-4159.2004.02359.x; Yeon SW, 2001, BIOCHEM BIOPH RES CO, V280, P782, DOI 10.1006/bbrc.2000.4181; Yogev-Falach M, 2003, FASEB J, V17, P2325, DOI 10.1096/fj.03-0078fje; Yogev-Falach M, 2002, FASEB J, V16, P1674, DOI 10.1096/fj.02-0198fje; Youdim MBH, 2004, ANN NY ACAD SCI, V1012, P306, DOI 10.1196/annals.1306.025; Youdim MBH, 2003, BIOCHEM PHARMACOL, V66, P1635, DOI 10.1016/S0006-2952(03)00535-5; Youdim MBH, 2001, CELL MOL NEUROBIOL, V21, P555, DOI 10.1023/A:1015131516649; Youdim MBH, 2001, BRIT J PHARMACOL, V132, P500, DOI 10.1038/sj.bjp.0703826; Youdim MBH, 2001, ANN NY ACAD SCI, V939, P450; YOUDIM MBH, 2003, NEUROTHERAPEUTICS, V3, P737; YOUDIM MBH, 2004, J NEURAL TRANSM, P1; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	80	124	133	0	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0173	1872-6321		BRAIN RES REV	Brain Res. Rev.	APR	2005	48	2			SI		379	387		10.1016/j.brainresrev.2004.12.027			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	933KV	WOS:000229628200027	15850677				2022-02-06	
J	Arnold, G; Boone, KB; Lu, P; Dean, A; Wen, J; Nitch, S; McPherson, S				Arnold, G; Boone, KB; Lu, P; Dean, A; Wen, J; Nitch, S; McPherson, S			Sensitivity and specificity of finger tapping test scores for the detection of suspect effort	CLINICAL NEUROPSYCHOLOGIST			English	Article							REITAN NEUROPSYCHOLOGICAL TESTS; SEX-DIFFERENCES; NORMATIVE DATA; HEAD-INJURY; HALSTEAD; PERFORMANCE; PATTERNS; ANXIETY; AGE	Past studies indicate that patients with incentive to fake neuropsychological symptoms are likely to have lower finger tapping scores than credible patients. The present study builds upon past research by investigating finger tapping performance for seven groups: (a) noncredible patients (as determined by failed psychometric and behavioral criteria), and patients with (h) closed head injury, (c) dementia, (d) mental retardation, (e) psychosis, or (f) depression, and (g) healthy older controls. Results showed that men tapped faster than women, requiring that groups be divided by gender. Noncredible male and female patients tapped slower than their comparison group counterparts. Dominant hand score proved to be more sensitive to noncredible performance than other scores (nondominant, sum of both hands, difference between dominant and nondominant), especially for women. Sensitivity, specificity, and positive and negative predictive values tables are presented. With specificity set at 90% for the comparison groups combined, a dominant hand cutoff score of <= 35 for men yielded 50% sensitivity, while a score of <= 28 yielded 61% sensitivity for women. Specificity values for specific cutoff scores varied significantly across the comparison groups, indicating that cutoffs should he adjusted for the particular differential diagnosis. In conclusion, results indicate that when using finger tapping scores to detect noncredible performance: (a) Dominant hand performance is more sensitive, and (b) cutoffs should be selected based on gender and claimed diagnosis.	Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA; Kaiser Permanente Los Angeles Med Ctr, Dept Psychiat, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA		Boone, KB (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, Bldg F-9,W Carson St, Torrance, CA 90509 USA.	kboone@rei.edu					ARDILA A, 1989, DEV NEUROPSYCHOL, V5, P307, DOI 10.1080/87565648909540441; BAK JS, 1980, J CONSULT CLIN PSYCH, V48, P395, DOI 10.1037/0022-006X.48.3.395; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; BORNSTEIN RA, 1987, CLIN NEUROPSYCHOL, V1, P209; CHAVEZ EL, 1983, PERCEPT MOTOR SKILL, V56, P923, DOI 10.2466/pms.1983.56.3.923; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DODRILL CB, 1979, J CLIN PSYCHOL, V35, P236, DOI 10.1002/1097-4679(197904)35:2<236::AID-JCLP2270350202>3.0.CO;2-9; ECHTERNACHT R, 1981, CLIN NEUROPSYCHOLOGY, V3, P8; FILSKOV SB, 1986, HDB CLIN NEUROPSYCHO, V2; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; FROMMAUCH D, 1983, J CLIN NEUROPSYCHOL, V5, P221, DOI 10.1080/01688638308401171; GOLDSTEIN SG, 1974, PERCEPT MOTOR SKILL, V38, P1139, DOI 10.2466/pms.1974.38.3c.1139; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; HARRIS M, 1981, ARCH CLIN NEUROPSYCH, V8, P525; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heaton RK, 1991, COMPREHENSIVE NORMS; Heaton RK, 1986, NEUROPSYCHOLOGICAL A; HOFFMAN DT, 1969, PERCEPT MOTOR SKILL, V29, P676, DOI 10.2466/pms.1969.29.2.676; KING GD, 1978, J CONSULT CLIN PSYCH, V46, P375, DOI 10.1037/0022-006X.46.2.375; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; MCKEEVER WF, 1991, J CLIN EXP NEUROPSYC, V13, P91; MORRISON MW, 1979, PERCEPT MOTOR SKILL, V48, P139, DOI 10.2466/pms.1979.48.1.139; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; ROGERS R, 1988, CLIN ASSESSMENT MALI; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; RUSSELL EW, 1993, ARCH CLIN NEUROPSYCH, V8, P327, DOI 10.1016/0887-6177(93)90023-T; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SURE J, 1997, J CLIN EXPT NEUROPSY, V19, P500; TRAHAN DE, 1987, 15 ANN M INT NEUR SO; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; VILLARDITA C, 1985, ARCH GERONTOL GERIAT, V4, P311, DOI 10.1016/0167-4943(85)90038-X; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	36	124	126	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2005	19	1					105	120		10.1080/13854040490888567			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	912YF	WOS:000228115300008	15814482				2022-02-06	
J	D'Ambrosio, R; Fender, JS; Fairbanks, JP; Simon, EA; Born, DE; Doyle, DL; Miller, JW				D'Ambrosio, R; Fender, JS; Fairbanks, JP; Simon, EA; Born, DE; Doyle, DL; Miller, JW			Progression from frontal-parietal to mesial-temporal epilepsy after fluid percussion injury in the rat	BRAIN			English	Article						trauma; drug screening; electrocorticography; partial seizures; gliosis	TRAUMATIC BRAIN-INJURY; GENETIC ABSENCE EPILEPSY; LOBE EPILEPSY; POSTTRAUMATIC EPILEPSY; HIPPOCAMPAL SCLEROSIS; WAVE DISCHARGES; SEIZURE; STIMULATION; PATTERNS; FEATURES	We recently described an in vivo model of post-traumatic epilepsy (PTE) in the rat where chronic spontaneous recurrent seizures appear following a single episode of fluid percussion injury (FPI). PTE, studied during the first 2 months post-injury, was focal and seizures originated predominantly from the frontal-parietal neocortex at or around the injury site. However, rarer bilateral seizures originating from a different and undefined focus were also observed. To shed light on the Posttraumatic Epileptogenic mechanisms and on the generation of bilateral seizures, we studied rats up to 7 months post-injury. In vivo paired epidural and depth-electrode recordings indicated that the anterior hippocampus evolves into an epileptic focus which initiates bilateral seizures. The rate of frontal-parietal seizures remained constant over time after 2 weeks post-injury, while the rate of hippocampal seizures greatly increased over time, suggesting that different mechanisms mediate neocortical and hippocampal post-traumatic epileptogenesis. Because of different temporal evolution of these foci, the epileptic syndrome was characterized by predominant frontal-parietal seizures early after injury, but by predominant mesio-temporal seizures at later time points. Pathological analysis demonstrated progressive hippocampal and temporal cortex pathology that paralleled the increase in frequency and duration of bilateral seizures. These results demonstrate that FPI-induced frontal-parietal epilepsy (FPE) progresses to mesial-temporal lobe epilepsy (MTLE) with dual pathology. These observations establish numerous similarities between FPI-induced and human PTE and further validate it as a clinically relevant model of PTE.	Univ Washington, Harborview Med Ctr, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Sch Med, Dept Neurol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Sch Med, Reg Epilepsy Ctr, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Sch Med, Dept Pathol, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Sch Med, Ctr Human Dev & Disabil, Seattle, WA 98104 USA		D'Ambrosio, R (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurosurg, Box 359915,325 9th Ave, Seattle, WA 98104 USA.	raid@u.washington.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS040823, R01 NS040823-02, R01 NS040823] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040823] Funding Source: NIH RePORTER		Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arruda F, 1996, ANN NEUROL, V40, P446, DOI 10.1002/ana.410400314; Benbadis SR, 2003, SEIZURE-EUR J EPILEP, V12, P167, DOI 10.1016/S1059-1311(02)00320-5; Bertram EH, 1999, NEUROSCIENCE, V92, P15, DOI 10.1016/S0306-4522(98)00712-X; BROWNING RA, 1986, EXP NEUROL, V93, P546, DOI 10.1016/0014-4886(86)90174-3; BROWNING RA, 1987, EPILEPSY RETICULAR F, P137; CAVAZOS JE, 1990, BRAIN RES, V527, P1, DOI 10.1016/0006-8993(90)91054-K; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2004, PHARMACOL THERAPEUT, V103, P95, DOI 10.1016/j.pharmthera.2004.05.004; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DAMBROSIO R, 2003, YOUMANS NEUROLOGICAL, P2449; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DollemanVanderWeel MJ, 1997, J NEUROSCI, V17, P5640; ENGEL JJ, 1991, KINDLING SYNAPTIC PL, P196; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Fuerst D, 2003, ANN NEUROL, V53, P413, DOI 10.1002/ana.10509; Gale K, 1988, MECHANISMS EPILEPTOG, P111; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Holmes GL, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.9_suppl_5.S3; INOUE M, 1990, PHYSIOL BEHAV, V48, P199, DOI 10.1016/0031-9384(90)90285-C; JUULJENSEN P, 1986, INTRACTABLE EPILEPSY, P5; Kelly Kevin M, 2004, Epilepsy Curr, V4, P160, DOI 10.1111/j.1535-7597.2004.44015.x; Kuba R, 2003, EUR J NEUROL, V10, P641, DOI 10.1046/j.1468-1331.2003.00684.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105; MATHERN GW, 1994, EPILEPSY RES, V19, P129, DOI 10.1016/0920-1211(94)90023-X; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; PIREDDA S, 1985, NATURE, V317, P623, DOI 10.1038/317623a0; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Salanova V, 2002, EPILEPSIA, V43, P170, DOI 10.1046/j.1528-1157.2002.33800.x; Salin P, 1995, J NEUROSCI, V15, P8234; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Satow T, 2002, EPILEPSIA, V43, P1425, DOI 10.1046/j.1528-1157.2002.34501.x; Schauwecker PE, 2002, PROG BRAIN RES, V135, P139; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SNEAD OC, 1999, JASPERS BASIC MECH E, P253; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002; Tinuper P, 1998, J NEUROL NEUROSUR PS, V64, P231, DOI 10.1136/jnnp.64.2.231; VADASZ C, 1995, AM J MED GENET, V60, P55, DOI 10.1002/ajmg.1320600111; VANLUIJTELAAR ELJM, 1986, NEUROSCI LETT, V70, P393, DOI 10.1016/0304-3940(86)90586-0; Vergnes M, 2003, EXP NEUROL, V184, P549, DOI 10.1016/S0014-4886(03)00098-0; WILLIAMSON PD, 1986, EPILEPSIA, V27, pS46, DOI 10.1111/j.1528-1157.1986.tb05740.x; WILLOUGHBY JO, 1992, LAB ANIM SCI, V42, P551	56	124	127	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2005	128		1				174	188		10.1093/brain/awh337			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885WK	WOS:000226187800019	15563512	Green Accepted, Bronze			2022-02-06	
J	Perlstein, WM; Cole, MA; Demery, JA; Seignourel, PJ; Dixit, NK; Larson, MJ; Briggs, RW				Perlstein, WM; Cole, MA; Demery, JA; Seignourel, PJ; Dixit, NK; Larson, MJ; Briggs, RW			Parametric manipulation of working memory load in traumatic brain injury: Behavioral and neural correlates	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Proceedings Paper	32nd Annual Meeting of the Society-for-Neuroscience	NOV 02-07, 2002	ORLANDO, FL	Soc Neurosci		traumatic brain injury; working memory; functional magnetic resonance imaging	PREFRONTAL CORTEX DYSFUNCTION; DUAL-TASK PERFORMANCE; CARD SORTING TEST; EXECUTIVE FUNCTIONS; HEAD-INJURY; DEFICITS; ACTIVATION; SYSTEM; IMPAIRMENTS; RELATIVES	Traumatic brain injury (TBI) is often associated with enduring impairments in high-level cognitive functioning, including working memory (WM). We examined WM function in predominantly chronic patients with mild, moderate and severe TBI and healthy comparison subjects behaviorally and, in a small subset of moderate-to-severe TBI patients, with event-related functional magnetic resonance imaging (fMRI), using a visual n-back task that parametrically varied WM load. TBI patients showed severity-dependent and load-related WM deficits in performance accuracy, but not reaction time. Performance of mild TBI patients did not differ from controls; patients with moderate and severe TBI were impaired, relative to controls and mild TBI patients, but only at higher WM-load levels. fMRI results show that TBI patients exhibit altered patterns of activation in a number of WM-related brain regions, including the dorsolateral prefrontal cortex and Broca's area. Examination of the pattern of behavioral responding and the temporal course of activations suggests that WM deficits in moderate-to-severe TBI are due to associative or strategic aspects of WM, and not impairments in active maintenance of stimulus representations. Overall, results demonstrate that individuals with moderate-to-severe TBI exhibit WM deficits that are associated with dysfunction within a distributed network of brain regions that support verbally mediated WM.	Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; Univ Florida, McKnight Brain Inst, Gainesville, FL USA; Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX USA		Perlstein, WM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, HSC Box 100165, Gainesville, FL 32610 USA.	wmp@grove.ufl.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH001857] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01 MH01857] Funding Source: Medline		ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; Baddeley A.D., 1986, WORKING MEMORY; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; BRAVER SL, 1993, PSYCHOL BULL, V113, P379, DOI 10.1037/0033-2909.113.2.379; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; CHAPMAN LJ, 1989, J ABNORM PSYCHOL, V98, P357, DOI 10.1037/0021-843X.98.4.357; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P153; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; Huynh H., 1976, J EDUC STAT, V1, P69, DOI [10.3102/10769986001001069, DOI 10.3102/10769986001001069, 10.2307/1164736]; Jonides J, 1997, STUD COGNIT, P243; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KEPPEL G, 1982, DESIGN ANAL RES HDB; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Miller E, 1970, Cortex, V6, P121; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; NOLL DC, 1995, JMRI-J MAGN RESON IM, V5, P49, DOI 10.1002/jmri.1880050112; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Perlstein WM, 2003, NEUROSCI LETT, V342, P191, DOI 10.1016/S0304-3940(03)00226-X; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Perlstein WM, 2003, BIOL PSYCHIAT, V53, P25, DOI 10.1016/S0006-3223(02)01675-X; Phillips L. H, 1997, METHODOLOGY FRONTAL, P191; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; PRICE CJ, 2001, HDB FUNCTIONAL NEURO, P379; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Spielberger CD., 1970, STATE TRAIT ANXIETY; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Strauss ME, 2001, J ABNORM PSYCHOL, V110, P6, DOI 10.1037//0021-843X.110.1.6; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	70	124	126	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2004	10	5					724	741		10.1017/S1355617704105110			18	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychiatry; Psychology	848XZ	WOS:000223502700009	15327720				2022-02-06	
J	Hibbard, MR; Ashman, TA; Spielman, LA; Chun, D; Charatz, HJ; Melvin, S				Hibbard, MR; Ashman, TA; Spielman, LA; Chun, D; Charatz, HJ; Melvin, S			Relationship between depression and psychosocial functioning after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	State of the Science Conference	APR, 2002	Geroge Washington Univ, Washington, DC	Rehabilitat Res & Training Ctr, NIDRR	Geroge Washington Univ	brain injuries; depression; psychiatry; rehabilitation	HEAD-INJURY; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; SOCIAL SUPPORT; RISK-FACTORS; AXIS-I; REHABILITATION; PREVALENCE; DISABILITY; OUTPATIENTS	Objective: To examine the relationship between depression and psychosocial functioning up to 5 years after traumatic brain injury (TBI). Design: Longitudinal cohort study with 2 assessments completed. Setting: Community. Participants: Individuals (N = 188) with TBI living in the community. Interventions: Not applicable. Main Outcome Measures: Structured Clinical Interview for Depression, self-reports of depression severity, functional symptoms, quality of life (QOL), unmet important needs, and psychosocial functioning. Results: Based on observed depression patterns at initial and repeat assessment, 4 subgroups were created: no depression, resolved depression, late-onset depression, and chronic depression. Groups were equivalent in terms of demographic and injury-related factors but differed significantly in perceived psychosocial functioning. The no-depression group reported fewer depressive symptoms and higher levels of psychosocial functioning, whereas the chronic-depression group reported the poorest psychosocial functioning, with a further decline in QOL at reassessment. Although the resolved-depression and late-onset-depression groups reported similar psychosocial functioning at initial assessment, psychosocial functioning had improved for the resolved-depression group and declined for the late-onset-depression group at reassessment. Pre- and post-psychiatric diagnoses were common in all groups, with pre-TBI diagnosis of depression not predictive of post-TBI depression. Conclusions: Findings highlight the need for broad-based assessments and timely interventions for both mood and psychosocial challenges after TBI.	Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Hibbard, MR (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave Levy Pl,Box 1240, New York, NY 10029 USA.	mary.hibbard@mssm.edu	Ashman, Teresa/B-1621-2013	Ashman, Teresa/0000-0003-2401-7192			Andrews F. M., 1976, SOCIAL INDICATORS WE; [Anonymous], 1998, BRAIN INJ SCREEN QUE; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Beck AT, 1987, BECK DEPRESSION INVE; Beekman ATF, 1998, SOC PSYCH PSYCH EPID, V33, P463, DOI 10.1007/s001270050080; BIGELOW D, 1992, PSYCHOL REHABIL J, V14, P94; Boekamp JR, 1996, INT J PSYCHIAT MED, V26, P329, DOI 10.2190/CMU6-24AH-E4JG-8KBN; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROWN David, 1998, NATIONS NATL, V4, P1, DOI [DOI 10.1111/J.1354-5078.1998.00001.X, 10.1111/j.1354-5078.1998.00001.x]; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; Gibbon M., 1997, USERS GUIDE STRUCTUR; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Grieco E. M., 2001, CENSUS 2000 BRIEF OV; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Hall K., 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Higgins, 1989, ADV EXPT SOCIAL PSYC, V22, P93, DOI DOI 10.1016/S0065-2601(08)60306-8; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KOSCIULEK JF, 1994, REHABIL COUNS BULL, V37, P244; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lehmkuhl D, 1988, TIRR SYMPTOM CHECKLI; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; *MED COLL VIRG DEP, TBI SYMPT CHECKL; *MET OUTC TRUST, 1992, MED OUTC TRUST SF 36; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; *MOUNT SIN SCH MED, 1994, QUAL LIF INT HLTH IN; *MOUNT SIN SCH MED, 1998, LIV LIF TBI LLATBI; Picard M., 1991, HELPS; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; RUTHERFORD WH, 1977, LANCET, V1, P1; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Seligman MEP., 1998, LEARNED OPTIMISM; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	58	124	124	0	9	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2004	85	4		2			S43	S53		10.1016/j.apmr.2003.08.116			11	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	812FL	WOS:000220825300006	15083421				2022-02-06	
J	Janusz, JA; Kirkwood, MW; Yeates, KO; Taylor, HG				Janusz, JA; Kirkwood, MW; Yeates, KO; Taylor, HG			Social problem-solving skills in children with traumatic brain injury: Long-term outcomes and prediction of social competence	CHILD NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; NEUROBEHAVIORAL SYMPTOMS; BEHAVIOR PROBLEMS; ADJUSTMENT; RELIABILITY; RECOVERY	The effects of childhood traumatic brain injury (TBI) on social problem-solving were examined in 35 children with severe TBI, 40 children with moderate TBI, and 46 children with orthopedic injuries (01). The children were recruited prospectively following injuries that occurred between 6 and 12 years of age. They were followed longitudinally, and ranged from 9 to 18 years of age at the time of the current study, which occurred on average 4 years post injury. They were administered a semi-structured interview used in previous research on social problem-solving to assess the developmental level of their responses to hypothetical dilemmas involving social conflict. Children in the severe TBI group,defined the social dilemmas and generated alternative strategies to solve those dilemmas at the same developmental level as did children in the OI group. However, they articulated lower-level strategies as the best way to solve the dilemmas and used lower-level reasoning to evaluate the effectiveness of the strategies: After controlling for group membership, race, socioeconomic status, IQ, and age, children's social problem-solving; and particularly the developmental level of their preferred strategies for resolving conflicts, predicted parents ratings of children's social skills, peer relationships, aggressive behavior, and academic performance. The findings indicate that children with severe TBI demonstrate selective, long-term deficits in their social problem-solving skills that may help to account for their poor social and academic outcomes.	Childrens Hosp, Dept Psychol, Columbus, OH 43205 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA		Yeates, KO (corresponding author), Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH 43205 USA.		Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Janusz, Jennifer/0000-0002-6877-0947	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5 R01 NS36335] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ 390611] Funding Source: Medline		Achenbach TM, 1991, MANUAL CHILD BEHAV C; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Ciccetti D., 1984, VINELAND ADAPTIVE BE; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cohen J., 2013, STAT POWER ANAL BEHA; COOLEY EA, 1997, STUDENTS ACQUIRED BR, P255; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Dodge KA, 2002, PSYCHOL ASSESSMENT, V14, P60, DOI 10.1037//1040-3590.14.1.60; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; Gresham FM, 2001, EXCEPT CHILDREN, V67, P331, DOI 10.1177/001440290106700303; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LEVINE MJ, 1993, BRAIN INJURY, V7, P153, DOI 10.3109/02699059309008169; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; MAYER T, 1980, J PEDIATR SURG, V15, P19; MCGANN W, 1995, BRAIN INJURY, V9, P93, DOI 10.3109/02699059509004575; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; MCGUIRE TL, 1986, J HEAD TRAUMA REHAB, V1, P1; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nassau JH, 1997, J PEDIATR PSYCHOL, V22, P771, DOI 10.1093/jpepsy/22.6.771; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Sattler JM, 1992, ASSESSMENT CHILDREN, Vthird; Schultz L.H., 1988, INTERPERSONAL NEGOTI; SELMAN RL, 1997, FOSTERING FRIENDSHIP; SELMAN RL, 1990, MAKING FRIEND YOUTH; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D., 1991, WISC 3 WECHSLER INTE; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; YEATES KO, 1991, MERRILL PALMER QUART, V37, P369; YEATES KO, 1990, CLIN PSYCHOL REV, V10, P567, DOI 10.1016/0272-7358(90)90097-T; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	50	124	124	2	21	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	SEP	2002	8	3					179	194		10.1076/chin.8.3.179.13499			16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	677FM	WOS:000182796300004	12759833				2022-02-06	
J	Jagoda, AS; Cantrill, SV; Wears, RL; Valadka, A; Gallagher, EJ; Gottesfeld, SH; Pietrzak, MP; Bolden, J; Bruns, JJ; Zimmerman, R				Jagoda, AS; Cantrill, SV; Wears, RL; Valadka, A; Gallagher, EJ; Gottesfeld, SH; Pietrzak, MP; Bolden, J; Bruns, JJ; Zimmerman, R			Clinical policy: Neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting	ANNALS OF EMERGENCY MEDICINE			English	Article							MINOR HEAD-INJURY; CRANIAL COMPUTED-TOMOGRAPHY; SIGNIFICANT INTRACRANIAL INJURY; HIGH-YIELD CRITERIA; COMA-SCALE SCORE; LOW-RISK; EXTRADURAL HEMATOMAS; SKULL RADIOGRAPHY; CT SCANS; MANAGEMENT		Mt Sinai Sch Med, Dept Emergency Med, IBIA, New York, NY 10029 USA; Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA; Univ Florida, Sch Med, Dept Emergency Med, ACEP, Jacksonville, FL USA; Baylor Coll Med, Dept Neurosurg,Sect Neurotrauma & Crit Care, Amer Assoc Neurol Surgeons, Congress Neurol Surgeons, Houston, TX 77030 USA; Ben Taub Gen Hosp, Houston, TX 77030 USA; Albert Einstein Coll Med, Dept Emergency Med, New York, NY USA; Int Brain Injury Assoc, Alexandria, VA USA; Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; New York Presbyterian, Dept Radiol, New York, NY USA		Jagoda, AS (corresponding author), Mt Sinai Sch Med, Dept Emergency Med, IBIA, New York, NY 10029 USA.		Wright, David/F-1209-2013; Wears, Robert/N-5959-2014	Wright, David/0000-0002-7145-9105; Wears, Robert/0000-0001-9826-954X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [200-2007-21367] Funding Source: Medline		Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; BELL RS, 1971, NEW ENGL J MED, V284, P236, DOI 10.1056/NEJM197102042840504; Bergman DA, 1999, PEDIATRICS, V104, P1407; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cook L S, 1994, Acad Emerg Med, V1, P227; COOPER PR, 1983, NEUROSURGERY, V13, P136, DOI 10.1227/00006123-198308000-00005; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Dunham CM, 1996, J TRAUMA, V41, P679, DOI 10.1097/00005373-199610000-00014; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Holmes JF, 1997, ACAD EMERG MED, V4, P788, DOI 10.1111/j.1553-2712.1997.tb03786.x; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; LEVITT MA, 1994, AM J EMERG MED, V12, P172, DOI 10.1016/0735-6757(94)90240-2; LEWIS LM, 1992, SOUTHERN MED J, V85, P348, DOI 10.1097/00007611-199204000-00004; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MADDEN C, 1995, ACAD EMERG MED, V2, P240; Marx JA, 2000, NEW ENGL J MED, V343, P138, DOI 10.1056/NEJM200007133430212; MASTERS SJ, 1980, AM J ROENTGENOL, V135, P539, DOI 10.2214/ajr.135.3.539; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MCCLEAN PM, 1984, ANN EMERG MED, V13, P607, DOI 10.1016/S0196-0644(84)80287-5; MIKHAIL MG, 1992, AM J EMERG MED, V10, P24, DOI 10.1016/0735-6757(92)90119-I; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MILLS ML, 1986, ANN EMERG MED, V15, P1167, DOI 10.1016/S0196-0644(86)80859-9; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; MORAN SG, 1994, AM SURGEON, V60, P533; MURSHID WR, 1994, ACTA NEUROCHIR, V129, P11, DOI 10.1007/BF01400866; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Nee PA, 1999, J NEUROL NEUROSUR PS, V66, P470, DOI 10.1136/jnnp.66.4.470; POZZATI E, 1980, J TRAUMA, V20, P795, DOI 10.1097/00005373-198009000-00015; RAM Z, 1989, J NEUROSURG, V71, P608, DOI 10.3171/jns.1989.71.4.0608; REINUS WR, 1993, ANN EMERG MED, V22, P1148, DOI 10.1016/S0196-0644(05)80981-3; Riesgo P, 1997, SURG NEUROL, V48, P226, DOI 10.1016/S0090-3019(97)00194-8; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTS CJ, 1980, LANCET, V2, P1234; Ruff RM, 1999, BRAIN INJURY, V13, P943; SAUNDERS CE, 1986, ANN EMERG MED, V15, P160, DOI 10.1016/S0196-0644(86)80012-9; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; SERVADEI F, 1988, J NEUROL NEUROSUR PS, V51, P526, DOI 10.1136/jnnp.51.4.526; SERVADEI F, 1989, ACTA NEUROCHIR, V96, P39, DOI 10.1007/BF01403493; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SHAFFER MA, 1982, ANN EMERG MED, V11, P303, DOI 10.1016/S0196-0644(82)80128-5; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TUNCER R, 1993, ACTA NEUROCHIR, V121, P48, DOI 10.1007/BF01405182; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Vilke GM, 2000, AM J EMERG MED, V18, P159, DOI 10.1016/S0735-6757(00)90009-3; Volans AP, 1998, J ACCID EMERG MED, V15, P159; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wysoki MG, 1998, RADIOLOGY, V208, P125, DOI 10.1148/radiology.208.1.9646802; ZIMMERMAN RA, 1978, AM J ROENTGENOL, V131, P27, DOI 10.2214/ajr.131.1.27; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	86	124	129	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	AUG	2002	40	2					231	249		10.1067/mem.2002.125782			19	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	579GR	WOS:000177170700014	19285163				2022-02-06	
J	Bigler, ED; Andersob, CV; Blatter, DD				Bigler, ED; Andersob, CV; Blatter, DD			Temporal lobe morphology in normal aging and traumatic brain injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							APOLIPOPROTEIN-E GENOTYPE; AGE-RELATED-CHANGES; HIPPOCAMPAL VOLUME; ALZHEIMERS-DISEASE; GRAY-MATTER; ENTORHINAL CORTEX; QUANTITATIVE MR; PREFRONTAL GRAY; AXONAL INJURY; ATROPHY	BACKGROUND AND PURPOSE: Little is known regarding changes in the temporal lobe associated with traumatic brain injury (TBI) in early-to-mid adulthood. We report on two quantitative MR studies: study 1 addressed age-related changes of the temporal lobe in subjects aged 16-72 years; information obtained in this study provided a normative database for comparison with findings in 118 patients with TBI who were included in study 2. We expected stable morphology in healthy subjects and trauma-related atrophy in patients with TBI. METHODS: MR multispectral tissue segmentation was used to calculate bilateral temporal lobe gyrus and sulcus, sylvian fissure CSF, hippocampus, and temporal horn volumes and to measure the white matter (WM) temporal stem. RESULTS: With normal aging, gyral volume remained stable, decreasing approximately 0.26% per year (total, approximate to11%). Sulcal CSF volume doubled. Hippocampal volume decreased (minimally, significantly); temporal horn volume increased (not significantly) and was minimally related to hippocampal volume. WM measurements were constant. Trauma changed morphology; WM measures decreased. Gyral volumes were not different between the groups. In TBI, CSF volume increased significantly, was most related to reduced WM measurements, and was relatively independent of gyral volume. Temporal horn dilatation was related more to WM atrophy than to hippocampal atrophy. In TBI, subarachnoid sulcal and temporal horn CSF volumes were most related to WM atrophy, which was relatively independent of gyral volume; gyral and hippocampal volumes and WM measures were related to memory performance. CONCLUSION. Age-related changes cause minimal temporal lobe gyral, hippocampal, temporal horn, and WM atrophy. Only subarachnoid sulcal CSF volume changed robustly. Trauma produced disproportionate WM loss associated with increased temporal horn and sulcal CSF volumes; it caused substantial hippocampal atrophy, which was related to memory impairment. Gyral volume did not decrease, although it was related to memory performance.	Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; LDS Hosp, Salt Lake City, UT 84143 USA; Univ Utah, Salt Lake City, UT 84112 USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1082 SWKT, Provo, UT 84602 USA.						Arnold SE, 1996, SCHIZOPHRENIA BULL, V22, P5, DOI 10.1093/schbul/22.1.5; Barber R, 1999, ARCH NEUROL-CHICAGO, V56, P961, DOI 10.1001/archneur.56.8.961; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Bertoni MA, 1998, INT J NEURORADIOL, V4, P291; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Double KL, 1996, NEUROBIOL AGING, V17, P513; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Fox NC, 2000, NEUROLOGY, V54, P807, DOI 10.1212/WNL.54.4.807; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Frisoni GB, 1999, NEUROLOGY, V52, P91, DOI 10.1212/WNL.52.1.91; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gean AD, 1994, IMAGING HEAD TRAUMA; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Geroldi C, 1999, NEUROLOGY, V53, P1825, DOI 10.1212/WNL.53.8.1825; Geroldi C, 2000, J NEUROL NEUROSUR PS, V68, P93, DOI 10.1136/jnnp.68.1.93; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; GOLDSTEIN FC, 1990, TRAUMATIC BRAIN INJU, P51; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Goldszal AF, 2000, BIOMED EN S, P185; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P769, DOI 10.1001/archpsyc.57.8.769; HARRIS GJ, 1994, AM J NEURORADIOL, V15, P225; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; *IM TREAM, 1999, SPSS GRAD PACK 10 0; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Jack CR, 1998, ANN NEUROL, V43, P303, DOI 10.1002/ana.410430307; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; JESSELL TM, 1991, PRINCIPLES NEURAL SC, P258; Juottonen K, 1999, AM J NEURORADIOL, V20, P139; Kidron D, 1997, NEUROLOGY, V49, P1504, DOI 10.1212/WNL.49.6.1504; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kohler S, 1998, NEUROPSYCHOLOGIA, V36, P901, DOI 10.1016/S0028-3932(98)00017-7; Laidlaw DH, 2000, BIOMED EN S, P195; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Mathern GW, 1996, BRAIN, V119, P965, DOI 10.1093/brain/119.3.965; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; McDonald B, 2000, AM J PSYCHIAT, V157, P40, DOI 10.1176/ajp.157.1.40; Mu QW, 1999, AM J NEURORADIOL, V20, P207; Mueller EA, 1998, NEUROLOGY, V51, P1555, DOI 10.1212/WNL.51.6.1555; Naugle RI, 1990, TRAUMATIC BRAIN INJU, P69; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; Phillips LL, 1998, HIPPOCAMPUS, V8, P390, DOI 10.1002/(SICI)1098-1063(1998)8:4<390::AID-HIPO7>3.3.CO;2-9; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Reddick WE, 1998, MAGN RESON IMAGING, V16, P413, DOI 10.1016/S0730-725X(98)00014-9; Reiman EM, 1998, ANN NEUROL, V44, P288, DOI 10.1002/ana.410440226; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Salat DH, 1999, ARCH NEUROL-CHICAGO, V56, P338, DOI 10.1001/archneur.56.3.338; Shah PT, 1997, NEUROSCIENCE, V79, P999, DOI 10.1016/S0306-4522(97)00013-4; Smith CD, 1999, J NEUROIMAGING, V9, P2, DOI 10.1111/jon1999912; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Soininen HS, 1996, TRENDS NEUROSCI, V19, P224, DOI 10.1016/0166-2236(96)10027-8; Stout JC, 1999, NEUROPSYCHOLOGY, V13, P188, DOI 10.1037/0894-4105.13.2.188; Symonds LL, 1999, J NEUROIMAGING, V9, P201, DOI 10.1111/jon199994201; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson PM, 1998, CEREB CORTEX, V8, P492, DOI 10.1093/cercor/8.6.492; Utsunomiya H, 1999, AM J NEURORADIOL, V20, P717; VanHoesen GW, 1997, J NEUROPSYCH CLIN N, V9, P331; von Gunten A, 2000, J NEUROPSYCH CLIN N, V12, P493, DOI 10.1176/appi.neuropsych.12.4.493; Weschler D, 1987, WESCHLER MEMORY SCAL	75	124	125	0	11	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	2002	23	2					255	266					12	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	532JX	WOS:000174472300015	11847051				2022-02-06	
J	Devor, M; Zalkind, V				Devor, M; Zalkind, V			Reversible analgesia, atonia, and loss of consciousness on bilateral intracerebral microinjection of pentobarbital	PAIN			English	Article						anesthesia; barbiturate; coma; consciousness; microinjection; pentobarbital; loss of consciousness; mesopontine reticular formation	PONTINE RETICULAR-FORMATION; EYE-MOVEMENT SLEEP; GABA(A) RECEPTOR; REM-SLEEP; GENERAL-ANESTHESIA; RAT-BRAIN; CARBACHOL; PATHWAYS; REGIONS; NEURONS	Concussion, asphyxia, and systemically administered general anesthetics all induce reversible depression of the organism's response to noxious stimuli as one of the elements of loss of consciousness. This is so even for barbiturate anesthetics, which have only modest analgesic efficacy at subanesthetic doses. Little is known about the neural circuits involved in this form of antinociception, although for anesthetic agents, at least, it is usually presumed that the drugs act in widely distributed regions of the nervous system. We now report the discovery of a focal zone in the brainstem mesopontine tegmentum in rats at which microinjection of minute quantities of pentobarbital induces a transient, reversible anesthetic-like state with non-responsiveness to noxious stimuli, flaccid atonia, and absence of the righting reflex. The behavioral suppression is accompanied by slow-wave EEG and, presumably, loss of consciousness. This zone, which we refer to as the mesopontine tegmental anesthesia locus (MPTA), apparently contains a barbiturate-sensitive 'switch' for both cortical and spinal activity. The very existence of the MPTA locus has implications for an understanding of the neural circuits that control motor functions and pain sensation, and for the cerebral representation of consciousness. (C) 2001 International Association for the Study of Pain. Published by Elsevier Science BN. All rights reserved.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel		Devor, M (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel.						BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Bjorvatn B, 1998, PHYSIOL BEHAV, V63, P413, DOI 10.1016/S0031-9384(97)00460-5; Bland BH, 1998, NEUROSCI BIOBEHAV R, V22, P259, DOI 10.1016/S0149-7634(97)00013-4; BOLANDER HG, 1984, ACTA PHARMACOL TOX, V54, P33; BOURGIN P, 1995, NEUROREPORT, V6, P532, DOI 10.1097/00001756-199502000-00031; BROWNING RA, 1981, EPILEPSIA, V22, P583, DOI 10.1111/j.1528-1157.1981.tb04130.x; CARLI G, 1965, ARCH ITAL BIOL, V103, P751; COLLINS JG, 1995, TRENDS NEUROSCI, V18, P549, DOI 10.1016/0166-2236(95)98377-B; DEBLAS AL, 1988, J NEUROSCI, V8, P602; ELAZAR Z, 1990, NEUROSCI LETT, V115, P226, DOI 10.1016/0304-3940(90)90459-M; FIELD KJ, 1993, LAB ANIM, V27, P258, DOI 10.1258/002367793780745471; Fields HL, 1999, TXB PAIN, P309; FOLKMAN J, 1968, ANESTHESIOLOGY, V29, P419, DOI 10.1097/00000542-196805000-00007; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; FRENCH JD, 1953, AMA ARCH NEUROL PSY, V69, P519, DOI 10.1001/archneurpsyc.1953.02320280107010; GNADT JW, 1986, BRAIN RES, V384, P29, DOI 10.1016/0006-8993(86)91216-3; Hajnik T, 2000, J NEUROPHYSIOL, V84, P1942, DOI 10.1152/jn.2000.84.4.1942; Heier T, 1996, ACTA ANAESTH SCAND, V40, P1087, DOI 10.1111/j.1399-6576.1996.tb05570.x; Hodgson PS, 1999, ANESTHESIOLOGY, V91, P1687, DOI 10.1097/00000542-199912000-00021; Johnston GAR, 1996, PHARMACOL THERAPEUT, V69, P173, DOI 10.1016/0163-7258(95)02043-8; Jones Barbara E., 1995, P155; KILLAM EK, 1962, PHARMACOL REV, V14, P175; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; KOSAKA T, 1988, EXP BRAIN RES, V70, P605; LAI YY, 1988, J NEUROSCI, V8, P4790; Lai YY, 1999, NEUROSCIENCE, V90, P469, DOI 10.1016/S0306-4522(98)00429-1; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; LIEBESKIND JC, 1976, SENSORY FUNCTIONS SK, P561; LIEGHTON KM, 1970, J CAN ANAESTHESIOL S, V17, P112; LINDSLEY DB, 1950, ELECTROEN CLIN NEURO, V2, P483, DOI 10.1016/0013-4694(50)90086-1; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; MAGOUN HW, 1946, J NEUROPHYSIOL, V9, P166; Maloney KJ, 2000, J NEUROSCI, V20, P4669, DOI 10.1523/JNEUROSCI.20-12-04669.2000; MARK LC, 1958, J PHARMACOL EXP THER, V123, P70; Marks GA, 1998, NEUROSCIENCE, V86, P29, DOI 10.1016/S0306-4522(98)00005-0; Mendelson WB, 1996, LIFE SCI, V59, P1821, DOI 10.1016/S0024-3205(96)00400-6; MILLER RD, 1993, ANESTHESIA, V1, P229; MONTAGNECLAVEL J, 1995, NEUROSCI LETT, V196, P69, DOI 10.1016/0304-3940(95)11847-P; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; MYERS RD, 1978, BRAIN RES BULL, V3, P601, DOI 10.1016/0361-9230(78)90006-0; MYERS RD, 1966, PHYSIOL BEHAV, V1, P171, DOI 10.1016/0031-9384(66)90064-3; Nunez A, 1998, BRAIN RES, V804, P144, DOI 10.1016/S0006-8993(98)00681-7; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; RYE DB, 1987, J COMP NEUROL, V259, P483, DOI 10.1002/cne.902590403; SANDKUHLER J, 1987, EXP BRAIN RES, V68, P168; SANDKUHLER J, 1987, PAIN, V31, P381, DOI 10.1016/0304-3959(87)90166-7; Starmark J.-E., 1996, TRAUMA CARE, P27; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Steriade M., 1990, BRAINSTEM CONTROL WA; STRYKER MP, 1987, J COMP NEUROL, V258, P297, DOI 10.1002/cne.902580209; TAGUCHI O, 1992, BRAIN RES, V595, P107, DOI 10.1016/0006-8993(92)91458-Q; TSOU K, 1964, SCI SINICA, V13, P1099; Tverskoy M, 1996, ANAESTHESIA, V51, P652; VERTES RP, 1984, PROG NEUROBIOL, V22, P241, DOI 10.1016/0301-0082(84)90020-0; WHELAN G, 1992, LAB ANIM-UK, V26, P153, DOI 10.1258/002367792780740602; Xi MC, 1999, J NEUROPHYSIOL, V82, P2015, DOI 10.1152/jn.1999.82.4.2015; YAKSH TL, 1976, BRAIN RES, V114, P83, DOI 10.1016/0006-8993(76)91009-X; Yanagida H, 1971, Masui, V20, P51; Zanchetti, 1959, ARCH ITAL BIOL, V97, P33; ZHANG JH, 1991, J COMP NEUROL, V303, P637, DOI 10.1002/cne.903030409; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	63	124	127	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959			PAIN	Pain	OCT	2001	94	1					101	112		10.1016/S0304-3959(01)00345-1			12	Anesthesiology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	484EW	WOS:000171678100011	11576749				2022-02-06	
J	Levin, HS; Brown, SA; Song, JX; McCauley, SR; Boake, C; Contant, CF; Goodman, H; Kotrla, KJ				Levin, HS; Brown, SA; Song, JX; McCauley, SR; Boake, C; Contant, CF; Goodman, H; Kotrla, KJ			Depression and Posttraumatic stress disorder at three months after mild to moderate traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							HEAD-INJURY; MAJOR DEPRESSION; SOCIAL SUPPORT; LOBE DYSFUNCTION; COMMUNITY SAMPLE; SEQUELAE; CONSEQUENCES; IMPAIRMENT; SYMPTOMS; MEMORY	To investigate the frequency and risk factors of major depressive disorder (MDD) after mild to moderate traumatic brain injury (TBI), 69 TBI and 52 general trauma (GT) patients were prospectively recruited and studied at 3-months postinjury. There was a nonsignificant difference in the proportion of MDD patients in the TBI and GT groups. Therefore, a composite MDD group (TBI and GT patients) was compared to patients who were nondepressed. Female gender was related to MDD, but no other risk factors were identified. MDD was associated with disability (Glasgow Outcome Scale, Community Integration Questionnaire) and cognitive impairment. MDD was comorbid with posttraumatic stress disorder. Implications for postacute management of mild to moderate TBI are discussed.	Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX USA		Levin, HS (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1333 Moursund Ave,A 205, Houston, TX 77030 USA.	hlevin@bcm.tmc.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [258-0020-308] Funding Source: Medline; ODCDC CDC HHS [R49-CCR612707] Funding Source: Medline		AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barefoot JC, 2000, AM J CARDIOL, V86, P438, DOI 10.1016/S0002-9149(00)00961-9; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; BLANCHARD EB, 1994, BEHAV RES THER, V32, P283, DOI 10.1016/0005-7967(94)90123-6; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; BRAND N, 1987, PSYCHOL MED, V17, P145, DOI 10.1017/S0033291700013040; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; *COMM INJ SCAL, 1990, ABBR INJ SCAL; DAVIS GC, 1994, PSYCHIAT CLIN N AM, V17, P289; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; First MB, 1995, STRUCTURED CLIN INTE; FLAHERTY JA, 1983, AM J PSYCHIAT, V140, P473; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; GRONWALL D, 1974, LANCET, V2, P605; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HART RP, 1987, PSYCHOL AGING, V2, P111, DOI 10.1037/0882-7974.2.2.111; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HICKLING EJ, 1992, HEADACHE, V32, P147, DOI 10.1111/j.1526-4610.1992.hed3203147.x; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; JENNETT B, 1975, LANCET, V1, P480; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1986, EXPT TECHNIQUES HUMA, P309; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MASSMAN PJ, 1992, J CLIN EXP NEUROPSYC, V14, P687, DOI 10.1080/01688639208402856; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Matthews CG., 1964, INSTRUCTION MANUAL A; MAYBERG HS, 1994, J NEUROPSYCH CLIN N, V6, P428; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; RUTHERFORD WH, 1977, LANCET, V1, P1; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Smith A., 1982, SYMBOL DIGIT MODALIT; Stevens M M, 1982, J Neurosurg Nurs, V14, P239; TEASDALE G, 1974, LANCET, P281; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TRICHARD C, 1995, PSYCHOL MED, V25, P79, DOI 10.1017/S0033291700028105; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; [No title captured]	76	124	127	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2001	23	6					754	769		10.1076/jcen.23.6.754.1021			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	535QL	WOS:000174655200005	11910542				2022-02-06	
J	Ahmed, SM; Rzigalinski, BA; Willoughby, KA; Sitterding, HA; Ellis, EF				Ahmed, SM; Rzigalinski, BA; Willoughby, KA; Sitterding, HA; Ellis, EF			Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons	JOURNAL OF NEUROCHEMISTRY			English	Article						mitochondria; ATP; energy; astrocytes; neurons; in vitro studies	TRAUMATIC BRAIN INJURY; CEREBRAL ENERGY-METABOLISM; DELAYED DEPOLARIZATION; SUPEROXIDE-DISMUTASE; CORTICAL-NEURONS; IN-VITRO; CELLS; GLUTAMATE; CALCIUM; RATS	Energy deficit after traumatic brain injury (TBI) may alter ionic homeostasis, neurotransmission, biosynthesis, and cellular transport. Using an in vitro model for TBI, we tested the hypothesis that stretch-induced injury alters mitochondrial membrane potential (Delta psi(m)) and ATP in astrocytes and neurons. Astrocytes, pure neuronal cultures, and mixed neuronal plus glial cultures grown on Silastic membranes were subjected to mild, moderate, and severe stretch. After injury, Delta psi(m), was measured using rhodamine-123, and ATP was quantified with a luciferin-luciferase assay. In astrocytes, Delta psi(m) dropped significantly, and ATP content declined 43-52% 15 min after mild or moderate stretch but recovered by 24 h. In pure neurons, Delta psi(m) declined at 15 min only in the severely stretched group. At 48 h postinjury, Delta psi(m) remained decreased in severely stretched neurons and dropped in moderately stretched neurons. Intracellular ATP content did not change in any group of injured pure neurons. We also found that astrocytes and neurons release ATP extracellularly following injury. In contrast to pure neurons, Delta psi(m) in neurons of mixed neuronal plus glial cultures declined 15 min after mild, moderate, or severe stretch and recovered by 24-48 h. ATP content in mixed cultures declined 22-28% after mild to severe stretch with recovery by 24 h. Our findings demonstrate that injury causes mitochondrial dysfunction in astrocytes and suggest that astrocyte injury alters mitochondrial function in local neurons.	Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA		Rzigalinski, BA (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, POB 980613, Richmond, VA 23298 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027214] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-27214, NS-07288] Funding Source: Medline		AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; ANDERSEN BJ, 1988, J NEUROSURG, V68, P601, DOI 10.3171/jns.1988.68.4.0601; Barnard EA, 1997, MOL NEUROBIOL, V15, P103, DOI 10.1007/BF02740631; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Bolanos JP, 1997, BIOCHEM SOC T, V25, P944, DOI 10.1042/bst0250944; Budd SL, 1996, J NEUROCHEM, V67, P2282; BUNTING JR, 1992, BIOPHYS CHEM, V42, P163, DOI 10.1016/0301-4622(92)85006-P; Chinnery PF, 1997, QJM-INT J MED, V90, P657, DOI 10.1093/qjmed/90.11.657; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hall ED, 1996, J NEUROSCI RES, V44, P293, DOI 10.1002/(SICI)1097-4547(19960501)44:3<293::AID-JNR10>3.0.CO;2-6; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HOFFMANN SW, 1996, J NEUROTRAUM, V13, P619; Inoue K, 1996, PROG NEUROBIOL, V50, P483, DOI 10.1016/S0301-0082(96)00037-8; KASTRITSIS CHC, 1992, J NEUROCHEM, V58, P1277; Lamb RG, 1997, J NEUROCHEM, V68, P1904; MCINTOSH TK, 1992, J NEUROTRAUM, V9, pS201; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MILANI D, 1990, CELL CALCIUM, V11, P191, DOI 10.1016/0143-4160(90)90070-B; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; Peng TI, 1998, EXP NEUROL, V149, P1, DOI 10.1006/exnr.1997.6599; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Peuchen S, 1996, NEUROSCIENCE, V71, P855, DOI 10.1016/0306-4522(95)00480-7; Rzigalinski BA, 1997, J NEUROCHEM, V68, P289; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; RZIGALINSKI BA, 1998, J NEUROTRAUM, V15, P894; Schild L, 1997, BIOCHEM J, V328, P205, DOI 10.1042/bj3280205; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schreiber D., 1995, P 1995 INT RES C BIO, P233; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vercesi AE, 1997, BIOSCIENCE REP, V17, P43, DOI 10.1023/A:1027335217774; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; WEBER JT, 1998, J NEUROTRAUM, V15, P901; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839; White RJ, 1996, J NEUROSCI, V16, P5688; WILLOUGHBY KA, 1998, J NEUROTRAUM, V15, P902; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	51	124	130	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3042			J NEUROCHEM	J. Neurochem.	MAY	2000	74	5					1951	1960		10.1046/j.1471-4159.2000.0741951.x			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	304CY	WOS:000086466200019	10800938				2022-02-06	
J	Regan, RF; Guo, YP				Regan, RF; Guo, YP			Estrogens attenuate neuronal injury due to hemoglobin, chemical hypoxia, and excitatory amino acids in murine cortical cultures	BRAIN RESEARCH			English	Article						brain injury; brain ischemia; cortical neuron; equilin; estradiol; free radical; glutamate; lipid peroxidation	TRAUMATIC BRAIN INJURY; CELL-CULTURE; IN-VITRO; RAT HIPPOCAMPUS; NEUROTOXICITY; ESTRADIOL; DAMAGE; 17-BETA-ESTRADIOL; 21-AMINOSTEROIDS; ANTIOXIDANTS	A growing body of evidence supports the hypothesis that estrogens may be beneficial in Alzheimer's disease and other neurodegenerative processes. Less is known of their therapeutic potential in acute CNS insults. In this study, we assessed the effect of estrogens in three injury paradigms that may be relevant to CNS hemorrhage, trauma, and ischemia. Supraphysiologic concentrations of 17 beta-estradiol, estrone, or equilin attenuated neuronal loss due to prolonged exposure to the pro-oxidant hemoglobin, with complete protection at 10 mu M. Most of this effect persisted despite concomitant treatment with the antiestrogen ICI 182,780 or the protein synthesis inhibitor cycloheximide. In contrast, the non-estrogenic steroid methylprednisolone, which is currently in clinical use in spinal cord injury, reduced neuronal loss by only about 30%. High concentrations of equilin or estrone also attenuated the submaximal neuronal injury induced by 3.5-4.5 h exposure to the cytochrome oxidase inhibitor sodium azide, with near complete protection at 30 mu M. Estrogens had a weaker and somewhat variable effect on pure excitotoxic injury, reducing neuronal loss due to 24 h kainate exposure by about half, and due to 24 h NMDA exposure by 15-65%; similar neuroprotection was provided by the antioxidant 21-aminosteroid U74500A. These results suggest that estrogens may be beneficial in acute CNS injuries associated with oxidative and excitotoxic stress. Investigation of high dose estro en therapy in in vivo models of CNS hemorrhage, trauma, and ischemia is warranted. (C) 1997 Elsevier Science B.V.			Regan, RF (corresponding author), THOMAS JEFFERSON UNIV,DIV EMERGENCY MED,1020 SANSOM ST,PHILADELPHIA,PA 19107, USA.						BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; CAHN PH, 1996, STROKE, V27, P1124; CHOW HS, 1994, BRAIN RES, V639, P102, DOI 10.1016/0006-8993(94)91769-8; CHRISTENSEN SM, 1988, J BIOCHEM BIOPH METH, V17, P143, DOI 10.1016/0165-022X(88)90045-0; Cohen ML, 1996, DRUG DEVELOP RES, V37, P97, DOI 10.1002/(SICI)1098-2299(199602)37:2<97::AID-DDR5>3.0.CO;2-G; DARWISH H, 1991, J BIOL CHEM, V266, P551; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FERREIRA A, 1991, J NEUROSCI, V11, P392; Gazzaley AH, 1996, J NEUROSCI, V16, P6830; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Gu Q, 1996, J NEUROSCI, V16, P3620; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; HALLIWELL B, 1989, FREE RADICAL BIO MED, P250; HAYASHI T, 1994, BIOCHEM BIOPH RES CO, V203, P1013, DOI 10.1006/bbrc.1994.2283; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; LACORT M, 1995, LIPIDS, V30, P141, DOI 10.1007/BF02538267; MARTEL C, 1992, J STEROID BIOCHEM, V41, P597, DOI 10.1016/0960-0760(92)90390-5; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Mermelstein PG, 1996, J NEUROSCI, V16, P595; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; MORTEL KF, 1995, J NEUROPSYCH CLIN N, V7, P334; NAKANO M, 1987, BIOCHEM BIOPH RES CO, V142, P919, DOI 10.1016/0006-291X(87)91501-4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OKEEFE JA, 1990, DEV BRAIN RES, V57, P119, DOI 10.1016/0165-3806(90)90191-Z; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; PAZDERNIK TL, 1992, NEUROCHEM RES, V17, P11, DOI 10.1007/BF00966860; Regan R. F., 1996, Society for Neuroscience Abstracts, V22, P2158; Regan R. F., 1992, Society for Neuroscience Abstracts, V18, P1608; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; REGAN RF, 1995, BRAIN RES, V682, P144, DOI 10.1016/0006-8993(95)00330-S; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; SHOLL SA, 1989, DEV BRAIN RES, V50, P189, DOI 10.1016/0165-3806(89)90194-6; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; SIMPKINS JW, 1994, NEUROBIOL AGING, V15, pS195; SUDHIR K, 1995, J AM COLL CARDIOL, V26, P807, DOI 10.1016/0735-1097(95)00248-3; SWANSON RA, 1992, NEUROSCI LETT, V147, P143, DOI 10.1016/0304-3940(92)90580-Z; Tang MY, 1996, BBA-LIPID LIPID MET, V1299, P155, DOI 10.1016/0005-2760(95)00227-8; TANIGUCHI S, 1994, ENDOCR J, V41, P605, DOI 10.1507/endocrj.41.605; TORANALLERAND CD, 1996, J STEROID BIOCH MOL, V56, P168; Varming T, 1996, J NEUROSCI RES, V44, P40, DOI 10.1002/(SICI)1097-4547(19960401)44:1<40::AID-JNR5>3.0.CO;2-I; WAKELING AE, 1991, CANCER RES, V51, P3867; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; WINSLOW RM, 1992, BIOMATER ARTIF CELLS, V20, P413	49	124	130	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 1	1997	764	1-2					133	140		10.1016/S0006-8993(97)00437-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XT768	WOS:A1997XT76800016	9295202				2022-02-06	
J	Wang, CX; Nuttin, B; Heremans, H; Dom, R; Gybels, J				Wang, CX; Nuttin, B; Heremans, H; Dom, R; Gybels, J			Production of tumor necrosis factor in spinal cord following traumatic injury in rats	JOURNAL OF NEUROIMMUNOLOGY			English	Article						spinal cord injury; tumor necrosis factor	FACTOR-ALPHA; CEREBROSPINAL-FLUID; GENE-EXPRESSION; BRAIN; CYTOKINES; MODEL; INTERLEUKIN-6; INFLAMMATION; COMPRESSION; ASTROCYTES	Production of tumor necrosis factor (TNF) in the spinal cord following traumatic injury has been studied. In these experiments, the level of TNF was examined in the homogenate of the spinal cord, cerebrospinal fluid (CSF) and serum (n = 56). TNF could be detected in the injured spinal cord but not in the normal spinal cord. The TNF level increased in the spinal cord after the injury. At the lesion site, a maximal TNF concentration was observed 1 h after the injury, and the TNF concentration remained at this level until 8 h after the injury. Thereafter, it decreased gradually. However, TNF still could be detected 72 h after the injury. No TNF could be detected in the CSF and serum, collected from rats both with and without spinal cord injury (SCI). This study thus suggests that TNF is produced locally in the spinal cord following traumatic injury, and this TNF production is caused by the injury. The present results also demonstrate that TNF production is an acute and rapid reaction in the spinal cord following traumatic injury.	CATHOLIC UNIV LEUVEN,DEPT EXPT NEUROSURG,B-3000 LOUVAIN,BELGIUM; CATHOLIC UNIV LEUVEN,DEPT NEUROPATHOL,B-3000 LOUVAIN,BELGIUM; CATHOLIC UNIV LEUVEN,DEPT IMMUNOBIOL,B-3000 LOUVAIN,BELGIUM								Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; BAKHIT C, 1991, BRAIN RES, V554, P264, DOI 10.1016/0006-8993(91)90199-6; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; ENG LF, 1992, PROG BRAIN RES, V94, P353; FAJARDO LF, 1992, AM J PATHOL, V140, P539; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; GADIENT RA, 1990, NEUROSCI LETT, V117, P335, DOI 10.1016/0304-3940(90)90687-5; HEREMANS H, 1992, EUR J IMMUNOL, V22, P2395, DOI 10.1002/eji.1830220932; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; KHAN M, 1983, CAN J NEUROL SCI, V10, P161, DOI 10.1017/S031716710004484X; KLIR JJ, 1993, AM J PHYSIOL, V265, pR512, DOI 10.1152/ajpregu.1993.265.3.R512; LE JM, 1987, LAB INVEST, V56, P234; MCCRACKEN GH, 1989, PEDIATR INFECT DIS J, V8, P155; METHA VK, 1994, EUR J ENDOCRINOL, V130, P208; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; MOKATA T, 1991, J CBFM, V11, P966; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P460, DOI 10.1111/j.1600-0404.1988.tb03688.x; PRADO R, 1987, J NEUROSURG, V67, P745, DOI 10.3171/jns.1987.67.5.0745; RIVLIN AS, 1978, SURG NEUROL, V10, P39; ROTHWELL NJ, 1991, TRENDS PHARMACOL SCI, V12, P430, DOI 10.1016/0165-6147(91)90623-Z; SCHOBITZ B, 1994, PROG NEUROBIOL, V44, P397, DOI 10.1016/0301-0082(94)90034-5; SCHWARTZ M, 1991, BRAIN RES, V545, P334, DOI 10.1016/0006-8993(91)91309-O; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; SELMAJ KW, 1990, J IMMUNOL, V144, P129; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; TARLOV IM, 1952, ARCH NEUROL PSYCHIAT, V70, P813; TATOR CH, 1973, CAN J SURG, V16, P222; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TCHELINGERIAN JL, 1994, NEUROREPORT, V5, P585, DOI 10.1097/00001756-199401000-00013; TORRESPEIMBERT S, 1981, REV MEXICANA ASTR AP, V6, P315; Tracey KJ, 1994, CYTOKINE HDB, P289; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.immunol.10.1.411; VILCEK J, 1992, TUMOR NECROSIS FACTO, P269; WANG CX, 1993, NEUROSURGERY, V32, P269, DOI 10.1227/00006123-199302000-00016; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7	36	124	129	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728			J NEUROIMMUNOL	J. Neuroimmunol.	SEP	1996	69	1-2					151	156					6	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	VK244	WOS:A1996VK24400054	8823387				2022-02-06	
J	POSMANTUR, R; HAYES, RL; DIXON, CE; TAFT, WC				POSMANTUR, R; HAYES, RL; DIXON, CE; TAFT, WC			NEUROFILAMENT-68 AND NEUROFILAMENT-200 PROTEIN-LEVELS DECREASE AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; CALCIUM-ACTIVATED PROTEOLYSIS; CONTROLLED CORTICAL IMPACT; MIDDLE CEREBRAL-ARTERY; RAT OPTIC-NERVE; HIPPOCAMPAL SLICES; CALPAIN-I; CYTOSKELETAL PROTEINS; MONOCLONAL-ANTIBODIES; FOREBRAIN ISCHEMIA	We have examined the effect of lateral cortical impact injury on the levels of axonal cytoskeletal proteins in adult rats. Traumatic brain injury (TBI) causes a significant decrease in the protein levels of two prominent neurofilament (NF) proteins, NF68 and NF200. We employed quantitative immunoreactivity measurements on Western blots to examine NF68 and NF200 levels in homogenates of hippocampal and cortical tissue taken at several intervals postinjury. Sham injury had no effect on NF protein levels. However, injury was associated with a significant loss of NF68, restricted to the cortex ipsilateral to the injury site. NF68 loss was detectable as early as 3 h and lasted at least 2 weeks postinjury. Similarly, TBI induced a decrease in NF200 protein, although losses were observed both ipsilateral and contralateral to the injury site. No loss of NF68 or NF200 protein was detected in hippocampal samples obtained from the same injured animals. An increase in the presence of lower molecular weight (MW) NF68 immunopositive bands was associated with the decrease of NF68 in the ipsilateral cortex. This NF68 antigenicity pattern suggests the production of NF68 breakdown products caused by the pathologic activation of neuronal proteases, such as calpain. Putative NF68 breakdown products increase significantly until 1 day postinjury, suggesting that NF degradation may be ongoing until that time and indicating that a potential therapeutic window may exist within the first 24 h postinjury. In summary, these data identify specific biochemical alterations of the neuronal cytoskeleton following TBI and lay a foundation for further investigation of postinjury cytoskeletal changes in neuronal processes.	UNIV TEXAS,HLTH SCI CTR,SCH MED,DEPT NEUROSURG,HOUSTON,TX 77030						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21458, NS31998-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031998, R01NS021458] Funding Source: NIH RePORTER		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ARAI A, 1990, BRAIN RES, V532, P63, DOI 10.1016/0006-8993(90)91742-Y; ARAI A, 1991, BRAIN RES, V555, P276, DOI 10.1016/0006-8993(91)90352-V; BALENTINE JD, 1985, CENTRAL NERVOUS SYST, P455; BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; BEATTIE MS, 1988, PHARM APPROACHES TRE, P43; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P238; CHIN TK, 1983, BIOCHEM J, V215, P239, DOI 10.1042/bj2150239; DAUTIGNY A, 1988, BIOCHEM BIOPH RES CO, V154, P1099, DOI 10.1016/0006-291X(88)90254-9; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GENNARELLI T, 1989, J NEUROSURG, V67, P244; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; INUZUKA T, 1990, BRAIN RES, V526, P177, DOI 10.1016/0006-8993(90)90269-H; INUZUKA T, 1990, STROKE, V21, P917, DOI 10.1161/01.STR.21.6.917; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; JULIEN JP, 1982, J BIOL CHEM, V257, P467; KAKU Y, 1993, J CEREBR BLOOD F MET, V13, P402, DOI 10.1038/jcbfm.1993.54; KAMAKURA K, 1985, J NEUROSCI RES, V13, P391, DOI 10.1002/jnr.490130306; KUDO T, 1993, STROKE, V24, P259, DOI 10.1161/01.STR.24.2.259; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MEANEY DF, 1992, J NEUROTRAUMA, V9, P393; MELLGREN RL, 1990, INTRACELLULAR CALCIU; NAKAMURA M, 1992, EXP BRAIN RES, V89, P31; NIXON RA, 1984, J NEUROCHEM, V43, P507, DOI 10.1111/j.1471-4159.1984.tb00928.x; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; OLIVER MW, 1989, BRAIN RES, V505, P233, DOI 10.1016/0006-8993(89)91448-0; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; PERLMUTTER LS, 1988, SYNAPSE, V2, P79, DOI 10.1002/syn.890020111; PIETRINI V, 1993, CLIN NEUROPATHOL, V12, P1; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; SAUTTER J, 1991, BRAIN RES, V565, P23, DOI 10.1016/0006-8993(91)91732-G; SCHLAEPFER W, 1984, J NEUROCHEM, V48, P857; SCHLAEPFER WW, 1981, NEUROCHEM RES, V6, P243, DOI 10.1007/BF00964040; SCHLAEPFER WW, 1985, PROG BRAIN RES, V63, P185; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; SHAW G, 1986, BIOESSAYS, V4, P161, DOI 10.1002/bies.950040406; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; SISUKI H, 1984, NEUROSCI LETT, V89, P240; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TROOST D, 1992, ACTA NEUROPATHOL, V84, P664, DOI 10.1007/BF00227744; ULRICH J, 1987, PATHOL IMMUNOPATH R, V6, P273, DOI 10.1159/000157058; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	52	124	131	0	4	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1994	11	5					533	545		10.1089/neu.1994.11.533			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PR237	WOS:A1994PR23700007	7861446				2022-02-06	
J	EMERSON, CS; HEADRICK, JP; VINK, R				EMERSON, CS; HEADRICK, JP; VINK, R			ESTROGEN IMPROVES BIOCHEMICAL AND NEUROLOGIC OUTCOME FOLLOWING TRAUMATIC BRAIN INJURY IN MALE-RATS, BUT NOT IN FEMALES	BRAIN RESEARCH			English	Article						MAGNESIUM; NUCLEAR MAGNETIC RESONANCE; TRAUMA	INTRACELLULAR FREE MAGNESIUM; VOLTAGE-DEPENDENT BLOCK; EXCITATORY AMINO-ACIDS; SEX-DIFFERENCES; MG-2+; SPECTROSCOPY; RECEPTORS; RESPONSES; PH	Phosphorus magnetic resonance spectroscopy was used in conjunction with neurologic motor function tests to assess the effects of estrogen on biochemical and neurologic outcome following traumatic brain injury in male and female rats. Male (n = 18) and female (n = 18) rats. were randomly assigned into three groups, and 4 h prior to injury received either 17beta-estradiol (144 mug/kg intraperitoneally), equal volume vehicle (30% ethanol in saline), or no treatment. Traumatic brain injury was induced at 2.8 atm using a fluid percussion injury device, and animals monitored for 4 h using phosphorus magnetic resonance spectroscopy to determine brain intracellular pH, free magnesium concentration and cytosolic phosphorylation potential. Males treated with estrogen demonstrated a significant improvement in free magnesium concentration, and slightly improved values of cytosolic phosphorylation potential after trauma when compared to controls. There was also a significant improvement in post-traumatic motor function at 1 week after trauma. In contrast, estrogen treatment in females lowered cytosolic phosphorylation potential after trauma, but did not affect free magnesium concentration after trauma. Mortality in all female groups was significantly worse than in males. We conclude that estrogen is protective in males, but exacerbates brain injury in females through effects mediated by estrogen receptor binding.	JAMES COOK UNIV N QUEENSLAND, DEPT CHEM & BIOCHEM, TOWNSVILLE, QLD 4811, AUSTRALIA				Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; BROWN TJ, 1988, ENDOCRINOLOGY, V123, P1761, DOI 10.1210/endo-123-4-1761; DEGANI H, 1984, BIOCHEMISTRY-US, V23, P2572, DOI 10.1021/bi00307a006; EMERSON CS, 1992, NEUROREPORT, V3, P957, DOI 10.1097/00001756-199211000-00002; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GARFINKEL L, 1984, BIOCHEMISTRY-US, V23, P3547, DOI 10.1021/bi00310a025; GORSKI J, 1965, J CELL COMPAR PHYSL, V66, P91, DOI 10.1002/jcp.1030660410; GUPTA RK, 1983, PHYSIOL CHEM PHYS, V15, P265; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; HALL ED, 1991, CENTRAL NERVOUS SYST, pS1; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; JANE JA, 1991, CENTRAL NERVOUS SYST; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; KOSTANYAN A, 1992, BIOCHIM BIOPHYS ACTA, V1133, P301, DOI 10.1016/0167-4889(92)90051-C; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; RAINBOW TC, 1982, NATURE, V300, P648, DOI 10.1038/300648a0; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIESJO BK, 1985, CENTRAL NERVOUS SYST, P513; SMITH SS, 1989, BRAIN RES, V503, P354, DOI 10.1016/0006-8993(89)91691-0; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VINK R, 1989, BRAIN RES, V490, P144, DOI 10.1016/0006-8993(89)90440-X; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; VINK R, 1991, MAGNESIUM EXCITABLE, P695; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315	29	124	126	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 9	1993	608	1					95	100		10.1016/0006-8993(93)90778-L			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW778	WOS:A1993KW77800014	8495351				2022-02-06	
J	RAPPAPORT, M; DOUGHERTY, AM; KELTING, DL				RAPPAPORT, M; DOUGHERTY, AM; KELTING, DL			EVALUATION OF COMA AND VEGETATIVE STATES	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						BRAIN INJURY; COMA; COMA SCALE; REHABILITATION ASSESSMENT; VEGETATIVE STATES	DISABILITY RATING-SCALE; HEAD-INJURY; EVOKED-POTENTIALS; PRACTICAL SCALE; RELIABILITY; VALIDITY; RECOVERY	The Coma/Near-Coma (CNC) scale was designed to measure small clinical changes in patients with severe traumatic and nontraumatic brain injuries who were functioning at very low levels characteristic of near-vegetative and vegetative states. In 20 patients followed for 16 weeks the scale identified 25% who ultimately showed modest improvement. Interrater reliability was high (r = .95); validity was supported by significant correlations between CNC- and brain-multimodality evoked potential abnormality scores as well as between scores on the CNC and the Disability Rating Scale. The CNC scale was easily learned and it could be completed quickly and cost effectively. Staff found it useful in recognizing among relatively homogeneous low-level patients those most likely to respond to further rehabilitation care. The CNC appears to be useful for justifying ongoing intensive rehabilitation and for preventing premature transfer to lower levels of care.	WOODMERE HLTH CARE CTR,PLANTSVILLE,CT		RAPPAPORT, M (corresponding author), UNIV CALIF SAN JOSE,BRAIN FUNCT STUDY UNIT,AGNEWS DEV CTR,SAN JOSE,CA 95134, USA.				NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S07-RR05755] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S07RR005755] Funding Source: NIH RePORTER		ADAMS RD, 1989, PRINCIPLES NEUROLOGY, P273; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; COTE R, 1989, NEUROLOGY, V39, P638, DOI 10.1212/WNL.39.5.638; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANT I, 1986, NEUROPSYCHOLOGICAL A, P3; HALES RE, 1987, AM PSYCHIATRIC PRESS; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; JENNETT B, 1972, LANCET, V1, P734; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1976, NEUROPSYCHOLOGICAL A; MALKMUS D, 1980, REBHABILITATION HEAD; MOSES JA, 1982, NEUROPSYCHOLOGY COGN, V2; NEWLON PG, 1983, REHABILITATION HEAD; PARASKEVOPOULOS JN, 1969, DEV PSYCHOMETRIC CHA; PLUM F, 1972, DIAGNOSIS STUPOR COM, P2; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rappaport M, 1989, J HEAD TRAUMA REHAB, V4, P45; RAPPAPORT M, 1986, J HEAD TRAUMA REHABI, P00015, DOI DOI 10.1097/00001199-198603000-00005; SILVER B, 1990, JUN POSTGR COURS REH; TEASDALE G, 1974, LANCET, V2, P81; Weschler D, 1981, ADULT INTELLIGENCE S; 1990, J MED CARE SECTION, V28	27	124	127	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	1992	73	7					628	634					7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	JD139	WOS:A1992JD13900005	1622317				2022-02-06	
J	Morganti, JM; Riparip, LK; Rosi, S				Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna			Call Off the Dog(ma): M1/M2 Polarization Is Concurrent following Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; MACROPHAGE ACTIVATION; ALTERNATIVE ACTIVATION; CEREBRAL-CORTEX; WHITE-MATTER; SPINAL-CORD; MOUSE MODEL; IN-VIVO; INFLAMMATION; PARADIGM	Following the primary mechanical impact, traumatic brain injury (TBI) induces the simultaneous production of a variety of pro-and anti-inflammatory molecular mediators. Given the variety of cell types and their requisite expression of cognate receptors this creates a highly complex inflammatory milieu. Increasingly in neurotrauma research there has been an effort to define injury-induced inflammatory responses within the context of in vitro defined macrophage polarization phenotypes, known as "M1" and "M2". Herein, we expand upon our previous work in a rodent model of TBI to show that the categorization of inflammatory response cannot be so easily delineated using this nomenclature. Specifically, we show that TBI elicited a wide spectrum of concurrent expression responses within both pro-and anti-inflammatory arms. Moreover, we show that the cells principally responsible for the production of these inflammatory mediators, microglia/macrophages, simultaneously express both "M1" and "M2" phenotypic markers. Overall, these data align with recent reports suggesting thatmicroglia/macrophages cannot adequately switch to a polarized "M1-only" or "M2-only" phenotype, but display a mixed phenotype due to the complex signaling events surrounding them.	[Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA; [Morganti, Josh M.; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94143 USA		Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Phys Therapy, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Rehabil Sci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Neurol Surg, San Francisco, CA 94143 USA.	susanna.rosi@ucsf.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049	National Institute Of Neurological Disorders And StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F32NS090805, R21NS087458, R21AG042016]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS090805, R21NS087458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG042016] Funding Source: NIH RePORTER	Funded by National Institute Of Neurological Disorders And Stroke and National Institute on Aging of the National Institutes of Health under award numbers F32NS090805 (J.M.M.), R21NS087458 (S.R.); R21AG042016 (S.R.).	Belarbi K, 2013, CANCER RES, V73, P1201, DOI 10.1158/0008-5472.CAN-12-2989; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Josefowicz SZ, 2013, IMMUNOLOGY, V139, P299, DOI 10.1111/imm.12115; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	44	123	126	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2016	11	1							e0148001	10.1371/journal.pone.0148001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9FZ	WOS:000369527800262	26808663	Green Published, gold, Green Submitted			2022-02-06	
J	Hay, JR; Johnson, VE; Young, AMH; Smith, DH; Stewart, W				Hay, Jennifer R.; Johnson, Victoria E.; Young, Adam M. H.; Smith, Douglas H.; Stewart, William			Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Blood-brain barrier; Chronic traumatic encephalopathy; Fibrinogen; Traumatic brain injury	RECEPTOR-RELATED PROTEIN-1; ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; CEREBRAL MICROVASCULATURE; PERMEABILITY; INFLAMMATION; MICROVESSELS; PATHOLOGY; DYSFUNCTION	Traumatic brain injury (TBI) is a risk factor for dementia. Mixed neurodegenerative pathologies have been described in late survivors of TBI, but the mechanisms driving post-TBI neurodegeneration remain elusive. Increasingly, blood-brain barrier (BBB) disruption has been recognized in a range of neurologic disorders including dementias, but little is known of the consequences of TBI on the BBB. Autopsy cases of single moderate or severe TBI from the Glasgow TBI Archive (n = 70) were selected to include a range from acute (10 hours-13 days) to long-term (1-47 years) survival, together with age-matched uninjured controls (n = 21). Multiple brain regions were examined using immunohistochemistry for the BBB integrity markers fibrinogen and immunoglobulin G. After TBI, 40% of patients dying in the acute phase and 47% of those surviving a year or more from injury showed multifocal, abnormal, perivascular, and parenchymal fibrinogen and immunoglobulin G immunostaining localized to the gray matter, with preferential distribution toward the crests of gyri and deep neocortical layers. In contrast, when present, controls showed only limited localized immunostaining. These preliminary data demonstrate evidence of widespread BBB disruption in a proportion of TBI patients emerging in the acute phase and, intriguingly, persisting in a high proportion of late survivors.	[Hay, Jennifer R.; Stewart, William] Univ Glasgow, Glasgow, Lanark, Scotland; [Hay, Jennifer R.; Young, Adam M. H.; Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; [Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Smith, Douglas H.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA		Stewart, W (corresponding author), Queen Elizabeth Univ Hosp, Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	William.Stewart@glasgow.ac.uk		Stewart, William/0000-0003-2199-2582	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS038104, NS056202]; US Department of DefenseUnited States Department of Defense [PT110785]; Sackler Institute Endowment Fund, Department of Neurology, Queen Elizabeth University Hospital, Glasgow, United Kingdom; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202, R01NS038104] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health Grants NS038104 and NS056202; US Department of Defense Grant PT110785; and The Sackler Institute Endowment Fund, Department of Neurology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.	Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Grammas P, 1999, AM J PATHOL, V154, P337, DOI 10.1016/S0002-9440(10)65280-7; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Povlishock J T, 1980, Adv Exp Med Biol, V131, P227; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Starr JM, 2009, PSYCHIAT RES-NEUROIM, V171, P232, DOI 10.1016/j.pscychresns.2008.04.003; Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Vaz R, 1998, ACTA NEUROCHIR, V140, P76, DOI 10.1007/s007010050061; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; Viggars AP, 2011, NEUROSCI LETT, V505, P25, DOI 10.1016/j.neulet.2011.09.049; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Xu G, 2008, INT J CLIN PRACT, V62, P1070, DOI 10.1111/j.1742-1241.2007.01268.x; Zhang Y, 2001, J NEUROIMMUNOL, V114, P168, DOI 10.1016/S0165-5728(01)00242-9; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	72	123	124	0	26	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	DEC	2015	74	12					1147	1157		10.1093/jnen/74.12.1147			11	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	CX3PB	WOS:000365610200004	26574669	Bronze, Green Accepted			2022-02-06	
J	Glushakova, OY; Johnson, D; Hayes, RL				Glushakova, Olena Y.; Johnson, Danny; Hayes, Ronald L.			Delayed Increases in Microvascular Pathology after Experimental Traumatic Brain Injury Are Associated with Prolonged Inflammation, Blood-Brain Barrier Disruption, and Progressive White Matter Damage	JOURNAL OF NEUROTRAUMA			English	Article						BBB; CD 68; chronic TBI; GFAP; ICAM-1; microbleeds; microglia	CORTICAL IMPACT INJURY; MILD COGNITIVE IMPAIRMENT; CEREBRAL MICROBLEEDS; MICROGLIAL ACTIVATION; DISEASE; ASTROCYTES; IRON; RAT; DEGENERATION; DYSFUNCTION	Traumatic brain injury (TBI) is a significant risk factor for chronic traumatic encephalopathy (CTE), Alzheimer's disease (AD), and Parkinson's disease (PD). Cerebral microbleeds, focal inflammation, and white matter damage are associated with many neurological and neurodegenerative disorders including CTE, AD, PD, vascular dementia, stroke, and TBI. This study evaluates microvascular abnormalities observed at acute and chronic stages following TBI in rats, and examines pathological processes associated with these abnormalities. TBI in adult rats was induced by controlled cortical impact (CCI) of two magnitudes. Brain pathology was assessed in white matter of the corpus callosum for 24 h to 3 months following injury using immunohistochemistry (IHC). TBI resulted in focal microbleeds that were related to the magnitude of injury. At the lower magnitude of injury, microbleeds gradually increased over the 3 month duration of the study. IHC revealed TBI-induced focal abnormalities including blood-brain barrier (BBB) damage (IgG), endothelial damage (intercellular adhesion molecule 1 [ICAM-1]), activation of reactive microglia (ionized calcium binding adaptor molecule 1 [Iba1]), gliosis (glial fibrillary acidic protein [GFAP]) and macrophage-mediated inflammation (cluster of differentiation 68 [CD68]), all showing different temporal profiles. At chronic stages (up to 3 months), apparent myelin loss (Luxol fast blue) and scattered deposition of microbleeds were observed. Microbleeds were surrounded by glial scars and co-localized with CD68 and IgG puncta stainings, suggesting that localized BBB breakdown and inflammation were associated with vascular damage. Our results indicate that evolving white matter degeneration following experimental TBI is associated with significantly delayed microvascular damage and focal microbleeds that are temporally and regionally associated with development of punctate BBB breakdown and progressive inflammatory responses. Increased understanding of mechanisms underlying delayed microvascular damage following TBI could provide novel insights into chronic pathological responses to TBI and potential common mechanisms underlying TBI and neurodegenerative diseases.	[Glushakova, Olena Y.; Johnson, Danny; Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL 32615 USA		Glushakova, OY (corresponding author), Banyan Biomarkers Inc, 13400 Progress Blvd, Alachua, FL 32615 USA.	oglushakova@banyanbio.com	Glushakova, Olena/AAY-1130-2021	Glushakova, Olena/0000-0002-2109-3651	DoDUnited States Department of Defense [W81XWH-11-2-0002]	The authors thank Marda Jorgensen, at the University of Florida, McKnight Brain Institute Cell and Tissue Analysis Care (MBI CTAC) and the University of Florida Molecular Pathology Core for assistance with histology. This study was supported in part by DoD Award number W81XWH-11-2-0002.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P395, DOI 10.1007/s00401-011-0932-x; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Cordonnier Charlotte, 2010, Pract Neurol, V10, P94, DOI 10.1136/jnnp.2010.206086; De Reuck J, 2012, EUR J NEUROL, V19, P1355, DOI 10.1111/j.1468-1331.2012.03776.x; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Gouw AA, 2011, J NEUROL NEUROSUR PS, V82, P126, DOI 10.1136/jnnp.2009.204685; Gregoire SM, 2013, STROKE, V44, P1267, DOI 10.1161/STROKEAHA.111.000245; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Haller S, 2010, RADIOLOGY, V257, P764, DOI 10.1148/radiol.10100612; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Imaizumi T, 2011, J NEUROIMAGING, V21, P359, DOI 10.1111/j.1552-6569.2011.00593.x; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kadota E, 2000, ACT NEUR S, V76, P69; Kakar P, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012006; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kurumatani T, 1998, STROKE, V29, P1058, DOI 10.1161/01.STR.29.5.1058; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Schrag M, 2010, ACTA NEUROPATHOL, V119, P291, DOI 10.1007/s00401-009-0615-z; Schreiber Stefanie, 2013, Exp Transl Stroke Med, V5, P4, DOI 10.1186/2040-7378-5-4; Seo SW, 2007, STROKE, V38, P1949, DOI 10.1161/STROKEAHA.106.477315; Seylaz J, 1999, J CEREBR BLOOD F MET, V19, P863, DOI 10.1097/00004647-199908000-00005; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Staekenborg SS, 2009, STROKE, V40, P1269, DOI 10.1161/STROKEAHA.108.531343; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Tang WK, 2012, PSYCHOSOMATICS, V53, P439, DOI 10.1016/j.psym.2012.04.001; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Woertgen C, 2002, ACT NEUR S, V81, P205; Yanagawa Youichi, 2011, J Emerg Trauma Shock, V4, P355, DOI 10.4103/0974-2700.83863; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	79	123	126	1	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2014	31	13					1180	1193		10.1089/neu.2013.3080			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AL2VK	WOS:000338983500007	24564198				2022-02-06	
J	Guggenmos, DJ; Azin, M; Barbay, S; Mahnken, JD; Dunham, C; Mohseni, P; Nudo, RJ				Guggenmos, David J.; Azin, Meysam; Barbay, Scott; Mahnken, Jonathan D.; Dunham, Caleb; Mohseni, Pedram; Nudo, Randolph J.			Restoration of function after brain damage using a neural prosthesis	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						brain-machine-brain interface; neural plasticity; traumatic brain injury; closed-loop; long-term potentiation	LONG-TERM POTENTIATION; MOTOR CORTEX; CORTICAL STIMULATION; ELECTRICAL-STIMULATION; SENSORIMOTOR CORTEX; PLASTICITY; RECOVERY; STROKE; INJURY; NEOCORTEX	Neural interface systems are becoming increasingly more feasible for brain repair strategies. This paper tests the hypothesis that recovery after brain injury can be facilitated by a neural prosthesis serving as a communication link between distant locations in the cerebral cortex. The primary motor area in the cerebral cortex was injured in a rat model of focal brain injury, disrupting communication between motor and somatosensory areas and resulting in impaired reaching and grasping abilities. After implantation of microelectrodes in cerebral cortex, a neural prosthesis discriminated action potentials (spikes) in premotor cortex that triggered electrical stimulation in somatosensory cortex continuously over subsequent weeks. Within 1 wk, while receiving spike-triggered stimulation, rats showed substantially improved reaching and grasping functions that were indistinguishable from prelesion levels by 2 wk. Post hoc analysis of the spikes evoked by the stimulation provides compelling evidence that the neural prosthesis enhanced functional connectivity between the two target areas. This proof-of-concept study demonstrates that neural interface systems can be used effectively to bridge damaged neural pathways functionally and promote recovery after brain injury.	[Guggenmos, David J.; Barbay, Scott; Dunham, Caleb; Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Mahnken, Jonathan D.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA; [Guggenmos, David J.; Barbay, Scott; Dunham, Caleb; Nudo, Randolph J.] Univ Kansas, Med Ctr, Landon Ctr Aging, Kansas City, KS 66160 USA; [Azin, Meysam; Mohseni, Pedram] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA		Nudo, RJ (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.	rnudo@kumc.edu			Department of Defense Traumatic Brain Injury-Investigator-Initiated Research Award Program [W81XWH-10-1-0741/0742]; American Heart AssociationAmerican Heart Association [09BGIA2280495]; Advanced Platform Technology Center-A Veterans Affairs Research Center of Excellence (Cleveland, OH)	The authors thank Andrea Pack and Alexandra Brown for technical assistance, Cam Teskey for invaluable comments on the discussion, and Casey Wood for artistic contributions. This research was funded by the Department of Defense Traumatic Brain Injury-Investigator-Initiated Research Award Program under Awards W81XWH-10-1-0741/0742 (to P. M. and R.J.N.) and the American Heart Association under Award 09BGIA2280495 (to P. M.). The fabrication costs for the chip in the microdevice were generously supported by the Advanced Platform Technology Center-A Veterans Affairs Research Center of Excellence (Cleveland, OH).	Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Azin M, 2011, IEEE T BIO-MED ENG, V58, P2589, DOI 10.1109/TBME.2011.2159603; Azin M, 2011, IEEE J SOLID-ST CIRC, V46, P731, DOI 10.1109/JSSC.2011.2108770; Baba T, 2009, STROKE, V40, pE598, DOI 10.1161/STROKEAHA.109.563627; Berger TW, 2012, IEEE T NEUR SYS REH, V20, P198, DOI 10.1109/TNSRE.2012.2189133; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Carter AR, 2012, NEUROIMAGE, V62, P2271, DOI 10.1016/j.neuroimage.2012.02.070; Catani M, 2008, CORTEX, V44, P911, DOI 10.1016/j.cortex.2008.05.001; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute to Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Edwardson MA, 2013, EXP BRAIN RES, V224, P335, DOI 10.1007/s00221-012-3315-1; Fang PC, 2005, J COMP NEUROL, V490, P305, DOI 10.1002/cne.20665; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Friel KM, 2005, J NEUROPHYSIOL, V94, P1312, DOI 10.1152/jn.01251.2004; Hawes SL, 2013, J NEUROPHYSIOL, V110, P2027, DOI 10.1152/jn.00115.2013; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Henderson AK, 2012, NEUROSCIENCE, V215, P98, DOI 10.1016/j.neuroscience.2012.04.040; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Jackson A, 2012, NAT REV NEUROL, V8, P690, DOI 10.1038/nrneurol.2012.219; Jahanshahi A, 2013, EXP BRAIN RES, V231, P165, DOI 10.1007/s00221-013-3680-4; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McCulloch CE, 2001, GEN LINEAR MIXED MOD; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Nishimura Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00057; Nudo RJ, 2011, J COMMUN DISORD, V44, P515, DOI 10.1016/j.jcomdis.2011.04.004; Nudo RJ, 2009, EVOLUTIONARY NEUROSC, P727; Perez MA, 2009, TOP STROKE REHABIL, V16, P254, DOI 10.1310/tsr1604-254; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Plow EB, 2009, STROKE, V40, P1926, DOI 10.1161/STROKEAHA.108.540823; RACINE RJ, 1995, BRAIN RES, V702, P87, DOI 10.1016/0006-8993(95)01025-0; Rebesco JM, 2011, PROG BRAIN RES, V192, P83, DOI 10.1016/B978-0-444-53355-5.00006-3; Rebesco JM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00039; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Santos FJ, 2011, NEURON, V72, P197, DOI 10.1016/j.neuron.2011.10.004; SHATZ CJ, 1992, SCI AM, V267, P61, DOI 10.1038/scientificamerican0992-60; Skarpaas TL, 2009, NEUROTHERAPEUTICS, V6, P238, DOI 10.1016/j.nurt.2009.01.022; Trepel C, 1998, CEREB CORTEX, V8, P719, DOI 10.1093/cercor/8.8.719; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Webster Brian R, 2006, NeuroRx, V3, P474, DOI 10.1016/j.nurx.2006.07.008	42	123	126	1	30	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	DEC 24	2013	110	52					21177	21182		10.1073/pnas.1316885110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	277ZW	WOS:000328858800074	24324155	Green Published, Bronze			2022-02-06	
J	Grossman, EJ; Jensen, JH; Babb, JS; Chen, Q; Tabesh, A; Fieremans, E; Xia, D; Inglese, M; Grossman, RI				Grossman, E. J.; Jensen, J. H.; Babb, J. S.; Chen, Q.; Tabesh, A.; Fieremans, E.; Xia, D.; Inglese, M.; Grossman, R. I.			Cognitive Impairment in Mild Traumatic Brain Injury: A Longitudinal Diffusional Kurtosis and Perfusion Imaging Study	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							GAUSSIAN WATER DIFFUSION; AXONAL INJURY; HEAD-INJURY; SPECT; DYSFUNCTION; INVENTORY; SEVERITY; STATE	BACKGROUND AND PURPOSE: Cognitive impairment is frequent among patients with mild traumatic brain injury despite the absence of detectable damage on conventional MR imaging. In this study, the quantitative MR imaging techniques DTI, DKI, and ASL were used to measure changes in the structure and function in the thalamus and WM of patients with MTBI during a short follow-up period, to determine whether these techniques can be used to investigate relationships with cognitive performance and to predict outcome. MATERIALS AND METHODS: Twenty patients with MTBI and 16 controls underwent MR imaging at 3T and a neuropsychological battery designed to yield measures for attention, concentration, executive functioning, memory, learning, and information processing. MK, FA, MD, and CBF were measured in the thalamus by using region-of-interest analysis and inWMby using tract-based spatial statistics. Analyses were performed comparing regional imaging measures of subject groups and the results of testing of their associations with neuropsychological performance. RESULTS: Patients with MTBI exhibited significant differences from controls for DTI, DKI, and ASL measures in the thalamus and various WM regions both within 1 month after injury and >9 months after injury. At baseline, DTI and DKI measures in the thalamus and various WM regions were significantly associated with performance in different neuropsychological domains, and cognitive impairment was significantly associated with MK in the thalamus and FA in optic radiations. CONCLUSIONS: Combined application of DTI, DKI, and ASL to study MTBI might be useful for investigating dynamic changes in the thalamus andWMas well as cognitive impairment during a short follow-up period, though the small number of patients examined did not predict outcome.	[Grossman, E. J.; Babb, J. S.; Chen, Q.; Fieremans, E.; Xia, D.; Inglese, M.; Grossman, R. I.] NYU, Dept Radiol, Ctr Biomed Imaging, Sch Med, New York, NY 10016 USA; [Grossman, E. J.] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; [Jensen, J. H.; Tabesh, A.] Med Univ S Carolina, Dept Radiol & Radiol Sci, Charleston, SC 29425 USA; [Inglese, M.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA		Grossman, EJ (corresponding author), NYU, Dept Radiol, Ctr Biomed Imaging, Sch Med, 660 First Ave,4th Floor,Room 420, New York, NY 10016 USA.	Elan.Grossman@nyumc.org	Inglese, Matilde/AAH-3189-2020; Jensen, Jens H/A-8334-2009	Inglese, Matilde/0000-0002-9610-0297; Jensen, Jens H/0000-0003-3219-4287; Xia, Ding/0000-0002-1396-4082; Fieremans, Els/0000-0002-1384-8591; Babb, James/0000-0003-1798-1186	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS039135, R01NS051623]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135, R01NS051623] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grants R01NS039135 and R01NS051623.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Buxton RB, 2005, J MAGN RESON IMAGING, V22, P723, DOI 10.1002/jmri.20462; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Feig SL, 2000, EUR J NEUROSCI, V12, P2195, DOI 10.1046/j.1460-9568.2000.00093.x; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Grossman EJ, 2009, J MAGN RESON IMAGING, V29, P1425, DOI 10.1002/jmri.21794; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jacobs A, 1996, J NUCL MED, V37, P1605; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Sherman S.M., 2006, EXPLORING THALAMUS I, V2. ed; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stamatakis EA, 2002, J NUCL MED, V43, P476; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	40	123	133	0	26	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2013	34	5					951	957		10.3174/ajnr.A3358			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	301MR	WOS:000330536900014	23179649	Green Accepted, hybrid, Green Published			2022-02-06	
J	Maas, AIR; Menon, DK; Lingsma, HF; Pineda, JA; Sandel, ME; Manley, GT				Maas, Andrew I. R.; Menon, David K.; Lingsma, Hester F.; Pineda, Jose A.; Sandel, M. Elizabeth; Manley, Geoffrey T.			Re-Orientation of Clinical Research in Traumatic Brain Injury: Report of an International Workshop on Comparative Effectiveness Research	JOURNAL OF NEUROTRAUMA			English	Article						comparative effectiveness research; clinical research; clinical trials; methodology; systems biology; traumatic brain injury	SEVERE HEAD-INJURY; QUALITY-OF-LIFE; CEREBRAL PERFUSION-PRESSURE; INTENSIVE-CARE MANAGEMENT; PLACEBO-CONTROLLED TRIAL; COMMON DATA ELEMENTS; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; NEUROCRITICAL CARE; CONSORTIUM SURVEY	During the National Neurotrauma Symposium 2010, the DG Research of the European Commission and the National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) organized a workshop on comparative effectiveness research (CER) in traumatic brain injury (TBI). This workshop reviewed existing approaches to improve outcomes of TBI patients. It had two main outcomes: First, it initiated a process of re-orientation of clinical research in TBI. Second, it provided ideas for a potential collaboration between the European Commission and the NIH/NINDS to stimulate research in TBI. Advances in provision of care for TBI patients have resulted from observational studies, guideline development, and meta-analyses of individual patient data. In contrast, randomized controlled trials have not led to any identifiable major advances. Rigorous protocols and tightly selected populations constrain generalizability. The workshop addressed additional research approaches, summarized the greatest unmet needs, and highlighted priorities for future research. The collection of high-quality clinical databases, associated with systems biology and CER, offers substantial opportunities. Systems biology aims to identify multiple factors contributing to a disease and addresses complex interactions. Effectiveness research aims to measure benefits and risks of systems of care and interventions in ordinary settings and broader populations. These approaches have great potential for TBI research. Although not new, they still need to be introduced to and accepted by TBI researchers as instruments for clinical research. As with therapeutic targets in individual patient management, so it is with research tools: one size does not fit all.	[Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; [Menon, David K.] Univ Cambridge, Cambridge, England; [Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Pineda, Jose A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Pineda, Jose A.] Washington Univ, Sch Med, Dept Neurol, Div Crit Care Med, St Louis, MO 63110 USA; [Sandel, M. Elizabeth] Kaiser Fdn Rehabil Ctr, Vallejo, CA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA USA		Maas, AIR (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	andrew.maas@uza.be	Maas, Andrew IR/C-5584-2013; Pineda, Jose/W-2806-2019	Maas, Andrew IR/0000-0003-1612-1264; 	European CommissionEuropean CommissionEuropean Commission Joint Research Centre; National Institutes of Health/National Institute of Neurological Diseases and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390] Funding Source: researchfish	The workshop on CER was supported by the European Commission DG Research and the National Institutes of Health/National Institute of Neurological Diseases and Stroke (NIH/NINDS). We are grateful to Dr. Ramona Hicks (NIH/NINDS) and Dr. Patrizia Tosetti (DG Research, European Commission) for their insightful planning and coordination of the workshop. The authors of this manuscript were all speakers at the workshop. We wish to express our gratitude to Dr. Kenneth Curley, Dr. Alan Faden, and Prof. Nicole von Steinbuechel for contributing to the panel discussions. We are grateful to all attendees who participated in the workshop, many of whom traveled from afar specifically to attend the workshop, and for their contributions to the general discussions. Their input was essential in making this workshop a success. A particular word of thanks is due to Dr. Toril Skandsen (Trondheim, Norway), for providing her notes of the discussions, to Dr. Kenneth Curley for input in drafting the manuscript, to Eno Lavrysen for administrative support in preparing the manuscript, and to Sir Graham Teasdale for advice in editing the final version.	Aarabi Bizhan, 2001, Journal of Trauma Injury Infection and Critical Care, V51, pS1; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bischofs IB, 2009, P NATL ACAD SCI USA, V106, P6459, DOI 10.1073/pnas.0810878106; Black N, 1996, BRIT MED J, V312, P1215; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Carney NA, 2003, PEDIATR CRIT CARE ME, V4, P1; Carr BG, 2010, CURR OPIN PEDIATR, V22, P326, DOI 10.1097/MOP.0b013e3283392a48; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Correspondence NEJM, 2009, NEW ENGL J MED, V361, P536; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; DeWitt D S, 1995, New Horiz, V3, P376; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; Drummond MF, 2008, INT J TECHNOL ASSESS, V24, P244, DOI 10.1017/S0266462308080343; Edwards P, 2005, LANCET, V365, P1957; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GELPKE GJ, 1983, J NEUROSURG, V59, P745, DOI 10.3171/jns.1983.59.5.0745; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Green AR, 2002, CLIN EXP PHARMACOL P, V29, P1030, DOI 10.1046/j.1440-1681.2002.03767.x; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; IOM (Institute of Medicine), 2009, IN NAT PRIOR COMP EF; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1980, J NEUROL NEUROSUR PS, V43, P289, DOI 10.1136/jnnp.43.4.289; JENNETT B, 1976, LANCET, V1, P1031; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kapapa T, 2010, J CHILD NEUROL, V25, P409, DOI 10.1177/0883073809340697; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Maas Andrew I R, 2009, Crit Care, V13, P1016, DOI 10.1186/cc8163; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schweikhart SA, 2009, J INVEST MED, V57, P748, DOI 10.2310/JIM.0b013e3181b91b3a; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sox HC, 2010, CROAT MED J, V51, P191, DOI 10.3325/cmj.2010.51.191; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Spiro PA, 1997, P NATL ACAD SCI USA, V94, P7263, DOI 10.1073/pnas.94.14.7263; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; UK National Institute for Health and Clinical Excellence, 2003, HEAD INJ TRIAG ASS I, P4; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Winthrop AL, 2010, CURR OPIN PEDIATR, V22, P346, DOI 10.1097/MOP.0b013e3283394351; World Health Organization, 2009, GLOB STAT REP ROAD S	114	123	128	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2012	29	1					32	46		10.1089/neu.2010.1599			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	879GI	WOS:000299317300003	21545277	Green Published, Green Submitted			2022-02-06	
J	Lindvall, O; Kokaia, Z				Lindvall, Olle; Kokaia, Zaal			Stem Cell Research in Stroke How Far From the Clinic?	STROKE			English	Article						acute stroke; inflammation; neural stem cell; neurogenesis; neuroregeneration; stem cells; stroke recovery; transplantation	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; STROMAL CELLS; ADULT RATS; ENDOGENOUS NEUROGENESIS; FUNCTIONAL RECOVERY; NEURONAL DIFFERENTIATION; PROVIDE NEUROPROTECTION; FOREBRAIN NEUROGENESIS; THERAPEUTIC BENEFITS	Stem cell-based approaches hold much promise as potential novel treatments to restore function after stroke. Studies in animal models have shown that stem cell transplantation can improve function by replacing neurons or by trophic actions, modulation of inflammation, promotion of angiogenesis, remyelination and axonal plasticity, and neuroprotection. Endogenous neural stem cells are also potential therapeutic targets because they produce new neurons after stroke. Clinical trials are ongoing but there is currently no proven stem cell-based therapy for stroke. Preclinical studies and clinical research will be needed to optimize the therapeutic benefit and minimize the risks of stem cells in stroke. (Stroke. 2011;42:2369-2375.)	[Lindvall, Olle] Univ Hosp, Lab Neurogenesis & Cell Therapy, Wallenberg Neurosci Ctr, SE-22184 Lund, Sweden; [Kokaia, Zaal] Univ Hosp, Lab Neural Stem Cell Biol & Therapy, SE-22184 Lund, Sweden; [Lindvall, Olle; Kokaia, Zaal] Lund Stem Cell Ctr, Lund, Sweden		Lindvall, O (corresponding author), Univ Hosp, Lab Neurogenesis & Cell Therapy, Wallenberg Neurosci Ctr, SE-22184 Lund, Sweden.	olle.lindvall@med.lu.se	Kokaia, Zaal/AAL-6009-2020	Kokaia, Zaal/0000-0003-2296-2449	Swedish Research Council, EU through the European Stroke NetworkSwedish Research Council [201024]; Swedish Government Initiative for Strategic Research Areas	Our own work was supported by the Swedish Research Council, EU 7th work program through the European Stroke Network (grant no. 201024) and Swedish Government Initiative for Strategic Research Areas (StemTherapy).	Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Belayev L, 2009, BRAIN RES, V1280, P117, DOI 10.1016/j.brainres.2009.05.030; Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012; Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003; Buhnemann C, 2006, BRAIN, V129, P3238, DOI 10.1093/brain/awl261; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carter ME, 2011, TRENDS MOL MED  0223; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644; Daadi MM, 2009, MOL THER, V17, P1282, DOI 10.1038/mt.2009.104; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Hicks A, 2009, CELL STEM CELL, V5, P139, DOI 10.1016/j.stem.2009.07.009; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Honmou O, 2011, BRAIN           0414; Horie N, 2011, STEM CELLS      0114; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Jin KL, 2011, BRAIN RES, V1374, P56, DOI 10.1016/j.brainres.2010.12.037; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kawai H, 2010, J CEREBR BLOOD F MET, V30, P1487, DOI 10.1038/jcbfm.2010.32; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Lee HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005586; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li JM, 2010, BRAIN RES, V1334, P65, DOI 10.1016/j.brainres.2010.03.080; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lindvall Olle, 2004, NeuroRx, V1, P382; Lindvall Olle, 2008, V52, P549; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Liu YP, 2009, J CEREBR BLOOD F MET, V29, P780, DOI 10.1038/jcbfm.2009.1; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Liu ZW, 2010, J CEREBR BLOOD F MET, V30, P1288, DOI 10.1038/jcbfm.2010.8; Liu ZW, 2009, STROKE, V40, P2546, DOI 10.1161/STROKEAHA.109.547265; Love Z, 2007, J NUCL MED, V48, P2011, DOI 10.2967/jnumed.107.043166; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Mack GS, 2011, NAT BIOTECHNOL, V29, P95, DOI 10.1038/nbt0211-95; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Minger SL, 2007, REGEN MED, V2, P69, DOI 10.2217/17460751.2.1.69; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Park DH, 2009, CELL TRANSPLANT, V18, P985, DOI 10.3727/096368909X471279; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Rueger MA, 2010, J NEUROSCI, V30, P6454, DOI 10.1523/JNEUROSCI.6092-09.2010; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Wechsler LR, 2009, STROKE, V40, pS149, DOI 10.1161/STROKEAHA.108.533208; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zhang J, 2009, J CEREBR BLOOD F MET, V29, P1166, DOI 10.1038/jcbfm.2009.41; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	94	123	124	1	29	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	AUG	2011	42	8					2369	2375		10.1161/STROKEAHA.110.599654			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	796UE	WOS:000293077400054	21757669	Bronze			2022-02-06	
J	Miyai, I; Sonoda, S; Nagai, S; Takayama, Y; Inoue, Y; Kakehi, A; Kurihara, M; Ishikawa, M				Miyai, Ichiro; Sonoda, Shigeru; Nagai, Shota; Takayama, Yuko; Inoue, Yukiko; Kakehi, Atsuo; Kurihara, Masaki; Ishikawa, Makoto			Results of New Policies for Inpatient Rehabilitation Coverage in Japan	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						inpatient rehabilitation facility; rehabilitation outcome; stroke; medical insurance	EARLY SUPPORTED DISCHARGE; STROKE UNIT; MULTIDISCIPLINARY REHABILITATION; BENEFIT; MORTALITY; RECOVERY; PROGRAM; LENGTH; STAY; TIME	Background. A new interdisciplinary postacute rehabilitation unit, the Kaifukuki (convalescent) rehabilitation ward (KRW), has been incorporated into the Japanese medical insurance system since 2000. More than 57 000 beds (45 beds per 100 000 population) are currently available nationwide. The maximal coverage for therapy sessions increased from 2 to 3 hours per day, 7 days a week, in 2006. Objective. To investigate how changes in policy affected rehabilitation outcomes of KRWs in a retrospective cohort study of 87 917 patients over 10 years. Results. The mean (standard deviation) age of the patients was 73.0 (13.8) years, and 55.4% were women. Diagnoses included stroke (47.9%); orthopedic diseases, including hip fracture (35.2%); and traumatic brain and spinal cord injury (5.4 %). Onset-admission interval (OAI) was 31.5 (18.6) days, length of stay was 75.9 (46.1) days, and 69.1% were discharged home. Daily therapy time was 79.4 (34.5) minutes. Admission/discharge scores of the Barthel Index and the Functional Independence Measure were 49.3 (31.0)/70.4 (31.9) and 75.3 (31.2)/91.7 (31.8), respectively. Year-by-year comparison revealed that older age, greater initial disability, and shorter OAI were coupled with a higher dose of rehabilitative interventions and a higher rate of home discharge. Longitudinal data from a cohort of hospitals implied a small but significant dose-dependent effect of hours of therapy on rehabilitation outcome after stroke. Conclusions. Although the organization of KRWs is in flux as the system of hospitals grows, results over the past 8 years suggest that changes in national insurance policies are affecting the quantity and organization of rehabilitation interventions and improvement in patient outcomes.	[Miyai, Ichiro] Morinomiya Hosp, Neurorehabil Res Inst, Joto Ku, Osaka 5360025, Japan; [Miyai, Ichiro; Sonoda, Shigeru; Nagai, Shota; Takayama, Yuko; Kurihara, Masaki; Ishikawa, Makoto] Kaifukuki Rehabil Ward Assoc, Annual Survey Comm, Tokyo, Japan; [Sonoda, Shigeru] Fujita Hlth Univ, Tsu, Mie, Japan; [Nagai, Shota] Kinjo Univ, Haku San, Ishikawa, Japan; [Takayama, Yuko] Ukai Rehabil Hosp, Aichi, Japan; [Inoue, Yukiko; Kakehi, Atsuo] Natl Inst Publ Hlth, Saitama, Japan; [Kurihara, Masaki] Nagasaki Rehabil Hosp, Nagasaki, Japan; [Ishikawa, Makoto] Hatsudai Rehabil Hosp, Tokyo, Japan		Miyai, I (corresponding author), Morinomiya Hosp, Neurorehabil Res Inst, Joto Ku, 2-1-88 Morinomiya, Osaka 5360025, Japan.	webeo@ga2.so-net.ne.jp	Sonoda, Shigeru/V-9529-2019	Sonoda, Shigeru/0000-0001-7491-5308			Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; INDREDAVIK B, 1991, STROKE, V22, P1026, DOI 10.1161/01.STR.22.8.1026; Indredavik B, 2000, STROKE, V31, P2989, DOI 10.1161/01.STR.31.12.2989; JORGENSEN HS, 1995, STROKE, V26, P1178, DOI 10.1161/01.STR.26.7.1178; Kalra L, 2000, LANCET, V356, P894, DOI 10.1016/S0140-6736(00)02679-9; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Langhorne P, 2005, LANCET, V365, P501; Langhorne P, 2001, STROKE, V32, P268, DOI 10.1161/01.STR.32.1.268; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; MAHONEY F I, 1965, Md State Med J, V14, P61; Miyai I, 1998, J NEUROL REHABIL, V12, P95; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Shelton FDAP, 2001, NEUROREHAB NEURAL RE, V15, P229, DOI 10.1177/154596830101500311; Sonoda S, 2004, AM J PHYS MED REHAB, V83, P88, DOI 10.1097/01.PHM.0000107481.69424.E1; Stuart M, 2009, NEUROREHAB NEURAL RE, V23, P726, DOI 10.1177/1545968309332734; Thorsen AM, 2005, STROKE, V36, P297, DOI 10.1161/01.STR.0000152288.42701.a6; Yagura H, 2005, CEREBROVASC DIS, V20, P258, DOI 10.1159/000087708; Yagura H, 2003, ARCH PHYS MED REHAB, V84, P1687, DOI 10.1053/S0003-9993(03)00286-7	21	123	125	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUL-AUG	2011	25	6					540	547		10.1177/1545968311402696			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	774KL	WOS:000291384200006	21451116				2022-02-06	
J	Meehan, WP; Mannix, R				Meehan, William P., III; Mannix, Rebekah			Pediatric Concussions in United States Emergency Departments in the Years 2002 to 2006	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; COMPUTED-TOMOGRAPHY; HEAD-INJURY; FOOTBALL; MILD; EPIDEMIOLOGY; COLLEGIATE; MANAGEMENT; DISCHARGE	Objectives To estimate the incidence and demographics of concussions in children coming to emergency departments (EDs) in the United States and describe the rates of neuroimaging and follow-up instructions in these patients. Study design This is a cross-sectional study of children 0 to 19 years old diagnosed with concussion from the National Hospital Ambulatory Medical Care Survey. National Hospital Ambulatory Medical Care Survey collects data on approximately 25 000 visits annually to 600 randomly selected hospital emergency and outpatient departments. We examined visits to United States emergency departments between 2002 and 2006. Simple descriptive statistics were used. Results Of the 50 835 pediatric visits in the 5-year sample, 230 observations, representing 144 000 visits annually, were for concussions. Sixty-nine percent of concussion visits were by males. Thirty percent were sports-related. Sixty-nine percent of patients diagnosed with a concussion had head imaging. Twenty-eight percent of patients were discharged without specific instructions to follow-up with an outpatient provider for further treatment. Conclusions Approximately 144 000 pediatric patients present to emergency departments each year with a concussion. Most of these patients undergo computed tomography of the head, and nearly one-third are discharged without specific instructions to follow-up with an outpatient provider for further treatment. (J Pediatr 2010; 157: 889-93).	[Meehan, William P., III] Childrens Hosp, Sports Concuss Clin, Div Sports Med, Dept Orthoped, Boston, MA 02115 USA; [Meehan, William P., III; Mannix, Rebekah] Childrens Hosp, Div Emergency Med, Dept Med, Boston, MA 02115 USA		Meehan, WP (corresponding author), Childrens Hosp, Sports Concuss Clin, Div Sports Med, Dept Orthoped, 319 Longwood Ave, Boston, MA 02115 USA.	william.meehan@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		NIH through the Children's Hospital Child Health Research Center [K12 HD052896-01A1, T32 HD040128-06A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128, K12HD052896] Funding Source: NIH RePORTER	Supported by the NIH through the Children's Hospital Child Health Research Center Award to R.M. (K12 HD052896-01A1) and T32 Award to W.M. (T32 HD040128-06A1). The authors declare no conflicts of interest.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian J, 2000, BRAIN INJURY, V14, P285; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Cantu RC, 2009, NEUROSURGERY, V64, P786, DOI 10.1227/01.NEU.0000348539.13887.D3; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; MacMullan Jackie, 2007, BOSTON GLOBE    0202; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; MEADOWS B, 2007, PEOPLE MAGAZINE 1008; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Nowinski C., 2007, HEAD GAMES FOOTBALLS; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; SCHWARZ A, 2007, NY TIMES        0915; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Sosin DM, 1996, BRAIN INJURY, V10, P47; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0	38	123	123	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	DEC	2010	157	6					889	893		10.1016/j.jpeds.2010.06.040			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	681JG	WOS:000284307200007	20708747	Green Accepted			2022-02-06	
J	Beauchamp, KM; Kashuk, J; Moore, EE; Bolles, G; Rabb, C; Seinfeld, J; Szentirmai, O; Sauaia, A				Beauchamp, Kathryn M.; Kashuk, Jeffry; Moore, Ernest E.; Bolles, Gene; Rabb, Craig; Seinfeld, Joshua; Szentirmai, Oszkar; Sauaia, Angela			Cranioplasty After Postinjury Decompressive Craniectomy: Is Timing of the Essence?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	67th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma/Meeting of the Association-for-Acute-Medicine	SEP 24-27, 2008	Maui, HI	Amer Assoc Surg Trauma, Assoc Acute Med		Cranioplasty; Decompressive craniectomy	TRAUMATIC BRAIN-INJURY; BONE FLAP; DELAYED CRANIOPLASTY; HYDROCEPHALUS; PRESERVATION; CRANIOTOMY; CHILDREN	Background: The appropriate timing of cranioplasty after decompressive craniectomy for trauma is unknown. Potential benefits of delayed intervention (>6 weeks) for reducing the risk of infection must be balanced by persistent altered cerebrospinal fluid dynamics leading to hydrocephalus. We reviewed our recent 5-year experience in an effort to improve patient throughput and develop a rational decision making plan. Methods: A 5-year query (2003-2007) of our level I neurotrauma database. From 2,400 head injuries, we performed a total of 350 craniotomies. Of the 350 patients who underwent craniotomy for trauma, 70 patients (20%) underwent decompressive craniectomy requiring cranioplasty. Timing of cranioplasty, cranioplasty material, postoperative infections, and incidence of hydrocephalus were evaluated with logistic regression to study potential associations between complications and timing, adjusted for risk factors. Results: No specific time frame was predictive of hydrocephalus or infection, and logistic regression failed to identify significant predictors among the collected variables. Conclusion: In our experience, the prior practice of delayed cranioplasty (3-6 months postdecompressive craniectomy), requiring repeat hospital admission, does not seem to lower postcranioplasty infection rates nor the need for cerebrospinal fluid diversion procedures. Our current practice emphasizes cranioplasty during the initial hospital admission, as soon as there is resolution on computed tomography scan of brain swelling outside of the cranial vault with concurrent clinical examination. This occurs as early as 2 weeks postcraniectomy and should lower the overall cost of care by eliminating the need for additional hospital admissions.	[Beauchamp, Kathryn M.; Bolles, Gene; Rabb, Craig; Seinfeld, Joshua; Szentirmai, Oszkar] Denver Hlth Med Ctr, Rocky Mt Reg Trauma Ctr, Div Neurosurg, Denver, CO 80304 USA; [Kashuk, Jeffry; Moore, Ernest E.] Denver Hlth Med Ctr, Rocky Mt Reg Trauma Ctr, Dept Surg, Denver, CO 80304 USA; [Sauaia, Angela] Univ Colorado Denver Hlth Sci, Denver, CO USA		Beauchamp, KM (corresponding author), Denver Hlth Med Ctr, Rocky Mt Reg Trauma Ctr, Div Neurosurg, 777 Bannock MC 0206, Denver, CO 80304 USA.	kathryn.beauchamp@dhha.org					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aciduman A, 2007, SURG NEUROL, V68, P349, DOI 10.1016/j.surneu.2006.10.073; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; AZIZ T Z, 1990, British Journal of Neurosurgery, V4, P417, DOI 10.3109/02688699008992764; Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158; Bruce JN, 2003, J NEUROSURG, V98, P1203, DOI 10.3171/jns.2003.98.6.1203; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Flannery T, 2001, BRIT J NEUROSURG, V15, P518, DOI 10.1080/02688690120097732; Iwama T, 2003, NEUROSURGERY, V52, P591, DOI 10.1227/01.NEU.0000047891.86938.46; Jankowitz BT, 2006, NEUROSURGERY, V59, P585, DOI 10.1227/01.NEU.0000231849.12751.B9; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Krishnan P, 2006, NEUROL INDIA, V54, P291; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Tokoro K, 1989, Neurol Med Chir (Tokyo), V29, P196, DOI 10.2176/nmc.29.196; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348	20	123	127	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2010	69	2					270	274		10.1097/TA.0b013e3181e491c2			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	638JN	WOS:000280890800005	20699735				2022-02-06	
J	Bazarian, JJ; Cernak, I; Noble-Haeusslein, L; Potolicchio, S; Temkin, N				Bazarian, Jeffrey J.; Cernak, Ibolja; Noble-Haeusslein, Linda; Potolicchio, Samuel; Temkin, Nancy			Long-term Neurologic Outcomes After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Alzheimer's disease; amyotrophic lateral sclerosis; dementia; dementia pugilistica; endocrine disorders; epilepsy; multiple sclerosis; ocular disorders; postconcussive symptoms; postconcussive syndrome; parkinsonism; Parkinson's disease; seizure; traumatic brain injury; visuomotor disorders	AMYOTROPHIC-LATERAL-SCLEROSIS; POST-CONCUSSION SYNDROME; QUALITY-OF-LIFE; HEAD-INJURY; ALZHEIMERS-DISEASE; RISK-FACTORS; PARKINSONS-DISEASE; PITUITARY INSUFFICIENCY; POSTTRAUMATIC SEIZURES; COGNITIVE IMPAIRMENT	Objective: To determine the relations between traumatic brain injury (TBI) and several neurologic Outcomes 6 months or more after TBI. Participants: Not applicable. Design: Systematic review of the published, peer-reviewed literature. Primary Measures: Not applicable. Results: We identified 75 studies that examined the relations between TBI and neurologic outcomes. Unprovoked seizures are causally related to penetrating TBI as well as to moderate and severe TBI. There was only limited evidence of an association between seizures and mild TBI. Dementia of the Alzheimer's type (DAT) was associated with moderate and severe TBI, but not with mild TBI unless there was loss of consciousness (LOC); the evidence for the latter was limited. Parkinsonism was associated with moderate and severe TBI, but there was only modest evidence of a link with mild TBI without LOC. Dementia pugilistica was associated with professional boxing. There was insufficient evidence to support an association between TBI and both multiple sclerosis and amyotrophic lateral sclerosis. TBI appeared to produce a host of postconcussive symptoms (eg, memory problems, dizziness, and irritability). Moderate and severe TBI were associated with endocrine problems such as hypopituitarism and growth hormone deficiency and possibly with diabetes insipidus. There was only limited evidence of an association between mild TBI and the development of ocular/visual motor deterioration. Conclusion: TBI is strongly associated with several neurologic disorders 6 months or more after injury. Clinicians caring for TBI patients should monitor them closely for the development of these disorders. While some of these disorders can be treated after they arise (eg, seizures), a greater public health benefit would be achieved by preventing them before they develop. Research efforts to develop therapies aimed at secondary prevention are currently underway.	[Bazarian, Jeffrey J.] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA; [Cernak, Ibolja] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Noble-Haeusslein, Linda] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Potolicchio, Samuel] George Washington Univ, Med Ctr, Dept Neurol, Washington, DC 20037 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Bazarian, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Emergency Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu		Ibolja, Cernak/0000-0003-3214-698X	US Department of Veterans AffairsUS Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050159, R01NS077767] Funding Source: NIH RePORTER	The study was supported by a contract from the US Department of Veterans Affairs to the National Academy of Sciences, Institute of Medicine.	Aarsland D, 2002, J NEUROL NEUROSUR PS, V72, P708, DOI 10.1136/jnnp.72.6.708; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; ANNEGERS JF, 1995, EPILEPSIA, V36, P327, DOI 10.1111/j.1528-1157.1995.tb01005.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; CAVENESS WF, 1962, J NEUROSURG, V19, P122, DOI 10.3171/jns.1962.19.2.0122; CAVENESS WF, 1963, J NEUROSURG, V20, P570, DOI 10.3171/jns.1963.20.7.0570; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P810; Centers for Disease Control and Prevention, 1995, MMWR-MORBID MORTAL W, V44, P818; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; EVANS JH, 1962, NEUROLOGY, V12, P665, DOI 10.1212/WNL.12.10.665; Farlow MR, 2005, DEMENT GERIATR COGN, V20, P192, DOI 10.1159/000087301; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; FULCO C, 2009, J HEAD TRAUMA REHABI; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Goldacre MJ, 2006, J NEUROL NEUROSUR PS, V77, P351, DOI 10.1136/jnnp.2005.077693; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; *I MED, 2006, AM LAT SCLER VET; JENNETT B, 1973, SCOT MED J, V18, P8, DOI 10.1177/003693307301800103; Jennett W. B., 1969, LATE EFFECTS HEAD IN, P201; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; KURLAND LT, 1994, ANN NEUROL, V36, pS33, DOI 10.1002/ana.410360711; KURTZKE JF, 1980, NEUROLOGY, V30, P453, DOI 10.1212/WNL.30.5.453; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Loewenstein DA, 2004, AM J GERIAT PSYCHIAT, V12, P395, DOI 10.1176/appi.ajgp.12.4.395; Marr JE, 2005, DEV MED CHILD NEUROL, V47, P815, DOI 10.1017/S0012162205001726; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; MILLER JD, 1968, LANCET, V2, P991; *NIH, 2006, ALZH DIS FACT SHEET; Noonan CW, 2002, NEUROLOGY, V58, P136, DOI 10.1212/WNL.58.1.136; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Porter MD, 1996, CLIN J SPORT MED, V6, P90, DOI 10.1097/00042752-199604000-00005; Roberts A. H., 1979, SEVERE ACCIDENTAL HE, P89; ROBERTS AH, 1979, SEVERE ACCIDENTAL HE, P102; Russell W. R., 1969, LATE EFFECTS HEAD IN, P189; RUSSELL WR, 1968, JOHNS HOPKINS MED J, V122, P250; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sargent P, 1921, BRAIN, V44, P95, DOI 10.1093/brain/44.2.95; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SHALAT SL, 1987, NEUROLOGY, V37, P1630, DOI 10.1212/WNL.37.10.1630; Singer R B, 2001, J Insur Med, V33, P42; Stevenson WE, 1931, BRAIN, V54, P214, DOI 10.1093/brain/54.2.214; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#; VANDUIJN CM, 1994, GENET EPIDEMIOL, V11, P539, DOI 10.1002/gepi.1370110609; Wagstaffe WW, 1928, LANCET, V2, P861; Watson CW, 1946, RES PUBL ASSOC RES N, V26, P516; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	89	123	126	1	57	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2009	24	6					439	451		10.1097/HTR.0b013e3181c15600			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	528VW	WOS:000272476100004	19940677				2022-02-06	
J	Narayan, RK; Maas, AIR; Servadei, F; Skolnick, BE; Tillinger, MN; Marshall, LF				Narayan, Raj K.; Maas, Andrew I. R.; Servadei, Franco; Skolnick, Brett E.; Tillinger, Michael N.; Marshall, Lawrence F.		Traumatic Intracerebral Hemorrhage	Progression of traumatic intracerebral hemorrhage: A prospective observational study	JOURNAL OF NEUROTRAUMA			English	Article						cerebral contusions; deep vein thrombosis; intracerebral hemorrhage; thromboembolic complications; traumatic brain injury	SEVERE HEAD-INJURY; INTRA-CEREBRAL HEMATOMAS; BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; CRANICAL PRESSURE; CLINICAL-TRIALS; CT; COAGULOPATHY; THROMBOCYTOPENIA; PROGNOSIS	Preliminary evidence has shown that intracerebral hemorrhages, either spontaneous (sICH) or traumatic (tICH) often expand over time. An association between hemorrhage expansion and clinical outcomes has been described for sICH. The intent of this prospective, observational study was to characterize the temporal profile of hemorrhage progression, as measured by serial computed tomography (CT) scanning, with the aim of better understanding the natural course of hemorrhage progression in tICH. There was also a desire to document the baseline adverse event (AE) profile in this patient group. An important motive for performing this study was to set the stage for subsequent studies that will examine the role of a new systemic hemostatic agent in tICH. Subjects were enrolled if they had tICH lesions of at least 2 mL on a baseline CT scan obtained within 6 h of a head injury. CT scans were repeated at 24 and 72 h. Clinical outcomes and pre-defined AEs were documented. The data showed that 51% of the subjects demonstrated an increase in tICH volume, and that most of the increase occurred early. In addition, larger hematomas exhibited the greatest expansion. Thromboembolic complications were identified in 13% of subjects. This study demonstrates that tICH expansion between the baseline and 24-h CT scans occurred in approximately half of the subjects. The earlier after injury that the initial CT scan is obtained, the greater is the likelihood that the hematoma will expand on subsequent scans. The time frame during which hemorrhagic expansion occurs provides an opportunity for early intervention to limit a process with adverse prognostic implications.	[Narayan, Raj K.] Univ Cincinnati, Dept Neurosurg, Inst Neurosci, Univ Hosp, Cincinnati, OH 45267 USA; [Narayan, Raj K.] Mayfield Clin, Cincinnati, OH 45267 USA; [Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Servadei, Franco] Univ Hosp, Osped Maggiore, Neurosurg Neurotrauma Unit, Parma, Italy; [Tillinger, Michael N.] Novo Nordisk Inc, Princeton, NJ USA; [Marshall, Lawrence F.] Univ Calif San Diego, Div Neurosurg, San Diego, CA 92103 USA		Narayan, RK (corresponding author), Univ Cincinnati, Dept Neurosurg, Inst Neurosci, Univ Hosp, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	raj.narayan@uc.edu	Skolnick, Brett e/B-5140-2009; Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264; Servadei, Franco/0000-0002-3595-3464; Kaufmann, Anthony/0000-0001-6144-0382; Badjatia, Neeraj/0000-0003-1509-9034; Hitchon, Patrick/0000-0002-8175-9136; Theodore, Nicholas/0000-0001-5355-2683			BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pace MC, 2006, MINERVA ANESTESIOL, V72, P235; Procaccio F, 2000, J Neurosurg Sci, V44, P1; REILLY PL, 1975, LANCET, V2, P375; SERVADEI F, 2000, EUR BRAIN INJ CONSUT, V46, P70; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516; Zimmerman RD, 2006, AM J NEURORADIOL, V27, P666	35	123	134	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2008	25	6					629	639		10.1089/neu.2007.0385			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	326BW	WOS:000257633900006	18491950	Green Published			2022-02-06	
J	Cutler, SM; Cekic, M; Miller, DM; Wali, B; VanLandingham, JW; Stein, DG				Cutler, Sarah M.; Cekic, Milos; Miller, Darren M.; Wali, Bushra; VanLandingham, Jacob W.; Stein, Donald G.			Progesterone improves acute recovery after traumatic brain injury in the aged rat	JOURNAL OF NEUROTRAUMA			English	Article						aging; frontal cortex; inflammation; progesterone; recovery; traumatic brain injury	INFLAMMATORY RESPONSE; CEREBRAL-ISCHEMIA; P-GLYCOPROTEIN; FEMALE RATS; ACTIVATION; REMYELINATION; CONTRIBUTES; HIPPOCAMPUS; DYSFUNCTION; MECHANISMS	Recent evidence has demonstrated that treatment with progesterone can attenuate many of the pathophysiological events following traumatic brain injury (TBI) in young adult rats, but this effect has not been investigated in aged animals. In this study, 20-month-old male Fischer 344 rats with bilateral contusions of the frontal cortex (n = 4 per group) or sham operations received 8, 16, or 32 mg/kg of progesterone or vehicle. Locomotor activity was measured at 72 h to assess behavioral recovery. Brain tissue was harvested at 24, 48, and 72 h, and Western blotting was performed for inflammatory and apoptotic factors. Edema was assessed at 48 h by measuring brain water content. Injured animals treated with 8 and 16 mg/kg progesterone showed decreased expression of COX-2, IL-6, and NF kappa B at all time points, indicating a reduction in the acute inflammatory process compared to vehicle. The 16 mg/kg group also showed reduced apoptosis at all time points as well as decreased edema and improved locomotor outcomes. Thus, in aged male rats, treatment with 16 mg/kg progesterone improves short-term motor recovery and attenuates edema, secondary inflammation, and cell death after TBI.	Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; Mt Union Coll, Dept Psychol, Alliance, OH USA; Florida State Univ, Dept Biomed Sci, Tallahassee, FL USA		Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	donald.stein@emory.edu	Stein, Donald/AAJ-5139-2020; Cekic, Milos/AAR-8250-2020		NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008169] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [1R01N540825, 1R01N538664] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008169] Funding Source: NIH RePORTER		Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Azcoitia I, 2003, NEUROBIOL AGING, V24, P853, DOI 10.1016/S0197-4580(02)00234-8; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Campbell SJ, 2007, NEUROPATH APPL NEURO, V33, P108, DOI 10.1111/j.1365-2990.2006.00773.x; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Chang LL, 1999, J CELL BIOCHEM, V73, P563; Dazert P, 2006, NEUROSCIENCE, V142, P1071, DOI 10.1016/j.neuroscience.2006.07.056; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Gangula PRR, 2002, BIOL REPROD, V67, P1881, DOI 10.1095/biolreprod.102.007682; Geula C, 2003, J COMP NEUROL, V455, P249, DOI 10.1002/cne.10475; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Godbout JP, 2004, J NEUROIMMUNOL, V147, P141, DOI 10.1016/j.jneuroim.2003.10.031; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; Ibanez C, 2003, PROG NEUROBIOL, V71, P49, DOI 10.1016/j.pneurobio.2003.09.002; Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006; Karssen AM, 2004, ANN NY ACAD SCI, V1032, P308, DOI 10.1196/annals.1314.048; Kovacs EJ, 2005, EXP GERONTOL, V40, P549, DOI 10.1016/j.exger.2005.04.009; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Laumer R, 1992, Fortschr Med, V110, P241; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; LIPSITZ LA, 2004, SCI AGING KNOWLEDGE, pPE16; Lowery D. W., 2002, J NEUROTRAUM, V19, P1286; Maher FO, 2005, NEUROBIOL AGING, V26, P717, DOI 10.1016/j.neurobiolaging.2004.07.002; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Meng QY, 2007, MECH AGEING DEV, V128, P286, DOI 10.1016/j.mad.2006.12.008; Mima T, 1999, NEUROL RES, V21, P209, DOI 10.1080/01616412.1999.11740920; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Niewiadomska G, 2002, NEUROBIOL AGING, V23, P601, DOI 10.1016/S0197-4580(01)00345-1; Raza M, 2007, NEUROSCI LETT, V418, P77, DOI 10.1016/j.neulet.2007.03.005; ROOF RL, 1997, J NEUROTRAUM, V14, P760; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Ruppel RA, 2002, NEUROSURG CLIN N AM, V13, P169, DOI 10.1016/S1042-3680(01)00005-5; Stamatovic SM, 2006, ACTA NEUROCHIR SUPPL, V96, P444; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Verma A, 2000, J HEAD TRAUMA REHAB, V15, P1149, DOI 10.1097/00001199-200010000-00008; Williams BJ, 2006, PSYCHOPHARMACOLOGY, V188, P605, DOI 10.1007/s00213-006-0477-1; Wissink S, 1998, MOL ENDOCRINOL, V12, P355, DOI 10.1210/me.12.3.355; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932	50	123	125	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2007	24	9					1475	1486		10.1089/neu.2007.0294			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	214ZT	WOS:000249777600006	17892409				2022-02-06	
J	Wijnen, VJM; van Boxtel, GJM; Eilander, HJ; de Gelder, B				Wijnen, V. J. M.; van Boxtel, G. J. M.; Eilander, H. J.; de Gelder, B.			Mismatch negativity predicts recovery from the vegetative state	CLINICAL NEUROPHYSIOLOGY			English	Article						mismatch negativity; vegetative state; minimally conscious state; consciousness	MINIMALLY CONSCIOUS STATE; EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN INJURY; EVOKED-POTENTIALS; MEDICAL ASPECTS; WORKING PARTY; COMA; MANAGEMENT; GUIDELINES; DISORDERS	Objective: Mismatch negativity (MMN) is an automatic event related brain response, well investigated in the acute phase after severe brain injury: the presence of a MMN is often found to predict the emergence from coma, and the exclusion of shifting into a vegetative state (VS). In the present study MMN was examined during recovery from VS. Methods: Ten vegetative patients were repeatedly examined every 2 weeks for an average period of 3.5 months. Amplitudes and latencies were related to the patients' recovery from VS to consciousness, and to a healthy norm group. In addition, MMN was examined on its prognostic value in VS patients, in predicting recovery to consciousness and long-term functional outcome. Results: With recovery to consciousness MMN-amplitudes increased. A sudden increase was seen in MMN amplitude when patients started to show inconsistent behavioural responses to simple commands. At this level MMN resembled the MMN response as was seen in the norm group. In addition, the MMN-amplitude and latency during the first measurement predicted the patients' outcome on recovery to consciousness. Conclusions: With recovery from VS to consciousness the ability to process auditory stimulus deviance increases. A sudden enhancement in MMN-amplitude preceded overt communication with the environment. This might be indicative of the consolidation of neural networks underlying overt communication. Moreover, MMN can be helpful in identifying the ability to recover from VS. Significance: MMN can be used to track recovery from the vegetative state in the post-acute phase after severe brain injury. In addition, MMN can be used to predict the ability to recover from the vegetative state. (c) 2006 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	Tilburg Univ, Dept Psychol & Hlth, Cognit & Affect Neurosci Lab, NL-5000 LE Tilburg, Netherlands; Rehabil Ctr Leijpark, Div Res, Project VLB NAH, NL-5022 KE Tilburg, Netherlands; Harvard Univ, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA		van Boxtel, GJM (corresponding author), Tilburg Univ, Dept Psychol & Hlth, Cognit & Affect Neurosci Lab, Warandelaan 2, NL-5000 LE Tilburg, Netherlands.	G.J.M.vBoxtel@uvt.nl	Wijnen, Viona/G-1328-2016; Wijnen, Viona/AAX-3041-2021	Wijnen, Viona/0000-0001-7797-1882; van Boxtel, Geert/0000-0002-9105-7963			Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; Ansell BJ, 1989, W NEURO SENSORY STIM, P24; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bates D, 2003, CLIN MED, V3, P249; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; EILANDER HJ, UNPUB RELIABILITY VA; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Jennett B, 2005, NEUROPSYCHOL REHABIL, V15, P163, DOI 10.1080/09602010443000632; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1996, NEUROTRAUMA, P3; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; Keselman HJ, 2001, BRIT J MATH STAT PSY, V54, P1, DOI 10.1348/000711001159357; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kotchoubey B, 2003, NEUROSCI LETT, V352, P129, DOI 10.1016/j.neulet.2003.08.045; Kotchoubey B, 2001, NEUROSCI LETT, V301, P37, DOI 10.1016/S0304-3940(01)01600-7; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Morlet D, 2000, AUDIOL NEURO-OTOL, V5, P198, DOI 10.1159/000013881; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schiff Nicholas D., 2002, Thalamus & Related Systems, V2, P55, DOI 10.1016/S1472-9288(02)00028-6; Schroger E, 1998, BEHAV RES METH INS C, V30, P131, DOI 10.3758/BF03209423; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	39	123	134	0	18	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457			CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2007	118	3					597	605		10.1016/j.clinph.2006.11.020			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144CJ	WOS:000244772600012	17239656	Green Published			2022-02-06	
J	Jackson, JC; Hart, RP; Gordon, SM; Hopkins, RO; Girard, TD; Ely, EW				Jackson, James C.; Hart, Robert P.; Gordon, Sharon M.; Hopkins, Ramona O.; Girard, Timothy D.; Ely, E. Wesley			Post-traumatic stress disorder and post-traumatic stress symptoms following critical illness in medical intensive care unit patients: assessing the magnitude of the problem	CRITICAL CARE			English	Article							QUALITY-OF-LIFE; RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN INJURY; CUMULATIVE ADVERSITY; SEPTIC SHOCK; SURVIVORS; HEALTH; MEMORY; ADULTS; PREVALENCE	Introduction Post-traumatic stress disorder (PTSD) is a potentially serious psychiatric disorder that has traditionally been associated with traumatic stressors such as participation in combat, violent assault, and survival of natural disasters. Recently, investigators have reported that the experience of critical illness can also lead to PTSD, although details of the association between critical illness and PTSD remain unclear. Methods We conducted keyword searches of MEDLINE and Psych Info and investigations of secondary references for all articles pertaining to PTSD in medical intensive care unit (ICU) survivors. Results From 78 screened papers, 16 studies (representing 15 cohorts) and approximately 920 medical ICU patients met inclusion criteria. A total of 10 investigations used brief PTSD screening tools exclusively as opposed to more comprehensive diagnostic methods. Reported PTSD prevalence rates varied from 5% to 63%, with the three highest prevalence estimates occurring in studies with fewer than 30 patients. Loss to follow-up rates ranged from 10% to 70%, with average loss to follow-up rates exceeding 30%. Conclusion Exact PTSD prevalence rates cannot be determined due to methodological limitations such as selection bias, loss to follow-up, and the wide use of screening (as opposed to diagnostic) instruments. In general, the high prevalence rates reported in the literature are likely to be overestimates due to the limitations of the investigations conducted to date. Although PTSD may be a serious problem in some survivors of critical illness, data on the whole population are inconclusive. Because the magnitude of the problem posed by PTSD in survivors of critical illness is unknown, there remains a pressing need for larger and more methodologically rigorous investigations of PTSD in ICU survivors.	VA Tennessee Valley GRECC, CRCOE, Nashville, TN 37212 USA; Vanderbilt Univ, Div Allergy Pulm Crit Care Med, Med Ctr T1218, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Hlth Serv Res, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; Virginia Commonwealth Univ, Med Ctr, Dept Psychiat, West Hosp, Richmond, VA 23298 USA; Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; LDS Hosp, Dept Med, Div Pulm & Crit Care, Salt Lake City, UT 84113 USA		Jackson, JC (corresponding author), VA Tennessee Valley GRECC, CRCOE, 1310 24th Ave S, Nashville, TN 37212 USA.	james.c.jackson@vanderbilt.edu	Girard, Timothy/I-3008-2019; Ely, E. Wesley/Z-2018-2019	Girard, Timothy/0000-0002-9833-4871; Ely, E. Wesley/0000-0003-3957-2172			Alonzo AA, 2000, SOC SCI MED, V50, P1475, DOI 10.1016/S0277-9536(99)00399-8; Averill PM, 2000, J ANXIETY DISORD, V14, P133, DOI 10.1016/S0887-6185(99)00045-6; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 2004, BEHAV RES THER, V42, P569, DOI 10.1016/S0005-7967(03)00162-1; BONTKE CF, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI DOI 10.1097/00001199-199602000-00011; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; Brewin CR, 2000, J TRAUMA STRESS, V13, P499, DOI 10.1023/A:1007741526169; Bruce M, 2006, CLIN PSYCHOL REV, V26, P233, DOI 10.1016/j.cpr.2005.10.002; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Capuzzo M, 2005, Minerva Anestesiol, V71, P167; Creamer M, 2005, J AFFECT DISORDERS, V86, P175, DOI 10.1016/j.jad.2005.01.015; Cuthbertson BH, 2004, INTENS CARE MED, V30, P450, DOI 10.1007/s00134-003-2004-8; DAVIDSON JRT, 1991, PSYCHOL MED, V21, P713, DOI 10.1017/S0033291700022352; Deja M, 2006, CRIT CARE, V10, DOI 10.1186/cc5070; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2701; Eddleston JM, 2000, CRIT CARE MED, V28, P2293, DOI 10.1097/00003246-200007000-00018; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; FOREMAN M, 2004, PRIMARY PSYCHIAT, V11, P46; Frans O, 2005, ACTA PSYCHIAT SCAND, V111, P291, DOI 10.1111/j.1600-0447.2004.00463.x; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Hopkins RO, 2005, CURR OPIN CRIT CARE, V11, P369, DOI 10.1097/01.ccx.0000166399.88635.a5; Jones C, 2003, CRIT CARE MED, V31, P2456, DOI 10.1097/01.CCM.0000089938.56725.33; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; Kangas M, 2002, CLIN PSYCHOL REV, V22, P499, DOI 10.1016/S0272-7358(01)00118-0; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kimerling R, 2000, J TRAUMA STRESS, V13, P115, DOI 10.1023/A:1007729116133; Kimerling R, 1999, AIDS EDUC PREV, V11, P321; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Lasiuk GC, 2006, PERSPECT PSYCHIATR C, V42, P72, DOI 10.1111/j.1744-6163.2006.00056.x; Lloyd DA, 2003, AM J ORTHOPSYCHIAT, V73, P381, DOI 10.1037/0002-9432.73.4.381; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; Miranda Jeanne, 1999, J Ment Health Policy Econ, V2, P73, DOI 10.1002/(SICI)1099-176X(199906)2:2<73::AID-MHP40>3.0.CO;2-3; Nelson BJ, 2000, CRIT CARE MED, V28, P3626, DOI 10.1097/00003246-200011000-00013; Nickel Marius, 2004, J Intensive Care Med, V19, P285, DOI 10.1177/0885066604267684; Parkin AJ, 1999, CURR BIOL, V9, pR582, DOI 10.1016/S0960-9822(99)80378-9; Rattray JE, 2005, ANAESTHESIA, V60, P1085, DOI 10.1111/j.1365-2044.2005.04336.x; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHACTER DL, 1993, ANNU REV NEUROSCI, V16, P159, DOI 10.1146/annurev.ne.16.030193.001111; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Schelling G, 2001, BIOL PSYCHIAT, V50, P978, DOI 10.1016/S0006-3223(01)01270-7; Schelling G, 1999, CRIT CARE MED, V27, P2678, DOI 10.1097/00003246-199912000-00012; Scragg P, 2001, ANAESTHESIA, V56, P9, DOI 10.1046/j.1365-2044.2001.01714.x; Seedat S, 2005, CNS DRUGS, V19, P411, DOI 10.2165/00023210-200519050-00004; Shaw RJ, 2001, PSYCHOSOMATICS, V42, P35, DOI 10.1176/appi.psy.42.1.35; Shemesh E, 2006, PSYCHOSOMATICS, V47, P231, DOI 10.1176/appi.psy.47.3.231; Smith MY, 1999, PSYCHO-ONCOLOGY, V8, P521, DOI 10.1002/(SICI)1099-1611(199911/12)8:6<521::AID-PON423>3.0.CO;2-X; Spindler H, 2005, PSYCHOSOM MED, V67, P715, DOI 10.1097/01.psy.0000174995.96183.9b; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Tedstone JE, 2003, CLIN PSYCHOL REV, V23, P409, DOI 10.1016/S0272-7358(03)00031-X; Tedstone JE, 1997, BURNS, V23, P550, DOI 10.1016/S0305-4179(97)00083-1; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; Weinert C, 2005, CURR OPIN CRIT CARE, V11, P376, DOI 10.1097/01.ccx.0000168529.23078.64	63	123	128	1	19	BIOMED CENTRAL LTD	LONDON	MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND	1466-609X			CRIT CARE	Crit. Care		2007	11	1							R27	10.1186/cc5707			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	185OT	WOS:000247721000027	17316451	gold, Green Published			2022-02-06	
J	Treggiari, MM; Schutz, N; Yanez, ND; Romand, JA				Treggiari, Miriam M.; Schutz, Nicolas; Yanez, N. David; Romand, Jacques-Andre			Role of intracranial pressure values and patterns in predicting outcome in traumatic brain injury: a systematic review	NEUROCRITICAL CARE			English	Article						neurotrauma; Glasgow outcome score; ICP; TBI; head injury; neuromonitoring	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; INTRA-CRANICAL PRESSURE; AGGRESSIVE TREATMENT; MANAGEMENT; HYPERTENSION; EXPERIENCE; MANNITOL; CARE; ICP	Introduction Raised intracranial pressure (ICP) has been consistently associated with poor neurological outcome. Our purpose was to systematically review the literature to estimate the association between ICP values and patterns and short- and long-term vital and neurological outcome. Methods Systematic review of studies identified from MEDLINE, EMBASE, and COCHRANE Registry search from 1966 to 2005, and reference lists of identified articles, with independent assessment of methodological quality, population, ICP values and patterns, management of raised ICP and neurological outcomes. Summary odds ratios (OR) were calculated for the main outcomes using proportional odds models and logistic regression. Results Four prospective studies (409 patients) reported the effect of ICP values, and five studies (677 patients) reported the effect of ICP patterns on neurological outcome. No study reported neurological outcomes beyond I year. Relative to normal ICP (< 20 mmHg), raised ICP was associated with elevated OR of death: 3.5 [95%CI: 1.7, 7.3] for ICP 20-40, and 6.9 [95%CI: 3.9, 12.4] for ICP > 40. Raised but reducible ICP was associated with a 3-4-fold increase in the OR of death or poor neurological outcome. Refractory ICP pattern was associated with a dramatic increase in the relative risk of death (OR 114.3 [95%CI: 40.5, 322.3]). Conclusions Refractory ICP and response to treatment of raised ICP could be better predictors of neurological outcome than absolute ICP values. Limitations in the design of the studies analyzed precluded identification of the role of ICP monitoring in predicting short- and long-term outcomes.	Univ Washington, Sch Med, Dept Anesthesiol, Harborview Med Ctr, Seattle, WA 98104 USA; Univ Hosp Geneva, Div Intens Care, Dept Anesthesiol Pharmacol & Intens Care, Geneva, Switzerland; Univ Washington, Dept Biostat, Seattle, WA 98104 USA		Treggiari, MM (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Harborview Med Ctr, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	treggmm@u.washington.edu					Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; [Anonymous], 2000, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000033; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Biestro A, 1998, ACT NEUR S, V71, P5; Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P513; BUXTON RL, 1970, LANCET, V2, P498; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; FOWLER S, 1999, J NEUROSCI N7URS, V31, P370; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KOBAYASHI S, 1983, INTRACRANIAL PRESSUR, V5; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Marmarou A, 2005, ACT NEUR S, V95, P277; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P479, DOI DOI 10.1089/NEU.2000.17.479; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521; TROUPP J, 1965, J TRAUMA, V29, P373; TSUTSUMI H, 1986, INTRACRANIAL PRESSUR, V6, P661	35	123	136	0	10	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2007	6	2					104	112		10.1007/s12028-007-0012-1			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	179DW	WOS:000247270700006	17522793				2022-02-06	
J	Stein, SC; Browne, KD; Chen, XH; Smith, DH; Graham, DI				Stein, Sherman C.; Browne, Kevin D.; Chen, Xiao-Han; Smith, Douglas H.; Graham, David I.			Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: An autopsy study	NEUROSURGERY			English	Article						cerebral ischemia; intracranial vasospasm; ruptured intracranial aneurysm; subarachnoid hemorrhage; thromboembolism	TRAUMATIC BRAIN-INJURY; DISSEMINATED INTRAVASCULAR COAGULATION; INTERCELLULAR-ADHESION MOLECULE-1; TISSUE FACTOR; SYMPTOMATIC VASOSPASM; BLOOD-COAGULATION; ATORVASTATIN REDUCTION; NEUROLOGICAL DEFICITS; CEREBROSPINAL-FLUID; RATS	OBJECTIVE: Recent findings have cast doubt on vasospasm as the sole cause of delayed cerebral ischemia after subarachnoid hemorrhage. METHODS: We reviewed the medical records of 29 patients who died after subarachnoid hemorrhage. Brain sections were taken from the insula, cingulate gyrus, and hippocampus. Adjacent sections were stained with, hematoxylin-eosin and immunostained for thromboemboli. The density (burden) of the latter was calculated blindly and correlated with evidence for ischemia and with the amount of subarachnoid blood. RESULTS: There is a strong correlation between microclot burden and delayed cerebral ischemia. Patients with clinical or radiological evidence of delayed ischemia had mean microclot burdens of 10.0/cm(2) (standard deviation [SD], +/- 6.6); those without had mean burdens of 2.8 (SD, +/- 2.6), a highly significant difference (P = 0.002). There is also significant association (P = 0.001) between microclot burden and histological evidence of ischemia, with the mean burdens being 10.9 in sections exhibiting severe ischemia and 4.1 in those in which ischemia was absent. Microclot burden is high in patients who died within 2 days of hemorrhage, decreasing on Days 3 and 4. In delayed ischemia, the numbers rise again late in the first week and remain high until after the second week. In contrast, the average clot burden is low in patients dying without developing delayed ischemia. The amount of blood on an individual slide influenced the microclot burden on that slide to a highly significant extent (P < 0.001). CONCLUSION: Thromboembolism after subarachnoid hemorrhage may contribute to delayed cerebral ischemia, which parallels that caused by vasospasm. The pathogenesis of thromboembolism is discussed.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Glasgow, Dept Neuropathol, Glasgow G12 8QQ, Lanark, Scotland		Stein, SC (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 310 Spruce St, Philadelphia, PA 19104 USA.	sherman.stein@uphs.upenn.edu	smith, douglas/A-1321-2007				ADAMS HP, 1992, NEUROL CLIN, V10, P251, DOI 10.1016/S0733-8619(18)30245-7; Amin-Hanjani S, 2004, NEUROSURGERY, V54, P326, DOI 10.1227/01.NEU.0000103488.94855.4F; Antovic J, 2002, SCAND J CLIN LAB INV, V62, P195, DOI 10.1080/003655102317475452; Asakura H, 2002, CRIT CARE MED, V30, P161, DOI 10.1097/00003246-200201000-00023; BERGVALL U, 1973, NEURORADIOLOGY, V5, P24, DOI 10.1007/BF02464626; Bouchard BA, 1997, ARTERIOSCL THROM VAS, V17, P1, DOI 10.1161/01.ATV.17.1.1; Chow M, 2002, NEUROSURGERY, V51, P1333, DOI 10.1227/01.NEU.0000035902.55640.38; CLOWER BR, 1988, CEREBRAL VASOSPASM, P334; CROMPTON MR, 1964, BRAIN, V87, P263, DOI 10.1093/brain/87.2.263; Day SM, 2005, BLOOD, V105, P192, DOI 10.1182/blood-2004-06-2225; Deans KJ, 2005, J TRAUMA, V58, P867, DOI 10.1097/01.TA.0000158244.69179.94; Denton IC, 1971, STROKE, V2, P268, DOI 10.1161/01.STR.2.3.268; Dhainaut JF, 2004, CRIT CARE MED, V32, pS194, DOI 10.1097/01.CCM.0000128035.64448.45; Doshi SN, 2002, CRIT CARE MED, V30, pS241, DOI 10.1097/00003246-200205001-00012; Dreier JP, 2002, ANN NEUROL, V52, P825, DOI 10.1002/ana.10383; Echlin FA, 1942, ARCH NEURO PSYCHIATR, V47, P77, DOI 10.1001/archneurpsyc.1942.02290010087007; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Eichstaedt E, 1993, CAN J NEUROL SCI S1, V20, pS6; FINDLAY JM, 1989, NEUROSURGERY, V25, P736, DOI 10.1227/00006123-198911000-00008; Fisher C M, 1977, Neurosurgery, V1, P245; Frijns CJM, 2002, NEUROSURGERY, V50, P1223, DOI 10.1097/00006123-200206000-00009; Fujii Y, 1997, J NEUROSURG, V86, P594, DOI 10.3171/jns.1997.86.4.0594; GERAUD G, 1984, STROKE, V15, P301, DOI 10.1161/01.STR.15.2.301; Giller CA, 1998, NEUROSURGERY, V42, P490, DOI 10.1097/00006123-199803000-00010; Griffiths PD, 2001, AM J NEURORADIOL, V22, P1690; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; Hertel F, 2005, NEUROSURGERY, V56, P28, DOI 10.1227/01.NEU.0000144866.28101.6D; Hirashima Y, 2005, NEUROL MED-CHIR, V45, P177, DOI 10.2176/nmc.45.177; Hoh BL, 2005, NEUROSURGERY, V57, P432, DOI 10.1093/neurosurgery/57.2.432b; Hop JW, 2000, NEUROLOGY, V54, P872, DOI 10.1212/WNL.54.4.872; Iba T, 2005, INTENS CARE MED, V31, P1101, DOI 10.1007/s00134-005-2707-0; Ilveskero S, 2005, NEUROSURGERY, V57, P16, DOI 10.1227/01.NEU.0000163085.48999.D6; Juvela S, 2005, J NEUROSURG, V102, P194, DOI 10.3171/jns.2005.102.2.0194; Juvela S, 2002, J NEUROSURG, V97, P1287, DOI 10.3171/jns.2002.97.6.1287; Kagstrom E, 1966, EXCERPTA MED INT C S, V110, P629; Kasuya H, 2002, STROKE, V33, P1011, DOI 10.1161/01.STR.0000014563.75483.22; Kaynar MY, 2004, J NEUROSURG, V101, P1030, DOI 10.3171/jns.2004.101.6.1030; Kinouchi H, 2004, NEUROL MED-CHIR, V44, P569, DOI 10.2176/nmc.44.569; Klotzsch C, 1998, AM J NEURORADIOL, V19, P1315; Kobayashi T, 2001, SEMIN THROMB HEMOST, V27, P161, DOI 10.1055/s-2001-14076; Kusanagi H, 2002, NEUROL SURG TOKYO, V30, P399; Lee WL, 2000, INTENS CARE MED, V26, P1701, DOI 10.1007/s001340051349; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; McGirt MJ, 2002, NEUROSURGERY, V51, P1128, DOI 10.1097/00006123-200211000-00005; Mchedlishvili G, 2004, CLIN HEMORHEOL MICRO, V31, P129; Mizukami M, 1980, CEREBRAL ARTERIAL SP, P97; Mocco J, 2002, J NEUROSURG, V97, P537, DOI 10.3171/jns.2002.97.3.0537; Naidech AM, 2005, ARCH NEUROL-CHICAGO, V62, P410, DOI 10.1001/archneur.62.3.410; NEILDWYER G, 1994, ACTA NEUROCHIR, V131, P137, DOI 10.1007/BF01401464; NICOLL JAR, 1992, J NEUROL SCI, V113, P144, DOI 10.1016/0022-510X(92)90242-D; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Nina P, 2001, SURG NEUROL, V55, P197, DOI 10.1016/S0090-3019(01)00402-5; Ohkuma H, 2000, STROKE, V31, P1621, DOI 10.1161/01.STR.31.7.1621; Orlandi G, 2005, ARCH NEUROL-CHICAGO, V62, P1208, DOI 10.1001/archneur.62.8.1208; Park KW, 2001, ANESTH ANALG, V92, P990; Parra A, 2002, NEUROL RES, V24, P510, DOI 10.1179/016164102101200276; Rabinstein AA, 2005, STROKE, V36, P992, DOI 10.1161/01.STR.0000163090.59350.5a; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Rabinstein AA, 2003, J NEUROSURG, V98, P319, DOI 10.3171/jns.2003.98.2.0319; Reilly C, 2004, J NEUROSURG, V101, P255, DOI 10.3171/jns.2004.101.2.0255; ROBERTSON EG, 1949, BRAIN, V72, P150, DOI 10.1093/brain/72.2.150; Romano JG, 2002, NEUROSURGERY, V50, P1026, DOI 10.1097/00006123-200205000-00016; SCHNECK SA, 1964, NEUROLOGY, V14, P691, DOI 10.1212/WNL.14.8_Part_1.691; Sehba FA, 2005, J NEUROSURG, V102, P1094, DOI 10.3171/jns.2005.102.6.1094; Shimoda M, 2001, NEUROSURGERY, V49, P1341, DOI 10.1097/00006123-200112000-00010; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; STOLTENBURGDIDI.G, 1987, STROKE MICROCIRCULAT, P471; Stroobandt G, 1998, ACTA NEUROCHIR, V140, P148, DOI 10.1007/s007010050076; SUZUKI S, 1990, Neurologia Medico-Chirurgica, V30, P309, DOI 10.2176/nmc.30.309; Thai QA, 1999, STROKE, V30, P140, DOI 10.1161/01.STR.30.1.140; Toh CH, 2003, BRIT MED J, V327, P974, DOI 10.1136/bmj.327.7421.974; Treggiari MM, 2003, J NEUROSURG, V98, P978, DOI 10.3171/jns.2003.98.5.0978; Tsurutani H, 2003, STROKE, V34, P1497, DOI 10.1161/01.STR.0000070424.38138.30; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Zhang Z, 2001, STROKE, V32, P1665, DOI 10.1161/01.STR.32.7.1665	80	123	129	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2006	59	4					781	787		10.1227/01.NEU.0000227519.27569.45			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	095FS	WOS:000241294200024	16915120				2022-02-06	
J	Wood, RLL; Rutterford, NA				Wood, Rodger L. L.; Rutterford, Neil A.			Demographic and cognitive predictors of long-term psychosocial outcome following traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						brain injuries; outcome studies; demographic factors; neuropsychological tests; injury severity; social adjustment	COMMUNITY INTEGRATION QUESTIONNAIRE; CLOSED-HEAD INJURY; QUALITY-OF-LIFE; HOSPITAL ANXIETY; DISABILITY; SATISFACTION; IMPAIRMENT; HANDICAP; MODERATE; RETURN	Demographic factors and cognitive impairment have been found previously to have associations with outcome after brain injury. Kendall and Terry (1996) suggest that preinjury psychosocial functioning, neurological factors, and cognitive impairment have a direct relationship with multidimensional psychosocial adjustment, but that cognitive impairment also has an indirect relationship by means of the mediation of appraisal and coping variables. The aim of this study was to explore these theoretical relationships at very late stages of recovery after brain injury. A total of 131 participants who were more than 10 years after injury (mean = 15.31 yr) completed a neuropsychological assessment, plus outcome measures that included employment status, community integration, life satisfaction, quality of life (QoL), and emotion. Results indicated that injury severity was predictive of life satisfaction; gender and relationship status predicted community integration; and age at injury predicted employment status. Impairment in working memory directly predicted all outcomes except QoL and anxiety. An indirect relationship was also evident between working memory, life satisfaction, and depression. Results partially support Kendall and Terry's model but the variables that significantly influence outcome seem to be determined by the outcome dimensions selected.	Univ Coll Swansea, Sch Human Sci, Dept Psychol, Swansea SA2 8PP, W Glam, Wales		Wood, RLL (corresponding author), Univ Coll Swansea, Sch Human Sci, Dept Psychol, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swansea.ac.uk					ADDELEY A, 1992, SPEED CAPACITY LANGU; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess P.W., 1997, HAYLING BRIXTON TEST; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dawson DR, 2000, BRAIN COGNITION, V44, P35; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hoofien D, 2001, BRAIN INJURY, V15, P189; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; MCAULEY E, 1992, PERS SOC PSYCHOL B, V18, P566, DOI 10.1177/0146167292185006; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MOOREY S, 1991, BRIT J PSYCHIAT, V158, P255, DOI 10.1192/bjp.158.2.255; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reitan R, 1985, HALSTEAD REITAN NEUR; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Schwarzer R., 1993, MEASUREMENT PERCEIVE; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, BRAIN INJURY REHABIL, P355; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; WOOD RL, IN PRESS J NEUROLOGY; WOOD RL, IN PRESS ARCH CLIN N; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	51	123	124	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2006	12	3					350	358		10.1017/S1355617706060498			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	046PP	WOS:000237823800005	16903127				2022-02-06	
J	Kochanek, PM; Vagni, VA; Janesko, KL; Washington, CB; Crumrine, PK; Garman, RH; Jenkins, LW; Clark, RSB; Homanics, GE; Dixon, CE; Schnermann, J; Jackson, EK				Kochanek, PM; Vagni, VA; Janesko, KL; Washington, CB; Crumrine, PK; Garman, RH; Jenkins, LW; Clark, RSB; Homanics, GE; Dixon, CE; Schnermann, J; Jackson, EK			Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						controlled cortical impact; head injury; head trauma; purine; seizures	CONTROLLED CORTICAL IMPACT; TRANSIENT FOCAL ISCHEMIA; FLUID PERCUSSION INJURY; TERM CAFFEINE TREATMENT; TEMPORAL-LOBE EPILEPSY; ADENOSINE RECEPTORS; CEREBRAL-ISCHEMIA; IN-VITRO; KINDLED SEIZURES; MESSENGER-RNA	Adenosine, acting at A1 receptors, exhibits anticonvulsant effects in experimental epilepsy - and inhibits progression to status epilepticus ( SE). Seizures after traumatic brain injury (TBI) may contribute to pathophysiology. Thus, we hypothesized that endogenous adenosine, acting via A1 receptors, mediates antiepileptic benefit after experimental TBI. We subjected A1-receptor knockout (ko) mice, heterozygotes, and wild-type (wt) littermates (n = 115) to controlled cortical impact (CCI). We used four outcome protocols in male mice: ( 1) observation for seizures, SE, and mortality in the initial 2 h, ( 2) assessment of seizure score ( electroencephalogram ( EEG)) in the initial 2 h, ( 3) assessment of mortality at 24 h across injury levels, and ( 4) serial assessment of arterial blood pressure, heart rate, blood gases, and hematocrit. Lastly, to assess the influence of gender on this observation, we observed female mice for seizures, SE, and mortality in the initial 2 h. Seizure activity was noted in 83% of male ko mice in the initial 2 h, but was seen in no heterozygotes and only 33% of wt (P<0.05). Seizures in wt were brief (1 to 2 secs). In contrast, SE involving lethal sustained ( 41 h) tonic clonic activity was uniquely seen in ko mice after CCI ( 50% incidence in males), (P<0.05). Seizure score was twofold higher in ko mice after CCI versus either heterozygote or wt (P<0.05). An injury-intensity dose - response for 24 h mortality was seen in ko mice (P<0.05). Physiologic parameters were similar between genotypes. Seizures were seen in 100% of female ko mice after CCI versus 14% of heterozygotes and 25% wt (P<0.05) and SE was restricted to the ko mice ( 83% incidence). Our data suggest a critical endogenous anticonvulsant action of adenosine at A1 receptors early after experimental TBI.	Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; Childrens Hosp Pittsburgh, Div Child Neurol, Pittsburgh, PA 15213 USA; Consultants Vet Pathol Inc, Murrysville, PA USA; Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; NIDDK, NIH, Bethesda, MD USA; Univ Pittsburgh, Sch Med, Ctr Clin Pharmacol, Pittsburgh, PA USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Homanics, Gregg/0000-0003-3641-8153; Jackson, Edwin/0000-0002-8101-6009	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK068575, Z01DK043413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318, P01NS030318, R01NS038087] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK068575] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38087, NS30318] Funding Source: Medline		Avsar E, 2004, NEUROPHARMACOLOGY, V47, P427, DOI 10.1016/j.neuropharm.2004.04.015; BARRACO RA, 1984, NEUROSCI LETT, V46, P317, DOI 10.1016/0304-3940(84)90118-6; Bassin S, 2002, CRIT CARE, V6, P137, DOI 10.1186/cc1472; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chesi AJR, 1997, EXP BRAIN RES, V113, P303, DOI 10.1007/BF02450328; Clark RSB, 1997, NEUROSURGERY, V41, P1284, DOI 10.1097/00006123-199712000-00010; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRAGUNOW M, 1985, EPILEPSIA, V26, P480, DOI 10.1111/j.1528-1157.1985.tb05684.x; Dzhala V, 2000, ANN NEUROL, V48, P632, DOI 10.1002/1531-8249(200010)48:4<632::AID-ANA10>3.3.CO;2-V; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FRANKLIN PH, 1989, J PHARMACOL EXP THER, V251, P1229; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; George FR, 1993, EXP CLIN PSYCHOPHARM, V1, P7, DOI 10.1037/1064-1297.1.1-4.7; Glass M, 1996, BRAIN RES, V710, P56, DOI 10.1016/0006-8993(95)01313-X; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gouder N, 2003, EPILEPSIA, V44, P877, DOI 10.1046/j.1528-1157.2003.03603.x; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Harrison PK, 2003, EUR J PHARMACOL, V471, P97, DOI 10.1016/S0014-2999(03)01783-7; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Higashi H, 2002, J NEUROSURG, V96, P117, DOI 10.3171/jns.2002.96.1.0117; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Jiang N, 1997, EUR J PHARMACOL, V320, P131, DOI 10.1016/S0014-2999(96)00905-3; JOHANSSON B, 1993, N-S ARCH PHARMACOL, V347, P407, DOI 10.1007/BF00165391; Johansson B, 1997, BRAIN RES, V762, P153, DOI 10.1016/S0006-8993(97)00378-8; Knutsen Lars J. S., 1997, P423; KOCHANEK PM, 2005, IN PRESS J CEREB BLO; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MURRAY TF, 1985, NEUROPHARMACOLOGY, V24, P761, DOI 10.1016/0028-3908(85)90010-3; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; OHIGASHI T, 1993, AM J PHYSIOL, V265, pC934, DOI 10.1152/ajpcell.1993.265.4.C934; Olsson T, 2004, EUR J NEUROSCI, V20, P1197, DOI 10.1111/j.1460-9568.2004.03564.x; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Phillis JW, 2001, NEUROL RES, V23, P183, DOI 10.1179/016164101101198316; Pourgholami MH, 1997, BRAIN RES, V775, P37, DOI 10.1016/S0006-8993(97)00769-5; Pourgholami MH, 1997, BRAIN RES, V751, P259, DOI 10.1016/S0006-8993(96)01406-0; Robertson C, 2001, CRIT CARE MED, V29, pA190; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sachse KT, 2004, J NEUROTRAUM, V21, P1326; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sheng H, 2000, EXP NEUROL, V163, P392, DOI 10.1006/exnr.2000.7363; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Southam E, 2002, PHARMACOL BIOCHEM BE, V74, P111, DOI 10.1016/S0091-3057(02)00956-5; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Takigawa T, 2002, J PHYSIOL-LONDON, V539, P67, DOI 10.1113/jphysiol.2001.012883; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Von Lubitz DKJE, 1999, EUR J PHARMACOL, V371, P83, DOI 10.1016/S0014-2999(99)00135-1; VONLUBITZ DKJE, 1994, EUR J PHARMACOL, V253, P95, DOI 10.1016/0014-2999(94)90762-5; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160, DOI 10.1002/jlb.67.2.160; YOUNG D, 1994, NEUROSCIENCE, V58, P245, DOI 10.1016/0306-4522(94)90032-9; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	66	123	128	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	APR	2006	26	4					565	575		10.1038/sj.jcbfm.9600218			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	026LM	WOS:000236340400012	16121125	Bronze			2022-02-06	
J	Robertson, CL; Puskar, A; Hoffman, GE; Murphy, AZ; Saraswati, M; Fiskum, G				Robertson, CL; Puskar, A; Hoffman, GE; Murphy, AZ; Saraswati, M; Fiskum, G			Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats	EXPERIMENTAL NEUROLOGY			English	Article						brain mitochondria; progesterone; neuroprotection; apoptosis; hippocampus	CONTROLLED CORTICAL IMPACT; CEREBRAL-ARTERY OCCLUSION; OVARIECTOMIZED RATS; LIPID-PEROXIDATION; COGNITIVE RECOVERY; GENDER-DIFFERENCES; BINDING-PROTEIN; NEURONAL LOSS; SPINAL-CORD; CNS TRAUMA	Growing literature suggests important sex-based differences in Outcome following traumatic brain injury (TBI) in animals and humans. Progesterone has emerged as a key hormone involved in many potential neuroprotective pathways after acute brain injury and may be responsible for some of these differences. Many studies have utilized supraphysiologic levels of post-traumatic progesterone to reverse pathologic processes after TBI, but few Studies have focused on the role of endogenous physiologic levels of progesterone in neuroprotection. We hypothesized that progesterone at physiologic serum levels Would be neuroprotective in female rats after TBI and that progesterone would reverse early mitochondrial dysfunction seen in this model. Female, Sprague-Dawley rats were ovariectomized and implanted with silastic capsules containing either low or high physiologic range progesterone at 7 days prior to TBI. Control rats received ovariectomy with implants containing no hormone. Rats underwent controlled cortical impact to the left parietotemporal cortex and were evaluated for evidence of early mitochondrial dysfunction (1 h) and delayed hippocampal neuronal injury and cortical tissue loss (7 clays) after injury. Progesterone in the low physiologic range reversed the early postinjury alterations seen in mitochondrial respiration and reduced hippocampal neuronal loss in both the CA1 and CA3 subfields. Progesterone in the high physiologic range had a more limited pattern of hippocampal neuronal preservation in the CA3 region only. Neither progesterone dose significantly reduced cortical tissue loss. These findings have implications in understanding the sex-based differences in Outcome following acute brain injury. (c) 2005 Elsevier Inc. All rights reserved.	Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA		Robertson, CL (corresponding author), Univ Maryland, Sch Med, Dept Pediat, 22 S Greene St,N5E13, Baltimore, MD 21201 USA.	croberts@peds.umaryland.edu	Hoffman, Gloria E/AAU-3760-2021		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08 NS42805] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS042805] Funding Source: NIH RePORTER		Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Biggio G, 2001, INT REV NEUROBIOL, V46, P207; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Conti AC, 1998, J NEUROSCI, V18, P5663; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Follesa P, 2004, EUR J PHARMACOL, V500, P413, DOI 10.1016/j.ejphar.2004.07.041; GEORGE MS, 1994, BIOL PSYCHIAT, V35, P775, DOI 10.1016/0006-3223(94)91139-8; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hoffman GE, 2003, EXP NEUROL, V182, P124, DOI 10.1016/S0014-4886(03)00104-3; Hoffman GE, 2001, EXP NEUROL, V171, P272, DOI 10.1006/exnr.2001.7783; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Le WW, 1997, BRAIN RES, V778, P272, DOI 10.1016/S0006-8993(97)00971-2; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; SMITH SS, 1987, BRAIN RES, V400, P353, DOI 10.1016/0006-8993(87)90634-2; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; VERECZKI V, IN PRESS J CEREB BLO; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yu R, 1996, MOL BRAIN RES, V41, P163	55	123	130	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2006	197	1					235	243		10.1016/j.expneurol.2005.09.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	001LI	WOS:000234534200024	16259981				2022-02-06	
J	Haas, S; Weidner, N; Winkler, J				Haas, S; Weidner, N; Winkler, J			Adult stem cell therapy in stroke	CURRENT OPINION IN NEUROLOGY			English	Article						cerebral ischemia; hematopoietic stem cell; neurogenesis; transdifferentiation	MARROW STROMAL CELLS; FIBROBLAST GROWTH FACTOR-2; COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; BONE-MARROW; IN-VIVO; NEUROTROPHIC FACTOR; NEURAL PROGENITORS; DENTATE GYRUS	Purpose of review: Acute cerebral infarction causes irreversible locally restricted loss of the neuronal circuitry and supporting glial cells with consecutive functional deficits and disabilities. The currently available and effective therapy targets fast vessel recanalization accompanied by symptomatic measures. Research activities focusing on stem cells, which represent a promising source for organotypic cell replacement and functional recovery after stroke, have gained momentum in recent years, making regenerative cell-based therapies a much more feasible realistic approach. This review provides an update about preclinical and clinical cell-based studies in stroke focusing on stem cells derived from the adult central nervous and hematopoetic systems. Recent findings: Endogenous neural stem cells, which have been shown to reside throughout life in the central nervous system, have the capacity to replace lost neurons in models for numerous disorders, including cerebral ischemia. Considering adult neural stem cell transplantation as a regenerative strategy after stroke, progress has been made in isolating human adult neural stem cells and demonstrating the feasibility of autologous neural stem cell transplantation. An increasing number of studies provide evidence that hematopoietic stem cells, either after stimulation of endogenous stem cell pools or after exogenous hematopoietic stem cell application (transplantation), improve functional outcome after ischemic brain lesions. Various underlying mechanisms such as transdifferentiation into neural lineages, neuroprotection through trophic support, and cell fusion have been deciphered. Summary: Many preclinical studies employing adult stem cell-based strategies hold great promise. For endogenous approaches the correlate of cell replacement underlying functional improvement needs to be demonstrated. Transplantation approaches on the experimental level need further development before clinical application can be considered.	Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany		Winkler, J (corresponding author), Univ Regensburg, Dept Neurol, Univ Str 84, D-93053 Regensburg, Germany.	juergen.winkler@klinik.uni-regensburg.de					AIHARA N, 1994, BRAIN RES BULL, V33, P483, DOI 10.1016/0361-9230(94)90072-8; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; AOKI H, 1993, NEUROSCIENCE, V56, P345, DOI 10.1016/0306-4522(93)90336-E; Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FARBER SD, 1988, PROG BRAIN RES, V78, P103; Gustafsson E, 2003, EUR J NEUROSCI, V17, P2667, DOI 10.1046/j.1460-9568.2003.02713.x; HIRSCH MC, 2004, INTERBRAIN TOPOGRAPH; ICKENSTEIN G, 2004, 56 ANN M AM AC NEUR; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kempermann G, 2000, Prog Brain Res, V127, P35; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Larsson E, 2002, EXP NEUROL, V177, P1, DOI 10.1006/exnr.2002.7992; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mattsson B, 1997, STROKE, V28, P1225, DOI 10.1161/01.STR.28.6.1225; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; PFEIFER K, 2003, 33 ANN M SOC NEUR 8; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rice CM, 2004, LANCET, V364, P193, DOI 10.1016/S0140-6736(04)16633-6; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang Q, 2003, DEFENCE SCI J, V53, P259, DOI 10.14429/dsj.53.2274; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	56	123	150	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	FEB	2005	18	1					59	64		10.1097/00019052-200502000-00012			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	901PR	WOS:000227294900011	15655404				2022-02-06	
J	Zemper, ED				Zemper, ED			Two-year prospective study of relative risk of a second cerebral concussion	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain concussion; traumatic brain injury; relative risk; athletic injuries; football	TRAUMATIC BRAIN-INJURY; MANAGEMENT; SPORT	Objective: To prospectively measure the relative risk of cerebral concussion among those with a history of concussion compared with those having no previous concussions by using a population of high school and college football players. Design: A representative national sample of high school and college football players was followed for two football seasons over a 2-yr period (1997-1998) as part of a national football injury surveillance project. There were a total of 15,304 player-seasons and over 1 million athlete-exposures to the possibility of injury in practices and games; 975 of the player-seasons (6.4%) had a history of concussion in the previous 5 yr. Results: There were 572 concussions recorded, 161 among those with a history (16.5%) and 411 among those with no history (2.9%). Relative risk for individuals with a history of concussion is 5.8 times greater than for individuals with no history (95% confidence interval, 4.8-6.8). Conclusion: This large prospective cohort study indicates the risk of sustaining a cerebral concussion is nearly six times greater for individuals with a history of concussion than for individuals with no such history.	Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; Exercise Res Associates, Ann Arbor, MI USA		Zemper, ED (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 1500 E Med Ctr Dr,D4100 MPB, Ann Arbor, MI 48109 USA.						ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ruchinskas R A, 1997, Appl Neuropsychol, V4, P43, DOI 10.1207/s15324826an0401_5; SALCIDO R, 1992, Brain Injury, V6, P293, DOI 10.3109/02699059209029671; THOMPSON N, 1987, AM J SPORT MED, V15, P117, DOI 10.1177/036354658701500204; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; ZEMPER ED, 1994, AM SOC TEST MATER, V1229, P116, DOI 10.1520/STP12808S; ZEMPER ED, 1989, PHYSICIAN SPORTSMED, V17, P100, DOI 10.1080/00913847.1989.11709915; ZEMPER ED, 1990, SPORTS TRAIN MED REH, V1, P287; ZEMPER ED, 1993, PRIMARY CARE SPORTS, P63; ZEMPER ED, 1996, SAFETY AM FOOTBALL; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	24	123	127	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP	2003	82	9					653	659		10.1097/01.PHM.0000083666.74494.BA			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	714LT	WOS:000184916300001	12960905				2022-02-06	
J	Meyers, JE; Volbrecht, ME				Meyers, JE; Volbrecht, ME			A validation of multiple malingering detection methods in a large clinical sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neuropsychology; malingering; token test; finger tapping; Forced Choice Test; rey complex figure; dichotic listening; reliable digits; sentence repetition; rey auditory verbal learning test; judgment of line orientation	CLOSED-HEAD-INJURY; MEMORY; PERFORMANCE; BATTERY; SCALES; FAKING; TESTS	The purpose of this study is to further previous research that has shown that common neuropsychological tests can do "double duty" as test of motivation/malingering. Using a large clinical sample of 796 participants, it was found that the nine neuropsychological tests (when used together) were able to correctly identify litigant and nonlitigating groups. Failure on any two of the malingering tests suggested motivational/malingering issues. The groups consisted of mild, moderate, and severe traumatic brain-injured patients; chronic pain, depressed, community controls, and "malingering actors." Institutionalized and noninstitutionalized patient performance were also examined. This method showed 83% sensitivity and 100% specificity. A 0% false positive rate was found, suggesting good reliability especially in litigating settings. A group of patients for whom this method of motivational assessment might not be appropriate was also identified. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd. All rights reserved.	Mercy Rehabil Clin, Sioux City, IA 51101 USA; Sioux Valley Hosp, Sioux Falls, SD USA		Meyers, JE (corresponding author), Mercy Rehabil Clin, 500 Jackson St,Ste 360, Sioux City, IA 51101 USA.	jmeyers@mstar2.net					*AUD ST LOUIS, 1991, DICH WORD LIST TEST; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1992, ARCH CLIN NEUROPSYCH, V7, P155, DOI 10.1016/0887-6177(92)90009-C; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BRANDT J, 1985, ANN NY ACAD SCI, V444, P502, DOI 10.1111/j.1749-6632.1985.tb37625.x; DAMASIO H, 1979, NEUROLOGY, V29, P644, DOI 10.1212/WNL.29.5.644; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kozel JJ, 1998, ARCH CLIN NEUROPSYCH, V13, P327, DOI 10.1016/S0887-6177(97)00036-X; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Meyer-Abich KM, 2000, FORSCH KOMP KLAS NAT, V7, P154, DOI 10.1159/000021332; Meyers J., 1995, REY COMPLEX FIGURE R; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/09084280152829084; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Meyers J E, 1996, Appl Neuropsychol, V3, P89, DOI 10.1207/s15324826an0302_8; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P79, DOI 10.1016/S0887-6177(00)00105-0; MEYERS JE, 1988, APPL NEUROPSYCHOLOGY, V5, P120; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; OBERG RGE, 1985, NEUROBEHAVIOURAL MET, P130; Pilgrim B M, 1999, Appl Neuropsychol, V6, P243, DOI 10.1207/s15324826an0604_7; REITAN R, 1985, HALSTREADREITAN NEUR; RISSE GL, 1989, ARCH NEUROL-CHICAGO, V46, P437, DOI 10.1001/archneur.1989.00520400097026; Roberts M A, 1994, Appl Neuropsychol, V1, P45, DOI 10.1207/s15324826an0101&2_9; RUSSELL ML, 1993, 21 ANN M INT NEUR SO; SHIMOYAMA I, 1990, ARCH NEUROL-CHICAGO, V47, P681, DOI 10.1001/archneur.1990.00530060095025; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler D., 1997, MANUAL WECHSLER ADUL; [No title captured]	44	123	125	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2003	18	3					261	276	PII S0887-6177(02)00136-1	10.1016/S0887-6177(02)00136-1			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	666FJ	WOS:000182166200003	14591459	Bronze			2022-02-06	
J	Temkin, NR				Temkin, NR			Risk factors for posttraumatic seizures in adults	EPILEPSIA			English	Article						head injury; epilepsy; risk factors; posttraumatic seizures	EPILEPSY; PREVENTION	Purpose: Traumatic brain injury has long been known to be a cause of epilepsy. Most information on risk factors for developing posttraumatic seizures is from before computed tomography (CT) scanning became universal. This article looks at factors about the injury or individual that put people at especially high risk of developing posttraumatic seizures. Methods: We considered 783 cases at high risk of developing seizures, followed up for 2 years as part of seizure prophylaxis studies. Cumulative incidence of seizures in subgroups and standardized incidence ratios were used to identify factors related to unprovoked seizure risk. Results: Subgroups with significantly elevated risk include those with evacuation of a subdural hematoma; surgery for an intracerebral hematoma; Glasgow Coma Scale in the severe range of 3 to 8; early seizures, especially delayed early seizures; time to following commands of a week or more; depressed skull fracture that was not surgically elevated; dural penetration by injury; at least one nonreactive pupil; and parietal lesions on CT scan. Conclusions: Both the risk factors and the time course of the risk are important for designing seizure-prophylaxis studies and, if an effective prophylactic regimen is identified, for deciding on appropriate candidates for prophylaxis.	Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA		Temkin, NR (corresponding author), Univ Washington, Dept Neurol Surg, 710 9th Ave,Room 306, Seattle, WA 98104 USA.						Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; JENNETT B, 1975, EPILEPSY NONMISSILE; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006	8	123	134	0	4	BLACKWELL PUBLISHING INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0013-9580			EPILEPSIA	Epilepsia		2003	44			10			18	20		10.1046/j.1528-1157.44.s10.6.x			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	733YK	WOS:000186028100004	14511390				2022-02-06	
J	de Kruijk, JR; Leffers, P; Manheere, PPCA; Meerhoff, S; Rutten, J; Twijnstra, A				de Kruijk, JR; Leffers, P; Manheere, PPCA; Meerhoff, S; Rutten, J; Twijnstra, A			Prediction of post-traumatic complaints after mild traumatic brain injury: early symptoms and biochemical markers	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; MYELIN BASIC-PROTEIN; COMPUTED-TOMOGRAPHY; FOLLOW-UP; POSTTRAUMATIC HEADACHE; NERVOUS-SYSTEM; S-100 PROTEIN; SERUM; DAMAGE	Objectives: To identify parameters at first presentation after mild traumatic brain injury (MTBI) that are predictive of the severity of post-traumatic complaints (PTC) after six months. Early recognition of patients with MTBI who are at risk of developing PTC would be useful because early follow up at the outpatient clinic may help to reduce the severity of these complaints in the long run. Methods: The presence of symptoms in the emergency room (ER) (headache, dizziness, nausea, vomiting, and neck pain) and biochemical markers (neurone specific enolase and S-100B) in serum were assessed as possible predictive variables for the severity of PTC. Outcome variables were the severity of 16 PTC six months after the trauma. Result: After six months, the severity of most complaints had declined to pretrauma levels but medians for headache, dizziness, and drowsiness were still increased. In a series of 79 patients, 22 (28%) reported one or more PTC after six months. After adjustment for baseline variables, an at least twofold increased severity of all PTC subgroups was reported by those patients reporting headache, dizziness, or nausea in the ER. A twofold increased severity of "cognitive" and "vegetative" PTC was also found in those with increased concentrations of biochemical serum markers at first presentation. The prevalence of full recovery after six months increased from 50% in patients with three symptoms to 78% in those with no symptoms in the ER. Inclusion of biochemical markers showed that all 10 patients with no symptoms in the ER and normal markers recovered fully. Conclusions: The presence of headache dizziness, or nausea in the ER after MTBI is strongly associated with the severity of most PTC after six months. Identifying MTBI patients in the ER without headache, dizziness, nausea, or increased serum marker concentrations may be a promising strategy for predicting a good outcome.	Univ Hosp Maastricht, Dept Neurol, NL-6229 HX Maastricht, Netherlands; Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Clin Chem, Maastricht, Netherlands; Maastricht Univ, Sch Med, Maastricht, Netherlands		de Kruijk, JR (corresponding author), Univ Hosp Maastricht, Dept Neurol, P Debeylaan 25, NL-6229 HX Maastricht, Netherlands.		Rutten, Joost/L-4618-2015; Leffers, Pieter/B-8642-2009	Rutten, Joost/0000-0002-5259-9794; 			Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BOHNEN NJ, 1995, J NEUROL REHABIL, V9, P33; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Hanlon RE, 1999, BRAIN INJURY, V13, P873; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; KATO K, 1982, BRAIN RES, V237, P441, DOI 10.1016/0006-8993(82)90455-3; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kraus J, 1996, NEUROTRAUMA, P13; LAMERS KJB, 1995, ACTA NEUROL SCAND, V92, P247; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MEERHOFF S, 2000, NED TIJDSCHR GENEES, V144, P915; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Nee PA, 1999, J NEUROL NEUROSUR PS, V66, P470, DOI 10.1136/jnnp.66.4.470; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; PACKARD RC, 1994, J NEUROPSYCH CLIN N, V6, P229; Paniak C, 2000, BRAIN INJURY, V14, P219; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Ruff RM, 1999, BRAIN INJURY, V13, P943; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P7, DOI 10.2176/nmc.33.7; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	46	123	124	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	DEC	2002	73	6					727	732		10.1136/jnnp.73.6.727			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	622DM	WOS:000179631300024	12438478	Bronze, Green Published			2022-02-06	
J	McGarry, LJ; Thompson, D; Millham, FH; Cowell, L; Snyder, PJ; Lenderking, WR; Weinstein, MC				McGarry, LJ; Thompson, D; Millham, FH; Cowell, L; Snyder, PJ; Lenderking, WR; Weinstein, MC			Outcomes and costs of acute treatment of traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						brain injury; outcomes assessment; cost of illness; abbreviated injury scale; retrospective studies	HEAD-INJURY; SEVERITY; STAY; EPIDEMIOLOGY; CHARGES; LENGTH; TRENDS	Background. Although there are nearly a quarter of a million hospitalizations for traumatic brain injury (TBI) in the United States each year, data on the outcomes and costs of TBI treatment in the acute-care setting are limited. Methods. Using a large, geographically diverse, multihospital database, we examined inpatient records for persons aged 16 years or older who were hospitalized for TBI between January 1, 1997, and June 30, 1999. Patients were stratified by TBI severity using an adaptation of the Abbreviated Injury Scale for administrative data (ICD/AIS), as follows: 2 = "moderate"; 3 = "serious"; 4 = "severe"; and 5 = "critical." Patient characteristics, pat-terns of treatment, and outcomes and costs were examined by injury severity and mechanism of injury. Results. Of 8,717 study subjects identified, 12.5% had moderate, 44.8% had serious, 29.6% had severe, and 13.2% had critical TBI. Falls were the most common reported cause of injury (40.8%), followed by motor vehicle crashes (39.3%), blows to the head (11.3%), and gunshot wounds (2.4%). Average length of stay in hospital ranged from 6.7 days for moderate TBI to 17.5 days for critical TBI. The overall rate of death in hospital was relatively low among patients with moderate (1.3%), serious (5.7%), and severe (8.7%) TBIs, but much higher among the most critically injured patients (52.0%). Costs of hospitalization averaged $8,189 for moderate, $14,603 for serious, $16,788 for severe, and $33,537 for critical TBI. Costs also varied by injury type, averaging $20,084 for gunshot wounds, $20,522 for motor vehicle crashes, $15,860 for falls, and $19,949 for blows to the head. Conclusion. The economic burden of TBI in the acute-care setting is substantial; treatment outcomes and costs vary considerably by TBI severity and mechanism of injury.	Innovus Res Inc, Medford, MA 02155 USA; Boston Univ, Med Ctr, Boston, MA USA; Ctr Neurol Recovery, Newton, MA USA; Univ Connecticut, Storrs, CT USA; Pfizer Global Res & Dev, Groton, CT USA; Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA		Thompson, D (corresponding author), Innovus Res Inc, 10 Cabot Rd,Suite 102, Medford, MA 02155 USA.	dthompson@innovus.com		Snyder, Peter/0000-0003-0555-4654			*ASS ADV AUT MED, 1990, ABBR INJ SCAL REV ED; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; FIFE D, 1984, J NEUROSURG, V60, P697, DOI 10.3171/jns.1984.60.4.0697; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; *MMWR, 1997, MMWR-MORBID MORTAL W, V46, P8; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954	19	123	125	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2002	53	6					1152	1159		10.1097/00005373-200212000-00020			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	625NT	WOS:000179823100026	12478043				2022-02-06	
J	Finset, A; Andersson, S				Finset, A; Andersson, S			Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion location	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; POSTSTROKE DEPRESSION; MAJOR DEPRESSION; SYMPTOMS; RELIABILITY; ACTIVATION; TOMOGRAPHY; PREVALENCE; DISTRESS; VALIDITY	Coping strategies in individuals suffering severe traumatic brain injury (TBI), cerebrovascular accidents (CVA), or hypoxic brain injury (HBI) were investigated in relation to apathy, depression, and lesion location. Seventy patients (27 with TBI, 30 with CVA, and 13 with HBI) filled in a coping questionnaire (COPE) and were evaluated with respect to apathy and depression. A comparison sample of 71 students also filled in COPE. Patients coping strategies were similar to the comparison group, but patients tended to display less differentiated coping styles. A factor analysis indicated two dimensions of coping in the patient sample; approach oriented and avoidance oriented coping. Approach and avoidance coping sum scores, based on subscales from the two factors, were positively correlated in the patient sample, but not in the comparison group. Lack of active approach oriented coping was associated with apathy, whereas avoidant coping was associated with depression. Coping styles were not related to lesion location. Apathy was related to subcortical and right hemisphere lesions. In bivariate analyses, depression was unrelated to lesion location, but, in a MANCOVA, avoidant coping, apathy and lesion location (left hemisphere lesions) contributed to the variance in positive depressive symptoms. The consistent relationships between coping strategies and neuropsychiatric symptoms were interpreted as two dimensions of adaptational behaviour: an active vs. passive dimension and a depression-distress-avoidance dimension.	Univ Oslo, Dept Behav Sci Med, N-0317 Oslo, Norway; Sunnaas Rehabil Hosp, Neuropsychol Lab, Nesoddtangen, Norway		Finset, A (corresponding author), Univ Oslo, Dept Behav Sci Med, POB 1111 Blindern, N-0317 Oslo, Norway.						American Psychiatric Association, 1994, DIAGN CRIT DSM 4; ANDERSSON S, 1999, PSYCHOL MED; ASTROM M, 1993, STROKE, V24, P976, DOI 10.1161/01.STR.24.7.976; Beauregard M, 1998, NEUROREPORT, V9, P3253, DOI 10.1097/00001756-199810050-00022; BENCH CJ, 1993, PSYCHOL MED, V23, P579, DOI 10.1017/S0033291700025368; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; Bruder GE, 1998, PSYCHOPHYSIOLOGY, V35, P54, DOI 10.1111/1469-8986.3510054; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; DANTZER R, 1993, PSYCHOSOMATIC DELUSI; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844; FEIFEL H, 1989, PSYCHOL AGING, V4, P26, DOI 10.1037/0882-7974.4.1.26; FINSET A, 1988, CEREBRAL HEMISPHERE, P49; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; Folkman S., 1988, MANUAL WAYS COPING Q; FRANKENHAEUSER M, 1980, COPING HLTH, P203; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Henry JP, 1977, STRESS HLTH SOCIAL E; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; Hosking SG, 1996, NEUROPSYCHOL REV, V6, P107, DOI 10.1007/BF01874894; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; LAPLANE D, 1990, REV NEUROL, V146, P397; LAPLANE D, 1989, BRAIN, V112, P699, DOI 10.1093/brain/112.3.699; Macdonald EM, 1998, BRIT J PSYCHIAT, V172, P122, DOI 10.1192/S0007125000297778; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Mann R. S., 1996, REV PSYCHIAT, V15, P205; MARIN RS, 1993, J AFFECT DISORDERS, V28, P117, DOI 10.1016/0165-0327(93)90040-Q; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Middelboe T, 1997, ACTA PSYCHIAT SCAND, V96, P188, DOI 10.1111/j.1600-0447.1997.tb10150.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; ROHDE P, 1990, J PERS SOC PSYCHOL, V58, P499, DOI 10.1037/0022-3514.58.3.499; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; ROTH S, 1986, AM PSYCHOL, V41, P813, DOI 10.1037/0003-066X.41.7.813; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; Smari J, 1997, SCAND J PSYCHOL, V38, P151, DOI 10.1111/1467-9450.00021; SNAITH RP, 1986, BRIT J PSYCHIAT, V148, P599, DOI 10.1192/bjp.148.5.599; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; STARKSTEIN SE, 1992, AM PSYCHIAT PRESS TX, P449; Tandberg E, 1997, ARCH NEUROL-CHICAGO, V54, P625, DOI 10.1001/archneur.1997.00550170097020; Ursin H., 1978, PSYCHOBIOLOGY STRESS	47	123	123	0	21	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2000	14	10					887	905					19	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	364QG	WOS:000089902900004	11076135				2022-02-06	
J	Beer, R; Franz, G; Srinivasan, A; Hayes, RL; Pike, BR; Newcomb, JK; Zhao, X; Schmutzhard, E; Poewe, W; Kampfl, A				Beer, R; Franz, G; Srinivasan, A; Hayes, RL; Pike, BR; Newcomb, JK; Zhao, X; Schmutzhard, E; Poewe, W; Kampfl, A			Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						caspase-3; alpha-spectrin; neuron; astrocyte; oligodendrocyte; traumatic brain injury	CORTICAL IMPACT INJURY; CEREBELLAR GRANULE NEURONS; POLY(ADP-RIBOSE) POLYMERASE; MEDIATED APOPTOSIS; CEREBRAL-ISCHEMIA; CYSTEINE PROTEASE; DNA FRAGMENTATION; MEMORY DEFICITS; NERVOUS-SYSTEM; ALPHA-SPECTRIN	This study investigated the temporal expression and cell subtype distribution of activated caspase-3 following cortical impact-induced traumatic brain injury in rats. The animals were killed and examined for protein expression of the proteolytically active subunit of caspase-3, p18, at intervals from 6 h to 14 days after injury. In addition, we also investigated the effect of caspase-3 activation on proteolysis of the cytoskeletal protein alpha-spectrin. Increased protein levels of p18 and the caspase-3-specific 120-kDa breakdown product to alpha-spectrin were seen in the cortex ipsilateral to the injury site from 6 to 72 h after the trauma. Immunohistological examinations revealed increased expression of p18 in neurons, astrocytes, and oligodendrocytes from 6 to 72 h following impact injury, In contrast, no evidence of caspase-3 activation was seen in microglia at all time points investigated. Quantitative analysis of caspase-3-positive cells revealed that the number of caspase-3-positive neurons exceeded the number of caspase-3-positive glia cells from 6 to 72 h after injury. Moreover, concurrent assessment of nuclear histopathology using hematoxylin identified p18-immunopositive cells exhibiting apoptotic-like morphological profiles in the cortex ipsilateral to the injury site. In contrast, no evidence of increased p18 expression or alpha-spectrin proteolysis was seen in the ipsilateral hippocampus, contralateral cortex, or hippocampus up to 14 days after the impact. Our results are the first to demonstrate the concurrent expression of activated caspase-3 in different CNS cells after traumatic brain injury in the rat. Our findings also suggest a contributory role of activated caspase-3 in neuronal and glial apoptotic degeneration after experimental TBI in vivo.	Univ Innsbruck Hosp, Dept Neurol, A-6020 Innsbruck, Austria; IDUN Pharmaceut Inc, La Jolla, CA USA; Univ Florida, Inst Brain, Dept Neurosci, Ctr Traumat Brain Injury Studies, Gainesville, FL USA; Univ Texas, Houston Hlth Sci Ctr, Vivian L Smith Ctr Neurol Res, Dept Neurosurg, Houston, TX USA		Kampfl, A (corresponding author), Univ Innsbruck Hosp, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	andreas.kampfl@uibk.ac.at		Schmutzhard, Erich/0000-0003-3295-7491	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS40182] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040182] Funding Source: NIH RePORTER		Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Armstrong RC, 1997, J NEUROSCI, V17, P553; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Bosman FT, 1996, PATHOL RES PRACT, V192, P676, DOI 10.1016/S0344-0338(96)80089-6; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; BURSCH W, 1990, BIOCHEM CELL BIOL, V68, P1071, DOI 10.1139/o90-160; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chen J, 1998, J NEUROSCI, V18, P4914; Clark D, 1999, IEEE INTERNET COMPUT, V3, P13; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Conti AC, 1998, J NEUROSCI, V18, P5663; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Franz G, 1999, J NEUROCHEM, V73, P1615, DOI 10.1046/j.1471-4159.1999.0731615.x; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Gu CH, 1999, J NEUROSCI, V19, P3043; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Janicke RU, 1998, J BIOL CHEM, V273, P15540, DOI 10.1074/jbc.273.25.15540; Joashi UC, 1999, EUR J NEUROSCI, V11, P91, DOI 10.1046/j.1460-9568.1999.00409.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Namura S, 1998, J NEUROSCI, V18, P3659; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Nath R, 1998, J NEUROCHEM, V71, P186; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Ni BH, 1998, J CEREBR BLOOD F MET, V18, P248, DOI 10.1097/00004647-199803000-00003; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pike BR, 1998, J NEUROSCI RES, V52, P505, DOI 10.1002/(SICI)1097-4547(19980601)52:5<505::AID-JNR3>3.3.CO;2-Y; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; RINK A, 1995, AM J PATHOL, V147, P1575; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Stroh C, 1998, CELL DEATH DIFFER, V5, P997, DOI 10.1038/sj.cdd.4400451; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Velier JJ, 1999, J NEUROSCI, V19, P5932, DOI 10.1523/JNEUROSCI.19-14-05932.1999; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; WALKER NPC, 1994, CELL, V78, P343, DOI 10.1016/0092-8674(94)90303-4; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1987, J PATHOL, V153, P313, DOI 10.1002/path.1711530404; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x	68	123	128	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	SEP	2000	75	3					1264	1273		10.1046/j.1471-4159.2000.0751264.x			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	346JY	WOS:000088868500042	10936210				2022-02-06	
J	Horn, P; Munch, E; Vajkoczy, P; Herrmann, P; Quintel, M; Schilling, L; Schmiedek, P; Schurer, L				Horn, P; Munch, E; Vajkoczy, P; Herrmann, P; Quintel, M; Schilling, L; Schmiedek, P; Schurer, L			Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates	NEUROLOGICAL RESEARCH			English	Article						hypertonic saline; intracranial pressure; cerebral edema; head trauma; subarachnoid hemorrhage; plasma sodium; plasma osmolality	CEREBRAL BLOOD-FLOW; SMALL-VOLUME RESUSCITATION; HIGH-DOSE MANNITOL; HEMORRHAGIC-SHOCK; BRAIN INJURY; OXYGEN DELIVERY; HEAD-INJURY; HYPERTENSION; EDEMA; VISCOSITY	Critically elevated intracranial pressure (ICP) represents the most important cause of morbidity and mortality in patients suffering from severe traumatic brain injury (TBI) and is a serious complication after subarachnoid hemorrhage (SAH). Thus new strategies for the control of ICP are required. Based on the evidence available hypertonic saline solution (HSS) may be a promising approach. It was therefore the aim of the present study to evaluate in a prospective manner the effects of HSS on ICP and cerebral perfusion pressure (CPP) in patients with therapy-resistant elevation of ICP. A total of 48 bolus infusions of HSS (7.5%, 2 ml kg(-1) b.w.; infusion rate 20 ml min(-1)) were given intravenously (range 1-15 per patient) to 10 patients (age 41 +/- 6 years) with TBI and SAH. Only patients with ICP > 25 mmHg not responding to standard ICP-management protocol and plasma sodium (Na+) concentration < 150 mmol l(-1) were included in the study. Within the first hour after HSS application, ICP decreased from 33 +/- 9 mmHg to 19 +/- 6 mmHg (p < 0.05) and further to 18 +/- 5 mmHg at the lime of maximum effect (98 +/- 11 min post bolus). Decrease of ICP was accompanied by a rise of CPP from 68 +/- 11 mmHg to 79 +/- 11 mmHg (p < 0.05) after 1 h and further to 81 +/- 11 mmHg at the time of maximum effect. Plasma Na+ concentration was 141 +/- 6 mmol l(-1) before and 143 +/- 5 mmol l(-1) 1 h after HSS bolus. Corresponding values for plasma osmolality were 302 +/- 11 and 308 +/- 12 mOsm l(-1). When the ICP lowering effect was transient, subsequent HSS bolus was necessary 163 +/- 54 min after previous dosing. The present results indicate that repeated bolus application of HSS (7.5% NaCl, 2 ml kg(-1) b.w.) is an effective measure to decrease ICP which is otherwise refractory to standard therapeutic approaches. Whether or not the therapy scheme is also suited as primary measure for the control of ICP remains to be established.	Univ Heidelberg, Fac Clin Med Mannheim, Dept Neurosurg, D-68167 Mannheim, Germany; Univ Heidelberg, Fac Clin Med Mannheim, Dept Anesthesiol & Crit Care Med, D-68167 Mannheim, Germany; Hosp Bogenhausen, Dept Neurosurg, Munich, Germany		Horn, P (corresponding author), Univ Heidelberg, Fac Clin Med Mannheim, Dept Neurosurg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.			Herrmann, Peter/0000-0002-0348-2573			Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; ANDREWS RJ, 1993, SURG NEUROL, V39, P218, DOI 10.1016/0090-3019(93)90186-5; BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; BAUE AE, 1967, J TRAUM, V7, P743, DOI 10.1097/00005373-196709000-00012; Becker DP, 1972, INTRACRANIAL PRESSUR, P309; Bullock MR, 1996, J NEUROTRAUM, V13, P705; FISHER B, 1992, J NEUROSURG ANESTHES, V8, P4; GUNNAR W, 1988, SURGERY, V103, P398; Hartl R, 1997, ZBL CHIR, V122, P181; HARTL R, 1997, J TRAUMA, V42, P41; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; JENNETT B, 1975, LANCET, V1, P480; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Kempski O, 1996, ACT NEUR S, V66, P114; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; KOFKE WA, 1987, J NEUROSURG ANESTHES, V34, P442; MANNINEN PH, 1987, CAN J ANAESTH, V34, P442, DOI 10.1007/BF03014345; MCGRAW CP, 1983, NEUROSURGERY, V13, P269, DOI 10.1227/00006123-198309000-00009; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1984, J NEUROSURG, V61, P100; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; NAKAYAMA SI, 1985, J SURG RES, V38, P180, DOI 10.1016/0022-4804(85)90025-3; OKEN DE, 1994, RENAL FAILURE, V16, P147, DOI 10.3109/08860229409044856; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; PROUGH DS, 1986, J NEUROSURG, V64, P627, DOI 10.3171/jns.1986.64.4.0627; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; SCHURER L, 1991, EUR SURG RES, V24, P1; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; SHACKFORD SR, 1988, SURGERY, V104, P553; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P782; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VASSAR MJ, 1992, J INTENSIVE CARE MED, V7, P189; Weinstabl C, 1992, FORTSCHR ANAESTH, V6, P105; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478	38	123	131	0	4	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	DEC	1999	21	8					758	764		10.1080/01616412.1999.11741010			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	260KA	WOS:000083947500008	10596385				2022-02-06	
J	HarrisonFelix, C; Newton, CN; Hall, KM; Kreutzer, JS				HarrisonFelix, C; Newton, CN; Hall, KM; Kreutzer, JS			Descriptive findings from the traumatic brain injury model systems national data base	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; databases; outcome assessment	HEAD-INJURY; COMA; SCALE	To describe the current status of the Traumatic Brain Injury Model Systems (TBIMS) National Data Base and present major descriptive findings based on the original research and demonstration issues for which the database was developed, and to describe patient outcomes at discharge from inpatient rehabilitation and at 1 year post injury Design: Prospective, longitudinal multicenter study. Setting: TBIMS located at the Medical College of Virginia, Richmond, Va; Wayne State University/Rehabilitation Institute of Michigan, Detroit, Mich; The Institute for Rehabilitation and Research, Houston, Tex; and Santa Clara Valley Medical Center, San Jose, Calif. Data Set: Demographic, diagnostic, treatment, and outcome data on 660 individuals consecutively discharged from the four TBIMS between March 1989 and September 1995. Results: TBIMS individuals are typically in their mid-30s, male (77%), and white (51%); have a high school education or less (71%); and are as likely as not to be employed at the time of injury (50%). Vehicle-related injuries are the leading cause of injury (56%). Individuals tend to suffer moderate to severe brain injuries, with 77% experiencing loss of consciousness and 98% experiencing. posttraumatic amnesia. The average combined length of stay for acute care and inpatient rehabilitation decreased approximately 25%, from 83 days in 1989 in 63 days in 1994. The Functional Independence Measure scores indicated overall functional improvement from an average level of requiring ''Moderate Assistance'' at the time of rehabilitation admission to an average level between ''Moderate Independence'' and ''Complete Independence'' at 1 year post injury. As indicated by the Community Integration Questionnaire, individuals tended to do best in the social aspects of community integration and worst in productivity. Conclusion: This article addresses the original research and demonstration issues posed by the creators of the TBIMS National Data Base. It describes the TBIMS population and presents outcomes at rehabilitation discharge acid at 1 year post injury. This information provides a benchmark for future study.	BAYLOR COLL MED,INST REHABIL & RES,HOUSTON,TX 77030; SANTA CLARA VALLEY MED CTR,SAN JOSE,CA 95128; VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA,RICHMOND,VA		HarrisonFelix, C (corresponding author), WAYNE STATE UNIV,REHABIL INST MICHIGAN,RES DEPT,261 MACK BLVD,DETROIT,MI 48201, USA.						CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P130; *COMM PROF HOSP AC, 1986, INT CLASS DIS 9 REV; Devivo M. J., 1995, SPINAL CORD INJURY C; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GO BK, 1995, SPINAL CORD INJURY C; Hall K, 1992, NEUROREHABILITATION, V2, P98, DOI DOI 10.3233/NRE-1992-2410; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MERCY JA, 1993, HEALTH AFFAIR, V12, P7, DOI 10.1377/hlthaff.12.4.7; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENTHAL M, 1993, J HEAD TRAUMA REHABI, V8; Stover S. L., 1995, SPINAL CORD INJURY C; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thurman DJ., 1995, GUIDELINES SURVEILLA; *UN DAT SYST MED R, 1992, GUID UN DAT SET MED; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; *WAYN STAT U REH I, 1996, TRAUM BRAIN INJ MOD; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 1980, INT CLASS IMP DIS HA	18	123	123	0	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1996	11	5					1	14		10.1097/00001199-199610000-00002			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VP053	WOS:A1996VP05300002					2022-02-06	
J	Spikman, JM; vanZomeren, AH; Deelman, BG				Spikman, JM; vanZomeren, AH; Deelman, BG			Deficits of attention after closed-head injury: Slowness only?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							EXECUTIVE FUNCTIONS; REACTION-TIME; RECOVERY	The performance of a group of 60 severely closed-head-injured patients in the subacute stage of recovery on a series of tests addressing focused, divided, and sustained attention, and supervisory attentional control was compared to the performance of a matched group of 60 healthy controls. Patients performed significantly worse on each test with time pressure (those addressing focused and divided attention), indicating basic slowness of information processing, and on the self-paced tasks for supervisory attentional control. No indication was found of a sustained attention deficit. In a subsequent analysis the influence of the demonstrated slowness of information processing and other possibly confounding cognitive factors was controlled for by means of covariance analyses. This resulted in a disappearance of group differences on tests for focused and divided attention. The only difference that remained concerned a test for supervisory attentional control.	GRODNO STATE UNIV,GRONINGEN,NETHERLANDS		Spikman, JM (corresponding author), ACAD HOSP GRONINGEN,DEPT NEUROSPSYCHOL,CMC1-3,HANZEPLEIN 1,NL-9713 EZ GRONINGEN,NETHERLANDS.			Spikman, Jacoba/0000-0002-6477-0763			BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; BROUWER WH, 1985, THESIS STATE U GRONI; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Deelman B. G., 1980, NEUROPSYCHOLOGIE NED, P253; DENCKER SJ, 1958, ACTA PSYCHIAT N S122, V33; Grant D. A., 1948, WISCONSIN CARD SORTI; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Heaton R, WISCONSIN CARD SORTI; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; HOLM S, 1979, SCAND J STAT, V6, P65; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A.R., 1973, WORKING BRAIN; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Miller E, 1970, Cortex, V6, P121; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; STERNBERG RJ, 1977, PSYCHOL BULL, V84, P539, DOI 10.1037/0033-2909.84.3.539; Stevens J.P., 1992, APPL MULTIVARIATE ST, V2nd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1983, LOCALIZATION NEUROPS, P429; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VANZOMEREN AH, 1981, THESIS STATE U GRONI; VANZOMEREN AH, 1990, HDB CLIN NEUROLOGY, V13, P397; VELTMAN JC, 1996, NEUROPSYCHOLOGY, V10, P1; WALSH KW, 1991, UNDERSTANDING BRAIN, P163; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WIRSEN A, 1991, NEUROPSYCHOLOGY, V5, P151; [No title captured]; [No title captured]; [No title captured]	53	123	124	0	15	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT	1996	18	5					755	767		10.1080/01688639608408298			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	VU779	WOS:A1996VU77900012	8941860				2022-02-06	
J	Abbas, K; Shenk, TE; Poole, VN; Breedlove, EL; Leverenz, LJ; Nauman, EA; Talavage, TM; Robinson, ME				Abbas, Kausar; Shenk, Trey E.; Poole, Victoria N.; Breedlove, Evan L.; Leverenz, Larry J.; Nauman, Eric A.; Talavage, Thomas M.; Robinson, Meghan E.			Alteration of Default Mode Network in High School Football Athletes Due to Repetitive Subconcussive Mild Traumatic Brain Injury: A Resting-State Functional Magnetic Resonance Imaging Study	BRAIN CONNECTIVITY			English	Article						concussion; default mode network; fMRI; football; functional connectivity; mTBI; resting state; subconcussive		Long-term neurological damage as a result of head trauma while playing sports is a major concern for football athletes today. Repetitive concussions have been linked to many neurological disorders. Recently, it has been reported that repetitive subconcussive events can be a significant source of accrued damage. Since football athletes can experience hundreds of subconcussive hits during a single season, it is of utmost importance to understand their effect on brain health in the short and long term. In this study, resting-state functional magnetic resonance imaging (rs-fMRI) was used to study changes in the default mode network (DMN) after repetitive subconcussive mild traumatic brain injury. Twenty-two high school American football athletes, clinically asymptomatic, were scanned using the rs-fMRI for a single season. Baseline scans were acquired before the start of the season, and follow-up scans were obtained during and after the season to track the potential changes in the DMN as a result of experienced trauma. Ten noncollision-sport athletes were scanned over two sessions as controls. Overall, football athletes had significantly different functional connectivity measures than controls for most of the year. The presence of this deviation of football athletes from their healthy peers even before the start of the season suggests a neurological change that has accumulated over the years of playing the sport. Football athletes also demonstrate short-term changes relative to their own baseline at the start of the season. Football athletes exhibited hyperconnectivity in the DMN compared to controls for most of the sessions, which indicates that, despite the absence of symptoms typically associated with concussion, the repetitive trauma accrued produced long-term brain changes compared to their healthy peers.	[Abbas, Kausar; Shenk, Trey E.; Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, 465 Northwestern Ave, W Lafayette, IN 47907 USA; [Poole, Victoria N.; Nauman, Eric A.; Talavage, Thomas M.; Robinson, Meghan E.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Poole, Victoria N.; Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Leverenz, Larry J.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Robinson, Meghan E.] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA		Talavage, TM (corresponding author), Purdue Univ, Sch Elect & Comp Engn, 465 Northwestern Ave, W Lafayette, IN 47907 USA.	tmt@purdue.edu	Abbas, Kausar/ABA-3670-2021; Abbas, Kausar/ABA-1318-2021	Abbas, Kausar/0000-0001-5352-149X; Abbas, Kausar/0000-0001-5352-149X; Talavage, Thomas/0000-0003-4977-6398; Poole, Victoria/0000-0003-0974-2564			Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Belson K., 2013, NY TIMES, pB14; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Breslow Jason M., 2013, FRONTLINE; Brett M., 2002, NEUROIMAGE, V16, pS497; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Gregory S., 2013, TIME MAGAZINE, P36; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Johnson BD, 2014, J NEUROTRAUMA; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Landau E., 2013, CNN HLTH; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	59	122	124	1	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	MAR	2015	5	2					91	101		10.1089/brain.2014.0279			11	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VG7FN	WOS:000448192300003	25242171				2022-02-06	
J	Faden, AI; Loane, DJ				Faden, Alan I.; Loane, David J.			Chronic Neurodegeneration After Traumatic Brain Injury: Alzheimer Disease, Chronic Traumatic Encephalopathy, or Persistent Neuroinflammation?	NEUROTHERAPEUTICS			English	Article						Traumatic brain injury; Neurodegeneration; Concussion; Repetitive mild TBI; Alzheimer disease; Chronic traumatic encephalopathy; Microglial activation; Chronic traumatic brain inflammation	AMYLOID-BETA-PROTEIN; INTRACEREBRAL INFLAMMATORY RESPONSE; LONG-TERM ACCUMULATION; HEAD-INJURY; MICROGLIAL ACTIVATION; DIFFUSION-TENSOR; AXONAL INJURY; RISK-FACTOR; LONGITUDINAL CHANGES; SYNAPTIC PLASTICITY	It has long been suggested that prior traumatic brain injury (TBI) increases the subsequent incidence of chronic neurodegenerative disorders, including Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis. Among these, the association with Alzheimer disease has the strongest support. There is also a long-recognized association between repeated concussive insults and progressive cognitive decline or other neuropsychiatric abnormalities. The latter was first described in boxers as dementia pugilistica, and has received widespread recent attention in contact sports such as professional American football. The term chronic traumatic encephalopathy was coined to attempt to define a "specific" entity marked by neurobehavioral changes and the extensive deposition of phosphorylated tau protein. Nearly lost in the discussions of post-traumatic neurodegeneration after traumatic brain injury has been the role of sustained neuroinflammation, even though this association has been well established pathologically since the 1950s, and is strongly supported by subsequent preclinical and clinical studies. Manifested by extensive microglial and astroglial activation, such chronic traumatic brain inflammation may be the most important cause of post-traumatic neurodegeneration in terms of prevalence. Critically, emerging preclinical studies indicate that persistent neuroinflammation and associated neurodegeneration may be treatable long after the initiating insult(s).	[Faden, Alan I.; Loane, David J.] Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr,Hlth Sci Facil, Baltimore, MD 21201 USA		Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr,Hlth Sci Facil, S247 20,Penn St, Baltimore, MD 21201 USA.	afaden@anes.umm.edu	Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Faden, Alan I./0000-0003-0128-2348	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS037313, R01NS052568, R01NS082308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082308, R01NS037313, R01NS052568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028747] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants R01NS037313 and R01NS052568 (A.I. Faden), and R01NS082308 (D.J. Loane).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Horsburgh K, 2000, NEUROPATH APPL NEURO, V26, P124, DOI 10.1046/j.1365-2990.2000.026002124.x; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar R., 2014, J HEAD TRAUMA REHABI; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis KM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/578480; Leypoldt F, 2014, CLIN EXP IMMUNOL, V175, P336, DOI 10.1111/cei.12185; Leypoldt F, 2014, ANN N Y ACAD SCI; Lindqvist D, 2014, BRAIN BEHAV IMMUN; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roberts G, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rodgers KM, 2014, J NEUROTRAUM, V31, P487, DOI [10.1089/NEU.2013.3090, 10.1089/neu.2013.3090]; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	99	122	125	3	47	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	JAN	2015	12	1					143	150		10.1007/s13311-014-0319-5			8	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CB3PX	WOS:000349541800016	25421001	Green Published, Bronze			2022-02-06	
J	Evans, TA; Barkauskas, DS; Myers, JT; Hare, EG; You, JQ; Ransohoff, RM; Huang, AY; Silver, J				Evans, Teresa A.; Barkauskas, Deborah S.; Myers, Jay T.; Hare, Elisabeth G.; You, Jing Qiang; Ransohoff, Richard M.; Huang, Alex Y.; Silver, Jerry			High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury	EXPERIMENTAL NEUROLOGY			English	Article						Spinal cord injury; Two-photon microscopy; Microglia; Monocytes; Macrophages; Bone marrow chimera mice; Axonal dieback; Retraction bulb; CX3CR1; CCR2	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; FRACTALKINE RECEPTOR; CNS INJURY; IN-VIVO; FUNCTIONAL RECOVERY; TRANSGENIC MICE; BRAIN-BARRIER; REGENERATION; INFLAMMATION	After traumatic spinal cord injury, functional deficits increase as axons die back from the center of the lesion and the glial scar forms. Axonal dieback occurs in two phases: an initial axon intrinsic stage that occurs over the first several hours and a secondary phase which takes place over the first few weeks after injury. Here, we examine the secondary phase, which is marked by infiltration of macrophages. Using powerful time-lapse multi-photon imaging, we captured images of interactions between Cx3crl(+/GEP) macrophages and microglia and Thy-l(YFP) axons in a mouse dorsal column crush spinal cord injury model. Over the first few weeks after injury, axonal retraction bulbs within the lesion are static except when axonal fragments are lost by a blebbing mechanism in response to physical contact followed by phagocytosis by mobile Cx3Cr1(+/GFP) cells. Utilizing a radiation chimera model to distinguish marrow-derived cells from radio-resistant CNS-resident microglia, we determined that the vast majority of accumulated cells in the lesion are derived from the blood and only these are associated with axonal damage. Interestingly, CNS-resident CX3Cr1(+/GFP) microglia did not increasingly accumulate nor participate in neuronal destruction in the lesion during this time period. Additionally, we found that the blood-derived cells consisted mainly of singly labeled Ccr2(+/GFP) macrophages, singly labeled Cx3Cr1(+/GRP) macrophages and a small population of double-labeled cells. Since all axon destructive events were seen in contact with a Cx3Cr1(+/GFP) cell, we infer that the CCR2 single positive subset is likely not robustly involved in axonal dieback. Finally, in our model, deletion of CCR2, a chemokine receptor, did not alter the position of axons after dieback. Understanding the in vivo cellular interactions involved in secondary axonal injury may lead to clinical treatment candidates involving modulation of destructive infiltrating blood monocytes. (c) 2014 The Authors. Published by Elsevier Inc. All rights reserved.	[Evans, Teresa A.; Hare, Elisabeth G.; You, Jing Qiang; Silver, Jerry] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Barkauskas, Deborah S.] Case Western Reserve Univ, Sch Med, Dept Biomed Engn, Cleveland, OH 44106 USA; [Barkauskas, Deborah S.; Myers, Jay T.; Huang, Alex Y.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin Fdn, Lerner Res Inst, Neuroinflammat Res Ctr, Dept Neurosci, Cleveland, OH 44195 USA		Huang, AY (corresponding author), WRB 6528,2103 Cornell Rd, Cleveland, OH 44106 USA.	teresa.evans@case.edu; deborah.sim@case.edu; jay.myers@case.edu; ehare@laurelschool.org; jxy268@case.edu; ransohr@ccf.org; ayh3@case.edu; jxs10@case.edu	Huang, Alex/R-4662-2017; Huang, Alex Y./ABG-8182-2021; Zhang, Xiaolei/E-2761-2012	Huang, Alex/0000-0002-5701-4521; Huang, Alex Y./0000-0002-5701-4521; Zhang, Xiaolei/0000-0003-0117-7599; Barkauskas, Deborah S./0000-0002-1872-4109	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS25713]; NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01 CA154656]; Dana Foundation; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation; Gabrielle's Angel Foundation; Hyundai Hope-on-heels Research Program;  [MSTP T32 GM007250];  [5T32EB7509]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA154656] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB007509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS025713] Funding Source: NIH RePORTER	The following agencies provided critical funding support for this study: MSTP T32 GM007250 (T.A.E.), 5T32EB7509 (D.S.B.), NINDS RO1 NS25713 (J.S.), NCI R01 CA154656 (A.Y.H.), Dana Foundation (A.Y.H.), St. Baldrick's Foundation (A.Y.H.), Alex's Lemonade Stand Foundation (A.Y.H.), Gabrielle's Angel Foundation (A.Y.H.) and Hyundai Hope-on-heels Research Program (A.Y.H.). The authors are grateful to Dr. Izzy Charo, M.D., Ph.D. for the use of the CCR2 RFP mice, Hongmei Hu for technical help with genotyping, Ross Anderson for mounting the spinal stabilizing unit and Dr. Richard Zigmond, Ph.D., Dr. Marcello Chieppa, Ph.D. and Marc DePaul for thorough review and thoughtful critiques of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Cajal S.R.Y., 1907, NORDISKT MED ARK, V40, P1; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Corona AW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-93; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Filous A.R., 2013, SYNAPTIC LIKE CONNEC; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gaupp S, 2003, AM J PATHOL, V162, P139, DOI 10.1016/S0002-9440(10)63805-9; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Li ED, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-148; Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; MATSUMOTO Y, 1987, J NEUROIMMUNOL, V17, P71, DOI 10.1016/0165-5728(87)90032-4; Mawhinney LA, 2012, J NEUROPATH EXP NEUR, V71, P180, DOI 10.1097/NEN.0b013e3182479b41; McPhail LT, 2004, EUR J NEUROSCI, V20, P1984, DOI 10.1111/j.1460-9568.2004.03662.x; Nijagal A., 2011, J VIS EXP, V47, pe2303; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Oshima T, 2006, BRIT J OPHTHALMOL, V90, P218, DOI 10.1136/bjo.2005.077875; Popovich PG, 2003, EXP NEUROL, V182, P275, DOI 10.1016/S0014-4886(03)00120-1; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Titsworth WL, 2008, CNS NEUROL DISORD-DR, V7, P254, DOI 10.2174/187152708784936671; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	59	122	125	0	22	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2014	254						109	120		10.1016/j.expneurol.2014.01.013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AD5VM	WOS:000333321300012	24468477	Green Accepted, hybrid			2022-02-06	
J	Figley, SA; Khosravi, R; Legasto, JM; Tseng, YF; Fehlings, MG				Figley, Sarah A.; Khosravi, Ramak; Legasto, Jean M.; Tseng, Yun-Fan; Fehlings, Michael G.			Characterization of Vascular Disruption and Blood-Spinal Cord Barrier Permeability following Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						vascular permeability; blood-spinal cord barrier; vascular injury; spinal cord injury; endogenous angiogenesis	FUNCTIONAL RECOVERY; CONTUSION INJURY; TIME COURSE; EVANS BLUE; RAT; MECHANISMS; BRAIN; APOPTOSIS; ANGIOGENESIS; TRANSECTION	Significant vascular changes occur subsequent to spinal cord injury (SCI), which contribute to progressive pathophysiology. In the present study, we used female Wistar rats (300-350 g) and a 35-g clip-compression injury at T6 to T7 to characterize the spatial and temporal vascular changes that ensue post-SCI. Before sacrifice, animals were injected with vascular tracing dyes (2% Evans Blue (EB) or fluorescein isothiocyanate/Lycopersicon esculentum agglutinin [FITC-LEA]) to assess blood-spinal cord barrier (BSCB) integrity or vascular architecture, respectively. Spectrophotometry of EB tissue showed maximal BSCB disruption at 24 h postinjury, with significant disruption observed until 5 days postinjury (p<0.01). FITC-LEA-identified functional vasculature was dramatically reduced by 24 h. Similarly, RECA-1 immunohistochemistry showed a significant decrease in the number of vessels at 24 h postinjury, compared to uninjured animals (p<0.01), with slight increases in endogenous revascularization by 10 days postinjury. White versus gray matter (GM) quantification showed that GM vessels are more susceptible to SCI. Finally, we observed an endogenous angiogenic response between 3 and 7 days postinjury: maximal endothelial cell proliferation was observed at day 5. These data indicate that BSCB disruption and endogenous revascularization occur at specific time points after injury, which may be important for developing effective therapeutic interventions for SCI.	[Figley, Sarah A.; Fehlings, Michael G.] Univ Hlth Network, Krembil Neurosci Ctr, Toronto Western Res Inst, Dept Genet & Dev, Toronto, ON M5T 2S8, Canada; [Figley, Sarah A.; Fehlings, Michael G.] Univ Hlth Network, Krembil Neurosci Ctr, Spinal Program, Toronto, ON M5T 2S8, Canada; [Figley, Sarah A.; Khosravi, Ramak; Legasto, Jean M.; Tseng, Yun-Fan; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada		Fehlings, MG (corresponding author), Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, 399 Bathurst St,4WW-449, Toronto, ON M5T 2S8, Canada.	michael.fehlings@uhn.on.ca		Fehlings, Michael/0000-0002-5722-6364; Khosravi, Ramak/0000-0002-4181-3679	Gerald and Tootsie Halbert Chair in Neural Repair and Regeneration; Krembil Foundation	The authors express their gratitude to Eunice Cho and Sofia Khan for their help with tissue extraction, tissue processing, immunohistochemistry, and cell counting. The authors also thank Jared Wilcox, Behzad Azad, Yang Liu, and other members of the Fehlings' lab who assisted with postoperative animal care. This study was supported by the Gerald and Tootsie Halbert Chair in Neural Repair and Regeneration (held by Dr. Michael G. Fehlings) and by a grant received from the Krembil Foundation.	Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Bearden SE, 2004, MICROCIRCULATION, V11, P633, DOI 10.1080/10739680490517659; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Furlan JC, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E13; Glaser J, 2006, J NEUROSCI RES, V84, P724, DOI 10.1002/jnr.20982; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; HOLTZ A, 1990, NEUROSURGERY, V26, P952, DOI 10.1227/00006123-199006000-00005; IKEDA Y, 1994, ACTA NEUROCHIR, P119; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Ling X, 2007, J NEUROSCI RES, V85, P2175, DOI 10.1002/jnr.21362; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; NOBLE LJ, 1988, EXP NEUROL, V99, P567, DOI 10.1016/0014-4886(88)90173-2; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Raab S, 2007, ACTA NEUROPATHOL, V113, P607, DOI 10.1007/s00401-007-0228-3; Ribatti D, 2001, MECH DEVELOP, V100, P157, DOI 10.1016/S0925-4773(00)00522-0; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; vonEuler M, 1997, EXP NEUROL, V145, P502, DOI 10.1006/exnr.1997.6481; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R	36	122	134	1	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 15	2014	31	6					541	552		10.1089/neu.2013.3034			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AC3WV	WOS:000332453000002	24237182	Green Published			2022-02-06	
J	Tremblay, S; De Beaumont, L; Henry, LC; Boulanger, Y; Evans, AC; Bourgouin, P; Poirier, J; Theoret, H; Lassonde, M				Tremblay, Sebastien; De Beaumont, Louis; Henry, Luke C.; Boulanger, Yvan; Evans, Alan C.; Bourgouin, Pierre; Poirier, Judes; Theoret, Hugo; Lassonde, Maryse			Sports Concussions and Aging: A Neuroimaging Investigation	CEREBRAL CORTEX			English	Article						aging; neuroimaging; sports concussion	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; MAGNETIC-RESONANCE-SPECTROSCOPY; ALZHEIMERS-DISEASE; FOOTBALL PLAYERS; WHITE-MATTER; LONG-TERM; H-1; ENCEPHALOPATHY; DECLINE	Recent epidemiological and experimental studies suggest a link between cognitive decline in late adulthood and sports concussions sustained in early adulthood. In order to provide the first in vivo neuroanatomical evidence of this relation, the present study probes the neuroimaging profile of former athletes with concussions in relation to cognition. Former athletes who sustained their last sports concussion >3 decades prior to testing were compared with those with no history of traumatic brain injury. Participants underwent quantitative neuroimaging (optimized voxel-based morphometry hippocampal volume, and cortical thickness), proton magnetic resonance spectroscopy (H-1 MRS; medial temporal lobes and prefrontal cortices), and neuropsychological testing, and they were genotyped for APOE polymorphisms. Relative to controls, former athletes with concussions exhibited: 1) Abnormal enlargement of the lateral ventricles, 2) cortical thinning in regions more vulnerable to the aging process, 3) various neurometabolic anomalies found across regions of interest, 4) episodic memory and verbal fluency decline. The cognitive deficits correlated with neuroimaging findings in concussed participants. This study unveiled brain anomalies in otherwise healthy former athletes with concussions and associated those manifestations to the long-term detrimental effects of sports concussion on cognitive function. Findings from this study highlight patterns of decline often associated with abnormal aging.	[Tremblay, Sebastien; Henry, Luke C.; Theoret, Hugo; Lassonde, Maryse] CHUM Hosp St Luc, Ctr Rech Neuropsychol & Cognit, Montreal, PQ, Canada; [De Beaumont, Louis] CHUM Hosp St Luc, Montreal Sacre Coeur Hosp Res Ctr, Montreal, PQ, Canada; [Boulanger, Yvan] CHUM Hosp St Luc, Dept Radiol, Montreal, PQ, Canada; [Bourgouin, Pierre] Univ Montreal, Dept Radiol, Montreal, PQ H3C 3J7, Canada; [Theoret, Hugo; Lassonde, Maryse] Univ Montreal, St Justine Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [De Beaumont, Louis] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ GA9 5H7, Canada; [Evans, Alan C.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Poirier, Judes] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada		Lassonde, M (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	maryse.lassonde@umontreal.ca	Evans, Alan C/B-2373-2013	Evans, Alan C/0000-0003-3841-6098; Theoret, Hugo/0000-0002-7458-8797; Tremblay, Sebastien/0000-0001-6251-9797	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante du QuebecFonds de la Recherche en Sante du Quebec; Canadian Foundation for InnovationCanada Foundation for Innovation; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Canada Research Chair programCanada Research Chairs	This work was supported by the Canadian Institutes of Health Research, the Fonds de la Recherche en Sante du Quebec, the Canadian Foundation for Innovation, the Natural Sciences and Engineering Research Council of Canada, and the Canada Research Chair program. Conflict of Interest: none declared.	Allen J.S., 2005, NEUROBIOL AGING, V26, P79; Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Barbeau E, 2004, NEUROLOGY, V62, P1317, DOI 10.1212/01.WNL.0000120548.24298.DB; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chantal S, 2004, BRAIN RES, V1003, P26, DOI 10.1016/j.brainres.2003.11.074; Chao LL, 2010, NEUROBIOL AGING, V31, P368, DOI 10.1016/j.neurobiolaging.2008.05.004; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chou YY, 2010, NEUROBIOL AGING, V31, P1386, DOI 10.1016/j.neurobiolaging.2010.05.001; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 2002, NEUROSURGERY, V51, P80; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Fleisher AS, 2008, NEUROLOGY, V70, P191, DOI 10.1212/01.wnl.0000287091.57376.65; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giza CC, 2001, J ATHL TRAINING, V36, P228; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haga KK, 2009, NEUROBIOL AGING, V30, P353, DOI 10.1016/j.neurobiolaging.2007.07.005; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Jack CR, 2005, NEUROLOGY, V65, P1227, DOI 10.1212/01.wnl.0000180958.22678.91; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; Kantarci K, 2008, ARCH NEUROL-CHICAGO, V65, P1621, DOI 10.1001/archneur.65.12.1621; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Klunk WE, 1996, NEUROBIOL AGING, V17, P349, DOI 10.1016/0197-4580(96)00035-8; Kopp B, 2006, J COGNITIVE NEUROSCI, V18, P949, DOI 10.1162/jocn.2006.18.6.949; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Loewenstein DA, 2004, J INT NEUROPSYCH SOC, V10, P91; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Miller G, 2009, SCIENCE, V325, P670, DOI 10.1126/science.325_670; MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Salmon DP, 2002, NEUROLOGY, V59, P1022, DOI 10.1212/WNL.59.7.1022; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Valenzuela MJ, 2001, NEUROLOGY, V56, P592, DOI 10.1212/WNL.56.5.592; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Walhovd KB, 2005, NEUROBIOL AGING, V26, P75; Wang ZQ, 2009, ACTA RADIOL, V50, P312, DOI 10.1080/02841850802709219	76	122	122	1	59	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAY	2013	23	5					1159	1166		10.1093/cercor/bhs102			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	133KO	WOS:000318137500015	22581847	Green Published, Bronze			2022-02-06	
J	Moretti, L; Cristofori, I; Weaver, SM; Chau, A; Portelli, JN; Grafman, J				Moretti, Laura; Cristofori, Irene; Weaver, Starla M.; Chau, Aileen; Portelli, Jaclyn N.; Grafman, Jordan			Cognitive decline in older adults with a history of traumatic brain injury	LANCET NEUROLOGY			English	Article							PENETRATING HEAD-INJURY; NONINVASIVE CORTICAL STIMULATION; RANDOMIZED CONTROLLED-TRIAL; APOLIPOPROTEIN-E GENOTYPE; ALZHEIMERS-DISEASE; RISK-FACTOR; AXONAL INJURY; GRAY-MATTER; FOLLOW-UP; REHABILITATION OUTCOMES	Traumatic brain injury (TBI) is an important public health problem with potentially serious long-term neurobehavioural sequelae. There is evidence to suggest that a history of TBI can increase a person's risk of developing Alzheimer's disease. However, individuals with dementia do not usually have a history of TBI, and survivors of TBI do not invariably acquire dementia later in life. Instead, a history of traumatic brain injury, combined with brain changes associated with normal ageing, might lead to exacerbated cognitive decline in older adults. Strategies to increase or maintain cognitive reserve might help to prevent exacerbated decline after TBI. Systematic clinical assessment could help to differentiate between exacerbated cognitive decline and mild cognitive impairment, a precursor of Alzheimer's disease, with important implications for patients and their families.	[Moretti, Laura; Cristofori, Irene; Weaver, Starla M.; Chau, Aileen; Portelli, Jaclyn N.; Grafman, Jordan] Kessler Fdn, Traumat Brain Injury Res Lab, W Orange, NJ USA		Grafman, J (corresponding author), Rehabil Inst Chicago, Chicago, IL 60611 USA.	jgrafman@ric.org		Weaver, Starla/0000-0002-9559-8337; Grafman, Jordan H./0000-0001-8645-4457; Cristofori, Irene/0000-0003-2339-1457			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; [Anonymous], 2006, CDC INJ FACT BOOK; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 2003, J NEUROL NEUROSUR PS, V74, P1014, DOI 10.1136/jnnp.74.8.1014; Brown DR, 2009, THESCIENTIFICWORLDJO, V9, P1061, DOI 10.1100/tsw.2009.111; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Collie A, 2004, NEUROLOGY, V63, P2460, DOI 10.1212/WNL.63.12.2460; Collie A, 2001, NEUROLOGY, V56, P1533, DOI 10.1212/WNL.56.11.1533; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; CORKIN S, 1989, J NEUROSCI, V9, P3876; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Glass L, 2013, CEREB CORTEX, V23, P1663, DOI 10.1093/cercor/bhs153; Gow A.J., 2007, J INDIVID DIFFER, V28, P103, DOI [10.1027/1614-0001.28.3.103, DOI 10.1027/1614-0001.28.3.103]; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.7.1120-1122; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GRAFMAN J, 1986, J NEUROSCI, V6, P301; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hassing LB, 2004, AGE AGEING, V33, P355, DOI 10.1093/ageing/afh100; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Jellinger KA., 2001, BMC NEUROL, V1, P1; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kang EK, 2009, RESTOR NEUROL NEUROS, V27, P645, DOI 10.3233/RNN-2009-0514; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kramer AF, 2004, J GERONTOL A-BIOL, V59, P940; Kraus J. F., 1996, NEUROLOGY AND TRAUMA, V2, P3, DOI DOI 10.1055/s-2008-1041052; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marner L, 2003, J COMP NEUROL, V462, P144, DOI 10.1002/cne.10714; MASLIAH E, 1993, AM J PATHOL, V142, P871; Masliah E, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P91; Mattila J, 2011, J ALZHEIMERS DIS, V27, P163, DOI 10.3233/JAD-2011-110365; Mauri M, 2006, FUNCT NEUROL, V21, P223; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Rafnsson SB, 2007, J AM GERIATR SOC, V55, P700, DOI 10.1111/j.1532-5415.2007.01158.x; RAPOPORT M, 2004, CAN ALZHEIMERS DIS R, V1, P4; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont V, 2006, PROG BRAIN RES, V157, P199, DOI 10.1016/S0079-6123(06)57013-X; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Rocca MA, 2007, NEUROLOGY, V69, P2136, DOI 10.1212/01.wnl.0000295504.92020.ca; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; Salat DH, 1999, ARCH NEUROL-CHICAGO, V56, P338, DOI 10.1001/archneur.56.3.338; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Soininen H, 2012, NEURODEGENER DIS, V10, P149, DOI 10.1159/000332600; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; Tisserand DJ, 2002, NEUROIMAGE, V17, P657, DOI 10.1006/nimg.2002.1173; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; US Department of Defense, 1960, AFQT 7A DEP DEF FORM; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; VICTOR M, 2001, ADAMS VICTORS PRINCI; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zimmerman ME, 2006, AM J GERIAT PSYCHIAT, V14, P823, DOI 10.1097/01.JGP.0000238502.40963.ac	153	122	127	0	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2012	11	12					1103	1112		10.1016/S1474-4422(12)70226-0			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	044CX	WOS:000311598100018	23153408				2022-02-06	
J	Metting, Z; Wilczak, N; Rodiger, LA; Schaaf, JM; van der Naalt, J				Metting, Z.; Wilczak, N.; Rodiger, L. A.; Schaaf, J. M.; van der Naalt, J.			GFAP and S100B in the acute phase of mild traumatic brain injury	NEUROLOGY			English	Article							FIBRILLARY ACIDIC PROTEIN; MODERATE HEAD-INJURY; SERUM; WORK; PREDICTION; BIOMARKERS; COMPLAINTS; S-100B; RETURN; DAMAGE	Objective: The biomarkers glial fibrillary acid protein (GFAP) and S100B are increasingly used as prognostic tools in severe traumatic brain injury (TBI). Data for mild TBI are scarce. This study aims to analyze the predictive value of GFAP and S100B for outcome in mild TBI and the relation with imaging. Methods: In 94 patients biomarkers were determined directly after admission. Collected data included injury severity, patient characteristics, admission CT, and MRI 3 months postinjury. Six months postinjury outcome was determined with Glasgow Outcome Scale Extended (GOSE) and return to work (RTW). Results: Mean GFAP was 0.25 mu g/L (SD 1.08) and S100B 0.54 mu g/L (SD 1.18). In 63% GFAP was not discernible. GFAP was increased in patients with an abnormal CT (1.20 mu g/L, SD 2.65) compared to normal CT (0.05 mu g/L, SD 0.17, p < 0.05). Also in patients with axonal injury on MRI GFAP was higher (0.65 mu g/L, SD 0.91 vs 0.07 mu g/L, SD 0.2, p < 0.05). GFAP was increased in patients with incomplete RTW compared to complete RTW (0.69 mu g/L, SD 2.11 vs 0.12 mu g/L, SD 0.38, p < 0.05). S100B was not related to outcome or imaging studies. In multivariate analysis GFAP was not predictive for outcome determined by GOSE and RTW. Conclusions: A relation between GFAP with imaging studies and outcome (determined by RTW) was found in contrast to S100B. As the positive predictive value of GFAP is limited in this category of TBI patients, this biomarker is not suitable for prediction of individual patient outcome. Neurology (R) 2012;78:1428-1433	[Metting, Z.; Wilczak, N.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Rodiger, L. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Schaaf, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	j.van.der.naalt@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Konrad C, 2010, PSYCHOL MED; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Missler U, 1999, CLIN CHEM, V45, P138; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Webster MJ, 2001, BRAIN BEHAV IMMUN, V15, P388, DOI 10.1006/brbi.2001.0646; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	28	122	129	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAY	2012	78	18					1428	1433		10.1212/WNL.0b013e318253d5c7			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	935DB	WOS:000303498000014	22517109				2022-02-06	
J	Covassin, T; Elbin, RJ; Larson, E; Kontos, AP				Covassin, Tracey; Elbin, Robert J., III; Larson, Elizabeth; Kontos, Anthony P.			Sex and Age Differences in Depression and Baseline Sport-Related Concussion Neurocognitive Performance and Symptoms	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						neurocognitive testing; depression; ImPACT; concussion symptoms	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; NEUROPSYCHOLOGICAL FUNCTION; EPIDEMIOLOGY; PREDICTORS; RECOVERY; PLAY	Objective: To examine depression and baseline neurocognitive function and concussion symptoms in male and female high school and college athletes. Design: Cross sectional. Setting: Athletes completed testing at a designated computer laboratory at high schools and colleges. Participants: Participants included 1616 collegiate (n - 837) and high school (n - 779) athletes from 3 states participating in a variety of competitive sports. Interventions: Participants completed the baseline Immediate Postconcussion Assessment and Cognitive Test (ImPACT), symptom inventory, and Beck Depression Inventory II (BDI-II). Main Outcome Measures: Between-group comparisons for depression groups on ImPACT composite scores (verbal and visual memory, reaction time, motor processing speed), total symptoms, and symptom cluster (sleep, cognitive, emotional, somatic/migraine) scores. Between-group comparisons for age and sex on BDI-II, ImPACT, total symptoms, and symptom cluster scores. Results: The severe depression group scored worse on visual memory and reported more total, somatic/migraine, cognitive, emotional, and sleep symptoms than less depressed groups. High school athletes reported more somatic/migraine symptoms than collegiate athletes, whereas collegiate athletes reported more emotional and sleep symptoms than high school athletes. Women had higher verbal memory and reported more cognitive, emotional, and sleep symptom clusters compared with men. Women outperformed men on verbal memory, whereas collegiate athletes outperformed high school athletes on processing speed. Conclusions: Athletes with severe depression scored lower on visual memory than those with minimal depression. Athletes with severe depression report more concussion symptoms than athletes with minimal and moderate depression scores. Symptoms of depression should be included in baseline assessments to help disentangle depression from concussion symptoms.	[Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Elbin, Robert J., III; Kontos, Anthony P.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15261 USA; [Larson, Elizabeth] Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA.	covassin@msu.edu		Kontos, Anthony/0000-0002-3749-4310	National Operating Committee on Standards for Athletic Equipment	The authors thank the National Operating Committee on Standards for Athletic Equipment for funding this study. They also thank all the certified athletic trainers for their contributions to this study.	Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barth JT, 1989, MILD HEAD INJURY, P257; Bay E, 2007, ARCH PSYCHIAT NURS, V21, P2, DOI 10.1016/j.apnu.2006.07.005; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Iverson GL, 2006, CLIN NEUROPSYCHOL, V20, P695, DOI 10.1080/138540491005857; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kelly MM, 2008, DEPRESS ANXIETY, V25, P839, DOI 10.1002/da.20341; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2001, IMMEDIATE POSTCONCUS; MAJERES RL, 1988, INTELLIGENCE, V12, P149, DOI 10.1016/0160-2896(88)90013-X; MAJERES RL, 1990, INTELLIGENCE, V14, P357, DOI 10.1016/0160-2896(90)90023-M; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; *OFF APPL STUD, 2005, NSDUH SER H, V28; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Randolph C, 2005, J ATHL TRAINING, V40, P139; Weekes NY, 2005, STRESS HEALTH, V21, P147, DOI 10.1002/smi.1046; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	31	122	122	1	31	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2012	22	2					98	104		10.1097/JSM.0b013e31823403d2			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	908RG	WOS:000301507200005	22246342				2022-02-06	
J	Kishimoto, N; Shimizu, K; Sawamoto, K				Kishimoto, Norihito; Shimizu, Kohei; Sawamoto, Kazunobu			Neuronal regeneration in a zebrafish model of adult brain injury	DISEASE MODELS & MECHANISMS			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE ASTROCYTES; VENTRICULAR ZONE; OLFACTORY-BULB; PROGENITOR CELLS; FOREBRAIN NEUROGENESIS; TELEOST FISH; RADIAL GLIA; IN-VIVO	Neural stem cells in the subventricular zone (SVZ) of the adult mammalian forebrain are a potential source of neurons for neural tissue repair after brain insults such as ischemic stroke and traumatic brain injury (TBI). Recent studies show that neurogenesis in the ventricular zone (VZ) of the adult zebrafish telencephalon has features in common with neurogenesis in the adult mammalian SVZ. Here, we established a zebrafish model to study injury-induced neurogenesis in the adult brain. We show that the adult zebrafish brain possesses a remarkable capacity for neuronal regeneration. Telencephalon injury prompted the proliferation of neuronal precursor cells (NPCs) in the VZ of the injured hemisphere, compared with in the contralateral hemisphere. The distribution of NPCs, viewed by BrdU labeling and ngn1-promoter-driven GFP, suggested that they migrated laterally and reached the injury site via the subpallium and pallium. The number of NPCs reaching the injury site significantly decreased when the fish were treated with an inhibitor of gamma-secretase, a component of the Notch signaling pathway, suggesting that injury-induced neurogenesis mechanisms are at least partly conserved between fish and mammals. The injury-induced NPCs differentiated into mature neurons in the regions surrounding the injury site within a week after the injury. Most of these cells expressed T-box brain protein (Tbr1), suggesting they had adopted the normal neuronal fate in this region. These results suggest that the telencephalic VZ contributes to neural tissue recovery following telencephalic injury in the adult zebrafish, and that the adult zebrafish is a useful model for regenerative medicine.	[Kishimoto, Norihito; Shimizu, Kohei; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi 4678601, Japan; [Kishimoto, Norihito] Keio Univ, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan		Sawamoto, K (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Dev & Regenerat Biol, Nagoya, Aichi 4678601, Japan.	sawamoto@med.nagoya-cu.ac.jp		Sawamoto, Kazunobu/0000-0003-1984-5129	Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [20022035, LS104, 21670003]; Uehara Memorial FoundationUehara Memorial Foundation; International Human Frontier Science Program OrganizationHuman Frontier Science Program; Global COE at Keio University;  [20509005]	This work was supported by the Funding Program for Next Generation World-Leading Researchers [LS104] (to K. Sawamoto); a Grant-in-Aid for Young Scientists (S) [21670003] (to K. Sawamoto); a Grant-in-Aid for Scientific Research on Priority Areas-Molecular Brain Science-from the Ministry of Education, Culture, Sports, Science and Technology of Japan [20022035] (to K. Sawamoto); by the Uehara Memorial Foundation (to K. Sawamoto); by The International Human Frontier Science Program Organization (to K. Sawamoto); by Global COE Programs at Keio University (to K. Sawamoto, N.K.); and by a Grant-in-Aid for Scientific Research (C) [20509005] (to N.K.).	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Ayari B, 2010, J NEUROTRAUM, V27, P959, DOI 10.1089/neu.2009.0972; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Byrd CA, 2001, NEUROSCIENCE, V105, P793, DOI 10.1016/S0306-4522(01)00215-9; Chapouton P, 2007, BIOESSAYS, V29, P745, DOI 10.1002/bies.20615; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Clint SC, 2001, DEV BRAIN RES, V130, P15, DOI 10.1016/S0165-3806(01)00193-6; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 2001, BRAIN BEHAV EVOLUT, V58, P306, DOI 10.1159/000057572; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Font E, 2001, BRAIN BEHAV EVOLUT, V58, P276, DOI 10.1159/000057570; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Jankovski A, 1996, J COMP NEUROL, V371, P376; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kaneko N, 2009, NEUROSCI RES, V63, P155, DOI 10.1016/j.neures.2008.12.001; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kempermann G, 2002, E SCHERING RES FDN W, V35, P17; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kirsche W, 1965, Ergeb Anat Entwicklungsgesch, V38, P143; Kishimoto N, 2011, J COMP NEUROL, V519, P3549, DOI 10.1002/cne.22722; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Mueller T, 2002, MECH DEVELOP, V117, P123, DOI 10.1016/S0925-4773(02)00194-6; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Prosser HM, 2007, P NATL ACAD SCI USA, V104, P648, DOI 10.1073/pnas.0606884104; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Tatsumi K, 2010, J CHEM NEUROANAT, V39, P15, DOI 10.1016/j.jchemneu.2009.09.003; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Taylor KL, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-11; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83; Westerfield M., 2000, ZEBRAFISH BOOK; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000363; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y; Zupanc GKH, 1998, EXP NEUROL, V152, P221, DOI 10.1006/exnr.1998.6853; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 1999, EXP NEUROL, V160, P78, DOI 10.1006/exnr.1999.7182; Zupanc GKH, 2006, REGEN MED, V1, P207, DOI 10.2217/17460751.1.2.207; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007; Zupanc MM, 2006, PROTEOMICS, V6, P677, DOI 10.1002/pmic.200500167	71	122	126	1	34	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	MAR	2012	5	2					200	209		10.1242/dmm.007336			10	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	927IA	WOS:000302899700006	22028327	gold, Green Published			2022-02-06	
J	Vinclair, M; Broux, C; Faure, P; Brun, J; Genty, C; Jacquot, C; Chabre, O; Payen, JF				Vinclair, Marc; Broux, Christophe; Faure, Patrice; Brun, Julien; Genty, Celine; Jacquot, Claude; Chabre, Olivier; Payen, Jean-Francois			Duration of adrenal inhibition following a single dose of etomidate in critically ill patients	INTENSIVE CARE MEDICINE			English	Article						etomidate; adrenal; corticotropin; critical care	TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; SEPTIC SHOCK; ENDOTRACHEAL INTUBATION; EMERGENCY-DEPARTMENT; CORTISOL RESPONSE; INDUCTION AGENT; INSUFFICIENCY; ANESTHESIA; SEPSIS	Objective: To determine the incidence and duration of adrenal inhibition induced by a single dose of etomidate in critically ill patients. Design: Prospective, observational cohort study. Setting: Three intensive care units in a university hospital. Patients: Forty critically ill patients without sepsis who received a single dose of etomidate for facilitating endotracheal intubation. Measurements and main results: Serial serum cortisol and 11 beta-deoxycortisol samples were taken at baseline and 60 min after corticotropin stimulation test (250 mu g 1-24 ACTH) at 12, 24, 48, and 72 h after etomidate administration. Etomidate-related adrenal inhibition was defined by the combination of a rise in cortisol less than 250 nmol/l (9 mu g/dl) after ACTH stimulation and an excessive accumulation of serum 11 beta-deoxycortisol concentrations at baseline. At 12 h after etomidate administration, 32/40 (80%) patients fulfilled the diagnosis criteria for etomidate-related adrenal insufficiency. This incidence was significantly lower at 48 h (9%) and 72 h (7%). The cortisol to 11 beta-deoxycortisol ratio (F/S ratio), reflecting the intensity of the 11 beta-hydroxylase enzyme blockade, improved significantly over time. Conclusions: A single bolus infusion of etomidate resulted in wide adrenal inhibition in critically ill patients. However, this alteration was reversible by 48 h following the drug administration. The empirical use of steroid supplementation for 48 h following a single dose of etomidate in ICU patients without septic shock should thus be considered. Concomitant serum cortisol and 11 beta-deoxycortisol dosages are needed to provide evidence for adrenal insufficiency induced by etomidate in critically ill patients.	[Vinclair, Marc; Broux, Christophe; Brun, Julien; Jacquot, Claude; Payen, Jean-Francois] Albert Michallon Hosp, Dept Anesthesiol & Crit Care, F-38043 Grenoble, France; [Faure, Patrice] Albert Michallon Hosp, Dept Biol, Grenoble, France; [Faure, Patrice] INSERM, ER 117, Lab HP2, Grenoble, France; [Genty, Celine] Univ Grenoble 1, UMR 5525, THEMA TIMC, Grenoble, France		Payen, JF (corresponding author), Albert Michallon Hosp, Dept Anesthesiol & Crit Care, BP 217, F-38043 Grenoble, France.	jfpayen@ujf-grenoble.fr	Payen, Jean-Francois/L-6667-2014	CHABRE, Olivier/0000-0001-8756-7218			Absalom A, 1999, ANAESTHESIA, V54, P861; Annane D, 2005, INTENS CARE MED, V31, P325, DOI 10.1007/s00134-005-2560-1; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2006, AM J RESP CRIT CARE, V174, P1319, DOI 10.1164/rccm.200509-1369OC; Arbous MS, 2001, ANAESTHESIA, V56, P1141, DOI 10.1046/j.1365-2044.2001.02051.x; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; den Brinker M, 2005, J CLIN ENDOCR METAB, V90, P5110, DOI 10.1210/jc.2005-1107; DUTHIE DJR, 1985, BRIT J ANAESTH, V57, P156, DOI 10.1093/bja/57.2.156; GOODING JM, 1979, ANESTH ANALG, V58, P40; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Jackson WL, 2005, CHEST, V127, P1031, DOI 10.1378/chest.127.3.1031; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kamp R, 2007, CRIT CARE, V11, DOI 10.1186/cc5939; Liouber-Friedman D, 2007, CRIT CARE MED, V35, P1012, DOI 10.1097/01.CCM.0000259465.92018.6E; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; Mohammad Z, 2006, CRIT CARE, V10, DOI 10.1186/cc4979; Morris C, 2005, ANAESTHESIA, V60, P737, DOI 10.1111/j.1365-2044.2005.04325.x; Murray H, 2005, CHEST, V127, P707, DOI 10.1378/chest.127.3.707; Oglesby AJ, 2004, EMERG MED J, V21, P655, DOI 10.1136/emj.2003.009043; Ray DC, 2007, CRIT CARE, V11, DOI 10.1186/cc5916; Reich DL, 2005, ANESTH ANALG, V101, P622, DOI 10.1213/01.ANE.0000175214.38450.91; Salgado DR, 2006, CRIT CARE, V10, DOI 10.1186/cc5077; Schenarts CL, 2001, ACAD EMERG MED, V8, P1, DOI 10.1111/j.1553-2712.2001.tb00537.x; Siraux V, 2005, CRIT CARE MED, V33, P2479, DOI 10.1097/01.CCM.0000185641.87051.7C; Smith DC, 2000, J EMERG MED, V18, P13, DOI 10.1016/S0736-4679(99)00154-7; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202	29	122	126	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	APR	2008	34	4					714	719		10.1007/s00134-007-0970-y			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	278BV	WOS:000254259400017	18092151				2022-02-06	
J	Noreau, L; Lepage, C; Boissiere, L; Picard, R; Fougeyrollas, P; Mathieu, J; Desmarais, G; Nadeau, L				Noreau, Luc; Lepage, Celine; Boissiere, Lucie; Picard, Roger; Fougeyrollas, Patrick; Mathieu, Jean; Desmarais, Gilbert; Nadeau, Line			Measuring participation in children with disabilities using the assessment of life habits	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							HANDICAP SITUATIONS; CEREBRAL-PALSY; SOCIAL-PARTICIPATION; REHABILITATION; RELIABILITY; CONSEQUENCES; ASSOCIATION; VALIDATION	The objectives of this study were: (1) to examine the psychometric properties of the Assessment of Life Habits (LIFE-H) for children; and (2) to draw a profile of the level of participation among children of 5 to 13 years of age with various impairments. The research team adapted the adult version of the LIFE-H in order to render it more appropriate for the daily life experiences of children. Content validity was verified by an expert panel of 29 people, made up of parents, paediatric clinicians, and researchers. Reliability and construct validity of the LIFE-H for children (interview-administered form) was tested during an experiment that comprised three sessions of interviews with a group of 94 parents of children with disabilities (36 males, 58 females; mean age 8y 10mo [SD 2y 6 mo]; diagnostic groups: cerebral palsy, myelomeningocoele, sensory-motor neuropathy, traumatic brain injury, and developmental delay). Overall, the LIFE-H showed high intrarater reliability with intraclass correlation coefficient values of 0.78 or higher for 10 out of 11 categories. The correlations between the LIFE-H and the tools used in pediatric rehabilitation varied, and categories with similar constructs generally led to higher correlations. The psychometric properties of the LIFE-H are appropriate and its content allows a complete description of participation among children with disabilities.	Univ Laval, Fac Med, Rehabil Dept, Quebec City, PQ G1K 7P4, Canada; CIRRIS, Quebec City, PQ G1M 2S8, Canada; Inst Rehabil, Quebec City, PQ, Canada; Neuromuscular Clin, Jonquiere, PQ, Canada		Noreau, L (corresponding author), CIRRIS, 525 Blvd Hamel, Quebec City, PQ G1M 2S8, Canada.	Luc.Noreau@rea.ulaval.ca					Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; COSTER W, 1998, SCHOOL FUNCTION ASSE; Desrosiers J, 2002, DISABIL REHABIL, V24, P774, DOI 10.1080/09638280210125814; Detmar SB, 2005, CLIN REHABIL, V19, P73, DOI 10.1191/0269215505cr825oa; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Fougeyrollas P, 2001, HDB DISABILITY STUDI, P171; FOUGEYROLLAS P, 1989, RESEAU INT CIDIH, V2, P21; HALEY SM, 1991, PEDIATRIC PHYSICAL T, V3, P177; Jette AM, 2003, J REHABIL MED, V35, P145, DOI 10.1080/16501970310010501; King GA, 2007, CHILD CARE HLTH DEV, V33, P28, DOI 10.1111/j.1365-2214.2006.00613.x; King Gillian, 2002, Physical and Occupational Therapy in Pediatrics, V22, P53, DOI 10.1300/J006v22n02_04; Law M., 2004, SCAND J OCCUP THER, V11, P156, DOI DOI 10.1080/11038120410020755; LAW M, 2002, PHYS OCCUP THER PEDI, V22, P103; Lepage C, 1998, SCAND J REHABIL MED, V30, P263; Lepage C, 1998, PHYS THER, V78, P458, DOI 10.1093/ptj/78.5.458; Machin D., 1997, SAMPLE SIZE TABLES C; Morris C, 2005, CHILD CARE HLTH DEV, V31, P397, DOI 10.1111/j.1365-2214.2005.00519.x; Noreau L, 2004, DISABIL REHABIL, V26, P346, DOI 10.1080/09638280410001658649; Noreau L, 2000, DISABIL REHABIL, V22, P170; Ottenbacher KJ, 1996, DEV MED CHILD NEUROL, V38, P907; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rochette A, 2001, DISABIL REHABIL, V23, P559; Rosenbaum P, 2003, BRIT MED J, V326, P970, DOI 10.1136/bmj.326.7396.970; Simeonsson RJ, 2001, DISABIL REHABIL, V23, P49; Vincent C., 2002, TECHNOLOGY DISABILIT, V14, P113, DOI DOI 10.3233/TAD-2002-14306; World Health Organization, 2007, INT CLASS FUNCT DIS	27	122	123	0	18	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	SEP	2007	49	9					666	671		10.1111/j.1469-8749.2007.00666.x			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	203HU	WOS:000248966500008	17718822	Bronze			2022-02-06	
J	Calhoun, SL; Mayes, SD				Calhoun, SL; Mayes, SD			Processing speed in children with clinical disorders	PSYCHOLOGY IN THE SCHOOLS			English	Article							ATTENTION-DEFICIT DISORDER; TRAUMATIC HEAD-INJURY; WISC-III; LEARNING-DISABILITIES; ACADEMIC-ACHIEVEMENT; HYPERACTIVITY DISORDER; STRATEGY INSTRUCTION; READING DISABILITIES; SUBTEST PATTERNS; PROFILE TYPES	The Processing Speed Index (PSI) was first introduced on the Wechsler Intelligence Scale, Third Edition (WISC-III; D. Wechsler, 1991), and little is known about its clinical significance. In a referred sample (N = 980), children with neurological disorders (ADHD, autism, bipolar disorder, and LD) had mean PSI and Freedom from Distractibility Index (FDI) scores that were below the group mean IQ and lower than Verbal Comprehension (VCI) and Perceptual Organization (POI). For these groups, Coding was lower than Symbol Search. The majority of these children had learning, attention, writing, and processing speed weaknesses. This pattern was not found in the other clinical groups. For children with depression, only PSI was low. Children with anxiety disorders, oppositional -defiant disorder, and mental retardation had no PSI weakness. PSI and POI were both low in children with traumatic brain injury and spina bifida. Implications for a revision of the WISC-III (WISC-IV; D. Wechsler, 2003) are discussed. (c) 2005 Wiley Periodicals, Inc.	Milton S Hershey Med Ctr, Dept Psychiat, Hershey, PA 17033 USA; Penn State Univ, Coll Med, University Pk, PA 16802 USA		Mayes, SD (corresponding author), Milton S Hershey Med Ctr, Dept Psychiat, H073,POB 850, Hershey, PA 17033 USA.	SMayes@psu.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson JA, 2001, J EMOT BEHAV DISORD, V9, P106, DOI 10.1177/106342660100900205; BARKLEY RA, 1990, J CONSULT CLIN PSYCH, V58, P775, DOI 10.1037/0022-006X.58.6.775; Biederman J, 2001, J AM ACAD CHILD PSY, V40, P871, DOI 10.1097/00004583-200108000-00007; Bray MA, 1998, SCHOOL PSYCHOL INT, V19, P209, DOI 10.1177/0143034398193002; CANTWELL DP, 1992, J AM ACAD CHILD PSY, V31, P432, DOI 10.1097/00004583-199205000-00008; Carlson CL, 2002, J CLIN CHILD ADOLESC, V31, P123, DOI 10.1207/S15374424JCCP3101_14; Casey JE, 1996, CHILD NEUROPSYCHOL, V2, P83, DOI 10.1080/09297049608401354; Cohen J., 2013, STAT POWER ANAL BEHA; Crowell E., 1998, J ATTEN DISORD, V2, P217, DOI [10.1177/108705479800200402, DOI 10.1177/108705479800200402]; DANOFF B, 1993, J READING BEHAV, V25, P295, DOI 10.1080/10862969009547819; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; *FED REG, 1999, IND DIS ED ACT IDEA; FIEDOROWICZ C, 2001, MULTIDISCIPLINARY J, V11, P61; Fletcher J.M., 1998, LEARNING DISABILITIE, V13, P186; Fletcher JM, 1999, PEDIATR CLIN N AM, V46, P885, DOI 10.1016/S0031-3955(05)70161-9; Glassberg LA, 1999, BEHAV DISORDERS, V25, P9; GLUTTING JJ, 1994, SCHOOL PSYCHOL REV, V23, P619; GOODYEAR P, 1992, J CLIN CHILD PSYCHOL, V21, P273, DOI 10.1207/s15374424jccp2103_9; Gresham FM, 1996, J LEARN DISABIL, V29, P570, DOI 10.1177/002221949602900601; Hale JB, 2001, SCHOOL PSYCHOL QUART, V16, P31, DOI 10.1521/scpq.16.1.31.19158; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Hooper SR, 2002, J LEARN DISABIL-US, V35, P57, DOI 10.1177/002221940203500105; Hooper SR, 1997, ADV CLIN CHILD PSYCH, V19, P133; Hoskyn M, 2000, SCHOOL PSYCHOL REV, V29, P102; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1088, DOI 10.1001/archpsyc.56.12.1088; Jimenez JE, 2003, J LEARN DISABIL-US, V36, P34, DOI 10.1177/00222194030360010501; Kaufman, 1994, INTELLIGENT TESTING; Kay JB, 1999, J CLIN EXP NEUROPSYC, V21, P186, DOI 10.1076/jcen.21.2.186.927; Keith TZ, 1997, SCHOOL PSYCHOL QUART, V12, P89, DOI 10.1037/h0088950; KRAMER JH, 1993, PSYCHOL ASSESSMENT, V5, P193; LANE SE, 1994, J PSYCHOEDUC ASSESS, V12, P142, DOI 10.1177/073428299401200204; Larsen L., 2001, LEARNING DISABILITIE, V16, P74, DOI [10.1111/0938-8982.00009, DOI 10.1111/0938-8982.00009]; *LEARN DIS ROUNDT, 2002, SPEC LEARN DIS FIND; MacArthur CA, 1996, J LEARN DISABIL, V29, P344, DOI 10.1177/002221949602900403; MacArthur CA, 2000, TOP LANG DISORD, V20, P85, DOI 10.1097/00011363-200020040-00008; Mayes SD, 1998, PSYCHOL SCHOOLS, V35, P309; Mayes SD, 2000, J LEARN DISABIL-US, V33, P417, DOI 10.1177/002221940003300502; Mayes SD, 2003, J AUTISM DEV DISORD, V33, P329, DOI 10.1023/A:1024462719081; MAYES SD, 2003, ANN M AM PSYCH ASS S; McBurnett K, 2001, J ABNORM CHILD PSYCH, V29, P207, DOI 10.1023/A:1010377530749; MCDERMOTT PA, 1990, J PSYCHOEDUC ASSESS, V8, P290, DOI 10.1177/073428299000800307; Mealer C., 1996, J ATTEN DISORD, V1, P133, DOI [DOI 10.1177/108705479600100302, 10.1177/108705479600100302]; Naglieri JA, 2003, J PSYCHOEDUC ASSESS, V21, P32, DOI 10.1177/073428290302100103; NEWBY RF, 1993, J PSYCHOEDUC ASSESS, P87; Nyden A, 2001, DEV MED CHILD NEUROL, V43, P165, DOI 10.1017/S0012162201000329; Oh HJ, 1999, J PSYCHOEDUC ASSESS, V17, P362, DOI 10.1177/073428299901700406; PRIFITERA A, 1993, J PSYCHOEDUC ASSESS, P43; Prifitera A., 1998, WISC 3 CLIN USE INTE, P1, DOI [10.1016/B978-012564930-8/50002-4, DOI 10.1016/B978-012564930-8/50002-4]; Raskind WH, 2001, LEARN DISABILITY Q, V24, P141, DOI 10.2307/1511240; Saklofske D. H., 1995, CANADIAN J SCH PSYCH, V10, P167, DOI [10.1177/082957359501000210, DOI 10.1177/082957359501000210]; Sattler J. M., 2002, ASSESSMENT CHILDREN; SAWYER RJ, 1992, J EDUC PSYCHOL, V84, P340, DOI 10.1037/0022-0663.84.3.340; SCHWEAN VL, 1993, J PSYCHOEDUC ASSESS, P56; SEIDMAN LJ, 1995, J AM ACAD CHILD PSY, V34, P1015, DOI 10.1097/00004583-199508000-00011; Snow JB, 2000, PSYCHOL REP, V87, P759, DOI 10.2466/PR0.87.7.759-765; Tannock R., 2000, ATTENTION DEFICIT DI; TRAMONTANA MG, 1990, J AM ACAD CHILD PSY, V29, P265, DOI 10.1097/00004583-199003000-00016; Vaughn S, 2000, EXCEPT CHILDREN, V67, P99, DOI 10.1177/001440290006700107; Ward TJ, 1999, SCHOOL PSYCHOL REV, V28, P629; Wechsler D., 2003, WISC 4 TECHNICAL INT; Wechsler D, 1992, MANUAL WECHLSER INDI; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; [No title captured]; [No title captured]	66	122	128	1	51	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0033-3085	1520-6807		PSYCHOL SCHOOLS	Psychol. Schools	APR	2005	42	4					333	343		10.1002/pits.20067			11	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	912BT	WOS:000228052800001					2022-02-06	
J	Holbrook, TL; Hoyt, DB; Coimbra, R; Potenza, B; Sise, M; Anderson, JP				Holbrook, TL; Hoyt, DB; Coimbra, R; Potenza, B; Sise, M; Anderson, JP			Long-term posttraumatic stress disorder persists after major trauma in adolescents: New data on risk factors and functional outcome	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	63rd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 29-OCT 02, 2004	Maui, HI	Amer Assoc Surg Trauma			QUALITY-OF-LIFE; MOTOR-VEHICLE ACCIDENTS; RECOVERY PROJECT; MULTIPLE TRAUMA; GENERAL HEALTH; INJURY; IMPACT; CHILDREN; GENDER; WOMEN	Background: Little is known about long-term psychological outcomes after major trauma in adolescents, a leading cause of death and preventable morbidity in this age group. A prospective epidemiologic study was conducted to examine quality of life (QoL) and posttramnatic stress disorder (PTSD) outcomes in injured adolescents. The specific objectives of the present report are to describe long-term PTSD and to identify risk factors for long-term PTSD and the impact of PTSD on QoL. Methods: Between April 26, 1999, and November 13, 2002, 401 eligible trauma patients aged 12 to 19 years triaged to five participating trauma center hospitals in a regionalized trauma system were enrolled in the study. The admission criteria for patients were as follows: age 12 to 19 years and injury diagnoses excluding severe traumatic brain injury or spinal cord injury. PTSD was diagnosed with the Impact of Events Scale-Revised; scores of 24+ were used to diagnose PTSD. QoL after trauma was measured using the Quality of Well-Being scale, a sensitive and well-validated functional index (range: 0 = death to 1.000 = optimum functioning). Patient outcomes were assessed at discharge and at 3, 6, 12, 18, and 24 months after discharge. Results: The rate of long-term PTSD was 27%, with high rates over the follow-up period. Risk factors for long-term PTSD were perceived threat to life (odds ratio [OR], 2.2; p < 0.001.); death of a family member at the scene (OR, 4.7; p < 0.001); no control over injury event (OR, 1.7; p < 0.05), and violence-related injury (OR, 2.2; p < 0.05). PTSD in adolescents was significantly and strongly associated with female gender, older age, low socioeconomic status, drug and alcohol abuse, and other adolescent behavioral problems. Long-term PTSD was also associated with marked and significant QoL deficits throughout the 24-month follow-up interval. Conclusion: High rates of long-term PTSD persist after major trauma in adolescents. Injury events such as perceived threat to life and control over the event are strongly associated with PTSD risk. Prolonged PTSD severely impacts QoL outcomes. Early identification and treatment of risk factors for long-term PTSD will be important to improve outcomes in injured adolescents.	Univ Calif San Diego, Med Ctr, Dept Family & Prevent Med, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Surg, Div Trauma, San Diego, CA 92103 USA; Mercy Hosp, Ctr Trauma, San Diego, CA USA		Holbrook, TL (corresponding author), Univ Calif San Diego, Med Ctr, Dept Family & Prevent Med, 8896,200 W Arbor Dr, San Diego, CA 92103 USA.	tholbrook@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851	AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01 HS 07611] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS007611] Funding Source: NIH RePORTER		ANDERSON JP, 1986, MED CARE, V24, P454, DOI 10.1097/00005650-198605000-00008; ANDERSON JP, 1988, J CLIN EPIDEMIOL, V41, P127, DOI 10.1016/0895-4356(88)90087-X; Anke AGW, 1997, J TRAUMA, V42, P54, DOI 10.1097/00005373-199701000-00010; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; BLANCHARD EB, 1995, BEHAV RES THER, V33, P529, DOI 10.1016/0005-7967(94)00079-Y; Bouillon B, 2002, RESTOR NEUROL NEUROS, V20, P125; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Brown ES, 2000, COMPR PSYCHIAT, V41, P19, DOI 10.1016/S0010-440X(00)90126-3; Bryant RA, 1996, J TRAUMA STRESS, V9, P223, DOI 10.1002/jts.2490090206; Bush JW., 1982, HEALTH PSYCHOL, V1, P61, DOI [10.1037/0278-6133.1.1.61, DOI 10.1037/0278-6133.1.1.61]; Butcher JL, 1996, J TRAUMA, V41, P4, DOI 10.1097/00005373-199607000-00002; Caffo E, 2003, CHILD ADOL PSYCH CL, V12, P493, DOI 10.1016/S1056-4993(03)00004-X; Chaffin M, 2001, CHILD ABUSE NEGLECT, V25, P401, DOI 10.1016/S0145-2134(00)00257-X; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holbrook TL, 2001, J TRAUMA, V50, P91, DOI 10.1097/00005373-200101000-00016; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; KAPLAN J, 2001, WORKINT PREVENT CONT; KAPLAN RM, 1984, J CHRON DIS, V37, P85, DOI 10.1016/0021-9681(84)90050-X; KAPLAN RM, 1988, J CONSULT CLIN PSYCH, V56, P1; KAPLAN RM, 1978, P AM STAT ASSOC, P704; LANDSMAN IS, 1990, J BEHAV MED, V13, P561, DOI 10.1007/BF00844735; MacKenzie EJ, 1996, J TRAUMA, V41, P799, DOI 10.1097/00005373-199611000-00006; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Michaels AJ, 1999, J TRAUMA, V47, P867, DOI 10.1097/00005373-199911000-00009; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Ott R, 1996, UNFALLCHIRURG, V99, P267; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Richmond TS, 1998, J TRAUMA, V44, P635, DOI 10.1097/00005373-199804000-00012; Schlesselman JJ., 1982, CASE CONTROL STUDIES; Seekamp A, 1996, INJURY, V27, P133, DOI 10.1016/0020-1383(95)00178-6; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Winston FK, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e90	41	122	124	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2005	58	4					764	769		10.1097/01.TA.0000159247.48547.7D			6	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	919VS	WOS:000228646300029	15824653				2022-02-06	
J	Ikeda, M; Sugiyama, K; Kang, CT; Takagaki, T; Oka, Y				Ikeda, M; Sugiyama, K; Kang, CT; Takagaki, T; Oka, Y			Comminuted fractures of the radial head - Comparison of resection and internal fixation	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							OPEN REDUCTION; CLOSED FRACTURE; FOLLOW-UP; EXCISION; ELBOW; JOINT; VALGUS; ADULTS; SCREW	Background: Satisfactory internal fixation of comminuted radial head fractures is often difficult to achieve, and radial head resection has been the accepted treatment. In this study, we compared the results of radial head resection with those of open reduction and internal fixation in patients with a comminuted radial head fracture. Methods: Twenty-eight patients with a Mason type-III radial head fracture (some with associated injuries) were enrolled in the study. Fifteen patients underwent radial head resection as the initial treatment (Group I), and thirteen patients underwent open reduction and internal fixation (Group II). The age at the operation averaged 41.1 and 38.2 years, respectively, and the duration of follow-up averaged ten and three years, respectively. The outcomes were assessed on the basis of pain, motion, radiographic findings, and strength measured with Cybex testing. The overall outcome was rated with the functional rating score described by Broberg and Morrey and with the American Shoulder and Elbow Surgeons Elbow Assessment Form. Results: Elbow motion averaged 15.5degrees (extension loss) to 131.4degrees (flexion) in Group I and 7.1degrees to 133.8degrees in Group II. The carrying angle and ulnar variance averaged 8.2degrees and 1.9 mm in Group I and 1.5degrees and 0.5 mm in Group II. Compared with Group II, Group I had a loss of strength in extension, pronation, and supination (p < 0.01). The Broberg and Morrey functional rating score averaged 81.4 points in Group I and 90.7 points in Group II (p = 0.0034). The score on the American Shoulder and Elbow Surgeons Elbow Assessment Form averaged 87.3 points in Group I and 94.6 points in Group II (p = 0.0031). Conclusions: The patients in whom the comminuted radial head fracture was treated with open reduction and internal fixation had satisfactory joint motion, with greater strength and better function than the patients who had undergone radial head resection. These results support a recommendation for open reduction and internal fixation in the treatment of this fracture. Level of evidence.	Tokai Univ, Oiso Hosp, Dept Orthopaed Surg, Oio, Kanagawa 2590198, Japan		Ikeda, M (corresponding author), Tokai Univ, Oiso Hosp, Dept Orthopaed Surg, 21-1 Gakkyo, Oio, Kanagawa 2590198, Japan.	zenryo@oiso.u-tokai.ac.jp					ADLER J B, 1964, J Trauma, V4, P115, DOI 10.1097/00005373-196401000-00009; BAKALIM G, 1970, ACTA ORTHOP SCAND, V41, P320, DOI 10.3109/17453677008991518; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; BUNKER TD, 1985, INJURY, V16, P621, DOI 10.1016/0020-1383(85)90011-7; COLEMAN DA, 1987, J BONE JOINT SURG AM, V69A, P385; ESSER RD, 1995, J ORTHOP TRAUMA, V9, P318, DOI 10.1097/00005131-199509040-00008; Frankle MA, 1999, J SHOULDER ELB SURG, V8, P355, DOI 10.1016/S1058-2746(99)90160-X; Fuchs S, 1999, J SHOULDER ELB SURG, V8, P247, DOI 10.1016/S1058-2746(99)90137-4; Geel C W, 1990, J Orthop Trauma, V4, P270, DOI 10.1097/00005131-199004030-00006; GEEL CW, 1992, CLIN ORTHOP RELAT R, P79; GOLDBERG I, 1986, J BONE JOINT SURG AM, V68A, P675, DOI 10.2106/00004623-198668050-00006; GUSTILO RB, 1990, J BONE JOINT SURG AM, V72A, P299, DOI 10.2106/00004623-199072020-00023; Hotchkiss, 1997, J Am Acad Orthop Surg, V5, P1; Ikeda A, 2003, J BONE JOINT SURG BR, V85B, P1040, DOI 10.1302/0301-620X.85B7.13823; Janssen RPA, 1998, J BONE JOINT SURG BR, V80B, P231, DOI 10.1302/0301-620X.80B2.8255; Jensen SL, 1999, J SHOULDER ELB SURG, V8, P238, DOI 10.1016/S1058-2746(99)90135-0; JOHNSTON G W, 1962, Ulster Med J, V31, P51; King G J, 1991, J Orthop Trauma, V5, P21, DOI 10.1097/00005131-199103000-00004; King GJW, 1999, J SHOULDER ELB SURG, V8, P351; Kuntz DG, 1999, ORTHOP CLIN N AM, V30, P37, DOI 10.1016/S0030-5898(05)70060-2; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; MCARTHUR RA, 1987, CLIN ORTHOP RELAT R, P79; MEZERA K, 2001, ROCKWOOD GREENS FRAC, V1, P940; MIKIC ZD, 1983, CLIN ORTHOP RELAT R, P220; MORREY BF, 1991, CLIN ORTHOP RELAT R, P187; Morrey BF, 1997, J BONE JOINT SURG AM, V79A, P460, DOI 10.2106/00004623-199703000-00023; MORREY BF, 1979, J BONE JOINT SURG AM, V61, P63, DOI 10.2106/00004623-197961010-00012; Morrey BF, 2000, ELBOW ITS DISORDERS, P341; Pearce MS, 1996, J ROY SOC MED, V89, pP340, DOI 10.1177/014107689608900616; REGAN W, 1989, J BONE JOINT SURG AM, V71A, P1348, DOI 10.2106/00004623-198971090-00011; Ring D, 2002, J BONE JOINT SURG AM, V84A, P1811, DOI 10.2106/00004623-200210000-00011; Sanchez-Sotelo J, 2000, J ORTHOP TRAUMA, V14, P354, DOI 10.1097/00005131-200006000-00009; SANDERS RA, 1986, AM J SPORT MED, V14, P130, DOI 10.1177/036354658601400206; Shepard MF, 2001, J BONE JOINT SURG AM, V83A, P92, DOI 10.2106/00004623-200101000-00013; SOWA DT, 1995, CLIN ORTHOP RELAT R, P106; STEPHEN IBM, 1981, ACTA ORTHOP SCAND, V52, P409, DOI 10.3109/17453678109050121; SUTRO CJ, 1985, B HOSP JOINT DIS ORT, V45, P65; TAYLOR TKF, 1964, J BONE JOINT SURG BR, V46, P83, DOI 10.1302/0301-620X.46B1.83	38	122	134	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	JAN	2005	87A	1					76	84		10.2106/JBJS.C.01323			9	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	887OR	WOS:000226315900011	15634816				2022-02-06	
J	Cernak, I; Vink, R; Zapple, DN; Cruz, MI; Ahmed, F; Chang, T; Fricke, ST; Faden, AI				Cernak, I; Vink, R; Zapple, DN; Cruz, MI; Ahmed, F; Chang, T; Fricke, ST; Faden, AI			The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats	NEUROBIOLOGY OF DISEASE			English	Article						diffuse traumatic brain injury; rat; model; manganese-enhanced magnetic resonance	CLOSED-HEAD-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; INTRACELLULAR FREE MAGNESIUM; CONTROLLED CORTICAL IMPACT; AXONAL INJURY; COGNITIVE IMPAIRMENT; CA CHANNELS; TIME-COURSE; LONG-TERM; EDEMA	Experimental models of traumatic brain injury have been developed to replicate selected aspects of human head injury, such as contusion, concussion, and/or diffuse axonal injury. Although diffuse axonal injury is a major feature of clinical head injury, relatively few experimental models of diffuse traumatic brain injury (TBI) have been developed, particularly in smaller animals such as rodents. Here, we describe the pathophysiological consequences of moderate diffuse TBI in rats generated by a newly developed, highly controlled, and reproducible model. This model of TBI caused brain edema beginning 20 min after injury and peaking at 24 h post-trauma, as shown by wet weight/dry weight ratios and diffusion-weighted magnetic resonance imaging. Increased permeability of the blood-brain barrier was present up to 4 h post-injury as evaluated using Evans blue dye. Phosphorus magnetic resonance spectroscopy showed significant declines in brain-free magnesium concentration and reduced cytosolic phosphorylation potential at 4 h post-injury. Diffuse axonal damage was demonstrated using manganese-enhanced magnetic resonance imaging, and intracerebral injection of a fluorescent vital dye (Fluoro-Ruby) at 24-h and 7-day post-injury. Morphological evidence of apoptosis and caspase-3 activation were also found in the cerebral hemisphere and brainstent at 24 h after trauma. These results show that this model is capable of reproducing major biochemical and neurological changes of diffuse clinical TBI. (C) 2004 Elsevier Inc. All rights reserved.	Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA; Univ Adelaide, Dept Pathol, Adelaide, SA, Australia; Georgetown Univ, Off Informat Serv, Adv Res Comp, Washington, DC 20057 USA; Childrens Hosp, Dept Pediat Neurol, Washington, DC USA		Cernak, I (corresponding author), Georgetown Univ, Dept Neurosci, 3970 Reservoir Rd NW,Res Bldg,Room EP04, Washington, DC 20057 USA.	ifc@georgetown.edu	Vink, Robert/S-5616-2019; Cernak, Ibolja/A-6399-2008; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ibolja, Cernak/0000-0003-3214-698X; Chang, Taeun/0000-0002-1797-8449			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Aoki I, 2003, MAGNET RESON MED, V50, P7, DOI 10.1002/mrm.10528; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BECKMAN DL, 1970, J APPL PHYSIOL, V29, P631, DOI 10.1152/jappl.1970.29.5.631; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; De Mulder G, 2000, ACT NEUR S, V76, P409; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P355, DOI 10.1097/01.WCB.0000046144.31247.33; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; Faden AI., 1994, NEUROBIOLOGY CENTRAL, P3; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; GUPTA RK, 1978, J BIOL CHEM, V253, P6172; Hall E.D., 1995, CENTRAL NERVOUS SYST, P213; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KITA H, 1994, ACTA NEUROCHIR, P452; KLATZO I, 1987, Z KARDIOL, V76, P67; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Li FH, 1996, DRUG TODAY, V32, P615; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Mahoney EJ, 2003, J TRAUMA, V55, P1065, DOI 10.1097/01.TA.0000100381.89107.93; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morita H, 2002, NEUROSCI LETT, V326, P101, DOI 10.1016/S0304-3940(02)00330-0; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHIBUYA I, 1993, CELL CALCIUM, V14, P33, DOI 10.1016/0143-4160(93)90016-Y; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Tannock GW, 1992, LACTIC ACID BACTERIA, V1, P21; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Teasdale GM, 1999, ACT NEUR S, V73, P111; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Vink R, 1996, J NEUROCHEM, V66, P2477; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; VINK R, 2003, ENCY NEUROSCIENCE; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yuan XQ, 1991, J NEUROTRAUM, V8, P219, DOI 10.1089/neu.1991.8.219; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	78	122	135	0	17	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2004	17	1					29	43		10.1016/j.nbd.2004.05.011			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855AC	WOS:000223944200004	15350963				2022-02-06	
J	Hallam, TM; Floyd, CL; Folkerts, MM; Lee, LL; Gong, QZ; Lyeth, BG; Muizelaar, JP; Berman, RF				Hallam, TM; Floyd, CL; Folkerts, MM; Lee, LL; Gong, QZ; Lyeth, BG; Muizelaar, JP; Berman, RF			Comparison of behavioral deficits and acute neuronal degeneration in rat lateral fluid percussion and weight-drop brain injury models	JOURNAL OF NEUROTRAUMA			English	Article						fluoro-Jade; hypoxia; lateral fluid percussion; memory; motor behavior; neuronal degeneration; traumatic brain injury; weight-drop impact acceleration	IMPACT-ACCELERATION INJURY; METABOTROPIC GLUTAMATE ANTAGONIST; WATER MAZE PERFORMANCE; VOLATILE ANESTHETICS; CEREBRAL-ISCHEMIA; FLUORO-JADE; HEAD-INJURY; COGNITIVE IMPAIRMENT; HIPPOCAMPUS; MOTOR	The behavioral and histological effects of the lateral fluid percussion (LFP) brain injury model were compared with the weight drop impact-acceleration model with 10 min of secondary hypoxia (WDIA+H). LFP injury resulted in significant motor deficits on the beam walk and inclined plane, and memory deficits on the radial arm maze and Morris water maze. Motor deficits following LFP remained throughout 6 weeks of behavioral testing. WDIA+H injury produced significant motor deficits on the beam walk and inclined plane immediately following injury, but these effects were transient and recovered by 14 days post-injury. In contrast to the LFP injury, the WDIA+H injured animals showed no memory deficits on the radial arm maze and Morris water maze. In order to determine if the differences in behavioral outcome between models were due to differences in injury mechanism or injury severity, 10 LFP-injured animals were matched with 10 WDIA-injured animals based on injury severity (i.e., time to regain righting reflex after brain injury). The LFP-matched injury group showed greater impairment than the WDIA+H matched injury group on the radial arm maze and Morris water maze. Histological examination of LFP-injured brains with Fluoro-Jade staining 24 h, 48 h, and 7 days post-injury revealed degenerating neurons in the cortex, thalamus, hippocampus, caudate-putamen, brainstem, and cerebellum, with degenerating fibers tracts in the corpus callosum and other major tracts throughout the brain. Fluoro-Jade staining following WDIA+H injury revealed damage to fibers in the optic tract, lateral olfactory tract, corpus callosum, anterior commissure, caudate-putamen, brain stem, and cerebellum. While both models produce reliable and characteristic behavioral and neuronal pathologies, their differences are important to consider when choosing a brain injury model.	Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA		Berman, RF (corresponding author), Univ Calif Davis, Dept Neurosurg, Neurotrauma Res Labs, 1 Shields Ave, Davis, CA 95616 USA.	rfberman@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045136, R01NS039090, R01NS029995] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 45136, NS 39090, NS 29995] Funding Source: Medline		BAUGHMAN VL, 1988, ANESTHESIOLOGY, V69, P192, DOI 10.1097/00000542-198808000-00007; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Beaumont A, 2000, NEUROL RES, V22, P665; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Di X, 1999, J NEUROTRAUM, V16, P195, DOI 10.1089/neu.1999.16.195; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Kudo M, 2001, ANESTHESIOLOGY, V95, P756, DOI 10.1097/00000542-200109000-00031; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maughan PH, 2000, J NEUROTRAUM, V17, P1141, DOI 10.1089/neu.2000.17.1141; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MICHENFELDER JD, 1987, ANESTHESIOLOGY, V67, P336, DOI 10.1097/00000542-198709000-00010; Miyazaki H, 1997, ANESTHESIOLOGY, V86, P1359, DOI 10.1097/00000542-199706000-00018; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; RUTA TS, 1991, CAN J ANAESTH, V38, P129, DOI 10.1007/BF03009176; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Swanson L.W., 1998, BRAIN MAPS STRUCTURE, V2; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; WARNER DS, 1991, J CEREBR BLOOD F MET, V11, P794, DOI 10.1038/jcbfm.1991.137; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Wise-Faberowski L, 2001, ANESTH ANALG, V93, P1281, DOI 10.1097/00000539-200111000-00051; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	60	122	126	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2004	21	5					521	539		10.1089/089771504774129865			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821LK	WOS:000221461900004	15165361				2022-02-06	
J	Hang, CH; Shi, JX; Li, JS; Wu, W; Yin, HX				Hang, CH; Shi, JX; Li, JS; Wu, W; Yin, HX			Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats	WORLD JOURNAL OF GASTROENTEROLOGY			English	Article							MULTIPLE ORGAN FAILURE; HEAD-INJURY; PERMEABILITY; GUT; TRANSLOCATION; INFLAMMATION; ENDOTOXEMIA; INJECTION; SEVERITY	AIM: Gastrointestinal dysfunction is a common complication in patients with traumatic brain injury (TBI). However, the effect of traumatic brain injury on intestinal mucosa has not been studied previously. The aim of the current study was to explore the alterations of intestinal mucosa morphology and barrier function, and to determine how rapidly the impairment of gut barrier function occurs and how long it persists following traumatic brain injury. METHODS: Male Wistar rats were randomly divided into six groups (6 rats each group) including controls without brain injury and traumatic brain injury groups at hours 3, 12, 24, and 72, and on day 7. The intestinal mucosa structure was detected by histopathological examination and electron microscopy. Gut barrier dysfunction was evaluated by detecting serum endotoxin and intestinal permeability. The level of serum endotoxin and intestinal permeability was measured by using chromogenic limulus amebocyte lysate and lactulose/mannitol (L/M) ratio, respectively. RESULTS: After traumatic brain injury, the histopathological alterations of gut mucosa occurred rapidly as early as 3 hours and progressed to a serious state, including shedding of epithelial cells, fracture of villi, focal ulcer, fusion of adjacent villi, dilation of central chyle duct, mucosal atrophy, and vascular dilation, congestion and edema in the villous interstitium and lamina propria. Apoptosis of epithelial cells, fracture and sparseness of microvilli, loss of tight junction between enterocytes, damage of mitochondria and endoplasm, were found by electron microscopy. The villous height, crypt depth and surface area in jejunum decreased progressively with the time of brain injury. As compared with that of control group (183.7 +/- 41.8 EU/L), serum endotoxin level was significantly increased at 3, 12, and 24 hours following TBI (434.8 +/- 54.9 EU/L, 324.2 +/- 61.7 EU/L and 303.3 +/- 60.2 EU/L, respectively),and peaked at 72 hours (560.5 +/- 76.2 EU/L), then declined on day 7 (306.7 +/- 62.4 EU/L, P<0.01). Two peaks of serum endotoxin level were found at hours 3 and 72 following TBI. L/M ratio was also significantly higher in TBI groups than that in control group (control, 0.0172 +/- 0.0009; 12 h, 0.0303 +/- 0.0013; 24 h, 0.0354 +/- 0.0025; 72 h, 0.0736 +/- 0.0105; 7 d, 0.0588 +/- 0.0083; P<0.01). CONCLUSION: Traumatic brain injury can induce significant damages of gut structure and impairment of barrier function which occur rapidly as early as 3 hours following brain injury and lasts for more than 7 days with marked mucosal atrophy.	Coll Nanjing Univ, Dept Neurosurg, Jinling Hosp, Nanjing 210002, Jiangsu Provinc, Peoples R China; Nanjing Univ, Jinling Hosp, Res Inst Gen Surg, Sch Clin Med, Nanjing 210002, Jiangsu Provinc, Peoples R China		Hang, CH (corresponding author), Jinling Hosp, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Provinc, Peoples R China.	hang1965@public1.ptt.js.cn	Yin, Hong/AAC-5784-2020				Ahmed SH, 2000, STROKE, V31, P193, DOI 10.1161/01.STR.31.1.193; Bohatschek M, 2001, EXP NEUROL, V172, P137, DOI 10.1006/exnr.2001.7764; BROWN TH, 1989, GASTROINTEST ENDOSC, V35, P37, DOI 10.1016/S0016-5107(89)72683-3; Buttenschoen K, 2000, J TRAUMA, V48, P918, DOI 10.1097/00005373-200005000-00017; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GLAVIN GB, 1992, ACTA PHYSIOL HUNG, V80, P107; Gong JP, 2002, WORLD J GASTROENTERO, V8, P923, DOI 10.3748/wjg.v8.i5.923; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; KAMADA T, 1977, J TRAUMA, V17, P44, DOI 10.1097/00005373-197701000-00006; Kamei H, 2000, J SURG RES, V89, P20, DOI 10.1006/jsre.1999.5802; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; MonteroMenei CN, 1996, BRAIN RES, V724, P55, DOI 10.1016/0006-8993(96)00268-5; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; PEDOTO MJ, 1995, ARCH PHYS MED REHAB, V76, P871, DOI 10.1016/S0003-9993(95)80555-9; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; PHILIP P A, 1992, Brain Injury, V6, P351, DOI 10.3109/02699059209034949; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; SALZMAN AL, 1994, AM J PHYSIOL, V266, pG633, DOI 10.1152/ajpgi.1994.266.4.G633; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; Shanahan F, 1999, Semin Gastrointest Dis, V10, P8; Suchner U, 1996, NUTRITION, V12, P13, DOI 10.1016/0899-9007(95)00016-X; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Wang XD, 1996, EUR SURG RES, V28, P402, DOI 10.1159/000129484; Zhu L, 2000, WORLD J GASTROENTERO, V6, P79, DOI 10.3748/wjg.v6.i1.79	34	122	135	1	11	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1007-9327	2219-2840		WORLD J GASTROENTERO	World J. Gastroenterol.	DEC	2003	9	12					2776	2781					6	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	757YY	WOS:000187606800030	14669332				2022-02-06	
J	Valovich, TC; Perrin, DH; Gansneder, BM				Valovich, TC; Perrin, DH; Gansneder, BM			Repeat administration elicits a practice effect with the balance error scoring system but not with the standardized assessment of concussion in high school athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						postural stability; serial assessments; cognitive assessment	MILD HEAD-INJURY; REPEATED NEUROPSYCHOLOGICAL ASSESSMENTS; POSTURAL STABILITY; FOOTBALL PLAYERS; PERFORMANCE; COLLEGIATE; SPORTS; EPIDEMIOLOGY; RECOVERY; SIDELINE	Objective: To assess whether repeated administration of the Standardized Assessment of Concussion (SAC) and Balance Error Scoring System (BESS) demonstrates a practice effect in high school athletes. Design and Setting: Subjects were assigned to either a control or practice group. Subjects in the control group were assessed twice, 30 days apart. Subjects in the practice group were assessed on 5 occasions. Four assessments were performed within a 7-day period and 1 more assessment 30 days after the initial test. Subjects: Thirty-two uninjured high school athletes participated in this investigation. Sixteen were randomly assigned to a control group and 16 to a practice group. Measurements: We measured performance on the SAC and on 6 test conditions of the BESS. Results: We found a significant time-by-group interaction on BESS performance on the day-30 test session. A significant practice effect of the BESS was found during the course of repeated administrations in the practice group. After repeated testing, the number of BESS errors decreased with each test session, and error scores on day 5 (10.94 +/- 2.17) and day 7 (9.44 +/- 3.32) were significantly lower than the baseline score (12.88 +/- 3.34). We did not find group differences or a practice effect on the SAC (baseline score = 26.16). Conclusions: Our results revealed no practice effect with the SAC and a slight practice effect with repeated administrations of the BESS, especially with the single-leg stance on foam. Clinicians must acknowledge the potential for practice effects when readministering these concussion assessments to track recovery of an athlete or as a guide in return-to-play decision making.	Arizona Sch Hlth Sci, Dept Sports Hlth Care, Mesa, AZ 85206 USA; Univ N Carolina, Greensboro, NC 27412 USA; Univ Virginia, Charlottesville, VA USA		Valovich, TC (corresponding author), Arizona Sch Hlth Sci, Dept Sports Hlth Care, 5850 E Still Circle, Mesa, AZ 85206 USA.		Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			BARR WB, 2001, J INT NEUROPSYCH SOC, V7, P396; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY, P257; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; EKDAHL C, 1989, SCAND J REHABIL MED, V21, P187; Gerberich SG, 1997, NEUROEPIDEMIOLOGY, V16, P1, DOI 10.1159/000109665; Gronwall D, 1989, MILD HEAD INJURY, P153; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HAMMAN R, 1995, J OTOLARYNGOL, V24, P221; HAMMAN RG, 1992, ARCH PHYS MED REHAB, V73, P738; Hertel J, 2000, J SPORT REHABIL, V9, P104, DOI 10.1123/jsr.9.2.104; JAMIESON M, 1998, NZ J SPORTS MED, V26, P50; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; MCCAFFREY RJ, 1993, ARCH CLIN NEUROPSYCH, V8, P519; MCCAFFREY RJ, 1992, CLIN NEUROPSYCHOL, V0006, P00032, DOI [DOI 10.1080/138540492084041_15, DOI 10.1080/13854049208404115]; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M., 2000, STANDARDIZED ASSESSM; Nordahl SHG, 2000, AVIAT SPACE ENVIR MD, V71, P889; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Onate JA, 2000, J ATHL TRAINING, V35, P155; Powell JW, 1999, J ATHL TRAINING, V34, P277; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 1997, J SPORT REHABIL, V6, P283, DOI 10.1123/jsr.6.3.283; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	35	122	123	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	JAN-MAR	2003	38	1					51	56					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	662VJ	WOS:000181969300008	12937472				2022-02-06	
J	Karni, A; Holtzman, R; Bass, T; Zorman, G; Carter, L; Rodriguez, L; Bennett-Shipman, VJ; Lottenberg, L				Karni, A; Holtzman, R; Bass, T; Zorman, G; Carter, L; Rodriguez, L; Bennett-Shipman, VJ; Lottenberg, L			Traumatic head injury in the anticoagulated elderly patient: A lethal combination	AMERICAN SURGEON			English	Article; Proceedings Paper	69th Annual Meeting of the Southeastern-Surgical-Congress	FEB 02-06, 2001	NEW ORLEANS, LOUISIANA	SE Surg Congress			WARFARIN	Warfarin is the most common oral anticoagulant used for chronic anticoagulation therapy. Even without any antecedent trauma overanticoagulation can result in intracranial hemorrhage. The triad of anticoagulation with warfarin, age greater than 65 years, and traumatic head injury frequently produces a lethal brain hemorrhage. A retrospective review of more than 2000 patients admitted to the Trauma Service between September 1998 and May 2000 produced 278 patients with head injury and CT-documented intracranial hemorrhage. Of these patients 21 were admitted with an elevated prothrombin time (PT) due to anticoagulation with warfarin. Eighteen patients (86%) were above the age of 70. The most common indications for anticoagulation were atrial fibrillation (71%), deep venous thrombosis (19%), aortic valve replacement (9%), and ischemic cerebral infarcts (9%). Fourteen injuries were the result of a fall, one resulted from a gunshot wound, and one resulted from an assault. The remaining five patients were excluded as their history, workup, and evaluation by neurosurgery suggested a spontaneous bleed leading to fall rather than a fall causing a traumatic bleed. The average Glasgow Coma Score on admission was 11. The average PT and International Normalized Ratio (INR) on admission were 19.2 and 2.99 respectively. Eight of the 16 patients analyzed died. The risk of intracranial hemorrhage with relatively minor head injury is increased dramatically in the anticoagulated patient. A mortality rate of 50 per cent far exceeds the mortality rate in patients with similar head injuries who are not anticoagulated. In addition the risk/benefit equation of anticoagulation for the elderly is more complex and differs from that for younger patients. Perhaps more frequent and judicious monitoring of prothrombin time levels with lower therapeutic ranges (INR 1.5-2) is necessary.	Mem Reg Trauma Ctr, Hollywood, FL USA		Karni, A (corresponding author), Mem Reg Trauma Ctr, Hollywood, FL USA.						Butler AC, 1998, BLOOD REV, V12, P35, DOI 10.1016/S0268-960X(98)90028-5; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; MATHIESEN T, 1995, ACTA NEUROL SCAND, V91, P208; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; Nakagawa Takao, 1995, Neurologia Medico-Chirurgica, V35, P156, DOI 10.2176/nmc.35.156; Saab M, 1996, J ACCID EMERG MED, V13, P208; SCHWAB CW, 2000, TRAUMA, P1099; Volans AP, 1998, J ACCID EMERG MED, V15, P159	8	122	126	0	4	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	NOV	2001	67	11					1098	1100					3	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	493DD	WOS:000172206000018	11730229				2022-02-06	
J	Kolakowsky-Hayner, SA; Miner, KD; Kreutzer, JS				Kolakowsky-Hayner, SA; Miner, KD; Kreutzer, JS			Long-term life quality and family needs after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; family needs; quality of life; support systems	SEVERE HEAD-INJURY; OF-LIFE; RELATIVES	Objectives: This investigation assessed the life quality and long-term family needs of caregivers of persons with brain injury. Design: Respondents completed the Virginia Traumatic Brain Injury Family Needs Assessment survey. Setting: Community-based sample. Participants: Respondents included 57 caregivers of persons with traumatic brain injury who were at least 4 years after injury and who resided in Virginia. Respondents ranged in age from 19 to 82 years and were primarily women and Caucasian. Outcome Measures: The Family Needs Questionnaire (FNQ) and quality of life questions. Results: Results indicate diminished life quality after injury. With regard to family needs, Health Information (51.43%) and involvement with Care (47.93%) needs were most often rated as met. Instrumental Support (31.52%) and Professional Support (28.38%) needs were most often rated as not met. Conclusions: Family needs and support systems for those needs change over time. This investigation provides evidence that unmet family needs extend well beyond the acute setting and that caregiver life quality diminishes over time. The importance of appreciating long-term family needs and other life quality issues should not be underestimated.	Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Kolakowsky-Hayner, SA (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Med Coll Virginia Campus,1200 E Broad St,Room 3-1, Richmond, VA 23298 USA.		Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BRUZY S, 1997, SOCIAL WORK HLTH CAR, V26, P77; Campbell C H, 1988, Rehabil Nurs, V13, P320; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; GRAFFI S, 1989, J APPL SOC SCI, V3, P293; GRANINGER W, 1992, CLIN INFECT DIS, V15, P49, DOI 10.1093/clinids/15.1.49; Hickey AM, 1997, PSYCHOL HEALTH, V12, P827, DOI 10.1080/08870449708406743; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Leathem J, 1996, BRAIN INJURY, V10, P27; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Mathis M, 1984, J Neurosurg Nurs, V16, P36; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; Moules S, 1999, BRAIN INJURY, V13, P983; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Panting A, 1972, REHABILITATION, V38, P33; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	32	122	123	0	9	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	2001	16	4					374	385		10.1097/00001199-200108000-00007			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	459YA	WOS:000170278000007	11461659				2022-02-06	
J	Fichtenberg, NL; Putnam, SH; Mann, NR; Zafonte, RD; Millard, AE				Fichtenberg, NL; Putnam, SH; Mann, NR; Zafonte, RD; Millard, AE			Insomnia screening in postacute traumatic brain injury - Utility and validity of the Pittsburgh Sleep Quality Index	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						traumatic brain injury; insomnia; Pittsburgh Sleep Quality Index; postacute rehabilitation	HEAD-INJURY; PERFORMANCE; RECOVERY; SCALE	Objective: To assess insomnia in a rehabilitation population, the authors examined the utility and validity of the Pittsburgh Sleep Quality Index (PSQI). The assessment of insomnia is relevant to the treatment of traumatic brain injury at the postacute level and routine screening for insomnia may be enhanced by the availability of a standardized, conveniently used, self-report sleep questionnaire. Design: The authors prospectively studied 91 consecutive patients with traumatic brain injury who were admitted to an outpatient neurorehabilitation program. Besides administering the PSQI, Beck Depression Inventory, Epworth Sleepiness Scale, and Multidimensional Pain Inventory, sleep diary and interview data were obtained and used to divide subjects into insomnia and noninsomnia groups according to the criteria established by the Diagnostic and Statistical Manual of Mental Disorders, ed 4. Results: Sensitivity and specificity rates to the clinical diagnosis of insomnia were 93% and 100%, respectively,for a PSQI Global Score of >8, and 83% and 100% for a diagnosis of insomnia based exclusively on PSQI-derived sleep variable data. Sleep diary data provided concurrent validity for PSQI estimates of sleep-onset latency, sleep duration, and sleep efficiency. The Beck Depression Inventory, Epworth Sleepiness Scale, and Multidimensional Pain Inventory established concurrent validity for individual PSQI items pertaining to mood, hypersomnia, and pain disturbance. Conclusion: The PSQI was demonstrated to be a valid and useful screening tool for assessing insomnia among postacute patients with traumatic brain injury.	Inst Rehabil, Detroit, MI USA; Wayne State Univ, Sch Med, Detroit, MI USA; Univ Michigan Hosp & Hlth Ctr, Ann Arbor, MI USA		Fichtenberg, NL (corresponding author), DMC Rehabil Ctr Novi, 42005 W 12 Mile Rd, Novi, MI 48377 USA.		Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604			Beck AT, 1987, BECK DEPRESSION INVE; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BUYSSE DJ, 1991, SLEEP, V14, P331; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Hagen C, 1979, LEVELS COGNITIVE FUN; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; KRUEGER GP, 1989, WORK STRESS, V3, P129, DOI 10.1080/02678378908256939; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MOELLER AA, 1991, J ACQ IMMUN DEF SYND, V4, P1000; MONK TH, 1992, SLEEP, V15, P322, DOI 10.1093/sleep/15.4.322; NIERENBERG AA, 1994, AM J PSYCHIAT, V151, P1069; NORMAN SE, 1986, SLEEP RES, V15, P95; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; REYNOLDS CF, 1993, BIOL PSYCHIAT, V34, P791, DOI 10.1016/0006-3223(93)90068-O; ROSEN J, 1991, AM J PSYCHIAT, V148, P62; STEIN MB, 1993, PSYCHIAT RES, V49, P251, DOI 10.1016/0165-1781(93)90065-O; Zafonte RD, 1996, NEUROREHABILITATION, V7, P189, DOI 10.3233/NRE-1996-7304	20	122	125	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY	2001	80	5					339	345		10.1097/00002060-200105000-00003			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	425BG	WOS:000168268000003	11327555				2022-02-06	
J	Rabchevsky, AG; Fugaccia, I; Sullivan, PG; Scheff, SW				Rabchevsky, AG; Fugaccia, I; Sullivan, PG; Scheff, SW			Cyclosporin A treatment following spinal cord injury to the rat: Behavioral effects and stereological assessment of tissue sparing	JOURNAL OF NEUROTRAUMA			English	Article						immunosuppression; lesion volume; stereology; traumatic brain injury	TRAUMATIC BRAIN INJURY; AXONAL DAMAGE; CONTUSION; ISCHEMIA; BARRIER; MITOCHONDRIAL; RECOVERY; PERMEABILITY; AMELIORATION; HOMEOSTASIS	The immunosuppressant drug cyclosporin A (CsA) has significant neuroprotective properties following CNS injury. In the present study, we assessed the efficacy of CsA therapy following a moderate spinal cord injury (SCI), Adult female rats were injured with the NYU impactor from a height of 12.5 mm, and CsA or vehicle therapy was initiated 15 min after the injury. All animals were behaviorally tested with the BBB locomotor rating scale prior to morphological assessment of changes in the spinal cord. CsA therapy failed to significantly improve the behavioral recovery following the injury. Using a unique stereological approach to assess tissue damage, it was determined that CsA did not alter the amount of spared tissue. The possible neuroprotective effects of CsA, observed in other models of CNS injury, do not appear to influence SCI pathology, perhaps reflecting both anatomical and physiological differences between these distinct regions of the CNS.	Univ Kentucky, Sanders Brown Ctr Aging 233, Lexington, KY 40536 USA		Scheff, SW (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging 233, Lexington, KY 40536 USA.	sscheff@pop.uky.edu	Rabchevsky, Alexander/AAQ-2451-2021	Rabchevsky, Alexander/0000-0002-1991-0915			Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baldwin SA, 1998, J NEUROSURG, V88, P874, DOI 10.3171/jns.1998.88.5.0874; Bancroft JD, 1996, THEORY PRACTICE HIST, V4th; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BEGLEY DJ, 1990, J NEUROCHEM, V55, P1222, DOI 10.1111/j.1471-4159.1990.tb03128.x; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; CEFALU WT, 1985, J NEUROCHEM, V45, P1954, DOI 10.1111/j.1471-4159.1985.tb10557.x; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Lemke M, 1990, J NEUROTRAUM, V7, P41, DOI 10.1089/neu.1990.7.41; Li PA, 1997, BRAIN RES, V753, P133, DOI 10.1016/S0006-8993(97)00005-X; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Olby NJ, 1996, J NEUROCYTOL, V25, P481, DOI 10.1007/BF02284817; Olby NJ, 1996, EXP NEUROL, V138, P82, DOI 10.1006/exnr.1996.0049; OORSCHOT DE, 1994, PROG NEUROBIOL, V44, P233, DOI 10.1016/0301-0082(94)90040-X; Palladini G, 1996, J BRAIN RES, V37, P145; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; Yoshimoto T, 1999, BRAIN RES, V839, P283, DOI 10.1016/S0006-8993(99)01733-3; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	37	122	123	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2001	18	5					513	522		10.1089/089771501300227314			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	435CN	WOS:000168860000004	11393254				2022-02-06	
J	Bergsneider, M; Hovda, DA; McArthur, DL; Etchepare, M; Huang, SC; Sehati, N; Satz, P; Phelps, ME; Becker, DP				Bergsneider, M; Hovda, DA; McArthur, DL; Etchepare, M; Huang, SC; Sehati, N; Satz, P; Phelps, ME; Becker, DP			Metabolic recovery following human traumatic brain injury based on FDG-PET: Time course and relationship to neurological disability	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						diaschisis; Disability Rating Scale; Glasgow coma scale; head injury; positron emission tomography; single photon emission tomography (SPECT)	POSITRON EMISSION TOMOGRAPHY; CEREBRAL GLUCOSE-UTILIZATION; CLOSED-HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; BLOOD-FLOW; MILD; PERFUSION; CT; CONSCIOUSNESS	Objective: Utilizing [F-18]fluoroaeoxyglucose positron emission tomography (FDG-PET), we assessed the temporal pattern and the correlation of functional and metabolic recovery following human traumatic brain injury Design and Subjects: Fifty-four patients with injury severity ranging from mild to severe were studied. Thirteen of these patients underwent both an acute and delayed FDG-PET study Results: Analysis of the pooled global cerebral metabolic rate of glucose (CMRglc) values revealed that the intermediate metabolic reduction phase begins to resolve approximately one month following injury regardless of injury severity. The correlation, in the 13 patients studied twice, between the extent of change in neurologic disability, assessed by the Disability Rating Scale (DRS), and the change in CMRglc from the early to late period was modest (r = -0.42). Potential explanations for this rather poor correlation are discussed. A review of the pertinent literature regarding the use of PET and related imaging modalities, including single photon emission tomography (SPECT) for the assessment of patients following traumatic brain injury is given. Conclusion: The dynamic profile of CMRglc that changes following traumatic brain injury is seemingly stereotypic across a broad range and severity of injury types. Quantitative FDG-PET cannot be used as a surrogate technique for estimating degree of global functional recovery following traumatic brain injury.	Univ Calif Los Angeles, Harbor Med Ctr, Brain Res Inst, Div Neurosurg,Dept Surg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Surg, Div Neurosurg,Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Surg, Div Neurosci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA		Bergsneider, M (corresponding author), Univ Calif Los Angeles, Harbor Med Ctr, Brain Res Inst, Div Neurosurg,Dept Surg, Box 957039, Los Angeles, CA 90095 USA.	mbergsneider@mednet.ucla.edu	McArthur, David/E-6442-2013	McArthur, David/0000-0003-3385-1314			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Abu-Judeh HH, 1998, J NUCL MED, V39, P1357; Alavi A, 1997, J NUCL MED, V38, P1717; Alavi A, 1989, J Neuropsychiatry Clin Neurosci, V1, pS45; Alavi A, 1996, J NUCL MED, V37, P1170; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; COLLE LM, 1986, BRAIN RES, V397, P27, DOI 10.1016/0006-8993(86)91366-1; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRAY BG, 1992, J NUCL MED, V33, P52; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; Hovda D.A., 1996, NEUROTRAUMA, P1459; HUANG SC, 1980, AM J PHYSIOL, V238, pE69, DOI 10.1152/ajpendo.1980.238.1.E69; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Imahori Y, 1999, NEUROREPORT, V10, P117; JACOBS A, 1994, J NUCL MED, V35, P942; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KOBAYASHI M, 1977, J NEUROCHEM, V29, P53, DOI 10.1111/j.1471-4159.1977.tb03923.x; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Lin KP, 1996, PHYS MED BIOL, V41, P2775, DOI 10.1088/0031-9155/41/12/014; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; POWELL MJD, 1964, COMPUT J, V7, P155, DOI 10.1093/comjnl/7.2.155; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; ROPER SN, 1991, J NUCL MED, V32, P1684; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SHAH KR, 1983, NEUROSCI LETT, V40, P287, DOI 10.1016/0304-3940(83)90053-8; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; TALAIRACH J, 1988, COPLANAR STEREOTAXIC, P84; TEASDALE G, 1974, LANCET, V2, P81; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; Umile EM, 1998, BRAIN INJURY, V12, P577; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; WORLEY G, 1995, DEV MED CHILD NEUROL, V37, P213; Yamaki T, 1996, J TRAUMA, V40, P50, DOI 10.1097/00005373-199601000-00010; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	49	122	123	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	2001	16	2					135	148		10.1097/00001199-200104000-00004			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	422HH	WOS:000168112100003	11275575				2022-02-06	
J	Vickery, CD; Berry, DTR; Inman, TH; Harris, MJ; Orey, SA				Vickery, CD; Berry, DTR; Inman, TH; Harris, MJ; Orey, SA			Detection of inadequate effort on neuropsychological testing: A meta-analytic review of selected procedures	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; FORCED-CHOICE METHOD; SIMULATED MEMORY IMPAIRMENT; MMPI-2 VALIDITY SCALES; REY 15-ITEM TEST; SYMPTOM VALIDITY; MALINGERING DETECTION; BELIEVABLE DEFICITS; PERFORMANCE; PROSPECTS	Thirty-two studies of commonly researched neuropsychological malingering tests were meta-analytically reviewed to evaluate their effectiveness in discriminating between honest responders and dissimulators. Overall, studies using the Digit Memory Test (DMT), Portland Digit Recognition Test (PDRT), 15-Item Test, 21-Item Test, and the Dot Counting Test had average effect sizes indicating that dissimulators obtain scores that are approximately 1.1 standard deviations below those of honest responders. The DMT separated the means of groups of honest and dissimulating responders by approximately 2 standard deviations, whereas the 21-Item Test and the PDRT separated the groups by nearly 1.5 and 1.25 standard deviations, respectively. The 15-Item Test and the Dot Counting Test were less effective, separating group means by approximately 3/4 of a standard deviation. Although the DMT, PDRT, 15-, and 21-Item Tests all demonstrated very high specificity rates, at the level of individual classification, the DMT had the highest sensitivity and overall hit-rate parameters. The PDRT and 15-Item Test demonstrated moderate sensitivity, whereas the 21-Item Test demonstrated poor sensitivity. The less than perfect sensitivities of all the measures included in this review argue against their use in isolation as malingering screening devices. (C) 2000 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA		Berry, DTR (corresponding author), Univ Kentucky, Dept Psychol, 115 Kastle Hall, Lexington, KY 40506 USA.						ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Binks PG, 1997, ARCH CLIN NEUROPSYCH, V12, P41, DOI 10.1016/S0887-6177(96)00019-4; CERCY S, 1993, THESIS SO ILLINOIS U; Cohen J, 1977, STAT POWER ANAL BEHA; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; GOLA T, 1994, THESIS WAYNE STATE U; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Hedges L.V., 1985, STAT METHODS META AN; HISCOCK CK, 1994, J PSYCHOPATHOL BEHAV, V16, P95, DOI 10.1007/BF02232721; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Johnson BT, 1993, DSTAT SOFTWARE METAA; King C., 1992, THESIS CALIFORNIA SC; LARRABEE GJ, 1992, FORENSIC REPORTS, V5, P257; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; MILLIKIN C, 1993, THESIS U WINDSOR WIN; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PAUL DS, 1992, INT J CLIN NEUROPSYC, V14, P1; Prigatano GP, 1997, ARCH CLIN NEUROPSYCH, V12, P609, DOI 10.1016/S0887-6177(97)00020-6; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; PRITCHARD D, 1992, FORENSIC REPORTS, V5, P287; Rey A., 1964, EXAMEN CLIN PSYCHOL; REYNOLDS C, 1998, DETECTION MALINGERIN; Rogers R., 1997, CLIN ASSESSMENT MALI; ROSEI EA, 1995, J HYPERTENS, V13, P349; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI 10.4135/9781412984997; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131	53	122	124	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2001	16	1					45	73		10.1016/S0887-6177(99)00058-X			29	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	389UN	WOS:000166257200005	14590192	Bronze			2022-02-06	
J	Paterakis, K; Karantanas, AH; Komnos, A; Volikas, Z				Paterakis, K; Karantanas, AH; Komnos, A; Volikas, Z			Outcome of patients with diffuse axonal injury: The significance and prognostic value of MRI in the acute phase	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							HEAD-INJURY; BRAIN-INJURY; TRAUMA; FEATURES; LESIONS	Background: To compare the magnetic resonance imaging (MRI) findings in the acute phase with outcome in patients with diffuse axonal injury (DAI). Methods: A group of 33 patients with closed head injury and discrepancy be tween the apparently normal computed tomographic scan findings and their neurologic statuses were studied with MRI during the First 48 hours. Among them, 24 were found to suffer from DAI-type lesions. According to the Glasgow Coma Scale (GCS), 19 patients suffered from severe head injury (GCS score <8) and 5 patients had moderate head injury (GCS score of 9-12), Four MRI sequences in various planes were applied. Patients were divided into three groups, according to staging described in the literature. Results: in five patients, MRI demonstrated nonhemorrhagic DAI lesions stage 1, In 11 patients, findings were consistent with DAI lesions stage 2, eight nonhemorrhagic and three hemorrhagic, Eight patients showed DAI lesions stage 3, six of which were nonhemorrhagic, Conclusions: MRI is more sensitive compared with computed tomography in the detection of traumatic brain lesions, especially the nonhemorrhagic DAI, The presence of hemorrhage in DAI-type lesions and the association with traumatic space-occupying lesions is a poor prognostic sign, Isolated nonhemorrhagic DAI-type lesions are not associated with poor clinical outcome.	Larissa Gen Hosp, CT MRI Dept, Larisa 41221, Greece; Univ Hosp, Dept Neurosurg, Larisa, Greece; Larissa Gen Hosp, ISU Dept, Larisa 41221, Greece; Univ Hosp, Dept Neurosurg, Alexandroupolis, Greece		Karantanas, AH (corresponding author), Larissa Gen Hosp, CT MRI Dept, 1 Tsakalof St, Larisa 41221, Greece.	apolsen@yahoo.com	Karantanas, Apostolos/AAE-6820-2020; Paterakis, Konstantinos/AAH-4554-2019	Karantanas, Apostolos/0000-0002-0927-2403; 			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P619, DOI 10.1016/S0009-9260(89)80324-1; EVANS SJJ, 1999, MRI, P1347; Gean AD, 1994, IMAGING HEAD TRAUMA; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gentry LR., 1996, MAGNETIC RESONANCE I, P611; GREENBERG MS, 1998, HDB NEUROSURGERY; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; LINDENBERG R, 1955, AM J PATHOL, V31, P297; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.0.CO;2-6; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; OKAWA T, 1992, ACTA NEUROCHIR, V55, P8; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; Wild JM, 1999, MAGN RESON MATER PHY, V8, P109; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; ZIMMERMAN RA, 1992, CRANIAL MRI CT, P509	27	122	145	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2000	49	6					1071	1075		10.1097/00005373-200012000-00016			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	383XG	WOS:000165909500017	11130491				2022-02-06	
J	Whalen, MJ; Carlos, TM; Kochanek, PM; Wisniewski, SR; Bell, MJ; Clark, RSB; DeKosky, ST; Marion, DW; Adelson, PD				Whalen, MJ; Carlos, TM; Kochanek, PM; Wisniewski, SR; Bell, MJ; Clark, RSB; DeKosky, ST; Marion, DW; Adelson, PD			Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury	CRITICAL CARE MEDICINE			English	Article						inflammation; cytokines; brain injury; pediatric; chemokines; interleukin-8; mortality; shaken baby syndrome	TRAUMATIC BRAIN INJURY; RESPIRATORY-DISTRESS SYNDROME; CENTRAL-NERVOUS-SYSTEM; INDUCED NEUTROPHIL CHEMOATTRACTANT; CEREBRAL REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; IN-VITRO; INFLAMMATORY MEDIATORS; BACTERIAL-MENINGITIS; CYTOKINE REGULATION	Objective: To determine interleukin (IL)-8 concentrations in ventricular cerebrospinal fluid from children with severe traumatic brain injury (TBI), Design: Prospective study. Setting: University children's hospital. Patients: Twenty-seven children hospitalized with severe TBI (Glasgow Coma Scale score less than or equal to 8), seven children with cerebrospinal fluid culture-positive bacterial meningitis, and twenty-four age-equivalent controls. Interventions: Placement of an intraventricular catheter and continuous drainage of cerebrospinal fluid. Measurements and Main Results: Median [range] cerebrospinal fluid IL-8 concentration in children with TBI (0-12 hrs) (4,452.5 [0-20,000] pg/mL) was markedly greater than that in controls (14.5 [0-250]) (p <.0001) and equivalent to concentrations in children with meningitis (5,300 [1,510-22,000] pg/mL) (p =.33), Cerebrospinal fluid IL-8 remained increased in children with severe TBI for up to 108 hrs after injury, Univariate logistic regression analysis demonstrated an association between cerebrospinal fluid IL-8 and child abuse (p =.07) and mortality (p =.01), Multivariate analysis demonstrated a strong, independent association between cerebrospinal fluid IL-8 and mortality (p =.01), Conclusions: The data are consistent with an acute inflammatory component of TBI in children and suggest an association between cerebrospinal fluid IL-8 and outcome after TBI, IL-8 may represent a potential target for anti-inflammatory therapy.	Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Whalen, MJ (corresponding author), Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15260 USA.		Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021; Adelson, David/W-2083-2019	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P01NS030318, P50NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318] Funding Source: Medline		Abrams D. J., 1998, Journal of Neurotrauma, V15, P29; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; ALOISI F, 1995, INT J DEV NEUROSCI, V13, P265, DOI 10.1016/0736-5748(94)00071-A; ALOISI F, 1992, J IMMUNOL, V149, P2358; ANDERSSON PB, 1992, J EXP MED, V176, P255, DOI 10.1084/jem.176.1.255; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; BAGGIOLINI M, 1994, CHEST, V105, pS95, DOI 10.1378/chest.105.3_Supplement.95S; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; BELL M, 1998, CRIT CARE MED, V26, pA86; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Ehrlich LC, 1998, J IMMUNOL, V160, P1944; FOLKESSON HG, 1995, J CLIN INVEST, V96, P107, DOI 10.1172/JCI118009; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GRONECK P, 1994, PEDIATRICS, V93, P712; Gupta AK, 1995, J CEREB BLOOD FLOW M, V15, pS33; HACK CE, 1992, INFECT IMMUN, V60, P2835, DOI 10.1128/IAI.60.7.2835-2842.1992; HALSTENSEN A, 1993, J INFECT DIS, V167, P471, DOI 10.1093/infdis/167.2.471; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hoch RC, 1996, J LAB CLIN MED, V128, P134, DOI 10.1016/S0022-2143(96)90005-0; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Horuk R, 1997, J IMMUNOL, V158, P2882; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Ishiguro A, 1997, CLIN EXP IMMUNOL, V109, P426, DOI 10.1046/j.1365-2249.1997.4681366.x; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Keane MP, 1997, J IMMUNOL, V159, P1437; Kettritz R, 1998, KIDNEY INT, V53, P84, DOI 10.1046/j.1523-1755.1998.00741.x; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; KUTKOSKI GJ, 1995, AM J RESP CRIT CARE, V151, pA599; LACY M, 1995, J NEUROIMMUNOL, V61, P71, DOI 10.1016/0165-5728(95)00075-D; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LOPEZCORTES LF, 1995, J INFECT DIS, V172, P581, DOI 10.1093/infdis/172.2.581; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MASTROIANNI CM, 1994, PEDIATR INFECT DIS J, V13, P1008; Matsumoto T, 1997, LAB INVEST, V77, P119; Matsumoto T, 1997, J LEUKOCYTE BIOL, V62, P581, DOI 10.1002/jlb.62.5.581; MCCLAIN C, 1991, J CLIN LAB MED, V118, P226; Miller EJ, 1996, CRIT CARE MED, V24, P1448, DOI 10.1097/00003246-199609000-00004; MILLER EJ, 1992, AM REV RESPIR DIS, V146, P427, DOI 10.1164/ajrccm/146.2.427; MullerLadner U, 1996, J NEUROL SCI, V144, P135, DOI 10.1016/S0022-510X(96)00217-1; Norrby K, 1996, CELL PROLIFERAT, V29, P315, DOI 10.1111/j.1365-2184.1996.tb01583.x; Ostergaard C, 1996, EUR J CLIN MICROBIOL, V15, P166, DOI 10.1007/BF01591492; Proost P, 1996, INT J CLIN LAB RES, V26, P211, DOI 10.1007/BF02602952; RAMPART M, 1989, AM J PATHOL, V135, P21; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; SEKI T, 1993, IMMUNOLOGY, V80, P333; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; SMITH WB, 1991, IMMUNOLOGY, V72, P65; Spanaus KS, 1997, J IMMUNOL, V158, P1956; Sprenger H, 1996, CLIN IMMUNOL IMMUNOP, V80, P155, DOI 10.1006/clin.1996.0109; Taub D D, 1994, Ther Immunol, V1, P229; VAN MEIR E, 1992, CANCER RES, V52, P4297; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Xia MQ, 1997, AM J PATHOL, V150, P1267; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767; Yamasaki Y, 1997, BRAIN RES, V759, P103, DOI 10.1016/S0006-8993(97)00251-5; YAMASAKI Y, 1995, STROKE, V26, P318, DOI 10.1161/01.STR.26.2.318; YOSHIMURA T, 1987, J IMMUNOL, V139, P788; ZAMPRONIO AR, 1994, AM J PHYSIOL, V266, pR1670, DOI 10.1152/ajpregu.1994.266.5.R1670; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	69	122	128	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	APR	2000	28	4					929	934		10.1097/00003246-200004000-00003			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311AV	WOS:000086862800003	10809261				2022-02-06	
J	Rao, VLR; Dogan, A; Bowen, KK; Dempsey, RJ				Rao, VLR; Dogan, A; Bowen, KK; Dempsey, RJ			Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus	EXPERIMENTAL NEUROLOGY			English	Article						astrocytes; microglia; mRNA; peripheral-type benzodiazepine receptor; PK11195; quantitative autoradiography; traumatic brain injury	TUMOR-NECROSIS-FACTOR; GLOBAL FOREBRAIN ISCHEMIA; CORTICAL IMPACT INJURY; PROTEIN MESSENGER-RNA; LIGAND H-3 PK11195; BINDING-SITES; PORTACAVAL ANASTOMOSIS; QUANTITATIVE AUTORADIOGRAPHY; CULTURED ASTROCYTES; ENHANCED EXPRESSION	In mammalian CNS, the peripheral-type benzodiazepine receptor (PTBR) is localized on the outer mitochondrial membrane within the astrocytes and microglia. PTBR transports cholesterol to the site of neurosteroid biosynthesis. Several neurodegenerative disorders were reported to be associated with increased densities of PTBR. In the present study, we evaluated the changes in the PTBR density and gene expression in the brains of rats as a function of time (6 h to 14 days) after traumatic brain injury (TBI). Sham-operated rats served as control. Between 3 and 14 days after TBI, there was a significant increased in the binding of PTBR antagonist [H-3]PK11195 (by 106 to 185%, P < 0.01, as assessed by quantitative autoradiography and in vitro filtration binding) and PTBR mRNA expression (by 2- to 3.4-fold, P < 0.01, as assessed by RT-PCR) in the ipsilateral thalamus. At 14 days after the injury, the neuronal number decreased significantly (by 85 to 90%, P < 0.01) in the ipsilateral thalamus. At the same time point, the ipsilateral thalamus also showed increased numbers of the glial fibrillary acidic protein positive cells (astrocytes, by similar to 3.5-fold) and the ED-1 positive cells (microglia/macrophages, by similar to 36-fold), the two cell types known to be associated with PTBR, Increased PTBR expression following TBI seems to be associated with microglia/macrophages than astrocytes as PTBR density at different periods after TBI correlated better with the number of ED-1 positive cells (r(2) = 0.95) than the GFAP positive cells (r(2) = 0.56). TBI-induced increased PTBR expression is possibly an adaptive response to cellular injury and may play a role in the pathophysiology of TBI. (C) 2000 Academic Press.	Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA; William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA		Rao, VLR (corresponding author), Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA.		Dogan, Aclan/AAF-8305-2019				AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BLACK KL, 1990, CANCER, V65, P93, DOI 10.1002/1097-0142(19900101)65:1<93::AID-CNCR2820650120>3.0.CO;2-1; BOURDIOL F, 1991, BRAIN RES, V543, P194, DOI 10.1016/0006-8993(91)90028-T; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conway EL, 1998, NEUROSCIENCE, V82, P805; CORNU P, 1992, ACTA NEUROCHIR, V119, P146, DOI 10.1007/BF01541799; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; Desjardins P, 1997, BRAIN RES, V758, P255, DOI 10.1016/S0006-8993(97)00339-9; DESJARDINS P, 1999, IN PRESS NEUROCHEM I; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DUCIS I, 1990, BRAIN RES, V531, P318, DOI 10.1016/0006-8993(90)90793-B; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Frye CA, 1998, PSYCHONEUROENDOCRINO, V23, P385, DOI 10.1016/S0306-4530(98)00009-2; GarciaSegura LM, 1996, CELL MOL NEUROBIOL, V16, P225, DOI 10.1007/BF02088178; Gavish M, 1997, CLIN NEUROPHARMACOL, V20, P473, DOI 10.1097/00002826-199712000-00001; Gehlert DR, 1997, NEUROCHEM INT, V31, P705, DOI 10.1016/S0197-0186(97)00007-7; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; GROOM GN, 1995, J NUCL MED, V36, P2207; GUILARTE TR, 1995, NEUROTOXICOLOGY, V16, P441; GUTH L, 1994, P NATL ACAD SCI USA, V91, P12308, DOI 10.1073/pnas.91.25.12308; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; ITZHAK Y, 1993, GLIA, V9, P211, DOI 10.1002/glia.440090306; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; JosephLiauzun E, 1997, J BIOL CHEM, V272, P28102, DOI 10.1074/jbc.272.44.28102; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Krueger KE, 1995, BBA-REV BIOMEMBRANES, V1241, P453, DOI 10.1016/0304-4157(95)00016-X; Lacor P, 1996, NEUROSCI LETT, V220, P61, DOI 10.1016/S0304-3940(96)13187-6; LAVOIE J, 1990, HEPATOLOGY, V11, P874, DOI 10.1002/hep.1840110524; LEONG DK, 1994, J CEREBR BLOOD F MET, V14, P100, DOI 10.1038/jcbfm.1994.14; Leong DK, 1996, ALCOHOL CLIN EXP RES, V20, P601, DOI 10.1111/j.1530-0277.1996.tb01101.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matthews MA, 1998, BRAIN RES, V794, P1, DOI 10.1016/S0006-8993(98)00107-3; McGeer E G, 1988, Alzheimer Dis Assoc Disord, V2, P331, DOI 10.1097/00002093-198802040-00001; MCPHERSON GA, 1994, RADLIG MANUAL VERSIO; Meziane H, 1996, PSYCHOPHARMACOLOGY, V126, P323, DOI 10.1007/BF02247383; MOHLER H, 1977, SCIENCE, V198, P849, DOI 10.1126/science.918669; Panizzon KL, 1998, NEUROREPORT, V9, P4131, DOI 10.1097/00001756-199812210-00024; Papadopoulos V, 1998, P SOC EXP BIOL MED, V217, P130; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; RAMSAY SC, 1992, LANCET, V339, P1054, DOI 10.1016/0140-6736(92)90576-O; Rao V. L. Raghavendra, 1993, Pediatric Research, V34, P777; RAO VLR, 1994, DIGEST DIS SCI, V39, P1055; Rao VLR, 1997, BRAIN RES, V765, P169, DOI 10.1016/S0006-8993(97)00652-5; Rao VLR, 1997, EUR J PHARMACOL, V340, P89, DOI 10.1016/S0014-2999(97)01395-2; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; SempleRowland SL, 1995, J NEUROTRAUM, V12, P1003, DOI 10.1089/neu.1995.12.1003; SPRENGEL R, 1989, J BIOL CHEM, V264, P20415; STEPHENSON DT, 1995, J NEUROSCI, V15, P5263; Todd KG, 1999, GLIA, V25, P190, DOI 10.1002/(SICI)1098-1136(19990115)25:2<190::AID-GLIA9>3.0.CO;2-B; Urani A, 1998, BRAIN RES, V799, P64, DOI 10.1016/S0006-8993(98)00469-7; Verma A, 1998, MOL MED, V4, P40, DOI 10.1007/BF03401728; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Waters SL, 1997, AM J PHYSIOL-RENAL, V273, pF869, DOI 10.1152/ajprenal.1997.273.6.F869; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; ZAVALA F, 1990, J PHARMACOL EXP THER, V255, P442; Zhu WJ, 1997, J NEUROSCI, V17, P4022; Zisterer DM, 1997, GEN PHARMACOL-VASC S, V29, P305, DOI 10.1016/S0306-3623(96)00473-9	62	122	122	2	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2000	161	1					102	114		10.1006/exnr.1999.7269			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	290FU	WOS:000085666300009	10683277				2022-02-06	
J	Sullivan, PG; Rabchevsky, AG; Hicks, RR; Gibson, TR; Fletcher-Turner, A; Scheff, SW				Sullivan, PG; Rabchevsky, AG; Hicks, RR; Gibson, TR; Fletcher-Turner, A; Scheff, SW			Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats	NEUROSCIENCE			English	Article						mitochondria; neuroprotective agents; fluid percussion; neurotrauma; immunosuppression; cortical contusion	CENTRAL-NERVOUS-SYSTEM; MITOCHONDRIAL PERMEABILITY TRANSITION; TRANSIENT FOREBRAIN ISCHEMIA; LATERAL FLUID-PERCUSSION; EXCITATORY AMINO-ACIDS; METHYL-D-ASPARTATE; HIPPOCAMPAL-NEURONS; CORTICAL CONTUSION; NMDA RECEPTORS; CELL-DEATH	Acute neuropathology following experimental traumatic brain injury results in the rapid necrosis of cortical tissue at the site of injury. This primary injury is exacerbated in the ensuing hours and days via the progression of secondary injury mechanism(s) leading to significant neurological dysfunction, Recent evidence from our laboratory demonstrates that the immunosuppressant cyclosporin A significantly ameliorates cortical damage following traumatic brain injury. The present study extends the previous findings utilizing a unilateral controlled cortical impact model of traumatic brain injury in order to establish a dose-response curve and optimal dosing regimen of cyclosporin A. Following injury to adult rats, cyclosporin A was administrated at various dosages and the therapy was initiated at different times post-injury. In addition to examining the effect of cyclosporin A on the acute disruption of the blued-brain barrier following controlled cortical impact, we also assessed the efficacy of cyclosporin A to reduce tissue damage utilizing the fluid percussion model of traumatic brain injury. The findings demonstrate that the neuroprotection afforded by cyclosporin A is dose-dependent and that a therapeutic window exists up to 24 h post-injury. Furthermore, the optimal cyclosporin dosage and regimen markedly reduces disruption of the blood-brain barrier acutely following a cortical contusion injury, and similarly affords significant neuroprotection following fluid percussion injury. These findings clearly suggest that the mechanisms responsible for tissue necrosis following traumatic brain injury are amenable to pharmacological intervention. (C) 2000 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98102 USA		Scheff, SW (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.		Rabchevsky, Alexander/AAQ-2451-2021	Rabchevsky, Alexander/0000-0002-1991-0915	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39828] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039828] Funding Source: NIH RePORTER		ALBERS GW, 1992, ARCH NEUROL-CHICAGO, V49, P418, DOI 10.1001/archneur.1992.00530280112031; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BELAYEV L, 1995, BRAIN RES, V702, P266, DOI 10.1016/0006-8993(95)01127-9; BERDEN JHM, 1985, LANCET, V1, P219; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; CADOUXHUDSON TAD, 1990, ACTA NEUROCHIR, V104, P1, DOI 10.1007/BF01842884; Choi D W, 1990, Adv Exp Med Biol, V268, P501; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEGROEN PC, 1987, NEW ENGL J MED, V317, P861, DOI 10.1056/NEJM198710013171404; Dessi F, 1995, NEUROSCI LETT, V201, P53, DOI 10.1016/0304-3940(95)12128-Q; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Du C, 1996, J NEUROTRAUM, V13, P215, DOI 10.1089/neu.1996.13.215; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; DUGAN LL, 1995, J NEUROSCI, V15, P6377; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAMIGLIO L, 1989, TRANSPLANTATION, V48, P316, DOI 10.1097/00007890-198908000-00025; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kochi S, 1999, EUR J PHARMACOL, V372, P287, DOI 10.1016/S0014-2999(99)00247-2; KOENIG H, 1992, BRAIN RES, V588, P297, DOI 10.1016/0006-8993(92)91589-7; Kristal BS, 1997, J NEUROCHEM, V69, P524; Li PA, 1997, BRAIN RES, V753, P133, DOI 10.1016/S0006-8993(97)00005-X; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1996, LAB INVEST, V74, P315; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNair ND, 1999, NURS CLIN N AM, V34, P637; Miller RD, 1996, J NEUROL SCI, V136, P37, DOI 10.1016/0022-510X(95)00309-P; NAG S, 1992, ACTA NEUROPATHOL, V84, P471, DOI 10.1007/BF00304465; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Povlishock J T, 1992, Hum Cell, V5, P345; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Prehn JHM, 1998, N-S ARCH PHARMACOL, V357, P316, DOI 10.1007/PL00005173; PROCTOR HJ, 1988, J TRAUMA, V28, P347, DOI 10.1097/00005373-198803000-00010; Scanlon JM, 1998, J NEUROCHEM, V71, P2392; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; SHIGA Y, 1992, BRAIN RES, V595, P145, DOI 10.1016/0006-8993(92)91465-Q; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; SIMS NR, 1987, J NEUROCHEM, V49, P1367, DOI 10.1111/j.1471-4159.1987.tb01001.x; STEVENS MK, 1990, J CEREBR BLOOD F MET, V10, P77, DOI 10.1038/jcbfm.1990.10; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 1999, J NEUROSCI, V19, P6248; THAYER SA, 1995, CLIN EXP PHARMACOL P, V22, P303, DOI 10.1111/j.1440-1681.1995.tb02004.x; Tibbs RE, 1998, ANAT REC, V253, P167; Uchino H, 1995, ACTA PHYSIOL SCAND, V155, P469, DOI 10.1111/j.1748-1716.1995.tb09999.x; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; WALKER RW, 1988, NEUROL CLIN, V6, P261, DOI 10.1016/S0733-8619(18)30869-7; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839; White RJ, 1996, J NEUROSCI, V16, P5688; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; ZAIDAN E, 1994, J NEUROCHEM, V63, P1812	70	122	129	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2000	101	2					289	295		10.1016/S0306-4522(00)00380-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	378BX	WOS:000165562800004	11074152				2022-02-06	
J	Cernak, I; Savic, J; Ignjatovic, D; Jevtic, M				Cernak, I; Savic, J; Ignjatovic, D; Jevtic, M			Blast injury from explosive munitions	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						blast injuries; explosive injuries; war injuries; eicosanoids	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN INJURY; COMBAT VETERANS; WAR; SYSTEM; PTSD; OVERPRESSURE; MEDIATORS; CROATIA; CARE	Objective: To evaluate the effect of blast in common war injuries. Methods: One thousand three hundred and three patients injured by explosive munitions and demonstrating extremity wounds without other penetrating injuries were admitted to the Military Medical Academy in Belgrade between 1991 and 1994. of these, 665 patients (51%) had symptoms and physical signs that were compatible with the clinical diagnosis of primary blast injury, whereas the remaining 658 patients did not. Results: Random sampling of 65 patients in the blast group during the early posttraumatic period showed statistically significant elevations in blood thromboxane A(2) (TxA(2)), prostacyclin (PGI(2)), and sulfidopeptide leukotrienes compared with the random sample of 62 patients in the nonblast group. This difference could not be accounted for by differing injury severity between the groups, because the severity of wounds as measured by both the Injury Severity Score and the Red Cross Wound Classification was similar in both groups. Amongst blast patients, 200 patients (30%) had long-term (1 year) symptoms and signs reflecting central nervous system disorders. These symptoms and signs were only sporadically found in 4% of the nonblast patients. These findings indicate that primary blast injury is more common in war injuries than previously thought and that of those affected by blast, a surprisingly high proportion retain long-term neurologic disability. The elevation in eicosanoids could be used to confirm and monitor blast injury. Conclusion In relation to the immediate management of patients injured by explosive weapons, it follows that particular attention should be paid to the presence and/or development of blast injury. Our findings indicate that blast is more common in war injuries than previously thought. Eicosanoid changes after blast injury suggest that blast injury causes a major physiologic stress. A variety of effects on the central nervous system suggest that blast injury could be responsible for some aspects of what is now considered to be the posttraumatic stress disorder.	Mil Med Acad, YU-11002 Belgrade, Serbia		Cernak, I (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.	Ibolja.Cernak@jcu.edu.au	Cernak, Ibolja/A-6399-2008	Ibolja, Cernak/0000-0003-3214-698X			*AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; Arandelovic S, 1993, Vojnosanit Pregl, V50, P561; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; BAJEC J, 1993, INJURY, V24, P517, DOI 10.1016/0020-1383(93)90026-3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 1999, WORLD J SURG, V23, P44, DOI 10.1007/s002689900563; Cernak I, 1996, J TRAUMA, V40, pS148, DOI 10.1097/00005373-199603001-00032; CERNAK I, 1997, INT REV ARMED FORCES, V6, P114; Cernak I., 1990, J TRAUMA S, V6, P267; Cernak Ibolja, 1995, Magnesium Research, V8, P249; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; COHEN H, 1946, ARCH PATHOL, V42, P12; Cooper GJ, 1996, J TRAUMA, V40, pS105, DOI 10.1097/00005373-199603001-00024; COUPLAND RM, 1992, WORLD J SURG, V16, P910, DOI 10.1007/BF02066991; Coupland RM, 1996, J ROY COLL SURG EDIN, V41, P65; Cuk V, 1994, Vojnosanit Pregl, V51, P376; ERCEG M, 1997, INT REV ARMED FORCES, V70, P89; Gebhard F, 1997, SHOCK, V7, P313, DOI 10.1097/00024382-199705000-00001; GORANSSON AM, 1988, J TRAUMA, V28, pS204; HABIBI B, 1989, VOEN MED ZH, V4, P35; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Huang JZ, 1996, J TRAUMA, V40, pS63, DOI 10.1097/00005373-199603001-00014; HULL J B, 1992, Journal of Audiovisual Media in Medicine, V15, P121, DOI 10.3109/17453059209018366; HULL JB, 1992, BRIT J SURG, V79, P1303, DOI 10.1002/bjs.1800791220; Jevtic M, 1996, J TRAUMA, V40, pS173, DOI 10.1097/00005373-199603001-00038; KUZMAN M, 1993, JAMA-J AM MED ASSOC, V270, P626, DOI 10.1001/jama.270.5.626; Labeeu F, 1996, J TRAUMA, V40, pS223, DOI 10.1097/00005373-199603001-00048; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; MELLOR SG, 1989, BRIT J SURG, V76, P1006, DOI 10.1002/bjs.1800761006; PERIC M, 1995, INJURY, V26, P507, DOI 10.1016/0020-1383(95)00105-I; Popovic M, 1994, Acta Chir Iugosl, V41, P53; POWELL WS, 1980, PROSTAGLANDINS, V20, P947, DOI 10.1016/0090-6980(80)90144-6; RADONIC V, 1995, CHIRURG, V66, P883; ROUMEN RMH, 1995, CRIT CARE MED, V23, P474, DOI 10.1097/00003246-199503000-00010; RUSCA F, 1914, DTSCH Z CHIR, V132, P315; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; TUTOHEL AK, 1989, VOEN MED ZH, V1, P27; Vojvodic V, 1996, J TRAUMA, V40, pS180, DOI 10.1097/00005373-199603001-00040; WATSON CG, 1991, J CLIN PSYCHOL, V47, P205, DOI 10.1002/1097-4679(199103)47:2<205::AID-JCLP2270470205>3.0.CO;2-W; WATSON CG, 1991, J CLIN PSYCHOL, V47, P179, DOI 10.1002/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137; Zunic G, 1996, JUGOSLAV MED BIOHEM, V15, P307	46	122	131	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	1999	47	1					96	103		10.1097/00005373-199907000-00021			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	216ZQ	WOS:000081474700018	10421194				2022-02-06	
J	WEBB, CR; WRIGLEY, M; YOELS, W; FINE, PR				WEBB, CR; WRIGLEY, M; YOELS, W; FINE, PR			EXPLAINING QUALITY-OF-LIFE FOR PERSONS WITH TRAUMATIC BRAIN INJURIES 2 YEARS AFTER INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SPINAL-CORD INJURY; HEAD-INJURY; REHABILITATION; DISABILITY; PREDICTION; ADMISSION; HANDICAP; OUTCOMES; DISTRESS	Objective: To model the complex effects of demographic, psychosocial, physical, and rehabilitation variables on quality of life 2 years after hospital discharge. Design: Medical record and longitudinal survey data on traumatic brain injury (TBI) survivors who did or did not receive formal rehabilitation services after being injured were analyzed. Setting: The study sample was selected from a representative sample of hospitals in north-central Alabama. Participants: Criteria for inclusion were: (1) 18 years and older with TBI; (2) discharged after hospital stay of 3 or more days; and (3) resided and injured in Alabama. There were 293 persons eligible for the 24-month follow-up survey, 186 (63%) of whom participated; the focus was on the 116 persons (of 186) who responded to the surveys themselves. Main Outcome Measure: A causal model of hypothesized direct and indirect effects of several variables on quality of life outcomes. Results: Employment was the strongest contributor of improved quality of life. Persons unable to pay for health care showed less improvement in functional independence 12 to 24 months postinjury and reported a poorer quality of life. The psychosocial variables of self-blame and family support improved quality of life by reducing impairments and increasing the likelihood of employment. Family support also improved quality of life by increasing functional independence. Fewer physical impairments and gains in functional independence directly improved quality of life. Conclusion: The interrelationships between psychosocial and physical variables are important when examining quality of life. Interventions are recommended targeting psychosocial variables and functional independence in efforts to improve quality of life. (C) 1995 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation	UNIV ALABAMA, INJURY CONTROL RES CTR, BIRMINGHAM, AL 35294 USA						PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR403641] Funding Source: Medline		BACH JR, 1994, ARCH PHYS MED REHAB, V75, P626, DOI 10.1016/0003-9993(94)90183-X; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BULMAN RJ, 1977, J PERS SOC PSYCHOL, V35, P351, DOI 10.1037/0022-3514.35.5.351; Chase B W, 1990, Int J Rehabil Res, V13, P325, DOI 10.1097/00004356-199012000-00006; CLAYTON KS, 1994, ARCH PHYS MED REHAB, V75, P633, DOI 10.1016/0003-9993(94)90184-8; COBB N, 1990, ARCH PHYS MED REHAB, V11, P330; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DEVIVO MJ, 1987, ARCH PHYS MED REHAB, V68, P494; Drewes A M, 1989, Int Disabil Stud, V11, P178; ENSEL WM, 1991, J HEALTH SOC BEHAV, V32, P321, DOI 10.2307/2137101; FABIAN ES, 1991, REHABIL COUNS BULL, V34, P344; FRATTALI CM, 1992, APHASIOLOGY, V6, P63, DOI 10.1080/02687039208248577; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; HAAS JF, 1988, ARCH PHYS MED REHAB, V69, P329; HOSUE JS, 1985, SOCIAL SUPPORT HLTH, P83; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; JOHNSTON MV, 1991, AM J PHYS MED REHAB, V70, P40, DOI 10.1097/00002060-199102000-00008; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KIM J, 1975, STATISTICAL PACKAGE, P383; Koehler M L, 1989, Rehabil Nurs, V14, P9; KOSKA MT, 1988, HOSPITALS, V62, P63; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KRAUSE JS, 1987, REHABIL PSYCHOL, V32, P205; KWASNICA CM, 1994, ARCH PHYS MED REHAB, V75, P384, DOI 10.1016/0003-9993(94)90159-7; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LUNDQVIST C, 1991, SPINE, V16, P78, DOI 10.1097/00007632-199101000-00014; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Nieves C C, 1991, Rehabil Nurs, V16, P129; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OLSON DH, 1979, FAM PROCESS, V18, P3, DOI 10.1111/j.1545-5300.1979.00003.x; PATRICK DL, 1990, ANNU REV PUBL HEALTH, V11, P165; PUTNAM SH, 1992, CLIN NEUROPSYCHOL, V6, P383; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SHOLOMSKAS DE, 1990, J APPL SOC PSYCHOL, V20, P548, DOI 10.1111/j.1559-1816.1990.tb00427.x; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; TATE D, 1994, AM J PHYS MED REHAB, V73, P175, DOI 10.1097/00002060-199406000-00006; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	47	122	124	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	1995	76	12					1113	1119		10.1016/S0003-9993(95)80118-9			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	TJ667	WOS:A1995TJ66700004	8540786				2022-02-06	
J	UOMOTO, JM; ESSELMAN, PC				UOMOTO, JM; ESSELMAN, PC			TRAUMATIC BRAIN INJURY AND CHRONIC PAIN - DIFFERENTIAL TYPES AND RATES BY HEAD-INJURY SEVERITY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						BRAIN INJURIES; HEADACHE; INTRACTABLE; PAIN	SYMPTOMS				UOMOTO, JM (corresponding author), UNIV WASHINGTON,SCH MED,DEPT REHABIL MED,RJ-30,SEATTLE,WA 98195, USA.		Uomoto, Jay/AAF-4809-2019				ANDERSON JM, 1990, ARCH PHYS MED REHAB, V71, P703; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; CARTLIDGE NEF, 1981, MAJOR PROBLEMS NEURO, V10, P95; COSGROVE JL, 1989, AM J PHYS MED REHAB, V68, P15, DOI 10.1097/00002060-198902000-00005; HORN LJ, 1990, REHABILITATION ADULT, P107; LIDVALL HF, 1974, ACTA NEUROL SCAND S, V56, P7; NORRIS SH, 1983, J BONE JOINT SURG BR, V65, P608, DOI 10.1302/0301-620X.65B5.6643566; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROWBOTHAM GF, 1941, COMPLICATIONS SEQUEL, V205, P379; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; TEASDALE G, 1974, LANCET, V2, P81; UOMOTO JM, 1990, HDB PHYSICAL MED REH, P1252; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	14	122	122	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	1993	74	1					61	64					4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KF917	WOS:A1993KF91700012	8420522				2022-02-06	
J	Villapol, S; Loane, DJ; Burns, MP				Villapol, Sonia; Loane, David J.; Burns, Mark P.			Sexual dimorphism in the inflammatory response to traumatic brain injury	GLIA			English	Article						cytokine; inflammation; microglia; sex-differences; trauma	MICROGLIAL ACTIVATION; ISCHEMIC-INJURY; FEMALE RATS; ESTROGEN; GENDER; NEURODEGENERATION; NEUROPROTECTION; EXPRESSION; NEUROINFLAMMATION; PROGESTERONE	The activation of resident microglial cells, alongside the infiltration of peripheral macrophages, are key neuroinflammatory responses to traumatic brain injury (TBI) that are directly associated with neuronal death. Sexual disparities in response to TBI have been previously reported; however it is unclear whether a sex difference exists in neuroinflammatory progression after TBI. We exposed male and female mice to moderate-to-severe controlled cortical impact injury and studied glial cell activation in the acute and chronic stages of TBI using immunofluorescence and in situ hybridization analysis. We found that the sex response was completely divergent up to 7 days postinjury. TBI caused a rapid and pronounced cortical microglia/macrophage activation in male mice with a prominent activated phenotype that produced both pro- (IL-1 beta and TNF alpha) and anti-inflammatory (Arg1 and TGF beta) cytokines with a single-phase, sustained peak from 1 to 7 days. In contrast, TBI caused a less robust microglia/macrophage phenotype in females with biphasic pro-inflammatory response peaks at 4 h and 7 days, and a delayed anti-inflammatory mRNA peak at 30 days. We further report that female mice were protected against acute cell loss after TBI, with male mice demonstrating enhanced astrogliosis, neuronal death, and increased lesion volume through 7 days post-TBI. Collectively, these findings indicate that TBI leads to a more aggressive neuroinflammatory profile in male compared with female mice during the acute and subacute phases postinjury. Understanding how sex affects the course of neuroinflammation following brain injury is a vital step toward developing personalized and effective treatments for TBI.	[Villapol, Sonia; Burns, Mark P.] Georgetown Univ, Dept Neurosci, Lab Brain Injury & Dementia, Washington, DC 20057 USA; [Loane, David J.] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Dept Anesthesiol, Baltimore, MD 21201 USA		Burns, MP (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, New Res Bldg EG11,3970 Reservoir Rd NW, Washington, DC 20057 USA.	mpb37@georgetown.edu	Loane, David/ABD-5177-2021; Villapol, Sonia/D-1949-2014	Loane, David/0000-0003-0393-3503; Villapol, Sonia/0000-0002-6174-4113; Burns, Mark P/0000-0003-4750-2000	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS067417, R01NS082308, R03NS095038]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS067417, R01NS082308, R01NS081068, R03NS095038] Funding Source: NIH RePORTER	NIH grants, Grant numbers: R01NS067417 (M.P. Burns), R01NS082308 (D.J. Loane), and R03NS095038 (S. Villapol)	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Ayoub AE, 2003, J NEUROSCI, V23, P7759; Bansal V, 2003, CURR OPIN CLIN NUTR, V6, P223, DOI 10.1097/00075197-200303000-00012; Belcredito S, 2001, BRAIN RES REV, V37, P335, DOI 10.1016/S0165-0173(01)00138-2; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Castellano B, 2016, ADV EXP MED BIOL, V949, P147, DOI 10.1007/978-3-319-40764-7_7; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Dimayuga FO, 2005, J NEUROIMMUNOL, V161, P123, DOI 10.1016/j.jneuroim.2004.12.016; Dotson AL, 2015, J NEUROIMMUNOL, V278, P289, DOI 10.1016/j.jneuroim.2014.11.020; Doyle HH, 2017, J NEUROSCI, V37, P3202, DOI 10.1523/JNEUROSCI.2906-16.2017; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Engler-Chiurazzi E. B., 2016, PROGR NEURO IN PRESS; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fleiss B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-70; GLENN JA, 1992, J ANAT, V180, P109; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Habib P, 2015, J STEROID BIOCHEM, V146, P3, DOI 10.1016/j.jsbmb.2014.02.018; Harry GJ, 2008, EXPERT OPIN DRUG MET, V4, P1265, DOI [10.1517/17425255.4.10.1265, 10.1517/17425255.4.10.1265 ]; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Jin X., 2012, PLOS ONE, V7; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; McCullough LD, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0015-5; Mirza MA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0251-6; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Moore CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000080; Morganti J. M., 2016, PLOS ONE, V11; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093650; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsawa K, 2011, GLIA, V59, P1793, DOI 10.1002/glia.21238; Ohsawa K, 2010, GLIA, V58, P790, DOI 10.1002/glia.20963; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Selenica MLB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-86; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Srinivasan D, 2004, J NEUROSCI, V24, P6482, DOI 10.1523/JNEUROSCI.5712-03.2004; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Tam WY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07279; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Villapol S, 2013, EXP NEUROL, V250, P353, DOI 10.1016/j.expneurol.2013.10.008; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052	77	121	122	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	SEP	2017	65	9					1423	1438		10.1002/glia.23171			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA5IL	WOS:000405476300003	28608978	Green Accepted			2022-02-06	
J	Mobashsher, AT; Abbosh, AM; Wang, YF				Mobashsher, Ahmed Toaha; Abbosh, Amin M.; Wang, Yifan			Microwave System to Detect Traumatic Brain Injuries Using Compact Unidirectional Antenna and Wideband Transceiver With Verification on Realistic Head Phantom	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Directional antenna; head imaging; head phantom; microwave imaging	MODELING HUMAN HEAD; DIRECTIONAL ANTENNA; RADAR; TISSUES; SENSOR; BODY	A portable microwave system to detect traumatic brain injuries is described. The wideband system utilizes a unidirectional antenna, microwave transceiver, and processing and image reconstruction algorithms. The utilized antenna is designed to have a compact three-dimensional (3-D) structure using a slotted dipole element and a folded parasitic structure. It attains directional radiation patterns with an average 9-dB front-to-back ratio and 102.2% fractional bandwidth covering the band 1.1-3.4 GHz, which is suitable for head imaging. To test the system, a realistic head phantom, which attains accurate internal and external anatomical structure and electrical properties, is fabricated by a 3-D printer using a detailed numerical model. Targets imitating the properties of bleeding are inserted at different positions in the fabricated head phantom to emulate brain injury scenarios. The integrated system is used in a virtual arrayed monostatic radar approach to detect the injuries. Using data sets recorded at 32 antenna positions around the head, a back projection algorithm is used to generate images of the scanned head. The achieved results demonstrate the feasibility of such a system as a portable module for brain injuries detection.	[Mobashsher, Ahmed Toaha; Abbosh, Amin M.; Wang, Yifan] Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia		Mobashsher, AT (corresponding author), Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia.	a.mobashsher@uq.edu.au	Mobashsher, Ahmed Toaha/H-6341-2019; Abbosh, Amin/C-3944-2009	Mobashsher, Ahmed Toaha/0000-0002-6351-8136; Abbosh, Amin/0000-0002-8015-5883	ARCAustralian Research Council [DP120101214]	This work was supported by ARC Discovery under Grant DP120101214. This paper is an expanded version from the IEEE MTT-S International Microwave Workshop Series on RF and Wireless Technologies for Biomedical and Healthcare Applications, Singapore, Dec. 9-11, 2013.	Akter M, 2007, ACAD RADIOL, V14, P1011, DOI 10.1016/j.acra.2007.05.013; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bassi M, 2013, IEEE T MICROW THEORY, V61, P2108, DOI 10.1109/TMTT.2013.2247052; Bialkowski M, 2010, ASIA PACIF MICROWAVE, P267; Callaway J., 2013, RISK, V29, P72; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Fhager A., 2012, Proceedings of the 2012 6th European Conference on Antennas and Propagation (EuCAP), P1796, DOI 10.1109/EuCAP.2012.6206715; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Guarnieri Massimo, 2010, 2010 14th Biennial IEEE Conference on Electromagnetic Field Computation (CEFC 2010), DOI 10.1109/CEFC.2010.5481709; Hofmann M, 2013, IEEE T MICROW THEORY, V61, P2195, DOI 10.1109/TMTT.2013.2250516; Ireland D, 2013, IEEE T ANTENN PROPAG, V61, P2352, DOI 10.1109/TAP.2013.2242037; Jalilvand M, 2014, ELECTRON LETT, V50, P255, DOI 10.1049/el.2013.4078; Jalilvand M, 2011, IEEE NATL RADAR CONF, P956; Karanasiou IS, 2004, IEEE T MICROW THEORY, V52, P1898, DOI 10.1109/TMTT.2004.831999; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Klemm M, 2005, IEEE T ANTENN PROPAG, V53, P3884, DOI 10.1109/TAP.2005.859906; Li XY, 2014, IEEE T ANTENN PROPAG, V62, P1808, DOI 10.1109/TAP.2013.2297158; Li YT, 2011, IEEE ANTENN WIREL PR, V10, P1397, DOI 10.1109/LAWP.2011.2178810; Meng X, 2013, IEEE T MICROW THEORY, V61, P316, DOI 10.1109/TMTT.2012.2224361; Mercuri M, 2013, IEEE T MICROW THEORY, V61, P2061, DOI 10.1109/TMTT.2013.2247619; Mobashsher AT, 2014, ELECTRON LETT, V50, P850, DOI 10.1049/el.2014.0616; Mobashsher AT, 2014, ELECTRON LETT, V50, P246, DOI 10.1049/el.2013.3909; Mobashsher A T, 2013, P IEEE MTT S INT MIC, P1, DOI DOI 10.1109/IMWS-BIO.2013.6756149; Mobashsher AT, 2014, IET MICROW ANTENNA P, V8, P171, DOI 10.1049/iet-map.2013.0374; Mohammed B., 2012, P INT C DIG IM COMP, P1; Mohammed B. J., 2011, Proceedings of the 2011 Seventh International Conference on Intelligent Sensors, Sensor Networks and Information Processing (ISSNIP), P17, DOI 10.1109/ISSNIP.2011.6146567; Mohammed BJ, 2014, MICROW OPT TECHN LET, V56, P979, DOI 10.1002/mop.28229; Mohammed BJ, 2014, IEEE T INSTRUM MEAS, V63, P117, DOI 10.1109/TIM.2013.2277562; Mustafa S, 2013, IEEE ANTENN WIREL PR, V12, P460, DOI 10.1109/LAWP.2013.2255095; Mustafa S, 2014, IEEE T ANTENN PROPAG, V62, P1354, DOI 10.1109/TAP.2013.2296323; Mustafa S, 2012, CAIRO INT BIOM ENG, P194, DOI 10.1109/CIBEC.2012.6473328; Park SW, 2013, IEEE T MICROW THEORY, V61, P2153, DOI 10.1109/TMTT.2013.2247211; Scapaticci R., 2012, Progress In Electromagnetics Research B, V40, P305; Schwerdt HN, 2013, IEEE T MICROW THEORY, V61, P2170, DOI 10.1109/TMTT.2013.2252916; Semenov SY, 2008, INT J ANTENN PROPAG, V2008, DOI 10.1155/2008/254830; Sperandio M, 2012, IEEE T BIO-MED ENG, V59, P383, DOI 10.1109/TBME.2011.2173197; Thotahewa KMS, 2013, IEEE T MICROW THEORY, V61, P2161, DOI 10.1109/TMTT.2013.2250515; Wang YF, 2014, IEEE T ANTENN PROPAG, V62, P698, DOI 10.1109/TAP.2013.2289355; Yarovoy AG, 2007, IEEE T MICROW THEORY, V55, P1288, DOI 10.1109/TMTT.2007.896791	39	121	121	2	27	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	SEP	2014	62	9			SI		1826	1836		10.1109/TMTT.2014.2342669			11	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	AT5NU	WOS:000344990400002					2022-02-06	
J	Hertle, DN; Dreier, JP; Woitzik, J; Hartings, JA; Bullock, R; Okonkwo, DO; Shutter, LA; Vidgeon, S; Strong, AJ; Kowoll, C; Dohmen, C; Diedler, J; Veltkamp, R; Bruckner, T; Unterberg, AW; Sakowitz, OW				Hertle, Daniel N.; Dreier, Jens P.; Woitzik, Johannes; Hartings, Jed A.; Bullock, Ross; Okonkwo, David O.; Shutter, Lori A.; Vidgeon, Steven; Strong, Anthony J.; Kowoll, Christina; Dohmen, Christian; Diedler, Jennifer; Veltkamp, Roland; Bruckner, Thomas; Unterberg, Andreas W.; Sakowitz, Oliver W.		Cooperative Study Brain Injury	Effect of analgesics and sedatives on the occurrence of spreading depolarizations accompanying acute brain injury	BRAIN			English	Article						spreading depolarization; isoelectric spreading; depolarization; ketamine; midazolam	RANDOMIZED CONTROLLED-TRIAL; HUMAN CEREBRAL-CORTEX; SUBARACHNOID HEMORRHAGE; GLYCINE ANTAGONIST; NMDA RECEPTOR; ACUTE STROKE; BLOOD-FLOW; DEPRESSION; KETAMINE; RAT	Spreading depolarizations are waves of mass neuronal and glial depolarization that propagate across the injured human cortex. They can occur with depression of neuronal activity as spreading depressions or isoelectric spreading depolarizations on a background of absent or minimal electroencephalogram activity. Spreading depolarizations are characterized by the loss of neuronal ion homeostasis and are believed to damage functional neurons, leading to neuronal necrosis or neurological degeneration and poor outcome. Analgesics and sedatives influence activity-dependent neuronal ion homeostasis and therefore represent potential modulators of spreading depolarizations. In this exploratory retrospective international multicentre analysis, we investigated the influence of midazolam, propofol, fentanyl, sufentanil, ketamine and morphine on the occurrence of spreading depolarizations in 115 brain-injured patients. A surface electrode strip was placed on the cortex, and continuous electrocorticographical recordings were obtained. We used multivariable binary logistic regression to quantify associations between the investigated drugs and the hours of electrocorticographical recordings with and without spreading depolarizations or clusters of spreading depolarizations. We found that administration of ketamine was associated with a reduction of spreading depolarizations and spreading depolarization clusters (P < 0.05). Midazolam anaesthesia, in contrast, was associated with an increased number of spreading depolarization clusters (P < 0.05). By using a univariate odds ratio analysis, we also found a significant association between ketamine administration and reduced occurrence of isoelectric spreading depolarizations in patients suffering from traumatic brain injury, subarachnoid haemorrhage and malignant hemispheric stroke (P < 0.05). Our findings suggest that ketamine-or another N-methyl-d-aspartate receptor antagonist-may represent a viable treatment for patients at risk for spreading depolarizations. This hypothesis will be tested in a prospective study.	[Hertle, Daniel N.; Unterberg, Andreas W.; Sakowitz, Oliver W.] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany; [Dreier, Jens P.] Charite, Dept Expt Neurol, D-10117 Berlin, Germany; [Woitzik, Johannes] Charite, Dept Neurosurg, D-10117 Berlin, Germany; [Hartings, Jed A.; Shutter, Lori A.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45219 USA; [Bullock, Ross] Univ Miami, Dept Neurosurg, Miami, FL 33136 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Vidgeon, Steven; Strong, Anthony J.] Kings Coll London, Dept Clin Neurosci, London SE5 8AF, England; [Kowoll, Christina; Dohmen, Christian] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany; [Diedler, Jennifer; Veltkamp, Roland] Univ Heidelberg, Dept Neurol, D-69120 Heidelberg, Germany; [Bruckner, Thomas] Univ Heidelberg, Inst Med Biometry & Informat, D-69120 Heidelberg, Germany		Hertle, DN (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, INF 400, D-69120 Heidelberg, Germany.	daniel.hertle@med.uni-heidelberg.de	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628; Dreier, Jens/0000-0001-7459-2828; Woitzik, Johannes/0000-0002-1865-4606; Hartings, Jed/0000-0001-8583-3471; Sakowitz, Oliver/0000-0003-3248-6335	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG DR 323/5-1]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)Federal Ministry of Education & Research (BMBF) [01 EO 0801]; Bundesministerium fur Bildung und Forschung (Bernstein Center for Computational Neuroscience Berlin)Federal Ministry of Education & Research (BMBF) [01GQ1001C B2]; US Army CDMRP PH/traumatic brain injury Research Program [W81XWH-08-2-0016]	The Deutsche Forschungsgemeinschaft (grant DFG DR 323/5-1 to J.P.D., O.W.S. and J.W.) and the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801; Bernstein Center for Computational Neuroscience Berlin 01GQ1001C B2 to J.P.D.). This work was funded in part by the US Army CDMRP PH/traumatic brain injury Research Program (Contract No. W81XWH-08-2-0016).	AITKEN PG, 1988, NEUROSCI LETT, V89, P187, DOI 10.1016/0304-3940(88)90379-5; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Alkire MT, 1999, ANESTHESIOLOGY, V90, P701, DOI 10.1097/00000542-199903000-00011; AVOLI M, 1991, ANN NEUROL, V30, P589, DOI 10.1002/ana.410300412; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Canals S, 2005, J NEUROPHYSIOL, V94, P943, DOI 10.1152/jn.01145.2004; DAWSON B, 1971, ANESTH ANAL CURR RES, V50, P443; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Gorji A, 2001, BRAIN RES, V906, P74, DOI 10.1016/S0006-8993(01)02557-4; Hartings JA, 2012, LANCET NEUROL, V11, P389, DOI 10.1016/S1474-4422(12)70085-6; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; IIJIMA T, 1992, J CEREBR BLOOD F MET, V12, P727, DOI 10.1038/jcbfm.1992.103; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; Langsjo JW, 2003, ANESTHESIOLOGY, V99, P614, DOI 10.1097/00000542-200309000-00016; Largo C, 1996, J NEUROSCI, V16, P1219; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; Obrenovitch TP, 1996, BRIT J PHARMACOL, V117, P931, DOI 10.1111/j.1476-5381.1996.tb15283.x; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P1719, DOI 10.1001/jama.285.13.1719; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09	38	121	124	1	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950			BRAIN	Brain	AUG	2012	135		8				2390	2398		10.1093/brain/aws152			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	984DQ	WOS:000307170300018	22719001	Bronze			2022-02-06	
J	Jin, XM; Ishii, H; Bai, ZB; Itokazu, T; Yamashita, T				Jin, Xuemei; Ishii, Hiroshi; Bai, Zhongbin; Itokazu, Takahide; Yamashita, Toshihide			Temporal Changes in Cell Marker Expression and Cellular Infiltration in a Controlled Cortical Impact Model in Adult Male C57BL/6 Mice	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CERVICAL LYMPH-NODES; FUNCTIONAL RECOVERY; IMMUNE-RESPONSE; T-CELLS; INFLAMMATION; MICROGLIA; SYSTEM; CNS	Background: Traumatic injury to the central nervous system (CNS) triggers a robust inflammatory response that leads to axonal damage and secondary degeneration of spared tissue. In contrast, some immune responses have neuroprotective effects. However, detailed information regarding the dynamics of immune responses after traumatic CNS injury is still unavailable. Methods: In the present study, changes in the immune cells present in the injured brain, spleen, and cervical lymph nodes (CLNs), which are draining lymphatic organs from the CNS, were analyzed after controlled cortical impact (CCI) by flow cytometry and immunohistochemistry. Results: The number of neutrophils and macrophages that infiltrated the injured brain immediately increased 1 d post-injury and declined rapidly thereafter. In the injured brain, resident microglia showed a bimodal increase during the first week and in the chronic phase (>= 3 weeks) after injury. Increase in the Iba-1(+) microglia/macrophages was observed around the injured site. Morphologic analysis showed that Iba-1(+) cells were round at 1 week, whereas those at 3 weeks were more ramified. Furthermore, CD86(+)/CD11b(+) M1-like microglia increased at 4 weeks after CCI, whereas CD206(+)/CD11b(+) M2-like microglia increased at 1 week. These results suggest that different subsets of microglia increased in the acute and chronic phases after CCI. Dendritic cells and T cells increased transiently within 1 week in the injured brain. In the CLNs and the spleen, T cells showed dynamic changes after CCI. In particular, the alteration in the number of T cells in the CLNs showed a similar pattern, with a 1-week delay, to that of microglia in the injured brain. Conclusion: The data from this study provide useful information on the dynamics of immune cells in CNS injuries.	[Jin, Xuemei; Ishii, Hiroshi; Itokazu, Takahide; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Jin, Xuemei; Ishii, Hiroshi; Itokazu, Takahide; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo, Japan; [Bai, Zhongbin] Yunnan Agr Univ, Key Lab Puer Tea Sci, Minist Educ, Kunming, Peoples R China		Jin, XM (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	; Wang, Jun/C-8434-2016; Schierup, Mikkel Heide/F-1675-2010; Wang, Jun/B-9503-2016; FANG, Xiaodong/K-6743-2018; Zhang, Guojie/J-7273-2019	He, Mingze/0000-0002-8164-2480; Yamashita, Toshihide/0000-0003-4559-7018; Wang, Jun/0000-0002-8540-8931; Schierup, Mikkel Heide/0000-0002-5028-1790; Wang, Jun/0000-0002-2113-5874; FANG, Xiaodong/0000-0001-7061-3337; Zhang, Guojie/0000-0001-6860-1521; Mailund, Thomas/0000-0001-6206-9239; Itokazu, Takahide/0000-0003-2977-7190; Hvilsom, Christina/0000-0001-7870-6888; Meng, Yuhuan/0000-0001-7464-3103; Jin, Xin/0000-0001-7554-4975	Core Research for Evolutional Science and Technology (CREST)Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST)Japan Science & Technology Agency (JST)	This work was supported by Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arneth BM, 2010, J NEUROIMMUNOL, V219, P123, DOI 10.1016/j.jneuroim.2009.12.011; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; Dardiotis E, 2012, BRAIN INJURY PATHOGE; De Haas AH, 2007, GLIA, V55, P1374, DOI 10.1002/glia.20554; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; FORD AL, 1995, J IMMUNOL, V154, P4309; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hatterer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003321; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Herz J, 2010, EXP NEUROL, V225, P9, DOI 10.1016/j.expneurol.2009.11.019; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nguyen HX, 2011, JOVE-J VIS EXP, DOI 10.3791/2698; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Sagar D, 2012, J NEUROIMMUNE PHARM, V7, P74, DOI 10.1007/s11481-011-9302-7; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Schwartz M, 2005, ACTA NEUROCHIR SUPPL, V93, P147; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Soares HD, 1995, J NEUROSCI, V15, P8223; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; WIDNER H, 1988, SCAND J IMMUNOL, V28, P563, DOI 10.1111/j.1365-3083.1988.tb01488.x; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; YAMADA S, 1991, AM J PHYSIOL, V261, pH1197, DOI 10.1152/ajpheart.1991.261.4.H1197; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	48	121	126	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41892	10.1371/journal.pone.0041892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	WOS:000306751300081	22911864	gold, Green Published, Green Submitted			2022-02-06	
J	Panzer, MB; Myers, BS; Capehart, BP; Bass, CR				Panzer, Matthew B.; Myers, Barry S.; Capehart, Bruce P.; Bass, Cameron R.			Development of a Finite Element Model for Blast Brain Injury and the Effects of CSF Cavitation	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Finite element model; Blast overpressure; Blast injury; Traumatic brain injury; Injury mechanism; CSF cavitation	CENTRAL-NERVOUS-SYSTEM; HEAD IMPACT MODEL; HYDROSTATIC-PRESSURE; DYNAMIC-RESPONSE; RISK-ASSESSMENT; TISSUE; CELLS; IRAQ; AFGHANISTAN; VISCOSITY	Blast-related traumatic brain injury is the most prevalent injury for combat personnel seen in the current conflicts in Iraq and Afghanistan, yet as a research community, we still do not fully understand the detailed etiology and pathology of this injury. Finite element (FE) modeling is well suited for studying the mechanical response of the head and brain to blast loading. This paper details the development of a FE head and brain model for blast simulation by examining both the dilatational and deviatoric response of the brain as potential injury mechanisms. The levels of blast exposure simulated ranged from 50 to 1000 kPa peak incident overpressure and 1-8 ms in positive-phase duration, and were comparable to real-world blast events. The frontal portion of the brain had the highest pressures corresponding to the location of initial impact, and peak pressure attenuated by 40-60% as the wave propagated from the frontal to the occipital lobe. Predicted brain pressures were primarily dependent on the peak overpressure of the impinging blast wave, and the highest predicted brain pressures were 30% less than the reflected pressure at the surface of blast impact. Predicted shear strain was highest at the interface between the brain and the CSF. Strain magnitude was largely dependent on the impulse of the blast, and primarily caused by the radial coupling between the brain and deforming skull. The largest predicted strains were generally less than 10%, and occurred after the shock wave passed through the head. For blasts with high impulses, CSF cavitation had a large role in increasing strain levels in the cerebral cortex and periventricular tissues by decoupling the brain from the skull. Relating the results of this study with recent experimental blast testing suggest that a rate-dependent strain-based tissue injury mechanism is the source primary blast TBI.	[Panzer, Matthew B.; Myers, Barry S.; Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Capehart, Bruce P.] Durham VA Med Ctr, OEF OIF Vet Program, Durham, NC 27705 USA; [Capehart, Bruce P.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA		Panzer, MB (corresponding author), Duke Univ, Dept Biomed Engn, 136 Hudson Hall,Box 90281, Durham, NC 27708 USA.	matthew.pan-zer@duke.edu; barry.myers@duke.edu; bruce.capehart@va.gov; dale.bass@duke.edu			Multidisciplinary Research Initiative (MURI) program through the Army Research Office (ARO) [W911MF-10-10526]; James H. McElhaney Biomechanics Fellowship	This work funded in part by the Multidisciplinary Research Initiative (MURI) program (W911MF-10-10526; University of Pennsylvania as prime institution) through the Army Research Office (ARO). We also acknowledge the support of the James H. McElhaney Biomechanics Fellowship for one of the authors (M. B. Panzer).	Ackerman MJ, 1998, P IEEE, V86, P504, DOI 10.1109/5.662875; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bass Cameron R Dale, 2005, Int J Occup Saf Ergon, V11, P347; BAZANT ZP, 1978, COMPUT METHOD APPL M, V16, P91, DOI 10.1016/0045-7825(78)90035-X; Bloomfield IG, 1998, PEDIATR NEUROSURG, V28, P246, DOI 10.1159/000028659; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Cronin D. S., 2008, NUMERICAL MODELING B; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Frey B, 2004, CELL MOL BIOL, V50, P459; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; GORDON C, 1989, TR89044 US ARM NAT R; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Hallquist J., 2007, LS DYNA KEYWORD USER; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Holland CM, 2008, STROKE, V39, P1127, DOI 10.1161/STROKEAHA.107.497438; Hyde DW, 2004, CONWEP 2 1 0 8 CONVE; IREMONGER MJ, 1997, SCI FDN TRAUMA, P189; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Lynnerup N., 2005, HEAD FACE MED, V1, P13, DOI DOI 10.1186/1746-160X-1-13; Mahmadi K, 2004, MATER SCI FORUM, V465-466, P439, DOI 10.4028/www.scientific.net/MSF.465-466.439; Manas P, 2004, APPL ENVIRON MICROB, V70, P1545, DOI 10.1128/AEM.70.3.1545-1554.2004; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; MCELHANEY JH, 1966, J APPL PHYSIOL, V21, P1231, DOI 10.1152/jappl.1966.21.4.1231; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nelson TJ, 2008, J TRAUMA, V65, P212, DOI 10.1097/01.ta.0000196010.50246.9a; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; NUSHOLTZ GS, 1995, J NEUROTRAUM, V12, P707, DOI 10.1089/neu.1995.12.707; NUSHOLTZ GS, 1995, AVIAT SPACE ENVIR MD, V66, P661; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer M. B., 2010, PASS QUEB CIT QC; Panzer MB, 2013, COMPUT METHOD BIOMEC, V16, P612, DOI 10.1080/10255842.2011.629615; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Prange M T, 2000, Stapp Car Crash J, V44, P205; Rafaels K. A., 2011, THESIS U VIRGINIA CH; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Richmond D. R., 1989, ANN OTOLRHINOLLARYNG, V140, P35; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; VALK PE, 1991, AM J NEURORADIOL, V12, P45; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wardlaw A., 2010, CAVITATION POSSIBLE; WILKINS ML, 1980, J COMPUT PHYS, V36, P281, DOI 10.1016/0021-9991(80)90161-8; Wood G. W., 2010, PASS QUEB CIT QC	56	121	121	2	39	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964			ANN BIOMED ENG	Ann. Biomed. Eng.	JUL	2012	40	7					1530	1544		10.1007/s10439-012-0519-2			15	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	959WL	WOS:000305348500012	22298329				2022-02-06	
J	Tong, XK; Lecrux, C; Hamel, E				Tong, Xin-Kang; Lecrux, Clotilde; Hamel, Edith			Age-Dependent Rescue by Simvastatin of Alzheimer's Disease Cerebrovascular and Memory Deficits	JOURNAL OF NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; TRANSGENIC MICE; MOUSE MODEL; SYNAPTIC PLASTICITY; SPATIAL MEMORY; IN-VIVO	Alzheimer's disease (AD) is now established as a progressive compromise not only of the neurons but also of the cerebral vasculature. Increasing evidence also indicates that cerebrovascular dysfunction may be a key or an aggravating pathogenic factor in AD, emphasizing the importance to properly control this deficit when aiming for effective therapy. Here, we report that simvastatin (3-6 months, 40 mg/kg/d) completely rescued cerebrovascular reactivity, basal endothelial nitric oxide synthesis, and activity-induced neurometabolic and neurovascular coupling in adult (6 months) and aged (12 months) transgenic mice overexpressing the Swedish and Indiana mutations of the human amyloid precursor protein (AD mice). Remarkably, simvastatin fully restored short-and long-term memory in adult, but not in aged AD mice. These beneficial effects occurred without any decreasing effect of simvastatin on brain amyloid-beta (A beta) levels or plaque load. However, in AD mice with recovered memory, protein levels of the learning-and memory-related immediate early genes c-Fos and Egr-1 were normalized or upregulated in hippocampal CA1 neurons, indicative of restored neuronal function. In contrast, the levels of phospholipase A2, enkephalin, PSD-95, synaptophysin, or glutamate NMDA receptor subunit type 2B were either unaltered in AD mice or unaffected by treatment. These findings disclose new sites of action for statins against A beta-induced neuronal and cerebrovascular deficits that could be predictive of therapeutic benefit in AD patients. They further indicate that simvastatin and, possibly, other brain penetrant statins bear high therapeutic promise in early AD and in patients with vascular diseases who are at risk of developing AD.	[Tong, Xin-Kang; Lecrux, Clotilde; Hamel, Edith] McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, Montreal, PQ H3A 2B4, Canada		Hamel, E (corresponding author), McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	edith.hamel@mcgill.ca	Lecrux, Clotilde/AAG-1415-2019	Lecrux, Clotilde/0000-0003-3521-5266	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-84275]; Heart & Stroke Foundation of Canada/Canadian Stroke Network	This work was supported by the Canadian Institutes of Health Research Grant MOP-84275 (to E. H.) and a fellowship from the Heart & Stroke Foundation of Canada/Canadian Stroke Network (to C. L.). We thank Dr. L. Mucke (Gladstone Institute of Neurological Disease and Department of Neurology, University of California, San Francisco, San Francisco, CA) and the J. David Gladstone Institutes for the APP transgenic mouse breeders. We are indebted to Ms. P. Fernandes [Montreal Neurological Institute (MNI), Montreal, Quebec, Canada] for the laser Doppler flowmetry experiments; J. Cakiroglu and Dr. B. Bedell (Small Animal Imaging Laboratory, MNI) for the MRI templates; Dr. P. Rosa-Neto (Brain Imaging Centre, MNI) for his help with the PET data analysis; Dr. N. Nicolakakis (MNI) for reviewing the manuscript; and P. Papadopoulos (MNI) for help with some treatments.	Aucoin JS, 2005, NEUROSCIENCE, V132, P73, DOI 10.1016/j.neuroscience.2004.11.047; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Beretta S, 2011, NEUROPHARMACOLOGY, V60, P878, DOI 10.1016/j.neuropharm.2011.01.003; Blanchard J, 2008, NEUROBIOL AGING, V29, P1011, DOI 10.1016/j.neurobiolaging.2007.02.010; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Butterfield DA, 2011, EXP NEUROL, V228, P15, DOI 10.1016/j.expneurol.2010.12.014; Carloni S, 2009, EXP NEUROL, V220, P82, DOI 10.1016/j.expneurol.2009.07.026; Carlsson CM, 2008, J ALZHEIMERS DIS, V13, P187; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; deIpolyi AR, 2008, NEUROBIOL AGING, V29, P253, DOI 10.1016/j.neurobiolaging.2006.10.021; Dickey CA, 2003, J NEUROSCI, V23, P5219; Drouin A, 2007, CARDIOVASC RES, V73, P73, DOI 10.1016/j.cardiores.2006.10.005; Erdos B, 2004, DIABETES, V53, P1352, DOI 10.2337/diabetes.53.5.1352; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Han BH, 2008, J NEUROSCI, V28, P13542, DOI 10.1523/JNEUROSCI.4686-08.2008; Hirao K, 2005, NEUROIMAGE, V28, P1014, DOI 10.1016/j.neuroimage.2005.06.066; Hong KW, 1996, AM J PHYSIOL-HEART C, V270, pH317, DOI 10.1152/ajpheart.1996.270.1.H317; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KITAZONO T, 1993, AM J PHYSIOL, V265, pH581, DOI 10.1152/ajpheart.1993.265.2.H581; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Kornblum HI, 2000, NAT BIOTECHNOL, V18, P655, DOI 10.1038/76509; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li G, 2007, NEUROLOGY, V69, P878, DOI 10.1212/01.wnl.0000277657.95487.1c; Li G, 2010, J AM GERIATR SOC, V58, P1311, DOI 10.1111/j.1532-5415.2010.02906.x; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Lloyd DJ, 2009, DIABETES OBES METAB, V11, P688, DOI 10.1111/j.1463-1326.2009.01034.x; Lopez J, 2008, J CARDIOVASC PHARM T, V13, P207, DOI 10.1177/1074248408321716; Maneen MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1042, DOI 10.1152/ajpheart.00800.2006; Mans RA, 2010, NEUROSCIENCE, V166, P435, DOI 10.1016/j.neuroscience.2009.12.062; Meilandt WJ, 2008, J NEUROSCI, V28, P5007, DOI 10.1523/JNEUROSCI.0590-08.2008; Miller AW, 2004, AM J PHYSIOL-REG I, V287, pR157, DOI 10.1152/ajpregu.00647.2003; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P200, DOI 10.1038/jcbfm.2010.78; Niwa K, 2002, NEUROBIOL DIS, V9, P61, DOI 10.1006/nbdi.2001.0460; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Park L, 2011, P NATL ACAD SCI USA, V108, P5063, DOI 10.1073/pnas.1015413108; Pedersen K, 2007, NEUROIMAGE, V35, P38, DOI 10.1016/j.neuroimage.2006.11.038; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Sparks DL, 2006, ACTA NEUROL SCAND, V114, P78, DOI 10.1111/j.1600-0404.2006.00689.x; Sugawara T, 2008, J NEUROSCI RES, V86, P3635, DOI 10.1002/jnr.21807; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Tong XK, 2009, NEUROBIOL DIS, V35, P406, DOI 10.1016/j.nbd.2009.06.003; Tong XK, 2005, J NEUROSCI, V25, P11165, DOI 10.1523/JNEUROSCI.4031-05.2005; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Yang XG, 2010, MOL NEUROBIOL, V41, P138, DOI 10.1007/s12035-010-8121-9; Yau JLW, 1996, MOL BRAIN RES, V42, P354, DOI 10.1016/S0169-328X(96)00220-3; Yoshida T, 2007, ANN NUCL MED, V21, P257, DOI 10.1007/s12149-007-0022-2; Yudoh K, 2010, AGING-US, V2, P990, DOI 10.18632/aging.100213	72	121	123	0	14	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	APR 4	2012	32	14					4705	4715		10.1523/JNEUROSCI.0169-12.2012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	925TD	WOS:000302783500002	22492027	Green Published, Bronze			2022-02-06	
J	Davenport, ND; Lim, KO; Armstrong, MT; Sponheim, SR				Davenport, Nicholas D.; Lim, Kelvin O.; Armstrong, Michael T.; Sponheim, Scott R.			Diffuse and spatially variable white matter disruptions are associated with blast-related mild traumatic brain injury	NEUROIMAGE			English	Article						Traumatic brain injury; White matter; Diffusion tensor imaging; Blast	PERSISTENT POSTCONCUSSIVE SYMPTOMS; TENSOR; CONCUSSION; IRAQ; AFGHANISTAN; SEQUELAE	Mild traumatic brain injury (mTBI) due to explosive blast is common among military service members and often associated with long term psychological and cognitive disruptions. Little is known about the neurological effects of blast-related mTBI and whether they differ from those of civilian, non-blast mTBI. Given that brain damage from blasts may be diffuse and heterogeneous, we tested the hypothesis that blast mTBI is associated with subtle white matter disruptions in the brain that are spatially inconsistent across individuals. We used diffusion tensor imaging to examine white matter integrity, as quantified by fractional anisotropy (FA), in a group of American military service members with (n = 25) or without (n = 33) blast-related rnTBI who had been deployed as part of Operation Iraqi Freedom or Operation Enduring Freedom. History of civilian non-blast mTBI was equally common across groups, which enabled testing of both blast and non-blast mTBI effects on measures sensitive to (1) concentrated, spatially consistent (average FA within a region of interest [ROI]), (2) concentrated, spatially variable (number of ROIs with low average FA), and (3) diffuse (number of voxels with low FA) disruptions of white matter integrity. Blast mTBI was associated with a diffuse, global pattern of lower white matter integrity, and this pattern was not affected by previous civilian mTBI. Neither type of mTBI had an effect on the measures sensitive to more concentrated and spatially consistent white matter disruptions. Additionally, individuals with more than one blast mTBI tended to have a larger number of low FA voxels than individuals with a single blast injury. These results indicate that blast mTBI is associated with disrupted integrity of several white matter tracts, and that these disruptions are diluted by averaging across the large number of voxels within an ROI. The reported pattern of effects supports the conclusion that the neurological effects of blast mTBI are diffuse, widespread, and spatially variable. (C) 2011 Elsevier Inc. All rights reserved.	[Davenport, Nicholas D.; Lim, Kelvin O.; Armstrong, Michael T.; Sponheim, Scott R.] Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA; [Lim, Kelvin O.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55454 USA		Davenport, ND (corresponding author), Minneapolis VA Med Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA.	daven012@umn.edu; kolim@umn.edu; Michael.Armstrong@va.gov; sponh001@umn.edu	Lim, Kelvin/C-2201-2012; Lim, Kelvin/AAF-6833-2020; Davenport, Nicholas/AAY-8057-2020; Sponheim, Scott/J-3857-2017	Davenport, Nicholas/0000-0002-3441-7256; Sponheim, Scott/0000-0002-2782-0856; Lim, Kelvin/0000-0002-2390-7268	Minnesota Veterans Research Institute (MVRI); Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0038]	This work was supported by grants from the Minnesota Veterans Research Institute (MVRI) and the Congressionally Directed Medical Research Program (W81XWH-08-2-0038) to Scott R. Sponheim. We are grateful to Nikki Fraser for assistance with acquisition of imaging data; Molly J. Charlesworth for efforts with recruitment and clinical assessment; and Amanda Ferrier-Auerbach, Nathaniel W. Nelson, James Hoelzle, and Kathryn A. McGuire for efforts characterizing the head injuries of participants.	Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	35	121	122	1	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	FEB 1	2012	59	3					2017	2024		10.1016/j.neuroimage.2011.10.050			8	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	881NS	WOS:000299494000005	22040736				2022-02-06	
J	Elder, GA; Mitsis, EM; Ahlers, ST; Cristian, A				Elder, Gregory A.; Mitsis, Effie M.; Ahlers, Stephen T.; Cristian, Adrian			Blast-induced Mild Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Blast-related brain injury; Improvised explosive device; Posttraumatic stress disorder; Traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; CENTRAL-NERVOUS-SYSTEM; DIFFUSE AXONAL INJURY; ADULT-RAT BRAIN; PERSISTENT POSTCONCUSSIVE SYMPTOMS; TYMPANIC-MEMBRANE PERFORATION; LASTING IMPULSE NOISE; NON-PENETRATIVE BLAST; WHITE-MATTER INJURY; HEAD-INJURY	Traumatic brain injury (TBI) has been a major cause of mortality and morbidity in the wars in Iraq and Afghanistan Blast exposure has been the most common cause of TBI, occurring through multiple mechanisms What is less clear is whether the primary blast wave causes brain damage through mechanisms that are distinct from those common in civilian TBI and whether multiple exposures to low-level blast can lead to long-term sequelae Complicating TBI in soldiers is the high prevalence of posttraumatic stress disorder At present the relationship is unclear Resolution of these issues will affect both treatment strategies and strategies for the protection of troops in the field	[Elder, Gregory A.] James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, Bronx, NY 10468 USA; [Elder, Gregory A.; Mitsis, Effie M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Elder, Gregory A.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Mitsis, Effie M.; Cristian, Adrian] James J Peters Vet Affairs Med Ctr, Rehabil Med Serv, Bronx, NY 10468 USA; [Ahlers, Stephen T.] Naval Med Res Ctr, Operat & Undersea Med Directorate, Silver Spring, MD 20910 USA; [Cristian, Adrian] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Elder, GA (corresponding author), James J Peters Vet Affairs Med Ctr, Neurol Serv, 130 W Kingsbridge Rd, Bronx, NY 10468 USA.						Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Alvarez L, 2008, NY TIMES, pA1; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bochicchio GV, 2008, AM SURGEON, V74, P267; BOGO V, 1971, EFFECTS AIRBLAST DIS, V2659, P1; Brookings Institution, 2010, IR IND TRACK VAR REC; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; COHEN H, 1946, ARCH PATHOL, V42, P12; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Veterans Affairs/ Department of Defense ( VA/ DoD), 2009, VA DOD CLIN PRACT GU; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kaur C, 1996, ARCH HISTOL CYTOL, V59, P239, DOI 10.1679/aohc.59.239; Kluger Yoram, 2007, Am J Disaster Med, V2, P21; Knudsen SK, 2003, NEUROSCI RES, V46, P377, DOI 10.1016/S0168-0102(03)00101-9; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mott FW, 1916, LANCET, V1, P441; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PESKIND ER, NEUROIMAGE; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Phillips Y., 1990, TXB MILITARY MED 1, V5, P221; PHILLIPS YY, 1988, J TRAUMA, V28, pS149, DOI 10.1097/00005373-198801001-00030; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Van Heertum RL, 2004, SEMIN NUCL MED, V34, P300, DOI 10.1053/j.semnuclmed.2004.03.003; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walilko T, 2009, J TRAUMA, V67, P1311, DOI 10.1097/TA.0b013e31819adc36; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Zhang Jiangyue, 2009, Biomed Sci Instrum, V45, P119; Zhang Jiangyue, 2008, Biomed Sci Instrum, V44, P129; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215	105	121	121	0	20	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					757	+		10.1016/j.psc.2010.08.001			26	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700003	21093677				2022-02-06	
J	Wood, JN; Hall, M; Schilling, S; Keren, R; Mitra, N; Rubin, DM				Wood, Joanne N.; Hall, Matthew; Schilling, Samantha; Keren, Ron; Mitra, Nandita; Rubin, David M.			Disparities in the Evaluation and Diagnosis of Abuse Among Infants With Traumatic Brain Injury	PEDIATRICS			English	Article						child abuse; nonaccidental trauma; traumatic brain injury; bone/radiography; skeletal survey; disparity	HEAD-INJURY	OBJECTIVE: To evaluate in a national database the association of race and socioeconomic status with radiographic evaluation and subsequent diagnosis of child abuse after traumatic brain injury (TBI) in infants. METHODS: We conducted a retrospective study of infants with nonmotor vehicle-associated TBI who were admitted to 39 pediatric hospitals from January 2004 to June 2008. Logistic regression controlling for age, type, and severity of TBI and the presence of other injuries was performed to examine the association of race and socioeconomic status with the principal outcomes of radiographic evaluation for suspected abuse and diagnosis of abuse. Regression coefficients were transformed to probabilities. RESULTS: After adjustment for type and severity of TBI, age, and other injuries, publicly insured/uninsured infants were more likely to have had skeletal surveys performed than were privately insured infants (81% vs 59%). The difference in skeletal survey performance for infants with public or no insurance versus private insurance was greater among white (82% vs 53%) infants than among black (85% vs 75%) or Hispanic (72% vs 55%) infants (P = .022). Although skeletal surveys were performed in a smaller proportion of white than black or Hispanic infants, the adjusted probability for diagnosis of abuse among infants evaluated with a skeletal survey was higher among white infants (61%) than among black (51%) or Hispanic (53%) infants (P = .009). CONCLUSIONS: National data suggest continued biases in the evaluation for abusive head trauma. The conflicting observations of fewer skeletal surveys among white infants and higher rates of diagnosis among those screened elicit concern for overevaluation in some infants (black or publicly insured/uninsured) or underevaluation in others (white or privately insured). Pediatrics 2010; 126: 408-414	[Wood, Joanne N.; Schilling, Samantha; Keren, Ron; Rubin, David M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Hall, Matthew; Keren, Ron; Mitra, Nandita; Rubin, David M.] Univ Penn, Sch Med, Leonard Davis Inst, Philadelphia, PA 19104 USA; [Mitra, Nandita] Univ Penn, Sch Med, Dept Biostat, Philadelphia, PA 19104 USA; [Wood, Joanne N.; Keren, Ron; Rubin, David M.] Univ Penn, Sch Med, Dept Epidemiol, Philadelphia, PA 19104 USA		Wood, JN (corresponding author), Childrens Hosp Philadelphia, 3535 Market St,Room 1517, Philadelphia, PA 19104 USA.	woodjo@email.chop.edu					*AM COLL RAD, ACR PRACT GUID SKEL; Belfer RA, 2001, AM J EMERG MED, V19, P122, DOI 10.1053/ajem.2001.21345; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Di Pietro MA, 2009, PEDIATRICS, V123, P1430, DOI 10.1542/peds.2009-0558; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Flaherty EG, 2008, PEDIATRICS, V122, P611, DOI 10.1542/peds.2007-2311; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Lane WG, 2007, CLIN ORTHOP RELAT R, P219, DOI 10.1097/BLO.0b013e31805c0849; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Schnitzer PG, 2006, AM FAM PHYSICIAN, V74, P1864; Sege RD, 2008, ARCH DIS CHILD, V93, P822, DOI 10.1136/adc.2006.100545; *STAT CORP LP, 2009, STAT CORP STAT BAS R, V2, P957; Theodore AD, 2005, PEDIATRICS, V115, pE331, DOI 10.1542/peds.2004-1033; U.S. Department of Health and Human Services Administration on Children Youth and Families, 2009, CHILD MALTR 2007; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467	20	121	121	0	6	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2010	126	3					408	414		10.1542/peds.2010-0031			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	646JK	WOS:000281535700002	20713477				2022-02-06	
J	Cederberg, D; Siesjo, P				Cederberg, David; Siesjo, Peter			What has inflammation to do with traumatic brain injury?	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Inflammation; Children; Markers; Secondary injury	SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; PROINFLAMMATORY CYTOKINE; MICE; INTERLEUKIN-6; EXPRESSION; ACTIVATION; CHILDREN; TISSUE; SERUM	Inflammation is an stereotypical response to tissue damage and has been extensively documented in experimental and clinical traumatic brain injury (TBI), including children. The initiation and orchestration of inflammation in TBI, as in other tissues, is complex and multifactorial encompassing pro- and anti-inflammatory cytokines, chemokines, adhesion molecules, complement factors, reactive oxygen and nitrogen species, and other undefined factors. It is evident that inflammation can have both beneficial and detrimental effects in TBI, but the mechanisms underlying this dichotomy are mostly unknown. Modification of the inflammatory response may be neuroprotective. Monitoring inflammation is now possible with techniques such as microdialysis; however, the prognostic value of measuring inflammatory mediators in TBI is still unclear with conflicting reports. Except for corticosteroids, no anti-inflammatory agents have been tested in TBI, and the negative results with these may have been flawed by their multiple side effects. Clinical trials with anti-inflammatory agents that target multiple or central and downstream pathways are warranted in adult and pediatric TBI. This review examines the mechanisms of inflammation after TBI, monitoring, and possible routes of intervention.	[Cederberg, David; Siesjo, Peter] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden		Siesjo, P (corresponding author), Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden.	peter.siesjo@med.lu.se		Siesjo, Peter/0000-0002-5848-690X	SIDA [GUN 2072790]	This work is supported by a SIDA grant GUN 2072790. The authors have no conflicts of interest to declare.	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Badie B, 2003, CLIN CANCER RES, V9, P872; Bell MJ, 1997, ACT NEUR S, V70, P96; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Ehrlich LC, 1998, J IMMUNOL, V160, P1944; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Garcia-Segura LM, 2009, FRONT NEUROENDOCRIN, V30, pV, DOI 10.1016/j.yfrne.2009.04.006; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Juliet PAR, 2008, BRAIN RES, V1210, P230, DOI 10.1016/j.brainres.2008.02.099; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Ma YL, 2005, AM J PHYSIOL-REG I, V289, pR1297, DOI 10.1152/ajpregu.00260.2005; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; MATHEW P, 1994, ACTA NEUROCHIR, P428; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Moochhala SM, 2005, J TRAUMA, V59, P448, DOI 10.1097/01.ta.0000174858.79847.6d; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Weil ZM, 2008, PROG NEUROBIOL, V86, P48, DOI 10.1016/j.pneurobio.2008.06.001; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	43	121	121	3	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2010	26	2					221	226		10.1007/s00381-009-1029-x			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	539GK	WOS:000273241700013	19940996				2022-02-06	
J	Hartings, JA; Strong, AJ; Fabricius, M; Manning, A; Bhatia, R; Dreier, JP; Mazzeo, AT; Tortella, FC; Bullock, MR				Hartings, Jed A.; Strong, Anthony J.; Fabricius, Martin; Manning, Andrew; Bhatia, Robin; Dreier, Jens P.; Mazzeo, Anna Teresa; Tortella, Frank C.; Bullock, M. Ross		CoOperative Study Brain Injury Dep	Spreading Depolarizations and Late Secondary Insults after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						electroencephalography; hyperthermia; intracranial hypertension; spreading cortical depression; vascular hypotension	FOCAL CEREBRAL-ISCHEMIA; PERIINFARCT DEPOLARIZATIONS; BLOOD-FLOW; DEPRESSION; SEIZURES; PRESSURE; RISK; MECHANISMS; HEMORRHAGE; HYPEREMIA	Here we investigated the incidence of cortical spreading depolarizations (spreading depression and peri-infarct depolarization) after traumatic brain injury (TBI) and their relationship to systemic physiologic values during neurointensive care. Subdural electrode strips were placed on peri-contusional cortex in 32 patients who underwent surgical treatment for TBI. Prospective electrocorticography was performed during neurointensive care with retrospective analysis of hourly nursing chart data. Recordings were 84 hr (median) per patient and 2,503 hr in total. In 17 patients (53%), 280 spreading depolarizations (spreading depressions and peri-infarct depolarizations) were observed. Depolarizations occurred in a bimodal pattern with peak incidence on days 1 and 7. The probability of a depolarization occurring increased significantly as a function of declining mean arterial pressure (MAP; R-2 = 0.78; p < 0.001) and cerebral perfusion pressure (R-2 = 0.85; p < 0.01), and increasing core temperature (R-2 = 0.44; p < 0.05). Depolarization probability was 7% for MAP values of > 100 mm Hg but 33% for MAP of <= 70 mm Hg. Temperatures of <= 38.4 degrees C were associated with a 21% depolarization risk, compared to 63% for > 38.4 degrees C. Intracranial pressures were higher in patients with depolarizations (18.3 +/- 9.3 vs. 13.5 +/- 6.7 mm Hg; p < 0.001). We conclude that depolarization phenomena are a common cortical pathology in TBI. Their association with lower perfusion levels and higher temperatures suggests that the labile balance of energy supply and demand is an important determinant of their occurrence. Monitoring of depolarizations might serve as a functional measure to guide therapeutic efforts and their blockade may provide an additional line of defense against the effects of secondary insults.	[Hartings, Jed A.] Univ Cincinnati, Dept Neurosurg, Inst Neurosci, Cincinnati, OH 45219 USA; [Strong, Anthony J.; Manning, Andrew; Bhatia, Robin] Kings Coll Hosp London, Dept Neurosurg, London, England; [Fabricius, Martin] Glostrup Cty Hosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Dreier, Jens P.] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Mazzeo, Anna Teresa; Bullock, M. Ross] Virginia Commonwealth Univ, Div Neurosurg, Richmond, VA USA; [Mazzeo, Anna Teresa] Univ Messina, Dept Neurosci Psychiat & Anesthesiol Sci, Messina, Italy; [Tortella, Frank C.] Walter Reed Army Inst Res, Dept Appl Neurobiol, Silver Spring, MD USA		Hartings, JA (corresponding author), Univ Cincinnati, Dept Neurosurg, Inst Neurosci, 260 Stetson St,Suite 2200, Cincinnati, OH 45219 USA.	jed.hartings@uc.edu		Mazzeo, Anna Teresa/0000-0002-8454-7243; Dreier, Jens/0000-0001-7459-2828; Hartings, Jed/0000-0001-8583-3471	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [PO1 NS12587-27]; German Research Foundation (DFG)German Research Foundation (DFG) [SFB Tr3 D10, DR 323/3-1]; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587] Funding Source: NIH RePORTER	We thank Charlotte Gilman, Marinella Gugliotta, and Amedeo Merenda for their valuable contributions. This work was supported in part by NINDS PO1 NS12587-27 (to R. B.), the German Research Foundation (DFG) SFB Tr3 D10 and DR 323/3-1 (to J. D.), and the Novo Nordisk Foundation (to M. F.).	Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHEN Q, 1993, J CEREBR BLOOD F MET, V13, P389, DOI 10.1038/jcbfm.1993.52; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; CORTBUS F, 1994, ACTA NEUROCHIR, V130, P117, DOI 10.1007/BF01405511; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kempski O, 2000, ACT NEUR S, V76, P251; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mun-Bryce S, 2001, BRAIN RES, V888, P248, DOI 10.1016/S0006-8993(00)03068-7; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2005, ADV TECH STAND NEUR, V30, P3, DOI 10.1007/3-211-27208-9_1; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Trabold R, 2006, BRAIN RES, V1071, P237, DOI 10.1016/j.brainres.2005.11.095; Umegaki M, 2005, J NEUROSCI, V25, P1387, DOI 10.1523/JNEUROSCI.4182-04.2005; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750	41	121	122	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1857	1866		10.1089/neu.2009.0961			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600001	19508156	Green Published			2022-02-06	
J	Powell, JM; Ferraro, JV; Dikmen, SS; Temkin, NR; Bell, KR				Powell, Janet M.; Ferraro, Joseph V.; Dikmen, Sureyya S.; Temkin, Nancy R.; Bell, Kathleen R.			Accuracy of mild traumatic brain injury diagnosis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain concussion; craniocerebral trauma; head injuries, closed; post-concussive syndrome; rehabilitation	MINOR HEAD-INJURY; RANDOMIZED-TRIAL	Objective: To determine how often emergency department (ED) patients meeting the Centers for Disease Control and Prevention (CDC) mild traumatic brain injury (TBI) criteria were diagnosed with a mild TBI by the ED physician. Design: Prospective identification of cases of mild TBI in the ED by study personnel using scripted interviews and medical record data was compared with retrospective review of ED medical record documentation of mild TBI. Setting: EDs of a level I trauma center and an academic nontrauma hospital. Participants: Prospective cohort of subjects (N=197; mean age, 32.6y; 70% men) with arrival at the ED within 48 hours of injury, Glasgow Coma Scale score of 13 to 15, and injury circumstances,alteration of consciousness, and memory dysfunction consistent with the CDC mild TBI definition. Interventions: Not applicable. Main Outcome Measure: ED medical record documentation of mild TBI. Results: Fifty-six percent of mild TBI cases identified by study personnel did not have a documented mild TBI-related diagnosis in the ED record. The greatest agreement between study personnel and ED physicians for positive mild TBI-related findings was for loss of consciousness (72% vs 65%) with the greatest discrepancy for confusion (94% vs 28%). Conclusions: The diagnosis of mild TBI was frequently absent from ED medical records despite patients reporting findings consistent with a mild TBI diagnosis when interviewed by study personnel. Asking a few targeted questions of ED patients with likely mechanisms of injury that could result in mild TBI could begin to improve diagnosis and, in turn, begin to improve patient management and the accuracy of estimates of mild TBI incidence.	[Powell, Janet M.] Univ Washington, Dept Rehabil Med, Div Occupat Therapy, Seattle, WA 98195 USA; [Dikmen, Sureyya S.; Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Ferraro, Joseph V.] N Florida S Georgia Vet Hlth Care Syst, Gainesville, FL USA		Powell, JM (corresponding author), Univ Washington, Dept Rehabil Med, Div Occupat Therapy, 1959 NE Pacific St,Box 345490, Seattle, WA 98195 USA.	jmpowell@u.washington.edu		Bell, Kathleen/0000-0002-0928-2046	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR023226] Funding Source: Medline		ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BELL KR, J NEUROL NE IN PRESS; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Department of Health and Human Services, 1989, INT CLASS DIS 9 REV; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Finkelstein E., 2006, INCIDENCE EC BURDEN; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Langlois J, 2005, TRAUMATIC BRAIN INJU; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rosner B., 1995, FUNDAMENTALS BIOSTAT; Ruff RM, 1999, BRAIN INJURY, V13, P943; Rutherford W. H., 1989, MILD HEAD INJURY, P217; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tellier A, 1999, BRAIN INJURY, V13, P463	31	121	121	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2008	89	8					1550	1555		10.1016/j.apmr.2007.12.035			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	336UP	WOS:000258390400018	18597735				2022-02-06	
J	Friese, RS; Diaz-Arrastia, R; McBride, D; Frankel, H; Gentilello, LM				Friese, Randall S.; Diaz-Arrastia, Ramon; McBride, Dara; Frankel, Heidi; Gentilello, Larry M.			Quantity and quality of sleep in the surgical intensive care unit: Are our patients sleeping?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	37th Annual Meeting of the Western-Trauma-Association	FEB 25-MAR 02, 2007	Steamboat Springs, CO	Western Trauma Assoc		sleep; intensive care unit; polysomnography; critical illness; injury	REDUCES NATURAL-KILLER; NOCTURNAL SLEEP; HOST-DEFENSE; DEPRIVATION; CYTOKINES; LYMPHOCYTE; METABOLISM; HUMANS	Background: The lack of adequate sleep during intensive care unit (ICU) admission is a frequently overlooked complication. Disrupted sleep is associated with immune system dysfunction, impaired resistance to infection, as well as alterations in nitrogen balance and wound healing. The effects of surgical ICU admission on patients' sleep quality and architecture remain poorly defined. The purpose of this study was to describe the quantity and quality of sleep as well as sleep architecture, as defined by polysomnography (PSG), in patients cared for in the surgical ICU. Methods: A prospective observational cohort study was performed at our urban Level 1 trauma center. A convenience sample of surgical or trauma ICU patients underwent continuous PSG for up to 24 hours to evaluate sleep patterns. A certified sleep technician performed, monitored, and scored all PSG recordings. A single neurologist trained in PSG interpretation reviewed all PSG recordings. chi(2) goodness-of-fit analysis was performed to detect differences in the proportion of time spent in stages 1 and 2 (superficial stages), stages 3 and 4 (deep stages), or rapid eye movement (REM) sleep between study patients and healthy historical controls. All PSG recordings were performed greater than 24 hours after the administration of a general anesthetic. Patients with traumatic brain injury were excluded. Results: Sixteen patients were selected to undergo PSG recordings. Median age was 37.5 years (range, 20-83), 81.3% were male patients, 62.5% were injured, and 31.3% were mechanically ventilated. Total PSG recording time was 315 hours (mean, 19.7 hours per patient), total sleep time captured by PSG was 132 hours (mean, 8.28 hours per patient), and there were 6.2 awakenings per hour of sleep measured. ICU patients had an increase in the proportion of time spent in the superficial stages of sleep, and a decrease in the proportion of time spent in the deeper stages of sleep as well as a decrease in REM sleep compared with healthy controls (p < 0.001). Conclusions: Patients do achieve measurable sleep while cared for in a surgical ICU setting. However, sleep is fragmented and the quality of sleep is markedly abnormal with significant reductions in stages 3 and 4 and REM, the deeper restorative stages of sleep. Further studies on the effects of a strategy to promote sleep during ICU care are warranted.	[Friese, Randall S.; McBride, Dara; Frankel, Heidi; Gentilello, Larry M.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burn, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA		Friese, RS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burn, 5323 Harry Blvd,Room E5-508, Dallas, TX 75390 USA.	randall.friese@utsouthwestern.edu	, 叶叶叶/ABE-1619-2020	Diaz-Arrastia, Ramon/0000-0001-6051-3594			BERTOUCH JV, 1983, BRIT MED J, V286, P1171, DOI 10.1136/bmj.286.6372.1171; Cooper AB, 2000, CHEST, V117, P809, DOI 10.1378/chest.117.3.809; Culebras A, 2002, SLEEP MEDICINE, P1; EVERSON CA, 1993, AM J PHYSIOL, V265, pR1148, DOI 10.1152/ajpregu.1993.265.5.R1148; Freedman NS, 1999, AM J RESP CRIT CARE, V159, P1155, DOI 10.1164/ajrccm.159.4.9806141; Gabor J Y, 2001, Curr Opin Crit Care, V7, P21, DOI 10.1097/00075198-200102000-00004; Gumustekin K, 2004, INT J NEUROSCI, V114, P1433, DOI 10.1080/00207450490509168; Hilton B A, 1976, J Adv Nurs, V1, P453, DOI 10.1111/j.1365-2648.1976.tb00932.x; IRWIN M, 1994, PSYCHOSOM MED, V56, P493, DOI 10.1097/00006842-199411000-00004; Irwin M, 2002, BRAIN BEHAV IMMUN, V16, P503, DOI 10.1016/S0889-1591(02)00003-X; Irwin M, 1996, FASEB J, V10, P643, DOI 10.1096/fasebj.10.5.8621064; JONES J, 1979, INTENS CARE MED, V5, P89, DOI 10.1007/BF01686054; KANT GJ, 1984, SLEEP, V7, P142, DOI 10.1093/sleep/7.2.142; Kapsimalis F, 2005, CURR OPIN PULM MED, V11, P481, DOI 10.1097/01.mcp.0000183062.98665.6b; KRACHMAN SL, 1995, CHEST, V107, P1713, DOI 10.1378/chest.107.6.1713; KRUEGER JM, 1990, CLIN IMMUNOL IMMUNOP, V57, P188, DOI 10.1016/0090-1229(90)90033-M; MOLDOFSKY H, 1995, INT J IMMUNOPHARMACO, V17, P649, DOI 10.1016/0192-0561(95)00051-3; MOOTE CA, 1988, ANESTHESIOLOGY, V69, P327, DOI 10.1097/00000542-198809000-00007; PALMBLAD J, 1976, J PSYCHOSOM RES, V20, P193, DOI 10.1016/0022-3999(76)90020-9; PALMBLAD J, 1979, PSYCHOSOM MED, V41, P273, DOI 10.1097/00006842-197906000-00001; Parthasarathy S, 2004, INTENS CARE MED, V30, P197, DOI 10.1007/s00134-003-2030-6; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Redwine L, 2004, BRAIN BEHAV IMMUN, V18, P333, DOI 10.1016/j.bbi.2004.01.001; SCRIMSHAW NS, 1966, AM J CLIN NUTR, V19, P313, DOI 10.1093/ajcn/19.5.313	24	121	126	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2007	63	6					1210	1214		10.1097/TA.0b013e31815b83d7			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	243AU	WOS:000251768100003	18212640				2022-02-06	
J	Slobounov, S; Slobounov, E; Sebastianelli, W; Cao, C; Newell, K				Slobounov, Semyon; Slobounov, Elena; Sebastianelli, Wayne; Cao, Cheng; Newell, Karl			Differential rate of recovery in athletes after first and second concussion episodes	NEUROSURGERY			English	Article						balance; mild traumatic brain injury; recurrent concussions; visual-kinesthetic integration	TRAUMATIC BRAIN-INJURY; CEREBRAL CONCUSSION; POSTURAL CONTROL; HIGH-SCHOOL; COLLEGIATE; PERFORMANCE; MANAGEMENT; RESPONSES; HISTORY; MOTION	OBJECTIVE: Clinical observations suggest that a history of previous concussions may cause a slower recovery of neurological function after recurrent concussion episodes. However, direct examination of this notion has not been provided. This report investigates the differential rate of restoring the visual-kinesthetic integration in collegiate athletes experiencing single versus recurrent concussion episodes. METHODS: One hundred sixty collegiate athletes were tested preseason using multimodal research methodology. Of these, 38 experienced mild traumatic brain injury (MTBI) and were tested on Days 10, 15, and 30 after injury. Nine of these MTBI patients experienced a second MTBI within 1 year after the first brain injury and were retested. The postconcussion symptoms checklist, neuropsychological evaluations, and postural responses to visual field motion were recorded using a virtual reality environment. RESULTS: All patients were asymptomatic at Day 10 of testing and were cleared for sport participation based on clinical symptoms resolution. Balance deficits, as evident by incoherence with visual field motion postural responses, were present at least 30 days after injury (P < 0.001). Most importantly, the rate of balance symptoms restoration was significantly reduced after a recurrent, second concussion (P < 0.001) compared with those after the first concussion. CONCLUSION:The findings of this study confirm our previous research indicating the presence of long-term residual visual-motor disintegration in concussed individuals with normal neuropsychological measures. Most importantly, athletes with a history of previous concussion demonstrate significantly slower rates of recovery of neurological functions after the second episode of MTBI.	Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA		Slobounov, S (corresponding author), Penn State Univ, Dept Kinesiol, 19 Recreat Hall, University Pk, PA 16802 USA.	sms18@psu.edu					Barth JT, 2001, J ATHL TRAINING, V36, P253; Bluml S, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P197, DOI 10.1007/0-387-32565-4_9; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; CANTU R, 2003, CONC ATHL 3 ANN SEM; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 2003, NEUROSURGERY, V53, P247, DOI 10.1227/01.NEU.0000072307.16102.F4; Cooper SJ, 2005, NEUROSCI BIOBEHAV R, V28, P851, DOI 10.1016/j.neubiorev.2004.09.009; CORKIN S, 1989, J NEUROSCI, V9, P3876; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hallett M, 2001, BRAIN RES REV, V36, P169, DOI 10.1016/S0165-0173(01)00092-3; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Keshner EA, 2000, J VESTIBUL RES-EQUIL, V10, P207; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Randolph C, 2001, J ATHL TRAINING, V36, P288; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; SLOBOUNOV S, 2006, FDN SPORT RELATED BR, P2; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Streepey JW, 2007, EXP BRAIN RES, V176, P182, DOI 10.1007/s00221-006-0677-2; Thatcher RW, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P241, DOI 10.1007/0-387-32565-4_11; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090	34	121	121	0	20	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2007	61	2					338	344		10.1227/01.NEU.0000280001.03578.FF			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	197AN	WOS:000248525400026	17762746				2022-02-06	
J	Foreman, BP; Caesar, RR; Parks, J; Madden, C; Gentilello, LM; Shafi, S; Carlile, MC; Harper, CR; Diaz-Arrastia, RR				Foreman, Brandon P.; Caesar, R. Ruth; Parks, Jennifer; Madden, Christopher; Gentilello, Larry M.; Shafi, Shahid; Carlile, Mary C.; Harper, Caryn R.; Diaz-Arrastia, Ramon R.			Usefulness of the abbreviated injury score and the injury severity score in comparison to the Glasgow Coma Scale in predicting outcome after traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						abbreviated injury scale; Glasgow Coma Scale; injury severity scale; traumatic brain injury	SEVERE HEAD-INJURY; VARIABLES; CLASSIFICATION; REGRESSION; MORTALITY; TREE	Background: Assessment of injury severity is important in the management of patients with brain trauma. We aimed to analyze the usefulness of the head abbreviated injury score (AIS), the injury severity score (ISS), and the Glasgow Coma Scale (GCS) as measures of injury severity and predictors of outcome after traumatic brain injury (TBI). Methods: Data were prospectively collected from 410 patients with TBI. AIS, ISS, and GCS were recorded at admission. Subjects' outcomes after TBI were measured using the Glasgow Outcome Scale (GOS-E) at 12 months postinjury. Uni- and multivariate analyses were performed. Results: Outcome information was obtained from 270 patients (66%). ISS was the best predictor of GOS-E (r(s) = -0.341, p < 0.001), followed by GCS score (r(s) = 0.227, p < 0.001), and head AIS (r(s) = -0.222, p < 0.001). When considered in combination, GCS score and ISS modestly improved the correlation with GOS-E (R = 0.335, p < 0.001). The combination of GCS score and head AIS had a similar effect (R = 0.275, p < 0.001). Correlations were stronger from patients <= 48 years old. We found comparable correlations between patients who suffered severe injuries (GCS <= 58) and those who suffered mild and moderate injuries (GCS > 8). Conclusions: GCS score, AIS, and ISS are weakly correlated with 12-month outcome. However, anatomic measures modestly outperform GCS as predictors of GOS-E. The combination of GCS and AIS/ISS correlate with outcome better than do any of the three measures alone. Results support the addition of anatomic measures such as AIS and ISS in clinical studies of TBI. Additionally, most of the variance in outcome is not accounted for by currently available measures of injury severity.	Baylor Inst Rehabil, Dallas, TX USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Surg, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Neurosurg, Dallas, TX 75235 USA		Harper, CR (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	caryn.harper@utsouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594; Foreman, Brandon/0000-0002-5418-674X			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; STATES JD, 1971, JAMA-J AM MED ASSOC, V215, P277; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	19	121	123	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2007	62	4					946	950		10.1097/01.ta.0000229796.14717.3a			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	157DJ	WOS:000245698500024	17426553				2022-02-06	
J	Chamelian, L; Feinstein, A				Chamelian, L; Feinstein, A			The effect of major depression on subjective and objective cognitive deficits in mild to moderate traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article; Proceedings Paper	15th Annual Meeting of the American-Neuropsychiatric-Association	FEB 21-24, 2004	Bal Harbour, FL	Amer Neuropsychiat Assoc			HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; TEST-PERFORMANCE; MEMORY DEFICITS; SYMPTOMS; RECOVERY; QUESTIONNAIRE; CONCUSSION; COMPLAINTS; ATTENTION	The effect of major depression on subjective and objective cognitive deficits 6 months following mild to moderate traumatic brain injury (TBI) was assessed in 63 subjects. Patients with subjective cognitive complaints (n = 63) were more likely to be women, with higher Glasgow Coma Scale (GCS) scores and have a diagnosis of major depression. They also performed significantly more poorly on various measures of memory, attention and executive functioning. Group differences on most but not all cognitive measures disappeared in a multivariate analysis when controlling for depression. In mild to moderate TBI, subjective cognitive deficits are linked in large measure to comorbid major depression. However, other mechanisms may also account for these deficits.	Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Traumat Brain Injury Clin, Toronto, ON M4N 3M5, Canada		Feinstein, A (corresponding author), Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Room FG08,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	antfeinstein@aol.com					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BEASONHAZEN S, 1994, J NEUROPSYCH CLIN N, V6, P43; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Delis D.C., 2000, CALIFORNIA VERBAL LE; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; First M.B., 1996, STRUCTURED CLIN INTE; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; GREEN WP, 1996, WORD MEMORY TEST USE; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KAPUR N, 1983, BRIT J PSYCHOL, V74, P409, DOI 10.1111/j.2044-8295.1983.tb01872.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kujala P, 1996, ACTA NEUROL SCAND, V93, P329; Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; McAllister T., 2001, J NEUROPSYCHIATRY CL, V13, P141; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCCULLAGH S, 2005, TXB TRAUMATIC BRAIN; Poutiainen E, 1996, J Int Neuropsychol Soc, V2, P219; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TAYLOR R, 1990, BRIT J CLIN PSYCHOL, V29, P251, DOI 10.1111/j.2044-8260.1990.tb00882.x; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	45	121	123	0	14	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2006	18	1					33	38		10.1176/appi.neuropsych.18.1.33			6	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychiatry	014YU	WOS:000235519900005	16525068				2022-02-06	
J	Gao, JL; Prough, DS; McAdoo, DJ; Grady, JJ; Parsley, MO; Ma, L; Tarensenko, YI; Wu, P				Gao, Junling; Prough, Donald S.; McAdoo, David J.; Grady, James J.; Parsley, Margaret O.; Ma, Long; Tarensenko, Yevgeniya I.; Wu, Ping			Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						traumatic brain injury; neural stem cell; transplantation; glial-cell-line-derived neurotrophic factor; hippocampus; cognitive function	CENTRAL-NERVOUS-SYSTEM; FLUID-PERCUSSION MODEL; NEUROTROPHIC FACTOR; PROGENITOR CELLS; DOPAMINERGIC-NEURONS; ADULT-RAT; INDUCED EXCITOTOXICITY; SENSORIMOTOR FUNCTION; CHOLINERGIC NEURONS; GENE-EXPRESSION	Traumatic brain injury (TBI) often produces cognitive impairments by primary or secondary neuronal loss. Stem cells are a potential tool to treat TBI. However, most previous studies using rodent stem or progenitor cells failed to correlate cell grafting and cognitive improvement. Furthermore, the efficacy of fetal human neural stem cells (hNSCs) for ameliorating TBI cognitive dysfunction is undetermined. This study therefore characterized phenotypic differentiation, neurotrophic factor expression and release and functional outcome of grafting hNSCs into TBI rat brains. Adult Sprague-Dawley rats underwent a moderate parasagittal fluid percussion TBI followed by ipsilateral hippocampal transplantation of hNSCs or vehicle I day post-injury. Prior to grafting, hNSCs were treated in vitro for 7 days with our previously developed priming procedure. Significant spatial learning and memory improvements were detected by the Morris water maze (MWM) test in rats 10 days after receiving hNSC grafts. Morphological analyses revealed that hNSCs survived and differentiated mainly into neurons in the injured hippocampus at 2 weeks after grafting. Furthermore, hNSCs expressed and released glial-cell-line-derived neurotrophic factor (GDNF) in vitro and when grafted in vivo, as detected by RT-PCR, inummostaining, microdialysis and ELISA. This is the first direct demonstration of the release of a neurotrophic factor in conjunction with stem cell grafting. In conclusion, human fetal neural stem cell grafts improved cognitive function of rats with acute TB L Grafted cells survived and differentiated into neurons and expressed and released GNDF in vivo, which may help protect host cells from secondary damage and aid host regeneration. (c) 2006 Elsevier Inc. All tights reserved.	Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Off Biostat, Galveston, TX 77555 USA		Wu, P (corresponding author), Univ Texas, Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd,MRB 10-138, Galveston, TX 77555 USA.	piwu@utmb.edu	Prough, Donald S/G-5793-2013; wu, Ping/G-8958-2011	Prough, Donald S/0000-0001-7994-532X; 	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS046025, NS042849] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042849, R01NS046025] Funding Source: NIH RePORTER		Al Nimer F, 2004, NEUROREPORT, V15, P1871, DOI 10.1097/00001756-200408260-00007; BAKER AJ, 1991, STROKE, V22, P666, DOI 10.1161/01.STR.22.5.666; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Bedell EA, 2004, J NEUROTRAUM, V21, P1212; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gao J, 2005, NEUROSCIENCE, V131, P257, DOI 10.1016/j.neuroscience.2004.10.033; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kitagawa H, 1999, J CEREBR BLOOD F MET, V19, P1336, DOI 10.1097/00004647-199912000-00007; Kohn D.F., 1997, ANESTHESIA ANALGESIA; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; LEON A, 1990, STROKE, V21, P95; Liberatore GT, 1997, NEUROREPORT, V8, P3097, DOI 10.1097/00001756-199709290-00018; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; MartinezSerrano A, 1997, TRENDS NEUROSCI, V20, P530, DOI 10.1016/S0166-2236(97)01119-3; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Muir JK, 1999, J NEUROTRAUM, V16, P403, DOI 10.1089/neu.1999.16.403; NIETOSAMPEDRO M, 1987, ANN NY ACAD SCI, V495, P108, DOI 10.1111/j.1749-6632.1987.tb23670.x; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Ourednik J, 2004, CELL TRANSPLANT, V13, P307, DOI 10.3727/000000004783983963; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Philips MF, 1999, J NEUROSURG, V90, P116, DOI 10.3171/jns.1999.90.1.0116; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Serkova N, 2004, MOL INTERV, V4, P97, DOI 10.1124/mi.4.2.7; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sheen VL, 1999, EXP NEUROL, V158, P47, DOI 10.1006/exnr.1999.7104; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Snyder EY, 1996, CLIN NEUROSCI, V3, P310; SOARES H, 1991, Journal of Neural Transplantation and Plasticity, V2, P207; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Wu P, 2002, GENE THER, V9, P245, DOI 10.1038/sj.gt.3301646	71	121	142	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2006	201	2					281	292		10.1016/j.expneurol.2006.04.039			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096RG	WOS:000241393900002	16904107				2022-02-06	
J	Vinchon, M; Defoort-Dhellemmes, S; Desurmont, M; Dhellemmes, P				Vinchon, M; Defoort-Dhellemmes, S; Desurmont, M; Dhellemmes, P			Accidental and nonaccidental head injuries in infants: a prospective study	JOURNAL OF NEUROSURGERY			English	Article						head injury; subdural hematoma; retinal hemorrhage; child abuse; infant	TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; SHAKEN-BABY SYNDROME; YOUNG-CHILDREN; HEMORRHAGES; POPULATION; PATTERNS; DAMAGE; ABUSE	Object. Head injury is a major cause of morbidity and death in infants, and child abuse is among its chief causes. Retinal hemorrhages (RHs) are of paramount importance for the diagnosis of child abuse; however, their sensitivity and specificity are poorly estimated. Subdural hematoma (SDH) is a common feature; however, its incidence and causative factors are poorly documented. Methods. To study the epidemiology of head injuries in infants, factors predisposing to SDH, value of RH for the diagnosis of child abuse, and prognostic factors, the authors prospectively collected data from cases of head injury in infants who were hospitalized at their institution over a 3-year period. One hundred fifty cases were collected, 57 of which were due to child abuse. This prospective study allows the comparison of clinical, radiological, and ophthalmological features in accidental and nonaccidental trauma in infants. Conclusions. Subdural hematomas were significantly correlated with RH and with child abuse but not with idiopathic macrocranium. The sensitivity and specificity of RH for the diagnosis of child abuse were 75 and 93.2%, respectively. Retinal hemorrhages associated with accidental trauma were always mild, and the specificity of more severe RH for the diagnosis of child abuse was 100%. The grading of RH requires the expertise of a trained neuroophthalmologist. Child abuse was also significantly associated with antecedents of perinatal illness, absence of signs of impact, and seizures on presentation. Although child abuse represented just 38% of traumas, it was the cause of 71% of deaths and 90% of severe disability in this series. Abuse and the clinical severity on presentation were two significant and independent factors conditioning outcome.	CHRU Lille, Serv Neurochirurg Pediat, F-59037 Lille, France; CHRU Lille, Dept Pediat Neurosurg, F-59037 Lille, France		Vinchon, M (corresponding author), CHRU Lille, Serv Neurochirurg Pediat, F-59037 Lille, France.	m-vinchon@chru-lille.fr		Vinchon, Matthieu/0000-0002-9122-6165			AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; DEFOORTDHELLEMM.S, 2004, CHILD NERV SYST, V20, P279; Duckett S., 1995, PEDIAT NEUROPATHOLOG, P243; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; IKEDA A, 1987, CHILD NERV SYST, V3, P19, DOI 10.1007/BF00707188; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; JENNETT B, 1975, LANCET, V1, P480; JOHNSON DL, 1993, NEUROSURGERY, V33, P231; KRAUS JF, 1987, PEDIATRICS, V79, P501; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Vinchon M, 2001, J NEUROSURG, V95, P249, DOI 10.3171/jns.2001.95.2.0249	26	121	124	1	3	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAY	2005	102	4		S			380	384		10.3171/ped.2005.102.4.0380			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	928CV	WOS:000229249600006	15926388				2022-02-06	
J	Saatman, KE; Abai, B; Grosvenor, T; Vorwerk, CK; Smith, DH; Meaney, DF				Saatman, KE; Abai, B; Grosvenor, T; Vorwerk, CK; Smith, DH; Meaney, DF			Traumatic axonal injury results in biphasic calpain activation and retrograde transport impairment in mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						axonal transport; brain injury; cytoskeleton; neurofilament; optic nerve; spectrin	AMYLOID PRECURSOR PROTEIN; RETINAL GANGLION-CELLS; SPINAL-CORD INJURY; PIG OPTIC-NERVE; BRAIN INJURY; HEAD-INJURY; CALCIUM INFLUX; NEUROFILAMENT SUBUNITS; MEDIATED PROTEOLYSIS; INDUCED DEGENERATION	Traumatic axonal injury (TAI) is one of the most important pathologies associated with closed head injury, and contributes to ensuing morbidity. The authors evaluated the potential role of calpains in TAI using a new model of optic nerve stretch injury in mice. Male C57BL/6 mice were anesthetized, surgically prepared, and subjected to a 2.0-mm optic nerve stretch injury (n = 34) or sham injury (n = 18). At various intervals up to 2 weeks after injury, optic nerves were examined for neurofilament proteins and calpain-mediated spectrin breakdown products using immunohistochemistry. In addition, fluorescent tracer was injected into the superior colliculi of mice I day before they were killed, to investigate the integrity of retrograde axonal transport to the retina. Optic nerve stretch injury resulted in persistent disruption of retrograde axonal transport by day 1, progressive accumulation and dephosphorylation of neurofilament protein in swollen and disconnected axons, and subsequent loss of neurofilament protein in degenerating axons at day 14. Calpains were transiently activated in intact axons in the first minutes to hours after stretch injury. A second stage of calpain-mediated proteolysis was observed at 4 days in axonal swellings, bulbs, and fragments. These data suggest that early calpain activation may contribute to progressive intraaxonal structural damage, whereas delayed calpain activation may be associated with axonal degeneration.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; Otto Von Guericke Univ, Dept Ophthalmol, Magdeburg, Germany		Saatman, KE (corresponding author), Univ Penn, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.		smith, douglas/A-1321-2007	Meaney, David/0000-0002-0954-4122	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, P50NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08AG021527] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 21527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803, NS 5712, NS 38104] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49 312712] Funding Source: Medline		Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cenni MC, 1996, EUR J NEUROSCI, V8, P1735, DOI 10.1111/j.1460-9568.1996.tb01317.x; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; LI ZH, 1995, NEUROCHEM INT, V27, P425, DOI 10.1016/0197-0186(95)00024-3; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SCHLAEPFER WW, 1974, BRAIN RES, V69, P203, DOI 10.1016/0006-8993(74)90002-X; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Smallwood I.M, 1996, HDB ORGANIC SOLVENT, P1; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; Vorwerk CK, 1996, INVEST OPHTH VIS SCI, V37, P2382; Wang MS, 2000, J NEUROPATH EXP NEUR, V59, P599, DOI 10.1093/jnen/59.7.599; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006	45	121	131	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2003	23	1					34	42		10.1097/01.WCB.0000035040.10031.B0			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	629LW	WOS:000180052000004	12500089	Bronze			2022-02-06	
J	Holly, LT; Kelly, DF; Counelis, GJ; Blinman, T; McArthur, DL; Cryer, HG				Holly, LT; Kelly, DF; Counelis, GJ; Blinman, T; McArthur, DL; Cryer, HG			Cervical spine trauma associated with moderate and severe head injury: incidence, risk factors, and injury characteristics	JOURNAL OF NEUROSURGERY			English	Article						cervical spine injury; traumatic brain injury; spinal stabilization	CORD INJURY; FLUOROSCOPY; PREDICTOR; PATIENT	Object. Diagnosing and managing cervical spine trauma in head-injured patients is problematic due to an altered level of consciousness in such individuals. The reported incidence of cervical spine trauma in head-injured patients has generally ranged from 4 to 8%. In this retrospective study the authors sought to define the incidence of cervical injury in association with moderate or severe brain injury, emphasizing the identification of high-risk patients. Methods. The study included 447 consecutive moderately (209 cases) or severely (238 cases) head injured patients who underwent evaluation at two Level 1 trauma centers over a 40-month period. Of the 447 patients, 24 (5.4%) suffered a cervical spine injury (17 men and seven women; mean age 39 years; median Glasgow Coma Scale [GCS] score of 6, range 3-14). Of these 24 patients, 14 (58.3%) sustained spinal cord injuries (SCIs). 14 sustained injuries in the occiput-C3 region, and 10 underwent a stabilization procedure. Of the 14 patients with SCIs, nine experienced an early hypotensive and/or hypoxic insult. Regarding the mechanism of injury, cervical injuries occurred in 21 (8.2%) of 256 patients involved in motor vehicle accidents (MVAs), either as passengers or pedestrians, compared with three (1.6%) of 191 patients with non-MVA-associated trauma (p < 0.01). In the subset of 131 MVA passengers, 13 (9.9%) sustained cervical injuries, Patients with an initial GCS score less than or equal to 8 were more likely to sustain a cervical injury than those with a score higher than 8 (odds ratio [OR] 2.77, 95% confidence interval [CI] = 1.11-7.73) and were more likely to sustain a cervical SCI (OR 5.5, 95% CI 1.22-24.85). At 6 months or more postinjury, functional neurological recovery had occurred in nine patients (37.5%) and eight (33.3%) had died. Conclusions. Head-injured patients sustaining MVA-related trauma and those with an initial GCS score less than or equal to 8 are at highest risk for concomitant cervical spine injury. A disproportionate number of these patients sustain high cervical injuries, the majority of which are mechanically unstable and involve an SCI. The development of safer and more rapid means of determining cervical spine integrity should remain a high priority in the care of head-injured patients.	Univ Calif Los Angeles, Med Ctr, Dept Surg, Div Neurosurg,Ctr Hlth Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Epidemiol, Div Neurosurg, Hlth Sci Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Harbor Med Ctr, Div Neurosurg, Torrance, CA 90509 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Kelly, DF (corresponding author), Univ Calif Los Angeles, Med Ctr, Dept Surg, Div Neurosurg,Ctr Hlth Sci, Room 18-219 NPI,Box 957039, Los Angeles, CA 90095 USA.	dfkelly@ucla.edu	McArthur, David/E-6442-2013	McArthur, David/0000-0003-3385-1314	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30308] Funding Source: Medline; ODCDC CDC HHS [R49/CCR903622] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308] Funding Source: NIH RePORTER		Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BUCHOLZ RW, 1979, J TRAUMA, V19, P768, DOI 10.1097/00005373-197910000-00009; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chendrasekhar A, 1998, AM SURGEON, V64, P604; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; D'Alise MD, 1999, J NEUROSURG, V91, P54, DOI 10.3171/spi.1999.91.1.0054; DAVIS JW, 1995, J TRAUMA, V39, P435; Davis JW, 2001, J TRAUMA, V50, P1044, DOI 10.1097/00005373-200106000-00011; FERGUSON J, 1993, INJURY, V24, P454, DOI 10.1016/0020-1383(93)90148-Y; FRYE G, 1994, ANN EMERG MED, V23, P797, DOI 10.1016/S0196-0644(94)70316-7; HARRIS OA, 2001, J NEUROSURG, V94, pA413; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; JENNETT B, 1975, LANCET, V1, P480; Kaups KL, 1998, J TRAUMA, V44, P865, DOI 10.1097/00005373-199805000-00020; MARCIANO FF, 1997, NEUROSURGERY, V41, P740; MARION D, 2000, DET CERV SPIN STAB T; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; Sees DW, 1998, J TRAUMA, V45, P768, DOI 10.1097/00005373-199810000-00026; SHRAGO GG, 1973, AM J ROENTGENOL, V118, P670, DOI 10.2214/ajr.118.3.670; TATOR CH, 1996, NEUROTRAUMA, P1059; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; WILLIAMS J, 1992, ANN EMERG MED, V21, P719, DOI 10.1016/S0196-0644(05)82786-6	24	121	130	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2002	96	3		S			285	291		10.3171/spi.2002.96.3.0285			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	537JB	WOS:000174754200006	11990836				2022-02-06	
J	Gururaj, G				Gururaj, G			Epidemiology of traumatic brain injuries: Indian scenario	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; epidemiology; road accidents; severity; impact; developing countries	ROAD TRAFFIC FATALITIES; MORTALITY; COUNTRIES; DELHI	Traumatic brain injuries (TBIs) are a leading cause of morbidity, mortality, disability and socioeconomic losses in India and other developing countries. Specific topics addressed in this paper include magnitude of the problem, causes, context of injury occurrence, risk factors, severity, outcome and impact of TBIs on rapidly transforming societies. It is estimated that nearly 1.5 to 2 million persons are injured and 1 million succumb to death every year in India. Road traffic injuries are the leading cause (60%) of TBIs followed by falls (20%-25%) and violence (10%). Alcohol involvement is known to be present among 15%-20% of TBIs at the time of injury. The rehabilitation needs of brain injured persons are significantly high and increasing from year to year. India and other developing countries face the major challenges of prevention, pre-hospital care and rehabilitation in their rapidly changing environments to reduce the burden of TBIs.	Natl Inst Mental Hlth & Neurosci, Dept Epidemiol, Bangalore 560029, Karnataka, India		Gururaj, G (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Epidemiol, Bangalore 560029, Karnataka, India.	guru@nimhans.kar.nic.in					[Anonymous], 1993, WORLD DEV REPORT INV; [Anonymous], 1999, WORLD HLTH REP 1999; BHARTI P, 1993, NEUROL INDIA, V41, P49; CHANNABASAVANNA SM, PR31993 KARN STAT CO; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; *FDN RES HLTH SYST, 1999, HLTH MON; GOURIEDEVI M, 1996, NEUROEPIDEMIOLOGY DE; GOURIEDEVI M, 1995, NEUROEPIDEMIOLOGICAL; GURUAJ G, 2000, P 5 WORLD C INJ PREV, P549; GURURAJ G, 1993, WHO SCI WORKSH NEUR; GURURAJ G, 1991, P REG SCI M INT EP A; GURURAJ G, 1999, J ACAD HOSP ADM, V11, P9; GURURAJ G, 1998, ACTIONAID DISABILITY, V9, P27; KALYANARAMAN S, 1977, NEUROL INDIA, V25, P95; KRAUS JF, 1972, NEUROL INDIA, V32, P356; KRAUS JF, 1992, NEUROEPIDEMIOLOGY TR, P334; MAHESHWARI J, 1989, J TRAFFIC MED, V17, P23; MOHAN D, 1985, ACCIDENT ANAL PREV, V17, P33, DOI 10.1016/0001-4575(85)90006-5; NATARAJAN M, 1987, ADJUSTMENTAL PROBLEM; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; ROMER C, 1999, PREVENTION CRITICAL; RYAN GA, 1993, P C AS ROAD SAF; SABESHAN S, 1993, J INDIAN MED ASSOC, V91, P37; SAHDEV P, 1994, ACCIDENT ANAL PREV, V26, P377, DOI 10.1016/0001-4575(94)90011-6; SAMBASIVAN M, 1993, NEUROL INDIA, V41, P3; Sethi D, 1999, EUR J PUBLIC HEALTH, V9, P65, DOI 10.1093/eurpub/9.1.65; Sidhu D S, 1993, J Indian Med Assoc, V91, P16; SODERLUND N, 1995, B WORLD HEALTH ORGAN, V73, P175; Tandon PN, 1986, NEUROL INDIA, V34, P1; TEASDALE G, 1974, LANCET, V2, P81; United Nations Children's Fund, 2000, STAT WORLDS CHILDR 2; *WHO, 1999, INJ LEAD CAUS GLOB B; ZWI A, 1993, TROP DIS B, V90, P6039	33	121	123	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2002	24	1					24	28		10.1179/016164102101199503			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	519WJ	WOS:000173748200005	11783750				2022-02-06	
J	Schwarz, S; Georgiadis, D; Aschoff, A; Schwab, S				Schwarz, S; Georgiadis, D; Aschoff, A; Schwab, S			Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke	STROKE			English	Article						brain edema; hypertonic solution; saline; intracranial pressure; stroke	CEREBRAL-ARTERY INFARCTION; RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; MANNITOL; HYPERTENSION; EDEMA; RESUSCITATION; INFUSIONS; DEXTRAN	Background and Purpose-The aim of this study was to evaluate the effects of hypertonic saline in stroke patients with increased intracranial pressure (ICP) after conventional therapy with mannitol had failed. Methods-Twenty-two episodes of ICP crisis occurred in 8 patients in whom the standard treatment of 200 mL of 20% mannitol was not effective. ICP crisis was defined as an increase in ICP of 20 nun Hg (n = 18), pupillary abnormality (n=3), or a combination of both (n=1). The patients were treated with 75 mL of 10% saline over the course of 15 minutes. ICP, mean arterial blood pressure, and cerebral perfusion pressure were monitored for 4 hours. Blood gases, hematocrit, hemoglobin, pH, osmolarity, and electrolytes levels were measured before and 15 and 60 minutes after the start of infusion. Treatment was regarded as effective if ICP decreased >10% or the pupillary reaction had normalized. Results-Treatment was effective in all 22 episodes. The maximum ICP decrease was 9.9 mm Hg 35 minutes after the start of infusion. Thereafter, ICP began to rise again. There was no constant effect on mean arterial blood pressure, whereas cerebral perfusion pressure was consistently increased. Blood osmolarity rose by 9 mmol/L and serum sodium by 5.6 mmol/L. Potassium levels, hemoglobin, hematocrit, and pH were slightly decreased. No unexpected side effects were noted. Conclusions-Infusion of 75 mL hypertonic (10%) saline decreases elevated ICP and increases cerebral perfusion pressure in stroke patients in whom mannitol had failed. The effect on the ICP and cerebral perfusion pressure reaches its maximum after the end of infusion and is seen for 4 hours.	Univ Heidelberg, Dept Neurol, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Neurosurg, D-69120 Heidelberg, Germany		Schwarz, S (corresponding author), Univ Heidelberg, Dept Neurol, 400 Neuenheimer Feld, D-69120 Heidelberg, Germany.						Bereczki D, 2000, STROKE, V31, P2719, DOI 10.1161/01.STR.31.11.2719; Biestro A, 1997, ACTA NEUROCHIR, V139, P725, DOI 10.1007/BF01420045; CANDELISE L, 1988, LANCET, V1, P318; DUBICK MA, 1995, SHOCK, V3, P137, DOI 10.1097/00024382-199502000-00009; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hartl R, 1997, ZBL CHIR, V122, P181; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; JENNETT B, 1975, LANCET, V1, P480; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kirkpatrick PJ, 1996, NEUROSURGERY, V39, P714, DOI 10.1097/00006123-199610000-00013; KRAMER GC, 1986, SURGERY, V100, P239; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 1998, J NEUROSURG ANESTH, V10, P188, DOI 10.1097/00008506-199807000-00010; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Schatzmann C, 1998, ACT NEUR S, V71, P31; Schwab S, 1997, NEUROLOGY, V48, P1608, DOI 10.1212/WNL.48.6.1608; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003	29	121	137	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	JAN	2002	33	1					136	140		10.1161/hs0102.100877			5	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	509KV	WOS:000173147700029	11779902	Bronze			2022-02-06	
J	Bigler, ED				Bigler, ED			Quantitative magnetic resonance imaging in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						computed tomography; magnetic resonance imaging; neuroimaging; traumatic brain injury	CORTICAL ATROPHY; LESION VOLUME; WHITE-MATTER; HEAD-INJURY; MEMORY; DEGENERATION; ENLARGEMENT; NEUROLOGY; DAMAGE; MR	Quantitative neuroimaging has now become a well-established method for analyzing magnetic resonance imaging in traumatic brain injury (TBI). A general review of studies that have examined quantitative changes following TBI is presented. The consensus of quantitative neuroimaging studies is that most brain structures demonstrate changes in volume or surface area after injury. The patterns of atrophy are consistent with the generalized nature of brain injury and diffuse axonal injury. Various clinical caveats are provided including how quantitative neuroimaging findings can be used clinically and in predicting rehabilitation outcome. The future of quantitative neuroimaging also is discussed.	Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; LDS Hosp, Salt Lake City, UT USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1082 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu					ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; BIGLER ED, 1984, INT J NEUROSCI, V24, P295, DOI 10.3109/00207458409089820; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BIGLER ED, 1996, HDB HUMAN BRAIN FUNC; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BOWEN JM, 1997, DEV MED CHILD NEUROL, P39; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; CONNOR PD, 1995, J INT NEUROPSYCH SOC, V1, P174; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GENNARELLI TA, 1998, NEUROSCIENTIST, P4; HAUG JO, 1962, ACTA PSYCHIAT SCAND, V165, P1; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KESLER SR, 2000, IN PRESS BRAIN INJUR; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; LAKLLAW DH, 1998, IEEE T MED IMAGING, V20, P100; LEVIN HS, 2000, REDUCTION CORPUS CAL, V54, P647; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MASSMAN PJ, 1986, INT J NEUROSCI, V30, P87, DOI 10.3109/00207458608985659; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Orrison WW., 2000, NEUROIMAGING; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT., 1996, NEUROTRAUMA, P1325; Primus EA, 1997, BRAIN INJURY, V11, P577; RYSER DK, 1996, INT PERSPECTIVES TRA, P79; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; SALAZAR AM, 1986, NEUROLOGY, V36, P459, DOI 10.1212/WNL.36.4.459; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; TATE DF, 2000, IN PRESS LEARNING ME; TURKHEIMER E, 1990, NEUROPSYCHOLOGIA, V28, P1011, DOI 10.1016/0028-3932(90)90136-C; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0	46	121	124	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	2001	16	2					117	134		10.1097/00001199-200104000-00003			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	422HH	WOS:000168112100002	11275574				2022-02-06	
J	Henshall, DC; Clark, RSB; Adelson, PD; Chen, M; Watkins, SC; Simon, RP				Henshall, DC; Clark, RSB; Adelson, PD; Chen, M; Watkins, SC; Simon, RP			Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy	NEUROLOGY			English	Article							SUSTAINED ELECTRICAL-STIMULATION; NONCONVULSIVE SEIZURES DAMAGE; TRAUMATIC BRAIN INJURY; CELL-DEATH; RAT-BRAIN; HIPPOCAMPAL-NEURONS; PERFORANT PATH; MESSENGER-RNA; KAINIC ACID; PROTOONCOGENE BCL-2	Objective: To address the role of cell death regulatory genes of the bcl-2 and caspase families in the neuropathology of human epilepsy using tissue extracted from patients undergoing temporal lobectomy for intractable seizures. Methods: Using Western blotting and immunohistochemistry, the authors investigated the expression of bcl-2, bcl-x(L), bar, caspase-1, and caspase-3 in temporal cortex samples from patients who had undergone temporal lobectomy surgery for intractable epilepsy (n = 19). Nonepileptic postmortem tissue from a brain bank served as control (n = 6). Results: Western blot analysis demonstrated significant increases in levels of bcl-2 and bcl-x(L) protein in seizure brain compared to control. Cleavage of caspase-1 was evidenced by a reduction in levels of the 45 kDa proenzyme form and an increase in levels of the p10 fragment. Levels of the 32 kDa proenzyme form of caspase-3 were elevated in seizure patients, as were levels of the 12 kDa cleaved fragment. Bcl-2, bar, and caspase-3 immunoreactivity was increased predominantly in cells with the morphologic appearance of neurons, whereas bcl-x(L) immunoreactivity was increased in cells with the appearance of glia. DNA fragmentation was detected in some but not all sections from epileptic brain samples. Conclusions: Cell death regulatory genes of the bcl-2 and caspase families may play a role in ongoing neuropathologic processes in human epilepsy, and offer novel targets as an adjunct to anticonvulsant therapy.	Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Physiol & Cell Biol, Pittsburgh, PA 15260 USA		Simon, RP (corresponding author), Legacy Clin Res & Technol Ctr, 1225 NE 2nd Ave, Portland, OR 97208 USA.		Watkins, Simon/ABG-2590-2021; Adelson, David/W-2083-2019; Henshall, David/C-3364-2012	Watkins, Simon/0000-0003-4092-1552; Henshall, David/0000-0001-6237-9632	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039016] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS39016] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [HP30 28836, 1K08 01946] Funding Source: Medline		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Aminoff MJ, 1998, ARCH NEUROL-CHICAGO, V55, P119, DOI 10.1001/archneur.55.1.119; Aschner M, 1998, NEUROTOXICOLOGY, V19, P7; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Chen J, 1998, J NEUROSCI, V18, P4914; Chen J, 1997, J CEREBR BLOOD F MET, V17, P2, DOI 10.1097/00004647-199701000-00002; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; DOURNAUD P, 1994, NEUROSCIENCE, V61, P755, DOI 10.1016/0306-4522(94)90399-9; Drache B, 1997, J NEUROSCI RES, V47, P98; DU F, 1993, NEUROSCIENCE, V55, P975, DOI 10.1016/0306-4522(93)90312-4; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Eriksson C, 1999, NEUROSCIENCE, V93, P915, DOI 10.1016/S0306-4522(99)00178-5; Faherty CJ, 1999, MOL BRAIN RES, V70, P159, DOI 10.1016/S0169-328X(99)00143-6; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; FILIPKOWSKI RK, 1994, NEUROREPORT, V5, P1538, DOI 10.1097/00001756-199407000-00032; GILLARDON F, 1995, NEUROSCI LETT, V192, P85, DOI 10.1016/0304-3940(95)11619-8; Gillardon F, 1997, MOL BRAIN RES, V50, P16, DOI 10.1016/S0169-328X(97)00162-9; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; Graham SH, 1996, RESTOR NEUROL NEUROS, V9, P243, DOI 10.3233/RNN-1996-9407; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; HAWRYLAK N, 1993, BRAIN RES, V603, P309, DOI 10.1016/0006-8993(93)91253-O; Kalviainen R, 1998, NEUROLOGY, V50, P1377, DOI 10.1212/WNL.50.5.1377; KANE DJ, 1995, J NEUROSCI RES, V40, P269, DOI 10.1002/jnr.490400216; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Lopez E, 1999, NEUROSCIENCE, V91, P1461, DOI 10.1016/S0306-4522(98)00704-0; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Mathern GW, 1997, BRAIN, V120, P1937, DOI 10.1093/brain/120.11.1937; Meldrum BS, 1992, GREENFIELDS NEUROPAT, P1246; Namura S, 1998, J NEUROSCI, V18, P3659; NIQUET J, 1994, J NEUROCYTOL, V23, P641, DOI 10.1007/BF01191558; OLNEY JW, 1983, BRAIN RES BULL, V10, P699, DOI 10.1016/0361-9230(83)90038-2; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; Salmenpera T, 1998, LANCET, V351, P35, DOI 10.1016/S0140-6736(05)78092-2; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Sloviter RS, 1998, NEUROLOGY, V50, P846, DOI 10.1212/WNL.50.4.846; Sloviter RS, 1996, J COMP NEUROL, V366, P516, DOI 10.1002/(SICI)1096-9861(19960311)366:3<516::AID-CNE10>3.0.CO;2-N; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; Spencer SS, 1999, EPILEPSIA, V40, P708, DOI 10.1111/j.1528-1157.1999.tb00767.x; Tasch E, 1999, ANN NEUROL, V45, P568, DOI 10.1002/1531-8249(199905)45:5<568::AID-ANA4>3.0.CO;2-P; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; WETZEL DM, 1994, BRAIN RES, V649, P117, DOI 10.1016/0006-8993(94)91054-5; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Young GB, 1998, ARCH NEUROL-CHICAGO, V55, P117, DOI 10.1001/archneur.55.1.117; Zhang LX, 1998, MOL BRAIN RES, V55, P198, DOI 10.1016/S0169-328X(97)00316-1	50	121	133	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	JUL 25	2000	55	2					250	257		10.1212/WNL.55.2.250			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	337FA	WOS:000088345700016	10908900				2022-02-06	
J	Grimm, MR; Vrahas, MS; Thomas, KA				Grimm, MR; Vrahas, MS; Thomas, KA			Pressure-volume characteristics of the intact and disrupted pelvic retroperitoneum	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	13th Annual Meeting of the Orthopaedic-Trauma-Association	OCT 17-19, 1997	LOUISVILLE, KY	Orthopaed Trauma Assoc			MULTIPLE TRAUMA; FRACTURES; HEMORRHAGE; MANAGEMENT; MORTALITY; RING; CLASSIFICATION; EMBOLIZATION; ANGIOGRAPHY; INJURIES	Hemorrhage is a major cause of mortality in pelvic fractures. Bleeding can be controlled in hypotensive patients by direct ligation, angiographic embolization, pelvic packing, and acute external fixation. Acute application of an external fixator can reduce pelvic volume and reduce bleeding fractures to effect tamponade. This therapy assumes that the pelvis represents a closed space, which clearly is not true anatomically. However, the premise may hold functionally. This study explored the relationship between pressure and volume in the intact and disrupted pelvic retroperitoneum. In cadaveric specimens, the external iliac vein was dissected, ruptured, and cannulated. This method allowed controlled pow of fluid, with simultaneous measurement of pressure, into the intact retroperitoneum. Open book pelvic fractures were created by applying external rotation to the pelvis through the femoral heads. The pressure-volume measurements, without and with external fixation applied, were repeated after the fracture, as well as after a laparotomy. In the intact retroperitoneum, pressures rapidly rose to an average of 30 mm Hg after infusion of 5 liters of fluid. After fracture, up to 20 liters of fluid could be infused at pressures not exceeding 35 mm Hg. External fixation increased pressures approximately 3 mm Hg at low fluid volumes, and approximately 11 mm Hg at the highest fluid volumes. Laparotomy decreased retroperitoneal pressure from approximately 35 mm Hg to approximately 15 mm Hg. The results of the study suggest that low-pressure venous hemorrhage may be tamponaded by an external fixator, given that enough fluid volume is present in the pelvic retroperitoneum. However, external fixation may not generate sufficient pressure to stop arterial bleeding. In any case, it seems that a large volume of fluid must be lost into the pelvis before an external fixator can have much effect on retroperitoneal pressures.	Louisiana State Univ, Med Ctr, Dept Orthopaed Surg, Bioengn Lab, New Orleans, LA 70112 USA		Thomas, KA (corresponding author), Louisiana State Univ, Med Ctr, Dept Orthopaed Surg, Bioengn Lab, 2025 Gravier St,Suite 400, New Orleans, LA 70112 USA.	kthoma@lsumc.edu					Berger J J, 1995, Surg Annu, V27, P107; BURGESS AR, 1990, J TRAUMA, V30, P848, DOI 10.1097/00005373-199007000-00015; DALAL SA, 1989, J TRAUMA, V29, P981, DOI 10.1097/00005373-198907000-00012; FAILINGER MS, 1992, J BONE JOINT SURG AM, V74A, P781, DOI 10.2106/00004623-199274050-00020; FLINT LM, 1979, ANN SURG, V189, P709, DOI 10.1097/00000658-197906000-00006; GANZ R, 1991, CLIN ORTHOP RELAT R, P71; GHANAYEM AJ, 1995, J TRAUMA, V38, P396, DOI 10.1097/00005373-199503000-00020; GILLILAND MG, 1982, AM J SURG, V144, P744, DOI 10.1016/0002-9610(82)90562-1; GRUEN GS, 1994, J TRAUMA, V36, P706, DOI 10.1097/00005373-199405000-00019; HANSON PB, 1991, J BONE JOINT SURG BR, V73, P325, DOI 10.1302/0301-620X.73B2.2005166; HENAO F, 1985, SURG GYNECOL OBSTET, V161, P106; HUITTINEN VM, 1973, SURGERY, V73, P454; KELLAM JF, 1987, ORTHOP CLIN N AM, V18, P25; KELLAM JF, 1989, CLIN ORTHOP RELAT R, P66; MANSOUR MA, 1990, J TRAUMA, V30, P1417, DOI 10.1097/00005373-199011000-00021; MARGOLIES MN, 1972, NEW ENGL J MED, V287, P317, DOI 10.1056/NEJM197208172870701; MATTA JM, 1989, CLIN ORTHOP RELAT R, P83; MCMURTRY R, 1980, CLIN ORTHOP RELAT R, P22; MORENO C, 1986, J TRAUMA, V26, P987, DOI 10.1097/00005373-198611000-00005; MUCHA P, 1988, SURG CLIN N AM, V68, P757; PANETTA T, 1985, J TRAUMA, V25, P1021; PELTIER LF, 1965, J BONE JOINT SURG AM, VA 47, P1060, DOI 10.2106/00004623-196547050-00018; POOLE GV, 1991, ANN SURG, V213, P532, DOI 10.1097/00000658-199106000-00002; RIEMER BL, 1993, J TRAUMA, V35, P671, DOI 10.1097/00005373-199311000-00003; ROTHENBERGER DA, 1978, SURGERY, V84, P356; Rubash H E, 1983, Instr Course Lect, V32, P329; SELIVANOV V, 1984, J TRAUMA, V24, P1022, DOI 10.1097/00005373-198412000-00004; STOCK JR, 1980, CLIN ORTHOP RELAT R, P31; Tile M, 1995, FRACTURES PELVIS ACE	29	121	126	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1998	44	3					454	459		10.1097/00005373-199803000-00006			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	ZD780	WOS:000072723100005	9529171				2022-02-06	
J	Turner, CP; Bergeron, M; Matz, P; Zegna, A; Noble, LJ; Panter, SS; Sharp, FR				Turner, CP; Bergeron, M; Matz, P; Zegna, A; Noble, LJ; Panter, SS; Sharp, FR			Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						heme; iron; neurotrauma; stress genes; stroke	CENTRAL-NERVOUS-SYSTEM; TRANSIENT FOREBRAIN ISCHEMIA; HUMAN-SKIN FIBROBLASTS; HSP32 MESSENGER-RNA; HEAT-SHOCK PROTEIN; RAT-BRAIN; NITRIC-OXIDE; CARBON-MONOXIDE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE	The heme oxygenase-1 gene, HO-1, induced by heme, ischemia, and heat shock, metabolizes heme to biliverdin, free iron, and carbon monoxide. Though the distribution of HO-1 has been described in normal rat brain, little is known about how extracellular heme proteins in the subarachnoid space distribute in brain. To address this issue, hemoglobin was injected into the cisterna magna of adult rats. Expression of HO-1 in these animals was compared with saline-injected, BSA-injected, and uninjected controls. Western blot analysis showed that 24 hours after injection oxyhemoglobin increased HO-1 levels approximately four-to fivefold in all brain regions studied compared with saline-injected and BSA-injected controls. In the brain, HO-1 immunoreactivity was evident at 4 hours and peaked at 24 hours after oxyhemoglobin injections, returning to control levels by 4 to 8 days. This HO-1 induction was detected mainly in cells with small, rounded somas bearing two to four truncated processes, a morphology consistent with that of microglia. These cells were double-stained with the microglial marker, OX42, in every brain region examined. II is proposed that subarachnoid hemoglobin may be taken up into a microglia wherein heme induces HO-1.	Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Neurosurg, San Francisco, CA 94143 USA		Turner, CP (corresponding author), Vet Adm Med Ctr, Dept Neurol V127, 4150 Clement St, San Francisco, CA 94121 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL053040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS014543, R01NS028167, P50NS014543] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL53040] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS14543, NS28167] Funding Source: Medline		ABRAHAM NG, 1988, INT J BIOCHEM, V20, P543, DOI 10.1016/0020-711X(88)90093-6; ALAM J, 1994, J BIOL CHEM, V269, P1001; ALAM J, 1992, J BIOL CHEM, V267, P21894; APPLEGATE LA, 1991, CANCER RES, V51, P974; BALLA G, 1992, J BIOL CHEM, V267, P18148; BALLA J, 1995, AM J PHYSIOL-LUNG C, V268, pL321, DOI 10.1152/ajplung.1995.268.2.L321; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; BASUMODAK S, 1993, CANCER RES, V53, P4505; Bergeron M, 1996, NEUROL RES, V18, P64, DOI 10.1080/01616412.1996.11740380; BERNABEU R, 1995, NEUROREPORT, V6, P516, DOI 10.1097/00001756-199502000-00027; BING O, 1995, NEUROREPORT, V6, P1369, DOI 10.1097/00001756-199507100-00002; BONITA R, 1985, STROKE, V16, P591, DOI 10.1161/01.STR.16.4.591; BRAUGHLER JM, 1986, J BIOL CHEM, V261, P282; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; CONNOR JR, 1992, ANN NEUROL, V32, pS51, DOI 10.1002/ana.410320710; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364; DAWSON DA, 1994, CEREBROVAS BRAIN MET, V6, P299; DELGADO TJ, 1985, STROKE, V16, P595, DOI 10.1161/01.STR.16.4.595; DWYER BE, 1992, GLIA, V5, P300, DOI 10.1002/glia.440050407; DWYER BE, 1995, NEUROREPORT, V6, P973, DOI 10.1097/00001756-199505090-00006; EISENSTEIN RS, 1991, P NATL ACAD SCI USA, V88, P688, DOI 10.1073/pnas.88.3.688; EWING JF, 1992, J NEUROCHEM, V58, P1140, DOI 10.1111/j.1471-4159.1992.tb09373.x; EWING JF, 1991, P NATL ACAD SCI USA, V88, P5364, DOI 10.1073/pnas.88.12.5364; EWING JF, 1993, J NEUROCHEM, V60, P1512, DOI 10.1111/j.1471-4159.1993.tb03315.x; EWING JF, 1992, MOL CELL NEUROSCI, V3, P559, DOI 10.1016/1044-7431(92)90068-D; GROTE E, 1988, NEUROSURGERY, V22, P654, DOI 10.1227/00006123-198804000-00006; GUTTERIDGE JMC, 1987, BIOCHIM BIOPHYS ACTA, V917, P219, DOI 10.1016/0005-2760(87)90125-1; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; KEYSE SM, 1990, CARCINOGENESIS, V11, P787, DOI 10.1093/carcin/11.5.787; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; KOEPPEN AH, 1993, ANN NEUROL, V34, P646, DOI 10.1002/ana.410340505; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; KUTTY RK, 1995, P NATL ACAD SCI USA, V92, P1177, DOI 10.1073/pnas.92.4.1177; LASH A, 1995, ANN CLIN LAB SCI, V25, P20; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Lee JC, 1960, NEUROLOGY, V10, P814, DOI 10.1212/WNL.10.9.814; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MAINES MD, 1993, J PHARMACOL EXP THER, V264, P457; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; Matz P, 1996, STROKE, V27, P504, DOI 10.1161/01.STR.27.3.504; Matz P, 1996, BRAIN RES, V713, P211, DOI 10.1016/0006-8993(95)01511-6; Matz PG, 1996, J NEUROSURG, V85, P892, DOI 10.3171/jns.1996.85.5.0892; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; MCDONAGH AF, 1990, CLIN PERINATOL, V17, P359, DOI 10.1016/S0095-5108(18)30572-4; MITANI K, 1991, BIOCHEM J, V277, P895, DOI 10.1042/bj2770895; MONCADA S, 1989, BIOCHEM SOC T, V17, P642, DOI 10.1042/bst0170642; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; MULLER RM, 1987, J BIOL CHEM, V262, P6795; MURPHY BJ, 1991, BRIT J CANCER, V64, P69, DOI 10.1038/bjc.1991.241; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nimura T, 1996, MOL BRAIN RES, V37, P201, DOI 10.1016/0169-328X(95)00315-J; OHYAGI Y, 1994, J NEUROL SCI, V126, P237, DOI 10.1016/0022-510X(94)90281-X; OKINAGA S, 1993, EUR J BIOCHEM, V212, P167, DOI 10.1111/j.1432-1033.1993.tb17647.x; PASCHEN W, 1994, NEUROSCI LETT, V180, P5, DOI 10.1016/0304-3940(94)90900-8; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; ROBERTS RL, 1993, J CELL SCI, V104, P521; ROSEN AD, 1979, EXP NEUROL, V66, P277, DOI 10.1016/0014-4886(79)90080-3; RUBLEVSKAYA I, 1994, J BIOL CHEM, V269, P26390; SCHACTER BA, 1988, SEMIN HEMATOL, V25, P349; SHIBAHARA S, 1993, J BIOCHEM-TOKYO, V113, P214, DOI 10.1093/oxfordjournals.jbchem.a124028; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; SOLOMON RA, 1985, STROKE, V16, P58, DOI 10.1161/01.STR.16.1.58; STEVENS CF, 1993, NATURE, V364, P147, DOI 10.1038/364147a0; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; SUN Y, 1990, J BIOL CHEM, V265, P8212; TAKEDA A, 1994, BRAIN RES, V666, P120, DOI 10.1016/0006-8993(94)90292-5; TRAKSHEL GM, 1989, J BIOL CHEM, V264, P1323; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VILLEGAS JC, 1993, J NEUROCYTOL, V22, P67, DOI 10.1007/BF01181571; VINCENT SR, 1994, NEUROSCIENCE, V63, P223, DOI 10.1016/0306-4522(94)90018-3; WEBER CM, 1994, J NEUROCHEM, V63, P953; WELLER RO, 1992, BRAIN PATHOL, V2, P277, DOI 10.1111/j.1750-3639.1992.tb00704.x; WHITESELL L, 1993, P NATL ACAD SCI USA, V90, P4665, DOI 10.1073/pnas.90.10.4665; WILLIAMS MA, 1993, CURR OPIN NEUROL, V6, P847, DOI 10.1097/00019052-199312000-00004; YEE F, 1994, CELL MOL NEUROBIOL, V14, P475, DOI 10.1007/BF02088832; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	81	121	123	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	1998	18	3					257	273		10.1097/00004647-199803000-00004			17	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	YZ707	WOS:000072282800004	9498842	Bronze			2022-02-06	
J	Max, JE; Robin, DA; Lindgren, SD; Smith, WL; Sato, Y; Mattheis, PJ; Stierwalt, JAG; Castillo, CS				Max, JE; Robin, DA; Lindgren, SD; Smith, WL; Sato, Y; Mattheis, PJ; Stierwalt, JAG; Castillo, CS			Traumatic brain injury in children and adolescents: Psychiatric disorders at two years	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						traumatic brain injury; children; adolescents; psychiatric disorder	HEAD-INJURY; RELIABILITY; SCALE; COMA	Objective: To extend findings regarding predictive factors of psychiatric outcome from the first to the second year after traumatic brain injury (TBI) in children and adolescents. Method: Subjects were children aged 6 to 14 years at the time they were hospitalized after TBI. The study used a prospective follow-up design. Assessments of preinjury psychiatric, behavioral, adaptive functioning, family functioning and family psychiatric history status were conducted. Severity of injury was assessed by standard clinical scales and neuroimaging was analyzed. The outcome measure was the presence of a psychiatric disorder, not present before the injury (''novel''), during the second year after TBI. Results: Fifty subjects enrolled, and the analyses focused on 42 subjects followed at 24 months. Severity of injury, preinjury family function, and preinjury lifetime psychiatric history predicted the development of a ''novel'' psychiatric disorder present in the second year. Conclusion: These data suggest that there are children, identifiable through clinical assessment, at increased risk for ''novel'' psychiatric disorders in the second year after TBI.	UNIV IOWA,DEPT RADIOL,IOWA CITY,IA 52242; UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; UNIV IOWA,DEPT SPEECH PATHOL & AUDIOL,IOWA CITY,IA 52242; CEDAR CTR,PSYCHIAT GRP,CEDAR RAPIDS,IA; UNIV MONTANA,MISSOULA,MT 59812		Max, JE (corresponding author), UNIV IOWA,DEPT PSYCHIAT,1876 JPP,IOWA CITY,IA 52242, USA.		Robin, Donald/F-2109-2010	Sato, Yutaka/0000-0002-5245-232X			ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BLACK P, 1981, BRAIN DYSFUNCTION CH, P171; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; Ciccetti D., 1984, VINELAND ADAPTIVE BE; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; GERSON AC, 1993, SCI P ANN M AM ACAD; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hoover H.D., 1986, MANUAL SCH ADM IOWA; KRAUS JF, 1987, PEDIATRICS, V79, P501; Last CG, 1996, J AM ACAD CHILD PSY, V35, P1502, DOI 10.1097/00004583-199611000-00019; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lindgren S.D., 1987, ADV BEHAVIORAL ASSES, V3, P57; MARSHALL LD, 1991, J NEUROSURG, V75, P514; Max J. E., 1992, NEUROPSYCHIATRIC RAT; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 1997, NEUROCASE, V3, P127; MILLER IW, 1994, FAM PROCESS, V33, P53, DOI 10.1111/j.1545-5300.1994.00053.x; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; *SPSS, 1995, SPSS WIND PROF STAT; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; TEASDALE G, 1974, LANCET, V2, P81	24	121	121	0	8	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0890-8567			J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	SEP	1997	36	9					1278	1285		10.1097/00004583-199709000-00021			8	Psychology, Developmental; Pediatrics; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	XT950	WOS:A1997XT95000022	9291730				2022-02-06	
J	Yousem, DM; Geckle, RJ; Bilker, WB; McKeown, DA; Doty, RL				Yousem, DM; Geckle, RJ; Bilker, WB; McKeown, DA; Doty, RL			Posttraumatic olfactory dysfunction: MR and clinical evaluation	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article						brain, magnetic resonance; head, injuries; nerves, olfactory (I)	SMELL IDENTIFICATION TEST; POST-TRAUMATIC ANOSMIA; KALLMANN SYNDROME; INTERNAL CONSISTENCY; HEAD TRAUMA; TASTE; RELIABILITY	PURPOSE: To evaluate the sites of injury in patients with posttraumatic olfactory deficits and to compare damage with findings on clinical olfactory tests. METHODS: Twenty-five patients with posttraumatic olfactory dysfunction were examined by means of olfactory testing, endoscopy, and MR imaging. MR surface-coil scans through the olfactory bulbs and tracts and head-coil scans of the temporal lobes were evaluated. Quantitative and qualitative gradings of damage to the olfactory bulbs, tracts, subfrontal region, hippocampus, and temporal lobes were compared with results on tests of odor identification, detection, memory, and discrimination. RESULTS: Twelve patients were anosmic, eight had severe impairment, and five were mildly impaired. Injuries to the olfactory bulbs and tracts (88% of patients), subfrontal region (60%), and temporal lobes (32%) were found, but these did not correlate well with individual olfactory test scores. Volumetric analysis showed that patients without smell function had greater volume loss in olfactory bulbs and tracts than did those posttraumatic patients who retained some sense of smell. Qualitative and quantitative assessments of damage showed few significant correlations with olfactory tests, probably because of multifocal injuries, primary olfactory nerve damage, and the constraints of a small sample size on the detection of clinically significant differences. CONCLUSION: MR imaging shows abnormalities in patients with posttraumatic olfactory dysfunction at a very high rate (88%), predominantly in the olfactory bulbs and tracts and the inferior frontal lobes.	UNIV PENN,MED CTR,CTR SMELL & TASTE,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT BIOSTAT & EPIDEMIOL,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,CTR CLIN EPIDEMIOL & BIOSTAT,PHILADELPHIA,PA 19104		Yousem, DM (corresponding author), UNIV PENN,MED CTR,DEPT RADIOL,3400 SPRUCE ST,PHILADELPHIA,PA 19104, USA.		Doty, Richard L/G-1602-2013; Bilker, Warren/AAS-3515-2021; Doty, Richard L/B-7623-2012		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P01DC000161] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [5 PO1 DC 00161-15] Funding Source: Medline		[Anonymous], 1942, Proc R Soc Med, V35, P601; BICK DP, 1993, AM J NEURORADIOL, V14, P852; BROMLEY SM, 1995, CORTEX, V31, P25, DOI 10.1016/S0010-9452(13)80103-7; CONSTANZO RM, 1985, BRAIN RES, V361, P258; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; COSTANZO RM, 1987, NY ACAD SCI, V510, P242; DOTY RL, 1985, CHEM SENSES, V10, P297; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DOTY RL, 1989, PERCEPT PSYCHOPHYS, V45, P381, DOI 10.3758/BF03210709; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HOTCHBERG Y, 1988, BIOMETRIKA, V75, P800; IIDA Y, 1994, ARCH OTOLARYNGOL, V120, P869; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; KNORR JR, 1993, AM J NEURORADIOL, V14, P845; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leigh AD, 1943, LANCET, V1, P38; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; LI C, 1994, AM J ROENTGENOL, V162, P411, DOI 10.2214/ajr.162.2.8310937; MOTT AE, 1991, MED CLIN N AM, V75, P1321, DOI 10.1016/S0025-7125(16)30391-1; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; SCHECHTER PJ, 1974, J NEUROL NEUROSUR PS, V37, P802, DOI 10.1136/jnnp.37.7.802; SMITH RS, 1993, PERCEPT PSYCHOPHYS, V54, P649, DOI 10.3758/BF03211788; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; TRUWIT CL, 1993, AM J NEURORADIOL, V14, P827; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; VOGL TJ, 1994, RADIOLOGY, V191, P53, DOI 10.1148/radiology.191.1.8134597; VOLLMECKE TA, 1985, CHEM SENSES, V10, P413; YOUSEM DM, 1993, AM J NEURORADIOL, V14, P839; YOUSEM DM, 1996, AJR AM J ROENTGENOL, V166, P711; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	31	121	129	1	5	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	JUN-JUL	1996	17	6					1171	1179					9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	UQ749	WOS:A1996UQ74900027	8791933				2022-02-06	
J	LEVIN, H; KRAUS, MF				LEVIN, H; KRAUS, MF			THE FRONTAL LOBES AND TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							CLOSED-HEAD-INJURY; DOUBLE-BLIND; POSTSTROKE DEPRESSION; METHYLPHENIDATE; DAMAGE; MEMORY; ORGANIZATION; PERFORMANCE; STRATEGIES; DEFICITS	The authors review 1) the pathophysiological, neuroimaging, and neurobehavioral evidence for frontal lobe involvement in closed head injury; 2) studies elucidating the cognitive deficits and behavioral disturbance related to frontal lobe lesions associated with head injury; and 3) pharmacologic treatment of the neuropsychiatric manifestations of frontal lobe injury, including emerging therapies.	JOHNS HOPKINS UNIV HOSP,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205		LEVIN, H (corresponding author), UNIV MARYLAND MED SYST,DIV NEUROSURG,22 S GREENE ST,BALTIMORE,MD 21201, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Andersson Stein, 1992, Tidsskrift for den Norske Laegeforening, V112, P2070; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; BLUMBERGS P, 1989, J NEUROL NEUROSUR PS, V52, P938; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; CAMPBELL JJ, 1994, J NEUROPSYCH CLIN N, V6, P411; CHUGANI HT, 1991, J NUCL MED, V32, P23; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; DENNEY DR, 1973, DEV PSYCHOL, V9, P275, DOI 10.1037/h0035092; DIAMOND A, 1989, BEHAV NEUROSCI, V103, P526, DOI 10.1037/0735-7044.103.3.526; DREWE E A, 1975, Cortex, V11, P8; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; EVANS R, 1987, J NERV MENT DIS, V162, P366; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GOLDMAN PS, 1971, EXP NEUROL, V32, P366, DOI 10.1016/0014-4886(71)90005-7; GOLDSTEIN FC, 1991, BRAIN COGNITION, V17, P23, DOI 10.1016/0278-2626(91)90063-E; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA; HIRST W, 1988, BRAIN COGNITION, V8, P379, DOI 10.1016/0278-2626(88)90060-7; ICHISE M, 1994, J NUCL MED, V35, P217; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; KAUFMANN MW, 1984, CAN J PSYCHIAT, V29, P46, DOI 10.1177/070674378402900112; KRAUS MF, 1992, SOUTHERN MED J, V85, P985, DOI 10.1097/00007611-199210000-00012; Kuczenski R., 1983, STIMULANTS NEUROCHEM, P31; LAZARUS LW, 1992, J CLIN PSYCHIAT, V53, P447; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1985, ARCH NEUROL-CHICAGO, V42, P963, DOI 10.1001/archneur.1985.04060090045012; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; LINGAM VR, 1988, J CLIN PSYCHIAT, V49, P151; LIPPER S, 1976, J NERV MENT DIS, V162, P366, DOI 10.1097/00005053-197605000-00008; Luria AR, 1963, RESTORATION FUNCTION; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MILNER B, 1985, HUM NEUROBIOL, V4, P137; OSCARBERMAN M, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P230; OTA Y, 1969, LATE EFFECTS HEAD IN, P110; PARKS RW, 1992, J NEUROPSYCH CLIN N, V4, P109; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; PORTEUS SD, 1962, J MENT SCI, V108, P53, DOI 10.1192/bjp.108.452.53; PRAYER L, 1993, ACTA RADIOL, V34, P593; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; SALLOWAY SP, 1994, J NEUROPSYCH CLIN N, V6, P388; SCHULMAN EA, 1992, NEUROLOGY, V42, P16; SEMLITSCH HV, 1992, J NEURAL TRANSM-PARK, V4, P319, DOI 10.1007/BF02260080; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHEFTELL FD, 1992, NEUROLOGY, V42, P32; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Silver Jonathan M., 1994, P631; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; WICKENS DD, 1970, PSYCHOL REV, V77, P1, DOI 10.1037/h0028569; WOODS SW, 1986, J CLIN PSYCHIAT, V47, P12; ZATORRE RJ, 1983, BRAIN COGNITION, V2, P331, DOI 10.1016/0278-2626(83)90017-9	60	121	122	0	16	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	1994	6	4					443	454					12	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	PN731	WOS:A1994PN73100012	7841815				2022-02-06	
J	Dompier, TP; Kerr, ZY; Marshall, SW; Hainline, B; Snook, EM; Hayden, R; Simon, JE				Dompier, Thomas P.; Kerr, Zachary Y.; Marshall, Stephen W.; Hainline, Brian; Snook, Erin M.; Hayden, Ross; Simon, Janet E.			Incidence of Concussion During Practice and Games in Youth, High School, and Collegiate American Football Players	JAMA PEDIATRICS			English	Article							LONGITUDINAL MRI; INJURIES; BRAIN; ADOLESCENCE; CHILDHOOD; SPORT	IMPORTANCE A report by the Institute of Medicine called for comprehensive nationwide concussion incidence data across the spectrum of athletes aged 5 to 23 years. OBJECTIVE To describe the incidence of concussion in athletes participating in youth, high school, and collegiate American football. DESIGN, SETTING, AND PARTICIPANTS Data were collected by athletic trainers at youth, high school, and collegiate football practices and games to create multiple prospective observational cohorts during the 2012 and 2013 football seasons. Data were collected from July 1, 2012, through January 31, 2013, for the 2012 season and from July 1, 2013, through January 31, 2014, for the 2013 season. The Youth Football Surveillance System included 118 youth football teams, providing 4092 athlete-seasons. The National Athletic Treatment, Injury and Outcomes Network program included 96 secondary school football programs, providing 11 957 athlete-seasons. The National Collegiate Athletic Association Injury Surveillance Program included 24 member institutions, providing 4305 athlete-seasons. EXPOSURES All injuries regardless of severity, including concussions, and athlete exposure information were documented by athletic trainers during practices and games. MAIN OUTCOMES AND MEASURES Injury rates, injury rate ratios, risks, risk ratios, and 95% Cls were calculated. RESULTS Concussions comprised 9.6%, 4.0%, and 8.0% of all injuries reported in the Youth Football Surveillance System; National Athletic Treatment, Injury and Outcomes Network; and National Collegiate Athletic Association Injury Surveillance Program, respectively. The game concussion rate was higher than the practice concussion rate across all 3 competitive levels. The game concussion rate for college athletes (3.74 per 1000 athlete exposures) was higher than those for high school athletes (injury rate ratio, 1.86; 95% Cl, 1.50-2.31) and youth athletes (injury rate ratio, 1.57; 95% Cl, 1.17-2.10). The practice concussion rate in college (0.53 per 1000 athlete exposures) was lower than that in high school (injury rate ratio, 0.80; 95% Cl, 0.67-0.96). Youth football had the lowest 1-season concussion risks in 2012(3.53%) and 2013(3.13%). The 1-season concussion risk was highest in high school (9.98%) and college (5.54%) in 2012. CONCLUSIONS AND RELEVANCE Football practices were a major source of concussion at all 3 levels of competition. Consussions during practice might be mitigated and should prompt an evaluation of technique and head impact exposure. Although it is more difficult to change the intensity or conditions of a game, many strategies can be used during practice to limit player-to-player contact and other potentially injurious behaviors.	[Dompier, Thomas P.; Kerr, Zachary Y.; Snook, Erin M.; Hayden, Ross] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN 46202 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Hainline, Brian] Natl Coll Athlet Assoc, Sport Sci Inst, Indianapolis, IN USA; [Simon, Janet E.] Univ Toledo, Dept Kinesiol, Toledo, OH 43606 USA		Dompier, TP (corresponding author), Datalys Ctr Sports Injury Res & Prevent Inc, 401 W Michigan St,Ste 500, Indianapolis, IN 46202 USA.	tdompier@datalyscenter.org		Kerr, Zachary/0000-0003-1423-1259	USA Football; National Athletic Trainers Association Research and Education Foundation; BioCrossroads; Central Indiana Corporate Partnership Foundation; National Collegiate Athletic Association	Funding for this study was provided by USA Football, the National Athletic Trainers Association Research and Education Foundation, BioCrossroads in partnership with the Central Indiana Corporate Partnership Foundation, and the National Collegiate Athletic Association.	Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Dompier T, 2011, J ATHL TRAI IN PRESS; Dompier TP, 2007, J ATHL TRAINING, V42, P395; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; GOLDBERG B, 1988, PEDIATRICS, V81, P255; Institute of Medicine, 2013, SPORTS REL CONC YOUT; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; National Collegiate Athletic Association, STUD ATHL PART 1981; National Council of Youth Sports, REP TRENDS PART ORG; National Federation of State High School Associations, PART STAT; Parsons J, 2013, 2013 14 SPORTS MED H, P63; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014	20	120	120	0	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	JUL	2015	169	7					659	665		10.1001/jamapediatrics.2015.0210			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CR0BF	WOS:000360982500013	25938704	Green Published, Bronze			2022-02-06	
J	Wilk, JE; Herrell, RK; Wynn, GH; Riviere, LA; Hoge, CW				Wilk, Joshua E.; Herrell, Richard K.; Wynn, Gary H.; Riviere, Lyndon A.; Hoge, Charles W.			Mild Traumatic Brain Injury (Concussion), Posttraumatic Stress Disorder, and Depression in US Soldiers Involved in Combat Deployments: Association With Postdeployment Symptoms	PSYCHOSOMATIC MEDICINE			English	Article						concussion; PTSD; depression; combat; deployment	POSTCONCUSSION-LIKE SYMPTOMS; MENTAL-HEALTH PROBLEMS; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; IRAQ; AFGHANISTAN; VETERANS; CARE; PREVALENCE; CRITERIA	Objectives: Several studies have examined the relationship between concussion/mild traumatic brain injury (mTBI), posttraumatic stress disorder (PTSD), depression, and postdeployment symptoms. These studies indicate that the multiple factors involved in postdeployment symptoms are not accounted for in the screening processes of the Department of Defense/Veteran's Affairs months after concussion injuries. This study examined the associations of single and multiple deployment-related mTBIs on postdeployment health. Methods: A total of 1502 U.S. Army soldiers were administered anonymous surveys 4 to 6 months after returning from deployment to Iraq or Afghanistan assessing history of deployment-related concussions, current PTSD, depression, and presence of postdeployment physical and neurocognitive symptoms. Results: Of these soldiers, 17% reported an mTBI during their previous deployment. Of these, 59% reported having more than one. After adjustment for PTSD, depression, and other factors, loss of consciousness was significantly associated with three postconcussive symptoms, including headaches (odds ratio [OR] = 1.5, 95% confidence interval [Cl] = 1.1-2.3). However, these symptoms were more strongly associated with PTSD and depression than with a history of mTBI. Multiple mTBIs with loss of consciousness increased the risk of headache (OR = 4.0, 95% CI = 2.4-6.8) compared with a single occurrence, although depression (OR = 4.2, 95% Cl = 2.6-6.8) remained as strong a predictor. Conclusions: These data indicate that current screening tools for mTBI being used by the Department of Defense/Veteran's Affairs do not optimally distinguish persistent postdeployment symptoms attributed to mTBI from other causes such as PTSD and depression. Accumulating evidence strongly supports the need for multidisciplinary collaborative care models of treatment in primary care to collectively address the full spectrum of postwar physical and neurocognitive health concerns.	[Wilk, Joshua E.] USA, Dept Mil Psychiat, Div Psychiat & Neurosci, Walter Reed Army Inst Res,Med Res & Mat Command, Silver Spring, MD 20910 USA		Wilk, JE (corresponding author), USA, Dept Mil Psychiat, Div Psychiat & Neurosci, Walter Reed Army Inst Res,Med Res & Mat Command, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	joshua.wilk@amedd.army.mil					[Anonymous], 2005, SPSS WIND COMP PROGR; [Anonymous], 2008, STATA COMP PROGR VER; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bliese PD, 2005, ARMY MED RES UNIT EU; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense and Veterans Brain Injury Center, 2006, DEF VET BRAIN INJ CT; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN GUID MAN; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gaetz M, 2000, BRAIN INJURY, V14, P1077; *GOV ACC OFF, 2008, GAO08276; Government Accountability Office, 2008, GAO08615; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCrea M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Southwick S., 2005, NEUROPSYCHOLOGY PTSD, P27; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	51	120	122	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	APR	2012	74	3					249	257		10.1097/PSY.0b013e318244c604			9	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	930JS	WOS:000303136300003	22366583				2022-02-06	
J	Leddy, JJ; Sandhu, H; Sodhi, V; Baker, JG; Willer, B				Leddy, John J.; Sandhu, Harkeet; Sodhi, Vikram; Baker, John G.; Willer, Barry			Rehabilitation of Concussion and Post-concussion Syndrome	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; post-concussion syndrome; physiology; rehabilitation; cognitive behavioral therapy		Context: Prolonged symptoms after concussion are called post-concussion syndrome (PCS), which is a controversial disorder with a wide differential diagnosis. Evidence Acquisition: MEDLINE and PubMed searches were conducted for the years 1966 to 2011 using the search terms brain concussion/complications OR brain concussion/diagnosis OR brain concussion/therapy AND sports OR athletic injuries. Secondary search terms included post-concussion syndrome, trauma, symptoms, metabolic, sports medicine, cognitive behavioral therapy, treatment and rehabilitation. Additional articles were identified from the bibliographies of recent reviews. Results: Of 564 studies that fulfilled preliminary search criteria, 119 focused on the diagnosis, pathophysiology, and treatment/rehabilitation of concussion and PCS and formed the basis of this review. Rest is the primary treatment for the acute symptoms of concussion. Ongoing symptoms are either a prolonged version of the concussion pathophysiology or a manifestation of other processes, such as cervical injury, migraine headaches, depression, chronic pain, vestibular dysfunction, visual dysfunction, or some combination of conditions. The pathophysiology of ongoing symptoms from the original concussion injury may reflect multiple causes: anatomic, neurometabolic, and physiologic. Conclusions: Treatment approaches depend on the clinician's ability to differentiate among the various conditions associated with PCS. Early education, cognitive behavioral therapy, and aerobic exercise therapy have shown efficacy in certain patients but have limitations of study design. An algorithm is presented to aid clinicians in the evaluation and treatment of concussion and PCS and in the return-to-activity decision.	[Leddy, John J.; Sandhu, Harkeet; Sodhi, Vikram; Baker, John G.] Dept Orthopaed, Buffalo, NY USA; [Leddy, John J.; Sandhu, Harkeet; Sodhi, Vikram; Baker, John G.] Sports Med Inst, Buffalo, NY USA; [Willer, Barry] SUNY Buffalo, Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Leddy, JJ (corresponding author), Univ Sports Med, 160 Farber Hall SUNY, Buffalo, NY 14214 USA.	leddy@buffalo.edu					Agrawal D, 2005, J NEUROSURG, V102, P167, DOI 10.3171/jns.2005.102.2.0167; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Del Percio C, 2009, BRAIN RES BULL, V79, P193, DOI 10.1016/j.brainresbull.2009.02.001; Dimberg EL, 2005, CLIN SPORT MED, V24, P637, DOI 10.1016/j.csm.2005.04.002; Dimeo F, 2001, BRIT J SPORT MED, V35, P114, DOI 10.1136/bjsm.35.2.114; Endo K, 2006, EUR SPINE J, V15, P886, DOI 10.1007/s00586-005-0970-y; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Friedman Jules M, 2004, Med Health R I, V87, P296; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gebke Kevin B, 2002, Curr Sports Med Rep, V1, P23; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gray T., 1989, NEUROPEPTIDES STRESS, P92; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2004, BRAIN INJURY, V18, P1; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; King ML, 1997, BRAIN INJURY, V11, P445; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levy M.N., 2006, BERNE LEVY PRINCIPLE; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Palmese CA, 2000, BRAIN INJURY, V14, P535; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Randolph C, 2005, J ATHL TRAINING, V40, P139; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SANO K, 1967, CONFIN NEUROL, V29, P257; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Shetter A G, 1979, Adv Neurol, V22, P5; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; TAYLOR AR, 1966, LANCET, V2, P178; TAYLOR AR, 1967, BRIT MED J, V3, P67, DOI 10.1136/bmj.3.5557.67; Teasdale TW, 1997, BRIT MED J, V315, P569; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vanravenswaaijarts CMA, 1993, ANN INTERN MED, V118, P436, DOI 10.7326/0003-4819-118-6-199303150-00008; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Ward A A Jr, 1964, Clin Neurosurg, V12, P95; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Yamaki T, 1998, BRAIN RES PROTOC, V3, P100, DOI 10.1016/S1385-299X(98)00030-0	118	120	121	2	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2012	4	2					147	154		10.1177/1941738111433673			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19WW	WOS:000214850100009	23016082	Green Published			2022-02-06	
J	Risling, M; Plantman, S; Angeria, M; Rostami, E; Bellander, BM; Kirkegaard, M; Arborelius, U; Davidsson, J				Risling, M.; Plantman, S.; Angeria, M.; Rostami, E.; Bellander, B. -M.; Kirkegaard, M.; Arborelius, U.; Davidsson, J.			Mechanisms of blast induced brain injuries, experimental studies in rats	NEUROIMAGE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SHELL SHOCK; EXPRESSION; BIOMARKERS; EXPOSURE	Traumatic brain injuries (TBI) potentially induced by blast waves from detonations result in significant diagnostic problems. It may be assumed that several mechanisms contribute to the injury. This study is an attempt to characterize the presumed components of the blast induced TBI. Our experimental models include a blast tube in which an anesthetized rat can be exposed to controlled detonations of explosives that result in a pressure wave with a magnitude between 130 and 260 kPa. In this model, the animal is fixed with a metal net to avoid head acceleration forces. The second model is a controlled penetration of a 2 mm thick needle. In the third model the animal is subjected to a high-speed sagittal rotation angular acceleration. Immunohistochemical labeling for amyloid precursor protein revealed signs of diffuse axonal injury (DAI) in the penetration and rotation models. Signs of punctuate inflammation were observed after focal and rotation injury. Exposure in the blast tube did not induce DAI or detectable cell death, but functional changes. Affymetrix Gene arrays showed changes in the expression in a large number of gene families including cell death, inflammation and neurotransmitters in the hippocampus after both acceleration and penetration injuries. Exposure to the primary blast wave induced limited shifts in gene expression in the hippocampus. The most interesting findings were a downregulation of genes involved in neurogenesis and synaptic transmission. These experiments indicate that rotational acceleration may be a critical factor for DAI and other acute changes after blast TBI. The further exploration of the mechanisms of blast TBI will have to include a search for long-term effects. (C) 2010 Elsevier Inc. All rights reserved.	[Risling, M.; Plantman, S.; Angeria, M.; Rostami, E.; Arborelius, U.] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Bellander, B. -M.] Karolinska Hosp, Dept Clin Neurosci, Neurosurg Sect, S-10401 Stockholm, Sweden; [Kirkegaard, M.] Karolinska Inst, Dept Clin Neurosci, Ctr Hearing & Commun Res, S-17177 Stockholm, Sweden; [Davidsson, J.] Chalmers Tech Univ, Div Vehicle Safety, Gothenburg, Sweden		Risling, M (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	Marten.Risling@ki.se	Davidsson, Johan/A-3229-2016; Kirkegaard, Mette/G-9731-2016	Davidsson, Johan/0000-0002-1717-1514; Kirkegaard, Mette/0000-0003-3568-0360	Karolinska institutetKarolinska Institutet; Swedish Defense	Funding for the project has been provided by Karolinska institutet and the Swedish Defense.	Abrams MB, 2007, EUR J NEUROSCI, V26, P1118, DOI 10.1111/j.1460-9568.2007.05725.x; Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Anderson R, 2005, HEAD INJURY PATHOPHY, P26; Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Burbridge B, 2004, CAN ASSOC RADIOL J, V55, P326; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; CLEMEDSON CARL-JOHAN, 1955, JOUR AVIATION MED, V26, P373; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; CLEMEDSON CJ, 1956, NATURE, V177, P380, DOI 10.1038/177380a0; Davidsson J., 2009, P INT RES C BIOM IMP, P43; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Kirkegaard M, 2006, NEUROSCIENCE, V142, P425, DOI 10.1016/j.neuroscience.2006.06.037; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Lidman O, 2003, J NEUROSCI, V23, P9817; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Macleod AD, 2004, J ROY SOC MED, V97, P86, DOI 10.1258/jrsm.97.2.86; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Murai N, 2008, J NEUROTRAUM, V25, P72, DOI 10.1089/neu.2007.0346; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Risling M, 2004, PROCEEDINGS OF THE 7TH INTERNATIONAL NEUROTRAUMA SYMPOSIUM, P119; Risling M, 2002, FOIR0757SE SWED DEF, P1; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	39	120	121	1	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN	2011	54			1			S89	S97		10.1016/j.neuroimage.2010.05.031			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	813ZF	WOS:000294408600013	20493951				2022-02-06	
J	Salinas-Navarro, M; Alarcon-Martinez, L; Valiente-Soriano, FJ; Jimenez-Lopez, M; Mayor-Torroglosa, S; Aviles-Trigueros, M; Villegas-Perez, MP; Vidal-Sanz, M				Salinas-Navarro, Manuel; Alarcon-Martinez, Luis; Valiente-Soriano, Francisco J.; Jimenez-Lopez, Manuel; Mayor-Torroglosa, Sergio; Aviles-Trigueros, Marcelino; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel			Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration	EXPERIMENTAL EYE RESEARCH			English	Article						ocular hypertension; adult albino rat retinal ganglion cells; retrograde axonal transport; fluorogold; dextran tetramethylrhodamine; Brn3a; RT97; fluorescent tracers; phosphorilated neurofilament heavy chain; neuronal degeneration	INTRAOCULAR-PRESSURE ELEVATION; TRANSIENT ISCHEMIA; MONOCLONAL-ANTIBODIES; TRABECULAR MESHWORK; MICROGLIAL CELLS; CIRCADIAN-RHYTHM; GENE-EXPRESSION; TIME-COURSE; RCS RAT; GLAUCOMA	Ocular hypertension (OHT) is the main risk factor of glaucoma, a neuropathy leading to blindness. Here we have investigated the effects of laser photocoagulation (LP)-induced OHT, on the survival and retrograde axonal transport (RAT) of adult rat retinal ganglion cells (RGC) from I to 12 wks. Active RAT was examined with fluorogold (FG) applied to both superior colliculi (SCi) 1 wk before processing and passive axonal diffusion with dextran tetramethylrhodamine (DTMR) applied to the optic nerve (ON) 2 d prior to sacrifice. Surviving RGCs were identified with FG applied 1 wk pre-LP or by Brn3a immunodetection. The ON and retinal nerve fiber layer were examined by RT97-neurofibrillar staining. RGCs were counted automatically and color-coded density maps were generated. OHT retinas showed absence of FG(+) or DTMR(+)RGCs in focal, pie-shaped and diffuse regions of the retina which, by two weeks, amounted to, approximately, an 80% of RGC loss without further increase. At this time, there was a discrepancy between the total number of surviving FG-prelabelled RGCs and of DMTR(+)RGCs, suggesting that a large proportion of RGCs had their RAT impaired. This was further confirmed identifying surviving RGCs by their Brn3a expression. From 3 weeks onwards, there was a close correspondence of DTMR(+)RGCs and FG(+)RGCs in the same retinal regions, suggesting axonal constriction at the ON head. Neurofibrillar staining revealed, in ONs, focal degeneration of axonal bundles and, in the retinal areas lacking backlabeled RGCs, aberrant staining of RT97 characteristic of axotomy. LP-induced OHT results in a crush-like injury to ON axons leading to the anterograde and protracted retrograde degeneration of the intraocular axons and RGCs. (C) 2009 Elsevier Ltd. All rights reserved.	[Salinas-Navarro, Manuel; Alarcon-Martinez, Luis; Valiente-Soriano, Francisco J.; Jimenez-Lopez, Manuel; Mayor-Torroglosa, Sergio; Aviles-Trigueros, Marcelino; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel] Univ Murcia, Fac Med, Dept Oftalmol, E-30100 Murcia, Spain		Vidal-Sanz, M (corresponding author), Univ Murcia, Fac Med, Dept Oftalmol, Campus Univ Espinardo, E-30100 Murcia, Spain.	ofmmv01@um.es	Vidal-Sanz, Manuel/J-6989-2016; Valiente-Soriano, Francisco J./Z-4980-2019; Aviles-Trigueros, Marcelino/K-2622-2012	Vidal-Sanz, Manuel/0000-0002-9216-1615; Aviles-Trigueros, Marcelino/0000-0001-9711-2196; Jimenez Lopez, Manuel/0000-0002-8768-9968; Valiente-Soriano, Francisco J,/0000-0002-1837-6589	Regional Government of Murcia Fundacion SenecaFundacion Seneca [05703/PI/07, 04446/GERM/07]; Spanish Ministry of Education and ScienceSpanish Government [SAF-2005-04812, SAF 2009-10385]; Spanish Ministry of HealthInstituto de Salud Carlos IIISpanish Government [ISCIII: FIS PIO06/0780, RD0710062/0001]	supported by research grants from the Regional Government of Murcia Fundacion Seneca 05703/PI/07, 04446/GERM/07; Spanish Ministry of Education and Science SAF-2005-04812, SAF 2009-10385; and Spanish Ministry of Health ISCIII: FIS PIO06/0780 and RD0710062/0001.	Agudo M, 2009, INVEST OPHTH VIS SCI, V50, P424, DOI 10.1167/iovs.08-2404; Agudo M, 2008, MOL VIS, V14, P1050; ALARCONMARTINEZ L, MOL VIS IN PRESS; ANDERTON BH, 1982, NATURE, V298, P84, DOI 10.1038/298084a0; Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; BALKEMA GW, 1985, NATURE, V316, P630, DOI 10.1038/316630a0; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Chidlow G, 2005, MOL VIS, V11, P387; Danias J, 2006, EXP EYE RES, V82, P219, DOI 10.1016/j.exer.2005.06.013; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P5151, DOI 10.1167/iovs.02-1101; DRAGER UC, 1984, NATURE, V309, P624, DOI 10.1038/309624a0; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Filippopoulos T, 2006, INVEST OPHTH VIS SCI, V47, P1968, DOI 10.1167/iovs.05-0955; FitzGibbon T, 1996, J COMP NEUROL, V375, P238; Gomez-Ramirez AM, 1999, INVEST OPHTH VIS SCI, V40, P414; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jeffery G, 2008, NEUROSCIENCE, V157, P637, DOI 10.1016/j.neuroscience.2008.09.021; Jeffery G, 2001, PHYSIOL REV, V81, P1393, DOI 10.1152/physrev.2001.81.4.1393; Jia LJ, 2000, INVEST OPHTH VIS SCI, V41, P1380; Johnson EC, 2000, INVEST OPHTH VIS SCI, V41, P431; KRISHNA R, 1995, OPHTHALMIC RES, V27, P163, DOI 10.1159/000267660; Lafuente MP, 2002, EXP EYE RES, V74, P181, DOI 10.1006/exer.2001.1122; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; Levkovitch-Verbin H, 2002, INVEST OPHTH VIS SCI, V43, P402; Lopez-Herrera MPL, 2002, EXP NEUROL, V178, P243, DOI 10.1006/exnr.2002.8043; MABUCHI F, 1994, INVEST OPHTH VIS SCI, V45, P4352; Marco-Gomariz MA, 2006, J COMP NEUROL, V498, P163, DOI 10.1002/cne.21028; Mayor-Torroglosa S, 2005, INVEST OPHTH VIS SCI, V46, P3825, DOI 10.1167/iovs.05-0392; MAYORTORROGLOSA S, 2004, OPHTHALMIC RES, V36, P19; MCKERRACHER L, 1990, J NEUROSCI, V10, P2834; MCKERRACHER L, 1990, J NEUROSCI, V10, P641; Moore CG, 1996, CURR EYE RES, V15, P185, DOI 10.3109/02713689608997412; MOORE CG, 1993, INVEST OPHTH VIS SCI, V34, P363; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Morrison JC, 2008, PROG BRAIN RES, V173, P285, DOI 10.1016/S0079-6123(08)01121-7; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nash MS, 1999, INVEST OPHTH VIS SCI, V40, P1293; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Pang IH, 2005, INVEST OPHTH VIS SCI, V46, P1313, DOI 10.1167/iovs.04-0829; Parrilla-Reverter G, 2009, VISION RES, V49, P2808, DOI 10.1016/j.visres.2009.08.020; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1983, INVEST OPHTH VIS SCI, V24, P1305; QUIGLEY HA, 1976, INVEST OPHTH VISUAL, V15, P606; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P640; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Salinas-Navarro M., 2006, INVEST OPHTHALMOL VI, P47; SALINASNAVARRO M, MOL VIS IN PRESS; Salvador-Silva M, 2000, J COMP NEUROL, V417, P431, DOI 10.1002/(SICI)1096-9861(20000221)417:4<431::AID-CNE4>3.0.CO;2-G; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schlamp CL, 2001, MOL VIS, V7, P192; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; THANOS S, 1989, J NEUROSCI RES, V22, P144, DOI 10.1002/jnr.490220206; Vidal-Sanz M, 2007, EYE, V21, pS42, DOI 10.1038/sj.eye.6702888; Vidal-Sanz M, 2001, SURV OPHTHALMOL, V45, pS261, DOI 10.1016/S0039-6257(01)00205-3; Vidal-Sanz M, 2000, NEUROTOX RES, V2, P215, DOI 10.1007/BF03033795; VIDALSANZ M, 1988, EXP NEUROL, V102, P92, DOI 10.1016/0014-4886(88)90081-7; VIDALSANZ M, 2005, OPHTHALMIC RES, V37, P48; VIDALSANZ M, 1993, NEUROPROTOCOLS, V3, P29; Villegas-Perez M, 2005, INVEST OPHTH VIS SCI, V46; Villegas-Perez MP, 1998, J COMP NEUROL, V392, P58, DOI 10.1002/(SICI)1096-9861(19980302)392:1<58::AID-CNE5>3.0.CO;2-O; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; VillegasPerez MP, 1996, NEUROREPORT, V7, P1995, DOI 10.1097/00001756-199608120-00028; Wang S, 2003, CURR EYE RES, V27, P183, DOI 10.1076/ceyr.27.3.183.16053; Wang SM, 2000, INVEST OPHTH VIS SCI, V41, P537; Woldemussie E, 2004, GLIA, V47, P109, DOI 10.1002/glia.20000; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; WOOD JN, 1981, BIOSCIENCE REP, V1, P263, DOI 10.1007/BF01114913; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004	79	120	121	0	11	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	JAN	2010	90	1					168	183		10.1016/j.exer.2009.10.003			16	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	542SW	WOS:000273516500022	19835874				2022-02-06	
J	Maloney-Wilensky, E; Gracias, V; Itkin, A; Hoffman, K; Bloom, S; Yang, W; Christian, S; LeRoux, PD				Maloney-Wilensky, Eileen; Gracias, Vicente; Itkin, Arthur; Hoffman, Katherine; Bloom, Stephanie; Yang, Wei; Christian, Susan; LeRoux, Peter D.			Brain tissue oxygen and outcome after severe traumatic brain injury: A systematic review	CRITICAL CARE MEDICINE			English	Article						brain tissue oxygen; Licox; intracranial pressure; monitoring; traumatic brain injury	INTRACRANIAL-PRESSURE MONITORS; CEREBRAL PERFUSION-PRESSURE; NEUROCRITICAL CARE; CLINICAL-TRIALS; HEAD; ISCHEMIA; TENSION; PO2; METABOLISM; DELIVERY	Objective: In this study, available medical literature were reviewed to determine whether brain hypoxia as measured by brain tissue oxygen (Bto(2)) levels is associated with increased risk of poor outcome after traumatic brain injury (TBI). A secondary objective was to examine the safety profile of a direct Bto(2) probe. Data Source and Extraction: Clinical studies published between 1993 and 2008 were identified from electronic databases, Index Medicus, bibliographies of pertinent articles, and expert consultation. The following inclusion criteria were applied for outcome analysis: 1) more than 10 patients described, 2) use of a direct Bto(2) monitor, 3) brain hypoxia defined as Bto(2) <10 mm Hg for >15 or 30 minutes, 4) 6-month outcome data, and 5) clear reporting of patient outcome associated with Bto(2). For the analysis, each selected article had to have adequate data to determine odds ratios (ORs) and confidence intervals (CIs). Thirteen studies met the initial inclusion criteria and three were included in the final outcome analysis. Safety data were abstracted from any report where it was mentioned. Data Synthesis. The three studies included 150 evaluable patients with severe TBI (Glasgow Coma Scale <= 8). Brain hypoxia was identified in 71 (47%) of these patients. Among the patients with brain hypoxia, 52 (73%) had unfavorable outcome including 39 (55%) who died. In the absence of brain hypoxia, 34 (43%) patients had an unfavorable outcome, including 17 (22%) who died. Overall brain hypoxia (Bto(2) <10 mm Hg >15 minutes) was associated with worse outcome (OR 4.0; 95% Cl 1.9-8.2) and increased mortality (OR 4.6; 95% Cl 2.2-9.6). We reviewed published safety data; in 292 patients monitored with a Bto(2) probe, only two adverse events were reported. Conclusion: Summary results indicate that brain hypoxia (<10 mm Hg) is associated with worse outcome after severe TBI and that Bto(2) probes are safe. These results imply that treating patients to increase Bto(2) may improve outcome after severe TBI. This question will require further study. (Crit Care Med 2009; 37:2057-2063)	[Maloney-Wilensky, Eileen; Bloom, Stephanie; LeRoux, Peter D.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Gracias, Vicente] Univ Penn, Sch Med, Div Trauma Surg & Surg Crit Care, Philadelphia, PA 19104 USA; [Yang, Wei] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Yang, Wei] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Itkin, Arthur; Hoffman, Katherine; Christian, Susan] Stat Trade Inc, Morrisville, PA USA		LeRoux, PD (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	lerouxp@uphs.upenn.edu	Yang, Wei/A-9223-2009	Yang, Wei/0000-0001-8984-4389			*AANS CNS, 2007, J NEUROTRAUMA S1, V24, pS65; Bardt TF, 1998, ACT NEUR S, V71, P153; Birmingham K, 2002, NAT MED, V8, P5, DOI 10.1038/nm0102-5a; Bruzzone P, 1998, ACT NEUR S, V71, P111; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Dings J, 1998, NEUROL RES, V20, pS71; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; EDDY VA, 1995, AM SURGEON, V61, P24; FARRAR JK, 1991, J CEREB BLOOD FLOW M, V11, pS553; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Guyot LL, 1998, ACT NEUR S, V71, P47; Haitsma IK, 2007, PROG BRAIN RES, V161, P207, DOI 10.1016/S0079-6123(06)61014-5; Harris CH, 2002, AM SURGEON, V68, P787; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Jensen RL, 1997, SURG NEUROL, V47, P16, DOI 10.1016/S0090-3019(96)00276-5; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Khan SH, 1998, ACT NEUR S, V71, P50; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kiening KL, 1998, ACT NEUR S, V71, P172; KIENING KL, 2005, NEUROTRAUMA EVIDENCE; Kim DH, 2006, NEUROCRIT CARE, V4, P83, DOI 10.1385/NCC:4:1:083; Lane PL, 2000, CAN J SURG, V43, P442; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maragos WF, 2004, J NEUROCHEM, V91, P257, DOI 10.1111/j.1471-4159.2004.02736.x; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mazzeo AT, 2007, J NEUROL SCI, V261, P1, DOI 10.1016/j.jns.2007.04.026; Meixensberger J, 1998, ACT NEUR S, V71, P260; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NHS Centre for Reviews and Dissemination, 2001, UND SYST REV RES EFF; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Oddo M, 2008, CRIT CARE MED, V36, P1984, DOI 10.1097/CCM.0b013e318176a9f6; PARAMORE CG, 1994, ACTA NEUROCHIR, V127, P79, DOI 10.1007/BF01808552; Petitti DB, 1994, METAANALYSIS DECISIO; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, P5103; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rose JC, 2006, CURR OPIN CRIT CARE, V12, P97, DOI 10.1097/01.ccx.0000216574.26686.e9; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Rossi S, 1998, ACT NEUR S, V71, P91; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; SARRAFZADEH AS, 1997, SEVERE HEAD INJURIES, P109; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Scheufler KM, 2002, ANESTH ANALG, V95, P1042, DOI 10.1097/00000539-200210000-00046; Shapiro S, 1996, SURG NEUROL, V45, P278, DOI 10.1016/0090-3019(95)00359-2; SPIOTTA A, 2005, P C NEUR SURG ANN M; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van den Brink WA, 1998, ACT NEUR S, V71, P190; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749	78	120	122	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2009	37	6					2057	2063		10.1097/CCM.0b013e3181a009f8			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	448ZK	WOS:000266300300032	19384213				2022-02-06	
J	Lee, JK; Kibler, KK; Benni, PB; Easley, RB; Czosnyka, M; Smielewski, P; Koehler, RC; Shaffner, DH; Brady, KM				Lee, Jennifer K.; Kibler, Kathleen K.; Benni, Paul B.; Easley, R. Blaine; Czosnyka, Marek; Smielewski, Peter; Koehler, Raymond C.; Shaffner, Donald H.; Brady, Ken M.			Cerebrovascular Reactivity Measured by Near-Infrared Spectroscopy	STROKE			English	Article						autoregulation; cerebral blood flow; hemoglobin; hypotension; near-infrared spectroscopy; neonate; piglet	DYNAMIC CEREBRAL AUTOREGULATION; BLOOD PRESSURE MEASUREMENTS; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; PREMATURE-INFANTS; NEWBORN-INFANTS; OXYGENATION; CIRCULATION	Background and Purpose-The pressure reactivity index (PRx) describes cerebral vessel reactivity by correlation of slow waves of intracranial pressure (ICP) and arterial blood pressure. In theory, slow changes in the relative total hemoglobin (rTHb) measured by near-infrared spectroscopy are caused by the same blood volume changes that cause slow waves of ICP. Our objective was to develop a new index of vascular reactivity, the hemoglobin volume index (HVx), which is a low-frequency correlation of arterial blood pressure and rTHb measured with near-infrared spectroscopy. Methods-Gradual hypotension was induced in piglets while cortical laser-Doppler flux was monitored. ICP was monitored, and rTHb was measured continuously using reflectance near-infrared spectroscopy. The HVx was recorded as a moving linear correlation between slow waves (20 to 300 seconds) of arterial blood pressure and rTHb. Autoregulation curves were constructed by averaging values of the PRx or HVx in 5-mm Hg bins of cerebral perfusion pressure. Results-The laser-Doppler flux-determined lower limit of autoregulation was 29.4 +/- 6.7 mm Hg (+/- SD). Coherence between rTHb and ICP was high at low frequencies. HVx was linearly correlated with PRx. The PRx and HVx both showed higher values below the lower limit of autoregulation and lower values above the lower limit of autoregulation. Areas under the receiver operator characteristic curves were 0.88 and 0.85 for the PRx and HVx, respectively. Conclusions-Coherence between the rTHb and ICP waveforms at the frequency of slow waves suggests that slow waves of ICP are related to blood volume changes. The HVx has potential for further development as a noninvasive alternative to the PRx. (Stroke. 2009; 40: 1820-1826.)	[Lee, Jennifer K.; Kibler, Kathleen K.; Easley, R. Blaine; Koehler, Raymond C.; Shaffner, Donald H.; Brady, Ken M.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Benni, Paul B.] CAS Med Syst Inc, Branford, CT USA; [Czosnyka, Marek; Smielewski, Peter] Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England		Brady, KM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol, Div Pediat Anesthesiol Crit Care Med, 600 N Wolfe St,Blalock 904, Baltimore, MD 21287 USA.	kbrady5@jhmi.edu		SHAFFNER, DONALD/0000-0001-5530-0746; Smielewski, Peter/0000-0001-5096-3938	Hartwell Foundation; Foundation for Anesthesia Education and Research; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390, G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G9439390, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This work was supported by grants from the Hartwell Foundation and the Foundation for Anesthesia Education and Research.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bassan H, 2005, PEDIATR RES, V57, P35, DOI 10.1203/01.PDR.0000147576.84092.F9; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brain Trauma Foundation: American association of Neurological surgeons, 2007, J NEUROTRAUMA S1, V24, pS59; Chambers IR, 2005, PHYSIOL MEAS, V26, P1019, DOI 10.1088/0967-3334/26/6/011; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Lavinio A, 2007, STROKE, V38, P402, DOI 10.1161/01.STR.0000254551.92209.5c; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; Panerai RB, 2008, PHYSIOL MEAS, V29, P497, DOI 10.1088/0967-3334/29/4/006; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Ragauskas A, 2005, ACTA NEUROCHIR SUPPL, V95, P367; Sammons EL, 2007, J APPL PHYSIOL, V103, P369, DOI 10.1152/japplphysiol.00271.2007; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STEINER LA, 2008, NEUROCRIT CARE  0920; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8	29	120	123	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	MAY	2009	40	5					1820	1826		10.1161/STROKEAHA.108.536094			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	438UB	WOS:000265579800044	19286593	Green Published, Bronze			2022-02-06	
J	Chen, SF; Hsu, CW; Huang, WH; Wang, JY				Chen, S-F; Hsu, C-W; Huang, W-H; Wang, J-Y			Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						baicalein; inflammation; tumour necrosis factor-alpha; interleukin-1 beta; interleukin-6; cytokines; traumatic brain injury	TUMOR-NECROSIS-FACTOR; CLOSED-HEAD INJURY; FACTOR-ALPHA; TNF-ALPHA; CEREBROSPINAL-FLUID; CEREBRAL-ISCHEMIA; OXIDATIVE-STRESS; RAT-BRAIN; ENDOTHELIAL-CELL; GLIOMA-CELLS	Background and purpose: Traumatic brain injury (TBI) triggers a complex series of inflammatory responses that contribute to secondary tissue damage. The aim of this study was to investigate the effect of baicalein, a flavonoid possessing potent anti-inflammatory properties, on functional and histological outcomes and inflammatory cytokine expression, following TBI in rats. Experimental approach: Rats subjected to controlled cortical impact injury were injected with baicalein (30 mg kg(-1)) or vehicle immediately after injury or daily for 4 days. Neurological status was evaluated using the rotarod, adhesive removal, modified neurological severity scores and beam walk tests. Contusion volume and neuronal degeneration were measured using cresyl violet and FluoroJade B (FJB) histochemistry. Levels of tumour necrosis factor-beta (TNF-beta), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) mRNA and protein were assessed by real-time quantitative reverse transcriptase-PCR, enzyme-linked immunosorbent assay and immunohistochemistry. Key results: Single-dose and multiple-dose treatment with baicalein significantly improved functional recovery and reduced contusion volumes up to day 28 post-injury, although multiple-dose baicalein was the more effective treatment. Single-dose baicalein also significantly reduced the number of degenerating neurons (31%) on post-injury day 1 as indicated by FJB staining. These changes were associated with significantly decreased levels, at the contusion site, of TNF-alpha, IL-1 beta and IL-6 mRNA at 6 h, and cytokine protein on day 1 post-injury. Conclusions and implications: Post-injury treatment with baicalein improved functional and histological outcomes and reduced induction of proinflammatory cytokines in rat TBI. The neuroprotective effect of baicalein may be related to a decreased inflammatory response following the injury.	[Hsu, C-W; Wang, J-Y] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Chen, S-F] Cheng Hsin Rehabil Med Ctr, Dept Phys Med & Rehabil, Taipei, Taiwan; [Huang, W-H] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan		Wang, JY (corresponding author), Natl Def Med Ctr, Dept Physiol, 161 Sec 6,Ming Chuan E Rd, Taipei, Taiwan.	jywang@ndmctsgh.edu.tw	Chen, Szu-Fu/K-5040-2012	Wang, Jia-Yi/0000-0002-9106-3351	National Science Council of Taiwan, Republic of ChinaMinistry of Science and Technology, Taiwan [NSC 94-2314-B-350-001]; National Defense Medical Center [DOD94-02-14, DOD 95-02-18]; Cheng Hsin General Hospital	We thank Mr Kuei-Han Lin and Mr Jay-How Yang for their expert technical assistance in the experiments. This study was supported in part by grants from the National Science Council of Taiwan, Republic of China. (NSC 94-2314-B-350-001), National Defense Medical Center (DOD94-02-14 and DOD 95-02-18) and the Cheng Hsin General Hospital.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen YC, 2006, TOXICOL APPL PHARM, V216, P263, DOI 10.1016/j.taap.2006.05.008; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Friedlander RM, 1996, J EXP MED, V184, P717, DOI 10.1084/jem.184.2.717; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao ZH, 2001, PHARMACOL RES, V43, P173, DOI 10.1006/phrs.2000.0761; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; HAMADA H, 1993, ARCH BIOCHEM BIOPHYS, V306, P261, DOI 10.1006/abbi.1993.1509; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Hong T, 2002, PLANTA MED, V68, P268, DOI 10.1055/s-2002-23143; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Huang WH, 2003, CHEM PHARM BULL, V51, P339; Hunter AJ, 1998, TRENDS PHARMACOL SCI, V19, P59, DOI 10.1016/S0165-6147(97)01157-7; Hwang YS, 2002, LIFE SCI, V71, P2105, DOI 10.1016/S0024-3205(02)01920-3; Im HI, 2005, J PHARMACOL SCI, V98, P185, DOI 10.1254/jphs.SC0050014; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kimura Y, 2001, PLANTA MED, V67, P331, DOI 10.1055/s-2001-14328; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Lapchak PA, 2007, NEUROSCIENCE, V150, P585, DOI 10.1016/j.neuroscience.2007.09.033; LASTER SM, 1988, J IMMUNOL, V141, P2629; Li FQ, 2005, J NEURAL TRANSM, V112, P331, DOI 10.1007/s00702-004-0213-0; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; MEGYERI P, 1992, NEUROSCI LETT, V148, P137, DOI 10.1016/0304-3940(92)90823-P; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakahata N, 1998, AM J CHINESE MED, V26, P311, DOI 10.1142/S0192415X9800035X; NAKAYAMA T, 2003, MONOGRAPHS MARINE MO, V6, P1; Phillis John W., 2003, Critical Reviews in Neurobiology, V15, P61, DOI 10.1615/CritRevNeurobiol.v15.i1.30; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shen YC, 2003, EUR J PHARMACOL, V465, P171, DOI 10.1016/S0014-2999(03)01378-5; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Suk K, 2003, J PHARMACOL EXP THER, V305, P638, DOI 10.1124/jpet.102.047373; TANNO Y, 1988, AM J CHINESE MED, V16, P145, DOI 10.1142/S0192415X88000212; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Touzani O, 1999, J NEUROIMMUNOL, V100, P203, DOI 10.1016/S0165-5728(99)00202-7; Tsai TH, 2002, BRIT J PHARMACOL, V137, P1314, DOI 10.1038/sj.bjp.0704959; van Leyen K, 2006, STROKE, V37, P3014, DOI 10.1161/01.STR.0000249004.25444.a5; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Wen LL, 2007, EXP NEUROL, V205, P270, DOI 10.1016/j.expneurol.2007.02.011; Woo KJ, 2006, IMMUNOBIOLOGY, V211, P359, DOI 10.1016/j.imbio.2006.02.002; Wu PH, 2006, TOXICOLOGY, V226, P238, DOI 10.1016/j.tox.2006.06.015	64	120	126	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	DEC	2008	155	8					1279	1296		10.1038/bjp.2008.345			18	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	380YF	WOS:000261501300016	18776918	Green Published			2022-02-06	
J	Chen, G; Shi, JX; Hu, ZG; Hang, CH				Chen, Gang; Shi, Jixin; Hu, Zhigang; Hang, Chunhua			Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: A potential neuroprotective mechanism of N-acetylcysteine	MEDIATORS OF INFLAMMATION			English	Article							FACTOR-KAPPA-B; NECROSIS-FACTOR-ALPHA; INDUCED APOPTOSIS; AXONAL INJURY; EXPRESSION; ACTIVATION; RELEASE	Although N-acetylcysteine (NAC) has been shown to be neuroprotective for traumatic brain injury (TBI), the mechanisms for this beneficial effect are still poorly understood. Cerebral inflammation plays an important role in the pathogenesis of secondary brain injury after TBI. However, it has not been investigated whether NAC modulates TBI-induced cerebral inflammatory response. In this work, we investigated the effect of NAC administration on cortical expressions of nuclear factor kappa B (NF-kappa B) and inflammatory proteins such as interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and intercellular adhesion molecule-1 (ICAM-1) after TBI. As a result, we found that NF-kappa B, proinflammatory cytokines, and ICAM-1 were increased in all injured animals. In animals given NAC post-TBI, NF-kappa B, IL-1 beta, TNF-alpha, and ICAM-1 were decreased in comparison to vehicle-treated animals. Measures of IL-6 showed no change after NAC treatment. NAC administration reduced brain edema, BBB permeability, and apoptotic index in the injured brain. The results suggest that post-TBI NAC administration may attenuate inflammatory response in the injured rat brain, and this may be one mechanism by which NAC ameliorates secondary brain damage following TBI. Copyright (C) 2008 Gang Chen et al.	[Chen, Gang; Shi, Jixin; Hu, Zhigang; Hang, Chunhua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Jiangsu 210002, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 E Zhongshan Rd, Jiangsu 210002, Peoples R China.	nju_neurosurgery@163.com		Chen, Gang/0000-0002-0758-1907			Akca T, 2005, J SURG RES, V129, P38, DOI 10.1016/j.jss.2005.05.026; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Carroll JE, 1998, MOL BRAIN RES, V56, P186, DOI 10.1016/S0169-328X(98)00045-X; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Conti AC, 1998, J NEUROSCI, V18, P5663; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FERRARI G, 1995, J NEUROSCI, V15, P2857; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer E, 2002, MEDIAT INFLAMM, V11, P321, DOI 10.1080/09629350210000015737; Hsu BG, 2006, LIFE SCI, V79, P2010, DOI 10.1016/j.lfs.2006.06.040; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Li J, 2002, J NUTR, V132, P3286, DOI 10.1093/jn/132.11.3286; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Tanel A, 2007, J PHARMACOL EXP THER, V321, P73, DOI 10.1124/jpet.106.114678; Vink R, 2003, ACT NEUR S, V86, P257; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86	30	120	127	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2008	2008								716458	10.1155/2008/716458			8	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	314IL	WOS:000256803000001	18483565	Green Published, Green Submitted, gold			2022-02-06	
J	Opii, WO; Nukala, VN; Sultana, R; Pandya, JD; Day, KM; Merchant, ML; Klein, JB; Sullivan, PG; Butterfield, DA				Opii, Wycliffe O.; Nukala, Vidya N.; Sultana, Rukhsana; Pandya, Jignesh D.; Day, Kristen M.; Merchant, Michael L.; Klein, Jon B.; Sullivan, Patrick G.; Butterfield, D. Allan			Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; mitochondria; oxidative stress; proteomics; reactive oxygen species; traumatic brain injury	ALZHEIMERS-DISEASE BRAIN; PYRUVATE-DEHYDROGENASE COMPLEX; ALPHA-KETOGLUTARATE DEHYDROGENASE; CEREBRAL OXIDATIVE-METABOLISM; ISOVALERYL-COA DEHYDROGENASE; CYTOCHROME-C; CYCLOSPORINE-A; PERMEABILITY TRANSITION; LIPID-PEROXIDATION; CELL-DEATH	Experimental traumatic brain injury (TBI) results in a significant loss of cortical tissue at the site of injury, and in the ensuing hours and days a secondary injury exacerbates this primary injury, resulting in significant neurological dysfunction. The mechanism of the secondary injury is not well understood, but evidence implicates a critical role for mitochondria in this cascade. This mitochondrial dysfunction is believed to involve excitotoxicity, disruption of Ca2+ homeostasis, production of reactive oxygen species (ROS), ATP depletion, oxidative damage of mitochondrial proteins, and an overall breakdown of mitochondrial bioenergetics. Although oxidative damage occurs following TBI, the identities of proteins undergoing oxidative modification after TBI have not been investigated. In the present study, we utilized the 3-h post-injury controlled cortical impact model of experimental TBI in 20 young adult male Sprague-Dawley rats, coupled with proteomics to identify specific mitochondrial fraction proteins from the cortex and hippocampus that were oxidatively modified after TBI. We identified, from the cortex, pyruvate dehydrogenase, voltage-dependent anion channel, fumarate hydratase 1, ATP synthase, and prohibitin. From the hippocampus, we identified cytochrome C oxidase Va, isovaleryl coenzyme A dehydrogenase, enolase-1, and glyceraldehyde-3-phosphate dehydrogenase as proteins that had undergone oxidative modification following TBI. In addition, we have also shown that, following TBI, there is a reduction in the activities of pyruvate dehydrogenase (PDH), complex 1, and complex IV. These findings demonstrate that, following TBI, several proteins involved in mitochondrial bioenergetics are highly oxidatively modified, which may possibly underlie the massive breakdown of mitochondrial energetics and eventual cell death known to occur in this model. The identification of these proteins provides new insights into the mechanisms that take place following TBI and may provide avenues for possible therapeutic interventions after TBI.	Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40506 USA; Univ Kentucky, Ctr Membrane Sci, Lexington, KY 40506 USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA; Univ Louisville, Dept Med, Core Proteom Lab, Kidney Dis Program, Louisville, KY 40292 USA		Butterfield, DA (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	dabcns@uky.edu	Klein, Jon/B-9833-2013; Merchant, Michael/F-7109-2013; Merchant, Michael/N-7444-2013	Merchant, Michael/0000-0003-4128-4057	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048191, R21NS046426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG010836] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-10836, AG-05119] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-46426, NS-48191] Funding Source: Medline		Aksenova M, 2002, J NEUROTRAUM, V19, P491, DOI 10.1089/08977150252932433; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baldwin SA, 1996, GLIA, V16, P266; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Bogaert YE, 2000, EXP NEUROL, V161, P115, DOI 10.1006/exnr.1999.7250; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Butterfield DA, 2004, INT REV NEUROBIOL, V61, P161; Butterfield DA, 2004, BRAIN RES, V1000, P1, DOI 10.1016/j.brainres.2003.12.012; Butterfield DA, 2003, J NEUROCHEM, V86, P1313, DOI 10.1046/j.1471-4159.2003.01948.x; Butterfield DA, 2003, CELL MOL BIOL, V49, P747; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Castegna A, 2004, J NEUROCHEM, V88, P1540, DOI 10.1046/j.1471-4159.2003.02288.x; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; DEMEIRLEIR L, 1993, PEDIATR NEUROL, V9, P216, DOI 10.1016/0887-8994(93)90088-T; Drake J, 2003, J NEUROSCI RES, V74, P917, DOI 10.1002/jnr.10810; Eaton P, 2003, J AM SOC NEPHROL, V14, pS290, DOI 10.1097/01.ASN.0000078024.50060.C6; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Gibson GE, 2004, J BIOENERG BIOMEMBR, V36, P335, DOI 10.1023/B:JOBB.0000041764.45552.f3; Gibson GE, 1998, ANN NEUROL, V44, P676, DOI 10.1002/ana.410440414; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hard ML, 2001, ALCOHOL, V25, P1, DOI 10.1016/S0741-8329(01)00156-2; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; LAMANNA JC, 1981, BRAIN RES, V204, P87, DOI 10.1016/0006-8993(81)90654-5; Lauderback CM, 2001, J NEUROCHEM, V78, P413, DOI 10.1046/j.1471-4159.2001.00451.x; LAVOIE J, 1995, ALCOHOL CLIN EXP RES, V19, P1073, DOI 10.1111/j.1530-0277.1995.tb00991.x; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Leyva JA, 2003, MOL MEMBR BIOL, V20, P27, DOI 10.1080/0968768031000066532; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu XH, 2004, PROTEOMICS, V4, P3167, DOI 10.1002/pmic.200300845; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; Maurer MH, 2005, J PROTEOME RES, V4, P96, DOI 10.1021/pr049841l; McNair ND, 1999, NURS CLIN N AM, V34, P637; Mohsen AA, 1998, BIOCHEMISTRY-US, V37, P10325, DOI 10.1021/bi973096r; Mohsen AWA, 2001, MOL GENET METAB, V73, P126, DOI 10.1006/mgme.2001.3183; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nicholls DG, 2002, BIOENERGETICS; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Pocernich CB, 2003, NEUROTOX RES, V5, P515, DOI 10.1007/BF03033161; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; Poon HF, 2004, NEUROSCIENCE, V126, P915, DOI 10.1016/j.neuroscience.2004.04.046; Poona HF, 2005, NEUROCHEM INT, V46, P159, DOI 10.1016/j.neuint.2004.07.008; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Rosenthal RE, 2003, STROKE, V34, P1311, DOI 10.1161/01.STR.0000066868.95807.91; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SHEU KFR, 1985, ANN NEUROL, V17, P444; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116; Sriram K, 1998, J NEUROSCI, V18, P10287; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sultana R, 2004, NEUROCHEM RES, V29, P2215, DOI 10.1007/s11064-004-7028-0; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Tabatabaie T, 1996, ARCH BIOCHEM BIOPHYS, V336, P290, DOI 10.1006/abbi.1996.0560; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Thongboonkerd V, 2002, KIDNEY INT, V62, P1461, DOI 10.1046/j.1523-1755.2002.00565.x; Tibbs RE, 1998, ANAT REC, V253, P167; TUBOI S, 1990, ADV ENZYME REGUL, V30, P289; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Volchenboum SL, 2000, J BIOL CHEM, V275, P7958, DOI 10.1074/jbc.275.11.7958; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WHARTON DC, 1964, J BIOL CHEM, V239, P2036; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yoo BC, 2001, ELECTROPHORESIS, V22, P172, DOI 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P; Zaidan E, 1998, J NEUROCHEM, V70, P233; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	92	120	125	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2007	24	5					772	789		10.1089/neu.2006.0229			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	167YT	WOS:000246489300003	17518533				2022-02-06	
J	Whyte, J; Katz, D; Long, D; DiPasquale, MC; Polansky, M; Kalmar, K; Giacino, J; Childs, N; Mercer, W; Novak, P; Maurer, P; Eifert, B				Whyte, J; Katz, D; Long, D; DiPasquale, MC; Polansky, M; Kalmar, K; Giacino, J; Childs, N; Mercer, W; Novak, P; Maurer, P; Eifert, B			Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: A multicenter study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						amantadine; brain injuries; dantrolene; minimally conscious state; persistent vegetative state; projections and predictions; rehabilitation; treatment outcome	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; PERSISTENT VEGETATIVE STATE; HEAD-INJURY; COMMON-DRUGS; RECOVERY; AMANTADINE; COMA; BROMOCRIPTINE; STIMULATION	Objectives: To develop predictive models of recovery from the vegetative state (VS) and minimally conscious state (MCS) after traumatic brain injury (TBI) and to gather preliminary evidence on the impact of various psychotropic medications on the recovery process to support future randomized controlled trials. Design: Longitudinal observational cohort design, in which demographic information, injury and acute care history, neuroimaging data, and an initial Disability Rating Scale (DRS) score were collected at the time of study enrollment. Weekly follow-up data, consisting of DRS score, current psychoactive medications, and medical complications, were gathered until discharge from inpatient rehabilitation. Setting: Seven acute inpatient rehabilitation facilities in the United States and Europe with specialized programs for treating patients in the VS and MCS. Participants: People with TBI (N = 124) who were in the VS or MCS 4 to 16 weeks after injury. Interventions: Not applicable. Main Outcome Measures: DRS score at 16 weeks after injury and time until commands were first followed (among those participants demonstrating no command following at study enrollment). Results: DRS score at enrollment, time between injury and enrollment, and rate of DRS change during the first 2 weeks of poststudy observation were all highly predictive of both outcomes. No variables related to injury characteristics or lesions on neuroimaging were significant predictors. Of the psychoactive medications, amantadine hydrochloride was associated with greater recovery and dantrolene sodium was associated with less recovery, in terms of the DRS score at 16 weeks but not the time until commands were followed. More detailed analysis of the timing of functional improvement, with respect to the initiation of amantadine provided suggestive, but not definitive, evidence of the drug's causal role. Conclusions: These findings show the feasibility of improving outcome prediction from the VS and MCS using readily available clinical variables and provide suggestive evidence for the effects of amantadine and dantrolene, but these results require confirmation through randomized controlled trials. (C) 2005 by American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	MossRehab, Inst Res, Albert Einstein Healthcare Network, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Dept Rehabil Med, Philadelphia, PA 19107 USA; HealthS Braintree Rehabil Hosp, Braintree, MA USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; Bryn Mawr Rehab Hosp, Malvern, PA USA; Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; JFK Johnson Rehabil Inst, Edison, NJ USA; New Jersey Neurosci Inst, Edison, NJ USA; Texas NeuroRehab Ctr, Austin, TX USA; Sunnyview Hosp, Schenectady, NY USA; Rehabil Ctr, Schenectady, NY USA; Fachkrankenhaus Neresheim Hosp, Neresheim, Germany		Whyte, J (corresponding author), MossRehab, Inst Res, Albert Einstein Healthcare Network, 1200 W Tabor Rd,Korman Bldg,Ste 213, Philadelphia, PA 19141 USA.	jwhyte@einstein.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Whyte, John/0000-0002-4381-1474			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; Borer-Alafi N, 2002, BRAIN INJURY, V16, P593, DOI 10.1080/02699050110119484; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CRISMON ML, 1988, CLIN NEUROPHARMACOL, V11, P462, DOI 10.1097/00002826-198810000-00007; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Forsyth R, 2003, COCHRANE DB SYST REV; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2003, J HEAD TRAUMA REHAB, V18, P4, DOI 10.1097/00001199-200301000-00003; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Giacino JT, 1996, NEUROREHABILITATION, V6, P69, DOI 10.3233/NRE-1996-6108; GIACINO JT, IN PRESS REHABILITAT; Goldstein LB, 1998, ARCH NEUROL-CHICAGO, V55, P454, DOI 10.1001/archneur.55.4.454; Goldstein LB, 1997, CURR OPIN NEUROL, V10, P52, DOI 10.1097/00019052-199702000-00011; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jennett B, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199708000-00003; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kater K M, 1989, West J Nurs Res, V11, P20, DOI 10.1177/019394598901100103; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Laborde A, 1997, J HEAD TRAUMA REHAB, V12, P90, DOI 10.1097/00001199-199708000-00009; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Laureys S, 2002, ACTA NEUROL BELG, V102, P176; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Lombardi F., 2002, COCHRANE DB SYST REV, V2002, DOI DOI 10.1002/14651858.CD001427; LONG DF, 1989, NEUROPSYCHOLOGICAL T, P39; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; *MULT SOC TASK FOR, 1994, NEW ENGL J MED, V26, P1572; ODELL MW, 1996, MED REHABILITATION T, P103; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reinhard DL, 1996, ARCH PHYS MED REHAB, V77, P80, DOI 10.1016/S0003-9993(96)90225-7; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; ROSS ED, 1981, NEUROLOGY, V31, P1435, DOI 10.1212/WNL.31.11.1435; Sazbon L, 1991, Brain Inj, V5, P1, DOI 10.3109/02699059108998504; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schneider WN, 1999, BRAIN INJURY, V13, P863; Showalter PEC, 2000, BRAIN INJURY, V14, P997; WALKERBATSON D, 1995, STROKE, V26, P2254, DOI 10.1161/01.STR.26.12.2254; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; WOOD R L, 1991, Brain Injury, V5, P401, DOI 10.3109/02699059109008113; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; Wroblewski Bruno, 1993, Brain Injury, V7, P353, DOI 10.3109/02699059309034962; Xie K, 2003, ACT NEUR S, V87, P19; Yamamoto T, 2003, ACTA NEUROCHIR SUPPL, V87, P15; Yamamoto T, 2002, ACT NEUR S, V79, P79; Zafonte RD, 1998, BRAIN INJURY, V12, P617; ZASLER ND, 1995, J HEAD TRAUMA REHAB, V10, P101, DOI 10.1097/00001199-199508000-00010; [No title captured]	70	120	128	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2005	86	3					453	462		10.1016/j.apmr.2004.05.016			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	904DB	WOS:000227475200016	15759228				2022-02-06	
J	Mizoe, J; Tsujii, H; Kamada, T; Matsuoka, Y; Tsuji, H; Osaka, Y; Hasegawa, A; Yamamoto, N; Ebihara, S; Konno, A				Mizoe, J; Tsujii, H; Kamada, T; Matsuoka, Y; Tsuji, H; Osaka, Y; Hasegawa, A; Yamamoto, N; Ebihara, S; Konno, A		Organizing Committee for the Wo	Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article						carbon ion radiotherapy; head-and-neck cancer; high LET radiotherapy; phase I/II clinical trial; dose escalation study	NEUTRON RADIATION-THERAPY; CHARGED-PARTICLE IRRADIATION; PERSPECTIVE; CARCINOMA; TUMORS; TRIAL	Purpose: To evaluate the toxicity and efficacy of carbon ion radiotherapy for head-and-neck cancer in a Phase I/II dose escalation clinical trial. Methods and Materials: Between June 1994 and January 1997, 36 patients with locally advanced, histologically proven, and new or recurrent cancer of the head and neck were treated with carbon ions. A dose escalation study was conducted, delivering 18 fractions through 6 weeks for 17 patients (Group A) and 16 fractions through 4 weeks for 19 patients (Group B). Eligibility and ineligibility criteria were the same in both groups. The dosages were escalated in increments of 10% after careful observation of at least 3 patients treated with the same dosages. The endpoints of the study were a Grade 3 reaction of the skin and the mucous membrane or local control of the tumors. Results: Follow-up time ranged from 77 to 108 months with a median of 90 months. Grade 3 acute reaction of the skin was detected in I of the 2 patients in Group A who were treated with 70.2 GyE/18 fractions/6 weeks. In Group B, Grade 3 acute skin reaction was detected in 20% (115), 27% (2/11), and 67% (2/3) patients treated with 52.8 GyE, 57.6 GyE, and 64.0 GyE through 16 fractions for 4 weeks, respectively. There was only 1 patient with a Grade 3 acute reaction of the mucous membrane. Only 1 patient developed a Grade 2 late reaction of the mucous membrane (superficial ulcer), which was located close to the tumor. No other Grade 2 or greater late reaction was noted until the time of analysis. Acute tumor reactions in 34 patients consisted of 10 patients of complete response 19 of partial response, 4 of no change, and 1 of progressive disease. Local control of 34 patients calculated by the Kaplan-Meier method was 75% at 5 years. Five years' local control of five malignant melanomas showed 100%, and that of 9 patients with adenoid cystic carcinoma was 90%. Also, local control of 8 patients of salivary glands and 4 patients of ears was 100% at 56 months and 5 years. Conclusions: The dose fractionation methods of 70.2 GyE through 18 fractions for 6 weeks and 64.0 GyE through 16 fractions for 4 weeks showed equal clinical outcome in terms of morbidity and local control. The outcome of carbon ion radiotherapy showed a specific effectiveness in local control of non-squamous cell carcinoma such as adenoid cystic carcinomas and malignant melanomas. From the results of this study, it can be concluded that carbon ion radiotherapy will deliver a high local control rate without unacceptable injuries to the surrounding normal tissues. (C) 2004 Elsevier Inc.	Natl Inst Radiol Sci Hosp, Res Ctr Charged Particle, Inage Ku, Chiba 2638555, Japan; Iwate Cent Prefectural Hosp, Dept Radiol, Morioka, Iwate, Japan; Hokkaido Univ Hosp, Dept Radiol, Sapporo, Hokkaido 060, Japan; Natl Canc Ctr Hosp, Dept Head & Neck Surg, Kashiwa, Chiba, Japan; So Tohoku Res Inst Neurosci, Ctr Allerg Head & Neck Dis, Koriyama, Fukushima, Japan		Mizoe, J (corresponding author), Natl Inst Radiol Sci Hosp, Res Ctr Charged Particle, Inage Ku, Anagawa 4-9-1, Chiba 2638555, Japan.	j_mizoe@nirs.go.jp					Ando K, 1999, INT J RADIAT BIOL, V75, P505, DOI 10.1080/095530099140438; BLAKELY EA, 1992, RADIAT ENVIRON BIOPH, V31, P181, DOI 10.1007/BF01214826; CASTRO JR, 1994, INT J RADIAT ONCOL, V29, P647, DOI 10.1016/0360-3016(94)90550-9; CASTRO JR, 1988, INT J RADIAT ONCOL, V14, P711, DOI 10.1016/0360-3016(88)90093-4; CASTRO JR, 1995, RADIAT ENVIRON BIOPH, V34, P45, DOI 10.1007/BF01210545; COHEN L, 1981, INT J RADIAT ONCOL, V7, P179, DOI 10.1016/0360-3016(81)90434-X; DUNCAN W, 1987, INT J RADIAT ONCOL, V13, P171, DOI 10.1016/0360-3016(87)90124-6; FEEHAN PE, 1992, INT J RADIAT ONCOL, V23, P881, DOI 10.1016/0360-3016(92)90663-3; GRIFFIN TW, 1984, INT J RADIAT ONCOL, V10, P2217, DOI 10.1016/0360-3016(84)90226-8; GRIFFIN TW, 1992, CRIT REV ONCOL HEMAT, V13, P17, DOI 10.1016/1040-8428(92)90014-H; Hiraos Y, 1992, NUCL PHYS A, V538, P541, DOI DOI 10.1016/0375-9474(92)90803-R; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KOH WJ, 1994, ACTA ONCOL, V33, P293, DOI 10.3109/02841869409098420; Laramore GE, 1997, SEMIN ONCOL, V24, P672; LINSTADT DE, 1991, INT J RADIAT ONCOL, V20, P761, DOI 10.1016/0360-3016(91)90020-5; PAKER RG, 1976, CANCER, V38, P1118; Schultz PW, 2000, J SOC ISSUES, V56, P391, DOI 10.1111/0022-4537.00174; SVENSSON H, 1994, ACTA ONCOL, V33, P227, DOI 10.3109/02841869409098412; TOBIAS CA, 1982, INT J RADIAT ONCOL, V8, P2109, DOI 10.1016/0360-3016(82)90554-5; TSUJII H, 2002, PROGR RADIO ONCOLOGY, V7, P393; Tsujiis H, 1997, J BRACHYTHERAPY INT, V13, P1; WAMBERSIE A, 1994, ACTA ONCOL, V33, P261, DOI 10.3109/02841869409098416; WHO, 1979, WHO OFFS PUBL, V48, P23	24	120	131	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0360-3016			INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	OCT 1	2004	60	2					358	364		10.1016/j.ijrobp.2004.02.067			7	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Radiology, Nuclear Medicine & Medical Imaging	855IJ	WOS:000223966500003	15380567				2022-02-06	
J	Lavoie, A; Ratte, S; Clas, D; Demers, J; Moore, L; Martin, M; Bergeron, E				Lavoie, A; Ratte, S; Clas, D; Demers, J; Moore, L; Martin, M; Bergeron, E			Preinjury warfarin use among elderly patients with closed head injuries in a trauma center	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						anticoagulant; head injuries; outcome	BRAIN-INJURY; MORTALITY; IMPACT; RISK	Background. This study aimed to determine the impact of warfarin use on the severity of injury among elderly patients presenting with closed head injuries. Methods. A cohort of patients 55 years of age or older with closed head injuries taken to a tertiary trauma center between April 1993 and March 2001 was retrospectively identified. Patient characteristics, mechanism of injury, type and severity of injury, and hospital survival data were obtained from the trauma registry. Each case then was reviewed for completeness of information, assessment of preinjury warfarin use, and comorbidity. Results: Among the 384 patients presenting with closed head injuries, 35 (9%) were receiving warfarin before their trauma. As compared with nonusers, anticoagulated patients had a higher frequency of isolated head trauma (54% vs. 32%; p = 0.008), more severe head injuries (65.7% vs. 44.1%; p = 0.02), and a higher rate of mortality (40% vs. 21%, p = 0.01). These associations remained evident even after population differences in age, gender, comorbidities, and mechanism of injury were taken into account. Indeed, according to multivariate logistic regression models, warfarin use was associated with a statistically significant risk of death (odds ratio [OR], 2.73; 95% confidence interval [CI], 1.22-6.12), statistically significant odds for more severe head injury (OR, 2.39; 95% CI, 1.10-5.17), and odds for isolated head injury that almost reached statistical significance (OR, 1.79; 95% Cl, 0.82-3.90). Conclusions:. Among patients 55 years of age or older who present with closed head injury, the use of warfarin before trauma appears to be associated with a higher frequency of isolated head trauma, more severe head trauma, and a higher likelihood of death. The findings of this retrospective study support the concern about the adverse effects of anticoagulants in cases of head trauma.	Hop Charles LeMoyne, Choc Trauma Monteregie, Quebec City, PQ J4V 2H1, Canada; Affilie Univ Quebec, Ctr Hosp, Quebec City, PQ, Canada; Univ Laval, Quebec City, PQ, Canada; Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada		Bergeron, E (corresponding author), Hop Charles LeMoyne, Choc Trauma Monteregie, 3120 Blvd Taschereau,Greenfield Pk, Quebec City, PQ J4V 2H1, Canada.	eric.bergeron@traumaquebec.org					*ASS ADV AUT MED, 1990, ABBR INJ SEV SCAL; Fleming B, 2001, CAN FAM PHYSICIAN, V47, P727; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Karni A, 2001, AM SURGEON, V67, P1098; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; MATTLE H, 1989, J NEUROL NEUROSUR PS, V52, P829, DOI 10.1136/jnnp.52.7.829; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Saab M, 1996, J ACCID EMERG MED, V13, P208; SCHWAB CW, 2000, TRAUMA, P1099; STEIN J, 1995, ARCH PHYS MED REHAB, V76, P840, DOI 10.1016/S0003-9993(95)80549-4; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wellman M, 1999, J Fam Pract, V48, P498; WINTZEN AR, 1982, ARCH NEUROL-CHICAGO, V39, P69, DOI 10.1001/archneur.1982.00510140003001; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	24	120	123	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2004	56	4					802	807		10.1097/01.TA.0000066183.02177.AF			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	818TZ	WOS:000221268700019	15187746				2022-02-06	
J	He, J; Hoffman, SW; Stein, DG				He, J; Hoffman, SW; Stein, DG			Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						cortical injury; neurosteroids; allopregnanolone; progesterone; GABA; neuroprotection	CORTICAL CONTUSION INJURY; PREFRONTAL CORTEX; NEUROSTEROID ALLOPREGNANOLONE; MEDIODORSAL NUCLEUS; GABA(A) RECEPTOR; FEMALE RATS; HEAD-INJURY; IN-VITRO; EXCITOTOXICITY; INFUSION	Purpose: In the Current study we investigated whether allopregnanolone, a metabolite of progesterone, could replicate progesterone's beneficial effects in promoting spatial learning ability after bilateral medial prefrontal cortex contusions in rats. Allopregnanolone has been shown to enhance GABA neurotransmission, whereas its isomer epiallopregnanolone does not have this property. Thus, epiallopregnanolone was chosen as a control substance to examine further the role of GABA transmission in post-trauma neuroprotection. Methods: After the contusion, rats were given 4 mg/kg treatment of either allopregnanolone or epiallopregnanolone for five consecutive days beginning 1 hr post-injury. Control groups only received vehicle treatment at the same time points. A spatial learning task (Morris Water Maze, MWM) was performed at 7 clays post-injury for 10 days. Subsequent histological analyses of brain tissue were conducted to determine quantitatively the neuronal losses in both the mediodorsal nucleus of the thalamus (MDN) and the nucleus basalis magnocellularis (NBM). Results: Allopregnanolone-treated rats showed better performance in the MWM compared to the vehicle-treated injury group. The histological analyses also revealed that the allopregnanolone-treated injury group had less neuronal loss in both the MDN and the NBM compared to the vehicle-treated injury group. In contrast, epiallopregnanolone did not facilitate MWM performance or reduce neuronal loss in the MDN and the NBM after TBI. Conclusion: Based on our findings, we Suggest that allopregnanolone may mediate the effects of progesterone in promoting cognitive and morphological recovery from TBI through, among others. its direct or indirect effects on GABA-modulated neurons in the MDN and the NBM.	Emory Univ, Dept Psychol, Brain Res Lab, Atlanta, GA 30322 USA; Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Dept Psychol, Brain Res Lab, 1648 Pierce Dr,Evans Bldg Room 261, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS38664] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038664] Funding Source: NIH RePORTER		AKHONDZADEH S, 1995, BRIT J PHARMACOL, V115, P527, DOI 10.1111/j.1476-5381.1995.tb16366.x; AKHONDZADEH S, 1995, BRAIN RES, V677, P311, DOI 10.1016/0006-8993(95)00165-M; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Brot MD, 1997, EUR J PHARMACOL, V325, P1, DOI 10.1016/S0014-2999(97)00096-4; Cavalli R, 1999, INT J PHARM, V182, P59, DOI 10.1016/S0378-5173(99)00066-6; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; CLARK AS, 1989, J CHEM NEUROANAT, V2, P259; Czlonkowska AI, 2001, POL J PHARMACOL, V53, P385; Darnaudery M, 1999, NEUROSCIENCE, V92, P583, DOI 10.1016/S0306-4522(99)00019-6; Dazzi L, 1996, BRAIN RES, V710, P275, DOI 10.1016/0006-8993(95)01478-0; di Michele F, 2000, NEUROSCI LETT, V284, P65, DOI 10.1016/S0304-3940(00)00965-4; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; FIBIGER HC, 1982, BRAIN RES REV, V4, P327, DOI 10.1016/0165-0173(82)90011-X; Galli R, 2001, EPILEPSIA, V42, P216, DOI 10.1046/j.1528-1157.2001.07600.x; Ghezzi P, 2000, EUR CYTOKINE NETW, V11, P464; Goodman YD, 1996, J NEUROCHEM, V66, P1836; GOSS CW, 2001, J NEUROTRAUM, V18, P1175; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hoffman S. W, 2001, ACAD EMERG MED, V8, P496; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Kajta M, 1999, POL J PHARMACOL, V51, P531; Khateb A, 1998, NEUROSCIENCE, V86, P937, DOI 10.1016/S0306-4522(98)00094-3; Laconi MR, 2001, EUR J PHARMACOL, V417, P111, DOI 10.1016/S0014-2999(01)00865-2; Ladurelle N, 2000, BRAIN RES, V858, P371, DOI 10.1016/S0006-8993(00)01953-3; Landgren S, 1998, ACTA PHYSIOL SCAND, V162, P77; LASALLE GL, 1988, EXP NEUROL, V101, P411, DOI 10.1016/0014-4886(88)90052-0; Limmroth V, 1996, BRIT J PHARMACOL, V117, P99, DOI 10.1111/j.1476-5381.1996.tb15160.x; LYETH BG, 1992, J NEUROTRAUMA S2, V9, P463; Mahesh VB, 1996, J STEROID BIOCHEM, V56, P209, DOI 10.1016/0960-0760(95)00238-3; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; Matthews DB, 2002, ALCOHOL CLIN EXP RES, V26, P1747, DOI 10.1097/01.ALC.0000037219.79257.17; Maurice T, 1999, JPN J PHARMACOL, V81, P125, DOI 10.1254/jjp.81.125; Miller L, 1998, J IMMUNOL, V160, P5098; Muir JK, 1996, J CEREBR BLOOD F MET, V16, P1211, DOI 10.1097/00004647-199611000-00015; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; OLNEY JW, 1994, J NEURAL TRANSM-SUPP, P47; Oyoshi T, 1996, J NEUROSCI, V16, P5812; PARKCHUNG MJ, 1994, MOL PHARMACOL, V46, P146; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; PIROT S, 1994, EUR J NEUROSCI, V6, P1225, DOI 10.1111/j.1460-9568.1994.tb00621.x; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; RODRIGUEZITHURRALDE D, 1994, J NEUROL SCI, V124, P52, DOI 10.1016/0022-510X(94)90176-7; Romanides AJ, 1999, NEUROSCIENCE, V92, P97, DOI 10.1016/S0306-4522(98)00747-7; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rupprecht R, 1999, PSYCHOPHARMACOLOGY, V143, P29, DOI 10.1007/s002130050916; SAVOLAINEN K, 1994, NEUROTOXICOLOGY, V15, P493; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; SCHMIDT RH, 1995, J NEUROSURG, V83, P495; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; Stein DG, 1991, J NEUROTRAUM, V8, P281, DOI 10.1089/neu.1991.8.281; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Urani A, 1998, BRAIN RES, V799, P64, DOI 10.1016/S0006-8993(98)00469-7; Wang MD, 2000, ACTA PHYSIOL SCAND, V169, P333, DOI 10.1046/j.1365-201x.2000.00744.x	59	120	125	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2004	22	1					19	31					13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	818NH	WOS:000221251300003	15096691				2022-02-06	
J	Manly, T; Owen, AM; McAvinue, L; Datta, A; Lewis, GH; Scott, SK; Rorden, C; Pickard, J; Robertson, IH				Manly, T; Owen, AM; McAvinue, L; Datta, A; Lewis, GH; Scott, SK; Rorden, C; Pickard, J; Robertson, IH			Enhancing the sensitivity of a sustained attention task to frontal damage: Convergent clinical and functional imaging evidence	NEUROCASE			English	Article						frontal cortex; brain injury; PET; sustained attention	CLOSED HEAD-INJURY; MEMORY; DYSFUNCTION; LOCALIZATION; SUPPRESSION; DEFICITS; LESIONS	Despite frequent reports of poor concentration following traumatic brain injury, studies have generally failed to find disproportionate time-on-task decrements using vigilance measures in this patient group. Using a rather different definition, neuropsychological and functional imaging research has however linked sustained attention performance to right prefrontal function - a region likely to be compromised by such injuries. These studies have emphasised more transitory lapses of attention during dull and ostensibly unchallenging activities. Here, an existing attention measure was modified to reduce its apparent difficulty or 'challenge'. Compared with the standard task, its capacity to discriminate traumatically head-injured participants from a control group was significantly enhanced. Unlike existing functional imaging studies, that have compared a sustained attention task with a no-task control, in study 2 we used positron emission tomography to contrast the two levels of the same task. Significantly increased blood flow in the dorsolateral region of the right prefrontal cortex was associated with the low challenge condition. While the results are discussed in terms of a frontal system involved in the voluntary maintenance of performance under conditions of low stimulation, alternative accounts in terms of strategy application are considered.	Addenbrookes Hosp, MRC, Cognit & Brain Sci Unit, Cambridge CB2 2QQ, England; Wolfson Brain Imaging Ctr, Cambridge, England; Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; Inst Cognit Neurosci, London, England		Manly, T (corresponding author), Addenbrookes Hosp, MRC, Cognit & Brain Sci Unit, Box 58, Cambridge CB2 2QQ, England.	tom.manly@mrc-cbu.cam.ac.uk	Owen, Adrian M/B-4997-2015; Scott, Sophie K/A-1843-2010	Scott, Sophie K/0000-0001-7510-6297; Rorden, Chris/0000-0002-7554-6142; Robertson, Ian H/0000-0001-8637-561X	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G9439390] Funding Source: Medline; Wellcome TrustWellcome TrustEuropean Commission [090961] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237] Funding Source: UKRI		Benson D F, 1970, Cortex, V6, P19; BOLLER F, 1973, LANCET, V1, P1143; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bor D, 2001, SCAND J PSYCHOL, V42, P217, DOI 10.1111/1467-9450.00232; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; COHEN RM, 1992, EXP BRAIN RES, V92, P165; Cohen RM, 1988, NEUROPSY NEUROPSY BE, V1, P3; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Conkey RC, 1938, ARCH PSYCHOL, P5; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1280, DOI 10.1016/S0028-3932(00)00033-6; de Zubicaray GI, 2000, NEUROPSYCHOLOGIA, V38, P1292, DOI 10.1016/S0028-3932(00)00026-9; Duncan J, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P567; FUSTER JM, 1982, J NEUROSCI, V2, P361; Gansler DA, 1996, BRAIN COGNITION, V30, P194, DOI 10.1006/brcg.1996.0012; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HEILMAN KM, 1987, HDB PHYSL 1, V5, P461; HOWES D, 1975, BRAIN, V98, P317, DOI 10.1093/brain/98.2.317; Lewin JS, 1996, J COMPUT ASSIST TOMO, V20, P695, DOI 10.1097/00004728-199609000-00002; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Petrides M., 1994, HDB NEUROPSYCHOLOGY, P59; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; POSNER MI, 1993, ATTENTION SELECTION, P390; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROA SC, 1997, SCIENCE, V276, P821; Robertson I.H., 2000, CLIN NEUROPSYCHOL, V3, P167; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; SPIKMAN JM, 1996, J CLIN EXPT NEUROPSY, V18, P1; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; STUSS DT, 1989, J NEUROL NEUROSUR PS, V79, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; TECCE JJ, 1972, PSYCHOL BULL, V77, P73, DOI 10.1037/h0032177; TENNANT A, 1995, TRAUMATIC BRAIN INJU, P12; WHITEHEAD R, 1991, J COGNITIVE NEUROSCI, V3, P329, DOI 10.1162/jocn.1991.3.4.329; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; WOODS DL, 1986, NEUROLOGY, V36, P212, DOI 10.1212/WNL.36.2.212; [No title captured]	50	120	120	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	AUG	2003	9	4					340	349		10.1076/neur.9.4.340.15553			10	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	707YT	WOS:000184538100006	12925947				2022-02-06	
J	Levin, HS; Boake, C; Song, J; McCauley, S; Contant, C; Diaz-Marchan, P; Brundage, S; Goodman, H; Kotrla, KJ				Levin, HS; Boake, C; Song, J; McCauley, S; Contant, C; Diaz-Marchan, P; Brundage, S; Goodman, H; Kotrla, KJ			Validity and sensitivity to change of the Extended Glasgow Outcome Scale in mild to moderate traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						Extended Glasgow Outcome Scale; traumatic brain injury	SEVERE HEAD-INJURY; DISABILITY; LONG	Using a structured outcome interview, this study addressed the validity and sensitivity to change of the Glasgow Outcome Scale (GOS) and the Extended GOS (GOSE) in a prospective study of patients who sustained mild (n = 30) to moderate (n = 13) traumatic brain injury (TBI) or general trauma (n = 44), The patients were recruited from the emergency center or inpatient units of Ben Taub General Hospital and invited to participate in follow-up examinations at 3 and 6 months. Using a series of functional outcome measures, assessment of affective status, and neuropsychological tests as criteria, the validity of the GOSE generally exceeded the GOS, Analysis of the outcome data for the patients who completed both the 3-month and 6-month assessments disclosed that the GOSE was more sensitive to change than the GOS, Comparison of the 3-month outcome data disclosed that the GOSE and GOS scores did not differ for the TBI and general trauma groups, These findings lend further support for utilization of the GOSE in clinical trials when it is based on a structured interview.	Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Phys Med & Rehabil, Houston, TX USA; Vet Affairs Med Ctr, Vet Integrated Serv Network 16, Mental Illness Res Educ & Clin Ctr, Houston, TX 77030 USA		Levin, HS (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 6560 Fannin St,Box 67,Suite 67, Houston, TX 77030 USA.	hlevin@bcm.tmc.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49 CCR612707] Funding Source: Medline		AITKEN RCB, 1969, P ROY SOC MED, V1, pS45; *ASS ADV AUT MED C, 1990, ABB INJ SC; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; GRONWALL D, 1974, LANCET, V2, P605; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Smith, 1973, SYMBOL DIGIT MODALIT; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	31	120	120	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2001	18	6					575	584		10.1089/089771501750291819			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	445ZQ	WOS:000169488800001	11437080				2022-02-06	
J	Matser, JT; Kessels, AGH; Lezak, MD; Troost, J				Matser, JT; Kessels, AGH; Lezak, MD; Troost, J			A dose-response relation of headers and concussions with cognitive impairment in professional soccer players	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							BRAIN; INJURY; SPORTS	The purpose of this study was to determine the effects of headers and concussions on cognitive impairment in professional soccer players. A group of 84 active professional soccer players from several premier league soccer clubs underwent neuropsychological evaluations. The dose-response relation between the number of headers in one professional season and the number of soccer-related concussions on cognitive functioning was investigated. It was found that the number of headers in one season was related to poorer results on tests measuring focused attention and visual / verbal memory. Soccer-related concussions were related to poorer results on tests measuring sustained attention and visuoperceptual processing. The findings suggest that headers as well as concussions separately contribute to cognitive impairment.	Erasmus Univ, Dept Anat, Rotterdam, Netherlands; Univ Hosp Maastricht, Res Unit Patient Care, Maastricht, Netherlands; Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA; Univ Hosp Maastricht, Dept Neurol, Maastricht, Netherlands		Matser, JT (corresponding author), St Anna Hosp, Dept Psychol Med, Postbus 90, NL-5660 AB Geldrop, Netherlands.						American Academy of Pediatrics, 1988, PHYSICIAN SPORTSMED, V16, P165; Autti T, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63019-X; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BOUMA A, 1996, HDB NEUROPSYCHOLOGIS, P2; Deelman B, 1980, NEUROPSYCHOLOGIE NED; Golden CJ, 1978, STROOP COLOR WORD TE; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Keller D., 1979, LEISTUNGSSPORT, V9, P394; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Luteyn, 1966, DUTCH J PSYCHOL, V2, P675; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Raven J. C., 1960, GUIDE STANDARD PROGR; SANFORD W, 1985, APPL LINEAR REGRESSI, P76; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Spreen O, 1991, COMPENDIUM NEUROPSYC; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Van De Loo L., 1956, TIJIKSCHRIFT PSYCHOL, V2, P33; VANDERVLUGT H, 1979, LATERALISATIES HERSE; VONSCHNEIDER PG, 1975, SPORTARTZ SPORTMEDIZ, V26, P222; Wechsler D, 1974, WECHSLER MEMORY SCAL; Wechsler D., 1981, WAIS R MANUAL; WITOL A, 1994, ARCH CLIN NEUROPSYCH, V9, P104	31	120	121	0	22	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2001	23	6					770	774		10.1076/jcen.23.6.770.1029			5	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	535QL	WOS:000174655200006	11910543				2022-02-06	
J	Koo, DDH; Welsh, KI; McLaren, AJ; Roake, JA; Morris, PJ; Fuggle, SV				Koo, DDH; Welsh, KI; McLaren, AJ; Roake, JA; Morris, PJ; Fuggle, SV			Cadaver versus living donor kidneys: Impact of donor factors on antigen induction before transplantation	KIDNEY INTERNATIONAL			English	Article; Proceedings Paper	Forefronts in Nephrology In and Out of Control - The Regulation of Renal Cell Growth	JUN 13-16, 1998	JACKSON HOLE, WYOMING	Int Soc Nephrol		adhesion molecules; rejection; renal transplantation; cadaver organ donors; allografts	RENAL-ALLOGRAFT REJECTION; CELL-ADHESION MOLECULES; CLASS-II ANTIGENS; MONOCLONAL-ANTIBODY; BRAIN-DEATH; E-SELECTIN; EPITHELIAL-CELLS; P-SELECTIN; EXPRESSION; LEUKOCYTE	Background. It is widely recognized that living-related donor (LRD) renal allografts have a higher overall graft survival than cadaver donor transplants. We tested the hypothesis that part of this is attributable to LRD kidneys being obtained under optimal conditions from healthy donors, whereas cadaveric kidneys may have experienced injury as a result of inflammatory events around the time of brain death. Methods. We have performed a comparative immunohistochemical analysis of pretransplant donor biopsies from cadaveric (N = 65) and LRD (N = 29) kidneys to determine any differences that may predispose them to subsequent damage. Cryostat sections were stained with antibodies to leukocytes, adhesion molecules, and human leukocyte antigen (HLA)-DR antigens, and the expression was assessed semiquantitatively. Results. High levels of endothelial E-selectin and proximal tubular expression of HLA-DR antigens, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 were detected in biopsies from cadaveric kidneys, whereas expression of these markers was markedly reduced in LRD kidneys. High levels of tubular antigen expression were significantly associated with traumatic death, prolonged ventilation, and episodes of infection in cadaver donors. Furthermore, the expression of pretransplant tubular antigens in cadaver donor kidneys was significantly associated with early acute rejection following transplantation, suggesting that such kidneys are predisposed to subsequent immune-mediated attack following transplantation. Conclusions. These results may explain, in part, the superior outcome of LRD allografts compared with cadaver renal allografts.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; Univ Oxford, John Radcliffe Hosp, Oxford Transplant Ctr, Oxford OX3 9DU, England		Fuggle, SV (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England.						ABBASSI O, 1993, J CLIN INVEST, V92, P2719, DOI 10.1172/JCI116889; AMADO JA, 1995, METABOLISM, V44, P812, DOI 10.1016/0026-0495(95)90198-1; Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; BEVERLEY PCL, 1981, EUR J IMMUNOL, V11, P329, DOI 10.1002/eji.1830110412; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BISHOP GA, 1989, KIDNEY INT, V36, P1078, DOI 10.1038/ki.1989.303; BROCKMEYER C, 1993, TRANSPLANTATION, V55, P610; CECKA JM, 1994, CLIN TRANSPLANT, V8, P324; CECKA JM, 1996, TRANSPLANT REV, V10, P216; DALCHAU R, 1980, EUR J IMMUNOL, V10, P737, DOI 10.1002/eji.1830101003; FAULL RJ, 1989, TRANSPLANTATION, V48, P226, DOI 10.1097/00007890-198908000-00009; FUGGLE SV, 1986, TRANSPLANTATION, V42, P144, DOI 10.1097/00007890-198608000-00008; Fuggle SV, 1998, TRANSPLANTATION, V65, P763, DOI 10.1097/00007890-199803270-00001; FUGGLE SV, 1993, TRANSPLANTATION, V55, P117, DOI 10.1097/00007890-199301000-00022; FUGGLE SV, 1987, TRANSPLANTATION, V44, P214, DOI 10.1097/00007890-198708000-00008; GRUNDMANN R, 1981, TRANSPLANTATION, V32, P184, DOI 10.1097/00007890-198109000-00003; Guesde R, 1998, LANCET, V352, P1178, DOI 10.1016/S0140-6736(98)05456-7; HASHEMI S, 1993, J CELL PHYSIOL, V154, P496, DOI 10.1002/jcp.1041540307; Herijgers P, 1996, TRANSPLANTATION, V62, P330, DOI 10.1097/00007890-199608150-00005; HILL PA, 1995, KIDNEY INT, V47, P1383, DOI 10.1038/ki.1995.194; Hirschl MM, 1996, NEPHROL DIAL TRANSPL, V11, P173; HOGG N, 1984, IMMUNOLOGY, V53, P753; JONES JW, 1994, TRANSPLANTATION, V57, P512; JONES RM, 1988, BRIT J SURG, V75, P4, DOI 10.1002/bjs.1800750104; KANWAR S, 1995, BLOOD, V86, P2760; KELLY PMA, 1988, J CLIN PATHOL, V41, P510, DOI 10.1136/jcp.41.5.510; KIRBY JA, 1993, KIDNEY INT, V43, pS124; Koo DDH, 1998, AM J PATHOL, V153, P557, DOI 10.1016/S0002-9440(10)65598-8; Langeron O, 1996, BRIT J ANAESTH, V76, P783, DOI 10.1093/bja/76.6.783; LAWRENCE MB, 1993, J IMMUNOL, V151, P6338; LIN Y, 1992, CLIN EXP IMMUNOL, V90, P111; LIN Y, 1993, CLIN EXP IMMUNOL, V92, P145; Lowell JA, 1996, SURGERY, V119, P538, DOI 10.1016/S0039-6060(96)80264-9; MANUCCI PM, 1990, ANNU REV MED, V41, P55; MANUCCI PM, 1988, BLOOD, V72, P1449; MCEVER RP, 1984, J BIOL CHEM, V259, P9799; MERTES PM, 1994, TRANSPLANTATION, V58, P414, DOI 10.1097/00007890-199408270-00004; Morgan J D, 1994, Transpl Immunol, V2, P326, DOI 10.1016/0966-3274(94)90010-8; MORRIS PJ, 1994, KIDNEY TRANSPLANTATI, P504; Opelz G, 1997, TRANSPLANTATION, V64, P1473, DOI 10.1097/00007890-199711270-00017; PELOSI G, 1986, EUR J ANAESTH, V3, P209; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; RAFTERY MJ, 1989, TRANSPLANTATION, V48, P238, DOI 10.1097/00007890-198908000-00011; SERON D, 1991, NEPHROL DIAL TRANSPL, V6, P917, DOI 10.1093/ndt/6.12.917; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Suzuki MM, 1997, BRIT MED BULL, V53, P854; Takada M, 1998, TRANSPLANTATION, V65, P1533, DOI 10.1097/00007890-199806270-00001; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; THIEL G, 1997, PROCUREMENT PRESERVA, P367; WUN T, 1995, J LAB CLIN MED, V126, P401	50	120	123	0	2	BLACKWELL SCIENCE INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0085-2538			KIDNEY INT	Kidney Int.	OCT	1999	56	4					1551	1559		10.1046/j.1523-1755.1999.00657.x			9	Urology & Nephrology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	237GV	WOS:000082648200063	10504507	Bronze			2022-02-06	
J	Maas, AIR; Steyerberg, EW; Murray, GD; Bullock, R; Baethmann, A; Marshall, LF; Teasdale, GM				Maas, AIR; Steyerberg, EW; Murray, GD; Bullock, R; Baethmann, A; Marshall, LF; Teasdale, GM			Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations	NEUROSURGERY			English	Article						clinical trials; head injury; neuroprotection; outcome; prognosis; statistical analysis	TRAUMATIC SUBARACHNOID HEMORRHAGE; TIRILAZAD MESYLATE; MULTICENTER; NIMODIPINE; GUIDELINES; MANAGEMENT; RELEASE; ADULTS; BRAIN; RAT	AN OVERVIEW OF the results of recent trials of neuroprotective agents in head injury is presented. None of the trials showed efficacy in the general population of patients with a severe head injury. A critical analysis of the possible reasons for this failure is given. Specific attention is focused on the heterogeneity of the patient population, the importance of baseline prognostic indicators, and the problems caused by the distribution of outcome and the dichotomization of these outcomes in the Glasgow Outcome Scale. Recommendations are presented for consideration in the design and analysis of future trials in head injury.	Erasmus Univ, Acad Hosp Rotterdam Dijkzigt, Dept Neurosurg, NL-3015 GD Rotterdam, Netherlands; Erasmus Univ, Ctr Clin Decis Sci, Dept Publ Hlth, NL-3015 GD Rotterdam, Netherlands; Univ Edinburgh, Sch Med, Med Stat Unit, Edinburgh, Midlothian, Scotland; Univ Glasgow, Dept Neurosurg, Glasgow, Lanark, Scotland; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; Univ Munich, Klinikum Grosshadern, Inst Chirurg Forsch, D-8000 Munich, Germany; Univ Calif San Diego, Dept Neurol Surg, San Diego, CA 92103 USA		Maas, AIR (corresponding author), Erasmus Univ, Acad Hosp Rotterdam Dijkzigt, Dept Neurosurg, Dr Molewaterplein 40, NL-3015 GD Rotterdam, Netherlands.		Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Steyerberg, Ewout/0000-0002-7787-0122; Murray, Gordon/0000-0001-9866-4734			Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; BULLOCK R, 1996, J NEUROTRAUM, V13, P643; BULLOCK R, 1994, P 9 INT S ICP ITS RE, P264; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; CHOI SC, 1996, NEUROTRAUMA, P779; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fleishaker JC, 1997, J PHARM SCI, V86, P434, DOI 10.1021/js960410e; Fleishaker Joseph C., 1995, Am J Ther, V2, P553, DOI 10.1097/00045391-199508000-00007; GAIL MH, 1984, BIOMETRIKA, V71, P431; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; HOGAN MJ, 1995, EXP NEUROL, V134, P56, DOI 10.1006/exnr.1995.1036; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KAKARIEKA A, 1997, TRAUMATIC SUBARACHNO; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; Knaus WA, 1996, CRIT CARE MED, V24, P46, DOI 10.1097/00003246-199601000-00010; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; MURRAY GD, IN PRESS ACTA NEUROC; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NISSEN JJ, 1995, J NEUROL NEUROSUR PS, V59, P206; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; Robinson LD, 1991, INT STAT REV, V58, P227; ROBINSON MJ, 1990, CEREBROVAS BRAIN MET, V2, P205; STRAW RN, 1995, PRELIMINARY EFFICACY; TEASDALE GM, IN PRESS ACTA NEUROC; Topol E, 1997, NEW ENGL J MED, V337, P1118; Treasure T, 1998, BRIT MED J, V317, P362; Vollmer DG, 1991, J NEUROSURG S, V75, P37; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Zauner A, 1996, ACT NEUR S, V67, P40	44	120	122	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	1999	44	6					1286	1298		10.1097/00006123-199906000-00076			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	201HB	WOS:000080588400065	10371629				2022-02-06	
J	Abdel-Dayem, HM; Abu-Judeh, H; Kumar, M; Atay, S; Naddaf, S; El-Zeftawy, H; Luo, JQ				Abdel-Dayem, HM; Abu-Judeh, H; Kumar, M; Atay, S; Naddaf, S; El-Zeftawy, H; Luo, JQ			SPECT brain perfusion abnormalities in mild or moderate traumatic brain injury	CLINICAL NUCLEAR MEDICINE			English	Article						SPECT brain perfusion imaging; Tc-99m ECD; Tc-99m HMPAO; traumatic brain injury	HM-PAO-SPECT; HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; CEREBRAL PERFUSION; CT; ATROPHY; ALWAYS	The purpose of this atlas is to present a review of the literature showing the advantages of SPECT brain perfusion imaging (BPI) in mild or moderate traumatic brain injury (TBI) over other morphologic imaging modalities such as x-ray CT or MRI. The authors also present the technical recommendations for SPECT brain perfusion currently practiced at their center. For the radiopharmaceutical of choice, a comparison between early and delayed images using Tc-99m HMPAO and Tc-99m ECD showed that Tc-99m HMPAO is more stable in the brain with no washout over time. Therefore, the authors feel that Tc-99m HMPAO is preferable to Tc-99m ECD. Recommendations regarding standardizing intravenous injection, the acquisition, processing parameters, and interpretation of scans using a ten grade color scale, and use of the cerebellum as the reference organ are presented. SPECT images of 228 patients (age range, 11 to 88; mean, 40.8 years) with mild or moderate TBI and no significant medical history that interfered with the results of the SPECT BP were reviewed. The etiology of the trauma was in the following order of frequency: motor vehicle accidents (45%) followed by blow to the head (36%) and a fall (19%). Frequency of the symptoms was headache (60.9%), memory problems (27.6%), dizziness (26.7%), and sleep disorders (8.7%). Comparison between patients imaged early (<3 months) Versus those imaged delayed (>3 months) from the time of the accident, showed that early imaging detected more lesions (4.2 abnormal lesions per study compared to 2.7 in those imaged more than 3 months after the accident). Of 41 patients who had mild traumatic injury without loss of consciousness and had normal CT, 28 studies were abnormal. Focal areas of hypoperfusion were seen in 77% (176 patients, 612 lesions) of the group of 228 patients. The sites of abnormalities were in the following order: basal ganglia and thalami, 55.2%, frontal lobes, 23.8%, temporal lobes, 13%, parietal, 3.7%, insular and occipital lobes together, 4.6%.	St Vincents Hosp & Med Ctr, Nucl Med Sect, Dept Radiol, New York, NY 10011 USA; New York Med Coll, Valhalla, NY 10595 USA; UNMD, Dept Radiol, Newark, NJ USA		Abdel-Dayem, HM (corresponding author), St Vincents Hosp & Med Ctr, Nucl Med Sect, Dept Radiol, 153 W 11th St, New York, NY 10011 USA.						ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; AbdelDayem HM, 1997, CLIN NUCL MED, V22, P310, DOI 10.1097/00003072-199705000-00007; ABDELDAYEM HM, 1997, J NUCL MED TECH, V25, P141; Alavi A, 1989, J Neuropsychiatry Clin Neurosci, V1, pS45; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Goncalves J M, 1992, Acta Neurochir Suppl (Wien), V55, P11; GRAY BG, 1992, J NUCL MED, V33, P52; ICHISE M, 1994, J NUCL MED, V35, P217; Ichise M, 1997, J NUCL MED, V38, P1253; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; KESTER N, 1993, BRAIN INJURY, V7, P469; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; MASDEU CJ, 1995, J NEUROIMAGING, V5, pS53; Masdeu J C, 1994, J Neuroimaging, V4, P177; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; *NIH, 1994, INT HEAD INJ TASK FO; PARKER R, 1995, J NEUROL ORTH MED S, V16, P118; Parker RS, 1996, NEUROPSYCHOL REV, V6, P135, DOI 10.1007/BF01874895; PARKER RS, 1995, J COGNITIVE REHABILI, V13, P14; PARKER RS, 1994, J NEUROL ORTH MED S, V15, P123; PRAYER L, 1993, ACTA RADIOL, V34, P593; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; SYED GMS, 1992, NUCL MED COMMUN, V13, P811, DOI 10.1097/00006231-199211000-00007; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29	33	120	124	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	MAY	1998	23	5					309	317		10.1097/00003072-199805000-00009			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	ZK831	WOS:000073368100009	9596157				2022-02-06	
J	Levine, B; Stuss, DT; Milberg, WP; Alexander, MP; Schwartz, M; MacDonald, R				Levine, B; Stuss, DT; Milberg, WP; Alexander, MP; Schwartz, M; MacDonald, R			The effects of focal and diffuse brain damage on strategy application: Evidence from focal lesions, traumatic brain injury and normal aging	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Proceedings Paper	Annual Meeting of the American-Psychological-Association	AUG 09-12, 1996	TORONTO, CANADA	Amer Psychol Assoc		executive functioning; strategy application; frontal lobe; traumatic brain injury; aging	FRONTAL-LOBE LESIONS; CLOSED-HEAD-INJURY; SPATIAL WORKING-MEMORY; CARD SORTING TEST; SUSTAINED ATTENTION; CORTEX; AGE; BEHAVIOR; COMA; DISTURBANCE	A new test of strategy application was designed to be relatively free of the constraints that limit the standard neuropsychological assessment of supervisory abilities. The validity of the test was assessed in 3 samples of participants with varying degrees of supervisory deficits and frontal systems dysfunction: focal frontal lesions, traumatic brain injury (TBI), and normal aging. Inefficient strategy application varied systematically across the 3 groups and was not due to extraneous factors such as forgetting the test instructions. Previous case studies have emphasized strategy application deficits in the face of normal neuropsychological test performance. In this study, it was shown that strategically impaired participants from a consecutive series can include those both with and without deficient neuropsychological test performance. When neuropsychological impairment was present, it was greatest on executive functioning tasks. Among participants with nonstrategic performance, there was evidence for a dissociation of knowledge from action. This finding was not specific to focal frontal lesions. A number of supervisory processes contributing to strategy application were identified. Exploratory analyses indicated differential effects of lesion location on these processes, especially inferior medial frontal and right hemisphere lesions. Overall, the results supported the use of unstructured tasks in the assessment of supervisory abilities.	Baycrest Ctr Geriatr Care, Rotman Res Inst, N York, ON M6A 2E1, Canada; Univ Toronto, Toronto, ON, Canada; Harvard Univ, Sch Med, Dept Psychiat, W Roxbury, MA USA; Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, W Roxbury, MA USA; Boston VAMC, Memory Disorders Res Ctr, Boston, MA USA; Harvard Univ, Sch Med Neurol, Boston, MA USA; Sunnybrook Hlth Sci Ctr, Dept Neurosurg, Toronto, ON M4N 3M5, Canada		Levine, B (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, N York, ON M6A 2E1, Canada.	blevine@rotman-baycrest.on.ca	Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Milberg, William/0000-0002-6078-7066			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERT MS, 1990, PSYCHOL AGING, V5, P94, DOI 10.1037/0882-7974.5.1.94; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Army Individual Test Battery, 1944, MAN DIR SCOR; Baddeley A.D., 1986, WORKING MEMORY; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benson D.F., 1986, FRONTAL LOBES; Blom G, 1958, STAT ESTIMATES TRANS; Cabeza R, 1997, J NEUROSCI, V17, P391; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; COFFEY CE, 1992, NEUROLOGY, V42, P527, DOI 10.1212/WNL.42.3.527; COURVILLE CB, 1937, PATHOLOGY CENTRAL NE; CRAIK FIM, 1987, PSYCHOL AGING, V2, P79, DOI 10.1037/0882-7974.2.1.79; CREASEY H, 1985, ANN NEUROL, V17, P2, DOI 10.1002/ana.410170103; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; Damasio H., 1989, LESION ANAL NEUROPSY; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FLOOD DG, 1988, NEUROBIOL AGING, V9, P453, DOI 10.1016/S0197-4580(88)80098-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; GOLDBERG E, 1981, BRAIN LANG, V14, P144, DOI 10.1016/0093-934X(81)90072-9; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; GUR RC, 1987, ARCH GEN PSYCHIAT, V44, P617; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; HASLAM C, 1995, NEUROPSYCHOLOGY, V9, P599, DOI 10.1037/0894-4105.9.4.599; Heaton PDRK., 1993, WISCONSIN CARD SORTI; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Kaplan E, 1983, BOSTON NAMING TEST; KARNATH HO, 1991, NEUROPSYCHOLOGIA, V29, P271, DOI 10.1016/0028-3932(91)90042-7; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; KNIGHT RT, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P139; KONOW A, 1970, NEUROPSYCHOLOGIA, V8, P489, DOI 10.1016/0028-3932(70)90044-8; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVINE B, 1995, J CLIN EXP NEUROPSYC, V17, P740, DOI 10.1080/01688639508405164; Levine B, 1997, NEUROPSYCHOLOGY, V11, P367, DOI 10.1037/0894-4105.11.3.367; LURIA AR, 1981, HIGHER CORTICAL FUNC; LURIA AR, 1973, WORKING BRAIN INTRO, P187; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Milner B, 1963, ARCH NEUROL-CHICAGO, V9, P100, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; Miotto EC, 1996, CORTEX, V32, P613, DOI 10.1016/S0010-9452(96)80034-7; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; PODELL K, 1995, J NEUROPSYCH CLIN N, V7, P491; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Scheerer M., 1941, PSYCHOL MONOGRAPHS, P53; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHALLICE T, 1993, ATTENTION SELECTION, P00171; Spreen O, 1991, COMPENDIUM NEUROPSYC; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 1996, PSYCHOL AGING, V11, P387, DOI 10.1037/0882-7974.11.3.387; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; STUSS DT, 1994, HDB NEUROPSYCHOLOGY, P149; TEASDALE G, 1974, LANCET, V2, P81; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, P125; Wechsler D, 1985, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; WOODS DL, 1986, NEUROLOGY, V36, P212, DOI 10.1212/WNL.36.2.212	92	120	120	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	1998	4	3					247	264		10.1017/S1355617798002471			18	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	103FA	WOS:000075146400003	9623000				2022-02-06	
J	DENNIS, M; BARNES, MA				DENNIS, M; BARNES, MA			KNOWING THE MEANING, GETTING THE POINT, BRIDGING THE GAP, AND CARRYING THE MESSAGE - ASPECTS OF DISCOURSE FOLLOWING CLOSED HEAD-INJURY IN CHILDHOOD AND ADOLESCENCE	BRAIN AND LANGUAGE			English	Article											DENNIS, M (corresponding author), HOSP SICK CHILDREN,DEPT PSYCHOL,DUNDAS SUITE,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.						ABELSON RP, 1981, AM PSYCHOL, V36, P715, DOI 10.1037/0003-066X.36.7.715; ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; ANDREWS J, 1986, COMMUN COGNITION, V19, P281; ASSAL G, 1973, NEUROCHIRURGIE, V19, P399; Baddeley A.D., 1987, WORKING MEMORY; BOLLER F, 1979, AUDITORY COMPREHENSI; Bowey J., 1984, METALINGUISTIC AWARE, V15, P73; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; COMETA MS, 1978, CHILD DEV, V49, P649, DOI 10.1111/j.1467-8624.1978.tb02365.x; DENNIS M, 1980, LANGUAGE DEV APHASIA, P45; DENNIS M, 1990, DISCOURSE ABILITY BR, P199; DENNIS M, 1989, CLIN NEUROPSYCHOL, V3, P203; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1985, SPEECH LANGUAGE EVAL, P71; GADDES WH, 1975, BRAIN LANG, V2, P257, DOI 10.1016/S0093-934X(75)80070-8; GAIDOLFI E, 1980, ITAL J NEUROL SCI, V1, P65; GLUCKSBERG S, 1989, METAPHOR SYMB ACT, V4, P125, DOI 10.1207/s15327868ms0403_2; GOLDMAN R, 1974, GOLDMANFRISTOEWOODCO; Guttmann E, 1942, BRAIN, V65, P205, DOI 10.1093/brain/65.2.205; HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2; Holland A., 1982, CLIN APH P C, P345; JOHNSON J, 1989, J EXP CHILD PSYCHOL, V48, P1, DOI 10.1016/0022-0965(89)90038-6; JONES J, 1989, LEARN DISABILITY Q, V12, P251, DOI 10.2307/1510208; Keil F, 1989, SEMANTIC CONCEPTUAL; KEIL FC, 1986, COGNITIVE DEV, V1, P73, DOI 10.1016/S0885-2014(86)80024-7; KEYSAR B, 1989, J MEM LANG, V28, P375, DOI 10.1016/0749-596X(89)90017-X; KOGAN N, 1980, MONOGR SOC RES CHILD, V45, P1, DOI 10.2307/1165832; LEVIN HS, 1979, CHILD BRAIN, V5, P281; MACKAY DG, 1970, ADV PSYCHOLINGUIST, P76; MCCLELLAND JL, 1987, ATTENTION PERFORM, V12, P3; Miller GA, 1993, METAPHOR THOUGHT, P357, DOI DOI 10.1017/CBO9781139173865.019; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; MISTLERLACHMAN JL, 1972, J VERB LEARN VERB BE, V11, P614, DOI 10.1016/S0022-5371(72)80045-8; NIEBERGALL G, 1974, Z KINDER JUGENDPSYCH, V2, P1; OELSCHLAEGER ML, 1974, J COMMUN DISORD, V9, P281; Olson D., 1983, WRITING FOCUS, P291; OLSON DR, 1988, METAPHOR SYMB ACT, V3, P215, DOI 10.1207/s15327868ms0304_2; ORTONY A, 1979, PSYCHOL REV, V86, P161, DOI 10.1037/0033-295X.86.3.161; PALERMO DS, 1989, ADV CHILD DEV BEHAV, V21, P269, DOI 10.1016/S0065-2407(08)60290-6; SATZ P, 1981, ACQUIRED APHASIA, P399; Schank R, 1977, SCRIPTS PLANS GOALS; Schank RC, 1982, DYNAMIC MEMORY; SCHANK RC, 1989, CURR CONTENTS, V38, P14; Spreen O., 1969, NEUROSENSORY CTR COM; SWINNEY DA, 1979, J VERB LEARN VERB BE, V18, P645, DOI 10.1016/S0022-5371(79)90355-4; THOMPSON JG, 1985, CHILD DEV, V56, P1134, DOI 10.1111/j.1467-8624.1985.tb00182.x; VANDONGEN HR, 1977, CORTEX, V13, P131, DOI 10.1016/S0010-9452(77)80004-X; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1974, WECHSLER INTELLIGENC; Wiig E. H., 1989, TEST LANGUAGE COMPET; Wiig E. H., 1988, NEUROPSYCHOLOGICAL S, P186; WIIG EH, 1978, PERCEPT MOTOR SKILL, V46, P959, DOI 10.2466/pms.1978.46.3.959; Winner E., 1988, POINT WORDS CHILDREN; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; YUILL N, 1989, BRIT J PSYCHOL, V80, P351, DOI 10.1111/j.2044-8295.1989.tb02325.x	55	120	120	1	4	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0093-934X			BRAIN LANG	Brain Lang.	OCT	1990	39	3					428	446		10.1016/0093-934X(90)90149-B			19	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	EM337	WOS:A1990EM33700006	2285861				2022-02-06	
J	Kenney, K; Amyot, F; Haber, M; Pronger, A; Bogoslovsky, T; Moore, C; Diaz-Arrastia, R				Kenney, Kimbra; Amyot, Franck; Haber, Margalit; Pronger, Angela; Bogoslovsky, Tanya; Moore, Carol; Diaz-Arrastia, Ramon			Cerebral Vascular Injury in Traumatic Brain Injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic cerebral vascular injury (TCVI); Traumatic brain injury (TBI); Neurovascular unit (NVU); Cerebrovascular reactivity (CVRx); Cerebral microvasculature; Microvascular injury; Cerebral blood flow (CBF); Controlled cortical impact (CCI); Fluid percussion injury (FPI); Chronic traumatic encephalopathy (CTE); Hypercapnia; Single photon emission computed tomography (SPECT); MRI-arterial spin labeling (MRI-ASL); Susceptibility-weighted imaging (SWI); Mild TBI(mTBI); Transcranial Doppler (TCD); Functional Near InfraRed Spectroscopy (fNIRS); Hypercapnia	NEAR-INFRARED SPECTROSCOPY; BIOGENIC-AMINE CONTENT; BLOOD-FLOW; ALZHEIMERS-DISEASE; CEREBROVASCULAR REACTIVITY; MICROVASCULAR ALTERATIONS; TEMPORAL PROFILE; RISK-FACTORS; HEAD TRAUMA; TIME-COURSE	Traumatic cerebral vascular injury (TCVI) is a very frequent, if not universal, feature after traumatic brain injury (TBI). It is likely responsible, at least in part, for functional deficits and TBI-related chronic disability. Because there are multiple pharmacologic and non-pharmacologic therapies that promote vascular health, TCVI is an attractive target for therapeutic intervention after TBI. The cerebral microvasculature is a component of the neurovascular unit (NVU) coupling neuronal metabolism with local cerebral blood flow. The NVU participates in the pathogenesis of TBI, either directly from physical trauma or as part of the cascade of secondary injury that occurs after TBI. Pathologically, there is extensive cerebral microvascular injury in humans and experimental animal, identified with either conventional light microscopy or ultrastructural examination. It is seen in acute and chronic TB!, and even described in chronic traumatic encephalopathy (CTE). Non-invasive, physiologic measures of cerebral microvascular function show dysfunction after TBI in humans and experimental animal models of TBI. These include imaging sequences (MRI-ASL), Transcranial Doppler (TCD), and Near InfraRed Spectroscopy (NIRS). Understanding the pathophysiology of TCVI, a relatively under-studied component of TBI, has promise for the development of novel therapies for TBI. Published by Elsevier Inc.	[Kenney, Kimbra; Amyot, Franck; Haber, Margalit; Pronger, Angela; Bogoslovsky, Tanya; Moore, Carol; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Diaz-Arrastia, R (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	ramon.diaz-arrastia@usuhs.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Chronic Effects of Neurotrauma Consortium; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003138] Funding Source: NIH RePORTER	Work in the authors' laboratory was supported by the Center for Neuroscience and Regenerative Medicine, and by the Chronic Effects of Neurotrauma Consortium. The contents of this paper are solely the responsibility of the authors and do not represent the official views of the Department of Defense or the Center for Neuroscience and Regenerative Medicine.	ADAMS CWM, 1989, J NEUROL NEUROSUR PS, V52, P600, DOI 10.1136/jnnp.52.5.600; Atalay B, 2006, NEUROSURGERY, V59, P1102, DOI 10.1227/01.NEU.0000245605.22817.44; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Cherian L, 2011, J PHARMACOL EXP THER, V337, P451, DOI 10.1124/jpet.110.176602; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; Danaila L, 2013, CHIRURGIA-BUCHAREST, V108, P319; del Zoppo GJ, 2013, STROKE, V44, P263, DOI 10.1161/STROKEAHA.112.653618; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Gardner A.J., 2014, BR J SPORTS MED; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; INOUE M, 1991, J CEREBR BLOOD F MET, V11, P242, DOI 10.1038/jcbfm.1991.56; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Castejon OJ, 2014, FOLIA NEUROPATHOL, V52, P10, DOI 10.5114/fn.2014.41740; Kainerstorfer JM, 2014, ACAD RADIOL, V21, P185, DOI 10.1016/j.acra.2013.10.012; Kassner Andrea, 2004, Top Magn Reson Imaging, V15, P58, DOI 10.1097/00002142-200402000-00006; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kontos H A, 1980, Adv Exp Med Biol, V131, P243; Kurland DB, 2013, PHARMACEUTICALS, V6, P1287, DOI 10.3390/ph6101287; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Marchesi VT, 2014, CELL MOL LIFE SCI, V71, P949, DOI 10.1007/s00018-013-1542-7; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; Matsumura M, 2009, J ATHEROSCLER THROMB, V16, P319, DOI 10.5551/jat.No026; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; Merzagora ACR, 2014, BRAIN IMAGING BEHAV, V8, P446, DOI 10.1007/s11682-013-9258-8; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P200, DOI 10.1038/jcbfm.2010.78; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Olesen J, 1971, STROKE, V2, P519, DOI 10.1161/01.STR.2.6.519; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PAPPIUS HM, 1988, J CEREBR BLOOD F MET, V8, P324, DOI 10.1038/jcbfm.1988.67; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Pifarre P, 2010, J NEUROCHEM, V112, P807, DOI 10.1111/j.1471-4159.2009.06518.x; Pronger AM, 2014, J NEUROTRAUM, V31, pA26; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Roy C S, 1890, J Physiol, V11, P85; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; SOKOLOFF L, 1981, J CEREBR BLOOD F MET, V1, P7, DOI 10.1038/jcbfm.1981.4; Stanimirovic DB, 2012, J CEREBR BLOOD F MET, V32, P1207, DOI 10.1038/jcbfm.2012.25; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang JY, 2014, NEUROBIOL DIS, V68, P91, DOI 10.1016/j.nbd.2014.04.014; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Xing CH, 2012, NEUROL RES, V34, P325, DOI 10.1179/1743132812Y.0000000019; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Yu GX, 2014, J NEUROTRAUM, V31, P739, DOI 10.1089/neu.2013.3187; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320; [No title captured]	121	119	122	2	36	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2016	275		3		SI		353	366		10.1016/j.expneurol.2015.05.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB2ED	WOS:000368320200006	26048614	Bronze			2022-02-06	
J	Babikian, T; Merkley, T; Savage, RC; Giza, CC; Levin, H				Babikian, Talin; Merkley, Tricia; Savage, Ronald C.; Giza, Christopher C.; Levin, Harvey			Chronic Aspects of Pediatric Traumatic Brain Injury: Review of the Literature	JOURNAL OF NEUROTRAUMA			English	Article						academic; chronic outcomes; health outcomes; neurocognitive; pediatric brain injury	CLOSED-HEAD-INJURY; BEHAVIOR RATING INVENTORY; LATERAL FLUID PERCUSSION; CORPUS-CALLOSUM; NEUROCOGNITIVE OUTCOMES; EXECUTIVE FUNCTION; INTRACRANIAL-PRESSURE; INTELLECTUAL ABILITY; UNMYELINATED AXONS; EMOTIONAL PROSODY	Traumatic brain injury (TBI) in children, while the brain is in a state of rapid change and development, can adversely impact their development, their extended environment, and their families. The extant literature has identified several physiological, genetic, and environmental variables that predict outcomes after pediatric TBI; nonetheless, the individual course of recovery and later development of a given child is uniquely shaped by injury-related factors (e.g., nature and extent of the injury itself, the developmental status of the child) as well as a number of personal and family variables (e.g., pre-injury cognitive, genetic, and psychological status of the child, family functioning and resources, coping style). Further, the effects of a brain injury during development may or may not become evident immediately after injury depending on a number of factors. Instead, observing trajectories of development over time may allow for a better understanding of the long-term consequences in many functional domains that interest researchers, clinicians, and families. The current article reviews the chronic aspects of medical/health, cognitive/academic, emotional/behavioral, and family/social outcomes after pediatric TBI, with the goal of providing monitoring and treatment strategies for affected children and their families, as well as serving as a resource for researchers designing studies to better understand this heterogeneous population.	[Babikian, Talin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Babikian, Talin; Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Merkley, Tricia] Barrow Neurol Inst, Dept Clin Neuropsychol, Phoenix, AZ 85013 USA; [Savage, Ronald C.] Int Pediat Brain Injury Soc, Sarasota, FL USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat & Neurosurg, Los Angeles, CA 90095 USA; [Levin, Harvey] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Babikian, T (corresponding author), Univ Calif Los Angeles, Semel Inst, 760 Westwood Plaza,Room C8-746, Los Angeles, CA 90095 USA.	tbabikian@mednet.ucla.edu	Merkley, Tricia L./AAN-2989-2020	Merkley, Tricia/0000-0002-0897-8391			Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barkovich A J, 1993, Top Magn Reson Imaging, V5, P96; Barrett LF, 2007, ANNU REV PSYCHOL, V58, P373, DOI 10.1146/annurev.psych.58.110405.085709; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bell MA, 2004, CHILD DEV, V75, P366, DOI 10.1111/j.1467-8624.2004.00679.x; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Bruce S., 2006, STRATEGIES MANAGING; Cacioppo JT, 1999, CURR DIR PSYCHOL SCI, V8, P133, DOI 10.1111/1467-8721.00031; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2008, J CHILD NEUROL, V23, P486, DOI 10.1177/0883073807309773; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Choe M.C., 2014, P NAT NEUR SOC ANN M, V2014; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cohen J., NAT C STAT LEG ZER 3; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Dennis M, 2010, CORTEX, V46, P1043, DOI 10.1016/j.cortex.2009.10.008; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Finger S, 1999, J Hist Neurosci, V8, P269, DOI 10.1076/jhin.8.3.269.1824; Garth J, 1997, Pediatr Rehabil, V1, P99; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Giedd JN, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-19; Gil AM, 2003, J SCHOOL PSYCHOL, V41, P337, DOI 10.1016/S0022-4405(03)00085-2; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA IP, 2000, BEHAV RATING INVENTO; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldman P S, 1974, Neurosci Res Program Bull, V12, P217; Goodman B., 2013, P AM AC NEUR 65 ANN; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hammond F., 2012, BRAIN INJURY, V10, P6; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Josie KL, 2008, J HEAD TRAUMA REHAB, V23, P357, DOI 10.1097/01.HTR.0000341431.29133.a8; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lajiness-O'Neill R, 2011, APPL NEUROPSYCHOL, V18, P298, DOI 10.1080/09084282.2011.595457; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LEVIN HS, 1992, CURR OPIN NEUROL NEU, V5, P673; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; National Scientific Council on the Developing Child, 2004, 2 NAT SCI COUNC DEV; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Newsome MR, 2012, INT J DEV NEUROSCI, V30, P255, DOI 10.1016/j.ijdevneu.2011.10.008; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Posner M.I., 2013, NEURAL CIRCUIT DEV F; Posner MI, 2013, TRENDS NEUROSCI EDUC, V2, P107, DOI 10.1016/j.tine.2013.09.001; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Savage R.C., 2012, NEUROTRAUMA NEWSLETT; Savage R.C., 2007, P N AM BRAIN INJ SOC; Schmidt AT, 2013, BRAIN INJURY, V27, P1528, DOI 10.3109/02699052.2013.828851; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; U.S. Department of Education OoSEP, 1999, 21 ANN C 1999 WASH D; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P493, DOI 10.1017/S1355617713000398; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	121	119	119	1	24	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2015	32	23			SI		1849	1860		10.1089/neu.2015.3971			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CX4TW	WOS:000365694200003	26414654				2022-02-06	
J	Dham, BS; Hunter, K; Rincon, F				Dham, Bhavpreet S.; Hunter, Krystal; Rincon, Fred			The Epidemiology of Status Epilepticus in the United States	NEUROCRITICAL CARE			English	Article						Status epilepticus; Epidemiology; Incidence; NHDS; National Hospital Discharge Survey	REFRACTORY STATUS EPILEPTICUS; CONVULSIVE STATUS EPILEPTICUS; 1ST EPISODE; SUBARACHNOID HEMORRHAGE; TERM MORTALITY; RISK-FACTORS; MINNESOTA; MORBIDITY; ROCHESTER; PROGNOSIS	To summarize trends in status epilepticus (SE) in the United States by age, race, sex, admission source, disposition, incidence rates, and mortality. Data from US National Hospital Discharge Survey were used from 1979 to 2010 to identify discharges with SE and common etiologies and complications of SE using International Classification of Diseases, 9th Revision, Clinical Modifications codes. Temporal trends in the incidence and in-hospital mortality of SE were examined with respect to age, sex, and race. We identified 760,117 discharges with SE over 32 years. The incidence of SE increased from 3.5 to 12.5/100,000 between 1979 and 2010, without a significant change in in-hospital mortality. Higher incidence, earlier age of onset, and higher mortality were observed among males. Age stratification revealed a "U-shaped" distribution with higher incidence at age < 10 years (14.3/100,000) and age > 50 years (approaching 28.4/100,000). In-hospital mortality, however, was the lowest (2.6 %) at age < 10 years and approached 20.2 % with age a parts per thousand yen80 years. The incidence of SE was higher among blacks (13.7/100,000), compared to whites (6.9/100,000) and other races (7.4/100,000). Mortality, however, was lower among blacks (7.2 %) compared to whites and other races (9.8 and 9.2 %, respectively). Black men had the highest incidence (15.0/100,000), relatively younger age of onset (39.3 years) and the lowest mortality (5.6 %). A net temporal decline in the reported prevalence of epilepsy, central nervous system infections, and traumatic brain injury was noted among SE cohort. The incidence of SE increased nearly fourfold with relatively unchanged mortality. Gender and racial disparities exist in the incidence of SE, and age is an important predictor of mortality.	[Dham, Bhavpreet S.] Cooper Univ Hosp, Dept Neurol, Camden, NJ USA; [Hunter, Krystal] Cooper Univ Hosp, Dept Biostat, Camden, NJ USA; [Rincon, Fred] Thomas Jefferson Univ, Div Crit Care & Neurotrauma, Dept Neurol & Neurol Surg, Philadelphia, PA 19107 USA; [Rincon, Fred] Jefferson Med Coll, Philadelphia, PA 19107 USA		Rincon, F (corresponding author), Thomas Jefferson Univ, Div Crit Care & Neurotrauma, Dept Neurol & Neurol Surg, 909 Walnut St,3rd Floor, Philadelphia, PA 19107 USA.	bhavpreet@hotmail.com; hunter-krystal@cooperhealth.edu; fred.rincon@jefferson.edu		Rincon, Fred/0000-0002-8510-118X			[Anonymous], 1981, Epilepsia, V22, P489; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Cascino GD, 1998, EPILEPSIA, V39, P829, DOI 10.1111/j.1528-1157.1998.tb01176.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chin RFM, 2004, EUR J NEUROL, V11, P800, DOI 10.1111/j.1468-1331.2004.00943.x; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2007, NEUROSURGERY, V61, P4; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Diaz-Arrastia R, 2002, JAMA-J AM MED ASSOC, V287, P2917, DOI 10.1001/jama.287.22.2917; Fountain NB, 2000, EPILEPSIA, V41, pS23, DOI 10.1111/j.1528-1157.2000.tb01521.x; Gastaut H, 1983, Adv Neurol, V34, P15; Hesdorffer DC, 1998, NEUROLOGY, V50, P735, DOI 10.1212/WNL.50.3.735; Holtkamp M, 2005, J NEUROL NEUROSUR PS, V76, P534, DOI 10.1136/jnnp.2004.041947; Kulkarni SC, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-16; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; Logroscino G, 2002, NEUROLOGY, V58, P537, DOI 10.1212/WNL.58.4.537; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Logroscino G, 2001, EPILEPSIA, V42, P1031, DOI 10.1046/j.1528-1157.2001.0420081031.x; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Penberthy LT, 2005, SEIZURE-EUR J EPILEP, V14, P46, DOI 10.1016/j.seizure.2004.06.001; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rincon F, 2013, NEUROCRIT CARE, V19, P95, DOI 10.1007/s12028-012-9793-y; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; United States Census Bureau, 2010, AG SEX COMP; Urtecho J, 2013, CRIT CARE MED, V41, P1853, DOI 10.1097/CCM.0b013e31828a3994; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070; Xian Y, 2011, ANN INTERN MED, V154, P152, DOI 10.7326/0003-4819-154-3-201102010-00004	33	119	123	0	10	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2014	20	3					476	483		10.1007/s12028-013-9935-x			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI7RH	WOS:000337092900018	24519080				2022-02-06	
J	Gotzl, JK; Mori, K; Damme, M; Fellerer, K; Tahirovic, S; Kleinberger, G; Janssens, J; van der Zee, J; Lang, CM; Kremmer, E; Martin, JJ; Engelborghs, S; Kretzschmar, HA; Arzberger, T; Van Broeckhoven, C; Haass, C; Capell, A				Goetzl, Julia K.; Mori, Kohji; Damme, Markus; Fellerer, Katrin; Tahirovic, Sabina; Kleinberger, Gernot; Janssens, Jonathan; van der Zee, Julie; Lang, Christina M.; Kremmer, Elisabeth; Martin, Jean-Jacques; Engelborghs, Sebastiaan; Kretzschmar, Hans A.; Arzberger, Thomas; Van Broeckhoven, Christine; Haass, Christian; Capell, Anja			Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis	ACTA NEUROPATHOLOGICA			English	Article						Frontotemporal lobar degeneration (FTLD); Progranulin (GRN); TDP-43; Neuronal ceroid lipofuscinosis (NCL); Cathepsin D; Lysosome; Neurodegeneration	AMYOTROPHIC-LATERAL-SCLEROSIS; MITOCHONDRIAL ATP SYNTHASE; PROTEIN-DEGRADATION PATHWAYS; TRAUMATIC BRAIN-INJURY; D-DEFICIENT MICE; CATHEPSIN-D; MUTATION CARRIERS; KNOCKOUT MICE; CELL-DEATH; SUBUNIT-C	Heterozygous loss-of-function mutations in the progranulin (GRN) gene and the resulting reduction of GRN levels is a common genetic cause for frontotemporal lobar degeneration (FTLD) with accumulation of TAR DNA-binding protein (TDP)-43. Recently, it has been shown that a complete GRN deficiency due to a homozygous GRN loss-of-function mutation causes neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disorder. These findings suggest that lysosomal dysfunction may also contribute to some extent to FTLD. Indeed, Grn(-/-) mice recapitulate not only pathobiochemical features of GRN-associated FTLD-TDP (FTLD-TDP/GRN), but also those which are characteristic for NCL and lysosomal impairment. In Grn(-/-) mice the lysosomal proteins cathepsin D (CTSD), LAMP (lysosomal-associated membrane protein) 1 and the NCL storage components saposin D and subunit c of mitochondrial ATP synthase (SCMAS) were all found to be elevated. Moreover, these mice display increased levels of transmembrane protein (TMEM) 106B, a lysosomal protein known as a risk factor for FTLD-TDP pathology. In line with a potential pathological overlap of FTLD and NCL, Ctsd(-/-) mice, a model for NCL, show elevated levels of the FTLD-associated proteins GRN and TMEM106B. In addition, pathologically phosphorylated TDP-43 occurs in Ctsd(-/-) mice to a similar extent as in Grn(-/-) mice. Consistent with these findings, some NCL patients accumulate pathologically phosphorylated TDP-43 within their brains. Based on these observations, we searched for pathological marker proteins, which are characteristic for NCL or lysosomal impairment in brains of FTLD-TDP/GRN patients. Strikingly, saposin D, SCMAS as well as the lysosomal proteins CTSD and LAMP1/2 are all elevated in patients with FTLD-TDP/GRN. Thus, our findings suggest that lysosomal storage disorders and GRN-associated FTLD may share common features.	[Goetzl, Julia K.; Mori, Kohji; Fellerer, Katrin; Kleinberger, Gernot; Lang, Christina M.; Haass, Christian; Capell, Anja] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Goetzl, Julia K.] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; [Damme, Markus] Univ Kiel, Dept Biochem, D-20498 Kiel, Germany; [Tahirovic, Sabina; Kremmer, Elisabeth; Arzberger, Thomas; Haass, Christian] German Ctr Neurodegenerat Dis DZNE Munich, D-80336 Munich, Germany; [Kleinberger, Gernot; Janssens, Jonathan; van der Zee, Julie; Van Broeckhoven, Christine] VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, B-2610 Antwerp, Belgium; [Kleinberger, Gernot; Janssens, Jonathan; van der Zee, Julie; Martin, Jean-Jacques; Engelborghs, Sebastiaan; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, B-2610 Antwerp, Belgium; [Kleinberger, Gernot; Haass, Christian] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Kremmer, Elisabeth] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany; [Kretzschmar, Hans A.; Arzberger, Thomas] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Arzberger, Thomas] Univ Munich, Dept Psychiat & Psychotherapy, D-80336 Munich, Germany		Haass, C (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	christian.haass@dzne.lmu.de; anja.capell@dzne.lmu.de	Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Mori, Kohji/AAM-8471-2020	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Mori, Kohji/0000-0003-2629-0723	European Research Council under European UnionEuropean Research Council (ERC) [321366]; Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF)Federal Ministry of Education & Research (BMBF); DFGGerman Research Foundation (DFG)European Commission [RTG1373]; Hans & Ilse Breuer foundation; MetLife Foundation Award; Belgian Science Policy Office Interuniversity Attraction Poles Program; Medical Foundation Queen Elisabeth; Foundation for Alzheimer Research (SAO/FRA); Flemish Government initiated Methusalem Excellence program; Agency for Innovation by Science and Technology (IWT) FlandersInstitute for the Promotion of Innovation by Science and Technology in Flanders (IWT); Research Foundation Flanders (FWO)FWO; University of Antwerp Research Fund; IWTInstitute for the Promotion of Innovation by Science and Technology in Flanders (IWT); London Neurodegenerative Disease Brain Bank and Brains for Dementia Research; Human Brain and Spinal Fluid Resource Center, VA West Los Angeles Healthcare Center, Los Angeles [CA 90073]; NINDS/NIMH, National Multiple Sclerosis Society	We thank Paul Saftig (Christian-Albrechts University of Kiel) for providing the Ctsd knockout mouse strain, Masugi Nishihara (University of Tokyo) for the Grn knockout mouse strain, Konrad Sandhoff (University of Bonn, Kekule-Institut fur Organische Chemie und Biochemie) for the saposin D antibody, Elizabeth Neufeld (University of California Los Angeles) for the SCMAS antibody and Virginia Lee and Alice Chen-Plotkin (University of Pennsylvania) for the TMEM106B antibody clone N2077. We are grateful to Andrea Wenninger-Weinzierl and Brigitte Kraft for excellent technical assistance and to Dorothee Dormann for critical reading of the manuscript and valuable comments. This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No. 321366-Amyloid (advanced grant to C. H.) and the Competence Network for Neurodegenerative Diseases (KNDD) of the Bundesministerium fur Bildung und Forschung (BMBF to C. H.). J.K.G. is supported by the RTG1373 (DFG) and C. M. L. by the Hans & Ilse Breuer foundation. The Antwerp site was in part funded by the MetLife Foundation Award (to C. V. B.), the Belgian Science Policy Office Interuniversity Attraction Poles Program, the Medical Foundation Queen Elisabeth, the Foundation for Alzheimer Research (SAO/FRA), Flemish Government initiated Methusalem Excellence program, the Agency for Innovation by Science and Technology (IWT) Flanders, the Research Foundation Flanders (FWO) and the University of Antwerp Research Fund. We acknowledge the contribution of genetic data by I. Gijselinck and M. Cruts, clinical and pathological data by the neurologists T. Van Langenhove, P. Cras, P.P. De Deyn and immunohistochemical data, autopsy brain samples and sections by the neuropathologist by A. Sieben. We are also grateful for the support by the research nurses at VIB, the personnel at the neurological departments at the Antwerp University Hospital and ZNA Middelheim, the Antwerp Biobank at the Institute Born-Bunge and the Genetic Service Facility at VIB. J.J. receives a Ph.D. fellowship of the IWT. We acknowledge the London Neurodegenerative Disease Brain Bank and Brains for Dementia Research, the Human Brain and Spinal Fluid Resource Center, VA West Los Angeles Healthcare Center, Los Angeles, CA 90073, which is sponsored by NINDS/NIMH, National Multiple Sclerosis Society and the Veterans Affairs West Los Angeles Healthcare Center for providing brain tissue. We thank the Batten Disease Registry, Genetic Services and Specialty Clinical Laboratories, NYS Institute for Basic Research in Developmental Disabilities.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Benussi L, 2008, NEUROBIOL AGING, V29, P427, DOI 10.1016/j.neurobiolaging.2006.10.028; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Brouwers N, 2007, ARCH NEUROL-CHICAGO, V64, P1436, DOI 10.1001/archneur.64.10.1436; Busch JI, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-36; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Elleder M, 1997, ACTA NEUROPATHOL, V93, P379, DOI 10.1007/s004010050629; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Fritchie K, 2009, ACTA NEUROPATHOL, V117, P201, DOI 10.1007/s00401-008-0426-7; Gallagher MD, 2014, ACTA NEUROPATHOL, V127, P407, DOI 10.1007/s00401-013-1239-x; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; HALL NA, 1991, BIOCHEM J, V275, P269, DOI 10.1042/bj2750269; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hiraiwa M, 1997, ARCH BIOCHEM BIOPHYS, V341, P17, DOI 10.1006/abbi.1997.9958; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jabs S, 2008, J NEUROCHEM, V106, P1415, DOI 10.1111/j.1471-4159.2008.05497.x; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Janssens J, 2013, HUM MOL GENET, V22, pR77, DOI 10.1093/hmg/ddt349; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; KLEIN A, 1994, BIOCHEM BIOPH RES CO, V200, P1440, DOI 10.1006/bbrc.1994.1612; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Martin JJ, 1997, ACTA NEUROL BELG, V97, P85; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mukherjee O, 2008, HUM MUTAT, V29, P512, DOI 10.1002/humu.20681; Nakanishi H, 2001, J NEUROSCI, V21, P7526, DOI 10.1523/JNEUROSCI.21-19-07526.2001; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nijssen PCG, 2003, BRAIN PATHOL, V13, P574; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Partanen S, 2008, J NEUROPATH EXP NEUR, V67, P16, DOI 10.1097/nen.0b013e31815f3899; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; TYYNELA J, 1993, FEBS LETT, V330, P8, DOI 10.1016/0014-5793(93)80908-D; Urwin H, 2010, HUM MOL GENET, V19, P2228, DOI 10.1093/hmg/ddq100; van Blitterswijk M, 2014, ACTA NEUROPATHOL, V127, P397, DOI 10.1007/s00401-013-1240-4; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Wang J, 2010, J NEUROCHEM, V112, P1305, DOI 10.1111/j.1471-4159.2009.06546.x; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Yu CE, 2010, ARCH NEUROL-CHICAGO, V67, P161, DOI 10.1001/archneurol.2009.328	87	119	121	1	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JUN	2014	127	6					845	860		10.1007/s00401-014-1262-6			16	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	AH6WO	WOS:000336273100005	24619111				2022-02-06	
J	Denning, JH				Denning, John H.			The Efficiency and Accuracy of The Test of Memory Malingering Trial 1, Errors on the First 10 Items of The Test of Memory Malingering, and Five Embedded Measures in Predicting Invalid Test Performance	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Test of Memory Malingering; Medical Symptom Validity Test; symptom validity testing; Malingering; Veterans; Neuropsychology	SYMPTOM VALIDITY TESTS; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; SELF-REPORTED SYMPTOMS; CLASSIFICATION ACCURACY; TOMM PERFORMANCE; CLINICAL-SAMPLE; RESPONSE BIAS; TEST FAILURE; DISABILITY CLAIMANTS	The current study attempted to improve upon the efficiency and accuracy of one of the most frequently administered measures of test validity, the Test of Memory Malingering (TOMM) by utilizing two short forms (TOMM trial 1 or TOMM1; and errors on the first 10 items of TOMM1 or TOMMe10). In addition, we cross-validated the accuracy of five embedded measures frequently used in malingering research. TOMM1 and TOMMe10 were highly accurate in predicting test validity (area under the curve [AUC] 92 and 87, respectively; TOMM1 40 and TOMMe10 epsilon 1; sensitivities 70 and specificities 90). A logistic regression of five embedded measures showed better accuracy compared with any individual embedded measure alone or in combination (AUC 87). TOMM1 and TOMMe10 provide evidence of greater sensitivity to invalid test performance compared with the standard TOMM administration and the use of regression improved the accuracy of the five embedded cognitive measures.	Alvin C York Vet Affairs Hosp, Tennessee Valley Healthcare Syst, Dept Psychol, Murfreesboro, TN 37129 USA		Denning, JH (corresponding author), Alvin C York Vet Affairs Hosp, Tennessee Valley Healthcare Syst, Dept Psychol, Murfreesboro, TN 37129 USA.	john.denning@va.gov			Department of Veterans Affairs, Veterans Health AdministrationUS Department of Veterans Affairs; Office of Research and Development	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, and Office of Research and Development.	Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Benedict R., 1997, BRIEF VISUOSPATIAL M; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Cohen J., 2013, STAT POWER ANAL BEHA; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Delis D.C., 2000, CALIFORNIA VERBAL LE; Duncan A, 2005, ASSESSMENT, V12, P123, DOI 10.1177/1073191105275512; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gavett BE, 2005, APPL NEUROPSYCHOL, V12, P1, DOI 10.1207/s15324826an1201_1; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gierok SD, 2005, ARCH CLIN NEUROPSYCH, V20, P755, DOI 10.1016/j.acn.2005.04.008; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; GREEN P, 2006, INT J FORENSIC PSYCH, V1, P1; Green P, 2004, GREENS MED SYMPTOM V; Green P., 2007, ASSESSMENT FEIGNED C; Green P.J.E., 2008, MANUAL NONVERBAL MED; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Guilmette TJ, 1996, PERCEPT MOTOR SKILL, V83, P1007, DOI 10.2466/pms.1996.83.3.1007; Gunner JH, 2012, ARCH CLIN NEUROPSYCH, V27, P1, DOI 10.1093/arclin/acr089; Haber AH, 2006, CLIN NEUROPSYCHOL, V20, P524, DOI 10.1080/13854040590967595; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hill S. K., 2003, J FORENSIC NEUROPSYC, P1, DOI [10.1300/J151v03n03_01, DOI 10.1300/J151V03N03_01]; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Horner MD, 2006, INT J NEUROSCI, V116, P1181, DOI 10.1080/00207450500514029; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Jasinski LJ, 2011, CLIN NEUROPSYCHOL, V25, P1415, DOI 10.1080/13854046.2011.630024; Kaufmann PM, 2009, CLIN NEUROPSYCHOL, V23, P1130, DOI 10.1080/13854040903107809; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kutner M.H., 2004, APPL LINEAR REGRESSI, V4th; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lindstrom WA, 2009, ARCH CLIN NEUROPSYCH, V24, P659, DOI 10.1093/arclin/acp071; Locke DEC, 2008, NEUROREHABILITATION, V23, P273; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; McCaffrey R.J., 2003, J FORENSIC NEUROPSYC, V3, P45, DOI [https://doi.org/10.1300/J151v03n03_03, DOI 10.1300/J151V03N03_03]; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morel KR, 2009, ARCH CLIN NEUROPSYCH, V24, P635, DOI 10.1093/arclin/acp062; Morgan J. E., 2009, NEUROPSYCHOLOGY MALI; Musso MW, 2011, ARCH CLIN NEUROPSYCH, V26, P756, DOI 10.1093/arclin/acr078; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Pella RD, 2012, ARCH CLIN NEUROPSYCH, V27, P45, DOI 10.1093/arclin/acr090; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; SCHROEDER R, 2011, ARCH CLIN NEUROPSYCH, V26, P564; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Shandera AL, 2010, PSYCHOL ASSESSMENT, V22, P50, DOI 10.1037/a0016585; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderslice-Barr JL, 2011, APPL NEUROPSYCHOL, V18, P34, DOI 10.1080/09084282.2010.523377; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weinborn M, 2003, J CLIN EXP NEUROPSYC, V25, P979, DOI 10.1076/jcen.25.7.979.16481; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Whiteside DM, 2009, CLIN NEUROPSYCHOL, V23, P523, DOI 10.1080/13854040802389169; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Yanez YT, 2006, ARCH CLIN NEUROPSYCH, V21, P161, DOI 10.1016/j.acn.2005.07.009	102	119	119	0	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2012	27	4					417	432		10.1093/arclin/acs044			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	944JX	WOS:000304198300005	22543569	Bronze			2022-02-06	
J	Zhu, YG; Nwabuisi-Heath, E; Dumanis, SB; Tai, LM; Yu, CJ; Rebeck, GW; Ladu, MJ				Zhu, Yuangui; Nwabuisi-Heath, Evelyn; Dumanis, Sonya B.; Tai, Leon M.; Yu, Chunjiang; Rebeck, G. William; Ladu, Mary Jo			APOE genotype alters glial activation and loss of synaptic markers in mice	GLIA			English	Article						Alzheimer's disease; microglia; astrocyte; inflammation; cytokine; synaptic protein loss; lipopolysaccharide	TARGETED-REPLACEMENT MICE; SYSTEM INFLAMMATORY RESPONSE; TRAUMATIC BRAIN-INJURY; INNATE IMMUNE-RESPONSE; APOLIPOPROTEIN-E GENE; N-TERMINAL KINASE; ALZHEIMERS-DISEASE; COMMON VARIANTS; TYPE-4 ALLELE; IN-VIVO	The ?4 allele of the Apolipoprotein E (APOE) gene is the strongest genetic risk factor for late-onset Alzheimer's disease (AD), and affects clinical outcomes of chronic and acute brain damages. The mechanisms by which apoE affect diverse diseases and disorders may involve modulation of the glial response to various types of brain damage. We examined glial activation in a mouse model where each of the human APOE alleles are expressed under the endogenous mouse APOE promoter, as well as in APOE knock-out mice. APOE4 mice displayed increased glial activation in response to intracerebroventricular lipopolysaccharide (LPS) compared to APOE2 and APOE3 mice by several measures. There were higher levels of microglia/macrophage, astrocytes, and invading T-cells after LPS injection in APOE4 mice. APOE4 mice also displayed greater and more prolonged increases of cytokines (IL-1 beta, IL-6, TNF-a) than APOE2 and APOE3 mice. We found that APOE4 mice had greater synaptic protein loss after LPS injection, as measured by three markers: PSD-95, drebin, and synaptophysin. In all assays, APOE knock-out mice responded similar to APOE4 mice, suggesting that the apoE4 protein may lack anti-inflammatory characteristics of apoE2 and apoE3. Together, these findings demonstrate that APOE4 predisposes to inflammation, which could contribute to its association with Alzheimer's disease and other disorders. (c) 2012 Wiley Periodicals, Inc.	[Zhu, Yuangui; Nwabuisi-Heath, Evelyn; Tai, Leon M.; Yu, Chunjiang; Ladu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Zhu, Yuangui] Fujian Med Univ, Union Hosp, Dept Neurol, Fuzhou, Fujian, Peoples R China; [Dumanis, Sonya B.; Rebeck, G. William] Georgetown Univ, Dept Neurosci, Washington, DC USA		Ladu, MJ (corresponding author), Univ Illinois, Dept Anat & Cell Biol, 808 S Wood St,CME Rm 578,M-C 512, Chicago, IL 60612 USA.	mladu@uic.edu	Yu, Chunjiang/E-9419-2012; Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X; LaDu, Mary Jo/0000-0003-2141-1450; Dumanis, Sonya/0000-0002-3345-9497	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 AG030128, P01 AG030128-03S1]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG030128] Funding Source: NIH RePORTER	Grant sponsor: NIH; Grant numbers: P01 AG030128, P01 AG030128-03S1.	Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Egensperger R, 1998, BRAIN PATHOL, V8, P439; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fukaya M, 2000, J COMP NEUROL, V426, P572; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Korwek KM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-21; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 1998, NEUROREPORT, V9, P615, DOI 10.1097/00001756-199803090-00010; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Li FQ, 2010, J PHARMACOL EXP THER, V334, P106, DOI 10.1124/jpet.110.167882; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; Maezawa I, 2006, FASEB J, V20, P797, DOI 10.1096/fj.05-5423fje; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; Ophir G, 2005, NEUROBIOL DIS, V20, P709, DOI 10.1016/j.nbd.2005.05.002; Ophir G, 2003, NEUROBIOL DIS, V12, P56, DOI 10.1016/S0969-9961(02)00005-0; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pocivavsek A, 2009, BIOCHEM BIOPH RES CO, V387, P516, DOI 10.1016/j.bbrc.2009.07.048; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; REBECK GW, 1994, NEUROLOGY, V44, P1513, DOI 10.1212/WNL.44.8.1513; REBECK GW, 1993, NEURON, V11, P575; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Trommer BL, 2004, NEUROREPORT, V15, P2655, DOI 10.1097/00001756-200412030-00020; Tukhovskaya EA, 2009, J NEUROSCI RES, V87, P677, DOI 10.1002/jnr.21874; Varvel NH, 2009, J CLIN INVEST, V119, P3692, DOI 10.1172/JCI39716; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Wang CS, 2005, NEUROBIOL DIS, V18, P390, DOI 10.1016/j.nbd.2004.10.013; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yip Agustin G, 2005, BMC Geriatr, V5, P2, DOI 10.1186/1471-2318-5-2	53	119	122	0	13	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0894-1491			GLIA	Glia	APR	2012	60	4					559	569		10.1002/glia.22289			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	888MC	WOS:000300006700004	22228589	Green Accepted			2022-02-06	
J	Armistead-Jehle, P				Armistead-Jehle, Patrick			Symptom Validity Test Performance in U. S. Veterans Referred for Evaluation of Mild TBI	APPLIED NEUROPSYCHOLOGY			English	Article						mild TBI; MSVT; Symptom Validity Testing	POSTTRAUMATIC-STRESS-DISORDER; PSYCHOGENIC NONEPILEPTIC SEIZURES; BASE RATES; NEUROPSYCHOLOGICAL TESTS; DISABILITY INCENTIVES; BRAIN-INJURY; EXAGGERATION; CLAIMANTS; FAILURE; FIBROMYALGIA	The current study examined Medical Symptom Validity Test (MSVT) performance in U.S. veterans referred for evaluation of mild traumatic brain injury (TBI) after scoring positive on the Veterans Health Administration (VHA) TBI screening measures. Fifty-eight percent of the sample scored below the MSVT cut scores on subtests more sensitive to effort than to neurological insult. There were no differences among those who did and those who did not pass the MSVT as a function of gender, age, education, ethnicity, previous posttraumatic stress disorder or substance use disorder diagnoses, or Personality Assessment Inventory validity scales designed to measure negative impression management. A higher number of those who were service connected and previously diagnosed with a depressive condition failed the measure at a higher rate than those who were not. These results are discussed in relation to the specific nature of VHA patient populations.	[Armistead-Jehle, Patrick] Pacific Isl Hlth Care Syst, Dept Vet Affairs, Dept Mental Hlth, Honolulu, HI USA		Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	patrick.jehle@armedd.army.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Gervais R, 1999, ARCH CLIN NEUROPSYCH, V14, P746, DOI 10.1016/S0887-6177(99)80247-9; Gervais R, 2000, ARCH CLIN NEUROPSYCH, V15, P841, DOI 10.1016/S0887-6177(00)80347-9; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Gill David, 2007, Med Leg J, V75, P64; Gold PB, 1999, J NERV MENT DIS, V187, P680, DOI 10.1097/00005053-199911000-00005; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2000, ARCH CLIN NEUROPSYCH, V15, P841, DOI 10.1016/S0887-6177(00)80346-7; Green P., 2003, GREENS WORD MEMORY T; Green P, 1996, MANUAL COMPUTERIZED; Green P, 2004, GREENS MED SYMPTOM V; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; HOWE LL, 2008, CLIN NEUROPSYCHOL, V21, P1; IVERSON G, 1999, J COGN REHABIL, V17, P2; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Kurtz JE, 2007, J PERS ASSESS, V88, P1, DOI 10.1080/00223890709336828; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey, 1991, PERSONALITY ASSESSME; Morey L. C., 2003, ESSENTIALS PAI ASSES; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tanielian T., 2008, INVISIBLE WOUNDS WAR; WHITNEY AW, 2009, ARCH CLIN NEUROPSYCH, V24, P145; Williamson David J., 2003, Epilepsia, V44, P13; Williamson DJ, 2004, EPILEPSIA, V45, P179	42	119	119	1	8	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	1					52	59	PII 919154983	10.1080/09084280903526182			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	554JY	WOS:000274432500007	20146122				2022-02-06	
J	Baumann, CR; Bassetti, CL; Valko, PO; Haybaeck, J; Keller, M; Clark, E; Stocker, R; Tolnay, M; Scammell, TE				Baumann, Christian R.; Bassetti, Claudio L.; Valko, Philipp O.; Haybaeck, Johannes; Keller, Morten; Clark, Erika; Stocker, Reto; Tolnay, Markus; Scammell, Thomas E.			Loss of Hypocretin (Orexin) Neurons With Traumatic Brain Injury	ANNALS OF NEUROLOGY			English	Article							CLOSED HEAD INJURY; PARKINSONS-DISEASE; NARCOLEPSY; LESIONS	Chronic, daytime sleepiness is a major, disabling symptom for many patients with traumatic brain injury (TBI), but thus far, its etiology is not Well understood. Extensive loss of the hypothalamic neurons that produce the wake-promoting neuropeptide hypocretin (orexin) causes the severe sleepiness of narcolepsy, and partial loss of these cells may contribute to the sleepiness of Parkinson disease and other disorders. We have found that the number of hypocretin neurons is significantly reduced in patients with severe TBI. This observation highlights the often overlooked hypothalamic injury in TBI and provides new insights into the causes of chronic sleepiness in patients with TBI.	[Baumann, Christian R.; Bassetti, Claudio L.; Valko, Philipp O.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Baumann, Christian R.; Clark, Erika; Scammell, Thomas E.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Haybaeck, Johannes; Tolnay, Markus] Univ Zurich Hosp, Dept Neuropathol, CH-8091 Zurich, Switzerland; [Keller, Morten] Univ Zurich Hosp, Dept Forens Med, CH-8091 Zurich, Switzerland; [Stocker, Reto] Univ Zurich Hosp, Dept Surg Intens Care, CH-8091 Zurich, Switzerland		Baumann, CR (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	christian.baumann@usz.ch	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Baumann, Christian/0000-0003-3417-1978	Foerderungskredit of the University of Zurich, Switzerland; Schweizerischer Versicherungsverband (SW), Switzerland; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH062589]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH062589] Funding Source: NIH RePORTER	This study was supported by the Foerderungskredit of the University of Zurich, Switzerland (Ch.B.), the Schweizerischer Versicherungsverband (SW), Switzerland (Ch.B.), and National Institutes of Health grant MH062589 (T.S.).	Adamantidis A, 2008, CELL MOL LIFE SCI, V65, P1475, DOI 10.1007/s00018-008-7521-8; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Baumann CR, 2008, REGUL PEPTIDES, V147, P1, DOI 10.1016/j.regpep.2007.11.006; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; CROMPTON MR, 1971, LANCET, V1, P669; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Espana RA, 2004, SLEEP, V27, P811; Fronczek R, 2007, BRAIN, V130, P1577, DOI 10.1093/brain/awm090; Guillery RW, 2002, J COMP NEUROL, V447, P1, DOI 10.1002/cne.10221; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Karovitaki N, 2006, J NEUROL NEUROSUR PS, V77, P276, DOI 10.1136/jnnp.2005.070482; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; ROPPER AH, 1985, ANN NEUROL, V18, P80, DOI 10.1002/ana.410180114; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Scammell T., 2007, SLEEP DISORDERS NEUR, P117; SCAMMELL TE, 2007, INFORMA HEALTHCARE, V547, P559; Scammell TE, 2006, SLEEP, V29, P601, DOI 10.1093/sleep/29.5.601; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2007, BRAIN, V130, P1586, DOI 10.1093/brain/awm097	24	119	122	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	OCT	2009	66	4					555	559		10.1002/ana.21836			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507SJ	WOS:000270874700016	19847903	Green Accepted			2022-02-06	
J	McKinlay, A; Grace, R; Horwood, J; Fergusson, D; MacFarlane, M				McKinlay, Audrey; Grace, Randolph; Horwood, John; Fergusson, David; MacFarlane, Martin			Adolescent Psychiatric Symptoms Following Preschool Childhood Mild Traumatic Brain Injury: Evidence From a Birth Cohort	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						birth cohort; children; longitudinal; mild traumatic brain injury; psychiatric disorders	CLOSED-HEAD-INJURY; PSYCHOSOCIAL OUTCOMES; PERSONALITY-CHANGE; CHILDREN; PREVALENCE; DISORDERS; MEMORY; PREDICTORS; SEQUELAE; ADULTS	Objective: To determine whether childhood mild traumatic brain injury (MTBI) is associated with behavioral problems in adolescence. Participants: Children from a longitudinal birth cohort (initial N = 1265) were assigned to 1 of 3 groups: (1) inpatient group (n = 19) comprised children admitted to hospital for MTBI before age 5 years; (2) outpatient group (n = 57), children with any incidence of MTBI before age 5 seen by a general practitioner or at ail accident and emergency department and sent home; (3) reference control group (n = 839). Outcome measures: Maternal and self-report regarding attention deficit/hyperactivity disorder, conduct disorder, anxiety disorder, mood disorder, and alcohol or illicit substance abuse/dependence obtained using Diagnostic and Statistical Manual of Mental Disorders (Third Edition Revised) criteria. Results: At age 14 to 16 years, children who had been hospitalized for MTBI during preschool years were significantly more likely to show symptoms of attention deficit/hyperactivity disorder (odds ratio = 4.2), conduct disorder/oppositional defiant disorder (odds ratio = 6.2), substance abuse (odds ratio = 3.6), and mood disorder (odds ratio = 3.1) but not anxiety disorder. Conclusions: Preschool MTBI is associated with persistent negative effects on psychosocial development. These continuing problems are consistent with the view that preschool years represent a period of particular vulnerability following MTBI.	[McKinlay, Audrey; Grace, Randolph] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [Horwood, John; Fergusson, David] Univ Otago, Christchurch Hlth & Dev Study, Christchurch, New Zealand; [MacFarlane, Martin] Christchurch Hosp, Dept Neurosurg, Christchurch, New Zealand		McKinlay, A (corresponding author), Univ Canterbury, Dept Psychol, Private Bag 4800, Christchurch 1, New Zealand.	audrey.mckinlay@canterbury.ac.nz		Grace, Randolph/0000-0003-1115-6089; Horwood, L./0000-0003-4881-1956; McKinlay, Audrey/0000-0001-9846-8514; Fergusson, David/0000-0002-8117-017X	Health Research Council of New ZealandHealth Research Council of New Zealand; National Child Health Research Foundation; Canterbury Medical Research Foundation; New Zealand Lottery; Neurological Foundation of New Zealand; New Zealand Foundation for Research Science and TechnologyNew Zealand Foundation for Research, Science and Technology; Todd Foundation	The Christchurch Health and Development Study has been funded by grants from the Health Research Council of New Zealand, the National Child Health Research Foundation, the Canterbury Medical Research Foundation, and the New Zealand Lottery, Grants Board. This research was funded by a grant from the Neurological Foundation of New Zealand. Andrew McKinley was sponsored v a scholarship from the New Zealand Foundation for Research Science and Technology, a Todd Foundation award for research excellence.	Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2000, BRAIN INJURY, V14, P679; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; CASEY R, 1986, PEDIATRICS, V78, P497; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Costello A, 1982, DIAGNOSTIC INTERVIEW; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1997, DEV PREFRONTAL CORTE, P295; Fergusson DM, 1998, J EMOT BEHAV DISORD, V6, P2, DOI 10.1177/106342669800600101; FERGUSSON DM, 1993, J AM ACAD CHILD PSY, V32, P1127, DOI 10.1097/00004583-199311000-00004; Fergusson DM, 2001, AUST NZ J PSYCHIAT, V35, P287, DOI 10.1046/j.1440-1614.2001.00902.x; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; MATTSON AJ, 1990, J CLIN EXP NEUROPSYC, V12, P104; Max JE, 1998, BRAIN INJURY, V12, P31; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, BRAIN INJURY, V11, P699; Max JE, 1998, BRAIN INJURY, V12, P41; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; MOFFITT TE, 1988, AUST NZ J CRIMINOL, V21, P227, DOI 10.1177/000486588802100405; Overweg-Plandsoen WCG, 1999, EUR J PEDIATR, V158, P249, DOI 10.1007/s004310051061; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; PRIOER M, 1994, AUST PSYCHOL, V29, P116, DOI 10.1080/00050069408257334; Quay HC, 1987, MANUAL REVISED BEHAV; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; WHITE HR, 1989, J STUD ALCOHOL, V50, P30, DOI 10.15288/jsa.1989.50.30; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	52	119	119	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2009	24	3					221	227		10.1097/HTR.0b013e3181a40590			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	448HD	WOS:000266252800008	19461369				2022-02-06	
J	Zygun, DA; Nortje, J; Hutchinson, PJ; Timofeev, I; Menon, DK; Gupta, AK				Zygun, David A.; Nortje, Jurgens; Hutchinson, Peter J.; Timofeev, Ivan; Menon, David K.; Gupta, Arun K.			The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						critical care; transfusion; craniocerebral trauma; anemia; microdialysis	SEVERE HEAD-INJURY; CARDIOPULMONARY BYPASS; CARE; MICRODIALYSIS; POPULATION; HEMATOCRIT; MORTALITY; ISCHEMIA; MODERATE; ANEMIA	Objective: There is evidence to suggest that anemia after severe traumatic brain injury (sTBI) is detrimental. However, there is a paucity of evidence supporting the use of transfusion of packed red blood cells in patients with sTBI. To understand the acute effect of packed red blood cell transfusion on cerebral oxygenation and metabolism in patients with sTBI. Design: Prospective clinical study. Setting: Addenbrooke's Neurosciences Critical Care Unit, a 21-bed tertiary academic unit. Patients: Thirty patients with sTBI. Interventions: Patients were randomized by computer random number generator to one of three transfusion thresholds: 8, 9, or 10 g/dL. When the patients' hemoglobin concentration fell below their assigned threshold, two units of packed red blood cells were transfused over 2 hours. A 1-hour period of stabilization was observed before final data collection. Measurements and Main Results: The primary outcome was change in brain tissue oxygen (P(bt)o(2)). Secondary outcomes included dependence of baseline hemoglobin concentration and baseline P(bt)o(2) on the relationship of transfusion and P(bt)o(2), and the effect of transfusion on lactate pyruvate ratio (LPR) and brain pH as markers of cerebral metabolic state. Fifty-seven percent of patients experienced an increase in P(bt)o(2) during the course of the study, whereas in 43% of patients, P(bt)o(2) either did not change or decreased. Multivariable generalized estimating equation analysis revealed change in hemoglobin concentration to significantly and positively associated with change in P(bt)o(2) [0.10 kPa/(g/dL) 95% confidence interval 0.03-0.17, p = 0.003]. Improvement in P(bt)o(2) was not associated with baseline hemoglobin concentration or low P(bt)o(2) (<1 kPa). Fifty-six percent of patients experienced an increase in LPR. No significant relationship between change in LPR or transfusion on pH(bt) and change in hemoglobin could be demonstrated. Conclusions: Transfusion of packed red blood cells acutely results in improved brain tissue oxygen without appreciable effect on cerebral metabolism.	[Zygun, David A.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Zygun, David A.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Menon, David K.; Gupta, Arun K.] Univ Cambridge, Neurosci Crit Care Unit, Cambridge CB2 1TN, England; [Nortje, Jurgens; Menon, David K.; Gupta, Arun K.] Univ Cambridge, Dept Anaesthesia, Cambridge CB2 1TN, England; [Hutchinson, Peter J.; Timofeev, Ivan] Addenbrookes Hosp, Acad Neurosurg, Cambridge, England; [Timofeev, Ivan; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England		Zygun, DA (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	david.zygun@calgaryhealthregion.ca	Timofeev, Ivan/AAE-7019-2019	Timofeev, Ivan/0000-0002-1168-0393	Association of Anesthetists of Great Britain and Ireland [G9439390 ID, 56833]; Royal College of Physicians and Surgeons of Canada; Meredith Graduate Master's Scholarship; University of Calgary, the Worker's Compensation Board of Alberta (DAZ); Academy of Medical Sciences/The Health Foundation-Senior Surgical Scientist Fellowship (PJH); British Journal of Anesthesia/Royal College of Anesthetists Research Fellowship (JN); Codman (Johnson & Johnson), the Evelyn Trust and a BP-TNK Kapitza scholarship (IT)Johnson & JohnsonJohnson & Johnson USA; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390] Funding Source: researchfish	Supported, in part, by G9439390 ID 56833 from Association of Anesthetists of Great Britain and Ireland, Intensive Care Society and Acute Brain Injury Program in the Wolfson Brain Imaging Centre, which was funded by the MRC. Supported by, the Detweiler Traveling Fellowship of the Royal College of Physicians and Surgeons of Canada, the Meredith Graduate Master's Scholarship, University of Calgary, the Worker's Compensation Board of Alberta (DAZ); the Academy of Medical Sciences/The Health Foundation-Senior Surgical Scientist Fellowship (PJH); British Journal of Anesthesia/Royal College of Anesthetists Research Fellowship (JN); Codman (Johnson & Johnson), the Evelyn Trust and a BP-TNK Kapitza scholarship (IT).	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; BEUTLER E, 1969, J LAB CLIN MED, V74, P300; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; GAEHTGENS P, 1987, J CEREBR BLOOD F MET, V7, P259, DOI 10.1038/jcbfm.1987.61; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Habib RH, 2003, J THORAC CARDIOV SUR, V125, P1438, DOI 10.1016/S0022-5223(02)73291-1; Hare GMT, 2003, J NEUROTRAUM, V20, P1134; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Jonas RA, 2003, J THORAC CARDIOV SUR, V126, P1765, DOI 10.1016/j.jtcvs.2003.04.003; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pendem S, 2006, NEUROCRIT CARE, V4, P63, DOI 10.1385/NCC:4:1:063; Pickett JL, 1999, AM J KIDNEY DIS, V33, P1122, DOI 10.1016/S0272-6386(99)70150-2; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; TIRET L, 1986, INT J EPIDEMIOL, V19, P133; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2006, CRIT CARE MED, V34, P1850, DOI 10.1097/01.CCM.0000219370.99823.5B; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	26	119	122	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAR	2009	37	3					1074	1078		10.1097/CCM.0b013e318194ad22			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413FW	WOS:000263779300039	19237920				2022-02-06	
J	Levin, HS; Wilde, EA; Chu, ZL; Yallampalli, R; Hanten, GR; Li, XQ; Chia, J; Vasquez, AC; Hunter, JV				Levin, Harvey S.; Wilde, Elisabeth A.; Chu, Zili; Yallampalli, Ragini; Hanten, Gerri R.; Li, Xiaoqi; Chia, Jon; Vasquez, Ana C.; Hunter, Jill V.			Diffusion tensor imaging in relation to cognitive and functional outcome of traumatic brain injury in children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; cognition diffusion tensor imaging; global outcome; traumatic brain injury	WHITE-MATTER ARCHITECTURE; AXONAL INJURY; MAGNETIC-RESONANCE; HEAD-INJURY; CORPUS-CALLOSUM; PRACTICAL SCALE; MATURATION; ANISOTROPY; CHILDHOOD; MRI	Objective: To investigate the relation of white matter integrity using diffusion tensor imaging (DTI) to cognitive and functional outcome of moderate to severe traumatic brain injury (TBI) in children. Design: Prospective observational study of children who had sustained moderate to severe TBI and a comparison group of children who had sustained orthopedic injury (01). Participants: Thirty-two children who had sustained moderate to severe TBI and 36 children with OI were studied. Methods: Fiber tracking analysis of DTI acquired at 3-month postinjury and assessment of global outcome and cognitive function within 2 weeks of brain imaging. Global outcome was assessed using the Glasgow Outcome Scale and the Flanker task was used to measure cognitive processing speed and resistance to interference. Results: Fractional anisotropy and apparent diffusion coefficient values differentiated the groups and both cognitive and functional outcome measures were related to the DTI findings. Dissociations were present wherein the relation of Fractional anisotropy to cognitive performance differed between the TBI and OI groups. A DTI composite measure of white matter integrity was related to global outcome in the children with TBI Conclusions: DTI is sensitive to white matter injury at 3 months following moderate to severe TBI in children, including brain regions that appear normal on conventional magnetic resonance imaging. DTI measures reflecting diffusion of water parallel and perpendicular to white matter tracts as calculated by fiber tracking analysis are related to global outcome, cognitive processing speed, and speed of resolving interference in children with moderate to severe TBI. Longitudinal data are needed to determine whether these relations between DTI and neurobehavioral outcome of TBI in children persist at longer follow-up intervals.	[Levin, Harvey S.; Wilde, Elisabeth A.; Yallampalli, Ragini; Hanten, Gerri R.; Li, Xiaoqi; Vasquez, Ana C.] Univ Texas Houston, Sch Med, Baylor Coll Med, Houston, TX 77030 USA; [Chu, Zili; Hunter, Jill V.] Texas Childrens Hosp, Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Hunter, Jill V.] Texas Childrens Hosp, EB Singleton Dept Diagnost Imaging, Houston, TX 77030 USA; [Yallampalli, Ragini] Univ Houston, Dept Psychol, Houston, TX USA; [Chia, Jon] Philips Med Syst, Cleveland, OH USA		Levin, HS (corresponding author), Univ Texas Houston, Sch Med, Baylor Coll Med, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889, R01 NS021889-24, R01 NS021889] Funding Source: Medline		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Cohen J., 2013, STAT POWER ANAL BEHA; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1975, LANCET, V1, P480; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Olesen PJ, 2003, COGNITIVE BRAIN RES, V18, P48, DOI 10.1016/j.cogbrainres.2003.09.003; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Schmithorst VJ, 2008, HUM BRAIN MAPP, V29, P696, DOI 10.1002/hbm.20431; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Sheskin DJ, HDB PARAMETRIC NONPA; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; TEASDALE G, 1974, LANCET, V2, P81; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	44	119	120	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2008	23	4					197	208		10.1097/01.HTR.0000327252.54128.7c			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	331KU	WOS:000258011900002	18650764	Green Accepted			2022-02-06	
J	Galarneau, MR; Woodruff, SI; Dye, JL; Mohrle, CR; Wade, AL				Galarneau, Michael R.; Woodruff, Susan I.; Dye, Judy L.; Mohrle, Charlene R.; Wade, Amber L.			Traumatic brain injury during operation Iraqi freedom: findings from the United States Navy-Marine Corps Combat Trauma Registry	JOURNAL OF NEUROSURGERY			English	Article						Navy-Marine Corps Combat Trauma Registry; operation Iraqi freedom; traumatic brain injury	SEVERITY SCORE	Object. The purpose of this study was to characterize traumatic brain injuries (TBIs) among military personnel (primarily Marines) during the second phase of Operation Iraqi Freedom from early in the medical care chain of evacuation through Landstuhl Regional Medical Center, a Level 4 American hospital in Germany. Methods. Data were obtained from the Navy-Marine Corps Combat Trauma Registry (CTR) and included both battle and nonbattle injuries. Follow-up of patients with TBI was conducted to examine the short-term medical and personnel-related effects of TBI among those surviving. Results. Those injured in battle were more likely than those not injured in battle to have multiple TBI diagnoses, a greater number of all diagnoses, more severe TBIs, and to be medically evacuated. Intracranial injuries (for example, concussions) were the predominant type of TBI, although skull fractures and open head wounds were also seen. Improvised explosive devices were the most common cause of TBIs among battle injuries; blunt trauma and motor vehicle crashes were the most common causes among nonbattle injuries. Short-term follow-up of surviving patients with TBI indicated higher morbidity and medical utilization among the patients with more severe TBI, although mental conditions were higher among patients with milder TBI. Conclusions. Data from the Navy-Marine Corps CTR provide useful information about combatants' TBIs identified early in the combat casualty process. Results may improve clinical care for those affected and suggest strategies for The CTR staff plans to conduct additional follow-up studies of this group of patients with TBI.	[Galarneau, Michael R.] USN, Hlt Res Ctr, Dept Med Modeling Simulat & Miss Support, San Diego, CA 92106 USA; [Woodruff, Susan I.; Dye, Judy L.; Mohrle, Charlene R.; Wade, Amber L.] Sci Applicat Int Corp Inc, Hlth Res & Appl Technol Div, San Diego, CA USA		Galarneau, MR (corresponding author), USN, Hlt Res Ctr, Dept Med Modeling Simulat & Miss Support, 140 Sylvester Rd, San Diego, CA 92106 USA.	michael.galarneau@med.navy.mil					Bagg Mark R, 2006, J Am Acad Orthop Surg, V14, pS7; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CAREY ME, 1987, MIL MED, V152, P6; *CDCP, 2006, NAT CTR INJ PREV CON; Coupland RM, 1999, BRIT MED J, V319, P410, DOI 10.1136/bmj.319.7207.410; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2005, ABBREVIATED INJURY S; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Gunderson EKE, 2005, MIL MED, V170, P172; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; MATTHEWS DE, 2005, USING UNDERSTANDING; MCCRAKEN DL, TRAUMATIC BRAIN INJU; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SCOTT BA, 1986, NEUROSURGERY, V18, P107, DOI 10.1227/00006123-198601000-00020; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Thurman DJ, 2001, HEAD TRAUMA, P327; Thurman DJ., 1995, GUIDELINES SURVEILLA; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Zouris JM, 2006, MIL MED, V171, P246, DOI 10.7205/MILMED.171.3.246	23	119	120	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2008	108	5					950	957		10.3171/JNS/2008/108/5/0950			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	293RE	WOS:000255351600008	18447712				2022-02-06	
J	Greve, KW; Ord, J; Curtis, KL; Bianchini, KJ; Brennan, A				Greve, Kevin W.; Ord, Jonathan; Curtis, Kelly L.; Bianchini, Kevin J.; Brennan, Adrianne			Detecting malingering in traumatic brain injury and chronic pain: A comparison of three forced-choice symptom validity tests	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	26th Annual Meeting of the National-Academy-of-Neuropsychology	OCT 25-28, 2006	San Antonio, TX	Natl Acad Neuropsychol			FAKE-BAD SCALE; DIGIT RECOGNITION TEST; CLOSED-HEAD INJURY; NEUROCOGNITIVE DYSFUNCTION; CLASSIFICATION ACCURACY; NEUROPSYCHOLOGICAL TESTS; RESPONSE BIAS; MONEY MATTERS; MMPI-2; VALIDATION	Individual and joint malingering detection accuracy of the Portland Digit Recognition Test (PDRT), Test of Memory Malingering (TOMM), and Word Memory Test (WMT) was examined in traumatic brain injury (TBI; 43 non-malingering, 27 malingering) and chronic pain (CP; 42 non-malingering, 58 malingering) using a known-groups design. At published cutoffs, the PDRT and TOMM were very specific but failed to detect about 50% of malingerers; the WMT was sensitive but prone to false positive errors. ROC analyses demonstrated comparable accuracy across all three tests. Joint classification accuracy was superior to that of the individual tests. Clinical and research implications are discussed.	[Greve, Kevin W.; Ord, Jonathan; Curtis, Kelly L.; Bianchini, Kevin J.] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Curtis, Kelly L.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA USA; [Brennan, Adrianne] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Astner K., 1996, MANUAL WORD MEMORY T; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bianchini K. J., 2004, J FORENSIC NEUROPSYC, V4, P65; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BIANCHINI KJ, 2007, CLASSIFICATION ACCUR; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1993, PORTLAND DIGIT RECOG; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BLANCHINI KB, 2001, CLIN NEUROPSYCHOL, V15, P461; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Dearth CS, 2005, ARCH CLIN NEUROPSYCH, V20, P95, DOI 10.1016/j.acn.2004.03.004; Etherton JL, 2005, ASSESSMENT, V12, P101, DOI 10.1177/1073191104270789; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Gansler DA, 1996, ARCH CLIN NEUROPSYCH, V11, P393, DOI 10.1016/0887-6177(96)83889-3; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; GERVAIS RO, 2001, J FORENSIC NEUROPSYC, V2, DOI DOI 10.1300/J151V02N02_01; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P117, DOI 10.1016/j.acn.2005.06.009; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Gunstad J, 2001, CLIN NEUROPSYCHOL, V15, P397, DOI 10.1076/clin.15.3.397.10271; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; Iverson GL, 2002, PSYCHOL REP, V90, P131, DOI 10.2466/PR0.90.1.131-136; Ju D, 2000, Appl Neuropsychol, V7, P201, DOI 10.1207/S15324826AN0704_1; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; ORD J, 2007, 35 ANN M INT NEUR SO; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; Ross SR, 2006, CLIN NEUROPSYCHOL, V20, P798, DOI 10.1080/13854040500328477; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; TYDECKS S, 2006, INT J FORENSIC PSYCH, V0001, P00029; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; VICTOR TL, 2006, 34 ANN M INT NEUR SO; Wasyliw O. E., 1985, BEHAV SCI LAW, V3, P149, DOI [10.1002/bsl.2370030204, DOI 10.1002/BSL.2370030204]; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; [No title captured]	68	119	119	0	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2008	22	5					896	918		10.1080/13854040701565208			23	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	342HP	WOS:000258775500010	18756391				2022-02-06	
J	Walker, WC; Marwitz, JH; Kreutzer, JS; Hart, T; Novack, TA				Walker, William C.; Marwitz, Jennifer H.; Kreutzer, Jeffrey S.; Hart, Tessa; Novack, Thomas A.			Occupational categories and return to work after traumatic brain injury: A multicenter study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; employment; occupations; rehabilitation; treatment outcome	HEAD-INJURY; ACUTE PREDICTORS; EMPLOYMENT; REHABILITATION; DISABILITY; RECOVERY	Objective: To further evaluate determinants of return to work (RTW) after traumatic brain injury (TBI), with focus on the relation between preinjury occupational category and RTW outcome. Design: Prospective collaborative cohort study. Setting: Seventeen National Institute on Disability and Rehabilitation Research-designated Traumatic Brain Injury Model Systems. Participants: Consecutive sample of 1341 patients (age range, 18-62y) who were hospitalized with a TBI diagnosis, received both acute neurotrauma services and inpatient rehabilitation services, consented to participate, were employed before injury, and completed a 1-year follow-up assessment. Intervention: An inpatient interdisciplinary brain injury rehabilitation program. Main Outcome Measure: Competitive employment at 1 year postinjury. Results: Participants were categorized into 1 of 3 groups depending on preinjury occupational title: professional/managerial (n=192), skilled (n=751), or manual labor (n=398). Chi-square analyses were computed to examine changes across occupation groups between preinjury occupation group and postinjury RTW. The rate of successful RTW was greatest for professional/managerial (56%), lower for skilled (40%), and lowest for manual labor (32%), yielding an odds ratio of 2.959 between the highest and lowest groups. Of those with successful RTW, most did so within the same occupational category grouping. A multiple logistic regression showed that preinjury occupation, education level, discharge FIM score, age, sex, marital status, and hospital length of stay each influenced RTW. Conclusions: Prior research has shown that preinjury employment status (employed vs unemployed) greatly influences the odds of successful RTW after TBI. A related hypothesis, that occupational classification also influences RTW outcome, has been understudied and has yielded conflicting results. The current study shows convincingly that the type of occupation influences RTW outcome, with the best prospect for RTW among people with professional/managerial jobs. Occupational category should be examined in the future development of predictive models for RTW after TBI.	Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Moss Rehabil Res Inst, Philadelphia, PA 19107 USA; Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980661, Richmond, VA 23298 USA.	wcwalker@mail2.vcu.edu	Walker, William C/N-3162-2014				Bell GD, 1998, B AM METEOROL SOC, V79, pS1, DOI 10.1175/1520-0477-79.5s.S1; Berkman L F, 1997, IARC Sci Publ, P51; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CONDELUCI A, 1992, Brain Injury, V6, P543, DOI 10.3109/02699059209008151; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; CRISP R, 1992, J REHABIL, V58, P27; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; EVANS RL, 1992, AM J PHYS MED REHAB, V71, P140, DOI 10.1097/00002060-199206000-00003; Fleming J, 1999, BRAIN INJURY, V13, P417; FORER S, 1982, J ORGAN REHABIL EVAL, V2, P29; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Regidor E, 2005, EUR J EPIDEMIOL, V20, P501, DOI 10.1007/s10654-005-4262-y; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; *STAT U NY, 1996, GUID UN DAT SET MED; *UN STAT DIV, 1988, INT STAND CLASS OCC; *US DEP COMM, 1992, 1990 OCC CLASS SYST; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	49	119	124	0	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2006	87	12					1576	1582		10.1016/j.apmr.2006.08.335			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	114OH	WOS:000242675000004	17141636				2022-02-06	
J	Ducrocq, SC; Meyer, PG; Orliaguet, GA; Blanot, S; Laurent-Vannier, A; Renier, D; Carli, PA				Ducrocq, Sarah C.; Meyer, Philippe G.; Orliaguet, Gilles A.; Blanot, Stephane; Laurent-Vannier, Anne; Renier, Dominique; Carli, Pierre A.			Epidemiology and early predictive factors of mortality and outcome in children with traumatic severe brain injury: Experience of a French pediatric trauma center	PEDIATRIC CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Pediatric-Academic-Societies	APR 28-MAY 13, 2001	Baltimore, MD	Pediat Acad Soc		severe traumatic brain injury; mortality; outcome; risks factors; pediatrics; trauma scores; child; critical care	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; PRACTICAL SCALE; DATA-BANK; MANAGEMENT; MULTIPLE; SCORE; CARE; AGE; LIMITATIONS	Objective. To describe the results of an integrated pre- and in-hospital approach to critical care in a large population of children with severe traumatic brain injury and to identify the early predictors of their outcome. Design: A 9-yr retrospective review of the data of a trauma data bank. Setting: Level III pediatric trauma center. Patients: All children (1 month to 15 yrs) with severe traumatic brain injury (Glasgow Coma Scale <= 8) hospitalized in our trauma center and followed until death or for >= 6 months after discharge. Interventions: None. Measurements and Main Results: Univariate and further multivariate analyses were performed to determine independent predictive factors of death and outcome at discharge and 6 months later. The Glasgow Outcome Scale was used to evaluate outcome; a poor outcome referred to Glasgow Outcome Scale >= 3. Receiver operating characteristic curves were drawn to determine the threshold values of predictors of death and outcome. Analysis concerned 585 children (67% male and 33% female). Mean age was 7 +/- 5 yrs. Predominant mechanisms of injury were road traffic accidents and falls. Mean values for Glasgow Coma Scale, Pediatric Trauma Score, and Injury Severity Score were 6 (3-8), 3 (-4,10), and 28 (4-75), respectively. Mortality rate was 22%; Glasgow Outcome Scale was <3 in 53% of the cases at discharge and 60% at 6 months. Multivariate analysis identified Glasgow Coma Scale, Injury Severity Score, and hypotension on arrival as independent predictors of death and poor outcome at discharge and at 6 months. Threshold values for death were 28 for Injury Severity Score and 5 for Glasgow Coma Scale. The same values were found for poor outcome, except for outcome at 6 months where threshold value for the Glasgow Coma Scale was 6. Conclusions: Initial hypotension, Glasgow Coma Scale, and Injury Severity Score are independent predictors of outcome in children with traumatic brain injury. Threshold values can be calculated for predicting poor outcome. These variables can be easily and detected early in this population and used for quality assessment.	Univ Paris 05, Hop Necker Enfants Malad, Div Pediat Anesthesia, F-75270 Paris 06, France; Univ Paris 05, Hop Necker Enfants Malad, Neurocrit Care Unit, F-75270 Paris 06, France; Univ Paris 05, Hop Necker Enfants Malad, Div Pediat Neurosurg, F-75270 Paris 06, France; Hop Natl St Maurice, Serv Reeduc Pathol Neurol Acquises, Div Pediat Rehabil, St Maurice, France		Ducrocq, SC (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Div Pediat Anesthesia, F-75270 Paris 06, France.		Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; Orliaguet, Gilles/0000-0003-0930-2251			ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HALL SC, 1994, INT ANESTHESIOL CLIN, V32, P1; Havill JH, 1998, ANAESTH INTENS CARE, V26, P642, DOI 10.1177/0310057X9802600605; HU XH, 1994, J TRAUMA, V37, P209, DOI 10.1097/00005373-199408000-00010; JENNETT B, 1975, LANCET, V1, P480; KEENAN HT, 2005, PEDIATR CRIT CARE ME, V6, P611; Kemp A, 1997, J ACCID EMERG MED, V14, P316; KLASEN HJ, 1996, UPDATE INTENSIVE CAR, P11; Lallier M, 1999, J PEDIATR SURG, V34, P1060, DOI 10.1016/S0022-3468(99)90564-X; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; Meyer P G, 1998, Curr Opin Anaesthesiol, V11, P285, DOI 10.1097/00001503-199806000-00008; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; NAKAYAMA DK, 1991, J TRAUMA, V31, P1521, DOI 10.1097/00005373-199111000-00010; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Orliaguet GA, 1998, ANESTH ANALG, V87, P537, DOI 10.1097/00000539-199809000-00006; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prat R, 1998, ACTA NEUROCHIR, V140, P1257, DOI 10.1007/s007010050247; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; SIMPSON D, 1982, LANCET, V2, P450; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Vernon DD, 1999, PEDIATRICS, V103, P20, DOI 10.1542/peds.103.1.20; WALKER ML, 1984, CHILD BRAIN, V11, P387; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	42	119	123	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	SEP	2006	7	5					461	467		10.1097/01.PCC.0000235245.49129.27			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Pediatrics	096PY	WOS:000241390500009	16885795				2022-02-06	
J	Collie, A; Makdissi, M; Maruff, P; Bennell, K; McCrory, P				Collie, A; Makdissi, M; Maruff, P; Bennell, K; McCrory, P			Cognition in the days following concussion: comparison of symptomatic versus asymptomatic athletes	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							COLLEGIATE FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; TEST-PERFORMANCE; REACTION-TIME; HEAD-INJURY; IMPAIRMENT; CONSISTENCY; SEVERITY; RECOVERY	Background: Concussion is a common neurological injury occurring during contact sport. Current guidelines recommend that no athlete should return to play while symptomatic or displaying cognitive dysfunction. This study compared post-concussion cognitive function in recently concussed athletes who were symptomatic/asymptomatic at the time of assessment with that of non-injured (control) athletes. Methods: Prospective study of 615 male Australian Rules footballers. Before the season, all participants (while healthy) completed a battery of baseline computerised (CogSport) and paper and pencil cognitive tasks. Sixty one injured athletes (symptomatic=25 and asymptomatic=36) were reassessed within 11 days of being concussed; 84 controls were also reassessed. The serial cognitive function of the three groups was compared using analysis of variance. Results: The performance of the symptomatic group declined at the post-concussion assessment on computerised tests of simple, choice, and complex reaction times compared with the asymptomatic and control groups. The magnitude of changes was large according to conventional statistical criteria. On paper and pencil tests, the symptomatic group displayed no change at reassessment, whereas large improvements were seen in the other two groups. Conclusion: Injured athletes experiencing symptoms of concussion displayed impaired motor function and attention, although their learning and memory were preserved. These athletes displayed no change in performance on paper and pencil tests in contrast with the improvement observed in asymptomatic and non-injured athletes. Athletes experiencing symptoms of concussion should be withheld from training and competition until both symptoms and cognitive dysfunction have resolved.	Univ Melbourne, Ctr Hlth Exercise & Sports Med, Parkville, Vic 3052, Australia; La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3083, Australia		Collie, A (corresponding author), 92B Abbeville Rd, London SW4 9NA, England.	acollie@unimelb.edu.au	Maruff, Paul/AAD-2454-2021; Maruff, Paul/ABA-1673-2020; McCrory, Paul/Q-8688-2019; Bennell, Kim/C-7022-2014	Maruff, Paul/0000-0002-6947-9537; Bennell, Kim/0000-0003-4982-5639; makdissi, michael/0000-0003-0334-7133; Collie, Alex/0000-0003-2617-9339			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BLAND M, 1996, LANCET, V1, P307; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; *COL MED SOC, 1991, REP SPORTS MED COMM; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Luce RD, 1986, RESPONSE TIMES THEIR; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, THESIS U MELBOURNE M; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory PR, 1999, BRIT J SPORT MED, V33, P297; MOLLICA C, IN PRESS J INT NEURO; MOLLICA C, IN PRESS HUM PSYCHOP; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Silbert BS, 2004, BRIT J ANAESTH, V92, P814, DOI 10.1093/bja/aeh157; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VVANZOMEREN AH, 1981, REACTION TIME ATTENT; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; WESCHLER D, 1981, WESCHLER ADULT INTEL; Wolfson, 1993, HALSTEAD REITAN NEUR	43	119	120	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	FEB	2006	77	2					241	245		10.1136/jnnp.2005.073155			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	011QY	WOS:000235284400026	16421129	Green Published			2022-02-06	
J	Greve, KW; Stickle, TR; Love, JA; Bianchini, KJ; Stanford, MS				Greve, KW; Stickle, TR; Love, JA; Bianchini, KJ; Stanford, MS			Latent structure of the Wisconsin Card Sorting Test: a confirmatory factor analytic study	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	31st Annual Meeting of the International-Neuropsychological-Society	FEB 05-08, 2003	HONOLULU, HI	Int Neuropsychol Soc		Wisconsin Card Sorting Test; confirmatory factor analysis; assessment; executive function	TRAUMATIC BRAIN-INJURY; TEST DIMENSIONS; PERFORMANCE; VALIDITY; SCHIZOPHRENIA; SAMPLE; WCST; ADOLESCENTS; AGGRESSION; DAMAGE	The present study represents the first large scale confirmatory factor analysis of the Wisconsin Card Sorting Test (WCST). The results generally support the three factor solutions reported in the exploratory factor analysis literature. However, only the first factor, which reflects general executive functioning, is statistically sound. The secondary factors, while likely reflecting meaningful cognitive abilities, are less stable except when all subjects complete all 128 cards. It is likely that having two discontinuation rules for the WCST has contributed to the varied factor analytic solutions reported in the literature and early discontinuation may result in some loss of useful information. Continued multivariate research will be necessary to better clarify the processes underlying WCST performance and their relationships to one another. (c) 2004 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; Jerrerson Neurobehav Grp, Metairie, LA USA		Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kwgps@uno.edu					Axelrod BN, 1997, ASSESSMENT, V4, P41, DOI 10.1177/107319119700400105; Bell MD, 1997, J CLIN EXP NEUROPSYC, V19, P933, DOI 10.1080/01688639708403774; Boone KB, 1998, ARCH CLIN NEUROPSYCH, V13, P585, DOI 10.1016/S0887-6177(97)00074-7; Bowden SC, 1998, NEUROPSYCHOL REHABIL, V8, P243, DOI 10.1080/713755573; CUESTA MJ, 1995, PSYCHIAT RES, V58, P45, DOI 10.1016/0165-1781(95)02649-H; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; GOODMAN LA, 1974, BIOMETRIKA, V61, P215, DOI 10.1093/biomet/61.2.215; GREVE KW, 1995, ARCH CLIN NEUROPSYCH, V10, P265, DOI 10.1016/0887-6177(94)00046-S; Greve KW, 1997, BRIT J CLIN PSYCHOL, V36, P283, DOI 10.1111/j.2044-8260.1997.tb01414.x; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 1999, ARCH CLIN NEUROPSYCH, V14, P497; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Kizilbash A, 1999, CHILD NEUROPSYCHOL, V5, P224, DOI 10.1076/0929-7049(199912)05:04;1-R;FT224; Koren D, 1998, NEUROPSYCHOLOGY, V12, P289, DOI 10.1037/0894-4105.12.2.289; Krueger RF, 1998, J ABNORM PSYCHOL, V107, P216, DOI 10.1037/0021-843X.107.2.216; Lin CCH, 2000, J CLIN EXP NEUROPSYC, V22, P69, DOI 10.1076/1380-3395(200002)22:1;1-8;FT069; Love JM, 2003, APPL NEUROPSYCHOL, V10, P246, DOI 10.1207/s15324826an1004_7; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; Merrick EE, 2003, CLIN NEUROPSYCHOL, V17, P153, DOI 10.1076/clin.17.2.153.16512; Milner B, 1963, ARCH NEUROL-CHICAGO, V9, P100, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; PAOLO AM, 1995, ARCH CLIN NEUROPSYCH, V10, P463, DOI 10.1016/0887-6177(95)00052-6; Rossi A, 2000, J PSYCHIAT RES, V34, P333, DOI 10.1016/S0022-3956(00)00025-X; Somsen RJM, 2000, ACTA PSYCHOL, V104, P227, DOI 10.1016/S0001-6918(00)00030-5; Stanford MS, 1997, PERS INDIV DIFFER, V23, P961, DOI 10.1016/S0191-8869(97)00120-7; Stickle TR, 2002, J PSYCHOPATHOL BEHAV, V24, P177, DOI 10.1023/A:1016062701325; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; SULLIVAN EV, 1993, PSYCHIAT RES, V46, P175, DOI 10.1016/0165-1781(93)90019-D; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; [No title captured], DOI DOI 10.1177/107319119600300108	30	119	120	0	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2005	20	3					355	364		10.1016/j.acn.2004.09.004			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology	919DN	WOS:000228598600007	15797171	Green Published, Bronze			2022-02-06	
J	Anderson, VA; Morse, SA; Catroppa, C; Haritou, F; Rosenfeld, JV				Anderson, VA; Morse, SA; Catroppa, C; Haritou, F; Rosenfeld, JV			Thirty month outcome from early childhood head injury: a prospective analysis of neurobehavioural recovery	BRAIN			English	Article						traumatic brain injury; children; IQ; language; memory	TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; CRANIAL IRRADIATION; FOLLOW-UP; AGE; PREDICTORS; SEVERITY; ADOLESCENTS; SEQUELAE; SKILLS	Traumatic brain injury (TBI) is a common cause of acquired disability during childhood. While much is now known about outcome following TBI in the school-aged population, recovery in infants and young children is less well documented. The aim of this study was to examine neurobehavioural function following TBI during early childhood, to plot recovery over the 30 months post-injury and to identify predictors of outcome. The study compared three groups of children, sustaining injuries of different severity (mild = 14, moderate = 46, severe = 24), aged 2.0-6.11 years at injury, with a healthy control group (n = 33). The groups were similar with respect to pre-injury adaptive and behavioural function, psychosocial characteristics, age and gender. Using a prospective, longitudinal design, intellectual, language and memory functions were investigated acutely post-injury and again at 12 and 30 months post-injury. Results suggested a strong association between injury severity across all neurobehavioural domains. Further, 30 month outcome was predicted by multiple factors including injury severity, socio-economic status, pre-injury adaptive abilities and age, with pre-injury child behaviour and specific lesion characteristics playing surprisingly little role. In conclusion, children with more severe injuries, lower pre-injury adaptive abilities and lower socio-economic status are at greatest risk of long-term neurobehavioural impairment, even several years post-injury.	Univ Melbourne, Melbourne, Vic, Australia; Royal Childrens Hosp, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Alfred Hosp, Melbourne, Vic, Australia; Monash Univ, Melbourne, Vic 3004, Australia		Anderson, VA (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Rosenfeld, Jeffrey V/B-7249-2011; Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Amacher AL, 1988, PEDIAT HEAD INJURIES; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V., 1995, NEUROPSYCHOLOGICAL A; ANDERSON V, 2004, IN PRESS J NEUROL NE; ANDERSON V, 2001, DEV NEUROPSYCHOLOY C; ANDERSON V, 2000, PED REHABIL, V3, P159; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson VA, 2000, BRIT J CANCER, V82, P255; Aram DM, 1986, DEV NEUROPSYCHOL, V2, P155, DOI 10.1080/87565648609540339; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BAYLEY N, 1969, BAYLYS SCALES INFANT; Begali V., 1992, HEAD INJURY CHILDREN; BIJUR P, 1988, AM J DIS CHILD, V142, P1307, DOI 10.1001/archpedi.1988.02150120061041; BRESLAU N, 1990, ARCH GEN PSYCHIAT, V47, P15; CARROWWOOLFOLK E, 1985, EXAMINERS MANUAL TES; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Christensen AL, 1979, LURIAS NEUROPSYCHOLO; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; CRAFT AW, 1972, BMJ-BRIT MED J, V4, P200, DOI 10.1136/bmj.4.5834.200; Daniel A., 1983, POWER PRIVILEGE PRES; Dennis M, 1996, J NEURO-ONCOL, V29, P91, DOI 10.1007/BF00165522; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; DENNIS M, 1980, BRAIN LANG, V10, P287, DOI 10.1016/0093-934X(80)90058-9; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; Dunn LM., 1981, PEABODY PICTURE VOCA; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Finger S., 1982, BRAIN DAMAGE RECOVER; FLETCHER EJ, 1995, RECEPTOR CHANNEL, V3, P21; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GARDNER MF, 1979, MANUAL EXPRESSIVE ON; Gronwall D, 1997, J INT NEUROPSYCH SOC, V6, P592; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kraus JF., 1995, TRAUMATIC HEAD INJUR, P117; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Lachar D., 1992, PERSONALITY INVENT S; LANGECOSACK H, 1979, NEUROPADIATRIE, V10, P105, DOI 10.1055/s-0028-1085318; LARSON CP, 1988, AM J DIS CHILD, V142, P1052, DOI 10.1001/archpedi.1988.02150100046023; Lenneberg E.H., 1967, BIOL FDN LANGUAGE; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVINE MA, 1988, PHYS SCRIPTA, VT22, P157, DOI 10.1088/0031-8949/1988/T22/024; LHERMITTE J, 1972, REV NEUROL, V74, P20; McCarthy D., 1972, MANUAL MCCARTHY SCAL; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Newman H, 1988, BRAIN IMPAIR, P223; NOLLER P, 1988, UNPUB ICPS FAMILY FU; PRIOER M, 1994, AUST PSYCHOL, V29, P116, DOI 10.1080/00050069408257334; Renfrew C, 1995, RENFREW BUS STORY MA, V3rd ed.; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; SMITH A, 1983, J CONSULT CLIN PSYCH, V51, P768, DOI 10.1037/0022-006X.51.5.768; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TAYLOR HG, 1993, J CLIN CHILD PSYCHOL, V22, P196, DOI 10.1207/s15374424jccp2202_6; TEASDALE G, 1974, LANCET, V2, P81; TEUBER H, 1962, Dev Med Child Neurol, V4, P3; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; Wechsler D., 1989, MANUAL PRESCHOOL PRI; Wilson BA, 1991, RIVERMEAD BEHAV MEMO; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; [No title captured]; [No title captured]	92	119	121	2	24	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	DEC	2004	127		12				2608	2620		10.1093/brain/awh320			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	874PE	WOS:000225361500007	15537678	Bronze			2022-02-06	
J	Barber, RC; Aragaki, CC; Rivera-Chavez, FA; Purdue, GF; Hunt, JL; Horton, JW				Barber, RC; Aragaki, CC; Rivera-Chavez, FA; Purdue, GF; Hunt, JL; Horton, JW			TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury	JOURNAL OF MEDICAL GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; INTERLEUKIN-6 PROMOTER POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; MULTIPLE ORGAN DYSFUNCTION; SEPTIC SHOCK; SIGNAL-TRANSDUCTION; GENE; MORTALITY; PLASMA; TIME	Context: Sepsis, organ failure, and shock remain common among patients with moderate to severe burn injuries. The inability of clinical factors to identify at-risk patients suggests that genetic variation may influence the risk for serious infection and the outcome from severe injury. Objective: Resolution of genetic variants associated with severe sepsis following burn injury. Patients: A total of 159 patients with burns greater than or equal to 20% of their total body surface area or any smoke inhalation injury without significant non-burn related trauma ( injury severity score (ISS)greater than or equal to 16), traumatic or anoxic brain injury, or spinal cord injury and who survived more than 48 h post- admission. Methods: Candidate single nucleotide polymorphisms (SNPs) within bacterial recognition (TLR4 + 896, CD14 - 159) and inflammatory response (TNF-alpha 2308, IL-1beta-31, IL-6 -174) loci were evaluated for association with increased risk for severe sepsis ( sepsis plus organ dysfunction or septic shock) and mortality. Results: After adjustment for age, full-thickness burn size, ethnicity, and gender, carriage of the TLR4 + 896 G-allele imparted at least a 1.8-fold increased risk of developing severe sepsis following a burn injury, relative to AA homozygotes (adjusted odds ratio (aOR) 6.4; 95% confidence interval (CI) 1.8 to 23.2). Carriage of the TNF-alpha -308 A-allele imparted a similarly increased risk, relative to GG homozygotes (aOR = 4.5; 95% CI 1.7 to 12.0). None of the SNPs examined were significantly associated with mortality. Conclusions: The TLR4 + 896 and TNF-alpha -308 polymorphisms were significantly associated with an increased risk for severe sepsis following burn trauma.	Univ Texas, SW Med Ctr, Dept Surg, Dallas, TX 75390 USA; Univ Texas, Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol, Dallas, TX 75230 USA; Univ Texas, Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Dallas, TX 75230 USA		Barber, RC (corresponding author), Univ Texas, SW Med Ctr, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.barber@utsouthwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM021681] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P50GM021681-38, P50 GM021681-38] Funding Source: Medline		Abraham E, 2000, CRIT CARE MED, V28, P232, DOI 10.1097/00003246-200001000-00039; Abraham LJ, 1999, J LEUKOCYTE BIOL, V66, P562, DOI 10.1002/jlb.66.4.562; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249; An HZ, 2002, IMMUNOLOGY, V106, P38, DOI 10.1046/j.1365-2567.2002.01401.x; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arslan E, 2000, BURNS, V26, P521, DOI 10.1016/S0305-4179(00)00024-3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280; Chapes SK, 2001, J LEUKOCYTE BIOL, V69, P381; Cumming J, 2001, J TRAUMA, V50, P510, DOI 10.1097/00005373-200103000-00016; DROST AC, 1993, J TRAUMA, V35, P335, DOI 10.1097/00005373-199309000-00001; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; ENDO S, 1993, BURNS, V19, P124, DOI 10.1016/0305-4179(93)90033-5; Ferrand PE, 2002, MOL HUM REPROD, V8, P1031, DOI 10.1093/molehr/8.11.1031; Fishman D, 1998, EUR CYTOKINE NETW, V9, P364; Fitzwater J, 2003, J TRAUMA, V54, P959, DOI 10.1097/01.TA.0000029382.26295.AB; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Ingalls RR, 2000, J ENDOTOXIN RES, V6, P411, DOI 10.1177/09680519000060050301; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Knight JC, 1999, P ASSOC AM PHYSICIAN, V111, P290, DOI 10.1046/j.1525-1381.1999.99237.x; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kroeger KM, 2000, CYTOKINE, V12, P110, DOI 10.1006/cyto.1999.0529; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Leveque G, 2003, INFECT IMMUN, V71, P1116, DOI 10.1128/IAI.71.3.1116-1124.2003; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; MARANO MA, 1990, SURG GYNECOL OBSTET, V170, P32; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; Sankaran D, 1999, KIDNEY INT, V56, P281, DOI 10.1046/j.1523-1755.1999.00536.x; Schluter B, 2002, CRIT CARE MED, V30, P32, DOI 10.1097/00003246-200201000-00005; Schwartz DA, 2002, INT J HYG ENVIR HEAL, V205, P221, DOI 10.1078/1438-4639-00117; Smirnova I, 2000, GENOME BIOL, V1; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195	47	119	129	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-2593	1468-6244		J MED GENET	J. Med. Genet.	NOV	2004	41	11					808	U1		10.1136/jmg.2004.021600			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867IA	WOS:000224834700002	15520404	Green Accepted, Green Published, Bronze			2022-02-06	
J	Felmingham, KL; Baguley, IJ; Green, AM				Felmingham, KL; Baguley, IJ; Green, AM			Effects of diffuse axonal injury on speed of information processing following severe traumatic brain injury	NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; MULTIPLE-SCLEROSIS; DIVIDED ATTENTION; DEFICITS; REHABILITATION; FLEXIBILITY; VALIDATION; COGNITION; RECOVERY; LESIONS	To test the hypothesis that slowed information processing in traumatic brain injury is related to diffuse axonal injury (DAI), the authors compared 10 patients with predominant DAI (diffuse group) and minimal DAI (mixed injury group) on the Symbol Digit Modalities Test, simple and choice reaction time, Trail Making Tests A and B, and the Stroop Neuropsychological Screening Test. The diffuse group was slower than the mixed injury and control groups on basic speed of processing tasks. This difference was not apparent on complex speeded tasks once basic speed of processing was controlled for. The diffuse group's slower speed of processing was not accounted for by differences in injury severity, age, or time postinjury. The diffuse group showed greater recovery over time.	Westmead Hosp, Brain Injury Rehabil Serv, Westmead, NSW 2145, Australia; Univ New S Wales, Dept Psychol, Sydney, NSW, Australia		Baguley, IJ (corresponding author), Westmead Hosp, Brain Injury Rehabil Serv, Westmead, NSW 2145, Australia.	ianb@biru.wsahs.nsw.gov.au	Baguley, Ian/AAM-5828-2021; Baguley, Ian J/K-6878-2013	Baguley, Ian J/0000-0001-5650-3705			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Archibald CJ, 2000, J CLIN EXP NEUROPSYC, V22, P686, DOI 10.1076/1380-3395(200010)22:5;1-9;FT686; Babor T., 1989, ALCOHOL USE DISORDER; Bigler ED, 1998, MED PEDIATR ONCOL, P17; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; De Sonneville LMJ, 2002, NEUROPSYCHOLOGIA, V40, P1751, DOI 10.1016/S0028-3932(02)00041-6; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; JENNETT B, 1977, LANCET, V1, P878; JOHNSON SC, 1994, NEUROPSYCHOLOGY, V8, P301; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Llorente AM, 1998, J CLIN EXP NEUROPSYC, V20, P60, DOI 10.1076/jcen.20.1.60.1489; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER EM, 1994, PERS INDIV DIFFER, V17, P803, DOI 10.1016/0191-8869(94)90049-3; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; PARKER JR, 1990, ANN CLIN LAB SCI, V20, P220; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TimothyA., 1985, HDB PSYCHOL AGING, V2nd ed., P400; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Smith, 1973, SYMBOL DIGIT MODALIT; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Tomei G, 1991, J Neurosurg Sci, V35, P61; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; VILKKI J, 1994, NEUROPSYCHOLOGIA, V32, P1257, DOI 10.1016/0028-3932(94)90107-4; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924	48	119	120	0	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2004	18	3					564	571		10.1037/0894-4105.18.3.564			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	838IK	WOS:000222706700017	15291734				2022-02-06	
J	Ewing-Cobbs, L; Prasad, MR; Landry, SH; Kramer, L; DeLeon, R				Ewing-Cobbs, L; Prasad, MR; Landry, SH; Kramer, L; DeLeon, R			Executive functions following traumatic brain injury in young children: A preliminary analysis	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; ATTENTION DEFICIT/HYPERACTIVITY DISORDER; WORKING-MEMORY; INHIBITORY CONTROL; FRONTAL-LOBE; INDIVIDUAL-DIFFERENCES; HUMAN INFANTS; AGE; CHILDHOOD; SEVERITY	To examine executive processes in young children with traumatic brain injury (TBI), we evaluated performance of 44 children who sustained moderate-to-severe TBI prior to age 6 and to 39 comparison children on delayed response (DR), stationary boxes, and spatial reversal (SR) tasks. The tasks have different requirements for holding mental representations in working memory (WM) over a delay, inhibiting prepotent responses, and shifting response set. Age at the time of testing was divided into 10- to 35- and 36- to 85-month ranges. In relation to the community comparison group, children with moderate-to-severe TBI scored significantly lower on indexes of WM/inhibitory control (IC) on DR and stationary boxes tasks. On the latter task, the Age x Group interaction indicated that performance efficiency was significantly reduced in the older children with TBI relative to the older comparison group; performance was similar in younger children irrespective of injury status. The TBI and comparison groups did not differ on the SR task, suggesting that shifting response set was not significantly altered by TBI. In both the TBI and comparison groups, performance improved with age on the DR and stationary boxes tasks. Age at testing was not significantly related to scores on the SR task. The rate of acquisition of working memory (WM) and IC increases steeply during preschool years, but the abilities involved in shifting response set show less increase across age groups (Espy, Kaufmann, Glisky, 2001; Luciana & Nelson, 1998). The findings of our study are consistent with the rapid development hypothesis, which predicts that skills in a rapid stage of development will be vulnerable to disruption by brain injury.	Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Radiol, Houston, TX 77030 USA; Univ Houston, Dept Psychol, Houston, TX USA		Ewing-Cobbs, L (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Pediat, 7000 Fannin,Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029462] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 29462] Funding Source: Medline		ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Baddeley A.D., 1986, WORKING MEMORY; Barkley R.A., 1997, ADHD NATURE SELF CON; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Bayley N., 2006, BAYLEY SCALES INFANT, V3rd; BJORKLUND DF, 1990, DEV REV, V10, P48, DOI 10.1016/0273-2297(90)90004-N; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Breslau N, 2001, AM J EPIDEMIOL, V154, P711, DOI 10.1093/aje/154.8.711; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Bryan J, 2001, J CLIN EXP NEUROPSYC, V23, P608, DOI 10.1076/jcen.23.5.608.1250; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; CHAPPELL JE, 1995, IEEE AERO EL SYS MAG, V10, P5; Chiappe P, 2000, MEM COGNITION, V28, P8, DOI 10.3758/BF03211570; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Cohen J., 2013, STAT POWER ANAL BEHA; Collins P, 1998, J COGNITIVE NEUROSCI, V10, P332, DOI 10.1162/089892998562771; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; DEMPSTER FN, 1991, INTELLIGENCE, V15, P157, DOI 10.1016/0160-2896(91)90028-C; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; DENNIS M, 1988, MASTER LECT SERIES C, P89; DIAMOND A, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P339; DIAMOND A, 1990, P637; Diamond A, 2001, DEV COGN NEUROSCI, P433; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; Diamond A., 1997, MONOGRAPHS SOC RES C, V62; Espy KA, 1999, DEV NEUROPSYCHOL, V15, P447, DOI 10.1080/87565649909540761; Espy KA, 1999, BRAIN COGNITION, V41, P178, DOI 10.1006/brcg.1999.1117; Espy KA, 2001, CLIN NEUROPSYCHOL, V15, P46, DOI 10.1076/clin.15.1.46.1908; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; GATHERCOLE SE, 1990, BRIT J PSYCHOL, V81, P439, DOI 10.1111/j.2044-8295.1990.tb02371.x; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; Griffith EM, 1999, CHILD DEV, V70, P817, DOI 10.1111/1467-8624.00059; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; HUTTENLOCHER PR, 1997, DEV PREFRONTAL CORTE, P69; Jacobsen CF, 1935, ARCH NEURO PSYCHIATR, V33, P558, DOI 10.1001/archneurpsyc.1935.02250150108009; KAUFMANN PM, 1990, J CLIN EXP NEUROPSYC, V12, P69; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Konrad KN, 2000, BRAIN INJURY, V14, P859; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marzocchi GM, 2002, DEV NEUROPSYCHOL, V21, P73, DOI 10.1207/S15326942DN2101_4; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; MCEVOY RE, 1993, J CHILD PSYCHOL PSYC, V34, P563, DOI 10.1111/j.1469-7610.1993.tb01036.x; Mishkin M., 1964, FRONTAL GRANULAR COR; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P163, DOI 10.1037//0096-3445.130.2.163; Ozonoff S, 2001, J AUTISM DEV DISORD, V31, P257, DOI 10.1023/A:1010794902139; PENNINGTON BF, 1994, MAC FDN MEN, P243; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; PRASAD M, 2002, PEDIAT NEUROSURGERY, V36, P4; Roberts RJ, 1996, DEV NEUROPSYCHOL, V12, P105, DOI 10.1080/87565649609540642; RONCADIN C, 2002, THESIS YORK U TORONT; Sattler, 1986, STANFORDBINET INTELL; Savoy, 1998, SOC NEUR ABSTR, V24, P1251; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Swanson HL, 1996, J EXP CHILD PSYCHOL, V63, P358, DOI 10.1006/jecp.1996.0054; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Zacks R. T., 1998, PSYCHOL LEARN MOTIV, P193; [No title captured]	81	119	120	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2004	26	1					487	512		10.1207/s15326942dn2601_7			26	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	844BO	WOS:000223132300007	15276906				2022-02-06	
J	Covassin, T; Swanik, CB; Sachs, ML				Covassin, T; Swanik, CB; Sachs, ML			Epidemiological considerations of concussions among intercollegiate athletes	APPLIED NEUROPSYCHOLOGY			English	Article						concussions; intercollegiate sports; male sports; female sports; National Collegiate Athletic Association; Injury Surveillance System; injury; athlete exposure; injury rate; incidence density ratio	TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; CEREBRAL CONCUSSION; COLLEGE FOOTBALL; SOCCER PLAYERS; HOCKEY PLAYERS; CONTACT-SPORTS; GUIDELINES	The purpose of this study was to examine epidemiological trends of concussions among 15 different intercollegiate sports during the 1997-1998, 1998-1999, and 1999-2000 seasons. Data were collected using the National Collegiate Athletic Association (NCAA) Injury Surveillance System (ISS). For the 15 sports studied during the 3 academic years, the NCAA ISS documented 3,535 team-seasons, 40,547 reportable injuries, 5,566,924 practice athlete exposures (AEs), and 1,090,298 game AEs. Concussions accounted for 62% of all reported injuries during this 3-year study. Of all the reported injuries, women lacrosse players (13.9%) reported the highest percentage of suffering a concussion during a game followed by women's soccer (11.4%), men's ice hockey (10.3%), men's lacrosse (10.1%), football (8.8%), women's basketball, (8.5%), field hockey (7.2%), men's soccer (7.0%), wrestling (66%), men's basketball (5.0%), baseball (4.2 %), and women's volleyball (4.1%). Female athletes from all 7 sports were found to be at a lower risk for suffering concussions during practice sessions than the 8 male sports. However, female athletes were found to be at a greater risk for suffering concussions during games compared to male athletes. Injury trends over the 3-year period indicate concussions continue to be on the rise for athletes participating in collegiate football, men's soccer, and women's and men's basketball.	Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA		Swanik, CB (corresponding author), Temple Univ, Dept Kinesiol, Pearson Hall 127, Philadelphia, PA 19122 USA.		Swanik, Charles/C-4377-2014	Swanik, Charles/0000-0001-9701-2005			*AM MED ASS, 1966, SUBC CLADD SPORT INJ; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barth JT, 1989, MILD HEAD INJURY, P257; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Brown J., 2001, LACROSSE MAGAZIN MAY, P26; Bruce D A, 1982, Clin Sports Med, V1, P495; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; KELLY J, 1995, CURRENT THERAPY SPOR; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LORENTZON R, 1988, AM J SPORT MED, V16, P392, DOI 10.1177/036354658801600415; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; *NAT COLL ATHL ASS, NCAA INJ SURV SYST; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; *QUAL STAND SUBC A, 1997, NEUROBIOLOGY, V48, P1; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954	30	119	123	1	24	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2003	10	1					12	22		10.1207/S15324826AN1001_3			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	780NF	WOS:000189386900003	12734071				2022-02-06	
J	Mussack, T; Biberthaler, P; Kanz, KG; Wiedemann, E; Gippner-Steppert, C; Mutschler, W; Jochum, M				Mussack, T; Biberthaler, P; Kanz, KG; Wiedemann, E; Gippner-Steppert, C; Mutschler, W; Jochum, M			Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						serum markers; traumatic brain injury; cardiac arrest; resuscitation; cytokines; S-100 protein; interleukins	CARDIOPULMONARY-RESUSCITATION; CEREBROSPINAL-FLUID; REPERFUSION INJURY; HEAD TRAUMA; PROTEIN; DAMAGE; BLOOD; ISCHEMIA; RECOVERY; STROKE	Objective: To compare S-100B and interleukin-8 serum values on scene/at admission and 12 hrs later with respect to neurologic long-term outcome 12 months after cardiac arrest and return of spontaneous circulation; as well as after severe traumatic brain injury. Design: Prospective comparative cohort study. Setting: On scene; intensive care units of a university hospital. Patients: Twenty patients with out-of-hospital cardiac arrest. Twenty patients with severe traumatic brain injury. Interventions: Therapy was adjusted to the standards of modern prehospital and intensive care management by physicians who were not involved in the study. Measurements and Main Results: First median S-100B values of the cardiac arrest group (4.42 ng/mL) mounted as high as those of the traumatic brain injury group (4.11 ng/ml.). Within 12 hrs, S-100B levels significantly decreased to 0.75 ng/mL in cardiac arrest patients and to 0.68 ng/mL in traumatic brain injury patients but remained significantly elevated compared with the controls (0.04 ng/mL). Interleukin-8 levels of the cardiac arrest patients on scene (30.33 pg/mL) were clearly elevated above normal (12.60 pg/mQ and increased significantly to 101.40 pg/mL after 12 hrs. They showed no significant difference compared with those of the traumatic brain injury patients (78.75 pg/mL and 96.00 pg/mL, respectively). Multivariate Cox regression analysis in cardiac arrest patients identified only the S-100B level measured 12 hrs after study entry as an independent predictor for unfavorable neurologic outcome according to the Glasgow Outcome Scale score. In contrast, S-100B as well as interleukin-8 levels quantified 12 hrs after admission significantly predicted an unfavorable neurologic course in the traumatic brain injury group. Conclusions. Significantly elevated S-100B and interleukin-8 serum levels 12 hrs after cardiac arrest suggest that primary brain damage and systemic inflammatory response are comparably serious with that of traumatic brain injury. In both collectives, increased S-100B values measured 12 hrs after insult correlated well with an unfavorable neurologic outcome after 12 months.	Univ Munich, Chirurg Klin & Poliklin Innenstadt, Munich, Germany; Univ Munich, Klin Chem Abt, Munich, Germany; Univ Munich, Klin Biochem Innenstadt, Munich, Germany; Univ Munchen Klinikum, Munich, Germany		Mussack, T (corresponding author), Univ Munich, Chirurg Klin & Poliklin Innenstadt, Munich, Germany.						Astudillo R, 1996, Eur J Cardiothorac Surg, V10, P1107, DOI 10.1016/S1010-7940(96)80358-7; BATES D, 1993, J NEUROL NEUROSUR PS, V56, P589, DOI 10.1136/jnnp.56.6.589; BEREK K, 1995, STROKE, V26, P543, DOI 10.1161/01.STR.26.4.543; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Ewy GA, 2000, NEW ENGL J MED, V342, P1599, DOI 10.1056/NEJM200005253422109; FUJIOKA M, 1994, STROKE, V25, P2091, DOI 10.1161/01.STR.25.10.2091; Gisvold SE, 1996, CRIT CARE MED, V24, pS69; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hammon JW, 2000, J THORAC CARDIOV SUR, V119, P130, DOI 10.1016/S0022-5223(00)70227-3; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Jean WC, 1998, NEUROSURGERY, V43, P1382, DOI 10.1097/00006123-199812000-00076; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Jorgensen EO, 1999, RESUSCITATION, V42, P173, DOI 10.1016/S0300-9572(99)00116-1; KIRSCH TD, 1999, EMERGENCY MED COMP S, P1631; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; METINKO AP, 1992, J CLIN INVEST, V90, P791, DOI 10.1172/JCI115953; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mussack T, 2000, ACT NEUR S, V76, P393; Mussack T, 2001, WORLD J SURG, V25, P539, DOI 10.1007/s002680020082; Mussack T, 2001, RESUSCITATION, V49, P193, DOI 10.1016/S0300-9572(00)00346-4; OLSEN TS, 1986, BRAIN, V109, P393, DOI 10.1093/brain/109.3.393; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Shaffner DH, 1999, CRIT CARE MED, V27, P1335, DOI 10.1097/00003246-199907000-00026; Shyu KG, 1997, AM HEART J, V134, P551, DOI 10.1016/S0002-8703(97)70094-2; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; STUMP DA, 1995, ANN THORAC SURG, V59, P1340, DOI 10.1016/0003-4975(95)00108-W; USUI A, 1989, CLIN CHEM, V35, P1942; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Westfal RE, 1996, AM J EMERG MED, V14, P364, DOI 10.1016/S0735-6757(96)90050-9; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; Zhang WD, 1999, J NEUROIMMUNOL, V101, P148, DOI 10.1016/S0165-5728(99)00137-X	42	119	131	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2002	30	12					2669	2674		10.1097/00003246-200212000-00010			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633AP	WOS:000180257300010	12483057				2022-02-06	
J	Stahl, N; Mellergard, P; Hallstrom, A; Ungerstedt, U; Nordstrom, CH				Stahl, N; Mellergard, P; Hallstrom, A; Ungerstedt, U; Nordstrom, CH			Intracerebral microdialysis and bedside biochemical analysis in patients with fatal traumatic brain lesions	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						head injury; cerebral ischemia; microdialysis; glucose; glutamate; glycerol; lactate; pyruvate	CEREBRAL-ISCHEMIA; VOLUME REGULATION; INCOMPLETE ISCHEMIA; ENERGY-METABOLISM; HEAD-INJURY; GLYCEROL; DEGRADATION; PRINCIPLES; PRESSURE; SEIZURES	Background: Microdialysis with bedside biochemical analysis was used to monitor cerebral biochemical alterations that precede and accompany increase in intracranial pressure (ICP), resulting in a complete cessation of cerebral blood flow. Methods: Seven patients, who died due to an untreatable increase in ICP, were included. The patients originate from a large, consecutive series of severely head injured patients (n: 95) monitored with intracerebral microdialysis (perfusion rate 0.3 mul/min). One microdialysis catheter was inserted via a separate burr hole frontally to that used for the intraventricular catheter ("better" position) and one catheter was inserted into cerebral cortex surrounding an evacuated focal contusion or underlying an evacuated haematoma ("worse" position). Biochemical analyses of glucose, lactate, glycerol, urea, glutamate, and pyruvate were performed at the bedside. All samples were frozen for subsequent HPLC (high-performance liquid chromatography) analyses of amino acids and ions. Results: Decreases in glucose and pyruvate and increases in lactate, glycerol, glutamate, and lactate/ pyruvate (la/py) ratio characterized cerebral ischaemia. The measured markers give information regarding substrate availability (glucose), redox state of the tissue (la/py ratio), degradation of glycerophospholipids in cell membranes (glycerol), and extracellular concentration of excitatory amino acids (glutamate). In the "worse" position biochemical deterioration occurred before the increase in ICP. In the "better" position biochemical deterioration was usually observed after the increase in ICP. Conclusion: Changes of cerebral energy metabolism that accompany cerebral ischaemia follow a certain pattern and may be detected at the bedside by intracerebral microdialysis before the secondary damage causes an increase in ICP.	Univ Lund Hosp, Dept Clin Neurosci, S-22185 Lund, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden		Nordstrom, CH (corresponding author), Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden.						ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P922, DOI 10.1111/j.1399-6576.1995.tb04199.x; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BERTRAND N, 1992, NEUROSCI LETT, V148, P81, DOI 10.1016/0304-3940(92)90809-L; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; GERCKEN G, 1973, PFLUG ARCH EUR J PHY, V344, P207, DOI 10.1007/BF00588461; Grande PO, 2000, ACTA ANAESTH SCAND, V44, P886, DOI 10.1034/j.1399-6576.2000.440718.x; GRANDE PO, 1997, J TRAUMA, V42, P23; HARPER HA, 1963, REV PHYSL CHEM; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Kongstad L, 1999, ACTA ANAESTH SCAND, V43, P501, DOI 10.1034/j.1399-6576.1999.430503.x; LINDROTH P, 1979, ANAL CHEM, V51, P1167; LJUNGGREN B, 1974, BRAIN RES, V77, P173, DOI 10.1016/0006-8993(74)90782-3; LUNDBERG N, 1960, ACTA PSYCHIAT NEUR S, V149; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NORDSTROM CH, 1978, STROKE, V9, P327, DOI 10.1161/01.STR.9.4.327; PASCHEN W, 1986, METAB BRAIN DIS, V1, P37, DOI 10.1007/BF00998475; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Saveland H, 1996, NEUROSURGERY, V38, P12, DOI 10.1097/00006123-199601000-00004; Siesj? BK., 1978, BRAIN ENERGY METABOL; TEASDALE G, 1974, LANCET, V2, P81; Ungerstedt U, 1997, PHYSIOLOGY, STRESS, AND MALNUTRITION, P361; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971	29	119	122	0	1	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	SEP	2001	45	8					977	985		10.1034/j.1399-6576.2001.450810.x			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	478ZX	WOS:000171380400010	11576049				2022-02-06	
J	Citerio, G; Vascotto, E; Villa, F; Celotti, S; Pesenti, A				Citerio, G; Vascotto, E; Villa, F; Celotti, S; Pesenti, A			Induced abdominal compartment syndrome increases intracranial pressure in neurotrauma patients: A prospective study	CRITICAL CARE MEDICINE			English	Article						intracranial pressure; intracranial physiology; head injuries; respiratory mechanics; abdominal physiology; prospective studies; intensive care; intracranial pressure	ELEVATED INTRAABDOMINAL PRESSURE; LAPAROSCOPIC CHOLECYSTECTOMY; HEAD-INJURY; CONSEQUENCES; PULMONARY	pObjective: To evaluate the effect of a stepwise increase in intra-abdominal pressure (IAP) on intracranial pressure (ICP) and to further define the pressure transmission characteristics of different body compartments. Design: A prospective, nonrandomized study. Setting: A multidisciplinary intensive care unit at a university medical center. Patients: Fifteen patients with moderate-to-severe head injury. Interventions: All patients were studied after the initial stabilization and resolution of intracranial hypertension. Measurements were carried out before and 20 mins after IAP was increased by positioning a soft, 15-L water bag on the patient's abdomen. Measurements and Main Results: Placing weights upon the abdomen generated a significant increase in IAP, which rose from 4.7 +/- 2.9 to 15.5 +/- 4.1 mm Hg (p < .001). The rise in IAP caused concomitant and rapid increases in central venous pressure (from 6.2 +/- 2.4 to 10.4 +/- 2.9 mm Hg; p < .001), internal jugular pressure (from 11.9 +/- 3.2 to 14.3 +/- 2.4 mm Hg; p < .001), and ICP (from 12.0 +/- 4.2 to 15.5 +/- 4.4 mm Hg; p < .001). Thoracic transmural pressure, calculated as the difference between central venous pressure and esophageal pressure, remained constant during the protocol. Respiratory system compliance decreased from 58.9 +/- 9.8 to 44.9 +/- 9.4 mL/cm H2O (p < .001) in all patients because of decreased chest wall compliance. The mean arterial pressure increased from 94 +/- 11 to 100 +/- 13 mm Hg (p < .01), which allowed the maintenance of a stable cerebral perfusion pressure (82.4 +/- 10.3 vs. 84.7 +/- 11.5 mm Hg; p = NS) despite the ICP increase. Conclusions: Increased IAP causes a significant rise in ICP in head trauma patients. This effect seems to be the result of an increase in intrathoracic pressure, which causes a functional obstruction to cerebral venous outflow. Routine assessment of IAP may help clinicians to identify remediable causes of increased ICP. Caution should be used when applying laparoscopic techniques in neurotrauma patients.	Nuovo Osped San Gerardo, Dipartimento Anestesia & Rianimaz, Monza, Italy		Citerio, G (corresponding author), Nuovo Osped San Gerardo, Dipartimento Anestesia & Rianimaz, Monza, Italy.		Citerio, Giuseppe/B-1839-2015; Pesenti, Antonio/H-7483-2012	Citerio, Giuseppe/0000-0002-5374-3161; Pesenti, Antonio/0000-0003-2593-729X			BARNES GE, 1985, AM J PHYSIOL, V248, pR208, DOI 10.1152/ajpregu.1985.248.2.R208; Bloomfield Geoffrey L., 1995, Surgical Forum, V46, P572; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Bloomfield GL, 1995, J TRAUMA, V39, P1168, DOI 10.1097/00005373-199512000-00028; CALDWELL CB, 1987, J SURG RES, V43, P14, DOI 10.1016/0022-4804(87)90041-2; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; CULLEN DJ, 1989, CRIT CARE MED, V17, P118, DOI 10.1097/00003246-198902000-00002; DHOOGHE TM, 1993, AM J OBSTET GYNECOL, V169, P1352, DOI 10.1016/0002-9378(93)90304-2; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; IBERTI TJ, 1987, CRIT CARE MED, V15, P1140, DOI 10.1097/00003246-198712000-00014; IRGAU I, 1995, ARCH SURG-CHICAGO, V130, P1011; JACQUES T, 1988, ANAESTH INTENS CARE, V16, P478, DOI 10.1177/0310057X8801600415; JOSEPHS LG, 1994, J TRAUMA, V36, P815, DOI 10.1097/00005373-199406000-00011; KASHTAN J, 1981, J SURG RES, V30, P249, DOI 10.1016/0022-4804(81)90156-6; KENDALL AP, 1995, ANAESTHESIA, V50, P286, DOI 10.1111/j.1365-2044.1995.tb04600.x; KRON IL, 1984, ANN SURG, V199, P28, DOI 10.1097/00000658-198401000-00005; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MCGREGOR M, 1979, NEW ENGL J MED, V301, P480, DOI 10.1056/NEJM197908303010905; NATHENS AB, 1998, CURR OPIN CRIT CARE, V4, P116; ORTELLS J, 1999, INTENSIVE CARE ME S1, V25, pS22; PELOSI P, 1995, AM J RESP CRIT CARE, V152, P531, DOI 10.1164/ajrccm.152.2.7633703; RICHARDS WO, 1983, ANN SURG, V197, P183, DOI 10.1097/00000658-198302000-00010; SAFRAN DS, 1985, AM J PHYSIOL, V248, pR208; SCHEIN M, 1995, J AM COLL SURGEONS, V180, P745; TEASDALE G, 1974, LANCET, V2, P81; WESTERBAND A, 1992, SURG GYNECOL OBSTET, V175, P535	26	119	130	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2001	29	7					1466	1471		10.1097/00003246-200107000-00027			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	453XX	WOS:000169944400027	11445709				2022-02-06	
J	Palmer, S; Bader, MK; Qureshi, A; Palmer, J; Shaver, T; Borzatta, M; Stalcup, C				Palmer, S; Bader, MK; Qureshi, A; Palmer, J; Shaver, T; Borzatta, M; Stalcup, C			The impact on outcomes in a community hospital setting of using the AANS traumatic brain injury guidelines	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						traumatic brain injury; intracranial pressure; neurotrauma; Sjo(2) monitoring	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; CEREBRAL OXYGENATION; CLINICAL-TRIAL; MANAGEMENT; HYPERVENTILATION; VENTRICULOSTOMY; SATURATION; PROGRAM	Background: Traumatic brain injury poses a serious public health challenge, Treatment paradigms have dramatically shifted with the introduction of the American Association of Neurologic Surgeons (AANS) Guidelines for the Management of Severe Head Injury, Implementation of the AANS guidelines positively affects patient outcomes and can be successfully introduced in a community hospital setting. Methods: Data were collected both retrospectively and prospectively from the records of all trauma patients between 1994 and 1999, A cohort of 93 patients was selected. Thirty-seven patients were treated before the implementation of the AANS guidelines, and these were statistically compared with 56 patients treated after the implementation of the guidelines. Results: Implementation of the recommendations in the AANS guidelines in a standardized protocol resulted in a 9.13 times higher odds ratio of a good outcome relative to the odds of a poor outcome or death compared with a group managed before the practice change. A Glasgow Coma Scale (GCS) admission score > 8 was associated with a 6.58 times higher odds ratio of a good outcome compared with a GCS admission score less than or equal to 8, Odds ratio of a good outcome decreased by a factor of 0.92 for each year increase in age of patients starting at age 9, A dedicated neurotrauma team and comprehensive treatment algorithms are critical elements to this success. Hospital charges increased by more than $97,000 per patient, but are justifiable in the face of significantly improved outcomes. Conclusion: Implementation of a traumatic brain injury protocol in a community hospital setting is practical and efficacious. Appropriate invasive monitoring of systemic and cerebral parameters guides care decisions. The protocol results in an increase in resource usage, but it also results in statistically improved outcomes justifying the increase in expenditures.	Mission Hosp Reg Med Ctr, Mission Viejo, CA USA; Sisters St Joseph Orange Corp, St Joseph Hlth Syst, Orange, CA USA		Palmer, S (corresponding author), 26732 Crown Valley Pkwy,Suite 561, Mission Viejo, CA 92691 USA.						Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BADER MK, 1995, HEART LUNG, V24, P166, DOI 10.1016/S0147-9563(05)80012-3; Baethmann A, 1998, ACT NEUR S, V71, P107; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bullock R, 1995, GUIDELINES MANAGEMEN; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chestnut R. M., 1996, NEUROTRAUMA, P445; DeWitt D S, 1995, New Horiz, V3, P376; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Feldman Z, 1997, CRIT CARE CLIN, V13, P51, DOI 10.1016/S0749-0704(05)70296-7; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Kelly DF, 1996, NEUROTRAUMA, P71; KELLY DF, 1995, NEUROLOGICAL SURG; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; McKinely BA, 1999, J TRAUMA, V46, P271, DOI 10.1097/00005373-199902000-00013; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prough DS, 1997, J TRAUMA, V42, pS10, DOI 10.1097/00005373-199705001-00003; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sikes P J, 1994, Crit Care Nurs Q, V17, P9; Simons R, 1999, J TRAUMA, V46, P811, DOI 10.1097/00005373-199905000-00008; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Woodman T, 1996, NEUROTRAUMA, P519; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	35	119	123	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2001	50	4					657	664		10.1097/00005373-200104000-00010			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	424QP	WOS:000168243200018	11303160				2022-02-06	
J	Kerns, KA; Eso, K; Thomson, J				Kerns, KA; Eso, K; Thomson, J			Investigation of a direct intervention for improving attention in young children with ADHD	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	26th Annual Meeting of the International-Neuropsychological-Society	FEB 04-05, 1998	HONOLULU, HAWAII	Int Neuropsychol Soc			TRAUMATIC BRAIN INJURY; HYPERACTIVE-CHILDREN; SUSTAINED ATTENTION; DEFICIT DISORDER; BOYS; PERFORMANCE	The efficacy of a new set of child-oriented direct intervention materials, Pay Attention!(1994), was investigated in 14 children, ages 7 to 11 years, diagnosed with attention deficit hyperactivity disorder (ADHD). Treatment and control groups were matched for age, sex, and medication status. Both groups completed pre- and posttraining assessment batteries that included psychometric measures of attention, a measure of academic efficiency, and behavioral rating scales completed by parents and teachers. Results indicate that children who received the direct intervention did significantly better on a number of nontrained measures of attention and academic efficiency. Behavioral ratings of inattention-impulsivity and hyperactivity completed by parents did not differ following treatment, although a marginally significant improvement in inattention-impulsivity was noted by school teachers. These results suggest that direct interventions aimed at improving attention may be a valuable treatment option for improving cognitive efficiency in children with ADHD and warrant further investigation.	Univ Victoria, Dept Psychol, Victoria, BC V8W 3P5, Canada; Calif State Coll Bakersfield, Bakersfield, CA 93309 USA; Univ Washington, Seattle, WA 98195 USA		Kerns, KA (corresponding author), Univ Victoria, Dept Psychol, POB 3050, Victoria, BC V8W 3P5, Canada.						ABIKOFF H, 1991, J LEARN DISABIL, V24, P205, DOI 10.1177/002221949102400404; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baribeau J, 1989, J NEUROL REHABIL, V3, P71; Barkley R.A., 1997, ADHD NATURE SELF CON; BARKLEY RA, 1992, J ABNORM CHILD PSYCH, V20, P163, DOI 10.1007/BF00916547; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Ben-Yishay Y., 1987, NEUROPSYCHOLOGICAL R, P165; CECI SJ, 1984, CHILD DEV, V55, P2193; Diller L, 1974, STUDIES COGNITION RE; Doehring D. G., 1968, PATTERN IMPAIRMENT S; DOUGLAS VI, 1983, DEV NEUROPSYCHIATRY, P280; Ethier M, 1989, CANADIAN J REHABILIT, V2, P223; EVERETT J, 1991, CHILD PSYCHIAT HUM D, V22, P79, DOI 10.1007/BF00707786; FINLEY G, 1987, P AM ASSOC CANC RES, V28, P180; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Golden CJ, 1978, STROOP COLOR WORD TE; Gray J M, 1989, Brain Inj, V3, P163, DOI 10.3109/02699058909004548; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hechtman LT, 1993, HYPERACTIVE CHILDREN; *HOM ENT, 1994, FREDD FISH COMP SOFT; HOOKS K, 1994, J CLIN CHILD PSYCHOL, V23, P69, DOI 10.1207/s15374424jccp2301_9; Hooper HE., 1983, HOOPER VISUAL ORG TE; JUDD CM, 1989, DATA ANAL MODEL COMP, P372; KAGAN J, 1966, J ABNORM PSYCHOL, V71, P17, DOI 10.1037/h0022886; Kaufman A. S., 1990, MANUAL KAUFMAN BRIEF; KERNS KA, 1996, ECOLOGICAL VALIDITY, P147; KERNS KA, 1998, UNPUB DEV PRESCHOOL; LANDAU S, 1992, CHILD DEV, V63, P928; LAROSE S, 1989, PERCEPT MOTOR SKILL, V69, P851, DOI 10.2466/pms.1989.69.3.851; Lorys A R, 1990, Arch Clin Neuropsychol, V5, P119, DOI 10.1016/0887-6177(90)90033-L; MALEC J, 1984, COGNITIVE REHABILITA, V2, P18; MANNUZZA S, 1993, ARCH GEN PSYCHIAT, V50, P565; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; Mateer CA, 1990, COGNITIVE REHABILITA, P68; Mateer CA, 1988, NEUROPSYCHOLOGICAL S, P202; MCCARNEY SB, 1989, ATTENTION DEFICIT DI; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; PENNINGTON BF, 1991, DIAGNOSING LEARNING, P82; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRINZ RJ, 1984, J CLIN CHILD PSYCHOL, V13, P250, DOI 10.1207/s15374424jccp1303_6; RASKIN S, 1993, M AM COLL REH MED DE; Raskin S, 1998, 26 ANN INT NEUR SOC; REID MK, 1987, J EDUC PSYCHOL, V79, P296, DOI 10.1037/0022-0663.79.3.296; ROURKE BP, 1986, NEUROPSYCHOLOGICAL A; SEIDEL WT, 1990, J ABNORM CHILD PSYCH, V18, P217, DOI 10.1007/BF00910732; Semrud-Clikeman M., 1998, 26 ANN INT NEUR SOC; SEMRUDCLIKEMAN M, IN PRESS J LEARNING; SIVAK M, 1984, ARCH PHYS MED REHAB, V65, P163; Sohlberg M. M., 1989, ATTENTION PROCESS TR; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; *SUNB COMM, 1984, MEM CAST COMP SOFTW; SZATMARI P, 1992, CHILD ADOLESC PSYCHI, V1, P361; Thomson JB, 1994, PAY ATTENTION; THOMSON JB, 23 ANN INT NEUR SOC; THOMSON JB, IN PRESS NEUROPSYCHO; TROMMER BL, 1988, ANN NEUROL, V24, P610, DOI 10.1002/ana.410240504; VANDERMEERE J, 1988, J ABNORM CHILD PSYCH, V16, P627, DOI 10.1007/BF00913474; WEBER AM, 1990, DEV NEUROPSYCHOL, V6, P13, DOI 10.1080/87565649009540446; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WHALEN CK, 1985, J ABNORM CHILD PSYCH, V13, P391, DOI 10.1007/BF00912724; Williams D.J., 1989, THESIS U WASHINGTON; WILSON C, 1992, NEUROPSYCHOL REHABIL, V2, P193; Wood R L, 1987, Int Disabil Stud, V9, P149; 1992, MATH BLASTER COMPUTE	68	119	121	1	21	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		1999	16	2					273	295		10.1207/S15326942DN1602_9			23	Psychology, Developmental; Psychology; Psychology, Experimental	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	238VX	WOS:000082736100009					2022-02-06	
J	Roberts, I; Schierhout, G; Alderson, P				Roberts, I; Schierhout, G; Alderson, P			Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						head injuries; systematic review; meta-analysis; randomised controlled trials	TRAUMATIC BRAIN INJURY; PRESSURE; TRIALS; MANNITOL	Objectives-To assess the effectiveness of interventions routinely used in the intensive care management of severe head injury, specifically, the effectiveness of hyperventilation, mannitol, CSF drainage, barbiturates, and corticosteroids. Methods-Systematic review of all unconfounded randomised trials, published or unpublished, that were available by August 1996. Results-None of the interventions has been reliably shown to reduce death or disability after severe head injury. One trial of hyperventilation was identified of 77 participants. The relative risk for death was 0.73 (95% confidence interval (95% CI) 0.36-1.49), and for death or disability it was 1.14 (95% CI 0.82-1.58), One trial of mannitol was identified of 41 participants. The relative risk for death was 1.75 (95% CI 0.48-6.38), no data were available for disability. No randomised trials of CSF drainage were identified. Two randomised trials of barbiturate therapy were identified, including 126 participants. The pooled relative risk for death was 1.12 (95% CI 0.81-1.54). Disability data were available for one trial. The relative risk for death or disability was 0.96 (95% CI 0.62-1.49). Thirteen randomised trials of corticosteroids were identified, comprising 2073 participants. The pooled relative risk for death was 0.95 (0.84 to 1.07) and for death or disability it was 1.01 (95% CI 0.91 to 1.11). On the basis of the currently available randomised evidence, for every intervention studied it is impossible to refute either a moderate increase or a moderate decrease in the risk of death or disability. Conclusion-Existing trials have been too small to support or refute the existence of a real benefit from using hyperventilation, mannitol, CSF drainage, barbiturates, or corticosteroids. Further large scale randomised trials of these interventions are required.	Univ London, Inst Child Hlth, Dept Epidemiol & Publ Hlth, Child Hlth Monitoring Unit, London WC1N 1EH, England; Cochrane Ctr, Oxford, England		Roberts, I (corresponding author), Univ London, Inst Child Hlth, Dept Epidemiol & Publ Hlth, Child Hlth Monitoring Unit, 30 Guilford St, London WC1N 1EH, England.			Schierhout, Gill/0000-0002-6399-7624			Alderson P, 1998, BRIT MED J, V316, P396; Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; ALDERSON P, 1998, INJURIES GROUP MODUL; ALEXANDER E, 1992, SURG NEUROL, V38, P478, DOI 10.1016/0090-3019(92)90124-6; [Anonymous], 1997, LANCET, V349, P1263; BOHN DJ, 1989, CRIT CARE MED S, V118, P17; Brain Trauma Foundation, 1995, GUID MAN SEV HEAD IN; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FANCONI S, 1988, INTENS CARE MED, V14, P163; GENTLEMAN D, 1990, INJURY, V21, P305, DOI 10.1016/0020-1383(90)90047-X; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; ROBERTS I, 1998, INJURIES GROUP MODUL; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; SCHIERHOUT G, 1998, INJURIES GROUP MODUL; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; YANO M, 1981, Neurologia Medico-Chirurgica, V21, P163	24	119	122	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	1998	65	5					729	733		10.1136/jnnp.65.5.729			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	133VC	WOS:000076706400022	9810947	Green Published, Bronze			2022-02-06	
J	Schmand, B; Lindeboom, J; Schagen, S; Heijt, R; Koene, T; Hamburger, HL				Schmand, B; Lindeboom, J; Schagen, S; Heijt, R; Koene, T; Hamburger, HL			Cognitive complaints in patients after whiplash injury: the impact of malingering	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						whiplash injury; neuropsychological tests; cognition disorders; malingering	COMMON WHIPLASH; FOLLOW-UP; DEFICITS; INCENTIVES; SYMPTOMS; MEMORY; UPDATE	Objectives-The validity of memory and concentration complaints that are often reported after a whiplash trauma is controversial. The prevalence of malingering or under performance in post-whiplash patients, and its impact on their cognitive test results were studied. Methods-The Amsterdam short term memory (ASTM) test, a recently developed malingering test, was used as well as a series of conventional memory and concentration tests. The study sample was a highly selected group of patients, who were examined either as part of a litigation procedure (n=36) or in the normal routine of an outpatient clinic (n=72). Results-The prevalence of underperformance, as defined by a positive score on the malingering test, was 61% (95% CI: 45-77) in the context of litigation, and 29% (95% CI: 18-40) in the outpatient clinic (p=0.003). Furthermore, the scores on the memory and concentration test of malingering post-whiplash patients (n=43) and non-malingering post-whiplash patients (n=65) were compared with the scores of patients with closed head injury (n=20) and normal controls (n=46). The malingering post-whiplash patients scored as low as the patients with closed head injury on most tests. Conclusions-The prevalence of malingering or cognitive underperformance in late post-whiplash patients is substantial, particularly in litigation contexts. it is not warranted to explain the mild cognitive disorders of whiplash patients in terms of brain damage, as some authors have done. The cognitive complaints of non-malingering post-whiplash patients are more likely a result of chronic pain, chronic fatigue, or depression.	Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; Slotervaartziekenhuis, Dept Psychol, Amsterdam, Netherlands; Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Med Psychol, Amsterdam, Netherlands; Slotervaartziekenhuis, Dept Neurol, Amsterdam, Netherlands; Slotervaartziekenhuis, Dept Clin Neurophysiol, Amsterdam, Netherlands		Schmand, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, H2-214,POB 22660, NL-1100 DD Amsterdam, Netherlands.						BAYER TL, 1985, SOC SCI MED, V20, P517, DOI 10.1016/0277-9536(85)90368-5; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bouma A., 1996, NEUROPSYCHOLOGISCHE; Cassens G, 1990, J Neuropsychiatry Clin Neurosci, V2, P202; DISTEFANO G, 1995, ACTA NEUROL SCAND, V91, P346; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Hammes J., 1978, STROOP KLEUR WOORD T; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LUTEIJN F, 1983, GRONINGER INTELLIGEN; MossMorris R, 1996, J NEUROL NEUROSUR PS, V60, P474, DOI 10.1136/jnnp.60.5.474; Nelson H.E., 1982, NATL ADULT READING T; OLSNES BT, 1989, ACTA NEUROL SCAND, V80, P584, DOI 10.1111/j.1600-0404.1989.tb03931.x; Otte A, 1996, EUR J NUCL MED, V23, P72, DOI 10.1007/BF01736993; PEARCE JMS, 1994, NEUROLOGY, V44, P1993, DOI 10.1212/WNL.44.11.1993; PEARCE JMS, 1995, COMMENTS NEUROLOGY, V45, P2116; *QUEB TASK FORC WH, 1995, SPINE S8, V20, pS12; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; RADANOV BP, 1993, ARCH NEUROL-CHICAGO, V50, P87, DOI 10.1001/archneur.1993.00540010081022; Radanov BP, 1996, SPINE, V21, P392, DOI 10.1097/00007632-199602010-00029; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schmand BL., 1992, NEDERLANDSE LEESLIJS NEDERLANDSE LEESTEST; Schrader H, 1996, LANCET, V347, P1207, DOI 10.1016/S0140-6736(96)90733-3; Smed A, 1997, ACTA NEUROL SCAND, V95, P73, DOI 10.1111/j.1600-0404.1997.tb00072.x; Stinissen J, 1970, HANDLEIDING BIJ NEDE; Turk DC, 1992, HDB PAIN ASSESSMENT; Van den Burg W., 1985, 15 WOORDENTEST PROVI; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO	31	119	124	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	1998	64	3					339	343		10.1136/jnnp.64.3.339			5	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	ZD117	WOS:000072653100011	9527145	Green Published, Bronze, Green Submitted			2022-02-06	
J	Springer, JE; Azbill, RD; Kennedy, SE; George, J; Geddes, JW				Springer, JE; Azbill, RD; Kennedy, SE; George, J; Geddes, JW			Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: Attenuation with riluzole pretreatment	JOURNAL OF NEUROCHEMISTRY			English	Article						microtubule-associated protein 2; spectrin; cytoskeleton; glutamate; calcium; calpain I; riluzole; CNS injury	MICROTUBULE-ASSOCIATED PROTEIN-2; EXCITATORY AMINO-ACIDS; FOCAL CEREBRAL-ISCHEMIA; BRAIN INJURY; NERVOUS-SYSTEM; RAT-BRAIN; NEUTRAL PROTEASE; MU-CALPAIN; CALCIUM; PROTEOLYSIS	Immunocytochemical and immunoblotting techniques were used to investigate calpain I activation and the stability of the calpain-sensitive cytoskeletal proteins microtubule-associated protein 2 (MAP2) and spectrin at 1, 4, and 24 h after contusion injury to the spinal cord. Spinal cord injury resulted in the activation of calpain I at all time points examined, with the highest level of activation occurring at 1 h. At the same early time point, there was a loss of dendritic MAP2 staining in spinal cord sections, accompanied by pronounced perikaryal accumulation. The loss in MAP2 staining in the injured spinal cord progressed over the 24-h survival period to affect regions 3 mm distant to the site of injury. The presence of calpain I-specific spectrin degradation was apparent in neuronal cell bodies and fibers as early as 1 h after injury, with the most intense staining occurring within and juxtaposed to the injury site. Spectrin breakdown products in neuronal cell bodies declined rapidly at 4 h and were nearly undetectable at 24 h after injury. Immunoblot studies confirmed the immunocytochemical results by demonstrating a significant increase in calpain I activation, a significant decrease in MAP2 levels, and a significant increase in spectrin breakdown. Finally, treatment of animals with riluzole, an inhibitor of glutamate release, before surgery reduced significantly the loss of MAP2 levels observed at 24 h after injury. These results demonstrate that Ca2+-dependent protease activation and degradation of critical cytoskeletal proteins are early events after spinal cord injury and that treatments that minimize the actions of glutamate may limit their breakdown.	UNIV KENTUCKY,MED CTR,SANDERS BROWN CTR AGING,LEXINGTON,KY 40536		Springer, JE (corresponding author), UNIV KENTUCKY,MED CTR,DEPT ANAT & NEUROBIOL,800 ROSE ST,LEXINGTON,KY 40536, USA.		springer, joe/B-2581-2014	springer, joe/0000-0001-9611-8107; Azbill, David/0000-0001-7989-1771	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-08974] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30248] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R35AG008974] Funding Source: NIH RePORTER		ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; ARAI A, 1990, BRAIN RES, V532, P63, DOI 10.1016/0006-8993(90)91742-Y; ARLINGHAUS L, 1991, EUR J PHARMACOL, V209, P123, DOI 10.1016/0014-2999(91)90022-I; BANIK NL, 1987, METAB BRAIN DIS, V2, P117, DOI 10.1007/BF00999722; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BINDER LI, 1984, P NATL ACAD SCI-BIOL, V81, P5613, DOI 10.1073/pnas.81.17.5613; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; CANER H, 1993, BRAIN RES, V607, P354, DOI 10.1016/0006-8993(93)91531-V; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CONG JY, 1989, J BIOL CHEM, V264, P10096; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 1988, J NEUROTRAUM, V5, P33, DOI 10.1089/neu.1988.5.33; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; GOMEZPINILLA F, 1989, EXP NEUROL, V104, P118, DOI 10.1016/S0014-4886(89)80004-4; Guttmann RP, 1997, J BIOL CHEM, V272, P2005, DOI 10.1074/jbc.272.3.2005; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; IWASAKI Y, 1987, BRAIN RES, V406, P99, DOI 10.1016/0006-8993(87)90773-6; IWASAKI Y, 1985, BRAIN RES, V347, P124, DOI 10.1016/0006-8993(85)90897-2; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; JOHNSON GVW, 1989, BIOCHEM BIOPH RES CO, V163, P1505, DOI 10.1016/0006-291X(89)91150-9; KAMPFL A, 1995, NEUROSCI LETT, V194, P149, DOI 10.1016/0304-3940(95)11745-I; Kampfl A, 1996, EUR J NEUROSCI, V8, P344, DOI 10.1111/j.1460-9568.1996.tb01218.x; Kampfl A, 1996, J NEUROCHEM, V67, P1575; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MORIYA T, 1994, J NEUROTRAUM, V11, P255, DOI 10.1089/neu.1994.11.255; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PERLMUTTER LS, 1988, SYNAPSE, V2, P79, DOI 10.1002/syn.890020111; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; PRATT J, 1992, NEUROSCI LETT, V140, P225, DOI 10.1016/0304-3940(92)90108-J; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SAMIS JA, 1987, BIOCHEM J, V246, P481, DOI 10.1042/bj2460481; SCHLAEPFER WW, 1985, ANN NY ACAD SCI, V455, P552, DOI 10.1111/j.1749-6632.1985.tb50435.x; SIMAN R, 1985, BRAIN RES, V347, P399, DOI 10.1016/0006-8993(85)90208-2; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; Stutzmann JM, 1996, NEUROREPORT, V7, P387, DOI 10.1097/00001756-199601310-00003; SUZUKI K, 1987, FEBS LETT, V220, P271, DOI 10.1016/0014-5793(87)80828-1; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; WAHL F, 1993, EUR J PHARMACOL, V230, P209, DOI 10.1016/0014-2999(93)90804-Q; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; ZIMMERMAN UJP, 1984, PROG NEUROBIOL, V23, P63, DOI 10.1016/0301-0082(84)90012-1; ZIMMERMAN UJP, 1991, BIOCHIM BIOPHYS ACTA, V1078, P192, DOI 10.1016/0167-4838(91)99009-H	60	119	120	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-3042			J NEUROCHEM	J. Neurochem.	OCT	1997	69	4					1592	1600		10.1046/j.1471-4159.1997.69041592.x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	XX057	WOS:A1997XX05700028	9326288	Bronze			2022-02-06	
J	Hicks, RR; Numan, S; Dhillon, HS; Prasad, MR; Seroogy, KB				Hicks, RR; Numan, S; Dhillon, HS; Prasad, MR; Seroogy, KB			Alterations in BDNF and NT-3 mRNAs in rat hippocampus after experimental brain trauma	MOLECULAR BRAIN RESEARCH			English	Article						traumatic brain injury; lateral fluid percussion; brain-derived neurotrophic factor; neurotrophin-3; hybridization, in situ; neuronal plasticity	NERVE GROWTH-FACTOR; NEUROTROPHIN-3 MESSENGER-RNAS; PHOSPHATIDYLINOSITOL BISPHOSPHATE; DOPAMINERGIC-NEURONS; KAINIC ACID; AMINO-ACIDS; INJURY; EXPRESSION; FOREBRAIN; VULNERABILITY	Previous studies have suggested that the neurotrophins brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) are neuroprotective or neurotrophic for certain subpopulations of hippocampal neurons following various brain insults. In the present study, the expression of BDNF and NT-3 mRNAs in rat hippocampus was examined after traumatic brain injury. Following lateral fluid percussion (FP) brain injury of moderate severity (2.0-2.1 atm) or sham injury, the hippocampi from adult rats were processed for the in situ hybridization localization of BDNF and NT-3 mRNAs using S-35-labeled cRNA. probes at post-injury survival times of 1, 3, 6, 24 and 72 h. Unilateral FP injury markedly increased hybridization for BDNF mRNA in the dentate gyrus bilaterally which peaked at 3 h and remained above control levels for up to 72 h post-injury. A moderate increase in BDNF mRNA expression was also observed bilaterally in the CA3 region of the hippocampus at 1, 3, and 6 h after FP injury, but expression declined to control levels by 24 h. Conversely, NT-3 mRNA was significantly decreased in the dentate gyrus following FP injury at the 6 and 24 h survival times. These results demonstrate that FP brain injury differentially modulates expression of BDNF and NT-3 mRNAs in the hippocampus, and suggest that neurotrophin plasticity is a functional response of hippocampal neurons to brain trauma. (C) 1997 Elsevier Science B.V.	UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT CLIN SCI, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT SURG, LEXINGTON, KY 40536 USA						NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH10806] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35164, NS31816] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH010806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031816, R01NS035164, R55NS031816] Funding Source: NIH RePORTER		BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GALL C, 1992, DENTATE GYRUS ITS RO, P171; GALL CM, 1992, MOL CELL NEUROSCI, V3, P56, DOI 10.1016/1044-7431(92)90009-Q; GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HAYES RL, 1995, NEUROSCI LETT, V191, P121, DOI 10.1016/0304-3940(95)11561-X; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; ISACKSON PJ, 1995, CURR OPIN NEUROBIOL, V5, P350, DOI 10.1016/0959-4388(95)80048-4; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; KOKAIA Z, 1994, NEUROREPORT, V5, P1241, DOI 10.1097/00001756-199406020-00021; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Murray KD, 1996, NEUROSCIENCE, V70, P617, DOI 10.1016/S0306-4522(96)83002-8; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Padmaperuma B, 1996, BRAIN RES, V714, P19, DOI 10.1016/0006-8993(95)01579-5; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PRASAD MR, 1994, J NEUROCHEM, V63, P773; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; RUDGE JS, 1995, J NEUROSCI, V15, P6856; SCHREIBER SS, 1995, TRENDS NEUROSCI, V18, P446, DOI 10.1016/0166-2236(95)94495-Q; Seroogy K., 1997, NEUROCHEMISTRY PRACT, P121; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TSUKAHARA T, 1994, NEUROSURGERY, V34, P323, DOI 10.1227/00006123-199402000-00016; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C	48	119	123	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-328X			MOL BRAIN RES	Mol. Brain Res.	SEP	1997	48	2					401	406		10.1016/S0169-328X(97)00158-7			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XV868	WOS:A1997XV86800023	9332737	Green Published			2022-02-06	
J	Verweij, BH; Muizelaar, JP; Vinas, FC; Peterson, PL; Xiong, Y; Lee, CP				Verweij, BH; Muizelaar, JP; Vinas, FC; Peterson, PL; Xiong, Y; Lee, CP			Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111)	NEUROLOGICAL RESEARCH			English	Article						brain mitochondria; traumatic brain injury; Ca2+; Ca channel blocker	CEREBRAL-ISCHEMIA; GLUTAMATE RELEASE; POTASSIUM	have recently demonstrated in a rat model that traumatic brain injury induces perturbation of cellular calcium homeostasis with an overload oi cytosolic calcium and excessive calcium adsorbed on the mitochondrial membrane, consequently the mitochondrial respiratory chain-linked oxidative phosphorylation was impaired. We report the effect of a selective N-type calcium channel blocker, SNX-111 on mitochondrial dysfunction induced by a controlled cortical impact. Intravenous administration of SNX-111 al varying times post injury was made. The concentration titration profile revealed SNX-111 at 4 mg kg(-1) to be optimal, and the time window to De administration at 4 h post-injury, in line with that reported on the effect of SNX-111 in experimental stroke. Under optimal conditions, SNX-111 significantly improved the mitochondrial respiratory chain-linked functions, such as the electron transfer activities with both succinate and NAD-linked substrates, and the accompanied energy coupling capacities measured as respiratory control indices (RCI) and ATP synthesis (P/O ratio), and the energy linked Ca2+ transport in order to assess the applicability of these data to the clinical setting, we have initiated studies with brain tissue which has to be resected during surgical treatment. Five patients suffered from brain trauma, one from intracranial hypertension due to stroke (noninfarcted tissue was taken), and one from epilepsy. Our data revealed that brain mitochondria derived from the patient with intracranial hypertension and the patient with epilepsy were tightly coupled with good respiratory rates with glutamate and malate as substrates, and high P/O ratios. The rates of respiration and A TP synthesis were severely impaired in the brain mitochondria isolated from traumatized patients. These results indicate that investigation of brain mitochondrial functions can be used as a measure for trauma-induced impairment of brain energy metabolism. The rime window for the effect of SNX-111 in mitochondrial function and the (preliminary) similarity between mitochondrial dysfunction in experimental animals and humans make the drug appear to be well suited for clinical trials in severe head injury.	WAYNE STATE UNIV, SCH MED, DEPT NEUROSURG, HLTH CTR 6E, DETROIT, MI 48201 USA; WAYNE STATE UNIV, SCH MED, DEPT NEUROL, DETROIT, MI 48201 USA; WAYNE STATE UNIV, SCH MED, DEPT BIOCHEM & MOL BIOL, DETROIT, MI 48201 USA					Xiong, Ye/0000-0001-9770-6031			BUCHAN AL, 1994, J CEREB BLOOD FLOW M, V14, P906; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; HOVDA DA, 1994, ACTA NEUROCHIR, P521; IKEDA Y, 1990, NEUROSURGERY, V27, P1; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Lee C. P., 1993, V2, P41; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAKAHARA I, 1991, J NEUROCHEM, V57, P839, DOI 10.1111/j.1471-4159.1991.tb08227.x; Nedergaard J, 1979, Methods Enzymol, V55, P3; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; SCIAMANNA MA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P223, DOI 10.1016/0167-4889(92)90180-J; SMITH ML, 1993, J CEREB BLOOD FLOW S, V13, pS700; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; TAKIZAWA S, 1995, J CEREBR BLOOD F MET, V15, P611, DOI 10.1038/jcbfm.1995.75; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V150, P459, DOI 10.1111/j.1748-1716.1994.tb09713.x	23	119	121	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	1997	19	3					334	339		10.1080/01616412.1997.11740821			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XC468	WOS:A1997XC46800020	9192388				2022-02-06	
J	GRIMWOOD, K; ANDERSON, VA; BOND, L; CATROPPA, C; HORE, RL; KEIR, EH; NOLAN, T; ROBERTON, DM				GRIMWOOD, K; ANDERSON, VA; BOND, L; CATROPPA, C; HORE, RL; KEIR, EH; NOLAN, T; ROBERTON, DM			ADVERSE OUTCOMES OF BACTERIAL-MENINGITIS IN SCHOOL-AGE SURVIVORS	PEDIATRICS			English	Article						CHILD; MENINGITIS; SEQUELAE	INFLUENZAE TYPE-B; LONG-TERM SEQUELAE; CLOSED HEAD-INJURY; DEXAMETHASONE THERAPY; ACADEMIC-ACHIEVEMENT; CEREBROSPINAL-FLUID; CHILDREN; INFANTS	Objective. To determine the outcomes of bacterial meningitis in school-age survivors. Design. Prospective cohort study. Setting. Teaching pediatric hospital. Children. During 1983 through 1986, 158 meningitis survivors, ages 3 months to 14 years, treated at a single center were enrolled. Between 1991 and 1993, 130 children, 82% of the original cohort, were evaluated at a mean age of 8.4 years and a mean of 6.7 years after their meningitis. Outcome measures. Blinded neurologic, neuropsychologic, audiologic, behavior, and socio-demographic assessments were compared with those from grade- and sex-matched control children. Multivariate analyses adjusted for age at testing and socio-demographic variables. Results. There was a systematic increase in risk of abnormality or poorer functioning for children with meningitis, compared with control children, across all categories tested, which was significant for fine motor function, Intelligence quotient (IQ) scores, and tests of school behavior, neuropsychologic function, and auditory figure-ground differentiation. Eleven children who had experienced meningitis (8.5%) had major deficits (IQ <70, seizures, hydrocephalus, spasticity, blindness, or severe to profound hearing loss); a further 24 (18.5%) cases and 14 (10.8%) control children had minor deficits (IQ 70 to 80, inability to read, mild to moderate hearing loss, abnormalities in speech discrimination, or school behavior problems). Overall, children who had meningitis were at greater risk (26.9%) for disability. Children with acute neurologic complications had more adverse outcomes than those with uncomplicated meningitis and control children (39% vs 18% vs 11%, respectively). Conclusions. One in four school-age meningitis survivors has either serious and disabling sequelae or a functionally important behavior disorder, neuropsychologic or auditory dysfunction adversely affecting academic performance. As a group, survivors function less well than their classroom peers, and risk is greatest for, but not confined to, those who had acute neurologic complications. All survivors require careful follow-up, at least until school age.	ROYAL CHILDRENS HOSP,DEPT PSYCHOL,PARKVILLE,VIC 3052,AUSTRALIA; ROYAL CHILDRENS HOSP,DEPT AUDIOL,PARKVILLE,VIC 3052,AUSTRALIA; UNIV MELBOURNE,DEPT PAEDIAT & CLIN EPIDEMIOL,MELBOURNE,VIC,AUSTRALIA; UNIV MELBOURNE,BIOSTAT UNIT,MELBOURNE,VIC,AUSTRALIA		GRIMWOOD, K (corresponding author), ROYAL CHILDRENS HOSP,DEPT GEN PAEDIAT,PARKVILLE,VIC 3052,AUSTRALIA.		Grimwood, Keith/F-9334-2011; Nolan, Terry/A-2236-2008; Catroppa, Cathy/AAX-9458-2021	Nolan, Terry/0000-0001-6018-3863; Catroppa, Cathy/0000-0002-9750-0436; BOND, LYNDAL/0000-0003-1693-5508; Grimwood, Keith/0000-0003-3174-9834			ACHENBACH TM, 1991, MANUAL CHILD BEHAVIO; ACHENBACHH TM, 1991, MANUAL TEACHERS REPO; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; BEERY KE, 1989, SCORING TEACHING MAN; BROOKHOUSER PE, 1988, LARYNGOSCOPE, V98, P940; COUSENS P, 1991, J PEDIATR PSYCHOL, V16, P475, DOI 10.1093/jpepsy/16.4.475; Daniel A., 1983, POWER PRIVILEGE PRES; DAVIES PA, 1989, DEV MED CHILD NEUROL, V31, P398; DEAN AG, 1990, EPI INFO, P30087; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DODGE PR, 1984, NEW ENGL J MED, V311, P869, DOI 10.1056/NEJM198410043111401; EMMETT M, 1980, AUST PAEDIATR J, V16, P90; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FEIGIN RD, 1976, J PEDIATR-US, V88, P542, DOI 10.1016/S0022-3476(76)80002-9; FELDMAN HM, 1988, PEDIATRICS, V81, P339; FELDMAN WE, 1982, J PEDIATR-US, V100, P209, DOI 10.1016/S0022-3476(82)80636-7; GILBERT GL, 1990, PEDIATR INFECT DIS J, V9, P252, DOI 10.1097/00006454-199004000-00006; JADAVJI T, 1986, PEDIATRICS, V78, P21; KAPLAN SL, 1986, PEDIATR INFECT DIS J, V5, P626, DOI 10.1097/00006454-198611000-00005; KEIR EH, 1984, 4TH NAT C AUD SOC AU; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; KLASS PE, 1992, PEDIATR INFECT DIS J, V11, P702, DOI 10.1097/00006454-199209000-00005; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; KUPST MJ, 1983, PEDIATR INFECT DIS J, V2, P12, DOI 10.1097/00006454-198301000-00004; LEBEL MH, 1988, NEW ENGL J MED, V319, P964, DOI 10.1056/NEJM198810133191502; LINDBERG J, 1977, PEDIATRICS, V60, P1; MCINTYRE P, 1993, MED J AUSTRALIA, V159, P766, DOI 10.5694/j.1326-5377.1993.tb141344.x; NEALE MD, 1988, NEALE ANAL READING A; OBERKLAID F, 1989, CLIN PEDIATR, V28, P397, DOI 10.1177/000992288902800902; PELTOLA H, 1992, LANCET, V340, P592, DOI 10.1016/0140-6736(92)92117-X; PELTOLA H, 1989, LANCET          0610, P1281; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; POMEROY SL, 1990, NEW ENGL J MED, V323, P1651, DOI 10.1056/NEJM199012133232402; REY A, 1964, LEXMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SCHAAD UB, 1993, LANCET, V342, P457, DOI 10.1016/0140-6736(93)91592-A; SCHAAD UB, 1990, NEW ENGL J MED, V322, P141, DOI 10.1056/NEJM199001183220301; SELL SH, 1983, PEDIATR INFECT DIS J, V2, P90, DOI 10.1097/00006454-198303000-00003; SELL SH, 1987, PEDIATR INFECT DIS J, V6, P775, DOI 10.1097/00006454-198708000-00035; SELL SHW, 1972, PEDIATRICS, V49, P206; SELL SHW, 1972, PEDIATRICS, V49, P212; SPROLES ET, 1969, J PEDIATR-US, V75, P782, DOI 10.1016/S0022-3476(69)80300-8; TAYLOR HG, 1990, NEW ENGL J MED, V323, P1657, DOI 10.1056/NEJM199012133232403; TAYLOR HG, 1984, PEDIATRICS, V74, P198; TAYLOR HG, 1992, J LEARN DISABIL, V25, P630, DOI 10.1177/002221949202501002; TAYLOR HG, 1993, J CLIN CHILD PSYCHOL, V22, P196, DOI 10.1207/s15374424jccp2202_6; TEASDALE TW, 1987, NATURE, V325, P119, DOI 10.1038/325119a0; TEJANI A, 1982, DEV MED CHILD NEUROL, V24, P338; TOUWEN B, 1970, CLIN DEV MED; VIENNY H, 1984, PEDIATRICS, V73, P579; Wechsler D., 1974, WECHSLER INTELLIGENC; WRIGHT M, 1994, ARCH DIS CHILD, V71, P64, DOI 10.1136/adc.71.1.64; 1988, SAS STATISTICS GUIDE; 1985, STATISTICS EPIDEMIOL; [No title captured], DOI DOI 10.1080/13854048708520056	56	119	119	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098	0031-4005			PEDIATRICS	Pediatrics	MAY	1995	95	5					646	656					11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	QW479	WOS:A1995QW47900005	7536915				2022-02-06	
J	MIDDELBOE, T; ANDERSEN, HS; BIRKETSMITH, M; FRIIS, ML				MIDDELBOE, T; ANDERSEN, HS; BIRKETSMITH, M; FRIIS, ML			MINOR HEAD-INJURY - IMPACT ON GENERAL HEALTH AFTER 1 YEAR - A PROSPECTIVE FOLLOW-UP-STUDY	ACTA NEUROLOGICA SCANDINAVICA			English	Article						MINOR HEAD INJURY; FOLLOW-UP; POSTCONCUSSIONAL SEQUELAE; STRESS RESPONSE	CONCUSSION	A prospective follow-up study of 51 patients hospitalized due to minor head injury (MHI) was performed. After one year 28 patients answered the General Health Questionnaire, the Impact of Event Scale and a symptom checklist. A significant impact on general wellbeing attributed to head injury, was indicated. Half of the patients reported some sequelae from head injury, only 25% to a degree that resulted in a case score on General Health Questionnaire. Incidence of prominent post-traumatic stress symptoms was around 20%. Outcome seemed without correlation to trauma severity. Patients with sequelae after one year reported more symptoms at one week after trauma, and the results point to the magnitude of the health problems due to sequelae throughout follow-up. Aspects of prevention and treatment are discussed.	NORDVANG HOSP,INST PERSONALITY THEORY & PSYCHOPATHOL,COPENHAGEN,DENMARK; BISPEBJERG HOSP,DEPT PSYCHIAT,DK-2400 COPENHAGEN,DENMARK		MIDDELBOE, T (corresponding author), BISPEBJERG HOSP,DEPT NEUROL,DK-2400 COPENHAGEN,DENMARK.						ANDERSEN H S, 1989, Ugeskrift for Laeger, V151, P2242; Edna T H, 1987, J Oslo City Hosp, V37, P41; Goldberg D. P., 1988, USERS GUIDE GENERAL; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KELLY R, 1981, J ROY SOC MED, V74, P242; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; KHALEK AIA, 1983, BR J CLIN PRACT  JUN, P209; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIDVALL HF, 1974, ACTA NEUROL SCAND  S, V56, P1; LISHMAN WA, 1987, ORGANIC PSYCHIATRY, P139; MALT UF, 1989, ACTA PSYCHIAT SCAND, V80, P103, DOI 10.1111/j.1600-0447.1989.tb05260.x; MELLERGARD M, 1967, THESIS COPENHAGEN; MILLON T, 1982, MILLON BEHAVIORAL HL; MODLIN HC, 1967, AM J PSYCHIAT, V123, P1008, DOI 10.1176/ajp.123.8.1008; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; RUTHERFORD WH, 1977, LANCET           JAN, P1; SABERS A, 1988, Ugeskrift for Laeger, V150, P1161; SKINHOJ E, 1954, UGESKRIFT LAEGER, V45, P1595; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SUNDHEDSSTYRELSEN, 1988, TIARSOVERSIGT SUNDHE, V4, P2; [No title captured]	25	119	119	0	3	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	JAN	1992	85	1					5	9					5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GZ634	WOS:A1992GZ63400002	1546534				2022-02-06	
J	Fann, JR; Ribe, AR; Pedersen, HS; Fenger-Gron, M; Christensen, J; Benros, ME; Vestergaard, M				Fann, Jesse R.; Ribe, Anette Riisgaard; Pedersen, Henrik Schou; Fenger-Gron, Morten; Christensen, Jakob; Benros, Michael Eriksen; Vestergaard, Mogens			Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study	LANCET PSYCHIATRY			English	Article							ALZHEIMER-DISEASE; ASSOCIATION; ENCEPHALOPATHY; DEATH; ONSET	Background Traumatic brain injury (TBI) has been associated with increased risk of dementia; however, large-scale studies with long follow-up have been scarce. We investigated the association between TBI, including severity and number of TBIs, and the subsequent long-term risk of dementia. Methods We did a nationwide population-based observational cohort study in Denmark using information on citizens from national registries. We used the Danish Civil Registration System to establish a population-based cohort consisting of all people born in Denmark who were living in the country on Jan 1, 1995, and who were at least 50 years old at some point during follow-up (between 1999 and 2013). We obtained information on TBIs from the Danish National Patient Register (NPR), and obtained information on dementia by combining data recorded in the NPR, the Danish Psychiatric Central Register, and the Danish National Prescription Registry (DNPR). The long-term risk of dementia after TBI was established using survival analysis. We used three prespecified models for each of the three analyses: different time periods since the TBI, multiple TBIs, and sex. The first model adjusted for sociodemographic factors, the second model added medical and neurological comorbidities, and the third added psychiatric comorbidities. Findings We used data from a cohort of 2 794 852 people for a total of 27 632 020 person-years (mean 9.89 years per patient) at risk of dementia. 132 093 individuals (4.7%) had at least one TBI during 1977-2013, and 126 734 (4.5%) had incident dementia during 1999-2013. The fully adjusted risk of all-cause dementia in people with a history of TBI was higher (hazard ratio [HR] 1.24, 95% CI 1.21-1.27) than in those without a history of TBI, as was the specific risk of Alzheimer's disease (1.16, 1.12-1.22). The risk of dementia was highest in the first 6 months after TBI (HR 4.06, 3. 79-4.34) and also increased with increasing number of events (1.22, 1.19-1.25 with one TBI to 2.83, 2.14-3.75 with five or more TBIs). Furthermore, TBI was associated with a higher risk of dementia (1.29, 1.26-1.33) in people with TBI than in individuals with a non-TBI fracture not involving the skull or spine. The younger a person was when sustaining a TBI, the higher the HRs for dementia when stratified by time since TBI. Interpretation TBI was associated with an increased risk of dementia both compared with people without a history of TBI and with people with non-TBI trauma. Greater efforts to prevent TBI and identify strategies to ameliorate the risk and impact of subsequent dementia are needed.	[Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ribe, Anette Riisgaard; Pedersen, Henrik Schou; Fenger-Gron, Morten; Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Dept Publ Hlth, Aarhus, Denmark; [Ribe, Anette Riisgaard; Pedersen, Henrik Schou; Fenger-Gron, Morten; Vestergaard, Mogens] Aarhus Univ, Sect Gen Med Practice, Dept Publ Hlth, Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark; [Benros, Michael Eriksen] Copenhagen Univ Hosp, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark		Fann, JR (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	fann@uw.edu	Benros, Michael Eriksen/N-5868-2016	Benros, Michael Eriksen/0000-0003-4939-9465; Fenger-Gron, Morten/0000-0002-6354-5871; Christensen, Jakob/0000-0002-9385-6435	Lundbeck FoundationLundbeckfonden	Lundbeck Foundation.	[Anonymous], 2015, C TRAUM BRAIN INJ US; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Institute of Medicine, 2009, GULF WAR HLTH, V7; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Katon W, 2015, JAMA PSYCHIAT, V72, P612, DOI 10.1001/jamapsychiatry.2015.0082; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Phung TKT, 2010, DEMENT GERIATR COGN, V29, P146, DOI 10.1159/000269933; Phung TKT, 2009, DEMENT GERIATR COGN, V27, P534, DOI 10.1159/000223664; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Skrbo A, 1999, Med Arh, V53, P57; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Yang Z, 2013, NEW ENGL J MED, V369, P489, DOI 10.1056/NEJMc1305541	43	118	118	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2215-0374			LANCET PSYCHIAT	Lancet Psychiatry	MAY	2018	5	5					424	431		10.1016/S2215-0366(18)30065-8			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	GE1VD	WOS:000431004000022	29653873		Y	N	2022-02-06	
J	Vespa, P; Tubi, M; Claassen, J; Buitrago-Blanco, M; McArthur, D; Velazquez, AG; Tu, B; Prins, M; Nuwer, M				Vespa, Paul; Tubi, Meral; Claassen, Jan; Buitrago-Blanco, Manuel; McArthur, David; Velazquez, Angela G.; Tu, Bin; Prins, Mayumi; Nuwer, Marc			Metabolic crisis occurs with seizures and periodic discharges after brain trauma	ANNALS OF NEUROLOGY			English	Article							CEREBRAL PERFUSION-PRESSURE; SUBARACHNOID HEMORRHAGE; NONCONVULSIVE SEIZURES; STATUS EPILEPTICUS; INJURY; MICRODIALYSIS; ELECTROENCEPHALOGRAPHY; ISCHEMIA; INCREASE	ObjectiveTraumatic brain injury (TBI) results in persistent disruption of brain metabolism that has yet to be mechanistically defined. Early post-traumatic seizures are one potential mechanism for metabolic crisis and hence could be a therapeutic target. We hypothesized that seizures and pseudoperiodic discharges (PDs) may be mechanistically linked to metabolic crisis as measured by cerebral microdialysis. MethodsA prospective multicenter study of surface and intracortical depth electroencephalography (EEG) was performed in conjunction with cerebral microdialysis in a cohort of severe TBI patients with time-locked analysis of the neurochemical response to seizures and pseudoperiodic discharges. ResultsSeizures or PDs occurred in 61% of 34 subjects, with 42.9% of these seizures noted only on intracortical depth EEG and in some cases lasting for many hours. Metabolic crisis as measured by elevated cerebral microdialysis lactate/pyruvate ratio occurred during seizures or PDs but not during electrically nonepileptic epochs. InterpretationIn TBI patients, seizures and periodic discharges are one mechanism for metabolic crisis, and hence represent a therapeutic target for future study. Ann Neurol 2016;79:579-590	[Vespa, Paul; Tubi, Meral; McArthur, David; Prins, Mayumi] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90095 USA; [Claassen, Jan; Velazquez, Angela G.; Tu, Bin] Columbia Univ, New York, NY USA; [Buitrago-Blanco, Manuel] Univ Calif Los Angeles, Med Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA; [Nuwer, Marc] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA		Vespa, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 757 Westwood Blvd,Room 6236A, Los Angeles, CA 90095 USA.	PVespa@mednet.ucla.edu	Claassen, Jan/AAA-5451-2020	Tubi, Meral/0000-0003-0435-8352	NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS03039, NS058489, PT074268, NS049471]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049471, P01NS058489] Funding Source: NIH RePORTER	This study was funded by the NIH National Institute of Neurological Disorders and Stroke (NS03039, NS058489, PT074268, NS049471).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; Dreier JP, 2013, ACTA NEUROCHIR SUPPL, V115, P125, DOI 10.1007/978-3-7091-1192-5_26; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Ko SB, 2011, ARCH NEUROL-CHICAGO, V68, P1323, DOI 10.1001/archneurol.2011.240; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721	17	118	122	1	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	APR	2016	79	4					579	590		10.1002/ana.24606			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DJ2AM	WOS:000374006100008	26814699				2022-02-06	
J	Togher, L; Wiseman-Hakes, C; Douglas, J; Stergiou-Kita, M; Ponsford, J; Teasell, R; Bayley, M; Turkstra, LS				Togher, Leanne; Wiseman-Hakes, Catherine; Douglas, Jacinta; Stergiou-Kita, Mary; Ponsford, Jennie; Teasell, Robert; Bayley, Mark; Turkstra, Lyn S.		INCOG Expert Panel	INCOG Recommendations for Management of Cognition Following Traumatic Brain Injury, Part IV: Cognitive Communication	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive communication; cognitive rehabilitation; guidelines; rehabilitation; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; PRACTICE GUIDELINES; REHABILITATION; PEOPLE; DEFICITS; INDIVIDUALS; DISCOURSE; ADULTS; SKILLS; CONVERSATIONS	Introduction: Cognitive-communication disorders are common in individuals with traumatic brain injury (TBI) and can have a major impact on long-term outcome. Guidelines for evidence-informed rehabilitation are needed, thus an international group of researchers and clinicians (known as INCOG) convened to develop recommendations for assessment and intervention. Methods: An expert panel met to select appropriate recommendations for assessment and treatment of cognitive-communication disorders based on available literature. To promote implementation, the team developed decision algorithms incorporating the recommendations, based on inclusion and exclusion criteria of published trials, and then prioritized recommendations for implementation and developed audit criteria to evaluate adherence to best practice recommendations. Results: Rehabilitation of individuals with cognitive-communication disorders should consider premorbid communication status; be individualized to the person's needs, goals, and skills; provide training in use of assistive technology where appropriate; include training of communication partners; and occur in context to minimize the need for generalization. Evidence supports treatment of social communication problems in a group format. Conclusion: There is strong evidence for person-centered treatment of cognitive-communication disorders and use of instructional strategies such as errorless learning, metacognitive strategy training, and group treatment. Future studies should include tests of alternative service delivery models and development of participation-level outcome measures.	[Togher, Leanne] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW, Australia; [Wiseman-Hakes, Catherine] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Douglas, Jacinta] La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic 3086, Australia; [Stergiou-Kita, Mary] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Ponsford, Jennie] Epworth Med Fdn, Melbourne, Vic, Australia; [Ponsford, Jennie] Monash Univ, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Ponsford, Jennie] Alfred Hosp, Melbourne, Vic, Australia; [Teasell, Robert] Parkwood Hosp, Lawson Hlth Res Inst, Aging Rehabil & Geriatr Care Program, London, ON, Canada; [Teasell, Robert] Univ Western Ontario, Schulich Sch Med, Dept Phys Med & Rehabil, London, ON, Canada; [Bayley, Mark] Univ Toronto, UHN Toronto Rehabil Inst, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Div Phys Med & Rehabil, Toronto, ON, Canada; [Turkstra, Lyn S.] Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI USA		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Rm 155,75 East St, Lidcombe, NSW, Australia.	Leanne.togher@sydney.edu.au	Turkstra, Lyn/ABC-5831-2021; Togher, Leanne/AAC-7083-2019; Wiseman-Hakes, Catherine/AAC-8303-2021	Wiseman-Hakes, Catherine/0000-0001-8441-884X; Bayley, Mark/0000-0001-7860-9463; Turkstra, Lyn/0000-0002-6948-6921; Douglas, Jacinta/0000-0003-0940-6624; Togher, Leanne/0000-0002-4518-6748	Victorian Transport Accident Commission (TAC) through its Victorian Neurotrauma Initiative (VNI), Monash University; Ontario Neurotrauma Foundation (ONF)	The authors gratefully acknowledge the support of the Victorian Transport Accident Commission (TAC) through its Victorian Neurotrauma Initiative (VNI), Monash University, and the Ontario Neurotrauma Foundation (ONF) for their support of this project.	ABIKUS Guideline Development Group, 2007, ABIKUS EV BAS REC RE; American Speech-Language-Hearing Association, 2004, ROL SPEECH LANG PATH; [Anonymous], 2014, AGREE ADV SCI PRACT; BALANDIN S, 1998, AUGMENTATIVE ALTERNA, V14, P239, DOI DOI 10.1080/07434619812331278416; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Bragge P, 2014, J HEAD TRAUMA REHAB, V29, P277, DOI 10.1097/HTR.0000000000000066; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Campbell L, 2002, ADV SPEECH LANG PATH, V4, P89; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; College of Audiologists and Speech-Language Pathologists of Ontario, 2002, PREF PRACT GUID COGN; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Deruyter F, 1988, J HEAD TRAUMA REHAB, V3, P35; DeRuyter F, 1991, COMMUNICATION DISORD, P317; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Doyle M, 2000, AUG ALTER COMMUN SER, P271; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Fager S, 2006, AUGMENT ALTERN COMM, V22, P37, DOI 10.1080/07434610500243990; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Fried-Oken M., 1992, J HEAD TRAUMA REHAB, V9, DOI [DOI 10.1097/00001199-199209000-00008, 10.1097/00001199-199209000-00008]; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Golper L, 2001, ACAD NEUROL COMMUN D; Graham Ian D, 2005, Evid Based Nurs, V8, P68, DOI 10.1136/ebn.8.3.68; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Holland A., 1982, CLIN APH P C, P345; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Katz R, 2002, J MED SPEECH-LANG PA, V10, pix; Kertesz A., 2006, W APHASIA BATTERY RE; Larkins B, 1999, ASIA PACIFIC J SPEEC, V4, P183; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Lindsay P, 2008, CAN MED ASSOC J, V179, pS1, DOI 10.1503/cmaj.081148.R2; MacDonald S., 1998, FUNCTIONAL ASSESSMEN; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milton S. B., 1986, CLIN NEUROPSYCHOLOGY, P223, DOI [10.1007/978-1-4613-2291-7_11, DOI 10.1007/978-1-4613-2291-7_11]; New Zealand Guidelines Group, 2006, GUIDE, P244; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Parente R, 1999, NEUROREHABILITATION, V13, P13; Powell LE, 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI 10.1080/09602011.2011.640466; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Rosewilliam S, 2011, CLIN REHABIL, V25, P501, DOI 10.1177/0269215510394467; *ROY COLL PHYS, 2003, REH FOLL ACQ BRAIN I; Russell A, 1995, AUGMENTATIVE ALTERNA, V11, P138; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Schrijnemaekers AC, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/01.HTR.0000438117.63852.b4; Snow P, 1997, BRAIN INJURY, V11, P409; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Sohlberg McKay Moore, 2005, Seminars in Speech and Language, V26, P268, DOI 10.1055/s-2005-922105; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tate R, 2004, NEUROPSYCHOL REHABIL, V14, P517, DOI 10.1080/09602010343000182; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; The ADAPTE Collaboration, 2009, ADAPTE PROC RES TOOL; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra Lyn S, 2005, Semin Speech Lang, V26, P213, DOI 10.1055/s-2005-922100; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Turner BJ, 2008, AUST OCCUP THER J, V55, P96, DOI 10.1111/j.1440-1630.2007.00660.x; Valitchka L, 2013, SEMIN SPEECH LANG, V34, P142, DOI 10.1055/s-0033-1358371; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	87	118	119	0	43	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2014	29	4					353	368		10.1097/HTR.0000000000000071			16	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AM2AK	WOS:000339650300011	24984097				2022-02-06	
J	Kramer, JH; Mungas, D; Possin, KL; Rankin, KP; Boxer, AL; Rosen, HJ; Bostrom, A; Sinha, L; Berhel, A; Widmeyer, M				Kramer, Joel H.; Mungas, Dan; Possin, Katherine L.; Rankin, Katherine P.; Boxer, Adam L.; Rosen, Howard J.; Bostrom, Alan; Sinha, Lena; Berhel, Ashley; Widmeyer, Mary			NIH EXAMINER: Conceptualization and Development of an Executive Function Battery	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article							TRAUMATIC BRAIN-INJURY; FRONTOTEMPORAL DEMENTIA; MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; BASAL GANGLIA; MEMORY SPAN; TASK; DISEASE; DEFICITS; PERFORMANCE		[Kramer, Joel H.; Possin, Katherine L.; Rankin, Katherine P.; Boxer, Adam L.; Rosen, Howard J.; Bostrom, Alan; Sinha, Lena; Berhel, Ashley] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Mungas, Dan] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Widmeyer, Mary] Rosalind Franklin Univ Med & Sci, Chicago, IL USA		Kramer, JH (corresponding author), 675 Nelson Rising Lane,Suite 190,MC 1207, San Francisco, CA 94158 USA.	jkramer@memory.ucsf.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [HHSN271200623661C, P50 AG023501, 1R01AG022983, 1R01AG032289]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG037566, R01AG010220, R01AG022983, P30AG010129, P50AG023501, R01AG032289] Funding Source: NIH RePORTER	This work was supported by NINDS contract HHSN271200623661C, P50 AG023501, 1R01AG022983 and 1R01AG032289. None of the authors have any conflicts to disclose.	Amieva H, 2003, BRAIN COGNITION, V53, P129, DOI 10.1016/S0278-2626(03)00094-0; Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; Aron AR, 2003, J COGNITIVE NEUROSCI, V15, P629, DOI 10.1162/089892903322307357; Asimakopulos J, 2012, AUST OCCUP THER J, V59, P402, DOI 10.1111/j.1440-1630.2011.00963.x; Barkley Russell A, 2010, J Clin Psychiatry, V71, pe17, DOI 10.4088/JCP.9066tx1c; Boone KB, 1999, J INT NEUROPSYCH SOC, V5, P616, DOI 10.1017/S1355617799577047; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Burgess P, 1996, BEHAV ASSESSMENT DYS; Caeyenberghs K, 2012, BRAIN STRUCTURE FUNC; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; *CAMBR COGN LTD, 1996, CANTAB; CASE R, 1982, J EXP CHILD PSYCHOL, V33, P386, DOI 10.1016/0022-0965(82)90054-6; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Delis DC., 2001, DELIS KAPLAN EXECUTI; Flores J., 2008, BATERIA NEUROPSICOLO; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Gerstenecker A, 2013, ARCH CLIN NEUROPSYCH, V28, P104, DOI 10.1093/arclin/acs098; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Griffin SL, 2002, ARCH CLIN NEUROPSYCH, V17, P497, DOI 10.1016/S0887-6177(01)00136-6; Hambleton RK., 1991, FUNDAMENTALS ITEM RE; Hellmuth J, 2012, NEUROLOGY, V78, P1824, DOI 10.1212/WNL.0b013e318258f785; Hutchinson AD, 2007, J NEUROL NEUROSUR PS, V78, P917, DOI 10.1136/jnnp.2006.100669; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Kray J, 2000, PSYCHOL AGING, V15, P126, DOI 10.1037//0882-7974.15.1.126; Krueger CE, 2009, NEUROLOGY, V73, P349, DOI 10.1212/WNL.0b013e3181b04b24; Krueger CE, 2011, CLIN NEUROPSYCHOL, V25, P741, DOI 10.1080/13854046.2011.569759; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luks TL, 2010, NEUROPSYCHOLOGIA, V48, P165, DOI 10.1016/j.neuropsychologia.2009.09.001; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Mirsky JB, 2011, COGN BEHAV NEUROL, V24, P50, DOI 10.1097/WNN.0b013e318223f6c6; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moorhouse P, 2010, J NEUROL SCI, V288, P142, DOI 10.1016/j.jns.2009.09.017; Mungas D, 2003, NEUROPSYCHOLOGY, V17, P380, DOI 10.1037/0894-4105.17.3.380; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Paulsen JS, 2011, CURR NEUROL NEUROSCI, V11, P474, DOI 10.1007/s11910-011-0215-x; Peters M, 2007, J INT NEUROPSYCH SOC, V13, P626, DOI 10.1017/S1355617707070786; Possin KL, 2013, NEUROLOGY, V80, P2180, DOI 10.1212/WNL.0b013e318296e940; Psychology Software Tools I., 2009, E PRIM 2; Ravizza SM, 2002, J COGNITIVE NEUROSCI, V14, P472, DOI 10.1162/089892902317361985; Reed BR, 2004, ARCH NEUROL-CHICAGO, V61, P1545, DOI 10.1001/archneur.61.10.1545; Reitan R, 1985, HALSTEAD REITAN NEUR; Schenk A., 2008, J INT NEUROPSYCH SOC, V14, P266; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shany-Ur T, 2011, CURR OPIN NEUROL, V24, P550, DOI 10.1097/WCO.0b013e32834cd42a; Slachevsky A, 2004, ARCH NEUROL-CHICAGO, V61, P1104, DOI 10.1001/archneur.61.7.1104; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded	52	118	120	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2014	20	1					11	19		10.1017/S1355617713001094			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	AC2VC	WOS:000332373400004	24103232	Green Accepted			2022-02-06	
J	Zatzick, D; Jurkovich, G; Rivara, FP; Russo, J; Wagner, A; Wang, J; Dunn, C; Lord, SP; Petrie, M; O'Connor, SS; Katon, W				Zatzick, Douglas; Jurkovich, Gregory; Rivara, Frederick P.; Russo, Joan; Wagner, Amy; Wang, Jin; Dunn, Chris; Lord, Sarah Peregrine; Petrie, Megan; O'Connor, Stephen S.; Katon, Wayne			A Randomized Stepped Care Intervention Trial Targeting Posttraumatic Stress Disorder for Surgically Hospitalized Injury Survivors	ANNALS OF SURGERY			English	Article						injury; physical function; PTSD; stepped care; surgical hospitalization; traumatic brain injury	COGNITIVE-BEHAVIORAL THERAPY; COLLABORATIVE CARE; FUNCTIONAL OUTCOMES; POPULATION-IMPACT; ANXIETY DISORDERS; TRAUMA CENTER; MAJOR TRAUMA; DEPRESSION; US; HEALTH	Objective: To test the effectiveness of a stepped care intervention model targeting posttraumatic stress disorder (PTSD) symptoms after injury. Background: Few investigations have evaluated interventions for injured patients with PTSD and related impairments that can be feasibly implemented in trauma surgical settings. Methods: The investigation was a pragmatic effectiveness trial in which 207 acutely injured hospitalized trauma survivors were screened for high PTSD symptom levels and then randomized to a stepped combined care management, psychopharmacology, and cognitive behavioral psychotherapy intervention (n = 104) or usual care control (n = 103) conditions. The symptoms of PTSD and functional limitations were reassessed at 1, 3, 6, 9, and 12 months after the index injury admission. Results: Regression analyses demonstrated that over the course of the year after injury, intervention patients had significantly reduced PTSD symptoms when compared with controls [group by time effect, CAPS (Clinician-Administered PTSD Scale): F(2, 185) = 5.50, P < 0.01; PCL-C (PTSD Checklist Civilian Version): F(4, 185) = 5.45, P < 0.001]. Clinically and statistically significant PTSD treatment effects were observed at the 6-, 9-, and 12-month postinjury assessments. Over the course of the year after injury, intervention patients also demonstrated significant improvements in physical function [MOS SF-36 PCS (Medical Outcomes Study Short Form 36 Physical Component Summary) main effect: F(1, 172) = 9.87, P < 0.01]. Conclusions: Stepped care interventions can reduce PTSD symptoms and improve functioning over the course of the year after surgical injury hospitalization. Orchestrated investigative and policy efforts could systematically introduce and evaluate screening and intervention procedures for PTSD at US trauma centers. (Trial Registration: clinicaltrials.gov identifier: NCT00270959)	[Zatzick, Douglas; Russo, Joan; Wagner, Amy; Wang, Jin; Dunn, Chris; Lord, Sarah Peregrine; Petrie, Megan; O'Connor, Stephen S.; Katon, Wayne] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Zatzick, Douglas; Jurkovich, Gregory; Rivara, Frederick P.; Wang, Jin; O'Connor, Stephen S.] Univ Washington, Sch Med, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Jurkovich, Gregory] Univ Washington, Sch Med, Dept Surg, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98104 USA; [Wagner, Amy] Portland VA Med Ctr, Portland, OR USA		Zatzick, D (corresponding author), Univ Washington, Sch Med, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359911, Seattle, WA 98104 USA.	dzatzick@u.washington.edu			National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01/MH073613, K24/MH086814]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K24MH086814, R01MH073613] Funding Source: NIH RePORTER	This work was supported by the National Institute of Mental Health grants R01/MH073613 and K24/MH086814 (Dr Zatzick).	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; *AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; Babor T., 1989, ALCOHOL USE DISORDER; Bergen GS., 2008, INJURY US 2007 CHART; Bonnie R.J., 1999, REDUCING BURDEN INJU; Bryant RA, 1998, J CONSULT CLIN PSYCH, V66, P862, DOI 10.1037/0022-006X.66.5.862; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Craske MG, 2011, ARCH GEN PSYCHIAT, V68, P378, DOI 10.1001/archgenpsychiatry.2011.25; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Fullerton CS, 2004, AM J PSYCHIAT, V161, P1370, DOI 10.1176/appi.ajp.161.8.1370; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Johns Hopkins Health Services Research and Development Center, 1989, DET INJ SEV HOSP DIS; Kassam-Adams N, 2011, J TRAUMA STRESS, V24, P252, DOI 10.1002/jts.20640; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koepsell TD, 2011, AM J PREV MED, V40, P191, DOI 10.1016/j.amepre.2010.10.022; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lagomasino IT, 2010, GEN HOSP PSYCHIAT, V32, P477, DOI 10.1016/j.genhosppsych.2010.06.005; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; National Institute of Mental Health, 2002, MENT HLTH MASS VIOL, V025138; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; Ramchand R, 2008, J CONSULT CLIN PSYCH, V76, P668, DOI 10.1037/0022-006X.76.4.668; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; Roberts JC, 2010, J TRAUMA, V69, P231, DOI 10.1097/TA.0b013e3181e16e2a; Roberts NP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006869.pub2; Roy-Byrne P, 2010, JAMA-J AM MED ASSOC, V303, P1921, DOI 10.1001/jama.2010.608; Shalev AY, 2012, ARCH GEN PSYCHIAT, V69, P166, DOI 10.1001/archgenpsychiatry.2011.127; Shalev AY, 2011, PSYCHIAT SERV, V62, P765, DOI 10.1176/ps.62.7.pss6207_0765; Shih RA, 2010, J TRAUMA, V69, P1560, DOI 10.1097/TA.0b013e3181e59c05; Terrell F, 2008, J AM COLL SURGEONS, V207, P630, DOI 10.1016/j.jamcollsurg.2008.05.021; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Trusz SG, 2011, PSYCHIATRY, V74, P207, DOI 10.1521/psyc.2011.74.3.207; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Wagner AW, 2007, COGN BEHAV PRACT, V14, P341, DOI 10.1016/j.cbpra.2006.05.002; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weathers FW, 1996, MEASUREMENT STRESS T, P250; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick DF, 2001, GEN HOSP PSYCHIAT, V23, P114, DOI 10.1016/S0163-8343(01)00140-2; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zatzick D, 2011, GEN HOSP PSYCHIAT, V33, P123, DOI 10.1016/j.genhosppsych.2011.01.001; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zatzick DF, 2009, PSYCHIATRY, V72, P346, DOI 10.1521/psyc.2009.72.4.346	55	118	120	0	25	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	MAR	2013	257	3					390	399		10.1097/SLA.0b013e31826bc313			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	088BN	WOS:000314808900004	23222034	Green Accepted			2022-02-06	
J	Schuss, P; Vatter, H; Marquardt, G; Imohl, L; Ulrich, CT; Seifert, V; Guresir, E				Schuss, Patrick; Vatter, Hartmut; Marquardt, Gerhard; Imoehl, Lioba; Ulrich, Christian T.; Seifert, Volker; Gueresir, Erdem			Cranioplasty after Decompressive Craniectomy: The Effect of Timing on Postoperative Complications	JOURNAL OF NEUROTRAUMA			English	Article						complications; cranioplasty; decompressive craniectomy; intracranial pressure	MIDDLE CEREBRAL-ARTERY; SUBARACHNOID HEMORRHAGE; HEMICRANIECTOMY; SURGERY; BRAIN; HYDROCEPHALUS; CONCUSSION; INFARCTION	Decompressive craniectomy (DC) due to intractably elevated intracranial pressure mandates later cranioplasty (CP). However, the optimal timing of CP remains controversial. We therefore analyzed our prospectively conducted database concerning the timing of CP and associated post-operative complications. From October 1999 to August 2011, 280 cranioplasty procedures were performed at the authors' institution. Patients were stratified into two groups according to the time from DC to cranioplasty (early, <= 2 months, and late, >2 months). Patient characteristics, timing of CP, and CP-related complications were analyzed. Overall CP was performed early in 19% and late in 81%. The overall complication rate was 16.4%. Complications after CP included epidural or subdural hematoma (6%), wound healing disturbance (5.7%), abscess (1.4%), hygroma (1.1%), cerebrospinal fluid fistula (1.1%), and other (1.1%). Patients who underwent early CP suffered significantly more often from complications compared to patients who underwent late CP (25.9% versus 14.2%; p = 0.04). Patients with ventriculoperitoneal (VP) shunt had a significantly higher rate of complications after CP compared to patients without VP shunt (p = 0.007). On multivariate analysis, early CP, the presence of a VP shunt, and intracerebral hemorrhage as underlying pathology for DC, were significant predictors of post-operative complications after CP. We provide detailed data on surgical timing and complications for cranioplasty after DC. The present data suggest that patients who undergo late CP might benefit from a lower complication rate. This might influence future surgical decision making regarding optimal timing of cranioplasty.	[Schuss, Patrick; Vatter, Hartmut; Marquardt, Gerhard; Imoehl, Lioba; Ulrich, Christian T.; Seifert, Volker; Gueresir, Erdem] Goethe Univ Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany		Schuss, P (corresponding author), Goethe Univ Frankfurt, Dept Neurosurg, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	patrick.schuss@med.uni-frankfurt.de	Guresir, Erdem/AAV-7224-2021; Guresir, Erdem/AAL-4484-2020; Schuss, Patrick/ABC-6469-2020	Guresir, Erdem/0000-0001-8319-0847; Schuss, Patrick/0000-0002-5806-2576			Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Guresir E, 2009, J NEUROL NEUROSUR PS, V80, P799, DOI 10.1136/jnnp.2008.155630; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Guresir E, 2008, NEUROSURGERY, V63, P1088, DOI 10.1227/01.NEU.0000335170.76722.B9; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Marion DW, 2006, NEUROSURGERY, V58, P655; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA., 2000, NEUROSURG FOCUS, V8, DOI [10.3171/foc.2000.8.1.1920, DOI 10.3171/FOC.2000.8.1.1920, DOI 10.3171/INS.2000.93.1.0053]; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yeo R., 2010, J NEUROTRAUMA; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zemack G, 2000, J NEUROSURG, V92, P941, DOI 10.3171/jns.2000.92.6.0941	27	118	129	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1090	1095		10.1089/neu.2011.2176			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100008	22201297				2022-02-06	
J	Gould, KR; Ponsford, JL; Johnston, L; Schonberger, M				Gould, K. R.; Ponsford, J. L.; Johnston, L.; Schoenberger, M.			The nature, frequency and course of psychiatric disorders in the first year after traumatic brain injury: a prospective study	PSYCHOLOGICAL MEDICINE			English	Article						Anxiety disorders; depressive disorders; psychiatric disorders; substance use disorders; traumatic brain injury	HEAD-INJURY; AXIS-I; DEPRESSION; PREVALENCE; ALCOHOL; SEVERITY; VALIDITY; RATES	Background. Psychiatric disorders are common following traumatic brain injury (TBI). However, few studies have examined the course of disorder development and the influence of pre-injury psychiatric history. The present study aimed to examine the frequency of, and association between, psychiatric disorders occurring pre- and post-injury, and to examine the post-injury course of disorders. Method. Participants were 102 adults (75.5% male) with predominantly moderate-severe TBI. Participants were initially assessed for pre-injury and current disorders, and reassessed at 3, 6 and 12 months post-injury using the Structured Clinical Interview for DSM-IV Disorders (SCID). Results. Over half of the participants had a pre-injury psychiatric disorder; predominantly substance use, mood, and anxiety disorders. In the first year post-injury, 60.8% of participants had a psychiatric disorder, commonly anxiety and mood disorders. Post-injury disorders were associated with the presence of a pre-injury history (p<0.01), with 74.5% of participants with a pre-injury psychiatric history experiencing a post-injury disorder, which commonly presented at initial assessment or in the first 6 months. However, 45.8% of participants without a pre-injury history developed a novel post-injury disorder, which was less likely to emerge at the initial assessment and generally developed later in the year. Conclusions. Despite evidence that most post-injury psychiatric disorders represent the continuation of pre-existing disorders, a significant number of participants developed novel psychiatric disorders. This study demonstrates that the timing of onset may differ according to pre-injury history. There seem to be different trajectories for anxiety and depressive disorders. This research has important implications for identifying the time individuals are most at risk of psychiatric disorders post-injury.	[Gould, K. R.; Ponsford, J. L.; Schoenberger, M.] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Gould, K. R.; Ponsford, J. L.; Johnston, L.; Schoenberger, M.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Schoenberger, M.] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol, D-7800 Freiburg, Germany		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@med.monash.edu.au	Gould, Kate Rachel/AAA-5511-2020	Gould, Kate Rachel/0000-0002-3564-7408	Victorian Neurotrauma Initiative [d150]; Australian Postgraduate AwardAustralian Government	This research was supported by a grant from the Victorian Neurotrauma Initiative (Ref: d150). We acknowledge the use of Australian Bureau of Statistics data and thank J. Taffe for statistical assistance. The authors also acknowledge the assistance of Mary Karamitsios with data collection and recruitment.; This research and manuscript were prepared during the course of employment at the Monash-Epworth Rehabilitation Centre for the authors J. Ponsford, K. Gould, L. Johnston and M. Schonberger. This research was conducted as partial fulfilment of the Doctorate in Clinical Neuropsychology at Monash University by K. Gould, an Australian Postgraduate Award scholarship recipient.	ABS, 2009, NAT SURV MENT HLTH W; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Deb S, 1999, AM J PSYCHIAT, V156, P374; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Harter M, 2007, PSYCHOTHER PSYCHOSOM, V76, P354, DOI 10.1159/000107563; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Nelson H.E., 1982, NATL ADULT READING T; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; RUTHERFORD WH, 1977, LANCET, V1, P1; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wade TD, 2006, AUST NZ J PSYCHIAT, V40, P121, DOI 10.1111/j.1440-1614.2006.01758.x; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wells JE, 2006, AUST NZ J PSYCHIAT, V40, P845, DOI 10.1111/j.1440-1614.2006.01903.x; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; [No title captured]	46	118	118	2	28	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	OCT	2011	41	10					2099	2109		10.1017/S003329171100033X			11	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	826BR	WOS:000295326900008	21477420				2022-02-06	
J	Babikian, T; Satz, P; Zaucha, K; Light, R; Lewis, RS; Asarnow, RF				Babikian, Talin; Satz, Paul; Zaucha, Ken; Light, Roger; Lewis, Richard S.; Asarnow, Robert F.			The UCLA Longitudinal Study of Neurocognitive Outcomes Following Mild Pediatric Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Child and adolescent; Cognitive; Mild TBI; Concussion; Longitudinal study	HEAD-INJURY; CRYSTALLIZED INTELLIGENCE; UNINTENTIONAL INJURY; AGED CHILDREN; RISK-FACTORS; ADOLESCENTS; SYMPTOMS; RECOVERY; SEQUELAE; FLUID	Comprehensive reviews of neurocognitive outcomes following mild, uncomplicated traumatic brain injury (TBI) in children have shown minimal effects on neurocognition, especially in methodologically rigorous studies. In this study, we report longitudinal (1,6, and 12 months post injury) results in four domains of neurocognitive functioning in a large sample of children with mild TBI (n = 124, ages 8-17 at injury) relative to two demographically matched control groups (other injury: 11 = 94 and non-injury: it = 106). After accounting for age and parental education, significant main effects of group were observed on 7 of the 10 neurocognitive tests. However, these differences were not unique to the TBI sample but were found between both the TBI and other injury groups relative to the non-injured group, suggesting a general injury effect. Effects were primarily within the domains measuring memory, psychomotor processing speed, and language. This is the largest longitudinal study to date of neurocognitive outcomes at discrete time points in pediatric mild TBI. When controlling for pre-injury factors, there is no evidence of long-term neurocognitive impairment in this group relative to another injury control group. The importance of longitudinal analyses and use of appropriate control groups are discussed in the context of evaluating the effects of mild TBI on cognition. (ENS, 2011, 17, 886-895)	[Light, Roger] Centinela Freeman Reg Med Ctr, Inglewood, CA USA; [Lewis, Richard S.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA; [Lewis, Richard S.] Pomona Coll, Dept Psychol, Claremont, CA 91711 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA		Babikian, T (corresponding author), Semel Inst Neurosci & Human Behav, 760 Westwood Plaza,Room C8-746, Los Angeles, CA 90024 USA.	tbabikian@mednet.ucla.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061504, R01HD061504] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026801, 1F32NS053169, F32 NS053169] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS053169, R01NS026801] Funding Source: NIH RePORTER		Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bruce B, 2007, PAED CHILD HEALT-CAN, V12, P749, DOI 10.1093/pch/12.9.749; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Dunn LM., 1981, PEABODY PICTURE VOCA; DURKIN MS, 1994, AM J PUBLIC HEALTH, V84, P587, DOI 10.2105/AJPH.84.4.587; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; GOLDEN JC, 1976, J CLIN PSYCHOL, V32, P654; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KOGAN MD, 1995, AM J PREV MED, V11, P99, DOI 10.1016/S0749-3797(18)30484-7; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; NUECHTERLEIN KH, 1983, J ABNORM PSYCHOL, V92, P4, DOI 10.1037/0021-843X.92.1.4; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Ramsay LJ, 2003, PUBLIC HEALTH, V117, P404, DOI 10.1016/S0033-3506(03)00072-6; Reitan RM, 1985, HALSTEADREITAN NEURO; RUSSELL EW, 1980, PERCEPT MOTOR SKILL, V51, P121, DOI 10.2466/pms.1980.51.1.121; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SATZ P, 1989, PIN TEST PROFESSIONA; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwebel DC, 2007, J DEV BEHAV PEDIATR, V28, P245, DOI 10.1097/01.DBP.0000268561.80204.2a; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; WICKENS DD, 1970, PSYCHOL REV, V77, P1, DOI 10.1037/h0028569; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	36	118	118	1	33	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2011	17	5					886	895		10.1017/S1355617711000907			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	821KV	WOS:000294974800013	21813031	Green Accepted			2022-02-06	
J	Lopez-Larson, MP; Bogorodzki, P; Rogowska, J; McGlade, E; King, JB; Terry, J; Yurgelun-Todd, D				Lopez-Larson, Melissa P.; Bogorodzki, Piotr; Rogowska, Jadwiga; McGlade, Erin; King, Jace B.; Terry, Janine; Yurgelun-Todd, Deborah			Altered prefrontal and insular cortical thickness in adolescent marijuana users	BEHAVIOURAL BRAIN RESEARCH			English	Article						Marijuana; Adolescents; Imaging; Cortical thickness	TRAUMATIC BRAIN-INJURY; SURFACE-BASED ANALYSIS; ONSET CANNABIS USE; MAGNETIC-RESONANCE; AFFECTIVE-DISORDERS; SMOKING MARIJUANA; DECISION-MAKING; TISSUE VOLUME; SUBSTANCE USE; GRAY-MATTER	Introduction: There are limited data regarding the impact of marijuana (MJ) on cortical development during adolescence. Adolescence is a period of substantial brain maturation and cortical thickness abnormalities may be indicative of disruptions of normal cortical development. This investigation applied cortical-surface based techniques to compare cortical thickness measures in MJ using adolescents compared to non-using controls. Methods: Eighteen adolescents with heavy MJ use and 18 non-using controls similar in age received MRI scans using a 3T Siemens scanner. Cortical reconstruction and volumetric segmentation was performed with FreeSurfer. Group differences in cortical thickness were assessed using statistical difference maps covarying for age and gender. Results: Compared to non-users, MJ users had decreased cortical thickness in right caudal middle frontal, bilateral insula and bilateral superior frontal cortices. Marijuana users had increased cortical thickness in the bilateral lingual, right superior temporal, right inferior parietal and left paracentral regions. In the MJ users, negative correlations were found between frontal and lingual regions for urinary cannabinoid levels and between age of onset of use and the right superior frontal gyrus. Conclusion: This is one of the first studies to evaluate cortical thickness in a group of adolescents with heavy MJ use compared to non-users. Our findings are consistent with prior studies that documented abnormalities in prefrontal and insular regions. Our results suggest that age of regular use may be associated with altered prefrontal cortical gray matter development in adolescents. Furthermore, reduced insular cortical thickness may be a biological marker for increased risk of substance dependence. Published by Elsevier B.V.	[Lopez-Larson, Melissa P.; McGlade, Erin; King, Jace B.; Terry, Janine; Yurgelun-Todd, Deborah] Univ Utah, Inst Brain, Salt Lake City, UT 84108 USA; [Lopez-Larson, Melissa P.; Yurgelun-Todd, Deborah] Univ Utah, Sch Med, Salt Lake City, UT 84108 USA; [Lopez-Larson, Melissa P.; McGlade, Erin; Yurgelun-Todd, Deborah] VISN 19 MIRREC, Salt Lake City, UT USA; [Bogorodzki, Piotr] Tech Univ Warsaw, Inst Radioelect, PL-00662 Warsaw, Poland; [Rogowska, Jadwiga] Harvard Univ, McLean Hosp, Sch Med, Brain Imaging Ctr, Belmont, MA 02178 USA		Lopez-Larson, MP (corresponding author), Univ Utah, Inst Brain, 383 Colorow Dr, Salt Lake City, UT 84108 USA.	mlopez-larson@hsc.utah.edu	McGlade, Erin C/K-1157-2016	McGlade, Erin C/0000-0003-2234-1984; King, Jace/0000-0002-0206-0475; Bogorodzki, Piotr/0000-0001-6596-5274	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01 DA020269-01]; American Psychiatric Association [5T32 MH19126]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019126, K23MH087831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA020269] Funding Source: NIH RePORTER	This work was supported by research grants from an NIH: 1R01 DA020269-01 to DYT and training awards through the American Psychiatric Association's Program for Minority Research Training in Psychiatry (5T32 MH19126)	ALMEIDA LG, 2010, J PSYCHIAT RES; *APA, 2000, GLOB ASS FUNCT DIAGN, P32; Bachman JG, 1998, AM J PUBLIC HEALTH, V88, P887, DOI 10.2105/AJPH.88.6.887; Batty MJ, 2010, J AM ACAD CHILD PSY, V49, P229, DOI 10.1016/j.jaac.2009.11.008; Bava S, 2009, PSYCHIAT RES-NEUROIM, V173, P228, DOI 10.1016/j.pscychresns.2009.04.005; Becker B, 2010, PROG NEURO-PSYCHOPH, V34, P837, DOI 10.1016/j.pnpbp.2010.03.032; Block RI, 2000, NEUROREPORT, V11, P491, DOI 10.1097/00001756-200002280-00013; Bogorodzki P, 2005, IEEE T MED IMAGING, V24, P389, DOI 10.1109/TMI.2004.843183; BOGOUSSLAVSKY J, 1987, J NEUROL NEUROSUR PS, V50, P607, DOI 10.1136/jnnp.50.5.607; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Borgwardt SJ, 2008, BIOL PSYCHIAT, V64, P966, DOI 10.1016/j.biopsych.2008.05.011; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; CAMPBELL AM, 1971, LANCET, V2, P1219; Chang L, 2006, BRAIN, V129, P1096, DOI 10.1093/brain/awl064; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Churchwell JC, 2011, INHIBITORY CONTROL AND DRUG ABUSE PREVENTION: FROM RESEARCH TO TRANSLATION, P101, DOI 10.1007/978-1-4419-1268-8_6; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delisi Lynn E, 2006, Harm Reduct J, V3, P17, DOI 10.1186/1477-7517-3-17; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DOLMATOVA LS, 1995, VOP MED KHIM, V41, P57; Ehrenreich H, 1999, PSYCHOPHARMACOLOGY, V142, P295, DOI 10.1007/s002130050892; Eldreth DA, 2004, NEUROIMAGE, V23, P914, DOI 10.1016/j.neuroimage.2004.07.032; Ennett ST, 1997, J HEALTH SOC BEHAV, V38, P55, DOI 10.2307/2955361; Filbey FM, 2009, P NATL ACAD SCI USA, V106, P13016, DOI 10.1073/pnas.0903863106; First M.B., 1996, STRUCTURED CLIN INTE; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fletcher JM, 1996, ARCH GEN PSYCHIAT, V53, P1051; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; GarciaSevilla JA, 1997, NEUROREPORT, V8, P1561, DOI 10.1097/00001756-199705060-00003; Geller B, 2001, J AM ACAD CHILD PSY, V40, P450, DOI 10.1097/00004583-200104000-00014; Giancola PR, 1998, J GEN PSYCHOL, V125, P297, DOI 10.1080/00221309809595339; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gruber SA, 2005, COGNITIVE BRAIN RES, V23, P107, DOI 10.1016/j.cogbrainres.2005.02.016; Gruber SA, 2000, FORENSIC SCI MED, P199; Gruber SA, 2009, DRUG ALCOHOL DEPEN, V105, P139, DOI 10.1016/j.drugalcdep.2009.06.019; HABETS P, 2010, BIOL PSYCHIAT; HAMILTON A, 1969, BRIT J PSYCHIAT, P76; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Huestegge L, 2002, PROG BRAIN RES, V140, P377; Jacobsen LK, 2007, BIOL PSYCHIAT, V61, P31, DOI 10.1016/j.biopsych.2006.02.014; Jacobsen LK, 2004, ANN NY ACAD SCI, V1021, P384, DOI 10.1196/annals.1308.053; JAGER G, 2010, J AM ACAD CHILD ADOL, V49, pE1; Jager G, 2007, EUR NEUROPSYCHOPHARM, V17, P289, DOI 10.1016/j.euroneuro.2006.10.003; Jager G, 2010, J AM ACAD CHILD PSY, V49, P561, DOI 10.1016/j.jaac.2010.02.001; Kanayama G, 2004, PSYCHOPHARMACOLOGY, V176, P239, DOI 10.1007/s00213-004-1885-8; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; KUHN S, 2010, BIOL PSYCHIAT; Lange N, 2010, DEV NEUROPSYCHOL, V35, P296, DOI 10.1080/87565641003696833; Lawyer Glenn, 2010, BMC Pharmacology, V10, P5, DOI 10.1186/1471-2210-10-5; Luks TL, 2004, NEUROIMAGE, V22, P1515, DOI 10.1016/j.neuroimage.2004.04.008; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Martin-Santos R, 2010, PSYCHOL MED, V40, P383, DOI 10.1017/S0033291709990729; Mata I, 2010, BRAIN RES, V1317, P297, DOI 10.1016/j.brainres.2009.12.069; McNair D. M., 1992, REVISED MANUAL PROFI; Mobbs D, 2004, NEUROLOGY, V62, P2070, DOI 10.1212/01.WNL.0000129536.95274.DC; Moss HB, 1997, PSYCHIAT RES-NEUROIM, V76, P101, DOI 10.1016/S0925-4927(97)00067-X; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; NARR KL, 2009, J AM ACAD CHILD ADOL; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Leary DS, 2007, HUM PSYCHOPHARM CLIN, V22, P135, DOI 10.1002/hup.832; O'Leary DS, 2002, NEUROPSYCHOPHARMACOL, V26, P802, DOI 10.1016/S0893-133X(01)00425-0; Ozaita A, 1998, J NEUROCHEM, V70, P1249; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pope HG, 1996, JAMA-J AM MED ASSOC, V275, P521, DOI 10.1001/jama.275.7.521; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Ray S, 2010, ALCOHOL ALCOHOLISM, V45, P437, DOI 10.1093/alcalc/agq042; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; SCHWEINSBURG AD, 2010, J PSYCHOACTIVE DRUGS, P42; Schweinsburg AD, 2008, PSYCHIAT RES-NEUROIM, V163, P40, DOI 10.1016/j.pscychresns.2007.04.018; Schweinsburg Alecia D, 2008, Curr Drug Abuse Rev, V1, P99; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; SHAW P, 2010, AM J PSYCHIAT; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SOLOWIJ N, 1995, LIFE SCI, V56, P2127, DOI 10.1016/0024-3205(95)00198-F; Sowell ER, 2008, CEREB CORTEX, V18, P136, DOI 10.1093/cercor/bhm039; Spielberger CD., 1970, STATE TRAIT ANXIETY; Squeglia LM, 2009, CLIN EEG NEUROSCI, V40, P31, DOI 10.1177/155005940904000110; Stoppel CM, 2009, HUM BRAIN MAPP, V30, P3759, DOI 10.1002/hbm.20804; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tapert SF, 2007, PSYCHOPHARMACOLOGY, V194, P173, DOI 10.1007/s00213-007-0823-y; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tzilos GK, 2005, AM J ADDICTION, V14, P64, DOI 10.1080/10550490590899862; von Sydow K, 2001, DRUG ALCOHOL DEPEN, V64, P347, DOI 10.1016/S0376-8716(01)00137-5; Wallace G. L., 2010, BRAIN; Weinberg NZ, 1998, J AM ACAD CHILD PSY, V37, P252, DOI 10.1097/00004583-199803000-00009; Wilson W, 2000, J ADDICT DIS, V19, P1, DOI 10.1300/J069v19n01_01; YAMANOUCHI N, 1995, AM J NEURORADIOL, V16, P1643; Yurgelun-Todd DA, 2002, PSYCHOL REP, V91, P743, DOI 10.2466/PR0.91.7.743-757	98	118	120	0	41	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 20	2011	220	1					164	172		10.1016/j.bbr.2011.02.001			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	752PC	WOS:000289703600021	21310189	Green Accepted			2022-02-06	
J	Honda, M; Tsuruta, R; Kaneko, T; Kasaoka, S; Yagi, T; Todani, M; Fujita, M; Izumi, T; Maekawa, T				Honda, Masahiro; Tsuruta, Ryosuke; Kaneko, Tadashi; Kasaoka, Shunji; Yagi, Takeshi; Todani, Masaki; Fujita, Motoki; Izumi, Tomonori; Maekawa, Tsuyoshi			Serum Glial Fibrillary Acidic Protein Is a Highly Specific Biomarker for Traumatic Brain Injury in Humans Compared With S-100B and Neuron-Specific Enolase	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head computed tomography; Brain-specific biomarker; Predictability	DAMAGE; GFAP; MARKER; S100B; MECHANISMS	Background: Serum glial fibrillary acidic protein (GFAP) is a specific predictor of brain damage and neurologic outcome in patients with traumatic brain injury (TBI). In this study, serum GFAP, S-100B, and neuron-specific enolase (NSE) were compared in the same samples from severe trauma patients to assess their ability to predict abnormalities detectable on head computed tomography (CT). Methods: This study was a retrospective analysis at a single university emergency center. Thirty-four trauma patients were included. Serum samples were collected from the patients for 3 days. Serum GFAP, S-100B, and NSE concentrations were measured with enzyme-linked immunosorbent assays and compared in patients with and without TBI, as evaluated by head CT. Results: Serum GFAP, S-100B, and NSE were significantly higher in the TBI patients than in the non-TBI patients (p < 0.05 for each protein). The receiver operating characteristic curves for TBI were compared for the three biomarkers for 3 days. Serum GFAP on day 1 had the largest area under the receiver operating characteristic curve (0.983), with 88.9% sensitivity and 100% specificity. Conclusions: Serum GFAP has remarkable diagnostic value for TBI, defined by abnormal head CT findings, in prehospital-triaged patients with severe trauma.	[Honda, Masahiro; Tsuruta, Ryosuke; Kaneko, Tadashi; Kasaoka, Shunji; Yagi, Takeshi; Todani, Masaki; Fujita, Motoki; Maekawa, Tsuyoshi] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan; [Izumi, Tomonori] Yamaguchi Univ, Grad Sch Med, Dept Stress & Bioresponse Med, Yamaguchi, Japan		Kaneko, T (corresponding author), Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, 1-1-1 Minamikogushi Ube, Yamaguchi, Japan.	kaneyui-ygc@umin.ac.jp	Kaneko, Tadashi/AAD-1516-2022	Kaneko, Tadashi/0000-0002-7171-7231	Japanese Ministry of Health, Labor, and WelfareMinistry of Health, Labour and Welfare, Japan [19791329]	Supported by the Japanese Ministry of Health, Labor, and Welfare research project grant 19791329.	Altura BM, 1999, ALCOHOL, V19, P119, DOI 10.1016/S0741-8329(99)00025-7; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; MERIC E, J EMERG MED IN PRESS; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mussack T, 2000, ACT NEUR S, V76, P393; Naeimi ZS, 2006, BRAIN INJURY, V20, P463, DOI 10.1080/02699050600664418; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Ribotta MG, 2004, ACTA NEUROCHIR SUPPL, V89, P87; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; VIJAYAN VK, 1990, MOL CHEM NEUROPATHOL, V13, P107, DOI 10.1007/BF03159912; Vissers JLM, 2006, CLIN CHIM ACTA, V366, P336, DOI 10.1016/j.cca.2005.11.017; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Woertgen C, 2002, ACT NEUR S, V81, P205	22	118	127	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2010	69	1					104	109		10.1097/TA.0b013e3181bbd485			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	627AQ	WOS:000280010600016	20093985				2022-02-06	
J	von Steinbuchel, N; Wilson, L; Gibbons, H; Hawthorne, G; Hofer, S; Schmidt, S; Bullinger, M; Maas, A; Neugebauer, E; Powell, J; von Wild, K; Zitnay, G; Bakx, W; Christensen, AL; Koskinen, S; Sarajuuri, J; Formisano, R; Sasse, N; Truelle, JL				von Steinbuechel, Nicole; Wilson, Lindsay; Gibbons, Henning; Hawthorne, Graeme; Hoefer, Stefan; Schmidt, Silke; Bullinger, Monika; Maas, Andrew; Neugebauer, Edmund; Powell, Jane; von Wild, Klaus; Zitnay, George; Bakx, Wilbert; Christensen, Anne-Lise; Koskinen, Sanna; Sarajuuri, Jaana; Formisano, Rita; Sasse, Nadine; Truelle, Jean-Luc		QOLIBRI Task Force	Quality of Life after Brain Injury (QOLIBRI): Scale Development and Metric Properties	JOURNAL OF NEUROTRAUMA			English	Article						multi-national study; outcome instrument; quality of life; traumatic brain injury	COMMUNITY INTEGRATION; MULTIPLE TRAUMA; HEALTH-STATUS; OUTCOMES; MODERATE; SF-36; REHABILITATION; QUESTIONNAIRE; SATISFACTION; INSTRUMENT	The consequences of traumatic brain injury (TBI) for health-related quality of life (HRQoL) are poorly investigated, and a TBI-specific instrument has not previously been available. The cross-cultural development of a new measure to assess HRQoL after TBI is described here. An international TBI Task Force derived a conceptual model from previous work, constructed an initial item bank of 148 items, and then reduced the item set through two successive multicenter validation studies. The first study, with eight language versions of the QOLIBRI, recruited 1528 participants with TBI, and the second with six language versions, recruited 921 participants. The data from 795 participants from the second study who had complete Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS) data were used to finalize the instrument. The final version of the QOLIBRI consists of 37 items in six scales (see Appendix). Satisfaction is assessed in the areas of "Cognition,'' "Self,'' "Daily Life and Autonomy,'' and "Social Relationships,'' and feeling bothered by "Emotions,'' and "Physical Problems.'' The QOLIBRI scales meet standard psychometric criteria (internal consistency, alpha = 0.75-0.89, test-retest reliability, r(tt) = 0.78-0.85). Test-retest reliability (r(tt) = 0.68-0.87) as well as internal consistency (alpha = 0.81-0.91) were also good in a subgroup of participants with lower cognitive performance. Although there is one strong HRQoL factor, a six-scale structure explaining additional variance was validated by exploratory and confirmatory factor analyses, and with Rasch modeling. The QOLIBRI is a new cross-culturally developed instrument for assessing HRQoL after TBI that fulfills standard psychometric criteria. It is potentially useful for clinicians and researchers conducting clinical trials, for assessing the impact of rehabilitation or other interventions, and for carrying out epidemiological surveys.	[von Steinbuechel, Nicole; Gibbons, Henning; Sasse, Nadine] Univ Gottingen, Dept Med Psychol & Med Sociol, Gottingen, Germany; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Hawthorne, Graeme] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Psychiat, Melbourne, Vic, Australia; [Hoefer, Stefan] Med Univ Innsbruck, Dept Med Psychol, Innsbruck, Austria; [Schmidt, Silke] Ernst Moritz Arndt Univ Greifswald, Inst Psychol, Dept Hlth & Prevent, Greifswald, Germany; [Bullinger, Monika] Univ Hosp Eppendorf, Dept Med Psychol, Hamburg, Germany; [Maas, Andrew] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Neugebauer, Edmund] Private Univ Witten Herdecke, IFOM, Cologne, Germany; [Powell, Jane] Univ London Goldsmiths Coll, Dept Psychol, London SE14 6NW, England; [von Wild, Klaus] Univ Munster, Fac Med, Munster, Germany; [Zitnay, George] Assoc Martha Jefferson Hosp, Charlottesville, VA USA; [Bakx, Wilbert] Maastricht Univ, Maastricht, Netherlands; [Bakx, Wilbert] Hoensbroeck Rehabil Ctr, Hoensbroeck, Netherlands; [Christensen, Anne-Lise] Univ Copenhagen, Ctr Rehabil Brain Injury, Copenhagen, Denmark; [Christensen, Anne-Lise] Univ Copenhagen, Ctr Cognit & Memory, Copenhagen, Denmark; [Koskinen, Sanna; Sarajuuri, Jaana] Kapyla Rehabil Ctr, Helsinki, Finland; [Formisano, Rita] Rehabil Hosp, IRCCS, Santa Lucia Fdn, Rome, Italy; [Truelle, Jean-Luc] CHU Raymond Poincare, Serv Med Phys & Readapt, Garches, France		von Steinbuchel, N (corresponding author), Univ Gottingen, Dept Med Psychol & Med Sociol, Waldweg 37, Gottingen, Germany.	nvsteinbuechel@med.uni-goettingen.de	Hofer, Stefan/N-8253-2019; Maas, Andrew IR/C-5584-2013; Sarajuuri, Jaana/AAD-8665-2019; Wilson, Lindsay/A-3659-2009; Wilson, Lindsay/O-8883-2019; Hofer, Stefan/B-8393-2008	Hofer, Stefan/0000-0002-6128-3687; Maas, Andrew IR/0000-0003-1612-1264; Sarajuuri, Jaana/0000-0002-6432-0295; Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Hofer, Stefan/0000-0002-6128-3687; Koskinen, Sanna/0000-0002-3453-5084			Acquadro C, 1996, QUALITY LIFE PHARMAC, P575; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bond T. G., 2007, APPL RASCH MODEL; Brod M, 1999, GERONTOLOGIST, V39, P25, DOI 10.1093/geront/39.1.25; BULLINGER M, 1993, QUAL LIFE RES, V2, P451, DOI 10.1007/BF00422219; Bullinger M, 2001, CURR PROB E, V16, P277; Callahan CD, 2005, REHABIL PSYCHOL, V50, P65, DOI 10.1037/0090-5550.50.1.65; Cattelani R, 2008, EUR J PHYS REHAB MED, V44, P245; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CRUM RM, 1993, JAMA-J AM MED ASSOC, V12, P2386; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; English TC, 1904, LANCET, V1, P485; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; Folstein M., 2003, TELEPHONE INTERVIEW; Folstein M, 1988, NEUROPSY NEUROPSY BE, V1, P111; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GERIN P, 1989, THERAPIE, V44, P355; GUYATT GH, 1989, CAN MED ASSOC J, V140, P1441; Hawthorne G, 2006, QUAL LIFE RES, V15, P1257, DOI 10.1007/s11136-006-0062-4; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hays R, 1988, USERS GUIDE MULTITRA; JENNETT B, 1975, LANCET, V1, P480; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Moosbrugger H., 2007, TESTTHEORIE FRAGEBOG, V2; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Novella JL, 2001, AGING CLIN EXP RES, V13, P362, DOI 10.1007/BF03351504; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; PAPULAYAN KF, 2006, ARCH PHYS MED REHAB, V87, P611; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Power M, 2005, QUAL LIFE RES, V14, P2197, DOI 10.1007/s11136-005-7380-9; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Riemsma R P, 2001, Health Technol Assess, V5, P1; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Schmidt S, 2006, J CLIN EPIDEMIOL, V59, P587, DOI 10.1016/j.jclinepi.2005.09.012; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Stucki G, 1997, Z RHEUMATOL, V56, P266, DOI 10.1007/s003930050041; Tazopoulou E, 2005, ACTA NEUROPSYCHOL, V1, P13; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Truelle JL, 2008, ACTA NEUROCHIR SUPPL, V101, P125; von Steinbuchel Nicole, 2006, Eur J Ageing, V3, P116, DOI 10.1007/s10433-006-0024-2; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; VONSTEINBUCHEL N, 1995, PRAVENTION REHABILIT, V7, P39; VONSTEINBUCHEL N, 2002, STUDY PROTOCOL UNPUB; Ware J. E., 1996, SF 36 HLTH SURVEY VE; Ware J.E., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1995, INT J TECHNOL ASSESS, V11, P525, DOI 10.1017/S0266462300008710; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wlodarczyk JH, 2004, ARCH GERONTOL GERIAT, V39, P25, DOI 10.1016/j.archger.2003.12.004; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599; [No title captured]	78	118	118	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2010	27	7					1167	1185		10.1089/neu.2009.1076			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	631FD	WOS:000280331100002	20486801	Green Accepted			2022-02-06	
J	Robertson, SD; Matthies, HJG; Galli, A				Robertson, S. D.; Matthies, H. J. G.; Galli, A.			A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters	MOLECULAR NEUROBIOLOGY			English	Article						Amphetamine; AMPH; Norepinephrine transporter; NET; Dopamine transporter; DAT; Monoamine transporter; Neurotransmitter transporter; Monoamines; Efflux; Trafficking	PROTEIN-KINASE-C; CARRIER-MEDIATED RELEASE; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; DEPENDENT MECHANISM; SURFACE EXPRESSION; EXCHANGE DIFFUSION; SYNAPTIC VESICLES; ADRENAL-MEDULLA; XENOPUS OOCYTES	Amphetamine (AMPH) and its derivatives are regularly used in the treatment of a wide array of disorders such as attention-deficit hyperactivity disorder (ADHD), obesity, traumatic brain injury, and narcolepsy (Prog Neurobiol 75:406-433, 2005; J Am Med Assoc 105:2051-2054, 1935; J Am Acad Child Adolesc Psychiatry 41:514-521, 2002; Neuron 43:261-269, 2004; Annu Rev Pharmacol Toxicol 47:681-698, 2007; Drugs Aging 21:67-79, 2004). Despite the important medicinal role for AMPH, it is more widely known for its psychostimulant and addictive properties as a drug of abuse. The primary molecular targets of AMPH are both the vesicular monoamine transporters (VMATs) and plasma membrane monoamine-dopamine (DA), norepinephrine (NE), and serotonin (5-HT)-transporters. The rewarding and addicting properties of AMPH rely on its ability to act as a substrate for these transporters and ultimately increase extracellular levels of monoamines. AMPH achieves this elevation in extracellular levels of neurotransmitter by inducing synaptic vesicle depletion, which increases intracellular monoamine levels, and also by promoting reverse transport (efflux) through plasma membrane monoamine transporters (J Biol Chem 237:2311-2317, 1962; Med Exp Int J Exp Med 6:47-53, 1962; Neuron 19:1271-1283, 1997; J Physiol 144:314-336, 1958; J Neurosci 18:1979-1986, 1998; Science 237:1219-1223, 1987; J Neurosc 15:4102-4108, 1995). This review will focus on two important aspects of AMPH-induced regulation of the plasma membrane monoamine transporters-transporter mediated monoamine efflux and transporter trafficking.	[Robertson, S. D.; Matthies, H. J. G.; Galli, A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Robertson, S. D.] Vanderbilt Univ, Neurosci Grad Program, Nashville, TN USA		Galli, A (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	aurelio.galli@Vanderbilt.Edu	Matthies, Heinrich/B-7284-2017; Matthies, Heinrich/AAD-2375-2019	Matthies, Heinrich/0000-0003-3615-7571; Matthies, Heinrich/0000-0003-3615-7571; Robertson, Sabrina/0000-0003-4598-6929	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH058921, DA13975, MH084755]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH058921, F31MH084755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R56DA013975, R01DA013975] Funding Source: NIH RePORTER	We thank Dr. Kevin Erreger and Jessica Moore for helpful and insightful discussions. This work was supported by NIH grants MH058921 (Galli, A.), DA13975 (Galli, A.), and MH084755 (Robertson, S. D.).	Androutsellis-Theotokis A, 2002, J NEUROSCI, V22, P8370; AXELROD JULIUS, 1965, RECENT PROG HORMONE RES, V21, P597; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Boudanova E, 2008, NEUROPHARMACOLOGY, V54, P605, DOI 10.1016/j.neuropharm.2007.11.007; BRUSS M, 1995, J BIOL CHEM, V270, P9197; BURN JH, 1958, J PHYSIOL-LONDON, V144, P314, DOI 10.1113/jphysiol.1958.sp006104; Burnette WB, 1996, ANAL CHEM, V68, P2932, DOI 10.1021/ac960022x; CARLSSON A, 1962, MED EXP, V6, P47; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; CHU PC, 1986, DIABETES, V35, P481, DOI 10.2337/diabetes.35.4.481; Cowell RM, 2000, EUR J PHARMACOL, V389, P59, DOI 10.1016/S0014-2999(99)00828-6; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Dipace C, 2007, MOL PHARMACOL, V71, P230, DOI 10.1124/mol.106.026690; Doolen S, 2001, J PHARMACOL EXP THER, V296, P931; Erreger K, 2008, J NEUROSCI, V28, P976, DOI 10.1523/JNEUROSCI.2796-07.2008; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Galici R, 2003, NEUROENDOCRINOLOGY, V77, P132, DOI 10.1159/000068650; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; GIAMBALVO CT, 1992, NEUROPHARMACOLOGY, V31, P1211, DOI 10.1016/0028-3908(92)90049-U; Gnegy ME, 2004, MOL PHARMACOL, V66, P137, DOI 10.1124/mol.66.1.137; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gulley JM, 2002, J NEUROCHEM, V83, P400, DOI 10.1046/j.1471-4159.2002.01133.x; HEIKKILA RE, 1975, J PHARMACOL EXP THER, V194, P47; Hersch SM, 1997, J COMP NEUROL, V388, P211; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Jones SR, 1998, J NEUROSCI, V18, P1979; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kahlig KM, 2003, EUR J PHARMACOL, V479, P153, DOI 10.1016/j.ejphar.2003.08.065; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kahlig KM, 2006, MOL PHARMACOL, V70, P542, DOI 10.1124/mol.106.023952; Kantor L, 1999, J NEUROSCI, V19, P3801; Kantor L, 1998, J PHARMACOL EXP THER, V284, P592; Kantor L, 2004, J PHARMACOL EXP THER, V311, P1044, DOI 10.1124/jpet.104.071068; Kantor L, 2001, J PHARMACOL EXP THER, V297, P1016; Karkanias GB, 1997, HORM BEHAV, V32, P19, DOI 10.1006/hbeh.1997.1401; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; KIRSHNER N, 1962, J BIOL CHEM, V237, P2311; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Lute BJ, 2008, BIOCHEM BIOPH RES CO, V372, P656, DOI 10.1016/j.bbrc.2008.05.091; Martinsson L, 2004, DRUG AGING, V21, P67, DOI 10.2165/00002512-200421020-00001; Mazei-Robison MS, 2008, J NEUROSCI, V28, P7040, DOI 10.1523/JNEUROSCI.0473-08.2008; Melikian HE, 1999, J NEUROSCI, V19, P7699; Olfson M, 2002, J AM ACAD CHILD PSY, V41, P514, DOI 10.1097/00004583-200205000-00008; Owens WA, 2005, J NEUROCHEM, V94, P1402, DOI 10.1111/j.1471-4159.2005.03289.x; PARKER EM, 1988, J PHARMACOL EXP THER, V245, P199; Pierce RC, 1997, J NEUROSCI, V17, P3254; Pifl C, 1999, MOL PHARMACOL, V56, P1047, DOI 10.1124/mol.56.5.1047; Pifl C, 2004, NEUROPHARMACOLOGY, V46, P223, DOI 10.1016/j.neuropharm.2003.09.007; Pifl C, 1997, BRIT J PHARMACOL, V121, P205, DOI 10.1038/sj.bjp.0701137; PIFL C, 1995, MOL PHARMACOL, V47, P368; Prinzmetal M, 1935, J AMER MED ASSOC, V105, P2051; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; RAITERI M, 1979, J PHARMACOL EXP THER, V208, P195; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Saitoh A, 1998, PHARMACOL BIOCHEM BE, V60, P161, DOI 10.1016/S0091-3057(97)00588-1; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schenk James O, 2002, Prog Drug Res, V59, P111; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; SEIDEN LS, 1993, ANNU REV PHARMACOL, V33, P639, DOI 10.1146/annurev.pa.33.040193.003231; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; SULZER D, 1995, J NEUROSCI, V15, P4102; Sung U, 2003, J NEUROSCI, V23, P1697; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; Williams J, 2007, PLOS BIOL, V5, P2369, DOI 10.1371/journal.pbio.0050274; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; ZACZEK R, 1991, J PHARMACOL EXP THER, V257, P830; Zhu MY, 2000, J PHARMACOL EXP THER, V295, P951	90	118	121	1	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2009	39	2					73	80		10.1007/s12035-009-8053-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418YD	WOS:000264185100001	19199083	Green Accepted			2022-02-06	
J	Barr, RG; Rivara, FP; Barr, M; Cummings, P; Taylor, J; Lengua, LJ; Meredith-Benitz, E				Barr, Ronald G.; Rivara, Frederick P.; Barr, Marilyn; Cummings, Peter; Taylor, James; Lengua, Liliana J.; Meredith-Benitz, Emily			Effectiveness of Educational Materials Designed to Change Knowledge and Behaviors Regarding Crying and Shaken-Baby Syndrome in Mothers of Newborns: A Randomized, Controlled Trial	PEDIATRICS			English	Article						prevention; crying; shaken baby syndrome	TRAUMATIC BRAIN-INJURY; AGE-RELATED INCIDENCE; MULTIPLE IMPUTATION; INFANT SYNDROME; SLEEP POSITION; PERPETRATOR; TRIGGER; CURVE	BACKGROUND. Infant crying is an important precipitant for shaken-infant syndrome. OBJECTIVE. To determine if parent education materials (The Period of PURPLE Crying [PURPLE]) change maternal knowledge and behavior relevant to infant shaking. METHODS. This study was a randomized, controlled trial conducted in prenatal classes, maternity wards, and pediatric practices. There were 1374 mothers of newborns randomly assigned to the PURPLE intervention and 1364 mothers to the control group. Primary outcomes were measured by telephone 2 months after delivery. These included 2 knowledge scales about crying and the dangers of shaking; 3 scales about behavioral responses to crying generally and to unsoothable crying, and caregiver self-talk in response to unsoothable crying; and 3 questions concerning the behaviors of sharing of information with others about crying, walking away if frustrated, and the dangers of shaking. RESULTS. The mean infant crying knowledge score was greater in the intervention group (69.5) compared with controls (63.3). Mean shaking knowledge was greater for intervention subjects (84.8) compared with controls (83.5). For reported maternal behavioral responses to crying generally, responses to unsoothable crying, and for self-talk responses, mean scores for intervention mothers were similar to those for controls. For the behaviors of information sharing, more intervention mothers reported sharing information about walking away if frustrated and the dangers of shaking, but there was little difference in sharing information about infant crying. Intervention mothers also reported increased infant distress. CONCLUSIONS. Use of the PURPLE education materials seem to lead to higher scores in knowledge about early infant crying and the dangers of shaking, and in sharing of information behaviors considered to be important for the prevention of shaking. Pediatrics 2009;123:972-980	[Barr, Ronald G.] Univ British Columbia, Child & Family Res Inst, Ctr Community Child Hlth Res, Vancouver, BC V6H 3V4, Canada; [Barr, Ronald G.] Univ British Columbia, Dept Pediat, Vancouver, BC V6H 3V4, Canada; [Rivara, Frederick P.; Taylor, James] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.; Cummings, Peter] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.; Cummings, Peter; Meredith-Benitz, Emily] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Barr, Marilyn] Natl Ctr Shaken Baby Syndrome, Ogden, UT USA; [Lengua, Liliana J.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA		Barr, RG (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Community Child Hlth Res, 4480 Oak St,L408, Vancouver, BC V6H 3V4, Canada.	rbarr@cw.bc.ca					*AM AC PED, 1994, TIPP BIRTH 6 MONTHS, P3; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr R. G., 1997, RONNICLOG BABYS DAY; Barr R. G., 2006, ENCY EARLY CHILDHOOD, P1; Barr R. G., 1985, BABYS DAY DIARY; Barr R.G, 2004, PERIOD PURPLE CRYING; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Barr RG, 2005, J DEV BEHAV PEDIATR, V26, P14; BARR RG, 1989, PEDIATRICS, V84, P514; BARR RG, 1988, ARCH DIS CHILD, V63, P380, DOI 10.1136/adc.63.4.380; BARR RG, 1990, DEV MED CHILD NEUROL, V32, P356; Barr RG, 2000, HDB DEV PSYCHOPATHOL, P327; Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641; Berger VW, 1999, CONTROL CLIN TRIALS, V20, P319, DOI 10.1016/S0197-2456(99)00014-8; Brewster AL, 1998, CHILD ABUSE NEGLECT, V22, P91, DOI 10.1016/S0145-2134(97)00132-4; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; CALINOIU N, 1998, PROGRAM INT SOC INFA, P5; *CAN ASS CHIEFS PO, 2001, J PAEDIATR CHILD H, V6, P663; Catherine NLA, 2008, J DEV BEHAV PEDIATR, V29, P508, DOI 10.1097/DBP.0b013e31818d0c0c; Cummings P, 2001, INJURY CONTROL, P64; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; DIAS MS, 2003, AAP NEWS, V23, P16; DYKES LJ, 1986, CHILD ABUSE NEGLECT, V10, P211, DOI 10.1016/0145-2134(86)90082-7; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; HUNZIKER UA, 1986, PEDIATRICS, V77, P641; *I AM YOUR CHILD F, 2007, KEEP YOUR INF SAF; Kairys SW, 2001, PEDIATRICS, V108, P206; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kramer MS, 2001, JAMA-J AM MED ASSOC, V286, P322, DOI 10.1001/jama.286.3.322; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Lazoritz S, 1997, CHILD ABUSE NEGLECT, V21, P1009, DOI 10.1016/S0145-2134(97)00061-6; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; LEHTONEN L, 1998, INFANT BEHAV DEV, V21, pG16; Levitt CJ, 1994, CHILD ABUSE MED DIAG, P1; Little R. J., 2019, STAT ANAL MISSING DA, V793; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Majnemer A, 2006, J PEDIATR-US, V149, P623, DOI 10.1016/j.jpeds.2006.05.009; Nicholson, 2003, INFLICTED CHILDHOOD, P269; Raghunathan TE, 2004, ANNU REV PUBL HEALTH, V25, P99, DOI 10.1146/annurev.publhealth.25.102802.124410; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Schafer JL, 1997, ANAL INCOMPLETE MULT; Soltis J, 2004, BEHAV BRAIN SCI, V27, P443, DOI 10.1017/S0140525X0400010X; St James-Roberts I, 2006, PEDIATRICS, V117, pE1146, DOI 10.1542/peds.2005-2387; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STARLING SP, 1995, PEDIATRICS, V95, P259; *STAT CORP, 2006, STAT STAT SOFTW COMP; STJAMESROBERTS I, 1993, ARCH DIS CHILD, V68, P82, DOI 10.1136/adc.68.1.82; *US DEP HHS, 2005, SAF SLEEP YOUR BAB; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Willinger M, 2000, JAMA-J AM MED ASSOC, V283, P2135, DOI 10.1001/jama.283.16.2135	53	118	119	0	21	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAR	2009	123	3					972	980		10.1542/peds.2008-0908			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	413XH	WOS:000263825500033	19255028				2022-02-06	
J	Ruttan, L; Martin, K; Liu, A; Colella, B; Green, RE				Ruttan, Lesley; Martin, Krystle; Liu, Anita; Colella, Brenda; Green, Robin E.			Long-Term Cognitive Outcome in Moderate to Severe Traumatic Brain Injury: A Meta-Analysis Examining Timed and Untimed Tests at 1 and 4.5 or More Years After Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Neuropsychology; Rehabilitation	CLOSED-HEAD-INJURY; SELECTIVE ATTENTION; MEMORY PERFORMANCE; DIVIDED ATTENTION; RECOVERY; SPEED; IMPAIRMENTS; INHIBITION; PREDICTORS; PLASTICITY	Objectives: To examine long-term outcome of moderate to severe traumatic brain injury (TBI) on timed and untimed cognitive tests using meta-analysis. Design: Meta-analysis examining outcome at 2 epochs, 6 to 18 months postinjury (epoch 1) and 4.5 to 11 years postinjury (epoch 2). Setting: Data source was published articles (1966-2007) identified through electronic and manual search. Participants: A total of 1380 subjects with moderate to severe TBI participated in the 16 studies meeting inclusion criteria. Interventions: Not applicable. Main Outcome Measures: Timed and untimed neuropsychologic tests with quantitative results (means, SDs, t, and df tests) from studies containing a healthy comparison group and a mean time since injury falling within 1 of the 2 epochs. Results: Patient versus control weighted effect sizes were medium to large at epoch 1 for both untimed tasks (r=-.46; confidence interval [CI], -.32 to -.65) and timed tasks (r=-.46; CI, -.35 to -.59). At epoch 2, effect sizes were slightly smaller for untimed tasks (r=-.38; CI -.25 to -.60) and timed tasks (r=-.40; CI, -.32 to -.62). Conclusions: Patients showed robust, persisting impairments on both timed and untimed tests at recovery plateau (ie, 6-18mo postinjury) and many years later. These findings converge with previous studies, though using an alternative approach that obviates some of the methodologic problems of longitudinal studies, such as selective attrition.	[Ruttan, Lesley; Liu, Anita; Colella, Brenda; Green, Robin E.] Toronto Rehabil Inst, Toronto, ON M4G 1R7, Canada; [Green, Robin E.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A1, Canada; [Martin, Krystle] Univ Toronto, Ontario Inst Studies Educ, Toronto, ON, Canada		Ruttan, L (corresponding author), Toronto Rehabil Inst, 345 Rumsey Rd, Toronto, ON M4G 1R7, Canada.	ruttan.lesley@torontorehab.on.ca	Liu, Anita/F-7179-2010	Green, Robin/0000-0001-9451-3963; Martin, Krystle/0000-0003-0419-8328	Ministry of Health and Long-Term Care in OntarioMinistry of Health and Long-Term Care, Ontario	We thank Kadeen Johns, BA, Joel Verwegan, and Areeba Adnan for their valuable contributions to the preparation of this article. We are also grateful to Todd Girard, PhD, for his thoughtful and insightful input.; The authors acknowledge the support of Toronto Rehabilitation Institute who receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario. The views expressed do not necessarily reflect those of the Ministry.	Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brooks D N, 1979, Int Rehabil Med, V1, P166; Ciaramelli E, 2006, BRAIN COGNITION, V60, P198; Cohen J., 2013, STAT POWER ANAL BEHA; COLLINS JG, 1990, DHHS PUBLICATION, V175, P1; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; EVANS J, NEUROPSYCHOLOGICAL R, V18, P372; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; GRADY MS, 2002, DIS NERV SYST, P1793; Gray C, 1998, BRAIN INJURY, V12, P429, DOI 10.1080/026990598122548; Greiffenstein MF, 2007, J CLIN EXP NEUROPSYC, V29, P113, DOI 10.1080/13803390600781105; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; HANNAY HJ, 2004, NEUROPSYCHOLOGICAL A, P157; Hedges L.V., 1985, STAT METHODS META AN; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; HOWELL DC, 1992, STAT METHODS PSYCHOL; Howieson D. B., 2004, NEUROPSYCHOLOGICAL A, P286; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; KAROL RL, 1989, CLIN NEUROPSYCHOL, V3, P244; KOLB B, 1996, RECOVERY FUNCTION FU, P539; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Orwin R.G., 1983, J EDUC STAT, V8, P157, DOI [10.2307/1164923, DOI 10.2307/1164923]; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Simpson A, 2000, NEUROPSYCHOLOGY, V14, P310, DOI 10.1037//0894-4105.14.2.310; Spikman JM, 2004, J INT NEUROPSYCH SOC, V10, P851, DOI 10.1017/S1355617704106061; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; THURMAN DJ, 2003, C MILD TRAUM BRAIN I; TILL C, ARCH PHYS M IN PRESS; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VANDERWERF E, 1992, ECOLOGY, V73, P1699, DOI 10.2307/1940021; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VANZOMEREN AH, 1994, CLIN NEUROPSYCHOLOGY, P250; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Wong PP, 2001, BRAIN INJURY, V15, P519, DOI 10.1080/02699050010005995; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995	83	118	119	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2008	89	12		2			S69	S76		10.1016/j.apmr.2008.07.007			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	388DB	WOS:000261999400009	19081444				2022-02-06	
J	Howard, JL; Cipolle, MD; Anderson, M; Sabella, V; Shollenberger, D; Li, PM; Pasquale, MD				Howard, Jerry Lee; Cipolle, Mark D.; Anderson, Meredith; Sabella, Victoria; Shollenberger, Daniele; Li, P. Mark; Pasquale, Michael D.			Outcome after decompressive craniectomy for the treatment of severe traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	20th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 16-20, 2007	Ft Myers, FL	Eastern Assoc Surg Trauma		craniectomy; decompressive craniectomy; severe traumatic brain injury; trauma; long-term; functional outcome; outcome	MANAGEMENT; SCALE	Background: Using decompressive craniectomy as part of the treatment regimen for severe traumatic brain injury (STBI) has become more common at our Level I trauma center. This study was designed to examine this practice with particular attention to long-term functional outcome. Methods: A retrospective review of prospectively collected data was performed for patients with STBI admitted from January 1, 2003 to December 31, 2005. Our institution manages patients using the Brain Trauma Foundation Guidelines. Data collected from patients undergoing decompressive craniectomy included: age, Injury Severity Score, admission and follow-up Glasgow Coma Score, timing of, and indication for decompressive craniectomy, and procedure-related complications. The Extended Glasgow Outcome Scale (GOSE) was performed by a experienced trauma clinical research coordinator using a structured phone interview to assess long-term outcome in the survivors. Student's t test and chi(2) were used to examine differences between groups. Results: Forty STBI patients were treated with decompressive craniectomy; 24 were performed primarily in conjunction with urgent evacuation of extra-axial hemorrhage and 16 were performed primarily in response to increased intracranial pressure with 4 of these after an initial craniotomy. Decompressive craniectomy was very effective at lowering intracranial pressure in these 16 patients (35.0 mm Hg +/- 13.5 mm Hg to 14.6 mm Hg 8.7 mm H g, p = 0.005). Twenty-two decompressive craniectomy patients did not survive to hospital discharge, whereas admission Glasgow Coma Score and admission pupil size and reactivity correlated with outcome, age, and Injury Severity Score did not At a mean of 11 months (range, 3-26 months) after decompressive craniectomy, 6 survivors had a poor functional outcome (GOSE 1-4), whereas 12 survivors had a good outcome (GOSE 5-8). Therefore, 70% of these patients had an unfavorable outcome (death or severe disability), and 30% had a favorable long-term functional outcome. Fifteen of 18 survivors went on to cranioplasty, whereas 4 of 18 had cerebrospinal infection. Conclusion: The majority of survivors after decompressive craniectomy have a good functional outcome as analyzed by GOSE. Overall, 30% of patients with STBI who underwent decompressive craniectomy had a favorable long-term outcome. Improving patient selection and optimizing timing of this procedure may further improve outcome in these very severely brain injured patients.	[Howard, Jerry Lee; Cipolle, Mark D.; Anderson, Meredith; Sabella, Victoria; Shollenberger, Daniele; Li, P. Mark; Pasquale, Michael D.] Lehigh Valley Hosp, Dept Surg, Div Trauma Surg Crit Care, Allentown, PA 18105 USA		Howard, JL (corresponding author), Lehigh Valley Hosp, Dept Surg, Div Trauma Surg Crit Care, Cedar Crest & I-78,POB 689, Allentown, PA 18105 USA.	sally.lutz@lvh.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; BULLOCK MR, 1958, NEUROSURGERY S3, V58; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; CZOSNYKA M, 1996, NEUROCHIRURGICA, V138, P541; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Grady MS, 2006, J NEUROSURG, V104, P467, DOI 10.3171/jns.2006.104.4.467; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hutcherson DA, 2004, BIOL BLOOD MARROW TR, V10, P104, DOI 10.1016/j.bbmt.2003.12.286; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kunze E, 1998, ACT NEUR S, V71, P16; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Schneider GH, 2002, ACT NEUR S, V81, P77; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005	23	118	129	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2008	65	2					380	385		10.1097/TA.0b013e31817c50d4			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	337US	WOS:000258461600028	18695475				2022-02-06	
J	Gioia, GA; Collins, M; Isquith, PK				Gioia, Gerard A.; Collins, Michael; Isquith, Peter K.			Improving identification and diagnosis of mild traumatic brain injury with evidence: Psychometric support for the Acute Concussion Evaluation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute concussion evaluation; assessment; concussion; mild traumatic brain injury; postconcussion symptoms; triage	SYMPTOMS; PERFORMANCE; RECOVERY; CHILDREN; IMPACT	Objectives: A dearth of standardized assessment tools exists to properly assess and triage mild traumatic brain injury (mTBI) in primary care and acute care settings. This article presents evidence of appropriate psychometric properties for the Acute Concussion Evaluation (ACE), a new structured clinical interview. Participants: Parent informants of 354 patients, aged 3 to 18 years, with suspected mTBI completed the ACE via telephone interview. Measure: Acute Concussion Evaluation. Results: Evidence is presented for appropriate item-scale membership, internal consistency reliability as well as content, predictive, convergent/divergent, and construct validity of the ACE symptom checklist. Conclusions: Overall, the ACE symptom checklist exhibits reasonably strong psychometric properties as an initial assessment tool for mTBI.	[Gioia, Gerard A.] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Dept Pediat & Psychiat & Behav Med, Washington, DC 20010 USA; George Washington Univ, Sch Med, Childrens Natl Med Ctr, Div Pediat Neuropsychol,Safe Consuss Outcome Reco, Washington, DC 20010 USA; [Collins, Michael] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Isquith, Peter K.] Dartmouth Med Sch, Dept Psychiat, Lebanon, NH USA		Gioia, GA (corresponding author), George Washington Univ, Sch Med, Childrens Natl Med Ctr, Dept Pediat & Psychiat & Behav Med, Washington, DC 20010 USA.		Isquith, Peter/AAY-4851-2020		NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5-M01-RR-020359-02] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U17/CCU323352-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR020359] Funding Source: NIH RePORTER		Axelrod BN, 1996, PSYCHOL ASSESSMENT, V8, P422, DOI 10.1037/1040-3590.8.4.422; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bergman DA, 1999, PEDIATRICS, V104, P1407; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; *CDCP, 2003, REP C MIL TRAUM BRAI; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CRONBACH LJ, 1951, PSYCHOMETRIKA, V42, P438; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Gioia G, 2006, ACUTE CONCUSSION EVA; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Gorsuch R.L., 1983, FACTOR ANAL; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, BRAIN INJURY, V18, P1; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kennedy JE, 2006, MIL MED, V171, P516, DOI 10.7205/MILMED.171.6.516; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LESCOHIER I, 1993, PEDIATRICS, V91, P721; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Piland SG, 2003, J ATHL TRAINING, V38, P104; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; World Health Organization, 2004, ICD 10 INT STAT CLAS; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	40	118	118	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2008	23	4					230	242		10.1097/01.HTR.0000327255.38881.ca			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	331KU	WOS:000258011900005	18650767				2022-02-06	
J	Maier, B; Lefering, R; Lehnert, M; Laurer, HL; Steudel, WI; Neugebauer, EA; Marzi, I				Maier, Bernd; Lefering, Rolf; Lehnert, Mark; Laurer, Helmut L.; Steudel, Wolf I.; Neugebauer, Edmund A.; Marzi, Ingo			Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma	SHOCK			English	Article						cytokine; late-onset MOF; multiple injuries; multiple organ failure; traumatic brain injury	SEVERE BLUNT TRAUMA; CEREBROSPINAL-FLUID; BRAIN-INJURY; INFLAMMATION; DYSFUNCTION; RECEPTOR; SERUM; P55; P75; PATHOPHYSIOLOGY	Although multiple organ failure (MOF) remains the leading cause of death after trauma, the pathogenic cellular and molecular mechanisms underlying MOF are poorly understood. In addition to proinflammatory and anti-inflammatory mediator cascades, the temporal onset of MOF has generated recent interest because the organ systems involved into MOF seem to deteriorate in a time-dependent fashion after trauma. We therefore investigated the temporal course of MOF in traumatized human patients and evaluated and compared the distribution patterns of cytokine expression, including interleukin (IL) 6, IL-8, IL-10, and the soluble tumor necrosis factor-a receptors sTNF-R p55 and sTNF-R p75 in early-onset versus late-onset MOF In addition, we analyzed the predictive value of cytokine biomarkers of MOF and lethal outcome. In a prospective observational cohort study conducted at three trauma centers, all patients (n = 352) admitted to two level 1 trauma centers in Germany were enrolled in the study based on the following inclusion criteria: severe traumatic brain injury (TBI) with a Glasgow Coma Scale (GCS) score of 8 or lower and/or distinct changes in cranial computed tomography and/or multiple injuries (MT) to the body (at least two regions had Abbreviated Injury Scale score of 3 or higher). The incidence of MOF was evaluated using the modified Goris-MOF score. The temporal onset of MOF was divided into early-onset MOF (EMOF, developing on days 0-3), late-onset MOF (LMOF, developing on days 4-10), combined early-onset and late-onset MOF (CMOF), and patients never showing signs of MOF during the observation period. In addition, the levels of the serum cytokine markers IL-6, IL-8, IL-10, sTNF-R p55, and sTNF-R p75 were analyzed at specific posttraumatic time points using established enzyme-linked immunosorbent assay techniques. A total of 352 patients (274 men and 78 women; TBI, 101; TBI + MT, 125; MT, 126) were enrolled into the study. Patients assigned to the EMOF group showed specific disruption of pulmonary and cardiocirculatory function, whereas LMOF was significantly associated with hepatic failure. The patients without signs of MOF and the EMOF patients had the same risk of lethal outcome (8.2% vs. 7.5%); LMOF and CMOF were found to be associated with a 3- to 4-fold increase in mortality (38.5% vs. 30.6%, respectively). Analysis of cytokine serum biomarkers revealed that patients with LMOF showed a biphasic elevation of IL-6 and significantly higher sTNF-R concentrations than did all other subgroups (P< 0.001). In addition, the initial values (days 0-1) of sTNF-R p55 and sTNF-R p75 expression levels had a good predictive capacity for the development of LMOF (p55, 0.75; p75, 0.72); values greater than 0.65 were accepted to have a predictive capacity. These results demonstrate that mortality differs significantly between the development of EMOF and LMOF after traumatic injury. Our results also suggest that serum cytokine measurements may be important early biochemical markers for predicting the development of delayed MOF.	Univ Frankfurt, Sch Med, Dept Trauma Hand & Reconstruct Surg, D-6000 Frankfurt, Germany; Univ Halle Wittenberg, Inst Res Operat Med, Cologne, Germany; Univ Saarland, Sch Med, Dept Neurosurg, D-6650 Homburg, Germany		Marzi, I (corresponding author), Univ Frankfurt, Klin Unfall Hand & Wiederherstellungschirurg, D-69590 Frankfurt, Germany.	marzi@trauma.uni-frankfurt.de					Baue AE, 2004, CRIT CARE MED, V32, P1440, DOI 10.1097/01.CCM.0000124853.82106.31; Baue AE, 2003, J TRAUMA, V55, P997, DOI 10.1097/01.TA.0000094631.54198.07; Baue AE, 2006, SHOCK, V26, P438, DOI 10.1097/01.shk.0000228172.32587.7a; BOUMA MG, 1997, IMMUNOCHEMISTRY, V2, P181; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DEITCH EA, 1992, ANN SURG, V216, P117, DOI 10.1097/00000658-199208000-00002; Durham RM, 2003, J TRAUMA, V55, P608, DOI 10.1097/01.TA.0000092378.10660.D1; EISEMAN B, 1977, SURG GYNECOL OBSTET, V144, P323; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Gomberg BFC, 1999, INJURY, V30, P431, DOI 10.1016/S0020-1383(99)00138-2; GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109; GORIS RJA, 1989, SCHWEIZ MED WSCHR, V119, P347; Hans VHJ, 1999, NEUROREPORT, V10, P409; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Laan MP, 1998, ALLERGY, V53, P51, DOI 10.1111/j.1398-9995.1998.tb03773.x; LAW MM, 1994, J TRAUMA, V37, P100, DOI 10.1097/00005373-199407000-00017; Lefering R, 2002, LANGENBECK ARCH SURG, V387, P14, DOI 10.1007/s00423-001-0269-3; Lendemans S, 2004, UNFALLCHIRURG, V107, P203, DOI 10.1007/s00113-004-0729-7; Maier B, 2005, J NEUROTRAUM, V22, P822, DOI 10.1089/neu.2005.22.822; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Maier B, 2006, SHOCK, V26, P122, DOI 10.1097/01.shk.0000223127.41641.f4; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Peschon JJ, 1998, J IMMUNOL, V160, P943; Rixen D, 2001, UNFALLCHIRURG, V104, P230, DOI 10.1007/s001130050719; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; ROUMEN RMH, 1995, CRIT CARE MED, V23, P474, DOI 10.1097/00003246-199503000-00010; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Strecker W, 1999, J TRAUMA, V47, P358, DOI 10.1097/00005373-199908000-00025; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	33	118	123	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	DEC	2007	28	6					668	674		10.1097/shk.0b013e318123e64e			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	237VC	WOS:000251403500007	18092384				2022-02-06	
J	Brannvall, K; Bergman, K; Wallenquist, U; Svahn, S; Bowden, T; Hilborn, J; Forsberg-Nilsson, K				Brannvall, K.; Bergman, K.; Wallenquist, U.; Svahn, S.; Bowden, T.; Hilborn, J.; Forsberg-Nilsson, K.			Enhanced neuronal differentiation in a three-dimensional collagen-hyaluronan matrix	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						3D cultures; neural stem/progenitor cells; hydrogel; scaffold; neurogenesis	NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; RAT SPINAL-CORD; PROGENITOR CELLS; FUNCTIONAL RECOVERY; ADULT BRAIN; CNS STEM; IN-VITRO; TRANSPLANTATION	Efficient 3D cell systems for neuronal induction are needed for future use in tissue regeneration. In this study, we have characterized the ability of neural stem/ progenitor cells (NS/PC) to survive, proliferate, and differentiate in a collagen type I-hyaluronan scaffold. Embryonic, postnatal, and adult NS/PC were seeded in the present 3D scaffold and cultured in medium containing epidermal growth factor and fibroblast growth factor-2, a condition that stimulates NS/PC proliferation. Progenitor cells from the embryonic brain had the highest proliferation rate, and adult cells the lowest, indicating a difference in mitogenic responsiveness. NS/PC from postnatal stages down-regulated nestin expression more rapidly than both embryonic and adult NS/PC, indicating a faster differentiation process. After 6 days of differentiation in the 3D scaffold, NS/PC from the postnatal brain had generated up to 70% neurons, compared with 14% in 2D. NS/PC from other ages gave rise to approximately the same proportion of neurons in 3D as in 2D (9-26% depending on the source for NS/PC). In the postnatal NS/PC cultures, the majority of Pill-tubulin-positive cells expressed glutamate, gamma-aminobutyric acid, and synapsin I after 11 days of differentiation, indicating differentiation to mature neurons. Here we report that postnatal NS/PC survive, proliferate, and efficiently form synapsin I-positive neurons in a biocompatible hydrogel. (c) 2007 Wiley-Liss, Inc.	Uppsala Univ, Dept Biochem Med, Ctr Biomed, S-75123 Uppsala, Sweden; Univ Uppsala, Dept Mat Chem Poly Chem, Angstrom Lab, S-75105 Uppsala, Sweden		Forsberg-Nilsson, K (corresponding author), Uppsala Univ, Dept Biochem Med, Ctr Biomed, Box 582, S-75123 Uppsala, Sweden.	karin.nilsson@imbim.uu.se	Forsberg-Nilsson, Karin/D-9604-2019; Hilborn, Jons/W-2864-2018	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Melander Bowden, Tim/0000-0003-0851-4316; Hilborn, Jons/0000-0001-6947-9601			Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Brannvall K, 2006, NEUROREPORT, V17, P623; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; GROSS J, 1958, J BIOL CHEM, V233, P355; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029; HOU S, 2005, IN PRESS NEUROSCIENC; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewis MC, 2005, BIOTECHNOL BIOENG, V91, P607, DOI 10.1002/bit.20508; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310141; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Zhang ZQ, 1998, J NEUROSCI, V18, P6928; Zhou FC, 2000, EXP NEUROL, V164, P200, DOI 10.1006/exnr.2000.7425	38	118	121	0	41	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	AUG 1	2007	85	10					2138	2146		10.1002/jnr.21358			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	196XO	WOS:000248516700008	17520747				2022-02-06	
J	Cohen, DB; Rinker, C; Wilberger, JE				Cohen, DB; Rinker, C; Wilberger, JE			Traumatic brain injury in anticoagulated patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						traumatic brain injury; anticoagulation; outcomes	MINOR HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; PROTHROMBIN TIME; WARFARIN; RISK; ABNORMALITY; OUTPATIENTS; MANAGEMENT	Background. Coumadin is widely used in the elderly population. Despite its widespread use, little is known about its effect on the outcome of elderly traumatic brain-injured patients. This study was undertaken to describe the outcomes of such a cohort. Methods: Clinical material was identified from a Level I trauma center prospective head injury database, and a database obtained from the American College of Surgeons Committee on Trauma Verification and Review Committee from 1999 to 2002. Both databases contain many relevant variables, including age, sex, Glasgow Coma Scale (GCS) score, mechanism of injury, Injury Severity Score, International Normalized Ratio (INR), computed tomography (CT) findings, operative procedure, time to operating room, complications, length of stay, and outcome at hospital discharge. Results: For patients with GCS scores less than 8, average INR was 6.0, with almost 50% having an initial value greater than 5.0. Overall mortality was 91.5%. For the 77 patients with GCS scores of 13 to 15, average INR was 4.4. Overall mortality for this group was 80.6%. A subset of patients deteriorated to a GCS score of less than 10 just hours after injury, despite most having normal initial CT scans. Mortality in this group was 84%. Conclusions: All patients on warfarin should have an INR performed, and a CT scan should be done in most anticoagulated patients. All supratherapeutically anticoagulated patients, as well as any anticoagulated patient with a traumatic CT abnormality, should be admitted for neurologic observation and consideration given to short term reversal of anticoagulation. Routine repeat CT scanning at 12 to 18 hours or when even subtle signs of neurologic worsening occur is a strong recommendation. A multi-institutional, prospective trial using these guidelines would be a first step toward demonstrating improved outcomes in the anticoagulated patient population after head trauma.	Allegheny Gen Hosp, Dept Neurosurg, Pittsburgh, PA 15212 USA; Surg Associztes Bozeman, Bozeman, MT USA		Wilberger, JE (corresponding author), Allegheny Gen Hosp, Dept Neurosurg, 420 E N Ave,Suite 302, Pittsburgh, PA 15212 USA.	jwilberg@wpahs.org					BOLLINGER O, 1891, HIRSCHWALD, V70, P457; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gilman AG, 1998, GOODMAN GILMANS PHAR; GURWITZ JH, 1992, ANN INTERN MED, V116, P901, DOI 10.7326/0003-4819-116-11-901; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Karni A, 2001, AM SURGEON, V67, P1098; KASE CS, 1985, NEUROLOGY, V35, P943, DOI 10.1212/WNL.35.7.943; LANDEFELD CS, 1989, AM J MED, V87, P153; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; PETITTI DB, 1989, J CLIN EPIDEMIOL, V42, P759, DOI 10.1016/0895-4356(89)90073-5; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Saab M, 1996, J ACCID EMERG MED, V13, P208; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; TEASDALE G, 1982, HEAD INJURY BASIC CL, P213; Volans AP, 1998, J ACCID EMERG MED, V15, P159; WINTZEN AR, 1984, ANN NEUROL, V16, P553, DOI 10.1002/ana.410160505; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	24	118	123	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2006	60	3					553	557		10.1097/01.ta.0000196542.54344.05			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	026WX	WOS:000236374900019	16531853				2022-02-06	
J	Winkler, D; Unsworth, C; Sloan, S				Winkler, D; Unsworth, C; Sloan, S			Factors that lead to successful community integration following severe traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						challenging; behaviour; disability; participation; predictors; severity of injury	QUALITY-OF-LIFE; HEAD-INJURY; PREMORBID INTELLIGENCE; QUESTIONNAIRE; DISABILITY; RECOVERY; OUTCOMES; REHABILITATION; POSTDISCHARGE; SATISFACTION	Objective: To assess and identify predictive factors of community integration of people 3 to 15 years after severe traumatic brain injury (TBI). Participants: Forty participants with severe TBI (an average of 8.8 years postinjury). Main Outcome Measures: The Community Integration Questionnaire, the Community Integration Measure, and the Sydney Psychosocial Reintegration Scale. Data related to factors that may predict community integration were also collected. Results: There was considerable variation in the level of community integration. Discriminant function analyses identified the following factors as predictive of the level of community integration: severity of injury, age at the time of injury, level of disability and challenging behavior. Conclusion: Interventions that minimize challenging behavior and disability may make a significant difference to the level of community integration experienced by people with severe TBI.	Monash Univ, Sch Primary Hlth Care, Melbourne, Vic 3004, Australia; Osborn Sloan & Assciates, Melbourne, Vic, Australia		Winkler, D (corresponding author), Monash Univ, Sch Primary Hlth Care, Melbourne, Vic 3004, Australia.	ypiresearch@optusnet.com.au		Unsworth, Carolyn/0000-0001-6430-2823; Winkler, Di/0000-0003-3899-6248			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BARRY P, 1989, ARCH PHYS MED REHAB, V63, P118; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bogdan R., 1991, BUILDING STRONGER CO; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Carnevale GJ, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199602000-00005; CHARLTON JRH, 1983, J EPIDEMIOL COMMUN H, V37, P296, DOI 10.1136/jech.37.4.296; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; *CTR OUTC MEAS BRA, CRAIG HOSP INV ENV F; Dawson DR, 2000, BRAIN COGNITION, V44, P35; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; ELSASS L, 1989, 14 ANN BRAIN IMP C M; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; FORTUNE N, 1999, DEFINITION INCIDENCE; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hal KM, 1997, J REHABILITATION OUT, V1, P63; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Jennett B, 1981, MANAGEMENT HEAD INJU; Karlovits T, 1999, BRAIN INJURY, V13, P845; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; MAHONEY F I, 1965, Md State Med J, V14, P61; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Nelson H.E., 1982, NATL ADULT READING T; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; O'Connor P., 1999, NEEDS OPPORTUNITIES; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; OCARROLL RE, 1986, BRIT J CLIN PSYCHOL, V25, P157, DOI 10.1111/j.2044-8260.1986.tb00690.x; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PATRICK D, 1981, 3 BIENN C HLTH SURV; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROGERS W, 1992, MEASURING FUNCTIONIN, P24; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; *SPSS INC, 1999, SPSS COMP PROGR VERS; *STAT U NEW YORK B, 1997, GUID UNDAT SET MED R; TABACHNICK BG, 2001, USING MULTIVARIATE S, P456; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; WILLER B, 1994, COMMUNITY INTEGRATIO; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P11; World Health Organization, 2007, INT CLASS FUNCT DIS; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	62	118	119	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2006	21	1					8	21		10.1097/00001199-200601000-00002			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	004WW	WOS:000234784300002	16456388				2022-02-06	
J	Scheff, SW; Price, DA; Hicks, RR; Baldwin, SA; Robinson, S; Brackney, C				Scheff, SW; Price, DA; Hicks, RR; Baldwin, SA; Robinson, S; Brackney, C			Synaptogenesis in the hippocampal CA1 field following traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						behavior; hippocampus; plasticity; stereology; synapse	LONG-TERM POTENTIATION; CONTROLLED CORTICAL IMPACT; COMBINED FLUID PERCUSSION; LESION-INDUCED SYNAPTOGENESIS; ENTORHINAL CORTEX LESIONS; CLOSED HEAD-INJURY; MORRIS WATER MAZE; DENTATE GYRUS; ADULT-RAT; REACTIVE SYNAPTOGENESIS	Traumatic brain injury (TBI) results in both acute and chronic disruption of cognitive ability that may be mediated through a disruption of hippocampal circuitry. Experimental models of TBI have demonstrated that cortical contusion injuries can result in the loss of specific neurons in the CA3 subfield of the ipsilateral hippocampus, resulting in partial loss of afferents to the CA1 subfield. Numerous studies have documented the ability of the central nervous system to compensate for deafferentation by initiating a plasticity response capable of restoring lost synaptic contacts. The present study was designed to examine the time course of loss and replacement of synaptic contacts in stratum radiatum dendritic field of CA1. Young adult rats were subjected to a lateral cortical contusion injury and assayed for total synaptic numbers using unbiased stereology coupled with transmission electron microscopy. Injured animals demonstrated a 60% loss of synapses in CA1 at 2 days post-injury, followed by a reinnervation process that was apparent as early as 10 days post-injury. By 60 days post-injury, total synaptic numbers had approached pre-injury levels but were still significantly lower. Some animals were behaviorally tested for spatial memory in a Morris Water Maze at 15 and 30 days post-injury. While there was some improvement in spatial memory, injured animals continued to demonstrate a significant deficit in acquisition. These results show that the hippocampus ipsilateral to the cortical contusion is capable of a significant plasticity response but that synapse replacement in this area does not necessarily result in significant improvement in spatial learning.	Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Scheff, SW (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, 101 Sanders Brown, Lexington, KY 40536 USA.	sscheff@email.uky.edu		Price, Douglas/0000-0003-3453-0643	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS31220, NS39828] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220, R01NS039828] Funding Source: NIH RePORTER		Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Amaral D.G., 2004, RAT NERVOUS SYSTEM, P635, DOI DOI 10.1016/B978-012547638-6/50022-5; ANDERSON KJ, 1986, J COMP NEUROL, V252, P374, DOI 10.1002/cne.902520306; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Calverley R.K.S., 1990, QUANTITATIVE QUALITA, P155; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cotman C W, 1988, Adv Neurol, V47, P313; COTMAN CW, 1981, PHYSIOL REV, V61, P684, DOI 10.1152/physrev.1981.61.3.684; Cotman CW., 1976, NEURONAL RECOGNITION, P69; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; Gasbarri A, 1996, EXP BRAIN RES, V112, P244; Geinisman Y, 2004, NEUROBIOL AGING, V25, P407, DOI 10.1016/j.neurobiolaging.2003.12.001; GOLDOWITZ D, 1980, BRAIN RES, V181, P325, DOI 10.1016/0006-8993(80)90616-2; GOLDOWITZ D, 1979, BRAIN RES, V170, P427, DOI 10.1016/0006-8993(79)90962-4; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRONWALL D, 1974, LANCET, V2, P605; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HOFF SF, 1982, J COMP NEUROL, V205, P246, DOI 10.1002/cne.902050304; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; KRAEMER PJ, 1995, PSYCHOBIOLOGY, V23, P144; LEE KS, 1977, EXP BRAIN RES, V29, P475; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYNCH G, 1975, GOLGI CENTENNIAL S P, P305; Marrone DF, 2004, BRAIN RES, V996, P19, DOI 10.1016/j.brainres.2003.09.073; MATTHEWS DA, 1976, BRAIN RES, V115, P23, DOI 10.1016/0006-8993(76)90820-9; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; NADLER JV, 1980, BRAIN RES, V191, P387, DOI 10.1016/0006-8993(80)91289-5; NYAKAS C, 1987, BRAIN RES BULL, V18, P533, DOI 10.1016/0361-9230(87)90117-1; OLTON DS, 1982, BRAIN RES, V233, P241, DOI 10.1016/0006-8993(82)91200-8; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Phillips LL, 1997, J NEUROSCI RES, V49, P197; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; RAMIREZ JJ, 1984, BEHAV BRAIN RES, V13, P53, DOI 10.1016/0166-4328(84)90029-9; Ramirez JJ, 2001, RESTOR NEUROL NEUROS, V19, P237; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; REEVES TM, 1995, EXP BRAIN RES, V106, P248; REEVES TM, 1986, EXP BRAIN RES, V65, P167; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SCHEFF SW, 1977, BEHAV BIOL, V21, P286, DOI 10.1016/S0091-6773(77)90374-1; SCHEFF SW, 1989, NEURAL REGENERATION, P137; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STEWARD O, 1983, J COMP NEUROL, V214, P370, DOI 10.1002/cne.902140403; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; WEIBEL ER, 1979, STEREOLOGICAL METHOD, P101; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	82	118	120	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2005	22	7					719	732		10.1089/neu.2005.22.719			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945VQ	WOS:000230530800001	16004576				2022-02-06	
J	Ramsey, D; Smithard, D; Kalra, L				Ramsey, D; Smithard, D; Kalra, L			Silent aspiration: What do we know?	DYSPHAGIA			English	Article						dysphagia; aspiration; deglutition disorders; stroke	FIBEROPTIC ENDOSCOPIC EVALUATION; BILATERAL STROKE PATIENTS; LARYNGEAL COUGH REFLEX; TRAUMATIC BRAIN-INJURY; ELDERLY-PATIENTS; GASTROESOPHAGEAL-REFLUX; MECHANICAL VENTILATION; SWALLOWING DYSFUNCTION; SYMPTOMLESS DYSPHAGIA; PULMONARY ASPIRATION	Although clinically evident aspiration is common in subjects with dysphagia, a significant proportion may aspirate silently, i.e., without any outward signs of swallowing difficulty. This article reviews the literature on the prevalence, etiology, and prognostic significance of silent aspiration. An electronic database search was performed using silent aspiration, aspiration, dysphagia, and stroke as search terms, together with hand-searching of articles. Silent aspiration has been described in many conditions and subgroups of patients (including normal individuals), using a number of detection methods, making comparisons a challenge. The best data are for acute stroke, in which 2%-25% of patients may aspirate silently. Mechanisms associated with silent aspiration may include central or local weakness/incoordination of the pharyngeal musculature, reduced laryngopharyngeal sensation, impaired ability to produce a reflexive cough, and low substance P or dopamine levels. In terms of prognosis, silent aspiration has been associated with increased morbidity and mortality in many but not all studies. However, some degree of silent aspiration at night may be normal in healthy individuals. The phenomenon of silent aspiration is poorly understood and further research is needed to improve methods of detection and thereby better define its prevalence and prognostic significance.	Univ London Kings Coll, GKT Med Sch, Dept Stroke Med, London SE5 9PJ, England; William Harvey Hosp, Hlth Care Older People Dept, Ashford, Kent, England		Ramsey, D (corresponding author), Univ London Kings Coll, GKT Med Sch, Dept Stroke Med, Bessemer Rd, London SE5 9PJ, England.	deborah.ramsey@kcl.ac.uk					Addington WR, 1999, ARCH PHYS MED REHAB, V80, P150, DOI 10.1016/S0003-9993(99)90112-0; ALESSI DM, 1989, ANN OTO RHINOL LARYN, V98, P586, DOI 10.1177/000348948909800803; Amberson J, 1937, INT ANESTHESIOL CLIN, V3, P126; Arai T, 2000, CHEST, V117, P1819, DOI 10.1378/chest.117.6.1819; Arai T, 1998, LANCET, V352, P115, DOI 10.1016/S0140-6736(98)85021-6; Arai T, 2003, NEUROLOGY, V61, P1625, DOI 10.1212/01.WNL.0000096395.80826.23; Arai T, 2003, J AM GERIATR SOC, V51, P1815, DOI 10.1046/j.1532-5415.2003.51572_2.x; ARVEDSON J, 1994, INT J PEDIATR OTORHI, V28, P173, DOI 10.1016/0165-5876(94)90009-4; Aviv JE, 1997, ANN OTO RHINOL LARYN, V106, P87; Balan KK, 1998, AM J GASTROENTEROL, V93, P946, DOI 10.1111/j.1572-0241.1998.00284.x; BARTLETT JG, 1975, CHEST, V68, P560, DOI 10.1378/chest.68.4.560; CAMERON JL, 1973, SURG GYNECOL OBSTET, V136, P68; Collins MJ, 1997, STROKE, V28, P1773, DOI 10.1161/01.STR.28.9.1773; CULVER GA, 1951, ANN SURG, V133, P289, DOI 10.1097/00000658-195103000-00001; Daniels SK, 1998, ARCH PHYS MED REHAB, V79, P14, DOI 10.1016/S0003-9993(98)90200-3; Daniels SK., 1997, AM J SPEECH-LANG PAT, V6, P17, DOI [DOI 10.1044/1058-0360.0604.17, 10.1044/1058-0360.0604.17]; ELPERN EH, 1994, CHEST, V105, P563, DOI 10.1378/chest.105.2.563; Frazier JB, 1996, DEV MED CHILD NEUROL, V38, P695, DOI 10.1111/j.1469-8749.1996.tb12139.x; Fuh JL, 1997, CLIN NEUROL NEUROSUR, V99, P106, DOI 10.1016/S0303-8467(97)00606-9; GARCIA PE, 1998, REV ESP ANESTESIOL R, V45, P298; GARDNER AMN, 1958, Q J MED, V27, P227; Garon BR, 1996, J NEUROL REHABIL, V10, P121; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Harrington OB, 1998, ANN THORAC SURG, V65, P1599, DOI 10.1016/S0003-4975(98)00239-2; Harrington Z, 2003, INT J PROSTHODONT, V16, P54; Hiss SG, 2003, LARYNGOSCOPE, V113, P1386, DOI 10.1097/00005537-200308000-00023; HOLAS MA, 1994, ARCH NEUROL-CHICAGO, V51, P1051, DOI 10.1001/archneur.1994.00540220099020; HORNER J, 1993, NEUROLOGY, V43, P430, DOI 10.1212/WNL.43.2.430; HORNER J, 1990, NEUROLOGY, V40, P1686, DOI 10.1212/WNL.40.11.1686; HORNER J, 1988, NEUROLOGY, V38, P1359; HORNER J, 1988, NEUROLOGY, V38, P317, DOI 10.1212/WNL.38.2.317; Hughes PJ, 2000, HEAD NECK-J SCI SPEC, V22, P393, DOI 10.1002/1097-0347(200007)22:4<393::AID-HED13>3.0.CO;2-2; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; Ishizuka Chie, 2000, No To Hattatsu, V32, P390; KIDD D, 1993, Q J MED, V86, P825; KIKUCHI R, 1994, AM J RESP CRIT CARE, V150, P251, DOI 10.1164/ajrccm.150.1.8025758; Kluin KJ, 1996, J NEUROL SCI, V138, P49, DOI 10.1016/0022-510X(95)00329-Z; Kobayashi H, 1996, LANCET, V348, P1320, DOI 10.1016/S0140-6736(05)65809-6; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Leder SB, 1999, J HEAD TRAUMA REHAB, V14, P448, DOI 10.1097/00001199-199910000-00005; Leder SB, 1998, DYSPHAGIA, V13, P19, DOI 10.1007/PL00009544; Leder SB, 2000, LARYNGOSCOPE, V110, P641, DOI 10.1097/00005537-200004000-00019; Leder SB, 2002, CHEST, V122, P1721, DOI 10.1378/chest.122.5.1721; Lefton-Greif MA, 2000, J PEDIATR-US, V136, P225, DOI 10.1016/S0022-3476(00)70106-5; Lim SHB, 2001, DYSPHAGIA, V16, P1, DOI 10.1007/s004550000038; LimDunham JE, 1997, AM J ROENTGENOL, V169, P1015, DOI 10.2214/ajr.169.4.9308454; LINDEN P, 1983, ARCH PHYS MED REHAB, V64, P281; Mann G, 2000, CEREBROVASC DIS, V10, P380, DOI 10.1159/000016094; MARTIN JH, 1994, ANN OTO RHINOL LARYN, V103, P749, DOI 10.1177/000348949410301001; Mathisen B, 1999, J PAEDIATR CHILD H, V35, P163, DOI 10.1046/j.1440-1754.1999.t01-1-00334.x; MEGURO K, 1992, TOHOKU J EXP MED, V167, P135, DOI 10.1620/tjem.167.135; Morgan A, 2002, J HEAD TRAUMA REHAB, V17, P220, DOI 10.1097/00001199-200206000-00004; Nakagawa T, 1997, ARCH INTERN MED, V157, P321, DOI 10.1001/archinte.157.3.321; NAKAGAWA T, 1995, LANCET, V345, P1447, DOI 10.1016/S0140-6736(95)92638-0; NAKAZAWA H, 1993, CHEST, V103, P1636, DOI 10.1378/chest.103.5.1636b; Niimi A, 2003, THORAX, V58, P152, DOI 10.1136/thorax.58.2.152; O'Donoghue S, 1999, FOLIA PHONIATR LOGO, V51, P158, DOI 10.1159/000021494; Ozcan M, 2003, ARCH OTOLARYNGOL, V129, P1006, DOI 10.1001/archotol.129.9.1006; Pannunzio T G, 1996, AACN Clin Issues, V7, P560, DOI 10.1097/00044067-199611000-00010; Perie S, 1998, AM J OTOLARYNG, V19, P18, DOI 10.1016/S0196-0709(98)90060-6; Pikus L, 2003, AM J ROENTGENOL, V180, P1613, DOI 10.2214/ajr.180.6.1801613; Ramsey DJC, 2003, STROKE, V34, P1252, DOI 10.1161/01.STR.0000066309.06490.B8; Sheikh S, 2001, CHEST, V120, P1190, DOI 10.1378/chest.120.4.1190; Silver Kenneth H., 1994, Dysphagia, V9, P107, DOI 10.1007/BF00714597; Smith CH, 1999, DYSPHAGIA, V14, P1, DOI 10.1007/PL00009579; Smith HA, 2000, AGE AGEING, V29, P495, DOI 10.1093/ageing/29.6.495; Smithard DG, 1998, AGE AGEING, V27, P99, DOI 10.1093/ageing/27.2.99; SPLAINGARD ML, 1988, ARCH PHYS MED REHAB, V69, P637; STANNERS AJ, 1993, AGE AGEING S2, V2, pA47; Stephens RE, 2003, AM J PHYS MED REHAB, V82, P379, DOI 10.1097/01.PHM.0000064730.54787.F5; Taenaka N, 1985, Masui, V34, P189; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167; Tonshoff G, 1996, NUKLEARMED, V35, P140; 1999, EVID REP TECHNOL ASS, V8, P1	74	118	131	1	17	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0179-051X			DYSPHAGIA	Dysphagia	SUM	2005	20	3					218	225		10.1007/s00455-005-0018-9			8	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	992UB	WOS:000233908400005	16362510				2022-02-06	
J	Bell, KR; Temkin, NR; Esselman, PC; Doctor, JN; Bombardier, CH; Fraser, RT; Hoffman, JM; Powell, JM; Dikmen, S				Bell, KR; Temkin, NR; Esselman, PC; Doctor, JN; Bombardier, CH; Fraser, RT; Hoffman, JM; Powell, JM; Dikmen, S			The effect of a scheduled telephone intervention on outcome after moderate to severe traumatic brain injury: A randomized trial	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; rehabilitation; telephone; treatment outcome	CARE; REHABILITATION; MANAGEMENT; SYSTEMS; MODEL; DEPRESSION; FAMILIES; SCALE; RACE	Objective: To measure the effectiveness of a scheduled telephone intervention offering counseling and education to people with traumatic brain injury (TBI) on behavioral outcomes compared with standard follow-up at 1 year postinjury. Design: Two-group randomized, prospective clinical trial throughout the first year after injury. Setting: Subjects' homes via telephone in an urban-rural catchment area from a level I trauma center. Participants: Subjects (N = 171; age range, 18-70y) with a primary diagnosis of TBI who were discharged from an acute rehabilitation unit. They were randomly assigned to the telephone intervention (n = 85) or to standard follow-up (n = 86) groups at discharge. Of these, 79 participated in the intervention and completed the outcome assessment (3 withdrew; 3 were lost to follow-up), and 78 participated in usual care and completed the outcome assessment (8 were lost to follow-up). Interventions: Subjects were randomly assigned to receive telephone calls at 2 and 4 weeks and 2, 3, 5, 7, and 9 months after discharge. The calls consisted of brief motivational interviewing, counseling, and education, plus facilitating usual care or usual care alone through follow-up appointments and therapy prescriptions. Main Outcome Measures: A composite outcome was used as the primary endpoint on an intent-to-treat basis. Secondary analyses were conducted with individual measures, including the FIM instrument, Disability Rating Scale, Community Integration Questionnaire, Neurobehavioral Functioning Inventory, Functional Status Examination, Glasgow Outcome Scale-Extended, Medical Outcomes Study 36-Item Short-Form Health Survey, Brief Symptom Inventory, EuroQol, and Modified Perceived Quality of Life scale. The primary analysis was a blocked Mann-Whitney U test. Results: At 1-year follow-up, those who had received scheduled telephone intervention fared significantly better on the primary composite outcome index (P = .002). In addition, this group fared better on specific composites such as functional status (P = .003) and quality of well-being (P = .006). There were no significant differences on vocational status (P = .08) or community integration status (P = .13). Conclusions: Scheduled telephone counseling and education resulted in improved overall outcome, particularly for functional status and quality of well-being, when compared with usual outpatient care. Telephone counseling shows promise as a low-cost, widely available rehabilitation intervention for TBI.	Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Med Educ & Med Informat, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Bell, KR (corresponding author), Univ Washington, Dept Rehabil Med, 1959 NE Pacific St,Box 356490, Seattle, WA 98195 USA.	krbell@u.washington.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283; Bell, Kathleen/0000-0002-0928-2046			Anderson LM, 2003, AM J PREV MED, V24, P68, DOI 10.1016/S0749-3797(02)00657-8; ATKINS BJ, 1980, J REHABIL, V46, P40; Austin JS, 1996, ARTHRIT CARE RES, V9, P391, DOI 10.1002/1529-0131(199610)9:5<391::AID-ANR1790090508>3.0.CO;2-V; Balas EA, 1997, JAMA-J AM MED ASSOC, V278, P152, DOI 10.1001/jama.278.2.152; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Bell KR, 2004, J HEAD TRAUMA REHAB, V19, P502, DOI 10.1097/00001199-200411000-00007; Bostrom J, 1996, APPL NURS RES, V9, P47, DOI 10.1016/S0897-1897(96)80402-2; BURKE DC, 1995, BRAIN INJURY, V9, P735, DOI 10.3109/02699059509008229; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Campbell C H, 1988, Rehabil Nurs, V13, P320; Clark M, 2001, PATIENT EDUC COUNS, V42, P247, DOI 10.1016/S0738-3991(00)00128-2; COPE DN, 1990, REHABILITATION ADULT, P253; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dornelas EA, 2000, PREV MED, V30, P261, DOI 10.1006/pmed.2000.0644; Dunn C, 2001, ADDICTION, V96, P1725, DOI 10.1046/j.1360-0443.2001.961217253.x; Engli M, 1993, J Neurosci Nurs, V25, P78; Fuhrer MJ, 1998, AM J PHYS MED REHAB, V77, P557, DOI 10.1097/00002060-199811000-00022; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Katon W, 2001, ARCH GEN PSYCHIAT, V58, P241, DOI 10.1001/archpsyc.58.3.241; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KEMENADE VEV, 1994, BR J CLIN PSYCHOL 3, V33, P367; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 1997, J HEAD TRAUMA REHAB, V12, P63, DOI 10.1097/00001199-199712000-00006; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; Marascuilo L. A., 1977, NONPARAMETRIC DISTRI; Martin EM, 2003, AM J NURS, V103, P75, DOI 10.1097/00000446-200310000-00036; Miller WR, 1991, MOTIVATIONAL INTERVI; *NAT COUNC DIS, 1999, LIFT EV VOIC MOD DIS; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Paterson B, 2001, Rehabil Nurs, V26, P48; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Snyder RE, 2000, MED CARE RES REV, V57, P196, DOI 10.1177/107755870005700204; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WARE JE, 1993, SF36 HLTH SURV MAN I; WEINBERGER M, 1993, ARTHRITIS RHEUM, V36, P243, DOI 10.1002/art.1780360216; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	51	118	119	3	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2005	86	5					851	856		10.1016/j.apmr.2004.09.015			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	928NM	WOS:000229278500001	15895327				2022-02-06	
J	Hoffer, ME; Gottshall, KR; Moore, R; Balough, BJ; Wester, D				Hoffer, ME; Gottshall, KR; Moore, R; Balough, BJ; Wester, D			Characterizing and treating dizziness after mild head trauma	OTOLOGY & NEUROTOLOGY			English	Article						traumatic brain injury (TBI); migraines; dizziness; vertigo; positional vertigo; vestibular rehabilitation	HISTORY; INJURY	Objective: The objectives of this study were to characterize patterns of dizziness seen after mild head trauma and to examine the diagnosis and treatment of this disorder. Study Design: Prospective patient registry. Setting: Tertiary referral center. Patients: Fifty-eight cases of active duty and retired military personnel who sustained mild head trauma and had resultant dizziness. Interventions: Vestibular evaluation, characterization by group, and treatment. Main Outcome Measures: Outcome measures include characterization of diagnosis types, patient distribution by diagnosis type, and patient outcome. Results: Individuals suffering from dizziness after mild head injury were divided into three diagnostic groups. Forty-one percent of the individuals suffered from posttraumatic vestibular migraines, 28% of the individuals had posttraumatic positional vertigo, and 19% of the individuals were classified as posttraumatic spatial disorientation. The remaining 12% of the patients could not be characterized. The positional group had objective physical examination findings, which cleared with treatment in all cases. The migraine group of patients and the disorientation group of patients had distinct abnormalities of the vestibulo-ocular reflex (VOR) and the vestibulo-spinal reflex (VSR). Eighty-four percent of the migraine group demonstrated an improvement of these test results as compared with 27% of the disorientation group. Mean time to return to work was less than 1 week for the positional group, 3.8 weeks for the migraine group, and greater than 3 months for the disorientation group. Conclusions: Using our patient registry of individuals suffering from dizziness after mild head trauma, we were able to characterize the majority of these cases into one of three more specific diagnostic groups. We present diagnostic criteria, suggested treatment guidelines, and our prognostic data.	USN, Med Ctr, Dept Otolaryngol, Dept Def,Spatial Orientat Ctr, San Diego, CA 92134 USA		Hoffer, ME (corresponding author), USN, Med Ctr, Dept Otolaryngol, Dept Def,Spatial Orientat Ctr, San Diego, CA 92134 USA.	mehoffer@nmcsd.med.navy.mil					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; DIKMEN SS, 1989, MILD HEAD INJURY, P229; GOTTSHALL KR, 1999, P 4 INT MEN M PAR, P663; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KURTZKE JF, 1993, CLIN NEUROLOGY; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Whitney SL, 2000, LARYNGOSCOPE, V110, P1528, DOI 10.1097/00005537-200009000-00022	13	118	123	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	MAR	2004	25	2					135	138		10.1097/00129492-200403000-00009			4	Clinical Neurology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	803XJ	WOS:000220263500009	15021772				2022-02-06	
J	Meeuwisse, WH; Sellmer, R; Hagel, BE				Meeuwisse, WH; Sellmer, R; Hagel, BE			Rates and risks of injury during intercollegiate basketball	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article							CRUCIATE LIGAMENT INJURY; HIGH-SCHOOL BASKETBALL; SPORTS INJURIES; PATTERNS; REGISTRY; PLAYERS; SOCCER; WOMEN; MEN	Background: Previous studies of basketball injury have not been able to assess injury incidence and risk. Purpose: To determine rates and risks of injury in Canadian intercollegiate basketball. Study Design: Prospective cohort study. Methods: Standardized data were collected with a validated instrument from 98.1% of the 318 athletes on the eight men's basketball teams in the Canada West Division of the Canadian Intercollegiate Athletic Union. Results: A total of 142 athletes sustained 215 injuries (44.7% of players injured) over the 2-year study period. The greatest number of injuries resulting in more than seven sessions of time loss involved the knee, whereas the most common injuries causing fewer than seven sessions of time loss involved the ankle. The most common mechanism of injury was contact with another player, especially in the "key." Injuries occurred 3.7 times more often in games than during practice. Centers had the highest rate of injury, followed by guards, and then forwards. The relative risk of reinjury was significantly increased by previous injuries to the elbow, shoulder, knee, hand, lower spine or pelvis, and by concussions. Conclusions: Risk factors for injury were previous injury, games as opposed to practice, player position, player contact, and court location. (C) 2003 American Orthopaedic Society for Sports Medicine.	Univ Calgary, Ctr Sports Med, Calgary, AB T2N 1N4, Canada		Meeuwisse, WH (corresponding author), Univ Calgary, Ctr Sports Med, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.		Hagel, Brent/AAK-3319-2020				ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611; Arendt EA, 1999, J ATHL TRAINING, V34, P86; Beachy G, 1997, AM J SPORT MED, V25, P675, DOI 10.1177/036354659702500515; CLARKE KS, 1980, AM J SPORT MED, V8, P187, DOI 10.1177/036354658000800308; DELOES M, 1995, INT J SPORTS MED, V16, P134, DOI 10.1055/s-2007-972980; Ellison L., 1995, CHRONIC DIS CAN, V16, P117; Finch C, 1998, BRIT J SPORT MED, V32, P220, DOI 10.1136/bjsm.32.3.220; GARRICK JG, 1978, PEDIATRICS, V61, P465, DOI 10.1542/peds.61.3.465; Gomez E, 1996, AM J SPORT MED, V24, P684, DOI 10.1177/036354659602400521; GUYETTE RF, 1993, CLIN SPORT MED, V12, P247; Harmon KG, 1998, CLIN J SPORT MED, V8, P260, DOI 10.1097/00042752-199810000-00002; HAYCOCK CE, 1976, JAMA-J AM MED ASSOC, V236, P163, DOI 10.1001/jama.236.2.163; Hickey GJ, 1997, CLIN J SPORT MED, V7, P252, DOI 10.1097/00042752-199710000-00002; Kingma J, 1998, PERCEPT MOTOR SKILL, V86, P675, DOI 10.2466/pms.1998.86.2.675; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; McKay G D, 1996, Aust J Sci Med Sport, V28, P12; Meeuwisse WH, 1997, SPORTS MED, V24, P184, DOI 10.2165/00007256-199724030-00008; Meeuwisse WH, 1998, CLIN J SPORT MED, V8, P164, DOI 10.1097/00042752-199807000-00003; Meeuwisse WH, 1999, J INFORMATICS PRIM C, P2; MEEUWISSE WH, 1994, THESIS U CALGARY CAL; Messina DF, 1999, AM J SPORT MED, V27, P294, DOI 10.1177/03635465990270030401; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; THOMPSON N, 1987, AM J SPORT MED, V15, P117, DOI 10.1177/036354658701500204; Twellaar M, 1996, AM J SPORT MED, V24, P528, DOI 10.1177/036354659602400419; Whiteside Patricia A, 1980, Phys Sportsmed, V8, P130, DOI 10.1080/00913847.1980.11948586; Yde J, 1990, Br J Sports Med, V24, P51; ZELISKO JA, 1982, AM J SPORT MED, V10, P297, DOI 10.1177/036354658201000507	27	118	124	1	31	AMER ORTHOPAEDIC SOC SPORT MED	WALTHAM	230 CALVARY STREET, WALTHAM, MA 02154 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	MAY-JUN	2003	31	3					379	385		10.1177/03635465030310030901			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	684CG	WOS:000183187400009	12750130				2022-02-06	
J	Chung, SY; Han, SH				Chung, SY; Han, SH			Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition	JOURNAL OF PINEAL RESEARCH			English	Article						epilepsy; kainic acid; melatonin; microglia; neurodegeneration; oxidative stress	CENTRAL-NERVOUS-SYSTEM; LIPID-PEROXIDATION; KAINATE; DAMAGE; RECEPTORS; GLUTAMATE; NEURONS; NEUROTRANSMITTER; LOCALIZATION; ANTAGONISTS	The antioxidant and anti-inflammatory effects of melatonin on kainic acid (KA)-induced neurodegeneration in the hippocampus were evaluated in vivo. It has been suggested that the pineal secretory product, melatonin, protects neurons in vitro from excitotoxicity mediated by kainate-sensitive glutamate receptors, and from oxidative stress-induced DNA damage and apoptosis. In this study, we injected 10 mg/kg kainate intraperitoneally (i.p.) into adult male Sprague-Dawley rats. This results in selective neuronal degeneration accompanied by intense microglial activation and triggers DNA damage in the hippocampus. We tested the in vivo efficacy of melatonin in preventing KA-induced neurodegeneration, oxidative stress and neuroinflammation in the hippocampus. Melatonin (2.5 mg/kg, i.p.) was given 20 min before, immediately after, and 1 and 2 hr after KA administration. Rats were killed 72 hr later and their hippocampi were examined for evidence of DNA damage (in situ dUTP end-labeling, i.e. TUNEL staining), cell viability (hematoxylin and eosin staining), and microglial (isolectin-B4 histochemistry) and astroglial responses (glial fibrillary acidic protein immunohistochemistry), as well as lipid peroxidation (4-hydroxynonenal immunohistochemistry). A cumulative dose of 10 mg/kg melatonin attenuates KA-induced neuronal death, lipid peroxidation, and microglial activation, and reduces the number of DNA breaks. A possible mechanism for melatonin-mediated neuroprotection involves its antioxidant and anti-inflammatory actions. The present data suggest that melatonin is potentially useful in the treatment of acute brain pathologies associated with oxidative stress-induced neuronal damage such as epilepsy, stroke, and traumatic brain injury.	Chungbuk Natl Univ, Med Res Inst, Chungbuk Natl Univ Hosp, Dept Neurol, Chungbuk 361711, South Korea; Catholic Univ, Coll Med, Our Lady Mercy Hosp, Dept Pediat, Inchon, South Korea		Han, SH (corresponding author), Chungbuk Natl Univ, Med Res Inst, Chungbuk Natl Univ Hosp, Dept Neurol, 62 Gaeshin Dong, Chungbuk 361711, South Korea.						Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cuzzocrea S, 1998, FREE RADICAL BIO MED, V24, P450, DOI 10.1016/S0891-5849(97)00280-3; DYKENS JA, 1987, J NEUROCHEM, V49, P1222, DOI 10.1111/j.1471-4159.1987.tb10014.x; FERKANY JW, 1982, NATURE, V298, P757, DOI 10.1038/298757a0; Giusti P, 1996, FASEB J, V10, P891, DOI 10.1096/fasebj.10.8.8666166; Hsu CH, 2002, J PINEAL RES, V32, P53, DOI 10.1034/j.1600-079x.2002.10809.x; Keller JN, 1998, REV NEUROSCIENCE, V9, P105; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kruman I, 1997, J NEUROSCI, V17, P5089; LEES GJ, 1992, J NEUROL SCI, V108, P221, DOI 10.1016/0022-510X(92)90055-P; Li XJ, 2002, J PINEAL RES, V32, P47, DOI 10.1034/j.1600-079x.2002.10831.x; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Matsuoka Y, 1999, NEUROPHARMACOLOGY, V38, P825, DOI 10.1016/S0028-3908(99)00020-9; MELCHIORRI D, 1995, FASEB J, V9, P1205, DOI 10.1096/fasebj.9.12.7672513; MENENDEZPELAEZ A, 1993, J PINEAL RES, V15, P59, DOI 10.1111/j.1600-079X.1993.tb00511.x; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; Nalder J.V., 1980, J COMP NEUROL, V192, P333; OLNEY JW, 1974, BRAIN RES, V77, P507, DOI 10.1016/0006-8993(74)90640-4; PALMER AM, 1992, ANN NY ACAD SCI, V648, P361, DOI 10.1111/j.1749-6632.1992.tb24583.x; Pappolla MA, 2002, J PINEAL RES, V32, P135, DOI 10.1034/j.1600-079x.2002.1o838.x; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Pei Z, 2002, J PINEAL RES, V32, P168, DOI 10.1034/j.1600-079x.2002.1o847.x; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; Reiter RJ, 2001, ANN NY ACAD SCI, V939, P200; Shen YX, 2002, J PINEAL RES, V32, P85, DOI 10.1034/j.1600-079x.2002.1819.x; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; STREIT WJ, 1990, J HISTOCHEM CYTOCHEM, V381, P683; Tan DX, 1998, J NEUROSCI RES, V54, P382, DOI 10.1002/(SICI)1097-4547(19981101)54:3<382::AID-JNR9>3.0.CO;2-Y; Uz T, 1996, NEUROSCIENCE, V73, P631, DOI 10.1016/0306-4522(96)00155-8; VIRGILI M, 1992, NEUROPHARMACOLOGY, V31, P469, DOI 10.1016/0028-3908(92)90085-4; Waeg G, 1996, FREE RADICAL RES, V25, P149, DOI 10.3109/10715769609149920; WASTERLAIN CG, 1993, EPILEPSIA, V34, pS37, DOI 10.1111/j.1528-1157.1993.tb05905.x; [No title captured]; [No title captured]	37	118	126	0	5	BLACKWELL MUNKSGAARD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0742-3098			J PINEAL RES	J. Pineal Res.	MAR	2003	34	2					95	102		10.1034/j.1600-079X.2003.00010.x			8	Endocrinology & Metabolism; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	641JM	WOS:000180741700003	12562500	Bronze			2022-02-06	
J	Tokutomi, T; Morimoto, K; Miyagi, T; Yamaguchi, S; Ishikawa, K; Shigemori, M				Tokutomi, T; Morimoto, K; Miyagi, T; Yamaguchi, S; Ishikawa, K; Shigemori, M			Optimal temperature for the management of severe traumatic brain injury: Effect of hypothermia on intracranial pressure, systemic and intracranial hemodynamics, and metabolism	NEUROSURGERY			English	Article						hemodynamics; hypothermia; intracranial pressure; metabolism; traumatic brain injury	CEREBRAL-BLOOD-FLOW; FLUID-PERCUSSION INJURY; CORTICAL IMPACT INJURY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; HEAD-INJURY; POSTTRAUMATIC HYPOTHERMIA; CEREBROSPINAL-FLUID; ADHESION MOLECULES; RADICAL PRODUCTION	OBJECTIVE: We studied the effect of hypothermia on intracranial pressure, systemic and intracranial hemodynamics, and metabolism in patients with severe traumatic brain injury to clarify the optimal temperature for hypothermia, with a view toward establishing the proper management techniques for such patients. METHODS: The study was performed in 31 patients with severe head injury (Glasgow Coma Scale score as high as 5). All patients were sedated, paralyzed, ventilated, and cooled to 33degreesC. Brain temperature, core temperature, intracranial pressure, cerebral perfusion pressure, jugular venous oxygen saturation, mixed venous oxygen saturation, cardiac output, oxygen delivery, oxygen consumption, and testing energy expenditure were monitored continuously. RESULTS: Intracranial pressure decreased significantly at brain temperatures below 37degreesC and decreased more sharply at temperatures 35 to 36degreesC, but no differences were observed at temperatures below 35degreesC. Cerebral perfusion pressure peaked at 35.0 to 35.9degreesC and decreased with further decreases in temperature. jugular venous oxygen saturation and mixed venous oxygen saturation remained in the normal range during hypothermia. Resting energy expenditure and cardiac output decreased progressively with hypothermia. Oxygen delivery and oxygen consumption decreased to abnormally low levels at rectal temperatures below 35degreesC, and the correlation between them became less significant at less than 35degreesC than that when temperatures were 35degreesC or higher. Brain temperature was consistently higher than rectal temperature by 0.5 +/- 0.3degreesC. CONCLUSION: These results suggest that, after traumatic brain injury, decreasing body temperature to 35 to 35.5degreesC can reduce intracranial hypertension while maintaining sufficient cerebral perfusion pressure without cardiac dysfunction or oxygen debt. Thus, 35 to 35.5degreesC seems to be the optimal temperature at which to treat patients with severe traumatic brain injury.	Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 8300011, Japan; Kurume Univ, Sch Med, Dept Anesthesiol, Kurume, Fukuoka 8300011, Japan		Tokutomi, T (corresponding author), Kurume Univ, Sch Med, Dept Neurosurg, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	toku@mail.med.kurume-u.ac.jp					Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHEN RYZ, 1978, AM J PHYSIOL, V235, pH136, DOI 10.1152/ajpheart.1978.235.2.H136; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DUCKROW RB, 1981, J NEUROSURG, V54, P607, DOI 10.3171/jns.1981.54.5.0607; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Maeda T, 1998, J NEUROTRAUM, V15, P655, DOI 10.1089/neu.1998.15.655; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; Mori K, 1998, NEUROL RES, V20, P719; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; PATEL PM, 1994, BRAIN RES, V650, P205, DOI 10.1016/0006-8993(94)91783-3; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SPRUNG J, 1992, ACTA ANAESTH SCAND, V36, P825, DOI 10.1111/j.1399-6576.1992.tb03572.x; VANOSS CJ, 1980, J RETICULOENDOTH SOC, V27, P561; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Yager JY, 1996, STROKE, V27, P919, DOI 10.1161/01.STR.27.5.919; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	46	118	123	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2003	52	1					102	111		10.1097/00006123-200301000-00013			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	631YL	WOS:000180195800021	12493106				2022-02-06	
J	Kline, AE; Massucci, JL; Marion, DW; Dixon, CE				Kline, AE; Massucci, JL; Marion, DW; Dixon, CE			Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact	JOURNAL OF NEUROTRAUMA			English	Article						dopamine; dopamine agonist; function; learning; memory; Morris water maze	FRONTAL-LOBE DYSFUNCTION; WATER MAZE PERFORMANCE; COGNITIVE DEFICITS; HEAD-INJURY; CELL-DEATH; EXPERIENCE; IMPAIRMENT; RECOVERY; IMPROVES; AGONIST	Cognitive impairments are pervasive and persistent sequelae of human traumatic brain injury (TBI). In vivo models of TBI, such as the controlled cortical impact (CCI) and fluid percussion (FP), are utilized extensively to produce deficits reminiscent of those seen clinically with the hope that empirical study will lead to viable therapeutic interventions. Both CCI and FP produce spatial learning acquisition deficits, but only the latter has been reported to impair working memory in rats tested in the Morris water maze (MWM). We hypothesized that a CCI injury would impair working memory similarly to that produced by FP, and that delayed and chronic treatment with the D2 receptor agonist bromocriptine would attenuate both working memory and spatial learning acquisition deficits. To test these hypotheses, isoflurane-anesthetized adult male rats received either a CCI (2.7 mm deformation, 4 m/sec) or sham injury, and 24 h later were administered bromocriptine (5 mg/kg, i.p.) or vehicle, with continued daily injections until all behavioral assessments were completed. Motor function was assessed on beam balance and beam walking tasks on postoperative days 1-5 and cognitive function was evaluated in the MWM on days 11-15 for working memory (experiment 1) and on days 14-18 for spatial learning acquisition (experiment 2). Histological examination (hippocampal CA(1) and CA(3) cell loss/survival and cortical lesion volume) was conducted 4 weeks after surgery. All injured groups exhibited initial impairments in motor function, working memory, and spatial learning acquisition. Bromocriptine did not affect motor function, but did ameliorate working memory and significantly attenuated spatial acquisition deficits relative to the injured vehicle-treated controls. Additionally, the injured bromocriptine-treated group exhibited significantly more morphologically intact CA(3) neurons than the injured vehicle-treated group (55.60 +/- 3.10% vs. 38.34 +/- 7.78% [p = 0.03]). No significant differences were observed among TBI groups in CA(1) cell survival (bromocriptine, 40.26 +/- 4.74% vs. vehicle, 29.13 +/- 6.63% [p = 0.14]) or cortical lesion volume (bromocriptine, 17.78 +/- 0.62 mm(3) vs. vehicle, 19.01 +/- 1.49 mm(3) [p > 0.05]). These data reveal that CCI produces working memory deficits in rats that are similar to those observed following FP, and that the delayed and chronic bromocriptine treatment regimen conferred cognitive and neural protection after TBI.	Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurosurg, Brain Trauma Res Ctr, 3434 5th Ave,Ste 201, Pittsburgh, PA 15260 USA.	edixon@neuronet.pitt.edu	Marion, Donald/AAR-5749-2021		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, P50NS030318, R01NS033150, P20NS030318, R01NS040125] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318, NS40125, NS33150] Funding Source: Medline		Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Allain P, 2001, BRAIN COGNITION, V45, P21, DOI 10.1006/brcg.2000.1249; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOISSARD CG, 1992, NEUROSCIENCE, V48, P807, DOI 10.1016/0306-4522(92)90268-7; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; BRANNAN T, 1993, J NEURAL TRANSM-PARK, V6, P81, DOI 10.1007/BF02261001; Chen YK, 2001, BRAIN RES, V896, P165, DOI 10.1016/S0006-8993(01)02081-9; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1999, AM J PHYSIOL, V277, P1196; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.3.CO;2-L; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Golden K. M., 2000, Journal of Neurotrauma, V17, P960; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Jackson David M., 1995, Naunyn-Schmiedeberg's Archives of Pharmacology, V351, P146; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2001, HEAD TRAUMA, P65; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; KLINE AE, 2002, IN PRESS NEUROSCI LE; KLINE AE, 2001, MO CL BI CC, V2, P267; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LIU XH, 1995, J NEUROL SCI, V129, P9, DOI 10.1016/0022-510X(94)00239-K; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MHarzi M, 1997, PHARMACOL BIOCHEM BE, V56, P663, DOI 10.1016/S0091-3057(96)00423-6; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; Morris RGM., 1983, NEUROBIOLOGY HIPPOCA, P405; Muralikrishnan D, 1998, FASEB J, V12, P905, DOI 10.1096/fasebj.12.10.905; O'Neill MJ, 1998, EUR J PHARMACOL, V352, P37, DOI 10.1016/S0014-2999(98)00333-1; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; PULASKI KH, 1994, AM J OCCUP THER, V48, P263, DOI 10.5014/ajot.48.3.263; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Tanaka K, 2001, NEUROCHEM RES, V26, P31, DOI 10.1023/A:1007672414239; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	65	118	120	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2002	19	4					415	425		10.1089/08977150252932370			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	542XP	WOS:000175071200003	11990348				2022-02-06	
J	Kersel, DA; Marsh, NV; Havill, JH; Sleigh, JW				Kersel, DA; Marsh, NV; Havill, JH; Sleigh, JW			Psychosocial functioning during the year following severe traumatic brain injury	BRAIN INJURY			English	Article							BLUNT HEAD-INJURY; SOCIAL RECOVERY; IMPAIRMENT	The psychosocial functioning of a group of 65 adults with severe traumatic brain injury was assessed at 6 months and 1 year post-injury. Aspects of emotional, behavioural, and social functioning were investigated. The prevalence of depression remained constant (24%) over time, although there was some individual variation in the reporting of symptoms. Impatience was the most frequently reported behavioural problem at both assessments. Whilst there was a slight increase in the number of behavioural problems and level of distress reported over time, the most obvious change was in the type of behavioural problems that caused distress. At 1 year post-injury, problems with emotional control were found to be most distressing for the patients. A comparison with pre-morbid social functioning showed the loss of employment to be 70%, 30% returned to live with their parents, and relationship breakdown occurred for 38%. There was also a significant and ongoing decrease in all five aspects of social and leisure activities.	Univ Waikato, Dept Psychol, Hamilton, New Zealand; Univ Glasgow, Dept Psychol Med, Glasgow, Lanark, Scotland; Waikato Hosp, Intens Care Unit, Hamilton, New Zealand		Marsh, NV (corresponding author), Univ Waikato, Dept Psychol, Private Bag 3105, Hamilton, New Zealand.	nvmarsh@waikato.ac.nz	Marsh, Nigel V./F-5433-2019; Marsh, Nigel/ABA-3609-2021	Marsh, Nigel V./0000-0002-4060-6432; Marsh, Nigel/0000-0002-4060-6432			BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; CRAWFORD C, 1983, NEW ZEAL MED J, V96, P972; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; GRIMM BH, 1986, HDB CLIN NEUROPSYCHO, V2, P495; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; HPAY H, 1971, HEAD INJURIES, P110; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1975, LANCET, V1, P480; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KERSEL DA, IN PRESS BRAIN INJUR; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KNIGHT RG, 1984, J CLIN PSYCHOL, V40, P751, DOI 10.1002/1097-4679(198405)40:3<751::AID-JCLP2270400320>3.0.CO;2-Y; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; MARSH NV, 1999, BRAIN DAM B, P175; MCKINLAY W, 1999, REHABILITATION ADULT, P74; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Smith LM, 1995, FAMILY SUPPORT PROGR; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Taylor, 1998, Semin Clin Neuropsychiatry, V3, P224; TEASDALE G, 1974, LANCET, V2, P81; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	40	118	119	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2001	15	8					683	696		10.1080/02699050010013662			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	462ZJ	WOS:000170452100003	11485609				2022-02-06	
J	Liu, DX; Ling, X; Wen, J; Liu, J				Liu, DX; Ling, X; Wen, J; Liu, J			The role of reactive nitrogen species in secondary spinal cord injury: Formation of nitric oxide, peroxynitrite, and nitrated protein	JOURNAL OF NEUROCHEMISTRY			English	Article						secondary spinal cord injury; nitric oxide; peroxynitrite; nitrotyrosine; protein nitration; Mn(III) tetrakis(4-benzoic acid)porphyrin	FOCAL CEREBRAL-ISCHEMIA; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN INJURY; SUPEROXIDE-DISMUTASE; NERVOUS-SYSTEM; L-ARGININE; NEURODEGENERATIVE DISEASES; GLUTAMATE NEUROTOXICITY; LIQUID-CHROMATOGRAPHY; SYNTHASE INHIBITION	To determine whether reactive nitrogen species contribute to secondary damage in CNS injury, the time courses of nitric oxide, peroxynitrite, and nitrotyrosine production were measured following impact injury to the rat spinal cord. The concentration of nitric oxide measured by a nitric oxide-selective electrode dramatically increased immediately following injury and then quickly declined. Nitro-L-arginine reduced nitric oxide production. The extracellular concentration of peroxynitrite, measured by perfusing tyrosine through a microdialysis fiber into the cord and quantifying nitrotyrosine in the microdialysates, significantly increased after injury to 3.5 times the basal level, and superoxide dismutase and nitro-L-arginine completely blocked peroxynitrite production. Tyrosine nitration examined immunohistochemically significantly increased at 12 and 24 h postinjury, but not in sham-control sections. Mn(III) tetrakis(4-benzoic acid)porphyrin (a novel cell-permeable superoxide dismutase mimetic) and nitro-L-arginine significantly reduced the numbers of nitrotyrosine-positive cells. Protein-bound nitrotyrosine was significantly higher in the injured tissue than in the sham-operated controls. These results demonstrate that traumatic injury increases nitric oxide and peroxynitrite production, thereby nitrating tyrosine, including protein-bound tyrosine. Together with our previous report that trauma increases superoxide, our results suggest that reactive nitrogen species cause secondary damage by nitrating protein through the pathway superoxide + nitric oxide --> peroxynitrite --> protein nitration.	Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA		Liu, DX (corresponding author), Univ Texas, Med Branch, Dept Neurol, Gail Borden Bldg,Room 4-468C, Galveston, TX 77555 USA.			liu, danxia/0000-0001-8172-2344	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035119, R29NS034048] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35119, NS34048] Funding Source: Medline		Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Arstall MA, 1999, CIRC RES, V85, P829, DOI 10.1161/01.RES.85.9.829; ASHWAL S, 1995, PEDIATR RES, V38, P652, DOI 10.1203/00006450-199511000-00004; BALENTINE JD, 1985, CENTRAL NERVOUS SYST, P455; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; BELAND FA, 1979, J CHROMATOGR, V174, P177, DOI 10.1016/S0021-9673(00)87048-X; Bolanos JP, 1997, J NEUROCHEM, V68, P2227; BRUCE AJ, 1995, FREE RADICAL BIO MED, V18, P993, DOI 10.1016/0891-5849(94)00218-9; BUCHAN AM, 1994, NEUROSCIENCE, V61, P1, DOI 10.1016/0306-4522(94)90054-X; CAZEVIEILLE C, 1993, FREE RADICAL BIO MED, V14, P389, DOI 10.1016/0891-5849(93)90088-C; CHOI DW, 1987, J NEUROSCI, V7, P357; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cuzzocrea S, 1999, BRIT J PHARMACOL, V128, P1241, DOI 10.1038/sj.bjp.0702826; Cuzzocrea S, 1999, FREE RADICAL BIO MED, V26, P25, DOI 10.1016/S0891-5849(98)00142-7; DAWSON DA, 1992, NEUROSCI LETT, V142, P151, DOI 10.1016/0304-3940(92)90361-A; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Dora CD, 1998, J NEUROTRAUM, V15, P473, DOI 10.1089/neu.1998.15.473; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413, DOI 10.1016/0922-4106(89)90023-0; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GATTI RM, 1994, FEBS LETT, V348, P287, DOI 10.1016/0014-5793(94)00625-3; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hare P E, 1977, Methods Enzymol, V47, P3; Hensley K, 1997, ANAL BIOCHEM, V251, P187, DOI 10.1006/abio.1997.2281; HESS DT, 1994, NEUROPHARMACOLOGY, V33, P1283, DOI 10.1016/0028-3908(94)90028-0; HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; ICHIMORI K, 1994, REV SCI INSTRUM, V65, P1; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Kamii H, 1996, J CEREBR BLOOD F MET, V16, P1153, DOI 10.1097/00004647-199611000-00009; Keller JN, 1998, J NEUROSCI, V18, P687; Konorev EA, 1999, ARCH BIOCHEM BIOPHYS, V368, P421, DOI 10.1006/abbi.1999.1337; KOZNIEWSKA E, 1995, STROKE, V26, P282, DOI 10.1161/01.STR.26.2.282; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU DX, 1993, BRAIN RES, V609, P293, DOI 10.1016/0006-8993(93)90885-Q; LIU DX, 1994, J NEUROCHEM, V62, P37; LIU DX, 1993, J BIOCHEM BIOPH METH, V27, P281, DOI 10.1016/0165-022X(93)90009-D; LIU DX, 1993, J NEUROTRAUM, V10, P349, DOI 10.1089/neu.1993.10.349; Liu DX, 1998, FREE RADICAL BIO MED, V25, P298, DOI 10.1016/S0891-5849(98)00055-0; LUO D, 1993, NEUROSCIENCE, V57, P897, DOI 10.1016/0306-4522(93)90035-E; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; NISHIKAWA T, 1993, STROKE, V24, P1717, DOI 10.1161/01.STR.24.11.1717; OHSHIMA H, 1990, FOOD CHEM TOXICOL, V28, P647, DOI 10.1016/0278-6915(90)90173-K; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Patel M, 1998, J NEUROCHEM, V71, P1068, DOI 10.1046/j.1471-4159.1998.71031068.x; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Qian H, 1997, NEUROCHEM RES, V22, P1231, DOI 10.1023/A:1021980929422; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; Scott GS, 1999, ANN NEUROL, V45, P120, DOI 10.1002/1531-8249(199901)45:1<120::AID-ART18>3.0.CO;2-I; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; SNYDER SH, 1992, SCIENCE, V257, P494, DOI 10.1126/science.1353273; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; VLIET A, 1994, FEBS LETT, V339, P89; WU WT, 1993, NEUROSCI LETT, V153, P121, DOI 10.1016/0304-3940(93)90303-3; YAMAMOTO S, 1992, J CEREBR BLOOD F MET, V12, P717, DOI 10.1038/jcbfm.1992.102; Young W, 1988, J Neurotrauma, V5, P219, DOI 10.1089/neu.1988.5.219; YOUNG W, 1992, J NEUROTRAUMA S1, V9, P9; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P259, DOI 10.1038/sj.bjp.0700872	72	118	121	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3042			J NEUROCHEM	J. Neurochem.	NOV	2000	75	5					2144	2154		10.1046/j.1471-4159.2000.0752144.x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	365AA	WOS:000089925200039	11032904	Bronze			2022-02-06	
J	Friedman, SD; Brooks, WM; Jung, RE; Hart, BL; Yeo, RA				Friedman, SD; Brooks, WM; Jung, RE; Hart, BL; Yeo, RA			Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; SEVERE HEAD-INJURY; DIFFUSE AXONAL INJURY; QUANTIFICATION; QUANTITATION; METABOLITES; PREDICTION; EXPERIENCE; SPECTRA; PROTEIN	BACKGROUND AND PURPOSE: Traumatic brain injury (TBI) causes substantial irreversible damage to neurons. Our aim was to investigate whether proton MR spectroscopic measures of diffuse cellular integrity were related to neuropsychological dysfunction after TBI, METHODS: Twelve patients with TBI (mean, 53 +/- 23 days postinjury) and 14 control subjects were included in the study using paired MR spectroscopy and neuropsychological assessment. N-acetylaspartate (NAA), creatine, and choline were measured in normal-appearing occipitoparietal white and occipital gray matter using short-echo quantitative spectroscopy. A composite measure of neuropsychological function was calculated from z-scored individual tests probing the major functional domains commonly impaired after head trauma. RESULTS: Patients with TBI displayed reduced NAA in white matter and elevated choline in gray matter, suggestive of neuronal injury and inflammation, respectively. NAA and creatine in white and gray matter were significantly associated with composite neuropsychological function and many individual neuropsychological tests. Gray matter choline, although abnormal, was not related to neuropsychological function, CONCLUSION: The concordance between neurometabolic levels and behavioral function supports the hypothesis that diffuse axonal injury is an important contributor to brain dysfunction after TBI.	Univ New Mexico, Hlth Sci Ctr, Ctr Non Invas Diag, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Radiol, Albuquerque, NM 87131 USA		Brooks, WM (corresponding author), Univ New Mexico, Hlth Sci Ctr, Ctr Non Invas Diag, 1201 Yale Blvd NE, Albuquerque, NM 87131 USA.			Jung, Rex/0000-0003-3718-0597; friedman, seth/0000-0001-8785-7215; brooks, william/0000-0001-6227-7636			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BARKER PB, 1993, NMR BIOMED, V6, P89, DOI 10.1002/nbm.1940060114; BIGLER ED, 1996, NEUROIMAGING, V2, P261; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BROOKS WM, IN PRESS J RHEUAMTOL; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; DICKMEN S, 1995, NEUROPSCYCHOLOGY, V9, P80; Feldman Z., 1996, NEUROTRAUMA, P43; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Graham D.I., 1996, NEUROTRAUMA, P43; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; Henriksen O, 1995, NMR BIOMED, V8, P139, DOI 10.1002/nbm.1940080402; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KOLLER KJ, 1984, J NEUROCHEM, V43, P1136, DOI 10.1111/j.1471-4159.1984.tb12854.x; Kreis R, 1996, J CLIN INVEST, V97, P1142, DOI 10.1172/JCI118528; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P372; LopezVillegas D, 1997, P NATL ACAD SCI USA, V94, P9854, DOI 10.1073/pnas.94.18.9854; LUYTEN PR, 1986, RADIOLOGY, V161, P795, DOI 10.1148/radiology.161.3.3786735; PIJNAPPEL WWF, 1992, J MAGN RESON, V97, P122, DOI 10.1016/0022-2364(92)90241-X; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; ROSS B, 1994, MAGN RESON QUART, V10, P191; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Steiger HJ, 1996, STROKE, V27, P2048, DOI 10.1161/01.STR.27.11.2048; SUTTON LN, 1995, PEDIATR NEUROSURG, V22, P81, DOI 10.1159/000120881; VANDENBOOGAART A, 1994, MAGNET RESON MED, V31, P347, DOI 10.1002/mrm.1910310402; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Zampolini M, 1997, EUR J NEUROL, V4, P246, DOI 10.1111/j.1468-1331.1997.tb00343.x	42	118	124	0	3	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	NOV-DEC	1998	19	10					1879	1885					7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	149DJ	WOS:000077589600018	9874540				2022-02-06	
J	HALL, ED				HALL, ED			LIPID ANTIOXIDANTS IN ACUTE CENTRAL-NERVOUS-SYSTEM INJURY	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	SYMP ON NEUROTRAUMA : CONCEPTS, CURRENT PRACTICE AND EMERGING THERAPIES	JUN 11-12, 1992	DEARBORN, MI	WAYNE STATE UNIV SCH MED, DEPT EMERGENCY MED		CENTRAL NERVOUS SYSTEM INJURY; LIPID ANTIOXIDANTS		Oxygen radical-mediated lipid peroxidation increasingly has been suggested to be an important factor in post-traumatic neuronal degeneration. Thus, numerous studies have evaluated the neuroprotective efficacy of pharmacologic agents with lipid antioxidant activity in models of spinal cord and brain injury. The glucocorticoid steroid methylprednisolone has been shown to possess significant antioxidant efficacy, and when administered to animals or human beings in antioxidant doses, it improves chronic neurologic recovery after spinal cord injury. This activity of methylprednisolone is independent of the steroid's glucocorticoid receptor-mediated actions and has been surpassed by the novel antioxidant 21-aminosteroids that have been developed that are devoid of glucocorticoid activity but have greater antioxidant efficacy than methylprednisolone. One of these, tirilazad mesylate (U-74006F), has been shown to be quite effective in animal models of brain and spinal cord injury and is the subject of phase Ill clinical trials. The consistent benefit afforded by antioxidant compounds further supports the concept that lipid peroxidation is an important therapeutic target for acute pharmacologic neuroprotection.			HALL, ED (corresponding author), UPJOHN CO,CNS DIS RES,KALAMAZOO,MI 49001, USA.		Hall, Edward D/F-8930-2013					0	118	125	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	1993	22	6					1022	1027		10.1016/S0196-0644(05)82745-3			6	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LE338	WOS:A1993LE33800011	8503522				2022-02-06	
J	MILLER, LP; LYETH, BG; JENKINS, LW; OLENIAK, L; PANCHISION, D; HAMM, RJ; PHILLIPS, LL; DIXON, CE; CLIFTON, GL; HAYES, RL				MILLER, LP; LYETH, BG; JENKINS, LW; OLENIAK, L; PANCHISION, D; HAMM, RJ; PHILLIPS, LL; DIXON, CE; CLIFTON, GL; HAYES, RL			EXCITATORY AMINO-ACID RECEPTOR SUBTYPE BINDING FOLLOWING TRAUMATIC BRAIN INJURY	BRAIN RESEARCH			English	Article									VET ADM MED CTR,NEUROSCI LAB 151S,WASHINGTON,DC 20422; GEORGETOWN UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,DEPT PSYCHOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,DEPT ANAT,RICHMOND,VA 23298					Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019550, R01NS021458, P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21458, NS19550, NS12587] Funding Source: Medline		BECKER DP, 1989, J CEREB BLOOD FLO S1, V9, pS302; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; COLLINS RC, 1986, METAB BRAIN DIS, V1, P231, DOI 10.1007/BF00999353; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P263, DOI 10.1016/0166-2236(87)90170-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAYES R, 1987, IEEE T SOFTWARE ENG, V13, P1254, DOI 10.1109/TSE.1987.232879; HAYES R L, 1988, Society for Neuroscience Abstracts, V14, P1153; Hayes R L, 1986, Cent Nerv Syst Trauma, V3, P163; HAYES RL, 1988, J NEUROTRAUM, V5, P287; HAYES RL, 1989, MILD HEAD INJURY, P54; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, IN PRESS NEUROTRAUMA, V4; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; JENKINS LW, 1989, MICHIGAN S SERIES TR, V1, P47; KATAYAMA Y, 1988, Society for Neuroscience Abstracts, V14, P1154; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; LYETH B G, 1987, Society for Neuroscience Abstracts, V13, P1253; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, IN PRESS BRAIN RES; MCINTOSH T, 1988, NEUROL NEUR, V46, P653; MENA EE, 1982, BRAIN RES, V243, P378, DOI 10.1016/0006-8993(82)90265-7; Miyazaki S, 1989, INTRACRANIAL PRESSUR, P651; MONAGHAN DT, 1985, BRAIN RES, V340, P378, DOI 10.1016/0006-8993(85)90936-9; MURPHY DE, 1987, NEUROCHEM RES, V12, P775, DOI 10.1007/BF00971514; OLENIAK L D, 1988, Society for Neuroscience Abstracts, V14, P1151; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; WESTERBERG E, 1989, J NEUROSCI, V9, P798; WIELOCH T, 1989, J CEREB BLOOD FLO S1, V9, pS6	33	118	121	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 27	1990	526	1					103	107		10.1016/0006-8993(90)90254-9			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ703	WOS:A1990DZ70300013	1964103				2022-02-06	
J	Leddy, JJ; Haider, MN; Ellis, MJ; Mannix, R; Darling, SR; Freitas, MS; Suffoletto, HN; Leiter, J; Cordingley, DM; Willer, B				Leddy, John J.; Haider, Mohammad N.; Ellis, Michael J.; Mannix, Rebekah; Darling, Scott R.; Freitas, Michael S.; Suffoletto, Heidi N.; Leiter, Jeff; Cordingley, Dean M.; Willer, Barry			Early Subthreshold Aerobic Exercise for Sport-Related Concussion A Randomized Clinical Trial	JAMA PEDIATRICS			English	Article							QUALITY-OF-LIFE; POSTCONCUSSION SYNDROME; ADOLESCENTS; SYMPTOMS; BALANCE; REHABILITATION; RELIABILITY; MEDICINE; CHILDREN; RECOVERY	IMPORTANCE: Sport-related concussion (SRC) is a significant public health problem without an effective treatment. OBJECTIVE: To assess the effectiveness of subsymptom threshold aerobic exercise vs a placebo-like stretching program prescribed to adolescents in the acute phase of recovery from SRC. DESIGN, SETTING, AND PARTICIPANTS: This multicenter prospective randomized clinical trial was conducted at university concussion centers. Male and female adolescent athletes (age 13-18 years) presenting within 10 days of SRC were randomly assigned to aerobic exercise or a placebo-like stretching regimen. INTERVENTIONS: After systematic determination of treadmill exercise tolerance on the first visit, participants were randomly assigned to a progressive subsymptom threshold aerobic exercise or a progressive placebo-like stretching program (that would not substantially elevate heart rate). Both forms of exercise were performed approximately 20 minutes per day, and participants reported daily symptoms and compliance with exercise prescription via a website. MAIN OUTCOMES AND MEASURES: Days from injury to recovery; recovery was defined as being asymptomatic, having recovery confirmed through an assessment by a physician blinded to treatment group, and returning to normal exercise tolerance on treadmill testing. Participants were also classified as having normal (<30 days) or delayed (>30 days) recovery. RESULTS: A total of 103 participants were included (aerobic exercise: n = 52; 24 female [46%]; stretching, n = 51; 24 female [47%]). Participants in the aerobic exercise group were seen a mean (SD) of 4.9 (2.2) days after the SRC, and those in the stretching group were seen a mean (SD) of 4.8 (2.4) days after the SRC. There were no differences in age, sex, previous concussions, time from injury, initial symptom severity score, or initial exercise treadmill test and physical examination results. Aerobic exercise participants recovered in a median of 13 (interquartile range [IQR], 10-18.5) days, whereas stretching participants recovered in 17 (IQR, 13-23) days (P = .009 by Mann-Whitney test). There was a nonsignificant lower incidence of delayed recovery in the aerobic exercise group (2 participants [4%] in the aerobic group vs 7 [14%] in the placebo group; P = .08). CONCLUSIONS AND RELEVANCE: This is, to our knowledge, the first RCT to show that individualized subsymptom threshold aerobic exercise treatment prescribed to adolescents with concussion symptoms during the first week after SRC speeds recovery and may reduce the incidence of delayed recovery.	[Leddy, John J.; Haider, Mohammad N.; Darling, Scott R.; Freitas, Michael S.; Suffoletto, Heidi N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthopaed & Sports Med, Buffalo, NY USA; [Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosci, Buffalo, NY USA; [Ellis, Michael J.] Univ Manitoba, Div Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Childrens Hosp, Res Inst Manitoba, Pan Am Clin Fdn, Pan Am Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Winnipeg, MB, Canada; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Leiter, Jeff; Cordingley, Dean M.] Pan Am Clin Fdn, Winnipeg, MB, Canada; [Willer, Barry] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Leddy, JJ (corresponding author), SUNY Buffalo, UBMD Orthopaed & Sports Med, 160 Farber Hall, Buffalo, NY 14214 USA.	leddy@buffalo.edu	Mannix, Rebekah/AAD-8702-2020		National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of Health (State University of New York at Buffalo) [UL1TR001412]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094444] Funding Source: NIH RePORTER	This study was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (grant 1R01NS094444) and the National Center for Advancing Translational Sciences of the National Institutes of Health (grant UL1TR001412; the State University of New York at Buffalo).	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Carson J, CAN FAM PHYS; Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Johnson BD, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13694; Kawasaki T, 2011, HYPERTENS RES, V34, P1059, DOI 10.1038/hr.2011.81; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Whaley MH, 2006, ACSMS GUIDELINES EXE; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	42	117	118	11	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	APR	2019	173	4					319	325		10.1001/jamapediatrics.2018.4397			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HU3HD	WOS:000465162600008	30715132	Bronze, Green Published	Y	N	2022-02-06	
J	Bahrami, N; Sharma, D; Rosenthal, S; Davenport, EM; Urban, JE; Wagner, B; Jung, Y; Vaughan, CG; Gioia, GA; Stitzel, JD; Whitlow, CT; Maldjian, JA				Bahrami, Naeim; Sharma, Dev; Rosenthal, Scott; Davenport, Elizabeth M.; Urban, Jillian E.; Wagner, Benjamin; Jung, Youngkyoo; Vaughan, Christopher G.; Gioia, Gerard A.; Stitzel, Joel D.; Whitlow, Christopher T.; Maldjian, Joseph A.			Subconcussive Head Impact Exposure and White Matter Tract Changes over a Single Season of Youth Football	RADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; DIFFUSION-TENSOR; TRACTOGRAPHY; ADOLESCENCE; PLAYERS; INTEGRITY; GRAY; ACCELERATION; BIOMECHANICS	Purpose: To examine the effects of subconcussive impacts resulting from a single season of youth (age range, 8-13 years) football on changes in specific white matter (WM) tracts as detected with diffusion-tensor imaging in the absence of clinically diagnosed concussions. Materials and Methods: Head impact data were recorded by using the Head Impact Telemetry system and quantified as the combined-probability risk-weighted cumulative exposure (RWE CP). Twenty-five male participants were evaluated for seasonal fractional anisotropy (FA) changes in specific WM tracts: the inferior fronto-occipital fasciculus (IFOF), inferior longitudinal fasciculus, and superior longitudinal fasciculus (SLF). Fiber tracts were segmented into a central core and two fiber terminals. The relationship between seasonal FA change in the whole fiber, central core, and the fiber terminals with RWE CP was also investigated. Linear regression analysis was conducted to determine the association between RWE CP and change in fiber tract FA during the season. Results: There were statistically significant linear relationships between RWEcp and decreased FA in the whole (R-2 = 0.433; P = .003), core (R-2 = 0.3649; P =.007), and terminals (R-2 = 0.5666; P < .001) of left IFOF. A trend toward statistical significance (P = .08) in right SLF was observed. A statistically significant correlation between decrease in FA of the right SLF terminal and RWE CP was also observed (R-2 = 0.2893; P = .028). Conclusion: This study found a statistically significant relationship between head impact exposure and change of FA value of whole, core, and terminals of left IFOF and right SLF's terminals where WM and gray matter intersect, in the absence of a clinically diagnosed concussion. (C) RSNA, 2016	[Bahrami, Naeim; Sharma, Dev; Davenport, Elizabeth M.; Jung, Youngkyoo; Whitlow, Christopher T.; Maldjian, Joseph A.] Wake Forest Sch Med, Adv Neurosci Imaging Res ANSIR Lab, Winston Salem, NC 27101 USA; [Rosenthal, Scott] Wake Forest Sch Med, Winston Salem, NC USA; [Jung, Youngkyoo; Whitlow, Christopher T.] Virginia Tech Wake Forest Sch Biomed Engn, Dept Radiol Neuroradiol, Blacksburg, VA 24061 USA; [Bahrami, Naeim; Urban, Jillian E.; Jung, Youngkyoo; Stitzel, Joel D.; Whitlow, Christopher T.] Virginia Tech Wake Forest Sch Biomed Engn, Dept Biomed Engn, Blacksburg, VA 24061 USA; [Whitlow, Christopher T.] Virginia Tech Wake Forest Sch Biomed Engn, Dept Family & Community Med, Blacksburg, VA 24061 USA; [Whitlow, Christopher T.] Virginia Tech Wake Forest Sch Biomed Engn, Dept Neurosurg, Blacksburg, VA 24061 USA; [Bahrami, Naeim; Urban, Jillian E.; Jung, Youngkyoo; Stitzel, Joel D.; Whitlow, Christopher T.] Virginia Tech Wake Forest Sch Biomed Engn, Blacksburg, VA 24061 USA; [Vaughan, Christopher G.; Gioia, Gerard A.] George Washington Univ, Sch Med, Childrens Natl Hlth Syst, Div Pediat Neuropsychol, Rockville, MD USA; [Stitzel, Joel D.] Wake Forest Sch Med, Childress Inst Pediat Trauma, Winston Salem, NC USA; [Davenport, Elizabeth M.; Wagner, Benjamin; Maldjian, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX USA		Whitlow, CT (corresponding author), Wake Forest Sch Med, Adv Neurosci Imaging Res ANSIR Lab, Winston Salem, NC 27101 USA.; Whitlow, CT (corresponding author), Virginia Tech Wake Forest Sch Biomed Engn, Dept Radiol Neuroradiol, Blacksburg, VA 24061 USA.; Whitlow, CT (corresponding author), Virginia Tech Wake Forest Sch Biomed Engn, Dept Biomed Engn, Blacksburg, VA 24061 USA.; Whitlow, CT (corresponding author), Virginia Tech Wake Forest Sch Biomed Engn, Dept Family & Community Med, Blacksburg, VA 24061 USA.; Whitlow, CT (corresponding author), Virginia Tech Wake Forest Sch Biomed Engn, Dept Neurosurg, Blacksburg, VA 24061 USA.; Whitlow, CT (corresponding author), Virginia Tech Wake Forest Sch Biomed Engn, Blacksburg, VA 24061 USA.	cwhitlow@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033; Jung, Youngkyoo/0000-0002-7236-8897; Maldjian, Joseph/0000-0002-6384-1072	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082453 NINDS, R03NS088082 NINDS]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082453, R03NS088082] Funding Source: NIH RePORTER	Supported by National Institutes of Health (grant no. R01NS082453 NINDS and R03NS088082 NINDS).	Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Ashtari M, 2007, NEUROIMAGE, V35, P501, DOI 10.1016/j.neuroimage.2006.10.047; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Ciccarelli O, 2003, NEUROIMAGE, V19, P1545, DOI 10.1016/S1053-8119(03)00190-3; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Held K, 1997, IEEE T MED IMAGING, V16, P878, DOI 10.1109/42.650883; Holl N, 2011, SURG RADIOL ANAT, V33, P713, DOI 10.1007/s00276-011-0816-8; Houston SM, 2014, CURR TOP BEHAV NEURO, V16, P3, DOI 10.1007/7854_2013_265; HUTTENLOCHER PR, 1990, NEUROPSYCHOLOGIA, V28, P517, DOI 10.1016/0028-3932(90)90031-I; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; MCARDLE CB, 1987, RADIOLOGY, V162, P223, DOI 10.1148/radiology.162.1.3786767; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; Tozer DJ, 2012, NEUROIMAGE, V59, P3094, DOI 10.1016/j.neuroimage.2011.10.088; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	52	117	117	3	18	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	DEC	2016	281	3					919	926		10.1148/radiol.2016160564			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	EJ4QI	WOS:000393201500025	27775478	Bronze, Green Published			2022-02-06	
J	Wu, LC; Nangia, V; Bui, K; Hammoor, B; Kurt, M; Hernandez, F; Kuo, C; Camarillo, DB				Wu, Lyndia C.; Nangia, Vaibhav; Bui, Kevin; Hammoor, Bradley; Kurt, Mehmet; Hernandez, Fidel; Kuo, Calvin; Camarillo, David B.			In Vivo Evaluation of Wearable Head Impact Sensors	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head impact sensors; Traumatic brain injury; Wearable sensors; Instrumented mouthguard; Instrumented skin patch; Instrumented skull cap; High speed video; Soft tissue modeling	SKIN-MOUNTED ACCELEROMETERS; BONE MOTION; FOOTBALL; KINEMATICS; ACCELERATION; MOVEMENT; SYSTEM	Inertial sensors are commonly used to measure human head motion. Some sensors have been tested with dummy or cadaver experiments with mixed results, and methods to evaluate sensors in vivo are lacking. Here we present an in vivo method using high speed video to test teeth-mounted (mouthguard), soft tissue-mounted (skin patch), and headgear-mounted (skull cap) sensors during 6-13 g sagittal soccer head impacts. Sensor coupling to the skull was quantified by displacement from an ear-canal reference. Mouthguard displacements were within video measurement error (< 1 mm), while the skin patch and skull cap displaced up to 4 and 13 mm from the ear-canal reference, respectively. We used the mouthguard, which had the least displacement from skull, as the reference to assess 6-degree-of-freedom skin patch and skull cap measurements. Linear and rotational acceleration magnitudes were over-predicted by both the skin patch (with 120% NRMS error for , 290% for ) and the skull cap (320% NRMS error for , 500% for ). Such over-predictions were largely due to out-of-plane motion. To model sensor error, we found that in-plane skin patch linear acceleration in the anterior-posterior direction could be modeled by an underdamped viscoelastic system. In summary, the mouthguard showed tighter skull coupling than the other sensor mounting approaches. Furthermore, the in vivo methods presented are valuable for investigating skull acceleration sensor technologies.	[Wu, Lyndia C.; Bui, Kevin; Hammoor, Bradley; Kurt, Mehmet; Camarillo, David B.] Stanford Univ, Dept Bioengn, 443 Via Ortega, Stanford, CA 94305 USA; [Nangia, Vaibhav; Hernandez, Fidel; Kuo, Calvin; Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA		Camarillo, DB (corresponding author), Stanford Univ, Dept Bioengn, 443 Via Ortega, Stanford, CA 94305 USA.	lyndiacw@stanford.edu	Kuo, Calvin/AAH-1933-2019; Wu, Lyndia/AAQ-1106-2020; Kurt, Mehmet/AAX-3303-2021	Kuo, Calvin/0000-0001-8401-9136; Wu, Lyndia/0000-0002-8236-032X; Kurt, Mehmet/0000-0002-5618-0296	National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [3R21EB01761101S1]; David and Lucile Packard FoundationThe David & Lucile Packard Foundation [38454]; Stanford Child Health Research Institute Transdisciplinary Initiatives Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB017611] Funding Source: NIH RePORTER	We thank X2 Biosystems Inc. for supplying skin patch sensors. The study was supported by the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1, David and Lucile Packard Foundation 38454, and the Stanford Child Health Research Institute Transdisciplinary Initiatives Program.	Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bouguet J. Y., CAMERA CALIBRATION T; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Christopher J. J, 2013, 2013010805 SAE; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Ewins D.J., 2000, MODAL TESTING THEORY; Funk JR, 2009, 2009010251 SAE; Heikkila J, 1997, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.1997.609468; Hernandez F., 2015, J BIOMECH IN PRESS; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Higgins M, 2007, J ATHL TRAINING, V42, P5; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; KIM W, 1993, J BIOMECH ENG-T ASME, V115, P47, DOI 10.1115/1.2895470; Knox T., 2004, 2004013538 SAE; Lucchetti L, 1998, J BIOMECH, V31, P977, DOI 10.1016/S0021-9290(98)00083-9; PELLMAN EJ, 2003, NEUROSURGERY, V53, P796; Reinschmidt C, 1997, J BIOMECH, V30, P729, DOI 10.1016/S0021-9290(97)00001-8; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Salzar R. S., 2014, 2008012978 SAE; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Shultz R, 2011, GAIT POSTURE, V34, P44, DOI 10.1016/j.gaitpost.2011.03.008; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; TRUJILLO DM, 1990, J BIOMECH ENG-T ASME, V112, P229, DOI 10.1115/1.2891176; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Zhang Z., 1999, P 7 IEEE INT C COMP, V1, P666, DOI DOI 10.1109/ICCV.1999.791289	27	117	118	1	36	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	APR	2016	44	4					1234	1245		10.1007/s10439-015-1423-3			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	DI8HJ	WOS:000373741800034	26289941	Green Accepted, Green Submitted			2022-02-06	
J	Bryan, CJ; Clemans, TA				Bryan, Craig J.; Clemans, Tracy A.			Repetitive Traumatic Brain Injury, Psychological Symptoms, and Suicide Risk in a Clinical Sample of Deployed Military Personnel	JAMA PSYCHIATRY			English	Article							HEAD-INJURY; ASSOCIATION; POPULATION; DEPRESSION; VETERANS; BEHAVIOR	IMPORTANCE Traumatic brain injury (TBI) is believed to be one factor contributing to rising suicide rates among military personnel and veterans. This study investigated the association of cumulative TBIs with suicide risk in a clinical sample of deployed military personnel referred for a TBI evaluation. OBJECTIVE To determine whether suicide risk is more frequent and heightened among military personnel with multiple lifetime TBIs than among those with no TBIs or a single TBI. DESIGN Patients completed standardized self-report measures of depression, posttraumatic stress disorder (PTSD), and suicidal thoughts and behaviors; clinical interview; and physical examination. Group comparisons of symptom scores according to number of lifetime TBIs were made, and generalized regression analyses were used to determine the association of cumulative TBIs with suicide risk. PARTICIPANTS Patients included 161 military personnel referred for evaluation and treatment of suspected head injury at a military hospital's TBI clinic in Iraq. MAIN OUTCOMES AND MEASURES Behavioral Health Measure depression subscale, PTSD Checklist-Military Version, concussion symptoms, and Suicide Behaviors Questionnaire-Revised. RESULTS Depression, PTSD, and TBI symptom severity significantly increased with the number of TBIs. An increased incidence of lifetime suicidal thoughts or behaviors was associated with the number of TBIs (no TBIs, 0%; single TBI, 6.9%; and multiple TBIs, 21.7%; P = .009), as was suicidal ideation within the past year (0%, 3.4%, and 12.0%, respectively; P = .04). The number of TBIs was associated with greater suicide risk (beta [SE] = .214 [.098]; P = .03) when the effects of depression, PTSD, and TBI symptom severity were controlled for. A significant interaction between depression and cumulative TBIs was also found (beta = .580 [.283]; P = .04). CONCLUSIONS AND RELEVANCE Suicide risk is higher among military personnel with more lifetime TBIs, even after controlling for clinical symptom severity. Results suggest that multiple TBIs, which are common among military personnel, may contribute to increased risk for suicide.	[Bryan, Craig J.] Natl Ctr Vet Studies, Salt Lake City, UT 84112 USA; [Clemans, Tracy A.] VA VISN 19 Mental Illness Res Educ Clin Ctr, Denver, CO USA		Bryan, CJ (corresponding author), Natl Ctr Vet Studies, 260 S Cent Campus Dr,Room 205, Salt Lake City, UT 84112 USA.	craig.bryan@utah.edu		Bryan, Craig/0000-0002-9714-0733; Clemans, Tracy/0000-0001-5994-1508	Department of DefenseUnited States Department of Defense; Department of the Air Force; San Antonio Life Sciences Institute	Dr Bryan reported receiving research grants from the Department of Defense, the Department of the Air Force, and the San Antonio Life Sciences Institute; speakers bureau honoraria from the American Association for Suicidology, the American Foundation for Suicide Prevention, and CMI Education; and salary from the American Association for Suicidology and Laredo Technical Services, for Department of Defense contracts to conduct military trainings.	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Blount TH, 2010, ANN M ASS BEHAV COGN; Brenner L.A., 2008, J MENTAL HEALTH COUN, V30, P211, DOI [10.17744/mehc.30.3.n6418tm72231j606, DOI 10.17744/MEHC.30.3.N6418TM72231J606]; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Bryan CJ, 2012, PERS INDIV DIFFER, V52, P374, DOI 10.1016/j.paid.2011.10.045; Defense and Veterans Brain Injury Center, 2007, MIL AC CONC EV; Department of the Army, 2012, ARM 2020 GEN HLTH DI; DOD/VA Traumatic Brain Injury Task Force, 2008, REP SURG GEN TRAUM B; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Kopta SM, 2002, PSYCHOTHER RES, V12, P413, DOI 10.1093/ptr/12.4.413; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Pernin C.G., 2011, WAR PREVENTING SUICI; Rudd M.D., 2006, ASSESSMENT MANAGEMEN; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Skopp Nancy A, 2012, MSMR, V19, P7; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; VISN 19 Mental Illness Research Education and Clinical Center, 2009, TRAUM BRAIN INJ SUIC; Weathers F.W., 1993, ANN CONV INT SOC TRA	28	117	119	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-622X	2168-6238		JAMA PSYCHIAT	JAMA Psychiatry	JUL	2013	70	7					686	691		10.1001/jamapsychiatry.2013.1093			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	197EA	WOS:000322831100008	23676987	Bronze			2022-02-06	
J	Nakase-Richardson, R; Whyte, J; Giacino, JT; Pavawalla, S; Barnett, SD; Yablon, SA; Sherer, M; Kalmar, K; Hammond, FM; Greenwald, B; Horn, LJ; Seel, R; McCarthy, M; Tran, J; Walker, WC				Nakase-Richardson, Risa; Whyte, John; Giacino, Joseph T.; Pavawalla, Shital; Barnett, Scott D.; Yablon, Stuart A.; Sherer, Mark; Kalmar, Kathleen; Hammond, Flora M.; Greenwald, Brian; Horn, Lawrence J.; Seel, Ron; McCarthy, Marissa; Tran, Johanna; Walker, William C.			Longitudinal Outcome of Patients with Disordered Consciousness in the NIDRR TBI Model Systems Programs	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; DOC; outcome; rehabilitation; TBI	PROLONGED UNCONSCIOUS STATE; SEVERE BRAIN-INJURY; INPATIENT REHABILITATION; GALVESTON ORIENTATION; VEGETATIVE STATE; RATING-SCALE; YOUNG-ADULTS; RECOVERY; CHILDREN; VALIDITY	Few studies address the course of recovery from prolonged disorders of consciousness (DOC) after severe traumatic brain injury (TBI). This study examined acute and long-term outcomes of persons with DOC admitted to acute inpatient rehabilitation within the National Institute on Disability and Rehabilitation Research (NIDRR) TBI Model Systems Programs (TBIMS). Of 9028 persons enrolled from 1988 to 2009, 396 from 20 centers met study criteria. Participants were primarily male (73%), Caucasian (67%), injured in motor vehicle collision (66%), with a median age of 28, and emergency department Glasgow Coma Scale (GCS) score of 3. Participant status was evaluated at acute rehabilitation admission and discharge and at 1, 2, and 5 years post-injury. During inpatient rehabilitation, 268 of 396 (68%) regained consciousness and 91 (23%) emerged from post-traumatic amnesia (PTA). Participants demonstrated significant improvements on GCS (z = 16.135, p <= 0.001) and Functional Independence Measure (FIM) (z = 15.584, p <= 0.001) from rehabilitation admission (median GCS = 9; FIM = 18) to discharge (median GCS = 14; FIM = 43). Of 337 with at least one follow-up visit, 28 (8%) had died by 2.1 years (mean) after discharge. Among survivors, 66 (21%) improved to become capable of living without in-house supervision, and 63 demonstrated employment potential using the Disability Rating Scale (DRS). Participants with follow-up data at 1, 2, and 5 years post-injury (n = 108) demonstrated significant improvement across all follow-up evaluations on the FIM Cognitive and Supervision Rating Scale (p < 0.01). Significant improvements were observed on the DRS and FIM Motor at 1 and 2 years post-injury (p < 0.01). Persons with DOC at the time of admission to inpatient rehabilitation showed functional improvement throughout early recovery and in years post-injury.	[Nakase-Richardson, Risa; Pavawalla, Shital; Barnett, Scott D.; McCarthy, Marissa; Tran, Johanna] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Nakase-Richardson, Risa; Barnett, Scott D.] Ctr Excellence Maximizing Rehabil Outcomes, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Tampa, FL USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Boston, MA USA; [Yablon, Stuart A.] Baylor Inst Rehabil, Dallas, TX USA; [Sherer, Mark] Baylor Coll Med, TIRR Mem Hermann, Houston, TX 77030 USA; [Kalmar, Kathleen] JFK Johnson Rehabil Inst, Edison, NJ USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ, Indianapolis, IN 46204 USA; [Greenwald, Brian] Mt Sinai Sch Med, New York, NY USA; [Horn, Lawrence J.] Wayne State Univ, Detroit, MI USA; [Seel, Ron] Shepherd Ctr, Atlanta, GA USA; [Walker, William C.] Virginia Commonwealth Univ, Richmond, VA USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd,Route 116B, Tampa, FL 33612 USA.	Risa.Richardson@va.gov	Giacino, Joseph/AAF-1952-2021; Walker, William C/N-3162-2014	Giacino, Joseph/0000-0002-7916-9698; Tran, Johanna/0000-0001-6231-5620; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research, Department of Education [H133A060038, H133A070043, H133A070040, H133A-080044, H133A070036, H133A070027, H133A070042, H133A031713, H133A070030, H133A070033]; HSR&D/RR&D Center of Excellence for Maximizing Rehabilitation Outcomes [COE-HFP 09-156]	The contents of this manuscript were developed under grants from the National Institute on Disability and Rehabilitation Research, Department of Education (H133A060038 [TBI Model System National Data and Statistical Center], H133A070043 [Texas TBI Model System of TIRR], H133A070040 [Moss TBI Model System], H133A-080044 [Southeastern Michigan TBI System], H133A070036 [Virginia Commonwealth TBI Model System], H133A070027 [North Texas TBI Model System], H133A070042 [Carolinas Traumatic Brain Injury Rehabilitation and Research System] H133A031713, H133A070030, H133A070033). However, those contents do not necessarily represent the policy of the Department of Education, and endorsement by the federal government should not be assumed. Statistical support was provided by the HSR&D/RR&D Center of Excellence for Maximizing Rehabilitation Outcomes [COE-HFP 09-156].	Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; Centers for Medicare and Medicaid Services, 2004, FED REGISTER, V69, P25; DUBROJA I, 1995, J NEUROL NEUROSUR PS, V58, P465, DOI 10.1136/jnnp.58.4.465; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; FIELDS AI, 1993, CRIT CARE MED, V21, P1890, DOI 10.1097/00003246-199312000-00016; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Ng YS, 2005, NEUROREHABILITATION, V20, P97; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; TEASDALE G, 1974, LANCET, V2, P81	31	117	117	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2012	29	1					59	65		10.1089/neu.2011.1829			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	879GI	WOS:000299317300006	21663544				2022-02-06	
J	Homsi, S; Piaggio, T; Croci, N; Noble, F; Plotkine, M; Marchand-Leroux, C; Jafarian-Tehrani, M				Homsi, Shadi; Piaggio, Tomaso; Croci, Nicole; Noble, Florence; Plotkine, Michel; Marchand-Leroux, Catherine; Jafarian-Tehrani, Mehrnaz			Blockade of Acute Microglial Activation by Minocycline Promotes Neuroprotection and Reduces Locomotor Hyperactivity after Closed Head Injury in Mice: A Twelve-Week Follow-Up Study	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; locomotor hyperactivity; microglial activation; minocycline; traumatic brain injury	TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; FLUID PERCUSSION INJURY; EXCITATORY AMINO-ACIDS; AXONAL INJURY; CEREBRAL EDEMA; MODEL; NEUROTOXICITY; EXPRESSION	Traumatic brain injury (TBI) causes a wide spectrum of consequences, such as microglial activation, cerebral inflammation, and focal and diffuse brain injury, as well as functional impairment. In this study we aimed to investigate the effects of acute treatment with minocycline as an inhibitor of microglial activation on cerebral focal and diffuse lesions, and on the spontaneous locomotor activity following TBI. The weight-drop model was used to induce TBI in mice. Microglial activation and diffuse axonal injury (DAI) were detected by immunohistochemistry using CD11b and beta-amyloid precursor protein (beta-APP) immunolabeling, respectively. Focal injury was determined by the measurement of the brain lesion volume. Horizontal and vertical locomotor activities were measured for up to 12 weeks post-injury by an automated actimeter. Minocycline or vehicle were administered three times post-insult, at 5 min (90mg/kg i.p.), 3 h, and 9 h post-TBI (45 mg/kg i.p.). Minocycline treatment attenuated microglial activation by 59% and reduced brain lesion volume by 58%, yet it did not affect DAI at 24 h post-TBI. More interestingly, minocycline significantly decreased TBI-induced locomotor hyperactivity at 48 h post-TBI, and its effect lasted for up to 8 weeks. Taken together, the results indicate that microglial activation appears to play an important role in the development of TBI-induced focal injury and the subsequent locomotor hyperactivity, and its short-term inhibition provides long-lasting functional recovery after TBI. These findings emphasize the fact that minocycline could be a promising new therapeutic strategy for head-injured patients.	[Homsi, Shadi; Piaggio, Tomaso; Croci, Nicole; Plotkine, Michel; Marchand-Leroux, Catherine; Jafarian-Tehrani, Mehrnaz] Univ Paris 05, Lab Pharmacol Circulat Cerebrale, EA 2510, Fac Sci Pharmaceut & Biol, F-75006 Paris, France; [Noble, Florence] Univ Paris 05, Lab Neuropsychopharmacol Addict, Fac Sci Pharmaceut & Biol, INSERM,U705,CNRS,UMR 7157, F-75006 Paris, France		Jafarian-Tehrani, M (corresponding author), Univ Paris 05, Lab Pharmacol Circulat Cerebrale, EA 2510, Fac Sci Pharmaceut & Biol, 4 Ave Observ, F-75006 Paris, France.	mehrnaz.jafarian@parisdescartes.fr	MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Noble, Florence/0000-0003-4497-0212; Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856			Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Boto GR, 2009, NEUROSURG REV, V32, P343, DOI 10.1007/s10143-008-0178-9; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Diguet E, 2004, EXP NEUROL, V189, P1, DOI 10.1016/j.expneurol.2004.05.016; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Elewa HF, 2006, PHARMACOTHERAPY, V26, P515, DOI 10.1592/phco.26.4.515; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fagan SC, 2004, EXP NEUROL, V186, P248, DOI 10.1016/j.expneurol.2003.12.006; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fei Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-96; Fujinaka T, 2003, NEUROL RES, V25, P35, DOI 10.1179/016164103101201094; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GOLANOV EV, 1995, J CEREBR BLOOD F MET, V15, P172, DOI 10.1038/jcbfm.1995.19; Goldstein Larry B, 2006, NeuroRx, V3, P451, DOI 10.1016/j.nurx.2006.07.010; Gonzalez JC, 2007, EUR J NEUROSCI, V26, P2481, DOI 10.1111/j.1460-9568.2007.05873.x; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kita T, 2000, INT J LEGAL MED, V113, P221, DOI 10.1007/s004149900095; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manev R, 2009, PROG NEURO-PSYCHOPH, V33, P166, DOI 10.1016/j.pnpbp.2008.11.004; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Reid WM, 2008, J NEUROTRAUM, V25, P248, DOI 10.1089/neu.2007.0389; Romero-Perez D, 2008, J AM COLL CARDIOL, V52, P1086, DOI 10.1016/j.jacc.2008.06.028; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Thomale UW, 2007, IMMUNOBIOLOGY, V212, P567, DOI 10.1016/j.imbio.2007.01.007; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Zhang L, 2007, NEUROPSYCHOPHARMACOL, V32, P2004, DOI 10.1038/sj.npp.1301313; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	74	117	119	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2010	27	5					911	921		10.1089/neu.2009.1223			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	599LX	WOS:000277915400013	20166806				2022-02-06	
J	Bell, KR; Hoffman, JM; Temkin, NR; Powell, JM; Fraser, RT; Esselman, PC; Barber, JK; Dikmen, S				Bell, K. R.; Hoffman, J. M.; Temkin, N. R.; Powell, J. M.; Fraser, R. T.; Esselman, P. C.; Barber, J. K.; Dikmen, S.			The effect of telephone counselling on reducing post-traumatic symptoms after mild traumatic brain injury: A randomised trial	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							ROUTINE FOLLOW-UP; HEAD-INJURY; EARLY INTERVENTION; ADULTS; IMPACT; CARE	Background: Mild traumatic brain injury (MTBI) is a significant public health problem affecting approximately 1 million people annually in the USA. A total of 10 - 15% of individuals are estimated to have persistent post-traumatic symptoms. This study aimed to determine whether focused, scheduled telephone counselling during the first 3 months after MTBI decreases symptoms and improves functioning at 6 months. Methods: This was a two-group, parallel, randomised clinical trial with the outcome assessed by blinded examiner at 6 months after injury. 366 of 389 eligible subjects aged 16 years or older with MTBI were enrolled in the emergency department, with an 85% follow-up completion rate. Five telephone calls were completed, individualised for patient concerns and scripted to address education, reassurance and reactivation. Two composites were analysed, one relating to post-traumatic symptoms that developed or worsened after injury and their impact on functioning, the other related to general health status. Results: The telephone counselling group had a significantly better outcome for symptoms (6.6 difference in adjusted mean symptom score, 95% confidence interval (CI) 1.2 to 12.0), but no difference in general health outcome (1.5 difference in adjusted mean functional score, 95% CI 2.2 to 5.2). A smaller proportion of the treatment group had each individual symptom (except anxiety) at assessment. Similarly, fewer of the treatment group had daily functioning negatively impacted by symptoms with the largest differences in work, leisure activities, memory and concentration and financial independence. Conclusions: Telephone counselling, focusing on symptom management, was successful in reducing chronic symptoms after MTBI.	[Bell, K. R.; Hoffman, J. M.; Temkin, N. R.; Powell, J. M.; Fraser, R. T.; Esselman, P. C.; Dikmen, S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, N. R.; Barber, J. K.; Dikmen, S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, N. R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Fraser, R. T.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA		Bell, KR (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.	krbell@u.washington.edu		Bell, Kathleen/0000-0002-0928-2046	Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CCR023226-03]; Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA	This research was funded by the Centers for Disease Control, Award No. R49/CCR023226-03. The Centers for Disease Control provided funding for the research but had no control over the design, data collection, analysis or interpretation of the data.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bandura A, 1986, SOCIAL FDN THOUGHT A; *CDC, 1999, FACTS CONC BRAIN INJ; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Dunn C, 2001, ADDICTION, V96, P1725, DOI 10.1046/j.1360-0443.2001.961217253.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; Glueckauf RL, 2002, REHABIL PSYCHOL, V47, P49, DOI 10.1037/0090-5550.47.1.49; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Liss HJ, 2002, REHABIL PSYCHOL, V47, P8, DOI 10.1037/0090-5550.47.1.8; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Miller WR, 1991, MOTIVATIONAL INTERVI; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; TEASDALE G, 1974, LANCET, V2, P81; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wallenstein S, 1997, STAT MED, V16, P1329, DOI 10.1002/(SICI)1097-0258(19970630)16:12<1329::AID-SIM567>3.0.CO;2-I; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	31	117	119	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2008	79	11					1275	1281		10.1136/jnnp.2007.141762			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	363EB	WOS:000260248900017	18469027				2022-02-06	
J	Milders, M; Ietswaart, M; Crawford, JR; Currie, D				Milders, Maarten; Ietswaart, Magdalena; Crawford, John R.; Currie, David			Social behavior following traumatic brain injury and its association with emotion recognition, understanding of intentions, and cognitive flexibility	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						traumatic brain injury; social behavior; emotion recognition; theory of mind; cognitive flexibility; follow-up	CLOSED-HEAD INJURY; PSYCHOSOCIAL ADJUSTMENT; ECOLOGICAL VALIDITY; EXECUTIVE FUNCTION; FACIAL EXPRESSION; SELF-AWARENESS; MIND; DEFICITS; IMPAIRMENTS; PERSONALITY	Although the adverse consequences of changes in social behavior following traumatic brain injury (TBI) are well documented, relatively little is known about possible underlying neuropsychological deficits. Following a model originally developed for social behavior deficits in schizophrenia, we investigated whether impairments in emotion recognition, understanding of other people's intentions ("theory of mind"), and cognitive flexibility soon after first TBI or 1 year later were associated with self and proxy ratings of behavior following TBI. Each of the three functions was assessed with two separate tests, and ratings of behavior were collected oil three questionnaires. Patients with TBI (n = 33) were impaired in emotion recognition, "theory of mind." and cognitive flexibility compared with matched orthopedic controls (n = 341). Proxy ratings showed increases in behavioral problems I year following injury in the TBI group but not in the control group. However, test performance was not associated with questionnaire data. Severity of the impairments in emotion recognition. understanding intention. and flexibility were unrelated to the severity of behavioral problems following TBI. These findings failed to confirm the Used model for social behavior deficits and may cast doubt on the alleged link between deficits in emotion recognition or theory of mind and social functioning.	[Milders, Maarten; Crawford, John R.] Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland; [Ietswaart, Magdalena] Northumbria Univ, Sch Psychol & Sport Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Currie, David] Aberdeen Royal Infirm, Dept Neurosurg, Aberdeen, Scotland		Milders, M (corresponding author), Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland.	nn.milders@abdn.ac.uk	Milders, Maarten/C-5560-2008; Crawford, John R/A-4165-2008	Crawford, John R/0000-0003-3403-3428; Ietswaart, Magdalena/0000-0003-4576-9393	Chief Scientist Office of the Scottish Executive [CZH/4/14]	This research was supported by the Chief Scientist Office of the Scottish Executive (CZH/4/14).	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bowers D., 1998, FLORIDA AFFECT BATTE; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; Braun C M, 1989, Brain Inj, V3, P5, DOI 10.3109/02699058909008068; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Corrigan PW, 1997, PSYCHIATRY, V60, P309, DOI 10.1080/00332747.1997.11024809; Crawford J.R, 2005, EFFECTIVENESS REHABI, P233, DOI DOI 10.1093/ACPROF:OSO/9780198526544.003.0019; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DOWNES JJ, 1993, BRAIN, V116, P887, DOI 10.1093/brain/116.4.887; Ekman P., 1976, PICTURES FACIAL AFFE; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Happe F, 2001, NEUROPSYCHOLOGIA, V39, P83, DOI 10.1016/S0028-3932(00)00093-2; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MARTIN AA, 1991, SULFUR LETT, V13, P225; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Office of National Statistics, 2005, NAT STAT SOC CLASS U; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	63	117	119	1	38	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2008	14	2					318	326		10.1017/S1355617708080351			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	338VJ	WOS:000258537200014	18282329	Green Published, Bronze, Green Accepted			2022-02-06	
J	Wallister, TW				Wallister, Thomas W.			Neurobehavioral sequelae of traumatic brain injury: evaluation and management	WORLD PSYCHIATRY			English	Article						traumatic brain injury; neurobehavioral sequelae; regional brain damage; cognitive deficits; personality changes	CLOSED HEAD-INJURY; FOLLOW-UP; AXIS-I; NEUROPSYCHIATRIC SEQUELAE; PSYCHIATRIC-DISORDERS; IMPAIRED AWARENESS; UNITED-STATES; RAT-BRAIN; MEMORY; MOOD	Traumatic brain injury (TBI) is a worldwide public health problem. Over the last several decades, improvements in acute care have resulted in higher survival rates. Unfortunately, the majority of survivors of moderate and severe TBI have chronic neurobehavioral sequelae, including cognitive deficits, changes in personality and increased rates of psychiatric illness. These neurobehavioral problems are understandable in the context of the typical profile of regional brain damage associated with trauma. This paper presents an overview of the neurobehavioral sequelae of TBI and outlines issues to consider in the evaluation and management of these challenges.	Dartmouth Coll, Hitchcock Med Ctr, Dept Psychiat, Lebanon, NH 03756 USA		Wallister, TW (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD048176, R01 HD048638] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS040472, R01 NS055020] Funding Source: Medline		Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas DB, 2005, CNS SPECTRUMS, V10, P1, DOI 10.1017/S1092852900026602; Arciniegas DB, 2000, CURRENT TREATMENT OP, V2, P169; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chau David T, 2004, Curr Psychiatry Rep, V6, P391, DOI 10.1007/s11920-004-0026-8; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CUESTA MJ, 1995, AM J PSYCHIAT, V152, P1380; CUESTA MJ, 1994, SCHIZOPHRENIA BULL, V20, P359, DOI 10.1093/schbul/20.2.359; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; EWINGCOBBS L, 1987, SEMIN PEDIAT NEUROL, V9, P209; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FAHY TJ, 1967, LANCET, V2, P475; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Flashman LA, 2001, J NEUROPSYCH CLIN N, V13, P255, DOI 10.1176/appi.neuropsych.13.2.255; FLASHMAN LA, UNPUB SELF REFLECTIO; FORD B, 1976, MED J AUSTRALIA, V1, P603, DOI 10.5694/j.1326-5377.1976.tb140904.x; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; GENNARELLI T, 2005, NEUROPSYCHIATRY TRAU, P27; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KRAUS JF, 2005, NEUROPSYCHIATRY TRAU, P3; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovell Mark R., 1994, P133; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McAllister T W, 2000, Semin Clin Neuropsychiatry, V5, P275, DOI 10.1053/scnp.2000.9557; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; MILLER H, 1965, LANCET, V1, P225; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OTA Y, 1969, LATE EFFECTS HEAD IN, P110; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; Perry EK, 2004, PROG BRAIN RES, V145, P287, DOI 10.1016/S0079-6123(03)45020-6; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; Ruff R. M., 1989, MILD HEAD INJURY, P176; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Shytle RD, 2002, DEPRESS ANXIETY, V16, P89, DOI 10.1002/da.10035; SORENSON SB, 1991, J HEAD TRAUMA REHAB, V5, P1; SOSIN DM, 1991, BRAIN INJURY, V10, P47, DOI DOI 10.1080/026990596124719; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tariot PN, 2002, ADV DRUG DELIVER REV, V54, P1567, DOI 10.1016/S0169-409X(02)00153-9; Tariot PN, 1999, J CLIN PSYCHIAT, V60, P29; TRUDEL TM, 1996, NEW HAMPSH BRAIN INJ; TSUIKI K, 1995, J NEUROCHEM, V64, P1319; U.S. Department of Health and Human Services, 1989, INT HEAD INJ TASK FO; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wei WH, 2005, ARCH PHYS MED REHAB, V86, P905, DOI 10.1016/j.apmr.2004.09.026; WEINTRAUB S, 1981, ARCH NEUROL-CHICAGO, V38, P742, DOI 10.1001/archneur.1981.00510120042004; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274	84	117	121	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2051-5545			WORLD PSYCHIATRY	World Psychiatry	FEB	2008	7	1					3	10					8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	265VF	WOS:000253389000002	18458777				2022-02-06	
J	Moser, RS; Iverson, GL; Echemendia, RJ; Lovell, MR; Schatz, P; Webbe, FM; Ruff, RM; Barth, JT				Moser, Rosemarie Scolaro; Iverson, Grant L.; Echemendia, Ruben J.; Lovell, Mark R.; Schatz, Philip; Webbe, Frank M.; Ruff, Ronald M.; Barth, Jeffrey T.		Nan Policy Planning Committee	Neuropsychological evaluation in the diagnosis and management of sports-related concussion	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						concussion; mild traumatic brain injury; sports; athletics; neuropsychological testing	INJURY SURVEILLANCE SYSTEM; COLLEGIATE FOOTBALL PLAYERS; ICE HOCKEY INJURIES; DESCRIPTIVE EPIDEMIOLOGY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; COGNITIVE IMPAIRMENT; BASKETBALL INJURIES; LACROSSE INJURIES; SOCCER INJURIES	A mild traumatic brain injury in sports is typically referred to as a concussion. This is a common injury in amateur and professional athletics, particularly in contact sports. This injury can be very distressing for the athlete, his or her family, coaches, and school personnel. Fortunately, most athletes recover quickly and fully from this injury. However, some athletes have a slow recovery, and there are reasons to be particularly concerned about re-injury during the acute recovery period. Moreover, some athletes who have experienced multiple concussions are at risk for long-term adverse effects. Neuropsychologists are uniquely qualified to assess the neurocognitive and psychological effects of concussion. The National Academy of Neuropsychology recommends neuropsychological evaluation for the diagnosis, treatment, and management of sports-related concussion at all levels of play. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Lovell, Mark R.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Schatz, Philip] St Josephs Univ, Philadelphia, PA 19131 USA; [Webbe, Frank M.] Florida Inst Technol, Melbourne, FL 32901 USA; [Ruff, Ronald M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Barth, Jeffrey T.] Univ Virginia, Sch Med, Charlottesville, VA 22903 USA			r.moser@patmedia.net	Webbe, Frank/A-8074-2009; Echemendia, Ruben/R-6939-2019	Webbe, Frank/0000-0002-4370-5698; Schatz, Philip/0000-0002-6222-6545; Iverson, Grant/0000-0001-7348-9570			Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P202; Agel J, 2007, J ATHL TRAINING, V42, P249; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 2001, J ATHL TRAINING, V36, P253; Barth JT, 1989, MILD HEAD INJURY, P257; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Dick R, 2007, J ATHL TRAINING, V42, P211; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P194; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory PR, 2002, PHYSICIAN SPORTSMED, V30, P43, DOI 10.3810/psm.2002.08.403; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Sosin DM, 1996, BRAIN INJURY, V10, P47; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	73	117	120	1	35	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2007	22	8					909	916		10.1016/j.acn.2007.09.004			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	244AL	WOS:000251838300001	17988831	Bronze			2022-02-06	
J	Yamasaki, TR; Blurton-Jones, M; Morrissette, DA; Kitazawa, M; Oddo, S; LaFerla, FM				Yamasaki, Tritia R.; Blurton-Jones, Mathew; Morrissette, Debbi A.; Kitazawa, Masashi; Oddo, Salvatore; LaFerla, Frank M.			Neural stem cells improve memory in an inducible mouse model of neuronal loss	JOURNAL OF NEUROSCIENCE			English	Article						transgenic; stem cells; neuronal death; functional recovery; memory; ablation	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; PROGENITOR-CELLS; SPINAL-CORD; NEUROTROPHIC FACTORS; RECOGNITION MEMORY; COGNITIVE FUNCTION; CEREBRAL-ISCHEMIA; PERIRHINAL CORTEX	Neuronal loss is a major pathological outcome of many common neurological disorders, including ischemia, traumatic brain injury, and Alzheimer disease. Stem cell-based approaches have received considerable attention as a potential means of treatment, although it remains to be determined whether stem cells can ameliorate memory dysfunction, a devastating component of these disorders. We generated a transgenic mouse model in which the tetracycline-off system is used to regulate expression of diphtheria toxin A chain. After induction, we find progressive neuronal loss primarily within the hippocampus, leading to specific impairments in memory. We find that neural stem cells transplanted into the brain after neuronal ablation survive, migrate, differentiate and, most significantly, improve memory. These results show that stem cells may have therapeutic value in diseases and conditions that result in memory loss.	Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA		LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, 1109 Gillespie Neurosci Bldg, Irvine, CA 92697 USA.	laferla@uci.edu	Kitazawa, Masashi/AAI-1721-2021; Morrissette, Debbi/AAR-3442-2021; Yamasaki, Tritia/AAN-8831-2020	Kitazawa, Masashi/0000-0003-2165-8197; Blurton-Jones, Mathew/0000-0002-7770-7157; Oddo, Salvatore/0000-0001-7304-7430	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM08620] Funding Source: Medline		Auerbach JM, 2000, EUR J NEUROSCI, V12, P1696, DOI 10.1046/j.1460-9568.2000.00067.x; Bernreuther C, 2006, J NEUROSCI, V26, P11532, DOI 10.1523/JNEUROSCI.2688-06.2006; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Buffalo EA, 1998, HIPPOCAMPUS, V8, P330, DOI 10.1002/(SICI)1098-1063(1998)8:4<330::AID-HIPO3>3.0.CO;2-L; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Jarrard LE, 2002, HIPPOCAMPUS, V12, P405, DOI 10.1002/hipo.10054; Jeltsch H, 2003, BEHAV BRAIN RES, V147, P217, DOI 10.1016/j.bbr.2003.09.018; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; KOCHI SK, 1993, EXP CELL RES, V208, P296, DOI 10.1006/excr.1993.1249; Kokaia Z, 1998, EXP NEUROL, V154, P289, DOI 10.1006/exnr.1998.6888; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mizumoto H, 2003, VISION RES, V43, P1699, DOI 10.1016/S0042-6989(03)00235-9; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Oliveira Alcyr A. Jr, 2005, Current Alzheimer Research, V2, P79, DOI 10.2174/1567205052772759; Parent JM, 1997, J NEUROSCI, V17, P3727; PARKINSON JK, 1988, J NEUROSCI, V8, P4159; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; TUSZYNSKI MH, 1995, MOL NEUROBIOL, V10, P151, DOI 10.1007/BF02740673; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Vora N, 2006, NEURODEGENER DIS, V3, P101, DOI 10.1159/000092100; Vroemen M, 2005, EXP NEUROL, V195, P127, DOI 10.1016/j.expneurol.2005.04.012; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	48	117	130	0	21	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 31	2007	27	44					11925	11933		10.1523/JNEUROSCI.1627-07.2007			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	226HB	WOS:000250577600021	17978032	Bronze, Green Published			2022-02-06	
J	Sullivan, PG; Krishnamurthy, S; Patel, SP; Pandya, JD; Rabchevsky, AG				Sullivan, Patrick G.; Krishnamurthy, Sairam; Patel, Samir P.; Pandya, Jignesh D.; Rabchevsky, Alexander G.			Temporal characterization of mitochondrial bioenergetics after spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						free radicals; lipid peroxidation; mitochondrial dysfunction; neuronal injury; oxidative stress; reactive oxygen species	AMYOTROPHIC-LATERAL-SCLEROSIS; LIPID-PEROXIDATION PRODUCT; EXCITOTOXIC NEURONAL DEATH; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; CELL-DEATH; PERMEABILITY TRANSITION; OXIDATIVE STRESS; FREE-RADICALS; THERAPEUTIC INTERVENTIONS	Mitochondrial dysfunction following spinal cord injury (SCI) may be critical for the development of secondary pathophysiology and neuronal cell death. Previous studies have demonstrated a loss of mitochondrial bioenergetics at 24 h following SCI. To begin to understand the evolution and study the contribution of mitochondrial dysfunction in pathophysiology of SCI, we investigated mitochondrial bioenergetics in the mid-thoracic region at 6, 12, and 24 h following contusion SCI. It is widely accepted that increased free radical generation plays a critical role in neuronal damage after SCI. Hence, to ascertain the role of free radicals in SCI-induced mitochondrial dysfunction, markers for oxidative damage, including nitrotyrosine (3-NT), lipid peroxidation byproduct (4-hydroxynonenal [HNE]), and protein oxidation (protein carbonyls) were quantified in the same samples of isolated mitochondria during the 24-h time course. The results demonstrate that a significant decline in mitochondrial function begins to occur 12 h post-injury and persists for a least 24 h following SCI. Furthermore, there was a progressive increase in mitochondrial oxidative damage that preceded the loss of mitochondrial bioenergetics, suggesting that free radical damage may be a major mitochondrial secondary injury process. Based on the present results, the temporal profile of mitochondrial dysfunction indicates that interventions targeting mitochondrial oxidative damage and dysfunction may serve as a beneficial pharmacological treatment for acute SCI.	Spinal Cord& Brain Injury Res Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA		Rabchevsky, AG (corresponding author), Spinal Cord& Brain Injury Res Ctr, Biomed & Biolog Sci Res Bldg 741 S Limestone St, Lexington, KY 40536 USA.	agrab@uky.edu	Rabchevsky, Alexander/AAQ-2451-2021	Rabchevsky, Alexander/0000-0002-1991-0915	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048191] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 048191] Funding Source: Medline		ANDERSON DK, 1982, J NEUROSURG, V56, P106, DOI 10.3171/jns.1982.56.1.0106; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Azbill RD, 2000, BRAIN RES, V871, P175, DOI 10.1016/S0006-8993(00)02430-6; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bracken MB, 2001, SPINE, V26, pS47, DOI 10.1097/00007632-200112151-00010; BRACKEN MB, 1990, MED J AUSTRALIA, V153, P368, DOI 10.5694/j.1326-5377.1990.tb136976.x; BRAUGHLER JM, 1983, J NEUROSURG, V59, P256, DOI 10.3171/jns.1983.59.2.0256; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hillard VH, 2004, J NEUROTRAUM, V21, P1405, DOI 10.1089/neu.2004.21.1405; Hunot S, 2001, SCIENCE, V292, P865, DOI 10.1126/science.1060885; ITO T, 1978, J NEUROSURG, V48, P434, DOI 10.3171/jns.1978.48.3.0434; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; Kalayci M, 2005, NEUROCHEM RES, V30, P403, DOI 10.1007/s11064-005-2615-2; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Kristal BS, 1997, J NEUROCHEM, V69, P524; Lai J C, 1979, Methods Enzymol, V55, P51; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Liu PK, 2002, ANN NY ACAD SCI, V962, P226, DOI 10.1111/j.1749-6632.2002.tb04071.x; Lopez-Vales R, 2005, J NEUROSCI RES, V81, P827, DOI 10.1002/jnr.20605; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MATTSON MP, 1995, NEUROBIOL AGING, V16, P679, DOI 10.1016/0197-4580(95)00063-K; MATTSON MP, 1993, J NEUROSCI, V13, P4575; Mattson MP, 1998, INT REV NEUROBIOL, V42, P103, DOI 10.1016/S0074-7742(08)60609-1; Mu XJ, 2000, BRAIN RES, V870, P66, DOI 10.1016/S0006-8993(00)02402-1; Mu XJ, 2002, J NEUROTRAUM, V19, P917, DOI 10.1089/089771502320317078; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Rabchevsky AG, 2001, ARCH NEUROL-CHICAGO, V58, P721, DOI 10.1001/archneur.58.5.721; Rosen CJ, 1999, J CLIN DENSITOM, V2, P3, DOI 10.1385/JCD:2:1:3; SANDERS DC, 1977, SURG FORUM, V28, P446; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; SIESJO BK, 1991, LIFE SCI R, V51, P35; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Smith RG, 1998, ANN NEUROL, V44, P696, DOI 10.1002/ana.410440419; Springer JE, 1997, J NEUROCHEM, V68, P2469; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; Young W, 1985, Cent Nerv Syst Trauma, V2, P109; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1	57	117	122	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2007	24	6					991	999		10.1089/neu.2006.0242			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	184EA	WOS:000247622700007	17600515				2022-02-06	
J	Kan, P; Amini, A; Hansen, K; White, GL; Brockmeyer, DL; Walker, ML; Kestle, JRW				Kan, Peter; Amini, Aminullah; Hansen, Kristine; White, George L., Jr.; Brockmeyer, Douglas L.; Walker, Marion L.; Kestle, John R. W.			Outcomes after decompressive craniectomy for severe traumatic brain injury in children	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; outcome; decompressive craniectomy; pediatric neurosurgery	SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; HYPERTONIC SALINE; MANAGEMENT; PRESSURE; DIAGNOSIS; BIOPSIES; SEIZURES; SCALE; COMA	Object. Severe traumatic brain injury (TBI) is often accompanied by early death due to transtentorial herniation. Decompressive craniectomy, performed alone or in conjunction with evacuation of the mass lesion, can reduce the incidence of raised intracranial pressure (ICP). In this paper the authors evaluate mortality and morbidity and long-term outcomes in children who underwent decompressive craniectomy for severe TBI at a single institution. Methods. Children with severe TBI who underwent decompressive craniectomy at the Primary Children's Medical Center between 1996 and 2005 were identified retrospectively. Descriptive statistics were used to report postoperative mortality and morbidity rates. Long-term recovery in patients who survived was reported using the King's Outcome Scale for Closed Head Injury (KOSCHI). Fifty-one children with a mean follow-up period of 18.6 months were identified. Nonaccidental trauma accounted for 23.5% of cases. The mean preoperative Glasgow Coma Scale (GCS) score was 4.6. Six patients underwent decompressive craniectomy for elevated ICP only; all other patients underwent decompressive craniectomy in conjunction with removal of the mass lesion. The mean postoperative GCS score was 9.7, and 69.4% of patients had normal ICP levels immediately after surgery. Sixteen children (31.4%) died, including five of six children who underwent decompressive craniectomy for raised ICP alone. Among surviving patients, 2.9% required a tracheostomy, 11.4% required a gastrostomy, 40% experienced posttraumatic shunt-dependent hydrocephalus, and 20% suffered posttraumatic epilepsy requiring antiepileptic agents. The mean KOSCHI score at the last follow-up examination was 4.5 and the mean time to cranioplasty was 2.3 months. Conclusions. Posttraumatic hydrocephalus and epilepsy were common complications encountered by children with severe TBI who underwent decompressive craniectomy. In patients who underwent decompressive surgery for raised ICP only, the mortality rate was exceedingly high.	Univ Utah, Primary Childrens Med Ctr, Dept Neurosurg, Div Pediat Neurosurg, Salt Lake City, UT 84113 USA		Kestle, JRW (corresponding author), Univ Utah, Primary Childrens Med Ctr, Dept Neurosurg, Div Pediat Neurosurg, 100 N Med Dr, Salt Lake City, UT 84113 USA.	john.kestle@hsc.utah.edu					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; GOLDSTEIN S, 1987, J NEUROSURG, V67, P341, DOI 10.3171/jns.1987.67.3.0341; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRUNERT P, 1994, NEUROSURG REV, V17, P59, DOI 10.1007/BF00309989; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; JOSAN VA, 2006, CHILDS NERV SYS 0222; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rekate Harold L., 2001, Child's Nervous System, V17, P632, DOI 10.1007/s003810100487; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; SHAPIRO K, 1985, J NEUROSURG, V63, P76, DOI 10.3171/jns.1985.63.1.0076; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	34	117	124	1	9	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	NOV	2006	105	5		S			337	342		10.3171/ped.2006.105.5.337			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	102HC	WOS:000241800600002	17328254				2022-02-06	
J	Zhang, J; Li, Y; Lu, M; Cui, YS; Chen, JL; Noffsinger, L; Elias, SB; Chopp, M				Zhang, Jing; Li, Yi; Lu, Mei; Cui, Yisheng; Chen, Jieli; Noffsinger, Lori; Elias, Stanton B.; Chopp, Michael			Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						axonal loss; bone marrow stromal cells; experimental autoimmune encephalomyelitis; nerve growth factor	MESENCHYMAL STEM-CELLS; NERVE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS LESIONS; RAT-BRAIN; INTRACEREBRAL TRANSPLANTATION; SYMPATHETIC NEURONS; THERAPEUTIC BENEFIT; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA	We investigated the ability of human bone marrow stromal cell (hBMSC) treatment to reduce axonal loss in experimental autoimmune encephalomyelitis (EAE) mice. EAE was induced in SJL/J mice by injection with proteolipid protein (PLP). Mice were injected intravenously with hBMSCs or PBS on the day of clinical onset, and neurological function was measured daily (score 0-5) until 45 weeks after onset. Mice were sacrificed at week 1, 10, 20, 34, and 45 after clinical onset. Bielshowsky silver was used to identify axons. Immunohistochemistry was performed to measure the expression of nerve growth factor (NGF) and MA131281, a marker of hBMSCs. hBMSC treatment significantly reduced the mortality, the disease severity, and the number of relapses in EAE mice compared with PBS treatment. Axonal density and NGF(+) cells in the EAE brain were significantly increased in the hBMSC group compared with the PBS group at 1, 10, 20, 34, and 45 weeks. Disease severity was significantly correlated with decreased axonal density and decreased NGF, and increased axonal density was significantly correlated with reduced loss of NGF expression after hBMSC treatment. Most of the NGF+ cells are brain parenchymal cells. Under 5% of MA131281(+) cells colocalized with NG2(+), a marker of oligodendrocyte progenitor cells. Nearly 10% of MA131281(+) cells colocalized with GFAP, a marker of astrocytes, and MAP-2, a marker of neurons. Our findings indicate that hBMSCs improve functional recovery and may provide a potential therapy aimed at axonal protection in EAE mice, in which NGF may play a vital role. (c) 2006 Wiley-Liss, Inc.	Henry Ford Hlth Sci Ctr, Dept Neurol, Detroit, MI 48202 USA; Cognate Therapeut Inc, Baltimore, MD USA; Oakland Univ, Dept Phys, Rochester, MI 48063 USA		Chopp, M (corresponding author), Henry Ford Hlth Sci Ctr, Dept Neurol, Educ & Res Bldg 3056,2799 W Grand Blvd, Detroit, MI 48202 USA.	chopp@neuro.hfh.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045041, R01 NS45041, P01 NS042345, P01 NS42345] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045041, P01NS042345] Funding Source: NIH RePORTER		Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aloe L, 1998, ARCH ITAL BIOL, V136, P247; Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x; Aloe Luigi, 2004, Ann Ist Super Sanita, V40, P89; Arredondo LR, 2001, EUR J IMMUNOL, V31, P625; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bechtold DA, 2004, ANN NEUROL, V55, P607, DOI 10.1002/ana.20045; BERNSTEIN DC, 1988, ANN NY ACAD SCI, V532, P207, DOI 10.1111/j.1749-6632.1988.tb36339.x; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bjartmar C, 2003, NEUROTOX RES, V5, P157, DOI 10.1007/BF03033380; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Bonini S, 2003, INT ARCH ALLERGY IMM, V131, P80, DOI 10.1159/000070922; Bracci-Laudiero L, 2005, BLOOD, V106, P3507, DOI 10.1182/blood-2004-10-4055; Bracci-Laudiero L, 2002, J NEUROIMMUNOL, V123, P58, DOI 10.1016/S0165-5728(01)00475-1; Brophy PJ, 2004, NEURON, V43, P154, DOI 10.1016/j.neuron.2004.07.005; CANEVA L, 1995, BLOOD CELL MOL DIS, V21, P73, DOI 10.1006/bcmd.1995.0011; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chitnis T., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P11, DOI 10.2174/1568008053174804; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Cohen RI, 1996, J NEUROSCI, V16, P6433; Conover W. J., 1998, PRACTICAL NONPARAMET, DOI DOI 1160687/QID%3D1105043505/SR%3D11-1/REF%3DSR%5F11%5F1/102-3876594-0537723; Cox DR, 1984, ANAL SURVIVAL DATA; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; EAVES CJ, 1991, BLOOD, V78, P110; Fainzilber Mike, 2002, EMBO Reports, V3, P1029, DOI 10.1093/embo-reports/kvf218; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Flugel A, 2001, EUR J IMMUNOL, V31, P11, DOI 10.1002/1521-4141(200101)31:1<11::AID-IMMU11>3.0.CO;2-G; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Grill RJ, 1997, EXP NEUROL, V148, P444, DOI 10.1006/exnr.1997.6704; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; HOLTZMAN DM, 1995, J NEUROSCI, V15, P7062; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; Jones LL, 2003, J NEUROSCI, V23, P9276; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Laurenzi MA, 1998, J LEUKOCYTE BIOL, V64, P228, DOI 10.1002/jlb.64.2.228; Levitan IB, 2002, NEURON CELL MOL BIOL, P408; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MacInnis BL, 2003, NEUROPHARMACOLOGY, V45, P995, DOI 10.1016/S0028-3908(03)00273-9; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Micera A, 2000, J NEUROIMMUNOL, V104, P116, DOI 10.1016/S0165-5728(99)00272-6; MOORE MAS, 1991, BLOOD, V78, P1; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Papadopoulos D, 2006, EXP NEUROL, V197, P373, DOI 10.1016/j.expneurol.2005.10.033; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; SAFFRAN BN, 1990, BRAIN RES, V525, P11, DOI 10.1016/0006-8993(90)91315-8; Saito T, 2002, ANN THORAC SURG, V74, P19, DOI 10.1016/S0003-4975(02)03591-9; Stampachiacchiere B, 2005, J NEUROIMMUNOL, V169, P20, DOI 10.1016/j.jneuroim.2005.07.022; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Triaca V, 2005, EXP NEUROL, V191, P53, DOI 10.1016/j.expneurol.2004.08.034; Villoslada P, 2000, J EXP MED, V191, P1799, DOI 10.1084/jem.191.10.1799; Walsh GS, 1999, J NEUROSCI, V19, P4155; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	78	117	121	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	AUG 15	2006	84	3					587	595		10.1002/jnr.20962			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	071FR	WOS:000239584700012	16773650				2022-02-06	
J	Betker, AL; Szturm, T; Moussavi, ZK; Nett, C				Betker, Aimee L.; Szturm, Tony; Moussavi, Zahra K.; Nett, Cristabel			Video game-based exercises for balance rehabilitation: A single-subject design	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	IASTED International Conference on Advances in Computer Science and Technology	JAN 23-25, 2006	Puerto Vallarta, MEXICO	Int Assoc Sci & Technol Dev, IASTED TCAI, IASTED TCCG, IASTED TCD, IASTED TC PDCS, IASTED TCSE		balance; biofeedback (psychology); exercise; movement; posture; pressure; rehabilitation; therapy, computer-assisted	INDUCED CORTICAL REORGANIZATION; INDUCED MOVEMENT THERAPY; CHRONIC MOTOR DEFICITS; TRUNK SWAY MEASURES; VIRTUAL-REALITY; STROKE PATIENTS; POSTURAL STABILITY; QUIET STANCE; BIOFEEDBACK; MOBILITY	Objectives: To investigate whether coupling foot center of pressure (COP)-controlled video games to standing balance exercises will improve dynamic balance control and to determine whether the motivational and challenging aspects of the video games would increase a subject's desire to perform the exercises and complete the rehabilitation process. Design: Case study, pre- and postexercise. Setting: University hospital outpatient clinic. Participants: A young adult with excised cerebellar tumor, 1 middle-aged adult with single right cerebrovascular accident, and I middle-aged adult with traumatic brain injury. Intervention: A COP-controlled, video game-based exercise system. Main Outcome Measures: The following were calculated during 12 different tasks: the number of falls, range of COP excursion, and COP path length. Results: Postexercise, subjects exhibited a lower fall count, decreased COP excursion limits for some tasks, increased practice volume, and increased attention span during training. Conclusions: The COP-controlled video game-based exercise regime motivated subjects to increase their practice volume and attention span during training. This in turn improved subjects' dynamic balance control.	Univ Manitoba, Sch Med Rehabil, Div Phys Therapy, Winnipeg, MB R3E 0T6, Canada; Univ Manitoba, Dept Elect & Comp Engn, Winnipeg, MB R3E 0T6, Canada		Szturm, T (corresponding author), Univ Manitoba, Sch Med Rehabil, Div Phys Therapy, R106,771 McDermot Ave, Winnipeg, MB R3E 0T6, Canada.	ptsturm@cc.umanitoba.ca					Allum JHJ, 2002, GAIT POSTURE, V16, P264, DOI 10.1016/S0966-6362(02)00011-5; Allum JHJ, 2001, GAIT POSTURE, V14, P227, DOI 10.1016/S0966-6362(01)00132-1; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Barclay-Goddard R., 2004, COCHRANE DB SYST REV, V18; Betker AL, 2006, IEEE T BIO-MED ENG, V53, P686, DOI 10.1109/TBME.2006.870222; Betker AL, 2005, IEEE T BIO-MED ENG, V52, P345, DOI 10.1109/TBME.2004.840466; BETKER AL, 2006, P ADV COMP SCI TECHN; BOULT C, 1994, J GERONTOL, V49, pM28, DOI 10.1093/geronj/49.1.M28; Bourbonnais D, 2002, AM J PHYS MED REHAB, V81, P890, DOI 10.1097/00002060-200212000-00002; Broeren J, 2004, ARCH PHYS MED REHAB, V85, P1247, DOI 10.1016/j.apmr.2003.09.020; Carr J. H., 1998, NEUROLOGICAL REHABIL; Cauraugh JH, 2005, PROG NEUROBIOL, V75, P309, DOI 10.1016/j.pneurobio.2005.04.001; Cheng PT, 2001, ARCH PHYS MED REHAB, V82, P1650, DOI 10.1053/apmr.2001.26256; Cogan A., 1977, 4 ANN C SYST DEV DIS, P187; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Cunningham D, 1999, ST HEAL T, V62, P90; Dean CM, 2000, ARCH PHYS MED REHAB, V81, P409, DOI 10.1053/mr.2000.3839; DEWEERDT WJ, 1985, PHYSIOTHERAPY, V71, P9; Di Nardo W, 1999, J DIABETES COMPLICAT, V13, P79, DOI 10.1016/S1056-8727(99)00032-X; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Fried L, 1991, J AGING HEALTH, V3, P285, DOI DOI 10.1177/089826439100300210; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Gill J, 2001, J GERONTOL A-BIOL, V56, pM438, DOI 10.1093/gerona/56.7.M438; Glanz M, 1997, J ROY SOC MED, V90, P33, DOI 10.1177/014107689709000110; Gourlay D, 2000, INT J MED INFORM, V60, P255, DOI 10.1016/S1386-5056(00)00100-3; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Johansen-Berg H, 2002, BRAIN, V125, P2731, DOI 10.1093/brain/awf282; Johansson Barbro B., 2004, Keio Journal of Medicine, V53, P231, DOI 10.2302/kjm.53.231; JORGENSEN HS, 1995, STROKE, V26, P1178, DOI 10.1161/01.STR.26.7.1178; KOZAK JJ, 1993, ERGONOMICS, V36, P777, DOI 10.1080/00140139308967941; Kriegsman DMW, 1997, J EPIDEMIOL COMMUN H, V51, P676, DOI 10.1136/jech.51.6.676; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; LAZZARO N, 2004, P C HUM FACT COMP SY, P1093; Lee MY, 1996, IEEE ENG MED BIOL, V15, P112, DOI 10.1109/51.544518; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lincoln NB, 1999, STROKE, V30, P573, DOI 10.1161/01.STR.30.3.573; LORD SR, 1993, DIABETIC MED, V10, P614, DOI 10.1111/j.1464-5491.1993.tb00133.x; Mackey DC, 2005, CLIN BIOMECH, V20, P776, DOI 10.1016/j.clinbiomech.2005.05.002; Malone T.W, 1982, CHI 82 P 1982 C HUMA, P63; Marin L, 1999, HUM MOVEMENT SCI, V18, P31, DOI 10.1016/S0167-9457(98)00032-3; Messier SP, 2000, J AM GERIATR SOC, V48, P131, DOI 10.1111/j.1532-5415.2000.tb03903.x; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; Moore EG, 1999, DISABIL REHABIL, V21, P196; Nelson DL, 1996, AM J OCCUP THER, V50, P639, DOI 10.5014/ajot.50.8.639; PAI YC, 1994, PHYS THER, V74, P647, DOI 10.1093/ptj/74.7.647; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; Richards CL, 2004, NEUROREHAB NEURAL RE, V18, P199, DOI 10.1177/1545968304269397; Rogers MW, 2001, EXP BRAIN RES, V136, P514, DOI 10.1007/s002210000615; Schaechter JD, 2002, NEUROREHAB NEURAL RE, V16, P326, DOI 10.1177/154596830201600403; Schaechter JD, 2004, PROG NEUROBIOL, V73, P61, DOI 10.1016/j.pneurobio.2004.04.001; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Shan GB, 2004, NEUROCOMPUTING, V61, P341, DOI 10.1016/j.neucom.2003.05.002; Shepard N T, 1992, Am J Audiol, V1, P45, DOI 10.1044/1059-0889.0104.45; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Sihvonen SE, 2004, GERONTOLOGY, V50, P87, DOI 10.1159/000075559; Szturm T, 1998, J VESTIBUL RES-EQUIL, V8, P381; TEASDALE N, 1991, J GERONTOL, V46, pB238, DOI 10.1093/geronj/46.6.B238; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Tsang WWN, 2004, MED SCI SPORT EXER, V36, P658, DOI 10.1249/01.MSS.0000122077.87090.2E; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; WHIPPLE R, 1993, J GERONTOL, V48, P71, DOI 10.1093/geronj/48.Special_Issue.71; Wittenberg GF, 2003, NEUROREHAB NEURAL RE, V17, P48, DOI 10.1177/0888439002250456; You SH, 2005, STROKE, V36, P1166, DOI 10.1161/01.STR.0000162715.43417.91	67	117	124	4	55	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2006	87	8					1141	1149		10.1016/j.apmr.2006.04.010			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	072KW	WOS:000239673300018	16876562				2022-02-06	
J	Heinly, MT; Greve, KW; Bianchini, KJ; Love, JM; Brennan, A				Heinly, MT; Greve, KW; Bianchini, KJ; Love, JM; Brennan, A			WAIS Digit Span-based indicators of malingered neurocognitive dysfunction - Classification accuracy in traumatic brain injury	ASSESSMENT			English	Article; Proceedings Paper	24th Annual Meeting of the National-Academy-of-Neuropsychology	NOV 17-20, 2004	Seattle, WA	Natl Acad Neuropsychol		Digit Span; reliable digit span; malingering; response bias; traumatic brain injury; neuropsychological assessment	CARD SORTING TEST; ADULT INTELLIGENCE SCALE; HEAD-INJURY; PERFORMANCE PATTERNS; RELIABLE DIGITS; RESPONSE BIAS; MEMORY; IDENTIFICATION; SPECIFICITY; SENSITIVITY	The present study determined specificity and sensitivity to malingered neurocognitive dysfunction (MND) in traumatic brain injury (TBI) for several Wechsler Adult Intelligence Scale (WAIS) Digit Span scores. TBI patients (n = 344) were categorized into one of five groups: no incentive, incentive only, suspect, probable MND, and definite MND. Performance of 1,063 nonincentive patients (e.g., cerebrovascular accident, memory disorder) was also examined. Digit Span scores included reliable digit span, maximum span forward both trials correct, maximum span forward, combined maximum forward and backward span, Digit Span scaled score, maximum span backward both trials correct, and maximum span backward. In TBI, sensitivity to MND ranged from 15% to greater than 30% at specificities of 92% to 98%. Patient groups with documented brain pathology had higher false-positive error rates. These results replicate previous known-groups malingering studies and provide valuable data supporting the WAIS Digit Span scores in detection and diagnosis of malingering.	Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BABIKIAN T, IN PRESS CLIN NEUROP; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, PORTLAND DIGIT RECOG; Butters N., 1980, ALCOHOLIC KORSAKOFFS; CARLESIMO GA, 1994, ACTA NEUROL SCAND, V89, P132; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; Etherton J, 2005, ASSESSMENT, V12, P130, DOI 10.1177/1073191105274859; Etherton JL, 2005, ASSESSMENT, V12, P101, DOI 10.1177/1073191104270789; ETHERTON JL, IN PRESS J CLIN EXPT; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Gouvier WD, 1998, CRIT ISS NE, P55; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heaton SK, 1993, WISCONSIN CARD SORTI; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; KAGEHIRO DK, 1990, PSYCHOL SCI, V1, P194, DOI 10.1111/j.1467-9280.1990.tb00197.x; KIERNAN RJ, 1983, NEUROBEHAVIORAL COGN; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; MAPOU RL, 1995, CLIN NEUROPSYCHOL, P295; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Ramsay MC, 1995, NEUROPSYCHOL REV, V5, P151, DOI 10.1007/BF02214760; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tamura Itaru, 2003, No To Shinkei, V55, P335; Thorndike R. L., 1986, STANFORD BINET INTEL; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wilde N, 2002, CLIN NEUROPSYCHOL, V16, P322, DOI 10.1076/clin.16.3.322.13858; Wilde NJ, 2004, J CLIN EXP NEUROPSYC, V26, P539, DOI 10.1080/13803390490496605; [No title captured]	53	117	118	1	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	DEC	2005	12	4					429	444		10.1177/1073191105281099			16	Psychology, Clinical	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology	984AM	WOS:000233274800007	16244123				2022-02-06	
J	O'Connor, CA; Cernak, I; Vink, R				O'Connor, CA; Cernak, I; Vink, R			Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats	BRAIN RESEARCH			English	Article						neurotrauma; hormone; female; blood brain barrier; brain injury	LIPID-PEROXIDATION; MESSENGER-RNA; GENDER; CONTUSION; STEROIDS	Females have reduced brain edema compared to males after experimental brain trauma, although contradictory reports exist as to whether this is due to either estrogen or progesterone. In the present study, we demonstrate in both male and ovariectomized female rats that a single physiological dose of either hormone at 30 min after diffuse traumatic brain injury reduces both blood brain,barrier permeability and edema formation. We conclude that both hormones may contribute to reduce edema in females after brain injury. (c) 2005 Elsevier B.V. All rights reserved.	Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia; Univ Adelaide, Dept Surg, Adelaide, SA 5005, Australia; Georgetown Univ, Dept Neurosci, Washington, DC USA		Vink, R (corresponding author), Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia.	Robert.Vink@adelaide.edu.au	Vink, Robert/J-7351-2012; Cernak, Ibolja/A-6399-2008; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ibolja, Cernak/0000-0003-3214-698X			Ayres S, 1998, AM J PHYSIOL-ENDOC M, V274, pE1002, DOI 10.1152/ajpendo.1998.274.6.E1002; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Gibbs RB, 1999, BRAIN RES, V844, P20, DOI 10.1016/S0006-8993(99)01880-6; Gibbs RB, 1998, BRAIN RES, V787, P259, DOI 10.1016/S0006-8993(97)01511-4; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Pelligrino DA, 1998, NEUROREPORT, V9, P3285, DOI 10.1097/00001756-199810050-00026; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; PLUM F, 1963, ARCH NEUROL-CHICAGO, V9, P571, DOI 10.1001/archneur.1963.00460120021002; Richard C, 2003, ENDOCRINOLOGY, V144, P1533, DOI 10.1210/en.2002-0033; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; STEIN DG, 2001, TRENDS NEUROSCI, P24; Vink R, 2003, ACT NEUR S, V86, P257; WOLFF JEA, 1992, J NEUROCHEM, V58, P1023, DOI 10.1111/j.1471-4159.1992.tb09357.x; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820	27	117	120	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 16	2005	1062	1-2					171	174		10.1016/j.brainres.2005.09.011			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	991CS	WOS:000233790500021	16256079				2022-02-06	
J	Bonnefont, X; Lacampagne, A; Sanchez-Hormigo, A; Fino, E; Creff, A; Mathieu, MN; Smallwood, S; Carmignac, D; Fontanaud, P; Travo, P; Alonso, G; Courtois-Coutry, N; Pincus, SM; Robinson, ICAF; Mollard, P				Bonnefont, X; Lacampagne, A; Sanchez-Hormigo, A; Fino, E; Creff, A; Mathieu, MN; Smallwood, S; Carmignac, D; Fontanaud, P; Travo, P; Alonso, G; Courtois-Coutry, N; Pincus, SM; Robinson, ICAF; Mollard, P			Revealing the large-scale network organization of growth hormone-secreting cells	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						biological rhythms; endocrinology; systems biology; connectivity; calcium	TRAUMATIC BRAIN-INJURY; ANTERIOR-PITUITARY; CONSCIOUS MALE; MICE; RAT; PROLACTIN; SURVIVORS; PROFILES; RELEASE; PEPTIDE	Pituitary growth hormone (GH)-secreting cells regulate growth and metabolism in animals and humans. To secrete highly ordered GH pulses (up to 1,000-fold rise in hormone levels in vivo), the pituitary GH cell population needs to mount coordinated responses to GH secretagogues, yet GH cells display an apparently heterogeneous scattered distribution in 2D histological studies. To address this paradox, we analyzed in 3D both positioning and signaling of GH cells using reconstructive, two-photon excitation microscopy to image the entire pituitary in GH-EGFP transgenic mice. Our results unveiled a homologous continuum of GH cells connected by adherens junctions that wired the whole gland and exhibited the three primary features of biological networks: robustness of architecture across lifespan, modularity correlated with pituitary GH contents and body growth, and connectivity with spatially stereotyped motifs of cell synchronization coordinating cell activity. These findings change our view of GH cells, from a collection of dispersed cells to a geometrically connected homotypic network of cells whose local morphology and connectivity can vary, to alter the timing of cellular responses to promote more coordinated pulsatile secretion. This large-scale 3D view of cell functioning provides a powerful approach to identify and understand other networks of endocrine cells that are thought to be scattered in situ. Many dispersed endocrine systems exhibit pulsatile outputs. We suggest that cell positioning and associated cell-cell connection mechanisms will be critical parameters that determine how well such systems can deliver a coordinated secretory pulse of hormone to their target tissues.	Univ Montpellier I, CNRS, INSERM, Inst Funct Genom,U661,Unite Mixte Rech 5203,Dept, 141 Rue Cardonille, F-34094 Montpellier, France; Univ Montpellier 2, CNRS, INSERM, Inst Funct Genom,U661,Unite Mixte Rech 5203,Dept, F-34094 Montpellier, France; Ctr Hosp Univ Arnaud de Villeneuve, INSERM, U637, F-34295 Montpellier, France; Natl Inst Med Res, Div Mol Neuroendocrinol, London NW7 1AA, England; CNRS, Montpellier RIO Imaging, Ctr Rech Biochim Macromol, F-34293 Montpellier, France		Mollard, P (corresponding author), Univ Montpellier I, CNRS, INSERM, Inst Funct Genom,U661,Unite Mixte Rech 5203,Dept, 141 Rue Cardonille, F-34094 Montpellier, France.	patrice.mollard@igf.cnrs.fr	BONNEFONT, Xavier/AAH-3882-2019; Lacampagne, Alain/S-3719-2016; Fino, Elodie/M-6586-2014; Smallwood, Sebastien/M-9783-2014; COUTRY, Nathalie/O-9352-2017	BONNEFONT, Xavier/0000-0003-4778-4060; Lacampagne, Alain/0000-0003-0264-1787; Fino, Elodie/0000-0003-1453-7784; COUTRY, Nathalie/0000-0001-5830-4013			Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Alonso G, 2003, EUR J NEUROSCI, V18, P1889, DOI 10.1046/j.1460-9568.2003.02927.x; Asa SL, 2002, NAT REV CANCER, V2, P836, DOI 10.1038/nrc926; Baker B.L., 1974, HDB PHYSIOLOGY END 1, V4, P45; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BOWERS CY, 1990, J CLIN ENDOCR METAB, V70, P975, DOI 10.1210/jcem-70-4-975; BRAZEAU P, 1982, P NATL ACAD SCI-BIOL, V79, P7909, DOI 10.1073/pnas.79.24.7909; CLARK RG, 1986, J ENDOCRINOL, V111, P27, DOI 10.1677/joe.0.1110027; CLARK RG, 1985, J ENDOCRINOL, V106, P281, DOI 10.1677/joe.0.1060281; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dasen JS, 2001, ANNU REV NEUROSCI, V24, P327, DOI 10.1146/annurev.neuro.24.1.327; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Fauquier T, 2002, TRENDS ENDOCRIN MET, V13, P304, DOI 10.1016/S1043-2760(02)00616-1; Fauquier T, 2001, P NATL ACAD SCI USA, V98, P8891, DOI 10.1073/pnas.151339598; Feyrter F., 1938, UBER DIFFUSE ENDOKRI; GAGE PJ, 1995, ENDOCRINOLOGY, V136, P1161, DOI 10.1210/en.136.3.1161; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Gleeson HK, 2004, ENDOCR-RELAT CANCER, V11, P589, DOI 10.1677/erc.1.00779; Guerineau NC, 1998, J BIOL CHEM, V273, P10389, DOI 10.1074/jbc.273.17.10389; GUILLEMIN RC, 1983, SYNERGETICS BRAIN, P155; HARTMAN ML, 1993, HORM RES, V40, P37, DOI 10.1159/000183766; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KOSTYO JL, 1999, HORMONAL CONTROL GRO; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Magoulas C, 2000, ENDOCRINOLOGY, V141, P4681, DOI 10.1210/en.141.12.4681; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PEARSE AGE, 1976, CLIN ENDOCRINOL, V5, pS229, DOI 10.1111/j.1365-2265.1976.tb03832.x; Pincus SM, 2000, AM J PHYSIOL-ENDOC M, V279, pE417, DOI 10.1152/ajpendo.2000.279.2.E417; Pincus SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE107, DOI 10.1152/ajpendo.1996.270.1.E107; PLOTSKY PM, 1985, SCIENCE, V230, P461, DOI 10.1126/science.2864742; Robinson IC, 1999, HORMONAL CONTROL GRO, P329; Rubinek T, 2003, J CLIN ENDOCR METAB, V88, P3724, DOI 10.1210/jc.2003-030090; SARTOR O, 1985, ENDOCRINOLOGY, V116, P952, DOI 10.1210/endo-116-3-952; SCHLEGEL W, 1987, NATURE, V329, P719, DOI 10.1038/329719a0; SLABAUGH MB, 1982, ENDOCRINOLOGY, V110, P1489, DOI 10.1210/endo-110-5-1489; STEWART JK, 1985, ENDOCRINOLOGY, V116, P1; Sweet Ian R, 2004, Diabetes Technol Ther, V6, P652, DOI 10.1089/dia.2004.6.652; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562; Tannenbaum GS, 2001, ENDOCRINOLOGY, V142, P4599, DOI 10.1210/en.142.11.4599; Veldhuis J D, 2000, Novartis Found Symp, V227, P163; Wick MR, 2000, AM J CLIN PATHOL, V113, P331, DOI 10.1309/ETJ3-QBUK-13QD-J8FP; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001	45	117	117	2	6	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 15	2005	102	46					16880	16885		10.1073/pnas.0508202102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PT	WOS:000233462900064	16272219	Green Published, Bronze			2022-02-06	
J	Croker, V; McDonald, S				Croker, V; McDonald, S			Recognition of emotion from facial expression following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; emotion recognition; perception; affect; facial expression	DIFFERENTIAL NEURAL RESPONSE; BLUNT HEAD-INJURY; SOCIAL-PERCEPTION; AMYGDALA DAMAGE; VISUAL-CORTEX; LOBE DAMAGE; FACE; IDENTITY; COMMUNICATION; IMPAIRMENTS	Primary Objective: To assess three domains of emotion recognition in people with traumatic brain injury (TBI). Research design: A between group comparison. Procedures: Twenty-four participants with severe TBI and 15 matched participants without brain damage were asked to label and match facial expressions with and without context. The participants with TBI were also interviewed regarding changes in subjective experience of emotion. Main outcomes and results: Participants with TBI were found to be significantly impaired on expression labelling and matching, but experienced some improvement when provided with context. Negative emotions were particularly affected. Affective semantic knowledge and face perception appeared to be relatively intact in this group. The majority of participants with TBI reported some change in the post-injury experience of everyday emotion, although the pattern of changes differed greatly between individuals. Reduced subjective experience, especially of sadness and fear, was associated with poor emotion matching but not emotion labelling.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 2003, NEUROPSYCHOLOGIA, V41, P119, DOI 10.1016/S0028-3932(02)00142-2; Adolphs R, 1996, J NEUROSCI, V16, P7678; Argyle M., 1976, GAZE MUTUAL GAZE; Argyle M., 1988, BODILY COMMUNICATION; BARBAS H, 1988, J COMP NEUROL, V276, P313, DOI 10.1002/cne.902760302; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; BOROD JC, 1993, J NERV MENT DIS, V181, P495; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Buchanan TW, 2004, BEHAV NEUROSCI, V118, P429, DOI 10.1037/0735-7044.118.2.429; Carroll JM, 1996, J PERS SOC PSYCHOL, V70, P205, DOI 10.1037/0022-3514.70.2.205; CROSSON B, 1987, CLIN NEUROPSYCHOL, V1, P335, DOI DOI 10.1080/13854048708520069; DEKOSKY ST, 1980, BRAIN LANG, V9, P206, DOI 10.1016/0093-934X(80)90141-8; Eckman P, 1976, PICTURES FACIAL AFFE; GEORGE MS, 1993, J NEUROPSYCH CLIN N, V5, P384; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; HUMPHREYS GW, 1993, NEUROPSYCHOLOGIA, V31, P173, DOI 10.1016/0028-3932(93)90045-2; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Johnston PJ, 2001, BIOL PSYCHOL, V58, P203, DOI 10.1016/S0301-0511(01)00114-4; KALSBEEK WD, 1980, J NEUROSURGERY S, V53, P19; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LU ST, 1991, NEUROSCIENCE, V43, P287, DOI 10.1016/0306-4522(91)90293-W; Mandal MK, 1999, J NERV MENT DIS, V187, P603, DOI 10.1097/00005053-199910000-00003; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McHugo GJ, 1996, MOTIV EMOTION, V20, P85, DOI 10.1007/BF02253867; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Mehrabian A., 1971, SILENT MESSAGES; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; OHMAN A, 1986, PSYCHOPHYSIOLOGY, V23, P123, DOI 10.1111/j.1469-8986.1986.tb00608.x; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 1999, PSYCHIAT RES-NEUROIM, V92, P11, DOI 10.1016/S0925-4927(99)00031-1; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; PRIGATANO GP, 1982, J PERCEPTUAL MOTOR S, V54, P859; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; YOUNG AW, 1993, BRAIN, V116, P941, DOI 10.1093/brain/116.4.941; [No title captured]	55	117	120	1	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2005	19	10					787	799		10.1080/02699050500110033			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	945EI	WOS:000230484800005	16175839				2022-02-06	
J	Williams, AJ; Hartings, JA; Lu, XCM; Rolli, ML; Dave, JR; Tortella, FC				Williams, AJ; Hartings, JA; Lu, XCM; Rolli, ML; Dave, JR; Tortella, FC			Characterization of a new rat model of penetrating ballistic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						ballistic; bullet wound; head injury; penetrating; rat; trauma	FOCAL CEREBRAL-ISCHEMIA; GUNSHOT WOUNDS; HEAD-INJURY; QUANTITATIVE ELECTROENCEPHALOGRAPHY; INTRACEREBRAL HEMORRHAGE; NEUROBEHAVIORAL OUTCOMES; EPILEPTIFORM DISCHARGES; SUBARACHNOID SPACE; SPREADING ISCHEMIA; MISSILE INJURIES	Penetrating brain injury (PBI) is a leading cause of mortality and morbidity in modern warfare and accounts for a significant number of traumatic brain injuries worldwide. Here we characterize the pathophysiology of a new rat model of PBI that simulates the large temporary cavity caused by energy dissipation from a penetrating bullet round. Male Sprague-Dawley rats (250-300 g) were subjected to a simulated ballistic wound to the right frontal hemisphere implemented by an inflatable penetrating probe. Three levels of injury severity were compared to control animals. Neurological and physiological outcome was assessed over a 3-day recovery period and brain tissue collected at 72 h for histopathological evaluation. Brain-injured regions included the ipsilateral frontal cortex and striatum with volumetric increases in intracranial hemorrhage (5-18 mm(3)) and lesion size (9-86 mm3) related to severity. Similarly, hemispheric swelling increased (3-14%) following PBI, associated, ated with a significant rise in intracranial pressure. Astrogliosis was present in regions adjacent to the core-injury along with microglial and leukocyte infiltration. Injury remote to the lesion was observed in the cerebral peduncle that may have accounted, in part, for observed neurological deficits. Neurological and balance beam testing revealed sensorimotor deficits that persisted through 72 h. Severe electroencephalographic disturbances included the occurrence of cortical spreading depression, slow-waves, and brain seizure activity. In conclusion, this rat PBI model replicates diverse, salient features of clinical PBI pathology, generates reproducible and quantifiable measures of outcome, and is scalable by injury severity, rendering it an attractive vehicle for experimental brain trauma research.	Walter Reed Army Inst Res, Dept Appl Neurobiol, Silver Spring, MD 20910 USA		Williams, AJ (corresponding author), Walter Reed Army Inst Res, Dept Appl Neurobiol, 503 Robert Grant Ave,Rm 2A40, Silver Spring, MD 20910 USA.	anthony.williams@na.amedd.army.mil	Dave, Jitendra R/A-8940-2011	Hartings, Jed/0000-0001-8583-3471			ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BELLAMY R, 1998, TXB MILITARY MED 1, V5, P107; BELLAMY RF, 1984, MIL MED, V149, P55; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Carey ME, 1998, MIL MED, V163, P581, DOI 10.1093/milmed/163.9.581; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Carey ME, 1990, J NEUROTRAUM, V7, P13, DOI 10.1089/neu.1990.7.13; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2004, STROKE, V35, P758, DOI 10.1161/01.STR.0000117235.11156.55; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; Finger S, 2004, ARCH NEUROL-CHICAGO, V61, P283, DOI 10.1001/archneur.61.2.283; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Giese A, 2002, SURG NEUROL, V57, P268, DOI 10.1016/S0090-3019(02)00643-2; GRANDMAISON F, 1991, ELECTROEN CLIN NEURO, V79, P264, DOI 10.1016/0013-4694(91)90121-J; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Hotz GA, 2000, BRAIN INJURY, V14, P649; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; JACOBS DG, 1995, AM SURGEON, V61, P647; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; LEEDHAM CS, 1993, MIL MED, V158, P508, DOI 10.1093/milmed/158.8.508; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Levy YS, 2002, NEUROTOX RES, V4, DOI 10.1080/1029842021000045624; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Marin R, 2003, PHYSIOL BEHAV, V80, P167, DOI 10.1016/j.physbeh.2003.06.001; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MOSHANG E, 2003, DAMD170110742; Nallet H, 2000, BRAIN RES, V879, P122, DOI 10.1016/S0006-8993(00)02760-8; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Nuwer M R, 1994, J Neuroimaging, V4, P82; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Pintar F A, 2001, Biomed Sci Instrum, V37, P429; Prgomet D, 1998, MIL MED, V163, P482, DOI 10.1093/milmed/163.7.482; REILLY P, 1997, HEAD INJURY, P385; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Sapsford W, 2003, J R Army Med Corps, V149, P5; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Schallert Tim, 2003, Phys Med Rehabil Clin N Am, V14, pS27, DOI 10.1016/S1047-9651(02)00055-4; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Singh P, 2003, NEUROL INDIA, V51, P215; SNODGRASS SM, 1989, J CLIN NEUROPHYSIOL, V6, P159, DOI 10.1097/00004691-198904000-00003; Stanimirovic D, 2000, BRAIN PATHOL, V10, P113; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Tan YH, 1998, J ORAL MAXIL SURG, V56, P345, DOI 10.1016/S0278-2391(98)90113-6; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; Vojvodic V, 1996, J TRAUMA, V40, pS180, DOI 10.1097/00005373-199603001-00040; Williams AJ, 2003, FUND CLIN PHARMACOL, V17, P581, DOI 10.1046/j.1472-8206.2003.00183.x; Williams AJ, 2004, STROKE, V35, P1186, DOI 10.1161/01.STR.0000125721.10606.dc; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Young G, 1988, AM J EEG TECHNOL, V28, P1; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226	65	117	119	0	6	MARY ANN LIEBERT INC	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2005	22	2					313	331		10.1089/neu.2005.22.313			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	900XU	WOS:000227248400010	15716636				2022-02-06	
J	Crisco, JJ; Chu, JJ; Greenwald, RM				Crisco, JJ; Chu, JJ; Greenwald, RM			An algorithm for estimating acceleration magnitude and impact location using multiple nonorthogonal single-axis accelerometers	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							PROFESSIONAL FOOTBALL; CONCUSSION; INJURIES	Accelerations of the head are the likely cause of concussion injury. but identifiing the specific etiology of concussion has been difficult due to the lack of a valid animal or computer model. Contact sports, in which concussions are a rising health care concern. offer a unique research laboratory environment. However measuring head acceleration in the field has many challenges including the need for large population sampling because of the relatively low incidence of concussions. We report a novel approach for calculating linear acceleration that can be incorporated into a head-mounted system for on-field use during contact sports. The advantages of this approach include the use of single axis linear accelerometers, which reduce costs, and a nonorthogonal arrangement of the accelerometers, which simplifies the design criteria for a head-mounted and helmet compatible system. The purpose of this study was to describe the algorithm and evaluate its accuracy for measuring linear acceleration magnitude and impact location using computer simulation and experimental tests with various accelerometer configurations. A 10% error in magnitude and a 10 deg error in impact location were achieved using as feu as six single-axis accelerometers mounted on a hemispherical headform.	Rhode Isl Hosp, Brown Med Sch, Dept Orthopaed, Providence, RI USA; Simbex LLC, Lebanon, NH USA; Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Crisco, JJ (corresponding author), Rhode Isl Hosp, Brown Med Sch, Dept Orthopaed, Providence, RI USA.	joseph_crisco@brown.edu		Crisco, Joseph/0000-0002-8786-0905	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R43HD40473 01] Funding Source: Medline		CANTU RC, 1990, J SPINAL DISORD, V3, P227; Cervelli P, 2001, J GEOPHYS RES-SOL EA, V106, P11217, DOI 10.1029/2000JB900399; GREENWALD R, 2003, 27 AM SOC BIOM M; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Ivarsson J, 2003, J BIOMECH ENG-T ASME, V125, P523, DOI 10.1115/1.1590360; Melvin J.W., 1993, ACCIDENTAL INJURY BI, P268; MERTZ HJ, 1967, KINEMATICS KINETICS; MITAL NK, 1979, J APPL MECH-T ASME, V46, P925, DOI 10.1115/1.3424679; Moon D W, 1971, Med Sci Sports, V3, P44; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; NUSHOLTZ G, 1988, MATH BIOSCI, P85; NUSHOLTZ GS, 1991, EXP MECH, V31, P264, DOI 10.1007/BF02326070; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; REID SE, 1971, SURG GYNECOL OBSTETR, V133, P929; SCHNEIDER R, 1965, CLIN NEUROSURG, V12, P226; SIEGMUND GP, 1997, 41 STAPP CAR CRASH C, P357	23	117	117	0	17	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2004	126	6					849	854		10.1115/1.1824135			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	901XD	WOS:000227314700020	15796345				2022-02-06	
J	McLeod, TCV; Perrin, DH; Guskiewicz, KM; Shultz, SJ; Diamond, R; Gansneder, BM				McLeod, TCV; Perrin, DH; Guskiewicz, KM; Shultz, SJ; Diamond, R; Gansneder, BM			Serial administration of clinical concussion assessments and learning effects in healthy young athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mild head injury; SAC; BESS; practice effects; children	MILD HEAD-INJURY; POSTURAL STABILITY; STANDARDIZED ASSESSMENT; BRAIN-INJURIES; UNITED-STATES; HIGH-SCHOOL; COLLEGIATE; CHILDREN; SPORT; PERFORMANCE	Objective: To determine if serial administration of the Standardized Assessment of Concussion (SAC) and Balance Error Scoring System (BESS) would elicit a learning effect in young athletes and to determine the intratester reliability of scoring the BESS. Design: A prospective study of 50 healthy young athletes who were assigned to either the control or practice group. All subjects were administered the assessments on 2 occasions, 60 days apart. In addition, subjects in the practice group received serial administration of the assessments on 3 occasions in the week following the initial assessment. Setting: University Sports Medicine/Athletic Training Research Laboratory. Subjects: Fifty uninjured young athletes between 9 and 14 years of age. Main Outcome Measured: Scores on 2 clinical concussion assessments, the SAC and the BESS. Results: We found a significant learning effect upon serial BESS testing in the practice group. BESS error scores were significantly lower than baseline (15.0 +/- 14.6) on days 5 (11.3 +/- 5.33), 7 (12.4 +/- 6.2), oand 60 (12.6 +/- 6.2). We also found a significant learning effect upon the day 60 BESS administration across all subjects. We did not find a practice or learning effect with serial SAC test administration. The intratester reliability of the investigator's ability to score repeated observations of the same BESS test ranged from 0.87 to 0.98. Conclusions: Our results demonstrated that serial administration of the BESS elicited a learning effect, which was more prominent during the tandem conditions. Clinicians utilizing the BESS as a measure of postural stability should be aware of the potential for improvement with repeated testing. Clinicians should not expect improvement with the SAC, as scores remained relatively stable across all trials.	Arizona Sch Hlth Sci, Dept Sports Hlth Care, Mesa, AZ 85206 USA; Univ N Carolina, Greensboro, NC 27412 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Virginia, Charlottesville, VA USA		McLeod, TCV (corresponding author), Arizona Sch Hlth Sci, Dept Sports Hlth Care, 5850 E Still Circle, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Guskiewicz, Kevin/0000-0002-8682-2130			Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; ATWATER SW, 1990, PHYS THER, V70, P79, DOI 10.1093/ptj/70.2.79; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; HOLLIDAY PJ, 1979, AGRESSOLOGIE, V20, P225; Kelly J, 1997, JAMA-J AM MED ASSOC, V277, P1190; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; LOMAX RG, 1992, STAT CONCEPTS; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; MANCUSO JJ, 2002, J ATHL TRAINING, V37, pS10; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M., 2000, STANDARDIZED ASSESSM; Nordahl SHG, 2000, AVIAT SPACE ENVIR MD, V71, P889; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Onate JA, 2000, J ATHL TRAINING, V35, P155; Randolph C, 2001, J ATHL TRAINING, V36, P288; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Westcott Sarah L., 1994, Physical and Occupational Therapy in Pediatrics, V14, P1, DOI 10.1300/J006v14n01_01; Westcott SL, 1997, PHYS THER, V77, P629, DOI 10.1093/ptj/77.6.629	32	117	118	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2004	14	5					287	295		10.1097/00042752-200409000-00007			9	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	943BX	WOS:000230327900007	15377968	Green Submitted			2022-02-06	
J	Sherer, M; Hart, T; Nick, TG; Whyte, J; Thompson, RN; Yablon, SA				Sherer, M; Hart, T; Nick, TG; Whyte, J; Thompson, RN; Yablon, SA			Early impaired self-awareness after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						awareness; brain injuries; rehabilitation	CLOSED-HEAD INJURY; REHABILITATION; PERCEPTIONS; DISABILITY; DEFICITS; COMA; CONSCIOUSNESS; RECOVERY; 1-YEAR; STAFF	Objectives: To evaluate predictors of early impaired self-awareness after traumatic brain injury (TBI); to examine interrelationships of the perceptions of patient, clinician, family, and significant other of how patients are functioning after TBI; and to determine how early impaired self-awareness helps to predict employability at rehabilitation discharge. Design: Inception cohort. Setting: Two inpatient rehabilitation programs. Participants: A total of 129 patients with TBI seen for inpatient rehabilitation at 1 of 2 rehabilitation centers. All subjects had emerged from posttraumatic amnesia before being assessed for this study. Interventions: Not applicable. Main Outcome Measures: Impaired self-awareness as measured by the Awareness Questionnaire (patient self-ratings, clinician ratings) and employability (rated on the Disability Rating Scale) at discharge from inpatient rehabilitation. Results: Regression analysis revealed that early impaired self-awareness was predicted by age and functional status (FIM(TM) instrument total score) at admission to inpatient rehabilitation. Spearman correlation coefficients revealed that clinician, family, and significant other ratings of patient functioning were related (r(s)=.42, P<.001), but were not related to patient self-ratings. Multiple logistic regression analysis revealed that early impaired self-awareness was predictive of employability at discharge from inpatient rehabilitation. Clinician ratings of patient functioning showed a positive relation to employability (P=.05), whereas patient self-ratings showed a trend toward a negative relation to employability (P=.09). Conclusions: Our results support the importance of early impaired self-awareness assessment, its predictive value for complex functional activities, and the need for further research to determine if treatment programs for impaired self-awareness enhance functional outcomes.	Methodist Rehabil Ctr, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Moss Rehabil Res Inst, Philadelphia, PA USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA		Sherer, M (corresponding author), Methodist Rehabil Ctr, 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	marks@mmrcrehab.org		Whyte, John/0000-0002-4381-1474			Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 1994, ARCH PHYS MED REHABI, V75, pSC; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kraus JF, 1993, HEAD INJURY, P1; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Newman AC, 2000, BRAIN INJURY, V14, P333; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; TEASDALE G, 1974, LANCET, V2, P81; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wallace CA, 2000, BRAIN INJURY, V14, P549; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; YOUNGBLOOD JR, 1989, REHABIL PSYCHOL, V94, P217	45	117	119	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					168	176		10.1053/apmr.2003.50045			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	643QV	WOS:000180872700004	12601646				2022-02-06	
J	Reinert, M; Barth, A; Rothen, HU; Schaller, B; Takala, J; Seiler, RW				Reinert, M; Barth, A; Rothen, HU; Schaller, B; Takala, J; Seiler, RW			Effects of cerebral perfusion pressure and increased fraction of inspired oxygen on brain tissue oxygen, lactate and glucose in patients with severe head injury	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; brain tissue oxygen; energy metabolites; hyperoxygenation	FREE-RADICAL PRODUCTION; FLUID-PERCUSSION INJURY; ENERGY-METABOLISM; EXTRACELLULAR POTASSIUM; HYPERBARIC-OXYGEN; GLUTAMATE RELEASE; BLOOD-FLOW; ISCHEMIA; TENSION; PO2	Objective. The purpose of the study was to measure the effects of increased inspired oxygen on patients suffering severe head injury and consequent influences on the correlations between CPP and brain tissue oxygen (PtiO2) and the effects on brain microdialysate glucose and lactate. Methods. In a prospective, observational study 20 patients suffering severe head injury (GCSless than or equal to8) were studied between January 2000 and December 2001. Each patient received an intraparenchymal ICP device and an oxygen sensor and, in 17 patients brain microdialysis was performed at the cortical-subcortical junction. A 6 h 100% oxygen challenge (FIO2 1.0) (Period A) was performed as early as possible in the first 24 hours after injury and compared with a similar 6 hour period following the challenge (Period B). Statistics were performed using the linear correlation analysis, one sample t-test, as well as the Lorentzian peak correlation analysis. Results. FIO2 was positively correlated with PtiO2 (p<0.0001) over the whole study period. PtiO2 was significantly higher (p<0.001) during Period A compared to Period B. CPP was positively correlated with PtiO2 (p<0.001) during the whole study. PtiO2 peaked at a CPP value of 78 mmHg performing a Lorentzian peak correlation analysis of all patients over the whole study. During Period A the brain microdialysate lactate was significantly lower (p=0.015) compared with Period B. However the brain microdialysate glucose remained unchanged. Conclusion. PtiO2 is significantly positively correlated with FIO2, meaning that PtiO2 can be improved by the simple manipulation of increasing FIO2 and ABGAO2. PtiO2 is positively correlated with CPP, peaking at a CPP value of 78 mmHg. Brain microdialysate lactate can be lowered by increasing PtiO2 values, as observed during the oxygen challenge, whereas microdialysate glucose is unchanged during this procedure. Extension of the oxygen challenge time and measurement of the intermediate energy metabolite pyruvate may clarify the metabolic effects of the intervention. Prospective comparative studies, including analysis of outcome on a larger multicenter basis, are necessary to assess the long term clinical benefits of this procedure.	Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; Univ Bern, Inselspital, Dept Intens Care Med, CH-3010 Bern, Switzerland		Reinert, M (corresponding author), Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland.	michael.reinert@neurochirurgie-bern.ch	Reinert, Michael/E-4964-2011; Rothen, Hans Ulrich/H-7100-2018; Reinert, Michael/AAA-3929-2019	Reinert, Michael/0000-0002-0971-9543; Schaller, Benoit/0000-0002-6861-2340			AGARDH CD, 1991, INT J DEV NEUROSCI, V9, P127, DOI 10.1016/0736-5748(91)90003-5; BARBER RE, 1970, NEW ENGL J MED, V283, P1478, DOI 10.1056/NEJM197012312832702; Bardt TF, 1998, ACT NEUR S, V71, P153; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Bruzzone P, 1998, ACT NEUR S, V71, P111; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CAO W, 2002, NEUROSCI LETT, V26, P233; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Chen T, 2000, ACT NEUR S, V76, P359; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dings J, 1998, NEUROL RES, V20, pS71; Doppenberg EMR, 1998, SURG NEUROL, V49, P650, DOI 10.1016/S0090-3019(97)00355-8; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; HOELPER B, 2002, UNPUB; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kiening KL, 1998, ACT NEUR S, V71, P172; LEVASSEUR J, 1998, J NEUROTRAUM, V15, P879; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; MAAS A, 1993, INTRACRANIAL PRESSUR, V8; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; MAGISTRETTI PJ, 1993, DEV NEUROSCI-BASEL, V15, P306, DOI 10.1159/000111349; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; Menzel M, 1998, ACT NEUR S, V71, P183; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; Morimoto T, 1996, J CEREBR BLOOD F MET, V16, P92, DOI 10.1097/00004647-199601000-00011; Muizelaar JP, 1996, NEUROTRAUMA, P553; Murakami N, 2001, CRIT CARE MED, V29, P814, DOI 10.1097/00003246-200104000-00027; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; QUINONESHINOJOS.A, 2001, J NEUROTRAUM, V18, P1137; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; ROCKSWOLD G, 1996, NEUROTRAUMA, P393; Rossi S, 1999, J NEUROSURG, V91, P1065; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P199; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Sarrafzadeh AS, 2002, ACTA NEUROCHIR SUPPL, V81, P319; Schneider GH, 1998, ACT NEUR S, V71, P62; Schousboe A, 1997, GLIA, V21, P99; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Siesj? BK., 1978, BRAIN ENERGY METABOL; SINGER MM, 2002, NEW ENGL J MED, V283, P1473; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stocchetti N, 1998, ACT NEUR S, V71, P162; THOMPSON RF, 2000, EYEBLINK CLASSICAL C, V2, P17; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; VANDEWATER JM, 2002, NEW ENGL J MED, V283, P621; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643	70	117	119	0	6	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		2003	145	5					341	350		10.1007/s00701-003-0027-0			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	691YG	WOS:000183633100002	12820040	Green Published			2022-02-06	
J	Rule, RR; Shimamura, AP; Knight, RT				Rule, Randall R.; Shimamura, Arthur P.; Knight, Robert T.			Orbitofrontal cortex and dynamic filtering of emotional stimuli	COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE			English	Article							CLOSED-HEAD-INJURY; PREFRONTAL CORTEX; WORKING-MEMORY; MONKEYS; DYSFUNCTION; BEHAVIOR; LESIONS; DAMAGE; ERP	Event-related potentials (ERPs) were recorded in response to mildly aversive somatosensory and auditory stimuli. Patients with orbitofrontal lesions exhibited enhanced ERPs (i.e., P3 amplitudes), as compared with control subjects. Moreover, these patients did not habituate to somatosensory stimuli across blocks of trials. The results were specific to orbitofrontal damage, since patients with damage to the dorsolateral prefrontal cortex did not exhibit enhanced P3 amplitudes. These findings suggest that damage to the orbitofrontal cortex impairs the ability to modulate or inhibit neural responses to aversive stimuli. The findings are couched in terms of dynamic filtering theory, which suggests that the orbitofrontal cortex is involved in the selection and active inhibition of neural circuits associated with emotional responses.	Univ Calif Berkeley, Berkeley, CA 94720 USA; Vet Affairs Hlth Care Syst, Martinez, CA USA		Shimamura, AP (corresponding author), Univ Calif Berkeley, Dept Psychol MC1650, Berkeley, CA 94720 USA.	aps@socrates.berkeley.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA14110, NS21135]; Veterans Administration Research ServiceUS Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021135, R37NS021135, R56NS021135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA014110] Funding Source: NIH RePORTER	This research was supported by NIH Grants DA14110 to A.P.S. and NS21135 to R.T.K. and by funding from the Veterans Administration Research Service. The authors thank Donatella Scabini and Clay Clayworth for advice and technical support. Address correspondence to A. P. Shimamura, Department of Psychology (MC1650), University of California, Berkeley, CA94720-1650(e-mail:aps@socrates.berkeley.edu).	Baldo JV, 2000, PSYCHOBIOLOGY, V28, P156; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BUTTER CM, 1964, SCIENCE, V144, P313, DOI 10.1126/science.144.3616.313; BUTTER CM, 1969, SCIENCE, V164, P1306, DOI 10.1126/science.164.3885.1306; Chao LL, 1996, COGNITIVE BRAIN RES, V4, P27, DOI 10.1016/0926-6410(95)00043-7; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Damasio A.R, 1998, PREFRONTAL CORTEX EX, P103; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hartikainen K., 2000, SOC NEUR ABSTR, V26, P2023; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Macmillan M., 1999, ODD KIND FAME STORIE; MACMILLAN MB, 1986, BRAIN COGNITION, V5, P67, DOI 10.1016/0278-2626(86)90062-X; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Opitz B, 1999, CEREB CORTEX, V9, P379, DOI 10.1093/cercor/9.4.379; Panksepp, 1998, AFFECTIVE NEUROSCIEN; Petrides M, 1995, HDB NEUROPSYCHOLOGY, P17; Petrides M., 1998, PREFRONTAL CORTEX EX, P103; PUCE A, 1995, J NEUROSURG, V83, P262, DOI 10.3171/jns.1995.83.2.0262; Roberts N. A., 2001, Society for Neuroscience Abstracts, V27, P1705; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; SHALLICE T, 1993, ATTENTION SELECTION, P00171; Shimamura A. P., HIST PHOTOG IN PRESS; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Soltani M., CRITICAL RE IN PRESS	40	117	117	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1530-7026	1531-135X		COGN AFFECT BEHAV NE	Cogn. Affect. Behav. Neurosci.	SEP	2002	2	3					264	270		10.3758/CABN.2.3.264			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	V32MG	WOS:000208954700006	12775190	Bronze			2022-02-06	
J	Cicerone, KD				Cicerone, KD			Remediation of 'working attention' in mild traumatic brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD INJURY; DEFICITS; MEMORY	Several studies have reported beneficial effects of treatments for attentional deficits following traumatic brain injury. Improvements in speed of processing appear to be less robust than improvements on non-speeded tasks, while several studies suggest greater benefits of training more complex forms of attention. The present study presents preliminary results concerning the effectiveness of an intervention for attentional deficits after mild traumatic brain injury. The treatment was based upon the conceptualization of deficits and interventions as a function of the central executive component of working memory, or 'working attention'. A prospective, case-comparison design was employed comparing four treatment participants with an untreated comparison sample. Treatment tasks were derived from experimental procedures which have been demonstrated to elicit working memory demands, consisting of 'n-back', random generation, and dual-task procedures. The intervention emphasized the conscious and deliberate use of strategies to effectively allocate attentional resources and manage the rate of information during task performance. Treatment participants were more likely to exhibit clinically significant improvement on measures of attention and reduction of self-reported attentional difficulties in their daily functioning. Further analysis suggested that the principal effect of the intervention was on working memory, i.e. the ability to temporarily maintain and manipulate information during task performance, with no direct effect on processing speed. The results are consistent with a strategy training model of remediation, in which the benefits of treatment are due to participants' improved ability to compensate for residual deficits and adopt strategies for the more effective allocation of their remaining attentional resources.	JFK Johnson Rehabil Inst, Edison, NJ 08820 USA		Cicerone, KD (corresponding author), JFK Johnson Rehabil Inst, 2048 Oak Tree Rd, Edison, NJ 08820 USA.						Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; Basso A, 2000, NEUROPSYCHOL REHABIL, V10, P219, DOI 10.1080/096020100389138; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; CICERONE KD, 2000, UNPUB NATURE ATTENTI; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; Heaton RK, 1991, COMPREHENSIVE NORMS; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Mateer CA, 1990, COGNITIVE REHABILITA, P68; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; Patton J.H., 1991, CLIN NEUROPSYCHOL, V5, P33, DOI [10.1080/13854049108401840, DOI 10.1080/13854049108401840]; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; Reason J., 1993, ATTENTION SELECTION, P406; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Weiskrantz L., 1993, ATTENTION SELECTION, P152	22	117	117	0	29	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK,, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2002	16	3					185	195		10.1080/02699050110103959			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	526HP	WOS:000174124800001	11874612				2022-02-06	
J	Tate, MC; Shear, DA; Hoffman, SW; Stein, DG; Archer, DR; LaPlaca, MC				Tate, MC; Shear, DA; Hoffman, SW; Stein, DG; Archer, DR; LaPlaca, MC			Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain	CELL TRANSPLANTATION			English	Article; Proceedings Paper	8th Annual Conference of the American-Society-for-Neural-Transplantation-and-Repair	MAY 03-06, 2001	CLEARWATER, FLORIDA	Amer Soc Neural Transplantat & Repair		traumatic brain injury; tissue engineering; fibronectin; extracellular matrix; neural progenitor cells; stem cells	RAT SPINAL-CORD; CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; RESTRICTED PRECURSORS; PERIPHERAL-NERVE; GRAFT-SURVIVAL; GROWTH; MODEL; TISSUE	Multipotential stem cells are an attractive choice for cell therapy after traumatic brain injury (TBI), as replacement of multiple cell types may be required for functional recovery. In the present study, neural stem cells (NSCs) derived from the germinal zone of E14.5 GFP-expressing mouse brains were cultured as neurospheres in FGF2-enhanced medium. When FGF2 was removed in vitro, NSCs expressed phenotypic markers for neurons, astrocytes, and oligodendrocytes and exhibited migratory behavior in the presence of adsorbed fibronectin (FN). NSCs (10(5) cells) were transplanted into mouse brains 1 week after a unilateral, controlled, cortical contusion (depth = 1 mm, velocity = 6 m/s, duration = 150 ms) (it = 19). NSCs were injected either directly into the injury cavity with or without an injectable FN-based scaffold [collagen I (CnI)/ FN gel; n = 14] or into the striatum below the injury cavity (n = 5). At all time points examined (1 week to 3 months posttransplant), GFP+ cells were confined to the ipsilateral host brain tissue. At 1 week, cells injected into the injury cavity lined the injury penumbra while cells inserted directly into the striatum remained in or around the needle track. Striatal transplants had a lower number of surviving GFP+ cells relative to cavity injections at the 1 week time point (p < 0.01). At the longer survival times (3 weeks-3 months), 63-76% of transplanted cells migrated into the fimbria hippocampus regardless of injection site, perhaps due to cues from the degenerating hippocampus. Furthermore, cells injected into the cavity within a FN-containing matrix showed increased survival and migration at 3 weeks (p < 0.05 for both) relative to injections of cells alone. These results suggest that FGF2-responsive NSCs present a promising approach for cellular therapy following trauma and that the transplant location and environment may play an important role in graft survival and integration.	Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA		LaPlaca, MC (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, 315 Ferst Dr, Atlanta, GA 30332 USA.		Shear, Deborah/B-3607-2011; Stein, Donald/AAJ-5139-2020				Baldwin SP, 1996, INT J DEV NEUROSCI, V14, P351, DOI 10.1016/0736-5748(96)00018-4; Branton RL, 1998, NEUROREPORT, V9, P3223, DOI 10.1097/00001756-199810050-00017; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chauhan NB, 1999, INT J DEV NEUROSCI, V17, P255, DOI 10.1016/S0736-5748(99)00003-9; Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4; DAVIES SJA, 1993, EUR J NEUROSCI, V5, P95, DOI 10.1111/j.1460-9568.1993.tb00474.x; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOUCETTE R, 1994, BRAIN RES, V649, P334, DOI 10.1016/0006-8993(94)91083-9; Duan WM, 2000, NEUROSCIENCE, V100, P521, DOI 10.1016/S0306-4522(00)00299-2; EGAN RA, 1991, BRAIN RES, V568, P330, DOI 10.1016/0006-8993(91)91421-V; Fulop ZL, 1997, INT J NEUROSCI, V90, P203, DOI 10.3109/00207459709000639; Gray JA, 2000, CELL TRANSPLANT, V9, P153, DOI 10.1177/096368970000900203; HOOVLER DW, 1991, ACTA NEUROPATHOL, V81, P303, DOI 10.1007/BF00305872; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Jacques TS, 1998, DEVELOPMENT, V125, P3167; KOZLOVA EN, 1990, DOKL AKAD NAUK SSSR+, V313, P1241; LEFCORT F, 1992, DEVELOPMENT, V116, P767; LESCAUDRON L, 1990, NEUROPSYCHOLOGIA, V28, P585, DOI 10.1016/0028-3932(90)90036-N; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; LIESI P, 1984, EMBO J, V3, P683, DOI 10.1002/j.1460-2075.1984.tb01867.x; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; MATHEWS GA, 1995, J NEUROBIOL, V26, P171, DOI 10.1002/neu.480260203; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Milward EA, 1997, J NEUROSCI RES, V50, P862, DOI 10.1002/(SICI)1097-4547(19971201)50:5<862::AID-JNR22>3.3.CO;2-O; MIZUTANI K, 1987, ACTA HISTOCHEM CYTOC, V20, P87, DOI 10.1267/ahc.20.87; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Park KI, 1999, J NEUROTRAUM, V16, P675, DOI 10.1089/neu.1999.16.675; Rao MS, 1999, ANAT RECORD, V257, P137; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; SHIHABUDDIN LS, 1995, J NEUROSCI, V15, P6666; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Tornqvist N, 2000, EXP NEUROL, V164, P130, DOI 10.1006/exnr.2000.7411; VALOUSKOVA V, 1995, NEUROSCI LETT, V186, P103, DOI 10.1016/0304-3940(95)11295-8; VANDERWOLF CH, 1990, EXP BRAIN RES, V81, P426; Watts C, 2000, EXP NEUROL, V163, P85, DOI 10.1006/exnr.1999.7341; Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543; Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467; Woerly S, 2000, NEUROSURG REV, V23, P59	43	117	128	0	8	COGNIZANT COMMUNICATION CORP	ELMSFORD	3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA	0963-6897			CELL TRANSPLANT	Cell Transplant.		2002	11	3					283	295					13	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	561LD	WOS:000176141400012	12075994				2022-02-06	
J	White, JRM; Farukhi, Z; Bull, C; Christensen, J; Gordon, T; Paidas, C; Nichols, DG				White, JRM; Farukhi, Z; Bull, C; Christensen, J; Gordon, T; Paidas, C; Nichols, DG			Predictors of outcome in severely head-injured children	CRITICAL CARE MEDICINE			English	Article						pediatrics; traumatic brain injury; Glasgow Coma Scale; mannitol; supranormal blood pressure; length of stay; survival; outcome; risk factors; resource utilization	CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; MANNITOL; MANAGEMENT; SURVIVAL; SEVERITY; THERAPY; SALINE	Objective: Determine variables in the acute care period associated with survival and pediatric intensive care unit (PICU) length of stay (LOS) for children with severe traumatic brain injury. Design: Retrospective cohort. Setting: Level 1 pediatric trauma center. Patients: Children (0-17 yrs) admitted 1991 to 1995 with nonpenetrating traumatic brain injury and admission Glasgow Coma Scale score of less than or equal to8. Interventions: None. Measurements and Main Result's: The first 72 hrs of hospitalization were analyzed in detail for 136 patients. The primary end point was survival; secondary end points were PICU LOS, cost, and day at which Glasgow Coma Scale score was greater than or equal to 14. Predictors of outcome were abstracted, including Pediatric Trauma Score, Glasgow Coma Scale score, Pediatric Risk of Mortality, physiologic variables, computed tomography evidence of brain injury, and neuroresuscitative medications. The fatality rate was 24%. Age and gender were similar between groups (p greater than or equal to .1). Survival was independently predicted by 6-hr Glasgow Coma Scale score (odds ratio [OR] 4.6; 95% confidence interval [CI] 2.06-11.9; p < .001) and maximum systolic blood pressure (OR 1.05; 95% CI 1.01-1.09; p < .02). Odds of survival increased 19-fold when maximum systolic blood pressure was greater than or equal to 135 mm Hg (OR 18.8; 95% CI 2.0-178.0; p < .01). By discharge, 67% of patients had an age-appropriate Glasgow Coma Scale score. Median hospital costs were $8,798 for survivors: only mannitol use independently predicted high cost (odds ratio 4.9; 95% CI 1.2-19.1; p < .01). For survivors, median PICU LOS was 2 days, although 25% had LOS >6 days. Six-hour Glasgow Coma Scale score (OR 0.62; 95% GI 0.48-0.80; p < .001) and mannitol (OR 7.9; 95% CI 2.3-27.3; p < .001) were each independently associated with a prolonged LOS among survivors. Conclusions: Patients with higher 6-hr Glasgow Coma Scale scores were more likely to survive. Adjusting for severity of injury, survival was associated with maximum systolic blood pressure greater than or equal to 135 mm Hg, suggesting that supranormal blood pressures are associated with improved outcome, Mannitol administration was associated with prolonged LOS, yet conferred no survival advantage. We suggest reevaluation of blood pressure targets and mannitol use in children with severe traumatic brain injury.	Childrens Natl Med Ctr, Div Pediat Crit Care Med, Washington, DC 20010 USA; Johns Hopkins Hosp, Div Pediat Crit Care Med, Baltimore, MD 21287 USA; Johns Hopkins Hosp, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; Johns Hopkins Hosp, Dept Surg, Baltimore, MD 21287 USA; Johns Hopkins Sch Hyg & Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; Johns Hopkins Hosp, Dept Pediat Rehabil, Baltimore, MD USA; Johns Hopkins Hosp, Kennedy Krieger Inst, Baltimore, MD USA; Johns Hopkins Hosp, Dept Phys Med & Rehabil, Baltimore, MD USA; Johns Hopkins Hosp, Dept Pediat, Baltimore, MD USA; Sch Med, Baltimore, MD USA		White, JRM (corresponding author), Childrens Natl Med Ctr, Div Pediat Crit Care Med, Washington, DC 20010 USA.						BISHOP MH, 1993, CRIT CARE MED, V21, P56, DOI 10.1097/00003246-199301000-00013; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CRUZ J, 1995, CRIT CARE MED, V23, P1412, DOI 10.1097/00003246-199508000-00016; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; JENNETT B, 1977, LANCET, V1, P878; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Luvisotto TL, 1996, NEUROSURGERY, V38, P131, DOI 10.1097/00006123-199601000-00031; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; *NAT CTR HLTH STAT, 1996, VIT STAT US 1991 A, V2, P36; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; PIGULA FA, 1993, J PEDIATR SURG, V28, P315; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SAHR R, 1998, CONSUMER PRICE INDEX; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soriano SG, 1996, CAN J ANAESTH, V43, P461, DOI 10.1007/BF03018107; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; WARD JD, 1995, MANAGEMENT PEDIAT TR, P177; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WINKLER SR, 1995, SURG NEUROL, V43, P59, DOI 10.1016/0090-3019(95)80039-J	30	117	120	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	MAR	2001	29	3					534	540		10.1097/00003246-200103000-00011			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	411WM	WOS:000167522400009	11373416				2022-02-06	
J	Sinson, G; Bagley, LJ; Cecil, KM; Torchia, M; McGowan, JC; Lenkinski, RE; McIntosh, TK; Grossman, RI				Sinson, G; Bagley, LJ; Cecil, KM; Torchia, M; McGowan, JC; Lenkinski, RE; McIntosh, TK; Grossman, RI			Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: Correlation with clinical outcome after traumatic brain injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article; Proceedings Paper	Annual Meeting of the American-Association-of-Neurological-Surgeons	APR 25-30, 1998	PHILADELPHIA, PA	Amer Assoc Neurol Surgeons			SEVERE HEAD-INJURY; REMITTING MULTIPLE-SCLEROSIS; PROBABLE ALZHEIMERS-DISEASE; N-ACETYL-ASPARTATE; RESONANCE SPECTROSCOPY; COMPUTERIZED-TOMOGRAPHY; PROGNOSTIC VALUE; WHITE-MATTER; HISTOPATHOLOGIC CORRELATION; PARKINSONS-DISEASE	BACKGROUND AND PURPOSE: Current imaging does not permit quantification of neural injury after traumatic brain injury (TBI) and therefore limits both the development of new treatments and the appropriate counseling of patients concerning prognosis. We evaluated the utility of magnetization transfer ratio (MTR) and proton MR spectroscopy in identifying patients with neuronal injury after TBI. METHODS: Thirty patients with TBI (21-77 years old; mean age, 42 years; admission Glasgow Coma Scale (GOS) scores 3-15; mean score, 11) were studied on a 1.5-T system with magnetization transfer imaging and MR spectroscopy of the splenium, Magnetization transfer imaging was also performed in the brain stem in all patients, and other areas of the brain were sampled in one patient. The splenium of the corpus callosum and brain stem were studied because these are often affected by diffuse axonal injury. Scans were obtained 2 to 1129 days after injury (median, 41 days). MTR was considered abnormal if it was more than 2 SD below normal. Proton MR spectroscopy was used to calculate the N-acetylaspartate (NAA)/creatine (Cr) ratio, GOS was determined at least 3 months after injury. RESULTS: In 10 patients with a GOS of 1 to 4, the mean NAA/Cr was 1.24 =/- 0.28; two of these patients had abnormal MTR in normal-appearing white matter (NAWM). In 20 patients with a GOS of 5, the mean NAA/Cr was 1.53 +/- 0.37 (P <.05); four of these patients had abnormal MTR in NAWM, MTR abnormalities in NAWM were Identified in six patients, but these changes did not correlate with GOS or MR spectroscopy changes. CONCLUSION: MTR and MR spectroscopy can quantify damage after TBI, and NAA levels may be a sensitive indicator of the neuronal damage that results in a worse clinical outcome.	Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Radiol, Philadelphia, PA 19104 USA		Sinson, G (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.		Lenkinski, Robert/F-9045-2014	Lenkinski, Robert/0000-0001-7371-5048; Cecil, Kim/0000-0001-8233-5485	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR002305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, R29NS034353, P50NS008803, R55NS034353] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR-02305] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-34353, NS-08803] Funding Source: Medline		ALGES WM, 1996, NEUROTRAUMA, P947; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; BARKER PB, 1995, RADIOLOGY, V195, P58, DOI 10.1148/radiology.195.1.7892496; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CHARLES HC, 1994, PROG NEURO-PSYCHOPH, V18, P995, DOI 10.1016/0278-5846(94)90125-2; Cheng LL, 1997, P NATL ACAD SCI USA, V94, P6408, DOI 10.1073/pnas.94.12.6408; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; CHRISTIANSEN P, 1995, MAGN RESON IMAGING, V13, P457, DOI 10.1016/0730-725X(94)00113-H; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P799, DOI 10.1016/0730-725X(93)90197-L; CLARKE DD, 1975, J NEUROCHEM, V24, P479, DOI 10.1111/j.1471-4159.1975.tb07665.x; COLLINS JG, 1990, VITAL HLTH STAT, V10, P175; Constantinidis I, 1996, BRIT J RADIOL, V69, P15, DOI 10.1259/0007-1285-69-817-15; DAVIES SEC, 1995, J NEUROCHEM, V64, P742; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Falconer JC, 1996, J NEUROCHEM, V66, P717; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Federico F, 1997, J NEUROL NEUROSUR PS, V62, P239, DOI 10.1136/jnnp.62.3.239; Federico F, 1996, J NEUROL, V243, P241, DOI 10.1007/BF00868521; Fu L, 1996, NMR BIOMED, V9, P339, DOI 10.1002/(SICI)1099-1492(199612)9:8<339::AID-NBM422>3.0.CO;2-X; Fulton JC, 1999, AM J NEURORADIOL, V20, P1951; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Gillard JH, 1996, AM J NEURORADIOL, V17, P873; Gonen O, 2000, NEUROLOGY, V54, P15, DOI 10.1212/WNL.54.1.15; Gredal O, 1997, NEUROLOGY, V48, P878, DOI 10.1212/WNL.48.4.878; GROSSMAN RI, 1994, RADIOGRAPHICS, V14, P279, DOI 10.1148/radiographics.14.2.8190954; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harms L, 1997, J NEUROL NEUROSUR PS, V62, P27, DOI 10.1136/jnnp.62.1.27; Heun R, 1997, INT J GERIATR PSYCH, V12, P349, DOI 10.1002/(SICI)1099-1166(199703)12:3<349::AID-GPS508>3.0.CO;2-S; HIEHLE JF, 1994, MAGNET RESON MED, V32, P285, DOI 10.1002/mrm.1910320303; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Hu MTM, 1999, J NEUROL NEUROSUR PS, V67, P20, DOI 10.1136/jnnp.67.1.20; Iranzo A, 1999, J NEUROL NEUROSUR PS, V66, P520, DOI 10.1136/jnnp.66.4.520; JAARSMA D, 1994, J NEUROL SCI, V127, P230, DOI 10.1016/0022-510X(94)90077-9; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; Kimura H, 1996, AM J NEURORADIOL, V17, P1539; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; KLUNK WE, 1992, NEUROLOGY, V42, P1578, DOI 10.1212/WNL.42.8.1578; Kraus J, 1996, NEUROTRAUMA, P13; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; Lazeyras F, 1998, PSYCHIAT RES-NEUROIM, V82, P95, DOI 10.1016/S0925-4927(98)00010-9; LEE JH, 1994, NEW ENGL J MED, V331, P439, DOI 10.1056/NEJM199408183310704; LEXA FJ, 1994, AM J NEURORADIOL, V15, P201; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MacKay S, 1996, ARCH NEUROL-CHICAGO, V53, P167, DOI 10.1001/archneur.1996.00550020079018; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; Matthews PM, 1996, BRAIN, V119, P715, DOI 10.1093/brain/119.3.715; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.0.CO;2-6; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MEYERHOFF DJ, 1994, ANN NEUROL, V36, P40; Miki Y, 1999, RADIOLOGY, V213, P395, DOI 10.1148/radiology.213.2.r99oc01395; Miller JD, 1996, NEUROTRAUMA, P61; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; OPPENHEIMER SM, 1995, MAGN RESON MED, V33, P61, DOI 10.1002/mrm.1910330109; Parnetti L, 1997, MECH AGEING DEV, V97, P9, DOI 10.1016/S0047-6374(97)01877-0; Passani LA, 1997, MOL CHEM NEUROPATHOL, V31, P97, DOI 10.1007/BF02815236; PATEL TB, 1980, BIOCHEM J, V188, P163, DOI 10.1042/bj1880163; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rose SE, 1999, MAGN RESON IMAGING, V17, P291, DOI 10.1016/S0730-725X(98)00168-4; Ross BD, 1996, NMR BIOMED, V9, P279, DOI 10.1002/(SICI)1099-1492(199610)9:7<279::AID-NBM435>3.0.CO;2-V; Rubin Y, 1997, J NEUROTRAUM, V14, P441, DOI 10.1089/neu.1997.14.441; Schuff N, 1998, RADIOLOGY, V207, P91, DOI 10.1148/radiology.207.1.9530304; SHIINO A, 1993, SURG NEUROL, V39, P143, DOI 10.1016/0090-3019(93)90093-G; SHONK TK, 1995, RADIOLOGY, V195, P65, DOI 10.1148/radiology.195.1.7892497; SIGNORETTI S, 1999, 17 ANN NAT NEUR S MI; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tedeschi G, 1996, NEUROLOGY, V47, P696, DOI 10.1212/WNL.47.3.696; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; [No title captured]	89	117	128	0	13	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JAN	2001	22	1					143	151					9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	397WK	WOS:000166720700024	11158900				2022-02-06	
J	Kim, WK; Kan, YQ; Ganea, D; Hart, RP; Gozes, I; Jonakait, GM				Kim, WK; Kan, YQ; Ganea, D; Hart, RP; Gozes, I; Jonakait, GM			Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway	JOURNAL OF NEUROSCIENCE			English	Article						VIP; PACAP; TNF-alpha; microglia; cAMP; PKA; spinal cord injury; LPS	NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL TRAUMATIC INJURY; SUPERIOR CERVICAL-GANGLION; HUMAN MONOCYTIC CELLS; CLOSED-HEAD INJURY; TNF-ALPHA; MESSENGER-RNA; IN-VITRO; BRAIN INJURY	Tumor necrosis factor-alpha (TNF-alpha) production accompanies CNS insults of all kinds. Because the neuropeptide vasoactive intestinal peptide (VIP) and the structurally related peptide pituitary adenylyl cyclase-activating polypeptide (PACAP) have potent anti-inflammatory effects in the periphery, we investigated whether these effects extend to the CNS. TNF-alpha mRNA was induced within 2 hr after rat spinal cord transection, and its upregulation was suppressed by a synthetic VIP receptor agonist. Cultured rat microglia were used to examine the mechanisms underlying this inhibition because microglia are the likely source of TNF-alpha in injured CNS. In culture, increases in TNF-alpha mRNA resulting from lipopolysaccharide (LPS) stimulation were reduced significantly by 10(-7) M VIP and completely eliminated by PACAP at the same concentration. TNF-alpha protein levels were reduced 90% by VIP or PACAP at 10(-7) M. An antagonist of VPAC(1) receptors blocked the action of VIP and PACAP, and a PAC(1) antagonist blocked the action of PACAP. A direct demonstration of VIP binding on microglia and the existence of mRNAs for VPAC(1) and PAC(1) (but not VPAC(2)) receptors argue for a receptor-mediated effect. The action of VIP is cAMP-mediated because (1) activation of cAMP by forskolin mimics the action; (2) PKA inhibition by H89 reverses the neuropeptide-induced inhibition; and (3) the lipophilic neuropeptide mimic, stearyl-norleucine(17) VIP (SNV), which does not use a cAMP-mediated pathway, fails to duplicate the inhibition. We conclude that VIP and PACAP inhibit the production of TNF-alpha from activated microglia by a cAMP-dependent pathway.	Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel		Jonakait, GM (corresponding author), Rutgers State Univ, Dept Biol Sci, 101 Warren St, Newark, NJ 07102 USA.		Hart, Ronald/D-5219-2009; Hart, Ronald/G-6530-2019	Hart, Ronald/0000-0003-4836-8712	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI041786, R21AI041786] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [AI 41786-02] Funding Source: Medline		Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; ALBRECHT H, 1995, J INFLAMM, V45, P64; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; BOUDARD F, 1991, J NEUROSCI RES, V29, P29, DOI 10.1002/jnr.490290104; BREDER CD, 1993, J COMP NEUROL, V337, P543, DOI 10.1002/cne.903370403; BREDER CD, 1988, SCIENCE, V240, P321, DOI 10.1126/science.3258444; BRENNEMAN DE, 1985, PEPTIDES, V6, P35, DOI 10.1016/0196-9781(85)90132-9; Bruccoleri A, 1998, J NEUROCHEM, V71, P1577; Campard PK, 1997, DNA CELL BIOL, V16, P323, DOI 10.1089/dna.1997.16.323; CHAO CC, 1995, DEV NEUROSCI-BASEL, V17, P97, DOI 10.1159/000111278; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; CHEEPSUNTHORN P, 1999, SOC NEUR ABSTR, V25; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; de Bock F, 1998, EUR J NEUROSCI, V10, P3107, DOI 10.1046/j.1460-9568.1998.00317.x; Delgado M, 1998, J BIOL CHEM, V273, P31427, DOI 10.1074/jbc.273.47.31427; Delgado M, 1999, J IMMUNOL, V162, P4685; Delgado M, 1999, J IMMUNOL, V162, P2358; Delgado M, 1999, J IMMUNOL, V162, P1707; Delgado M, 1999, J NEUROIMMUNOL, V96, P167, DOI 10.1016/S0165-5728(99)00023-5; Delgado M, 1999, J IMMUNOL, V162, P1200; Dickinson T, 1999, TRENDS PHARMACOL SCI, V20, P324, DOI 10.1016/S0165-6147(99)01340-1; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Goodman Y, 1996, J NEUROCHEM, V66, P869, DOI 10.1046/j.1471-4159.1996.66020869.x; GOZES I, 1995, J PHARMACOL EXP THER, V273, P161; HART RP, 1999, SOC NEUR ABSTR, V25; Haviv R, 1999, J NEUROSCI RES, V55, P269; Hayashi Mito, 1997, Acta Anatomica Nipponica, V72, P209; Hisahara S, 1997, J NEUROCHEM, V69, P10; HYATTSACHS H, 1993, J NEUROSCI, V13, P1642; ICHINOSE M, 1994, REGUL PEPTIDES, V54, P457, DOI 10.1016/0167-0115(94)90543-6; Jonakait GM, 1996, DEV BIOL, V177, P85, DOI 10.1006/dbio.1996.0147; Jongeneel C V, 1994, Prog Clin Biol Res, V388, P367; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; KLIMASCHEWSKI L, 1995, NEUROSCI LETT, V195, P133, DOI 10.1016/0304-3940(95)11799-3; Klimaschewski L, 1996, NEUROSCIENCE, V72, P265, DOI 10.1016/0306-4522(95)00551-X; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Kong LY, 1999, NEUROSCIENCE, V91, P493, DOI 10.1016/S0306-4522(98)00606-X; Lafortune L, 1996, J NEUROPATH EXP NEUR, V55, P515, DOI 10.1097/00005072-199605000-00003; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; LEE SC, 1993, J IMMUNOL, V150, P2659; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Martinez C, 1996, J IMMUNOL, V156, P4128; Martinez C, 1998, J LEUKOCYTE BIOL, V63, P591, DOI 10.1002/jlb.63.5.591; MATTSON MP, 1995, J NEUROSCI RES, V42, P357, DOI 10.1002/jnr.490420310; Moller K, 1997, BRAIN RES, V775, P156, DOI 10.1016/S0006-8993(97)00937-2; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Parry GCN, 1997, J IMMUNOL, V159, P5450; RAO MS, 1993, J NEUROBIOL, V24, P571, DOI 10.1002/neu.480240504; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SCHWARTZ M, 1991, BRAIN RES, V545, P334, DOI 10.1016/0006-8993(91)91309-O; SEBIRE G, 1993, J IMMUNOL, V150, P1517; SELMAJ K, 1991, J NEUROCHEM, V57, P823, DOI 10.1111/j.1471-4159.1991.tb08225.x; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; SHARIF SF, 1993, NEUROL RES, V15, P109; SHEHAB SAS, 1986, BRAIN RES, V372, P37, DOI 10.1016/0006-8993(86)91456-3; SHENG WS, 1995, CLIN DIAGN LAB IMMUN, V2, P604, DOI 10.1128/CDLI.2.5.604-608.1995; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SIRIANNI MC, 1992, REGUL PEPTIDES, V38, P79, DOI 10.1016/0167-0115(92)90074-5; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Sullivan PG, 1999, J NEUROSCI, V19, P6248; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; TANG H, 1995, J INTERF CYTOK RES, V15, P993, DOI 10.1089/jir.1995.15.993; Uno H, 1997, J CEREBR BLOOD F MET, V17, P491, DOI 10.1097/00004647-199705000-00002; Vastag M, 1999, MICROVASC RES, V57, P52, DOI 10.1006/mvre.1998.2115; Viviani B, 1998, TOXICOL APPL PHARM, V150, P271, DOI 10.1006/taap.1998.8406; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Wang HY, 1996, J IMMUNOL, V156, P3243; Wei RT, 1999, J NEUROIMMUNOL, V95, P8, DOI 10.1016/S0165-5728(98)00248-3; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; ZHANG X, 1993, EXP BRAIN RES, V93, P450; Zhang YZ, 1996, NEUROSCIENCE, V74, P1099, DOI 10.1016/S0306-4522(96)00168-6; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou XR, 1999, J NEUROSCI RES, V57, P953, DOI 10.1002/(SICI)1097-4547(19990915)57:6<953::AID-JNR21>3.3.CO;2-I	85	117	122	0	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAY 15	2000	20	10					3622	3630		10.1523/JNEUROSCI.20-10-03622.2000			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	312JK	WOS:000086940000018	10804204	Bronze, Green Published			2022-02-06	
J	Douglas, JM; O'Flaherty, CA; Snow, PC				Douglas, JM; O'Flaherty, CA; Snow, PC			Measuring perception of communicative ability: the development and evaluation of the La Trobe communication questionnaire	APHASIOLOGY			English	Article							TRAUMATIC BRAIN INJURY; CLOSED-HEAD-INJURY; SPEECH STYLE; DEFICITS; ADULTS; RELATIVES; GENDER; ISSUES	The La Trobe communication questionnaire (LCQ) was designed to measure perceived communicative ability. It was developed to enable collection of information from various sources including the self-perceptions of individuals as well as the perceptions of close others. In this paper we report the development of the questionnaire, its psychometric properties and normative data for the perceptions of young adults and the comparative perceptions of their close others. Participants in the study were 256 adults comprising 147 primary subjects and 109 close others. Primary subjects ranged in age from 16-39 years with a mean age of 20.6 years. The 30 item questionnaire was structured using a modified Likert-type scale with four possible levels of response: (1) never or rarely; (2) sometimes; (3) often; and (4) usually or always. Internal consistency was high (Cronbach's alpha = 0.8596) and good stability over time for self-report was demonstrated (r = 0.7558). There was a significant difference (p < 0.0001) between the perceptions of primary subjects and close others with primary subjects perceiving themselves to have more frequent communication difficulties, than did their close others. Overall, our findings suggest that the LCQ is a promising means of measuring perceived communicative ability in young adults.	La Trobe Univ, Sch Human Commun Sci, Melbourne, Vic, Australia		Douglas, JM (corresponding author), La Trobe Univ, Sch Human Commun Sci, Melbourne, Vic, Australia.		Douglas, Jacinta M/C-2380-2009	Snow, Pamela/0000-0002-2426-8349; Douglas, Jacinta/0000-0003-0940-6624			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Anastasi A., 1982, PSYCHOL TESTING; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Chelune GJ, 1986, ADV CLIN NEUROPSYCHO, V3, P95, DOI [10.1007/978-1-4613-2211-5_4, DOI 10.1007/978-1-4613-2211-5_4]; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COMREY AL, 1992, FIRST COURSE FACTOR; CRAWFORD M, 1987, J PSYCHOLINGUIST RES, V16, P83; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Damico J. S., 1985, COMMUNICATION SKILLS, P165; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; DILLER L, 1981, J CONSULT CLIN PSYCH, V49, P822, DOI 10.1037/0022-006X.49.6.822; DOUGLAS J, 1994, THESIS U VICTORIA BR; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Enderby P., 1997, THERAPY OUTCOME MEAS; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FURROW D, 1990, J PSYCHOLINGUIST RES, V19, P375, DOI 10.1007/BF01068885; GILLIES S, 1990, UNPUB PERCEPTIONS CO; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GOLDSTEIN G, 1995, INT J REHABILITATION, V1, P23; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; MARTIN CL, 1990, CHILD DEV, V61, P1891, DOI 10.1111/j.1467-8624.1990.tb03573.x; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCNEILLBROWN D, 1997, INT PERSPECTIVES TRA, P247; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; RUBIN DL, 1983, LANG SPEECH, V26, P273, DOI 10.1177/002383098302600308; Selltiz C, 1976, RES METHODS SOCIAL R; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; SNOW P, 1999, 22 ANN BRAIN IMP C S; Spender D., 1981, MAN MADE LANGUAGE; STRAHAN R, 1972, J CLIN PSYCHOL, V28, P191, DOI 10.1002/1097-4679(197204)28:2<191::AID-JCLP2270280220>3.0.CO;2-G; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TANNER DC, 1988, APHASIOLOGY, V2, P79; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002	43	117	119	0	16	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	MAR	2000	14	3					251	268		10.1080/026870300401469			18	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	294DV	WOS:000085896800002					2022-02-06	
J	Fleming, J; Tooth, L; Hassell, M; Chan, W				Fleming, J; Tooth, L; Hassell, M; Chan, W			Prediction of community integration and vocational outcome 2-5 years after traumatic brain injury rehabilitation in Australia	BRAIN INJURY			English	Article							DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; MULTICENTER ANALYSIS; FUNCTIONAL OUTCOMES; RECOVERY; RETURN; WORK; PROGNOSIS; MODERATE; VALIDITY	Objectives: To predict community integration and vocational outcomes 2-5 years after traumatic brain injury (TBI). Design: Multivariate correlational design incorporating retrospective data collection and questionnaire follow-up. Methods: Four hundred and forty six patients admitted to a Head Injury Unit between 1991 and 1995 were contacted. Data on predictor variables (demographic, injury severity and functional) were retrieved from hospital records. Community integration and vocational outcome was assessed by self-administered questionnaire. Two hundred and nine patients/carers completed and returned the questionnaires. Mean follow-up was 3.5 years. Data were analysed by descriptive statistics, multiple regression and discriminant analysis using SPSS. Results: Community integration was predicted by age, disability level and cognition. Length of PTA, cognition, disability levels, GCS, functional status, length of acute stay and prior occupation discriminated those who returned to work. A total of 46.5% returned to work with 74.5% in the same or similar jobs. Conclusion: Long term outcomes post-TBI can be predicted by demographic, injury severity and functional status variables.	Univ Queensland, Dept Occupat Therapy, Brisbane, Qld 4072, Australia; Princess Alexandra Hosp, Brisbane, Qld 4102, Australia		Fleming, J (corresponding author), Univ Queensland, Dept Occupat Therapy, Brisbane, Qld 4072, Australia.		Tooth, Leigh/F-2769-2010; Fleming, Jennifer M/B-4436-2011	Tooth, Leigh/0000-0002-1569-934X			*AUSTR BUR STAT, 1990, ASCO OCC DEF AUSTR C; BARRY P, 1989, ARCH PHYS MED REHAB, V70, P902; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cohen J., 1983, APPL MULTIPLE REGRES; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; CREPEAU F, 1993, NEUROPSYCHOLOGICAL R, V4, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EAMES P, 1995, BRAIN INJURY, V10, P631; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Fleming JM, 1997, J HEAD TRAUMA REHAB, V12, P27, DOI 10.1097/00001199-199706000-00004; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Johnson R, 1987, Int Disabil Stud, V9, P49; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; *LAF INSTR COMP IN, LAF GROOV PEGB; MAHONEY F I, 1965, Md State Med J, V14, P61; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Millis S R, 1994, Int J Neurosci, V79, P165; NAJMAN JM, 1991, AUST NZ J SOCIOL, V27, P218; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; ROSENTHAL M, 1990, REHABILITATION ADULT, P516; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; TEASDALE G, 1974, LANCET, V2, P81; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; WILSON B, 1991, RIVENNEAD BEHAV MEMO	48	117	119	0	17	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1999	13	6					417	431					15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	204DA	WOS:000080746600003	10401543				2022-02-06	
J	MCDONALD, S				MCDONALD, S			PRAGMATIC LANGUAGE-SKILLS AFTER CLOSED HEAD-INJURY - ABILITY TO MEET THE INFORMATIONAL NEEDS OF THE LISTENER	BRAIN AND LANGUAGE			English	Article							VERBAL IMPAIRMENT; DISCOURSE; APHASIA				MCDONALD, S (corresponding author), LIDCOMBE HOSP, DEPT NEUROPSYCHOL, JOSEPH ST, LIDCOMBE, NSW 2141, AUSTRALIA.		McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094			ARMSTRONG E, 1987, CLIN APHASIOLOGY, V17, P210; BRAUN CMJ, 1987, CLIN APHASIOLOGY, V17, P326; Cronbach L.J., 1972, DEPENDABILITY BEHAVI; DEANE A, 1987, THESIS MACQUARIE U S; Edgington E. S., 1980, RANDOMIZATION TESTS; FLAVELL JH, 1975, DEV ROLE TAKING COMM; Flood J., 1984, UNDERSTANDING READIN; Grice H.P., 1978, SYNTAX SEMANTICS, V9; Halliday M. A. K., 1985, INTRO FUNCTIONAL GRA; Halliday Michael Alexander Kirkwood, 1989, LANGUAGE CONTEXT TEX; Hasan Ruqaiya, 1985, LANGUAGE CONTEXT TEX; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HOLLAND AL, 1984, CLIN APHASIOLOGY, V14, P345; KERTESZ A, 1981, W APHASIA BATTERY; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Milton S. B., 1984, CLIN APHASIOLOGY, V14, P114; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; ROLLINS J, 1987, LANGUAGE HEAD INJURY; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1988, SCAND J REHABIL MED, P55; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SNOW P, 1986, BRAIN IMPAIRMENT; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; ULATOWSKA HK, 1983, BRAIN LANG, V19, P317, DOI 10.1016/0093-934X(83)90074-3; Walsh K. W., 1985, UNDERSTANDING BRAIN	32	117	121	2	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	JAN	1993	44	1					28	46		10.1006/brln.1993.1003			19	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	KK455	WOS:A1993KK45500003	8467376				2022-02-06	
J	LEVIN, HS; SAYDJARI, C; EISENBERG, HM; FOULKES, M; MARSHALL, LF; RUFF, RM; JANE, JA; MARMAROU, A				LEVIN, HS; SAYDJARI, C; EISENBERG, HM; FOULKES, M; MARSHALL, LF; RUFF, RM; JANE, JA; MARMAROU, A			VEGETATIVE STATE AFTER CLOSED-HEAD INJURY - A TRAUMATIC COMA DATA-BANK REPORT	ARCHIVES OF NEUROLOGY			English	Article							IMPAIRED CONSCIOUSNESS; PROGNOSIS	To elucidate the clinical course of the vegetative state after severe closed-head injury, the Traumatic Coma Data Bank was analyzed for outcome at the time of discharge from the hospital and after follow-up intervals ranging up to 3 years after injury. Of 650 patients with closed-head injury available for analysis, 93 (14%) were discharged in a vegetative state. In comparison with conscious survivors, patients in a vegetative state sustained more severe closed-head injury as reflected by the Glasgow Coma Scale scores and pupillary findings and more frequently had diffuse injury complicated by swelling or shift in midline structures. Of 84 patients in a vegetative state who provided follow-up data, 41% became conscious by 6 months, 52% regained consciousness by 1 year, and 58% recovered consciousness within the 3-year follow-up interval. A logistic regression failed to identify predictors of recovery from the vegetative state.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROSURG,RICHMOND,VA 23298; UNIV CALIF SAN DIEGO,DIV NEUROSURG,LA JOLLA,CA 92093; UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550; NIH,OFF BIOMETRY,BETHESDA,MD 20892; UNIV VIRGINIA,DEPT NEUROSURG,CHARLOTTESVILLE,VA 22903						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01NS032341, N01NS032339, N01NS032340] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [N01-NS-3-2340, N01-NS-3-2341, N01-NS-3-2339] Funding Source: Medline		BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEASDALE G, 1974, LANCET, V2, P81	14	117	123	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	JUN	1991	48	6					580	585		10.1001/archneur.1991.00530180032013			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FP881	WOS:A1991FP88100006	2039378				2022-02-06	
J	Harting, MT; Srivastava, AK; Zhaorigetu, S; Bair, H; Prabhakara, KS; Furman, NET; Vykoukal, JV; Ruppert, KA; Cox, CS; Olson, SD				Harting, Matthew T.; Srivastava, Amit K.; Zhaorigetu, Siqin; Bair, Henry; Prabhakara, Karthik S.; Furman, Naama E. Toledano; Vykoukal, Jody V.; Ruppert, Katherine A.; Cox, Charles S., Jr.; Olson, Scott D.			Inflammation-Stimulated Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Inflammation	STEM CELLS			English	Article						Mesenchymal stromal cells; Mesenchymal stem cells; Extracellular vesicles; Exosomes; Microvesicles; Inflammation; Current good manufacturing practices	TRAUMATIC BRAIN-INJURY; LONG NONCODING RNAS; STEM-CELLS; EXOSOMES; MICROVESICLES; MICRORNAS; COMMUNICATION; MACROPHAGES; ACTIVATION; MECHANISM	Extracellular vesicles (EVs) secreted by mesenchymal stromal cells (MSCs) have been proposed to be a key mechanistic link in the therapeutic efficacy of cells in response to cellular injuries through paracrine effects. We hypothesize that inflammatory stimulation of MSCs results in the release of EVs that have greater anti-inflammatory effects. The present study evaluates the immunomodulatory abilities of EVs derived from inflammation-stimulated and naive MSCs (MSCEv(+) and MSCEv, respectively) isolated using a current Good Manufacturing Practice-compliant tangential flow filtration system. Detailed characterization of both EVs revealed differences in protein composition, cytokine profiles, and RNA content, despite similarities in size and expression of common surface markers. MSCEv(+) further attenuated release of pro-inflammatory cytokines in vitro when compared to MSCEv, with a distinctly different pattern of EV-uptake by activated primary leukocyte subpopulations. The efficacy of EVs was partially attributed to COX2/PGE(2) expression. The present study demonstrates that inflammatory stimulation of MSCs renders release of EVs that have enhanced anti-inflammatory properties partially due to COX2/PGE(2) pathway alteration.	[Harting, Matthew T.; Srivastava, Amit K.; Zhaorigetu, Siqin; Bair, Henry; Prabhakara, Karthik S.; Furman, Naama E. Toledano; Ruppert, Katherine A.; Cox, Charles S., Jr.; Olson, Scott D.] Univ Texas Houston, McGovern Med Sch, Dept Pediat Surg, 6431 Fannin St,MSB 5-233, Houston, TX 77030 USA; [Vykoukal, Jody V.] Univ Texas MD Anderson Canc Ctr, McCombs Inst Early Detect & Treatment Canc, Houston, TX 77030 USA		Harting, MT (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Pediat Surg, 6431 Fannin St,MSB 5-233, Houston, TX 77030 USA.	matthew.t.harting@uth.tmc.edu	Srivastava, Amit/L-7019-2019	Srivastava, Amit/0000-0001-7554-7201; Harting, Matthew/0000-0002-8929-8311; Bair, Henry/0000-0002-3422-0373; Olson, Scott/0000-0001-8032-3755	Center for Clinical and Translational Sciences Training Award, University of Texas McGovern Medical School [5KL2-TR000370-10]; Ladybug; Glassell Family Stem Cell Research Fund; Ansh Labs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000370] Funding Source: NIH RePORTER	This study was supported by grants Center for Clinical and Translational Sciences Training Award, University of Texas McGovern Medical School (5KL2-TR000370-10) (M.T.H.); Ladybug (C.S.C. and M.T.H.); Glassell Family Stem Cell Research Fund. We acknowledge Ansh Labs support with Activin-A, follistatin, and PAPP-A2 assays.	Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Butler J, 2017, CIRC RES, V120, P332, DOI 10.1161/CIRCRESAHA.116.309717; Camussi G, 2013, BIOCHEM SOC T, V41, P283, DOI 10.1042/BST20120192; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; Cruz FF, 2015, STEM CELL TRANSL MED, V4, P1302, DOI 10.5966/sctm.2014-0280; Deng ZB, 2013, J IMMUNOL, V190, P3579, DOI 10.4049/jimmunol.1203170; Elling R, 2016, EUR J IMMUNOL, V46, P504, DOI 10.1002/eji.201444558; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gamez-Valero A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33641; Gardiner C, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32945; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Heinemann ML, 2014, J CHROMATOGR A, V1371, P125, DOI 10.1016/j.chroma.2014.10.026; Heward JA, 2014, TRENDS IMMUNOL, V35, P408, DOI 10.1016/j.it.2014.07.005; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Katakowski M, 2016, CELL MOL NEUROBIOL, V36, P343, DOI 10.1007/s10571-015-0280-9; Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373; Kim CW, 2002, CANCER RES, V62, P6312; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Koniusz S, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00109; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kota DJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04565; Lai Ruenn Chai, 2012, Int J Proteomics, V2012, P971907, DOI 10.1155/2012/971907; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Lee HD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35250; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; Liu J, 2016, STEM CELLS, V34, P2943, DOI 10.1002/stem.2448; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Mao XH, 2017, IMMUNOLOGY, V150, P379, DOI 10.1111/imm.12698; Nakai W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33935; Njock MS, 2015, BLOOD, V125, P3202, DOI 10.1182/blood-2014-11-611046; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Ropper AE, 2017, P NATL ACAD SCI USA, V114, pE820, DOI 10.1073/pnas.1616340114; Schageman J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/253957; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Silva AM, 2017, EUR J PHARM SCI, V98, P86, DOI 10.1016/j.ejps.2016.09.017; Srivastava AK, 2016, EXP NEUROL, V275, P154, DOI 10.1016/j.expneurol.2015.10.008; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Ti DD, 2016, SCI CHINA LIFE SCI, V59, P1305, DOI 10.1007/s11427-016-0240-4; Ti DD, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0642-6; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140551; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Zhou Y, 2016, AM J PHYSIOL-RENAL, V310, pF27, DOI 10.1152/ajprenal.00303.2015	56	116	121	3	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1066-5099	1549-4918		STEM CELLS	Stem Cells	JAN	2018	36	1					79	90		10.1002/stem.2730			12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Oncology; Cell Biology; Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology	FR3CB	WOS:000418942500009	29076623	Bronze			2022-02-06	
J	Mckee, CA; Lukens, JR				Mckee, Celia A.; Lukens, John R.			Emerging Roles for the Immune System in Traumatic Brain Injury	FRONTIERS IN IMMUNOLOGY			English	Article						traumatic brain injury; neuroinflammation; cytokine; inflammasome; innate immunology; neuroprotection; microglia; neurodegeneration	TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; AMYLOID PROTEIN DEPOSITION; CONTROLLED CORTICAL IMPACT; COLONY-STIMULATING FACTOR; NEURONAL CELL-DEATH; CLOSED-HEAD INJURY; INFLAMMATORY RESPONSE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID	Traumatic brain injury (TBI) affects an ever-growing population of all ages with long-term consequences on health and cognition. Many of the issues that TBI patients face are thought to be mediated by the immune system. Primary brain damage that occurs at the time of injury can be exacerbated and prolonged for months or even years by chronic inflammatory processes, which can ultimately lead to secondary cell death, neurodegeneration, and long-lasting neurological impairment. Researchers have turned to rodent models of TBI in order to understand how inflammatory cells and immunological signaling regulate the post-injury response and recovery mechanisms. In addition, the development of numerous methods to manipulate genes involved in inflammation has recently expanded the possibilities of investigating the immune response in TBI models. As results from these studies accumulate, scientists have started to link cells and signaling pathways to pro-and anti-inflammatory processes that may contribute beneficial or detrimental effects to the injured brain. Moreover, emerging data suggest that targeting aspects of the immune response may offer promising strategies to treat TBI. This review will cover insights gained from studies that approach TBI research from an immunological perspective and will summarize our current understanding of the involvement of specific immune cell types and cytokines in TBI pathogenesis.	[Mckee, Celia A.; Lukens, John R.] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA		Lukens, JR (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA.	jrl7n@virginia.edu		McKee, Celia/0000-0002-5271-7877; Lukens, John/0000-0002-6795-0866	Owens Family Foundation; University of Virginia Research and Development Committee Award	The authors apologize to authors whose work could not be referenced in this review due to space limitations. The authors also thank members of the Lukens Lab for their valuable comments on the manuscript. This work was supported by the Owens Family Foundation (JL) and the University of Virginia Research and Development Committee Award (JL).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; [Anonymous], 2012, LANCET NEUROL, V11, P651, DOI 10.1016/S1474-4422(12)70166-7; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chio CC, 2014, J NEUROCHEM, V131, P816, DOI 10.1111/jnc.12971; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Ellwardt E, 2016, TRENDS IMMUNOL, V37, P154, DOI 10.1016/j.it.2015.12.008; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feng L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0409-2; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Frieler RA, 2015, BRAIN RES, V1624, P103, DOI 10.1016/j.brainres.2015.07.011; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gustin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130624; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jones KJ, 2015, J NEUROIMMUNE PHARM, V10, P587, DOI 10.1007/s11481-015-9625-x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu YQ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-141; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Lukens John R, 2014, Rare Dis, V2, pe27742, DOI 10.4161/rdis.27742; Lukens JR, 2014, SEMIN IMMUNOPATHOL, V36, P595, DOI 10.1007/s00281-014-0434-8; Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Lunny CA, 2014, J NEUROL SCI, V336, P13, DOI 10.1016/j.jns.2013.08.011; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mencl S, 2014, J NEUROIMMUNOL, V274, P125, DOI 10.1016/j.jneuroim.2014.07.010; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Ramirez K, 2016, CURRENT TOPICS BEHAV, P1; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Schwarzmaier SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00358; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Soares HD, 1995, J NEUROSCI, V15, P8223; Song SJ, 2016, J NEUROSCI RES, V94, P409, DOI 10.1002/jnr.23714; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Taylor JM, 2014, NEUROBIOL AGING, V35, P1012, DOI 10.1016/j.neurobiolaging.2013.10.089; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Van Cauwenberghe C, 2016, GENET MED, V18, P421, DOI 10.1038/gim.2015.117; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang RG, 2011, GLIA, V59, P946, DOI 10.1002/glia.21167; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Warren SA, 2013, CAN J NEUROL SCI, V40, P168, DOI 10.1017/S0317167100013688; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	168	116	127	0	28	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	DEC 5	2016	7								556	10.3389/fimmu.2016.00556			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ED8XR	WOS:000389154700001	27994591	gold, Green Published			2022-02-06	
J	Schallner, N; Pandit, R; LeBlanc, R; Thomas, AJ; Ogilvy, CS; Zuckerbraun, BS; Gallo, D; Otterbein, LE; Hanafy, KA				Schallner, Nils; Pandit, Rambhau; LeBlanc, Robert, III; Thomas, Ajith J.; Ogilvy, Christopher S.; Zuckerbraun, Brian S.; Gallo, David; Otterbein, Leo E.; Hanafy, Khalid A.			Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1	JOURNAL OF CLINICAL INVESTIGATION			English	Article							TRAUMATIC BRAIN-INJURY; FRACTALKINE RECEPTOR CX(3)CR1; CARBON-MONOXIDE PROTECTS; RAT-BRAIN; OXIDATIVE STRESS; LUNG INJURY; PHARMACOLOGICAL INDUCTION; INTRACEREBRAL HEMORRHAGE; INFLAMMATORY RESPONSE; PROVIDES PROTECTION	Subarachnoid hemorrhage (SAH) carries a 50% mortality rate. The extravasated erythrocytes that surround the brain contain heme, which, when released from damaged red blood cells, functions as a potent danger molecule that induces sterile tissue injury and organ dysfunction. Free heme is metabolized by heme oxygenase (HO), resulting in the generation of carbon monoxide (CO), a bioactive gas with potent immunomodulatory capabilities. Here, using a murine model of SAH, we demonstrated that expression of the inducible HO isoform (HO-1, encoded by Hmox1) in microglia is necessary to attenuate neuronal cell death, vasospasm, impaired cognitive function, and clearance of cerebral blood burden. Initiation of CO inhalation after SAH rescued the absence of microglial HO-land reduced injury by enhancing erythrophagocytosis. Evaluation of correlative human data revealed that patients with SAH have markedly higher HO-1 activity in cerebrospinal fluid (CSF) compared with that in patients with unruptured cerebral aneurysms. Furthermore, cisternal hematoma volume correlated with HO-1 activity and cytokine expression in the CSF of these patients. Collectively, we found that microglial HO-1 and the generation of CO are essential for effective elimination of blood and heme after SAH that otherwise leads to neuronal injury and cognitive dysfunction. Administration of CO may have potential as a therapeutic modality in patients with ruptured cerebral aneurysms.	[Schallner, Nils; Thomas, Ajith J.; Ogilvy, Christopher S.; Gallo, David; Otterbein, Leo E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02140 USA; [Schallner, Nils] Univ Med Ctr Freiburg, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Pandit, Rambhau; LeBlanc, Robert, III; Hanafy, Khalid A.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02140 USA; [Zuckerbraun, Brian S.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Otterbein, Leo E.] Aston Univ, Birmingham B4 7ET, W Midlands, England		Hanafy, KA (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Neurointens Care Med,Neurol, 3 Blackfan Circle, Boston, MA 02140 USA.	khanafy@bidmc.harvard.edu	Thomas, Ajith/AAX-9054-2020	Thomas, Ajith/0000-0003-4412-3152	VAUS Department of Veterans Affairs [1I01BX000566-01] Funding Source: Federal RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL076167, R01 HL071797, HL-076167, HL-071797] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM082830] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS078048, K08 NS078048] Funding Source: Medline; BLRD VA [I01 BX000566] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071797, R01HL076167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM082830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS078048] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000566] Funding Source: NIH RePORTER		Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Almeida AS, 2012, J BIOL CHEM, V287, P10761, DOI 10.1074/jbc.M111.306738; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; Beck K, 2010, CIRC RES, V107, P1490, DOI 10.1161/CIRCRESAHA.110.231985; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Boscia F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006486; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Chang EF, 2003, J NEUROSCI, V23, P3689; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Foresti R, 2013, PHARMACOL RES, V76, P132, DOI 10.1016/j.phrs.2013.07.010; Foussat A, 2000, EUR J IMMUNOL, V30, P87, DOI 10.1002/1521-4141(200001)30:1<87::AID-IMMU87>3.3.CO;2-Z; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Goebel U, 2008, ANESTHESIOLOGY, V108, P1025, DOI 10.1097/ALN.0b013e3181733115; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; HIJDRA A, 1986, NEUROLOGY, V36, P329, DOI 10.1212/WNL.36.3.329; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; King JT, 1997, NEUROIMAG CLIN N AM, V7, P659; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kuroki M, 1998, STROKE, V29, P683, DOI 10.1161/01.STR.29.3.683; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin QS, 2008, FREE RADICAL BIO MED, V44, P847, DOI 10.1016/j.freeradbiomed.2007.11.012; Liu YQ, 2013, NEUROREPORT, V24, P281, DOI 10.1097/WNR.0b013e32835f2810; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Matz P, 1996, BRAIN RES, V713, P211, DOI 10.1016/0006-8993(95)01511-6; Matz PG, 1997, NEUROSURGERY, V40, P152, DOI 10.1097/00006123-199701000-00034; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Montero M, 2009, BRAIN RES, V1291, P140, DOI 10.1016/j.brainres.2009.06.097; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakaso K, 2000, NEUROSCI LETT, V293, P49, DOI 10.1016/S0304-3940(00)01491-9; Ogawa T, 2011, J CEREBR BLOOD F MET, V31, P2231, DOI 10.1038/jcbfm.2011.87; Otterbein LE, 1999, J CLIN INVEST, V103, P1047, DOI 10.1172/JCI5342; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosengart AJ, 2007, J NEUROSURG, V107, P253, DOI 10.3171/JNS-07/08/0253; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Saleem S, 2008, STROKE, V39, P3389, DOI 10.1161/STROKEAHA.108.523480; Shimada Y, 2009, EUR J PHARMACOL, V620, P16, DOI 10.1016/j.ejphar.2009.08.009; Smith A, 2013, CLIN CHIM ACTA, V424, P231, DOI 10.1016/j.cca.2013.06.017; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; Soulet D, 2008, CURR OPIN PHARMACOL, V8, P508, DOI 10.1016/j.coph.2008.04.002; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; Sutherland BA, 2009, NEUROSCI RES, V65, P326, DOI 10.1016/j.neures.2009.08.007; Takeda A, 1996, NEUROSCI LETT, V205, P169, DOI 10.1016/0304-3940(96)12405-8; Tayem Y, 2014, PHARMACOL RES, V81, P1, DOI 10.1016/j.phrs.2014.01.001; Tong N, 2000, J IMMUNOL, V164, P1333, DOI 10.4049/jimmunol.164.3.1333; Turner CP, 1999, MOL BRAIN RES, V65, P87, DOI 10.1016/S0169-328X(98)00340-4; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wang HQ, 2012, NEUROTOX RES, V21, P368, DOI 10.1007/s12640-011-9292-5; Wegiel B, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.97; Wegiel B, 2014, ANTIOXID REDOX SIGN, V20, P1709, DOI 10.1089/ars.2013.5667; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zhang F, 2012, STROKE, V43, P1390, DOI 10.1161/STROKEAHA.111.647420; Zhang XC, 2003, J BIOL CHEM, V278, P22061, DOI 10.1074/jbc.M301858200; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zuckerbraun BS, 2003, J EXP MED, V198, P1707, DOI 10.1084/jem.20031003	75	116	121	0	8	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	JUL	2015	125	7					2609	2625		10.1172/JCI78443			17	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CM3AK	WOS:000357553300011	26011640	Green Accepted, Green Published			2022-02-06	
J	Weissberg, I; Wood, L; Kamintsky, L; Vazquez, O; Milikovsky, DZ; Alexander, A; Oppenheim, H; Ardizzone, C; Becker, A; Frigerio, F; Vezzani, A; Buckwalter, MS; Huguenard, JR; Friedman, A; Kaufer, D				Weissberg, Itai; Wood, Lydia; Kamintsky, Lyn; Vazquez, Oscar; Milikovsky, Dan Z.; Alexander, Allyson; Oppenheim, Hannah; Ardizzone, Carolyn; Becker, Albert; Frigerio, Federica; Vezzani, Annamaria; Buckwalter, Marion S.; Huguenard, John R.; Friedman, Alon; Kaufer, Daniela			Albumin induces excitatory synaptogenesis through astrocytic TGF-beta/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction	NEUROBIOLOGY OF DISEASE			English	Article						Epilepsy; Albumin; TGF-beta; Synaptogenesis; Blood-brain barrier (BBB); Seizures; Astrocytes; Post-insult epilepsy (PIE); Post-traumatic epilepsy (PIE); ALK5	KAINIC ACID; TGF-BETA; SYNAPTIC CONNECTIVITY; FUNCTIONAL RECOVERY; CNS SYNAPTOGENESIS; SECRETED PROTEINS; VASCULAR CHANGES; CEREBRAL-CORTEX; AMPA RECEPTORS; EPILEPTOGENESIS	Post-injury epilepsy (PIE) is a common complication following brain insults, including ischemic, and traumatic brain injuries. At present, there are no means to identify the patients at risk to develop PIE or to prevent its development. Seizures can occur months or years after the insult, do not respond to anti-seizure medications in over third of the patients, and are often associated with significant neuropsychiatric morbidities. We have previously established the critical role of blood-brain barrier dysfunction in PIE, demonstrating that exposure of brain tissue to extravasated serum albumin induces activation of inflammatory transforming growth factor beta (TGF-beta) signaling in astrocytes and eventually seizures. However, the link between the acute astrocytic inflammatory responses and reorganization of neural networks that underlie recurrent spontaneous seizures remains unknown. Here we demonstrate in vitro and in vivo that activation of the astrocytic ALK5/MF+beta-pathway induces excitatory, but not inhibitory, synaptogenesis that precedes the appearance of seizures. Moreover, we show that treatment with SJN2511, a specific ALK5/TGF-beta inhibitor, prevents synaptogenesis and epilepsy. Our findings point to astrocyte-mediated synaptogenesis as a key epileptogenic process and highlight the manipulation of the TGF-beta-pathway as a potential strategy for the prevention of PIE. (C) 2015 Elsevier Inc. All rights reserved.	[Weissberg, Itai; Kamintsky, Lyn; Milikovsky, Dan Z.; Friedman, Alon] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Weissberg, Itai; Kamintsky, Lyn; Milikovsky, Dan Z.; Friedman, Alon] Ben Gurion Univ Negev, Dept Cognit & Brain Sci, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Wood, Lydia; Oppenheim, Hannah; Ardizzone, Carolyn; Kaufer, Daniela] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Vazquez, Oscar; Kaufer, Daniela] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Alexander, Allyson; Buckwalter, Marion S.; Huguenard, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Becker, Albert] Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; [Frigerio, Federica; Vezzani, Annamaria] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy; [Kaufer, Daniela] Canadian Inst Adv Res CIFAR, Program Child & Brain Dev, Toronto, ON M5G 1Z8, Canada		Friedman, A (corresponding author), Ben Gurion Univ Negev, POB 653, IL-8410501 Beer Sheva, Israel.	alonf@bgu.ac.il; danielak@berkeley.edu	Alexander, Allyson Laura/AAB-5568-2022; Becker, Albert J/F-6248-2012; Vezzani, Annamaria/AAB-1882-2020; Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Vezzani, Annamaria/0000-0003-0573-6175; Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Buckwalter, Marion/0000-0003-2807-2447; Weissberg, Itai/0000-0002-5513-1599; Kamintsky, Lyna/0000-0001-6776-0969; Milikovsky, Dan Z/0000-0002-4826-5273	European UnionEuropean Commission [602102]; Israel Science FoundationIsrael Science Foundation [713/11]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1/NINDS NS066005]; German Science Foundation (DFG)German Research Foundation (DFG) [SFB TR3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066005, R01NS067132, R01NS090911] Funding Source: NIH RePORTER	The research leading to these results has received funding from the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no.602102 (EPITARGET, AF), the Israel Science Foundation (713/11, AF), the National Institute of Health (RO1/NINDS NS066005, DK, AF), and the German Science Foundation (DFG-SFB TR3, AF).	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Aronica E, 2008, NEUROSCIENCE, V151, P272, DOI 10.1016/j.neuroscience.2007.10.036; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Braganza O, 2012, EPILEPSIA, V53, P1898, DOI 10.1111/j.1528-1167.2012.03665.x; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Cekanaviciute E, 2014, GLIA, V62, P1227, DOI 10.1002/glia.22675; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2012, CURR OPIN NEUROBIOL, V22, P438, DOI 10.1016/j.conb.2011.10.003; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Crawford DC, 2012, J NEUROSCI, V32, P13100, DOI 10.1523/JNEUROSCI.2604-12.2012; Crunelli V., 2014, NEUROSCIENTIST; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; deLanerolle N. C., 2012, JASPERS BASIC MECH E; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Diniz L.P., 2014, GLIA; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; Elmariah SB, 2005, J NEUROSCI, V25, P3638, DOI 10.1523/JNEUROSCI.3980-04.2005; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Friedman A., 2012, JASPERS BASIC MECH E; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Frigerio F, 2012, EPILEPSIA, V53, P1887, DOI 10.1111/j.1528-1167.2012.03666.x; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kaya M, 2012, EPILEPSIA, V53, P31, DOI 10.1111/j.1528-1167.2012.03700.x; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lapilover EG, 2012, NEUROBIOL DIS, V48, P495, DOI 10.1016/j.nbd.2012.06.024; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Li LY, 2013, J MOL NEUROSCI, V50, P109, DOI 10.1007/s12031-012-9879-1; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2014, TRENDS NEUROSCI, V37, P55, DOI 10.1016/j.tins.2013.11.002; Marco P, 1997, EXP BRAIN RES, V114, P1, DOI 10.1007/PL00005608; Marcon J, 2009, NEUROBIOL DIS, V34, P121, DOI 10.1016/j.nbd.2008.12.018; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; NUSSER Z, 1995, EUR J NEUROSCI, V7, P630, DOI 10.1111/j.1460-9568.1995.tb00667.x; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; PONT F, 1995, NEUROSCI LETT, V184, P52, DOI 10.1016/0304-3940(94)11166-G; Raabe A, 2012, EPILEPSIA, V53, P539, DOI 10.1111/j.1528-1167.2012.03405.x; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; RUTH RE, 1984, EPILEPSIA, V25, P259, DOI 10.1111/j.1528-1157.1984.tb04185.x; SAIJA A, 1992, LIFE SCI, V51, P467, DOI 10.1016/0024-3205(92)90023-I; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schmitz AK, 2013, SEIZURE-EUR J EPILEP, V22, P144, DOI 10.1016/j.seizure.2012.10.014; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Tomkins O, 2001, CELL MOL NEUROBIOL, V21, P675, DOI 10.1023/A:1015147920283; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2014, NEUROBIOL DIS, V63, P74, DOI 10.1016/j.nbd.2013.11.019; Vezzani A, 2011, BRAIN BEHAV IMMUN, V25, P1281, DOI 10.1016/j.bbi.2011.03.018; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Viviani B, 2003, J NEUROSCI, V23, P8692; Yu C-V., 2014, NERUOMOL MED; ZUCKER DK, 1983, EXP NEUROL, V79, P422, DOI 10.1016/0014-4886(83)90223-6	68	116	116	0	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUN	2015	78						115	125		10.1016/j.nbd.2015.02.029			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI0IH	WOS:000354419800012	25836421	Green Accepted			2022-02-06	
J	Grayson, B; Leger, M; Piercy, C; Adamson, L; Harte, M; Neill, JC				Grayson, Ben; Leger, Marianne; Piercy, Chloe; Adamson, Lisa; Harte, Michael; Neill, Joanna C.			Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents	BEHAVIOURAL BRAIN RESEARCH			English	Article						Object recognition; Alzheimer's disease; Schizophrenia; Parkinson's disease; Autistic spectrum disorder; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; HIPPOCAMPAL CELL-PROLIFERATION; PRENATAL IMMUNE ACTIVATION; ENVIRONMENTAL RISK-FACTORS; ALZHEIMERS-DISEASE; MEMORY DEFICITS; PARKINSONS-DISEASE; VISUAL RECOGNITION	The novel object recognition test (NOR) test is a two trial cognitive paradigm that assesses recognition memory. Recognition memory is disturbed in a range of human disorders and NOR is widely used in rodents for investigating deficits in a variety of animal models of human conditions where cognition is impaired. It possesses several advantages over more complex tasks that involve lengthy training procedures and/or food or water deprivation. It is quick to administer, non-rewarded, provides data quickly, cost effective and most importantly, ethologically relevant as it relies on the animal's natural preference for novelty. A PubMed search revealed over 900 publications in rats and mice using this task over the past 3 years with 34 reviews in the past 10 years, demonstrating its increasing popularity with neuroscientists. Although it is widely used in many disparate areas of research, no articles have systematically examined this to date, which is the subject of our review. We reveal that NOR may be used to study recognition memory deficits that occur in Alzheimer's disease and schizophrenia, where research is extensive, in Parkinson's disease and Autism Spectrum Disorders (ASD) where we observed markedly reduced numbers of publications. In addition, we review the use of NOR to study cognitive deficits induced by traumatic brain injury and cancer chemotherapy, not disorders per se, but situations in which cognitive deficits dramatically reduce the quality of life for those affected, see Fig. 1 for a summary. Our review reveals that, in all these animal models, the NOR test is extremely useful for identification of the cognitive deficits observed, their neural basis, and for testing the efficacy of novel therapeutic agents. Our conclusion is that NOR is of considerable value for cognitive researchers of all disciplines and we anticipate that its use will continue to increase due to its versatility and several other advantages, as detailed in this review. (C) 2014 Elsevier B.V. All rights reserved.	[Grayson, Ben; Leger, Marianne; Piercy, Chloe; Adamson, Lisa; Harte, Michael; Neill, Joanna C.] Univ Manchester, Manchester Pharm Sch, Manchester M13 9PT, Lancs, England		Grayson, B (corresponding author), Univ Manchester, Manchester Pharm Sch, Manchester M13 9PT, Lancs, England.	Ben.grayson@manchester.ac.uk; Joanna.neill@manchester.ac.uk	neill, joanna c/L-5155-2016	neill, joanna c/0000-0002-2717-9739; Leger, Marianne/0000-0002-7811-8522; Harte, Michael/0000-0002-4702-4785			Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adler BL, 2014, NEUROBIOL AGING, V35, P793, DOI 10.1016/j.neurobiolaging.2013.10.076; Vilatela MEA, 2012, ARCH MED RES, V43, P622, DOI 10.1016/j.arcmed.2012.10.017; Ambree O, 2009, NEUROBIOL AGING, V30, P1192, DOI 10.1016/j.neurobiolaging.2007.11.010; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; ARITA I, 1990, CARCINOGENESIS, V11, P1733, DOI 10.1093/carcin/11.10.1733; Bardgett ME, 2011, NEUROBIOL LEARN MEM, V95, P64, DOI 10.1016/j.nlm.2010.10.008; Benito-Leon J, 2011, J NEUROL SCI, V310, P176, DOI 10.1016/j.jns.2011.06.054; Berlyne DE, 1950, B J PSYCHOL-GEN SECT, V41, P68, DOI 10.1111/j.2044-8295.1950.tb00262.x; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bisen-Hersh EB, 2013, CLIN CANCER RES, V19, P3008, DOI 10.1158/1078-0432.CCR-12-3764; Brown MW, 2012, NEUROPSYCHOLOGIA, V50, P3122, DOI 10.1016/j.neuropsychologia.2012.07.034; Capurro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056870; Chao OYH, 2013, EXP NEUROL, V247, P373, DOI 10.1016/j.expneurol.2013.01.003; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Cheng D, 2014, BEHAV BRAIN RES, V260, P111, DOI 10.1016/j.bbr.2013.11.046; Christensen TO, 2007, INT J PSYCHIAT CLIN, V11, P89, DOI 10.1080/13651500600969061; D'Agostino G, 2012, NEUROPSYCHOPHARMACOL, V37, P1784, DOI 10.1038/npp.2012.25; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; Dalaker TO, 2011, MOVEMENT DISORD, V26, P297, DOI 10.1002/mds.23443; Davis KE, 2013, J ALZHEIMERS DIS, V33, P681, DOI 10.3233/JAD-2012-121543; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Deprez S, 2011, HUM BRAIN MAPP, V32, P480, DOI 10.1002/hbm.21033; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Didic M, 2013, DEMENT GERIATR COGN, V35, P291, DOI 10.1159/000347203; Didic M, 2010, J ALZHEIMERS DIS, V22, P1269, DOI 10.3233/JAD-2010-101257; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Dos Santos ACD, 2013, J NEUROSCI RES, V91, P1508, DOI 10.1002/jnr.23258; ELBeltagy M, 2010, BEHAV BRAIN RES, V208, P112, DOI 10.1016/j.bbr.2009.11.017; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Escribano L, 2010, NEUROPSYCHOPHARMACOL, V35, P1593, DOI 10.1038/npp.2010.32; FALLIS RJ, 1987, J NEUROIMMUNOL, V14, P205, DOI 10.1016/0165-5728(87)90055-5; Fardell JE, 2014, PSYCHOPHARMACOLOGY, V231, P841, DOI 10.1007/s00213-013-3301-8; Fardell JE, 2012, PSYCHOPHARMACOLOGY, V220, P183, DOI 10.1007/s00213-011-2466-2; Fernandes VS, 2012, BEHAV BRAIN RES, V231, P154, DOI 10.1016/j.bbr.2012.03.008; Fernandes VS, 2008, PROG NEURO-PSYCHOPH, V32, P1479, DOI 10.1016/j.pnpbp.2008.05.004; Filali M, 2012, BEHAV BRAIN RES, V234, P334, DOI 10.1016/j.bbr.2012.07.004; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; GAFFAN D, 1994, EXP BRAIN RES, V99, P411; Gandal MJ, 2008, NEUROSCIENCE, V157, P95, DOI 10.1016/j.neuroscience.2008.08.060; Gerenu G, 2013, BBA-MOL BASIS DIS, V1832, P837, DOI 10.1016/j.bbadis.2013.02.018; Giovanoli S, 2014, BRAIN BEHAV IMMUN, V40, P48, DOI 10.1016/j.bbi.2014.04.005; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Giuliani A, 2013, J NEUROCHEM, V124, P613, DOI 10.1111/jnc.12136; Goes ATR, 2014, NEUROSCIENCE, V256, P61, DOI 10.1016/j.neuroscience.2013.09.042; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Gomes GM, 2013, TOXICON, V76, P23, DOI 10.1016/j.toxicon.2013.08.059; Good MA, 2007, BEHAV NEUROSCI, V121, P1180, DOI 10.1037/0735-7044.121.6.1180; Greco SJ, 2010, J ALZHEIMERS DIS, V19, P1155, DOI 10.3233/JAD-2010-1308; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Green MF, 1996, AM J PSYCHIAT, V153, P321; Guzman-Ramos K, 2012, LEARN MEMORY, V19, P453, DOI 10.1101/lm.026070.112; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harvey PD, 2006, DRUGS, V66, P1465, DOI 10.2165/00003495-200666110-00004; He PP, 2013, HORM BEHAV, V64, P1, DOI 10.1016/j.yhbeh.2013.04.009; Heneka MT, 2006, J NEUROSCI, V26, P1343, DOI 10.1523/JNEUROSCI.4236-05.2006; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Ho SC, 2014, BEHAV BRAIN RES, V268, P177, DOI 10.1016/j.bbr.2014.04.022; Ho YJ, 2011, BEHAV BRAIN RES, V219, P280, DOI 10.1016/j.bbr.2011.01.028; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Isono T, 2013, NEUROSCI RES, V77, P180, DOI 10.1016/j.neures.2013.08.005; Janelsins MC, 2014, INT REV PSYCHIATR, V26, P102, DOI 10.3109/09540261.2013.864260; Jardanhazi-Kurutz D, 2010, NEUROCHEM INT, V57, P375, DOI 10.1016/j.neuint.2010.02.001; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Kamboh MI, 2004, ANN HUM GENET, V68, P381, DOI 10.1046/j.1529-8817.2004.00110.x; Kane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048975; Keefe Richard S E, 2012, Handb Exp Pharmacol, P11, DOI 10.1007/978-3-642-25758-2_2; Kendall I, 2011, PSYCHOPHARMACOLOGY, V213, P413, DOI 10.1007/s00213-010-1854-3; Kesler SR, 2013, BRAIN IMAGING BEHAV, V7, P501, DOI 10.1007/s11682-013-9228-1; Knowles JK, 2013, NEUROBIOL AGING, V34, P2052, DOI 10.1016/j.neurobiolaging.2013.02.015; Korosoglou G, 2012, J MAGN RESON IMAGING, V35, P804, DOI 10.1002/jmri.22879; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Lu P, 2009, BRIT J PHARMACOL, V157, P1270, DOI 10.1111/j.1476-5381.2009.00295.x; Luques L, 2007, EXP NEUROL, V206, P209, DOI 10.1016/j.expneurol.2007.04.007; Lyall K, 2014, INT J EPIDEMIOL, V43, P443, DOI 10.1093/ije/dyt282; Lyon L, 2012, PSYCHOPHARMACOLOGY, V220, P647, DOI 10.1007/s00213-011-2536-5; Magen I, 2012, EUR J NEUROSCI, V35, P870, DOI 10.1111/j.1460-9568.2012.08012.x; Marco EM, 2013, NEUROPHARMACOLOGY, V68, P223, DOI 10.1016/j.neuropharm.2012.08.014; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Matsuo K, 2014, J NEUROIMMUNOL, V266, P1, DOI 10.1016/j.jneuroim.2013.11.002; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; McIntosh AL, 2013, PSYCHOPHARMACOLOGY, V228, P31, DOI 10.1007/s00213-013-3011-2; McLean SL, 2011, EUR NEUROPSYCHOPHARM, V21, P333, DOI 10.1016/j.euroneuro.2010.06.003; Meltzer HY, 2013, INT J NEUROPSYCHOPH, V16, P2181, DOI 10.1017/S1461145713000928; Meunier J, 2013, EUR J PHARMACOL, V698, P193, DOI 10.1016/j.ejphar.2012.10.033; MEUNIER M, 1993, J NEUROSCI, V13, P5418, DOI 10.1523/JNEUROSCI.13-12-05418.1993; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Middei S, 2006, GENES BRAIN BEHAV, V5, P249, DOI 10.1111/j.1601-183X.2005.00160.x; Mondie CM, 2010, BEHAV BRAIN RES, V209, P66, DOI 10.1016/j.bbr.2010.01.016; Moore H, 2010, SCHIZOPHRENIA BULL, V36, P1066, DOI 10.1093/schbul/sbq106; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Morley JE, 2012, CURR PHARM DESIGN, V18, P1123; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; MUMBY DG, 1994, BEHAV NEUROSCI, V108, P11, DOI 10.1037/0735-7044.108.1.11; Murray DK, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-5; Mychasiuk R, 2012, DEV NEUROSCI-BASEL, V34, P268, DOI 10.1159/000341786; Neill JC, 2010, PHARMACOL THERAPEUT, V128, P419, DOI 10.1016/j.pharmthera.2010.07.004; O'Farrell E, 2013, CURR ONCOL REP, V15, P260, DOI 10.1007/s11912-013-0307-7; O'Grada C, 2007, HUM PSYCHOPHARM CLIN, V22, P397, DOI 10.1002/hup.861; O'Tuathaigh CMP, 2010, EUR J NEUROSCI, V31, P349, DOI 10.1111/j.1460-9568.2009.07069.x; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ohta H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030007; Ferreira APO, 2014, PSYCHOPHARMACOLOGY, V231, P1935, DOI 10.1007/s00213-013-3336-x; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Onishi T, 2011, J NEUROCHEM, V119, P1330, DOI 10.1111/j.1471-4159.2011.07532.x; Ozawa K, 2006, BIOL PSYCHIAT, V59, P546, DOI 10.1016/j.biopsych.2005.07.031; Papaleo F, 2012, NEUROPHARMACOLOGY, V62, P1204, DOI 10.1016/j.neuropharm.2011.04.025; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Platt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027068; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Presti-Torres J, 2007, NEUROPHARMACOLOGY, V52, P724, DOI 10.1016/j.neuropharm.2006.09.020; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Pyter LM, 2010, BRAIN BEHAV IMMUN, V24, P903, DOI 10.1016/j.bbi.2010.02.004; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Ribes D, 2012, ALZ DIS ASSOC DIS, V26, P179, DOI 10.1097/WAD.0b013e3182211ab1; Ryan D, 2013, CELL MOL LIFE SCI, V70, P2603, DOI 10.1007/s00018-013-1314-4; Sanna KG, 2011, RES AUTISM SPECT DIS, V5, P622, DOI 10.1016/j.rasd.2010.07.007; Santos JR, 2013, BEHAV BRAIN RES, V253, P68, DOI 10.1016/j.bbr.2013.06.031; Sawamoto N, 2008, BRAIN, V131, P1294, DOI 10.1093/brain/awn054; Scali C, 1997, EUR J PHARMACOL, V325, P173, DOI 10.1016/S0014-2999(97)00128-3; Scholtzova H, 2008, J NEUROSCI RES, V86, P2784, DOI 10.1002/jnr.21713; Scullion GA, 2011, NEUROPHARMACOLOGY, V60, P223, DOI 10.1016/j.neuropharm.2010.09.002; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Silverman JL, 2013, NEUROPHARMACOLOGY, V64, P268, DOI 10.1016/j.neuropharm.2012.07.013; Sipos E, 2007, NEUROSCIENCE, V147, P28, DOI 10.1016/j.neuroscience.2007.04.011; Sivilia S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-44; Snowden JS, 2011, BRAIN, V134, P2478, DOI 10.1093/brain/awr189; Spilman P, 2014, BRAIN RES, V1551, P25, DOI 10.1016/j.brainres.2013.12.029; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Tsunekawa H, 2008, BEHAV BRAIN RES, V190, P224, DOI 10.1016/j.bbr.2008.03.002; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; Vardy J, 2007, CRIT REV ONCOL HEMAT, V63, P183, DOI 10.1016/j.critrevonc.2007.06.001; Wang DY, 2013, J BIOL CHEM, V288, P10298, DOI 10.1074/jbc.M112.415141; Wefel JS, 2012, CURR NEUROL NEUROSCI, V12, P267, DOI 10.1007/s11910-012-0264-9; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Wolf JM, 2008, AUTISM RES, V1, P329, DOI 10.1002/aur.56; Yabuki Y, 2014, NEUROSCIENCE, V259, P126, DOI 10.1016/j.neuroscience.2013.11.051; Yamaguchi Y, 2012, J PHARMACOL SCI, V119, P160, DOI 10.1254/jphs.12036FP; Yan JJ, 2013, BIOL PHARM BULL, V36, P140, DOI 10.1248/bpb.b12-00798; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Yuede CM, 2009, NEUROBIOL DIS, V35, P426, DOI 10.1016/j.nbd.2009.06.002; Zhang L, 2006, BEHAV BRAIN RES, V173, P246, DOI 10.1016/j.bbr.2006.06.034; Zhang R, 2012, J ALZHEIMERS DIS, V31, P801, DOI 10.3233/JAD-2012-120151; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144; Zufferey V, 2013, BRAIN RES BULL, V94, P17, DOI 10.1016/j.brainresbull.2013.01.011	165	116	118	1	45	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 15	2015	285				SI		176	193		10.1016/j.bbr.2014.10.025			18	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CG2CU	WOS:000353083300017	25447293				2022-02-06	
J	Ge, XT; Lei, P; Wang, HC; Zhang, AL; Han, ZL; Chen, X; Li, SH; Jiang, RC; Kang, CS; Zhang, JN				Ge, Xin-Tong; Lei, Ping; Wang, Hai-Chen; Zhang, An-Ling; Han, Zhao-Li; Chen, Xin; Li, Sheng-Hui; Jiang, Rong-Cai; Kang, Chun-Sheng; Zhang, Jian-Ning			miR-21 improves the neurological outcome after traumatic brain injury in rats	SCIENTIFIC REPORTS			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR STABILIZATION; CARDIAC-HYPERTROPHY; ANGIOGENESIS; EXPRESSION; CELLS; PROLIFERATION; ANGIOPOIETIN1/TIE2; OVEREXPRESSION; VULNERABILITY	The expression levels of microRNAs (miRNAs) including miR-21, have been reported to change in response to traumatic brain injury (TBI), suggesting that they may influence the pathophysiological process in brain injury. To analyze the potential effect of miR-21 on neurological function after TBI, we employed the fluid percussion injury rat model and manipulated the expression level of miR-21 in brain using intracerebroventricular infusion of miR-21 agomir or antagomir. We found that upregulation of miR-21 level in brain conferred a better neurological outcome after TBI by improving long-term neurological function, alleviating brain edema and decreasing lesion volume. To further investigate the mechanism underlying this protective effect, we evaluated the impact of miR-21 on apoptosis and angiogenesis in brain after TBI. We found that miR-21 inhibited apoptosis and promoted angiogenesis through regulating the expression of apoptosis-and angiogenesis-related molecules. In addition, the expression of PTEN, a miR-21 target gene, was inhibited and Akt signaling was activated in the procedure. Taken together, these data indicate that miR-21 could be a potential therapeutic target for interventions after TBI.	[Ge, Xin-Tong; Han, Zhao-Li; Chen, Xin; Li, Sheng-Hui; Jiang, Rong-Cai; Zhang, Jian-Ning] Tianjin Neurol Inst, Lab Neurotrauma, Tianjin, Peoples R China; [Ge, Xin-Tong; Lei, Ping; Zhang, An-Ling; Han, Zhao-Li; Chen, Xin; Li, Sheng-Hui; Jiang, Rong-Cai; Kang, Chun-Sheng; Zhang, Jian-Ning] Minist Educ, Key Lab Post Trauma Neurorepair & Regenerat Cent, Tianjin, Peoples R China; [Ge, Xin-Tong; Lei, Ping; Zhang, An-Ling; Han, Zhao-Li; Chen, Xin; Li, Sheng-Hui; Jiang, Rong-Cai; Kang, Chun-Sheng; Zhang, Jian-Ning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Ge, Xin-Tong; Lei, Ping; Zhang, An-Ling; Chen, Xin; Li, Sheng-Hui; Jiang, Rong-Cai; Kang, Chun-Sheng; Zhang, Jian-Ning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Lei, Ping; Han, Zhao-Li] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin, Peoples R China; [Lei, Ping; Han, Zhao-Li] Tianjin Geriatr Inst, Lab Neuro Trauma & Neurodegenerat Disorders, Tianjin, Peoples R China; [Wang, Hai-Chen] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [Zhang, An-Ling; Kang, Chun-Sheng] Tianjin Neurol Inst, Lab Neurooncol, Tianjin, Peoples R China		Zhang, JN (corresponding author), Tianjin Neurol Inst, Lab Neurotrauma, Tianjin, Peoples R China.	jianningzhang@hotmail.com	Kang, Chunsheng/AAM-5979-2021; Ge, Xintong/X-4889-2019	Kang, Chunsheng/0000-0002-3255-3369; Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81471252, 81271361]	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81330029, 81471252 and 81271361). We express special acknowledgement to our senior professor Chun-Sheng Kang who contributes greatly on experiment design and guidance. The authors also appreciate Lei Han, Ying Li, Li Liu, Wei-Yun Cui, Fang-Lian Chen, Zhi-Fan Jia and Guang-Xiu Wang from Tianjin Neurological Institute, Bao-Cun Sun and Xiu-Lan Zhao from the Department of Pathology, Tianjin Medical University for their technical support.	Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573; Chen JL, 2009, J CELL MOL MED, V13, P1348, DOI 10.1111/j.1582-4934.2008.00380.x; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cuello-Carrion FD, 1999, J HISTOCHEM CYTOCHEM, V47, P837, DOI 10.1177/002215549904700614; Cyran CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076009; Dong J, 2011, ARCH MED RES, V42, P8, DOI 10.1016/j.arcmed.2011.01.006; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Guillamo JS, 2009, CLIN CANCER RES, V15, P3697, DOI 10.1158/1078-0432.CCR-08-2042; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Karuppagounder SS, 2007, NEUROBIOL DIS, V26, P353, DOI 10.1016/j.nbd.2007.01.011; LAI YL, 1983, J APPL PHYSIOL, V54, P1754, DOI 10.1152/jappl.1983.54.6.1754; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Li T, 2014, J NEUROL SCI, V341, P88, DOI 10.1016/j.jns.2014.04.009; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Nehme B, 2011, J NEUROSCI METH, V196, P281, DOI 10.1016/j.jneumeth.2011.01.018; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Ren Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-27; Schoknecht K, 2012, EPILEPSIA, V53, P7, DOI 10.1111/j.1528-1167.2012.03697.x; Senger DR, 2010, MOL BIOL CELL, V21, P377, DOI 10.1091/mbc.E09-07-0591; Silva CG, 2007, NEUROBIOL DIS, V27, P182, DOI 10.1016/j.nbd.2007.04.018; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang K, 2012, J BIOL CHEM, V287, P589, DOI 10.1074/jbc.M111.266940; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Xiong BH, 2013, INT J ONCOL, V42, P219, DOI 10.3892/ijo.2012.1707; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zacharek A, 2006, NEUROSCI LETT, V404, P28, DOI 10.1016/j.neulet.2006.05.027; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126; Zhu Y, 2006, ACTA NEUROCHIR SUPPL, V96, P438; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	50	116	122	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 24	2014	4								6718	10.1038/srep06718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR4ZJ	WOS:000343594500001	25342226	Green Published, gold			2022-02-06	
J	Camarillo, DB; Shull, PB; Mattson, J; Shultz, R; Garza, D				Camarillo, David B.; Shull, Pete B.; Mattson, James; Shultz, Rebecca; Garza, Daniel			An Instrumented Mouthguard for Measuring Linear and Angular Head Impact Kinematics in American Football	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; mTBI; Brain; Angular velocity; Linear acceleration; Translational acceleration; Angular acceleration; Rotational velocity; Gyroscope	TRAUMATIC BRAIN-INJURY; ACCELERATION; CONCUSSION; COLLEGIATE; EPIDEMIOLOGY; SYSTEM	The purpose of this study was to evaluate a novel instrumented mouthguard as a research device for measuring head impact kinematics. To evaluate kinematic accuracy, laboratory impact testing was performed at sites on the helmet and facemask for determining how closely instrumented mouthguard data matched data from an anthropomorphic test device. Laboratory testing results showed that peak linear acceleration (r (2) = 0.96), peak angular acceleration (r (2) = 0.89), and peak angular velocity (r (2) = 0.98) measurements were highly correlated between the instrumented mouthguard and anthropomorphic test device. Normalized root-mean-square errors for impact time traces were 9.9 +/- A 4.4% for linear acceleration, 9.7 +/- A 7.0% for angular acceleration, and 10.4 +/- A 9.9% for angular velocity. This study demonstrates the potential of an instrumented mouthguard as a research tool for measuring in vivo impacts, which could help uncover the link between head impact kinematics and brain injury in American football.	[Camarillo, David B.; Shull, Pete B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Mattson, James; Shultz, Rebecca; Garza, Daniel] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA		Camarillo, DB (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	dcamarillo@stanford.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1UL1 RR025744]; Lucile Packard Foundation for Children's Health; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R21EB017611] Funding Source: NIH RePORTER	The authors would like to thank X2Impact for donation of devices and equipment required for laboratory testing. This work was supported in part by the NIH Clinical and Translational Science Award 1UL1 RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum) and by the Lucile Packard Foundation for Children's Health.	Abramowitz M., 1965, HDB MATH FUNCTIONS F, V55; [Anonymous], 2007, J2111 SAE; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Craig M. J., 2007, THESIS WAYNE STATE U; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Higgins M, 2007, J ATHL TRAINING, V42, P5; Holbourn AHS, 1943, LANCET, V2, P438; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis LM, 2001, ACAD EMERG MED, V8, P604, DOI 10.1111/j.1553-2712.2001.tb00171.x; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2009, 00108M10 NOCSAE DOC; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NOCSAE, 2006, 08104M04 NOCSAE DOC; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Walker Jr L. B., 1973, P STAPP CAR CRASH C; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	31	116	116	0	66	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2013	41	9					1939	1949		10.1007/s10439-013-0801-y			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	209EJ	WOS:000323736800015	23604848	Green Accepted			2022-02-06	
J	Magnoni, S; Esparza, TJ; Conte, V; Carbonara, M; Carrabba, G; Holtzman, DM; Zipfel, GJ; Stocchetti, N; Brody, DL				Magnoni, Sandra; Esparza, Thomas J.; Conte, Valeria; Carbonara, Marco; Carrabba, Giorgio; Holtzman, David M.; Zipfel, Greg J.; Stocchetti, Nino; Brody, David L.			Tau elevations in the brain extracellular space correlate with reduced amyloid-beta levels and predict adverse clinical outcomes after severe traumatic brain injury	BRAIN			English	Article						traumatic brain injury; microdialysis; amyloid-beta; tau; neurofilament	DIFFUSE AXONAL INJURY; NEUROFILAMENT LIGHT-CHAIN; REPETITIVE HEAD-INJURY; WHITE-MATTER INJURY; CEREBROSPINAL-FLUID; IN-VIVO; CEREBRAL MICRODIALYSIS; STRUCTURED INTERVIEWS; PRECURSOR PROTEIN; MILD	Axonal injury is believed to be a major determinant of adverse outcomes following traumatic brain injury. However, it has been difficult to assess acutely the severity of axonal injury in human traumatic brain injury patients. We hypothesized that microdialysis-based measurements of the brain extracellular fluid levels of tau and neurofilament light chain, two low molecular weight axonal proteins, could be helpful in this regard. To test this hypothesis, 100 kDa cut-off microdialysis catheters were placed in 16 patients with severe traumatic brain injury at two neurological/neurosurgical intensive care units. Tau levels in the microdialysis samples were highest early and fell over time in all patients. Initial tau levels were >3-fold higher in patients with microdialysis catheters placed in pericontusional regions than in patients in whom catheters were placed in normal-appearing right frontal lobe tissue (P = 0.005). Tau levels and neurofilament light-chain levels were positively correlated (r = 0.6, P = 0.013). Neurofilament light-chain levels were also higher in patients with pericontusional catheters (P = 0.04). Interestingly, initial tau levels were inversely correlated with initial amyloid-beta levels measured in the same samples (r = -0.87, P = 0.000023). This could be due to reduced synaptic activity in areas with substantial axonal injury, as amyloid-beta release is closely coupled with synaptic activity. Importantly, high initial tau levels correlated with worse clinical outcomes, as assessed using the Glasgow Outcome Scale 6 months after injury (r = -0.6, P = 0.018). Taken together, our data add support for the hypothesis that axonal injury may be related to long-term impairments following traumatic brain injury. Microdialysis-based measurement of tau levels in the brain extracellular space may be a useful way to assess the severity of axonal injury acutely in the intensive care unit. Further studies with larger numbers of patients will be required to assess the reproducibility of these findings and to determine whether this approach provides added value when combined with clinical and radiological information.	[Esparza, Thomas J.; Holtzman, David M.; Brody, David L.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Magnoni, Sandra; Conte, Valeria; Carbonara, Marco; Stocchetti, Nino] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anaesthesia & Intens Care, I-20100 Milan, Italy; [Carrabba, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosurg, I-20100 Milan, Italy; [Holtzman, David M.; Zipfel, Greg J.; Brody, David L.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Zipfel, Greg J.] Washington Univ, Dept Neurol Surg, St Louis, MO 63110 USA		Brody, DL (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu	Magnoni, Sandra/AAC-7479-2022; Carrabba, Giorgio/AAC-3746-2022; Carbonara, Marco/N-3793-2015; Carrabba, Giorgio/AAB-3925-2019; Stocchetti, Nino/O-7444-2017	Magnoni, Sandra/0000-0002-1723-0844; Carbonara, Marco/0000-0002-1431-8322; Carrabba, Giorgio/0000-0002-0170-0653; Stocchetti, Nino/0000-0003-3250-6834	Burroughs Wellcome Career Award in the Biomedical SciencesBurroughs Wellcome Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 NS049237, R01 NS065069]; Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS049237, R01NS065069] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award in the Biomedical Sciences (to D.L. B.); National Institutes of Health (grant numbers K08 NS049237 and R01 NS065069 to D.L.B.); Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico, departmental funds.	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Afinowi R, 2009, J NEUROSCI METH, V181, P95, DOI 10.1016/j.jneumeth.2009.02.021; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Arruda DL, 2009, EXPERT REV MOL DIAGN, V9, P749, DOI 10.1586/ERM.09.47; BENNETT M, 1995, IRISH MED J, V88, P59; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; Fishman R. A., 1992, CEREBROSPINAL FLUID, V2nd; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koel-Simmelink MJA, 2011, ANN NEUROL, V69, P1065, DOI 10.1002/ana.22438; Kondo K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-147; Koura SS, 1998, ACT NEUR S, V71, P244; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Osuchowski MF, 2006, METHODS, V38, P304, DOI 10.1016/j.ymeth.2005.11.009; PANT HC, 1988, BIOCHEM J, V256, P665, DOI 10.1042/bj2560665; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; SHAW G, 1988, P NATL ACAD SCI USA, V85, P2854, DOI 10.1073/pnas.85.8.2854; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Van Geel WJA, 2005, J IMMUNOL METHODS, V296, P179, DOI 10.1016/j.jim.2004.11.015; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	88	116	122	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	APR	2012	135		4				1268	1280		10.1093/brain/awr286			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	927ZH	WOS:000302948700029	22116192	Green Published, Bronze			2022-02-06	
J	Shultz, SR; Bao, F; Omana, V; Chiu, C; Brown, A; Cain, DP				Shultz, Sandy R.; Bao, Feng; Omana, Vanessa; Chiu, Charlotte; Brown, Arthur; Cain, Donald Peter			Repeated Mild Lateral Fluid Percussion Brain Injury in the Rat Causes Cumulative Long-Term Behavioral Impairments, Neuroinflammation, and Cortical Loss in an Animal Model of Repeated Concussion	JOURNAL OF NEUROTRAUMA			English	Article						behavior; inflammation; learning and memory; models of injury; traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; NATIONAL-FOOTBALL-LEAGUE; ANXIETY-RELATED BEHAVIOR; ELEVATED PLUS-MAZE; HEAD-INJURY; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; WATER MAZE; FUNCTIONAL ABNORMALITIES; SPATIAL NAVIGATION	There is growing evidence that repeated brain concussion can result in cumulative and long-term behavioral symptoms, neuropathological changes, and neurodegeneration. Little is known about the factors and mechanisms that contribute to these effects. The current study addresses the need to investigate and better understand the effects of repeated concussion through the development of an animal model. Male Long-Evans rats received 1, 3, or 5 mild lateral fluid percussion injuries or sham injuries spaced 5 days apart. After the final injury, rats received either a short (24 h) or long (8 weeks) post-injury recovery period, followed by a detailed behavioral analysis consisting of tests for rodent anxiety-like behavior, cognition, social behavior, sensorimotor function, and depression-like behavior. Brains were examined immunohistochemically to assess neuroinflammation and cortical damage. Rats given 1, 3, or 5 mild percussion injuries displayed significant short-term cognitive impairments. Rats given repeated mild percussion injuries displayed significantly worse short- and long-term cognitive impairments. Rats given 5 mild percussion injuries also displayed increased anxiety- and depression-like behaviors. Neuropathological analysis revealed short-term neuroinflammation in 3-injury rats, and both short- and long-term neuroinflammation in 5-injury rats. There was also evidence that repeated injuries induced short- and long-term cortical damage. These cumulative and long-term changes are consistent with findings in human patients suffering repeated brain concussion, provide support for the use of repeated mild lateral fluid percussion injuries to study repeated concussion in the rat, and suggest that neuroinflammation may be important for understanding the cumulative and chronic effects of repeated concussion.	[Shultz, Sandy R.; Cain, Donald Peter] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Shultz, Sandy R.; Chiu, Charlotte; Cain, Donald Peter] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Bao, Feng; Omana, Vanessa; Brown, Arthur] Univ Western Ontario, Robarts Res Inst, London, ON, Canada		Shultz, SR (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Dept Med, Parkville, Vic 3010, Australia.	sshultz@unimelb.edu.au	Brown, Arthur/K-6837-2013; Brown, Arthur/K-8328-2013	Brown, Arthur/0000-0002-8725-3195; Shultz, Sandy/0000-0002-2525-8775	Natural Science and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); CIHRCanadian Institutes of Health Research (CIHR)	This research was supported by a grant from the Natural Science and Engineering Research Council (NSERC) to Dr. Donald P. Cain, a scholarship from NSERC to Dr. Sandy R. Shultz, and a grant from CIHR to Dr. Arthur Brown. We thank Drs. R. Sutton and D. Hovda, UCLA Brain Injury Research Center, for training. Additional thanks go to Drs. K.-P. Ossenkopp and D. MacFabe, and to F. Boon, L. Tichenoff, and R. Taylor for technical assistance. Dr. Sandy R. Shultz is now at the Department of Medicine (Royal Melbourne Hospital), Melbourne Brain Centre, University of Melbourne, Parkville, Victoria, Australia.	AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Beiko J, 1997, BEHAV BRAIN RES, V88, P201, DOI 10.1016/S0166-4328(97)02298-5; Beiko J, 2004, BEHAV BRAIN RES, V151, P239, DOI 10.1016/j.bbr.2003.08.019; Bissiere S, 2006, BEHAV BRAIN RES, V175, P195, DOI 10.1016/j.bbr.2006.08.022; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Cain DP, 2003, BRAIN RES, V972, P64, DOI 10.1016/S0006-8993(03)02486-7; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Cantu RC, 2009, CURR SPORT MED REP, V8, P6, DOI 10.1249/JSR.0b013e31819677db; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Giza CC, 2001, J ATHL TRAINING, V36, P228; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; KOLB B, 1985, BEHAV BRAIN RES, V17, P25, DOI 10.1016/0166-4328(85)90005-1; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Li SH, 2006, NEUROSCI LETT, V409, P182, DOI 10.1016/j.neulet.2006.09.054; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Nandoe RDS, 2002, J ALZHEIMERS DIS, V4, P303, DOI 10.3233/JAD-2002-4405; O'Sullivan JB, 2009, INT J NEUROPSYCHOPH, V12, P687, DOI 10.1017/S146114570800967X; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Saucier DM, 2008, ANIM COGN, V11, P129, DOI 10.1007/s10071-007-0096-1; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shultz SR, 2008, NEUROPHARMACOLOGY, V54, P901, DOI 10.1016/j.neuropharm.2008.01.013; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Shultz SR, 2009, BEHAV BRAIN RES, V200, P33, DOI 10.1016/j.bbr.2008.12.023; Spalletta G, 2006, MOL PSYCHIATR, V11, P984, DOI 10.1038/sj.mp.4001879; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weaver LC, 2001, J NEUROTRAUM, V18, P1107, DOI 10.1089/08977150152693782; Whishaw IQ, 1995, HIPPOCAMPUS, V5, P595, DOI 10.1002/hipo.450050610; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Zilka N, 2006, Bratisl Lek Listy, V107, P374	66	116	118	0	23	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 20	2012	29	2					281	294		10.1089/neu.2011.2123			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	885SO	WOS:000299801300008	21933013				2022-02-06	
J	Gysland, SM; Mihalik, JP; Register-Mihalik, JK; Trulock, SC; Shields, EW; Guskiewicz, KM				Gysland, Sonia M.; Mihalik, Jason P.; Register-Mihalik, Johna K.; Trulock, Scott C.; Shields, Edgar W.; Guskiewicz, Kevin M.			The Relationship Between Subconcussive Impacts and Concussion History on Clinical Measures of Neurologic Function in Collegiate Football Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion history; Cumulative exposure; Subconcussive impacts; Mild traumatic brain injury	HIGH-SCHOOL; HEAD IMPACTS; BRAIN-INJURY; STANDARDIZED ASSESSMENT; PROFESSIONAL FOOTBALL; SPORTS CONCUSSION; POSTURAL CONTROL; NCAA CONCUSSION; UNITED-STATES; EPIDEMIOLOGY	Concussions sustained during college and professional football careers have been associated with both acute and chronic neurologic impairment. The contribution of subconcussive impacts to this impairment has not been adequately studied. Therefore, we investigated the relationship between subconcussive impacts and concussion history on clinical measures of neurologic function. Forty-six collegiate football players completed five clinical measures of neurologic function commonly employed in the evaluation of concussion before and after a single season. These tests included the Automated Neuropsychological Assessment Metrics, Sensory Organization Test, Standardized Assessment of Concussion, Balance Error Scoring System, and Graded Symptom Checklist. The Head Impact Telemetry (HIT) System recorded head impact data including the frequency, magnitude, and location of impacts. College football players sustain approximately 1,000 subconcussive impacts to the head over the course of a season, but for the most part, do not demonstrate any clinically meaningful changes from preseason to postseason on measures of neurologic function. Changes in performance were mostly independent of prior concussion history, and the total number, magnitude and location of sustained impacts over one season as observed R-2 values ranged between 0.30 and 0.35. Repetitive subconcussive head impacts over a single season do not appear to result in short-term neurologic impairment, but these relationships should be further investigated for a potential dose-response over a player's career.	[Gysland, Sonia M.; Mihalik, Jason P.; Register-Mihalik, Johna K.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Trulock, Scott C.] Univ N Carolina, Campus Hlth Serv, Chapel Hill, NC 27599 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Dept Exercise & Sport Sci, 2207 Stallings Evans Sports Med Complex,Campus Bo, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Mihalik, Jason/0000-0001-6085-8322; Guskiewicz, Kevin/0000-0002-8682-2130; Register-Mihalik, Johna/0000-0002-4229-4743	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Operating Committee on Standards for Athletic Equipment	This study was supported in part by the Centers for Disease Control and Prevention and the National Operating Committee on Standards for Athletic Equipment.	Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Delaney JS, 2005, CLIN J SPORT MED, V15, P212; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Riemann BL, 1999, J SPORT REHABIL, V8, P171, DOI 10.1123/jsr.8.3.171; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Talavage TM, 2010, J NEUROTRAUMA; Valovich TC, 2003, J ATHL TRAINING, V38, P51	35	116	116	0	39	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		14	22		10.1007/s10439-011-0421-3			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700002	21994067				2022-02-06	
J	Benson, BW; Meeuwisse, WH; Rizos, J; Kang, J; Burke, CJ				Benson, Brian W.; Meeuwisse, Willem H.; Rizos, John; Kang, Jian; Burke, Charles J.			A prospective study of concussions among National Hockey League players during regular season games: the NHL-NHLPA Concussion Program	CANADIAN MEDICAL ASSOCIATION JOURNAL			English	Article							SPORT-RELATED CONCUSSION; ICE HOCKEY; INJURIES; STATEMENT; RECOVERY; TIME; EPIDEMIOLOGY; PREDICTORS; SYMPTOMS; FOOTBALL	Background: In 1997, the National Hockey League (NHL) and NHL Players' Association (NHLPA) launched a concussion program to improve the understanding of this injury. We explored initial postconcussion signs, symptoms, physical examination findings and time loss (i.e., time between the injury and medical clearance by the physician to return to competitive play), experienced by male professional ice-hockey players, and assessed the utility of initial postconcussion clinical manifestations in predicting time loss among hockey players. Methods: We conducted a prospective case series of concussions over seven NHL regular seasons (1997-2004) using an inclusive cohort of players. The primary outcome was concussion and the secondary outcome was time loss. NHL team physicians documented postconcussion clinical manifestations and recorded the date when a player was medically cleared to return to play. Results: Team physicians reported 559 concussions during regular season games. The estimated incidence was 1.8 concussions per 1000 player-hours. The most common postconcussion symptom was headache (71%). On average, time loss (in days) increased 2.25 times (95% confidence interval [CI] 1.41-3.62) for every subsequent (i.e., recurrent) concussion sustained during the study period. Controlling for age and position, significant predictors of time loss were postconcussion headache (p < 0.001), low energy or fatigue (p = 0.01), amnesia (p = 0.02) and abnormal neurologic examination (p = 0.01). Using a previously suggested time loss cut-point of 10 days, headache (odds ratio [OR] 2.17, 95% CI 1.33-3.54) and low energy or fatigue (OR 1.72, 95% CI 1.04-2.85) were significant predictors of time loss of more than 10 days. Interpretation: Postconcussion headache, low energy or fatigue, amnesia and abnormal neurologic examination were significant predictors of time loss among professional hockey players.	[Benson, Brian W.; Meeuwisse, Willem H.; Kang, Jian] Univ Calgary, Fac Kinesiol, Sport Med Ctr, Roger Jackson Ctr Hlth & Wellness Res, Calgary, AB, Canada; [Rizos, John] Credit Valley Hosp, Dept Emergency Med, Mississauga, ON, Canada; [Rizos, John] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Burke, Charles J.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA		Benson, BW (corresponding author), Univ Calgary, Fac Kinesiol, Sport Med Ctr, Roger Jackson Ctr Hlth & Wellness Res, Calgary, AB, Canada.	bbenson@ucalgary.ca			The Alberta Heritage Foundation for Medical ResearchAlberta Heritage Foundation for Medical Research; The Alberta Provincial CIHR; National Hockey League (NHL); National Hockey League Players Association (NHLPA)	The Alberta Heritage Foundation for Medical Research and The Alberta Provincial CIHR Training Program in Bone and Joint Health provided financial support as part of the principal investigator's Doctorate Program in Epidemiology, Department of Community Health Sciences, Faculty of Medicine, University of Calgary.; The authors acknowledge the following individuals, groups and funding organizations: the National Hockey League (NHL), the National Hockey League Players Association (NHLPA), the NHL team physicians, athletic therapists and athletic trainers who collected information for the NHL-NHLPA Concussion Program, members of the previous NHL Concussion Program Committee (including Dave Dryden, Dr. Mark Lovell and Kristen Hawn), the current NHL-NHLPA Concussion Working Group (including Dr. Ruben Echemendia (Chair), Dr. Mark Aubry, Dr. Paul Comper, Julie Grand, Jim McCrossin and Rob Zamuner), the Alberta Heritage Foundation for Medical Research and the Alberta Provincial CIHR Training Program in Bone and Joint Health.	Agel J, 2007, J ATHL TRAINING, V42, P241; Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Cantu RC, 1997, CLIN J SPORT MED, V7, P83, DOI 10.1097/00042752-199704000-00001; Cantu RC, 2007, NEW ENGL J MED, V356, P1787; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Kohl HW, 2003, CLIN J SPORT MED, V13, P277, DOI 10.1097/00042752-200309000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Molsa JJ, 1999, INT J SPORTS MED, V20, P64, DOI 10.1055/s-2007-971095; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X	31	116	117	3	21	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0820-3946	1488-2329		CAN MED ASSOC J	Can. Med. Assoc. J.	MAY 17	2011	183	8					905	911		10.1503/cmaj.092190			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762AZ	WOS:000290446000056	21502355	Green Published, gold			2022-02-06	
J	Naziroglu, M				Naziroglu, Mustafa			TRPM2 Cation Channels, Oxidative Stress and Neurological Diseases: Where Are We Now?	NEUROCHEMICAL RESEARCH			English	Article						TRPM2; Ca(2+); Neuronal cells; Oxidative stress; ADP-ribose; Glial cells; Alzheimer' disease	AMYOTROPHIC-LATERAL-SCLEROSIS; PEROXIDE-INDUCED TOXICITY; 2ND-MESSENGER ADP-RIBOSE; RAT STRIATAL NEURONS; HYDROGEN-PEROXIDE; CALCIUM INFLUX; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; PARKINSONISM-DEMENTIA; HIPPOCAMPAL-NEURONS	The Na+ and Ca(2+)-permeable melastatin related transient receptor potential 2 (TRPM2) channels can be gated either by ADP-ribose (ADPR) in concert with Ca(2+) or by hydrogen peroxide (H(2)O(2)), an experimental model for oxidative stress, binding to the channel's enzymatic Nudix domain. Since the mechanisms that lead to TRPM2 gating in response to ADPR and H(2)O(2) are not understood in neuronal cells, I summarized previous findings and important recent advances in the understanding of Ca(2+) influx via TRPM2 channels in different neuronal cell types and disease processes. Considering that TRPM2 is activated by oxidative stress, mediated cell death and inflammation, and is highly expressed in brain, the channel has been investigated in the context of central nervous system. TRPM2 plays a role in H(2)O(2) and amyloid beta-peptide induced striatal cell death. Genetic variants of the TRPM2 gene confer a risk of developing Western Pacific amyotropic lateral sclerosis and parkinsonism-dementia complex and bipolar disorders. TRPM2 also contributes to traumatic brain injury processes such as oxidative stress, inflammation and neuronal death. There are a limited number of TRPM2 channel blockers and they seem to be cell specific. For example, ADPR-induced Ca(2+) influx in rat hippocampal cells was not blocked by N-(p-amylcinnomoyl)anthralic acid (ACA), the IP(3) receptor inhibitor 2-aminoethoxydiphenyl borate or PLC inhibitor flufenamic acid (FFA). However, the Ca(2+) entry in rat primary striatal cells was blocked by ACA and FFA. In conclusion TRPM2 channels in neuronal cells can be gated by either ADPR or H(2)O(2). It seems to that the exact relationship between TRPM2 channels activation and neuronal cell death still remains to be determined.	[Naziroglu, Mustafa] Suleyman Demirel Univ, Neurosci Res Ctr, TR-32260 Isparta, Turkey		Naziroglu, M (corresponding author), Suleyman Demirel Univ, Fac Med, Dept Biophys, TR-32260 Isparta, Turkey.	mnaziroglu@med.sdu.edu.tr					Amina S, 2010, J NEUROENDOCRINOL, V22, P460, DOI 10.1111/j.1365-2826.2010.01978.x; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Bond CE, 2007, GLIA, V55, P1348, DOI 10.1002/glia.20547; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cook NL, 2010, J MOL NEUROSCI, V42, P192, DOI 10.1007/s12031-010-9347-8; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P179, DOI 10.1080/10799890600637522; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Freestone PS, 2009, EUR J NEUROSCI, V30, P1849, DOI 10.1111/j.1460-9568.2009.06990.x; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Harteneck C, 2007, CARDIOVASC DRUG REV, V25, P61, DOI 10.1111/j.1527-3466.2007.00005.x; Heiner I, 2006, BIOCHEM J, V398, P225, DOI 10.1042/BJ20060183; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hill K, 2006, NEUROPHARMACOLOGY, V50, P89, DOI 10.1016/j.neuropharm.2005.08.021; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Hoffmann A, 2010, J NEUROCHEM, V114, P654, DOI 10.1111/j.1471-4159.2010.06644.x; Inamura K, 2003, J MEMBRANE BIOL, V191, P201, DOI 10.1007/s00232-002-1057-x; Kahlert S, 2005, J NEUROSCI RES, V79, P262, DOI 10.1002/jnr.20322; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Kuhn FJP, 2009, NEUROCHEM RES, V34, P227, DOI 10.1007/s11064-008-9755-0; Kuhn FJP, 2005, PFLUG ARCH EUR J PHY, V451, P212, DOI 10.1007/s00424-005-1446-y; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016; Massullo P, 2006, SEMIN CELL DEV BIOL, V17, P654, DOI 10.1016/j.semcdb.2006.11.006; McQuillan A, 2006, MOL PSYCHIATR, V11, P134, DOI 10.1038/sj.mp.4001759; Morale MC, 2006, NEUROSCIENCE, V138, P869, DOI 10.1016/j.neuroscience.2005.07.060; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Naziroglu M., 2007, Reactive oxygen species and diseases, 2007, P239; Naziroglu M, 2008, NEUROCHEM RES, V33, P1256, DOI 10.1007/s11064-007-9577-5; Naziroglu M, 2008, J NEUROL SCI, V270, P152, DOI 10.1016/j.jns.2008.03.003; Naziroglu M, 2007, NEUROCHEM RES, V32, P1990, DOI 10.1007/s11064-007-9386-x; Naziroglu M, 2007, CELL BIOCHEM FUNCT, V25, P383, DOI 10.1002/cbf.1310; Naziroglu M, 2009, NEUROCHEM RES, V34, P2181, DOI 10.1007/s11064-009-0015-8; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Ohana L, 2009, CHANNELS, V3, P129, DOI 10.4161/chan.3.2.8609; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Pedersen MO, 2009, PROG HISTOCHEM CYTO, V44, P1, DOI 10.1016/j.proghi.2008.10.002; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; Staaf S, 2010, GENE EXPR PATTERNS, V10, P65, DOI 10.1016/j.gep.2009.10.003; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Xu C, 2006, AM J MED GENET B, V141B, P36, DOI 10.1002/ajmg.b.30239; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yamamoto S, 2007, BBA-MOL BASIS DIS, V1772, P958, DOI 10.1016/j.bbadis.2007.03.006; Yamamoto S, 2010, PROG BIOPHYS MOL BIO, V103, P18, DOI 10.1016/j.pbiomolbio.2010.05.005; YANAGIHARA R, 1984, ANN NEUROL, V15, P42, DOI 10.1002/ana.410150108; YASE Y, 1972, LANCET, V2, P292, DOI 10.1016/S0140-6736(72)92903-0; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5	67	116	118	0	14	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190			NEUROCHEM RES	Neurochem. Res.	MAR	2011	36	3					355	366		10.1007/s11064-010-0347-4			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	716RB	WOS:000286990100001	21140288				2022-02-06	
J	Chen, T; Liu, WB; Chao, XD; Zhang, L; Qu, Y; Huo, JL; Fei, Z				Chen, Tao; Liu, WenBo; Chao, XiaoDong; Zhang, Lei; Qu, Yan; Huo, JunLi; Fei, Zhou			Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice	BRAIN RESEARCH BULLETIN			English	Article						Salvianolic acid B; Traumatic brain injury; Neuroprotection; Cytokines; Anti-inflammation	CENTRAL-NERVOUS-SYSTEM; DEFICIENT MOUSE AORTA; SMOOTH-MUSCLE-CELLS; CLOSED-HEAD INJURY; TNF-ALPHA; IN-VIVO; CYTOKINE PRODUCTION; ENDOTHELIAL-CELLS; GROWTH-FACTOR; NITRIC-OXIDE	Salvianolic acid B (SalB), a bioactive compound isolated from the Chinese medicinal herb Danshen, has been shown to exert various anti-oxidative and anti-inflammatory activities in in vitro and in vivo studies. Here, we investigated the protective effects of SalB on traumatic brain injury (TBI) in mice. When administered within 2 h after TBI onset, SalB (25 mg/kg) reduced brain edema, lesion volume and motor functional deficits, and improved spatial learning and memory abilities. Moreover, SalB treatment inhibited the neutrophil infiltration and microglial activation at 48 h after TBI. Enzyme-linked immunosorbent assay (ELISA) for brain tissue homogenates was performed at 24 h after TBI to evaluate the expression of inflammation-related cytokines. The results showed that SalB suppressed the expression of pro-inflammatory cytokines TNE-alpha and IL-1 beta, whereas enhanced the expression of anti-inflammatory cytokines IL-10 and TGF-beta 1. All of these findings extended the protective role of SalB in the model of TBI and suggested that these protective effects might be associated with its anti-inflammatory activities. Thus SalB may have therapeutic potential for patients with TBI and perhaps other forms of acute brain injury. (C) 2010 Elsevier Inc. All rights reserved.	[Chen, Tao; Liu, WenBo; Chao, XiaoDong; Zhang, Lei; Qu, Yan; Huo, JunLi; Fei, Zhou] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xijing Inst Clin Neurosci, Xian 710032, Shaanxi, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xijing Inst Clin Neurosci, Xian 710032, Shaanxi, Peoples R China.	zhoufei@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670796, 30930093]	This work was financially supported by the National Natural Science Foundation of China (Nos. 30670796 and 30930093).	Balasingam V, 1996, J NEUROSCI, V16, P2945; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; Chao X, 2010, BRAIN RES; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Chen YH, 2001, J CELL BIOCHEM, V82, P512, DOI 10.1002/jcb.1176; Chen YL, 2006, J CELL BIOCHEM, V98, P618, DOI 10.1002/jcb.20793; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Imanshahidi M, 2006, PHYTOTHER RES, V20, P427, DOI 10.1002/ptr.1898; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Lin SJ, 2007, J CELL BIOCHEM, V100, P372, DOI 10.1002/jcb.21042; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Pang L, 2001, STROKE, V32, P544, DOI 10.1161/01.STR.32.2.544; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Tang MK, 2006, BEHAV PHARMACOL, V17, P493, DOI 10.1097/00008877-200609000-00015; Tian JW, 2009, BRAIN RES, V1263, P114, DOI 10.1016/j.brainres.2009.01.034; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Wang SX, 2010, NEUROCHEM RES, V35, P1029, DOI 10.1007/s11064-010-0151-1; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Yu SS, 2010, BRAIN RES, V1308, P167, DOI 10.1016/j.brainres.2009.10.037; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhou Z, 2005, J CELL BIOCHEM, V96, P109, DOI 10.1002/jcb.20567	42	116	128	1	22	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230			BRAIN RES BULL	Brain Res. Bull.	FEB 1	2011	84	2					163	168		10.1016/j.brainresbull.2010.11.015			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	733YZ	WOS:000288301700008	21134421				2022-02-06	
J	Beggs, S; Liu, XJ; Kwan, C; Salter, MW				Beggs, Simon; Liu, Xue Jun; Kwan, Chun; Salter, Michael W.			Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier	MOLECULAR PAIN			English	Article							GENE-RELATED PEPTIDE; NEUROPATHIC PAIN; SPINAL-CORD; ANTIDROMIC VASODILATATION; NEUROGENIC INFLAMMATION; UP-REGULATION; SUBSTANCE-P; TIME-COURSE; RAT; SKIN	Background: The blood-brain barrier (BBB) plays the crucial role of limiting exposure of the central nervous system (CNS) to damaging molecules and cells. Dysfunction of the BBB is critical in a broad range of CNS disorders including neurodegeneration, inflammatory or traumatic injury to the CNS, and stroke. In peripheral tissues, the vascular-tissue permeability is normally greater than BBB permeability, but vascular leakage can be induced by efferent discharge activity in primary sensory neurons leading to plasma extravasation into the extravascular space. Whether discharge activity of sensory afferents entering the CNS may open the BBB or blood-spinal cord barrier (BSCB) remains an open question. Results: Here we show that peripheral nerve injury (PNI) produced by either sciatic nerve constriction or transecting two of its main branches causes an increase in BSCB permeability, as assessed by using Evans Blue dye or horseradish peroxidase. The increase in BSCB permeability was not observed 6 hours after the PNI but was apparent 24 hours after the injury. The increase in BSCB permeability was transient, peaking about 24-48 hrs after PNI with BSCB integrity returning to normal levels by 7 days. The increase in BSCB permeability was prevented by administering the local anaesthetic lidocaine at the site of the nerve injury. BSCB permeability was also increased 24 hours after electrical stimulation of the sciatic nerve at intensity sufficient to activate C-fibers, but not when A-fibers only were activated. Likewise, BSCB permeability increased following application of capsaicin to the nerve. The increase in permeability caused by C-fiber stimulation or by PNI was not anatomically limited to the site of central termination of primary afferents from the sciatic nerve in the lumbar cord, but rather extended throughout the spinal cord and into the brain. Conclusions: We have discovered that injury to a peripheral nerve and electrical stimulation of C-fibers each cause an increase in the permeability of the BSCB and the BBB. The increase in permeability is delayed in onset, peaks at about 24 hours and is dependent upon action potential propagation. As the increase is mimicked by applying capsaicin to the nerve, the most parsimonious explanation for our findings is that the increase in permeability is mediated by activation of TRPV1-expressing primary sensory neurons. Our findings may be relevant to the development of pain and neuroplastic changes in the CNS following nerve injury. In addition, our findings may provide the basis for developing methods to purposefully open the BBB when needed to increase brain penetration of therapeutic agents that might normally be excluded by an intact BBB.	[Salter, Michael W.] Univ Toronto, Hosp Sick Children, Dept Physiol, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; Univ Toronto, Ctr Study Pain, Toronto, ON, Canada		Salter, MW (corresponding author), Univ Toronto, Hosp Sick Children, Dept Physiol, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada.	mike.salter@utoronto.ca	Beggs, Simon/AAI-4438-2021	Beggs, Simon/0000-0002-1582-8391	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MT 11219]; Krembil Foundation; Ontario Neurotrauma Foundation; Jacob's Ladder	Supported by Canadian Institutes of Health Research (CIHR) grant MT 11219 to MWS as well as by the Krembil Foundation, the Ontario Neurotrauma Foundation and Jacob's Ladder. CK was the recipient of a CIHR Fellowship. MWS is an International Research Scholar of the Howard Hughes Medical Institute and holds a Canada Research Chair (Tier I) in Neuroplasticity and Pain.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bayliss WM, 1901, J PHYSIOL-LONDON, V26, P173; Beggs S, 2008, NAT MED, V14, P243, DOI 10.1038/nm0308-243; Beggs S, 2010, CURR OPIN NEUROBIOL, V20, P474, DOI 10.1016/j.conb.2010.08.005; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; BRODIN E, 1987, NEUROSCI LETT, V76, P357, DOI 10.1016/0304-3940(87)90429-0; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; Carmichael NME, 2008, NEUROSCIENCE, V153, P832, DOI 10.1016/j.neuroscience.2008.02.068; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Dale H H, 1934, Science, V80, P450; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Gee MD, 1997, J PHYSIOL-LONDON, V503, P31, DOI 10.1111/j.1469-7793.1997.031bi.x; Gonzalez HL, 2005, J PAIN, V6, P681, DOI 10.1016/j.jpain.2005.06.004; Gordh T, 2006, PAIN, V124, P211, DOI 10.1016/j.pain.2006.05.020; Hathway GJ, 2009, PAIN, V144, P110, DOI 10.1016/j.pain.2009.03.022; HOLZER P, 1988, NEUROSCIENCE, V24, P739, DOI 10.1016/0306-4522(88)90064-4; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; JANCSO G, 1992, EXP PHYSIOL, V77, P405, DOI 10.1113/expphysiol.1992.sp003603; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; KOLTZENBURG M, 1990, BRAIN RES, V509, P145, DOI 10.1016/0006-8993(90)90322-3; KWAN C, 11 WORLD C IASP 2008; Lewis T, 1926, Br Med J, V2, P61; LYNN B, 1988, NEUROSCIENCE, V24, P769, DOI 10.1016/0306-4522(88)90065-6; Nasu-Tada K, 2006, GLIA, V53, P769, DOI 10.1002/glia.20339; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Pitcher GM, 1999, PAIN, V83, P37, DOI 10.1016/S0304-3959(99)00085-8; Romanovsky AA, 2004, FRONT BIOSCI-LANDMRK, V9, P494, DOI 10.2741/1247; SZOLCSANYI J, 1988, AGENTS ACTIONS, V23, P4, DOI 10.1007/BF01967170; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2008, GLIA, V56, P579, DOI 10.1002/glia.20641; VILLAR MJ, 1989, NEUROSCIENCE, V33, P587, DOI 10.1016/0306-4522(89)90411-9; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	37	116	119	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1744-8069			MOL PAIN	Mol. Pain	NOV 2	2010	6								74	10.1186/1744-8069-6-74			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680VE	WOS:000284263200001	21044346	Green Published, gold			2022-02-06	
J	White, B; Driver, S; Warren, AM				White, Brian; Driver, Simon; Warren, Ann Marie			Resilience and Indicators of Adjustment During Rehabilitation From a Spinal Cord Injury	REHABILITATION PSYCHOLOGY			English	Article						resilience; depressive symptomatology; functional independence; satisfaction with life; spirituality	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; PERSONALITY PROTOTYPES; MAJOR DEPRESSION; SPIRITUALITY; HEALTH; ADOLESCENTS; COMMUNITY; RELIGION; PEOPLE	Objectives: The purposes of this study were to (a) identify changes in resilience and indicators of adjustment (i.e., satisfaction with life, depressive symptomatology, spirituality, functional independence) during inpatient rehabilitation after spinal cord injury (SCI) and (b) examine the relationship between each variable at different stages of the rehabilitation process. Design: The sample consisted of 42 individuals with a SCI, including 33 men and 9 women who were inpatients for a mean stay of 51 days (SD = 14.63). A repeated measures design was employed, with questionnaires completed at 3 times during the rehabilitation program (admit, 3 weeks, and discharge). Results: Results front the repeated measures multivariate analysis of covarance and post hoc follow-up tests indicated that there was no significant change in resilience, but that there was significant change for each indicator of adjustment during inpatient rehabilitation. Findings also indicated significant correlations between resilience, satisfaction with life, spirituality. and depressive symptoms. Conclusion: Future studies that focus oil developing interventions and examine the factors that predict resilience could help build resilience, which in turn may improve rehabilitation outcomes.	[White, Brian; Driver, Simon] Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA; [Warren, Ann Marie] Baylor Inst Rehabil, Dept Phys Med & Rehabil, Dallas, TX USA		Driver, S (corresponding author), Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, POB 310769, Denton, TX 76203 USA.	simon.driver@unt.edu		Warren, Ann Marie/0000-0002-3753-5573; driver, simon/0000-0003-2356-432X			Amatea E.S., 2006, PROF SCH COUNS, V9, P177, DOI [DOI 10.5330/PRSC.9.3.43751461038M4M68, 10.5330/prsc.9.3.43751461038m4m68]; Anderson NB, 2003, EMOTIONAL LONGEVITY; Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408.abs; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Burnett DM, 2002, NEUROREHABILITATION, V17, P187; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Charlifue S, 2004, NEUROREHABILITATION, V19, P91; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Connor KM, 2003, J TRAUMA STRESS, V16, P487, DOI 10.1023/A:1025762512279; Davey M, 2003, J ADOLESCENT RES, V18, P347, DOI 10.1177/0743558403018004002; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Dixon GS, 2005, DISABIL REHABIL, V27, P643, DOI 10.1080/09638280400018429; Elliott TR, 2004, REHABIL PSYCHOL, V49, P134, DOI 10.1037/0090-5550.49.2.134; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; FRANK RG, 1987, CLIN PSYCHOL REV, V7, P611, DOI 10.1016/0272-7358(87)90009-2; Froehlich JP, 2006, PASTOR PSYCHOL, V54, P465, DOI 10.1007/s11089-005-0011-0; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hodge DR, 2003, J SOC SERV RES, V30, P41, DOI 10.1300/J079v30n01_03; Hodges S, 2002, J ADULT DEV, V9, P109, DOI 10.1023/A:1015733329006; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Johnstone B, 2007, DISABIL REHABIL, V29, P1153, DOI 10.1080/09638280600955693; Johnstone B, 2009, REHABIL PSYCHOL, V54, P422, DOI 10.1037/a0017758; Kennedy P, 2000, SPINAL CORD, V38, P498, DOI 10.1038/sj.sc.3101021; LaFromboise TD, 2006, J COMMUNITY PSYCHOL, V34, P193, DOI 10.1002/jcop.20090; Luthar SS, 1996, J RES ADOLESCENCE, V6, P581; Luthar SS, 2000, DEV PSYCHOPATHOL, V12, P857, DOI 10.1017/S0954579400004156; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Mancini AD, 2006, J CLIN PSYCHOL, V62, P971, DOI 10.1002/jclp.20283; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Matheis EN, 2006, REHABIL PSYCHOL, V51, P265, DOI 10.1037/0090-5550.51.3.265; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; Munce SEP, 2007, PSYCHOSOMATICS, V48, P394, DOI 10.1176/appi.psy.48.5.394; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Nyland J, 2000, SPINAL CORD, V38, P649, DOI 10.1038/sj.sc.3101070; Rammstedt B, 2004, EUR J PERSONALITY, V18, P1, DOI 10.1002/per.495; Ray O, 2004, AM PSYCHOL, V59, P29, DOI 10.1037/0003-066X.59.1.29; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Riolli L, 2002, J APPL SOC PSYCHOL, V32, P1604, DOI 10.1111/j.1559-1816.2002.tb02765.x; Scherer MJ, 2001, DISABIL REHABIL, V23, P387; Schoon I, 2006, RISK AND RESILIENCE: ADAPTATIONS IN CHANGING TIMES, P1, DOI 10.2277/ 0521833744; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Sherman JE, 2004, REHABIL PSYCHOL, V49, P140, DOI 10.1037/0090-5550.49.2.140; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tabachnick B.G., 2001, USING MULTIVARIATE S; Vera EA, 2006, COUNS PSYCHOL, V34, P80, DOI 10.1177/0011000005282365; Weed K, 2006, J APPL DEV PSYCHOL, V27, P60, DOI 10.1016/j.appdev.2005.12.007; Westphal M, 2007, APPL PSYCHOL-INT REV, V56, P417, DOI 10.1111/j.1464-0597.2007.00298.x; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Woolrich Rachel A, 2006, Psychol Health Med, V11, P80, DOI 10.1080/13548500500294211; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]; [No title captured]; [No title captured]	57	116	131	1	22	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2010	55	1					23	32		10.1037/a0018451			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	563NJ	WOS:000275139000003	20175631				2022-02-06	
J	Lumpkins, KM; Bochicchio, GV; Keledjian, K; Simard, JM; McCunn, M; Scalea, T				Lumpkins, Kimberly M.; Bochicchio, Grant V.; Keledjian, Kaspar; Simard, J. Marc; McCunn, Maureen; Scalea, Thomas			Glial Fibrillary Acidic Protein is Highly Correlated With Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Glial fibrillary acidic protein	NEURON-SPECIFIC-ENOLASE; TRAUMATIC BRAIN; CEREBROSPINAL-FLUID; HEMORRHAGIC-SHOCK; SERUM-LEVELS; RELEASE; SEVERITY; S-100B; STROKE; BLOOD	Background. Glial fibrillary acidic protein (GFAP) is an intermediate filament protein found in the cytoskeleton of astroglia. Recent work has indicated that GFAP may serve as a serum marker of traumatic brain injury (TBI) that is released after central nervous system cell damage. Methods: Serum from 51 critically injured trauma patients was prospectively collected on admission and on hospital day 2. All patients underwent an admission head computed tomography (CT) scan as a part of their clinical evaluation. Patients with facial fractures in the absence of documented TBI and patients with spinal cord injury were excluded. Demographic and outcome data were collected prospectively. Serum GFAP was measured in duplicate using enzyme-linked immunosorbent assay techniques. Results: Thirty-nine (76%) of the 51 patients had CT-documented TBI. The study cohort was 72.5% men with a mean age of 43 years and mean Injury Severity Score (ISS) of 30.2. There were no statistically significant demographic differences between the two groups. At admission day, the mean GFAP level in non-TBI patients was 0.07 pg/mL compared with 6.77 pg/mL in TBI patients (p = 0.002). On day 2 the mean GFAP level was 0.02 in non-TBI patients compared with 2.17 in TBI patients (p = 0.003). Using regression analysis to control for age, sex, and ISS, the Head Abbreviated Injury Scale was predictive of the level of GFAP on both days I and 2 (p values 0.006 and 0.026, respectively). Although GFAP levels were not predictive of increased hospital length of stay, intensive care unit length of stay, or ventilator days, high GFAP levels on hospital day 2 were predictive of mortality when controlling for age, sex, and ISS (odds ratio 1.45, p value 0.028). The area under the receiver operating characteristic curve for GFAP was 0.90 for day I and 0.88 for day 2. A GFAP cutoff point of I pg/mL yielded 100% specificity and 50% to 60% sensitivity for TBI. Conslusions: GFAP is a serum marker of TBI, and persistent elevation on day 2 is predictive of increased mortality. Excellent specificity for CT-documented brain injury was found using a cutoff point of I pg/mL.	[Lumpkins, Kimberly M.; Bochicchio, Grant V.; Keledjian, Kaspar; Simard, J. Marc; McCunn, Maureen; Scalea, Thomas] R Adams Cowley Shock Trauma Ctr, Div Clin & Outcomes Res, Baltimore, MD 21201 USA		Bochicchio, GV (corresponding author), R Adams Cowley Shock Trauma Ctr, Div Clin & Outcomes Res, 22 S Greene St, Baltimore, MD 21201 USA.	gbochicchio@umm.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1T32GM075767] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM075767] Funding Source: NIH RePORTER		AURELL A, 1991, STROKE, V22, P1254, DOI 10.1161/01.STR.22.10.1254; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Missler U, 1999, CLIN CHEM, V45, P138; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, SHOCK, V22, P88, DOI 10.1097/01.shk.0000130157.34382.3f; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pelinka LE, 2003, SHOCK, V19, P422, DOI 10.1097/01.shk.0000055345.58165.52; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Steiner J, 2006, J NEUROL NEUROSUR PS, V77, P1284, DOI 10.1136/jnnp.2006.093427; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; Vissers JLM, 2006, CLIN CHIM ACTA, V366, P336, DOI 10.1016/j.cca.2005.11.017; Vos PE, 2006, EUR J NEUROL, V13, P632, DOI 10.1111/j.1468-1331.2006.01332.x; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wunderlich MT, 2006, EUR J NEUROL, V13, P1118, DOI 10.1111/j.1468-1331.2006.01435.x	17	116	119	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2008	65	4					778	784		10.1097/TA.0b013e318185db2d			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	361JS	WOS:000260124500007	18849790				2022-02-06	
J	Colville, G; Kerry, S; Pierce, C				Colville, Gillian; Kerry, Sally; Pierce, Christine			Children's factual and delusional memories of intensive care	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article						post-traumatic stress; hallucinations; memory; opiates; benzodiazepines	POSTTRAUMATIC-STRESS-DISORDER; MECHANICALLY VENTILATED PATIENTS; PRINCIPAL-COMPONENTS-ANALYSIS; CRITICAL ILLNESS; EVENT SCALE; DELIRIUM; WITHDRAWAL; IMPACT; PHENOMENOLOGY; MORTALITY	Rationale Delusional memories are significantly associated with post-traumatic stress in adult patients after intensive care. Objectives: In this study, we attempted to establish whether this relationship was found in children. We also examined the association between factual memory and distress. Methods: One hundred two consecutive children, aged between 7 and 17 years, were interviewed about their pediatric intensive care unit (PICU) experience 3 months after discharge from a PICU. Principal measures were the ICU Memory Tool (a checklist of intensive care memories) and an abbreviated version of the Impact of Event Scale (a screen for post-traumatic stress disorder). Measurements and Main Results: In total, 64 of 102 (63%) children reported at least one factual memory of their admission and 33 of 102 (32%) reported delusional memories, including disturbing hallucinations. Traumatic brain injury was negatively associated with factual memory (odds ratio, 0.23; 95% confidence interval [CI], 0.09-0.58; P = 0.002). Longer duration of opiates/benzodiazepines was associated with delusional memory (odds ratio, 4.98; 95% CI, 1.3-20.0; P = 0.023). Post-traumatic stress scores were higher in children reporting delusional memories (adjusted difference, 3.0; 95% Cl, 0.06-5.9; P = 0.045) when illness severity and emergency status were controlled for. Factual memory was not significantly associated with post-traumatic stress. Conclusions: This study indicates that delusional memories are reported by almost one-third of children and are associated both with the duration of opiates/benzodiazepines and risk of post-traumatic stress. More research is needed on the presence of delusional memories and associated risk factors in children receiving intensive care treatment.	[Colville, Gillian] Gen Hosp St Georg, Pediat Psychol Serv, London SW17 0QT, England; [Kerry, Sally] St Georges Univ London, Community Hlth Sci, London, England; [Pierce, Christine] Great Ormond St Hosp Sick Children, Pediat Intens Care Unit, London WC1N 3JH, England		Colville, G (corresponding author), Gen Hosp St Georg, Pediat Psychol Serv, London SW17 0QT, England.	gcolvill@sgul.ac.uk	Colville, Gillian/ABH-3180-2020	Colville, Gillian/0000-0001-8530-2822			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Capuzzo M, 2004, CRIT CARE, V8, pR48, DOI 10.1186/cc2416; Colville G, 2006, CRIT CARE MED, V34, pA20, DOI 10.1097/00003246-200612002-00080; CUTTING J, 1987, BRIT J PSYCHIAT, V151, P324, DOI 10.1192/bjp.151.3.324; Ducharme Celine, 2005, Intensive Crit Care Nurs, V21, P179; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fonsmark L, 1999, CRIT CARE MED, V27, P196, DOI 10.1097/00003246-199901000-00052; Gaudreau JD, 2005, PSYCHOSOMATICS, V46, P302, DOI 10.1176/appi.psy.46.4.302; Griffiths J, 2007, INTENS CARE MED, V33, P1506, DOI 10.1007/s00134-007-0730-z; HUGHES J, 1994, ACTA PAEDIATR, V83, P1194; HUGHES J, 1998, INTENSIVE CRIT CARE, V4, P8; Hulst JM, 2005, INTENS CARE MED, V31, P880, DOI 10.1007/s00134-005-2647-8; Ista E, 2007, INTENS CARE MED, V33, P1396, DOI 10.1007/s00134-007-0696-x; Jones C, 2007, INTENS CARE MED, V33, P978, DOI 10.1007/s00134-007-0600-8; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; Jones C, 1999, INTENS CARE MED, V25, P1183, DOI 10.1007/s001340051035; Jones C., 2000, CLIN INTENSIVE CARE, V11, P252; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Magarey Judith M, 2005, Intensive Crit Care Nurs, V21, P344; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Meagher DJ, 2001, BMJ-BRIT MED J, V322, P144, DOI 10.1136/bmj.322.7279.144; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; *PAED INT CAR AUD, 2005, ANN REP 2003 2004; Pandharipande P, 2006, CRIT CARE CLIN, V22, P313, DOI 10.1016/j.ccc.2006.02.010; Pearson GA, 2001, ARCH DIS CHILD, V84, P125, DOI 10.1136/adc.84.2.125; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; Playfor S, 2000, ARCH DIS CHILD, V83, P445, DOI 10.1136/adc.83.5.445; Playfor S, 2006, INTENS CARE MED, V32, P1125, DOI 10.1007/s00134-006-0190-x; Rees G, 2004, INTENS CARE MED, V30, P1607, DOI 10.1007/s00134-004-2310-9; Rennick Janet E, 2004, Pediatr Crit Care Med, V5, P358, DOI 10.1097/01.PCC.0000128603.20501.0D; Ringdal Mona, 2006, Intensive Crit Care Nurs, V22, P346, DOI 10.1016/j.iccn.2006.03.001; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Schieveld JNM, 2007, INTENS CARE MED, V33, P1033, DOI 10.1007/s00134-007-0637-8; Scott CK, 2006, J TRAUMA STRESS, V19, P757, DOI 10.1002/jts.20186; Scragg P, 2001, ANAESTHESIA, V56, P9, DOI 10.1046/j.1365-2044.2001.01714.x; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Stallard P, 1999, J CHILD PSYCHOL PSYC, V40, P1075, DOI 10.1017/S0021963099004473; Tobias JD, 2000, CRIT CARE MED, V28, P2122, DOI 10.1097/00003246-200006000-00079; Tobias JD, 2007, PEDIATR CRIT CARE ME, V8, P115, DOI 10.1097/01.PCC.0000257100.31779.41; Townsend P, 1988, HLTH DEPRIVATION INE; Truog RD, 2005, INTENS CARE MED, V31, P760, DOI 10.1007/s00134-005-2646-9; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Turkel SB, 2003, J NEUROPSYCH CLIN N, V15, P431, DOI 10.1176/appi.neuropsych.15.4.431; YULE W, 1994, PERS INDIV DIFFER, V16, P685, DOI 10.1016/0191-8869(94)90210-0; Yule W., 1997, CHILD PSYCHOL PORTFO	50	116	119	1	12	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	MAY 1	2008	177	9					976	982		10.1164/rccm.200706-857OC			7	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	295PJ	WOS:000255486100010	18244955				2022-02-06	
J	Sabet, AA; Christoforou, E; Zatlin, B; Genin, GM; Bayly, PV				Sabet, Arash A.; Christoforou, Eftychios; Zatlin, Benjamin; Genin, Guy M.; Bayly, Philip V.			Deformation of the human brain induced by mild angular head acceleration	JOURNAL OF BIOMECHANICS			English	Article						angular acceleration; brain trauma; strain; head injury; brain deformation; MRI	DIFFUSE AXONAL INJURY; MOTION; MODEL; CRITERIA; MRI	Deformation of the human brain was measured in tagged magnetic resonance images (MRI) obtained dynamically during angular acceleration of the head. This study was undertaken to provide quantitative experimental data to illuminate the mechanics of traumatic brain injury (TBI). Mild angular acceleration was imparted to the skull of a human volunteer inside an MR scanner, using a custom MR-compatible device to constrain motion. A grid of MR "tag" lines was applied to the MR images via spatial modulation of magnetization (SPAMM) in a fast gradient echo imaging sequence. Images of the moving brain were obtained dynamically by synchronizing the imaging process with the motion of the head. Deformation of the brain was characterized quantitatively via Lagrangian strain. Consistent patterns of radial-circumferential shear strain occur in the brain, similar to those observed in models of a viscoelastic gel cylinder subjected to angular acceleration. Strain fields in the brain, however, are clearly mediated by the effects of heterogeneity, divisions between regions of the brain (such as the central fissure and central sulcus) and the brain's tethering and suspension system, including the dura mater, falx cerebri, and tentorium membranes. (c) 2007 Elsevier Ltd. All rights reserved.	[Sabet, Arash A.; Genin, Guy M.; Bayly, Philip V.] Washington Univ, Dept Mech Aerosp & Struct Engn, St Louis, MO 63130 USA; [Bayly, Philip V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Christoforou, Eftychios] Univ Cyprus, Dept Elect & Comp Engn, Nicosia, Cyprus; [Zatlin, Benjamin] Univ So Calif, Los Angeles, CA 90089 USA		Bayly, PV (corresponding author), Washington Univ, Dept Mech Aerosp & Struct Engn, St Louis, MO 63130 USA.	pvb@me.wustl.edu		Bayly, Philip/0000-0003-4303-0704	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24CA083060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R24 CA083060, R24-CA83060] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS055951-01A1, R56 NS055951, R01 NS055951-02, R01 NS055951, NS-55951] Funding Source: Medline		AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; BAYLY PV, 2007, IN PRESS MAGNETIC RE; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Ji Songbai, 2004, Stapp Car Crash J, V48, P227; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Reese TG, 2002, MAGN RESON MED, V47, P665, DOI 10.1002/mrm.10111; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; THURMAN D, 2001, HEAD TRAUMA BASIC PR; WEDEEN V, 1996, ENCY NUCL MAGNETIC R; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018; [No title captured], DOI DOI 10.1016/0021-9290(90)90029-3	24	116	116	1	23	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.		2008	41	2					307	315		10.1016/j.jbiomech.2007.09.016			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	263LY	WOS:000253219800009	17961577	Green Accepted			2022-02-06	
J	Pistollato, F; Chen, HL; Schwartz, PH; Basso, G; Panchision, DM				Pistollato, Francesca; Chen, Hui-Ling; Schwartz, Philip H.; Basso, Giuseppe; Panchision, David M.			Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						brain; stem cells/Progenitor cells; oxygen; oligodendrocyte; astrocyte; CD133 antigen; bone morphogenetic proteins	BONE MORPHOGENETIC PROTEINS; NEURAL PROGENITOR CELLS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ADULT HUMAN BRAIN; STEM-CELLS; IN-VITRO; OXIDATIVE STRESS; DOPAMINERGIC DIFFERENTIATION; SUBVENTRICULAR ZONE	Human neural precursor proliferation and potency is limited by senescence and loss of oligodendrocyte potential. We found that in vitro expansion of human postnatal brain CD133(+) nestin(+) precursors is enhanced at 5% oxygen, while raising oxygen tension to 20% depletes precursors and promotes astrocyte differentiation even in the presence of mitogens. Higher cell densities yielded more astrocytes regardless of oxygen tension. This was reversed by noggin at 5%, but not 20%, oxygen due to a novel repressive effect of low oxygen on bone morphogenetic protein (BMP) signaling. When induced to differentiate by mitogen withdrawal, 5% oxygen-expanded precursors generated 17-fold more oligodendrocytes than cells expanded in 20% oxygen. When precursors were expanded at 5% oxygen and then differentiated at 20% oxygen, oligodendrocyte maturation was further enhanced 2.5-fold. These results indicate that dynamic control of oxygen tension regulates different steps in fate and maturation and may be crucial for treating neurodegenerative diseases. (c) 2007 Elsevier Inc. All rights reserved.	Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; Univ Padua, Dept Pediat, Hematooncol Lab, I-35100 Padua, Italy; Childrens Hosp Orange Cty Res Inst, Orange, CA USA; Univ Calif Irvine, Irvine, CA USA		Panchision, DM (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, 5th Floor,Suite 5340,111 Michigan Ave NW, Washington, DC 20010 USA.	dpanchision@cnmcresearch.org	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; BASSO, GIUSEPPE/0000-0002-2634-9302			Adam AAG, 2004, JPN J VET RES, V52, P77; Adelman DM, 2000, ADV EXP MED BIOL, V475, P275; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 1998, J NEUROSCI, V18, P6241; Bernier PJ, 2000, NEUROSCI RES, V37, P67, DOI 10.1016/S0168-0102(00)00102-4; Blakemore WF, 2002, GLIA, V38, P155, DOI 10.1002/glia.10067; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Carson S, 2005, CLIN REHABIL, V19, P819, DOI 10.1191/0269215505cr907oa; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Catt J W, 2000, Hum Reprod, V15 Suppl 2, P199; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Gerstner B, 2006, J NEUROSCI RES, V84, P306, DOI 10.1002/jnr.20880; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Guyton AC, 2006, TXB MED PHYSL, Vxxxv; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hoge RD, 2001, J CHEM NEUROANAT, V22, P43, DOI 10.1016/S0891-0618(01)00114-4; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Ivanovic Z, 2004, STEM CELLS, V22, P716, DOI 10.1634/stemcells.22-5-716; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kilani RT, 2003, PLACENTA, V24, P826, DOI 10.1016/S0143-4004(03)00129-2; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Madhavan L, 2006, STEM CELLS, V24, P2110, DOI 10.1634/stemcells.2006-0018; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Ostenfeld T, 2004, STEM CELLS, V22, P798, DOI 10.1634/stemcells.22-5-798; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; PANCHISION DM, 2007, IN PRESS STEM CELLS; Postovit LM, 2002, J BIOL CHEM, V277, P35730, DOI 10.1074/jbc.M204529200; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708; Saito A, 2005, MOL NEUROBIOL, V31, P105, DOI 10.1385/MN:31:1-3:105; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tokuda Y, 2000, J CELL PHYSIOL, V182, P414, DOI 10.1002/(SICI)1097-4652(200003)182:3<414::AID-JCP12>3.0.CO;2-5; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Ungerstedt U, 1997, Acta Anaesthesiol Scand Suppl, V110, P123; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Wu XQ, 2006, CIRC RES, V99, P240, DOI 10.1161/01.RES.0000237021.65103.24; Yanagisawa M, 2001, NEUROSCI RES, V41, P391, DOI 10.1016/S0168-0102(01)00297-8; Yu XB, 2002, DEVELOPMENT, V129, P505; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044; Zhang SC, 2000, J NEUROSCI RES, V59, P421, DOI 10.1002/(SICI)1097-4547(20000201)59:3<421::AID-JNR17>3.0.CO;2-C; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	83	116	119	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431			MOL CELL NEUROSCI	Mol. Cell. Neurosci.	JUL	2007	35	3					424	435		10.1016/j.mcn.2007.04.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190KL	WOS:000248057600003	17498968				2022-02-06	
J	Brennan, KC; Beltran-Parrazal, L; Lopez-Valdes, HE; Theriot, J; Toga, AW; Charles, AC				Brennan, Kevin C.; Beltran-Parrazal, Luis; Lopez-Valdes, Hector E.; Theriot, Jeremy; Toga, Arthur W.; Charles, Andrew C.			Distinct vascular conduction with cortical spreading depression	JOURNAL OF NEUROPHYSIOLOGY			English	Article							OPTICAL INTRINSIC SIGNALS; CALCIUM WAVES; BLOOD-FLOW; ARTERIOLAR DILATION; CEREBRAL-CORTEX; RATS; K+; REACTIVITY; RESPONSES; CATS	Cortical spreading depression (CSD) is associated with significant vasodilatation and vasoconstriction, but the relationship between the cortical parenchymal and vascular phenomena remains poorly understood. We used optical intrinsic signal (OIS) imaging and electrophysiology to simultaneously examine the vascular and parenchymal changes that occur with CSD in anesthetized mice and rats. CSD was associated with a propagated multiphasic change in optical reflectance, with correlated negative DC shift in field potential. Dilatation of cortical surface arterioles propagated with a significantly greater intrinsic velocity than the parenchymal CSD wavefront measured by OIS and electrophysiology. Dilatation traveled in a circuitous pattern along individual arterioles, indicating specific vascular conduction as opposed to concentric propagation of a parenchymal signal. Arteriolar dilatation propagated into areas beyond the spread of parenchymal OIS and electrophysiological changes of CSD. Conversely, vasomotor activity could be experimentally dissociated from the parenchymal CSD wave. Frequent repetitive CSD evoked by continuous stimulation was associated with a reduced or absent arteriolar response despite preserved parenchymal OIS and electrophysiological changes. Similarly, dimethylsulfoxide at high concentrations (10%) inhibited arteriolar reactivity despite preserved parenchymal OIS and electrophysiological changes. These results suggest a mechanism, intrinsic to the vasculature, for propagation of vasodilatation associated with CSD. Distinct vascular conduction could be important for the pathogenesis of conditions that involve CSD, including migraine, stroke, and traumatic brain injury.	Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Lab Neuro Imaging, Los Angeles, CA USA		Charles, AC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Neurosci Res Bldg,Room 575,635 Charles E Young Dr, Los Angeles, CA 90095 USA.	acharles@ucla.edu	Beltran-Parrazal, Luis/L-3424-2019; Beltran-Parrazal, Luis/A-9330-2016; Lopez-Valdes, Hector Eduardo/J-9069-2017	Beltran-Parrazal, Luis/0000-0002-4765-9051; Beltran-Parrazal, Luis/0000-0002-4765-9051; Lopez-Valdes, Hector Eduardo/0000-0002-5980-6039; Brennan, K.C./0000-0003-4193-5841	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH052083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P50DA005010] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [P50 DA005010] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH-052083] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-39961] Funding Source: Medline		Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Ba AM, 2002, J NEUROPHYSIOL, V88, P2726, DOI 10.1152/jn.00729.2001; Basarsky TA, 1998, J NEUROSCI, V18, P7189; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; COLONNA DM, 1994, STROKE, V25, P2463, DOI 10.1161/01.STR.25.12.2463; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; Domenighetti AA, 1998, J PHYSIOL-LONDON, V513, P103, DOI 10.1111/j.1469-7793.1998.103by.x; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23, DOI 10.1152/ajpheart.1995.269.1.H23; FLORENCE G, 1994, AM J PHYSIOL, V266, pR1136, DOI 10.1152/ajpregu.1994.266.4.R1136; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Guiou M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852556; Horiuchi T, 2002, STROKE, V33, P2692, DOI 10.1161/01.STR.0000034791.52151.6B; Iadecola C, 1997, J NEUROPHYSIOL, V78, P651, DOI 10.1152/jn.1997.78.2.651; Kunkler PE, 1998, J NEUROSCI, V18, P3416; LACOMBE P, 1992, EXP NEUROL, V117, P278, DOI 10.1016/0014-4886(92)90137-F; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; Leao AAP, 1944, J NEUROPHYSIOL, V7, P391, DOI 10.1152/jn.1944.7.6.391; NARAYAN SM, 1994, CEREB CORTEX, V4, P195, DOI 10.1093/cercor/4.2.195; Ngai AC, 2007, STROKE, V38, P124, DOI 10.1161/01.STR.0000252157.93998.47; O'Farrell AM, 2000, NEUROREPORT, V11, P2121, DOI 10.1097/00001756-200007140-00013; Osada T, 2006, NEUROREPORT, V17, P1365, DOI 10.1097/01.wnr.0000227992.00175.fa; Peters O, 2003, J NEUROSCI, V23, P9888; PIPER RD, 1991, AM J PHYSIOL, V261, pH96, DOI 10.1152/ajpheart.1991.261.1.H96; PITTS LH, 1986, STROKE, V17, P483, DOI 10.1161/01.STR.17.3.483; Pouratian N., 2002, BRAIN MAPPING METHOD, P97; Reuter U, 1998, AM J PHYSIOL-HEART C, V274, pH1979, DOI 10.1152/ajpheart.1998.274.6.H1979; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Seitz I, 2004, J CEREBR BLOOD F MET, V24, P526, DOI 10.1097/00004647-200405000-00006; SHIBATA M, 1991, AM J PHYSIOL, V261, pR828, DOI 10.1152/ajpregu.1991.261.4.R828; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sonn J, 2000, BRAIN RES, V882, P212, DOI 10.1016/S0006-8993(00)02827-4; Tomita M, 2005, J CEREBR BLOOD F MET, V25, P742, DOI 10.1038/sj.jcbfm.9600074; Tomita M, 2003, ACTA NEUROCHIR SUPPL, V86, P219; Tomita Y, 2002, NEUROSCI LETT, V322, P157, DOI 10.1016/S0304-3940(02)00072-1; VANHARREVELD A, 1957, AM J PHYSIOL, V189, P159, DOI 10.1152/ajplegacy.1957.189.1.159; WAHL M, 1973, CIRC RES, V32, P162, DOI 10.1161/01.RES.32.2.162; WAHL M, 1987, BRAIN RES, V411, P72, DOI 10.1016/0006-8993(87)90682-2; Yashiro Y, 2000, CIRC RES, V87, P1048, DOI 10.1161/01.RES.87.11.1048	39	116	119	1	8	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	JUN	2007	97	6					4143	4151		10.1152/jn.00028.2007			9	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	188RY	WOS:000247938200030	17329631				2022-02-06	
J	Bisson, E; Contant, B; Sveistrup, H; Lajoie, Y				Bisson, E.; Contant, B.; Sveistrup, H.; Lajoie, Y.			Functional balance and dual-task reaction times in older adults are improved by virtual reality and biofeedback training	CYBERPSYCHOLOGY & BEHAVIOR			English	Article							EXERCISE; STRENGTH; GAIT; POSTURE; RISK	Virtual reality (VR) training has been used successfully to rehabilitate functional balance and mobility in both traumatic brain injury (TBI) survivors and elderly subjects. Similarly, computer-based biofeedback (BF) training has resulted in decreased sway during quiet stance and decreased reaction times during a dual-task reaction time paradigm in elderly subjects. The objective of this study was to determine the effect of VR and BF training on balance and reaction time in older adults. Two groups of twelve healthy older adults completed 10-week training programs consisting of two 30-min sessions per week. VR training required that participants lean sideways to juggle a virtual ball. Participants in the BF group viewed a red dot representing their center of gravity on a screen and were required to move the dot to the four corners of the monitor. Measures of functional balance and mobility ( Community Balance and Mobility Scale [CB&M]), sway during quiet stance, and reaction time during a dual task paradigm were recorded before training, as well as 1 week and 1 month after the end of the program. Both groups showed significant improvements on the CB&M, as well as decreased reaction times with training. Postural sway during quiet stance did not change significantly.	Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON K1N 6N5, Canada		Lajoie, Y (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, 125 Univ St, Ottawa, ON K1N 6N5, Canada.	ylajoie@uottawa.ca					Barrett C, 2002, AUST J PHYSIOTHER, V48, P215, DOI 10.1016/S0004-9514(14)60226-9; Bellew JW, 2003, J STRENGTH COND RES, V17, P121; Brown DA, 2002, NEUROLOGY REPORT, V26, P105, DOI DOI 10.1097/01253086-200226020-00009; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; Evans WJ, 1999, MED SCI SPORT EXER, V31, P12, DOI 10.1097/00005768-199901000-00004; Gallova J, 2004, COLLOID SURFACE B, V38, P11, DOI 10.1016/j.colsurfb.2004.07.012; GEURTS ACH, 1994, J MOTOR BEHAV, V26, P162, DOI 10.1080/00222895.1994.9941670; HAMMAN R, 1995, J OTOLARYNGOL, V24, P221; Holden M.K, 2002, NEUROLOGY REPORT, V26, P62, DOI [10.1097/01253086-200226020-00003, DOI 10.1097/01253086-200226020-00003]; Hunter MC, 2001, GAIT POSTURE, V13, P41, DOI 10.1016/S0966-6362(00)00089-8; Inness E, 2000, PHYSIOTHER CAN, V52, pS72; Inness L, 2002, SYNAPSE, V22, P2; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Lajoie Y, 2004, AGING CLIN EXP RES, V16, P363; Lord S. R., 2001, FALLS OLDER PEOPLE R; Lord SR, 2003, J AM GERIATR SOC, V51, P1645, DOI 10.1046/j.1532-5415.2003.51518.x; MCCOMAS J, 2002, NEUROLOGY REPORT, V26, P55, DOI DOI 10.1097/01253086-200226020-00002; Pimentel K, 1995, VIRTUAL REALITY NEW, V2nd; Ryushi Tomoo, 2000, Journal of Physiological Anthropology and Applied Human Science, V19, P143, DOI 10.2114/jpa.19.143; SCHMIDT RA, 1982, MOTOR CONTROL LEARN; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Sveistrup Heidi, 2004, J Neuroeng Rehabil, V1, P10, DOI 10.1186/1743-0003-1-10; Taggart HM, 2002, APPL NURS RES, V15, P235, DOI 10.1053/apnr.2002.35975; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Wolf SL, 1997, PHYS THER, V77, P371, DOI 10.1093/ptj/77.4.371; WOLFSON L, 1995, J GERONTOL A-BIOL, V50, P64; Wolfson L, 1996, J AM GERIATR SOC, V44, P498, DOI 10.1111/j.1532-5415.1996.tb01433.x; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	28	116	120	2	21	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1094-9313			CYBERPSYCHOL BEHAV	CyberPsychol. Behav.	FEB	2007	10	1					16	23		10.1089/cpb.2006.9997			8	Communication; Psychology, Applied	Social Science Citation Index (SSCI)	Communication; Psychology	143IK	WOS:000244713800003	17305444				2022-02-06	
J	Nesic, O; Lee, J; Ye, Z; Unabia, GC; Rafati, D; Hulsebosch, CE; Perez-Polo, JR				Nesic, O.; Lee, J.; Ye, Z.; Unabia, G. C.; Rafati, D.; Hulsebosch, C. E.; Perez-Polo, J. R.			Acute and chronic changes in aquaporin 4 expression after spinal cord injury	NEUROSCIENCE			English	Article						spinal cord injury; astrocytes; aquaporin 4; water content; glia limitans	TRAUMATIC BRAIN-INJURY; WATER CHANNELS; RAT-BRAIN; EDEMA; MICE; BARRIER; DELETION; IMMUNOREACTIVITY; HYPONATREMIA; PERMEABILITY	The effect of spinal cord injury (SCI) on the expression levels and distribution of water channel aquaporin 4 (AQP4) has not been studied. We have found AQP4 in gray and white matter astrocytes in both uninjured and injured rat spinal cords. AQP4 was detected in astrocytic processes that were tightly surrounding neurons and blood vessels, but more robustly in glia limitans externa and interna, which were forming an interface between spinal cord parenchyma and cerebrospinal fluid (CSF). Such spatial distribution of AQP4 suggests a critical role that astrocytes expressing AQP4 play in the transport of water from blood/CSF to spinal cord parenchyma and vice versa. SCI induced biphasic changes in astrocytic AQP4 levels, including its early down-regulation and subsequent persistent up-regulation. However, changes in AQP4 expression did not correlate well with the onset and magnitude of astrocytic activation, when measured as changes in GFAP expression levels. It appears that reactive astrocytes began expressing increased levels of AQP4 after migrating to the wound area (thoracic region) two weeks after SCI, and AQP4 remained significantly elevated for months after SCI. We also showed that increased levels of AQP4 spread away from the lesion site to cervical and lumbar segments, but only in chronically injured spinal cords. Although overall AQP4 expression levels increased in chronically-injured spinal cords, AQP4 immunolabeling in astrocytic processes forming glia limitans externa was decreased, which may indicate impaired water transport through glia limitans externa. Finally, we also showed that SCI-induced changes in AQP4 protein levels correlate, both temporally and spatially, with persistent increases in water content in acutely and chronically injured spinal cords. Although correlative, this finding suggests a possible link between AQP4 and impaired water transport/edema/syringomyelia in contused spinal cords. (c) 2006 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Texas, Med Branch, Dept BMB, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA		Nesic, O (corresponding author), Univ Texas, Med Branch, Dept BMB, MRB 7-138G,301 Univ Blvd, Galveston, TX 77555 USA.	Olnesic@utmb.edu	Perez-Polo, Jose R./B-6250-2009; nesic, olivera/C-6456-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS039161] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39161, P01 NS039161, P01 NS039161-05] Funding Source: Medline		Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2004, FASEB J, V18, P542, DOI 10.1096/fj.03-0869fje; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Carroll AM, 2005, SPINE, V30, P1206, DOI 10.1097/01.brs.0000162277.76012.0b; FRIGERI A, 1995, J CELL SCI, V108, P2993; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Gunnarson E, 2005, NEUROSCIENCE, V136, P105, DOI 10.1016/j.neuroscience.2005.07.027; Imura T, 2006, GLIA, V53, P277, DOI 10.1002/glia.20281; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Li S, 1999, SPINAL CORD, V37, P820, DOI 10.1038/sj.sc.3100941; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; MARMAROU A, 1994, AM J PHYSIOL, V267, pH514, DOI 10.1152/ajpheart.1994.267.2.H514; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Nesic-Taylor O, 2005, J NEUROSCI RES, V79, P628, DOI 10.1002/jnr.20400; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Oshio K, 2004, NEUROSCIENCE, V127, P685, DOI 10.1016/j.neuroscience.2004.03.016; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Perdiki M, 1998, ACTA NEUROPATHOL, V96, P8, DOI 10.1007/s004010050854; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Rash JE, 1999, CELL TISSUE RES, V296, P307, DOI 10.1007/s004410051291; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Sato S, 2000, ACTA NEUROCHIR SUPPL, V76, P239; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Ulger H, 2002, ANAT HISTOL EMBRYOL, V31, P31, DOI 10.1046/j.1439-0264.2002.00357.x; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Vitellaro-Zuccarello L, 2005, GLIA, V51, P148, DOI 10.1002/glia.20196; WAGNER FC, 1981, J NEUROSURG, V54, P802, DOI 10.3171/jns.1981.54.6.0802; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Zai LJ, 2005, BRAIN RES, V1052, P147, DOI 10.1016/j.brainres.2005.05.071; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	48	116	123	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 13	2006	143	3					779	792		10.1016/j.neuroscience.2006.08.079			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	114DP	WOS:000242647200012	17074445	Green Accepted			2022-02-06	
J	Garner, JP; Thogerson, CM; Wurbel, H; Murray, JD; Mench, JA				Garner, Joseph P.; Thogerson, Collette M.; Wuerbel, Hanno; Murray, James D.; Mench, Joy A.			Animal neuropsychology: Validation of the Intra-Dimensional Extra-Dimensional set shifting task for mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						executive; prefrontal cortex; Wisconsin card sort test; autism; obsessive compulsive disorder; traumatic brain injury; trichotillomania	TEMPORAL-LOBE EXCISIONS; AMYGDALO-HIPPOCAMPECTOMY; LABORATORY ENVIRONMENT; PREFRONTAL CORTEX; BEHAVIORAL-TESTS; MOUSE BEHAVIOR; DISCRIMINATION; STANDARDIZATION; SCHIZOPHRENIA; STEREOTYPIES	Research in animal neuropsychology is providing an exciting new generation of behavioral tests for mice that promise to overcome many of the limitations of current high-throughput testing, and provide direct animal homologues of clinically important measures in human research. Set shifting tasks are some of the best understood and widely used human neuropsychological tasks, with clinical relevance to traumatic brain injury, schizophrenia, autism, obsessive compulsive disorder, trichotillomania, and many other disorders. Here we report the first successful modification of a human set shifting neuropsychological task, the Intra-Dimensional Extra-Dimensional (IDED) task, for use with mice. We presented mice with a series of compound discrimination and reversal tasks where one stimulus dimension consistently cued reward. Task performance improved with a new set of compound stimuli, as did reversal performance-indicating the formation of a cognitive-attentional set. We then overtrained a subset of the mice, and presented control and overtrained mice with a new compound discrimination where a novel stimulus dimension cued reward. As is the case in human control subjects, control mice persisted in responding to the now-incorrect stimulus dimension, performing poorly on this extra-dimensional shift compared with the previous intra-dimensional shift, thereby validating the task as a measure of set shifting. Furthermore, overtrained mice were impaired on this extra-dimensional shift compared with controls, further validating the task. The advantages and disadvantages of the IDED task compared to high-throughput approaches are discussed. (c) 2006 Elsevier B.V. All rights reserved.	Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; Univ Giessen, Div Anim Welf & Ethol, D-35392 Giessen, Germany; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA		Garner, JP (corresponding author), Purdue Univ, Dept Anim Sci, 125 S Russell St, W Lafayette, IN 47907 USA.	jgarner@purdue.edu	Wurbel, Hanno/D-6281-2012; Citations, TLC SAB/C-4006-2011; Garner, Joseph P/C-8422-2009	Wurbel, Hanno/0000-0002-2934-3010; 	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [5 R03 MH 63907-2] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH063907] Funding Source: NIH RePORTER		Binder E, 2004, BEHAV BRAIN RES, V155, P197, DOI 10.1016/j.bbr.2004.04.017; Birrell JM, 2000, J NEUROSCI, V20, P4320; Brigman JL, 2005, BEHAV NEUROSCI, V119, P839, DOI 10.1037/0735-7044.119.3.839; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P957, DOI 10.1037/0735-7044.115.4.957; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Colacicco G, 2002, BEHAV BRAIN RES, V132, P95, DOI 10.1016/S0166-4328(01)00391-6; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; CRAWLEY JN, 2000, BEHAV PHENOTYPING TR, V13, P329; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DIVAC I, 1972, PHYSIOL BEHAV, V8, P519, DOI 10.1016/0031-9384(72)90339-3; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; Garner JP, 2004, COMPARATIVE MED, V54, P216; Garner JP, 2003, BEHAV BRAIN RES, V145, P125, DOI 10.1016/S0166-4328(03)00115-3; GARNER JP, UNPUB ETHOLOGY VALID; GARNER JP, 2003, P 37 INT C INT SOC A, P75; GARNER JP, IN PRESS STEREOTYPIC; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; GRAFEN A, 2002, MODERN STAT LIFE SCI, V15, P351; HEAD D, 1989, BIOL PSYCHIAT, V25, P929, DOI 10.1016/0006-3223(89)90272-2; Hossain SM, 2004, GENES BRAIN BEHAV, V3, P167, DOI 10.1111/j.1601-183x.2004.00069.x; HOWITT D, 1997, INTRO STAT PSYCHOL C, V12, P482; Kas MJH, 2004, TRENDS NEUROSCI, V27, P366, DOI 10.1016/j.tins.2004.04.011; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; Laurent V, 2004, BEHAV PHARMACOL, V15, P141, DOI 10.1097/00008877-200403000-00006; LITTELL RC, 2002, SAS LINEAR MODELS, V12, P466; Mackintosh N.J, 1974, PSYCHOL ANIMAL LEARN, Vxiv, P730; MACKINTOSH NJ, 1962, J COMP PHYSIOL PSYCH, V55, P555; Marino MD, 2005, BEHAV BRAIN RES, V161, P197, DOI 10.1016/j.bbr.2005.02.005; Miller KA, 2005, APPL ANIM BEHAV SCI, V92, P113, DOI 10.1016/j.applanim.2004.10.016; Miller KA, 2006, ANIM BEHAV, V71, P1323, DOI 10.1016/j.anbehav.2005.08.018; Newman JA, 1997, ECOLOGY, V78, P1312; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; OWEN AM, 1991, NEUROPSYCHOLOGIA, V29, P993, DOI 10.1016/0028-3932(91)90063-E; Owen AM, 1996, BRAIN, V119, P1597, DOI 10.1093/brain/119.5.1597; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; Pfaff D, 2001, P NATL ACAD SCI USA, V98, P5957, DOI 10.1073/pnas.101128598; RAINE A, 1992, PSYCHIAT RES-NEUROIM, V45, P123, DOI 10.1016/0925-4927(92)90006-P; ROLLS ET, 1994, REV NEUROL-FRANCE, V150, P648; Russell W.M.S, 1959, PRINCIPLES HUMANE EX, P238; Turner M, 1997, AUTISM EXECUTIVE DIS, P57; Wahlsten D, 2003, TRENDS NEUROSCI, V26, P132, DOI 10.1016/S0166-2236(03)00033-X; Wurbel H, 2000, NAT GENET, V26, P263, DOI 10.1038/81541; Wurbel H, 2002, GENES BRAIN BEHAV, V1, P3, DOI 10.1046/j.1601-1848.2001.00006.x; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; YOUNG RJ, 1994, ANIM BEHAV, V47, P1488, DOI 10.1006/anbe.1994.1202	46	116	116	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	OCT 2	2006	173	1					53	61		10.1016/j.bbr.2006.06.002			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	086DE	WOS:000240652500007	16842867				2022-02-06	
J	Morrison, B; Cater, HL; Benham, CD; Sundstrom, LE				Morrison, B; Cater, HL; Benham, CD; Sundstrom, LE			An in vitro model of traumatic brain injury utilising two-dimensional stretch of organotypic hippocampal slice cultures	JOURNAL OF NEUROSCIENCE METHODS			English	Article						deformation; neurodegeneration; neuron; glia; mechanical injury; brain	DIFFUSE AXONAL INJURY; MECHANICAL STRETCH; HEAD-INJURY; NEURAL TRAUMA; STRAIN-RATE; NEURONS; DEFORMATION; TISSUE; CELLS; NMDA	Traumatic brain injury (TBI) is caused by rapid deformation of the brain, resulting in a cascade of pathological events and ultimately neurodegeneration. Understanding how the biomechanics of brain deformation leads to tissue damage remains a considerable challenge. We have developed an in vitro model of TBI utilising organotypic hippocampal slice cultures on deformable silicone membranes, and an injury device, which generates tissue deformation through stretching the silicone substrate. Our injury device controls the biomechanical parameters of the stretch via feedback control, resulting in a reproducible and equi-biaxial deformation stimulus. Organotypic cultures remain well adhered to the membrane during deformation, so that tissue strain is 93 and 86% of the membrane strain in the x- and y-axis, respectively. Cell damage following injury is positively correlated with strain. In conclusion, we have developed a unique in vitro model to study the effects of mechanical stimuli within a complex cellular environment that mimics the in vivo environment. We believe this model could be a powerful tool to study the acute phases of TBI and the induced cell degeneration could provide a good platform for the development of potential therapeutic approaches and may be a useful in vitro alternative to animal models of TBI. (c) 2005 Elsevier B.V. All rights reserved.	Univ Southampton, Div Clin Neurosci, Southampton SO16 7PX, Hants, England; Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; GlaxoSmithKline Res & Dev Ltd, Neurol, Harlow CM19 5AW, Essex, England; GlaxoSmithKline Res & Dev Ltd, GI CEDD, Harlow CM19 5AW, Essex, England		Cater, HL (corresponding author), Univ Southampton, Div Clin Neurosci, Rm 6207,Biomed Sci Bldg,Boldrewood,Bassett Cresce, Southampton SO16 7PX, Hants, England.	hlcater@yahoo.co.uk	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Cater, Heather/0000-0002-8696-6070			Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Cater HL, 2003, J NEUROCHEM, V87, P1381, DOI 10.1046/j.1471-4159.2003.02100.x; CATER HL, IN PRESS J BIOMECH; CLAESSENS M, 1997, STAPP CAR CRASH J, P41; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hardy W N, 2001, Stapp Car Crash J, V45, P337; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Pringle AK, 1997, BRAIN RES, V755, P36, DOI 10.1016/S0006-8993(97)00089-9; Pringle AK, 1996, STROKE, V27, P2124, DOI 10.1161/01.STR.27.11.2124; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Wang CCB, 2002, J BIOMECH ENG-T ASME, V124, P557, DOI 10.1115/1.1503795; Weber JT, 2002, J NEUROTRAUM, V19, P1433, DOI 10.1089/089771502320914660; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Zhang JP, 2000, NEUROSCI LETT, V290, P21, DOI 10.1016/S0304-3940(00)01311-2; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; ZHOU C, 1995, STAPP CAR CRASH J, V39, P121	53	116	118	0	28	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 30	2006	150	2					192	201		10.1016/j.jneumeth.2005.06.014			10	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	013OG	WOS:000235418000006	16098599				2022-02-06	
J	Ramaswamy, S; Goings, GE; Soderstrom, KE; Szele, FG; Kozlowski, DA				Ramaswamy, S; Goings, GE; Soderstrom, KE; Szele, FG; Kozlowski, DA			Cellular proliferation and migration following a controlled cortical impact in the mouse	BRAIN RESEARCH			English	Article						traumatic brain injury; subventricular zone; BrdU; migration; sensorimotor cortex	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN INJURY; NEURAL STEM-CELLS; FLUORESCENT LATEX MICROSPHERES; MICROTUBULE-ASSOCIATED PROTEIN; SUBVENTRICULAR ZONE CELLS; NEWLY GENERATED NEURONS; ADULT MAMMALIAN BRAIN; NEUROTROPHIC FACTOR; PROGENITOR CELLS	Neurogenesis following neural degeneration has been demonstrated in many models of disease and injury. The present study further examines the early proliferative and migratory response of the brain to a controlled cortical impact (CCI) model of traumatic brain injury. The CCI was centered over the forelimb sensorimotor cortex, unilaterally, in the adult mouse. To examine proliferation, bromo-deoxyuridine (BrdU) was injected i.p. immediately post-injury and on post-injury days 1, 2, and 3. To assess migration, we labeled SVZ cells with inert latex microspheres immediately post-injury. By combining microsphere labeling with BrdU, we determined if migrating cells had gone through the S-phase of the cell cycle after the lesion. In addition, we used a marker of neurogenesis and migration, doublecortin, to further characterize the response of the SVZ to the injury. Lastly, we determined whether subregions of the SVZ respond differentially to injury. The current study demonstrates that 3 days following CCI cellular proliferation is seen around the cortex, in the SVZ, corpus callosum, and subcortical areas anatomically connected to, but not directly damaged by the impact. It delineates that an increase in proliferation occurs in the dorsal-most aspect of the ipsilateral SVZ following impact. Lastly, it demonstrates that proliferating cells migrate from the SVZ to cortical and subcortical structures affected by the injury and that some of these cells are migrating neuroblasts. (c) 2005 Elsevier B.V. All rights reserved.	De Paul Univ, Dept Biol Sci, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Dept Pediat, Childrens Mem Res Ctr, Chicago, IL 60614 USA		Kozlowski, DA (corresponding author), De Paul Univ, Dept Biol Sci, 2325 N Clifton, Chicago, IL 60614 USA.	dkozlows@depaul.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG42253] Funding Source: Medline		Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Alifragis P, 2002, EXP NEUROL, V174, P259, DOI 10.1006/exnr.2002.7870; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; COLIN W, 1989, BRAIN RES, V486, P334, DOI 10.1016/0006-8993(89)90520-9; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dixon CE, 1996, NEUROTRAUMA, P1337; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; EMMETT CJ, 1988, BRAIN RES, V447, P223, DOI 10.1016/0006-8993(88)91123-7; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Fitch MT, 1999, J NEUROSCI, V19, P8182; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Goldman SA, 1998, J NEUROBIOL, V36, P267, DOI 10.1002/(SICI)1097-4695(199808)36:2<267::AID-NEU12>3.3.CO;2-N; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; GUTH L, 1985, EXP NEUROL, V88, P1, DOI 10.1016/0014-4886(85)90109-8; HATTON JD, 1993, INT J DEV NEUROSCI, V11, P583, DOI 10.1016/0736-5748(93)90047-H; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Jankovski A, 1998, EUR J NEUROSCI, V10, P3853, DOI 10.1046/j.1460-9568.1998.00397.x; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jones E.G., 1985, THALAMUS; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Lie DC, 2002, J NEUROSCI, V22, P6639; Liu JL, 1998, J NEUROSCI, V18, P7768; Loos M, 2003, NEUROSCIENCE, V122, P373, DOI 10.1016/S0306-4522(03)00498-6; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mason HA, 2001, J NEUROSCI, V21, P7654, DOI 10.1523/JNEUROSCI.21-19-07654.2001; MILLER MW, 1987, EXP BRAIN RES, V67, P339; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; Nolte J., 1993, HUMAN BRAIN INTRO IT; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Paxinos G., 2004, RAT NERVOUS SYSTEM; PEDERSEN PH, 1995, INT J CANCER, V62, P767, DOI 10.1002/ijc.2910620620; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Risold PY, 2004, RAT NERVOUS SYSTEM, P605; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Suzuki Y, 1998, ANN NY ACAD SCI, V855, P252, DOI 10.1111/j.1749-6632.1998.tb10577.x; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Yang HKC, 2004, J NEUROSCI RES, V76, P282, DOI 10.1002/jnr.20071; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004	73	116	123	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 16	2005	1053	1-2					38	53		10.1016/j.brainres.2005.06.042			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	959YM	WOS:000231555500006	16051202				2022-02-06	
J	Gil, S; Caspi, Y; Ben-Ari, IZ; Koren, D; Klein, E				Gil, S; Caspi, Y; Ben-Ari, IZ; Koren, D; Klein, E			Does memory of a traumatic event increase the risk for posttraumatic stress disorder in patients with traumatic brain injury? A prospective study	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							FEAR	Objective: The present study examined prospectively the relationship between memory of the traumatic event and subsequent development of posttraumatic stress disorder ( PTSD). More specifically, the aims of this study were to 1) investigate the possibility that lack of memory of the traumatic event might be a protective factor; 2) assess whether memory of the traumatic event equally affects the three symptom clusters of PTSD: reexperiencing, avoidance, and hyperarousal; and 3) explore the predictive value of memory of the traumatic event for the development of subsequent PTSD in the immediate aftermath of the event. Method: One hundred twenty subjects with mild traumatic brain injury who were hospitalized for observation were assessed immediately after the trauma and followed up 1 week, 3 months, and 6 months later. All participants underwent psychiatric evaluation and self-assessment of their memory of the traumatic event. Results: Overall, 17 (14%) of the participants met full criteria for PTSD at 6 months. Subjects with memory of the traumatic event were significantly more likely to develop PTSD than those without memory of the traumatic event; the difference between the groups resulted primarily from the reexperiencing cluster. Logistic regression analysis revealed that memory of the traumatic event within the first 24 hours is a strong predictor of PTSD 6 months after the event. Conclusions: Our study indicated that memory of a traumatic event is a strong predictor and a potential risk factor for subsequent development of PTSD. Future studies are needed to show whether these findings can be generalized to other traumatic conditions.	Rambam Med Ctr, Dept Psychiat, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Univ Haifa, Sch Social Work, Fac Social Welf & Hlth Studies, IL-31999 Haifa, Israel; Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel		Klein, E (corresponding author), Rambam Med Ctr, Dept Psychiat, POB 9602, IL-31096 Haifa, Israel.	e_klein@rambam.health.gov.il		Koren, Danny/0000-0003-0238-766X			*ASS ADV AUT MED, 1990, AIS ABBR INJ SCAL 19; Ballenger JC, 2000, J CLIN PSYCHIAT, V61, P60; Beck AT, 1987, MANUAL REVISED BECK; Beck AT, 1988, MANUAL BECK ANXIETY; Blake D.D., 1990, CLIN ADM PTSD SCALE; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; First M., 1997, STRUCTURED CLIN INTE; Foa E. B, 1999, AM J CLIN PSYCHIAT, V60, P5; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Koren D, 1999, AM J PSYCHIAT, V156, P367; Lavie Peretz, 2001, TRAUMA DREAMS, P114; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; MARMAR CR, 1994, AM J PSYCHIAT, V151, P902; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Parkin AJ, 1999, CURR BIOL, V9, pR582, DOI 10.1016/S0960-9822(99)80378-9; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Reeves D, 1996, NCRFSR9601; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SIEGEL DJ, 1995, J PSYCHOTHERAPY PRAC, V0004, P00093; SQUIRE LR, 1990, COLD SH Q B, V55, P1007; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; TEASDALE G, 1974, LANCET, V2, P81; van der Kolk B. A., 2001, J AGGRESS MALTREAT T, V4, P9, DOI [10.1300/j146v04n02_02, 10.1300/J146v04n02_02, DOI 10.1300/J146V04N02_02]; Van Der Kolk Bessel A., 1996, P279; [No title captured], DOI DOI 10.1300/J146V04N02	32	116	118	0	7	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0002-953X	1535-7228		AM J PSYCHIAT	Am. J. Psychiat.	MAY	2005	162	5					963	969		10.1176/appi.ajp.162.5.963			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	922JJ	WOS:000228833100020	15863799				2022-02-06	
J	Pfeifer, R; Borner, A; Krack, A; Sigusch, HH; Surber, R; Figulla, HR				Pfeifer, R; Borner, A; Krack, A; Sigusch, HH; Surber, R; Figulla, HR			Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale	RESUSCITATION			English	Article						cardiopulmonary resuscitation; outcome neuron-specific enolase; S-100 protein; Glasgow Coma Scale	HYPOXIC BRAIN-DAMAGE; NEUROLOGICAL RECOVERY; SERUM-LEVELS; HEAD-INJURY; BLOOD; PROGNOSIS; SURVIVAL; MARKERS	Background and purpose: Patients resuscitated from cardiac arrest are at risk of subsequent death or poor neurological outcome up to a persistent vegetative state. We investigated the prognostic value of several epidemiological and clinical markers and two neuroproteins, neuron-specific enolase (NSE) and S-100 protein (S-100), in 97 patients undergoing cardiopulmonary resuscitation (CPR) after non-traumatic cardiac arrest between 1998 and 2002. Results: 52.6% of the patients died, 28.8% survived with severe, moderate or without neurological disorders, and 18.6% remained in a persistent vegetative state. Unconsciousness > 48 h after CPR predicted a 60.6-fold (95% Cl 14.3287-257.205, p = 0.001) and a Glasgow Coma Scale (GCS) < 6 points after 72 h a 11.2-fold (CI 95%, 3.55-36.44, p < 0.001) risk of poor neurological outcome. Serum levels > 65 ng/ml for NSE and > 1.5 mu g/l for S-100 increased the risk of death and persistent vegetative state 16.8 (95% Cl 2.146-131.520)- and 12.6 (95% Cl 1.1093-99.210)- fold, respectively. By combination of the GCS with elevated serum concentrations of both neuroproteins above the cut off levels on third day after CPR a poor neurological outcome was predicted with a specificity of 100%. Conclusion: The combination of GCS with the serum levels of both neuroproteins at 72 It after CPR permit a more reliable prediction of outcome in post arrest coma than the single markers alone, independent of the application of anaesthetic agents. (c) 2004 Elsevier Ireland Ltd. All rights reserved.	Univ Jena, Dept Internal Med 1, Div Cardiol & Intens Care Med, D-07740 Jena, Germany; Univ Jena, Inst Clin Chem, D-07740 Jena, Germany; Univ Jena, Diagnost Lab, D-07740 Jena, Germany		Pfeifer, R (corresponding author), Univ Jena, Dept Internal Med 1, Div Cardiol & Intens Care Med, Erlanger Allee 101, D-07740 Jena, Germany.	Ruediger.Pfeifer@med.uni-jena.de					ABRAMSON NS, 1985, CRIT CARE MED, V13, P930, DOI 10.1097/00003246-198511000-00020; BATES D, 1977, ANN NEUROL, V2, P211, DOI 10.1002/ana.410020306; Berek K, 1997, EUR NEUROL, V37, P135, DOI 10.1159/000117426; BIALECKI L, 1995, CHEST, V108, P1009, DOI 10.1378/chest.108.4.1009; BOKONJIC N, 1961, CEREBRAL ANOXIA ELEC, P118; Bottiger BW, 2001, CIRCULATION, V103, P2694; Cooper S, 1997, RESUSCITATION, V35, P17, DOI 10.1016/S0300-9572(97)00020-8; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Fogel W, 1997, CRIT CARE MED, V25, P1133, DOI 10.1097/00003246-199707000-00012; GRUBB NR, 1995, LANCET, V346, P417, DOI 10.1016/S0140-6736(95)92784-0; Hallstrom AP, 1996, CIRCULATION, V93, P2019, DOI 10.1161/01.CIR.93.11.2019; HERLITZ J, 1994, RESUSCITATION, V28, P27, DOI 10.1016/0300-9572(94)90051-5; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnsson P, 1995, J CARDIOTHOR VASC AN, V9, P694, DOI 10.1016/S1053-0770(05)80231-9; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; Meynaar IA, 2003, INTENS CARE MED, V29, P189, DOI 10.1007/s00134-002-1573-2; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Mullner M, 1997, J CEREBR BLOOD F MET, V17, P430; PAHLMAN S, 1984, TUMOUR BIOL, V5, P127; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Rosen H, 1998, STROKE, V29, P473, DOI 10.1161/01.STR.29.2.473; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; SCHAARSCHMIDT H, 1994, STROKE, V25, P558, DOI 10.1161/01.STR.25.3.558; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; SELLMAN M, 1992, SCAND J THORAC CARD, V26, P39, DOI 10.3109/14017439209099051; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; SNYDER BD, 1977, NEUROLOGY, V27, P807, DOI 10.1212/WNL.27.9.807; Westaby S, 1996, ANN THORAC SURG, V61, P88, DOI 10.1016/0003-4975(95)00904-3; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977	33	116	125	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	APR	2005	65	1					49	55		10.1016/j.resuscitation.2004.10.011			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	919FY	WOS:000228605000008	15797275				2022-02-06	
J	Lemay, S; Bedard, MA; Rouleau, I; Tremblay, PLG				Lemay, S; Bedard, MA; Rouleau, I; Tremblay, PLG			Practice effect and test-retest reliability of attentional and executive tests in middle-aged to elderly subjects	CLINICAL NEUROPSYCHOLOGIST			English	Article						executive functions; neuropsychological tests; practice effect; reliability; test-retest	VERBAL-LEARNING TEST; CHOICE-REACTION-TIME; REPEATED NEUROPSYCHOLOGICAL ASSESSMENTS; CLOSED-HEAD-INJURY; REPEATED ADMINISTRATIONS; ALZHEIMERS-DISEASE; COGNITIVE DEFICITS; PARKINSONS-DISEASE; HEALTHY-SUBJECTS; ALTERNATE FORMS	There is a lack of data about the practice effect and test-retest reliability (TRR) on many attentional and executive tests in neuropsychology. In this study, 37 subjects aged 52 to 80 were tested three times with an inter-assessment interval of 14 days. The battery included the Rey Auditory Verbal Learning Test, the Stroop interference test, the Letter-Number Sequencing test, Wechsler Adult Intelligence Scale-III (WAIS-III), the Ruff 2 and 7 Selective Attention Test, the Tower of London, the Verbal Fluency test, and simple, choice, and sequential reaction time tests. The results showed that tasks were generally subject to a practice effect, except for those with alternate forms. In all tests, there were a number of scores demonstrating good TRR, but others, although largely used in clinical practice, failed to reach acceptable TRR standards. Usually, time derived scores were associated with the best TRR.	Univ Quebec, Ctr Neurosci Cognit, Montreal, PQ H3C 3P8, Canada		Bedard, MA (corresponding author), Univ Quebec, Ctr Neurosci Cognit, Case Postale 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada.	bedard.marc-andre@uqam.ca		Bedard, Marc-Andre/0000-0002-7807-8532			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAKER SJ, 1986, PERCEPT MOTOR SKILL, V63, P767, DOI 10.2466/pms.1986.63.2.767; BARDI CA, 1995, ARCH CLIN NEUROPSYCH, V10, P295; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; Bruggemans EF, 1997, J CLIN EXP NEUROPSYC, V19, P543, DOI 10.1080/01688639708403743; Burgess P., 1997, METHODOLOGY FRONTAL, P81; *CAMBR COGN, 1998, TEMP STAB TEST RET R; CASEY JE, 1989, J CLIN EXP NEUROPSYC, V11, P461, DOI 10.1080/01688638908400906; CHATELOIS J, 1996, STROOP FLEXIBILITE, V4; Chiu HFK, 1997, J GERONTOL B-PSYCHOL, V52, pP247, DOI 10.1093/geronb/52B.5.P247; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CONNOR A, 1988, INT J CLIN NEUROPSYC, V10, P1; Cooper DB, 2001, CLIN NEUROPSYCHOL, V15, P125, DOI 10.1076/clin.15.1.125.1914; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DEBRABANDER B, 1992, PERCEPT MOTOR SKILL, V75, P165, DOI 10.1177/003151259207500101; DESROSIERS G, 1987, INT J CLIN NEUROPSYC, V9, P162; Diesfeldt H F, 1985, Tijdschr Gerontol Geriatr, V16, P17; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Fastenau PS, 2002, J INT NEUROPSYCH SOC, V8, P151; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI [10.1080/13854049108404102, DOI 10.1080/13854049108404102]; Frank R, 1996, NEUROEPIDEMIOLOGY, V15, P257, DOI 10.1159/000109915; Franzen M D, 1987, Arch Clin Neuropsychol, V2, P265, DOI 10.1016/0887-6177(87)90014-X; GEFFEN GM, 1994, ARCH CLIN NEUROPSYCH, V9, P303, DOI 10.1016/0887-6177(94)90018-3; GOLDEN CJ, 1975, J PERS ASSESS, V39, P386, DOI 10.1207/s15327752jpa3904_10; GOLDSTEIN G, 1990, HYPERTENSION, V15, P361, DOI 10.1161/01.HYP.15.4.361; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Harrison JE, 2000, BRIT J CLIN PSYCHOL, V39, P181, DOI 10.1348/014466500163202; Hermann BP, 1996, EPILEPSIA, V37, P942, DOI 10.1111/j.1528-1157.1996.tb00531.x; HORTON AM, 1992, PERCEPT MOTOR SKILL, V75, P257, DOI 10.2466/PMS.75.4.257-258; IVNIK RJ, 1995, PSYCHOL ASSESSMENT, V7, P155, DOI 10.1037/1040-3590.7.2.155; Ivnik RJ, 1999, NEUROPSYCHOLOGY, V13, P121, DOI 10.1037/0894-4105.13.1.121; Jensen A R, 1965, Acta Psychol (Amst), V24, P398; JOHNSON BF, 1991, PROG NEURO-PSYCHOPH, V15, P625, DOI 10.1016/0278-5846(91)90052-3; KLAPP ST, 1995, J EXP PSYCHOL HUMAN, V21, P1015, DOI 10.1037/0096-1523.21.5.1015; Lepage M, 1996, BRAIN, V119, P1289, DOI 10.1093/brain/119.4.1289; LETOURNEAU JE, 1990, PERCEPT MOTOR SKILL, V70, P256, DOI 10.2466/PMS.70.1.256-258; LETOURNEAU JE, 1986, PERCEPT MOTOR SKILL, V62, P667, DOI 10.2466/pms.1986.62.2.667; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; Mattis S., 1976, GERIATRIC PSYCHIAT H, P77; MCCAFFREY RJ, 1993, ARCH CLIN NEUROPSYCH, V8, P519; McCaffrey RJ, 2001, ARCH CLIN NEUROPSYCH, V16, P9, DOI 10.1016/S0887-6177(99)00055-4; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; MCCAFFREY RJ, 1992, CLIN NEUROPSYCHOL, V6, P34; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; Owen AM, 1997, NEUROPSYCHOLOGIA, V35, P519, DOI 10.1016/S0028-3932(96)00101-7; Pantelis C, 1997, BRAIN, V120, P1823, DOI 10.1093/brain/120.10.1823; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Rabbitt P., 1997, METHODOLOGY FRONTAL, P1; Rey A, 1970, EXAMEN CLIN PSYCHOL; ROBBINS TW, 1994, J NEUROL NEUROSUR PS, V57, P79, DOI 10.1136/jnnp.57.1.79; Rockstroh S, 1995, Int Psychogeriatr, V7, P377, DOI 10.1017/S1041610295002122; RUFF RM, 1986, PERCEPT MOTOR SKILL, V62, P407, DOI 10.2466/pms.1986.62.2.407; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; RUFF RM, 1992, PERCEPT MOTOR SKILL, V75, P1311, DOI 10.2466/PMS.75.8.1311-1319; RUFF RM, 1996, RUFF 2 7 SELECTIVE A; RYAN JJ, 1986, J CLIN EXP NEUROPSYC, V8, P611, DOI 10.1080/01688638608405179; RYAN JJ, 1992, CLIN NEUROPSYCHOL, V6, P3, DOI DOI 10.1080/13854049208404111; Sacks T. L., 1991, CLIN NEUROPSYCHOL, V5, P220, DOI [10.1080/13854049108404093, DOI 10.1080/13854049108404093]; Salinsky MC, 2001, J INT NEUROPSYCH SOC, V7, P597, DOI 10.1017/S1355617701755075; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; Schnirman GM, 1998, ASSESSMENT, V5, P355, DOI 10.1177/107319119800500404; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shatz M W, 1981, J Clin Neuropsychol, V3, P171, DOI 10.1080/01688638108403123; Siegrist M, 1995, PERCEPT MOTOR SKILL, V81, P1295, DOI 10.2466/pms.1995.81.3f.1295; SNOW WG, 1988, J CLIN EXP NEUROPSYC, V10, P60; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; SUNDERLAND A, 1992, NEUROPSYCHOL REHABIL, V2, P137; Tabachnick B. G., 1989, USING MULTIVARIATE S; Theisen ME, 1998, ASSESSMENT, V5, P85, DOI 10.1177/107319119800500110; UCHIYAMA CL, 1995, ARCH CLIN NEUROPSYCH, V10, P133, DOI 10.1016/0887-6177(94)E0034-M; Urbina S, 1997, PSYCHOL TESTING; van den Burg W, 1999, ARCH CLIN NEUROPSYCH, V14, P545, DOI 10.1016/S0887-6177(98)00042-0; Versavel M, 1997, ARZNEIMITTEL-FORSCH, V47, P781; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; Welsh MC, 2000, PERCEPT MOTOR SKILL, V90, P562, DOI 10.2466/PMS.90.2.562-572; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; [No title captured]	91	116	119	3	43	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY	2004	18	2					284	302		10.1080/13854040490501718			19	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	850HU	WOS:000223602600008	15587675				2022-02-06	
J	Nordstrom, CH; Reinstrup, P; Xu, WB; Gadenfors, A; Ungerstedt, U				Nordstrom, CH; Reinstrup, P; Xu, WB; Gadenfors, A; Ungerstedt, U			Assessment of the lower limit for cerebral perfusion pressure in severe head injuries by bedside monitoring of regional energy metabolism	ANESTHESIOLOGY			English	Article							INTRACEREBRAL MICRODIALYSIS; VOLUME REGULATION; MANAGEMENT; HEMODYNAMICS; PRINCIPLES; THERAPY	Background: In patients with severe traumatic brain lesions, the lower limit for cerebral perfusion pressure (CPP) is controversial. The aim of this prospective study was to assess this limit from bedside measurements of cerebral energy metabolism and to clarify whether the penumbra zone surrounding a focal lesion is more sensitive to a decrease in CPP than less-injured areas. Methods: Fifty patients with severe head injury were included after evacuation of an intracranial hematoma and/or focal brain contusion. They were treated according to intensive care routine (Lund concept), including continuous monitoring of intracranial pressure. One microdialysis catheter was inserted in less-injured brain tissue ("better" position), and one or two catheters were inserted into the boundary of injured cerebral cortex ("worse" position). Concentrations of glucose, pyruvate, and lactate were analyzed and displayed bedside and were related to CPP (n = 29,495). Results. Mean interstitial glucose concentration was unaffectcd by the level of the CPP within the studied ranges. Increases in lactate concentration (P = 0.0008) and lactate-pyruvate ratio (P = 0.01) were obtained in the "worse" but not in the "better" position at CPP less than 50 mmHg compared with the same positions at CPP greater than 50 mmHg. Conclusions. The study results support the view that CPP may be reduced to 50 mmHg in patients with severe traumatic brain lesions, provided that the physiologic and pharmacologic principles of the Lund concept are recognized. In the individual patient, preservation of normal concentrations of energy metabolites within cerebral areas at risk can be guaranteed by intracerebral microdialysis and bedside biochemical analyses.	Univ Lund Hosp, Dept Clin Neurosci, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Anesthesiol & Intens Care, S-22185 Lund, Sweden; Kunming Med Coll, Affiliated Hosp 1st, Kunming, Peoples R China; Malmo Univ Hosp, Dept Anesthesia & Intens Care, Malmo, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden		Nordstrom, CH (corresponding author), Univ Lund Hosp, Dept Clin Neurosci, S-22185 Lund, Sweden.	carl-henrik.nordstrom@skane.se					ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P922, DOI 10.1111/j.1399-6576.1995.tb04199.x; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; FENSTERMACHER JD, 1984, EDEMA, P383; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P827, DOI 10.1111/j.1399-6576.1995.tb04179.x; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SIESJO BK, 1970, ACTA NEUROL SCAND, V46, P187, DOI 10.1111/j.1600-0404.1970.tb05615.x; SIESJO BK, 1978, BRAIN ENERGY METABOL, P479; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860	21	116	119	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	APR	2003	98	4					809	814		10.1097/00000542-200304000-00004			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	660ZG	WOS:000181865500003	12657839				2022-02-06	
J	Hibbard, MR; Cantor, J; Charatz, H; Rosenthal, R; Ashman, T; Gundersen, N; Ireland-Knight, L; Gordon, W; Avner, J; Gartner, A				Hibbard, MR; Cantor, J; Charatz, H; Rosenthal, R; Ashman, T; Gundersen, N; Ireland-Knight, L; Gordon, W; Avner, J; Gartner, A			Peer support in the community: Initial findings of a mentoring program for individuals with traumatic brain injury and their families	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						families; participatory action research; peer support; self-help; traumatic brain injury	PARTICIPATORY ACTION RESEARCH; PARENT PROGRAMS; SOCIAL SUPPORT; FOLLOW-UP; DISTRESS; BURDEN; STRESS	Objectives: To evaluate the impact of a community-based peer support program for individuals and their family members following traumatic brain injury (TBI), Settings: Community-based sample of family members and individuals with traumatic brain injury, Participants: Twenty individuals who had participated in the peer support program (I I individuals with Till and 9 family members), Main Outcome Measures: Quantitative and qualitative approaches were used: a retrospective structured interview assessing self-reported impacts of peer support on empowerment, quality Of life, mood, skills and knowledge, and social supports; an in-depth qualitative interview with a subgroup of family members focused on the specific benefits/limitations of the peer support program. Results: participants in the peer support program reported positive impacts of peer support on increasing their knowledge of TBI, enhancing their overall quality of life, improving their general outlook, and enhancing their ability to cope with depression post TBI The peer support program was reported to have had a minimal impact on enhancing social support from families. friends, and the community, with varying impacts noted on levels of happiness, coping with anger and anxiety, communication with professionals, and control over one's life, Qualitative analysis suggests the merits of this tyye of community-based Support and areas of improvement for the peer support program itself. Conclusions: Preliminary data suggest that peer support is a promising approach to enhancing coping for both individuals and their family members after TBI.	CUNY Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; Brain Injury Assoc New York State, Albany, NY USA; Natl Self Help Clearing House, New York, NY USA		Hibbard, MR (corresponding author), CUNY Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1 Gustave L Levy Pl, New York, NY 10029 USA.		Ashman, Teresa/B-1621-2013				ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Andrews F. M., 1976, SOCIAL INDICATORS WE; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Bruyere S. M, 1993, J VOCATIONAL REHABIL, V3, P62; CHESLER MA, 1991, AM J COMMUN PSYCHOL, V19, P757, DOI 10.1007/BF00938043; Cornwall A, 1995, SOC SCI MED, V41, P1667, DOI 10.1016/0277-9536(95)00127-S; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; DUNST CJ, 1988, ENABLING EMPOWERING; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Gualtari CT, 1991, BRAIN INJURY, V5, P219; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HARRISJK, 2001, BRIAN INJURY, V15, P223; Hartman A F, 1992, Issues Compr Pediatr Nurs, V15, P55, DOI 10.3109/01460869209078240; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KOSCIULEK JF, 1994, REHABIL COUNS BULL, V37, P244; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PIERCE G, 1986, SOCIAL SUPPORT QUEST; Rogers ES, 1997, PSYCHIATR SERV, V48, P1042; Santelli B, 1996, INFANT YOUNG CHILD, V9, P53, DOI 10.1097/00001163-199607000-00007; Santelli B, 1998, J ASSOC PERS SEVERE, V23, P211, DOI 10.2511/rpsd.23.3.211; SANTELLI B, 1995, INFANT YOUNG CHILD, V8, P48, DOI 10.1097/00001163-199510000-00007; Santelli B, 1997, Pediatr Nurs, V23, P303; SANTELLI B, 1993, PARENT PARENT NATL S; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; SILVER JM, 1992, AM PSYCHIAT PRESS TX; SILVER JM, 1998, 9 ANN M AM NEUR ASS; Skell RL, 2000, BRAIN INJURY, V14, P705; Stevens PE, 1998, AIDS EDUC PREV, V10, P387; Taylor, 1998, Semin Clin Neuropsychiatry, V3, P224; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tyerman A, 2001, NEUROREHABILITATION, V16, P59; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; White G. W., 2001, J PREVENTION INTERVE, V21, P15; WILLER B, 1991, CAN J REHABIL, V33, P173	44	116	120	0	25	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	2002	17	2					112	131		10.1097/00001199-200204000-00004			20	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	535YT	WOS:000174674500004	11909510				2022-02-06	
J	Wright, DW; Bauer, ME; Hoffman, SW; Stein, DG				Wright, DW; Bauer, ME; Hoffman, SW; Stein, DG			Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats	JOURNAL OF NEUROTRAUMA			English	Article						head injury; neuroprotection; neurosteroids; progesterone; traumatic brain injury	SEVERE HEAD-INJURY; PERIPHERAL NERVOUS-SYSTEM; SEX STEROID-HORMONES; GLIAL-CELLS; CORTICAL CONTUSION; LIPID-PEROXIDATION; ARTERY OCCLUSION; NEUROSTEROIDS; RECEPTORS; CORTEX	Previous animal research suggests that progesterone may have powerful neuroprotective effects in traumatic brain injury (TBI). This experiment tested the hypothesis that progesterone levels correlate with decreased cerebral edema in male rats with bilateral medial frontal cortex injuries. Three groups of male Sprague-Dawley rats were used: injured given progesterone (4 mg/kg), injured given vehicle (oil), and uninjured controls given vehicle. Progesterone or vehicle was administered intraperitoneally at 1, 6, and 24 h postinjury. At 48 h postinjury, the rats were killed, brains extracted, and assayed for edema. Percent difference in water content of the area surrounding the lesion was compared to posterior cortex. A strong inverse relationship was found between serum progesterone levels and percent cerebral edema; the higher the progesterone levels, the lower the percent edema. Both progesterone and oil-treated animals had some edema compared to sham-operated controls. The brains of the injured animals given control solution were higher in water content than either the uninjured group or injured progesterone-treated rats 48 h postinjury. These findings confirm that progesterone significantly decreases cerebral edema after TBI in adult male subjects.	Emory Univ, Sch Med, Dept Emergency Med, Emergency Med Res Ctr, Atlanta, GA 30322 USA; Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA		Wright, DW (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Emergency Med Res Ctr, Atlanta, GA 30322 USA.		Stein, Donald/AAJ-5139-2020; Wright, David/F-1209-2013	Wright, David/0000-0002-7145-9105			AKWA Y, 1991, J STEROID BIOCHEM, V40, P71, DOI 10.1016/0960-0760(91)90169-6; Allolio B, 1995, EUR J ENDOCRINOL, V133, P696, DOI 10.1530/eje.0.1330696; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; BACKSTROM T, 1984, ACTA NEUROL SCAND, V69, P240; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; BAULIEU EE, 1992, ADV BIOCHEM PSYCHOPH, V47, P1; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Baulieu EE, 1997, MULT SCLER J, V3, P105, DOI 10.1177/135245859700300209; Bergeron R, 1996, J NEUROSCI, V16, P1193; BETZ AL, 1990, ACT NEUR S, V51, P256; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Bitran D, 1996, PSYCHOPHARMACOLOGY, V125, P65, DOI 10.1007/BF02247394; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; CamachoArroyo I, 1996, NEUROSCI LETT, V214, P25; CAMACHOARROYO I, 1994, J STEROID BIOCHEM, V50, P299, DOI 10.1016/0960-0760(94)90135-X; Cargill RS, 1999, J NEUROTRAUM, V16, P983; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; *DIAGN PROD CORP, 1998, IMM PROG; FARLEY D, 1990, FDA CONSUM, V24, P8; GANONG WF, 1987, REV MED PHYSL, P346; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Genazzani A R, 1997, Eur J Contracept Reprod Health Care, V2, P63; GENAZZANI AR, 1996, 1 TUSC C REPR MED PI; Goldfien A, 1989, BASIC CLIN PHARM, P493; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Goodman YD, 1996, J NEUROCHEM, V66, P1836; GOUJARD J, 1977, LANCET, V1, P482; HOCHBERG RB, 1990, SER FDN S BUD HUNG; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Jung-Testas I, 1998, J STEROID BIOCHEM, V65, P243, DOI 10.1016/S0960-0760(97)00191-X; JUNGTESTAS I, 1994, J STEROID BIOCHEM, V48, P145, DOI 10.1016/0960-0760(94)90261-5; JUNGTESTAS I, 1989, ENDOCRINOLOGY, V125, P2083; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763, DOI 10.1152/ajpendo.1996.271.4.E763; Limmroth V, 1996, BRIT J PHARMACOL, V117, P99, DOI 10.1111/j.1476-5381.1996.tb15160.x; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1995, J NEUROTRAUM, V12, P929, DOI 10.1089/neu.1995.12.929; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MURAD F, GOODMAN GILMANS PHAR, P1384; Reddy DS, 1996, PSYCHOPHARMACOLOGY, V128, P280, DOI 10.1007/s002130050136; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROOF RL, 1994, SOC NEUR MIAM BEACH; ROOF RL, 1996, 26 SOC NEUR M BETH M; ROOF RL, 1996, SOC NEUR WASH DC; ROOF RL, 1997, J NEUROTRAUM, V14, P760; Schumacher M, 1995, CIBA F SYMP, V191, P90; SUTTON RL, 1998, COMP BIOCH PHYSL A, V119, P711; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Unterberg AW, 1997, ACT NEUR S, V70, P106; Vedder H, 1999, J NEUROCHEM, V72, P2531, DOI 10.1046/j.1471-4159.1999.0722531.x; Waynforth HB, 1980, EXPT SURG TECHNIQUE	59	116	123	0	14	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2001	18	9					901	909		10.1089/089771501750451820			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	471TP	WOS:000170945000006	11565602				2022-02-06	
J	Gopinath, SP; Valadka, AB; Uzura, M; Robertson, CS				Gopinath, SP; Valadka, AB; Uzura, M; Robertson, CS			Comparison of jugular venous oxygen saturation and brain tissue Po-2 as monitors of cerebral ischemia after head injury	CRITICAL CARE MEDICINE			English	Article						cerebral oxygenation; cerebral ischemia; traumatic brain injury; jugular venous oxygen saturation; tissue Po-2	BLOOD-FLOW; COMATOSE PATIENTS; COMPUTERIZED-TOMOGRAPHY; CARDIOPULMONARY BYPASS; NEUROSURGICAL PATIENTS; PERFUSION-PRESSURE; SUBDURAL-HEMATOMA; METABOLISM; BULB; DESATURATION	Objective: To compare the characteristics of jugular venous oxygen saturation (Sjvo(2)) and brain tissue Po-2 (Pbto(2)) as monitors for cerebral ischemia after severe head injury. Sjvo(2) has been useful as a monitor for cerebral ischemia, but it is limited by its inability to identify regional cerebral ischemia. Pbto(2) may be superior to Sjvo(2) for this purpose, because oxygenation in localized areas of the brain can be monitored. Design: Sjvo(2) and Pbto(2) were successfully monitored in 58 patients with severe head injury. The changes in Sjvo(2) and Pbto(2) were compared during ischemic episodes. Setting: Neurosurgical intensive care unit of a level I trauma center. Measurements and Main Results: During the monitoring period, which averaged 90 hrs/patient, there were 54 episodes during which Sjvo(2) decreased to <50% and/or Pbto(2) decreased to <8 torr. Two of these episodes were caused by an infarction in the area of the Po-2 probe, leaving 52 episodes of global hypoxia/ischemia that were identified by one of the two monitors. The sensitivities of the two monitors for detecting ischemia, using the thresholds of 50% and 8 torr for Sjvo(2) and Pbto(2), respectively, were similar. The Sjvo(2) catheter detected 69.7% of the episodes and the Pbto(2) catheter detected 63.5% of the episodes. In most of the remaining episodes, both probes reflected a decrease in oxygenation, but not to levels below the defined thresholds. The major differences in the two measures of oxygenation included the following: a) Sjvo(2) more consistently reflected a reduction in oxygenation during hyperventilation; b) Pbto(2) was affected more by changes in arterial Po-2; and c) during severe global ischemia, Pbto(2) decreased to 0 and remained at 0, whereas Sjvo(2) initially decreased but then increased again as cerebral blood flow ceased, and the only blood in the jugular bulb was of extracerebral origin. Conclusions: The two monitors provide complimentary information, and neither monitor alone identifies all episodes of ischemia. The best strategy for using these monitors is to take advantage of the unique features of each monitor. Sjvo(2) should be used as a monitor of global oxygenation; but Pbto(2) should be used as a monitor of local oxygenation, ideally with the catheter placed in an area of the brain that is vulnerable to ischemia but that may be salvageable with appropriate treatment.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER		BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; CROUGHWELL ND, 1994, ANN THORAC SURG, V58, P1702, DOI 10.1016/0003-4975(94)91666-7; CRUZ J, 1985, CRIT CARE MED, V13, P284, DOI 10.1097/00003246-198504000-00047; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; Dings J, 1996, ZBL NEUROCHIR, V57, P177; Feldman Z, 1997, CRIT CARE CLIN, V13, P51, DOI 10.1016/S0749-0704(05)70296-7; GARLICK R, 1987, SCAND J CLIN LAB INV, V47, P47; GIBBS EL, 1945, AM J PSYCHIAT, V102, P184, DOI 10.1176/ajp.102.2.184; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; Hans P, 1991, Acta Anaesthesiol Belg, V42, P213; HANTSON P, 1992, INTENS CARE MED, V18, P59, DOI 10.1007/BF01706431; Hoffman WE, 1996, ANESTH ANALG, V82, P582, DOI 10.1097/00000539-199603000-00027; Hoffman WE, 1997, SURG NEUROL, V47, P455, DOI 10.1016/S0090-3019(97)82798-X; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LASSEN NA, 1968, SCAND J CLIN LAB S D, V102; Lennox WG, 1935, ARCH NEURO PSYCHIATR, V34, P1001, DOI 10.1001/archneurpsyc.1935.02250230073006; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; MEYER JS, 1965, NEUROLOGY, V15, P892, DOI 10.1212/WNL.15.10.892; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1983, J NEUROSURG, V59, P439, DOI 10.3171/jns.1983.59.3.0439; Ritter AM, 1996, J CLIN MONITOR, V12, P285, DOI 10.1007/BF02221748; RITTER AM, 1994, NEUROSURGICAL CLIN N, P633; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Sapire KJ, 1997, CRIT CARE MED, V25, P1655, DOI 10.1097/00003246-199710000-00014; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Souter M. J., 1995, Journal of Neurotrauma, V12, P471; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812	42	116	120	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	1999	27	11					2337	2345		10.1097/00003246-199911000-00003			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258AA	WOS:000083814800002	10579245				2022-02-06	
J	Gupta, AK; Hutchinson, PJ; Al-Rawi, P; Gupta, S; Swart, M; Kirkpatrick, PJ; Menon, DK; Datta, AK				Gupta, AK; Hutchinson, PJ; Al-Rawi, P; Gupta, S; Swart, M; Kirkpatrick, PJ; Menon, DK; Datta, AK			Measuring brain tissue oxygenation compared with jugular venous oxygen saturation for monitoring cerebral oxygenation after traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							SEVERE HEAD-INJURY; BLOOD-FLOW; NEUROSURGICAL PATIENTS; INTENSIVE-CARE; METABOLISM; PRESSURE	Jugular bulb oximetry is the most widely used method of monitoring cerebral oxygenation. More recently, measurement of brain tissue oxygenation has been reported in head-injured patients. We compared the changes in brain tissue oxygen partial pressure (PbO2) with changes in jugular venous oxygen saturation (SjVO(2)) in response to hyperventilation in areas of brain with and without focal pathology. Thirteen patients with severe head injuries were studied. A multiparameter sensor was inserted into areas of brain with focal pathology in five patients and outside areas of focal pathology in eight patients. A fiberoptic catheter was inserted into the right jugular bulb. Patients were hyperventilated in a stepwise manner from a PaCO2 of approximately 35 mm Hg to a PaCO2 of 22 mm Hg. There was no significant change in cerebral perfusion pressure or arterial partial pressure of oxygen with hyperventilation. In areas without focal pathology, there was a good correlation between changes in SjVO(2) and PbO2 (Delta SjVO(2) and Delta PbO2, r(2) = 0.69, P < 0.0001). In areas with focal pathology, there was no correlation between Delta SjVO(2), and Delta PbO2 (r(2) = 0.07, P = 0.23). In this study, we demonstrated that measurement of local tissue oxygenation can highlight focal differences in regional cerebral oxygenation that are disguised when measuring SjVO(2). Thus, monitoring of PbO2 is a useful addition to multimodal monitoring of patients with traumatic head injury. Implications: Brain oxygenation is currently monitored by using jugular bulb oximetry, which attracts a number of potential artifacts and may not reflect regional changes in oxygenation. We compared this method with measurement of brain tissue oxygenation using a multiparameter sensor inserted into brain tissue. The brain tissue monitor seemed to reflect regional brain oxygenation better than jugular bulb oximetry.	Univ Cambridge, Addenbrookes Hosp, Dept Anesthesia, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Neurosci Crit Care, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England		Gupta, AK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Anesthesia, Level 4, Cambridge CB2 2QQ, England.	akg01@globalnet.co.uk					Andrews PJD, 1996, J NEUROSURG ANESTH, V8, P220, DOI 10.1097/00008506-199607000-00006; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bouma G J, 1995, New Horiz, V3, P384; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chieregato A, 1996, J NEUROSURG ANESTH, V8, P21, DOI 10.1097/00008506-199601000-00006; CZOSNYKA M, 1994, INT J CLIN MONIT COM, V11, P223, DOI 10.1007/BF01139874; GUPTA AK, 1997, J NEUROSURG ANESTHES, V8, P325; Heath K, 1998, J NEUROSURG ANESTH, V10, P22, DOI 10.1097/00008506-199801000-00005; HOFFMAN WE, 1995, NEUROL RES, V17, P417, DOI 10.1080/01616412.1995.11740354; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; SALVANT JB, 1993, NEUROSURGERY, V33, P387; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812	21	116	123	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	MAR	1999	88	3					549	553		10.1097/00000539-199903000-00016			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	171AX	WOS:000078840900016	10072004				2022-02-06	
J	Sander, AM; Kreutzer, JS; Rosenthal, M; Delmonico, R; Young, ME				Sander, AM; Kreutzer, JS; Rosenthal, M; Delmonico, R; Young, ME			A multicenter longitudinal investigation of return to work and community integration following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community integration; employment; longitudinal investigation; outcome	SEVERE HEAD-INJURY; PREDICTING RETURN; REHABILITATION; QUESTIONNAIRE	Objective: To characterize changes in employment status and community integration following tau matic brain injury and to investigate relationships among outcome, sociodemographic, and injury related variables. Design: Longitudinal analyses of employment (n=42) and community integration (n=53) were conducted, with data examined at three follow-up periods. Chi-square (chi(2)) and analysis of variance (ANOVA) were used to investigate the relationship between employment, time since injury, and demographic and injury-related variables. Repeated measures ANOVA and multiple regression analyses were utilized to investigate similar relationships for the community integration sample, Setting: Outpatient clinics affiliated with the TBI Model Systems programs. Participants: Patients with traumatic brain injury who received acute medical care at a Level 1 Trauma Center and received Inpatient rehabilitation, Mean age of subjects was 33.9 years. The full range of injury severity was represented. Main Outcome Measures: Employment status determined through structured interview and scores on the Community Integration Questionnaire. Results: Less than 40% of persons employed before injury were employed at any Follow-up interval. Fewer persons were employed at year 2 than at years 1 and years 3 or 4. Seventy-five percent of persons employed at year 1 were also employed at year 3 or 4. Fifty percent of persons unemployed It I ear 1 were either employed or otherwise productively engaged at year 3 or 4. Unemployed persons had Longer acute hospital stays than employed persons at all follow-up intervals. Conclusions: TBI has an adverse, long-term Impact on employment and productivity. Findings highlight the need for postacute rehabilitation programs with particular emphasis on vocational rehabilitation. Uncertainties remain about the impact of brain injury on socialization and home activity patterns, partly because of Limitations in measurement of community integration.	WAYNE STATE UNIV, DETROIT, MI USA; SANTA CLARA VALLEY MED CTR, SAN JOSE, CA 95128 USA; BAYLOR COLL MED, HOUSTON, TX 77030 USA		Sander, AM (corresponding author), VIRGINIA COMMONWEALTH UNIV MED COLL VIRGINIA, DEPT PHYS MED & REHABIL, POB 980542, RICHMOND, VA 23298 USA.						Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1976, LANCET, V1, P1031; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levin HS., 1982, NEUROBEHAVIORAL CONS; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Millis S R, 1994, Int J Neurosci, V79, P165; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1984, CLOSED HEAD INJURY P; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wehman P., 1988, J HEAD TRAUMA REHAB, V3, P82, DOI DOI 10.1097/00001199-198812000-00012; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WHITENECK G, 1987, REHABILITATION OUTCO; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103	33	116	116	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1996	11	5					70	84		10.1097/00001199-199610000-00007			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VP053	WOS:A1996VP05300007					2022-02-06	
J	Rivara, JB; Jaffe, KM; Polissar, NL; Fay, GC; Liao, SQ; Martin, KM				Rivara, JB; Jaffe, KM; Polissar, NL; Fay, GC; Liao, SQ; Martin, KM			Predictors of family functioning and change 3 years after traumatic brain injury in children	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							BLUNT HEAD-INJURY; HANDICAPPED-CHILDREN; CYSTIC-FIBROSIS; SPINA-BIFIDA; FOLLOW-UP; RELATIVES; PARENTS; IMPACT; STRESS; CARE	Objectives: To examine changes in family functioning from injury to 3 years after pediatric traumatic brain injury; to determine factors most predictive of family outcomes at 3 years and variables that promote positive outcomes and changes over time. Design: Prospective cohort study Setting: Two regional tertiary care centers; cases followed for 3 years into community. Participants: Families of 81 children, ages 6 to 15 years, who sustained closed head injury and loss of consciousness (mild=43, moderate=20, severe=18), consecutively en rolled over 15 months. Main Outcome Measures: Family Environment Scale, Family Assessment Device, Family Inventory of Life Events, Health Insurance Survey-General Well-Being, NYU Problem Checklist for Significant Others, Family Interview Rating Scale, Family Global Assessment Scale. All were obtained initially and at 3 months, 1 year, and 3 years postinjury. Predictor variables were selected from the instuments above, as well as from the parent and teacher versions of the Child Behavior Checklist, socioeconomic status, and injury severity. Results: Preinjury functioning was the best predictor of 3-year outcomes. Fewer changes in family functioning were reported over 3 years in the mild or moderate groups, whereas more deterioration occurred in the severe group. At 3 years, one third to one half of parents in either the moderate or severe groups reported medium to high strain in 19 of 34 problem areas. Low levels of family control and high levels of expressiveness correlated with better outcomes for severe group. Positive change for the severe group was marked by better preinjury levels of communication, expressiveness, problem solving, use of resources, role flexibility, greater activity orientation, and less conflict, control, and stress. Preinjury variables and severity explained from 26% to 69% of the variation in 3-year outcomes. Conclusions: Families at risk for poorer outcomes can prospectively identified and should be supported and encouraged in their efforts to develop new coping resources. (C) 1996 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT NEUROL SURG,SEATTLE,WA 98195; UNIV WASHINGTON,CHILDRENS HOSP & MED CTR,DIV NEUROL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH SOCIAL WORK,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,SCH SOCIAL WORK,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,SCH SOCIAL WORK,DEPT NEUROL SURG,SEATTLE,WA 98195; UNIV WASHINGTON,SCH SOCIAL WORK,DEPT BIOSTAT,SEATTLE,WA 98195; UNIV WASHINGTON,SCH SOCIAL WORK,DEPT REHABIL MED,SEATTLE,WA 98195; STAT & EPIDEMIOL RES CORP,SEATTLE,WA; NORTHWEST HOSP,SEATTLE,WA		Rivara, JB (corresponding author), CHILDRENS HOSP & MED CTR,DEPT REHABIL MED CH71,4800 SAND POINT WAY NE,POB C-5371,SEATTLE,WA 98105, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR002299] Funding Source: Medline		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; Austin J K, 1988, J Neurosci Nurs, V20, P174; BEAVERS J, 1986, FAM PROCESS, V25, P365, DOI 10.1111/j.1545-5300.1986.00365.x; BEGLEITER ML, 1976, SOC BIOL, V23, P260, DOI 10.1080/19485565.1976.9988237; BROOK RH, 1979, MED CARE S7, V7, pS16; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DONAVAN AM, 1988, AM J MENT RETARD, V92, P502; Edelbrock C., 1986, MANUAL TEACHERS REPO; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FREY KS, 1989, AM J MENT RETARD, V94, P240; GATH A, 1980, ARCH DIS CHILD, V55, P371, DOI 10.1136/adc.55.5.371; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P867; HAUSER ST, 1986, HEALTH PSYCHOL, V5, P273, DOI 10.1037/0278-6133.5.3.273; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KAY T, 1988, HEAD INJURY FAMILY I; KAZAK AE, 1989, J AUTISM DEV DISORD, V19, P501, DOI 10.1007/BF02212854; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; KUPST MJ, 1988, J PEDIATR PSYCHOL, V13, P7, DOI 10.1093/jpepsy/13.1.7; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MARTIN DA, 1988, J LEARN DISABIL, V21, P464, DOI 10.1177/002221948802100803; MCCORMICK MC, 1986, DEV MED CHILD NEUROL, V28, P53; MCCUBBIN HI, 1983, SOCIAL STRESS FAMILY; McCubbin HI, 1980, FAMILY ASSESSMENT RE; MCCUBBIN MA, 1989, FAM RELAT, V38, P436, DOI 10.2307/585750; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Moos RH, 1974, SOCIAL CLIMATE SCALE; MRAZEK D, 1985, P 32 ANN M AM AC CHI; ODDEY M, 1980, J NEUROL NEUROSUR PS, V43, P798; PATTERSON JM, 1985, FAM RELAT, V34, P79, DOI 10.2307/583760; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; SPINETTA JJ, 1988, J PSYCHOSOC ONCOL, V6, P179; STEIN REK, 1984, PEDIATRICS, V73, P845; TEASDALE G, 1974, LANCET, V2, P81; TEW B, 1975, BRIT J PREV SOC MED, V29, P27; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WATSON SM, 1990, J ABNORM CHILD PSYCH, V18, P143, DOI 10.1007/BF00910727; WINER BJ, 1978, STATISTICAL PRINCIPL	46	116	116	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1996	77	8					754	764		10.1016/S0003-9993(96)90253-1			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	VA965	WOS:A1996VA96500004	8702368				2022-02-06	
J	MATTSON, MP; CHENG, B; BALDWIN, SA; SMITHSWINTOSKY, VL; KELLER, J; GEDDES, JW; SCHEFF, SW; CHRISTAKOS, S				MATTSON, MP; CHENG, B; BALDWIN, SA; SMITHSWINTOSKY, VL; KELLER, J; GEDDES, JW; SCHEFF, SW; CHRISTAKOS, S			BRAIN INJURY AND TUMOR NECROSIS FACTORS INDUCE CALBINDIN D-28K IN ASTROCYTES - EVIDENCE FOR A CYTOPROTECTIVE RESPONSE	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						ACIDOSIS; CALCIUM-BINDING PROTEIN; CORPUS CALLOSUM; CYTOKINE; EXCITOTOXICITY; FURA-2; HIPPOCAMPUS; KAINATE; NERVE GROWTH FACTOR; TRAUMATIC BRAIN INJURY	NERVE GROWTH-FACTOR; FACTOR-ALPHA; RAT-BRAIN; BINDING PROTEIN; SELECTIVE VULNERABILITY; MOLECULAR-CLONING; FACTOR RECEPTOR; MESSENGER-RNA; BIOLOGICAL CHARACTERIZATION; HIPPOCAMPAL-NEURONS	Calbindin is a 28 kDa calcium-binding protein expressed in restricted neuronal populations in the mammalian brain where it may play a role in protecting neurons against excitotoxic insults. Recent findings indicate that electrical activity and some neurotropic factors can induce the expression of calbindin in neurons. We now report that brain injury, effected by systemic administration of the excitotoxin kainate or mechanical trauma, induces expression of calbindin in cells of the corpus callosum and subcortical white matter. Immunohistochemical analysis using antibodies to the astrocyte-specific proteins (glial fibrillary acidic protein and S-100beta) established the identity of calbindin immunoreactive cells as astrocytes. Because brain injury is known to induce the expression of several neurotrophic factors and cytokines, we employed cultures of hippocampal and neocortical astrocytes to test the hypothesis that such factors can induce expression of calbindin in astrocytes. Tumor necrosis factors (TNFalpha and TNFbeta), cytokines that are expressed in response to brain injury, induced the expression of calbindin in cultured rat hippocampal and neocortical astrocytes. Two neurotrophic factors, basic fibroblast growth factor and nerve growth factor, did not induce calbindin in astrocytes. TNF-treated, calbindin-expressing astrocytes were resistant to acidosis and calcium ionophore toxicity, suggesting that TNFs and calbindin may serve a cytoprotective role in astrocytes in the injured brain.	UNIV KENTUCKY,DEPT ANAT & NEUROBIOL,LEXINGTON,KY 40506; UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT BIOCHEM & MOLEC BIOL,NEWARK,NJ 07103		MATTSON, MP (corresponding author), UNIV KENTUCKY,SANDERS BROWN RES CTR AGING,211 SANDERS BROWN BLDG,LEXINGTON,KY 40506, USA.		Mattson, Mark P/F-6038-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029001, R01NS030583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG010678] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG10678] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 29001, NS 30583] Funding Source: Medline		Aggarwal B B, 1992, Immunol Ser, V56, P61; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BALASINGAM V, 1994, J NEUROSCI, V14, P846; BEAL MF, 1993, J NEUROCHEM, V61, P1147, DOI 10.1111/j.1471-4159.1993.tb03633.x; BENVENISTE EN, 1989, J NEUROIMMUNOL, V25, P209, DOI 10.1016/0165-5728(89)90139-2; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; BIANCHI M, 1992, NEUROSCI LETT, V148, P76, DOI 10.1016/0304-3940(92)90808-K; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BOYES BE, 1986, NEUROSCIENCE, V17, P857, DOI 10.1016/0306-4522(86)90050-3; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; CADELLI DS, 1992, EXP NEUROL, V115, P189, DOI 10.1016/0014-4886(92)90246-M; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CHRISTAKOS S, 1987, METHOD ENZYMOL, V139, P534; CHUNG IY, 1990, J IMMUNOL, V144, P2999; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EDDY LJ, 1992, BIOCHEM BIOPH RES CO, V184, P1056, DOI 10.1016/0006-291X(92)90698-K; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; FARRAH T, 1992, NATURE, V358, P26, DOI 10.1038/358026b0; FILLIT H, 1991, NEUROSCI LETT, V131, P318; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; FREUND TF, 1990, EXP BRAIN RES, V83, P55; GADIENT RA, 1990, NEUROSCI LETT, V117, P335, DOI 10.1016/0304-3940(90)90687-5; GENDRON RL, 1991, INT J NEUROSCI, V60, P129, DOI 10.3109/00207459109082043; GIFFARD RG, 1990, BRAIN RES, V530, P138, DOI 10.1016/0006-8993(90)90670-7; GOODMAN JH, 1993, BRAIN RES, V606, P309, DOI 10.1016/0006-8993(93)90999-4; GOODWIN RG, 1993, CELL, V73, P447, DOI 10.1016/0092-8674(93)90133-B; GRAY PW, 1990, P NATL ACAD SCI USA, V87, P7380, DOI 10.1073/pnas.87.19.7380; HATTORI A, 1993, J BIOL CHEM, V268, P2577; HEIZMANN CW, 1992, TRENDS NEUROSCI, V15, P259, DOI 10.1016/0166-2236(92)90067-I; HELLER RA, 1990, P NATL ACAD SCI USA, V87, P6151, DOI 10.1073/pnas.87.16.6151; HELLER RA, 1992, CELL, V70, P47; HOFFMAN SR, 1989, J NEUROPATH EXP NEUR, V48, P331, DOI 10.1097/00005072-198905000-00098; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Kronke M, 1992, Immunol Ser, V56, P189; LAEMMLI UK, 1970, NATURE, V277, P680; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LIBERSKI PP, 1993, NEURODEGENERATION, V2, P215; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LIU FC, 1992, J NEUROSCI, V12, P674; Loetscher H, 1992, Immunol Ser, V56, P161; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; LOWENSTEIN DH, 1991, NEURON, V6, P627, DOI 10.1016/0896-6273(91)90065-8; MATTHEWSON AJ, 1985, BRAIN RES, V327, P61; MATTSON MP, 1993, HIPPOCAMPUS, V3, P73; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MATTSON MP, 1993, BRAIN RES, V621, P35, DOI 10.1016/0006-8993(93)90295-X; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; MATTSON MP, 1993, SEMIN NEUROSCI, V5, P295; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; MIYAKE T, 1989, BRAIN RES, V489, P31, DOI 10.1016/0006-8993(89)90005-X; NADLER JV, 1980, BRAIN RES, V195, P47; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; OH YJ, 1992, J NEUROCHEM, V58, P2131, DOI 10.1111/j.1471-4159.1992.tb10955.x; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RAMI A, 1992, J NEUROSCI RES, V31, P89, DOI 10.1002/jnr.490310113; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHARFMAN HE, 1989, SCIENCE, V246, P257, DOI 10.1126/science.2508225; SCHWARTZ M, 1991, BRAIN RES, V545, P334, DOI 10.1016/0006-8993(91)91309-O; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; SEQUIER JM, 1990, EUR J NEUROSCI, V2, P1118, DOI 10.1111/j.1460-9568.1990.tb00023.x; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; SMITH RA, 1992, IMMUNOL SER, V56, P149; SOLIVEN B, 1992, J NEUROSCI, V12, P2665; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; Turetskaya R L, 1992, Immunol Ser, V56, P35; YOSHIDA K, 1992, J NEUROCHEM, V59, P919, DOI 10.1111/j.1471-4159.1992.tb08331.x	77	116	119	0	1	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	OCT 15	1995	42	3					357	370		10.1002/jnr.490420310			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TC366	WOS:A1995TC36600009	8583504				2022-02-06	
J	HAMM, RJ; LYETH, BG; JENKINS, LW; ODELL, DM; PIKE, BR				HAMM, RJ; LYETH, BG; JENKINS, LW; ODELL, DM; PIKE, BR			SELECTIVE COGNITIVE IMPAIRMENT FOLLOWING TRAUMATIC BRAIN INJURY IN RATS	BEHAVIOURAL BRAIN RESEARCH			English	Article						TRAUMATIC BRAIN INJURY; FLUID PERCUSSION; LEARNING; MEMORY; PASSIVE AVOIDANCE; MORRIS WATER MAZE; RAT	CLOSED-HEAD-INJURY; HIPPOCAMPAL-LESIONS; NUCLEUS BASALIS; KAINIC ACID; MEMORY; RECOVERY; DEFICITS; AMNESIA; DAMAGE; CORTEX	Impairment of cognitive abilities is a frequent and significant sequelae of traumatic brain injury (TBI). The purpose of this experiment was to examine the generality of the cognitive deficits observed after TBI. The performance of three tasks was evaluated. Two of the tasks (passive avoidance and a constant-start version of the Morris water maze) were chosen because they do not depend on hippocampal processing. The third task examined was the standard version of the Morris water maze which is known to rely on hippocampal processing. Rats were either injured at a moderate level (2.1 atm) of fluid percussion brain injury or surgically prepared but not injured (sham-injured control group). Nine days after fluid percussion injury, injured (n = 9) and sham-injured rats (n = 8) were trained on the one-trial passive avoidance task with retention assessed 24 h later. On days 11-15 following injury, injured (n = 9) and sham-injured (n = 8) rats were trained on a constant-start Version of the Morris water maze that has the animals begin the maze from a fixed start position on each trial. Additional injured (n = 8) and sham-injured (n = 8) animals were trained on days 11-15 after injury on the standard (i.e. using variable start positions) version of the Morris water maze. The results of this experiment revealed that performance of the passive avoidance and the constant-start Version of the Morris water maze were not impaired by fluid percussion TBI. However, performance on a task that is usually disrupted by hippocampal damage (variable-start version of the Morris water maze) was significantly impaired by TBI. Thus, the hippocampus appears to be selectively damaged following TBI.	VIRGINIA COMMONWEALTH UNIV,DEPT NEUROSURG,RICHMOND,VA 23284		HAMM, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,DEPT PSYCHOL,VCU BOX 2018,RICHMOND,VA 23284, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline		BARTUS RT, 1986, PHARMACOL BIOCHEM BE, V24, P1287, DOI 10.1016/0091-3057(86)90186-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Deangelis M. M., 1992, Society for Neuroscience Abstracts, V18, P172; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUNN LT, 1988, BEHAV NEUROSCI, V102, P3, DOI 10.1037/0735-7044.102.1.3; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; GRONWALL D, 1974, LANCET, V2, P605; HALL S, 1991, J NEUROSURG, V75, P378, DOI 10.3171/jns.1991.75.3.0378; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; JARRARD LE, 1980, PHYSIOL PSYCHOL, V8, P198; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MUNDY WR, 1988, NEUROTOXICOLOGY, V9, P511; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; OLTON DS, 1982, BRAIN RES, V233, P241, DOI 10.1016/0006-8993(82)91200-8; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; PULSINELLI W, 1982, ANN NEUROL, P491; SANTUCCI AC, 1989, PHARMACOL BIOCHEM BE, V33, P485, DOI 10.1016/0091-3057(89)90535-2; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SUTHERLAND RJ, 1989, PSYCHOBIOLOGY, V17, P129; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; TAGHZOUTI K, 1985, BRAIN RES, V344, P9, DOI 10.1016/0006-8993(85)91184-9; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9	32	116	117	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	DEC 31	1993	59	1-2					169	173		10.1016/0166-4328(93)90164-L			5	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	MW335	WOS:A1993MW33500020	8155285				2022-02-06	
J	SMITH, DH; OKIYAMA, K; GENNARELLI, TA; MCINTOSH, TK				SMITH, DH; OKIYAMA, K; GENNARELLI, TA; MCINTOSH, TK			MAGNESIUM AND KETAMINE ATTENUATE COGNITIVE DYSFUNCTION FOLLOWING EXPERIMENTAL BRAIN INJURY	NEUROSCIENCE LETTERS			English	Article						BRAIN INJURY; MEMORY; MAGNESIUM; KETAMINE; FLUID PERCUSSION	NEURONS; RELEASE; RAT; PHENCYCLIDINE; HIPPOCAMPUS; MEMBRANES; TRAUMA; DRUGS	We evaluated the therapeutic effects of two noncompetitive antagonists of the N-methyl-D-aspartate (NMDA) receptor, MgCl2 and ketamine, both individually and together, on cognitive dysfunction observed following parasagittal fluid-percussion (FP) brain injury in the rat. Using a modified Morris water maze technique, we found significant attenuation of post-traumatic memory dysfunction in animals treated with either MgCl2 (125 mumol) or ketamine (4 mg/kg) (P < 0.005). Combined MgCl2 and ketamine treatment also preserved memory function (P < 0.005), with no apparent additive effect.			SMITH, DH (corresponding author), UNIV PENN,DIV NEUROSURG,105 HAYDEN HALL,240 S 33RD ST,PHILADELPHIA,PA 19104, USA.		smith, douglas/A-1321-2007		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, R01NS026818, P01NS008803, R55NS026818] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 08803, NS 26818] Funding Source: Medline		ALVES WM, 1992, CENTRAL NERVOUS SYST, P255; BLAIR JL, 1989, STROKE, V20, P1507; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FADEN AI, 1989, SCIENCE, V244, P789; FAGG GE, 1987, NEUROSCI LETT, V76, P221, DOI 10.1016/0304-3940(87)90719-1; Hicks R. R., 1992, Society for Neuroscience Abstracts, V18, P170; HOFFMAN WE, 1992, ANESTHESIOLOGY, V76, P755, DOI 10.1097/00000542-199205000-00014; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; LOBNER D, 1990, NEUROSCI LETT, V117, P169, DOI 10.1016/0304-3940(90)90139-Z; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MCINTOSH T, 1988, NEUROL NEUR, V46, P653; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCINTOSH TK, 1992, EXCITATORY AMINO ACI, P247; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MONAGHAN DT, 1986, P NATL ACAD SCI USA, V83, P7532, DOI 10.1073/pnas.83.19.7532; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; PETERSEN EN, 1989, PHARMACOL TOXICOL, V65, P299, DOI 10.1111/j.1600-0773.1989.tb01177.x; ROBERTSON CS, 1986, J NEUROSURG, V64, P633, DOI 10.3171/jns.1986.64.4.0633; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; SHARP FR, 1991, ANN NEUROL, V30, P801, DOI 10.1002/ana.410300609; Smith D. H., 1992, Society for Neuroscience Abstracts, V18, P170; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; TSUDA T, 1991, HIPPOCAMPUS, P335; VINK R, 1988, J BIOL CHEM, V263, P757; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I	34	116	117	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JUL 23	1993	157	2					211	214		10.1016/0304-3940(93)90739-8			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LR741	WOS:A1993LR74100022	8233056				2022-02-06	
J	COGBILL, TH; MOORE, EE; MORRIS, JA; HOYT, DB; JURKOVICH, GJ; MUCHA, P; ROSS, SE; FELICIANO, DV; SHACKFORD, SR; LANDERCASPER, J; MOORE, FA; VANAALST, JA; DAVIS, JW; OFFNER, PJ; RHODES, M; OMALLEY, KF; SWIERZEWSKI, MJ; SCHMOKER, JD; STRUTT, PJ				COGBILL, TH; MOORE, EE; MORRIS, JA; HOYT, DB; JURKOVICH, GJ; MUCHA, P; ROSS, SE; FELICIANO, DV; SHACKFORD, SR; LANDERCASPER, J; MOORE, FA; VANAALST, JA; DAVIS, JW; OFFNER, PJ; RHODES, M; OMALLEY, KF; SWIERZEWSKI, MJ; SCHMOKER, JD; STRUTT, PJ			DISTAL PANCREATECTOMY FOR TRAUMA - A MULTICENTER EXPERIENCE	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article								During a 5-year period, 74 patients with pancreatic injuries were managed by distal pancreatic resection at nine referral trauma centers. Patient ages ranged from 4 to 72 years. Injury mechanism was blunt trauma in 34 (46%) patients, gunshot wound in 27 (36%), stab wound in 11 (15%), and shotgun blast in two (3%). There were 19 class II, 50 class III, and 5 class IV pancreatic injuries. The resection comprised up to 33% of the pancreas in 21 (28%) patients, from 34% to 66% in 45 (61%), and greater than 67% in eight (11%). The pancreatic resection margin was closed with staples in 44 (59%), silk sutures in 20 (27%), and polypropylene sutures in eight (11%). Of 32 patients in whom the spleen was uninjured, the spleen was left intact in 17 (53%). There were nine (12%) deaths. The cause of death was irreversible shock in three patients, multiple organ failure in five, and severe head injury in one. Pancreas-related complications occurred in 32 (45%) of 71 patients who survived the initial operation. Intra-abdominal abscess developed in 24 patients; 11 were managed by percutaneous drainage alone. Pancreatic fistula developed in 10 patients; eight closed spontaneously from 6 to 54 days. Other pancreas-related morbidity included pancreatitis (6), pseudocyst (2), and hemorrhage (2). Exocrine insufficiency was not evident in any patient and diet-controlled hyperglycemia occurred in one individual following 80% pancreatic resection. We conclude: (1) distal pancreatectomy can be safely performed without concomitant splectomy; (2) pancreas-related morbidity is frequent after pancreatic resection for trauma, regardless of method of pancreatic closure; and (3) endocrine and exocrine insufficiency are rare after distal pancreatectomy for trauma.	GUNDERSEN LUTHERAN MED CTR, DEPT SURG, LA CROSSE, WI USA; DENVER GEN HOSP, DEPT SURG, DENVER, CO 80204 USA; UNIV COLORADO, HLTH SCI CTR, DEPT SURG, DENVER, CO 80262 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT SURG, NASHVILLE, TN 37232 USA; UNIV CALIF SAN DIEGO, MED CTR, DEPT SURG, SAN DIEGO, CA 92103 USA; UNIV WASHINGTON, HARBORVIEW MED CTR, DEPT SURG, SEATTLE, WA 98104 USA; UNIV WASHINGTON, SCH MED, DEPT SURG, SEATTLE, WA 98195 USA; ALLENTOWN HOSP, LEHIGH VALLEY HOSP CTR, DEPT SURG, ALLENTOWN, PA 18102 USA; UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT SURG, CAMDEN, NJ USA; UNIV ROCHESTER, MED CTR, DEPT SURG, ROCHESTER, NY 14642 USA; UNIV VERMONT, MED CTR, DEPT SURG, BURLINGTON, VT 05405 USA					landercasper, jeffrey/0000-0002-4000-4546			ADAMS DB, 1990, ARCH SURG-CHICAGO, V125, P1554; ANANESEFAH J, 1975, ARCH SURG-CHICAGO, V110, P161; ANDERSEN DK, 1980, J TRAUMA, V20, P347; [Anonymous], 1990, ABBREVIATED INJURY S; BACH RD, 1971, AM J SURG, V121, P20, DOI 10.1016/0002-9610(71)90073-0; BERNI GA, 1982, AM J SURG, V143, P602, DOI 10.1016/0002-9610(82)90173-8; BORLASE BC, 1990, J TRAUMA, V30, P1340, DOI 10.1097/00005373-199011000-00006; BOUWMAN DL, 1984, J TRAUMA, V24, P573, DOI 10.1097/00005373-198407000-00004; BURNWEIT C, 1990, J TRAUMA, V30, P1273, DOI 10.1097/00005373-199010000-00013; CARR ND, 1989, BRIT J SURG, V76, P1244, DOI 10.1002/bjs.1800761206; CIVIL ID, 1987, SURGICAL ROUNDS, P29; COGBILL TH, 1982, ARCH SURG-CHICAGO, V117, P722; DAWSON DL, 1986, J TRAUMA, V26, P1142, DOI 10.1097/00005373-198612000-00018; FABIAN TC, 1990, ANN SURG, V211, P724, DOI 10.1097/00000658-199006000-00011; FITZGIBBONS TJ, 1982, SURG GYNECOL OBSTET, V154, P225; FLYNN WJ, 1990, ARCH SURG-CHICAGO, V125, P1539; FREY CF, 1989, SURG CLIN N AM, V69, P499; GRAHAM JM, 1978, AM J SURG, V136, P744, DOI 10.1016/0002-9610(78)90349-5; HAYWARD SR, 1989, ARCH SURG-CHICAGO, V124, P745; HEITSCH RC, 1976, SURGERY, V80, P523; HORST HM, 1989, ARCH SURG-CHICAGO, V124, P1093; JEFFREY RB, 1983, RADIOLOGY, V147, P491, DOI 10.1148/radiology.147.2.6836127; JONES RC, 1985, AM J SURG, V150, P698, DOI 10.1016/0002-9610(85)90412-X; JONES RC, 1978, ANN SURG, V187, P555, DOI 10.1097/00000658-197805000-00015; JURKOVICH GJ, 1990, SURG CLIN N AM, V70, P575; KARL HW, 1977, AM J SURG, V134, P549, DOI 10.1016/0002-9610(77)90431-7; KELLUM JM, 1988, TRAUMA, V28, P700; KUDSK KA, 1986, J TRAUMA, V26, P320, DOI 10.1097/00005373-198604000-00003; LARAJA RD, 1986, J TRAUMA, V26, P1146, DOI 10.1097/00005373-198612000-00019; MALANGONI MA, 1986, ANN SURG, V203, P605, DOI 10.1097/00000658-198606000-00004; MARTIN FM, 1989, ARCH SURG-CHICAGO, V124, P571; MOORE EE, 1981, J TRAUMA, V21, P439; MOORE EE, 1990, J TRAUMA, V30, P1427, DOI 10.1097/00005373-199011000-00035; OLSEN WR, 1973, J TRAUMA, V13, P200, DOI 10.1097/00005373-197303000-00003; PACHTER HL, 1979, SURGERY, V85, P166; PACHTER HL, 1989, J TRAUMA, V29, P1352, DOI 10.1097/00005373-198910000-00010; PEDERZOLI P, 1986, SURG GYNECOL OBSTET, V163, P428; PEITZMAN AB, 1986, J TRAUMA, V26, P585, DOI 10.1097/00005373-198607000-00001; PRINZ RA, 1988, AM J SURG, V155, P36, DOI 10.1016/S0002-9610(88)80255-1; ROBEY E, 1982, ANN SURG, V196, P695, DOI 10.1097/00000658-198212001-00014; SCOTTCONNER CEH, 1989, SURG GYNECOL OBSTET, V168, P451; SIMS EH, 1984, J TRAUMA, V24, P125, DOI 10.1097/00005373-198402000-00006; SMEGO DR, 1985, J TRAUMA, V25, P771, DOI 10.1097/00005373-198508000-00007; STEELE M, 1973, ARCH SURG-CHICAGO, V106, P544; STONE HH, 1981, J TRAUMA, V21, P257, DOI 10.1097/00005373-198104000-00001; TAXIER M, 1980, SURG GYNECOL OBSTET, V150, P65; WALTERS RL, 1966, AM J SURG, V111, P364, DOI 10.1016/S0002-9610(66)80013-2; WISNER DH, 1990, ARCH SURG-CHICAGO, V125, P1109	48	116	123	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	1991	31	12					1600	1606		10.1097/00005373-199112000-00006			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GW885	WOS:A1991GW88500006	1749029				2022-02-06	
J	Ghajari, M; Hellyer, PJ; Sharp, DJ				Ghajari, Mazdak; Hellyer, Peter J.; Sharp, David J.			Computational modelling of traumatic brain injury predicts the location of chronic traumatic encephalopathy pathology	BRAIN			English	Article						computational modelling; diffusion imaging; traumatic brain injury	DIFFUSE AXONAL INJURY; DYNAMIC STRETCH INJURY; CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER INJURY; COGNITIVE IMPAIRMENT; HEAD-INJURY; TOLERANCE; CONCUSSION; TISSUE; DEFORMATION	Traumatic brain injury can lead to the neurodegenerative disease chronic traumatic encephalopathy. This condition has a clear neuropathological definition but the relationship between the initial head impact and the pattern of progressive brain pathology is poorly understood. We test the hypothesis that mechanical strain and strain rate are greatest in sulci, where neuropathology is prominently seen in chronic traumatic encephalopathy, and whether human neuroimaging observations converge with computational predictions. Three distinct types of injury were simulated. Chronic traumatic encephalopathy can occur after sporting injuries, so we studied a helmet-to-helmet impact in an American football game. In addition, we investigated an occipital head impact due to a fall from ground level and a helmeted head impact in a road traffic accident involving a motorcycle and a car. A high fidelity 3D computational model of brain injury biomechanics was developed and the contours of strain and strain rate at the grey matter-white matter boundary were mapped. Diffusion tensor imaging abnormalities in a cohort of 97 traumatic brain injury patients were also mapped at the grey matter-white matter boundary. Fifty-one healthy subjects served as controls. The computational models predicted large strain most prominent at the depths of sulci. The volume fraction of sulcal regions exceeding brain injury thresholds were significantly larger than that of gyral regions. Strain and strain rates were highest for the road traffic accident and sporting injury. Strain was greater in the sulci for all injury types, but strain rate was greater only in the road traffic and sporting injuries. Diffusion tensor imaging showed converging imaging abnormalities within sulcal regions with a significant decrease in fractional anisotropy in the patient group compared to controls within the sulci. Our results show that brain tissue deformation induced by head impact loading is greatest in sulcal locations, where pathology in cases of chronic traumatic encephalopathy is observed. In addition, the nature of initial head loading can have a significant influence on the magnitude and pattern of injury. Clarifying this relationship is key to understanding the long-term effects of head impacts and improving protective strategies, such as helmet design.	[Ghajari, Mazdak] Imperial Coll London, Dyson Sch Design Engn, London SW7 2AZ, England; [Hellyer, Peter J.] Imperial Coll London, Dept Bioengn, South Kensington Campus, London SW7 2AZ, England; [Sharp, David J.] Imperial Coll London, Computat & Clin Neuroimaging Lab, Cognit & Clin Neuroimaging Lab, Div Brain Sci, London W12 0NN, England		Ghajari, M (corresponding author), Imperial Coll London, Dyson Sch Design Engn, London SW7 2AZ, England.	m.ghajari@imperial.ac.uk	Sharp, David J/A-2119-2013; Hellyer, Peter J/F-7112-2013; Lang, Steven/AAE-8102-2021	Hellyer, Peter J/0000-0002-5139-3401; Lang, Steven/0000-0003-1669-9146	Imperial College London Junior Research Fellowship; Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Imperial College NIHR Biomedical Research Centre; Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust); National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-011-048] Funding Source: researchfish	This work was supported by an Imperial College London Junior Research Fellowship (M.G.) and the Medical Research Council (UK). D.J.S. has a National Institute of Health Research Professorship - RP-011-048. The work was also supported by the Imperial College NIHR Biomedical Research Centre. P.J.H is funded by a Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust).	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; [Anonymous], 2001, COST327 EUR COMM; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ghajari M, 2011, INT J CRASHWORTHINES, V16, P285, DOI 10.1080/13588265.2011.559798; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hallquist JO, 2013, LS DYNA KEYW US MAN; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; King A. I., 2003, IRCOBI C LISB PORT; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nicolle S, 2005, BIORHEOLOGY, V42, P209; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Shreiber DI, 1997, STAPP CAR CRASH J, V41, P277; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	52	115	115	1	27	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	FEB	2017	140		2				333	343		10.1093/brain/aww317			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EP3XV	WOS:000397315900018	28043957	Green Published, Bronze			2022-02-06	
J	Vanderploeg, RD; Belanger, HG; Horner, RD; Spehar, AM; Powell-Cope, G; Luther, SL; Scott, SG				Vanderploeg, Rodney D.; Belanger, Heather G.; Horner, Ronnie D.; Spehar, Andrea M.; Powell-Cope, Gail; Luther, Stephen L.; Scott, Steven G.			Health Outcomes Associated With Military Deployment: Mild Traumatic Brain Injury, Blast, Trauma, and Combat Associations in the Florida National Guard	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Blast injuries; Brain concussion; Military personnel; Neurobehavioral manifestations; Outcome assessment; Rehabilitation; Sequelae	POSTTRAUMATIC-STRESS-DISORDER; PRIMARY-CARE; FUNCTIONAL IMPAIRMENT; IRAQ; VETERANS; AFGHANISTAN; SYMPTOMS; COMPLAINTS; SEVERITY; SEQUELAE	Objectives: To determine the association between specific military deployment experiences and immediate and longer-term physical and mental health effects, as well as examine the effects of multiple deployment-related traumatic brain injuries (TBIs) on health outcomes. Design: Online survey of cross-sectional cohort. Odds ratios were calculated to assess the association between deployment-related factors (ie, physical injuries, exposure to potentially traumatic deployment experiences, combat, blast exposure, and mild TBI) and current health status, controlling for potential confounders, demographics, and predeployment experiences. Setting: Nonclinical. Participants: Members (N=3098) of the Florida National Guard (1443 deployed, 1655 not deployed). Interventions: Not applicable. Main Outcome Measures: Presence of current psychiatric diagnoses and health outcomes, including postconcussive and non postconcussive symptoms. Results: Surveys were completed an average of 31.8 months (SD=24.4, range=0-95) after deployment. Strong, statistically significant associations were found between self-reported military deployment-related factors and current adverse health status. Deployment-related mild TBI was associated with depression, anxiety, posttraumatic stress disorder (PTSD), and postconcussive symptoms collectively and individually. Statistically significant increases in the frequency of depression, anxiety, PTSD, and a postconcussive symptom complex were seen comparing single to multiple TBIs. However, a predeployment TBI did not increase the likelihood of sustaining another TBI in a blast exposure. Associations between blast exposure and abdominal pain, pain on deep breathing, shortness of breath, hearing loss, and tinnitus suggested residual barotrauma. Combat exposures with and without physical injury were each associated not only with PTSD but also with numerous postconcussive and non postconcussive symptoms. The experience of seeing others wounded or killed or experiencing the death of a buddy or leader was associated with indigestion and headaches but not with depression, anxiety, or FTSD. Conclusions: Complex relationships exist between multiple deployment-related factors and numerous overlapping and co-occurring current adverse physical and psychological health outcomes. Various deployment-related experiences increased the risk for postdeployment adverse mental and physical health outcomes, individually and in combination. These findings suggest that an integrated physical and mental health care approach would be beneficial to postdeployment care.	[Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley Vet Hosp, Mental Hlth & Behav Sci Psychol Serv, Tampa, FL 33612 USA; [Scott, Steven G.] James A Haley Vet Hosp, Phys Med & Rehabil Serv, Tampa, FL 33612 USA; [Spehar, Andrea M.] James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; [Powell-Cope, Gail; Luther, Stephen L.] James A Haley Vet Hosp, Nursing Serv, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.; Spehar, Andrea M.; Powell-Cope, Gail; Luther, Stephen L.; Scott, Steven G.] James A Haley Vet Hosp, Hlth Serv Res & Dev HSR&D Rehabil Res & Dev RR&D, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Powell-Cope, Gail; Luther, Stephen L.] Univ S Florida, Dept Publ Hlth, Tampa, FL USA; [Scott, Steven G.] Univ S Florida, Dept Internal Med, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.; Scott, Steven G.] James A Haley Vet Affairs Med Ctr, Def & Vet Brain Injury Ctr, Tampa, FL USA; [Horner, Ronnie D.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci Psychol Serv 116B, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Rodney.Vanderploeg@va.gov		Powell-Cope, Gail/0000-0002-4608-0128	Department of Veterans Affairs, Veterans Health AdministrationUS Department of Veterans Affairs; Veterans Administration HSRD [CCN 06-164]; James A. Haley Veterans' HospitalUS Department of Veterans Affairs; HSR&D/RR&D Center of Excellence	Supported by the Department of Veterans Affairs, Veterans Health Administration, and Veterans Administration HSR&D (grant no. CCN 06-164). Further support was provided by the James A. Haley Veterans' Hospital and its HSR&D/RR&D/RR&D Center of Excellence. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Veterans Affairs or the US government.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BABOR TF, 1992, AUDIT ALC US DIS ID; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Deployment Health Clinical Center, 2010, POSTD HLTH ASS PDHA; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Grumbach K, 2002, JAMA-J AM MED ASSOC, V288, P889, DOI 10.1001/jama.288.7.889; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jones E, 2006, PHILOS T R SOC B, V361, P533, DOI 10.1098/rstb.2006.1814; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kehle SM, 2010, J TRAUMA STRESS, V23, P33, DOI 10.1002/jts.20480; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shea MT, 2010, J TRAUMA STRESS, V23, P100, DOI 10.1002/jts.20497; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; World Health Organization, 2004, ICD 10 INT STAT CLAS	35	115	116	0	38	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2012	93	11					1887	1895		10.1016/j.apmr.2012.05.024			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	031VQ	WOS:000310671100001	22705240				2022-02-06	
J	Ciurli, P; Formisano, R; Bivona, U; Cantagallo, A; Angelelli, P				Ciurli, Paola; Formisano, Rita; Bivona, Umberto; Cantagallo, Anna; Angelelli, Paola			Neuropsychiatric Disorders in Persons With Severe Traumatic Brain Injury: Prevalence, Phenomenology, and Relationship With Demographic, Clinical, and Functional Features	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						neuropsychiatric disorders; Neuropsychiatric Inventory; severe traumatic brain injury	CLOSED-HEAD-INJURY; APATHY EVALUATION SCALE; DIFFUSE AXONAL INJURY; CEREBRAL-BLOOD-FLOW; QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; ALZHEIMER-DISEASE; PRACTICAL SCALE; AXIS-I; DEPRESSION	Objective: To characterize neuropsychiatric symptoms in a large group of individuals with severe traumatic brain injury (TBI) and to correlate these symptoms with demographic, clinical, and functional features. Methods: The Neuropsychiatric Inventory (NPI), a frequently used scale to assess behavioral, emotional, and motivational disorders in persons with neurological diseases, was administered to a sample of 120 persons with severe TBI. Controls were 77 healthy subjects. Results: A wide range of neuropsychiatric symptoms was found in the population with severe TBI: apathy (42%), irritability (37%), dysphoria/depressed mood (29%), disinhibition (28%), eating disturbances (27%), and agitation (24%). A clear relationship was also found with other demographic and clinical variables. Conclusion: Neuropsychiatric disorders constitute an important part of the comorbidity in populations with severe TBI. Our study emphasizes the importance of integrating an overall assessment of cognitive disturbances with a specific neuropsychiatric evaluation to improve clinical understanding and treatment of persons with TBI.	[Ciurli, Paola; Formisano, Rita; Bivona, Umberto] IRCCS Santa Lucia Fdn, Rome, Italy; [Cantagallo, Anna] Hosp & Univ Ferrara, Dept Neurosci Rehabil, Ferrara, Italy; [Angelelli, Paola] Univ Bari, Dept Psychol, Bari, Italy		Ciurli, P (corresponding author), IRCCS Santa Lucia Hosp, Via Ardeatina 306, Rome, Italy.	p.ciurli@hsantalucia.it		Angelelli, Paola/0000-0001-9870-6009			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; American Psychiatric Association, 1995, DIAGN STAT MAN MENT; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Arciniegas DB, 2000, CURR TREAT OPTION NE, V2, P186; Babin PR, 2003, BRAIN INJURY, V17, P889, DOI 10.1080/0269905031000088595; Binetti G, 1998, ARCH NEUROL-CHICAGO, V55, P539, DOI 10.1001/archneur.55.4.539; BROWN RG, 1990, PSYCHOL MED, V20, P77, DOI 10.1017/S0033291700013246; Cantagallo A, 2003, EUR MED PHYS, V38, P167; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Craig AH, 1996, ARCH NEUROL-CHICAGO, V53, P1116, DOI 10.1001/archneur.1996.00550110056012; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Finset A, 2000, BRAIN INJURY, V14, P887; First MB, 1995, BECK STRUCTURED CLIN; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Graham D.I., 1996, NEUROTRAUMA, P43; Greve KW, 2001, BRAIN INJURY, V15, P255; Hagen C, 1979, REHABILITATION HEAD, P87; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1986, ACTA NEUROCHIR, V36, P90; Jorge R, 2002, NEUROREHABILITATION, V17, P311; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kraus MF, 1999, TRAUMATIC BRAIN INJU, V14, P173; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Levy M, 2005, NEUROREHABILITATION, V20, P279; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; MARIN RS, 1993, J AFFECT DISORDERS, V28, P117, DOI 10.1016/0165-0327(93)90040-Q; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marin RS, 2005, J HEAD TRAUMA REHAB, V20, pCP1; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McAllister TW, 2002, NEUROREHABILITATION, V17, P263; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McAllister TW, 2002, AM J PSYCHIAT, V17, P357; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mega MS, 1996, NEUROLOGY, V46, P130, DOI 10.1212/WNL.46.1.130; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Resnick B, 1998, Rehabil Nurs, V23, P141; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Silver JM, 1994, AM PSYCHIAT PRESS TX, P313; SORENSON SB, 1991, J HEAD TRAUMA REHAB, V5, P1; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1974, LANCET, V2, P81; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; van der Naalt J, 2000, BRAIN INJURY, V14, P781; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; ZWIL AS, 1992, INT J PSYCHIAT MED, V22, P377, DOI 10.2190/J71J-FTML-JY1E-RKKG	72	115	116	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2011	26	2					116	126		10.1097/HTR.0b013e3181dedd0e			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	732OR	WOS:000288197200002	20485191				2022-02-06	
J	Lange, RT; Iverson, GL; Rose, A				Lange, Rael T.; Iverson, Grant L.; Rose, Alice			Depression Strongly Influences Postconcussion Symptom Reporting Following Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; mild traumatic brain injury; postconcussion symptoms	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYNDROME; COMPLAINT BASE RATES; GOOD OLD DAYS; MAJOR DEPRESSION; HEAD-INJURY; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; CHRONIC PAIN; EXPECTATION	Objective: To examine the influence of depression on postconcussion symptom reporting in patients following mild traumatic brain injury (MTBI). Participants: Sixty patients referred to a specialty clinic following MTBI, 58 outpatients with Structured Clinical Interview for DSM-diagnosed depression, and 72 healthy community control participants. Procedure: Participants with MTBI were divided into 2 subgroups on the basis of self-reported symptoms of depression (23 MTBI-depressed, 37 MTBI-not depressed). All participants completed a postconcussion symptom questionnaire. Main outcome measure: British Columbia Post-concussion Symptom Inventory. Results: There were significant differences in total reported postconcussion symptoms among all 4 groups (all P < .002; Cohen's d = 0.68-3.24, large to very large effect sizes; MTBI-depressed > depressed outpatients > MTBI-no depression > healthy controls). There were significant differences in the number of symptoms endorsed (P < .05), with the highest number of symptoms endorsed by the MTBI-depressed group, followed by depressed outpatients, MTBI-no depression, and healthy controls. Conclusions: Patients who experience MTBIs and who have a postinjury recovery course complicated by significant depression report more postconcussion symptoms, and more severe symptoms, than (a) outpatients with depression, and (b) patients with MTBIs who do not have significant symptoms of depression.	[Lange, Rael T.; Iverson, Grant L.] PHSA Res & Networks, British Columbia Mental Hlth & Addict Serv, Vancouver, BC V5Z 4C2, Canada; [Rose, Alice] Univ British Columbia, GF Strong Rehab Ctr, Vancouver, BC V5Z 1M9, Canada		Lange, RT (corresponding author), PHSA Res & Networks, British Columbia Mental Hlth & Addict Serv, Ste 201,601 W Broadway St, Vancouver, BC V5Z 4C2, Canada.	rael.lange@gmail.com		Iverson, Grant/0000-0001-7348-9570			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ATKINSON JH, 1991, PAIN, V45, P111, DOI 10.1016/0304-3959(91)90175-W; Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647; Breslau N, 2000, NEUROLOGY, V54, P308, DOI 10.1212/WNL.54.2.308; Campbell LC, 2003, BIOL PSYCHIAT, V54, P399, DOI 10.1016/S0006-3223(03)00545-6; Channon S, 1999, J NEUROL NEUROSUR PS, V66, P162, DOI 10.1136/jnnp.66.2.162; DUNN JT, 1995, J CLIN PSYCHOL, V51, P577, DOI 10.1002/1097-4679(199507)51:4<577::AID-JCLP2270510418>3.0.CO;2-E; Ericsson M, 2002, DISABIL REHABIL, V24, P334, DOI 10.1080/09638280110096241; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; FRANK E, 1990, ARCH GEN PSYCHIAT, V47, P1093; Franklin CL, 2001, J NERV MENT DIS, V189, P548, DOI 10.1097/00005053-200108000-00008; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gibbon M, 1998, STRUCTURED CLIN INTE; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hung CI, 2006, CEPHALALGIA, V26, P26, DOI 10.1111/j.1468-2982.2005.00985.x; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2004, PSYCHOL REP, V95, P1241, DOI 10.2466/pr0.95.3f.1241-1247; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; IVERSON GL, BLACK BOOK IN PRESS; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; Kessing LV, 2004, ACTA PSYCHIAT SCAND, V109, P339, DOI 10.1046/j.1600-0447.2003.00266.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mulder RT, 2006, AM J PSYCHIAT, V163, P95, DOI 10.1176/appi.ajp.163.1.95; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; Pettit JW, 2006, PSYCHIAT RES, V141, P271, DOI 10.1016/j.psychres.2005.07.022; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Williams JMG, 2006, J AFFECT DISORDERS, V91, P189, DOI 10.1016/j.jad.2006.01.002; Wilson KG, 2002, CLIN J PAIN, V18, P77, DOI 10.1097/00002508-200203000-00002; World Health Organization, 2004, ICD 10 INT STAT CLAS; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111	66	115	116	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2011	26	2					127	137		10.1097/HTR.0b013e3181e4622a			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	732OR	WOS:000288197200003	20631632				2022-02-06	
J	Sponheim, SR; McGuire, KA; Kang, SS; Davenport, ND; Aviyente, S; Bernat, EM; Lim, KO				Sponheim, Scott R.; McGuire, Kathryn A.; Kang, Seung Suk; Davenport, Nicholas D.; Aviyente, Selin; Bernat, Edward M.; Lim, Kelvin O.			Evidence of disrupted functional connectivity in the brain after combat-related blast injury	NEUROIMAGE			English	Article							INDUCED NEUROTRAUMA; MILITARY TBI; EEG; CONCUSSION; MECHANISMS; IRAQ; NEUROPSYCHOLOGY; AFGHANISTAN; MANAGEMENT; SYMPTOMS	Non-impact blast-related mild traumatic brain injury (mTBI) appears to be present in soldiers returning from deployments to Afghanistan and Iraq. Although mTBI typically results in cognitive deficits that last less than a month, there is evidence that disrupted coordination of brain activity can persist for at least several months following injury (Thatcher et al., 1989, 2001). In the present study we examined whether neural communication may be affected in soldiers months after blast-related mTBI, and whether coordination of neural function is associated with underlying white matter integrity. The investigation included an application of a new time-frequency based method for measuring electroencephalogram (EEG) phase synchronization (Aviyente et al., 2010) as well as fractional anisotropy measures of axonal tracts derived from diffusion tensor imaging (DTI). Nine soldiers who incurred a blast-related mTBI during deployments to Afghanistan or Iraq were compared with eight demographically similar control subjects. Despite an absence of cognitive deficits, the blast-related mTBI group exhibited diminished EEG phase synchrony of lateral frontal sites with contralateral frontal brain regions suggesting diminished interhemispheric coordination of brain activity as a result of blast injury. For blast injured (i.e., blast-related mTBI) soldiers we found that EEG phase synchrony was associated with the structural integrity of white matter tracts of the frontal lobe (left anterior thalamic radiations and the forceps minor including the anterior corpus callosum). Analyses revealed that diminished EEG phase synchrony was not the consequence of combat-stress symptoms (e. g., post-traumatic stress and depression) and commonly prescribed medications. Results provide evidence for poor coordination of frontal neural function after blast injury that may be the consequence of damaged anterior white matter tracts. Published by Elsevier Inc.	[Sponheim, Scott R.; McGuire, Kathryn A.; Kang, Seung Suk; Davenport, Nicholas D.; Lim, Kelvin O.] Vet Affairs Med Ctr, Minneapolis, MN USA; [Sponheim, Scott R.; McGuire, Kathryn A.; Kang, Seung Suk; Davenport, Nicholas D.; Lim, Kelvin O.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Sponheim, Scott R.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Aviyente, Selin] Michigan State Univ, Dept Elect Engn, E Lansing, MI 48824 USA; [Bernat, Edward M.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA		Sponheim, SR (corresponding author), VA Med Ctr 116B, 1 Vet Dr, Minneapolis, MN 55417 USA.	sponh001@umn.edu	Kang, Seung/AAO-7849-2020; Sponheim, Scott/J-3857-2017; Davenport, Nicholas/AAY-8057-2020; Lim, Kelvin/AAF-6833-2020	Sponheim, Scott/0000-0002-2782-0856; Davenport, Nicholas/0000-0002-3441-7256; Aviyente, Selin/0000-0001-9023-107X; Lim, Kelvin/0000-0002-2390-7268	Minnesota Veterans Medical Research and Education Foundation (formerly Minnesota Veterans Research Institute [MVRI]); Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0038]; Minnesota Veterans Medical Research and Education Foundation	This work was supported by grants from the Minnesota Veterans Medical Research and Education Foundation (formerly Minnesota Veterans Research Institute [MVRI]) and the Congressionally Directed Medical Research Program (W81XWH-08-2-0038) to Scott R. Sponheim and a grant from the Minnesota Veterans Medical Research and Education Foundation to Kathryn A. McGuire.	AVIYENTE S, 2010, HUM BRAIN MAPP; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CRAMER F, 1949, ARCH NEURO PSYCHIATR, V61, P1; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; FABING HD, 1947, ARCH NEURO PSYCHIATR, V57, P14, DOI 10.1001/archneurpsyc.1947.02300240030002; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Georgopoulos AP, 2007, J NEURAL ENG, V4, P349, DOI 10.1088/1741-2560/4/4/001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jeyakumar SLE, 2004, EDUC PSYCHOL MEAS, V64, P71, DOI 10.1177/0013164403258407; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMenamin BW, 2010, NEUROIMAGE, V49, P2416, DOI 10.1016/j.neuroimage.2009.10.010; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F.W., 1991, PCL C DSM 4; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	49	115	115	0	30	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	JAN	2011	54			1			S21	S29		10.1016/j.neuroimage.2010.09.007			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	813ZF	WOS:000294408600004	20851190				2022-02-06	
J	Datta, A; Bikson, M; Fregni, F				Datta, Abhishek; Bikson, Marom; Fregni, Felipe			Transcranial direct current stimulation in patients with skull defects and skull plates: High-resolution computational FEM study of factors altering cortical current flow	NEUROIMAGE			English	Article						tDCS; TBI; Skull defects; Skull plates; Finite element modeling; MRI human head model	EXPERIMENTAL CEREBRAL-ISCHEMIA; NONINVASIVE BRAIN-STIMULATION; MRI TISSUE CHARACTERIZATION; PREFRONTAL CORTEX; DC-STIMULATION; PAIN; RAT; POLARIZATION; EXCITABILITY; MODULATION	Preliminary positive results of transcranial direct current stimulation (tDCS) in enhancing the effects of cognitive and motor training indicate that this technique might also be beneficial in traumatic brain injury or patients who had decompressive craniectomy for trauma and cerebrovascular disease. One perceived hurdle is the presence of skull defects or skull plates in these patients that would hypothetically alter the intensity and location of current flow through the brain. We aimed to model tDCS using a magnetic resonance imaging (MRI)-derived finite element head model with several conceptualized skull injuries. Cortical electric field (current density) peak intensities and distributions were compared with the healthy (skull intact) case. The factors of electrode position (C3-supraorbital or O1-supraorbital), electrode size skull defect size, skull defect state (acute and chronic) or skull plate (titanium and acrylic) were analyzed. If and how electric current through the brain was modulated by defects was found to depend on a specific combination of factors. For example, the condition that led to largest increase in peak cortical electric field was when one electrode was placed directly over a moderate sized skull defect. In contrast, small defects midway between electrodes did not significantly change cortical currents. As the conductivity of large skull defects/plates was increased (chronic to acute to titanium), current was shunted away from directly underlying cortex and concentrated in cortex underlying the defect perimeter. The predictions of this study are the first step to assess safety of transcranial electrical therapy in subjects with skull injuries and skull plates. (C) 2010 Elsevier Inc. All rights reserved.	[Datta, Abhishek] CUNY City Coll, Grove Sch Engn, Dept Biomed Engn, Neural Engn Lab, New York, NY 10031 USA; [Fregni, Felipe] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Lab Neuromodulat, Boston, MA 02114 USA; [Fregni, Felipe] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA		Datta, A (corresponding author), CUNY City Coll, Grove Sch Engn, Dept Biomed Engn, Neural Engn Lab, T-463 Steinman Hall,160 Convent Ave, New York, NY 10031 USA.	abhishek.datta@gmail.com; ffregni@partners.org		Fregni, Felipe/0000-0001-9359-8643	CIMIT (Center for Integration of Medicine and Innovative Technology); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S06GM008168, NS054783]; Wallace H. Coulter Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [S06GM008168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS054783] Funding Source: NIH RePORTER	We acknowledge Viet Bui Xuan of Simpleware Ltd.; and Varun Bansal and Davide Reato of The City College of New York. Felipe Fregni is partially funded by CIMIT (Center for Integration of Medicine and Innovative Technology). Marom Bikson is partially funded by NIH (nos. S06GM008168 NS054783) and the Wallace H. Coulter Foundation.	Ardolino G, 2005, J PHYSIOL-LONDON, V568, P653, DOI 10.1113/jphysiol.2005.088310; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Bikson Marom, 2008, Curr Treat Options Neurol, V10, P377, DOI 10.1007/s11940-008-0040-y; Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Boggio PS, 2009, NEUROSCI LETT, V463, P82, DOI 10.1016/j.neulet.2009.07.041; Butson CR, 2007, ACTA NEUROCHIR SUPPL, V97, P569; CHEW E, 2009, 5 WORLD C ISPRM; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; Datta A, 2009, IEEE ENG MED BIO, P670, DOI 10.1109/IEMBS.2009.5333673; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; Fregni F, 2006, EPILEPSIA, V47, P335, DOI 10.1111/j.1528-1167.2006.00426.x; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobs MA, 2001, STROKE, V32, P943, DOI 10.1161/01.STR.32.4.943; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Liebetanz D, 2009, CLIN NEUROPHYSIOL, V120, P1161, DOI 10.1016/j.clinph.2009.01.022; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Miranda PC, 2009, CLIN NEUROPHYSIOL, V120, P1183, DOI 10.1016/j.clinph.2009.03.023; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Rotenberg A, 2007, CLIN NEUROPHYSIOL, V118, P2536, DOI 10.1016/j.clinph.2007.08.003; Rotenberg A, 2009, CLIN NEUROPHYSIOL, V120, P1417, DOI 10.1016/j.clinph.2009.05.004; RUSH S, 1968, ANESTH ANAL CURR RES, V47, P717; Sekhar LN, 2006, ATLAS NEUROSURGICAL; Soltanian-Zadeh H, 2003, J MAGN RESON IMAGING, V17, P398, DOI 10.1002/jmri.10256; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027	35	115	118	1	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	OCT 1	2010	52	4					1268	1278		10.1016/j.neuroimage.2010.04.252			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	635YY	WOS:000280695200016	20435146	Green Accepted			2022-02-06	
J	Dai, SS; Zhou, YG; Li, W; An, JH; Li, P; Yang, N; Chen, XY; Xiong, RP; Liu, P; Zhao, Y; Shen, HY; Zhu, PF; Chen, JF				Dai, Shuang-Shuang; Zhou, Yuan-Guo; Li, Wei; An, Jian-Hong; Li, Ping; Yang, Nan; Chen, Xing-Yun; Xiong, Ren-Ping; Liu, Ping; Zhao, Yan; Shen, Hai-Ying; Zhu, Pei-Fang; Chen, Jiang-Fan			Local Glutamate Level Dictates Adenosine A(2A) Receptor Regulation of Neuroinflammation and Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article							ACTIVATED PROTEIN-KINASES; CORTICAL IMPACT MODEL; NERVE GROWTH-FACTOR; EXTRACELLULAR CONCENTRATIONS; METABOTROPIC GLUTAMATE-5; INDUCED EXCITOTOXICITY; SYNAPTIC-TRANSMISSION; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; RAT HIPPOCAMPUS	During brain injury, extracellular adenosine and glutamate levels increase rapidly and dramatically. We hypothesized that local glutamate levels in the brain dictates the adenosine-adenosineA(2A) receptor (A(2A)R) effects on neuroinflammation and brain damage outcome. Here, we showed that, in the presence of low concentrations of glutamate, the A(2A)R agonist 3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid (CGS21680) inhibited lipopolysaccharide (LPS)-induced nitric oxide synthase (NOS) activity of cultured microglial cells, an effect that was dependent on the protein kinase A (PKA) pathway. However, in high concentrations of glutamate, CGS21680 increased LPS-induced NOS activity in a protein kinase C (PKC)-dependent manner. Thus, increasing the local level of glutamate redirects A(2A)R signaling from the PKA to the PKC pathway, resulting in a switch in A(2A)R effects from antiinflammatory to proinflammatory. In a cortical impact model of traumatic brain injury (TBI) in mice, brain water contents, behavioral deficits, and expression of tumor necrosis factor-alpha, interleukin-1 mRNAs, and inducible NOS were attenuated by administering CGS21680 at post-TBI time when brain glutamate levels were low, or by administering the A(2A)R antagonist ZM241385 [4-(2-{[5-amino-2-(2-furyl)[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-yl] amino}ethyl)phenol] at post-TBI time when brain glutamate levels were elevated. Furthermore, pre-TBI treatment with the glutamate release inhibitor (S)-4C3HPG [(S)-4-carboxy-3-hydroxyphenylglycine] converted the debilitating effect of CGS21680 administered at post-TBI time with high glutamate level to a neuroprotective effect. This further indicates that the switch in the effect of A(2A)R activation in intact animals from antiinflammatory to proinflammatory is dependent on glutamate concentration. These findings identify a novel role for glutamate in modulation of neuroinflammation and brain injury via the adenosine-A(2A)R system.	[Dai, Shuang-Shuang; Zhou, Yuan-Guo; Li, Wei; An, Jian-Hong; Li, Ping; Yang, Nan; Chen, Xing-Yun; Xiong, Ren-Ping; Liu, Ping; Zhao, Yan; Shen, Hai-Ying; Zhu, Pei-Fang] Third Mil Med Univ, Inst Surg Res, Ctr Mol Biol, State Key Lab Trauma Burn & Combined Injury, Chongqing 400042, Peoples R China; [Dai, Shuang-Shuang; Zhou, Yuan-Guo; Li, Wei; An, Jian-Hong; Li, Ping; Yang, Nan; Chen, Xing-Yun; Xiong, Ren-Ping; Liu, Ping; Zhao, Yan; Shen, Hai-Ying; Zhu, Pei-Fang] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Shen, Hai-Ying; Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Dai, Shuang-Shuang] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China		Zhou, YG (corresponding author), Third Mil Med Univ, Inst Surg Res, Ctr Mol Biol, State Key Lab Trauma Burn & Combined Injury, 10 Changjiang Zhilu, Chongqing 400042, Peoples R China.	ygzhou@cta.cq.cn	Li, ping/J-6507-2019	Shen, Hai-Ying/0000-0001-8430-2978; Chen, Xingyun/0000-0001-7699-4425	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30328015, 30671918]; U.S. Public Health ServiceUnited States Department of Health & Human ServicesUnited States Public Health Service [NS41083, NS48995]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048995, R01NS041083] Funding Source: NIH RePORTER	This work was supported by National Natural Science Foundation of China Grants 30328015 and 30671918, and U.S. Public Health Service Grants NS41083 and NS48995. We gratefully acknowledge the technical and equipment support provided by Drs. Minghui Xu and Guansong Wang. We thank Chun Hu and Hao Wang for handling of the animals and Dr. Susan E. Lewis for editing this manuscript.	BEGLEY DJ, 1994, J CHROMATOGR B, V657, P185, DOI 10.1016/0378-4347(94)80085-5; Blum D, 2003, J NEUROSCI, V23, P5361; Bracken N, 2006, BRIT J PHARMACOL, V148, P1108, DOI 10.1038/sj.bjp.0706809; Canas PM, 2009, J NEUROSCI, V29, P14741, DOI 10.1523/JNEUROSCI.3728-09.2009; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-10-j0001.2001; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Cheng HC, 2002, J BIOL CHEM, V277, P33930, DOI 10.1074/jbc.M201206200; Chou SY, 2005, J NEUROCHEM, V93, P310, DOI 10.1111/j.1471-4159.2005.03029.x; Cobine CA, 2007, AM J PHYSIOL-HEART C, V292, pH3079, DOI 10.1152/ajpheart.01261.2006; Coccurello R, 2004, NEUROPSYCHOPHARMACOL, V29, P1451, DOI 10.1038/sj.npp.1300444; Corsi C, 1999, NEUROREPORT, V10, P687, DOI 10.1097/00001756-199903170-00005; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Cunha RA, 2000, NEUROSCI LETT, V289, P127, DOI 10.1016/S0304-3940(00)01295-7; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008; de Mendonca A, 2000, BRAIN RES REV, V33, P258, DOI 10.1016/S0165-0173(00)00033-3; Ferre S, 2002, P NATL ACAD SCI USA, V99, P11940, DOI 10.1073/pnas.172393799; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; Genovese T, 2009, SHOCK, V32, P578, DOI 10.1097/SHK.0b013e3181a20792; Gianfriddo M, 2004, NEUROBIOL DIS, V17, P77, DOI 10.1016/j.nbd.2004.05.008; Gill SS, 2001, TOXICOL PATHOL, V29, P208, DOI 10.1080/019262301317052486; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Ikeda K, 2002, J NEUROCHEM, V80, P262, DOI 10.1046/j.0022-3042.2001.00694.x; Jones PA, 1998, BRAIN RES, V800, P328, DOI 10.1016/S0006-8993(98)00540-X; Jones PA, 1998, NEUROSCIENCE, V85, P229, DOI 10.1016/S0306-4522(97)00613-1; Kachroo A, 2005, J NEUROSCI, V25, P10414, DOI 10.1523/JNEUROSCI.3660-05.2005; Khoa ND, 2006, MOL PHARMACOL, V69, P1311, DOI 10.1124/mol.105.016857; Lai HL, 1997, J BIOL CHEM, V272, P4970, DOI 10.1074/jbc.272.8.4970; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Li Y, 2006, NEUROSCIENCE, V141, P2029, DOI 10.1016/j.neuroscience.2006.05.014; Lorenc-Koci E, 2001, BRAIN RES, V903, P177, DOI 10.1016/S0006-8993(01)02438-6; Malek RL, 1999, J BIOL CHEM, V274, P35499, DOI 10.1074/jbc.274.50.35499; Marchi M, 2002, BRIT J PHARMACOL, V136, P434, DOI 10.1038/sj.bjp.0704712; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; Melani A, 2006, BRAIN RES, V1073, P470, DOI 10.1016/j.brainres.2005.12.010; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; Pedata F, 2001, ANN NY ACAD SCI, V939, P74; Phillis JW, 1995, BRAIN RES, V705, P79, DOI 10.1016/0006-8993(95)01153-6; Pinto-Duarte A, 2005, J NEUROCHEM, V93, P595, DOI 10.1111/j.1471-4159.2005.03071.x; Popoli P., 2003, Neurology, V61, pS69; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Popoli P, 1995, EUR J PHARMACOL, V287, P215, DOI 10.1016/0014-2999(95)00679-6; Popoli P, 2008, CURR PHARM DESIGN, V14, P1500, DOI 10.2174/138161208784480117; Saura J, 2005, J NEUROCHEM, V95, P919, DOI 10.1111/j.1471-4159.2005.03395.x; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Si QS, 1996, EXP NEUROL, V137, P345, DOI 10.1006/exnr.1996.0035; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stone TW, 2007, J NEUROSCI RES, V85, P1077, DOI 10.1002/jnr.21212; Tebano MT, 2005, J NEUROCHEM, V95, P1188, DOI 10.1111/j.1471-4159.2005.03455.x; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Yu LQ, 2008, ANN NEUROL, V63, P338, DOI 10.1002/ana.21313; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103	56	115	122	1	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	APR 21	2010	30	16					5802	5810		10.1523/JNEUROSCI.0268-10.2010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	586PQ	WOS:000276923700032	20410132	Bronze, Green Published			2022-02-06	
J	Guo, JS; Leung, KKG; Su, HX; Yuan, QJ; Wang, L; Chu, TH; Zhang, WM; Pu, JKS; Ng, GKP; Wong, WM; Dai, X; Wu, WT				Guo, Jiasong; Leung, Ka Kit Gilberto; Su, Huanxing; Yuan, Qiuju; Wang, Li; Chu, Tak-Ho; Zhang, Wenming; Pu, Jenny Kan Suen; Ng, Gloria Kowk Po; Wong, Wai Man; Dai, Xiang; Wu, Wutian			Self-assembling peptide nanofiber scaffold promotes the reconstruction of acutely injured brain	NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE			English	Article						Self-assembling peptide nanofiber scaffold; Traumatic brain injury; Reconstruction; Inflammation	TISSUE REGENERATION; LESION; HYDROGEL; DELIVERY; CULTURE; GROWTH; VOLUME	Traumatic brain injury (TBI) or brain surgery may cause extensive loss of cerebral parenchyma. However, no strategy for reconstruction has been clinically effective. Our previous study had shown that self-assembling peptide nanofiber scaffold (SAPNS) can bridge the injured spinal cord, elicit axon regeneration, and eventually promote locomotor functional recovery. In the present study we investigated the effect of SAPNS for the reconstruction of acutely injured brain. The lesion cavity of the injured cortex was filled with SAPNS or saline immediately after surgically induced TBI, and the rats were killed 2 days, 2 weeks, or 6 weeks after the surgery for histology, immunohistochemistry, and TUNEL studies. Saline treatment in the control animals resulted in a large cavity in the injured brain, whereas no cavity of any significant size was found in the SAPNS-treated animals. Around the lesion site in control animals were many macrophages (ED1 positive) but few TUNEL-positive cells, indicating that the TBI caused secondary tissue loss mainly by means of necrosis, not apoptosis. In the SAPNS-treated animals the graft of SAPNS integrated well with the host tissue with no obvious gaps. Moreover, there were fewer astrocytes (GFAP positive) and macrophages (ED1 positive) around the lesion site in the SAPNS-treated animals than were found in the controls. Thus, SAPNS may help to reconstruct the acutely injured brain and reduce the glial reaction and inflammation in the surrounding brain tissue.	[Guo, Jiasong; Su, Huanxing; Yuan, Qiuju; Wang, Li; Chu, Tak-Ho; Zhang, Wenming; Wong, Wai Man; Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Leung, Ka Kit Gilberto; Pu, Jenny Kan Suen; Ng, Gloria Kowk Po] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Wu, Wutian] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China; [Guo, Jiasong; Dai, Xiang] So Med Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China		Wu, WT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	wtwu@hkucc.hku.hk	Yuan, Qiuju/AAJ-3101-2020; Su, Huanxing/X-3980-2019; Su, Huanxing/X-3954-2019; Chu, Tak-Ho/AAB-4608-2021; Chu, Tak Ho/C-4153-2009; Guo, Jiasong/I-2206-2019; Leung, Gilberto Ka Kit/C-4337-2009	Su, Huanxing/0000-0002-0513-4943; Su, Huanxing/0000-0003-3254-825X; Chu, Tak-Ho/0000-0002-3123-207X; Guo, Jiasong/0000-0002-7885-2903; Leung, Gilberto Ka Kit/0000-0003-3147-3057	University of Hong KongUniversity of Hong Kong; Hong Kong Research Grants CouncilHong Kong Research Grants Council	Financial support was provided by the University of Hong Kong and Hong Kong Research Grants Council.	Castillo-Ruiz MM, 2007, EXP GERONTOL, V42, P343, DOI 10.1016/j.exger.2006.10.008; Crooks Carol Y, 2008, Mo Med, V105, P140; Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/0897715042441828; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Ellis-Behnke RG, 2006, NANOMED-NANOTECHNOL, V2, P207, DOI 10.1016/j.nano.2006.08.001; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Navarro-Alvarez N, 2006, CELL TRANSPLANT, V15, P921, DOI 10.3727/000000006783981387; Oehmichen M, 2000, J NEUROTRAUM, V17, P155, DOI 10.1089/neu.2000.17.155; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Zhang HZ, 2007, BRAIN RES, V1132, P29, DOI 10.1016/j.brainres.2006.09.117; Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3	24	115	119	1	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1549-9634	1549-9642		NANOMED-NANOTECHNOL	Nanomed.-Nanotechnol. Biol. Med.	SEP	2009	5	3					345	351		10.1016/j.nano.2008.12.001			7	Nanoscience & Nanotechnology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Research & Experimental Medicine	503VS	WOS:000270570000010	19268273				2022-02-06	
J	Fox, ZG; Mihalik, JP; Blackburn, JT; Battaglini, CL; Guskiewicz, KM				Fox, Zachary G.; Mihalik, Jason P.; Blackburn, J. Troy; Battaglini, Claudio L.; Guskiewicz, Kevin M.			Return of postural control to baseline after anaerobic and aerobic exercise protocols	JOURNAL OF ATHLETIC TRAINING			English	Article						balance; fatigue; recovery; concussions; mild head injuries; mild traumatic brain injuries	ERROR SCORING SYSTEM; SPORT-RELATED CONCUSSION; MILD HEAD-INJURY; STANDARDIZED ASSESSMENT; PERCEIVED EXERTION; ANKLE FATIGUE; STABILITY; BALANCE; RECOVERY; RELIABILITY	Context: With regard to sideline concussion testing, the effect of fatigue associated with different types of exercise on postural control is unknown. Objective: To evaluate the effects of fatigue on postural control in healthy college-aged athletes performing anaerobic and aerobic exercise protocols and to establish an immediate recovery time course from each exercise protocol for postural control measures to return to baseline status. Design: Counterbalanced, repeated measures. Setting: Research laboratory. Patients or Other Participants: Thirty-six collegiate athletes (18 males, 18 females; age = 19.00 +/- 1.01 years, height = 172.44 +/- 10.47 cm, mass = 69.72 +/- 12.84 kg). Intervention(s): Participants completed 2 counterbalanced sessions within 7 days. Each session consisted of 1 exercise protocol followed by postexercise measures of postural control taken at 3-, 8-, 13-, and 18-minute time intervals. Baseline measures were established during the first session, before the specified exertion protocol was performed. Main Outcome Measure(s): Balance Error Scoring System (BESS) results, sway velocity, and elliptical sway area. Results: We found a decrease in postural control after each exercise protocol for all dependent measures. An interaction was noted between exercise protocol and time for total BESS score (P = .002). For both exercise protocols, all measures of postural control returned to baseline within 13 minutes. Conclusions: Postural control was negatively affected after anaerobic and aerobic exercise protocols as measured by total BESS score, elliptical sway area, and sway velocity. The effect of exertion lasted up to 13 minutes after each exercise was completed. Certified athletic trainers and clinicians should be aware of these effects and their recovery time course when determining an appropriate time to administer sideline assessments of postural control after a suspected mild traumatic brain injury.	[Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 204 Fetzer Gymnasium,South Rd, Chapel Hill, NC 27599 USA.	gus@email.unc.edu	Battaglini, Claudio L/D-7247-2013; Mihalik, Jason P/E-7059-2010	Mihalik, Jason/0000-0001-6085-8322; Guskiewicz, Kevin/0000-0002-8682-2130			Adlerton Anna-Karin, 2003, Physiother Res Int, V8, P187, DOI 10.1002/pri.289; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Caron O, 2003, NEUROSCI LETT, V340, P83, DOI 10.1016/S0304-3940(02)01455-6; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; CROWELL DH, 2000, J ATHL TRAIN S2, V36, pS33; Derave W, 1998, ERGONOMICS, V41, P782, DOI 10.1080/001401398186630; Gauchard GC, 2002, INT J NEUROSCI, V112, P1191, DOI 10.1080/00207450290026157; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harkins KM, 2005, J ATHL TRAINING, V40, P191; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Moyna NM, 2001, MED SCI SPORT EXER, V33, P1404, DOI 10.1097/00005768-200108000-00025; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Nardone A, 1998, ARCH PHYS MED REHAB, V79, P920, DOI 10.1016/S0003-9993(98)90088-0; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robertson RJ, 2000, MED SCI SPORT EXER, V32, P2120, DOI 10.1097/00005768-200012000-00024; SELIGA R, 1991, AM IND HYG ASSOC J, V52, P417, DOI 10.1202/0002-8894(1991)052<0417:EOWLAR>2.0.CO;2; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Yaggie J, 2004, J SPORT REHABIL, V13, P312, DOI 10.1123/jsr.13.4.312; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	33	115	119	0	20	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2008	43	5					456	463		10.4085/1062-6050-43.5.456			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	356FQ	WOS:000259764500002	18833307	Bronze, Green Submitted, Green Published			2022-02-06	
J	Oluellet, MC; Morin, CM				Oluellet, Marie-Christine; Morin, Charles M.			Efficacy of cognitive-behavioral therapy for insomnia associated with traumatic brain injury: A single-case experimental design	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						behavior therapy; brain injuries; cognitive therapy; insomnia; rehabilitation	MULTIDIMENSIONAL FATIGUE INVENTORY; PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; SLEEP COMPLAINTS; DISTURBANCES; METAANALYSIS; CANCER; INDIVIDUALS; VALIDATION; FREQUENCY	Objective: To test the efficacy of a cognitive-behavioral therapy (CBT) for insomnia in persons having sustained traumatic brain injury (TBI). Design: Single-case design with multiple baselines across participants. Setting: Outpatient rehabilitation center. Participants: Eleven subjects having sustained mild to severe TBI who developed insomnia after the injury. Intervention: Eight-week CBT for insomnia including stimulus control, sleep restriction, cognitive restructuring, sleep hygiene education, and fatigue management. Main Outcome Measures: Total wake time, sleep efficiency, and diagnostic criteria. Results: Visual analyses, corroborated by intervention time series analyses and t tests, revealed clinically and statistically significant reductions in total wake time and sleep efficiency for 8 (73%) of 11 participants. An average reduction of 53.9% in total wake time was observed across participants from pre- to post-treatment. Progress was in general well maintained at the 1-month and 3-month follow-ups. The average sleep efficiency augmented significantly from pretreatment (77.2%) to post-treatment (87.9%), and also by the 3-month follow-up (90.9%). Improvements in sleep were accompanied by a reduction in symptoms of general and physical fatigue. Conclusions: The results of this study show that psychologic interventions for insomnia are a promising therapeutic avenue for TBI survivors.	[Oluellet, Marie-Christine] Hop Enfants Jesus, Ctr Hosp Affilie, Rech Traumatol Med Urgence, Quebec City, PQ G1J 1Z4, Canada; [Morin, Charles M.] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada		Oluellet, MC (corresponding author), Hop Enfants Jesus, Ctr Hosp Affilie, Rech Traumatol Med Urgence, 1401 18E Rue, Quebec City, PQ G1J 1Z4, Canada.	marie-christine.ouellet@mail.mcgill.ca	Morin, Charles/G-1021-2011; Morin, Charles M./A-4700-2008	Morin, Charles M./0000-0002-8649-8895; Ouellet, Marie-Christine/0000-0003-3477-1893			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; American Sleep Disorders Association, 1997, INT CLASS SLEEP DIS; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Blais FC, 1997, ENCEPHALE, V23, P447; BOOTZIN RR, 1991, STIMULUS CONTROL INS, P19; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fillion L, 2003, CANCER NURS, V26, P143, DOI 10.1097/00002820-200304000-00008; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; FREESTON MH, 1994, ENCEPHALE, V20, P47; Frieboes RM, 1999, J NEUROPSYCH CLIN N, V11, P354, DOI 10.1176/jnp.11.3.354; GEORGE B, 1981, NEUROCHIRURGIE, V27, P35; GERVAIS M, 1999, QUEBEC RAPPORT RECHE; Gorman B. S., 1996, DESIGN ANAL SINGLE C, P159; HAURI PJ, 1991, CASE STUDIES INSOMNI; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Holzner B, 2003, CANCER-AM CANCER SOC, V97, P1564, DOI 10.1002/cncr.11253; Holzner B, 2002, ANN ONCOL, V13, P965, DOI 10.1093/annonc/mdf122; Huitema BE, 2000, EDUC PSYCHOL MEAS, V60, P38, DOI 10.1177/00131640021970358; Kazdin A. E., 1998, RES DESIGN CLIN PSYC, V3rd; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; Lichstein KL, 2000, PSYCHOL AGING, V15, P232, DOI 10.1037/0882-7974.15.2.232; MELLINGER GD, 1985, ARCH GEN PSYCHIAT, V42, P225, DOI 10.1001/archpsyc.1985.01790260019002; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Morin CM, 2002, BEHAV RES THER, V40, P741, DOI 10.1016/S0005-7967(01)00055-9; Morin CM, 1996, CLIN PSYCHOL REV, V16, P521, DOI 10.1016/0272-7358(96)00027-X; MORIN CM, 1994, BEHAV THER, V25, P291, DOI 10.1016/S0005-7894(05)80289-8; MORIN CM, 1993, INDOMNIA PSYCHOL ASS; MURTAGH DR, 1994, J CONSULT CLIN PSYCH, V63, P79; Nowell PD, 1997, JAMA-J AM MED ASSOC, V278, P2170; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Parrino L, 1996, PSYCHOPHARMACOLOGY, V126, P1, DOI 10.1007/BF02246405; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Quesnel C, 2003, J CONSULT CLIN PSYCH, V71, P189, DOI 10.1037/0022-006X.71.1.189; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Shan RSLP, 2004, AM J PHYS MED REHAB, V83, P421, DOI 10.1097/00002060-200406000-00003; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith MT, 2005, CLIN PSYCHOL REV, V25, P559, DOI 10.1016/j.cpr.2005.04.004; SPIELMAN AJ, 1987, SLEEP, V10, P45; [No title captured], DOI DOI 10.1037/H0081254	51	115	116	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2007	88	12					1581	1592		10.1016/j.apmr.2007.09.006			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	242OE	WOS:000251734200004	18047872				2022-02-06	
J	Muller, K; Townend, W; Biasca, N; Unden, J; Waterloo, K; Romner, B; Ingebrigtsen, T				Muller, Kay; Townend, Will; Biasca, Nicola; Unden, Johan; Waterloo, Knut; Romner, Bertil; Ingebrigtsen, Tor			S100B serum level predicts computed tomography findings after minor head injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						head injury; guidelines; protein S100B; computed tomography	TRAUMATIC BRAIN INJURY; CEREBRAL INJURY; S-100 PROTEIN; MILD; ELIMINATION; GUIDELINES; MULTICENTER; MANAGEMENT; DIAGNOSIS; SURGERY	Background: Mild head injury (MHI) implies a risk for traumatic brain injury and even a small risk for development of an intracranial hematoma. Head computed tomography (CT) is recommended for early detection of such pathologic findings. The present multicenter study was performed to investigate whether determination of protein S100B in serum could contribute to the selection of patients for CT scanning. Methods: We included 226 patients with a history of head injury and a Glasgow Coma Scale (GCS) score of 13 to 15 at admission to hospital. Blood samples for S100B analysis and head CT were obtained within 12 hours after the injury. The diagnostic properties of S100B measurements for prediction of intracranial injury revealed by CT were tested with receiver operating characteristic (ROC) analysis and cross-table analysis at different cut-off levels. We also included analysis of S100B levels normalized to correspond to blood sampling I hour after the injury. Results: CT showed intracranial injury in 21 (9.3%) patients. S100B levels were significantly (p < 0.001) elevated in patients with intracranial injury (mean, 0.36; 95% CI, 0.21-0.50 mu g/L) compared with those in patients without intracranial injury (mean, 0.18; 95% CI, 0.16-0.20 mu g/L). ROC curve analysis showed a significant (p = 0.001) area under the curve (0.73; 95% CI, 0.62-0.84). Cross-table analysis showed that 20 of 21 (sensitivity 0.95) patients with intracranial injury were detected at a cut-off level of 0.10 mu g/L, but 141 of 205 (specificity 0.31) patients with no such injury also had a S100B level above this limit. Exclusion of cases with blood samples collected more than 3 hours after injury or normalization did not improve the diagnostic properties. Conclusion: Determination of serum S100B cannot replace the clinical examination or use of CT for patients with minor head injury, but adding S100B measurement to the clinical evaluation might support selection of patients for CT scanning.	Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway; Univ Hosp N Norway, Dept Neurol, Tromso, Norway; Univ Tromso, Inst Clin Med, Tromso, Norway; Hope Univ Hosp, Emergency Dept, Salford, Lancs, England; Spital Oberengadin, Dept Orthoped Surg Sports Med & Trauma Surg, Samedan St Moritz, Switzerland; Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden		Ingebrigtsen, T (corresponding author), Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway.	tor.ingebrigtsen@unn.no		Ingebrigtsen, Tor/0000-0001-5966-9786			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; *NAT I CLIN EXC, HEAD INJ TRIAG ASS I; ROMNER B, 2000, J NEURORRAUMA, V17, P473; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Stiell IG, 2000, NEW ENGL J MED, V343, P1570; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217	27	115	124	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2007	62	6					1452	1456		10.1097/TA.0b013e318047bfaa			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	179YM	WOS:000247326600031	17563665				2022-02-06	
J	Ayalon, L; Borodkin, K; Dishon, L; Kanety, H; Dagan, Y				Ayalon, L.; Borodkin, K.; Dishon, L.; Kanety, H.; Dagan, Y.			Circadian rhythm sleep disorders following mild traumatic brain injury	NEUROLOGY			English	Article							PHASE SYNDROME; WAKE SYNDROME; MELATONIN; PAIN; INSOMNIA; HUMANS; ONSET	Objective: To describe the physiologic and behavioral characteristics of circadian rhythm sleep disorders (CRSDs) following minor traumatic brain injury (mTBI) in patients complaining of insomnia. Methods: Forty two patients with insomnia complaints following mTBI were screened. Those suspected of having CRSD underwent actigraphy, saliva melatonin and oral temperature measurement, and polysomnography. All patients also filled out a self- reported questionnaire to determine their circadian preference. Results: Fifteen of the 42 patients (36%) with complaints of insomnia following mTBI were diagnosed with CRSD. Eight patients displayed a delayed sleep phase syndrome (DSPS), whereas seven displayed an irregular sleep-wake pattern (ISWP). Whereas all patients with DSPS exhibited a 24- hour periodicity of oral temperature rhythm, three of seven patients with ISWP lacked such a daily rhythm. In addition, ISWP patients exhibited smaller amplitude of oral temperature rhythm vs the DSPS group. Subjective Morningness-Eveningness Questionnaire scores were in accordance with the clinical diagnosis of DSPS or ISWP based on actigraphy. Conclusions: Minor traumatic brain injury might contribute to the emergence of circadian rhythm sleep disorders. Two types of these disorders were observed: delayed sleep phase syndrome and irregular sleep-wake pattern. The types differed in the subjective questionnaire scores and had distinct profiles of melatonin and temperature circadian rhythms.	Univ Calif San Diego, Dept Psychiat, San Diego, CA 92161 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; Tel Aviv Univ, Sackler Fac Med, Dept Behav Sci, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sheba Med Ctr, Inst Endocrinol, IL-69978 Tel Aviv, Israel		Ayalon, L (corresponding author), Univ Calif San Diego, Dept Psychiat, 3350 La Jolla Village Dr,115B, San Diego, CA 92161 USA.	layalon@ucsd.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604; Borodkin, Katy/0000-0001-5960-6865			American Academy of Sleep, 2005, INT CLASS SLEEP DIS; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Dagan Y, 1999, CHRONOBIOL INT, V16, P213, DOI 10.3109/07420529909019087; Dagan Y, 1998, J PSYCHOSOM RES, V45, P15, DOI 10.1016/S0022-3999(97)00299-7; Dagan Y, 1996, J PSYCHOSOM RES, V41, P357, DOI 10.1016/S0022-3999(96)00165-1; Dagan Y, 1998, CHRONOBIOL INT, V15, P181, DOI 10.3109/07420529808998682; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Kamei Y, 2000, PSYCHIAT CLIN NEUROS, V54, P381, DOI 10.1046/j.1440-1819.2000.00724.x; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P272; Nagtegaal JE, 1997, FUNCT NEUROL, V12, P345; Nagtegaal JE, 1998, J SLEEP RES, V7, P135, DOI 10.1046/j.1365-2869.1998.00102.x; Nagtegaal JE, 2000, J PSYCHOSOM RES, V48, P45, DOI 10.1016/S0022-3999(99)00075-6; OLDANI A, 1994, J NEUROL NEUROSUR PS, V55, P665; Onen SH, 2005, CLIN J PAIN, V21, P422, DOI 10.1097/01.ajp.0000129757.31856.f7; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Quinto C, 2000, NEUROLOGY, V54, P250, DOI 10.1212/WNL.54.1.250; RECHTSCHAFFEN A, 1968, PHS PUBLICATION, V204; ROBERTSTHOMSON IC, 1988, AUST NZ J MED, V18, P569, DOI 10.1111/j.1445-5994.1988.tb00126.x; Shibui K, 1999, J BIOL RHYTHM, V14, P72, DOI 10.1177/074873099129000371; Steele DL, 2005, CHRONOBIOL INT, V22, P89, DOI 10.1081/CBI-200042428; Tuunainen A, 2001, CHRONOBIOL INT, V18, P957, DOI 10.1081/CBI-100107971; Uchiyama M, 2000, NEUROSCI LETT, V294, P101, DOI 10.1016/S0304-3940(00)01551-2; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; WEITZMAN ED, 1981, ARCH GEN PSYCHIAT, V38, P737	28	115	120	1	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	APR 3	2007	68	14					1136	1140		10.1212/01.wnl.0000258672.52836.30			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152ZY	WOS:000245402400014	17404196				2022-02-06	
J	Mooney, G; Speed, J; Sheppard, S				Mooney, G; Speed, J; Sheppard, S			Factors related to recovery after mild traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; concussion; recovery; industrial injury; symptom validity testing	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; MINOR HEAD-INJURY; CHRONIC PAIN; POSTCONCUSSIVE SYMPTOMS; RISK-FACTORS; MODERATE; DEPRESSION; MEMORY; PREDICTION	Primary objectives: To study the variables that relate to outcome after mild traumatic brain injury (TBI). Methods and procedures: Sixty-seven adults with disappointing recoveries after mild TBI most occurring in a compensation or litigation context were studied with regard to pre-injury, neuro-trauma, physical, emotional and cognitive variables on outcome. Validity of physical, emotional and cognitive symptoms was controlled for. Main outcomes and results: Except for prior psychological traumatization, neither pre-injury, neuro-trauma or cognitive variables were related to outcome. Variables most consistently related to outcome were depression, pain and symptom invalidity on measures of response bias. These factors accounted for the majority of variance in outcome. Conclusions: In cases of poor recovery after mild TBI where compensation or litigation may be a factor, most of the variance in recovery seems to be explained by depression, pain and symptom invalidity, rather than by the injury variables themselves.	Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA		Mooney, G (corresponding author), Univ Utah, Div Phys Med & Rehabil, 30 North 1900 East, Salt Lake City, UT 84132 USA.	gmooney@hsc.utah.edu					Allen L., 1997, CARB 97 COMPUTERIZED; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Bierley RA, 2001, BRAIN INJURY, V15, P697, DOI 10.1080/02699050010013671; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BRANDON AD, 1985, DIGITAL FINGER TAPPI; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; CICERONE K, 1993, 70 ANN SESS AM C REH; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; DEVORE JR, 1998, PHYSICAL MED REHABIL, V12, P111; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; GREEN WP, 1996, WORD MEMORY TEST USE; Greene R. L, 1991, MMPI 2 MMPI INTERPRE; GRIGSBY J, 1993, BRAIN INJURY, V7, P507, DOI 10.3109/02699059309008178; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V81, P403, DOI 10.2466/pms.1995.81.2.403; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; HATHAWAY SR, 1989, MINNESOTA MULTIPHASI, V2; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Hooper H., 1958, HOOPER VISUAL ORG TE; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kaplan E, 1983, BOSTON NAMING TEST; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kuhajda MC, 2002, PAIN, V97, P213, DOI 10.1016/S0304-3959(01)00488-2; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Mooney G, 1997, NEUROREHABILITATION, V8, P223, DOI 10.3233/NRE-1997-8308; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Prohl J, 2001, J NERV MENT DIS, V189, P602, DOI 10.1097/00005053-200109000-00005; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reitan RM, 1985, HALSTEADREITAN NEURO; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schofferman J., 1992, SPINE S6, V17, pS1380; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sosin DM, 1996, BRAIN INJURY, V10, P47; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Taylor AE, 1996, ARCH PHYS MED REHAB, V77, P529, DOI 10.1016/S0003-9993(96)90290-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Umile EM, 1998, BRAIN INJURY, V12, P577; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	66	115	118	2	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2005	19	12					975	987		10.1080/02699050500110264			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZA	WOS:000233269700004	16263640				2022-02-06	
J	Parslow, RC; Morris, KP; Tasker, RC; Forsyth, RJ; Hawley, CA				Parslow, RC; Morris, KP; Tasker, RC; Forsyth, RJ; Hawley, CA		UK Paediat Traumat Brain Injury St; Paediat Intens Care Soc Study Grp	Epidemiology of traumatic brain injury in children receiving intensive care in the UK	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							HEAD-INJURY; HEALTH; SEVERITY; TRENDS	Aims: To describe the epidemiology of children with traumatic brain injury (TBI) admitted to paediatric intensive care units (PICUs) in the UK. Methods: Prospective collection of clinical and demographic information from paediatric and adult intensive care units in the UK and Eire between February 2001 and August 2003. Results: The UK prevalence rate for children ( 0-14 years) admitted to intensive care with TBI between February 2001 and August 2003 was 5.6 per 100 000 population per year ( 95% Poisson exact confidence intervals 5.17 to 6.05). Children admitted to PICUs with TBI were more deprived than the population as a whole ( mean Townsend score for TBI admissions 1.19 v 0). The commonest mechanism of injury was a pedestrian accident ( 36%), most often occurring in children over 10. There was a significant summer peak in admissions in children under 10 years. Time of injury peaked in the late afternoon and early evening, a pattern that remained constant across the days of the week. Injuries involving motor vehicles have the highest mortality rates ( 23% of vehicle occupants, 12% of pedestrians) compared with cyclists (8%) and falls (3%). In two thirds of admissions (65%) TBI was an isolated injury. Conclusions: TBI in children requiring intensive care is more common in those from poorer backgrounds who have been involved in accidents as pedestrians. The summer peak in injury occurrence for 0-10 year olds and late afternoon timing give clear targets for community based injury prevention.	Univ Leeds, Ctr Biostat & Epidemiol, Paediat Epidemiol Grp, Leeds LS2 9JT, W Yorkshire, England; Prince Wales Childrens Hosp, Birmingham, W Midlands, England; Univ Cambridge, Sch Clin, Dept Paediat, Addenbrookes Hosp, Cambridge, England; Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Sch Clin Med Sci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Warwick, Warwick Med Sch, Div Hlth Community, Coventry CV4 7AL, W Midlands, England		Parslow, RC (corresponding author), Univ Leeds, Ctr Biostat & Epidemiol, Paediat Epidemiol Grp, 30 Hyde Terrace, Leeds LS2 9JT, W Yorkshire, England.	parslow@leeds.ac.uk	Hawley, Carol/AAG-3830-2019; Tasker, Robert C/R-5837-2019; Forsyth, Rob J/I-9226-2012; Parslow, Roger/AAV-1477-2020; Forsyth, Rob/H-9193-2019	Forsyth, Rob J/0000-0002-5657-4180; Forsyth, Rob/0000-0002-5657-4180; Parslow, Roger/0000-0002-3945-5294; Tasker, Robert/0000-0003-3647-8113			Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bunn F, 2003, INJURY PREV, V9, P200, DOI 10.1136/ip.9.3.200; CRAFT AW, 1972, BMJ-BRIT MED J, V4, P200, DOI 10.1136/bmj.4.5834.200; EDWARDS JH, 1961, ANN HUM GENET, V25, P83, DOI 10.1111/j.1469-1809.1961.tb01501.x; General Register Office for Scotland, 2001, CENS STAND AR STAT S; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hippisley-Cox J, 2002, BRIT MED J, V324, P1132, DOI 10.1136/bmj.324.7346.1132; James HE, 1985, BRAIN INSULTS INFANT, P179; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kendrick D, 2004, ARCH DIS CHILD, V89, P330, DOI 10.1136/adc.2003.032052; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Liabo Kristin, 2003, Arch Dis Child, V88, P235, DOI 10.1136/adc.88.3.235; *N IR STAT RES AG, 2001, 2001 CENS STAD AR ST; *OFF NAT STAT, 2004, MORT STAT INJ PO DH4; *OFF NAT STAT, 2004, MORT STAT CHILDH DH3; Office for National Statistics, 2001, 2001 CENS STAND AR S; PHILLIMORE P, 1994, BRIT MED J, V308, P1125, DOI 10.1136/bmj.308.6937.1125; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; SHARPLES PM, 1990, BRIT MED J, V301, P1193, DOI 10.1136/bmj.301.6762.1193; Stark AD, 2002, BRIT MED J, V324, P457, DOI 10.1136/bmj.324.7335.457; StataCorp, 2004, STAT STAT SOFTW REL; Williamson LM, 2002, J EPIDEMIOL COMMUN H, V56, P285, DOI 10.1136/jech.56.4.285; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	26	115	119	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	NOV	2005	90	11					1182	1187		10.1136/adc.2005.072405			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	976HI	WOS:000232723500025	16049060	Green Published, Bronze			2022-02-06	
J	Marit, RS; Wilkosz, PA				Marit, RS; Wilkosz, PA			Disorders of diminished motivation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						abulia; akinetic mutism; anterior cingulum; apathy; cholinesterase inhibitor; disorders of diminished motivation; dopamine agonist; methylpbenidate; traumatic brain injury; ventral pallidum	TRAUMATIC BRAIN-INJURY; APATHY; RELIABILITY; STRATEGIES; ATTENTION; VALIDITY; DEFICITS; LOBE	Disorders of diminished motivation occur frequently in individuals with traumatic brain injury. Motivation is an ever-present, essential determinant of behavior and adaptation. The major syndromes of diminished motivation are apathy, abulia, and akinetic mutism. Depending on their etiology, disorders of diminished motivation may be a primary clinical disturbance, a symptom of another disorder, or a coexisting second disorder. This article presents a biopsychosocial approach to the assessment and management of motivational impairments in patients with traumatic brain injury. The recognition and differential diagnosis of disorders of diminished motivation, as well as the mechanism and clinical pathogenesis, are discussed.	Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA		Wilkosz, PA (corresponding author), Western Psychiat Inst & Clin, 3811 OHara St, Pittsburgh, PA 15213 USA.	wilkpa@msx.upmc.edu					Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Atkinson JW, 1978, INTRO MOTIVATION; Benson D. F., 1990, NEUROPSY NEUROPSY BE, V3, P36; BERRIOS GE, 1995, ACTA PSYCHIAT SCAND, V92, P161, DOI 10.1111/j.1600-0447.1995.tb09561.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Campbell JJ, 1997, PSYCHIAT ANN, V27, P44, DOI 10.3928/0048-5713-19970101-11; Cole G.D.H., 1955, NEBRASKA S MOTIVATIO, pv; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; Finset A, 2000, BRAIN INJURY, V14, P887; Fisher C M, 1983, Clin Neurosurg, V31, P9; Gerring JP, 1996, PSYCHIAT RES, V63, P205, DOI 10.1016/0165-1781(96)02841-7; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; GILES GM, 1993, BRAIN INJURY REHABIL; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; Hecaean H, 1975, PSYCHIATRIC ASPECTS, P137; Heimer L, 2003, AM J PSYCHIAT, V160, P1726, DOI 10.1176/appi.ajp.160.10.1726; HOEHNSARIC R, 1990, J CLIN PSYCHOPHARM, V32, P672; Kalivas PW, 1993, LIMBIC MOTOR CIRCUIT; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LILLY R, 1983, NEUROLOGY, V33, P1141, DOI 10.1212/WNL.33.9.1141; Mann R. S., 1996, REV PSYCHIAT, V15, P205; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; Marin RS, 1997, PSYCHIAT ANN, V27, P30, DOI 10.3928/0048-5713-19970101-08; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MARIN RS, 2000, HDB PSYCHIAT MEASURE, P409; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Mega MS, 1997, NEUROPSY NEUROPSY BE, V10, P254; MESULAM MM, 1983, TRENDS NEUROSCI, V6, P384, DOI 10.1016/0166-2236(83)90171-6; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Palmese CA, 2000, BRAIN INJURY, V14, P535; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Ross E. D, 2000, PRINCIPLES BEHAV COG, V2, P316; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; WIDLOCHER DJ, 1983, PSYCHIAT CLIN N AM, V6, P27	49	115	119	1	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2005	20	4					377	388		10.1097/00001199-200507000-00009			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941MV	WOS:000230219800009	16030444				2022-02-06	
J	Junge, A; Cheung, K; Edwards, T; Dvorak, J				Junge, A; Cheung, K; Edwards, T; Dvorak, J			Injuries in youth amateur soccer and rugby players - comparison of incidence and characteristics	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							FOOTBALL INJURIES; PERFORMANCE PROJECT; SPORTS INJURIES; EPIDEMIOLOGY; PREVENTION; SCHOOL; EXERCISE; SEVERITY; ETIOLOGY; SEASON	Objectives: In reviewing the literature on sports injuries, few studies could be found in which exposure related incidences of injury in different types of sport were compared. These studies indicated that ice hockey, handball, basketball, soccer, and rugby are popular team sports with a relatively high risk of injury. The aim of the study was to compare the characteristics and incidence of injuries in male youth amateur soccer and rugby players. Methods: This prospective cohort study comprised an initial baseline examination to ascertain the characteristics of the players and their level of performance, and a one season observation period during which a physician visited the team weekly and documented all occurring injuries. Twelve soccer and 10 rugby school teams with male amateur players aged 14-18 years were selected for the study. 145 soccer and 123 rugby players could be followed up over one season. Results: Comparison of the incidence of soccer and rugby injuries indicated that rugby union football was associated with a significantly higher rate of injury than soccer. The differences were pronounced for contact injuries, injuries of the head, neck, shoulder, and upper extremity, as well as for concussion, fractures, dislocations, and strains. Rugby players incurred 1.5 times more overuse and training injuries in relation to exposure time, and 2.7 times more match injuries than soccer players. Three rugby players but no soccer players had to stop their participation in sport because of severe injury. Conclusion: The incidence of injury in New Zealand school teams playing soccer or rugby union is high, probably in part because of the low ratio of hours spent in training relative to hours spent playing matches. The development and implementation of preventive interventions to reduce the rate and severity of injury is recommended.	FIFA Med Assessment & Res Ctr, Schulthess Klin, CH-8008 Zurich, Switzerland; Univ Auckland, Goodfellow Unit, Auckland 1, New Zealand		Junge, A (corresponding author), FIFA Med Assessment & Res Ctr, Schulthess Klin, Lengghalde 2, CH-8008 Zurich, Switzerland.	ajunge@kws.ch					Addley K, 1988, Br J Sports Med, V22, P22; Arnason A, 1996, SCAND J MED SCI SPOR, V6, P40, DOI 10.1111/j.1600-0838.1996.tb00069.x; BACKX FJG, 1991, AM J SPORT MED, V19, P124, DOI 10.1177/036354659101900206; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; CLARK DR, 1990, S AFR MED J, V77, P559; DELOES M, 1988, INT J SPORTS MED, V9, P461, DOI 10.1055/s-2007-1025052; DELOES M, 1995, INT J SPORTS MED, V16, P134, DOI 10.1055/s-2007-972980; DURIE RM, 2000, NZ J SPORTS MED, V28, P84; Dvorak J, 2000, AM J SPORT MED, V28, pS69; Dvorak J, 2000, AM J SPORT MED, V28, pS3; Finch CF, 1997, SPORTS MED, V24, P157, DOI 10.2165/00007256-199724030-00002; FRIED T, 1992, SPORTS MED, V14, P269, DOI 10.2165/00007256-199214040-00005; GARRAWAY M, 1995, LANCET, V345, P1485; HUGHES DC, 1994, CLIN J SPORT MED, V4, P249; INKLAAR H, 1994, SPORTS MED, V18, P81, DOI 10.2165/00007256-199418020-00002; Inklaar H, 1996, INT J SPORTS MED, V17, P229, DOI 10.1055/s-2007-972837; INKLAAR H, 1994, SPORTS MED, V18, P55, DOI 10.2165/00007256-199418010-00006; Junge A, 2000, AM J SPORT MED, V28, pS40; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; LINDENFELD TN, 1994, AM J SPORT MED, V22, P364, DOI 10.1177/036354659402200312; NATHAN M, 1983, S AFR MED J, V64, P132; Nicholl JP, 1995, BRIT J SPORT MED, V29, P232, DOI 10.1136/bjsm.29.4.232; NIELSEN AB, 1989, AM J SPORT MED, V17, P803, DOI 10.1177/036354658901700614; Peterson L, 2000, AM J SPORT MED, V28, pS51; Pringle RG, 1998, BRIT J SPORT MED, V32, P49, DOI 10.1136/bjsm.32.1.49; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; ROUX CE, 1987, S AFR MED J, V71, P307; Schmidt-Olsen S, 1985, Br J Sports Med, V19, P161; SCHMIDTOLSEN S, 1991, AM J SPORT MED, V19, P273, DOI 10.1177/036354659101900311; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; SULLIVAN JA, 1980, AM J SPORT MED, V8, P325, DOI 10.1177/036354658000800505; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	33	115	117	2	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR 1	2004	38	2					168	172		10.1136/bjsm.2002.003020			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	805XB	WOS:000220397900016	15039253	Green Published, Bronze			2022-02-06	
J	Knight, C; Alderman, N; Burgess, PW				Knight, C; Alderman, N; Burgess, PW			Development of a simplified version of the multiple errands test for use in hospital settings	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE LESIONS; STRATEGY APPLICATION; MULTITASKING; ATTENTION; DAMAGE	Problems with executive functioning may have catastrophic consequences following brain injury. Valid neuropsychological assessment procedures are required if the nature and extent of these are to be understood. However, some existing measures do not adequately reflect how executive impairments are manifested in the context of everyday functioning. Shallice and Burgess (1991) described one procedure, the Multiple Errands Test (MET), which did attain this goal. While successful, it was designed for people who performed within or above the normal range when tested using existing psychometric measures: however, it is acknowledged that many patients seen in routine clinical practice perform below normal limits. Furthermore, while the procedure was carried out in a public place a range of constraints may prevent this with some patients. In this paper the utility of a simplified MET designed for use within a hospital environment is explored. Twenty neurologically healthy participants and 20 people with acquired brain injury took part. People with acquired brain injury were clearly discriminated from healthy controls through the number of errors made. Furthermore, one category of error proved highly predictive of difficulties attributable to executive dysfunction observed in the context of everyday living. While one other test correlated almost as well with these difficulties, it was argued that MET methodology is more advantageous to clinicians regarding assessment and rehabilitation.	St Andrews Hosp, Kemsley Div, Northampton NN1 5DG, England; UCL, London WC1E 6BT, England		Knight, C (corresponding author), St Andrews Hosp, Kemsley Div, Billing Rd, Northampton NN1 5DG, England.	cknight@standrew.co.uk	Burgess, Paul W/A-1811-2010	Alderman, Nick/0000-0002-8523-4142			ACIMOVIC ML, 1993, J COGNITIVE REHABILI, V11, P8; ALDERMAN N, IN PRESS J INT NEURO; ALDERMAN N, 2000, IMP 2000 INT C BRAIN; Baddeley A.D., 1986, WORKING MEMORY; Broks P, 1996, BEHAV NEUROL, V9, P135, DOI 10.3233/BEN-1996-93-405; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1996, CORTEX, V32, P241, DOI 10.1016/S0010-9452(96)80049-9; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Christensen AL., 1974, LURIAS NEUROPSYCHOLO; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P209, DOI 10.1080/713755574; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Everitt B. S., 1996, MAKING SENSE STAT PS; FOGEL BS, 1994, J NEUROPSYCH CLIN N, V6, P343; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; KNIGHT C, 1999, THESIS U BIRMINGHAM; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; Loewenthal K.M., 1996, INTRO PSYCHOL TESTS; LURIA AR, 1981, HIGHER CORTICAL FUNC; MANLY T, UNPUB REHABILITATION; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Robertson I., 1994, TEST EVERYDAY ATTENT; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; Spitzer RL, 1978, PSYCHOPHARMACOLOGY G; Teuber H. L., 1964, FRONTAL GRANULAR COR; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler, 1997, WECHSLER ADULT INTEL; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	42	115	119	1	9	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUN	2002	12	3					231	255		10.1080/09602010244000039			25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	561RG	WOS:000176155900003					2022-02-06	
J	Touzani, O; Boutin, H; LeFeuvre, R; Parker, L; Miller, A; Luheshi, G; Rothwell, N				Touzani, O; Boutin, H; LeFeuvre, R; Parker, L; Miller, A; Luheshi, G; Rothwell, N			Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor	JOURNAL OF NEUROSCIENCE			English	Article						cerebrovascular accident; brain infarction; receptors; interleukin-1; mice; knock-out; cytokines	CEREBRAL-ARTERY OCCLUSION; ACCESSORY PROTEIN; ALZHEIMER-DISEASE; NEURONAL DAMAGE; RAT; ANTAGONIST; IL-1; MICE; EXPRESSION; CLONING	The cytokine interleukin-1 beta (IL-1 beta) contributes to ischemic, excitotoxic, and traumatic brain injury. IL-1 beta actions depend on interaction with a single receptor (IL-1RI), which associates with an accessory protein (IL-1RAcP), and is blocked by IL-1 receptor antagonist (IL-1ra). Here we show that in normal mice [wild-type (WT)], intracerebroventricular injection of IL-1ra markedly reduces (-50%; p < 0.01) ischemic brain damage caused by reversible occlusion of the middle cerebral artery, whereas injection of IL-1<beta> exacerbates damage (+45%; p < 0.05). Mice lacking IL-1RI [IL-1RI knock-out (KO)] exhibited ischemic brain damage that is almost identical to that of the WT (infarct volume 43.7 +/- 6.1 and 46.2 +/- 6.2 mm(3), respectively), but failed to respond to injection of IL-1ra. However, injection of IL-1<beta> (intracerebroventricularly) exacerbated ischemic brain damage in IL-1RI KO (+61%; p < 0.001) and in WT mice (+45%). This effect of IL-1<beta> was abolished by heat denaturation in all animals, and was reversed by IL-1ra in WT, but not IL-1RI KO mice. In contrast, IL-1RI KO mice were completely resistant to effects of IL-1 beta on food intake or body weight. IL-1RAcP mRNA was increased by stroke in WT, but reduced in IL-1RI KO mice compared with sham-operated mice. Type II IL-1 receptor mRNA was significantly increased 4 hr after ischemia in WT and IL-1RI KO (+20%) animals. These data show that IL-1 beta can exacerbate ischemic brain damage independently of IL-1RI and suggest the existence of additional signaling receptor or receptors for IL-1 in the brain.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England		Rothwell, N (corresponding author), Univ Manchester, Sch Biol Sci, 1-124 Stopford Bldg, Manchester M13 9PT, Lancs, England.		Aston, Sam/F-9699-2010; TOUZANI, Omar/C-1897-2008; Le Feuvre, Rosalind/A-7034-2013; Boutin, Herve/C-4532-2011	TOUZANI, Omar/0000-0002-9513-097X; Boutin, Herve/0000-0002-0029-5246			Allan SM, 2000, P NATL ACAD SCI USA, V97, P5580, DOI 10.1073/pnas.090464197; Anforth HR, 1998, EUR CYTOKINE NETW, V9, P279; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; CELI FS, 1993, NUCLEIC ACIDS RES, V21, P1047, DOI 10.1093/nar/21.4.1047; Clark WM, 1997, NEUROL RES, V19, P641; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; Davies CA, 1999, J CEREBR BLOOD F MET, V19, P87, DOI 10.1097/00004647-199901000-00010; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; French RA, 1999, J NEUROIMMUNOL, V93, P194, DOI 10.1016/S0165-5728(98)00224-0; GARCIA JH, 1995, AM J PATHOL, V147, P1477; Glaccum MB, 1997, J IMMUNOL, V159, P3364; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Josephs MD, 2000, AM J PHYSIOL-REG I, V278, pR824, DOI 10.1152/ajpregu.2000.278.4.R824; Kluger M.J, 1996, CYTOKINES NERVOUS SY, P73; Labow M, 1997, J IMMUNOL, V159, P2452; Lawrence CB, 1998, EUR J NEUROSCI, V10, P1188, DOI 10.1046/j.1460-9568.1998.00136.x; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Legos JJ, 2000, NEUROSCI LETT, V282, P189, DOI 10.1016/S0304-3940(00)00907-1; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu CL, 1996, J NEUROIMMUNOL, V66, P41, DOI 10.1016/0165-5728(96)00016-1; Loddick SA, 1998, BRAIN RES REV, V26, P306, DOI 10.1016/S0165-0173(97)00037-4; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; MARTINEZ O. J., 1994, GLOBAL BOUNDARIES WO, V1, P1, DOI [10.1163/9789401204774_002, DOI 10.4324/9780203211960]; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Mrak RE, 2000, J NEUROPATH EXP NEUR, V59, P471, DOI 10.1093/jnen/59.6.471; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Rothwell N, 1997, J CLIN INVEST, V100, P2648, DOI 10.1172/JCI119808; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x; Roux-Lombard P, 1998, EUR CYTOKINE NETW, V9, P565; Stroemer RP, 1997, J CEREBR BLOOD F MET, V17, P597; Stroemer RP, 1998, J CEREBR BLOOD F MET, V18, P833, DOI 10.1097/00004647-199808000-00003; TAKAO T, 1992, J NEUROIMMUNOL, V41, P51, DOI 10.1016/0165-5728(92)90195-Q; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Touzani O, 1999, J NEUROIMMUNOL, V100, P203, DOI 10.1016/S0165-5728(99)00202-7; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Zhu SG, 1999, J NEUROPATH EXP NEUR, V58, P582, DOI 10.1097/00005072-199906000-00002	43	115	121	1	13	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JAN	2002	22	1					38	43		10.1523/JNEUROSCI.22-01-00038.2002			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	505GU	WOS:000172905700011	11756486	Bronze, Green Published			2022-02-06	
J	Makdissi, M; Collie, A; Maruff, P; Darby, DG; Bush, A; McCrory, P; Bennell, K				Makdissi, M; Collie, A; Maruff, P; Darby, DG; Bush, A; McCrory, P; Bennell, K			Computerised cognitive assessment of concussed Australian Rules footballers	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						concussion; football; neuropsychology; cognitive; head injury	NEUROPSYCHOLOGICAL ASSESSMENT; HEAD-INJURY	Background-"Paper and pencil" neuropsychological tests play an important role in the management of sports related concussions. They provide objective information on the athlete's cognitive function and thus facilitate decisions on safe return to sport. It has been proposed that computerised cognitive tests have many advantages over such conventional tests, but their role in this domain is yet to be established. Objectives-To measure cognitive impairment after concussion in a case series of concussed Australian Rules footballers, using both computerised and paper and pencil neuropsychological tests. To investigate the role of computerised cognitive tests in the assessment and follow up of sports related concussions. Methods-Baseline measures on the Digit Symbol Substitution Test (DSST), Trail Making Test-Part B (TMT), and a simple reaction time (SRT) test from a computerised cognitive test battery (CogState) were obtained in 240 players. Tests were repeated in players who had sustained a concussive injury. A group of non-injured players were used as matched controls. Results-Six concussions were observed over a period of nine weeks. At the follow up, DSST and TMT scores did not significantly differ from baseline scores in both control and concussed groups. However, analysis of the SRT data showed an increase in response variability and latency after concussion in the injured athletes. This was in contrast with a decrease in response variability and no change in latency on follow up of the control players (p<0.02). Conclusion-Increased variability in response time may be an important cognitive deficit after concussion. This has implications for consistency of an athlete's performance after injury, as well as for tests used in clinical assessment and follow up of head injuries.	Mental Hlth Res Inst Victoria, Neuropsychol Lab, Parkville, Vic 3052, Australia; Univ Melbourne, Ctr Sports Med Res Educ, Parkville, Vic 3052, Australia; Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; Mental Hlth Res Inst Victoria, Behav Neurol Lab, Parkville, Vic, Australia		Collie, A (corresponding author), Mental Hlth Res Inst Victoria, Neuropsychol Lab, Locked Bag 11, Parkville, Vic 3052, Australia.		McCrory, Paul/Q-8688-2019; Maruff, Paul/ABA-1673-2020; Bush, Ashley I/A-1186-2007; Maruff, Paul/AAD-2454-2021; Bush, Ashley/Y-2457-2019; Bennell, Kim/C-7022-2014	Bush, Ashley I/0000-0001-8259-9069; Maruff, Paul/0000-0002-6947-9537; Bush, Ashley/0000-0001-8259-9069; makdissi, michael/0000-0003-0334-7133; Collie, Alex/0000-0003-2617-9339; Bennell, Kim/0000-0003-4982-5639			Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; COLLIE A, 2001, BR J SPORTS MED, V34; GRONWALL D, 1975, LANCET, V2, P995; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Wechsler, 1997, WECHSLER ADULT INTEL; Westerman R., 2001, ADF HLTH, V2, P29	19	115	116	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	OCT	2001	35	5					354	360		10.1136/bjsm.35.5.354			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	479FR	WOS:000171394800022	11579074	Green Published, Bronze			2022-02-06	
J	Kim, GM; Xu, J; Xu, JM; Song, SK; Yan, P; Ku, G; Xu, XM; Hsu, CY				Kim, GM; Xu, J; Xu, JM; Song, SK; Yan, P; Ku, G; Xu, XM; Hsu, CY			Tumor necrosis factor receptor deletion reduces nuclear factor-kappa B activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury	JOURNAL OF NEUROSCIENCE			English	Article						apoptosis; caspase-3; tumor necrosis factor; TNFR1; TNFR2; cytokine	AUTOIMMUNE-MEDIATED DEMYELINATION; FOCAL CEREBRAL-ISCHEMIA; TRANSCRIPTION FACTOR; BRAIN INJURY; TNF-ALPHA; MICE LACKING; INFLAMMATORY CYTOKINES; HIPPOCAMPAL-NEURONS; ENDOTHELIAL-CELLS; MOUSE MODEL	Tumor necrosis factor-alpha (TNF-alpha) expression has been documented extensively in animal models of traumatic spinal cord injury (SCI). However, the pathophysiological significance of TNF-alpha expression in the injured cord remains to be delineated. The TNF receptor (TNFR)-nuclear factor-kappaB (NF-kappaB) signal transduction pathway is important for maintaining cell viability. NF-kappaB exerts anti-apoptotic effects via an endogenous caspase inhibitory system mediated by cellular inhibitor of apoptosis protein 2 (c-IAP2). NF-kappaB transactivates c-IAP2 to inhibit caspase-3 activation. Progressive cell death, including morphological and biochemical features suggestive of apoptosis, has been noted after SCI. We explored the effects of TNFR1 or TNFR2 deletion on the apoptotic events downstream of NF-kappaB in relation to SCI pathology and functional recovery. Nuclear proteins from the injured cords of the TNFR1(-/-) mice had a reduced NF-kappaB binding activity compared with the wild-type controls. This decrease in NF-kappaB activation was accompanied by a reduction in c-IAP2 expression and an increase in the active form of caspase-3 protein. After SCI the TNFR1(-/-) mice had greater numbers of apoptotic cells, a larger lesion size, and worse functional recovery than wild-type mice. TNFR2-deficient mice had a similar, although not as pronounced, consequence as the TNFR1(-/-) mice. These findings support the argument that the TNFR-NF-kappaB pathway is beneficial for limiting apoptotic cell death after SCI and that a defective TNFR-NF-kappaB pathway results in a poorer neurological outcome. A worse functional outcome in TNFR-/- mice suggests that an endogenous apoptosis inhibitory mechanism mediated by TNFR activation, NF-kappaB, and c-IAP2 may be of pathophysiological importance.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63104 USA		Hsu, CY (corresponding author), Washington Univ, Sch Med, Dept Neurol, Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.			Xu, Xiao-ming/0000-0002-7229-0081; Hsu, Chung Y./0000-0002-5632-2733	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37230, NS36350, NS40162, NS39577] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037230, R01NS036350, P01NS039577, R01NS040162] Funding Source: NIH RePORTER		AN G, 1993, ANN NEUROL, V33, P457, DOI 10.1002/ana.410330508; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, INT J BIOCHEM CELL B, V29, P867, DOI 10.1016/S1357-2725(96)00159-8; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bilgen M, 2000, MAGN RESON MED, V43, P594; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DSOUZA S, 1995, J NEUROSCI, V15, P7293; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Farooque M, 2001, J NEUROTRAUM, V18, P105, DOI 10.1089/089771501750055811; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Ghosh S, 1999, IMMUNOL RES, V19, P183, DOI 10.1007/BF02786486; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HACKNEY DB, 1994, NEUROSURGERY, V35, P1104, DOI 10.1227/00006123-199412000-00013; Han BH, 2000, NEUROBIOL DIS, V7, P38; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; Hong SY, 2000, J BIOL CHEM, V275, P18022, DOI 10.1074/jbc.M001202200; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jakeman LB, 2000, J NEUROTRAUM, V17, P299, DOI 10.1089/neu.2000.17.299; Katoh K, 1996, NEUROSCI LETT, V216, P9; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Kuhn PL, 1998, J NEUROTRAUM, V15, P125, DOI 10.1089/neu.1998.15.125; Kumari M, 1997, HEAT MASS TRANSFER, V32, P393, DOI 10.1007/s002310050136; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li M, 2000, NEUROSCIENCE, V99, P333, DOI 10.1016/S0306-4522(00)00173-1; Li Qun, 1998, Society for Neuroscience Abstracts, V24, P738; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Liu XZ, 1997, J NEUROSCI, V17, P5395; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Ohta K, 1999, SPINAL CORD, V37, P580, DOI 10.1038/sj.sc.3100881; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; PROBERT L, 1995, P NATL ACAD SCI USA, V92, P11294, DOI 10.1073/pnas.92.24.11294; Riches DWH, 1998, J BIOL CHEM, V273, P22800, DOI 10.1074/jbc.273.35.22800; Rosenberg LJ, 1997, J NEUROTRAUM, V14, P823, DOI 10.1089/neu.1997.14.823; Rosenbluth J, 1997, EXP NEUROL, V147, P172, DOI 10.1006/exnr.1997.6583; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; VAN AD, 1996, SCIENCE, V274, P787; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; Xu DG, 1999, J NEUROSCI, V19, P5026; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Xu J, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0001.2001; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yan P, 1999, J NEUROSCI, V19, P9355; Yang GY, 1998, NEUROREPORT, V9, P2131, DOI 10.1097/00001756-199806220-00041; Yu ZF, 1999, J NEUROSCI, V19, P8856, DOI 10.1523/JNEUROSCI.19-20-08856.1999	86	115	122	1	6	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	SEP 1	2001	21	17					6617	6625		10.1523/JNEUROSCI.21-17-06617.2001			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467FC	WOS:000170690900020	11517251	Green Published, Bronze			2022-02-06	
J	de Kruijk, JR; Leffers, P; Menheere, PPCA; Meerhoff, S; Twijnstra, A				de Kruijk, JR; Leffers, P; Menheere, PPCA; Meerhoff, S; Twijnstra, A			S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients - A comparison with healthy controls	ACTA NEUROLOGICA SCANDINAVICA			English	Article						mild traumatic brain injury; neuron-specific enolase; S-100B; vomiting	SEVERE HEAD-INJURY; MYELIN BASIC-PROTEIN; COMPUTED-TOMOGRAPHY; DAMAGE	Objectives - The aim of the study was to determine whether serum concentrations of neuron-specific enolase (NSE) and S100-B in mild traumatic brain injury (MTBI) patients are higher than in serum of healthy controls. Material and methods - Blood samples from 104 MTBI patients were taken shortly after the trauma for measurement of S-100B and NSE in serum. In 92 healthy persons these markers were also measured. Marker concentrations in serum of patients and controls were compared. In the patient group the relation between serum-marker concentrations and clinical symptoms and signs, that occurred shortly after the traumatic event, were evaluated. Results - Median NSE concentration was only slightly higher in patients (9.8 mug/l; 10 to 90 percentile range 6.9 to 14.3,mug/l) than in controls (9.4 mug/l; 6.3 to 13.3 mug/l). Median S-100B concentration was significantly higher in patients (0.25 mug/l; 0.00 to 0.68 mug/l) than in controls (0.02 mug/l; 0.90 to 0.13 mug/l). An association was found between S-100B concentrations and vomiting in patients. Conclusions - S-100B is a useful marker for brain damage in MTBI patients and seems to be associated with the presence of vomiting after the trauma.	Univ Hosp Maastricht, Dept Neurol, NL-6229 HX Maastricht, Netherlands; Univ Hosp Maastricht, Dept Clin Chem, Maastricht, Netherlands; Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands		de Kruijk, JR (corresponding author), Univ Hosp Maastricht, Dept Neurol, P Debeylaan 25, NL-6229 HX Maastricht, Netherlands.		Leffers, Pieter/B-8642-2009				Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; KATO K, 1982, BRAIN RES, V237, P441, DOI 10.1016/0006-8993(82)90455-3; LAMERS KJB, 1995, ACTA NEUROL SCAND, V92, P247; Nee PA, 1999, J NEUROL NEUROSUR PS, V66, P470, DOI 10.1136/jnnp.66.4.470; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; USUI A, 1989, CLIN CHEM, V35, P1942; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P7, DOI 10.2176/nmc.33.7; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	14	115	119	0	3	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	MAR	2001	103	3					175	179		10.1034/j.1600-0404.2001.103003175.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404MN	WOS:000167104100006	11240565				2022-02-06	
J	Ashikaga, R; Araki, Y; Ishida, O				Ashikaga, R; Araki, Y; Ishida, O			MRI of head injury using FLAIR	NEURORADIOLOGY			English	Article						brain, injury; fluid-attenuated inversion-recovery (FLAIR) magnetic resonance imaging	PULSE SEQUENCES; TRAUMA; EXPERIENCE; FEATURES; BRAIN; CT	We studied the utility of fluid-attenuated inversion-recovery (FLAIR) MRI in the investigation of head injury. We examined 56 patients with head injuries with T2-weighted spin-echo (SE) and FLAIR sequences. In all cases, the sensitivity of FLAIR images to equal or superior to that of conventional SE images to the traumatic lesions. In 9 cases, central diffuse axonal injury of the fornix and corpus callosum could be seen only on sagittal FLAIR images.			Ashikaga, R (corresponding author), KINKI UNIV,SCH MED,DEPT RADIOL,377-1 OHNOHIGASHI,OSAKA,OSAKA 589,JAPAN.						COENE BD, 1992, AJNR, V13, P1555; DAVIS WL, 1994, DIAGNOSTIC NEURORADI, P199; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1991, MAGNETIC RESONANCE I, P439; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P841, DOI 10.1097/00004728-199211000-00001; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; RYDBERG JN, 1994, RADIOLOGY, V193, P173, DOI 10.1148/radiology.193.1.8090888; WHITE SJ, 1992, MAGNET RESON MED, V28, P153, DOI 10.1002/mrm.1910280116	10	115	117	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-3940			NEURORADIOLOGY	Neuroradiology	APR	1997	39	4					239	242		10.1007/s002340050401			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	WW392	WOS:A1997WW39200001	9144669				2022-02-06	
J	HintonBayre, AD; Geffen, G; McFarland, K				HintonBayre, AD; Geffen, G; McFarland, K			Mild head injury and speed of information processing: A prospective study of professional rugby league players	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							AUSTRALIAN RULES FOOTBALLERS; CONCUSSION; GUIDELINES; SPORTS; MANAGEMENT; PREVENTION; SEQUELAE	The sensitivity of several short tests of speed of information processing to the effects of mild head injury in rugby league football was investigated. The measures used were the Symbol Digit Modalities Test, the Digit Symbol Substitution Test, and the Speed of Comprehension Test. Two studies were conducted, the first to examine the effect of practice, the second to determine sensitivity to cognitive impairment immediately following injury. The first study established alternate form equivalence and demonstrated that performance on the Speed of Comprehension and Digit Symbol Substitution tests improved with practice, whereas the Symbol Digit Modalities test remained stable. A second study of 10 players who subsequently sustained mild head injuries showed that measures of speed of information processing were sensitive to impairment in the postacute phase, whereas an untimed task of word recognition (Spot-the-Word) was not. Speed of Comprehension was more sensitive to postinjury impairment than either the Digit Symbol Substitution or Symbol Digit Modalities tests. A repeated baseline assessment before injury using the higher score to reflect a player's potential, allowed measurement of impaired performance on sensitive tests.	UNIV QUEENSLAND,COGNIT PSYCHOPHYSIOL LAB,HERSTON,QLD 4006,AUSTRALIA; QUEENSLAND HLTH,CLIN STUDIES UNIT,BRISBANE,QLD,AUSTRALIA								BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Baddeley A., 1992, SPEED CAPACITY LANGU; Bashford G, 1993, Aust Fam Physician, V22, P2067; BRATH JT, 1989, MILD HEAD INJURY, P257; BROOKS DN, 1987, NEUROBEHAVIORAL RECO, P57; BROOKS DN, 1989, RECOVERY BRAIN INJUR, P67; BRUKNER P, 1993, CLIN SPORTS MED, P155; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Clark C., 1988, HDB DICHOTIC LISTENI, P71; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Dicker G, 1993, Aust Fam Physician, V22, P750; DIKMEN S, 1987, NEUROBEHAVIORAL RECO, P73; FICK DS, 1995, POSTGRAD MED, V97, P53, DOI 10.1080/00325481.1995.11945958; GARNHAM AP, 1992, TXB SCI MED SPORT, P279; GENTILINI M, 1989, MILD HEAD INJURY, P163; GIBBS N, 1993, AM J SPORT MED, V21, P696, DOI 10.1177/036354659302100510; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL D, 1992, NZ J SPORTS MED, V20, P19; Gronwall D, 1989, MILD HEAD INJURY, P153; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; HAZARD H, 1987, SPORTS COAHC, P9; HOY G, 1987, SPORT HLTH, V5, P26; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LEBLANC KE, 1994, AM FAM PHYSICIAN, V50, P801; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, AUST PSYCHOL, V30, P125, DOI 10.1080/00050069508258916; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; MCCRORY P, 1994, HEAD BRAIN INJURY SP; MILLER RE, 1984, HYPERTENSION, V6, P202, DOI 10.1161/01.HYP.6.2_Pt_1.202; National Health and Medical Research Council, 1994, FOOTB INJ HEAD NECK; Nelson H. E, 1982, NATIONAL ADULT READI; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Reitan RM, 1985, HALSTEADREITAN NEURO; Sacks T. L., 1991, CLIN NEUROPSYCHOL, V5, P220, DOI [10.1080/13854049108404093, DOI 10.1080/13854049108404093]; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Smith A., 1982, SYMBOL DIGIT MODALIT; STRAUSS ME, 1987, NEUROBEHAVIORAL RECO, P88; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; Wechsler, 1997, WECHSLER ADULT INTEL; WRIGHTSON P, 1992, NZ J SPORTS MED, V20, P19; YOUNGJOHN JR, 1992, CLIN NEUROPSYCHOLOGI, V3, P276; [No title captured]; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	49	115	115	0	5	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1997	19	2					275	289		10.1080/01688639708403857			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	XC634	WOS:A1997XC63400011	9240486				2022-02-06	
J	Guskiewicz, KM; Perrin, DH; Gansneder, BM				Guskiewicz, KM; Perrin, DH; Gansneder, BM			Effect of mild head injury on postural stability in athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; balance; postural sway	SENSORY INTERACTION; BALANCE; SWAY; CONCUSSION; ADAPTATION; STANCE	Objective: Athletic trainers and team physicians are often faced with the dilemma of when to return athletes to participation following mild head injury. Unfortunately, clinicians rarely have quantitative information on which to base their decisions. The purpose of this investigation was to identify postural stability changes in athletes with acute mild head injury. Design and Setting: High school and college male athletes were prescreened for postural stability before the start of their season. Subjects suffering injury during the season returned for testing on days 1, 3, 5, and 10 following injury, and 1 month postseason. Control subjects were selected for comparisons. Subjects: Ten prescreened subjects (age = 17.4 +/- 2.2 yr; ht = 183.8 +/- 8.1 cm; wt = 87.7 +/- 17.3 kg) returned for testing following an injury. Ten matched control subjects (age = 18.6 +/- 2.6 yr; ht = 185.7 +/- 6.7 cm; wt = 84.5 +/- 19.5 kg) were selected for comparisons. Additionally, nine subjects (eight mate and one female) (age = 19.9 +/- 4.2 yr; ht = 182.3 +/- 10.9 cm; wt = 89.6 +/- 25.2 kg) who had sustained a mild head injury from other varsity sports teams were recruited. Nine matched controls (age = 22.1 +/- 3.3 yr; ht = 181.0 +/- 9.9 cm; wt = 84.9 +/- 25.6 kg) were again utilized. Measurements: Sway index and center of balance were measured using the Chattecx Balance System during three eye conditions and three surface conditions for all subjects. Results: Repeated measures analyses of Variance (ANOVA) for each prescreened subject's sway index revealed significant differences between injured subjects and control subjects on day 1 postinjury as compared with the prescreening and/or subsequent tests. The analysis for sway index and center of balance inclusive of all 19 subjects with mild head injury and all 19 control subjects demonstrated increased postural sway compared with control subjects on day 1 postinjury during all platform conditions, and on day 3 during the foam platform condition. The analysis for center of balance using the same subjects revealed that injured subjects maintained their center of balance farther away on day 1 postinjury compared with subsequent tests (p < .05). Conclusions: These findings suggest that computerized dynamic posturography is a useful tool in objectively assessing postural stability in subjects with mild head injuries. Subjects with mild head injury appear to demonstrate impaired postural stability 1 to 3 days following injury. This information should aid clinicians in determining when an athlete can safely return to participation.	UNIV VIRGINIA,CURRY SCH EDUC,DEPT HUMAN SERV,CHARLOTTESVILLE,VA 22903		Guskiewicz, KM (corresponding author), UNIV N CAROLINA,DEPT PHYS EDUC EXERCISE & SPORT SCI,CHAPEL HILL,NC 27514, USA.			Guskiewicz, Kevin/0000-0002-8682-2130			ADAMS J, 1975, HDB CLIN NEUROLOGY I, P35; ARCAN M, 1977, SCAND J REHABIL MED, V9, P165; BRUCE D, 1982, PRIMARY CARE, V11, P175; BYL NN, 1991, SPINE, V16, P325, DOI 10.1097/00007632-199103000-00012; Cantu, 1991, Adolesc Med, V2, P141; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; *CHATT GROUP INC, 1992, BAL SYST CLIN DESK R, P4; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; GUYTON A, 1986, TXB MED PHYSL, P610; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; LEVIN H, 1994, P MILD BRAIN INJ SPO, P53; MAURITZ KH, 1979, BRAIN, V102, P461, DOI 10.1093/brain/102.3.461; MCINTOSH T, 1989, MILD MODERATE HEAD I, P35; NASHNER L, 1978, BRAIN RES, V150, P403, DOI 10.1016/0006-8993(78)90291-3; NASHNER LM, 1982, J NEUROSCI, V2, P536; NASHNER LM, 1982, TRENDS NEUROSCI, V5, P358, DOI 10.1016/0166-2236(82)90204-1; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; *NAT ATHL TRAIN AS, 1994, P MILD BRAIN INJ SPO, P2; NEWTON R, 1989, BAL P AM PHYS THER A, P69; NORRE ME, 1993, J LARYNGOL OTOL, V107, P496, DOI 10.1017/S0022215100123564; Ommaya A, 1994, P MILD BRAIN INJ SPO, P72; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Weir Mitchell S, 1886, AM J MED SCI, V92, P363	30	115	115	0	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247	1062-6050			J ATHL TRAINING	J. Athl. Train.	OCT-DEC	1996	31	4					300	306					7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	WA362	WOS:A1996WA36200003	16558414				2022-02-06	
J	Masson, F; Maurette, P; Salmi, LR; Dartigues, JF; Vecsey, J; Destaillats, JM; Erny, P				Masson, F; Maurette, P; Salmi, LR; Dartigues, JF; Vecsey, J; Destaillats, JM; Erny, P			Prevalence of impairments 5 years after a head injury, and their relationship with disabilities and outcome	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; HOSPITAL ADMISSIONS; COMMUNITY; EPIDEMIOLOGY; FRANCE; DEATHS; CONSCIOUSNESS; AQUITAINE; RECOVERY; COUNTY	To determine what consequences cognitive, behavioural or somatic impairments had on disabilities and recovery after a head injury (HI), a population-based sample of 231 adult patients was studied 5 years after an HI. Eighty lower-limb-injured (LLI) patients were considered as controls. Sixty-four LLI and 176 HI patients were reviewed (114 minor, 35 moderate, and 27 severe HI). Prevalence values of headaches (44-54%), dizziness (26-37%), and anxiety (47-63%) were not significantly different in the three HI severity groups, but were significantly lower in patients with an isolated limb injury (12-15%). Memory problems and depressive mood increased with injury severity. Mental impairments were frequent in severe HI patients (18-40% of patients). In minor and moderate HI patients, most disabilities were related to associated injuries. According to the Glasgow Outcome Scale (GOS), recovery was not considered as good because of somatic, behavioural or cognitive complaints in 2.5%, 5.7% and 59.2% of surviving patients in each of the above HI groups. Somatic or behavioural complaints may have considerable consequences in some minor HI patients, and the long-term management of certain patients needs improvement because these impairments are misunderstood.	UNIV BORDEAUX 2, DEPT EPIDEMIOL & INFORMAT MED, INSERM 330, BORDEAUX, FRANCE; HOP PELLEGRIN, SERV READAPTAT FONCT, BORDEAUX, FRANCE		Masson, F (corresponding author), HOP PELLEGRIN, DEPT ANESTHESIE REANIMAT, PL AMELIE RABA LEON, F-33076 BORDEAUX, FRANCE.		Salmi, Louis-Rachid/T-1982-2019; DARTIGUES, Jean Francois/T-4513-2019				ABENHAIM L, 1992, J CLIN EPIDEMIOL, V45, P103, DOI 10.1016/0895-4356(92)90002-5; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Annoni J M, 1992, Disabil Rehabil, V14, P23; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GRONWALL D, 1974, LANCET, V2, P605; HOOK O, 1988, SCAND J REHABIL MED, P65; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHANSSON E, 1991, SCAND J REHABIL MED, V23, P179; *JOINT COMM INJ SC, 1980, ABBR INJ SCAL 1980 R; JONES JH, 1992, ARCH PHYS MED REHAB, V73, P145; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MAURETTE P, 1992, J TRAUMA, V33, P728, DOI 10.1097/00005373-199211000-00023; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MCCLELLAND RJ, 1994, J ROY SOC MED, V87, P508; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; *ORG MOND SANT, 1988, CLASS INT HAND DEF I; PARIENTE P, 1992, PSYCHOL MED, V22, P181, DOI 10.1017/S0033291700032839; RUNE V, 1970, ACTA PAEDIATR SCAND, P1; RUTHERFORD WH, 1977, LANCET, V1, P1; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Symonds C P, 1937, Proc R Soc Med, V30, P1081; TEASDALE G, 1974, LANCET, V2, P81; TIRET L, 1989, AM J PUBLIC HEALTH, V79, P316, DOI 10.2105/AJPH.79.3.316; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	39	115	116	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	1996	10	7					487	497		10.1080/026990596124205			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UU819	WOS:A1996UU81900002	8806009				2022-02-06	
J	KOSKINIEMI, M; KYYKKA, T; NYBO, T; JARHO, L				KOSKINIEMI, M; KYYKKA, T; NYBO, T; JARHO, L			LONG-TERM OUTCOME AFTER SEVERE BRAIN INJURY IN PRESCHOOLERS IS WORSE THAN EXPECTED	ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE			English	Article							CLOSED-HEAD-INJURY; CHILDREN; TRAUMA; ADOLESCENTS; PROGNOSIS; SCALE; COMA	Objective: To determine the long-term outcome after severe brain injury at preschool age. Design: Follow-up until adult life. Setting: A centralized guidance center for all traffic-associated injuries. Patients: Children with severe brain injury at preschool age between January 1959 and December 1969. Main Outcome Measure: Final evaluation in adulthood was performed by our team. The capability to work and live independently was rated. Results: Twenty three (59%) of 39 children attended a typical school, eight (21%) attended a school for the physically disabled, and seven (18%) attended a school for the mentally retarded; information was not available for one child. In adulthood, nine patients (23%) were able to work full-time, 10 (26%) worked at sheltered workplaces, 14 (36%) lived independently at home, and six (15%) needed physical and/or psychotherapeutic support. The difference between normal school performance (59%) and ca pability to work full-time (23%) was significant (P<.05). In evaluating different aspects after the severe brain injury, the sense of identity was the best indicator of final outcome. Conclusions: The final evaluation of severe brain injury at preschool age should be performed in adulthood. Normal school performance or normal intelligence functioning is not a guarantee for good long-term prognosis. To let the child develop a firm identity is essential for good outcome.	KAUNIALA HOSP DISABLED WAR VET,SF-02700 KAUNIAINEN,FINLAND; REHABIL CTR INSURANCE CO,KAUNIAINEN,FINLAND; UNIV HELSINKI,DEPT VIROL,HELSINKI,FINLAND								ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; COHADON F, 1991, J NEUROL SCI, V103, pS27; COSTEFF H, 1988, BRAIN DEV-JPN, V10, P371, DOI 10.1016/S0387-7604(88)80095-0; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DOBBING J, 1968, APPLIED NEUROCHEMIST; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GURLAND BJ, 1972, ARCH GEN PSYCHIAT, V27, P259; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; HEISKANEN O, 1974, DEV MED CHILD NEUROL, V16, P11; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1993, CURR OPIN NEUROL, V6, P841, DOI 10.1097/00019052-199312000-00003; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; OVERGAARD J, 1973, LANCET, V2, P631; RIVARA F, 1987, PEDIATRICS, V80, P579; ZIMMERMAN RA, 1978, AM J ROENTGENOL, V131, P27, DOI 10.2214/ajr.131.1.27	24	115	116	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	1072-4710			ARCH PEDIAT ADOL MED	Arch. Pediatr. Adolesc. Med.	MAR	1995	149	3					249	254		10.1001/archpedi.1995.02170150029004			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	QK484	WOS:A1995QK48400003	7532073				2022-02-06	
J	PALMER, AM; MARION, DW; BOTSCHELLER, ML; BOWEN, DM; DEKOSKY, ST				PALMER, AM; MARION, DW; BOTSCHELLER, ML; BOWEN, DM; DEKOSKY, ST			INCREASED TRANSMITTER AMINO-ACID CONCENTRATION IN HUMAN VENTRICULAR CSF AFTER BRAIN TRAUMA	NEUROREPORT			English	Article						ASPARTATE; CSF; EXCITOTOXICITY; GLUTAMATE; HUMAN INJURY; TRAUMATIC BRAIN INJURY; GABA	INJURY; GLUTAMATE; EXCITOTOXICITY; ASPARTATE; RELEASE; RECEPTORS; TOXICITY; SCALE; RATS; COMA	THE concentrations of L-aspartate, L-glutamate, L-serine, glycine and gamma-aminobutyric acid (GABA) were determined in repeated samples of ventricular CSF from five patients with severe closed head injury. The values were compared with those obtained from five subjects undergoing surgical treatment for intractable depression. In the head-injured patients, the concentrations of aspartate, glutamate and glycine were 2- to 8-fold higher and the concentration of GABA 56- to 317-fold higher than control values; the concentration of serine was unaffected. Spearman correlation analysis indicated that the concentration of glutamate significantly increased after injury (R(s) = 0.60, p < 0.0001, n = 42), reaching an average concentration of about 7 mu M 3 days after the injury. This is probably sufficient to cause further excitotoxicity, which suggests the use of excitatory amino acid receptor antagonists as a treatment following severe head injury may require prolonged administration for maximum therapeutic benefit.	UNIV PITTSBURGH,SCH MED,DEPT PSYCHIAT,PITTSBURGH,PA; UNIV PITTSBURGH,SCH MED,DEPT NEUROL SURG,PITTSBURGH,PA 15261; INST NEUROL,DEPT NEUROCHEM,LONDON,ENGLAND		PALMER, AM (corresponding author), WYETH AYERST RES,HUNTERCOMBE LANE S,TAPLOW SL6 0PH,BERKS,ENGLAND.		Marion, Donald/AAR-5749-2021	Marion, Donald/0000-0003-4627-7702; DeKosky, Steven/0000-0003-3743-2758	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P20NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30318] Funding Source: Medline		Adams JH, 1992, GREENFIELDS NEUROPAT, P106; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BENVENISTE H, 1990, CEREBROVAS BRAIN MET, V3, P213; BERNERT H, 1992, SOC NEUR ABSTR, V18, P4572; ENGELSEN BA, 1985, NEUROSCI LETT, V62, P97, DOI 10.1016/0304-3940(85)90290-3; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLECK MW, 1993, J NEUROSCI, V13, P3944; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HUTSON PH, 1985, J NEUROCHEM, V44, P1266, DOI 10.1111/j.1471-4159.1985.tb08753.x; JENNETT B, 1985, LANCET, V1, P480; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PANGALOS MN, 1992, BRIT J PSYCHIAT, V160, P638, DOI 10.1192/bjp.160.5.638; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PERRY TL, 1975, J NEUROCHEM, V24, P587, DOI 10.1111/j.1471-4159.1975.tb07680.x; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; TEASDALE G, 1974, LANCET, V2, P81; WESTERGREN I, 1994, J NEUROCHEM, V62, P159; ZEEVALK GD, 1989, J NEUROCHEM, V53, P1610, DOI 10.1111/j.1471-4159.1989.tb08559.x; ZEEVALK GD, 1991, J PHARMACOL EXP THER, V257, P870; ZEEVALK GD, 1993, J NEUROCHEM, V61, P1445, DOI 10.1111/j.1471-4159.1993.tb13639.x	25	115	118	0	3	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-4965			NEUROREPORT	Neuroreport	DEC 30	1994	6	1					153	156		10.1097/00001756-199412300-00039			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QD829	WOS:A1994QD82900038	7703404				2022-02-06	
J	JAFFE, KM; FAY, GC; POLISSAR, NL; MARTIN, KM; SHURTLEFF, H; RIVARA, JB; WINN, HR				JAFFE, KM; FAY, GC; POLISSAR, NL; MARTIN, KM; SHURTLEFF, H; RIVARA, JB; WINN, HR			SEVERITY OF PEDIATRIC TRAUMATIC BRAIN INJURY AND EARLY NEUROBEHAVIORAL OUTCOME - A COHORT STUDY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						CHILDREN; CLOSED HEAD INJURY; OUTCOME; TRAUMATIC BRAIN INJURY	CLOSED-HEAD-INJURY; INTELLECTUAL ABILITY; FOLLOW-UP; CHILDREN; MEMORY; SEQUELAE; RECOVERY; ADOLESCENTS; PERFORMANCE	Traumatic brain injury (TBI) is a major cause of pediatric disability. Its neurobehavioral sequelae can often be difficult to distinguish from premorbid problems. To establish the early neurobehavioral consequences of TBI, we compared a cohort of brain injured children with controls, individually matched on premorbid characteristics. Ninety-eight children, aged 6 to 15 years, with mild, moderate, and severe closed head injuries, were consecutively identified on presentation to two regional medical centers. Individually selected controls were matched for age, gender, school grade, behavior, and academic performance. Intellectual, neuropsychologic. and academic assessments were undertaken 3 weeks after full orientation was achieved. No significant case-control differences were found on 20 variables measuring premorbid status. The pattern of decline in performance with increasing severity of brain injury was consistent for measures assessing intelligence, memory, speeded motor performance, adaptive problem solving, and academic performance. Moderately and severely injured patients performed at normal levels in reference to standardized intellectual norms, but they showed impairment when compared with their matched controls. The impairments uncovered in this study place moderately and severely brain injured children at risk for problems in the acquisition of academic skills and higher-order cognitive abilities.	UNIV WASHINGTON,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT NEUROL SURG,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PSYCHIAT & BEHAV SCI,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195; UNIV WASHINGTON,SCH SOCIAL WORK,SEATTLE,WA 98195		JAFFE, KM (corresponding author), CHILDRENS HOSP & MED CTR,DEPT REHABIL MED,POB C-5371,4800 SAND POINT WAY NE,SEATTLE,WA 98105, USA.			Shurtleff, Hillary/0000-0003-0959-2842	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR 002299] Funding Source: Medline		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ARMITAGE P, 1971, STATISTICAL METHODS; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BIJUR PE, 1990, PEDIATRICS, V86, P337; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Conover W.J., 1998, PRACTICAL NONPARAMET; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DELIS DC, 1989, CALIFORNIA VERBAL LE; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN S, 1987, NEUROBEHAVIORAL RECO, P73; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; GOTTFRIED AW, 1985, MERRILL PALMER QUART, V31, P85; GRONWALL D, 1974, LANCET, V2, P605; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; NBRUININKS RH, 1984, SCALES INDEPENDENT B; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SLATER EJ, 1988, AM J DIS CHILD, V142, P1048, DOI 10.1001/archpedi.1988.02150100042022; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; WALLER JA, 1988, J TRAUMA, V28, P1632, DOI 10.1097/00005373-198812000-00003; Wechsler D., 1974, WECHSLER INTELLIGENC; Wilkinson, 1984, WIDE RANGE ACHIEVEME; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	38	115	115	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	1992	73	6					540	547					8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HX739	WOS:A1992HX73900005	1622302				2022-02-06	
J	Shafiei, SS; Guerrero-Munoz, MJ; Castillo-Carranza, DL				Shafiei, Scott S.; Guerrero-Munoz, Marcos J.; Castillo-Carranza, Diana L.			Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage	FRONTIERS IN AGING NEUROSCIENCE			English	Article						tauopathy; tau oligomers; tau secretion; propagation; mitochondrial dysfunction	HEPARAN-SULFATE PROTEOGLYCANS; TRAUMATIC BRAIN-INJURY; V337M HUMAN TAU; ALZHEIMERS-DISEASE; IN-VIVO; NEUROFIBRILLARY TANGLES; EXTRACELLULAR TAU; ENDOGENOUS TAU; MOUSE MODEL; TRANSGENIC MICE	Aging has long been considered as the main risk factor for several neurodegenerative disorders including a large group of diseases known as tauopathies. Even though neurofibrillary tangles (NFTs) have been examined as the main histopathological hallmark, they do not seem to play a role as the toxic entities leading to disease. Recent studies suggest that an intermediate form of tau, prior to NFT formation, the tau oligomer, is the true toxic species. However, the mechanisms by which tau oligomers trigger neurodegeneration remain unknown. This review summarizes recent findings regarding the role of tau oligomers in disease, including release from cells, propagation from affected to unaffected brain regions, uptake into cells, and toxicity via mitochondrial dysfunction. A greater understanding of tauopathies may lead to future advancements in regards to prevention and treatment.	[Shafiei, Scott S.] Univ Texas Med Branch, Dept Neurol Neurosci & Cell Biol, Galveston, TX 77555 USA; [Guerrero-Munoz, Marcos J.] Hampton Univ, Dept Chem Engn, Hampton, VA 23668 USA; [Castillo-Carranza, Diana L.] Hampton Univ, Minor Mens Hlth, Hampton, VA 23668 USA		Castillo-Carranza, DL (corresponding author), Hampton Univ, Minor Mens Hlth, Hampton, VA 23668 USA.	diana.castillocarranza@hamptonu.edu		Castillo-Carranza, Diana/0000-0003-2511-949X	NIH National Institute for Minority Health & Health Disparities (NIMHD) award [4U54MD008621-04]	This work was supported by funds from NIH National Institute for Minority Health & Health Disparities (NIMHD) award 4U54MD008621-04. We thank Ms. Urmi Sengupta and Julia Gerson for contributing to the editing process.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Castillo-Carranza DL, 2014, J ALZHEIMERS DIS, V40, pS97, DOI 10.3233/JAD-132477; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Castillo-Carranza Diana L, 2013, Front Biosci (Schol Ed), V5, P426; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; Davizon P, 2010, SEMIN THROMB HEMOST, V36, P857, DOI 10.1055/s-0030-1267039; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Dennissen FJA, 2016, P NATL ACAD SCI USA, V113, P11597, DOI 10.1073/pnas.1603119113; Doeuvre L, 2009, J NEUROCHEM, V110, P457, DOI 10.1111/j.1471-4159.2009.06163.x; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Dujardin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100760; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Gendreau KL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00160; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Gerson JE, 2014, ACS CHEM NEUROSCI, V5, P752, DOI 10.1021/cn500143n; Gerson JE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-73; Gerson JE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00093; Goedert M, 2000, ANN NY ACAD SCI, V920, P74; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2009, EUR NEUROPSYCHOPHARM, V19, P708, DOI 10.1016/j.euroneuro.2009.04.006; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hooper NM, 2011, J NEUROCHEM, V116, P721, DOI 10.1111/j.1471-4159.2010.06936.x; Hutton M, 2000, ANN NY ACAD SCI, V920, P63; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Ihara Y, 2001, NEUROBIOL AGING, V22, P123, DOI 10.1016/S0197-4580(00)00200-1; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Khalyfa A, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-162; Kim SH, 2001, LIFE SCI, V68, P2741, DOI 10.1016/S0024-3205(01)01074-8; Kozlov MM, 1999, BIOPHYS J, V77, P604, DOI 10.1016/S0006-3495(99)76917-1; Kuchibhotla KV, 2014, P NATL ACAD SCI USA, V111, P510, DOI 10.1073/pnas.1318807111; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lasagna-Reeves CA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-56; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Medina M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00113; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; Mondragon-Rodriguez S, 2012, J BIOL CHEM, V287, P32040, DOI 10.1074/jbc.M112.401240; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pooler AM, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt214; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Pooler AM, 2010, BIOCHEM SOC T, V38, P1012, DOI 10.1042/BST0381012; Quintanilla RA, 2009, J BIOL CHEM, V284, P18754, DOI 10.1074/jbc.M808908200; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Reed LA, 2001, NEUROBIOL AGING, V22, P89, DOI 10.1016/S0197-4580(00)00202-5; Rudinskiy N, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-63; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sengupta U, 2015, BIOL PSYCHIAT, V78, P672, DOI 10.1016/j.biopsych.2014.12.019; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Spillantini MG, 2000, NEUROGENETICS, V2, P193, DOI 10.1007/s100489900084; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Takashima A, 2013, J ALZHEIMERS DIS, V37, P565, DOI 10.3233/JAD-130653; Tanemura K, 2001, NEUROBIOL DIS, V8, P1036, DOI 10.1006/nbdi.2001.0439; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tian H., 2013, Int. J. Cell Biol., V2013, DOI DOI 10.1155/2013/260787; van Horssen J, 2001, ACTA NEUROPATHOL, V102, P604; Ward SM, 2012, BIOCHEM SOC T, V40, P667, DOI 10.1042/BST20120134; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	94	114	117	6	23	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	APR 4	2017	9								83	10.3389/fnagi.2017.00083			9	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	EQ6ZZ	WOS:000398233600001	28420982	Green Published, gold			2022-02-06	
J	Pollack, MM; Holubkov, R; Funai, T; Berger, JT; Clark, AE; Meert, K; Berg, RA; Carcillo, J; Wessel, DL; Moler, F; Dalton, H; Newth, CJL; Shanley, T; Harrison, RE; Doctor, A; Jenkins, TL; Tamburro, R; Dean, JM				Pollack, Murray M.; Holubkov, Richard; Funai, Tomohiko; Berger, John T.; Clark, Amy E.; Meert, Kathleen; Berg, Robert A.; Carcillo, Joseph; Wessel, David L.; Moler, Frank; Dalton, Heidi; Newth, Christopher J. L.; Shanley, Thomas; Harrison, Rick E.; Doctor, Allan; Jenkins, Tammara L.; Tamburro, Robert; Dean, J. Michael		Eunice Kennedy Shriver Natl Inst C	Simultaneous Prediction of New Morbidity, Mortality, and Survival Without New Morbidity From Pediatric Intensive Care: A New Paradigm for Outcomes Assessment	CRITICAL CARE MEDICINE			English	Article						critical care; functional status; functional status score; intensive care; morbidity; outcome prediction; pediatric critical care; pediatric intensive care; pediatrics; severity of illness	CHRONIC HEALTH EVALUATION; MULTIPLE ORGAN DYSFUNCTION; NEONATAL ACUTE PHYSIOLOGY; HOSPITAL-WIDE MORTALITY; FUNCTIONAL STATUS SCALE; TRAUMATIC BRAIN-INJURY; PERFORMANCE CATEGORY; AHRQ QUALITY; ROC ANALYSIS; MANAGEMENT	Objectives: Assessments of care including quality assessments adjusted for physiological status should include the development of new morbidities as well as mortalities. We hypothesized that morbidity, like mortality, is associated with physiological dysfunction and could be predicted simultaneously with mortality. Design: Prospective cohort study from December 4, 2011, to April 7, 2013. Setting: General and cardiac/cardiovascular PICUs at seven sites. Patients: Randomly selected PICU patients from their first PICU admission. Interventions: None. Measurements and Main Results: Among 10,078 admissions, the unadjusted morbidity rates (measured with the Functional Status Scale and defined as an increase of >= 3 from preillness to hospital discharge) were 4.6% (site range, 2.6-7.7%) and unadjusted mortality rates were 2.7% (site range, 1.3-5.0%). Morbidity and mortality were significantly (p < 0.001) associated with physiological instability (measured with the Pediatric Risk of Mortality III score) in dichotomous (survival and death) and trichotomous (survival without new morbidity, survival with new morbidity, and death) models without covariate adjustments. Morbidity risk increased with increasing Pediatric Risk of Mortality III scores and then decreased at the highest Pediatric Risk of Mortality III values as potential morbidities became mortalities. The trichotomous model with covariate adjustments included age, admission source, diagnostic factors, baseline Functional Status Scale, and the Pediatric Risk of Mortality III score. The three-level goodness-of-fit test indicated satisfactory performance for the derivation and validation sets (p > 0.20). Predictive ability assessed with the volume under the surface was 0.50 +/- 0.019 (derivation) and 0.50 +/- 0.034 (validation) (vs chance performance = 0.17). Site-level standardized morbidity ratios were more variable than standardized mortality ratios. Conclusions: New morbidities were associated with physiological status and can be modeled simultaneously with mortality. Trichotomous outcome models including both morbidity and mortality based on physiological status are suitable for research studies and quality and other outcome assessments. This approach may be applicable to other assessments presently based only on mortality.	[Pollack, Murray M.; Berger, John T.; Wessel, David L.] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA; [Pollack, Murray M.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Pollack, Murray M.; Dalton, Heidi] Phoenix Childrens Hosp, Dept Child Hlth, Phoenix, AZ USA; [Pollack, Murray M.] Univ Arizona, Sch Med, Phoenix, AZ USA; [Holubkov, Richard; Funai, Tomohiko; Clark, Amy E.; Dean, J. Michael] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Meert, Kathleen] Childrens Hosp Michigan, Dept Pediat, Washington, DC USA; [Berg, Robert A.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Carcillo, Joseph] Childrens Hosp Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Moler, Frank; Shanley, Thomas] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Dalton, Heidi] Univ Arizona, Coll Med, Phoenix, AZ USA; [Newth, Christopher J. L.] Childrens Hosp Los Angeles, Dept Anesthesiol & Crit Care Med, Los Angeles, CA 90027 USA; [Harrison, Rick E.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Doctor, Allan] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Doctor, Allan] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA; [Jenkins, Tammara L.; Tamburro, Robert] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Trauma & Crit Illness Branch, NIH, Bethesda, MD USA		Pollack, MM (corresponding author), Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA.	mpollack@childrensnational.org		Shanley, Thomas/0000-0001-8936-377X; Holubkov, Richard/0000-0003-0431-3381	Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human ServicesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD050096, U10HD049981, U10HD049983, U10HD050012, U10HD063108, U10HD063106, U10HD063114, U01HD049934]; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Association for Pediatric Pulmonary Hypertension; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH/NICHD (Collaborative Pediatric Critical Care Research Network); NICHD (Collaborative Pediatric Critical Care Research Network [CPCCRN] grant); NIH (Clinical and Translational Science Award grant)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NICHD (CPCCRN grant); NIH (CPCCRN)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH (Therapeutic Hypothermia for Pediatric Cardiac Arrest)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; American Hospital Association; Children's Discovery Institute; U.S. Food and Drug Administration Office of Orphan Product Development Grant; Health Services and Resources Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD063114, U10HD049981, UG1HD049981, UG1HD050096, UG1HD049983, U10HD050012, UG1HD063108, U10HD063108, U10HD049983, U01HD049934, UG1HD050012, U10HD063106, U10HD050096] Funding Source: NIH RePORTER	Supported, in part, by the following cooperative agreements from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services: U10HD050096, U10HD049981, U10HD049983, U10HD050012, U10HD063108, U10HD063106, U10HD063114, and U01HD049934.; Dr. Pollack received grant support from the National Institute of Child Health and Human Development (NICHD), has planned patents through Children's National Medical Center (his not-for-profit employer), and received support for article research from the National Institutes of Health (NIH). Dr. Holubkov served as a board member for Pfizer, the National Burn Association, and Fibrocell (Data Safety Board Membership); consulted for St. Jude Medical, Physicians Committee for Responsible Medicine, and Covidien (Biostatistical Consulting); received support for article research from the NIH. Dr. Holubkov and his institution received grant support (Salary support [biostatistician]) and support for travel (Steering Committee Meeting Travel) from the NIH. Dr. Funai received support for article research from the NIH. Dr. Funai and his institution received grant support from the NIH (salaries support Biostatistician). Dr. Berger received support for article research from the NIH. His institution received grant support from the NIH and the Association for Pediatric Pulmonary Hypertension. Dr. Clark received support for article research from the NIH. Her institution received grant support from the NIH. Dr. Meert received support for article research from the NIH. Her institution received grant support from the NIH. Dr. Berg received grant support from the NICHD and received support for article research from the NIH. Dr. Carcillo received support for article research from the NIH. His institution received grant support and support for travel. Dr. Wessel received support for article research from the NIH. His institution received grant support from the NIH (ongoing). Dr. Moler received support for article research from the NIH. His institution received grant support and support for travel from the NICHD. Dr. Dalton lectured for rEVO Biologics, received royalties from the Society of Critical Care Medicine (SCCM) for Pediatric Multidisciplinary Board Review Book, and received support for article research from the NIH. Her institution received grant support from the NIH. Dr. Newth received support for article research from the NIH. His institution received grant support from the NIH/NICHD (Collaborative Pediatric Critical Care Research Network). Dr. Shanley received support for article research from the NIH and served as a board member for International Pediatric Research Foundation (Society for Pediatric Research Representative on Executive Committee). His institution received grant support from the NICHD (Collaborative Pediatric Critical Care Research Network [CPCCRN] grant) and the NIH (Clinical and Translational Science Award grant) and received support for travel from the NICHD (CPCCRN grant). Dr. Harrison lectured for the SCCM (board review lectures for my professional society) and received support for article research from the NIH. His institution received grant support from the NIH (CPCCRN funding and Therapeutic Hypothermia for Pediatric Cardiac Arrest trial funding via NIH). Dr. Doctor consulted for the NICHD/CPCCRN (honorarium to serve as Steering Committee chairperson), Terumo, BCT, iNO Therapeutics, Novartis, and Galleon Pharmaceuticals; received support for travel from the NICHD/CPCCRN; and lectured for Terumo, BCT. His institution received grant support from the NIH, the American Hospital Association, and the Children's Discovery Institute. Dr. Jenkins received support for article research from the NIH and disclosed government work. Dr. Tamburro received grant support from the U.S.; Food and Drug Administration Office of Orphan Product Development Grant to study calfactant in pediatric stem cell transplant patients (No longer co-principal investigator on the trial secondary to accepting a new position), received royalties from Springer Publisher (received royalties for serving as an associate editor on a pediatric critical care textbook and study guide), received support for article research from the NIH, and disclosed government work. Dr. Dean received support for article research from the NIH. His institution received grant support from the NIH and Health Services and Resources Administration.	Black N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2066; Borzecki AM, 2010, MED CARE, V48, P1117, DOI 10.1097/MLR.0b013e3181ef9d53; Borzecki AM, 2010, MED CARE, V48, P694, DOI 10.1097/MLR.0b013e3181e419e3; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Burstein DS, 2011, PEDIATRICS, V127, pE1482, DOI 10.1542/peds.2010-2796; Checkley W, 2014, CRIT CARE MED, V42, P344, DOI 10.1097/CCM.0b013e3182a275d7; Cook R, 2001, CRIT CARE MED, V29, P2046, DOI 10.1097/00003246-200111000-00002; Cook SF, 2002, CRIT CARE MED, V30, P2765, DOI 10.1097/00003246-200212000-00024; Daily OP, 2004, TRANSPLANTATION, V77, P1309, DOI 10.1097/01.TP.0000120943.94789.E4; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donnino MW, 2013, RESUSCITATION, V84, P651, DOI 10.1016/j.resuscitation.2012.10.024; Elixhauser A, 2005, JT COMM J QUAL PATIE, V31, P533, DOI 10.1016/S1553-7250(05)31069-5; Fagerland MW, 2008, STAT MED, V27, P4238, DOI 10.1002/sim.3202; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Forthman M Thane, 2010, Qual Manag Health Care, V19, P265, DOI 10.1097/QMH.0b013e3181eb143d; Graf J, 2003, CRIT CARE MED, V31, P2163, DOI 10.1097/01.CCM.0000079607.87009.3A; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Horbar JD, 2010, CLIN PERINATOL, V37, P29, DOI 10.1016/j.clp.2010.01.003; Hussey PS, 2013, JT COMM J QUAL PATIE, V39, P177, DOI 10.1016/S1553-7250(13)39024-2; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kerlin MP, 2013, NEW ENGL J MED, V368, P2201, DOI 10.1056/NEJMoa1302854; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Knoester H, 2008, INTENS CARE MED, V34, P1076, DOI 10.1007/s00134-008-1061-4; Kramer AA, 2014, CRIT CARE MED, V42, P544, DOI 10.1097/CCM.0b013e3182a66a49; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Li JL, 2008, BIOSTATISTICS, V9, P566, DOI 10.1093/biostatistics/kxm050; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marshall JC, 2005, CRIT CARE MED, V33, P1708, DOI 10.1097/01.CCM.0000174478.70338.03; Mayr VD, 2006, CRIT CARE, V10, DOI 10.1186/cc5086; Mentzelopoulos SD, 2013, JAMA-J AM MED ASSOC, V310, P270, DOI 10.1001/jama.2013.7832; Mossman D, 1999, MED DECIS MAKING, V19, P78, DOI 10.1177/0272989X9901900110; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Ferreira AMP, 2011, SEMIN RESP CRIT CARE, V32, P543, DOI 10.1055/s-0031-1287862; POLLACK MM, 1987, NEW ENGL J MED, V316, P134, DOI 10.1056/NEJM198701153160304; POLLACK MM, 1991, CRIT CARE MED, V19, P150, DOI 10.1097/00003246-199102000-00007; POLLACK MM, 1994, JAMA-J AM MED ASSOC, V272, P941, DOI 10.1001/jama.272.12.941; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Pollack MM, 2013, PEDIATR CRIT CARE ME, V14, P448, DOI 10.1097/PCC.0b013e31828a7270; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Proulx F, 2009, PEDIATR CRIT CARE ME, V10, P12, DOI 10.1097/PCC.0b013e31819370a9; RICHARDSON DK, 1993, PEDIATRICS, V91, P617; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shahian DM, 2012, AM J MED QUAL, V27, P112, DOI 10.1177/1062860611412358; Shahian DM, 2010, NEW ENGL J MED, V363, P2530, DOI 10.1056/NEJMsa1006396; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Stausberg Jurgen, 2011, Qual Manag Health Care, V20, P198, DOI 10.1097/QMH.0b013e318223d00a; TERES D, 1987, CRIT CARE MED, V15, P208, DOI 10.1097/00003246-198703000-00005; Waegeman W, 2008, PATTERN RECOGN LETT, V29, P1, DOI 10.1016/j.patrec.2007.07.019; Wetzel RC, 2001, PEDIATR CLIN N AM, V48, P795, DOI 10.1016/S0031-3955(05)70340-0; WILKINSON JD, 1986, CRIT CARE MED, V14, P271, DOI 10.1097/00003246-198604000-00002; Willson DF, 2010, PEDIATR CRIT CARE ME, V11, P1, DOI 10.1097/PCC.0b013e3181c01302; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0; Zupancic JAF, 2007, PEDIATRICS, V119, pE156, DOI 10.1542/peds.2005-2957	58	114	117	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	AUG	2015	43	8					1699	1709		10.1097/CCM.0000000000001081			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC5JA	WOS:000369256100036	25985385	Green Accepted			2022-02-06	
J	Marshall, S; Bayley, M; McCullagh, S; Velikonja, D; Berrigan, L; Ouchterlony, D; Weegar, K				Marshall, Shawn; Bayley, Mark; McCullagh, Scott; Velikonja, Diana; Berrigan, Lindsay; Ouchterlony, Donna; Weegar, Kelly			Updated clinical practice guidelines for concussion/mild traumatic brain injury and persistent symptoms	BRAIN INJURY			English	Article						Concussion; diagnosis; guideline recommendations; management; mild traumatic brain injury; persistent post-concussive symptoms	HEAD-INJURY; YOUNG-PEOPLE; POSTCONCUSSION SYNDROME; FOLLOW-UP; MILD; DISABILITY; ADULTS; SPORT; TRIAL	Objective: To introduce a set of revised guidelines for the management of mild traumatic brain injury (mTBI) and persistent symptoms following concussive injuries. Quality of evidence: The Guidelines for Mild Traumatic Brain Injury and Persistent Symptoms were made available in March 2011 based on literature and information up to 2008. A search for new clinical practice guidelines addressing mTBI and a systematic review of the literature evaluating treatment of persistent symptoms was conducted. Healthcare professionals representing a range of disciplines from Canada and abroad attended a consensus conference to revise the original guidelines in light of new evidence. Main message: A modified Delphi process was used to create 96 recommendations addressing the diagnosis and management of mTBI and persistent symptoms, including post-traumatic headache, sleep disturbances, mental health disorders, cognitive difficulties, vestibular and vision dysfunction, fatigue and return to activity/work/school. Numerous resources, tools and treatment algorithms were also included to aid implementation of the recommendations. Conclusion: The revised clinical practice guideline reflects the most current evidence and is recommended for use by clinicians who provide care to people who experience PPCS following mTBI.	[Marshall, Shawn; Weegar, Kelly] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Marshall, Shawn] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Bayley, Mark] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Dept Med, Toronto, ON, Canada; [McCullagh, Scott; Velikonja, Diana] Hamilton Hlth Sci, Hamilton, ON, Canada; [McCullagh, Scott; Velikonja, Diana] McMaster Univ, Dept Pscyhiatry, Hamilton, ON, Canada; [Berrigan, Lindsay] St Francis Xavier Univ, Antigonish, NS B2G 1C0, Canada; [Ouchterlony, Donna] St Michaels Hosp, Toronto, ON M5B 1W8, Canada		Marshall, S (corresponding author), Ottawa Hosp Rehabil Ctr, 505 Smyth Rd, Ottawa, ON K1H 8M2, Canada.	smarshall@ottawahospital.on.ca	Meijer, Anna/K-5118-2016	Bayley, Mark/0000-0001-7860-9463	Ontario Neurotrauma Foundation	The authors report no conflicts of interest. The Ontario Neurotrauma Foundation initiated and funded the development of the original and updated guidelines. The project team independently managed the development and production of the guideline and, thus, editorial independence is retained.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 2011, AANN ARN CLIN PRACT; Bajor LA, 2011, HARVARD REV PSYCHIAT, V19, P240, DOI 10.3109/10673229.2011.614483; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; Fann J, 2011, J NEUROTRAUM, V26, P2383; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; Forbes D, 2010, J TRAUMA STRESS, V23, P537, DOI 10.1002/jts.20565; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gulli C., 2011, CONCUSSIONS UNTOLD S; Hilton MP, 2004, COCHRANE DB SYST REV, V2, P1; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kane L., 2013, TORONTO STAR    0723; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Linstone H.A., 1975, DELPHI METHOD TECHNI; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marshall S, 2013, GUIDELINES CONCUSSIO; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Mihoces G., 2013, US TODAY; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; New South Wales Ministry of Health, 2011, AD TRAUM CLIN PRACT; New South Wales Motor Accident Authority, 2008, GUID MILD TRAUM BRAI; New Zealand Guidelines Group, 2007, TRAUM BRAIN INJ DIAG; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet M, 2012, BRAIN INJURY MED PRI; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Scottish Intercollegiate Guidelines Network, 2009, EARL MAN PAT HEAD IN; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Stergiou-Kita M, 2012, J OCCUP REHABIL, V22, P166, DOI 10.1007/s10926-011-9332-2; Susskind O, 2010, J REHABILITATION RES, V49, P17; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Workplace Safety and Insurance Board of Ontario, 2012, MILD TRAUM BRAIN INJ; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	57	114	115	0	42	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					688	700		10.3109/02699052.2015.1004755			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700003	25871303				2022-02-06	
J	Brenner, LA; Ignacio, RV; Blow, FC				Brenner, Lisa A.; Ignacio, Rosalinda V.; Blow, Frederic C.			Suicide and Traumatic Brain Injury Among Individuals Seeking Veterans Health Administration Services	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						suicide; traumatic brain	POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE-ABUSE; MORTALITY; BEHAVIOR; SYSTEM; IRAQ; CARE	Objective: To examine associations between history of traumatic brain injury (TBI) diagnosis and death by suicide among individuals receiving care within the Veterans Health Administration (VHA). Method: Individuals who received care between fiscal years 2001 to 2006 were included in analyses. Cox proportional hazards survival models for time to suicide, with time-dependent covariates, were utilized. Covariance sandwich estimators were used to adjust for the clustered nature of the data, with patients nested within VHA facilities. Analyses included all patients with a history of TBI (n = 49 626) plus a 5% random sample of patients without TBI (n = 389 053). Of those with a history of TBI, 105 died by suicide. Models were adjusted for demographic and psychiatric covariates. Results: Veterans with a history of TBI were 1.55 (95% confidence interval [CI], 1.24-1.92) times more likely to die by suicide than those without a history of TBI. Analyses by TBI severity were also conducted, and they suggested that in comparison to those without an injury history, those with (1) concussion/cranial fracture were 1.98 times more likely (95% CI, 1.39-2.82) to die by suicide and (2) cerebral contusion/traumatic intracranial hemorrhage were 1.34 times more likely (95% CI, 1.09-1.64) to die by suicide. This increased risk was not explained by the presence of psychiatric disorders or demographic factors. Conclusions: Among VHA users, those with a diagnosis of TBI were at greater risk for suicide than those without this diagnosis. Further research is indicated to identify evidence-based means of assessment and treatment for those with TBI and suicidal behavior.	[Brenner, Lisa A.] VISN 19 Mental Illness Res Educ & Clin Ctr MIRECC, Denver, CO 80220 USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Denver, CO USA; [Ignacio, Rosalinda V.; Blow, Frederic C.] Vet Affairs Serious Mental Illness Treatment Res, Ann Arbor, MI USA; [Ignacio, Rosalinda V.; Blow, Frederic C.] Univ Michigan, Ann Arbor, MI 48109 USA		Brenner, LA (corresponding author), VISN 19 Mental Illness Res Educ & Clin Ctr MIRECC, Denver, CO 80220 USA.	Lisa.Brenner@va.gov	Brenner, Lisa A./AAG-2442-2019		VISN 19 MIRECC; VA SMITREC; VA Office of Mental Health Services	The project was supported by the VISN 19 MIRECC, VA SMITREC, and the VA Office of Mental Health Services.	Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BRENNER LA, 2010, 8 WORLD C BRAIN INJ; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Department of Defense Task Force on Prevention of Suicide by Members of the Armed Forces, 2010, EX SUMM; Department of Veterans Affairs, 2008, REP BLUE RIBB WORK G; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; WHO, 2004, INT STAT CLASS DIS R; World Health Organization, 1977, INT STAT CLASS DIS R	24	114	115	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2011	26	4					257	264		10.1097/HTR.0b013e31821fdb6e			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	789FZ	WOS:000292501700003	21734509				2022-02-06	
J	Utomo, WK; Gabbe, BJ; Simpson, PM; Cameron, PA				Utomo, Wesley K.; Gabbe, Belinda J.; Simpson, Pamela M.; Cameron, Peter A.			Predictors of in-hospital mortality and 6-month functional outcomes in older adults after moderate to severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Trauma registry; Older adults; Outcome study; Glasgow Outcome Scale	HEAD-INJURY; AGE; POPULATION; EPIDEMIOLOGY; HYPOTENSION; AUSTRALIA; DISCHARGE; REGISTRY; PATIENT	Introduction: Traumatic brain injury (TBI) is the single largest cause of death and disability following injury worldwide. While TBI in older adults is less common, it still contributes to significant morbidity and mortality in this group. Understanding the patient characteristics that result in good and poor outcome after TBI is important in the clinical management and prognosis of older adult TBI patients. This population-based study investigated predictors of mortality and longer term functional outcomes following serious TBI in older adults. Methods: All older adults (aged > 64 years), isolated moderate to severe TBI cases from the population based Victorian State Trauma Registry for the period July 2005 to June 2007 (inclusive) were extracted for analysis. Demographic, injury event, injury diagnosis, management and comorbid status information were obtained and the outcomes of interest were in-hospital mortality, and the Glasgow Outcome Scale-Extended (GOS-E) score at 6 months post-injury. Multivariate logistic regression analyses were used to identify independent predictors of in-hospital mortality and independent living (GOS-E > 4) status at 6 months. Results: Of the 428 isolated, older adult TBI cases, the majority were the result of a fall (88%), male (55%), and aged > 74 years (76%). The in-hospital death rate was 28% and increasing age (p = 0.009), decreasing GCS (p < 0.001) and injury type (p = 0.002) were significant independent predictors of in-hospital mortality. Of the 310 patients who survived to discharge, 65% were successfully followed-up 6 months following injury. There was no difference between patients lost to follow-up and those successfully followed-up with respect to the key population indicators of age, gender, or head injury severity. Younger (<75 years) patients, and those with an SBP on arrival at hospital of 131-150 mmHg, were at increased odds of living independently at follow-up. No patients with a GCS < 9 had a good 6-month outcome, and most of them died. The survival rate for brainstem injury was also low (21%). Conclusion: In this population-based study, we found that age. GCS, brainstem injury, and systolic blood pressure were the most important factors in predicting outcome in older adults with an isolated moderate to severe TBI. (C) 2009 Elsevier Ltd. All rights reserved.	[Utomo, Wesley K.; Gabbe, Belinda J.; Simpson, Pamela M.; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Utomo, Wesley K.] Erasmus Univ, Sch Med, Erasmus Med Ctr, Rotterdam, Netherlands; [Gabbe, Belinda J.; Cameron, Peter A.] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Cameron, Peter A.] Emergency & Trauma Ctr, Melbourne, Vic, Australia		Cameron, PA (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Commercial Rd, Melbourne, Vic 3004, Australia.	peter.cameron@med.monash.edu.au	Utomo, Wesley Kristian/P-5442-2014	Utomo, Wesley Kristian/0000-0002-9060-3547; Gabbe, Belinda/0000-0001-7096-7688; Cameron, Peter/0000-0002-1443-557X	Victorian State Trauma Registry is a Department of Human Services (Victoria); TAC Health Research; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	The Victorian State Trauma Registry is a Department of Human Services (Victoria) and TAC Health Research funded and approved initiative. Dr Belinda Gabbe was supported by a Career Development Award from the National Health and Medical Research Council of Australia. The authors would like to acknowledge the considerable help provided by VSTR staff, data collectors and members of the Steering Committee over the study period.	Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Camilloni L, 2008, INT J INJ CONTROL SA, V15, P25, DOI 10.1080/17457300701800118; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Engberg AW, 2004, ACTA NEUROL SCAND, V110, P281, DOI 10.1111/j.1600-0404.2004.00323.x; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; HELPS Y, 2008, AUSTR I HLTH WELFARE; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Shafi S, 2005, J TRAUMA, V59, P830, DOI 10.1097/01.ta.0000188147.36232.c0; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	23	114	115	2	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2009	40	9					973	977		10.1016/j.injury.2009.05.034			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	487KE	WOS:000269271500013	19540490				2022-02-06	
J	Byrnes, KR; Stoica, B; Loane, DJ; Riccio, A; Davis, MI; Faden, AI				Byrnes, Kimberly R.; Stoica, Bogdan; Loane, David J.; Riccio, Angela; Davis, Margaret I.; Faden, Alan I.			Metabotropic Glutamate Receptor 5 Activation Inhibits Microglial Associated Inflammation and Neurotoxicity	GLIA			English	Article						metabotropic glutamate receptor; neurotoxic; nitric oxide; ROS; signal transduction	NECROSIS-FACTOR-ALPHA; TRAUMATIC NEURONAL INJURY; SPINAL-CORD-INJURY; CELL-DEATH; NITRIC-OXIDE; BRAIN-INJURY; GROUP-I; NEUROPROTECTIVE ACTIVITY; DEPENDENT MECHANISM; FUNCTIONAL RECOVERY	The Group I metabotropic glutamate receptor 5 (mGluR5) can modulate addiction, pain, and neuronal cell death. Expression of some mGluRs, such as Group II and III mGluRs, has been reported in microglia and may affect their activation. However, the expression and role of mGluR5 in microglia is unclear. Using immunocytochemistry and Western blot, we demonstrate that mGluR5 protein is expressed in primary microglial cultures. Activation of mGluR5 using the selective agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) significantly reduces microglial activation in response to lipopolysaccharide, as indicated by a reduction in nitric oxide, reactive oxygen species, and TNF alpha production. Microglial induced neurotoxicity is also markedly reduced by CHPG treatment. The anti-inflammatory effects of CHPG are not observed in microglial cultures from mGluR5 knockout mice and are blocked by selective mGluR5 antagonists, suggesting that these actions are mediated by the mGluR5 receptor. Anti-inflammatory actions of mGluR5 activation are attenuated by phospholipase C and protein kinase C inhibitors, as well as by calcium chelators, suggesting that the mGluR5 activation in microglia involves the G(alpha q)-protein signal transduction pathway. These data indicate that microglial mGluR5 may represent a novel target for modulating neuroinflammation, an important component of both acute and chronic neurodegenerative disorders. (C) 2008 Wiley-Liss, Inc.	[Byrnes, Kimberly R.; Stoica, Bogdan; Loane, David J.; Riccio, Angela; Faden, Alan I.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Davis, Margaret I.] NIAAA, NIH, Rockville, MD 20852 USA		Byrnes, KR (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Room EP12A,New Res Bldg,3970 Reservoir Rd NW, Washington, DC 20057 USA.	krb27@georgetown.edu	Davis, Margaret/F-4165-2010; STOICA, BOGDAN/H-9782-2013; Loane, David/ABD-5177-2021	STOICA, BOGDAN/0000-0002-2501-6434; Loane, David/0000-0003-0393-3503; Davis, Margaret/0000-0002-0489-8351; Byrnes, Kimberly/0000-0002-7501-7734	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037313] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01 NS 037313-08, R01 NS037313-08, R01 NS037313] Funding Source: Medline		Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Barger SW, 2007, J NEUROCHEM, V101, P1205, DOI 10.1111/j.1471-4159.2007.04487.x; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bond A, 1999, NEUROSCI LETT, V273, P191, DOI 10.1016/S0304-3940(99)00663-1; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Endoh T, 2004, BRAIN RES, V1024, P212, DOI 10.1016/j.brainres.2004.07.074; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Faden AI, 1997, J NEUROTRAUM, V14, P885, DOI 10.1089/neu.1997.14.885; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Folbergrova J, 2005, EXP NEUROL, V192, P420, DOI 10.1016/j.expneurol.2004.12.019; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Guo YL, 1998, J BIOL CHEM, V273, P10362, DOI 10.1074/jbc.273.17.10362; He Y, 2003, J NEUROCHEM, V86, P1338, DOI 10.1046/j.1471-4159.2003.01938.x; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Jeohn GH, 2000, BRAIN RES, V880, P173, DOI 10.1016/S0006-8993(00)02737-2; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Lee JS, 2007, NEUROSCIENCE, V146, P375, DOI 10.1016/j.neuroscience.2007.01.015; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Movsesyan VA, 2006, J NEUROTRAUM, V23, P117, DOI 10.1089/neu.2006.23.117; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; Munch G, 2003, EXP BRAIN RES, V150, P1, DOI 10.1007/s00221-003-1389-5; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Olive MF, 2005, MOL PHARMACOL, V67, P349, DOI 10.1124/mol.104.003319; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Rezzani R, 2003, ACTA HISTOCHEM, V105, P81, DOI 10.1078/0065-1281-00688; Surin A, 2007, NEUROPHARMACOLOGY, V52, P744, DOI 10.1016/j.neuropharm.2006.09.018; Szydlowska K, 2007, EUR J PHARMACOL, V554, P18, DOI 10.1016/j.ejphar.2006.09.061; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Taylor DL, 2002, J NEUROCHEM, V82, P1179, DOI 10.1046/j.1471-4159.2002.01062.x; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Taylor DL, 2003, J NEUROSCI, V23, P2150; Vernon AC, 2007, J PHARMACOL EXP THER, V320, P397, DOI 10.1124/jpet.106.108159; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Zhao XR, 2001, J NEUROSCI RES, V64, P121, DOI 10.1002/jnr.1059; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	53	114	118	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	APR 1	2009	57	5					550	560		10.1002/glia.20783			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	416NE	WOS:000264012000008	18816644	Green Accepted			2022-02-06	
J	Coburn, M; Maze, M; Franks, NP				Coburn, Mark; Maze, Mervyn; Franks, Nicholas P.			The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						neuroprotection; neuroprotectant; traumatic brain injury; xenon; helium; hyperbaric chamber	ORGANOTYPIC CULTURES; HYDROSTATIC-PRESSURE; HIPPOCAMPAL SLICES; UNITED-STATES; DAMAGE; ISOFLURANE; PROTECTION; ISCHEMIA; SYSTEM; NEUROTOXICITY	Objectives: The "inert" gas xenon has been shown to be an effective neuroprotectant in a variety of in vitro and in vivo models of neuronal injury. We examined its neuroprotective properties in an in vitro model of traumatic brain injury. Design. Controlled laboratory study. Setting: Academic research laboratory. Subjects. Organotypic hippocampal brain slices from mice pups. Interventions. The cultured brain slices were subjected to a focal mechanical trauma, and injury was monitored in the presence and absence of inert gases at normal and elevated pressures and under both normothermic and hypothermic conditions. Measurements and Main Results: Neuronal injury was quantified using propidium iodide, which becomes fluorescent only when it enters injured cells. Low pressures of both helium and xenon were effective neuroprotectants when applied in addition to 1 atm of air. Moreover, both gases were effective at normal pressures when they replaced nitrogen in a gas mixture. Conclusions. The inert gases helium and xenon are effective neuroprotectants in a model for traumatic brain injury, and this novel treatment warrants further investigation. Xenon was particularly effective at reducing the secondary injury that developed following the initial trauma and could be administered at least 3 hrs postinjury with only a small reduction in efficacy.	[Coburn, Mark] Univ Hosp RWTH Aachen, Dept Anesthesiol, D-52074 Aachen, Germany		Coburn, M (corresponding author), Univ Hosp RWTH Aachen, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	mcoburn@ukaachen.de; n.franks@imperial.ac.uk		Franks, Nicholas/0000-0003-4874-4212; Coburn, Mark/0000-0002-7930-0270			Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Adembri C, 2004, J NEUROTRAUM, V21, P1103, DOI 10.1089/0897715041651079; ASHFORD MLJ, 1982, J PHYSIOL-LONDON, V333, P531, DOI 10.1113/jphysiol.1982.sp014467; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; COLTON CA, 1982, BRAIN RES, V251, P221, DOI 10.1016/0006-8993(82)90740-5; Crain SM, 1998, METHODS, V16, P228, DOI 10.1006/meth.1998.0681; Daniels S., 2003, BENNET ELLIOTTS PHYS, P265; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; Davies A R, 2005, Crit Care Resusc, V7, P238; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Dean JB, 2003, J APPL PHYSIOL, V95, P883, DOI 10.1152/japplphysiol.00920.2002; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; FAGNI L, 1987, EXP BRAIN RES, V65, P513; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; GROSSMAN Y, 1988, J NEUROPHYSIOL, V60, P1497, DOI 10.1152/jn.1988.60.4.1497; Hall EJ, 2003, HEALTH PHYS, V85, P31, DOI 10.1097/00004032-200307000-00008; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Hei TK, 2006, MOL CARCINOGEN, V45, P455, DOI 10.1002/mc.20219; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; Lango T, 1996, UNDERSEA HYPERBAR M, V23, P247; LAWRENCE JH, 1947, J PHYSIOL-LONDON, V105, P197; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Ma DQ, 2003, ANESTHESIOLOGY, V98, P690, DOI 10.1097/00000542-200303000-00017; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Miura Y, 1998, ANESTHESIOLOGY, V89, P391, DOI 10.1097/00000542-199808000-00016; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Mulkey DK, 2003, J APPL PHYSIOL, V95, P922, DOI 10.1152/japplphysiol.00865.2002; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Olney JW, 2003, CURR OPIN PHARMACOL, V3, P101, DOI 10.1016/S1471-4892(02)00002-4; PARMENTIER JL, 1981, UNDERSEA BIOMED RES, V8, P175; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; ROSTAIN JC, 1983, J APPL PHYSIOL, V54, P1063, DOI 10.1152/jappl.1983.54.4.1063; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; Sanders RD, 2003, BRIT J ANAESTH, V91, P709, DOI 10.1093/bja/aeg232; Seppelt I, 2005, Crit Care Resusc, V7, P233; Sosin DM, 1996, BRAIN INJURY, V10, P47; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Talpalar AE, 2004, J NEUROPHYSIOL, V92, P3309, DOI 10.1152/jn.00178.2004; TASKER RC, 1992, J NEUROSCI, V12, P4298; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tisherman Samuel A, 2004, Curr Opin Crit Care, V10, P512; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wilhelm S, 2002, ANESTHESIOLOGY, V96, P1485, DOI 10.1097/00000542-200206000-00031	51	114	122	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2008	36	2					588	595		10.1097/01.CCM.0B013E3181611F8A6			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257JB	WOS:000252794000030	18216607				2022-02-06	
J	Yang, S; Xing, D; Zhou, Q; Xiang, L; Lao, Y				Yang, Sihua; Xing, Da; Zhou, Quan; Xiang, Liangzhong; Lao, Yeqi			Functional imaging of cerebrovascular activities in small animals using high-resolution photoacoustic tomography	MEDICAL PHYSICS			English	Article						photoacoustic imaging; photoacoustic signal; brain vascular; traumatic lesion; drug stimulation	CEREBRAL-BLOOD-FLOW; TIME-DOMAIN RECONSTRUCTION; IN-VIVO; THERMOACOUSTIC TOMOGRAPHY; BIOLOGICAL TISSUES; ACETAZOLAMIDE; BRAIN; ALGORITHM; ARCHITECTURE; STIMULATION	Photoacoustic imaging (PAI) is a noninvasive, nonionizing modality based on the differences in light absorption of various biological tissues. PAI utilizes the endogenous contrast characteristics of traditional optical imaging, while benefiting from high spatial resolution of the ultrasound imaging. A PAI system was developed to reconstruct the two-dimensional cross section image and to visualize the cerebrovascular activities of mouse in vivo. The spatial resolution of the PAI system was determined to be 0.110 mm by a two-point-source phantom with the Rayleigh criterion. The potential applications of the system were clearly demonstrated by successfully mapping a traumatic lesion in the mouse brain cerebral cortex, by its ability to monitor physiological changes in the brain due to carotid ligation and drug stimulation, and two-dimensional sliced images of a traumatic mouse brain at different depths were also provided. Our experimental results indicate that PAI has the potential for studying of traumatic brain injury and physiological functions of the brain. (c) 2007 American Association of Physicists in Medicine.	S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou 510631, Peoples R China; S China Normal Univ, Inst Laser Life Sci, Guangzhou 510631, Peoples R China; Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou 510630, Peoples R China		Xing, D (corresponding author), S China Normal Univ, MOE Key Lab Laser Life Sci, Guangzhou 510631, Peoples R China.	xingda@scnu.edu.cn	Xiang, Liangzhong/C-8458-2016	Xiang, Liangzhong/0000-0002-7228-0510			Barton JK, 2001, PHOTOCHEM PHOTOBIOL, V73, P642, DOI 10.1562/0031-8655(2001)073<0642:CPITPT>2.0.CO;2; Bravata DM, 2003, STROKE, V34, P699, DOI 10.1161/01.STR.0000057578.26828.78; CHOLLET F, 1989, STROKE, V20, P458, DOI 10.1161/01.STR.20.4.458; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; HAUGE A, 1983, ACTA PHYSIOL SCAND, V117, P233, DOI 10.1111/j.1748-1716.1983.tb07202.x; Hoelen CGA, 1998, OPT LETT, V23, P648, DOI 10.1364/OL.23.000648; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; HOJERPEDERSEN E, 1987, STROKE, V18, P887, DOI 10.1161/01.STR.18.5.887; Karabutov AA, 1999, P SOC PHOTO-OPT INS, V3601, P284, DOI 10.1117/12.350011; Kolkman RGM, 2004, PHYS MED BIOL, V49, P4745, DOI 10.1088/0031-9155/49/20/006; Kruger RA, 1999, MED PHYS, V26, P1832, DOI 10.1118/1.598688; Kruger Robert A, 2003, Mol Imaging, V2, P113, DOI 10.1162/153535003322331993; Liu PY, 1998, PHYS MED BIOL, V43, P667, DOI 10.1088/0031-9155/43/3/017; McPherson JA, 2001, ARTERIOSCL THROM VAS, V21, P791, DOI 10.1161/01.ATV.21.5.791; Niederhauser JJ, 2005, IEEE T MED IMAGING, V24, P436, DOI 10.1109/TMI.2004.843199; Norton SJ, 2003, J OPT SOC AM A, V20, P1859, DOI 10.1364/JOSAA.20.001859; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Paltauf G, 2002, J ACOUST SOC AM, V112, P1536, DOI 10.1121/1.1501898; Siphanto RI, 2005, OPT EXPRESS, V13, P89, DOI 10.1364/OPEX.13.000089; Vernieri F, 2001, STROKE, V32, P1552, DOI 10.1161/01.STR.32.7.1552; Vijungco Joseph, 2005, Perspect Vasc Surg Endovasc Ther, V17, P279, DOI 10.1177/153100350501700402; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; VORSTRUP S, 1986, STROKE, V17, P1291, DOI 10.1161/01.STR.17.6.1291; VORSTRUP S, 1984, J CLIN INVEST, V74, P1634, DOI 10.1172/JCI111579; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; WANG X, 2006, J BIOMED OPT, V11; Wang XD, 2004, OPT LETT, V29, P730, DOI 10.1364/OL.29.000730; Wang XD, 2003, OPT LETT, V28, P1739, DOI 10.1364/OL.28.001739; Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839; Wang XD, 2002, MED PHYS, V29, P2799, DOI 10.1118/1.1521720; Wang Y, 2004, PHYS MED BIOL, V49, P3117, DOI 10.1088/0031-9155/49/14/006; Wang YW, 2004, NANO LETT, V4, P1689, DOI 10.1021/nl049126a; Xiang LZ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2437752; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Xu MH, 2003, IEEE T BIO-MED ENG, V50, P1086, DOI 10.1109/TBME.2003.816081; Xu MH, 2002, IEEE T MED IMAGING, V21, P814, DOI 10.1109/TMI.2002.801176; Yamazaki M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2137287; Yang DW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2198488; Yang DW, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2119417; Yuan Z, 2005, OPT LETT, V30, P3054, DOI 10.1364/OL.30.003054; Yuan Z, 2007, MED PHYS, V34, P538, DOI 10.1118/1.2409234; Yuan Z, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2209883; Yuan Z, 2006, OPT EXPRESS, V14, P6749, DOI 10.1364/OE.14.006749; Zeng LM, 2007, MED PHYS, V34, P556, DOI 10.1118/1.2426406; Zeng YG, 2004, OPT LETT, V29, P1760, DOI 10.1364/OL.29.001760	48	114	130	1	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	AUG	2007	34	8					3294	3301		10.1118/1.2757088			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	202IP	WOS:000248895500022	17879793	Bronze			2022-02-06	
J	Cohen, BA; Inglese, M; Rusinek, H; Babb, JS; Grossman, RI; Gonen, O				Cohen, B. A.; Inglese, M.; Rusinek, H.; Babb, J. S.; Grossman, R. I.; Gonen, O.			Proton MR spectroscopy and MRI-volumetry in mild traumatic brain injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; DIFFUSE AXONAL INJURY; HEAD-INJURY; N-ACETYLASPARTATE; WHITE-MATTER; GRAY-MATTER; QUANTITATIVE-ANALYSIS; CORPUS-CALLOSUM; UNITED-STATES; ATROPHY	BACKGROUND AND PURPOSE: More than 85% of brain traumas are classified as "mild"; MR imaging findings are minimal if any and do not correspond to clinical symptoms. Our goal, therefore, was to quantify the global decline of the neuronal marker N-acetylaspartate (NAA), as well as gray (GM) and white matter (WM) atrophy after mild traumatic brain injury (mTBI). MATERIALS AND METHODS: Twenty patients (11 male, 9 female; age range, 19-57 years; median, 35 years) with mTBI (Glasgow Coma Scale score 13-15 with loss of consciousness for at least 30 seconds) and 19 age- and sex-matched control subjects were studied. Seven patients were studied within 9 days of TBI; the other 13 ranged from 1.2 months to 31.5 years (average and median of 4.6 and 1.7 years, respectively) after injury. Whole-brain NAA (WBNAA) concentration was obtained in all subjects with nonlocalizing proton MR spectroscopy. Brain volume and GM and WM fractions were segmented from T1-weighted MR imaging and normalized to the total intracranial volume, suitable for intersubject comparisons. The data were analyzed with least squares regression. RESULTS: Patients with mTBI exhibited, on average, a 12% WBNAA deficit that increased with age, compared with the control subjects (p <.05). Adjusted for age effects, patients also suffered both global atrophy (-1.09%/year; P =.029) and GM atrophy (-0.89%/year; P =.042). Patients with and without visible MR imaging pathology, typically punctate foci of suspected shearing injury, were indistinguishable in both atrophy and WBNAA. CONCLUSION: WBNAA detected neuronal/axonal injury beyond the minimal focal MR-visible lesions in mTBI. Combined with GM atrophy, the findings may provide further, noninvasive insight into the nature and progression of mTBI.	NYU, Dept Radiol, Sch Med, New York, NY 10016 USA		Gonen, O (corresponding author), NYU, Dept Radiol, Sch Med, 650 1st Ave,6th Floor, New York, NY 10016 USA.	oded.gonen@med.nyu.edu	Inglese, Matilde/AAH-3189-2020	Inglese, Matilde/0000-0002-9610-0297; Gonen, Oded/0000-0002-3148-2028; Babb, James/0000-0003-1798-1186	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB001015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135] Funding Source: NIH RePORTER; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [EB01015, R01 EB001015] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS039135, NS39135] Funding Source: Medline		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; COLLINS JG, 1990, VITAL HLTH STAT, V10, P175; Conti AC, 1998, J NEUROSCI, V18, P5663; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gonen O, 2000, NEUROLOGY, V54, P15, DOI 10.1212/WNL.54.1.15; Gonen O, 1998, MAGNET RESON MED, V40, P684, DOI 10.1002/mrm.1910400506; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Pierce JES, 1996, J NEUROSCI, V16, P1083; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; RINK A, 1995, AM J PATHOL, V147, P1575; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; RUSINEK H, 1991, RADIOLOGY, V178, P109, DOI 10.1148/radiology.178.1.1984287; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; Wang Y, 1998, MAGNET RESON MED, V39, P28, DOI 10.1002/mrm.1910390107; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416	54	114	117	0	10	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2007	28	5					907	913					7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	169ON	WOS:000246601600030	17494667				2022-02-06	
J	Staab, JP; Ruckenstein, MJ				Staab, Jeffrey P.; Ruckenstein, Michael J.			Expanding the differential diagnosis of chronic dizziness	ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY			English	Article							ANXIETY; MIGRAINE; VERTIGO; DISORDERS; 1ST	Objective: To improve treatment outcomes for patients with chronic dizziness by identifying clinical conditions associated with persistent symptoms and delineating key diagnostic features that differentiate its causes and direct attention to specific treatments. Design: Prospective cohort study from 1998 to 2004. Setting: Tertiary care balance center. Patients: A total of 345 men and women, aged 15 to 89 years, referred for evaluation of chronic dizziness (duration of :3 months) of uncertain cause. Interventions: Patients were systematically directed through multiple specialty examinations until definitive diagnoses were made. Main Outcome Measure: Final diagnoses associated with dizziness. Results: Nearly all patients with chronic subjective dizziness were diagnosed with psychiatric or neurologic illnesses. These included primary and secondary anxiety disorders (n = 206 [59.7%]) and central nervous system conditions (n = 133 [38.6%]), specifically migraine headaches, mild traumatic brain injuries, and neurally mediated dysautonomias. A small number of patients (6 [1.7%]) had dysrhythmias. Four of 5 patients with migraine or dysrhythmias had comorbid anxiety. Conclusions: Chronic dizziness has several common causes, including anxiety disorders, migraine, traumatic brain injuries, and dysautonomia, that require different treatments. Key features of the clinical history distinguish these illnesses from one another and from active neurotologic conditions. The high prevalence of secondary anxiety may give a false impression of psycho-gehicity.	Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; Univ Penn, Balance Ctr, Philadelphia, PA 19104 USA		Staab, JP (corresponding author), Univ Penn, Dept Psychiat, 3535 Market St Room 677, Philadelphia, PA 19104 USA.	jeffrey.staab@uphs.upenn.edu	Staab, Jeffrey/B-8792-2015	Staab, Jeffrey/0000-0002-1516-3131			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baloh RW, 2002, CURR OPIN NEUROL, V15, P17, DOI 10.1097/00019052-200202000-00004; Baloh RW, 1999, POSTGRAD MED, V105, P161, DOI 10.3810/pgm.1999.02.555; Brignole M, 2004, EUROPACE, V6, P467, DOI 10.1016/j.eupc.2004.08.008; Cass SP, 1997, ANN OTO RHINOL LARYN, V106, P182, DOI 10.1177/000348949710600302; Eckhardt-Henn A, 2003, J ANXIETY DISORD, V17, P369, DOI 10.1016/S0887-6185(02)00226-8; First M.B., 1994, STRUCTURED CLIN INTE; Furman JM, 2005, J NEUROL NEUROSUR PS, V76, P1, DOI 10.1136/jnnp.2004.048926; Godemann F, 2005, J PSYCHIATR RES, V39, P529, DOI 10.1016/j.jpsychires.2004.12.006; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lin J K, 1993, Zhonghua Yi Xue Za Zhi (Taipei), V51, P289; Lipton RB, 2002, NEUROLOGY, V58, P885, DOI 10.1212/WNL.58.6.885; Pollak L, 2003, OTOLARYNG HEAD NECK, V128, P829, DOI 10.1016/S0194-5998(03)00454-6; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Staab JP, 2005, ARCH OTOLARYNGOL, V131, P675, DOI 10.1001/archotol.131.8.675; Staab JP, 2004, LARYNGOSCOPE, V114, P1637, DOI 10.1097/00005537-200409000-00025; Staab JP, 2003, LARYNGOSCOPE, V113, P1714, DOI 10.1097/00005537-200310000-00010; Staab JP, 2002, LARYNGOSCOPE, V112, P1346, DOI 10.1097/00005537-200208000-00005; World Health Organization, 1994, INT STAT CLASS DIS R, V10th	21	114	127	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0886-4470	1538-361X		ARCH OTOLARYNGOL	Arch. Otolaryngol. Head Neck Surg.	FEB	2007	133	2					170	176		10.1001/archotol.133.2.170			7	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	135TM	WOS:000244176400013	17309987	Bronze			2022-02-06	
J	Lee, ST; Chu, K; Sinn, DI; Jung, KH; Kim, EH; Kim, SJ; Kim, JM; Ko, SY; Kim, M; Roh, JK				Lee, ST; Chu, K; Sinn, DI; Jung, KH; Kim, EH; Kim, SJ; Kim, JM; Ko, SY; Kim, M; Roh, JK			Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; endothelial nitric oxide synthase; extracellular signal-regulated kinase; erythropoietin; inflammation; intracerebral hemorrhage; STAT3	NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; SENSORIMOTOR RECOVERY; ENHANCES NEUROGENESIS; APOPTOSIS; PROTECTS; STROKE	Erythropoietin (EPO), a pleiotropic cytokine involved in erythropoiesis, is tissue-protective in ischemic, traumatic, toxic and inflammatory injuries. In this study, we investigated the effect of EPO in experimental intracerebral hemorrhage (ICH). Two hours after inducing ICH via the stereotaxic infusion of collagenase, recombinant human EPO (500 or 5000 IU/kg, ICH + EPO group) or PBS (ICH + vehicle group) was administered intraperitoneally, then once daily afterwards for 1 or 3 days. ICH + EPO showed the better functional recovery in both rotarod and modified limb placing tests. The brain water content was decreased in ICH + EPO dose-dependently, as compared with ICH + vehicle. The effect of EPO on the brain water content was inhibited by N(omega)-Nitro-L-arginine methyl ester hydrochloride (L-NAME, 10 mg/kg). Mean hemorrhage volume was also decreased in ICH + EPO. EPO reduced the numbers of TUNEL +, myeloperoxidase + or OX-42 + cells in the perihematomal area. In addition, EPO reduced the mRNA level of TNF-alpha, Fas and Fas-L, as well as the activities of caspase-8, 9 and 3. EPO treatment showed up-regulations of endothelial nitric oxide synthase (eNOS) and p-eNOS, pAkt, pSTAT3 and pERK levels. These data suggests that EPO treatment in ICH induces better functional recovery with reducing perihematomal inflammation and apoptosis, coupled with activations of eNOS, STAT3 and ERK.	Seoul Natl Univ Hosp, Dept Neurol, Stem Cell Res Ctr, Stroke & Neural Stem Cell Lab,Clin Res Inst, Seoul 110744, South Korea; Seoul Natl Univ, Program Neurosci, Neurosci Res Inst, SNUMRC, Seoul, South Korea; Seoul Natl Univ Hosp, Ctr Alcohol & Drug Addict Res, Seoul 110744, South Korea; Korea Ctr Dis Control & Prevent, Div Epidem Intelligence Serv, Seoul, South Korea; Seoul Natl Univ, Brain Korea 21 Project Med Sci, Seoul, South Korea		Roh, JK (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Stem Cell Res Ctr, Stroke & Neural Stem Cell Lab,Clin Res Inst, 28,Yongondong, Seoul 110744, South Korea.	rohjk@snu.ac.kr	Kim, Manho/J-2738-2012; Lee, Soon-Tae/C-4663-2013; Roh, Jae Kyu/J-5459-2012				Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Agnoletti L, 1999, CIRCULATION, V100, P1983, DOI 10.1161/01.CIR.100.19.1983; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P452, DOI 10.1097/00004647-200003000-00002; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chen M, 2002, APOPTOSIS, V7, P313, DOI 10.1023/A:1016167228059; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03038.x; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009; Furuke K, 1999, J IMMUNOL, V163, P1473; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Genc S, 2004, BRAIN RES, V1000, P19, DOI 10.1016/j.brainres.2003.12.037; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Grimm C, 2004, J NEUROSCI, V24, P5651, DOI 10.1523/JNEUROSCI.1288-04.2004; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Huang DM, 2004, EUR J PHARMACOL, V503, P17, DOI 10.1016/j.ejphar.2004.09.040; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jung KH, 2004, STROKE, V35, P1744, DOI 10.1161/01.STR.0000131270.45822.85; KILIC E, 2005, IN PRESS FASEB J; Kilic U, 2004, FASEB J, V18, P249, DOI 10.1096/fj.04-2493fje; Kirito K, 1997, J BIOL CHEM, V272, P16507, DOI 10.1074/jbc.272.26.16507; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Lee SR, 2003, STROKE, V34, P2704, DOI 10.1161/01.STR.0000096540.40826.BA; LEE ST, 2006, IN PRESS J CEREB BLO; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; Mendelow AD, 2005, LANCET, V365, P387; Park HK, 2005, BRAIN RES, V1041, P125, DOI 10.1016/j.brainres.2004.11.067; Peeling J, 2001, EXP NEUROL, V167, P341, DOI 10.1006/exnr.2000.7564; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Sasaki R, 2003, INTERNAL MED, V42, P142, DOI 10.2169/internalmedicine.42.142; Silva Y, 2005, STROKE, V36, P86, DOI 10.1161/01.STR.0000149615.51204.0b; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Spandou E, 2005, BRAIN RES, V1045, P22, DOI 10.1016/j.brainres.2005.03.013; Suzuki S, 2001, EXP NEUROL, V170, P63, DOI 10.1006/exnr.2001.7701; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; WANG L, 2005, IN PRESS J CEREB BLO; Watowich SS, 2000, J INTERF CYTOK RES, V20, P1065, DOI 10.1089/107999000750053726; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036	66	114	119	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2006	96	6					1728	1739		10.1111/j.1471-4159.2006.03697.x			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	019MX	WOS:000235842100022	16539688	Bronze			2022-02-06	
J	McMurtray, A; Clark, DG; Christine, D; Mendez, MF				McMurtray, A; Clark, DG; Christine, D; Mendez, MF			Early-onset dementia: Frequency and causes compared to late-onset dementia	DEMENTIA AND GERIATRIC COGNITIVE DISORDERS			English	Article						dementia, early onset, late onset; Alzheimer's disease	FRONTOTEMPORAL LOBAR DEGENERATION; PRESENILE-DEMENTIA; PREVALENCE; YOUNG; ASCERTAINMENT; POPULATION; MINNESOTA; ROCHESTER; PEOPLE	Background: Research on the epidemiology of dementia has focused on the elderly. Few investigations have studied differences in etiologic frequencies between early-onset dementia (EOD), with onset at an age of less than 65 years old, and the more common late-onset disorder. Objectives: To determine relative frequencies and characteristics of EOD versus late-onset dementia (LOD; age of onset 6 65 years) diagnosed in a large memory disorders program over a 4-year period. Methods: We reviewed medical records, including an extensive neurobehavioral and neurological evaluation, of all patients seen at a large Veteran's Affairs Medical Center Memory Disorders clinic between 2001 and 2004 and assessed demographic variables, final diagnoses, presence of dementia, and differential diagnosis of dementing illnesses. Results: Among 1,683 patients presenting for evaluation of an acquired decline in memory or cognition, 948 (56%) met established clinical criteria for a dementing illness. About 30% (n = 278) of these had an age of onset of <65 years, compared to 670 with LOD. Patients were predominantly male (98%). Compared to the late-onset group, the EOD patients were less severely impaired on presentation, but they did not differ in gender distribution or educational background. The EOD group had significantly more dementia attributed to traumatic brain injury, alcohol, human immunodeficiency virus (HIV), and frontotemporal lobar degeneration compared to the LOD patients. In contrast, the LOD group had significantly more Alzheimer's disease compared to the EOD group. Conclusions: This study, conducted at a Veterans Affairs Hospital, is the largest series to date on EOD, and found a previously unexpectedly large number of patients below the age of 65 with cognitive deficits and impaired functioning consequent to head trauma, alcohol abuse, and HIV. These findings highlight the differential distribution and importance of preventable causes of dementia in the young. Copyright (C) 2006 S. Karger AG, Basel.	VA Greater Los Angeles Healthcare Syst, Neurobehav Unit, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA USA		McMurtray, A (corresponding author), VA Greater Los Angeles Healthcare Syst, Neurobehav Unit, 116AF,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	amcmurtray@mednet.ucla.edu					American Psychiatric Association, 1994, DIAGN STAT MAN; DELANY N, 1995, INT J GERIATR PSYCH, V10, P597, DOI 10.1002/gps.930100710; Elberling TV, 2002, NEUROLOGY, V59, P1259, DOI 10.1212/WNL.59.8.1259; Ferran J, 1996, INT J GERIATR PSYCH, V11, P863, DOI 10.1002/(SICI)1099-1166(199610)11:10<863::AID-GPS394>3.0.CO;2-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujihara S, 2004, ARQ NEURO-PSIQUIAT, V62, P592, DOI 10.1590/S0004-282X2004000400005; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; Harvey RJ, 1998, YOUNG ONSET DEMENTIA; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Ikeda M, 2001, NEUROLOGY, V57, P839, DOI 10.1212/WNL.57.5.839; Johnson JK, 2005, ARCH NEUROL-CHICAGO, V62, P925, DOI 10.1001/archneur.62.6.925; Knopman DS, 2004, NEUROLOGY, V62, P506, DOI 10.1212/01.WNL.0000106827.39764.7E; KOKMEN E, 1989, NEUROLOGY, V39, P773, DOI 10.1212/WNL.39.6.773; MCGONIGAL G, 1993, BRIT MED J, V306, P680, DOI 10.1136/bmj.306.6879.680; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MENDEZ MF, 2003, CLIN APPROACH; Nestor P, 2000, SEMIN NEUROL, V20, P439, DOI 10.1055/s-2000-13176; NEWENS AJ, 1993, PSYCHOL MED, V23, P631, DOI 10.1017/S0033291700025411; Panegyres PK, 2000, MED J AUSTRALIA, V173, P279, DOI 10.5694/j.1326-5377.2000.tb125651.x; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Sampson EL, 2004, POSTGRAD MED J, V80, P125, DOI 10.1136/pgmj.2003.011171; Smith DM, 1995, INT J ADDICT, V30, P1843, DOI 10.3109/10826089509071058; TREVES T, 1986, ARCH NEUROL-CHICAGO, V43, P26, DOI 10.1001/archneur.1986.00520010022014; Varma AR, 2002, ACTA NEUROL SCAND, V105, P261, DOI 10.1034/j.1600-0404.2002.1o148.x; Woodburn K, 1999, INT J GERIATR PSYCH, V14, P362, DOI 10.1002/(SICI)1099-1166(199905)14:5<362::AID-GPS914>3.3.CO;2-L; World Health Organization, 1992, INT CLASS DIS	27	114	119	0	23	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1420-8008	1421-9824		DEMENT GERIATR COGN	Dement. Geriatr. Cogn. Disord.		2006	21	2					59	64		10.1159/000089546			6	Geriatrics & Gerontology; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology; Psychiatry	002ZL	WOS:000234651300001	16276111				2022-02-06	
J	Cho, KS; Yang, L; Lu, B; Ma, HF; Huang, XZ; Pekny, M; Chen, DF				Cho, KS; Yang, L; Lu, B; Ma, HF; Huang, XZ; Pekny, M; Chen, DF			Re-establishing the regenerative potential of central nervous system axons in postnatal mice	JOURNAL OF CELL SCIENCE			English	Article						astrocyte intermediate filament; GFAP; vimentin; Bcl-2; axon regeneration	FIBRILLARY ACIDIC PROTEIN; RETINAL GANGLION-CELLS; INTERMEDIATE-FILAMENTS; SPINAL-CORD; TRANSGENIC MICE; PROMOTE REGENERATION; NOGO-RECEPTOR; WHITE-MATTER; BCL-2; VIMENTIN	At a certain point in development, axons in the mammalian central nervous system lose their ability to regenerate after injury. Using the optic nerve model, we show that this growth failure coincides with two developmental events: the loss of Bcl-2 expression by neurons and the maturation of astrocytes. Before postnatal day 4, when astrocytes are immature, overexpression of Bcl-2 alone supported robust and rapid optic nerve regeneration over long distances, leading to innervation of brain targets by day 4 in mice. As astrocytes matured after postnatal day 4, axonal regeneration was inhibited in mice overexpressing Bcl-2. Concurrent induction of Bcl-2 and attenuation of reactive gliosis reversed the failure of CNS axonal re-elongation in postnatal mice and led to rapid axonal regeneration over long distances and reinnervation of the brain targets by a majority of severed optic nerve fibers up to 2 weeks of age. These results suggest that an early postnatal downregulation of Bcl-2 and post-traumatic reactive gliosis are two important elements of axon regenerative failure in the CNS.	Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci, Arvid Carlsson Inst Neurosci, SE-41390 Gothenburg, Sweden; Harvard Univ, Sch Med, Schepens Eye Res Inst, Program Neurosci, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA		Pekny, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Neurosci, Arvid Carlsson Inst Neurosci, Medicinaregatan 9A, SE-41390 Gothenburg, Sweden.	milos.pekny@medkem.gu.se; dfchen@vision.eri.harvard.edu	Chen, Dong/AAJ-2444-2020	Cho, Kin-Sang/0000-0003-4285-615X	NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY012983] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012983] Funding Source: NIH RePORTER		Bonfanti L, 1996, J NEUROSCI, V16, P4186; Bregman BS, 1998, CURR OPIN NEUROBIOL, V8, P800, DOI 10.1016/S0959-4388(98)80124-4; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Chen DF, 1998, CELL DEATH DIFFER, V5, P816, DOI 10.1038/sj.cdd.4400431; Chierzi S, 1999, J NEUROSCI, V19, P8367; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Cristino L, 2000, NEUROSCIENCE, V101, P451, DOI 10.1016/S0306-4522(00)00393-6; DAHL D, 1981, EUR J CELL BIOL, V24, P191; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hilton M, 1997, CURR BIOL, V7, P798, DOI 10.1016/S0960-9822(06)00339-3; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang XH, 2003, INVEST OPHTH VIS SCI, V44, P347, DOI 10.1167/iovs.02-0198; Hunt D, 2002, J NEUROCYTOL, V31, P93, DOI 10.1023/A:1023941421781; JHAVERI S, 1991, EXP BRAIN RES, V87, P371; JHAVERI S, 1992, GLIA, V6, P138, DOI 10.1002/glia.440060208; JIAO JW, 2005, IN PRESS EMBO J; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Karim F, 2001, BRAIN RES REV, V36, P204, DOI 10.1016/S0165-0173(01)00096-0; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; Li Y, 2003, J NEUROSCI, V23, P7783; Lodovichi C, 2001, EUR J NEUROSCI, V13, P833, DOI 10.1046/j.1460-9568.2001.01440.x; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Merry DE, 1997, ANNU REV NEUROSCI, V20, P245, DOI 10.1146/annurev.neuro.20.1.245; MERRY DE, 1994, DEVELOPMENT, V120, P301; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Oh YJ, 1996, NEUROSCI LETT, V202, P161, DOI 10.1016/0304-3940(95)12235-4; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; SILVER J, 1994, J NEUROL, V242, pS22, DOI 10.1007/BF00939236; TAKADA M, 1986, HISTOL HISTOPATHOL, V1, P271; Vela JM, 1998, BRAIN RES REV, V26, P29, DOI 10.1016/S0165-0173(97)00055-6; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Yin YQ, 2003, J NEUROSCI, V23, P2284; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	48	114	121	0	7	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	MAR 1	2005	118	5					863	872		10.1242/jcs.01658			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	916IK	WOS:000228378400004	15731004	Green Accepted, hybrid			2022-02-06	
J	Wehman, P; Targett, P; West, M; Kregel, J				Wehman, P; Targett, P; West, M; Kregel, J			Productive work and employment for persons with traumatic brain injury - What have we learned after 20 years?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						employment; return to work; supported employment; traumatic brain injury	SUPPORTED EMPLOYMENT; FOLLOW-UP; VOCATIONAL-REHABILITATION; PROGRAM-DEVELOPMENT; ACUTE PREDICTORS; RETURN; PLACEMENT; MODEL; AWARENESS; OUTCOMES	This article describes return to work outcomes for individuals with traumatic brain injury (TBI) through a selective review of the published literature and an examination of TBI labor force participation from the Rehabilitation Services Administration 911 and the Social Security Administration Benefits Planning, Assistance and Outreach databases. Implications and recommendations to further our understanding about the different parts of the work outcome profile of individuals with TBI are offered.	Virginia Commonwealth Univ, Rehabil Res & Training Ctr Workplace Supports, Richmond, VA 23284 USA		Wehman, P (corresponding author), Virginia Commonwealth Univ, Rehabil Res & Training Ctr Workplace Supports, 1314 W Main St, Richmond, VA 23284 USA.	pwehman@vcu.edu					Ben-Yishay Y., 1989, NEUROPSYCHOLOGICAL T, V1, P271; BISSONETTE D, 1994, TRADITION JOB DEV; Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Drake RE, 1999, PSYCHIAT QUART, V70, P289, DOI 10.1023/A:1022086131916; EZARACHI O, 1991, J HEAD TRAUMA REHAB, V6, P71; FRASER RT, 1995, NEUROREHABILITATION, V5, P39, DOI 10.3233/NRE-1995-5104; Fraser RT, 2000, TRAUMATIC BRAIN INJU; FRASER RT, 2001, BRAIN INJ SOURCS FEB, P222; GARDNER M, 2004, PERSENTATION STATE P; GILSON B, 2004, INCLUSIVE EMPLOYMENT; HAFFEY WJ, 1991, J HEAD TRAUMA REHAB, V6, P24; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kowalske K, 2000, J HEAD TRAUMA REHAB, V15, P989, DOI 10.1097/00001199-200008000-00003; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LONDONER P, IN PRESS INCLUSIVE E; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Partridge T M, 1996, Work, V7, P63, DOI 10.3233/WOR-1996-7108; Pettifer S., 1993, J OCCUP SCI, V1, P20, DOI 10.1080/14427591.1993.9686380.; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; THORNTON C, 2004, EVALUATION TICKET WO; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wehman P, 1999, EDUC TRAIN MENT RET, V34, P3; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298; WEHMAN P, 1994, AM J PHYS MED REHAB, V73, P280, DOI 10.1097/00002060-199407000-00010; WEHMAN P, IN PRESS INCLUSIVE E; Wehman P., 2001, SUPPORTED EMPLOYMENT; WEHMAN P, 2000, MENTAL RETARDATION 2; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; West M, 2002, MENT RETARD, V40, P142, DOI 10.1352/0047-6765(2002)040<0142:MHWASE>2.0.CO;2; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zafonte RD, 1996, NEUROREHABILITATION, V6, P19, DOI 10.3233/NRE-1996-6104; [No title captured]	52	114	115	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2005	20	2					115	127		10.1097/00001199-200503000-00001			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	910VV	WOS:000227961200001	15803036				2022-02-06	
J	Rapoport, MJ; McCullagh, S; Shammi, P; Feinstein, A				Rapoport, MJ; McCullagh, S; Shammi, P; Feinstein, A			Cognitive impairment associated with major depression following mild and moderate traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							EXECUTIVE FUNCTION; DEFICITS; RECOVERY; SYMPTOMS; DISORDER	Traumatic brain injury (TBI) and major depression are neuropsychiatric conditions that have been associated with cognitive dysfunction. The aim of this study was to explore the relationship between major depression and cognitive impairment following mild and moderate TBI. Seventy-four TBI patients were assessed for the presence of major depression using the Structured Clinical Interview for the DSM-IV and completed a neurocognitive assessment battery. Subjects with major depression (28.4%), compared to those without, were found to have significantly lower scores on measures of working memory, processing speed, verbal memory and executive function. Potential mechanisms and implications for treatment are discussed.	Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Traumat Brain Injury Clin, Toronto, ON M4N 3M5, Canada; Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON, Canada		Rapoport, MJ (corresponding author), Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, FG37,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	Mark.Rapoport@sw.ca	Rapoport, Mark/AAD-8581-2020				ATTEBERRYBENNETT J, 1986, INT J CLIN NEUROPSYC, V8, P114; Benedict R., 1997, BRIEF VISUOSPATIAL M; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Delis DC, 1987, CALIFORNIA VERBAL LE; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; First M.B., 1996, STRUCTURED CLIN INTE; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Heaton PDRK., 1993, WISCONSIN CARD SORTI; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KILOH LG, 1961, ACTA PSYCHIAT SCAND, V37, P336, DOI 10.1111/j.1600-0447.1961.tb07367.x; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Mayberg Helen S, 2002, Semin Clin Neuropsychiatry, V7, P255, DOI 10.1053/scnp.2002.35223; MCCULLAGH S, 2004, TXB TRAUMATIC BRAIN, P321; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Ottowitz WE, 2002, HARVARD REV PSYCHIAT, V10, P86, DOI 10.1080/10673220216210; *PSYCHOL CORP, 1997, WECHSL AD INT SCAL T; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; RICHARDSON JTE, 2000, CLIN NEUROPSYCHOL, P97; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	36	114	115	0	11	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FEB	2005	17	1					61	65		10.1176/appi.neuropsych.17.1.61			5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	902RP	WOS:000227374500008	15746484				2022-02-06	
J	Andersen, TE; Arnason, A; Engebretsen, L; Bahr, R				Andersen, TE; Arnason, A; Engebretsen, L; Bahr, R			Mechanisms of head injuries in elite football	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							PROFESSIONAL SOCCER PLAYERS; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; ASSOCIATION FOOTBALL; VIDEO ANALYSIS; BALL; EPIDEMIOLOGY; MANAGEMENT; IMPAIRMENT; INCIDENTS	Objectives: The aim of this study was to describe, using video analysis, the mechanisms of head injuries and of incidents with a high risk of head injury in elite football. Methods: Videotapes and injury information were collected prospectively for 313 of the 409 matches played in the Norwegian ( 2000 season) and Icelandic ( 1999 and 2000 season) professional leagues. Video recordings of incidents where a player appeared to be hit in the head and the match was consequently interrupted by the referee were analysed and cross referenced with reports of acute time loss injuries from the team medical staff. Results: The video analysis revealed 192 incidents (18.8 per 1000 player hours). Of the 297 acute injuries reported, 17 (6%) were head injuries, which corresponds to an incidence of 1.7 per 1000 player hours (concussion incidence 0.5 per 1000 player hours). The most common playing action was a heading duel with 112 cases (58%). The body part that hit the injured player's head was the elbow/arm/hand in 79 cases (41%), the head in 62 cases (32%), and the foot in 25 cases (13%). In 67 of the elbow/arm/hand impacts, the upper arm of the player causing the incident was at or above shoulder level, and the arm use was considered to be active in 61 incidents (77%) and intentional in 16 incidents (20%). Conclusions: This study suggests that video analysis provides detailed information about the mechanisms for head injuries in football. The most frequent injury mechanism was elbow to head contact, followed by head to head contact in heading duels. In the majority of the elbow to head incidents, the elbow was used actively at or above shoulder level, and stricter rule enforcement or even changes in the laws of the game concerning elbow use should perhaps be considered, in order to reduce the risk of head injury.	Norwegian Univ Sport & Phys Educ, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway		Andersen, TE (corresponding author), Norwegian Univ Sport & Phys Educ, Oslo Sports Trauma Res Ctr, POB 4014,Ulleval Stad, N-0806 Oslo, Norway.	thor.einar.andersen@nih.no	Bahr, Roald/B-6964-2014	Arnason, Arni/0000-0003-1007-4719; Bahr, Roald/0000-0001-5725-4237; Andersen, Thor Einar/0000-0003-4172-4518			Albert M, 1983, ATHLETIC TRAINING, V18, P218; Andersen TE, 2004, BRIT J SPORT MED, V38, P626, DOI 10.1136/bjsm.2003.007955; Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; Arnason A, 1996, SCAND J MED SCI SPOR, V6, P40, DOI 10.1111/j.1600-0838.1996.tb00069.x; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Barnett C, 2003, INT J GERIATR PSYCH, V18, P88, DOI 10.1002/gps.728; Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dvorak J, 2000, AM J SPORT MED, V28, pS3; EKSTRAND J, 1990, FOOT ANKLE, V11, P41, DOI 10.1177/107110079001100108; GRONWALL D, 1975, LANCET, V2, P995; Hawkins RD, 1996, BRIT J SPORT MED, V30, P165, DOI 10.1136/bjsm.30.2.165; Hawkins RD, 1999, BRIT J SPORT MED, V33, P196, DOI 10.1136/bjsm.33.3.196; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; INKLAAR H, 1994, SPORTS MED, V18, P55, DOI 10.2165/00007256-199418010-00006; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Lewin G., 1989, PHYSIOTHERAPY, V75, P601, DOI [10.1016/S0031-9406(10)62366-8, DOI 10.1016/S0031-9406(10)62366-8]; LOHNES JH, 1994, SPORTS INJURIES MECH; Luthje P, 1996, SCAND J MED SCI SPOR, V6, P180; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; NIELSEN AB, 1989, AM J SPORT MED, V17, P803, DOI 10.1177/036354658901700614; Orchard J., 1993, SPORTS HEALTH, V11, P39; Peterson L, 2000, AM J SPORT MED, V28, pS51; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Sandelin J, 1985, Br J Sports Med, V19, P30; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; SULLIVAN JA, 1980, AM J SPORT MED, V8, P325, DOI 10.1177/036354658000800505; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421	43	114	114	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC 1	2004	38	6					690	696		10.1136/bjsm.2003.009357			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	873SH	WOS:000225300700008	15562161	Green Published, Bronze			2022-02-06	
J	Peek-Asa, C; Zwerling, C; Stallones, L				Peek-Asa, C; Zwerling, C; Stallones, L			Acute traumatic injuries in rural populations	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							FIREARM INJURIES; BRAIN-INJURIES; RISK-FACTORS; URBAN; SYSTEM; COUNTY; CARE; IOWA; STABILIZATION; MORTALITY	In the United States, injuries are the leading cause of death among individuals aged 1 to 45 years and the fourth leading cause of death overall. Rural populations exhibit disproportionately high injury mortality rates. Deaths resulting from motor vehicle crashes, traumatic occupational injuries, drowning, residential fires, and suicide all increase with increasing rurality. We describe differences in rates and patterns of injury among rural and urban populations and discuss factors that contribute to these differences.	Univ Iowa, Coll Publ Hlth, Injury Prevent Res Ctr, Iowa City, IA 52242 USA		Peek-Asa, C (corresponding author), 100 Oakdale Blvd,114 IREH, Iowa City, IA 52242 USA.	corinne-peek-asa@uiowa.eda	Stallones, Lorann/AAC-6248-2021	Stallones, Lorann/0000-0001-7616-582X	ODCDC CDC HHS [CCR 811509, CCR703640] Funding Source: Medline		Baker D R, 2000, J Okla State Med Assoc, V93, P496; BAKER SP, 1988, J TRAUMA, V28, P741, DOI 10.1097/00005373-198806000-00003; BAKER SP, 1987, NEW ENGL J MED, V316, P1384, DOI 10.1056/NEJM198705283162206; Baker SP, 1992, THE INJURY FACT BOOK, VSecond; Blatt J, 1998, ACCIDENT ANAL PREV, V30, P705, DOI 10.1016/S0001-4575(98)00014-1; Centers for Disease Control and Prevention, 1993, INJ CONTR 1990S NAT; Chevalley T, 2002, OSTEOPOROSIS INT, V13, P113, DOI 10.1007/s001980200002; Costello T M, 2003, J Agric Saf Health, V9, P19; Demetriades D, 1996, ARCH SURG-CHICAGO, V131, P133; Duhart, 2000, URBAN SUBURBAN RURAL; Eberhardt M., 2001, URBAN RURAL HLTH CHA; FALLON MJ, 1990, ANN EMERG MED, V19, P914, DOI 10.1016/S0196-0644(05)81570-7; FINGERHUT LA, 1997, NJURY CHARTBOOK HLTH; FUORTES LJ, 1990, AM J IND MED, V18, P211, DOI 10.1002/ajim.4700180213; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; GARRISON HG, 1989, AM J EMERG MED, V7, P384, DOI 10.1016/0735-6757(89)90043-0; GERBERICH SG, 1991, OLMSTEAD AGR TRAUMA; GRAHAM JD, 1993, ANNU REV PUBL HEALTH, V14, P515; Grossman DC, 1997, J TRAUMA, V42, P723, DOI 10.1097/00005373-199704000-00024; Hall J R Jr, 1994, NFPA J, V88, P36; Harlos S, 1999, Inj Prev, V5, P183; Harvey PA, 1998, PUBLIC HEALTH REP, V113, P459; *I MED, 1999, RED BURD INJ ADV PRE; Karlaftis MG, 2002, ACCIDENT ANAL PREV, V34, P357, DOI 10.1016/S0001-4575(01)00033-1; KARTER MJ, 1999, NATL FIRE PROTECTION, V93, P88; Layde Peter M., 1995, Annals of Epidemiology, V5, P419, DOI 10.1016/1047-2797(95)00056-9; Lee B, 2002, CHILDHOOD AGR INJURY; Leff M, 2003, INJURY PREV, V9, P332, DOI 10.1136/ip.9.4.332; Lundell JA, 2003, TEX J RURAL HLTH, V21, P2; MAIO RF, 1992, ACCIDENT ANAL PREV, V24, P631, DOI 10.1016/0001-4575(92)90015-B; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; McCurdy SA, 2000, AM J IND MED, V38, P463, DOI 10.1002/1097-0274(200010)38:4&lt;463::AID-AJIM13&gt;3.0.CO;2-N; McGwin G, 2000, J BURN CARE REHABIL, V21, P75, DOI 10.1097/00004630-200021010-00016; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Merchant James, 1995, P267; Merchant James A., 1989, AGR RISK REPORT NATI; Muelleman RL, 1996, J TRAUMA, V41, P315, DOI 10.1097/00005373-199608000-00020; Mullins Richard J., 1999, J TRAUMA, V47, pS9; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Myers J, 1998, NIOSH PUBLICATION, V98-153; Nance ML, 2002, ARCH PEDIAT ADOL MED, V156, P781, DOI 10.1001/archpedi.156.8.781; *NAT SAF COUNC, 2003, INJ FACTS 2002; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; National Highway Traffic Safety Administration, 2001, TRAFF SAF FACTS 2001; PETREA RE, 2003, USING HIST ACCOMPLIS; Reed DB, 2000, AM J PREV MED, V18, P70, DOI 10.1016/S0749-3797(00)00143-4; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Rivara F P, 1997, Inj Prev, V3, P190, DOI 10.1136/ip.3.3.190; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Rogers FB, 2000, J TRAUMA, V48, P577; Rogers FB, 1997, ARCH SURG-CHICAGO, V132, P376; RUNYAN CW, 1992, NEW ENGL J MED, V327, P859, DOI 10.1056/NEJM199209173271207; RUTLEDGE R, 1994, ANN SURG, V219, P547, DOI 10.1097/00000658-199405000-00013; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schootman M, 1999, BRAIN INJURY, V13, P995; Schwab W, 1998, J TRAUMA, V44, P815, DOI 10.1097/00005373-199805000-00012; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; SHARAR SR, 1988, J TRAUMA, V28, P794, DOI 10.1097/00005373-198806000-00012; Sing RF, 1997, J TRAUMA, V43, P825, DOI 10.1097/00005373-199711000-00015; Sprince N L, 2003, J Agric Saf Health, V9, P5; Stallones L, 2003, INJURY PREV, V9, P241, DOI 10.1136/ip.9.3.241; STALLONES L, 1989, J RURAL HEALTH, V5, P246, DOI DOI 10.1111/J.1748-0361.1989.TB00985.X; Stennies G, 1999, ARCH PEDIAT ADOL MED, V153, P586; Svenson JE, 1996, ARCH PEDIAT ADOL MED, V150, P583, DOI 10.1001/archpedi.1996.02170310017002; *US FIR ADM, 1997, RUR FIR PROBL US; WALLER JA, 1992, J OCCUP ENVIRON MED, V34, P414; Xiang HY, 1999, J AGING HEALTH, V11, P65, DOI 10.1177/089826439901100104; Young JS, 1998, AM SURGEON, V64, P88; Zwerling C, 2001, AM J PREV MED, V20, P230, DOI 10.1016/S0749-3797(00)00316-0; Zwerling C, 1996, J OCCUP ENVIRON MED, V38, P698, DOI 10.1097/00043764-199607000-00013; ZWERLING C, 1995, AM J EPIDEMIOL, V141, P878, DOI 10.1093/oxfordjournals.aje.a117524; ZWERLING C, 2000, EPIDEMIOLOGY WORK RE, P267	73	114	114	1	10	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	OCT	2004	94	10					1689	1693		10.2105/AJPH.94.10.1689			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	860AQ	WOS:000224309900013	15451733	Green Published			2022-02-06	
J	Corrigan, JD; Whiteneck, G; Mellick, D				Corrigan, JD; Whiteneck, G; Mellick, D			Perceived needs following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavioral control; cognitive problems; employment; needs; traumatic brain injury	QUALITY-OF-LIFE; HEAD-INJURIES; INDIVIDUALS; SEQUELAE	Objectives: (1) Provide population-based estimates of perceived needs following traumatic brain injury (TBI) and the prevalence of unmet needs 1 year postinjury; (2) identify relations among needs that define unique clusters of individuals; and (3) identify risk factors for experiencing selected needs. Design: Telephone survey 1 year after injury of a prospective cohort of all people hospitalized with TBI in the state of Colorado during 2000. Measures: Self-reported need for assistance in 13 areas of functioning. Results: A total of 58.8% of persons hospitalized with TBI experienced at least 1 need during the year following injury; 40.2% will experience at least 1 unmet need 1 year after injury. Most frequently experienced needs were "improving your memory, solving problems better"(34.1%), "managing stress, emotional upsets" (27.9%), and "managing your money, paying bills" (23.3%). Cluster analysis revealed 8 distinctive groupings of subjects. If a need existed, those least likely to be met involved cognitive abilities, employment, and alcohol and/or drug use. Conclusions: Results were consistent with findings from previous assessments of need for services based on surveys of convenience samples; however, the prevalence of unmet needs 1 year after injury may be higher than previously suspected. More post-hospital services addressing cognitive and emotional problems appear needed. Risk factors for experiencing needs suggest potential avenues for clinical intervention.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Craig Hosp, Dept Res, Englewood, CO USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, Dodd Hall,480 W 9th Ave, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Corrigan, John D./E-2921-2011		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [IC 09900] Funding Source: Medline; ODCDC CDC HHS [U17 CCU 812447] Funding Source: Medline		Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Brooks CA, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90152-0; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; COONLEYHOGANSON R, 1984, NEUROSURGERY, V14, P315, DOI 10.1227/00006123-198403000-00009; Corrigan J D, 1994, NeuroRehabilitation, V4, P109, DOI 10.3233/NRE-1994-4207; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; *DEP HHS, 1989, INT CLASS DIS; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; McKillip J., 1987, NEED ANAL TOOLS HUMA; PATRICK D, 1989, DISABLEMENT COMMUNIT, P1; RUTHERFORD WH, 1977, LANCET, V1, P1; Schootman M, 1999, BRAIN INJURY, V13, P995; STRUPP HH, 1977, AM PSYCHOL, V32, P187, DOI 10.1037/0003-066X.32.3.187; Thurman DJ., 1995, GUIDELINES SURVEILLA; Witkin B. R., 1995, PLANNING CONDUCTING; [No title captured]; [No title captured]	20	114	115	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2004	19	3					205	216		10.1097/00001199-200405000-00002			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	826JB	WOS:000221824300002	15247843				2022-02-06	
J	Anderson, MI; Parmenter, TR; Mok, M				Anderson, MI; Parmenter, TR; Mok, M			The relationship between neurobehavioural problems of severe traumatic brain injury (TBI), family functioning and the psychological wellbeing of the spouse/caregiver: path model analysis	BRAIN INJURY			English	Article							BLUNT HEAD-INJURY; RELATIVES; CAREGIVERS; DISTRESS; PATIENT; SYMPTOMS	This study used a modern theory of stress as a framework to strengthen the understanding of the relationship between neurobehavioural problems of TBI, family functioning and psychological distress in spouse/caregivers. The research was an ex post facto design utilising a cross-sectional methodology. Path analysis was used to determine the structural effect of neurobehavioural problems on family functioning and psychological distress. Forty-seven female and 17 male spouse/caregivers of partners with severe TBI were recruited. Spouse/caregivers who reported partners with TBI as having high levels of behavioural and cognitive problems experienced high levels of unhealthy family functioning. High levels of unhealthy family functioning were related to high levels of distress in spouse/caregivers, as family functioning had a moderate influence on psychological distress. Furthermore, indirect effects of behavioural and cognitive problems operating through family functioning intensified the level of psychological distress experienced by spouse/caregivers. Additionally, spouse/caregivers who reported high levels of behavioural, communication and social problems in their partners also experienced high levels of psychological distress. This study was significant because the impact of TBI on the spouse/caregiver from a multidimensional perspective is an important and under-researched area in the brain injury and disability field.	Avondale Coll, Fac Nursing & Hlth, Wahroonga, NSW, Australia; Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; Hong Kong Inst Educ, Ctr Res & Int Collaborat, Hong Kong, Hong Kong, Peoples R China		Anderson, MI (corresponding author), Avondale Coll, Fac Nursing & Hlth, Sydney Adventist Hosp Campus, Wahroonga, NSW, Australia.		Mok, Magdalena M. C./G-1713-2017	Mok, Magdalena M. C./0000-0002-6503-8152; Anderson, Malcolm/0000-0003-2963-7497			Arbuckle J, 1995, AMOS USERS GUIDE; ARBUCKLE JL, 1994, AMOS 3 51; BIDDLE BJ, 1987, CHILD DEV, V58, P4, DOI 10.1111/j.1467-8624.1987.tb03486.x; BISHOP DS, 1986, ARCH PHYS MED REHAB, V67, P84, DOI 10.1016/0003-9993(86)90107-3; BISHOP DS, 1987, ARCH PHYS MED REHAB, V68, P610; Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; Bragg RM, 1992, J HEAD TRAUMA REHAB, V7, P94; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CAMPLAIR PS, 1989, THESIS VIRGINIA COMM; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; DEROGATIS LR, 1993, BRIEF SYSMPTOM INVEN; Elliott GR, 1982, STRESS HUMAN HLTH; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EPSTEIN NB, 1978, J MARRIAGE FAMILY CO, V4, P191; Frosch S, 1997, BRAIN INJURY, V11, P891; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; JORESKOB KG, 1993, LISREL 8 USERS REFER; Kay Thomas, 1994, P533; KEITNER GI, 1987, COMPR PSYCHIAT, V28, P54; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kreutzer J., 1987, GEN HLTH HIST QUESTI; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LAMONT M, 1992, THESIS LA TROBE U ME; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Leathem J, 1996, BRAIN INJURY, V10, P27; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MacCallum RC, 1997, MULTIVAR BEHAV RES, V32, P193, DOI 10.1207/s15327906mbr3202_5; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McDonald RP, 1996, MULTIVAR BEHAV RES, V31, P239, DOI 10.1207/s15327906mbr3102_5; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MILLER IW, 1986, COMPR PSYCHIAT, V27, P302, DOI 10.1016/0010-440X(86)90006-4; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PEDHAZUR EJ, 1997, MULTIPLE EGRESSION B; Schumacker R.E., 1996, BEGINNERS GUIDE STRU; Spielberger C.D., 1992, J FAMILY PSYCHOL, V6, P99, DOI [10.1037/0893-3200.6.2.99, DOI 10.1037/0893-3200.6.2.99]; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; [No title captured]	46	114	116	0	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2002	16	9					743	757		10.1080/02699050210128906			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	585PD	WOS:000177532800001	12217201				2022-02-06	
J	Mooney, G; Speed, J				Mooney, G; Speed, J			The association between mild traumatic brain injury and psychiatric conditions	BRAIN INJURY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; MINOR HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; RECOVERY; SCALE	The majority of patients with mild traumatic brain injury (TBI) recover fairly quickly and are usually restored to their previous level of functioning. However, a significant minority have prolonged, complicated, or incomplete recoveries and have outcomes disproportionately worse than would have been predicted by the objective facts of the injury. This failure to recover as expected was the focus of this study. The participants were 80 adults with actual or suspected mild TBI who were referred to an outpatient mild TBI clinic. Most were characterized by problematic recoveries. The results indicated that those individuals who only had brain injuries made good recoveries, but that those with psychiatric comorbidity did not (chi (2) = 19.65, p=0.0002). Most of the new psychiatric conditions responsible for poor recovery consisted of depression, anxiety disorders or conversion disorder. Dissociative phenomena appeared common after mild TBI and scores on the Dissociative Experiences Scale predicted brain injury outcome with 77% accuracy.	Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA		Mooney, G (corresponding author), Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA.						Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Cantagallo A, 1999, BRAIN INJURY, V13, P219, DOI 10.1080/026990599121593; CHAMBLESS DL, 1984, J CONSULT CLIN PSYCH, V52, P1090, DOI 10.1037/0022-006X.52.6.1090; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; DEVORE JR, 1998, PHYSICAL MED REHABIL, V12, P111; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRIGSBY J, 1993, BRAIN INJURY, V7, P507, DOI 10.3109/02699059309008178; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hathaway S. R., 1951, MMPI MANUAL; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LOWENSTEIN RJ, 1988, DISSOCIATION, V1, P17; MARKS IM, 1979, BEHAV RES THER, V17, P263, DOI 10.1016/0005-7967(79)90041-X; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McNair D.M., 1981, PROFILE MOOD STATES; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mooney G, 1997, NEUROREHABILITATION, V8, P223, DOI 10.3233/NRE-1997-8308; MOONEY G, 1994, 4 ANN C INT ASS STUD; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; ROSS CA, 1992, GEN HOSP PSYCHIAT, V14, P350, DOI 10.1016/0163-8343(92)90071-H; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Smyser C. H., 1993, DISSOCIATION, V6, P42; Sosin DM, 1996, BRAIN INJURY, V10, P47; UOMOTO JM, 1992, WESTERN J MED, V157, P665	39	114	116	0	11	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2001	15	10					865	877		10.1080/02699050110065286			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	483HF	WOS:000171627000003	11595083				2022-02-06	
J	Zhou, F; Zhu, XW; Castellani, RJ; Stimmelmayr, R; Perry, G; Smith, MA; Drew, KL				Zhou, F; Zhu, XW; Castellani, RJ; Stimmelmayr, R; Perry, G; Smith, MA; Drew, KL			Hibernation, a model of neuroprotection	AMERICAN JOURNAL OF PATHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; FOCAL CEREBRAL-ISCHEMIA; IN-GROUND SQUIRRELS; MICRODIALYSIS; MICROGLIA; DAMAGE; STROKE; TISSUE; SUPPRESSION; TOLERANCE	Hibernation, a natural model of tolerance to cerebral ischemia, represents a state of pronounced fluctuation in cerebral blood flow where no brain damage occurs. Numerous neuroprotective aspects may contribute in concert to such tolerance. The purpose of this study was to determine whether hibernating brain tissue is tolerant to penetrating brain injury modeled by insertion of microdialysis probes. Guide cannulae were surgically implanted in striatum of Arctic ground squirrels before any of the animals began to hibernate. Microdialysis probes were then inserted in some animals after they entered hibernation and in others while they remained euthermic. The brain tissue from hibernating and euthermic animals was examined 3 days after implantation of microdialysis probes. Tissue response, indicated by examination of hematoxylin and eosin-stained tissue sections and immunocytochemical identification of activated microglia, astrocytes, and hemeoxygenase-1 immunoreactivity, was dramatically attenuated around probe tracks in hibernating animals com pared to euthermic controls. No difference in tissue response around guide cannulae was observed between groups. Further study of the mechanisms underlying neuroprotective aspects of hibernation may lead to novel therapeutic strategies for stroke and traumatic brain injury.	Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska, Dept Chem & Biochem, Fairbanks, AK 99775 USA; Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA		Drew, KL (corresponding author), Univ Alaska, Inst Arctic Biol, POB 757000, Fairbanks, AK 99775 USA.		Zhu, Xiongwei/A-9629-2009; Drew, Kelly L/B-7995-2013; Perry, George/A-8611-2009; Castellani, Rudy J/A-9555-2009; Smith, Mark A/A-9053-2009	Zhu, Xiongwei/0000-0003-2092-6508; Perry, George/0000-0002-6547-0172; 	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54 NS041069, NS41069, NS38648, R01 NS038648] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038648, U54NS041069] Funding Source: NIH RePORTER		BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUZADZIC B, 1990, FREE RADICAL BIO MED, V9, P407, DOI 10.1016/0891-5849(90)90017-D; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; DELANGE ECM, 1995, BRAIN RES, V702, P261, DOI 10.1016/0006-8993(95)01184-X; Drew KL, 1999, BRAIN RES, V851, P1, DOI 10.1016/S0006-8993(99)01969-1; Du C, 1996, BRAIN RES, V718, P233, DOI 10.1016/0006-8993(96)00162-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; GARCIA JH, 1992, J NEUROPATH EXP NEUR, V51, P387, DOI 10.1097/00005072-199207000-00001; Gentile NT, 1996, NEUROCHEM RES, V21, P947, DOI 10.1007/BF02532345; GREGSON NA, 1999, CELLULAR RESPONSES P, P43; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; HU Y, 1998, SOC NEUROSCI; Knight JE, 2000, MOL CELL BIOL, V20, P6374, DOI 10.1128/MCB.20.17.6374-6379.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LYMAN CP, 1948, J EXP ZOOL, V109, P55, DOI 10.1002/jez.1401090105; MANNOJI H, 1986, ACTA NEUROPATHOL, V71, P341, DOI 10.1007/BF00688060; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCKENNA TM, 1968, P SOC EXP BIOL MED, V129, P720; Nagayama T, 2000, J NEUROCHEM, V75, P1716, DOI 10.1046/j.1471-4159.2000.0751716.x; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Osborne PG, 1999, BRAIN RES, V839, P1, DOI 10.1016/S0006-8993(99)01627-3; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Shi J, 2000, NEUROBIOL AGING, V21, P357, DOI 10.1016/S0197-4580(00)00119-6; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIDKY YA, 1969, P SOC EXP BIOL MED, V132, P760; SNAPP BD, 1981, PHYSIOL ZOOL, V54, P297, DOI 10.1086/physzool.54.3.30159944; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; TOEIN O, IN PRESS AM J PHYSL; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; WAHLGREN NG, 1997, NEUROPROTECTIVE AGEN, P337; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160, DOI 10.1002/jlb.67.2.160; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S	46	114	116	0	8	AMER SOC INVESTIGATIVE PATHOLOGY, INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA	0002-9440			AM J PATHOL	Am. J. Pathol.	JUN	2001	158	6					2145	2151		10.1016/S0002-9440(10)64686-X			7	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	439VN	WOS:000169138400031	11395392	Green Published			2022-02-06	
J	Hellawell, DJ; Taylor, R; Pentland, B				Hellawell, DJ; Taylor, R; Pentland, B			Cognitive and psychosocial outcome following moderate or severe traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; DEPRESSION; MANAGEMENT; COMPLAINTS; RELATIVES; SCALE; EPIDEMIOLOGY; IMPAIRMENT; PROFILE; ANXIETY	The outcome of 96 consecutive adult patients with moderate to severe head injury was sequentially measured at 6, 12 and 24 months post-injury. In addition to global outcome using the Glasgow Outcome Scale (GOS) and a battery of neuropsychological tests of cognitive function, the Head Injury Symptom Checklist (HISC) and Relative's Questionnaire (RQ) Were used. Although poorer GOS scores and severe cognitive impairments were typically associated with greater severity of initial injury, relatives reported similar functional problems irrespective of injury severity. This illustrates the legacy of moderate head injury in influencing many aspects of everyday life, supporting the argument that the needs of this group should not be overlooked.	Astley Ainslie Hosp, Rehabil Studies Unit, Edinburgh EH9 2HL, Midlothian, Scotland; Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland		Pentland, B (corresponding author), Astley Ainslie Hosp, Rehabil Studies Unit, Edinburgh EH9 2HL, Midlothian, Scotland.	Brian.Pentland@ed.ac.uk					ANDERSON SI, 1994, CLIN REHABIL, V8, P301; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; BENTON AL, 1964, J NERV MENT DIS, V139, P110, DOI 10.1097/00005053-196408000-00003; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brooks D N, 1979, Int Rehabil Med, V1, P166; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DILLER L, 1987, REHABILITATION OUTCO, P209; Eaker S, 1998, AM J EPIDEMIOL, V147, P74; Enderby PM, 1987, FRENCHAY APHASIA SCR; ENGBERG A, 1995, ACTA NEUROLOGIC S164, V92, P10; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; GOLDBERG RJ, 1995, AM J MED, V98, P278, DOI 10.1016/S0002-9343(99)80375-1; GREENWOOD RJ, 1994, BRIT MED J, V308, P1199, DOI 10.1136/bmj.308.6938.1199; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HENRY GK, 1990, J CLIN EXP NEUROPSYC, V12, P502, DOI 10.1080/01688639008400996; IVISON D, 1986, J CLIN EXP NEUROPSYC, V8, P317, DOI 10.1080/01688638608401322; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1981, MANAGEMENT HEAD INJU; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kaplan E, 1983, BOSTON NAMING TEST; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1996, NEUROLOGY TRAUMA, P3; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; McPherson K, 1997, NEUROPSYCHOL REHABIL, V7, P241, DOI 10.1080/713755530; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nelson H.E., 1982, NATL ADULT READING T; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Santos ME, 1998, BRAIN INJURY, V12, P759, DOI 10.1080/026990598122151; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Taylor LB., 1979, FUNCTIONAL NEUROSURG, P165; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tickle M, 1996, Community Dent Health, V13, P193; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; VANGIJN J, 1994, STROKE, V25, P1623, DOI 10.1161/01.STR.25.8.1623; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Wade D, 1992, MEASUREMENT NEUROLOG; WALSH K, 1994, BRIT J GEN PRACT, V44, P118; Wechsler D., 1981, WAIS R MANUAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	69	114	116	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	1999	13	7					489	504					16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	215GT	WOS:000081374100003	10462147				2022-02-06	
J	Durkin, MS; Laraque, D; Lubman, I; Barlow, B				Durkin, MS; Laraque, D; Lubman, I; Barlow, B			Epidemiology and prevention of traffic injuries to urban children and adolescents	PEDIATRICS			English	Article						adolescent; bicyclist; child; community; epidemiology evaluation; incidence; injury; motor vehicle; pedestrian; prevention; traffic	PEDESTRIAN INJURY; CHILDHOOD INJURIES; POISSON REGRESSION; RATES; PROGRAM; RISK; NEIGHBORHOODS; COMMUNITY; DEATHS	Objectives. To describe the incidence of severe traffic injuries before and after implementation of a comprehensive, hospital-initiated injury prevention program aimed at the prevention of traffic injuries to school-aged children in an urban community. Materials and Methods. Hospital discharge and death certificate data on severe pediatric injuries (ie, injuries resulting in hospital admission and/or death to persons age <17 years) in northern Manhattan over a 13-year period (1983-1995) were linked to census counts to compute incidence. Rate ratios with 95% CIs, both unadjusted and adjusted for annual trends, were calculated to test for a change in injury incidence after implementation of the Harlem Hospital Injury Prevention Program. This program was initiated in the fall of 1988 and continued throughout the study period. It included 1) school and community based traffic safety education implemented in classroom settings in a simulated traffic environment, Safety City, and via theatrical performances in community settings; 2) construction of new playgrounds as well as improvement of existing playgrounds and parks to provide expanded off-street play areas for children; 3) bicycle safety clinics and helmet distribution; and 4) a range of supervised recreational and artistic activities for children in the community. Primary Results. Traffic injuries were a leading cause of severe childhood injury in this population, accounting for nearly 16% of the injuries, second only to falls (24%). During the preintervention period (1983-1988), severe traffic injuries occurred at a rate of 147.2/100 000 children <17 years per year. Slightly <2% of these injuries were fatal. Pedestrian injuries accounted for two thirds of all severe traffic injuries in the population. Among school-aged children, average annual rates (per 100 000) of severe injuries before the intervention were 127.2 for pedestrian, 37.4 for bicyclist, and 25.5 for motor vehicle occupant injuries. Peak incidence of pedestrian and bicyclist injuries occurred during the summer months and afternoon hours, whereas motor vehicle occupant injuries showed little seasonal variation and were more common during evening and night-time hours. Age-specific rates showed peak incidence of pedestrian injuries among 6- to 10-year-old children, of bicyclist injuries among 9- to 15-year-old children, and of motor vehicle occupant injuries among: adolescents between the ages of 12 and 16 years. The peak age for all traffic injuries combined was 15 years, an age at which nearly 3 of every 1000 children each year in this population sustained a severe traffic injury. Among children hospitalized for traffic injuries during the preintervention period, 6.3% sustained major head trauma (including concussion with loss of consciousness for greater than or equal to 1 hour, cerebral laceration and/or cerebral hemorrhage), and 36.9% sustained minor head trauma (skull fracture and/or concussion with no loss of consciousness greater than or equal to 1 hour and no major head injury). The percentage of injured children with major and minor head trauma was higher among those injured in traffic than among those injured by all other means (43.2% vs 14.2%, respectively; chi(2) = 336; degrees of freedom = 1). The percentages of children sustaining head trauma were 45.4% of those who were injured as pedestrians, 40.2% of those who were injured as bicyclists, and 38.9% of those who were injured as motor vehicle occupants. During the intervention period, the average incidence of traffic injuries among school aged children declined by 36% relative to the preintervention period (rate ratio: .64; 95% CI: .58, .72). After adjusting for annual trends in incidence, pedestrian injuries declined during the intervention period among school aged children by 45% (adjusted rate ratio: .55; 95% CI: .38, .79). No comparable reduction occurred in nontargeted injuries among school-aged children (adjusted rate ratio: .89; 95% CI:.72, 1.09) or in traffic injuries among younger children who were not targeted specifically by the program (adjusted rate ratio: 1.32; 95% CI: .57, 3.07). Conclusion. Child traffic injuries, particularly those involving pedestrians, are a major public health problem in urban communities. Although the incidence of child pedestrian injuries is declining nationally and internationally, perhaps attributable to declines in walking, this trend may not be applicable in inner city communities such as northern Manhattan, in which walking remains a dominant mode of transportation. Community interventions involving the creation of safe and accessible play areas as well as traffic safety education and supervised activities for school-aged children may be effective in preventing traffic injuries to children in these communities. Additional controlled evaluations are needed to confirm the benefits of such interventions.	Columbia Univ, Gertrude H Sergievsky Ctr, Fac Med, New York, NY 10032 USA; Columbia Univ, Joseph L Mailman Sch Publ Hlth, Div Epidemiol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Harlem Hosp, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; New York Dept Transportat, Safety Div, New York, NY USA; Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, Div Pediat & Pediat Surg, New York, NY 10032 USA		Durkin, MS (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Fac Med, P&S Box 16,630 W 16th St, New York, NY 10032 USA.	durkinm@sergievsky.cpmc.columbia.edu	Durkin, Maureen/B-7834-2015		AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [U01HS007399] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [FU01HSO7399] Funding Source: Medline		[Anonymous], 1997, MMWR Recomm Rep, V46, P1; BACKETT EM, 1959, BRIT MED J, V1, P409, DOI 10.1136/bmj.1.5119.409; BERGMAN AB, 1991, PEDIATRICS, V88, P69; BRILLINGER DR, 1986, BIOMETRICS, V42, P69; Davidson L L, 1992, Paediatr Perinat Epidemiol, V6, P153, DOI 10.1111/j.1365-3016.1992.tb00757.x; DAVIDSON LL, 1994, AM J PUBLIC HEALTH, V84, P580, DOI 10.2105/AJPH.84.4.580; Davidson LL, 1994, CHILD, V11, P3; *DIV SURV EP, 1995, EP INF; Durkin MS, 1996, J TRAUMA, V41, P667, DOI 10.1097/00005373-199610000-00012; DURKIN MS, 1994, AM J PUBLIC HEALTH, V84, P587, DOI 10.2105/AJPH.84.4.587; FIFE D, 1984, AM J PUBLIC HEALTH, V74, P473, DOI 10.2105/AJPH.74.5.473; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P1340, DOI 10.2105/AJPH.74.12.1340; GUYER B, 1985, PEDIATR CLIN N AM, V32, P163; HADDON W, 1961, J CHRON DIS, V14, P665; KENDRICK D, 1993, ARCH DIS CHILD, V68, P669, DOI 10.1136/adc.68.5.669; KUHN L, 1994, AM J EPIDEMIOL, V140, P943, DOI 10.1093/oxfordjournals.aje.a117183; LARAQUE D, 1994, AM J PUBLIC HEALTH, V84, P1691; LARQUE D, 1995, J N Y ACAD MED, V72, P16; MALEK M, 1990, ACCIDENT ANAL PREV, V22, P301, DOI 10.1016/0001-4575(90)90046-N; *NY CIT DEP HLTH, 1985, SUMM VIT STAT; PREUSSER DF, 1988, B NY ACAD MED, V6, P623; PRICE SC, 1992, CHILD INJ PREV Q FAL, P7; Rao R, 1997, B NEW YORK ACAD MED, V74, P65; ROBERTS I, 1995, BRIT MED J, V310, P91, DOI 10.1136/bmj.310.6972.91; ROBERTS I, 1993, BRIT MED J, V306, P1737, DOI 10.1136/bmj.306.6894.1737; ROBERTS I, 1994, AUST J PUBLIC HEALTH, V18, P209; Robertson L. S, 1998, INJURY EPIDEMIOLOGY; RUNYAN CW, 1985, AM J PUBLIC HEALTH, V75, P1429, DOI 10.2105/AJPH.75.12.1429; *SAS I, 1989, SAS PROPR SOFTW; SMITH GS, 1991, EPIDEMIOL REV, V13, P228, DOI 10.1093/oxfordjournals.epirev.a036070; *SOC AMB CAR PROF, 1995, PARTN PREV INN COMM, P10; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; *US BUR CENS, 1981, 1980 CENS; *US BUR CENS, 1996, PPL80 US BUR CENS; *US CENS BUR, 1990, C90STF3B US CENS BUR; WALLER AE, 1989, AM J PUBLIC HEALTH, V79, P310, DOI 10.2105/AJPH.79.3.310; WILLIAMS BC, 1990, PEDIATRICS, V86, P1067; World Health Organization, 1980, INT CLASS DIS; YTTERSTAD B, 1995, ACCIDENT ANAL PREV, V27, P111, DOI 10.1016/0001-4575(94)00036-L; 1992, MMMWR MORB MORTAL WK, V41, P249	41	114	117	0	16	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JUN	1999	103	6	1						e74	10.1542/peds.103.6.e74			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	201UF	WOS:000080613400003	10353971				2022-02-06	
J	Hillier, SL; Sharpe, MH; Metzer, J				Hillier, SL; Sharpe, MH; Metzer, J			Outcomes 5 years post-traumatic brain injury (with further reference to neurophysical impairment and disability)	BRAIN INJURY			English	Article							HEAD-INJURY; ADULTS; SCALE	The assessment of recovery and outcomes post-traumatic brain injury (TBI) has often been poorly researched and reported in past Literature. Indeed, an accurate documentation of outcomes in this population had never been performed in the state of South Australia. To redress this situation this study collected data on people who had sustained a TBI 5 years previously, using medical records, personal interview/questionnaire and neurophysical assessment in order to investigate broad outcomes as well as the specific nature and prevalence of any residual physical impairment and disability. The results (n = 67) indicate that the subjects' living arrangements had not altered significantly, and nearly half had returned to some form of paid work, though over 50% were reliant on the welfare system. The majority (57%) felt they had improved in all areas, 19% partially improved and 8% felt they had actually deteriorated. Considering the physical data, the most frequent areas of residual impairment were headaches, followed by balance difficulties and fatigue/weakness. Functionally, 30% had some degree of deficit in upper limb activity and 9% required assistance for particular transfer tasks. Overall balance was impaired in 34% and gait was altered in 24% with 9% reliant on wheelchairs for mobility. Such data may be used in the education of people with TBI and those who live and/or work with them, as well as in future studies assessing the impact of various factors on recovery and outcomes. Evidence was also provided that residual physical issues should be considered along with the more researched areas of cognition and psychosocial issues.	UNIV S AUSTRALIA,SCH PHYSIOTHERAPY,ADELAIDE,SA 5001,AUSTRALIA; UNIV S AUSTRALIA,SCH PSYCHOL,ADELAIDE,SA 5001,AUSTRALIA				Hillier, Susan/D-4590-2009	Hillier, Susan/0000-0002-6071-6137			BADCOCK KM, 1987, HEAD INJURY STUDY FL; Bond M R, 1975, Ciba Found Symp, P141; BOND MR, 1990, REHABILITATION ADULT, P59; BRENNAN MA, 1981, IRISH MED J, V74, P5; COSTA LD, 1963, J CONSULT PSYCHOL, V10, P146; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; De Weerdt WJG., 1985, PHYSIOTHER CAN, V37, P65, DOI DOI 10.3138/PTC.37.2.065; DIAMOND SG, 1983, NEUROLOGY, V33, P1098, DOI 10.1212/WNL.33.8.1098; FREGLY AR, 1972, AEROSPACE MED, V43, P395; FREGLY AR, 1968, AEROSPACE MED, V39, P277; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Herdman SJ., 1990, J HEAD TRAUMA REHAB, V5, P63, DOI 10.1097/00001199-199012000-00008; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KAPLAN E, 1968, THESIS CLARKE U; KATZ DI, 1990, J HEAD TRAUMA REHAB, V5, P86; *LAF INSTR COMP, 1979, INSTR NORM DAT MOD 3, P1; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LINDMARK B, 1988, SCAND J REHABIL MED, V20, P111; LINDMARK B, 1988, SCAND J REHABIL MED, V20, P103; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RINEHART MA, 1983, PHYS THER, V63, P1975, DOI 10.1093/ptj/63.12.1975; ROBINSON JL, 1981, PHYS THER, V61, P351, DOI 10.1093/ptj/61.3.351; SABARI JS, 1991, AM J OCCUP THER, V45, P523, DOI 10.5014/ajot.45.6.523; SHARPE MH, 1983, NEUROPSYCHOLOGIA, V21, P455, DOI 10.1016/0028-3932(83)90002-7; SWEENEY JK, 1983, PHYS THER, V63, P2018, DOI 10.1093/ptj/63.12.2018; TALMAGE EW, 1983, PHYS THER, V63, P2010, DOI 10.1093/ptj/63.12.2010; TEASDALE G, 1974, LANCET, V2, P81; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1980, INT CLASS IMP DIS HA; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13, DOI 10.1097/00001199-199309000-00004	33	114	116	0	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	SEP	1997	11	9					661	675					15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XT726	WOS:A1997XT72600005	9376834				2022-02-06	
J	Dixon, CE; Flinn, P; Bao, JL; Venya, R; Hayes, RL				Dixon, CE; Flinn, P; Bao, JL; Venya, R; Hayes, RL			Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats	EXPERIMENTAL NEUROLOGY			English	Article							FIMBRIA-FORNIX TRANSECTION; CONTROLLED CORTICAL IMPACT; MEDIAL SEPTUM; HEAD-INJURY; AGED RATS; ACETYLCHOLINE SYNTHESIS; GLUTATHIONE-PEROXIDASE; MEMORY IMPAIRMENT; FACTOR RECEPTOR; NEURONS	Traumatic brain injury (TBI) results in chronic derangements in central cholinergic neurotransmission that may contribute to posttraumatic memory deficits. Intraventricular cannula (IVC) nerve growth factor (NGF) infusion can reduce axotomy-induced spatial memory deficits and morphologic changes observed in medial septal cholinergic neurons immunostained for choline acetyltransferase (ChAT). We examined the efficacy of NGF to (1) ameliorate reduced posttraumatic spatial memory performance, (2) release of hippocampal acetylcholine (ACh), and (3) ChAT immunoreactivity in the rat medial septum. Rats (n = 36) were trained prior to TBI on the functional tasks and retested on Days 1-5 (motor) and on Day 7 (memory retention). Immediately following injury, an IVC and osmotic pump were implanted, and NGF or vehicle was infused for 7 days. While there were no differences in motor performance, the NGF-treated group had significantly better spatial memory retention (P < 0.05) than the vehicle-treated group. The IVC cannula was then removed on Day 7, and a microdialysis probe was placed into the dorsal hippocampus. After a 22-h equilibration period, samples were collected prior to and after administration of scopolamine (1 mg/kg), which evoked ACh release by blocking autoreceptors. The posttraumatic reduction in scopolamine-evoked ACh release was completely reversed with NGF. Injury produced a bilateral reduction in the number and cross-sectional area of ChAT immunopositive medial septal neurons that was reversed by NGF treatment. These data suggest that cognitive but not motor deficits following TBI are, in part, mediated by chronic deficits in cholinergic systems that can be modulated by neurotrophic factors such as NGF. (C) 1997 Academic Press.	UNIV TEXAS,HLTH SCI CTR,DEPT NEUROSURG,HOUSTON,TX 77030		Dixon, CE (corresponding author), UNIV PITTSBURGH,MED CTR,DEPT NEUROSURG,3434 5TH AVE,SUITE 201,PITTSBURGH,PA 15260, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033150, P01NS031998] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [CDC-R49-CCR303547] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NIH-NS33150, NIH-NS31998] Funding Source: Medline		ARMSTRONG DM, 1987, J COMP NEUROL, V264, P421, DOI 10.1002/cne.902640309; Backman C, 1996, J NEUROSCI, V16, P5437; BATCHELOR PE, 1989, J COMP NEUROL, V284, P187, DOI 10.1002/cne.902840204; BLAKER SN, 1988, J COMP NEUROL, V272, P127, DOI 10.1002/cne.902720109; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COLLERTON D, 1986, NEUROSCIENCE, V19, P1, DOI 10.1016/0306-4522(86)90002-3; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Dixon C. E., 1995, Journal of Neurotrauma, V12, P491; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; DUNNETT SB, 1982, BRAIN RES, V251, P335, DOI 10.1016/0006-8993(82)90751-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; GAGE FH, 1988, J COMP NEUROL, V269, P147, DOI 10.1002/cne.902690112; GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; HAGG T, 1993, EXP NEUROL, V119, P37, DOI 10.1006/exnr.1993.1005; HAGG T, 1989, BRAIN RES, V505, P29, DOI 10.1016/0006-8993(89)90112-1; HAGG T, 1988, EXP NEUROL, V101, P303, DOI 10.1016/0014-4886(88)90013-1; HALL ED, 1992, J NEUROTRAUM, V9, pS425; Hall Edward D., 1993, Journal of Emergency Medicine, V11, P31; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1990, BRAIN CHOLINERGIC SY, P173; JACKSON GR, 1994, BRAIN RES, V634, P69, DOI 10.1016/0006-8993(94)90259-3; JACKSON GR, 1994, DEV NEUROSCI-BASEL, V16, P285, DOI 10.1159/000112121; JIANG JY, 1994, BRAIN RES, V640, P240; JOPE RS, 1979, BRAIN RES REV, V1, P313, DOI 10.1016/0165-0173(79)90009-2; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KNIPPER M, 1994, EUR J NEUROSCI, V6, P668, DOI 10.1111/j.1460-9568.1994.tb00312.x; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; NEWCOMB JK, IN PRESS J NEUROTRAU; NISTICO G, 1992, FREE RADICAL BIO MED, V12, P177, DOI 10.1016/0891-5849(92)90024-B; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; PAN ZH, 1993, J NEUROCHEM, V61, P1713, DOI 10.1111/j.1471-4159.1993.tb09808.x; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; POSMANTUR R, 1997, J NEUROSCI, V77, P875; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; RYLETT RJ, 1993, J NEUROSCI, V13, P3956; RYLETT RJ, 1993, BRAIN RES, V626, P184, DOI 10.1016/0006-8993(93)90578-B; SCHMIDT RH, 1995, J NEUROSURG, V83, P406; SINSON B, 1995, J NEUROSCI; SINSON G, 1995, J NEUROCHEM, V65, P2209; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SMITH ML, 1995, NEUROSCIENCE, V67, P679, DOI 10.1016/0306-4522(95)00076-U; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SPENCER DG, 1983, DRUG DEVELOP RES, V3, P489, DOI 10.1002/ddr.430030602; TUSZYNSKI MH, 1990, NEUROSCIENCE, V36, P33, DOI 10.1016/0306-4522(90)90349-9; VAHLSING HL, 1991, BRAIN RES, V552, P320, DOI 10.1016/0006-8993(91)90098-G; YANG K, 1995, J NEUROSCI RES, V42, P571, DOI 10.1002/jnr.490420415	70	114	114	0	0	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0014-4886			EXP NEUROL	Exp. Neurol.	AUG	1997	146	2					479	490		10.1006/exnr.1997.6557			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XR256	WOS:A1997XR25600022	9270059				2022-02-06	
J	Rockwood, K; Joyce, B; Stolee, P				Rockwood, K; Joyce, B; Stolee, P			Use of goal attainment scaling in measuring clinically important change in cognitive rehabilitation patients	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						cognitive rehabilitation; change measures; goal attainment scaling; functional capacity; relative efficiency	TRAUMATIC BRAIN INJURY; HEALTH-STATUS; QUALITY; CARE; SENSITIVITY; ARTHRITIS; SYSTEM; INDEX; LIFE	Measuring the effectiveness of cognitive rehabilitation programs poses both conceptual and practical challenges. We compared several standardized outcome measures with goal attainment scaling (GAS) to assess their sensitivity to changes in health status in patients undergoing cognitive rehabilitation. GAS is a measurement. approach that accommodates multiple individual patient goals, and has a scoring system which allows for comparisons between patients. Forty-four patients were evaluated. GAS yielded a mean 4.4 goals per patient. The mean gain in the GAS score was compared with the change in the Rappaport Disability Rating Scale, the Kohlman Evaluation of Daily Living Skills, the Milwaukee Evaluation of Daily Living, the Klein-Bell elimination scale and mobility scale, the Instrumental Activities of Daily Living Scale, and the Spitzer Quality of Life Index. Using a relative efficiency statistic, GAS proved more responsive than any other measure. The effect size statistic also demonstrated greater responsiveness to change with GAS compared with standard measures. GAS shows promise as a responsive measure in cognitive rehabilitation. This study replicates a similar study of GAS in frail elderly patients, suggesting that individualized measures may have broad merit in evaluating rehabilitation programs. (C) 1997 Elsevier Science Inc.	DALHOUSIE UNIV, DIV GERIATR MED, HALIFAX, NS, CANADA; DALHOUSIE UNIV, DIV PHYS MED & REHABIL, HALIFAX, NS, CANADA; SW ONTARIO REG GERIATR PROGRAM, LONDON, ON, CANADA				Rockwood, Kenneth/AAD-8951-2019; Stolee, Paul/ABB-2660-2020	Stolee, Paul/0000-0002-5685-0843			*AN SOFTW INC, 1994, STAT VERS 4 1; ANDERSON JJ, 1989, ARTHRITIS RHEUM, V32, P844; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BERROL S, 1990, ARCH NEUROL-CHICAGO, V47, P219, DOI 10.1001/archneur.1990.00530020127025; FEINSTEIN AR, 1994, ANN INTERN MED, V120, P799, DOI 10.7326/0003-4819-120-9-199405010-00012; Feinstein AR, 1987, CLINIMETRICS; Feinstein AR, 1967, CLIN JUDGEMENT; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P145; HACHINSKI V, 1990, ARCH NEUROL-CHICAGO, V47, P224, DOI 10.1001/archneur.1990.00530020132028; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; KIRESUK TJ, 1978, EVALUATION HUMAN SER; KLEIN RM, 1982, ARCH PHYS MED REHAB, V63, P335; KRAEMER HC, 1987, HOW MANY SUBJECTS ST, pCH3; LACHS MS, 1993, J CLIN EPIDEMIOL, V46, P1091, DOI 10.1016/0895-4356(93)90107-C; Law M, 1990, Can J Occup Ther, V57, P82; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leonardelli C. A., 1988, MILWAUKEE EVALUATION; LEVIN HS, 1990, ARCH NEUROL-CHICAGO, V47, P223, DOI 10.1001/archneur.1990.00530020131027; LIANG MH, 1985, ARTHRITIS RHEUM, V28, P542, DOI 10.1002/art.1780280513; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; MCGOURTY LK, 1988, MENTAL HLTH ASSESSME; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; PALISANO RJ, 1992, PHYS THER, V72, P432, DOI 10.1093/ptj/72.6.432; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROCKWOOD K, 1993, J CLIN EPIDEMIOL, V46, P1113, DOI 10.1016/0895-4356(93)90110-M; Rockwood K, 1996, NEUROEPIDEMIOLOGY, V15, P330, DOI 10.1159/000109923; ROGERS WH, 1990, JAMA-J AM MED ASSOC, V264, P1989, DOI 10.1001/jama.264.15.1989; Singh A C, 1989, Acta Psychiatr Scand Suppl, V347, P1; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; STOLEE P, 1992, J AM GERIATR SOC, V40, P574, DOI 10.1111/j.1532-5415.1992.tb02105.x; VOPLE B, 1990, ARCH NEUROL-CHICAGO, V47, P220	37	114	116	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	MAY	1997	50	5					581	588		10.1016/S0895-4356(97)00014-0			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Public, Environmental & Occupational Health	XD004	WOS:A1997XD00400009	9180650				2022-02-06	
J	Hamm, RJ; Temple, MD; ODell, DM; Pike, BR; Lyeth, BG				Hamm, RJ; Temple, MD; ODell, DM; Pike, BR; Lyeth, BG			Exposure to environmental complexity promotes recovery of cognitive function after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						environments; memory; Morris water maze; recovery; traumatic brain injury	PROTEIN-KINASE-C; CLOSED HEAD-INJURY; RATS; PERFORMANCE; ENRICHMENT; NEURONS; MEMORY; LESIONS; CORTEX; TASK	This study was designed to determine whether exposure to a complex environment after traumatic brain injury (TBI) would promote the recovery of cognitive function. Rats were injured at a moderate level of fluid percussion injury (2.1 atm) or were prepared for injury but were not injured (sham injury), Immediately after the injury or sham injury, the injured/complex (n = 8) and the sham/complex (n = 7) groups were placed into a complex environment. The complex environment was a 89 x 89-cm enclosure with different types of bedding and objects that provided motor, ol-factory, tactile, and visual stimulation. The injured/standard (n = 8) and the sham/standard (n = 8) groups were returned to the animal vivarium where they were housed individually in standard wire mesh cages (24 x 20 x 18 cm). On days 11-15 (postinjury), performance in the Morris water maze was assessed. Analysis of the latency to reach the goal platform indicated that injured animals recuperating in the complex environment performed significantly better than injured animals recovering in the standard environment (p < 0.01). In fact, injured animals in the complex environment performed as well as both sham-injured groups. The improved performance of injured rats recovering in the enriched environment occurred in the absence of environmentally induced alterations in brain weight. These results indicate that exposure to environmental complexity enhances recovery of cognitive function after TBI.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT NEUROSURG,RICHMOND,VA 23284		Hamm, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,POB 842018,RICHMOND,VA 23284, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline		BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BRENNER E, 1983, NEUROSCI LETT, V42, P13, DOI 10.1016/0304-3940(83)90414-7; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P335; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DONOVICK PJ, 1973, PHYSIOL BEHAV, V11, P543, DOI 10.1016/0031-9384(73)90041-3; EINON DF, 1980, Q J EXP PSYCHOL, V32, P137, DOI 10.1080/00335558008248239; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FERCHMIN PA, 1987, PHARMACOL BIOCHEM BE, V26, P341, DOI 10.1016/0091-3057(87)90128-6; FERCHMIN PA, 1970, BRAIN RES, V20, P49, DOI 10.1016/0006-8993(70)90153-8; FERCHMIN PA, 1986, DEV PSYCHOBIOL, V10, P511; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GONZALEZLIMA F, 1994, DEV PSYCHOBIOL, V27, P343, DOI 10.1002/dev.420270603; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; GREER ER, 1981, EXP NEUROL, V72, P366, DOI 10.1016/0014-4886(81)90230-2; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; Kolb B, 1991, CEREB CORTEX, V1, P189, DOI 10.1093/cercor/1.2.189; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LILJEQUIST R, 1993, BEHAV BRAIN RES, V56, P107, DOI 10.1016/0166-4328(93)90027-N; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MOHAMMED AK, 1986, BRAIN RES, V398, P6, DOI 10.1016/0006-8993(86)91243-6; MURTHA S, 1990, BEHAV BRAIN RES, V39, P249, DOI 10.1016/0166-4328(90)90031-9; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; PAYLOR R, 1992, BEHAV BRAIN RES, V52, P49, DOI 10.1016/S0166-4328(05)80324-9; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; ROSENZWEIG M R, 1969, Developmental Psychobiology, V2, P87, DOI 10.1002/dev.420020208; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P429, DOI 10.1037/h0041137; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SCHWARTZ S, 1964, J COMP PHYSIOL PSYCH, V57, P72, DOI 10.1037/h0045518; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; WAINWRIGHT PE, 1993, NEUROTOXICOL TERATOL, V15, P11, DOI 10.1016/0892-0362(93)90040-U; WALSH RN, 1981, INT J NEUROSCI, V12, P33, DOI 10.3109/00207458108990671; WEHNER JM, 1990, BRAIN RES, V523, P181, DOI 10.1016/0006-8993(90)91485-Y; Weiner N, 1985, PHARMACOL BASIS THER, P130; WHISHAW IQ, 1984, BEHAV NEURAL BIOL, V42, P183, DOI 10.1016/S0163-1047(84)91046-X; WILL BE, 1976, PHYSIOL BEHAV, V16, P603, DOI 10.1016/0031-9384(76)90221-3; WILL BE, 1977, J COMP PHYSIOL PSYCH, V91, P33, DOI 10.1037/h0077306; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	53	114	114	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1996	13	1					41	47		10.1089/neu.1996.13.41			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TW167	WOS:A1996TW16700006	8714862				2022-02-06	
J	Chiu, CC; Liao, YE; Yang, LY; Wang, JY; Tweedie, D; Karnati, HK; Greig, NH; Wang, JY				Chiu, Chong-Chi; Liao, Yi-En; Yang, Ling-Yu; Wang, Jing-Ya; Tweedie, David; Karnati, Hanuma K.; Greig, Nigel H.; Wang, Jia-Yi			Neuroinflammation in animal models of traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury (TBI); Neuroinflammation; Glia cells; Astrocytes; Microglia; Controlled cortical impact; Weight-drop impact; Lateralfluid percussion; Measurements evaluating neuroinflammation	NECROSIS-FACTOR-ALPHA; CONTROLLED CORTICAL IMPACT; PEPTIDE-1 RECEPTOR AGONIST; FLUID PERCUSSION INJURY; CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION; CEREBRAL-CORTEX	Traumatic brain injury (TBI) is a leading cause of mortality and morbidity worldwide. Neuroinflammation is prominent in the short and long-term consequences of neuronal injuries that occur after TBI. Neuroinflammation involves the activation of glia, including microglia and astrocytes, to release inflammatory mediators within the brain, and the subsequent recruitment of peripheral immune cells. Various animal models of TBI have been developed that have proved valuable to elucidate the pathophysiology of the disorder and to assess the safety and efficacy of novel therapies prior to clinical trials. These models provide an excellent platform to delineate key injury mechanisms that associate with types of injury (concussion, contusion, and penetration injuries) that occur clinically for the investigation of mild, moderate, and severe forms of TBI. Additionally, TBI modeling in genetically engineered mice, in particular, has aided the identification of key molecules and pathways for putative injury mechanisms, as targets for development of novel therapies for human TBI. This Review details the evidence showing that neuroinflammation, characterized by the activation of microglia and astrocytes and elevated production of inflammatory mediators, is a critical process occurring in various TBI animal models, provides a broad overview of commonly used animal models of TBI, and overviews representative techniques to quantify markers of the brain inflammatory process. A better understanding of neuroinflammation could open therapeutic avenues for abrogation of secondary cell death and behavioral symptoms that may mediate the progression of TBI. (C) 2016 Elsevier B.V. All rights reserved.	[Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Gen Surg, Tainan, Taiwan; [Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Gen Surg, Liouying, Taiwan; [Liao, Yi-En] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Yang, Ling-Yu; Wang, Jing-Ya; Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Coll Med, 250 Wu Xing St, Taipei 110, Taiwan; [Tweedie, David; Karnati, Hanuma K.; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Wang, Jia-Yi] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, 250 Wu Xing St, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw	Karnati, Hanuma kumar/V-2002-2019; karnati, Hanuma kumar/ABH-8371-2020	karnati, Hanuma kumar/0000-0002-1259-6900; Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST104-2923-B-038-001-MY3]; Chi Mei Medical Center, Tainan and Liouying, Taiwan [100CM-TMU-05]; Intramural Research Program of the National Institute on Aging, NIH, Baltimore, MD, USA; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000994] Funding Source: NIH RePORTER	This study was supported in part by (i) a grant (MOST104-2923-B-038-001-MY3) from the Ministry of Science and Technology, Taiwan; (ii) a grant (100CM-TMU-05) from Chi Mei Medical Center, Tainan and Liouying, Taiwan; and (iii) the Intramural Research Program of the National Institute on Aging, NIH, Baltimore, MD, USA.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen Y, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00022; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Deselms H., 2016, J NEUROSCI METH; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong XQ, 2011, INFLAMM RES, V60, P533, DOI 10.1007/s00011-010-0300-7; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Du YZ, 2002, J NEUROSCI RES, V68, P647, DOI 10.1002/jnr.10245; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Galgano M., 2015, J NEUROL NEUROBIOL, V2; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gervasi NM, 2008, REGEN MED, V3, P907, DOI 10.2217/17460751.3.6.907; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Gunther M, 2012, ACTA NEUROCHIR, V154, P689, DOI 10.1007/s00701-012-1297-1; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Jin W, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/502564; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Jung CS, 2014, INT J MOL SCI, V15, P4088, DOI 10.3390/ijms15034088; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Karve I.P., 2015, BR J PHARM; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kotter MR, 2011, BRAIN, V134, P1882, DOI 10.1093/brain/awr014; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kumar A., 2016, J NEUROTRAUMA; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Leonardo CC, 2012, TRANSL STROKE RES, V3, P357, DOI 10.1007/s12975-012-0203-8; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mattiasson G, 2004, CYTOM PART A, V62A, P89, DOI 10.1002/cyto.a.20089; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nimmerjahn A, 2009, J PHYSIOL-LONDON, V587, P1639, DOI 10.1113/jphysiol.2008.167171; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Parekkadan B, 2008, NEUROSCI LETT, V438, P190, DOI 10.1016/j.neulet.2008.03.094; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Rau TF, 2014, INT J MOL SCI, V15, P1402, DOI 10.3390/ijms15011402; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Seker E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125504; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Singh K., 2015, EXP NEUROL; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Tweedie D., 2016, J NEUROSCI METHODS; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; VAUGHAN DW, 1974, J NEUROCYTOL, V3, P405, DOI 10.1007/BF01098730; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wei L, 2014, CLIN EXP PHARMACOL P, V41, P134, DOI 10.1111/1440-1681.12186; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Ye SM, 2001, NEUROIMMUNOMODULAT, V9, P183, DOI 10.1159/000049025; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	145	113	117	2	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 15	2016	272				SI		38	49		10.1016/j.jneumeth.2016.06.018			12	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA6LF	WOS:000386740000005	27382003	Green Accepted			2022-02-06	
J	Tai, XY; Koepp, M; Duncan, JS; Fox, N; Thompson, P; Baxendale, S; Liu, JYW; Reeves, C; Michalak, Z; Thom, M				Tai, Xin You; Koepp, Matthias; Duncan, John S.; Fox, Nick; Thompson, Pamela; Baxendale, Sallie; Liu, Joan Y. W.; Reeves, Cheryl; Michalak, Zuzanna; Thom, Maria			Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections	BRAIN			English	Article						temporal lobe epilepsy; neurofibrillary tangles; tau; Alzheimer's disease; dementia	CHRONIC TRAUMATIC ENCEPHALOPATHY; DOUBLECORTIN-EXPRESSING CELLS; ALZHEIMERS-DISEASE; HIPPOCAMPAL SCLEROSIS; PATHOLOGICAL PROCESS; TDP-43 IMMUNOREACTIVITY; GENERAL-POPULATION; NEURONAL-ACTIVITY; CEREBRAL-CORTEX; MOUSE MODELS	Temporal lobe epilepsy (TLE) is associated with a high prevalence of cognitive decline. Tai et al. reveal the presence of hyperphosphorylated tau in resected temporal lobe tissue from patients with TLE. The quantity of pathological tau correlates with cognitive decline and its distribution suggests an epilepsy-related tauopathy.Temporal lobe epilepsy, the most prevalent form of chronic focal epilepsy, is associated with a high prevalence of cognitive impairment but the responsible underlying pathological mechanisms are unknown. Tau, the microtubule-associated protein, is a hallmark of several neurodegenerative diseases including Alzheimer's disease and chronic traumatic encephalopathy. We hypothesized that hyperphosphorylated tau pathology is associated with cognitive decline in temporal lobe epilepsy and explored this through clinico-pathological study. We first performed pathological examination on tissue from 33 patients who had undergone temporal lobe resection between ages 50 and 65 years to treat drug-refractory temporal lobe epilepsy. We identified hyperphosphorylated tau protein using AT8 immunohistochemistry and compared this distribution to Braak patterns of Alzheimer's disease and patterns of chronic traumatic encephalopathy. We quantified tau pathology using a modified tau score created specifically for analysis of temporal lobectomy tissue and the Braak staging, which was limited without extra-temporal brain areas available. Next, we correlated tau pathology with pre- and postoperative cognitive test scores and clinical risk factors including age at time of surgery, duration of epilepsy, history of secondary generalized seizures, history of head injury, handedness and side of surgery. Thirty-one of 33 cases (94%) showed hyperphosphorylated tau pathology in the form of neuropil threads and neurofibrillary tangles and pre-tangles. Braak stage analysis showed 12% of our epilepsy cohort had a Braak staging III-IV compared to an age-matched non-epilepsy control group from the literature (8%). We identified a mixture of tau pathology patterns characteristic of Alzheimer's disease and chronic traumatic encephalopathy. We also found unusual patterns of subpial tau deposition, sparing of the hippocampus and co-localization with mossy fibre sprouting, a feature of temporal lobe epilepsy. We demonstrated that the more extensive the tau pathology, the greater the decline in verbal learning (Spearman correlation, r = -0.63), recall (r = -0.44) and graded naming test scores (r = -0.50) over 1-year post-temporal lobe resection (P < 0.05). This relationship with tau burden was also present when examining decline in verbal learning from 3 months to 1 year post-resection (r = -0.54). We found an association between modified tau score and history of secondary generalized seizures (likelihood-ratio chi(2), P < 0.05) however there was no clear relationship between tau pathology and other clinical risk factors assessed. Our findings suggest an epilepsy-related tauopathy in temporal lobe epilepsy, which contributes to accelerated cognitive decline and has diagnostic and treatment implications.	[Tai, Xin You; Liu, Joan Y. W.; Reeves, Cheryl; Michalak, Zuzanna; Thom, Maria] UCL Inst Neurol, Div Neuropathol, Queen Sq, London WC1N 3BG, England; [Tai, Xin You; Koepp, Matthias; Duncan, John S.; Thompson, Pamela; Baxendale, Sallie; Liu, Joan Y. W.; Reeves, Cheryl; Michalak, Zuzanna; Thom, Maria] UCL Inst Neurol, Dept Clin & Expt Epilepsy, Queen Sq, London WC1N 3BG, England; [Fox, Nick] UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, Queen Sq, London WC1N 3BG, England		Thom, M (corresponding author), UCL, Inst Neurol, Div Neuropathol, 1st Floor,Queen Sq House,Queen Sq, London WC1N 3BG, England.; Thom, M (corresponding author), UCL, Inst Neurol, Dept Clin & Expt Epilepsy, 1st Floor,Queen Sq House,Queen Sq, London WC1N 3BG, England.	m.thom@ucl.ac.uk	Fox, Nick C/B-1319-2009; Baxendale, Sallie/AAN-8312-2020; Reeves, Cheryl/M-6192-2019	Fox, Nick C/0000-0002-6660-657X; Baxendale, Sallie/0000-0002-9930-6469; Duncan, John S/0000-0002-1373-0681; Liu, Joan/0000-0002-0777-5189	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/JO127OX/1]; Department of Health's NIHR Biomedical Research CentresNational Institute for Health Research (NIHR); European UnionEuropean Commission [602102]; Epilepsy Society; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/J01270X/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/J01270X/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0509-10161, NF-SI-0515-10000, NF-SI-0513-10134, NF-SI-0508-10123] Funding Source: researchfish	This work is supported by the Medical Research Council (grant MR/JO127OX/1). This work was undertaken at UCLH/UCL who received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. Z.M. received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement EPITARGET, #602102. The Epilepsy Society Brain and Tissue Bank at UCL was funded by the Epilepsy Society.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Black LC, 2010, EPILEPSY BEHAV, V17, P412, DOI 10.1016/j.yebeh.2010.01.006; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Braak H, 2013, ACTA NEUROPATHOL, V126, P631, DOI [10.1007/s00401-013-1139-0, 10.1007/s00401-013-1153-2]; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Cormack F, 2005, NEUROIMAGE, V27, P635, DOI 10.1016/j.neuroimage.2005.05.023; Dijkstra KK, 2013, J NEUROL NEUROSUR PS, V84, P379, DOI 10.1136/jnnp-2012-303141; Duyckaerts C, 2015, ACTA NEUROPATHOL, V129, P749, DOI 10.1007/s00401-015-1390-7; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Griffith HR, 2007, EPILEPSY RES, V74, P91, DOI 10.1016/j.eplepsyres.2007.01.002; Griffith HR, 2006, EPILEPSY BEHAV, V8, P161, DOI 10.1016/j.yebeh.2005.09.004; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Hermann BP, 2006, ANN NEUROL, V60, P80, DOI 10.1002/ana.20872; Hogh P, 2002, NEUROLOGY, V58, P298, DOI 10.1212/WNL.58.2.298; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kandratavicius L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/960126; Lee EB, 2008, ACTA NEUROPATHOL, V115, P305, DOI 10.1007/s00401-007-0331-5; Lewis J, 2016, ACTA NEUROPATHOL, V131, P27, DOI 10.1007/s00401-015-1507-z; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; Liu RSN, 2003, ANN NEUROL, V53, P312, DOI 10.1002/ana.10463; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Oyegbile TO, 2004, NEUROLOGY, V62, P1736, DOI 10.1212/01.WNL.0000125186.04867.34; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; SHENG JG, 1994, J NEUROCHEM, V63, P1872; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Springer JA, 1999, BRAIN, V122, P2033, DOI 10.1093/brain/122.11.2033; Srikandarajah N, 2009, EPILEPSIA, V50, P2619, DOI 10.1111/j.1528-1167.2009.02194.x; Tellez-Zenteno JF, 2005, EPILEPSIA, V46, P1955, DOI 10.1111/j.1528-1167.2005.00344.x; Thom M, 2014, NEUROPATH APPL NEURO, V40, P520, DOI 10.1111/nan.12150; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Thompson PJ, 2015, SEIZURE-EUR J EPILEP, V29, P41, DOI 10.1016/j.seizure.2015.03.017; Vuono R, 2015, BRAIN, V138, P1907, DOI 10.1093/brain/awv107; Wolfe MS, 2012, SCI CAIRO, V2012; Xiong K, 2008, EXP NEUROL, V211, P271, DOI 10.1016/j.expneurol.2008.02.003; Zhang XM, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.017.2009	47	113	115	0	15	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	SEP	2016	139		9				2441	2455		10.1093/brain/aww187			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DW5WX	WOS:000383719500019	27497924	Bronze, Green Submitted, Green Published, Green Accepted			2022-02-06	
J	Covassin, T; Moran, R; Elbin, RJ				Covassin, Tracey; Moran, Ryan; Elbin, R. J.			Sex Differences in Reported Concussion Injury Rates and Time Loss From Participation: An Update of the National Collegiate Athletic Association Injury Surveillance Program From 2004-2005 Through 2008-2009	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiology; traumatic brain injuries; sports	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL SPORTS; STATES HIGH-SCHOOL; UNITED-STATES; GENDER-DIFFERENCES; RISK-FACTORS; EPIDEMIOLOGY; SYMPTOMS; SYSTEM	Context: Epidemiologic studies have identified differences in concussion incidence between the sexes. However, few authors to date have updated injury rates (IRs) and time loss between male and female concussed athletes. Objective: To examine sex differences in IRs and time loss in concussed National Collegiate Athletic Association (NCAA) athletes. Design: Descriptive epidemiologic study. Setting: National Collegiate Athletic Association athletics. Patients or Other Participants: A total of 1702 concusssed NCAA athletes, consisting of 903 females and 779 males participating in soccer, basketball, ice hockey, lacrosse, softball, or baseball over a 5-year period from 2004-2005 through 2008-2009. Main Outcome Measure(s): Using the NCAA Injury Surveillance Program, athletic trainers reported concussions, athlete-exposures (AEs), and time loss across 10 NCAA sports. An IR is the number of injuries in a particular category divided by the number of AEs in that category. Results: During the study period, 1702 concussions were reported during 4 170 427 AEs for an overall total of 5.47 per 10 000 AEs. In sex-comparable sports, females had a 1.4 times higher overall concussion IR than males (IRs = 4.84 and 3.46, respectively), with greater rates in women's baseball/softball, basketball, ice hockey, and soccer than men. Female soccer and basketball players also displayed more time loss after concussion compared with male basketball and soccer players. Conclusions: Female athletes sustained a higher rate of concussion and, in all sports except lacrosse, had greater time loss from concussion than male athletes. Additional research is needed on sex differences in time loss after concussions.	[Covassin, Tracey; Moran, Ryan] Michigan State Univ, 105 IM Sports Circle, E Lansing, MI 48824 USA; [Elbin, R. J.] Univ Arkansas, Fayetteville, AR 72701 USA		Covassin, T (corresponding author), Michigan State Univ, 105 IM Sports Circle, E Lansing, MI 48824 USA.	covassin@msu.edu					Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dragoo JL, 2012, AM J SPORT MED, V40, P990, DOI 10.1177/0363546512442336; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Esposito G, 1996, J NUCL MED, V37, P559; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 2001, J ATHL TRAINING, V36, P307; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Roos KG, 2015, AM J SPORT MED, V43, P1790, DOI 10.1177/0363546515580790; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	22	113	113	0	24	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2016	51	3					189	194		10.4085/1062-6050-51.3.05			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DK2PB	WOS:000374755800001	26950073	Bronze, Green Published			2022-02-06	
J	Weiner, MW; Veitch, DP; Aisen, PS; Beckett, LA; Cairns, NJ; Cedarbaum, J; Donohue, MC; Green, RC; Harvey, D; Jack, CR; Jagust, W; Morris, JC; Petersen, RC; Saykin, AJ; Shaw, L; Thompson, PM; Toga, AW; Trojanowski, JQ				Weiner, Michael W.; Veitch, Dallas P.; Aisen, Paul S.; Beckett, Laurel A.; Cairns, Nigel J.; Cedarbaum, Jesse; Donohue, Michael C.; Green, Robert C.; Harvey, Danielle; Jack, Clifford R.; Jagust, William; Morris, John C.; Petersen, Ronald C.; Saykin, Andrew J.; Shaw, Leslie; Thompson, Paul M.; Toga, Arthur W.; Trojanowski, John Q.		Alzheimer's Dis Neuroimaging Initi	Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Data-sharing; Amyloid phenotyping; Clinical trial biomarkers; Tau imaging; AD biomarker signature; Worldwide ADNI	MILD COGNITIVE IMPAIRMENT; TENSOR-BASED MORPHOMETRY; GENOME-WIDE ASSOCIATION; CEREBROSPINAL-FLUID BIOMARKERS; POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER HYPERINTENSITIES; MULTITASK FEATURE-SELECTION; BETA-AMYLOID MEASURES; NORMAL OLDER-ADULTS; HIPPOCAMPAL VOLUME	Introduction: The Alzheimer's Disease Neuroimaging Initiative (ADNI) was established in 2004 to facilitate the development of effective treatments for Alzheimer's disease (AD) by validating biomarkers for AD clinical trials. Methods: We searched for ADNI publications using established methods. Results: ADNI has (1) developed standardized biomarkers for use in clinical trial subject selection and as surrogate outcome measures; (2) standardized protocols for use across multiple centers; (3) initiated worldwide ADNI; (4) inspired initiatives investigating traumatic brain injury and posttraumatic stress disorder in military populations, and depression, respectively, as an AD risk factor; (5) acted as a data-sharing model; (6) generated data used in over 600 publications, leading to the identification of novel AD risk alleles, and an understanding of the relationship between biomarkers and AD progression; and (7) inspired other public-private partnerships developing biomarkers for Parkinson's disease and multiple sclerosis. Discussion: ADNI has made myriad impacts in its first decade. A competitive renewal of the project in 2015 would see the use of newly developed tau imaging ligands, and the continued development of recruitment strategies and outcome measures for clinical trials. (C) 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.	[Weiner, Michael W.; Veitch, Dallas P.] Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Aisen, Paul S.] Univ Calif San Francisco, Dept Neurosci, San Francisco, CA 94143 USA; [Beckett, Laurel A.; Harvey, Danielle] Univ Calif Davis, Div Biostat, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Cairns, Nigel J.; Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cedarbaum, Jesse] Biogen Idec Inc, Neurol Early Clin Dev, Cambridge, MA USA; [Donohue, Michael C.] Univ Calif San Diego, Div Biostat & Bioinformat, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Green, Robert C.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Green, Robert C.] Harvard Univ, Sch Med, Boston, MA USA; [Jack, Clifford R.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Jagust, William] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jagust, William] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Petersen, Ronald C.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Saykin, Andrew J.] Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN 46204 USA; [Shaw, Leslie] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Thompson, Paul M.] Univ So Calif, Imaging Genet Ctr, Inst Neuroimaging & Informat, Marina Del Rey, CA USA; [Toga, Arthur W.] Univ So Calif, Keck Sch Med, Lab Neuroimaging, Inst Neuroimaging & Informat, Los Angeles, CA 90033 USA; [Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Ctr Neurodegenerat Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Trojanowski, John Q.] Univ Penn, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA; [Trojanowski, John Q.] Univ Penn, Alzheimers Dis Core Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Trojanowski, John Q.] Univ Penn, Udall Parkinsons Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA		Weiner, MW (corresponding author), Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA 94121 USA.	michael.weiner@ucsf.edu	Jack, Clifford R/F-2508-2010; Harvey, Danielle/A-5496-2017; Thompson, Paul M/C-4194-2018; Cairns, Nigel/AAB-9713-2020; Jagust, William/ABE-6426-2020; Saykin, Andrew/A-1318-2007	Jack, Clifford R/0000-0001-7916-622X; Thompson, Paul M/0000-0002-4720-8867; Cairns, Nigel/0000-0001-9858-3344; Saykin, Andrew/0000-0002-1376-8532; Veitch, Dallas/0000-0002-9918-0640	NIH - National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5U01AG024904-10]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040060, U01AG024904, P30AG010124, P30AG010129] Funding Source: NIH RePORTER	This work was supported by NIH grant 5U01AG024904-10 funded by the National Institute on Aging to Dr Michael Weiner.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; [Anonymous], 2011, PROG NEUROBIOL, V95, P629, DOI DOI 10.1016/J.PNEUROBIO.2011.09.005; Apostolova LG, 2010, NEUROBIOL AGING, V31, P1284, DOI 10.1016/j.neurobiolaging.2010.05.003; Arai H, 2010, TOHOKU J EXP MED, V221, P87, DOI 10.1620/tjem.221.87; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Barnes J, 2013, NEUROBIOL AGING, V34, P1996, DOI 10.1016/j.neurobiolaging.2013.02.003; Beckett LA, 2010, ALZHEIMERS DEMENT, V6, P257, DOI 10.1016/j.jalz.2010.03.002; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P184, DOI 10.1016/j.jalz.2013.03.001; Boyes RG, 2008, NEUROIMAGE, V39, P1752, DOI 10.1016/j.neuroimage.2007.10.026; Bracoud L., 2013, CLIN TRIALS ALZH DIS; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Cardoso MJ, 2013, MED IMAGE ANAL, V17, P671, DOI 10.1016/j.media.2013.02.006; Carmichael O, 2010, ARCH NEUROL-CHICAGO, V67, P1370, DOI 10.1001/archneurol.2010.284; Caroli A, 2010, NEUROBIOL AGING, V31, P1263, DOI 10.1016/j.neurobiolaging.2010.04.024; Carrillo MC, 2012, ALZHEIMERS DEMENT, V8, P337, DOI 10.1016/j.jalz.2012.04.007; Cedarbaum JM, 2013, ALZHEIMERS DEMENT, V9, pS45, DOI 10.1016/j.jalz.2011.11.002; Chen KW, 2011, NEUROIMAGE, V56, P52, DOI 10.1016/j.neuroimage.2011.01.049; Chen KW, 2010, NEUROIMAGE, V51, P654, DOI 10.1016/j.neuroimage.2010.02.064; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Chou YY, 2010, NEUROBIOL AGING, V31, P1386, DOI 10.1016/j.neurobiolaging.2010.05.001; Chou YY, 2009, NEUROIMAGE, V46, P394, DOI 10.1016/j.neuroimage.2009.02.015; Clarkson MJ, 2009, NEUROIMAGE, V47, P1506, DOI 10.1016/j.neuroimage.2009.05.045; Crane PK, 2012, BRAIN IMAGING BEHAV, V6, P502, DOI 10.1007/s11682-012-9186-z; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1318, DOI 10.1001/archneurol.2012.1282; Donohue MC, 2014, ALZHEIMERS DEMENT, V10, pS400, DOI 10.1016/j.jalz.2013.10.003; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Ellis KA, 2010, ALZHEIMERS DEMENT, V6, P291, DOI 10.1016/j.jalz.2010.03.009; Evans MC, 2010, EUR RADIOL, V20, P674, DOI 10.1007/s00330-009-1581-5; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fodero-Tavoletti MT, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt240; Fox NC, 2011, NEUROIMAGE, V57, P15, DOI 10.1016/j.neuroimage.2011.01.077; Frisoni GB, 2011, ALZHEIMERS DEMENT, V7, P171, DOI 10.1016/j.jalz.2010.06.007; Frisoni GB, 2010, ALZHEIMERS DEMENT, V6, P280, DOI 10.1016/j.jalz.2010.03.005; Furney SJ, 2011, MOL PSYCHIATR, V16, P1130, DOI 10.1038/mp.2010.123; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Grill JD, 2013, NEUROBIOL AGING, V34, P62, DOI 10.1016/j.neurobiolaging.2012.03.006; Gunter JL, 2009, MED PHYS, V36, P2193, DOI 10.1118/1.3116776; Guo LH, 2013, EUR ARCH PSY CLIN N, V263, P325, DOI 10.1007/s00406-012-0349-0; Guzman Vanessa A, 2013, Alzheimers Dement, V9, pS124, DOI 10.1016/j.jalz.2012.11.009; Habeck C, 2012, BRAIN IMAGING BEHAV, V6, P568, DOI 10.1007/s11682-012-9208-x; Haight TJ, 2013, JAMA NEUROL, V70, P1039, DOI 10.1001/jamaneurol.2013.1878; Han MR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-90; Han SD, 2012, BRAIN IMAGING BEHAV, V6, P610, DOI 10.1007/s11682-012-9177-0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hill DLG, 2014, ALZHEIMERS DEMENT, V10, P421, DOI 10.1016/j.jalz.2013.07.003; Hobart J, 2013, ALZHEIMERS DEMENT, V9, pS10, DOI 10.1016/j.jalz.2012.08.006; Hobart J, 2013, ALZHEIMERS DEMENT, V9, pS4, DOI 10.1016/j.jalz.2012.08.005; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047739; Holland D, 2012, HUM BRAIN MAPP, V33, P2586, DOI 10.1002/hbm.21386; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hostage CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054483; Hua X, 2013, NEUROIMAGE, V66, P648, DOI 10.1016/j.neuroimage.2012.10.086; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2011, ARCH NEUROL-CHICAGO, V68, P1526, DOI 10.1001/archneurol.2011.183; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 2010, ALZHEIMERS DEMENT, V6, P212, DOI 10.1016/j.jalz.2010.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Jahanshad N, 2013, P NATL ACAD SCI USA, V110, P4768, DOI 10.1073/pnas.1216206110; Jedynak BM, 2012, NEUROIMAGE, V63, P1478, DOI 10.1016/j.neuroimage.2012.07.059; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Kang JH, 2012, METHODS, V56, P484, DOI 10.1016/j.ymeth.2012.03.023; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Karow DS, 2010, RADIOLOGY, V256, P932, DOI 10.1148/radiol.10091402; Khachaturian AS, 2014, ALZHEIMERS DEMENT, V10, pS90, DOI 10.1016/j.jalz.2014.05.1085; Khachaturian ZS, 2000, ANN NY ACAD SCI, V924, P184; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070269; Klein G, 2015, COMP ASSESSMENT SUVR; Klein G., 2013, ALZH ASS INT C BOST; Klein G., 2014, CLIN TRIALS ALZH DIS; Klein G., 2015, 12 INT C ALZH PARK D; Korecka M, 2014, J ALZHEIMERS DIS, V41, P441, DOI 10.3233/JAD-132489; Korff A, 2013, J ALZHEIMERS DIS, V36, P679, DOI 10.3233/JAD-130458; Kozauer N, 2013, NEW ENGL J MED, V368, P1169, DOI 10.1056/NEJMp1302513; Kruggel F, 2010, NEUROIMAGE, V49, P2123, DOI 10.1016/j.neuroimage.2009.11.006; Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Leow AD, 2009, NEUROIMAGE, V45, P645, DOI 10.1016/j.neuroimage.2009.01.004; Leow AD, 2006, NEUROIMAGE, V31, P627, DOI 10.1016/j.neuroimage.2005.12.013; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Liu F, 2013, LECT NOTES COMPUT SC, V8149, P308, DOI 10.1007/978-3-642-40811-3_39; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Liu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055246; Llano DA, 2010, ALZ DIS ASSOC DIS, V25, P73; Llano DA, 2013, ALZ DIS ASSOC DIS, V27, P233, DOI 10.1097/WAD.0b013e31826d597a; Lo RY, 2012, NEUROLOGY, V79, P1349, DOI 10.1212/WNL.0b013e31826c1b9d; Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123; Lowe VJ, 2013, NEUROLOGY, V80, P2130, DOI 10.1212/WNL.0b013e318295d6cf; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; McDonald CR, 2012, NEUROBIOL AGING, V33, P242, DOI 10.1016/j.neurobiolaging.2010.03.015; Mintun M., 2013, ALZHEIMERS DEMENTIA, V9, pP842; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Mouiha A, 2012, J ALZHEIMERS DIS, V30, P91, DOI 10.3233/JAD-2012-111367; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Murphy KR, 2013, NEUROIMAGE, V78, P474, DOI 10.1016/j.neuroimage.2013.04.048; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Ness S, 2012, NAT REV DRUG DISCOV, V11, P655, DOI 10.1038/nrd3822; Nettiksimmons J, 2010, NEUROBIOL AGING, V31, P1419, DOI 10.1016/j.neurobiolaging.2010.04.025; Nettiksimmons J, 2014, ALZHEIMERS DEMENT, V10, P511, DOI 10.1016/j.jalz.2013.09.003; Nettiksimmons J, 2013, PSYCHOL AGING, V28, P191, DOI 10.1037/a0031063; Nho K, 2013, MOL PSYCHIATR, V18, P781, DOI [10.1038/mp.2013.24, 10.1038/mp.2013.81]; Nir T, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1405, DOI 10.1109/ISBI.2012.6235831; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 1996, ANN NY ACAD SCI, V802, P58, DOI 10.1111/j.1749-6632.1996.tb32599.x; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2013, ANN NEUROL, V74, P199, DOI 10.1002/ana.23931; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Provenzano FA, 2013, JAMA NEUROL, V70, P455, DOI 10.1001/jamaneurol.2013.1321; Qureshi SU, 2010, J AM GERIATR SOC, V58, P1627, DOI 10.1111/j.1532-5415.2010.02977.x; Rajagopalan P, 2013, NEW ENGL J MED, V369, P1565, DOI 10.1056/NEJMc1306509; Ramanan VK, 2014, MOL PSYCHIATR, V19, P351, DOI 10.1038/mp.2013.19; Ramanan VK, 2012, BRAIN IMAGING BEHAV, V6, P634, DOI 10.1007/s11682-012-9196-x; Rammohan K., 2014, 6 COOP M CONS MULT S; Randall C, 2013, FRONT BIOSCI-LANDMRK, V18, P1150, DOI 10.2741/4170; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; Ridge PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079771; Risacher SL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00011; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Roche F., 2013, ALZH ASS INT C WASH; Roche F., 2014, ALZH ASS INT C COP D; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schott JM, 2010, NEUROBIOL AGING, V31, P1452, DOI 10.1016/j.neurobiolaging.2010.04.011; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Schuff N, 2012, NEUROBIOL AGING, V33, P845, DOI 10.1016/j.neurobiolaging.2010.07.012; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shen L, 2014, BRAIN IMAGING BEHAV, V8, P183, DOI 10.1007/s11682-013-9262-z; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Shin J, 2008, NEUROIMAGE, V43, P236, DOI 10.1016/j.neuroimage.2008.07.022; Spampinato MV, 2011, RADIOLOGY, V258, P843, DOI 10.1148/radiol.10100307; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Stricker NH, 2012, BRAIN IMAGING BEHAV, V6, P599, DOI 10.1007/s11682-012-9171-6; Swaminathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050640; Toga AW, 2010, ALZHEIMERS DEMENT, V6, P247, DOI 10.1016/j.jalz.2010.03.001; Toledo JB, 2015, JAMA NEUROL, V72, P571, DOI 10.1001/jamaneurol.2014.4829; Toledo JB, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-65; Toledo JB, 2013, ACTA NEUROPATHOL, V126, P683, DOI 10.1007/s00401-013-1148-z; Trzepacz PT, 2014, NEUROBIOL AGING, V35, P143, DOI 10.1016/j.neurobiolaging.2013.06.018; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Vemuri P, 2010, ANN NEUROL, V67, P308, DOI 10.1002/ana.21953; Villemagne VL, 2014, ALZHEIMERS DEMENT, V10, pS254, DOI 10.1016/j.jalz.2014.04.013; Villemagne VL, 2014, EUR J NUCL MED MOL I, V41, P816, DOI 10.1007/s00259-013-2681-7; Weigand SD, 2011, ALZHEIMERS DEMENT, V7, P133, DOI 10.1016/j.jalz.2010.08.230; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Weiner MW, 2014, ALZHEIMERS DEMENT, V10, pS226, DOI 10.1016/j.jalz.2014.04.005; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Weiner Michael W, 2013, Alzheimers Dement, V9, pe111, DOI [10.1016/j.jalz.2011.09.172, 10.1016/j.jalz.2013.05.1769]; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Wilhelm EE, 2014, JAMA-J AM MED ASSOC, V311, P1201, DOI 10.1001/jama.2014.850; Wolz R, 2014, ALZHEIMERS DEMENT, V10, P430, DOI 10.1016/j.jalz.2013.09.014; Wolz R, 2010, NEUROIMAGE, V52, P109, DOI 10.1016/j.neuroimage.2010.04.006; Wolz R, 2010, NEUROIMAGE, V49, P1316, DOI 10.1016/j.neuroimage.2009.09.069; Wu X, 2010, J NEUROSCI METH, V192, P277, DOI 10.1016/j.jneumeth.2010.07.030; Wyman BT, 2013, ALZHEIMERS DEMENT, V9, P332, DOI 10.1016/j.jalz.2012.06.004; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; Yang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047406; Young AL, 2014, BRAIN, V137, P2564, DOI 10.1093/brain/awu176; Yu P, 2014, NEUROBIOL AGING, V35, P808, DOI 10.1016/j.neurobiolaging.2013.09.039; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	189	113	118	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUL	2015	11	7					865	884		10.1016/j.jalz.2015.04.005			20	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN1RS	WOS:000358198400014	26194320	Green Accepted, Green Submitted			2022-02-06	
J	Fulk, GD; Combs, SA; Danks, KA; Nirider, CD; Raja, B; Reisman, DS				Fulk, George D.; Combs, Stephanie A.; Danks, Kelly A.; Nirider, Coby D.; Raja, Bhavana; Reisman, Darcy S.			Accuracy of 2 Activity Monitors in Detecting Steps in People With Stroke and Traumatic Brain Injury	PHYSICAL THERAPY			English	Article							BERG BALANCE SCALE; PHYSICAL-ACTIVITY; COMMUNITY AMBULATION; WALKING SPEED; GAIT SPEED; RELIABILITY; REHABILITATION; PEDOMETERS; VALIDITY; AGREEMENT	Background. Advances in sensor technologies and signal processing techniques provide a method to accurately measure walking activity in the home and community. Activity monitors geared toward consumer or patient use may be an alternative to more expensive monitors designed for research to measure stepping activity. Objective. The objective of this study was to examine the accuracy of 2 consumer/patient activity monitors, the Fitbit Ultra and the Nike+ Fuelband, in identifying stepping activity in people with stroke and traumatic brain injury (TBI). Secondarily, the study sought to compare the accuracy of these 2 activity monitors with that of the Step Watch Activity Monitor (SAM) and a pedometer, the Yamax Digi-Walker SW-701 pedometer (YDWP). Design. A cross-sectional design was used for this study. Method. People with chronic stroke and TBI wore the 4 activity monitors while they performed the Two-Minute Walk Test (2MWT), during which they were video-taped. Activity monitor estimated steps taken were compared with actual steps taken counted from videotape. Accuracy and agreement between activity monitor estimated steps and actual steps were examined using intraclass correlation coefficients ([CC [2,11) and the Bland-Altman method. Results. The SAM demonstrated the greatest accuracy (ICC [2,1] =.97, mean difference between actual steps and SAM estimated steps=4.7 steps) followed by the Fitbit Ultra (ICC [2,1] =.73, mean difference between actual steps and Fitbit Ultra estimated steps=-9.7 steps), the YDWP (ICC [2,1] =.42, mean difference between actual steps and YDWP estimated steps=-28.8 steps), and the Nike+ Fuelband (ICC [2,1] =.20, mean difference between actual steps and Nike+ Fuelband estimated steps=-66.2 steps). Limitations. Walking activity was measured over a short distance in a closed environment, and participants were high functioning ambulators, with a mean gait speed of 0.93 m/s. Conclusions. The Fitbit Ultra may be a low-cost alternative to measure the stepping activity in level, predictable environments of people with stroke and TBI who can walk at speeds >= 0.58 m/s.	[Fulk, George D.] Clarkson Univ, Phys Therapy Dept, Potsdam, NY 13699 USA; [Combs, Stephanie A.] Univ Indianapolis, Krannert Sch Phys Therapy, Indianapolis, IN 46227 USA; [Danks, Kelly A.; Reisman, Darcy S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Nirider, Coby D.] Touchstone Neurorecovery Ctr, Conroe, TX USA; [Raja, Bhavana] Western Univ, Coll Allied Hlth Profess, Pomona, CA USA		Fulk, GD (corresponding author), Clarkson Univ, Phys Therapy Dept, 8 Clarkson Ave, Potsdam, NY 13699 USA.	gfulk@clarkson.edu		Miller, Stephanie A./0000-0002-7810-186X; Raja, Bhavana/0000-0003-3328-3732			Altman D.G., 1990, PRACTICAL STAT MED R; ALTMAN DG, 1991, PRACTICAL STAT MED R, P398; ANDREWS K, 1979, RHEUMATOL REHABIL, V18, P43, DOI 10.1093/rheumatology/18.1.43; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; BOHANNON RW, 1988, INT J REHABIL RES, V11, P181, DOI 10.1097/00004356-198806000-00012; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Carroll SL, 2012, ARCH PHYS MED REHAB, V93, P466, DOI 10.1016/j.apmr.2011.08.047; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Dobkin BH, 2011, NEUROREHAB NEURAL RE, V25, P788, DOI 10.1177/1545968311425908; Elsworth C, 2009, CLIN REHABIL, V23, P171, DOI 10.1177/0269215508098895; Feito Y, 2012, MED SCI SPORT EXER, V44, P733, DOI 10.1249/MSS.0b013e3182351913; Feld JA, 2001, NEUROREHAB NEURAL RE, V15, P239, DOI 10.1177/154596830101500312; Fulk George D, 2008, J Neurol Phys Ther, V32, P8, DOI 10.1097/NPT0b013e31816593c0; Fulk GD, 2011, TOP STROKE REHABIL, V18, P746, DOI 10.1310/tsr1806-746; Fulk GD, 2011, J NEUROL PHYS THER, V35, P82, DOI 10.1097/NPT.0b013e318218e2f2; Gebruers N, 2010, ARCH PHYS MED REHAB, V91, P288, DOI 10.1016/j.apmr.2009.10.025; Gorter JW, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/329284; Haeuber E, 2004, ARCH PHYS MED REHAB, V85, P1997, DOI 10.1016/j.apmr.2003.11.035; Ivey F M, 2005, Top Stroke Rehabil, V12, P1; Jain NB, 2007, AM J PHYS MED REHAB, V86, P387, DOI 10.1097/PHM.0b013e31804a7d00; Le Masurier GC, 2004, MED SCI SPORT EXER, V36, P905, DOI 10.1249/01.MSS.0000126777.50188.73; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Lord SE, 2005, STROKE, V36, P1457, DOI 10.1161/01.STR.0000170698.20376.2e; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Lord S, 2008, STROKE, V39, pE75, DOI 10.1161/STROKEAHA.107.502203; Macko RF, 2002, MED SCI SPORT EXER, V34, P394, DOI 10.1097/00005768-200203000-00002; Mannini A, 2010, SENSORS-BASEL, V10, P1154, DOI 10.3390/s100201154; Miller PA, 2002, PHYSIOTHER CAN, V54, P241; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Motl RW, 2011, DISABIL HEALTH J, V4, P52, DOI 10.1016/j.dhjo.2010.02.003; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Richards CL, 1999, CLIN GERIATR MED, V15, P833; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Saremi K, 2006, NEUROREHAB NEURAL RE, V20, P297, DOI 10.1177/1545968306287171; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1630; Shany T, 2012, IEEE SENS J, V12, P658, DOI 10.1109/JSEN.2011.2146246; Shaughnessy M, 2005, STROKE, V36, P1305, DOI 10.1161/01.STR.0000166202.00669.d2; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shuger SL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-41; Skidmore FM, 2008, J REHABIL RES DEV, V45, P1343, DOI 10.1682/JRRD.2008.01.0002; Storti KL, 2008, MED SCI SPORT EXER, V40, P59, DOI 10.1249/mss.0b013e318158b504; Taraldsen K, 2011, PHYS THER, V91, P277, DOI 10.2522/ptj.20100159; Tudor-Locke CE, 2001, RES Q EXERCISE SPORT, V72, P1; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314	48	113	113	1	35	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	FEB	2014	94	2					222	229		10.2522/ptj.20120525			8	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	304MK	WOS:000330750800006	24052577	Bronze			2022-02-06	
J	Llewellyn, T; Burdette, GT; Joyner, AB; Buckley, TA				Llewellyn, Tracy; Burdette, G. Trey; Joyner, A. Barry; Buckley, Thomas A.			Concussion Reporting Rates at the Conclusion of an Intercollegiate Athletic Career	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; reporting rates	PROFESSIONAL FOOTBALL PLAYERS; HISTORY; SPORT	Objective: The purpose of this study was to explore the current reported, unreported, and potentially unrecognized concussion rates among collegiate student-athletes who have completed their collegiate athletic career. Design: Retrospective survey. Setting: College and University athletic training rooms. Participants: One hundred sixty-one collegiate student-athletes (56.5% women; aged 21.5 +/- 1.3; 3.7 +/- 1.0 years of collegiate athletic experience) from 10 institutions who had either completed their intercollegiate athletic eligibility or were no longer participating. Main Outcome Measures: The self-reported concussion rate, the unreported rate and reasons, and the potentially unrecognized concussion rate. Results: The self-reported concussion rate was 33.5% (54/161), and 22.2% (12) self-reported at least 3 concussions. The unreported rate was 11.8% (19/161), and the potentially unrecognized rate was 26.1% (42/161) with the most common unrecognized symptom being "knocked silly/seen stars" (23.6% [38/161]). Conclusions: Overall, 49.7% of all respondents (80/161) reported 1 acknowledged, unreported, or potential concussion. The unreported rate was lower than previous high school studies; however, the potentially unrecognized rate remains high and should be clinically concerning. These findings suggest educational interventions targeting collegiate student-athletes should remain and continue to focus on identifying concussion symptoms and dispelling the common misconception that "bell ringers" and "dings" are not concussions.	[Llewellyn, Tracy] Valdosta State Univ, Dept Intercollegiate Athlet, Valdosta, GA USA; [Burdette, G. Trey; Joyner, A. Barry; Buckley, Thomas A.] Georgia So Univ, Dept Hlth & Kinesiol, Statesboro, GA 30460 USA		Buckley, TA (corresponding author), Georgia So Univ, Dept Hlth & Kinesiol, POB 8076, Statesboro, GA 30460 USA.	TBuckley@Georgiasouthern.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Llewellyn, Tracy/0000-0002-6483-2776			Boswell D, 2004, ARCH CLIN NEUROPSYCH, V19, P958; Echlin P. S., 2010, NEUROSURG FOCUS, V29, P1, DOI DOI 10.3171/2010.9FOCUS10187; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Register-Mihalik JK., 2011, J ATHL TRAINING, V46, pS15; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	10	113	113	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2014	24	1					76	79		10.1097/01.jsm.0000432853.77520.3d			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	AE0RZ	WOS:000333675200010	24157468				2022-02-06	
J	Kontos, AP; Elbin, RJ; Lau, B; Simensky, S; Freund, B; French, J; Collins, MW				Kontos, Anthony P.; Elbin, R. J.; Lau, Brian; Simensky, Steven; Freund, Brin; French, Jonathan; Collins, Michael W.			Posttraumatic Migraine as a Predictor of Recovery and Cognitive Impairment After Sport-Related Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; headache; migraine; mild traumatic brain injury; sports; symptoms	BRAIN-STEM ACTIVATION; MILD HEAD TRAUMA; HIGH-SCHOOL; PROTRACTED RECOVERY; DEPRESSION; OUTCOMES; INJURY; RISK	Background: Although previous research has demonstrated that patients with posttraumatic migraine (PTM) after concussion report more symptoms and cognitive deficits after injury than do those without PTM, it is not known whether these effects persist beyond the first week of injury or whether PTM predicts recovery time. Purpose: To determine whether PTM during the first week after injury predicts (1) cognitive impairment and symptoms in the second week after injury and (2) overall recovery time. Study Design: Cohort study; Level of evidence, 2. Methods: Participants were 138 male high school football players with a mean age of 15.96 years (SD, 1.18 years; range, 13-19 years). They were classified into 3 groups: PTM (headache, nausea, and photosensitivity or phonosensitivity), headache (headache without the other PTM symptoms), or no headache (no headache or PTM symptoms). The Immediate Post-concussion Assessment and Cognitive Test (ImPACT) was used to assess cognitive performance and symptoms at baseline, postinjury days 1-7, and postinjury days 8-14. Recovery time data were collected from medical records. Results: The PTM group performed worse on verbal memory than did the headache group at 8-14 days after injury. The PTM group performed worse on visual memory, reaction time, and symptoms than did the other groups at 1-7 days and 8-14 days after injury. The PTM group was 7.3 times (95% confidence interval, 1.80-29.91) more likely to have protracted recovery (>20 days) than the no headache group and 2.6 times (95% confidence interval, 1.10-6.54) more likely than the headache group. Conclusion: Results suggest that PTM is associated with cognitive impairments and protracted recovery and that headache alone is not a good predictor of recovery.	Univ Pittsburgh, Pittsburgh, PA USA; Humboldt State Univ, Arcata, CA 95521 USA		Kontos, AP (corresponding author), Univ Pittsburgh, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Kontos, Anthony/0000-0002-3749-4310			Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LARSSON LI, 1976, BRAIN RES, V113, P400, DOI 10.1016/0006-8993(76)90951-3; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Margulies S, 2000, J CLIN NEUROSCI, V7, P495, DOI 10.1054/jocn.1999.0773; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Neinstein L, 2000, J ADOLESCENT HEALTH, V27, P119, DOI 10.1016/S1054-139X(99)00099-3; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; TAYLOR AR, 1966, LANCET, V2, P178; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658	27	113	113	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2013	41	7					1497	1504		10.1177/0363546513488751			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	301HS	WOS:000330524000010	23698389				2022-02-06	
J	Dean, PJA; Sterr, A				Dean, Philip J. A.; Sterr, Annette			Long-term effects of mild traumatic brain injury on cognitive performance	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						head injury; minor; post-concussion syndrome; cognition; neuropsychological tests	POST-CONCUSSION SYMPTOMS; DEFAULT MODE NETWORK; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION-LIKE SYMPTOMS; WORKING-MEMORY LOAD; HEAD-INJURY; FUNCTIONAL MRI; NEUROPSYCHOLOGICAL PERFORMANCE; UNIVERSITY-STUDENTS; RESTING-STATE	Although a proportion of individuals report chronic cognitive difficulties after mild traumatic brain injury (mTBI), results from behavioral testing have been inconsistent. In fact, the variability inherent to the mTBI population may be masking subtle cognitive deficits. We hypothesized that this variability could be reduced by accounting for post-concussion syndrome (PCS) in the sample. Thirty-six participants with mTBI (> 1 year post-injury) and 36 non-head injured controls performed information processing speed (Paced Visual Serial Addition Task, PVSAT) and working memory (n-Back) tasks. Both groups were split by PCS diagnosis (4 groups, all n = 18), with categorization of controls based on symptom report. Participants with mTBI and persistent PCS had significantly greater error rates on both the n-Back and PVSAT, at every difficulty level except 0-Back (used as a test of performance validity). There was no difference between any of the other groups. Therefore, a cognitive deficit can be observed in mTBI participants, even 1 year after injury. Correlations between cognitive performance and symptoms were only observed for mTBI participants, with worse performance correlating with lower sleep quality, in addition to a medium effect size association (falling short of statistical significance) with higher PCS symptoms, post-traumatic stress disorder (PTSD), and anxiety. These results suggest that the reduction in cognitive performance is not due to greater symptom report itself, but is associated to some extent with the initial injury. Furthermore, the results validate the utility of our participant grouping, and demonstrate its potential to reduce the variability observed in previous studies.	[Dean, Philip J. A.; Sterr, Annette] Univ Surrey, Dept Psychol, Guildford GU2 7XH, Surrey, England		Dean, PJA (corresponding author), Univ Surrey, Dept Psychol, Guildford GU2 7XH, Surrey, England.	p.dean@surrey.ac.uk		Dean, Philip/0000-0002-2362-513X	Wingate Foundation Scholarship, UK	This study was supported by a Wingate Foundation Scholarship, UK. We would like to thank Darragh O'Neill for his help in the preparation of this manuscript.	American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell BD, 1999, ARCH CLIN NEUROPSYCH, V14, P389, DOI 10.1016/S0887-6177(98)00020-1; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Cohen J., 2013, STAT POWER ANAL BEHA; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Fos L A, 2000, Appl Neuropsychol, V7, P140, DOI 10.1207/S15324826AN0703_4; GILLBERG M, 1994, SLEEP, V17, P236, DOI 10.1093/sleep/17.3.236; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kemp S, 2008, J PSYCHOSOM RES, V65, P319, DOI 10.1016/j.jpsychores.2008.02.010; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moore E, 2006, PARIS REV, P117; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; NCIPC, 2003, REP C MILD TRAUM BRA; Nelson H.E., 1982, NATL ADULT READING T; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Pella RD, 2012, ARCH CLIN NEUROPSYCH, V27, P45, DOI 10.1093/arclin/acr090; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Ptito A, 2007, NEUROREHABILITATION, V22, P217; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sandrone S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00261; Sandrone S, 2012, J NEUROSCI, V32, P1915, DOI 10.1523/JNEUROSCI.5637-11.2012; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Solbakk AK, 2005, J CLIN EXP NEUROPSYC, V27, P205, DOI 10.1080/13803390490515739; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Weiss D. S, 2007, CROSS CULTURAL ASSES, P218; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543	104	113	120	2	80	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 12	2013	7								30	10.3389/fnhum.2013.00030			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	101MP	WOS:000315779400001	23408228	Green Published, gold			2022-02-06	
J	Slobounov, SM; Gay, M; Zhang, K; Johnson, B; Pennell, D; Sebastianelli, W; Horovitz, S; Hallett, M				Slobounov, S. M.; Gay, M.; Zhang, K.; Johnson, B.; Pennell, D.; Sebastianelli, W.; Horovitz, S.; Hallett, M.			Alteration of brain functional network at rest and in response to YMCA physical stress test in concussed athletes: RsFMRI study	NEUROIMAGE			English	Article						Mild traumatic brain injury (mTBI); Resting state fMRI (rsFMRI); YMCA physical stress test	DIFFUSE AXONAL INJURY; ALZHEIMERS-DISEASE; CORPUS-CALLOSUM; MILD; CONNECTIVITY; ABNORMALITIES; MRI; FMRI; SYMPTOMS; SCALE	There is still controversy in the literature whether a single episode of mild traumatic brain injury (mTBI) results in short- and/or long-term functional and structural deficits in the concussed brain. With the inability of traditional brain imaging techniques to properly assess the severity of brain damage induced by a concussive blow, there is hope that more advanced applications such as resting state functional magnetic resonance imaging (rsFMRI) will be more specific in accurately diagnosing mTBI. In this rsFMRI study, we examined 17 subjects 10 +/- 2 days post-sports-related mTBI and 17 age-matched normal volunteers (NVs) to investigate the possibility that the integrity of the resting state brain network is disrupted following a single concussive blow. We hypothesized that advanced brain imaging techniques may reveal subtle alterations of functional brain connections in asymptomatic mTBI subjects. There are several findings of interest. All mTBI subjects were asymptomatic based upon clinical evaluation and neuropsychological (NP) assessments prior to the MRI session. The mTBI subjects revealed a disrupted functional network both at rest and in response to the YMCA physical stress test. Specifically, interhemispheric connectivity was significantly reduced in the primary visual cortex, hippocampal and dorsolateral prefrontal cortex networks (p < 0.05). The YMCA physical stress induced nonspecific and similar changes in brain network connectivity patterns in both the mTBI and NV groups. These major findings are discussed in relation to underlying mechanisms, clinical assessment of mTBI, and current debate regarding functional brain connectivity in a clinical population. Overall, our major findings clearly indicate that functional brain alterations in the acute phase of injury are overlooked when conventional clinical and neuropsychological examinations are used. (C) 2011 Elsevier Inc. All rights reserved.	[Slobounov, S. M.; Gay, M.; Zhang, K.; Johnson, B.] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Slobounov, S. M.; Horovitz, S.; Hallett, M.] NINDS, NIH, Bethesda, MD USA; [Pennell, D.] Penn State Univ, Chandlee Lab, Social Life & Engn Sci Imaging Ctr, University Pk, PA 16802 USA; [Slobounov, S. M.; Gay, M.; Sebastianelli, W.] Penn State Univ, Dept Orthopaed & Med Rehabil, HMC, University Pk, PA 16802 USA		Slobounov, SM (corresponding author), Penn State Univ, Dept Kinesiol, 19 Recreat Bldg, University Pk, PA 16802 USA.	sms18@psu.edu	Li, Yiou/G-4991-2010; Zhang, Kai/F-3261-2015	Zhang, Kai/0000-0002-5460-6150; Horovitz, Silvina G./0000-0002-5501-5918	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS056227-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002667, ZIANS002669, R01NS056227] Funding Source: NIH RePORTER	This study was supported by NIH Grant RO1 NS056227-01A2 "Identification of Athletes at Risk for Traumatic Brain Injury" awarded to Dr. Slobounov, PI.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Cao C, CLIN NEUROP IN PRESS; Cao C., 2009, IEEE T NEURAL SYST R; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; ELBERT T, 1992, BIOL PSYCHIAT, V32, P595, DOI 10.1016/0006-3223(92)90072-8; FITZPATRICK NM, 2008, 36 ANN M INT NEUR SO; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FOSTER JK, 1994, COGNITIVE NEUROPSYCH, V11, P133, DOI 10.1080/02643299408251971; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Gates KM, 2011, NEUROIMAGE, V54, P1151, DOI 10.1016/j.neuroimage.2010.08.051; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jeong J, 1998, ELECTROEN CLIN NEURO, V106, P220, DOI 10.1016/S0013-4694(97)00079-5; Jerbi K, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00027; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marquez de la Plata C., ARCH NEUROL IN PRESS; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Purves D., 2007, NEUROSCIENCE; Quigley M, 2003, AM J NEURORADIOL, V24, P208; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rosenbaum RS, 2010, NEUROBIOL AGING, V31, P780, DOI 10.1016/j.neurobiolaging.2008.06.002; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Silberstein RB, 2004, BRAIN TOPOGR, V16, P249; Slobounov S, 2009, EXP BRAIN RES, V199, P1, DOI 10.1007/s00221-009-1956-5; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Trimble MR, 2008, HBK BEHAV NEUROSCI, V18, P363, DOI 10.1016/S1569-7339(08)00220-8; TRIMBLE MR, 1990, SEMIN NEUROL, V10, P287, DOI 10.1055/s-2008-1041280; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wang K, 2006, LECT NOTES COMPUT SC, V4191, P340; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	58	113	116	0	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	APR 15	2011	55	4					1716	1727		10.1016/j.neuroimage.2011.01.024			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	741DO	WOS:000288843500033	21255654	Green Accepted			2022-02-06	
J	Anderson, V; Brown, S; Newitt, H; Hoile, H				Anderson, Vicki; Brown, Sandra; Newitt, Heidi; Hoile, Hannah			Long-Term Outcome From Childhood Traumatic Brain Injury: Intellectual Ability, Personality, and Quality of Life	NEUROPSYCHOLOGY			English	Article						child traumatic brain injury; adult outcome; IQ; personality; quality of life	HEAD-INJURY; EXECUTIVE FUNCTION; CHILDREN; RECOVERY; TBI; AGE	Objective: Only a handful of studies have attempted to explore very long-term outcomes from childhood traumatic brain injury (TB!). These studies have generally failed to fully consider the impact of injury severity or employ measures sensitive to the survivor's day-to-day function. This study examined outcomes in adulthood, with a focus on functional abilities including education, employment, and quality of life (QOL), and employed predictors including injury severity, age at injury, socioeconomic factors, intelligence, and personality. Method: The study was retrospective and cross-sectional and included 50 adult survivors of child TBI (31 males), aged 19-30 years at evaluation (M = 24.2, SD = 3.6), with injury on average 13.3 years prior to evaluation. Participants were divided according to injury severity mild (n = 20), moderate (n = 12), and severe (n = 18) completed an intellectual evaluation and questionnaires regarding educational and employment status, personality, and quality of life. Results: Intellectual and personality measures indicated good outcomes, with mean scores for all groups in the average range and few severity-based findings. In contrast, those with more severe TBI were more likely to have educational and employment problems. QOL was significantly reduced in the context of severe insult, with lower IQ and personality factors most predictive of outcome in this domain. Mild and moderate TBI were generally more benign. Conclusions: Findings suggest that, while TBI is a lifelong problem, its impact is most dramatic in the domain of QOL, where a complex interaction occurs between injury factors, cognition, and personality.	[Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Newitt, Heidi; Hoile, Hannah] Univ Melbourne, Dept Psychol Sci, Melbourne, Vic 3010, Australia		Anderson, V (corresponding author), Royal Childrens Hosp, Dept Psychol, Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au					Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; *AUSTR BUR STAT, 2006, DIS LONG TERM HLTH C; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Costa P. T., 1992, REVISED NEO PERSONAL; Daniel A., 1983, POWER PRIVILEGE PRES; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; MAX J, 1997, J AM ACAD CHILD ADOL, V36, P83; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Nybo T, 1999, BRAIN INJURY, V13, P759; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	36	113	113	1	31	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2011	25	2					176	184		10.1037/a0021217			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	731ZF	WOS:000288149000005	21219074				2022-02-06	
J	Honeybul, S				Honeybul, S.			Complications of decompressive craniectomy for head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Complications; Decompressive craniectomy; Neurotrauma; Head injury	TRAUMATIC BRAIN-INJURY; NEUROSURGICAL SITE INFECTIONS; SURGICAL DECOMPRESSION; SUBDURAL HYGROMA; RISK-FACTORS; CRANIOPLASTY; CRANIOTOMY; CHILDREN; EDEMA; PATHOGENESIS	There is much interest in the use of decompressive craniectomy for intracranial hypertension. Whilst technically straightforward, the procedure is not without significant complications. A retrospective analysis was undertaken of 41 patients who had had a decompressive craniectomy for severe head injury in the years 2006 and 2007 at the two major hospitals in Western Australia, Sir Charles Gairdner Hospital and Royal Perth Hospital. Complications attributable to the decompressive surgery were: herniation of the cortex through the bone defect, 18 patients (51%); subdural effusion, 22 patients (62%); seizures, five patients (14%) and hydrocephalus, four patients (11%). Complications attributable to the subsequent cranioplasty were: infection, four patients (11%) and bone flap resorption, six patients (17%). Syndrome of the trephined occurred in three (7%) of those patients whose bone flap had significantly resorbed. Two deaths (5.5%) occurred as a direct complication of the craniectomy or cranioplasty procedure. I attempted to define what may be regarded as a complication of the decompressive procedure rather than what may be a consequence of the primary pathological process of traumatic brain injury. (C) 2009 Elsevier Ltd. All rights reserved.	[Honeybul, S.] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia; [Honeybul, S.] Royal Perth Hosp, Nedlands, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Nedlands, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; Csokay A, 2001, NEUROSURG REV, V24, P209, DOI 10.1007/s101430100158; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Groswasser Z, 1988, Brain Inj, V2, P267, DOI 10.3109/02699058809150897; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guyot LL, 2000, NEUROL RES, V22, P25; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Idali B, 2004, MED MALADIES INFECT, V34, P221, DOI 10.1016/j.medmal.2003.12.011; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Korinek AM, 2005, BRIT J NEUROSURG, V19, P155, DOI 10.1080/02688690500145639; Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Licata C, 2001, J Neurosurg Sci, V45, P141; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tokoro K, 1989, Neurol Med Chir (Tokyo), V29, P196, DOI 10.2176/nmc.29.196; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	34	113	127	1	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2010	17	4					430	435		10.1016/j.jocn.2009.09.007			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	574SU	WOS:000276014600004	20181482				2022-02-06	
J	Chaichana, KL; Pradilla, G; Huang, J; Tamargo, RJ				Chaichana, Kaisorn L.; Pradilla, Gustavo; Huang, Judy; Tamargo, Rafael J.			Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage	WORLD NEUROSURGERY			English	Article						Endothelial cells; Haptoglobin; Hemoglobin; Inflammation; Leukocytes; Subarachnoid hemorrhage; Vasospasm	CEREBRAL-BLOOD-FLOW; INTERCELLULAR-ADHESION MOLECULE-1; CONTROLLED-RELEASE POLYMER; SERINE-PROTEASE INHIBITOR; NITRIC-OXIDE DONOR; C-REACTIVE PROTEIN; TRANSLUMINAL BALLOON ANGIOPLASTY; HAPTOGLOBIN-HEMOGLOBIN COMPLEX; FUNCTION-ASSOCIATED ANTIGEN-1; VEHICLE-CONTROLLED TRIAL	Background: Delayed vasospasm is the leading cause of morbidity and mortality after aneurysmal subarachnoid hemorrhage (aSAH). This phenomenon was first described more than 50 years ago, but only recently has the role of inflammation in this condition become better understood. Methods: The literature was reviewed for studies on delayed vasospasm and inflammation. Results: There is increasing evidence that inflammation and, more specifically, leukocyte-endothelial cell interactions play a critical role in the pathogenesis of vasospasm after aSAH, as well as in other conditions including meningitis and traumatic brain injury. Although earlier clinical observations and indirect experimental evidence suggested an association between inflammation and chronic vasospasm, recently direct molecular evidence demonstrates the central role of leukocyte-endothelial cell interactions in the development of chronic vasospasm. This evidence shows in both clinical and experimental studies that cell adhesion molecules (CAMs) are up-regulated in the perivasospasm period. Moreover, the use of monoclonal antibodies against these CAMs, as well as drugs that decrease the expression of CAMs, decreases vasospasm in experimental studies. It also appears that certain individuals are genetically predisposed to a severe inflammatory response after aSAH based on their haptoglobin genotype, which in turn predisposes them to develop clinically symptomatic vasospasm. Conclusion: Based on this evidence, leukocyte-endothelial cell interactions appear to be the root cause of chronic vasospasm. This hypothesis predicts many surprising features of vasospasm and explains apparently unrelated phenomena observed in aSAH patients. Therapies aimed at preventing inflammation may prevent and/or reverse arterial narrowing in patients with aSAH and result in improved outcomes. (C) 2010 Elsevier Inc. All rights reserved.	[Chaichana, Kaisorn L.; Pradilla, Gustavo; Huang, Judy; Tamargo, Rafael J.] Johns Hopkins Univ, Sch Med, Div Cerebrovasc Neurosurg, Dept Neurosurg, Baltimore, MD 21205 USA		Tamargo, RJ (corresponding author), Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA.	rtamarg@jhmi.edu		Huang, Judy/0000-0002-0675-1935			Agarwal N, 2007, ADV EXP MED BIOL, V618, P195; AGIL A, 1995, CLIN CHEM, V41, P220; Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.me.38.020187.001135; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Asleh R, 2005, CIRC RES, V96, P435, DOI 10.1161/01.RES.0000156653.05853.b9; Atkinson SH, 2007, CLIN INFECT DIS, V44, P802, DOI 10.1086/511868; Bavbek M, 1998, STROKE, V29, P1930, DOI 10.1161/01.STR.29.9.1930; Beijani GK, 1997, NEUROCHIRURGIE, V43, P164; Blum S, 2007, J AM COLL CARDIOL, V49, P82, DOI 10.1016/j.jacc.2006.08.044; Borsody M, 2006, NEUROLOGY, V66, P634, DOI 10.1212/01.wnl.0000200781.62172.1d; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; BOWMAN BH, 1982, ADV HUM GENET, V12, P453; Bowman G, 2004, NEUROSURGERY, V54, P719, DOI 10.1227/01.NEU.0000108981.73153.6E; Bowman G, 2006, NEUROCRIT CARE, V5, P222, DOI 10.1385/NCC:5:3:222; Bruder N, 1998, ANESTH ANALG, V86, P320, DOI 10.1097/00000539-199802000-00020; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; CHAICHANA K, 2007, NEUROSURGERY, V60, pE207; Chaichana Kaisorn, 2007, Neurosurgery, V60, pE206, DOI 10.1227/01.NEU.0000249193.68904.B4; Chaichana KL, 2007, STROKE, V38, P3266, DOI 10.1161/STROKEAHA.107.490003; Chan JR, 2001, J EXP MED, V193, P1149, DOI 10.1084/jem.193.10.1149; CHAPELLE JP, 1982, NEW ENGL J MED, V307, P457, DOI 10.1056/NEJM198208193070801; Chello M, 2004, J CARDIOTHOR VASC AN, V18, P605, DOI 10.1053/j.jvca.2004.07.019; CHYATTE D, 1984, J NEUROSURG, V60, P923, DOI 10.3171/jns.1984.60.5.0923; CHYATTE D, 1987, NEUROSURGERY, V21, P157, DOI 10.1227/00006123-198708000-00004; CHYATTE D, 1989, STROKE, V20, P1021, DOI 10.1161/01.STR.20.8.1021; CHYATTE D, 1983, J NEUROSURG, V59, P925, DOI 10.3171/jns.1983.59.6.0925; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Clatterbuck RE, 2003, J NEUROSURG, V99, P376, DOI 10.3171/jns.2003.99.2.0376; Clatterbuck RE, 2002, J NEUROSURG, V97, P676, DOI 10.3171/jns.2002.97.3.0676; CLOZEL M, 1993, NATURE, V365, P759, DOI 10.1038/365759a0; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; COSENTINO F, 1993, J CARDIOVASC PHARM, V22, pS332, DOI 10.1097/00005344-199322008-00087; Costacou T, 2008, DIABETES, V57, P1702, DOI 10.2337/db08-0095; CROMPTON MR, 1964, BRAIN, V87, P491, DOI 10.1093/brain/87.3.491; Cuzzocrea S, 2005, PHARMACOL RES, V52, P72, DOI 10.1016/j.phrs.2005.02.016; DAHLQVIST SR, 1985, HUM HERED, V35, P207; DAHLQVIST SR, 1988, HUM HERED, V38, P44; Datta PK, 2006, BIOMED PHARMACOTHER, V60, P561, DOI 10.1016/j.biopha.2006.07.087; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; Doering TJ, 1996, AM J PHYS MED REHAB, V75, P408, DOI 10.1097/00002060-199611000-00002; Doo YC, 2005, CLIN CARDIOL, V28, P72, DOI 10.1002/clc.4960280206; DORSCH NWC, 1995, BRIT J NEUROSURG, V9, P403, DOI 10.1080/02688699550041403; DULKERIAN SJ, 1995, J PEDIATR-US, V126, P872, DOI 10.1016/S0022-3476(95)70199-0; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; EDWARDS DH, 1992, J NEUROSURG, V76, P830, DOI 10.3171/jns.1992.76.5.0830; EDWARDS DH, 1986, CARDIOVASC RES, V20, P549, DOI 10.1093/cvr/20.8.549; EGEMEN N, 1993, NEUROL RES, V15, P310; Egge A, 2001, NEUROSURGERY, V49, P593, DOI 10.1097/00006123-200109000-00012; el Hendawy M, 2000, Neurol Neurochir Pol, V34, P114; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Elnoamany MF, 2007, J AM SOC ECHOCARDIOG, V20, P462, DOI 10.1016/j.echo.2006.10.003; ENDO A, 1992, J LIPID RES, V33, P1569; Fassbender K, 1996, J NEUROL NEUROSUR PS, V61, P57, DOI 10.1136/jnnp.61.1.57; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; FASSBENDER K, 1997, J NEUROIMMUNOL; Feigin VL, 1998, NEUROLOGY, V50, P876, DOI 10.1212/WNL.50.4.876; FERRIS EJ, 1968, RADIOLOGY, V90, P727, DOI 10.1148/90.4.727; Filer Andrew, 1800, Discov Med, V7, P20; FINDLAY JM, 1995, NEUROSURGERY, V37, P168, DOI 10.1227/00006123-199507000-00041; Fisher C M, 1977, Neurosurgery, V1, P245; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Florey H, 1925, BRAIN, V48, P43, DOI 10.1093/brain/48.1.43; Frazier JL, 2004, J NEUROSURG, V101, P93, DOI 10.3171/jns.2004.101.1.0093; Gabikian P, 2002, STROKE, V33, P2681, DOI 10.1161/01.STR.0000033931.62992.B1; Gaetani P, 1998, NEUROL RES, V20, P337, DOI 10.1080/01616412.1998.11740528; Gallia GL, 2006, NEUROL RES, V28, P750, DOI 10.1179/016164106X152025; German JW, 1996, NEUROSURGERY, V39, P141, DOI 10.1097/00006123-199607000-00028; GIBLETT E R, 1963, J Forensic Sci, V8, P446; Green G A, 2001, Clin Cornerstone, V3, P50, DOI 10.1016/S1098-3597(01)90069-9; GRIFFITH TM, 1984, NATURE, V308, P645, DOI 10.1038/308645a0; GULL W, 1859, GUYS HOSP REP, V5, P281; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; HALEY EC, 1994, J NEUROSURG, V80, P788, DOI 10.3171/jns.1994.80.5.0788; HAMANN G, 1993, STROKE, V24, P383, DOI 10.1161/01.STR.24.3.383; HANDA Y, 1991, NEUROSURGERY, V28, P542, DOI 10.1227/00006123-199104000-00010; HANDA Y, 1995, ACTA NEUROCHIR, V132, P92, DOI 10.1007/BF01404854; HANDA Y, 1991, NEUROSURGERY, V28, P380, DOI 10.1227/00006123-199103000-00007; HASHI K, 1988, Brain and Nerve (Tokyo), V40, P373; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Henker R, 2007, AACN ADV CRIT CARE, V18, P76, DOI 10.1097/01256961-200701000-00010; HIJDRA A, 1988, STROKE, V19, P1250, DOI 10.1161/01.STR.19.10.1250; Hino A, 1996, J CEREBR BLOOD F MET, V16, P688, DOI 10.1097/00004647-199607000-00020; Hofbauer R, 1999, LIFE SCI, V65, P2453, DOI 10.1016/S0024-3205(99)00511-1; Hoh BL, 2005, NEUROSURG CLIN N AM, V16, P501, DOI 10.1016/j.nec.2005.04.004; HOOPER DC, 1981, BIOCHIM BIOPHYS ACTA, V653, P118, DOI 10.1016/0005-2787(81)90110-6; HOSHI T, 1984, Neurologia Medico-Chirurgica, V24, P647, DOI 10.2176/nmc.24.647; Huang J, 2000, STROKE, V31, P3047, DOI 10.1161/01.STR.31.12.3047; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; HUGHES JT, 1978, J NEUROSURG, V48, P515, DOI 10.3171/jns.1978.48.4.0515; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; JACKSON IJ, 1949, ARCH NEURO PSYCHIATR, V62, P572, DOI 10.1001/archneurpsyc.1949.02310170047004; Jaffar Z, 2007, J IMMUNOL, V179, P6193, DOI 10.4049/jimmunol.179.9.6193; JAVID J, 1965, VOX SANG, V10, P320, DOI 10.1111/j.1423-0410.1965.tb01396.x; Jost SC, 2005, J NEUROSURG, V103, P25, DOI 10.3171/jns.2005.103.1.0025; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kaminogo M, 1998, NEUROL MED-CHIR, V38, P704, DOI 10.2176/nmc.38.704; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Kapiotis S, 1996, LIFE SCI, V58, P2167, DOI 10.1016/0024-3205(96)00210-X; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KASSELL NF, 1992, J NEUROSURG, V77, P848, DOI 10.3171/jns.1992.77.6.0848; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Kasuya H, 2005, NEUROSURGERY, V56, P895; KASUYA H, 1989, J NEUROSURG, V71, P741, DOI 10.3171/jns.1989.71.5.0741; Kaynar MY, 2004, J NEUROSURG, V101, P1030, DOI 10.3171/jns.2004.101.6.1030; Keyrouz SG, 2007, CRIT CARE, V11, DOI 10.1186/cc5958; KINO K, 1980, J BIOL CHEM, V255, P9616; KINO K, 1987, J HISTOCHEM CYTOCHEM, V35, P381, DOI 10.1177/35.3.3546486; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; Kinouchi H, 2004, NEUROL MED-CHIR, V44, P569, DOI 10.2176/nmc.44.569; Klimo P, 2004, J NEUROSURG, V100, P215, DOI 10.3171/jns.2004.100.2.0215; Koh KK, 2004, INT J CARDIOL, V95, P185, DOI 10.1016/j.ijcard.2003.05.018; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOHLER W, 1978, NATURE, V271, P373, DOI 10.1038/271373a0; Kordestani RK, 1997, NEUROSURGERY, V41, P351, DOI 10.1097/00006123-199708000-00003; Kramer AH, 2008, NEUROSURGERY, V62, P422, DOI 10.1227/01.neu.0000316009.19012.e3; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lange V, 1992, Anthropol Anz, V50, P281; Langlois MR, 1996, CLIN CHEM, V42, P1589; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Lemanske RF, 1997, JAMA-J AM MED ASSOC, V278, P1855, DOI 10.1001/jama.278.22.1855; Lennihan L, 2000, STROKE, V31, P383, DOI 10.1161/01.STR.31.2.383; Levy AP, 2007, ARTERIOSCL THROM VAS, V27, P134, DOI 10.1161/01.ATV.0000251020.24399.a2; Levy AP, 2003, ACTA DIABETOL, V40, pS330, DOI 10.1007/s00592-003-0114-y; LEY K, 1991, BLOOD, V77, P2553; Lin CL, 2005, SURG NEUROL, V64, P201, DOI 10.1016/j.surneu.2005.04.038; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; Mack WJ, 2007, NEUROSURGERY, V61, P255, DOI 10.1227/01.NEU.0000255518.96837.8E; Mack WJ, 2002, J NEUROSURG, V96, P71, DOI 10.3171/jns.2002.96.1.0071; Maiuri F, 1987, J Neurosurg Sci, V31, P45; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Manno EM, 1997, NEUROSURGERY, V40, P289, DOI 10.1097/00006123-199702000-00010; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Mascia L, 2001, STROKE, V32, P1185, DOI 10.1161/01.STR.32.5.1185; MATSUMURA Y, 1991, LIFE SCI, V49, P841, DOI 10.1016/0024-3205(91)90249-B; MCCORMICK DJ, 1990, J PROTEIN CHEM, V9, P735, DOI 10.1007/BF01024768; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; McGirt MJ, 2002, STROKE, V33, P2950, DOI 10.1161/01.STR.0000038986.68044.39; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Mocco J, 2002, J NEUROSURG, V97, P537, DOI 10.3171/jns.2002.97.3.0537; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; MORI T, 1995, NEUROPATH APPL NEURO, V21, P378, DOI 10.1111/j.1365-2990.1995.tb01074.x; MORI T, 1994, J VET MED SCI, V56, P535, DOI 10.1292/jvms.56.535; MORI T, 1993, J VET MED SCI, V55, P581, DOI 10.1292/jvms.55.581; Muizelaar JP, 1999, J NEUROSURG, V91, P51, DOI 10.3171/jns.1999.91.1.0051; Mukai AO, 2006, PEDIATR NEUROL, V34, P25, DOI 10.1016/j.pediatrneurol.2005.06.003; Nagata K, 1996, SURG NEUROL, V45, P442, DOI 10.1016/0090-3019(95)00455-6; NAGATA K, 1993, J NEUROSURG, V79, P710, DOI 10.3171/jns.1993.79.5.0710; Nam DH, 2001, NEUROSCI LETT, V312, P41, DOI 10.1016/S0304-3940(01)02194-2; NEILDWYER G, 1974, BRAIN, V97, P79, DOI 10.1093/brain/97.1.79; Niikawa S, 1998, NEUROL MED-CHIR, V38, P844, DOI 10.2176/nmc.38.844; Niikawa Shuji, 1997, Neurologia Medico-Chirurgica, V37, P881, DOI 10.2176/nmc.37.881; Nishizawa S, 2005, TRENDS CARDIOVAS MED, V15, P24, DOI 10.1016/j.tcm.2004.12.002; Nishizawa S, 2000, ACTA NEUROCHIR, V142, P1409, DOI 10.1007/s007010070013; NISHIZAWA S, 1993, NEUROSURGERY, V32, P986, DOI 10.1227/00006123-199306000-00018; Nissen JJ, 2000, ACT NEUR S, V76, P55; Nissen JJ, 2001, J NEUROL NEUROSUR PS, V71, P329, DOI 10.1136/jnnp.71.3.329; Nissim A., 2008, V181, P3; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Oshiro EM, 1997, STROKE, V28, P2031, DOI 10.1161/01.STR.28.10.2031; OSTERGAARD JR, 1987, J NEUROSURG, V66, P891, DOI 10.3171/jns.1987.66.6.0891; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Parra A, 2005, NEUROSURGERY, V56, P476, DOI 10.1227/01.NEU.0000153925.96889.8A; PELLETTIERI L, 1981, EXPERIENTIA, V37, P1170, DOI 10.1007/BF01989900; PELLETTIERI L, 1986, NEUROSURGERY, V19, P767, DOI 10.1227/00006123-198611000-00008; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PETERSON JW, 1990, STROKE, V21, P133, DOI 10.1161/01.STR.21.1.133; PETERSON JW, 1990, J NEUROSURG, V72, P767, DOI 10.3171/jns.1990.72.5.0767; PFISTER HW, 1992, NEUROLOGY, V42, P1497, DOI 10.1212/WNL.42.8.1497; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; PIGOTT R, 1992, BIOCHEM BIOPH RES CO, V187, P584, DOI 10.1016/0006-291X(92)91234-H; PIMSTONE NR, 1971, J EXP MED, V133, P1264, DOI 10.1084/jem.133.6.1264; Pluta RM, 2005, JAMA-J AM MED ASSOC, V293, P1477, DOI 10.1001/jama.293.12.1477; Pluta RM, 1997, J NEUROSURG, V87, P287, DOI 10.3171/jns.1997.87.2.0287; Pluta RM, 1997, J NEUROSURG, V87, P746, DOI 10.3171/jns.1997.87.5.0746; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Pluta RM, 2006, NEUROL RES, V28, P730, DOI 10.1179/016164106X152052; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Polin RS, 1998, NEUROSURGERY, V42, P1256, DOI 10.1097/00006123-199806000-00031; Pozzesi N, 2007, J CHEMOTHERAPY, V19, P562, DOI 10.1179/joc.2007.19.5.562; Pradilla G, 2005, NEUROSURGERY, V57, P184, DOI 10.1227/01.NEU.0000163604.52273.28; Pradilla G, 2004, NEUROSURGERY, V55, P1393, DOI 10.1227/01.NEU.0000143615.26102.1A; Pradilla G, 2004, J NEUROSURG, V101, P88, DOI 10.3171/jns.2004.101.1.0088; Pritchard DI, 2005, DRUG DISCOV TODAY, V10, P688, DOI 10.1016/S1359-6446(05)03395-7; Qureshi AI, 2000, CRIT CARE MED, V28, P984, DOI 10.1097/00003246-200004000-00012; Recinos PF, 2006, SURG NEUROL, V66, P463, DOI 10.1016/j.surneu.2006.04.010; Rezaie-Majd A, 2003, ARTERIOSCL THROM VAS, V23, P397, DOI 10.1161/01.ATV.0000059384.34874.F0; Ries S, 1997, J NEUROL, V244, P51; Rinkel GJ, 2004, COCHRANE DB SYST REV; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Rittner Heike L, 2007, Curr Rheumatol Rep, V9, P503, DOI 10.1007/s11926-007-0081-3; ROBERTSON EG, 1949, BRAIN, V72, P150, DOI 10.1093/brain/72.2.150; Rosen S D, 1993, Semin Immunol, V5, P237, DOI 10.1006/smim.1993.1028; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Rothoerl RD, 2006, J NEUROSURG ANESTH, V18, P68, DOI 10.1097/01.ana.0000181693.30750.af; ROUSSEAUX P, 1980, SURG NEUROL, V14, P459; Rowe BH, 2008, CAN RESPIR J, V15, P20, DOI 10.1155/2008/431390; RYBA M, 1993, ACTA NEUROCHIR, V122, P194, DOI 10.1007/BF01405528; RYBA M, 1992, ACTA NEUROCHIR, V117, P34, DOI 10.1007/BF01400632; RYBA M, 1991, ACTA NEUROCHIR, V112, P25, DOI 10.1007/BF01402450; RYBA M, 1991, STROKE, V22, P531, DOI 10.1161/str.22.4.531a; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Saeed SA, 2007, BIOCHEM BIOPH RES CO, V353, P915, DOI 10.1016/j.bbrc.2006.12.092; SAKURAI T, 1991, BIOCHEM BIOPH RES CO, V175, P44, DOI 10.1016/S0006-291X(05)81197-0; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Satoh M, 2001, STROKE, V32, P225, DOI 10.1161/01.STR.32.1.225; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schoch B, 2007, NEUROSURGERY, V60, P828, DOI 10.1227/01.NEU.0000255440.21495.80; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sethi S, 2001, NITRIC OXIDE-BIOL CH, V5, P482, DOI 10.1006/niox.2001.0375; SHIMIZU T, 1982, Neurologia Medico-Chirurgica, V22, P613, DOI 10.2176/nmc.22.613; SHINYAMA H, 1991, BIOCHEM BIOPH RES CO, V178, P24, DOI 10.1016/0006-291X(91)91774-7; Shor M, 2007, AM J CARDIOL, V100, P1767, DOI 10.1016/j.amjcard.2007.07.052; Shreenivas S, 2007, CLIN HEMORHEOL MICRO, V37, P157; Sills AK, 1997, NEUROSURGERY, V41, P453, DOI 10.1097/00006123-199708000-00025; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; SPALLONE A, 1987, SURG NEUROL, V27, P253, DOI 10.1016/0090-3019(87)90038-3; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Suarez JI, 2004, J NEUROSURG, V100, P585, DOI 10.3171/jns.2004.100.4.0585; SUZUKI SC, 2008, DEV GROWTH DIFFER; Takemae T, 1978, No To Shinkei, V30, P861; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Thai QA, 1999, STROKE, V30, P140, DOI 10.1161/01.STR.30.1.140; Tseng MY, 2007, STROKE, V38, P1545, DOI 10.1161/STROKEAHA.106.475905; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Ursino M, 1998, J NEUROSURG, V89, P255, DOI 10.3171/jns.1998.89.2.0255; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Vajkoczy P, 2001, STROKE, V32, P498, DOI 10.1161/01.STR.32.2.498; Van Vlierberghe H, 2004, CLIN CHIM ACTA, V345, P35, DOI 10.1016/j.cccn.2004.03.016; VANDEUREN M, 1995, J INFECT DIS, V172, P433, DOI 10.1093/infdis/172.2.433; WALTON J N, 1955, Can Med Assoc J, V72, P165; Wang Yong, 2007, Neurosci Bull, V23, P151, DOI 10.1007/s12264-007-0022-1; Watanabe M, 2007, J ATHEROSCLER THROMB, V14, P325, DOI 10.5551/jat.E489; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; WEIR B, 1989, NEUROSURGERY, V25, P161, DOI 10.1227/00006123-198908000-00002; WEJMAN JC, 1984, J MOL BIOL, V174, P343, DOI 10.1016/0022-2836(84)90342-5; WEJMAN JC, 1984, J MOL BIOL, V174, P319, DOI 10.1016/0022-2836(84)90341-3; Weyerbrock A, 2003, J NEUROSURG, V99, P728, DOI 10.3171/jns.2003.99.4.0728; WHITE RP, 1983, NEUROSURGERY, V12, P40, DOI 10.1227/00006123-198301000-00008; Woodside DG, 2008, BIODRUGS, V22, P85, DOI 10.2165/00063030-200822020-00002; YAMASHIMA T, 1985, NEUROSURGERY, V16, P546, DOI 10.1227/00006123-198504000-00018; YAMASHIMA T, 1986, J NEUROL, V233, P348, DOI 10.1007/BF00313921; YAMAURA I, 1992, J NEUROSURG, V76, P99, DOI 10.3171/jns.1992.76.1.0099; YANAMOTO H, 1992, NEUROSURGERY, V30, P351, DOI 10.1227/00006123-199203000-00007; YANAMOTO H, 1994, SURG NEUROL, V42, P374, DOI 10.1016/0090-3019(94)90339-5; YANAMOTO H, 1992, NEUROSURGERY, V30, P358, DOI 10.1227/00006123-199203000-00008; YANAMOTO H, 1992, NEUROSURGERY, V30, P356; Yatsushige H, 2005, STROKE, V36, P1538, DOI 10.1161/01.STR.0000170713.22011.c8; Zhou CM, 2004, J CEREBR BLOOD F MET, V24, P419, DOI 10.1097/00004647-200404000-00007; Zubkov AY, 2000, STROKE, V31, P526, DOI 10.1161/01.STR.31.2.526; Zubkov ZY, 2000, SURG NEUROL, V53, P126; Zuccarello M, 1998, STROKE, V29, P1924, DOI 10.1161/01.STR.29.9.1924; Zucker MB, 1944, AM J PHYSIOL, V142, P12, DOI 10.1152/ajplegacy.1944.142.1.12; 정진환, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P1	272	113	114	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2010	73	1					22	41		10.1016/j.surneu.2009.05.027			20	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	790YE	WOS:000292625900005	20452866				2022-02-06	
J	Khan, M; Im, YB; Shunmugavel, A; Gilg, AG; Dhindsa, RK; Singh, AK; Singh, I				Khan, Mushfiquddin; Im, Yeong-Bin; Shunmugavel, Anandakumar; Gilg, Anne G.; Dhindsa, Ramanpreet K.; Singh, Avtar K.; Singh, Inderjit			Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact	JOURNAL OF NEUROINFLAMMATION			English	Article							NITRIC-OXIDE SYNTHASE; RECEPTOR AGONIST 8-OH-DPAT; CEREBRAL-BLOOD-FLOW; MATRIX METALLOPROTEINASES; COGNITIVE DEFICITS; FLAP SURVIVAL; RECOVERY; NEUROPROTECTION; NITROSYLATION; MODULATION	Background: Traumatic brain injury (TBI) is a major cause of preventable death and serious morbidity in young adults. This complex pathological condition is characterized by significant blood brain barrier (BBB) leakage that stems from cerebral ischemia, inflammation, and redox imbalances in the traumatic penumbra of the injured brain. Once trauma has occurred, combating these exacerbations is the keystone of an effective TBI therapy. Following other brain injuries, nitric oxide modulators such as S-nitrosoglutathione (GSNO) maintain not only redox balance but also inhibit the mechanisms of secondary injury. Therefore, we tested whether GSNO shows efficacy in a rat model of experimental TBI. Methods: TBI was induced by controlled cortical impact (CCI) in adult male rats. GSNO (50 mu g/kg body weight) was administered at two hours after CCI. GSNO-treated injured animals (CCI+GSNO group) were compared with vehicle-treated injured animals (CCI+VEH group) in terms of tissue morphology, BBB leakage, edema, inflammation, cell death, and neurological deficit. Results: Treatment of the TBI animals with GSNO reduced BBB disruption as evidenced by decreased Evan's blue extravasation across brain, infiltration/activation of macrophages (ED1 positive cells), and reduced expression of ICAM-1 and MMP-9. The GSNO treatment also restored CCI-mediated reduced expression of BBB integrity proteins ZO-1 and occludin. GSNO-mediated improvements in tissue histology shown by reduction of lesion size and decreased loss of both myelin (measured by LFB staining) and neurons (assayed by TUNEL) further support the efficacy of GSNO therapy. GSNO-mediated reduced expression of iNOS in macrophages as well as decreased neuronal cell death may be responsible for the histological improvement and reduced exacerbations. In addition to these biochemical and histological improvements, GSNO-treated injured animals recovered neurobehavioral functions as evaluated by the rotarod task and neurological score measurements. Conclusion: GSNO is a promising candidate to be evaluated in humans after brain trauma because it not only protects the traumatic penumbra from secondary injury and improves overall tissue structure but also maintains the integrity of BBB and reduces neurologic deficits following CCI in a rat model of experimental TBI.	[Khan, Mushfiquddin; Im, Yeong-Bin; Shunmugavel, Anandakumar; Gilg, Anne G.; Dhindsa, Ramanpreet K.; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Singh, Avtar K.] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson VA Med Ctr, Charleston, SC 29401 USA		Singh, I (corresponding author), Med Univ S Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA.	khanm@musc.edu; imyb@musc.edu; anandak@musc.edu; gilg@musc.edu; mushfiquddinkhan@gmail.com; singha@musc.edu; singhi@musc.edu			Betty and Guy Beatty Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-22576, NS-34741, NS-37766]; Veteran Administration Merit; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06 RR018823, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037766, R37NS022576, R01NS034741, R01NS022576] Funding Source: NIH RePORTER	These studies were supported by grants from Betty and Guy Beatty Foundation, National Institutes of Health (NS-22576, NS-34741 and NS-37766) and Veteran Administration Merit Award. This work was also supported by the NIH, Grants C06 RR018823 and No C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. We thank Dr Md Nasrul Hoda and Dr Bilgen Mehmet for their valuable technical assistance. We are grateful to Dr Tom Smith from the MUSC Writing Center for his valuable editing and correction of the manuscript. We would like to thank Ms. Joyce Bryan for procurement of animals and chemicals and Chara Williams for secretarial assistance.	Avila MA, 2008, J CEREBR BLOOD F MET, V28, P1733, DOI 10.1038/jcbfm.2008.66; Barbaccia J J, 2001, Curr Opin Anaesthesiol, V14, P227, DOI 10.1097/00001503-200104000-00016; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Botteri M, 2008, CRIT CARE MED, V36, P3089, DOI 10.1097/CCM.0b013e31818bd7df; BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Chiueh Chuang C., 2002, Pediatric Research, V51, P414, DOI 10.1203/00006450-200204000-00002; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gaston Benjamin M, 2003, Mol Interv, V3, P253, DOI 10.1124/mi.3.5.253; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Heiss C, 2006, J AM COLL CARDIOL, V47, P573, DOI 10.1016/j.jacc.2005.06.089; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Kaposzta Z, 2002, CIRCULATION, V106, P3057, DOI 10.1161/01.CIR.0000041251.07332.28; Kaposzta Z, 2002, CIRCULATION, V105, P1480, DOI 10.1161/01.CIR.0000012347.47001.97; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kluge I, 1997, J NEUROCHEM, V69, P2599; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Kuo YR, 2004, SURGERY, V135, P437, DOI 10.1016/j.surg.2003.07.006; Kuo YR, 2004, J SURG RES, V119, P92, DOI 10.1016/j.jss.2003.08.006; LANE P, 2001, SCI STKE, pRE1; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; Megson IL, 2000, DRUG FUTURE, V25, P701, DOI 10.1358/dof.2000.025.07.858691; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Molloy J, 1998, CIRCULATION, V98, P1372, DOI 10.1161/01.CIR.98.14.1372; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Nakamura T, 2009, NEURON, V63, P3, DOI 10.1016/j.neuron.2009.06.013; Nath N, 2009, BIOCHEM BIOPH RES CO, V386, P16, DOI 10.1016/j.bbrc.2009.05.106; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Parathath SR, 2006, J CELL SCI, V119, P339, DOI 10.1242/jcs.02734; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; RAPOPORT SI, 1980, AM J PHYSIOL, V238, pR421, DOI 10.1152/ajpregu.1980.238.5.R421; Rashid Parveen A, 2003, J Stroke Cerebrovasc Dis, V12, P82, DOI 10.1053/jscd.2003.9; Rauhala P, 1998, FASEB J, V12, P165, DOI 10.1096/fasebj.12.2.165; Salama NN, 2006, ADV DRUG DELIVER REV, V58, P15, DOI 10.1016/j.addr.2006.01.003; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schonhoff CM, 2006, P NATL ACAD SCI USA, V103, P2404, DOI 10.1073/pnas.0507243103; Schrammel A, 2003, FREE RADICAL BIO MED, V34, P1078, DOI 10.1016/S0891-5849(03)00038-8; Sehba FA, 1999, STROKE, V30, P1955, DOI 10.1161/01.STR.30.9.1955; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Steffen M, 2001, BIOCHEM J, V356, P395, DOI 10.1042/0264-6021:3560395; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tuzgen S, 2003, NEUROL RES, V25, P31, DOI 10.1179/016164103101201085; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; WEISSMAN DE, 1988, J NEURO-ONCOL, V6, P339; Zeng H, 2001, AM J PHYSIOL-HEART C, V281, pH432, DOI 10.1152/ajpheart.2001.281.1.H432; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	77	113	118	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	NOV 4	2009	6								32	10.1186/1742-2094-6-32			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	525XX	WOS:000272252200001	19889224	Green Published, gold			2022-02-06	
J	Temkin, NR; Corrigan, JA; Dikmen, SS; Machamer, J				Temkin, Nancy R.; Corrigan, John A.; Dikmen, Sureyya S.; Machamer, Joan			Social Functioning After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						closed TBI; employment; leisure activities; living situation; penetrating TBI; psychosocial outcome; social outcome; traumatic brain injury	MILD HEAD-INJURY; LONG-TERM DISABILITY; QUALITY-OF-LIFE; FOLLOW-UP; UNITED-STATES; 1ST YEAR; WORK; POPULATION; RECOVERY; MODERATE	Objective: To determine the relationship between adult-onset traumatic brain injury (TBI) and social functioning including employment, social relationships, independent living, recreation, functional status, and quality of life 6 months or longer after injury. Participants: Not applicable. Design: Systematic review of the published, peer-reviewed literature. Primary Measures: Not applicable. Results: Fourteen primary and 25 secondary studies were identified that allowed comparison to controls for adults who were at least 6 months post-TBI. TBI decreases the probability of employment after injury in those who were workers before their injury, lengthens the timing of their return if they do return to work, and decreases the likelihood that they will return to the same position. Those with moderate and severe TBI are clearly affected, but there was insufficient evidence of a relationship between unemployment and mild TBI. Penetrating head injury sustained in wartime is clearly associated with increased unemployment. TBI also adversely affects leisure and recreation, social relationships, functional status, quality of life, and independent living. Although there is a dose-response relationship between seventy of injury and social outcomes, there is insufficient evidence to determine at what level of severity the adverse effects are demonstrated. Conclusion: TBI clearly has adverse effects on social functioning for adults. While some consequences might arise from injuries to other parts of the body, those with moderate to severe TBI have more impaired functioning Thai do those with other injuries alone.	[Temkin, Nancy R.; Dikmen, Sureyya S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Temkin, Nancy R.; Dikmen, Sureyya S.; Machamer, Joan] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Corrigan, John A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Temkin, NR (corresponding author), Univ Washington, Dept Neurol Surg, Box 359924,325 9th Ave, Seattle, WA 98104 USA.	temkin@uw.edu			US Department of Veterans AffairsUS Department of Veterans Affairs	This study was supported by a contract from the US Department of Veterans Affairs to the National Academy of Sciences, Institute of Medicine.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Finkelstein E., 2006, INCIDENCE EC BURDEN; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Gerberich SG, 1997, NEUROEPIDEMIOLOGY, V16, P1, DOI 10.1159/000109665; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; JENNETT B, 1975, LANCET, V1, P480; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; McLeod A, 2004, OCCUP ENVIRON MED, V61, P414, DOI 10.1136/oem.2003.007336; Millimet DL, 2003, J ECONOMETRICS, V113, P83, DOI 10.1016/S0304-4076(02)00168-9; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Ommaya A. K., 1996, TRAUMATIC BRAIN INJU; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Walker A., 1969, HEAD INJURED MEN 15, P85; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	49	113	114	0	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2009	24	6					460	467		10.1097/HTR.0b013e3181c13413			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	528VW	WOS:000272476100006	19940679				2022-02-06	
J	Israelsson, C; Bengtsson, H; Kylberg, A; Kullander, K; Lewen, A; Hillered, L; Ebendal, T				Israelsson, Charlotte; Bengtsson, Henrik; Kylberg, Annika; Kullander, Klas; Lewen, Anders; Hillered, Lars; Ebendal, Ted			Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						Cxcl10; dendritic cells; inflammatory monocytes; integrin alpha X; TBI	CENTRAL-NERVOUS-SYSTEM; RAT CEREBRAL-CORTEX; DENDRITIC CELLS; GENE-EXPRESSION; MULTIPLE-SCLEROSIS; BLOOD MONOCYTES; MOUSE-BRAIN; RECEPTORS; RESPONSES; ISCHEMIA	Cerebral gene expressions change in response to traumatic brain injury (TBI), and future trauma treatment may improve with increased knowledge about these regulations. We subjected C57BL/6J mice to injury by controlled cortical impact (CCI). At various time points post-injury, mRNA from neocortex and hippocampus was isolated, and transcriptional alterations studied using quantitative real-time polymerase chain reaction (PCR) and gene array analysis. Spatial distribution of enhanced expression was characterized by in situ hybridization. Products of the upregulated transcripts serve functions in a range of cellular mechanisms, including stress, inflammation and immune responses, and tissue remodeling. We also identified increased transcript levels characterizing reactive astrocytes, oligodendrocytes, and microglia, and furthermore, we demonstrated a novel pattern of scattered cell clusters expressing the chemokine Cxcl10. Notably, a sustained increase in integrin alpha X (Itgax), characterizing antigen-presenting dendritic cells, was found with the transcript located to similar cell clusters. In contrast, T-cell receptor alpha transcript showed only a modest increase. The induced P-selectin (Selp) expression level in endothelial cells, and chemokines from microglia, may guide perivascular accumulation of extravasating inflammatory monocytes differentiating into dendritic cells. In conclusion, our study shows that following TBI, secondary injury chiefly involves inflammatory processes and chemokine signaling, which comprise putative targets for pharmaceutical neuroprotection.	[Israelsson, Charlotte; Bengtsson, Henrik; Kylberg, Annika; Ebendal, Ted] Uppsala Univ, Biomed Ctr, Dept Neurosci, SE-75123 Uppsala, Sweden; [Lewen, Anders; Hillered, Lars] Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden		Ebendal, T (corresponding author), Uppsala Univ, Biomed Ctr, Dept Neurosci, POB 587, SE-75123 Uppsala, Sweden.	Ted.Ebendal@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Kullander, Klas/0000-0001-6418-5460; Hillered, Lars/0000-0002-2808-9292	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2006-3014, 2004-6210, 2004-5567, 2003-2258]; Swedish Brain Research Foundation/Sparbanksstiftelsen Upland	Kimberly Zaia kindly performed subcloning of the Ccl3 probe and assisted in the cluster analysis, and Nestor Carri gave advice regarding histology. Niklas Marklund critically read the manuscript. Ali Moshfegh, Malin Linde, Hanna Goransson, and Maria Rydaker carried out the GeneChip procedures. This research was supported by the Swedish Research Council ( grants 2006-3014 to T. E., 2004-6210 to L. H., and 2004-5567 and 2003-2258 to K. K.) and the Swedish Brain Research Foundation/Sparbanksstiftelsen Upland ( to T. E. and C. I.).	Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x; Fischer HG, 2001, J IMMUNOL, V166, P2717, DOI 10.4049/jimmunol.166.4.2717; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hausmann EHS, 1998, BRAIN RES, V788, P49, DOI 10.1016/S0006-8993(97)01160-8; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1333, DOI 10.1097/01.WCB.0000141559.17620.36; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1317, DOI 10.1097/01.WCB.0000141558.40491.75; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Karman J, 2006, J IMMUNOL, V177, P7750, DOI 10.4049/jimmunol.177.11.7750; Kieseier BC, 2002, BRAIN, V125, P823, DOI 10.1093/brain/awf070; Klein RS, 2004, J CELL BIOCHEM, V92, P213, DOI 10.1002/jcb.20052; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Kury P, 2004, EUR J NEUROSCI, V19, P1708, DOI 10.1111/j.1460-9568.2004.03226.x; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Matyszak MK, 1996, NEUROSCIENCE, V74, P599, DOI 10.1016/0306-4522(96)00160-1; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McMahon EJ, 2006, NEUROCHEM INT, V49, P195, DOI 10.1016/j.neuint.2006.04.004; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Newman TA, 2005, J NEUROIMMUNOL, V166, P167, DOI 10.1016/j.jneuroim.2005.04.026; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Potts Mathew B, 2006, NeuroRx, V3, P143; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Reichmann G, 2002, J NEUROIMMUNOL, V129, P125, DOI 10.1016/S0165-5728(02)00184-4; Savitz SI, 2007, EXP NEUROL, V205, P20, DOI 10.1016/j.expneurol.2007.03.003; Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Sugawara T, 2002, J NEUROTRAUM, V19, P85, DOI 10.1089/089771502753460268; Szczucinski A, 2007, ACTA NEUROL SCAND, V115, P137, DOI 10.1111/j.1600-0404.2006.00749.x; Trifilo MJ, 2004, VIROLOGY, V327, P8, DOI 10.1016/j.virol.2004.06.027; Trifilo MJ, 2003, J NEUROVIROL, V9, P315, DOI 10.1080/13550280390201029; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Xu HP, 2005, J IMMUNOL, V175, P6915, DOI 10.4049/jimmunol.175.10.6915; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	46	113	115	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2008	25	8					959	974		10.1089/neu.2008.0562			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	343ZT	WOS:000258895700002	18665806				2022-02-06	
J	Bayir, H; Kagan, VE; Clark, RSB; Janesko-Feldman, K; Rafikov, R; Huang, ZT; Zhang, XJ; Vagni, V; Billiar, TR; Kochanek, PM				Bayir, Hulya; Kagan, Valerian E.; Clark, Robert S. B.; Janesko-Feldman, Keri; Rafikov, Ruslan; Huang, Zhentai; Zhang, Xiaojing; Vagni, Vincent; Billiar, Timothy R.; Kochanek, Patrick M.			Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						1400W; 7-nitroindazole; controlled cortical impact; head injury; myeloperoxidase	NITRIC-OXIDE SYNTHASE; CORTICAL IMPACT INJURY; EXACERBATES CEREBRAL INFARCTION; FREE-RADICAL SCAVENGERS; OXIDATIVE STRESS; TYROSINE NITRATION; LIPID-PEROXIDATION; PROTEIN NITRATION; MICE DEFICIENT; CYTOCHROME-C	Manganese superoxide dismutase (MnSOD) provides the first line of defense against superoxide generated in mitochondria. SOD competes with nitric oxide for reaction with superoxide and prevents generation of peroxynitrite, a potent oxidant that can modify proteins to form 3-nitrotyrosine. Thus, sufficient amounts of catalytically competent MnSOD are required to prevent mitochondrial damage. Increased nitrotyrosine immunoreactivity has been reported after traumatic brain injury (TBI); however, the specific protein targets containing modified tyrosine residues and functional consequence of this modification have not been identified. In this study, we show that MnSOD is a target of tyrosine nitration that is associated with a decrease in its enzymatic activity after TBI in mice. Similar findings were obtained in temporal lobe cortical samples obtained from TBI cases versus control patients who died of causes not related to CNS trauma. Increased nitrotyrosine immunoreactivity was detected at 2 h and 24 h versus 72 h after experimental TBI and co-localized with the neuronal marker NeuN. Inhibition and/or genetic deficiency of neuronal nitric oxide synthase (nNOS) but not endothelial nitric oxide synthase (eNOS) attenuated MnSOD nitration after TBI. At 24 h after TBI, there was predominantly polymorphonuclear leukocytes accumulation in mouse brain whereas macrophages were the predominant inflammatory cell type at 72 h after injury. However, a selective inhibitor or genetic deficiency of inducible nitric oxide synthase (iNOS) failed to affect MnSOD nitration. Nitration of MnSOD is a likely consequence of peroxynitrite within the intracellular milieu of neurons after TBI. Nitration and inactivation of MnSOD could lead to self-amplification of oxidative stress in the brain progressively enhancing peroxynitrite production and secondary damage.	Univ Pittsburgh, Med Ctr, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Dept Crit Care Med, Pittsburgh, PA USA; Dept Surg, Pittsburgh, PA USA; Dept Environm & Occupat Hlth & Pharmacol, Pittsburgh, PA USA		Bayir, H (corresponding author), Univ Pittsburgh, Med Ctr, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	bayihx@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Huang, Zhentai/C-6926-2012; Rafikov, Ruslan/AAG-9352-2019; zhang, xueji/B-1904-2010	Kochanek, Patrick M/0000-0002-2627-913X; Huang, Zhentai/0000-0002-8102-464X; Kagan, Valerian E./0000-0002-7245-1885; Rafikov, Ruslan/0000-0001-5950-4076	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038087, P50NS030318, P01NS030318, P20NS030318] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL64145] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318, NS38087] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U19A1068021] Funding Source: Medline		Aoyama K, 2000, ANN NEUROL, V47, P524, DOI 10.1002/1531-8249(200004)47:4<524::AID-ANA19>3.0.CO;2-5; Baldus S, 2001, J CLIN INVEST, V108, P1759; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bemeur C, 2004, NEUROCHEM INT, V45, P1167, DOI 10.1016/j.neuint.2004.06.010; Bidmon HJ, 1998, STROKE, V29, P203, DOI 10.1161/01.STR.29.1.203; Bolan EA, 2000, J NEUROSCI, V20, P4798; BOS A, 1978, BIOCHIM BIOPHYS ACTA, V525, P37, DOI 10.1016/0005-2744(78)90197-3; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Cantuti-Castelvetri I, 2002, BRAIN RES, V930, P170, DOI 10.1016/S0006-8993(02)02244-8; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cobbs CS, 1996, CANCER RES, V56, P3192; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2; Cruthirds DL, 2003, ARCH BIOCHEM BIOPHYS, V412, P27, DOI 10.1016/S0003-9861(03)00039-0; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Earnhardt JN, 2002, J NEUROTRAUM, V19, P1065, DOI 10.1089/089771502760341974; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; GAETANI P, 1994, NEUROCHEM RES, V19, P839, DOI 10.1007/BF00967453; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; GRAY B, 1992, BIOCHEM J, V281, P795, DOI 10.1042/bj2810795; Gray Keith D, 2004, Surg Infect (Larchmt), V5, P166, DOI 10.1089/1096296041839453; Guo W, 2003, AM J PHYSIOL-HEART C, V285, pH1396, DOI 10.1152/ajpheart.00096.2003; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; KATO H, 1995, J CEREBR BLOOD F MET, V15, P60, DOI 10.1038/jcbfm.1995.7; Keller JN, 1998, J NEUROSCI, V18, P687; Kifle Y, 1996, J NEUROCHEM, V66, P2128; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kissner R, 2003, IUBMB LIFE, V55, P567, DOI 10.1080/15216540310001628690; Koeck T, 2004, J BIOL CHEM, V279, P27257, DOI 10.1074/jbc.M401586200; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Lacza Z, 2004, J NEUROCHEM, V90, P942, DOI 10.1111/j.1471-4159.2004.02553.x; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lores-Arnaiz S, 2004, ARCH BIOCHEM BIOPHYS, V430, P170, DOI 10.1016/j.abb.2004.07.012; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; MacMillan-Crow LA, 2001, FREE RADICAL BIO MED, V31, P1603, DOI 10.1016/S0891-5849(01)00750-X; MacMillan-Crow LA, 1999, ARCH BIOCHEM BIOPHYS, V366, P82, DOI 10.1006/abbi.1999.1202; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; MacMillan-Crow LA, 1999, METHOD ENZYMOL, V301, P135; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mehl M, 1999, NITRIC OXIDE-BIOL CH, V3, P142, DOI 10.1006/niox.1999.0217; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Murakami K, 1998, J NEUROSCI, V18, P205; Muscoli C, 2004, PAIN, V111, P96, DOI 10.1016/j.pain.2004.06.004; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Onishi Y, 1999, EUR J BIOCHEM, V261, P148, DOI 10.1046/j.1432-1327.1999.00247.x; Pittman KM, 2002, EXP EYE RES, V74, P463, DOI 10.1006/exer.2002.1141; Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; Przedborski S, 2001, J NEUROCHEM, V76, P637, DOI 10.1046/j.1471-4159.2001.00174.x; Ria F, 2001, BRIT J CANCER, V84, P529, DOI 10.1054/bjoc.2000.1594; Riobo NA, 2002, J BIOL CHEM, V277, P42447, DOI 10.1074/jbc.M204580200; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Shaw IC, 1995, NEURODEGENERATION, V4, P391, DOI 10.1006/neur.1995.0047; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Strong MJ, 1998, BIOCHEM BIOPH RES CO, V248, P157, DOI 10.1006/bbrc.1998.8930; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Todorovic A, 2005, ANN NY ACAD SCI, V1048, P369, DOI 10.1196/annals.1342.041; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WAKAI M, 1994, ACTA NEUROPATHOL, V88, P151; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Wei EP, 1996, AM J PHYSIOL-HEART C, V271, pH1262, DOI 10.1152/ajpheart.1996.271.3.H1262; Wei G, 1999, BBA-MOL BASIS DIS, V1455, P23, DOI 10.1016/S0925-4439(99)00051-4; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005; Xu SQ, 2006, DIABETES, V55, P110, DOI 10.2337/diabetes.55.1.110; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085	91	113	117	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	APR	2007	101	1					168	181		10.1111/j.1471-4159.2006.04353.x			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	145SU	WOS:000244885600016	17394464				2022-02-06	
J	Kamm, K; VanderKolk, W; Lawrence, C; Jonker, M; Davis, AT				Kamm, K; VanderKolk, W; Lawrence, C; Jonker, M; Davis, AT			The effect of traumatic brain injury upon the concentration and expression of interieukin-1 beta and interleukin-10 in the rat	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	18th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 11-15, 2005	Ft Lauderdale, FL	Eastern Assoc Surg Trauma		cytokines; traumatic brain injury; animal model	TUMOR-NECROSIS-FACTOR; CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; FACTOR-ALPHA; TNF-ALPHA; CYTOKINE EXPRESSION; BARRIER; TRANSPORT; BETA; MICE	Background: Using a model of traumatic brain injury (TBI) in the rat, this study was undertaken to characterize the short-term biochemical changes of IL-1 beta, IL-10, and tumor necrosis factor TNF-alpha to determine whether injury in the brain elicits a systemic cytokine response. Methods: Sprague-Dawley rats were subjected to a TBI using a weight-drop model and then killed at various time points after injury. Samples of blood, brain, and liver were recovered and analyzed for concentrations of IL-1 beta, IL-10, and TNF-alpha as well as IL-1 beta and IL-10 mRNA expression in liver and brain. Results: In brain, IL-1 beta increased in the first hour after injury, peaked at 8 hours, and declined during the final 16 hours. IL-10 quickly increased during the first 4 hours and then gradually rose over the last 20 hours. Analysis of liver showed no upregulation of these markers and plasma IL-1 beta and IL-10 were unchanged compared with controls. Although not upregulated in brain, TNF-alpha showed a statistically significant (p < 0.05) rise in plasma from 14 +/- 16 pg/mL at 20 minutes to 91 +/- 28 pg/mL at 24 hours. Conclusion: Using a model of TBI, we have demonstrated that there is a rise in both IL-1 beta and IL-10 in the injured rat brain within the first 24 hours after injury without a corresponding rise in either plasma or liver. Therefore, it appears as if two strong indicators of brain injury severity are expressed and possibly carry out their actions solely in the brain.	Michigan State Univ, Dept Trauma Spectrum Butterworth Hosp, Grand Rapids, MI USA; Univ Wisconsin, Madison, WI 53706 USA		Kamm, K (corresponding author), 221 Michigan St NE,Suite 200A, Grand Rapids, MI 49503 USA.	kkamm@siumed.edu					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Banks WA, 2001, J PHARMACOL EXP THER, V299, P536; BANKS WA, 1989, BRAIN RES BULL, V23, P433, DOI 10.1016/0361-9230(89)90185-8; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; BENVENISTE EN, 1995, INT J DEV NEUROSCI, V13, P341, DOI 10.1016/0736-5748(94)00061-7; BOGDAN C, 1992, J BIOL CHEM, V267, P23301; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; CHAO CC, 1995, DEV NEUROSCI-BASEL, V17, P97, DOI 10.1159/000111278; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; FAN L, 1995, MOL BRAIN RES, V30, P125; FINK MP, 2004, SABISTON TXB SURG, P50; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GIULIAN D, 1988, J NEUROSCI, V8, P2485; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; HOCH RC, 1993, CRIT CARE MED, V21, P839, DOI 10.1097/00003246-199306000-00010; HOEDEMA RE, 2001, 14 ANN M E ASS SURG; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Kastin AJ, 2003, MOL BRAIN RES, V114, P168, DOI 10.1016/S0169-328X(03)00167-0; Kipnis J, 2003, J NEUROTRAUM, V20, P559, DOI 10.1089/089771503767168483; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; MALEFYT RD, 1991, J EXP MED, V174, P915; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; Osburg B, 2002, AM J PHYSIOL-ENDOC M, V283, pE899, DOI 10.1152/ajpendo.00436.2001; Plotkin SR, 2000, BRAIN RES, V881, P57, DOI 10.1016/S0006-8993(00)02772-4; Raff T, 1997, BIOTECHNIQUES, V23, P456, DOI 10.2144/97233st02; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Weight DG, 1998, PSYCHIAT CLIN N AM, V21, P609, DOI 10.1016/S0193-953X(05)70026-5; Yokoyama Y, 2004, AM J PHYSIOL-GASTR L, V286, pG942, DOI 10.1152/ajpgi.00502.2003; YONG VW, 1991, P NATL ACAD SCI USA, V88, P7016, DOI 10.1073/pnas.88.16.7016	44	113	118	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2006	60	1					152	157		10.1097/01.ta.0000196345.81169.a1			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	008UN	WOS:000235066300033	16456449				2022-02-06	
J	Baumann, CR; Stocker, R; Imhof, HG; Trentz, O; Hersberger, M; Mignot, E; Bassetti, CL				Baumann, CR; Stocker, R; Imhof, HG; Trentz, O; Hersberger, M; Mignot, E; Bassetti, CL			Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury	NEUROLOGY			English	Article							NARCOLEPSY	Hypocretin-1 is involved in the regulation of the sleep-wake cycle. The authors prospectively assessed CSF hypocretin-1 levels in 44 consecutive patients with acute traumatic brain injury (TBI). Compared with controls, hypocretin-1 levels were abnormally lower in 95% of patients with moderate to severe TBI and in 97% of patients with posttraumatic brain CT changes. Hypocretin-1 deficiency after TBI may reflect hypothalamic damage and be linked with the frequent development of posttraumatic sleep-wake disorders.	Univ Spital Zurich, Dept Neurol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Intens Care Med, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Traumat Surg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; Stanford Ctr Narcolepsy, Palo Alto, CA USA		Bassetti, CL (corresponding author), Univ Spital Zurich, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland.	claudio.bassetti@usz.ch		Hersberger, Martin/0000-0002-4472-329X; Baumann, Christian/0000-0003-3417-1978			Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mochizuki T, 2003, CURR BIOL, V13, pR563, DOI 10.1016/S0960-9822(03)00474-3; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Thorley RR, 2001, ARCH PHYS MED REHAB, V82, P246, DOI 10.1053/apmr.2001.18698	7	113	115	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 12	2005	65	1					147	149		10.1212/01.wnl.0000167605.02541.f2			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944KP	WOS:000230427200032	16009905				2022-02-06	
J	Houweling, AR; Bazhenov, M; Timofeev, I; Steriade, M; Sejnowski, TJ				Houweling, AR; Bazhenov, M; Timofeev, I; Steriade, M; Sejnowski, TJ			Homeostatic synaptic plasticity can explain post-traumatic epileptogenesis in chronically isolated neocortex	CEREBRAL CORTEX			English	Article						brain trauma; computational model; deafferentation; epilepsy; injury; slow oscillation	ACTIVITY-DEPENDENT REGULATION; SEIZURE-LIKE ACTIVITY; QUANTAL AMPLITUDE; PYRAMIDAL NEURONS; NEUROTRANSMITTER RELEASE; NMDA RECEPTORS; MODEL; AMPA; CONDUCTANCES; EXCITABILITY	Chronically isolated neocortex develops chronic hyperexcitability and focal epileptogenesis in a period of days to weeks. The mechanisms operating in this model of post-traumatic epileptogenesis are not well understood. We hypothesized that the spontaneous burst discharges recorded in chronically isolated neocortex result from homeostatic plasticity (a mechanism generally assumed to stabilize neuronal activity) induced by low neuronal activity after deafferentation. To test this hypothesis we constructed computer models of neocortex incorporating a biologically based homeostatic plasticity rule that operates to maintain firing rates. After deafferentation, homeostatic upregulation of excitatory synapses on pyramidal cells, either with or without concurrent downregulation of inhibitory synapses or upregulation of intrinsic excitability, initiated slowly repeating burst discharges that closely resembled the epileptiform burst discharges recorded in chronically isolated neocortex. These burst discharges lasted a few hundred ms, propagated at 1-3 cm/s and consisted of large (10-15 mV) intracellular depolarizations topped by a small number of action potentials. Our results support a role for homeostatic synaptic plasticity as a novel mechanism of post-traumatic epileptogenesis.	Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA; Univ Laval, Neurophysiol Lab, Ste Foy, PQ G1K 7P4, Canada		Houweling, AR (corresponding author), Erasmus MC, Dept Neurosci, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	arthur@salk.edu	Sejnowski, Terrence/AAV-5558-2021; Timofeev, Igor/AAP-7529-2021; Timofeev, Igor/E-8828-2012	Timofeev, Igor/0000-0002-1389-5857	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040522] Funding Source: NIH RePORTER; Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS40522] Funding Source: Medline		Abbott LF, 1997, SCIENCE, V275, P220; Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; BRAILOWSKY S, 1988, BRAIN RES, V442, P175, DOI 10.1016/0006-8993(88)91448-5; BURNS BD, 1979, PROC R SOC SER B-BIO, V203, P347, DOI 10.1098/rspb.1979.0002; BURNS BD, 1951, J PHYSIOL-LONDON, V112, P156, DOI 10.1113/jphysiol.1951.sp004517; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Bush PC, 1999, J NEUROPHYSIOL, V82, P1748, DOI 10.1152/jn.1999.82.4.1748; Carmichael ST, 2002, J NEUROSCI, V22, P6062; CARPENTER GA, 1983, BIOL CYBERN, V48, P35, DOI 10.1007/BF00336883; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; ECHLIN FA, 1963, ARCH NEUROL-CHICAGO, V9, P154, DOI 10.1001/archneur.1963.00460080064009; FURSHPAN EJ, 1989, NEURON, V3, P199, DOI 10.1016/0896-6273(89)90033-0; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; Golowasch J, 1999, NEURAL COMPUT, V11, P1079, DOI 10.1162/089976699300016359; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; GRAFSTEIN B, 1957, ELECTROEN CLIN NEURO, V9, P723, DOI 10.1016/0013-4694(57)90096-2; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HIRSCH JC, 1983, BRAIN RES, V259, P308, DOI 10.1016/0006-8993(83)91264-7; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; JAHR CE, 1990, J NEUROSCI, V10, P3178; KELLAWAY P, 1966, EXP NEUROL, V14, P281, DOI 10.1016/0014-4886(66)90115-4; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu Z, 1998, J NEUROSCI, V18, P2309; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Prince D A, 1999, Adv Neurol, V79, P665; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; PURPURA DP, 1961, EXP NEUROL, V4, P377, DOI 10.1016/0014-4886(61)90025-5; RAMAKERS GJA, 1990, EXP BRAIN RES, V79, P157; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Salin P, 1995, J NEUROSCI, V15, P8234; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SHARPLESS SK, 1962, ELECTROEN CLIN NEURO, V14, P244, DOI 10.1016/0013-4694(62)90034-2; Sharpless SK, 1969, BASIC MECH EPILEPSIE, P329; SIEGEL M, 1994, P NATL ACAD SCI USA, V91, P11308, DOI 10.1073/pnas.91.24.11308; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; vandenPol AN, 1996, NEUROSCIENCE, V74, P653, DOI 10.1016/0306-4522(96)00153-4; VANOOYEN A, 1994, J THEOR BIOL, V167, P27, DOI 10.1006/jtbi.1994.1047; vanOoyen A, 1996, J THEOR BIOL, V179, P229, DOI 10.1006/jtbi.1996.0063; Wang XJ, 1999, J NEUROSCI, V19, P9587; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7	65	113	115	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JUN	2005	15	6					834	845		10.1093/cercor/bhh184			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	926HJ	WOS:000229113900015	15483049	Green Accepted, Green Published, Bronze			2022-02-06	
J	Ballesteros, MF; Dischinger, PC; Langenberg, P				Ballesteros, MF; Dischinger, PC; Langenberg, P			Pedestrian injuries and vehicle type in Maryland, 1995-1999	ACCIDENT ANALYSIS AND PREVENTION			English	Article						pedestrians; crashes; vehicle characteristics; fatalities	ROAD TRAFFIC ACCIDENTS; IMPACT SPEED; MASS; COLLISIONS; SAFETY; AGE	Pedestrian deaths constitute the second largest category of motor vehicle deaths in the US. The present study examined how pedestrian injury is associated with vehicle type, while controlling for vehicle weight and speed. Police, trauma registry, and autopsy data were linked for injured pedestrians. Logistic regression analyses were performed to control for vehicle weight and speed. Outcomes included pedestrian mortality, injury severity score, and injuries to specific body regions. Compared to conventional cars, pedestrians hit by sport utility vehicles and pick-up trucks were more likely to have higher injury severity scores (odds ratio = 1.48; 95% confidence interval: 1.18-1.87) and to die (odds ratio = 1.72; 95% confidence interval: 1.31-2.28). These relationships diminished when vehicle weight and speed were controlled for. At lower speeds, pedestrians struck by sport utility vehicles, pick-up trucks, and vans were approximately two times as likely to have traumatic brain, thoracic, and abdominal injuries; at higher speeds, there was no such association. The overall increased danger sport utility vehicles and pick-up trucks present to pedestrians may be explained by larger vehicle masses and faster speeds. At slower speeds being hit by sport utility vehicles, and pick-up trucks, and vans resulted in specific injuries, indicating that vehicle design may contribute to different injury patterns. (C) 2003 Elsevier Science Ltd. All rights reserved.	Univ Maryland, Charles McC Mathias Jr Natl Study Ctr Trauma & EM, Baltimore, MD 21201 USA; Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA		Dischinger, PC (corresponding author), Univ Maryland, Charles McC Mathias Jr Natl Study Ctr Trauma & EM, 701 W Pratt St,5th Floor, Baltimore, MD 21201 USA.	pdischin@som.umaryland.edu					ASHTON S, 1982, PEDESTRIAN ACCIDENTS; Ashton S.J, 1979, P 23 STAPP CAR CRASH, P353; ASHTON SJ, 1978, P 22 C AM ASS AUT ME, P216; ATKINS RM, 1988, BRIT MED J, V297, P1431, DOI 10.1136/bmj.297.6661.1431; Baker SP, 1992, THE INJURY FACT BOOK, VSecond; BARANCIK JI, 1986, AM J EPIDEMIOL, V123, P846, DOI 10.1093/oxfordjournals.aje.a114314; Buzeman DG, 1998, ACCIDENT ANAL PREV, V30, P713, DOI 10.1016/S0001-4575(98)00020-7; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P465; GALLOWAY DJ, 1982, INJURY, V13, P294, DOI 10.1016/0020-1383(82)90324-2; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; GRIME G, 1979, ERGONOMICS, V22, P93, DOI 10.1080/00140137908924592; Harrison SP, 1998, EQUINE VET J, V30, P1, DOI 10.1111/j.2042-3306.1998.tb04078.x; *INS I HIGHW SAF, 1998, STATUS REPORT, V33, P1; Insurance Institute for Highway Safety, 1999, STATUS REPORT, V34, P1; KINGMA J, 1994, PERCEPT MOTOR SKILL, V79, P1680, DOI 10.2466/pms.1994.79.3f.1680; LANE PL, 1994, J TRAUMA, V36, P231, DOI 10.1097/00005373-199402000-00016; McGinnis G S, 1989, J Neurosci Nurs, V21, P201; MEYERS M, 2000, METRO PEDESTRIAN DEA, pC2; Mizuno K, 1999, ACCIDENT ANAL PREV, V31, P381, DOI 10.1016/S0001-4575(98)00076-1; MOORE VM, 1995, EPIDEMIOLOGY, V6, P258, DOI 10.1097/00001648-199505000-00012; *NAT HIGHW TRAFF S, 1996, WHY DAT LINK; National Highway Traffic Safety Administration, 1999, TRAFF SAF FACTS 1999; TOLONEN J, 1984, ANN CHIR GYNAECOL FE, V73, P14; ZIVOT U, 1993, AM J FOREN MED PATH, V14, P185, DOI 10.1097/00000433-199309000-00002	24	113	117	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2004	36	1					73	81	PII S0001-4575(02)00129-X	10.1016/S0001-4575(02)00129-X			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	760VM	WOS:000187856000009	14572829				2022-02-06	
J	Mazzini, L; Campini, R; Angelino, E; Rognone, F; Pastore, I; Oliveri, G				Mazzini, L; Campini, R; Angelino, E; Rognone, F; Pastore, I; Oliveri, G			Posttraumatic hydrocephalus: A clinical, neuroradiologic, and neuropsychologic assessment of long-term outcome	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						diagnosis; hydrocephalus; outcome assessment (health care); rehabilitation; treatment outcome	CLOSED-HEAD-INJURY; NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN INJURY; COMPUTED-TOMOGRAPHY; PRACTICAL SCALE; RATING-SCALE; DIAGNOSIS; SPECT; COMA; CT	Objectives: To detect the clinical and radiologic characteristics of posttraumatic hydrocephalus (PTH), to define its prognostic value, and to assess the effects of shunt surgery. Design: Correlational study on a prospective cohort. Setting: Brain injury rehabilitation center. Participants: One hundred forty patients with severe traumatic brain injury (TBI) referred to an inpatient intensive rehabilitation unit of primary care in a university-based system. Interventions: Not applicable. Main Outcome Measures: The Glasgow Outcome Scale (GOS), Disability Rating Scale (DRS), FIM(TM) instrument, and Neurobehavioural Rating Scale (NRS), as well as single-photon emission computed tomography (SPECT) and magnetic resonance imaging. Results: PTH was found in 45% of patients. Risk factors for PTH were as follows: age (P<.04), duration of coma (P<.0001), and decompressive craniectomy (P<.0001). PTH correlated with the degree of hypoperfusion in the temporal lobes (P<.001). Patients who showed clinical deterioration improved after surgery. PTH correlated significantly with GOS, DRS. FIM, and NRS (P<.0001) I year after the trauma, and it influenced the appearance of posttraumatic epilepsy (P<.02). Conclusions: PTH concerns about 50% of patients with severe TBI. It influences functional and behavioral outcome and the appearance of posttraumatic epilepsy. The selection of patients for surgery can be defined principally on a clinical basis. SPECT may be helpful for differentiating ventricular enlargement due to cortical atrophy and hydrocephalus.	San Giovanni Bosco Hosp, Dept Neurol, Turin, Italy; San Giovanni Bosco Hosp, Dept Neurosurg, Turin, Italy; Sci Inst Pavia, Pavia, Italy; Univ Amedeo Avogadro, Dept Neurol, Novara, Italy		Mazzini, L (corresponding author), San Giovanni Bosco Hosp, Dept Neurol, Largo Donatori Sangue 3, Turin, Italy.		Mazzini, Letizia/AAA-2262-2021	Mazzini, Letizia/0000-0003-2479-9120			BARKOVICH AJ, 1992, PEDIATR NEUROSURG, V18, P65; BEYRL B, 1984, NEUROSURGERY, V15, P257; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; GRAY BG, 1992, J NUCL MED, V33, P52; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Guyot LL, 2000, NEUROL RES, V22, P25; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; JENNETT B, 1975, LANCET, V1, P480; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; KOO AH, 1977, RADIOLOGY, V123, P345, DOI 10.1148/123.2.345; Kristensen B, 1996, J NEUROL NEUROSUR PS, V60, P282, DOI 10.1136/jnnp.60.3.282; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; NAIDICH TP, 1982, RADIOL CLIN N AM, V20, P143; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; PHILIPPON J, 1976, NEUROCHIRURGIE, V22, P111; Piatt JH, 1996, NEUROSURGERY, V39, P722, DOI 10.1097/00006123-199610000-00014; PRAYER L, 1993, ACTA RADIOL, V34, P593; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SELIGER G M, 1992, Brain Injury, V6, P71, DOI 10.3109/02699059209008125; SHEFFLER LR, 1994, ARCH PHYS MED REHAB, V75, P338, DOI 10.1016/0003-9993(94)90039-6; TEASDALE G, 1974, LANCET, V2, P81; Vanneste JAL, 2000, J NEUROL, V247, P5, DOI 10.1007/s004150050003; WOOD JH, 1974, NEUROLOGY, V24, P517, DOI 10.1212/WNL.24.6.517	27	113	127	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2003	84	11					1637	1641		10.1053/S0003-9993(03)00314-9			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	741PR	WOS:000186466900010	14639563				2022-02-06	
J	Li, RC; Row, BW; Gozal, E; Kheirandish, L; Fan, QA; Brittian, KR; Guo, SZ; Sachleben, LR; Gozal, D				Li, RC; Row, BW; Gozal, E; Kheirandish, L; Fan, QA; Brittian, KR; Guo, SZ; Sachleben, LR; Gozal, D			Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article						sleep apnea; neurocognitive deficits; inflammation; episodic hypoxia	TRAUMATIC BRAIN-INJURY; NEURONAL CELL-DEATH; PROSTAGLANDIN E-2; CEREBRAL-CORTEX; INDUCIBLE CYCLOOXYGENASE; SPREADING DEPRESSION; SELECTIVE-INHIBITION; ALZHEIMERS-DISEASE; GLUTAMATE RELEASE; GENE-EXPRESSION	Intermittent hypoxia (IH) during sleep, a critical feature of sleep apnea, induces significant neurobehavioral deficits in the rat. Cyclooxygenase (COX)-2 is induced during stressful conditions such as cerebral ischemia and could play an important role in IH-induced learning deficits. We therefore examined COX-1 and COX-2 genes and COX-2 protein expression and activity (prostaglandin E2 [PGE2] tissue concentration) in cortical regions of rat brain after exposure to either IH (10% O-2 alternating with 21% O-2 every 90 seconds) or sustained hypoxia (10% O-2). In addition, the effect of selective COX-2 inhibition with NS-398 on IH-induced neurobehavioral deficits was assessed. IH was associated with increased COX-2 protein and gene expression from Day I to Day 14 of exposure. No changes were found in COX-1 gene expression after exposure to hypoxia. IH-induced COX-2 upregulation was associated with increased PGE2 tissue levels, neuronal apoptosis, and neurobehavioral deficits. Administration of NS-398 abolished IH-induced apoptosis and PGE2 increases without modifying COX-2 mRNA expression. Furthermore, NS-398 treatment attenuated IH-induced deficits in the acquisition and retention of a spatial task in the water maze. We conclude that IH induces upregulation and activation of COX-2 in rat cortex and that COX-2 may play a role in IH-mediated neurobehavioral deficits.	Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pediat, Louisville, KY 40202 USA; Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA		Gozal, D (corresponding author), Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pediat, 570 S Preston St,Suite 321, Louisville, KY 40202 USA.		Gozal, David/M-9492-2017	Gozal, Leila/0000-0003-3332-1057	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL063912, R01HL069932] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL69932, HL63912] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32 HD42396] Funding Source: Medline		Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Baik EJ, 1999, BRAIN RES, V843, P118, DOI 10.1016/S0006-8993(99)01797-7; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bidmon HJ, 2000, J CHEM NEUROANAT, V20, P163, DOI 10.1016/S0891-0618(00)00081-8; Blom MAA, 1997, BRAIN RES, V777, P210, DOI 10.1016/S0006-8993(97)01204-3; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; CHEN J, 1995, NEUROREPORT, V6, P245; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Domoki F, 2000, NEUROREPORT, V11, P3435, DOI 10.1097/00001756-200011090-00007; Domoki F, 2001, NEUROREPORT, V12, P4065, DOI 10.1097/00001756-200112210-00041; Fiebich BL, 2001, J NEUROCHEM, V79, P950, DOI 10.1046/j.1471-4159.2001.00652.x; Figueiredo-Pereira ME, 2002, J BIOL CHEM, V277, P25283, DOI 10.1074/jbc.M109145200; Futaki N, 1997, INFLAMM RES, V46, P496, DOI 10.1007/s000110050232; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Hara K, 1998, NEUROSCI LETT, V256, P53, DOI 10.1016/S0304-3940(98)00755-1; Hewett SJ, 2000, J PHARMACOL EXP THER, V293, P417; Ho L, 1998, J NEUROIMMUNOL, V89, P142, DOI 10.1016/S0165-5728(98)00132-5; Hoozemans JJM, 2001, EXP GERONTOL, V36, P559, DOI 10.1016/S0531-5565(00)00226-6; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Iadecola C, 1999, ACTA NEUROPATHOL, V98, P9, DOI 10.1007/s004010051045; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Kim EJ, 2001, BRAIN RES, V908, P1, DOI 10.1016/S0006-8993(01)02432-5; Koistinaho J, 2000, NEUROCHEM RES, V25, P645, DOI 10.1023/A:1007559003261; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McCown TJ, 1997, BRAIN RES, V767, P370, DOI 10.1016/S0006-8993(97)00773-7; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; Miettinen S, 1997, P NATL ACAD SCI USA, V94, P6500, DOI 10.1073/pnas.94.12.6500; Mirjany M, 2002, J PHARMACOL EXP THER, V301, P494, DOI 10.1124/jpet.301.2.494; MITANI A, 1991, NEUROSCI LETT, V122, P167, DOI 10.1016/0304-3940(91)90849-O; Nagayama M, 1999, J CEREBR BLOOD F MET, V19, P1213, DOI 10.1097/00004647-199911000-00005; Nogawa S, 1997, J NEUROSCI, V17, P2746; PHILLIS JW, 1989, NEUROSCI LETT, V106, P147, DOI 10.1016/0304-3940(89)90217-6; Reese J, 2001, ENDOCRINOLOGY, V142, P3198, DOI 10.1210/en.142.7.3198; Sairanen T, 1998, ANN NEUROL, V43, P738, DOI 10.1002/ana.410430608; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Takadera T, 2002, NEUROSCI LETT, V317, P61, DOI 10.1016/S0304-3940(01)02449-1; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; Toti P., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P245; Vane JR, 2000, INT J CLIN PRACT, V54, P7; Xiang ZM, 2002, NEUROBIOL AGING, V23, P327, DOI 10.1016/S0197-4580(01)00282-2; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T	50	113	119	0	3	AMER THORACIC SOC	NEW YORK	1740 BROADWAY, NEW YORK, NY 10019-4374 USA	1073-449X			AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	AUG 15	2003	168	4					469	475		10.1164/rccm.200211-1264OC			7	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	709ZC	WOS:000184655600014	12773326				2022-02-06	
J	Umile, EM; Sandel, ME; Alavi, A; Terry, CM; Plotkin, RC				Umile, EM; Sandel, ME; Alavi, A; Terry, CM; Plotkin, RC			Dynamic imaging in mild traumatic brain injury: Support for the theory of medial temporal vulnerability	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; postconcussion syndrome; rehabilitation; tomography, positron-emission; tomography, emission-computed, single-photon	MINOR HEAD-INJURY; ENDURING MEMORY IMPAIRMENT; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; CONCUSSION; SEQUELAE; SYMPTOMS; DEFICITS; HISTORY; LOBE	Objective: To determine whether patients with mild traumatic brain injury (TBI) and persistent postconcussive symptoms have evidence of temporal lobe injury on dynamic imaging. Design: Case series. Setting: An academic medical center. Participants: Twenty patients with a clinical diagnosis of mild TBI and persistent postconcussive symptoms were referred for neuropsychologic evaluation and dynamic imaging. Fifteen (75%) had normal magnetic resonance imaging (MRI) and/or computed tomography (CT) scans at the time of injury. Interventions: Neuropsychologic testing, positron-emission tomography (PET), and single-photon emission-computed tomography (SPECT). Main Outcome Measures: Temporal lobe findings on static imaging (MRI, CT) and dynamic imaging (PET, SPECT); neuropsychologic test findings on measures of verbal and visual memory. Results: Testing documented neurobehavioral deficits in 19 patients (95%). Dynamic imaging documented abnormal findings in 18 patients (90%). Fifteen patients (75%) had temporal lobe abnormalities on PET and SPECT (primarily in medial temporal regions); abnormal findings were bilateral in 10 patients (50%) and unilateral in 5 (25%). Six patients (30%) had frontal abnormalities, and 8 (40%) had nonfrontotemporal abnormalities. Correlations between neuropsychologic testing and dynamic imaging could be established but not consistently across the whole group. Conclusions: Patients with mild TBI and persistent postconcussive symptoms have a high incidence of temporal lobe injury (presumably involving the hippocampus and related structures), which may explain the frequent finding of memory disorders in this population. The abnormal temporal lobe findings on PET and SPECT in humans may be analogous to the neuropathologic evidence of medial temporal injury provided by animal studies after mild TBI.	St Lawrence Rehabil Ctr, Brain Injury Unit, Lawrenceville, NJ USA; Univ Penn, Med Ctr, Dept Rehabil Med, Philadelphia, PA 19104 USA; Univ Penn, Med Ctr, Dept Radiol, Philadelphia, PA 19104 USA		Sandel, ME (corresponding author), Kaiser Fdn, Rehabil Ctr, Kaiser Permanente Med Ctr, 975 Sereno Dr, Vallejo, CA 94589 USA.	elizabeth.sandel@kp.org			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS 08803] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER		ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; ALVES WM, 1985, CENTRAL NERVOUS SYST, P255; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; DELIS DC, 1989, HDB NEUROPSYCHOLOGY, V3, P26; Delis DC, 1987, CALIFORNIA VERBAL LE; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Goldstone BP, 2001, READ TEACH, V55, P362; GRAY BG, 1992, J NUCL MED, V33, P52; GRONWALL D, 1974, LANCET, V2, P605; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Holbourn AHS, 1943, LANCET, V2, P438; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; JACOBS A, 1994, J NUCL MED, V35, P942; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KAY T, 1992, Neurology, V42, P411; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; Meyers J. E., 1996, REY COMPLEX FIGURE T; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Newberg AB, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199612000-00009; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RAO N, 1984, ARCH PHYS MED REHAB, V65, P780; REBA RC, 1993, J CLIN PSYCHIAT, V54, P26; REEVES DW, 1994, CLIN ASSESSMENT MEMO; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rey A., 1964, EXAMEN CLIN PSYCHOL; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SCHAPIRO SR, 1993, MINOR HEAD TRAUMA AS, P86; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Squire L. R., 1984, MEMORY CONSOLIDATION, P185; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; Wechsler D, 1987, MEMORY SCALE REVISED; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; Williams J. M, 1990, MEMORY ASSESSMENT SC; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253; [No title captured]	56	113	115	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2002	83	11					1506	1513		10.1053/apmr.2002.35092			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	612TP	WOS:000179091800002	12422317				2022-02-06	
J	Moore, AH; Osteen, CL; Chatziioannou, AF; Hovda, DA; Cherry, SR				Moore, AH; Osteen, CL; Chatziioannou, AF; Hovda, DA; Cherry, SR			Quantitative assessment of longitudinal metabolic changes in vivo after traumatic brain injury in the adult rat using FDG-MicroPET	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						MicroPET; cerebral; glucose metabolism; conscious rat; traumatic; brain injury; positron emission tomography	POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL GLUCOSE-UTILIZATION; IMAGING SMALL ANIMALS; PET SCANNER; RHESUS MACAQUES; RESOLUTION; MONKEYS; PERFORMANCE; DETECTORS	With the advent and emerging importance of neurobiology and its relation to behavior, scientists desire the capability to apply noninvasive, quantitative imaging of neuronal activity to small rodents. To this end, the authors' laboratory has developed microPET. a high-resolution positron emission tomography (PET) scanner that is capable of performing in vivo molecular imaging at a resolution sufficient to resolve major structures in the rat brain. The authors report in this article that, in conjunction with 2-[F-18]fluoro-2-deoxyglucose (FDG), microPET provides accurate rates of cerebral glucose metabolism (59.7 to 108.5 mu mol/100 g.min) in conscious adult rats as validated by within-subject autoradiographic measurements (59.5 to 136.2 mu mol/100 g.min; r = 0.88; F-[1.46] = 168.0; P < 0.001). By conducting repeated quantitative scanning, the authors demonstrate the sensitivity and accuracy of FDG- microPET to detect within-subject metabolic changes induced by traumatic brain injury. In addition, the authors report that longitudinal recovery From traumatic brain injury-induced metabolic depression, as measured by quantitative FDG-microPET, is significantly correlated (r = 0.65; P < 0.05) to recovery of behavioral dysfunction, as assessed by the Morris Water Maze performance of the same rats, after injury. This is the first study to demonstrate that FDG-microPET is quantitative, reproducible, and sensitive to metabolic changes, introducing a new approach to the longitudinal study of small animal models in neuroscience research.	Univ Calif Los Angeles, Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Div Neurosurg, Neurotrauma Lab, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med & Mol Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA		Cherry, SR (corresponding author), Univ Calif Los Angeles, Sch Med, Crump Inst Mol Imaging, 700 Westwood Plaza, Los Angeles, CA 90095 USA.		Cherry, Simon/AAH-1000-2019	Cherry, Simon/0000-0002-0155-5644			ACKERMANN RF, 1989, J CEREBR BLOOD F MET, V9, P774, DOI 10.1038/jcbfm.1989.111; Bloomfield PM, 1997, PHYS MED BIOL, V42, P389, DOI 10.1088/0031-9155/42/2/010; Bruyndonckx P, 1997, NUCL INSTRUM METH A, V392, P407, DOI 10.1016/S0168-9002(97)00281-7; Chatziioannou AF, 1999, J NUCL MED, V40, P1164; CHAVOIX C, 1995, HDB NEUROPSYCHOLOGY, V10, P483; Cherry SR, 1997, IEEE T NUCL SCI, V44, P1161, DOI 10.1109/23.596981; DelGuerra A, 1996, IEEE T NUCL SCI, V43, P1958, DOI 10.1109/23.507253; DOUDET D, 1995, AM J PSYCHIAT, V152, P1782; EBERLING JL, 1995, NEUROBIOL AGING, V16, P825, DOI 10.1016/0197-4580(95)00085-S; HOFFMAN EJ, 1979, J COMPUT ASSIST TOMO, V3, P299, DOI 10.1097/00004728-197906000-00001; JACOBS B, 1995, CEREB CORTEX, V5, P222, DOI 10.1093/cercor/5.3.222; Jeavons AP, 1999, IEEE T NUCL SCI, V46, P468, DOI 10.1109/23.775564; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Kuge Y, 1997, J CEREBR BLOOD F MET, V17, P116, DOI 10.1097/00004647-199701000-00015; MARRIOTT CJ, 1994, J NUCL MED, V35, P1390; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Moore AH, 2000, DEV BRAIN RES, V120, P141, DOI 10.1016/S0165-3806(00)00005-5; Moore AH, 1999, J NEUROSCI METH, V88, P123, DOI 10.1016/S0165-0270(99)00013-8; MORI K, 1990, J NEUROCHEM, V54, P307, DOI 10.1111/j.1471-4159.1990.tb13316.x; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; SIEGEL S, 1992, IEEE T NUCL SCI, V39, P1117, DOI 10.1109/23.159770; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Watanabe M, 1997, IEEE T NUCL SCI, V44, P1277, DOI 10.1109/23.597001; Weber S, 1997, IEEE T MED IMAGING, V16, P684, DOI 10.1109/42.640759; YOSHINO A, 1991, BRAIN RES, V12, P996	27	113	116	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2000	20	10					1492	1501		10.1097/00004647-200010000-00011			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	360WN	WOS:000089690500011	11043912	Bronze			2022-02-06	
J	Cernak, I; Savic, VJ; Lazarov, A; Joksimovic, M; Markovic, S				Cernak, I; Savic, VJ; Lazarov, A; Joksimovic, M; Markovic, S			Neuroendocrine responses following graded traumatic brain injury in male adults	BRAIN INJURY			English	Article							TRANSIENT HYPOGONADOTROPIC HYPOGONADISM; SEVERE CRANIOCEREBRAL TRAUMA; THYROID-FUNCTION; NERVOUS-SYSTEM; WAR CASUALTIES; BLAST INJURY; HEAD-INJURY; EPIDEMIOLOGY; HORMONES; ILLNESS	In an effort to characterize thyroid, gonadal and adrenal function following neurotrauma, the present study determined serum concentrations of thyroid-stimulating hormone (TSH), total triiodothyronine (T-3), thyroxine (T-4), testosterone and cortisol over a 7 day period in 31 patients with traumatic brain injury. The study group consisted of eight patients with mild closed head injury (Glasgow Coma Scale-GCS 13-15), 10 patients with extensive penetrating head injury (GCS 4-6) and 13 patients with blast injuries but without direct head trauma. The latter group was included in the study because the development of indirect brain trauma has previously been implicated in blast injuries. Patients with multiple injuries were not included. Following mild injury (GCS 13-15), TSH was increased up until day 3 after injury. T-3 levels were elevated on days 1, 5 and 7 after injury while T-4 remained unchanged throughout. While testosterone was decreased over only the first 2 days post-trauma, cortisol was increased over these first 2 days after injury. In contrast, following severe penetrating injury (GCS 4-6), there were significant declines in TSH, T-3 and testosterone over the 7 day observation period post trauma. Serum cortisol also declined in these patients between 1-3 days after injury, before increasing again on days 5 and 7 after injury. Following indirect neurotrauma, TSH was slightly decreased immediately after trauma but increased to above normal levels on days 5 and 7 post-trauma. Similarly, T-3 initially declined after injury, but then increased to above normal levels between 5 and 7 days after injury. T-4 and testosterone remained unchanged over the entire post-traumatic period. Serum cortisol was significantly increased after indirect neurotrauma but only up to day 2 post-trauma. In summary, patients with both direct and indirect traumatic brain injury demonstrated endocrine alterations after trauma, the dynamics of which may be a reflection of the severity of brain damage.	Mil Med Acad, YU-11002 Belgrade, Serbia		Cernak, I (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.	Ibolja.Cernak@jcu.edu.au	Cernak, Ibolja/A-6399-2008	Ibolja, Cernak/0000-0003-3214-698X			Aboutanos MB, 1997, J TRAUMA, V43, P719, DOI 10.1097/00005373-199710000-00031; Ansari SA, 1998, BRIT J NEUROSURG, V12, P340; BARTON RN, 1987, BAILLIERE CLIN ENDOC, V1, P355, DOI 10.1016/S0950-351X(87)80067-8; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; BAUE AE, 1984, ARCH SURG-CHICAGO, V119, P1125; Cameron P, 1995, AUST NZ J SURG, V65, P848, DOI 10.1111/j.1445-2197.1995.tb00574.x; Carey ME, 1996, J TRAUMA, V40, pS165, DOI 10.1097/00005373-199603001-00036; CAREY ME, 1982, ACTA CHIR SCAND, P351; Cemak I., 1997, INT REV ARMED FORCES, V70, P114; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 1999, WORLD J SURG, V23, P44, DOI 10.1007/s002689900563; Cernak I, 1997, WORLD J SURG, V21, P240, DOI 10.1007/s002689900223; Chaloner EJ, 1996, J ROY COLL SURG EDIN, V41, P398; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; FLEISCHER AS, 1978, J NEUROSURG, V49, P650, DOI 10.3171/jns.1978.49.5.0650; GALLOE AM, 1993, DAN MED BULL, V40, P492; Gofrit ON, 1997, MIL MED, V162, P24, DOI 10.1093/milmed/162.1.24; GOTTARDIS M, 1990, INTENS CARE MED, V16, P163, DOI 10.1007/BF01724795; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; Hetz W, 1996, J ACCID EMERG MED, V13, P243; HILL JF, 1979, ANN ROY COLL SURG, V61, P4; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; KUSHNER JP, 1996, ENDOCRINOL METAB, V3, P219; LEE SC, 1994, BRAIN INJURY, V8, P571; Munno I, 1998, IMMUNOPHARM IMMUNOT, V20, P519, DOI 10.3109/08923979809031513; Peng R, 1998, AM SURGEON, V64, P950; Pentelenyi T, 1992, Acta Neurochir Suppl (Wien), V55, P21; PENTELENYI T, 1984, INJURY, V15, P397, DOI 10.1016/0020-1383(84)90205-5; SHUTOV AA, 1993, ZH NEVROPATOL PSIKH, V93, P39; SHUTOV AA, 1980, ZH VOPROSY NEIROKHIR; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; SPRATT DI, 1992, J CLIN ENDOCR METAB, V75, P1562, DOI 10.1210/jc.75.6.1562; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; VITEK V, 1987, INJURY, V18, P336, DOI 10.1016/0020-1383(87)90056-8; Vojvodic V, 1996, J TRAUMA, V40, pS180, DOI 10.1097/00005373-199603001-00040; WOOLF PD, 1986, CLIN ENDOCRINOL, V25, P265, DOI 10.1111/j.1365-2265.1986.tb01691.x; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011	41	113	119	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	1999	13	12					1005	1015					11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	264UJ	WOS:000084200600006	10628505				2022-02-06	
J	Levin, HS; Mendelsohn, D; Lilly, MA; Yeakley, J; Song, J; Scheibel, RS; Harward, H; Fletcher, JM; Kufera, JA; Davidson, KC; Bruce, D				Levin, HS; Mendelsohn, D; Lilly, MA; Yeakley, J; Song, J; Scheibel, RS; Harward, H; Fletcher, JM; Kufera, JA; Davidson, KC; Bruce, D			Magnetic resonance imaging in relation to functional outcome of pediatric closed head injury: A test of the Ommaya-Gennarelli model	NEUROSURGERY			English	Article						closed head injury; magnetic resonance imaging; outcome	CHILDREN; CONSCIOUSNESS; ADOLESCENTS; COMA	OBJECTIVE: To characterize late neuropathological findings of pediatric closed head injury (CHI), to assess depth of brain lesion in relation to acute severity, and to assess long-term outcome to test the Ommaya-Gennarelli model. METHODS: Magnetic resonance imaging (MRI) at least 3 months postinjury in a prospective sample (n 5 169) and at least 3 years after CHI in a retrospective sample (n 5 82) was studied. Lesion volume was measured by planimetry. Acute CHI severity was measured by the Glasgow Coma Scale. Patients were classified according to the depth of the deepest parenchymal lesion into no lesion, cortical, subcortical, and deep central gray/brain stem groups. The outcomes were assessed by the Glasgow Outcome Scale and the Vineland Adaptive Behavior Scale, which were performed at the time of the MRI in the retrospective sample and up to 3 years postinjury in the prospective sample. RESULTS: Focal brain lesions were present in 55.4% of the total sample. Depth of brain lesion was directly related to severity of acute impairment of consciousness and inversely related to outcome, as measured by both the Glasgow Outcome Scale and the Vineland Adaptive Behavior Scale. A rostrocaudal gradient of hemispheric lesion frequency was observed, whereas the posterior lesions of the corpus callosum were particularly common. Total lesion volume could not explain the depth of lesion effect. CONCLUSION: Our findings extend support for the Ommaya-Gennarelli model to pediatric CHI, indicating that depth of brain lesion is related to functional outcome. The relative frequency of focal brain lesions revealed by late MRI is higher than that of previous findings using acute computed tomography. Future investigations could explore whether depth of lesion observed using late MRI is sensitive to neuroprotective interventions.	UNIV TEXAS,SW MED CTR,DEPT RADIOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT NEUROSURG,DALLAS,TX 75235; UNIV TEXAS,SCH MED,DEPT RADIOL,HOUSTON,TX 77030; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77030; UNIV TEXAS,CALLIER CTR COMMUN DISORDERS,DALLAS,TX 75235; NATL STUDY CTR TRAUMA & EMERGENCY MED SYST,BALTIMORE,MD; FSD DATA SERV INC,HOUSTON,TX		Levin, HS (corresponding author), BAYLOR COLL MED,PM&R RES OFF,DEPT PHYS MED & REHABIL,1333 MOURSUND AVE,ROOM A205,HOUSTON,TX 77030, USA.		Fletcher, Jack/AAX-2931-2020; fletcher, jack/Q-5975-2019	Davidson, Kevin/0000-0001-5799-1325	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01-RR02558] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR002558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Damasio H., 1989, LESION ANAL NEUROPSY; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; JENNETT B, 1975, LANCET, V1, P480; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; *PMIC, 1991, INT CLASS DIS 9 REV, V1; *PMIC, 1991, INT CLASS DIS 9 REV, V2; TEASDALE G, 1974, LANCET, V2, P81; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	20	113	114	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	MAR	1997	40	3					432	440		10.1097/00006123-199703000-00002			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WJ763	WOS:A1997WJ76300005	9055281				2022-02-06	
J	ANDREWS, PJD; DEARDEN, NM; MILLER, JD				ANDREWS, PJD; DEARDEN, NM; MILLER, JD			JUGULAR BULB CANNULATION - DESCRIPTION OF A CANNULATION TECHNIQUE AND VALIDATION OF A NEW CONTINUOUS MONITOR	BRITISH JOURNAL OF ANAESTHESIA			English	Article						BRAIN, HEAD INJURY; ISCHEMIA; EQUIPMENT, CONTINUOUS INVIVO OXIMETRY; MONITORING, JUGULAR BULB OXYGEN SATURATION	CEREBRAL BLOOD-FLOW; COMATOSE PATIENTS; HEAD-INJURY; HYPERTENSION; METABOLISM	We have compared in vivo oxygen saturation recordings obtained from the Oximetrix 3 with in vitro measurements using the Instrumentation Laboratories 282 Co-Oximeter. The small mean difference (0.85%) and close limits of agreement (-4% to 6%) are close enough for clinical purposes, provided in vivo calibration is performed after insertion of the fibreoptic catheter and repeated at least every 12 h. Continuous monitoring of jugular bulb oxygen saturation during intensive care of brain injured patients is now possible using fibreoptic technology. This technique may be of value in detecting global ischaemia, and as a predictor and monitor of cerebral perfusion pressure therapy.	UNIV EDINBURGH,WESTERN GEN HOSP,DEPT ANAESTHESIA,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND								ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; BRICOLO AP, 1981, J NEUROSURG, V55, P397, DOI 10.3171/jns.1981.55.3.0397; CRUZ J, 1984, Society for Neuroscience Abstracts, V10, P542; DEARDEN NM, 1989, INTRACRANIAL PRESSUR, V7; GARLICK R, 1987, SCAND J CLIN LAB INV, V47, P47; GETTINGER A, 1987, ANESTHESIOLOGY, V66, P373, DOI 10.1097/00000542-198703000-00017; GIBBS EL, 1945, AM J PSYCHIAT, V102, P184, DOI 10.1176/ajp.102.2.184; NELSON LD, 1986, ANN SURG, V203, P329, DOI 10.1097/00000658-198603000-00020; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1983, J CEREBRAL BLOOD F S, V1, P567; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; 1989, MINITAB REFERENCE MA	13	113	115	0	1	PROF SCI PUBL	LONDON	TAVISTOCK HOUSE EAST, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0007-0912			BRIT J ANAESTH	Br. J. Anaesth.	NOV	1991	67	5					553	558		10.1093/bja/67.5.553			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GP137	WOS:A1991GP13700008	1751268	Bronze			2022-02-06	
J	SHOHAMI, E; SHAPIRA, Y; YADID, G; REISFELD, N; YEDGAR, S				SHOHAMI, E; SHAPIRA, Y; YADID, G; REISFELD, N; YEDGAR, S			BRAIN PHOSPHOLIPASE-A2 IS ACTIVATED AFTER EXPERIMENTAL CLOSED HEAD-INJURY IN THE RAT	JOURNAL OF NEUROCHEMISTRY			English	Article									HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT BIOCHEM,IL-91010 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT ANESTHESIOL,IL-91010 JERUSALEM,ISRAEL		SHOHAMI, E (corresponding author), HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT PHARMACOL,POB 1172,IL-91010 JERUSALEM,ISRAEL.						ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480; BANGA HS, 1986, P NATL ACAD SCI USA, V83, P9197, DOI 10.1073/pnas.83.23.9197; BAZAN NG, 1971, J NEUROCHEM, V18, P1379, DOI 10.1111/j.1471-4159.1971.tb00002.x; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; BAZAN NG, 1976, FUNCTION METABOLISM, P317; BORASCHI D, 1985, J IMMUNOL, V135, P502; Brenner T, 1988, Ann N Y Acad Sci, V540, P403, DOI 10.1111/j.1749-6632.1988.tb27115.x; DAGAN A, 1987, BIOCHEM INT, V15, P801; DEMPSEY RJ, 1986, J NEUROSURG, V64, P118, DOI 10.3171/jns.1986.64.1.0118; DENGLER LA, 1986, PROG CLIN BIOL RES, V270, P291; EDGAR AD, 1982, J NEUROCHEM, V39, P1111, DOI 10.1111/j.1471-4159.1982.tb11503.x; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; GALLI C, 1976, J NEUROCHEM, V26, P401, DOI 10.1111/j.1471-4159.1976.tb04493.x; GARCIAGIL M, 1986, J IMMUNOL, V136, P259; GARDINER M, 1981, J NEUROCHEM, V36, P1500, DOI 10.1111/j.1471-4159.1981.tb00592.x; GAUDET RJ, 1980, J NEUROCHEM, V35, P653, DOI 10.1111/j.1471-4159.1980.tb03704.x; HIRATA F, 1980, P NATL ACAD SCI-BIOL, V77, P2533, DOI 10.1073/pnas.77.5.2533; HOVAV E, 1987, BIORHEOLOGY, V23, P377; JACOBS TP, 1987, STROKE, V18, P741, DOI 10.1161/01.STR.18.4.741; KEMPSKI O, 1987, STROKE, V18, P111, DOI 10.1161/01.STR.18.1.111; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; LISTER MD, 1988, J BIOL CHEM, V263, P7506; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOSKOWITZ MA, 1984, SCIENCE, V224, P886, DOI 10.1126/science.6719118; ROSENTHAL MD, 1988, J CELL PHYSIOL, V136, P333, DOI 10.1002/jcp.1041360217; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SHOHAMI E, 1982, STROKE, V13, P494, DOI 10.1161/01.STR.13.4.494; SHOHAMI E, 1985, J NEUROCHEM, V45, P132, DOI 10.1111/j.1471-4159.1985.tb05484.x; SHOHAMI E, 1988, NEUROSURGERY, V22, P859, DOI 10.1227/00006123-198805000-00007; SHOHAMI E, 1989, IN PRESS ANN NY ACAD; SLEIGHT RG, 1984, J CELL BIOL, V99, P742, DOI 10.1083/jcb.99.2.742; Slotboom A., 1982, PHOSPHOLIPIDS, P359; van den Bosch H, 1978, Adv Prostaglandin Thromboxane Res, V3, P69; VANDENBOSCH H, 1982, PHOSPHOLIPIDS, P313; VERGER R, 1982, CHEM PHYS LIPIDS, V30, P189, DOI 10.1016/0009-3084(82)90052-4; WAITE M, 1987, PHOSPHOLIPASES, P243; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; WEY HE, 1986, BIOCHIM BIOPHYS ACTA, V878, P380, DOI 10.1016/0005-2760(86)90246-8; WIELOCH T, 1984, J NEUROCHEM, V43, P160, DOI 10.1111/j.1471-4159.1984.tb06692.x; WOLFE LS, 1982, J NEUROCHEM, V38, P1, DOI 10.1111/j.1471-4159.1982.tb10847.x; YASUDA H, 1985, J NEUROCHEM, V45, P168, DOI 10.1111/j.1471-4159.1985.tb05489.x; YEDGAR S, 1982, J BIOL CHEM, V257, P2188; YEDGAR S, 1987, BIOCHEMISTRY-US, V26, P3395, DOI 10.1021/bi00386a022; YOSHIDA S, 1980, J NEUROSURG, V53, P323, DOI 10.3171/jns.1980.53.3.0323	47	113	115	1	5	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-3042			J NEUROCHEM	J. Neurochem.	NOV	1989	53	5					1541	1546		10.1111/j.1471-4159.1989.tb08550.x			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW235	WOS:A1989AW23500029	2477500				2022-02-06	
J	Steyerberg, EW; Wiegers, E; Sewalt, C; Buki, A; Citerio, G; De Keyser, V; Ercole, A; Kunzmann, K; Lanyon, L; Lecky, F; Lingsma, H; Manley, G; Nelson, D; Peul, W; Stocchetti, N; von Steinbuchel, N; Vande Vyvere, T; Verheyden, J; Wilson, L; Maas, AIR; Menon, DK				Steyerberg, Ewout W.; Wiegers, Eveline; Sewalt, Charlie; Buki, Andras; Citerio, Giuseppe; De Keyser, Veronique; Ercole, Ari; Kunzmann, Kevin; Lanyon, Linda; Lecky, Fiona; Lingsma, Hester; Manley, Geoffrey; Nelson, David; Peul, Wilco; Stocchetti, Nino; von Steinbuechel, Nicole; Vande Vyvere, Thijs; Verheyden, Jan; Wilson, Lindsay; Maas, Andrew I. R.; Menon, David K.		CENTER-TBI Participants Investigat	Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study	LANCET NEUROLOGY			English	Article							NEUROTRAUMA EFFECTIVENESS RESEARCH; QUALITY-OF-LIFE; SCALE; MORTALITY; ALCOHOL	Background The burden of traumatic brain injury (TBI) poses a large public health and societal problem, but the characteristics of patients and their care pathways in Europe are poorly understood. We aimed to characterise patient case-mix, care pathways, and outcomes of TBI. Methods CENTER-TBI is a Europe-based, observational cohort study, consisting of a core study and a registry. Inclusion criteria for the core study were a clinical diagnosis of TBI, presentation fewer than 24 h after injury, and an indication for CT. Patients were differentiated by care pathway and assigned to the emergency room (ER) stratum (patients who were discharged from an emergency room), admission stratum (patients who were admitted to a hospital ward), or intensive care unit (ICU) stratum (patients who were admitted to the ICU). Neuroimages and biospecimens were stored in repositories and outcome was assessed at 6 months after injury. We used the IMPACT core model for estimating the expected mortality and proportion with unfavourable Glasgow Outcome Scale Extended (GOSE) outcomes in patients with moderate or severe TBI (Glasgow Coma Scale [GCS] score <= 12). The core study was registered with ClinicalTrials.gov , number NCT02210221, and with Resource Identification Portal (RRID: SCR_015582). Findings Data from 4509 patients from 18 countries, collected between Dec 9,2014, and Dec 17,2017, were analysed in the core study and from 22782 patients in the registry. In the core study, 848 (19%) patients were in the ER stratum, 1523 (34%) in the admission stratum, and 2138 (47%) in the ICU stratum. In the ICU stratum, 720 (36%) patients had mild TBI (GCS score 13-15). Compared with the core cohort, the registry had a higher proportion of patients in the ER (9839 [43%]) and admission (8571138%1) strata, with more than 95% of patients classified as having mild TBI. Patients in the core study were older than those in previous studies (median age 50 years [IQR 30-66], 1254 128%1 aged >65 years), 462 (11%) had serious comorbidities, 772 (18%) were taking anticoagulant or antiplatelet medication, and alcohol was contributory in 1054 (25%) TBIs. MRI and blood biomarker measurement enhanced characterisation of injury severity and type. Substantial inter-country differences existed in care pathways and practice. Incomplete recovery at 6 months (GOSE <8) was found in 207 (30%) patients in the ER stratum, 665 (53%) in the admission stratum, and 1547 (84%) in the ICU stratum. Among patients with moderate-to-severe TBI in the ICU stratum, 623 (55%) patients had unfavourable outcome at 6 months (GOSE <5), similar to the proportion predicted by the IMPACT prognostic model (observed to expected ratio 1.06 [95% CI 0.97-1-14]), but mortality was lower than expected (0.70 [0.62-0.76]). Interpretation Patients with TBI who presented to European centres in the core study were older than were those in previous observational studies and often had comorbidities. Overall, most patients presented with mild TBI. The incomplete recovery of many patients should motivate precision medicine research and the identification of best practices to improve these outcomes. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Steyerberg, Ewout W.; Wiegers, Eveline; Sewalt, Charlie; Lingsma, Hester] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Buki, Andras] Univ Pecs, Dept Neurosurg, Med Sch, Pecs, Hungary; [Buki, Andras] Univ Pecs, Neurotrauma Res Grp, Janos Szentegothai Res Ctr, Pecs, Hungary; [Citerio, Giuseppe] ASST Monza, NeuroIntens Care, Monza, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [De Keyser, Veronique; Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, B-2650 Edegem, Belgium; [Vande Vyvere, Thijs] Antwerp Univ Hosp, Dept Radiol, Edegem, Belgium; [Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Kunzmann, Kevin] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Lanyon, Linda] Karolinska Inst, Int Neuroinformat Coordinating Facil, Stockholm, Sweden; [Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Lecky, Fiona] Univ Sheffield, Hlth Serv Res Sect, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Manley, Geoffrey] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Peul, Wilco] Leiden Univ, Med Ctr, The Hague, Netherlands; [Peul, Wilco] Leiden Univ, Med Ctr, Leiden, Netherlands; [Peul, Wilco] Univ Neurosurg Ctr Holland, Haaglanden Med Ctr, The Hague, Netherlands; [Peul, Wilco] Univ Neurosurg Ctr Holland, Haaglanden Med Ctr, Leiden, Netherlands; [Stocchetti, Nino] Milan Univ, Dept Pathophysiol & Transplantat, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci Intens Care Unit, Milan, Italy; [von Steinbuechel, Nicole] Univ Med Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Vande Vyvere, Thijs; Verheyden, Jan] Icometrix, Leuven, Belgium; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium		Maas, AIR (corresponding author), Antwerp Univ Hosp, Dept Neurosurg, B-2650 Edegem, Belgium.	andrew.maas@uza.be	Sahuquillo, Juan/B-3577-2008; Golubovic, Jagos/AAD-1270-2019; Badenes, Rafael/K-6628-2019; Cooper, D. James/G-7961-2013; Oresic, Matej/K-7673-2016; Castano-Leon, Ana M/ABF-6322-2020; Posti, Jussi P./Y-2908-2019; Vande Vyvere, Thijs/AAB-5180-2022; Wilson, Lindsay/A-3659-2009; Lagares, Alfonso/B-2969-2011; Laureys, Steven/AAN-2097-2021; Maas, Andrew IR/C-5584-2013; Volovici, Victor/AAZ-8901-2020; Ercole, Ari/B-6288-2009; Gomez, Pedro/E-2411-2014; Belli, Antonio/I-3799-2015; Raj, Rahul/K-7693-2012	Sahuquillo, Juan/0000-0003-0713-5875; Golubovic, Jagos/0000-0001-5524-246X; Badenes, Rafael/0000-0001-7017-0150; Cooper, D. James/0000-0002-5872-9051; Oresic, Matej/0000-0002-2856-9165; Castano-Leon, Ana M/0000-0002-7918-5049; Posti, Jussi P./0000-0002-5925-5193; Vande Vyvere, Thijs/0000-0003-4032-5443; Wilson, Lindsay/0000-0003-4113-2328; Lagares, Alfonso/0000-0003-3996-0554; Laureys, Steven/0000-0002-3096-3807; Maas, Andrew IR/0000-0003-1612-1264; Volovici, Victor/0000-0002-5798-5360; Ercole, Ari/0000-0001-8350-8093; Kondziella, Daniel/0000-0001-5562-9808; Bragge, Peter/0000-0003-0745-5131; Kunzmann, Kevin/0000-0002-1140-7143; Anke, Audny/0000-0002-2491-2560; Rossi, Sandra/0000-0002-9963-8121; Wang, Kevin/0000-0002-9343-6473; Carbonara, Marco/0000-0002-1431-8322; Radoi, Andreea/0000-0002-0677-3544; Coles, Jonathan/0000-0003-4013-679X; George, Pradeep/0000-0001-6771-2828; Caccioppola, Alessio/0000-0003-1936-3111; Stewart, William/0000-0003-2199-2582; Te Ao, Braden/0000-0002-1050-200X; Van Essen, Thomas/0000-0003-4657-5283; Nelson, David/0000-0003-2530-8207; Kolias, Angelos/0000-0003-3992-0587; Andelic, Nada/0000-0002-3719-4406; Huijben, Jilske (Antonia)/0000-0002-2892-5406; Newcombe, Virginia/0000-0001-6044-9035; Sanchez-Porras, Renan/0000-0002-9084-8114; Gomez, Pedro/0000-0002-4185-5238; Parizel, Paul M./0000-0002-0221-2854; Zeiler, Frederick/0000-0003-1737-0510; Belli, Antonio/0000-0002-3211-9933; Dawes, Helen/0000-0002-2933-5213; Sakowitz, Oliver/0000-0003-3248-6335; Della Corte, Francesco/0000-0003-1736-2318; Zoerle, Tommaso/0000-0001-8713-8085; Esser, Patrick/0000-0002-3227-0115; Donoghue, Emma/0000-0002-2745-9108; Gratz, Johannes/0000-0001-8717-0544; Raj, Rahul/0000-0003-4243-9591; Gravesteijn, Benjamin/0000-0001-8096-5803; Blaabjerg, Morten/0000-0001-6007-1861; van der Naalt, Joukje/0000-0001-9873-2418	European Union 7th Framework Programme; Hannelore Kohl Stiftung; OneMind; Integra LifeSciences Corporation; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI	European Union 7th Framework Programme, the Hannelore Kohl Stiftung, OneMind, and Integra LifeSciences Corporation.	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; CENTER-TBI, ETH APPR; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Huijben JA, 2018, J NEUROTRAUM, V35, P323, DOI 10.1089/neu.2017.5194; Huijben JA, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2000-6; Jackson CH, 2011, J STAT SOFTW, V38, P1; Jain S, 2019, J NEUROTRAUM, V36, P1794, DOI 10.1089/neu.2018.6183; Kehoe A, 2015, EMERG MED J, V32, P911, DOI 10.1136/emermed-2015-205265; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; LAMM AG, 2019, J NEUROTRAUM, V36, P2513, DOI DOI 10.1089/neu.2018.6014; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Legrand SA, 2012, FORENSIC SCI INT, V220, P224, DOI 10.1016/j.forsciint.2012.03.006; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marshall LF, 1991, NEW CLASSIFICATION H; Martin JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187320; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Timmermans C, 2019, J MAGN RESON IMAGING, V49, P955, DOI 10.1002/jmri.26333; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Van Buuren S., 2012, FLEXIBLE IMPUTATION; Volovici V, 2019, J CRIT CARE, V49, P158, DOI 10.1016/j.jcrc.2018.11.002; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Ware JE, 2002, USERS MANUAL SF 12V2; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Yue JK, 2017, J CLIN NEUROSCI, V45, P293, DOI 10.1016/j.jocn.2017.07.022; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	38	112	113	1	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	OCT	2019	18	10					923	934		10.1016/S1474-4422(19)30232-7			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX6HN	WOS:000485784000017	31526754	Green Published, Green Submitted, Green Accepted	Y	N	2022-02-06	
J	Oyeniyi, BT; Fox, EE; Scerbo, M; Tomasek, JS; Wade, CE; Holcomb, JB				Oyeniyi, Blessing T.; Fox, Erin E.; Scerbo, Michelle; Tomasek, Jeffrey S.; Wade, Charles E.; Holcomb, John B.			Trends in 1029 trauma deaths at a level 1 trauma center: Impact of a bleeding control bundle of care	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma death; Mortality; Hemorrhage; Temporal distribution	DAMAGE-CONTROL RESUSCITATION; ENDOVASCULAR BALLOON OCCLUSION; EMERGENCY-DEPARTMENT; HEMORRHAGE CONTROL; TOURNIQUET USE; INCREASES; MORTALITY; SURVIVAL; INJURY; TIME	Background: Over the last decade the age of trauma patients and injury mortality has increased. At the same time, many centers have implemented multiple interventions focused on improved hemorrhage control, effectively resulting in a bleeding control bundle of care. The objective of our study was to analyze the temporal distribution of trauma-related deaths, the factors that characterize that distribution and how those factors have changed over time at our urban level 1 trauma center. Methods: Records at an urban Level 1 trauma center were reviewed. Two time periods (2005-2006 and 2012-2013) were included in the analysis. Mortality rates were directly adjusted for age, gender and mechanism of injury. The Mann-Whitney and chi square tests were used to compare variables between periods, with significance set at 0.05. Results: 7080 patients (498 deaths) were examined in 2005-2006, while 8767 patients (531 deaths) were reviewed in 2012-2013. The median age increased 6 years, with a similar increase in those who died. In patients that died, no differences by gender, race or ethnicity were observed. Fall-related deaths are now the leading cause of death. Traumatic brain injury (TBI) and hemorrhage accounted for >91% of all deaths. TBI (61%) and multiple organ failure or sepsis (6.2%) deaths were unchanged, while deaths associated with hemorrhage decreased from 36% to 25% (p < 0.01). Across time periods, 26% of all deaths occurred within one hour of hospital arrival, while 59% occurred within 24 h. Unadjusted mortality dropped from 7.0% to 6.1 (p = 0.01) and in-hospital mortality dropped from 6.0% to 5.0% (p < 0.01). Adjusted mortality dropped 24% from 7.6% (95% CI: 6.9-8.2) to 5.8% (95% CI: 5.3-6.3) and in-hospital mortality decreased 30% from 6.6% (95% CI: 6.0-7.2) to 4.7 (95% CI: 4.2-5.1). Conclusions: Over the same time frame of this study, increases in trauma death across the globe have been reported. This single-site study demonstrated a significant reduction in mortality, attributable to decreased hemorrhagic death. It is possible that efforts focused on hemorrhage control interventions (a bleeding control bundle) resulted in this reduction. These changing factors provide guidance on future prevention and intervention efforts. (C) 2016 Elsevier Ltd. All rights reserved.	[Oyeniyi, Blessing T.; Fox, Erin E.; Scerbo, Michelle; Tomasek, Jeffrey S.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Div Acute Care Surg, Dept Surg,Med Sch, Houston, TX 77030 USA		Holcomb, JB (corresponding author), Ctr Translat Injury Res, Dept Surg, 6410 Fannin St UPB 1100, Houston, TX 77030 USA.	John.Holcomb@uth.tmc.edu	Scerbo, Michelle/AAX-2118-2020	holcomb, john/0000-0001-8312-9157	Center for Translational Injury Research; University of Texas Medical School at Houston-Office of the Dean; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	The Center for Translational Injury Research and The University of Texas Medical School at Houston-Office of the Dean.	Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Brown MA, 2009, J EMERG MED, V37, P1, DOI 10.1016/j.jemermed.2007.05.043; Callaway DW, 2015, PREHOSP EMERG CARE, V19, P320, DOI 10.3109/10903127.2014.964893; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Duchesne JC, 2011, AM SURGEON, V77, P201; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grumbach K, 2014, JAMA-J AM MED ASSOC, V311, P1109, DOI 10.1001/jama.2014.705; Gunst Mark, 2010, Proc (Bayl Univ Med Cent), V23, P349; Holcom JB, 2015, JAMA-J AM MED ASSOC, V313, P1463, DOI 10.1001/jama.2014.16802; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hu GQ, 2010, INJURY PREV, V16, P26, DOI 10.1136/ip.2009.023481; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mangram AJ, 2012, J TRAUMA ACUTE CARE, V72, P119, DOI 10.1097/TA.0b013e318241f0ba; Meislin H, 1997, J TRAUMA, V43, P433, DOI 10.1097/00005373-199709000-00008; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; Moore LJ, 2015, J TRAUMA ACUTE CARE, V79, P523, DOI 10.1097/TA.0000000000000809; National Trauma Insttitue, CAS TRAUM FUND; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Pang JM, 2008, INJURY, V39, P102, DOI 10.1016/j.injury.2007.05.022; Passos E, 2014, INJURY, V45, P573, DOI 10.1016/j.injury.2013.11.031; Rhee P, 2008, J TRAUMA, V64, P1093, DOI 10.1097/TA.0b013e31812f6dbc; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schwartz DA, 2014, J TRAUMA ACUTE CARE, V76, P134, DOI 10.1097/TA.0b013e3182ab0cfc; Shrestha B, 2015, J TRAUMA ACUTE CARE, V78, P336, DOI 10.1097/TA.0000000000000514; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh GK, 2014, AM J PREV MED, V46, pE19, DOI 10.1016/j.amepre.2013.10.017; Tisherman SA, 2014, ANN SURG, V2014; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Xu Jiaquan, 2014, NCHS Data Brief, P1	40	112	116	1	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2017	48	1					5	12		10.1016/j.injury.2016.10.037			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EF7YF	WOS:000390544600003	27847192	Green Accepted			2022-02-06	
J	Davis, JS; Satahoo, SS; Butler, FK; Dermer, H; Naranjo, D; Julien, K; Van Haren, RM; Namias, N; Blackbourne, LH; Schulman, CI				Davis, James S.; Satahoo, Shevonne S.; Butler, Frank K.; Dermer, Harrison; Naranjo, Daniel; Julien, Katherina; Van Haren, Robert M.; Namias, Nicholas; Blackbourne, Lorne H.; Schulman, Carl I.			An analysis of prehospital deaths: Who can we save?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Death; wounds and injuries; emergency medical services; trauma	OPERATION-IRAQI-FREEDOM; COMBAT CASUALTY CARE; MAJOR LIMB TRAUMA; TOURNIQUET USE; PREVENTABLE DEATH; RURAL STATE; MORTALITY; BATTLEFIELD; OUTCOMES; INJURY	BACKGROUND: Since their inception in the late 1970s, trauma networks have saved thousands of lives in the prehospital setting. However, few recent works have been done to evaluate the patients who die in the field. Understanding the epidemiology of these deaths is crucial for trauma system performance evaluation and improvement. We hypothesized that specific patterns of injury could be identified and targeted for intervention. METHODS: Medical examiner reports in a large, urban county were reviewed including all trauma deaths during 2011 that were not transported to a hospital (i.e., died at the scene) or dead on arrival. Age, sex, date of death, mechanism, and list of injuries were recorded. An expert panel reviewed each case to determine the primary cause of death, and if the patient's death was caused by potentially survivable injuries or nonsurvivable injuries. RESULTS: A total of 512 patients were included. Patients were 80% male, died mostly of blunt (53%) and penetrating (46%) causes, and included 21% documented suicides. The leading cause of death was neurotrauma (36%), followed by hemorrhage (34%), asphyxia (15%), and combined neurotrauma/hemorrhage (15%). The anatomic regions most frequently injured were the brain (59%), chest (54%), and abdomen (35%). Finally, 29% of the patient deaths were classified as a result of potentially survivable injuries given current treatment options, mostly from hemorrhage and chest injuries. CONCLUSION: More than one of every five trauma deaths in our study population had potentially survivable injuries. In this group, chest injuries and death via hemorrhage were predominant and suggest targets for future research and implementation of novel prehospital interventions. In addition, efforts targeting suicide prevention remain of great importance. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Davis, James S.; Satahoo, Shevonne S.; Naranjo, Daniel; Julien, Katherina; Van Haren, Robert M.; Namias, Nicholas; Schulman, Carl I.] Univ Miami, Miller Sch Med, DeWitt Daughtry Dept Surg, Jackson Mem Hosp, Miami, FL 33101 USA; [Butler, Frank K.] Joint Trauma Syst San Antonio, Comm Tact Combat Casualty Care & Prehosp Trauma C, San Antonio, TX USA; [Blackbourne, Lorne H.] Brooke Army Med Ctr, Dept Surg, San Antonio, TX USA; [Butler, Frank K.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA		Schulman, CI (corresponding author), Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, POB 016960 D-40, Miami, FL 33101 USA.	cschulman@med.miami.edu	Van Haren, Robert/T-8218-2019; Schulman, Carl/AAE-7448-2021	Schulman, Carl/0000-0001-8899-4350; Namias, Nicholas/0000-0001-7021-2250			Andersen RC, 2012, J AM ACAD ORTHOP SUR, V20, pS94, DOI 10.5435/JAAOS-20-08-S94; [Anonymous], 1976, Bull Am Coll Surg, V61, P15; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; Berbiglia L, 2013, AM SURGEON, V79, P764; Blackbourne LH, 1831, US ARMY MED DEP J, V2011, P6; Blackbourne Lorne H, 2008, US Army Med Dep J, P56; Blackbourne LH, 2010, J TRAUMA, V69, pS1, DOI 10.1097/TA.0b013e3181e4206f; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Butler FK, 2012, J TRAUMA ACUTE CARE, V73, pS395, DOI 10.1097/TA.0b013e3182754850; Committee on Trauma and Committee on Shock, ACC DEATH DIS NEGL D; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Esposito TJ, 2003, J TRAUMA, V54, P663, DOI 10.1097/01.TA.0000058124.78958.6B; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Gerhardt Robert T, 2011, US Army Med Dep J, P82; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kotwal Russ S, 2013, J Spec Oper Med, V13, P77; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Kragh JF, 2008, J TRAUMA, V64, pS38, DOI 10.1097/TA.0b013e31816086b1; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; Lee C, 2007, EMERG MED J, V24, P584, DOI 10.1136/emj.2007.046359; Maio RF, 1996, J TRAUMA, V41, P83, DOI 10.1097/00005373-199607000-00013; MAUGHON JS, 1970, MIL MED, V135, P8, DOI 10.1093/milmed/135.1.8; Morrison JJ, 2013, ANN SURG, V257, P330, DOI 10.1097/SLA.0b013e31827eefcf; Niven Martin, 2010, Emerg Nurse, V18, P32; SALE JP, 1984, ANAESTHESIA, V39, P795, DOI 10.1111/j.1365-2044.1984.tb06527.x; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; Savage E, 2011, CAN J SURG, V54, pS14, DOI 10.1503/cjs.025011; Tarpey M, 2005, US ARMY MED DEP J, P38; Travis D, 2009, MIAMI DADE FIRE RESC; Trunkey DD, 1974, J AM COLL EMERGENCY, V3, P368, DOI [10.1016/S0361-1124(74)80005-5, DOI 10.1016/S0361-1124(74)80005-5]; Van Haren RM, 2012, J TRAUMA ACUTE CARE, V73, P1512, DOI 10.1097/TA.0b013e318270d40f	33	112	114	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2014	77	2					213	218		10.1097/TA.0000000000000292			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AN0EJ	WOS:000340255700006	25058244				2022-02-06	
J	Alali, AS; Fowler, RA; Mainprize, TG; Scales, DC; Kiss, A; de Mestral, C; Ray, JG; Nathens, AB				Alali, Aziz S.; Fowler, Robert A.; Mainprize, Todd G.; Scales, Damon C.; Kiss, Alexander; de Mestral, Charles; Ray, Joel G.; Nathens, Avery B.			Intracranial Pressure Monitoring in Severe Traumatic Brain Injury: Results from the American College of Surgeons Trauma Quality Improvement Program	JOURNAL OF NEUROTRAUMA			English	Article						head injury; intracranial pressure; multilevel analysis; traumatic brain injury	BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; MULTILEVEL ANALYSIS; HEAD TRAUMA; MORTALITY; OUTCOMES; CARE; MANAGEMENT; HEALTH; TRIALS	Although existing guidelines support the utilization of intracranial pressure (ICP) monitoring in patients with traumatic brain injury (TBI), the evidence suggesting benefit is limited. To evaluate the impact on outcome, we determined the relationship between ICP monitoring and mortality in centers participating in the American College of Surgeons Trauma Quality Improvement Program (TQIP). Data on 10,628 adults with severe TBI were derived from 155 TQIP centers over 2009-2011. Random-intercept multilevel modeling was used to evaluate the association between ICP monitoring and mortality after adjusting for important confounders. We evaluated this relationship at the patient level and at the institutional level. Overall mortality (n=3769) was 35%. Only 1874 (17.6%) patients underwent ICP monitoring, with a mortality of 32%. The adjusted odds ratio (OR) for mortality was 0.44 [95% confidence interval (CI), 0.31-0.63], when comparing patients with ICP monitoring to those without. It is plausible that patients receiving ICP monitoring were selected because of an anticipated favorable outcome. To overcome this limitation, we stratified hospitals into quartiles based on ICP monitoring utilization. Hospitals with higher rates of ICP monitoring use were associated with lower mortality: The adjusted OR of death was 0.52 (95% CI, 0.35-0.78) in the quartile of hospitals with highest use, compared to the lowest. ICP monitoring utilization rates explained only 9.9% of variation in mortality across centers. Results were comparable irrespective of the method of case-mix adjustment. In this observational study, ICP monitoring utilization was associated with lower mortality. However, variability in ICP monitoring rates contributed only modestly to variability in institutional mortality rates. Identifying other institutional practices that impact on mortality is an important area for future research.	[Alali, Aziz S.; Fowler, Robert A.; Scales, Damon C.; Kiss, Alexander; de Mestral, Charles; Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.; Scales, Damon C.; Kiss, Alexander; Ray, Joel G.; Nathens, Avery B.] Univ Toronto, Clin Epidemiol Program, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Alali, Aziz S.] Univ Ottawa, Div Neurosurg, Ottawa, ON, Canada; [Fowler, Robert A.; Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.; Scales, Damon C.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Mainprize, Todd G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Neurosurg, Toronto, ON, Canada; [Kiss, Alexander] Sunnybrook Hlth Sci Ctr, Dept Res Design & Biostat, Toronto, ON M4N 3M5, Canada; [Ray, Joel G.; Nathens, Avery B.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [de Mestral, Charles; Nathens, Avery B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada		Alali, AS (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, 2075 Bayview Ave,Room D-574, Toronto, ON M4N 3M5, Canada.	aziz.alali@mail.utoronto.ca			Physicians' Services Inc. Foundation; Canada Research Chair Program in Systems of Trauma Care; Heart and Stroke Foundation Clinician Scientist Award; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This work was supported, in part, by funds from the Physicians' Services Inc. Foundation (to A. S. A.) and a Canada Research Chair Program in Systems of Trauma Care (to A.B.N.). R. A. F. was supported by a Heart and Stroke Foundation Clinician Scientist Award. D. C. S. was supported by a New Investigator Award from the Canadian Institutes of Health Research.	Akopian G, 2007, AM SURGEON, V73, P447; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chesnut R, 2011, J NEUROTRAUM, V28, pA111; Chesnut RM, 2008, J TRAUMA, V65, P500, DOI 10.1097/TA.0b013e31818020b3; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chesnut RM, 2012, NEUROSURGERY, V71, P1055, DOI 10.1227/NEU.0b013e31827276b7; Citerio G, 2008, INTENS CARE MED, V34, P1173, DOI 10.1007/s00134-008-1080-1; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Coronado V. G., 2012, EPIDEMIOLOG IN PRESS; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Finney JW, 2011, AM J PUBLIC HEALTH, V101, P1635, DOI 10.2105/AJPH.2011.300153; GUILLAUME J, 1951, REV NEUROL, V84, P131; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Lane PL, 2000, CAN J SURG, V43, P442; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lingsma HF, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-201; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Maas AI, 2008, J TRAUMA, V65, P966, DOI 10.1097/TA.0b013e318184ee7b; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Mittlbock M, 1996, STAT MED, V15, P1987, DOI 10.1002/(SICI)1097-0258(19961015)15:19<1987::AID-SIM318>3.0.CO;2-9; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; PAZZAGLIA P, 1975, J NEUROL NEUROSUR PS, V38, P149, DOI 10.1136/jnnp.38.2.149; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Salim A, 2008, AM SURGEON, V74, P1088; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wijeysundera DN, 2012, ANESTHESIOLOGY, V116, P25, DOI 10.1097/ALN.0b013e31823cfc03; Yang D, 2012, 3352012 SAS	50	112	117	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1737	1746		10.1089/neu.2012.2802			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000006	23731257	Green Published			2022-02-06	
J	Jadischke, R; Viano, DC; Dau, N; King, AI; McCarthy, J				Jadischke, Ron; Viano, David C.; Dau, Nathan; King, Albert I.; McCarthy, Joe			On the accuracy of the Head Impact Telemetry (HIT) System used in football helmets	JOURNAL OF BIOMECHANICS			English	Article						HIT system; Football helmets; Head acceleration; Measurement errors; Head/helmet contact pressure; Hybrid III dummy; Volunteer testing	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; CONCUSSION; PERFORMANCE; ACCELERATION; PLAYERS	On-field measurement of head impacts has relied on the Head Impact Telemetry (HIT) System, which uses helmet mounted accelerometers to determine linear and angular head accelerations. HIT is used in youth and collegiate football to assess the frequency and severity of helmet impacts. This paper evaluates the accuracy of HIT for individual head impacts. Most HIT validations used a medium helmet on a Hybrid III head. However, the appropriate helmet is large based on the Hybrid III head circumference (58 cm) and manufacturer's fitting instructions. An instrumented skull cap was used to measure the pressure between the head of football players (n=63) and their helmet. The average pressure with a large helmet on the Hybrid III was comparable to the average pressure from helmets used by players. A medium helmet on the Hybrid III produced average pressures greater than the 99th percentile volunteer pressure level. Linear impactor tests were conducted using a large and medium helmet on the Hybrid III. Testing was conducted by two independent laboratories. HIT data were compared to data from the Hybrid III equipped with a 3-2-2-2 accelerometer array. The absolute and root mean square error (RMSE) for HIT were computed for each impact (n=90). Fifty-five percent (n=49) had an absolute error greater than 15% while the RMSE was 59.1% for peak linear acceleration. (C) 2013 Elsevier Ltd. All rights reserved.	[Jadischke, Ron; Viano, David C.; Dau, Nathan; King, Albert I.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Viano, David C.] ProBiomechanics LLC, Bloomfield Hills, MI 48304 USA; [Jadischke, Ron; McCarthy, Joe] McCarthy Engn Inc, Windsor, ON N9C 4E4, Canada		King, AI (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA.	king@rrb.eng.wayne.edu			Department of Biomedical Engineering of Wayne State University; NFL	The first series of tests was supported by the Department of Biomedical Engineering of Wayne State University. The authors would like to express gratitude to Dr. Cindy Bir for the use the Sports Biomechanics Lab. The authors also appreciate the efforts of Chris Withnall and Michael Wonnacott at Biokinetics & Associates, Ltd., Ottawa, Canada, for their testing of the HIT in the second test series, which was sponsored by the NFL. Dr. Viano was co-chair of the MTBI Committee at the NFL during the second series of tests. The testing reported in this paper was designed to independently evaluate the HIT system, using a new method of determining the proper size of helmets used by football players. All testing were completed by December 2010.	Armstrong S., 1992, INT J FORECASTING, V8, P69; Backaitis S.H. Mertz H.J., 1994, SAE BOOK; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk J., 2007, 51 ANN P ASS ADV AUT, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hyndman RJ, 2006, INT J FORECASTING, V22, P679, DOI 10.1016/j.ijforecast.2006.03.001; Jadischke R., 2012, THESIS WAYNE STATE U; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Viano D.C., 2012, BRAIN INJURY MED; Viano D.C., 2011, COMP HIT HELMET SYST; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	23	112	112	1	41	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	SEP 3	2013	46	13					2310	2315		10.1016/j.jbiomech.2013.05.030			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	225NL	WOS:000324969500030	23891566				2022-02-06	
J	Goodrich, GS; Kabakov, AY; Hameed, MQ; Dhamne, SC; Rosenberg, PA; Rotenberg, A				Goodrich, Grant S.; Kabakov, Anatoli Y.; Hameed, Mustafa Q.; Dhamne, Sameer C.; Rosenberg, Paul A.; Rotenberg, Alexander			Ceftriaxone Treatment after Traumatic Brain Injury Restores Expression of the Glutamate Transporter, GLT-1, Reduces Regional Gliosis, and Reduces Post-Traumatic Seizures in the Rat	JOURNAL OF NEUROTRAUMA			English	Article						epilepsy; glia cell response to injury; immunoblots; recovery; traumatic brain injury	CEREBRAL-CORTEX; INDUCTION; EPILEPSY; LOCALIZATION; MECHANISMS; TERMINALS; GLT1A	Excessive extracellular glutamate after traumatic brain injury (TBI) contributes to excitotoxic cell death and likely to posttraumatic epilepsy. Glutamate transport is the only known mechanism of extracellular glutamate clearance, and glutamate transporter 1 (GLT-1) is the major glutamate transporter of the mammalian brain. We tested, by immunoblot, in the rat lateral fluid percussion injury TBI model whether GLT-1 expression is depressed in the cortex after TBI, and whether GLT-1 expression after TBI is restored after treatment with ceftriaxone, a well-tolerated b-lactam antibiotic previously shown to enhance GLT-1 expression in noninjured animals. We then tested whether treatment with ceftriaxone mitigates the associated regional astrogliosis, as reflected by glial fibrillary acid protein (GFAP) expression, and also whether ceftriaxone treatment mitigates the severity of post-traumatic epilepsy. We found that 7 days after TBI, GLT-1 expression in the ipsilesional cortex was reduced by 29% (n = 7/group; p < 0.01), relative to the contralesional cortex. However, the loss of GLT-1 expression was reversed by treatment with ceftriaxone (200 mg/kg, daily, intraperitoneally). We found that ceftriaxone treatment also decreased the level of regional GFAP expression by 43% in the lesioned cortex, relative to control treatment with saline (n = 7 per group; p < 0.05), and, 12 weeks after injury, reduced cumulative post-traumatic seizure duration (n = 6 rats in the ceftriaxone treatment group and n = 5 rats in the saline control group; p < 0.001). We cautiously conclude that our data suggest a potential role for ceftriaxone in treatment of epileptogenic TBI.	[Goodrich, Grant S.; Kabakov, Anatoli Y.; Hameed, Mustafa Q.; Dhamne, Sameer C.; Rosenberg, Paul A.; Rotenberg, Alexander] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Hameed, Mustafa Q.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA		Rotenberg, A (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02215 USA.	alexander.rotenberg@childrens.harvard.edu	Hameed, Mustafa/G-3677-2014	Hameed, Mustafa/0000-0003-4004-5564; Rosenberg, Paul/0000-0002-5185-1118	Department of Defense (DoD) Defense Medical Research and Development Program Basic Research Award [PT090716]; Citizens United for Research in Epilepsy;  [NS066019]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066019] Funding Source: NIH RePORTER	This work was supported by the Department of Defense (DoD) Defense Medical Research and Development Program Basic Research Award (PT090716; to A.R. and A.Y.K.), Citizens United for Research in Epilepsy (CURE; to A.R.), and NS066019 (to P.A.R.). The authors thank Drs. Roman Gersner and David Zurakowski for their advice related to statistical analysis of EEG data.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Berger UV, 2005, J COMP NEUROL, V492, P78, DOI 10.1002/cne.20737; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DeSilva TM, 2009, J NEUROSCI, V29, P7898, DOI 10.1523/JNEUROSCI.6129-08.2009; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Lai PC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-69; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Li TF, 2012, GLIA, V60, P83, DOI 10.1002/glia.21250; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntyre DC, 2007, EPILEPSIA, V48, P30, DOI 10.1111/j.1528-1167.2007.01398.x; Melone M, 2009, GLIA, V57, P108, DOI 10.1002/glia.20744; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; ROSENBERG PA, 1992, J NEUROSCI, V12, P56; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sari Y, 2009, J NEUROSCI, V29, P9239, DOI 10.1523/JNEUROSCI.1746-09.2009; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Shaw FZ, 2007, J NEUROPHYSIOL, V97, P238, DOI 10.1152/jn.00340.2006; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099	32	112	115	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1434	1441		10.1089/neu.2012.2712			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500007	23510201	Green Published			2022-02-06	
J	Howell, DR; Osternig, LR; Chou, LS				Howell, David R.; Osternig, Louis R.; Chou, Li-Shan			Dual-Task Effect on Gait Balance Control in Adolescents With Concussion	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Attention; Brain concussion; Brain injuries; Gait; Postural balance; Rehabilitation	STATES HIGH-SCHOOL; ATTENTIONAL DEFICITS; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; SPORT CONCUSSION; MOTOR FUNCTION; RECOVERY; EPIDEMIOLOGY; PERFORMANCE; MANAGEMENT	Objective: To prospectively and longitudinally examine how concussion affects gait balance control in adolescents during single- and dual-task walking. Design: Cohort, prospective, repeated-measures design. Setting: Motion analysis laboratory. Participants: Adolescents (N=20) identified as suffering a concussion were matched with healthy control subjects (N=20) and tested 5 times across a 2-month period after injury. Interventions: Not applicable. Main Outcome Measures: Gait temporal-distance parameters included average walking speed, step length, and step width; whole body center of mass (COM) parameters included medial/lateral displacement and peak COM medial/lateral and anterior velocities; dual-task cost, which was defined as percent change from single- to dual-task conditions; and Stroop test accuracy. Results: No between-group differences were observed for step length and step width. The dual-task cost for average walking speed for subjects with concussion was greater than control subjects across the 2-month testing period (main effect of group P=.019), as was the dual-task costs for peak anterior COM velocity (main effect of group P=.017) and total COM medial/lateral displacement (main effect of group P=.013). The total COM medial/lateral displacement (group x task interaction P=.006) and peak COM medial/lateral velocity (main effect of group P=.027; main effect of task P=.01) were significantly greater in subjects with concussion compared with control subjects during dual-task walking. Subjects with concussion were significantly less accurate than controls on the Stroop test (main effect of group P=.004). Conclusions: The findings suggest that concussion affects the ability of adolescents to control body posture during gait up to 2 months after injury. Furthermore, dual-task paradigms may provide additional useful information in the clinical assessment and recovery of concussion. Archives of Physical Medicine and Rehabilitation 2013;94:1513-20 (C) 2013 by the American Congress of Rehabilitation Medicine	[Howell, David R.; Osternig, Louis R.; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA		Chou, LS (corresponding author), Dept Human Physiol, 122 Esslinger Hall,1240 Univ Oregon, Eugene, OR 97403 USA.	chou@uoregon.edu	Meijer, Anna/K-5118-2016	Howell, David/0000-0002-2955-0191	Veterans AdministrationUS Department of Veterans Affairs [A4842C8, A4843C]; Department of Defense-Telemedicine Advanced Technology Research Center [W81XWH-11-1-0717]; University of Oregon and Peace Health Oregon Region	Supported by the Veterans Administration (subcontract awards nos. A4842C8 and A4843C); Department of Defense-Telemedicine Advanced Technology Research Center (award no. W81XWH-11-1-0717); and a translational research award from the University of Oregon and Peace Health Oregon Region.	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Fait P, J HEAD TRAU IN PRESS; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goethals I, 2004, EUR J NUCL MED MOL I, V31, P408, DOI 10.1007/s00259-003-1382-z; Hahn ME, 2004, J BIOMECH, V37, P837, DOI 10.1016/j.jbiomech.2003.11.010; Hahn ME, 2003, CLIN BIOMECH, V18, P737, DOI 10.1016/S0268-0033(03)00139-6; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchetti GF, 2008, PHYS THER, V88, P640, DOI 10.2522/ptj.20070130; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Register-Mihalik JK, J HEAD TRAU IN PRESS; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; SPREEN O, 1995, DEV NEUROPSYCHOLOGY; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stuss DT, 2006, ANN NY ACAD SCI, V769, P191; Tomei KL, 2012, NEUROSURG FOCUS, V33; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI 10.1002/9780470549148; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	42	112	114	1	48	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2013	94	8					1513	1520		10.1016/j.apmr.2013.04.015			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	196TZ	WOS:000322801600011	23643687				2022-02-06	
J	Mysliwiec, V; Gill, J; Lee, H; Baxter, T; Pierce, R; Barr, TL; Krakow, B; Roth, BJ				Mysliwiec, Vincent; Gill, Jessica; Lee, Hyunhwa; Baxter, Tristin; Pierce, Roslyn; Barr, Taura L.; Krakow, Barry; Roth, Bernard J.			Sleep Disorders in US Military Personnel A High Rate of Comorbid Insomnia and Obstructive Sleep Apnea	CHEST			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH DISORDERS; DAYTIME SLEEPINESS; FIRE EVACUEES; IRAQ; VETERANS; DISTURBANCE; NIGHTMARES; DEPLOYMENT	Background: Sleep disturbances are among the most common symptoms of military personnel who return from deployment. The objective of our study was to determine the presence of sleep disorders in US military personnel referred for evaluation of sleep disturbances after deployment and examine associations between sleep disorders and service-related diagnoses of depression, mild traumatic brain injury, pain, and posttraumatic stress disorder (PTSD). Methods: This was a cross-sectional study of military personnel with sleep disturbances who returned from combat within 18 months of deployment. Sleep disorders were assessed by clinical evaluation and polysomnogram with validated instruments to diagnose service-related illnesses. Results: Of 110 military personnel included in our analysis, 97.3% were men (mean age, 33.6 +/- 8.0 years; mean BMI, 30.0 +/- 4.3 kg/m(2)), and 70.9% returned from combat within 12 months. Nearly one-half (47.3%) met diagnostic criteria for two or more service-related diagnoses. Sleep disorders were diagnosed in 88.2% of subjects; 11.8% had a normal sleep evaluation and served as control subjects. Overall, 62.7% met diagnostic criteria for obstructive sleep apnea (OSA) and 63.6% for insomnia. The exclusive diagnoses of insomnia and OSA were present in 25.5% and 24.5% of subjects, respectively; 38.2% had comorbid insomnia and OSA. Military personnel with comorbid insomnia and OSA were significantly more likely to meet criteria for depression (P < .01) and PTSD (P < .01) compared with control subjects and those with OSA only. Conclusions: Comorbid insomnia and OSA is a frequent diagnosis in military personnel referred for evaluation of sleep disturbances after deployment. This diagnosis, which is difficult to treat, may explain the refractory nature of many service-related diagnoses.	[Mysliwiec, Vincent; Baxter, Tristin; Pierce, Roslyn; Roth, Bernard J.] Madigan Army Med Ctr, Tacoma, WA 98431 USA; [Gill, Jessica; Lee, Hyunhwa] NIH, Bethesda, MD 20892 USA; [Barr, Taura L.] W Virginia Univ, Morgantown, WV 26506 USA; [Barr, Taura L.] Robert Wood Johnson Fdn, Morgantown, WV USA; [Krakow, Barry] Maimonides Sleep Arts & Sci Ltd, Sleep & Human Hlth Inst, Albuquerque, NM USA		Mysliwiec, V (corresponding author), Madigan Army Med Ctr, Dept Pulm Crit Care & Sleep Med, 9040A Fitzsimmons Ave, Tacoma, WA 98431 USA.	vincent.mysliwiec.mil@mail.mil	Gill, Gill M/Q-2020-2017	Lee, Hyunhwa/0000-0002-5625-3141	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; intramural department of the National Institutes of Health, National Institute of Nursing Research; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027, ZIANR000029] Funding Source: NIH RePORTER	This study was supported, in part, by the Center for Neuroscience and Regenerative Medicine [Grant 60855]. Funding support was provided by the intramural department of the National Institutes of Health, National Institute of Nursing Research (to Drs Gill and Lee).	Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Al-Jawder SE, 2012, SLEEP BREATH, V16, P295, DOI 10.1007/s11325-011-0513-1; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; American Congress of Rehabilitation Medicine, DEF MILD TRAUM BRAIN; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P12; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P8; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Chung KF, 2005, RESPIRATION, V72, P460, DOI 10.1159/000087668; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collen JF, 2012, J CLIN SLEEP MED, V8, P667, DOI 10.5664/jcsm.2260; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; FERRER CF, 1995, AVIAT SPACE ENVIR MD, V66, P571; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Guilleminault C, 2008, SLEEP, V31, P1527, DOI 10.1093/sleep/31.11.1527; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iber C., 2007, AASM MANUAL SCORING, P7; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joint Mental Health Advisory Team 7 (J-MHAT 7), OP END FREED 2010; Krakow B, 2004, J TRAUMA STRESS, V17, P257, DOI 10.1023/B:JOTS.0000029269.29098.67; Krakow B, 2002, J NERV MENT DIS, V190, P442, DOI 10.1097/00005053-200207000-00004; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Krakow B, 2000, J PSYCHOSOM RES, V49, P291, DOI 10.1016/S0022-3999(00)00147-1; Krakow B, 2001, BIOL PSYCHIAT, V49, P948, DOI 10.1016/S0006-3223(00)01087-8; Krakow Barry, 2002, Sleep Breath, V6, P189; Krakow BJ, 2002, J CLIN PSYCHIAT, V63, P673, DOI 10.4088/JCP.v63n0804; Krell Suzanne B, 2005, Sleep Breath, V9, P104, DOI 10.1007/s11325-005-0026-x; Lettieri CJ, 2005, J CLIN SLEEP MED, V1, P381; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Miller NL, 2010, SLEEP, V33, P1623, DOI 10.1093/sleep/33.12.1623; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Peppard PE, 2013, SLEEP, V36, P7, DOI 10.5665/sleep.2284; Persson HE, 1996, CHEST, V109, P645, DOI 10.1378/chest.109.3.645; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Ryan CM, 2005, J APPL PHYSIOL, V99, P2440, DOI 10.1152/japplphysiol.00772.2005; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Sinnott C, 2005, DIABETES CARE, V28, P1534, DOI 10.2337/diacare.28.6.1534; Smith S, 2004, SLEEP MED, V5, P449, DOI 10.1016/j.sleep.2004.03.005; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; STOOHS RA, 1993, NEW ENGL J MED, V328, P1279, DOI 10.1056/NEJM199304293281714; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wickwire EM, 2010, CHEST, V137, P1449, DOI 10.1378/chest.09-1485; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yang CM, 2011, J PSYCHOSOM RES, V70, P355, DOI 10.1016/j.jpsychores.2010.12.005; Younes M, 2004, AM J RESP CRIT CARE, V169, P623, DOI 10.1164/rccm.200307-1023OC	60	112	113	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0012-3692	1931-3543		CHEST	Chest	AUG	2013	144	2					549	557		10.1378/chest.13-0088			9	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Respiratory System	199UQ	WOS:000323021400030	23681455	Green Published			2022-02-06	
J	Woo, SK; Kwon, MS; Ivanov, A; Gerzanich, V; Simard, JM				Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Gerzanich, Volodymyr; Simard, J. Marc			The Sulfonylurea Receptor 1 (Sur1)-Transient Receptor Potential Melastatin 4 (Trpm4) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNEL; K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; SPINAL-CORD-INJURY; ADULT-RAT BRAIN; REACTIVE ASTROCYTES; CELLS; SUR1; STOICHIOMETRY; TRAFFICKING	The sulfonylurea receptor 1 (Sur1)-NCCa-ATP channel plays a central role in necrotic cell death in central nervous system (CNS) injury, including ischemic stroke, and traumatic brain and spinal cord injury. Here, we show that Sur1-NCCa-ATP channels are formed by co-assembly of Sur1 and transient receptor potential melastatin 4 (Trpm4). Co-expression of Sur1 and Trpm4 yielded Sur1-Trpm4 heteromers, as shown in experiments with Forster resonance energy transfer (FRET) and co-immunoprecipitation. Co-expression of Sur1 and Trpm4 also yielded functional Sur1-Trpm4 channels with biophysical properties of Trpm4 and pharmacological properties of Sur1. Co-assembly with Sur1 doubled the affinity of Trpm4 for calmodulin and doubled its sensitivity to intracellular calcium. Experiments with FRET and co-immunoprecipitation showed de novo appearance of Sur1-Trpm4 heteromers after spinal cord injury in rats. Our findings depart from the long-held view of an exclusive association between Sur1 and K-ATP channels and reveal an unexpected molecular partnership with far-ranging implications for CNS injury.	[Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA		Simard, JM (corresponding author), Univ Maryland, Dept Neurosurg, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060801, NS061808, HL082517, NS061934, NS072501]; Department of Veterans Affairs (Baltimore, MD)US Department of Veterans Affairs; Department of the Army [W81XWH 1010898]; Christopher and Dana Reeve Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL082517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061934, R01NS072501, R01NS060801, R01NS061808] Funding Source: NIH RePORTER	This work was supported, in whole or in part, by National Institutes of Health Grants NS060801 and NS061808 (NINDS) and HL082517 (NHLBI) (to J. M. S.) and NS061934 and NS072501 (NINDS) (to V. G.). This work was also supported by grants from the Department of Veterans Affairs (Baltimore, MD), the Department of the Army (Grant W81XWH 1010898), and the Christopher and Dana Reeve Foundation (to J. M. S.). J. M. S. holds a United States patent (Number 7,285,574), "A novel non-selective cation channel in neural cells and methods for treating brain swelling." J. M. S. is a member of the scientific advisory board and holds shares in Remedy Pharmaceuticals. No support, direct or indirect, was provided to J. M. S., or for this project, by Remedy Pharmaceuticals.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 1998, PHYSIOL REV, V78, P227, DOI 10.1152/physrev.1998.78.1.227; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Conti LR, 2002, J BIOL CHEM, V277, P25416, DOI 10.1074/jbc.M203109200; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; GILLIS KD, 1989, AM J PHYSIOL, V257, pC1119, DOI 10.1152/ajpcell.1989.257.6.C1119; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Hyun YM, 2009, J IMMUNOL, V183, P359, DOI 10.4049/jimmunol.0803388; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Meissner M, 2011, TRP CHANNELS, P135; Mikhailov MV, 2001, FEBS LETT, V499, P154, DOI 10.1016/S0014-5793(01)02538-8; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Sala-Rabanal M, 2012, J BIOL CHEM, V287, P8746, DOI 10.1074/jbc.M111.336131; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2012, PFLUG ARCH EUR J PHY, V464, P573, DOI 10.1007/s00424-012-1166-z; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Song MY, 2010, ADV EXP MED BIOL, V661, P99, DOI 10.1007/978-1-60761-500-2_6; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vennekens R., 2007, V179, P269; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Winkler M, 2009, J BIOL CHEM, V284, P6752, DOI 10.1074/jbc.M805435200; Yoshida H, 2004, J MOL CELL CARDIOL, V37, P857, DOI 10.1016/j.yjmcc.2004.05.022; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	38	112	117	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3655	3667		10.1074/jbc.M112.428219			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	WOS:000314397900069	23255597	hybrid, Green Published			2022-02-06	
J	Jorge, RE; Acion, L; White, T; Tordesillas-Gutierrez, D; Pierson, R; Crespo-Facorro, B; Magnotta, VA				Jorge, Ricardo E.; Acion, Laura; White, Tonya; Tordesillas-Gutierrez, Diana; Pierson, Ronald; Crespo-Facorro, Benedicto; Magnotta, Vincent A.			White Matter Abnormalities in Veterans With Mild Traumatic Brain Injury	AMERICAN JOURNAL OF PSYCHIATRY			English	Article							OPERATION-IRAQI-FREEDOM; EXPLOSIVE BLAST; CORPUS-CALLOSUM; MODERATE; CHILDREN; HEAD; MILITARY; EXPOSURE; RECOVERY; SEQUELAE	Objective: It has been estimated that 10%-20% of U.S. veterans of the wars in Iraq and Afghanistan experienced mild traumatic brain injury (TBI), mostly secondary to blast exposure. Diffusion tensor imaging (DTI) may detect subtle white matter changes in both the acute and chronic stages of mild TBI and thus has the potential to detect white matter damage in patients with TBI. The authors used DTI to examine white matter integrity in a relatively large group of veterans with a history of mild TBI. Method: DTI images from 72 veterans of the wars in Iraq and Afghanistan who had mild TBI were compared with DTI images from 21 veterans with no exposure to TBI during deployment. Conventional voxel-based analysis as well as a method of identifying spatially heterogeneous areas of decreased fractional anisotropy ("potholes") were used. Veterans also underwent psychiatric and neuropsychological assessments. Results: Voxel-based analysis did not reveal differences in DTI parameters between the veterans with mild TBI and those with no TBI. However, the veterans with mild TBI had a significantly higher number of potholes than those without TBI. The difference in the number of potholes was not influenced by age, time since trauma, a history of mild TBI unrelated to deployment, or coexisting psychopathology. The number of potholes was correlated with the severity of TBI and with performance in executive functioning tasks. Conclusions: Veterans who had blast-related mild TBI showed evidence of multifocal white matter abnormalities that were associated with severity of the injury and with relevant functional measures. Overall, white matter potholes may constitute a sensitive biomarker of axonal injury that can be identified in mild TBI at acute and chronic stages of its clinical course. (Am J Psychiatry 2012; 169:1284-1291)	[Jorge, Ricardo E.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA; Univ Iowa, Iowa Consortium Subst Abuse Res & Evaluat, Iowa City, IA 52242 USA; Iowa City Vet Affairs VA Med Ctr, Iowa City, IA USA; Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; Univ Hosp Marques de Valdecilla, CIBERSAM, IFIMAV, Santander, Spain; Univ Cantabria, Dept Psychiat, Sch Med, E-39005 Santander, Spain; Brain Image Anal LLC, Coralville, IA USA		Jorge, RE (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA.	ricardo-jorge@uiowa.edu	Tordesillas-Gutierrez, Diana/H-6893-2015; Crespo-Facorro, BENEDICTO/AAY-2238-2021; White, Tonya/AAU-2226-2021	Tordesillas-Gutierrez, Diana/0000-0003-1458-3932; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; White, Tonya/0000-0003-0271-1896; Magnotta, Vincent/0000-0001-8639-5354; Acion, Laura/0000-0001-5213-6012	VA Merit Research Award [D7201I]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055827] Funding Source: NIH RePORTER	Supported by VA Merit Research Award D7201I to Dr. Jorge.	Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; Allen RMRCC, 1996, RUFF 2 7 SELECTIVE A; Babor T.F., 2001, AUDIT THE ALCOHOL US; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benedict R., 1997, BRIEF VISUOSPATIAL M; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu ZX, 2010, PROC SPIE, V7628, DOI 10.1117/12.844748; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Matthews CG., 1964, INSTRUCTION MANUAL A; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miller G, 2011, SCIENCE, V333, P514, DOI 10.1126/science.333.6042.514; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; Wechsler D, 1981, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412	45	112	112	0	47	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0002-953X			AM J PSYCHIAT	Am. J. Psychiat.	DEC	2012	169	12					1284	1291		10.1176/appi.ajp.2012.12050600			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	052EC	WOS:000312179500011	23212059	Green Accepted			2022-02-06	
J	Castile, L; Collins, CL; McIlvain, NM; Comstock, RD				Castile, Lianne; Collins, Christy L.; McIlvain, Natalie M.; Comstock, R. Dawn			The epidemiology of new versus recurrent sports concussions among high school athletes, 2005-2010	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL PERFORMANCE; SEX-DIFFERENCES; FOOTBALL; COLLEGIATE; RECOVERY; PLAY	Objectives To compare new versus recurrent concussions with respect to constellation of symptoms, symptom severity, symptom resolution; evaluate potential subset differences with respect to gender and sport; and to compare mechanisms and activities associated with new versus recurrent concussions. Methods Sports-related injury and exposure data were collected for nine sports from 2005 to 2010 from 100 nationally representative US high schools. Results Nationally, an estimated 732,805 concussions occurred. Of these reported concussions, 13.2% were recurrent. The rate of new concussions was 22.2 per 100,000 athletic exposures while the rate of recurrent concussions was 3.1 per 100,000 athletic exposures (RR 7.23, 95% CI 6.39 to 8.17, p<0.001). While 0.6% of new concussion symptoms took >1 month to resolve, 6.5% of recurrent concussion symptoms took >1 month to resolve (IPR 10.35; 95% CI 4.62 to 23.16; p<0.001). Loss of consciousness was reported more often with recurrent (7.7%) than new concussions (4.4%) (IPR 1.76; 95% CI 1.02 to 3.03; p=0.043). A greater proportion of athletes sustaining recurrent concussions returned to play in >3 weeks (7.5%) or were medically disqualified (16.2%) than athletes sustaining new concussions (3.8%; IPR 1.95; 95% CI 1.01 to 3.77; p=0.047 and 2.9%; IPR 5.58; 95% CI 3.50 to 8.88; p<0.001, respectively). The majority of new and recurrent concussions resulted from contact with another person (73.4% and 77.9%, respectively). Conclusions Athletes sustaining recurrent concussions had longer symptom resolution times, were kept out of play longer and reported loss of consciousness more frequently than athletes sustaining new concussions. With the possibility of long-term impairment and other negative sequelae, proper management and prevention of concussions at the high school level is imperative.	[Castile, Lianne; Collins, Christy L.; McIlvain, Natalie M.; Comstock, R. Dawn] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Comstock, R. Dawn] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Comstock, R. Dawn] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA		Collins, CL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	christy.collins@nationwidechildrens.org			Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations (NFHS); EyeBlack and DonJoy Orthotics; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000674, R49CE001172] Funding Source: NIH RePORTER	The content of this report was funded in part by the Centers for Disease Control and Prevention (CDC) grants # R49/CE000674-01 and # R49/CE001172-01. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the CDC. The authors acknowledge the generous research funding contributions of the National Federation of State High School Associations (NFHS), EyeBlack and DonJoy Orthotics.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Denke NJ, 2008, J EMERG NURS, V34, P363, DOI 10.1016/j.jen.2008.04.013; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; National Federation of State High School Associations, 2009, 2009 10 HIGH SCH ATH; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; United States Census Bureau, CENS REG US; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	34	112	112	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2012	46	8					603	610		10.1136/bjsports-2011-090115			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	959AB	WOS:000305281000012	22144000				2022-02-06	
J	Leddy, JJ; Baker, JG; Kozlowski, K; Bisson, L; Willer, B				Leddy, John J.; Baker, John G.; Kozlowski, Karl; Bisson, Leslie; Willer, Barry			Reliability of a Graded Exercise Test for Assessing Recovery From Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						traumatic brain injury; treadmill; symptoms; physiology; heart rate	TRAUMATIC BRAIN-INJURY; VALIDITY; SYMPTOMS; SPORTS	Objective: To evaluate a graded treadmill test for retest reliability (RTR) and interrater reliability (IRR) in the evaluation of the physiologic effects of symptom exacerbation from concussion. Design: Prospective case series (RTR) and blinded rater assessment of 10 actors portraying patients with and without symptom exacerbation (IRR). Setting: University Sports Medicine Concussion Clinic. Participants: For RTR, 21 refractory concussed patients (11 athletes and 10 nonathletes) and 10 healthy subjects; for IRR, 32 raters representing a variety of health care disciplines. Intervention: For RTR, a Balke protocol treadmill test to symptom exacerbation before and after 2 to 3 weeks. For IRR, video recordings of actors during the treadmill test viewed by raters blinded to condition. Main Outcome Measures: For RTR, agreement of the tests for maximal heart rate (HR), systolic blood pressure, diastolic blood pressure, and rating of perceived exertion. For IRR, presence or absence of symptom exacerbation and the symptom exacerbation HR. Results: Raters achieved a sensitivity of 99% for identifying actors with symptom exacerbation and a specificity of 89% for ruling out concussion symptoms and agreed on 304 of 320 observations (accuracy of 95%). The intraclass correlation coefficient for the symptom exacerbation HR was large at 0.90 (95% confidence interval, 0.78-0.98). The treadmill test had good RTR for maximum HR (intraclass correlation coefficient, 0.79) but not for systolic blood pressure, diastolic blood pressure, or rating of perceived exertion. Conclusions: The Balke exercise treadmill protocol has very good IRR and sufficient RTR for identifying patients with symptom exacerbation from concussion.	[Leddy, John J.; Bisson, Leslie] SUNY Buffalo, Dept Orthopaed, Buffalo, NY 14260 USA; [Leddy, John J.; Bisson, Leslie] SUNY Buffalo, Sports Med Inst, Buffalo, NY 14260 USA; [Baker, John G.] SUNY Buffalo, Dept Rehabil Med & Nucl Med, Buffalo, NY 14260 USA; [Kozlowski, Karl] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA		Leddy, JJ (corresponding author), Univ Sports Med, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	leddy@buffalo.edu	Kozlowski, Karl/H-5253-2019		Robert Rich Family Foundation; Buffalo Sabres Foundation; New York State Athletic Trainers' Association	The authors are very appreciative of the financial assistance of the Robert Rich Family Foundation, the Buffalo Sabres Foundation and the New York State Athletic Trainers' Association.	ADES PA, 1990, AM HEART J, V120, P585, DOI 10.1016/0002-8703(90)90015-P; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; COHEN J, 1988, STAT POWER ANAL BEHA, pR21; FERNHALL B, 1990, ARCH PHYS MED REHAB, V71, P1065; Fielding RA, 1997, MED SCI SPORT EXER, V29, P1109, DOI 10.1097/00005768-199708000-00018; Finch LE, 2004, AM J PHYS MED REHAB, V83, P613, DOI 10.1097/01.phm.0000133501.62602.3f; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; HAGBERG JM, 1994, BAILLIERE CLIN RHEUM, V8, P29, DOI 10.1016/S0950-3579(05)80223-7; Lamb KL, 1999, BRIT J SPORT MED, V33, P336, DOI 10.1136/bjsm.33.5.336; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; PALATINI P, 1990, EUR HEART J, V11, P348, DOI 10.1093/oxfordjournals.eurheartj.a059709; Rosengren DB, 2008, DRUG ALCOHOL DEPEN, V97, P130, DOI 10.1016/j.drugalcdep.2008.03.018; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; TONINO RP, 1988, J GERONTOL, V43, pM101, DOI 10.1093/geronj/43.4.M101	21	112	113	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2011	21	2					89	94		10.1097/JSM.0b013e3181fdc721			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	728AB	WOS:000287844100003	21358497				2022-02-06	
J	Vinchon, M; de Foort-Dhellemmes, S; Desurmont, M; Delestret, I				Vinchon, Matthieu; de Foort-Dhellemmes, Sabine; Desurmont, Marie; Delestret, Isabelle			Confessed abuse versus witnessed accidents in infants: comparison of clinical, radiological, and ophthalmological data in corroborated cases	CHILDS NERVOUS SYSTEM			English	Article						Subdural hematoma; Infant; Inflicted head injury; Shaken baby syndrome; Accidental trauma	SHAKEN BABY SYNDROME; TRAUMATIC BRAIN-INJURY; INFLICTED HEAD-INJURY; YOUNG-CHILDREN; HEMORRHAGES; PATTERNS; CANADA; FALLS	The diagnosis of inflicted head injury (IHI) or accidental trauma (AT) in infants is based on clinical, radiological, and/or ophthalmological findings such as subdural hematoma (SDH), encephalopathy, retinal hemorrhage (RH), and signs of impact. As a consequence, the diagnostic value of these criteria is difficult to assess because of a circularity bias. In order to assess the predictive value of these diagnostic criteria avoiding circularity, we studied prospectively corroborated cases of head injuries in infants, comparing IHI with AT. We selected 45 cases of confessed IHI and 39 cases of AT having occurred in public places. Patients were systematically evaluated clinically, with computed tomography scanner and ophthalmological evaluation by a trained ophthalmologist. RH was rated as absent, mild, and severe, according to the depth and extent of the RH. Brain ischemia was found in 26.7% of IHI; the most prominent elements in favor of IHI were SDH, severe RH, and absence of signs of impact; the predictive diagnostic values of these three features were 0.685, 0.961, and 0.830, respectively; however, only severe RH in the absence of ocular impact was specific of IHI. When all three features were combined, the specificity was 100%, but the sensitivity was only 24.4%. Our study confirms the high diagnostic value of RH, SDH, and signs of impact for the differential diagnosis between AT and IHI. The evaluation of head injuries in infants requires a high level of awareness and thorough and systematic examination by a trained multidisciplinary team.	[Vinchon, Matthieu] CHRU Lille, Serv Neurochirurg Pediat, F-59037 Lille, France; [Desurmont, Marie] Lille Univ Hosp, Dept Forens Med, Lille, France; [de Foort-Dhellemmes, Sabine] Lille Univ Hosp, Dept Neuroophthalmol, Lille, France; [Vinchon, Matthieu; Delestret, Isabelle] Lille Univ Hosp, Dept Pediat Neurosurg, Lille, France		Vinchon, M (corresponding author), CHRU Lille, Serv Neurochirurg Pediat, F-59037 Lille, France.	m-vinchon@chru-lille.fr		Vinchon, Matthieu/0000-0002-9122-6165			Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; GARDNER HB, 2005, PEDIATR NEUROSURG, V43, P433; Geddes JF, 2004, BMJ-BRIT MED J, V328, P719, DOI 10.1136/bmj.328.7442.719; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; HARWOODNASH DC, 1992, AM J NEURORADIOL, V13, P569; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; JOHNSON DL, 1993, NEUROSURGERY, V33, P231; King WJ, 2003, CAN MED ASSOC J, V168, P155; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Leestma, 2006, J AM PHYS SURG, V11, P14; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; Oehmichen M, 2005, NEUROPEDIATRICS, V36, P240, DOI 10.1055/s-2005-872812; Piatt J H Jr, 1999, Neurosurg Focus, V7, pe4; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Pollanen MS, 2002, FORENSIC SCI INT, V126, P101, DOI 10.1016/S0379-0738(02)00008-7; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11	27	112	113	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAY	2010	26	5					637	645		10.1007/s00381-009-1048-7			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	582NV	WOS:000276605600010	19946688				2022-02-06	
J	Harrison-Felix, CL; Whiteneck, GG; Jha, A; DeVivo, MJ; Hammond, FM; Hart, DM				Harrison-Felix, Cynthia L.; Whiteneck, Gale G.; Jha, Amitabh; DeVivo, Michael J.; Hammond, Flora M.; Hart, Denise M.			Mortality Over Four Decades After Traumatic Brain Injury Rehabilitation: A Retrospective Cohort Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cause of death; Life expectancy; Mortality; Rehabilitation	LONG-TERM SURVIVAL; SUDDEN UNEXPECTED DEATH; LIFE EXPECTANCY; HEAD-INJURY; EARLY PREDICTORS; RISK-FACTORS; EPILEPSY; AGE; DETERMINANTS; DISCHARGE	Objective: To investigate mortality, life expectancy, risk factors for death, and causes of death in persons with traumatic brain injury (TBI). Design: Retrospective cohort study. Setting: Used data from an inpatient rehabilitation facility, the Social Security Death Index, death certificates, and the U:S. population age-race-sex-specific and cause-specific mortality rates. Participants: Persons with TBI (N=1678) surviving to their first anniversary of injury admitted to rehabilitation from an acute care hospital within I year of injury between 1961 and 2002. Interventions: Not applicable. Main Outcome Measures: Vital status, standardized mortality ratio, life expectancy, cause of death. Results: Persons with TBI were 1.5 times more likely to die than persons in the general population of similar age, sex, and race, resulting in an estimated average life expectancy reduction of 4 years. Within the TBI population, the strongest independent risk factors for death after I year postinjury were being older, being male, having less education, having a longer hospitalization, having an earlier year of injury, and being in a vegetative state at rehabilitation discharge. After I year postinjury, persons with TBI were 49 times more likely to die of aspiration pneumonia, 22 times more likely to die of seizures, 4 times more likely to die of pneumonia, 3 times more likely to commit suicide, and 2.5 times more likely to die of digestive conditions than persons in the general population of similar age, sex, and race. Conclusions: This study demonstrated life expectancy after TBI rehabilitation is reduced and associated with specific risk factors and causes of death.	[Harrison-Felix, Cynthia L.; Whiteneck, Gale G.; Jha, Amitabh] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO 80202 USA; [DeVivo, Michael J.] Univ Alabama Birmingham, Birmingham, AL USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Harrison-Felix, Cynthia L.; Whiteneck, Gale G.; Jha, Amitabh; Hart, Denise M.] Craig Hosp, Englewood, CO 80113 USA		Harrison-Felix, CL (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	charrison-felix@craighospital.org			National Institute on Disability Rehabilitation and Research [H133G020182]	Supported by a Field Initiated Study from the National Institute on Disability Rehabilitation and Research (grant no. H133G020182). The opinions expressed are those of the authors and do not necessarily reflect the views of the National Institute on Disability Rehabilitation and Research.	ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Baguley I, 2000, BRAIN INJURY, V14, P505; Breslow N. E., 1987, STAT METHODS CANC RE, VII; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; DeVivo M. J, 2002, TOP SPINAL CORD INJ, V7, P49; DEVIVO MJ, 1993, ARCH PHYS MED REHAB, V74, P248; DEVIVO MJ, 1995, CHEST, V108, P226, DOI 10.1378/chest.108.1.226; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270; Fiedler RC, 2000, AM J PHYS MED REHAB, V79, P184, DOI 10.1097/00002060-200003000-00012; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; GARDNER P, 1996, LEADING CAUSES DE 20; Gordis L, 2000, EPIDEMIOLOGY; Hammond F. M., 2000, ARCH PHYS MED REHAB, V81, P1260; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KOCHANEK KD, 1995, ADV REPORT FINAL M S, V43; KOCHANEK KD, 2004, DEATHS FINAL DATA 20, P53; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Messite J, 1996, JAMA-J AM MED ASSOC, V275, P794, DOI 10.1001/jama.275.10.794; Morgan CL, 2002, EPILEPSIA, V43, P1251, DOI 10.1046/j.1528-1157.2002.38701.x; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nashef L, 2007, EPILEPSIA, V48, P859, DOI 10.1111/j.1528-1167.2007.01082.x; Opeskin K, 2003, SEIZURE-EUR J EPILEP, V12, P456, DOI 10.1016/S1059-1311(02)00352-7; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; *PRACT MAN INF COR, 2006, ICD9CM PRACT MAN INF; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Roberts A.V., 1979, SEVERE ACCIDENTAL HE, P140; Rosner B, 2000, FUNDAMENTALS BIOSTAT; Ryvlin P, 2006, CURR OPIN NEUROL, V19, P194, DOI 10.1097/01.wco.0000218238.90711.f4; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Sesso HD, 2000, AM J EPIDEMIOL, V152, P107, DOI 10.1093/aje/152.2.107; Shavelle R, 2000, J Insur Med, V32, P163; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Shavelle RM, 2007, BRAIN INJURY MED PRI, P247; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; *SOC SEC ADM, 2009, SOC SEC DEATH MAST F; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Strauss DJ, 2003, NEUROLOGY, V60, P395, DOI 10.1212/WNL.60.3.395; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; THURMAN D, 2001, EPIDEMIOLOGY EC HEAD; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomson T, 2005, EPILEPSIA, V46, P54, DOI 10.1111/j.1528-1167.2005.00411.x; *TRAUM BRAIN INJ M, 2009, TRAUM BRAIN INJ MOD, V25, P2009; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; WALKER AE, 1970, EPILEPSIA, V11, P17, DOI 10.1111/j.1528-1157.1970.tb03861.x; WALKER AE, 1989, ARCH NEUROL-CHICAGO, V46, P23, DOI 10.1001/archneur.1989.00520370025013; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270	77	112	113	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2009	90	9					1506	1513		10.1016/j.apmr.2009.03.015			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	496AA	WOS:000269938100008	19735778				2022-02-06	
J	de la Plata, CAM; Hart, T; Hammond, FH; Frol, AB; Hudak, A; Harper, CR; O'Neil-Pirozzi, TM; Whyte, J; Carlile, M; Diaz-Arrastia, R				de la Plata, Carlos A. Marquez; Hart, Tessa; Hammond, Flora H.; Frol, Alan B.; Hudak, Anne; Harper, Caryn R.; O'Neil-Pirozzi, Therese M.; Whyte, John; Carlile, Mary; Diaz-Arrastia, Ramon			Impact of age on long-term recovery from traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; disabled persons; rehabilitation	DIFFUSE AXONAL INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; RISK-FACTOR; SYSTEMATIC BIAS; FOLLOW-UP; PREDICTORS; DISABILITY; ASSOCIATION; INDUCTION	Objective: To determine whether older persons are at increased risk for progressive functional decline after traumatic brain injury (TBI). Design: Longitudinal cohort Study. Setting: Traumatic Brain Injury Model Systems (TBIMS) rehabilitation centers. Participants: Subjects enrolled in the TBIMS national dataset. Interventions: Not applicable. Main Outcome Measures: Disability Rating Scale (DRS), FIM instrument cognitive items, and the Glasgow Outcome Scale-Extended. Results: Participants were separated into 3 age tertiles: youngest (16-26y), intermediate (27-39y), and oldest (>= 40y). DRS scores were comparable across age groups at admission to,I rehabilitation center. The oldest group was slightly more disabled at discharge from rehabilitation despite having less severe acute injury severity than the younger groups. Although DRS scores for the 2 younger groups improved significantly from year 1 to year 5, the greatest magnitude of improvement in disability was seen among the youngest group. In addition, after dividing patients into groups according to whether their DRS scores improved (13%), declined (10%), or remained stable (77%) over time, the likelihood of decline was found to be greater for the 2 older groups than for the youngest group. A multiple regression model showed that age has a significant negative influence on DRS score 5 years post-TBI after accounting for the effects of covariates. Conclusions: This study supported our primary hypothesis that older patients show greater decline over the first 5 years after TBI than Younger patients. In addition, the greatest amount of improvement in disability was observed among the Youngest group of survivors. These results suggest that TBI Survivors. especially older patients, may be candidates for neuroprotective therapies after TBI.	[de la Plata, Carlos A. Marquez; Frol, Alan B.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [de la Plata, Carlos A. Marquez; Harper, Caryn R.; Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Hudak, Anne] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Carlile, Mary] Baylor Inst Rehabil, Dallas, TX USA; [Hart, Tessa; Whyte, John] Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; [Hart, Tessa; Whyte, John] Thomas Jefferson Univ, Jefferson Med Coll, Moss Rehabil Res Inst, Philadelphia, PA 19107 USA; [Hammond, Flora H.] Carolinas Rehabil, Charlotte, NC USA; [O'Neil-Pirozzi, Therese M.] Harvard Univ, Spaulding Rehabil Hosp, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA		Diaz-Arrastia, R (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ramon.diaz-arrastia@utsoutinvestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594; Whyte, John/0000-0002-4381-1474	National Institutes of Health, U.S. Department of EducationUS Department of EducationUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [H133 A020526, R01 HD48179, U01 HD42652]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, U.S. Department of Education (grant nos. H133 A020526, R01 HD48179, U01 HD42652).	Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Corrada MM, 1997, NEUROLOGY, V48, P5054; Corrigan J.D., 2003, TECHNICAL REPORT PRO; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hillbom M, 1999, J CARDIOVASC RISK, V6, P223; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAKIER A, 2002, ANN NEUROL, V9, P187; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Sapoznik S, 2006, LEARN MEMORY, V13, P719, DOI 10.1101/lm.351706; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Sherer M, 1999, BRAIN INJURY, V13, P973; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stuss DT, 2000, NEUROLOGY, V54, P1337, DOI 10.1212/WNL.54.6.1337; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; VERMA NP, 1992, CLIN ELECTROENCEPHAL, V23, P147, DOI 10.1177/155005949202300310; WALBRAN BB, 1981, ALCOHOL CLIN EXP RES, V5, P531, DOI 10.1111/j.1530-0277.1981.tb05355.x; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; ZABAR Y, 2000, NEURODEGENERATIVE DE, P79	53	112	116	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2008	89	5					896	903		10.1016/j.apmr.2007.12.030			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	341ST	WOS:000258735900016	18452739	Green Accepted			2022-02-06	
J	Shafi, S; de la Plata, CM; Diaz-Arrastia, R; Bransky, A; Frankel, H; Elliott, AC; Parks, J; Gentilello, LM				Shafi, Shahid; de la Plata, Carlos Marquez; Diaz-Arrastia, Ramon; Bransky, Aaron; Frankel, Heidi; Elliott, Alan C.; Parks, Jennifer; Gentilello, Larry M.			Ethnic disparities exist in trauma care	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	64th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 22-24, 2005	Atlanta, GA	Amer Assoc Surg Trauma		ethnic disparities; rehabilitation; trauma care; TBI	ACUTE MYOCARDIAL-INFARCTION; SPANISH-SPEAKING PATIENTS; BRAIN-INJURY; UNITED-STATES; HEALTH-CARE; OUTCOMES; IMPACT; RACE; EMERGENCY; MORTALITY	Background: An estimated 5.3 million people in the United States live with permanent disability related to traumatic brain injury (TBI). Access to rehabilitation after TBI is important in minimizing these disabilities. Ethnic disparities in access to health care have been documented in other diseases, but have not been studied in trauma care. We hypothesized that access to rehabilitation after TBI is influenced by race or ethnicity. Methods: Retrospective analysis of the National Trauma Data Bank patients with severe blunt TBI (head abbreviated injury score 3-5, n = 58,729) who survived the initial hospitalization was performed. Placement into rehabilitation after discharge was studied in three groups: non-Hispanic white (NHW 77%), African American (14%), and Hispanic (9%). The two minority groups were compared with NHW patients using logistic regression to control for differences in age, gender, overall injury severity (injury severity score), TBI severity (head abbreviated injury score and Glasgow Coma Scale score), associated injuries, and insurance status. Results: The three groups were similar in injury severity score, TBI severity, and associated injuries. After accounting for differences in potential confounders, including injury severity and insurance status, minority patients were 15% less likely to be placed in rehabilitation (odds ratio 0.85, 95% confidence interval 0.8-0.9, p < 0.0001). Conclusions: Ethnic minority patients are less likely to be placed in rehabilitation than NHW` patients are, even after accounting for insurance status, suggesting existence of systematic inequalities in access. Such inequalities may have a disproportionate impact on long-term functional outcomes of African American and Hispanic TBI patients, and suggest the need for an in-depth analysis of this disparity at a health policy level.	Univ Texas, SW Med Ctr, Dept Surg, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Clin Sci, Dallas, TX USA		Shafi, S (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	shahid.shafi@uthsouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594			BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Baker DW, 1996, JAMA-J AM MED ASSOC, V275, P783, DOI 10.1001/jama.275.10.783; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Barnhart JM, 2003, ARCH INTERN MED, V163, P461, DOI 10.1001/archinte.163.4.461; Bertoni AG, 2005, J NATL MED ASSOC, V97, P317; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Carrasquillo O, 1999, J GEN INTERN MED, V14, P82, DOI 10.1046/j.1525-1497.1999.00293.x; COLLINS K, 1999, HLTH CHARTBOOK; ERZINGER S, 1991, CULT MED PSYCHIAT, V15, P91, DOI 10.1007/BF00050829; Flattery Maureen P, 2004, J Cult Divers, V11, P25; FRANKOWSKI RAJ, 1985, DESCRIPTIVE EPIDEMIO; Franks P, 2002, MED CARE, V40, P717, DOI 10.1097/00005650-200208000-00011; Greenwood RJ, 2004, BRIT J NEUROSURG, V18, P462, DOI 10.1080/02688690400012327; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Mochari Heidi, 2006, Prev Cardiol, V9, P8, DOI 10.1111/j.1520-037X.2005.3703.x; *NAT CTR INJ PREV, 2002, CDC INJ RES AG; Perez-Stable EJ, 1997, MED CARE, V35, P1212, DOI 10.1097/00005650-199712000-00005; Reid AE, 2004, LIVER TRANSPLANT, V10, P834, DOI 10.1002/lt.20174; SEIJO R, 1991, HISPANIC J BEHAV SCI, V13, P363, DOI 10.1177/07399863910134001; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Underwood W, 2006, J AM COLL SURGEONS, V202, P284, DOI 10.1016/j.jamcollsurg.2005.09.009; *US DEP HHS, 2000, HLTH PEOP 2010; US Department of Health and Human Services, 2005, NAT HEALTHC DISP REP; Venkat A, 2003, ACAD EMERG MED, V10, P1199, DOI 10.1197/S1069-6563(03)00490-1; Weinick RM, 2000, MED CARE RES REV, V57, P36, DOI 10.1177/107755800773743592; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09	33	112	113	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2007	63	5					1138	1142		10.1097/TA.0b013e3181568cd4			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	232BX	WOS:000250994200033	17993963				2022-02-06	
J	Anderson, KJ; Miller, KM; Fugaccia, I; Scheff, SW				Anderson, KJ; Miller, KM; Fugaccia, I; Scheff, SW			Regional distribution of Fluoro-Jade B staining in the hippocampus following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						cell death; cortical contusion; Fluoro-Jade; hippocampus; stereology	ACUTE NEURONAL DEGENERATION; CONTROLLED CORTICAL IMPACT; LATERAL FLUID PERCUSSION; STEREOLOGICAL ESTIMATION; BEHAVIORAL DEFICITS; AGED RATS; ASTROCYTES; NUMBER; LOCALIZATION; FRACTIONATOR	Fluoro-Jade B (FJB) is an anionic fluorescein derivative that has been reported to specifically stain degenerating neurons. We were interested in applying FJB staining in a well-characterized model of traumatic brain injury (TBI) in order to estimate the total number of neurons in different regions of the hippocampus that die after a mild or moderate injury. Rats were subjected to a mild or moderate unilateral cortical contusion (1.0- or 1.5-min displacement from the cortical surface) with a controlled cortical impacting device. Animals were allowed to survive for 1, 2, or 7 days and the total number of FJB-positive neurons in hippocampal areas CA1, CA3, and the dentate gyrus granule layer was estimated using sterological methods. The region that had the highest number of FJP-positive neurons after TBI was the dentate gyrus. In both 1- and 1.5-mm injuries, 17,FJB-positive granule cells were observed throughout the rostro-caudal extent of the dentate. In contrast, labeled pyramidal neurons of area CA3 were most numerous after the 1.5-min injury. The area that had the fewest number of FJB-labeled cells was area CAI with only scattered neurons seen in the 1.5-inin group. In both injury groups and in all hippocampal regions, more FJB-positive neurons were seen at the earlier times post injury (1 and 2 days) than at 7 days. FJB appears to be a reliable marker for neuronal vulnerability following TB1. (c) 2004 Elsevier Inc. All rights reserved.	Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; Univ Kentucky, Sanders Brown Ctr, Lexington, KY 40536 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA		Anderson, KJ (corresponding author), Univ Florida, Dept Physiol Sci, POB 100144, Gainesville, FL 32610 USA.	kanders@ufbi.ufl.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021981] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG21981] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 39828] Funding Source: Medline		Amaral David G., 1995, P443; Anderson KJ, 2003, J NEUROTRAUM, V20, P1223, DOI 10.1089/089771503770802899; Baldwin SA, 1996, GLIA, V16, P266; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hopkins KJ, 2000, BRAIN RES, V864, P69, DOI 10.1016/S0006-8993(00)02137-5; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MADEIRA MD, 1988, J HIRNFORSCH, V29, P643; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; MITCHELL Y, 2002, NEUROPATHOL APPL NEU, V28, P160; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; Rasmussen T, 1996, NEUROBIOL AGING, V17, P143, DOI 10.1016/0197-4580(95)02032-2; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xavier GF, 1999, HIPPOCAMPUS, V9, P668, DOI 10.1002/(SICI)1098-1063(1999)9:6<668::AID-HIPO8>3.0.CO;2-9; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zwienenberg M, 2001, NEUROSURGERY, V48, P1119, DOI 10.1097/00006123-200105000-00031	38	112	115	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2005	193	1					125	130		10.1016/j.expneurol.2004.11.025			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916VB	WOS:000228413300012	15817271				2022-02-06	
J	Schafer, PW; Huisman, TAGM; Sorenson, AG; Gonzalez, RG; Schwamm, LH				Schafer, PW; Huisman, TAGM; Sorenson, AG; Gonzalez, RG; Schwamm, LH			Diffusion-weighted MR imaging in closed head injury: High correlation with initial Glasgow coma scale score and score on modified Rankin scale at discharge	RADIOLOGY			English	Article						brain, injuries; brain, MR; magnetic resonance (MR), comparative studies; magnetic resonance (MR), diffusion tensor; trauma	AXONAL INJURY; BRAIN INJURY; WHITE-MATTER; TRAUMA; STROKE; CT; EDEMA; CLASSIFICATION; FEATURES; HUMANS	PURPOSE: To determine whether diffusion-weighted magnetic resonance (MR) imaging findings and conventional MR imaging findings correlate with initial Glasgow Coma Scale score and score on modified Rankin scale at discharge. MATERIALS AND METHODS: Twenty-six patients (18 male and eight femald patients; mean age, 25.2 years; age range, 4-72 years) with diffuse axonal injury were examined with diffusion-weighted MR imaging and with fluid-attenuated inversion recovery, T2-weighted fast spin-echo, and T2*-weighted gradient-echo sequences. All images were evaluated by two neuroradiologists in consensus. Tissue volume with trauma-related signal-intensity abnormality on images form each sequence, number of lesions for teach sequence, number of lesions for all sequences, and number of lesions with reduced apparent diffusion coefficient were correlated with scores on Glasgow Coma Scale and modified Rankin scale. Involvement of brainstem, deep gray matter, and corpus callosum were also correlated with clinical scores. Spearman rank correlation coefficients (r) were calculated. RESULTS: The strongest correlation was between signal-intensity abnormality volume on diffusion-weighted images and modified Rankin score (r= 0.772, P < .001). The strength of this correlation did not improve when only volume of lesions with decreased apparent diffusion coefficient was considered. For lesion number, the strongest correlation was between lesion number on images acquired with all sequences and modified Rankin score (r=0.662, P < .001). For lesion location, the strongest correlation was between lesion location in the corpus callosum and modified Rankin score ( r=0.513, P = .007). CONCLUSION: Volume of lesions on diffusion-weighted MR images provides the strongest correlation with a score of subacute on modified Rankin scale at discharge. Total lesion number also correlates well with modified Rankin score. In future, diffusion-weighted images may be useful in determining treatment strategies for acute head injury. (C) RSNA, 2004.	Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA		Schafer, PW (corresponding author), Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St,Gray B285, Boston, MA 02114 USA.	pschaefer@partners.org	Schaefer, Pamela/AAA-1323-2019	Schwamm, Lee/0000-0003-0592-9145			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GEAN AD, 1994, IMAGING HEAD TRAUMA, P207; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, P824; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kuzma BB, 2000, SURG NEUROL, V53, P400; Lai SM, 1999, STROKE, V30, P1840, DOI 10.1161/01.STR.30.9.1840; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; PELLICANO G, 1997, NEURORADIOLOGY, V39, pS82; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; SEGATORE M, 1992, HEART LUNG, V21, P548; Sorensen AG, 1996, RADIOLOGY, V199, P391, DOI 10.1148/radiology.199.2.8668784; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; STARMARK JE, 1988, J NEUROSURG, V69, P692, DOI 10.3171/jns.1988.69.5.0692; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Unterberg AW, 1997, ACT NEUR S, V70, P106; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	41	112	124	0	3	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	OCT	2004	233	1					58	66		10.1148/radiol.2323031173			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	856WC	WOS:000224075000011	15304663				2022-02-06	
J	Mahmood, O; Rapport, LJ; Hanks, RA; Fichtenberg, NL				Mahmood, O; Rapport, LJ; Hanks, RA; Fichtenberg, NL			Neuropsychological performance and sleep disturbance following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						neuropsychological assessment; sleep disturbance; traumatic brain injury	NEUROBEHAVIORAL SYMPTOMS; GENDER-DIFFERENCES; READING TEST; HEAD-INJURY; INSOMNIA; COMPLAINTS; CONSEQUENCES; POPULATION; DISORDERS; ATTENTION	Objective: To examine the relation between sleep disturbance and neurocognitive ability among persons with traumatic brain injury (TBI). Design: Correlational research evaluating demographic and neuropsychological predictors of sleep disturbance using multiple regression analysis and analysis of variance. Participants: Eighty-seven patients with mild to severe TBI admitted to a comprehensive outpatient neurorehabilitation program. Main Outcome Measures: Sleep disturbance assessed using the Pittsburgh Sleep Quality Index. Results: Hierarchical regression analysis revealed that performance on selected measures of cognitive functioning significantly improved prediction of sleep disturbance, accounting for 14% of variance beyond that accounted for by injury severity and gender. The total model accounted for 31% of the variance in Pittsburgh Sleep Quality Index scores. Patients with mild TBI reported more sleep disturbance (P < .01) than did patients with severe TBI. Conclusions: Sleep disturbance among patients with TBI may be associated with a particular constellation of neuropsychological abilities. These issues are discussed in relation to prior findings that indicate the involvement of additional neuropsychiatric factors associated with sleep disturbance in mild TBI.	Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Rehabil Inst Michigan, Detroit, MI 48202 USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA.	rapport@sun.science.wayne.edu	Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604; Rapport, Lisa/0000-0001-8014-9523			Autret A, 2001, NEUROPHYSIOL CLIN, V31, P356, DOI 10.1016/S0987-7053(01)00282-9; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Call-Schmidt Tracy Ann, 2003, Pain Manag Nurs, V4, P124, DOI 10.1016/S1524-9042(02)54212-0; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Doi Y, 2003, SOC SCI MED, V56, P883, DOI 10.1016/S0277-9536(02)00089-8; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; Gasanov R L, 1998, Neurosci Behav Physiol, V28, P325, DOI 10.1007/BF02462964; Goldman-Rakic P. S., 1993, J HEAD TRAUMA REHAB, V8, P13; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hauri PJ, 1997, ACTA NEUROL BELG, V97, P113; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Jean-Louis G, 2000, BIOL PSYCHIAT, V47, P921, DOI 10.1016/S0006-3223(99)00169-9; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; Li RHY, 2002, J PSYCHOSOM RES, V53, P601, DOI 10.1016/S0022-3999(02)00437-3; Mahowald Mark W., 1996, P285; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Ohayon MM, 2002, SLEEP MED, V3, P115, DOI 10.1016/S1389-9457(01)00158-7; Portas CM, 1998, J NEUROSCI, V18, P8979; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Quan SF, 2003, SLEEP MED, V4, P13, DOI 10.1016/S1389-9457(02)00235-6; REEDER KP, 1994, ARCH CLIN NEUROPSYCH, V9, P491, DOI 10.1016/0887-6177(94)90040-X; RICHTER KJ, 1995, J HEAD TRAUMA REHAB, V10, P7, DOI 10.1097/00001199-199512000-00004; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Savis JC, 1997, INT J SPORT PSYCHOL, V28, P157; Smith MT, 2002, SLEEP, V25, P325; TEASDALE G, 1974, LANCET, V2, P81; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; WIENS AN, 1993, CLIN NEUROPSYCHOL, V7, P70, DOI 10.1080/13854049308401889; [No title captured]; [No title captured]; [No title captured]	44	112	113	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2004	19	5					378	390		10.1097/00001199-200409000-00003			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858UB	WOS:000224216300003	15597029				2022-02-06	
J	Stocchetti, N; Pagan, F; Calappi, E; Canavesi, K; Beretta, L; Citerio, G; Cormio, M; Colombo, A				Stocchetti, N; Pagan, F; Calappi, E; Canavesi, K; Beretta, L; Citerio, G; Cormio, M; Colombo, A			Inaccurate early assessment of neurological severity in head injury	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Coma Scale; head injury; neurological assessment; outcome; sedation	INTENSIVE-CARE; BRAIN-INJURY; SCALE; COMA; HYPOTENSION; GUIDELINES; ABUSE	Intubation, which requires sedation and myorelaxants, may lead to inaccurate neurological evaluation of severely head-injured patients. Aims of this study were to describe the early clinical evolution of traumatic brain injured (TBI) patients admitted to intensive care unit (ICU), to identify cases of over-estimated neurological severity, and to quantify the risk factors for this over-estimation. A total of 753 TBI patients consecutively admitted to ICU of three academic neurosurgical hospitals (NSH) were assessed. Cases whose severity was potentially over-estimated were identified by four criteria and indicated as "mistakenly severe" (MS): (1) no surgical intracranial masses; (2) could not follow commands at neurological assessment; (3) were dismissed from the ICU in :53 days to a regular ward; and (4) had regained the ability to obey commands. A total of 675 patients were intubated and/or sedated-paralyzed at the post-stabilization evaluation. In all, 304 patients had surgically treated intracranial masses. Among the 449 non-surgical cases, 58 patients fulfilling the criteria for MS were identified. The main features distinguishing MS from truly severe cases were younger age, higher Glasgow Coma Scale (GCS) score at all time points, Marshall classification of Computerized Tomographic (CT) scan mostly Diffuse Injury I and II, fewer pupillary abnormalities, and a lower frequency of hypoxia, hypotension, and extra-cranial injuries. In a certain proportion of non-surgical TBI patients, mostly intubated and sedated, neurological examination is difficult and severity can be over-estimated. Risk factors for this inaccurate evaluation can be identified, and clinical decisions should be based on further examination.	Univ Milan, IRCCS, Osped Policlin, Dept Anesthesia & Intens Care, I-20122 Milan, Italy; Osped San Raffaele, Dept Anesthesia & Intens Care, Milan, Italy; Osped San Gerardo, Dept Anesthesia & Intens Care, Monza, Italy		Stocchetti, N (corresponding author), Univ Milan, IRCCS, Osped Policlin, Dept Anesthesia & Intens Care, Padiglione Beretta Neuro,Via F Sforza 35, I-20122 Milan, Italy.	stocchet@policlinico.mi.it	; Stocchetti, Nino/O-7444-2017	Citerio, Giuseppe/0000-0002-5374-3161; Stocchetti, Nino/0000-0003-3250-6834			*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; LINDENBAUM GA, 1989, J TRAUMA, V29, P1654, DOI 10.1097/00005373-198912000-00012; Livingston BM, 2000, CRIT CARE MED, V28, P389, DOI 10.1097/00003246-200002000-00017; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marshall LF, 1991, J NEUROSURG S, V75, P14; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; TEASDALE G, LANCET, V2, P81; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	16	112	113	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1131	1140		10.1089/neu.2004.21.1131			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900003	15453984	Green Submitted			2022-02-06	
J	Sveistrup, H; McComas, J; Thornton, M; Marshall, S; Finestone, H; McCormick, A; Babulic, K; Mayhew, A				Sveistrup, H; McComas, J; Thornton, M; Marshall, S; Finestone, H; McCormick, A; Babulic, K; Mayhew, A			Experimental studies of virtual reality-delivered compared to conventional exercise programs for rehabilitation	CYBERPSYCHOLOGY & BEHAVIOR			English	Article; Proceedings Paper	1st Annual Cybertherapy Advanced Technologies in the Behavioral Social and Neurosciences Conference	JAN 19-21, 2003	SAN DIEGO, CALIFORNIA				FROZEN SHOULDER; MANIPULATION	This paper presents preliminary data from two clinical trials currently underway using flat screen virtual reality (VR) technology for physical rehabilitation. In the first study, we are comparing a VR-delivered exercise program to a conventional exercise program for the rehabilitation of shoulder joint range-of-motion in patients with chronic frozen shoulder. In the second study, we are comparing two exercise programs, VR and conventional, for balance retraining in subjects post-traumatic brain injury. Effective VR-based rehabilitation that is easily adapted for individuals to use both in inpatient, outpatient and home-based care could be used as a supplement or alternative to conventional therapy. If this new treatment approach is found to be effective, it could provide a way to encourage exercise and treatment compliance, provide safe and motivating therapy and could lead to the ability to provide exercises to clients in distant locations through telehealth applications of VR treatment. VR is a new technology and the possibilities for rehabilitation are only just beginning to be assessed.	Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON K1H 8M5, Canada; Ottawa Hosp, Rehabil Ctr, Div Phys Med & Rehabil, Ottawa, ON, Canada; Univ Ottawa, Elizabeth Bruyere Hlth Ctr, Dept Phys Med & Rehabil, Ottawa, ON, Canada; Ottawa Hosp, Rehabil Serv, Ottawa, ON, Canada; Univ Ottawa, Inst Heart, Prevent & Rehabil Ctr, Ottawa, ON, Canada		Sveistrup, H (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.						Beaton D E, 2001, J Hand Ther, V14, P128; BERG K, 1989, Physiotherapy Canada, V41, P304; Chipchase LS, 2000, J SHOULDER ELB SURG, V9, P12, DOI 10.1016/S1058-2746(00)90003-X; Codman E., 1934, SHOULDER; Dodenhoff RM, 2000, J SHOULDER ELB SURG, V9, P23, DOI 10.1016/S1058-2746(00)90005-3; DUETSCH JE, 2002, NEUROLOGY REPORT, V26, P79; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; Hillier SL, 1997, BRAIN INJURY, V11, P661; Holden M.K, 2002, NEUROLOGY REPORT, V26, P62, DOI [10.1097/01253086-200226020-00003, DOI 10.1097/01253086-200226020-00003]; Inness L, 2002, SYNAPSE, V22, P2; MANN NR, 1996, MED REHABILITATION T, P479; MCCOMAS J, 2002, NEUROLOGY REPORT, V26, P55, DOI DOI 10.1097/01253086-200226020-00002; McConnell SG, 1999, DASH OUTCOME MEASURE; OGILVIEHARRIS DJ, 1995, CLIN ORTHOP RELAT R, P238; REKOLA KE, 1993, J EPIDEMIOL COMMUN H, V47, P153, DOI 10.1136/jech.47.2.153; RIZK TE, 1994, ARCH PHYS MED REHAB, V75, P803; Rizzo AA, 2002, HUM FAC ER, P1027; ROSE FD, 1998, VIRTUAL ENV CLIN PSY, P233; RYAN L, 1997, PHYSIOTHERAPY CANADA, V4, P113; Tolfts Annabel, 1997, Physiotherapy Theory and Practice, V13, P197; Whitney S, 2002, NEUROLOGY REPORT, V26, P72	21	112	117	2	22	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	1094-9313			CYBERPSYCHOL BEHAV	CyberPsychol. Behav.	JUN	2003	6	3					245	249		10.1089/109493103322011524			5	Communication; Psychology, Applied	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Communication; Psychology	693BA	WOS:000183693700004	12855079				2022-02-06	
J	Zhi, DS; Zhang, S; Lin, X				Zhi, DS; Zhang, S; Lin, X			Study on therapeutic mechanism and clinical effect of mild hypothermia in patients with severe head injury	SURGICAL NEUROLOGY			English	Article						severe head injury; mild hypothermia; prognosis	TRAUMATIC BRAIN INJURY; MODERATE HYPOTHERMIA; TISSUE	BACKGROUND The therapeutic mechanism and clinical effect of mild hypothermia in patients with severe head injury were studied. METHODS All 396 patients with severe head injury [Glasgow Coma Scale score (GCS) equal to or less than 8 on admission] were randomly divided into the hypothermic group (198 cases) and the control group (198 cases). Hypothermia was induced within 24 hours of injury. Rewarming began 1 to 7 days (average 62.4 +/- 27.6 h) after the rectal temperature (RT) reached 32.0 to 35.0degreesC. Meanwhile, the vital signs, intracranial pressure (ICP), blood gas values, blood electrolytes, brain tissue oxygen pressure (PbtO2), brain tissue temperature (BT), cerebral blood flow (CBF), and jugular venous oxygen saturation (SjvO2) were measured. The rectal temperature of control patients was induced to 36.5 to 37.0degreesC. According to GOS, the prognosis of the patients was evaluated. RESULTS In comparison with control group, during mild hypothermia the high level of ICP, hyperglycemia and blood lactic acid significantly decreased (p < 0.05) and cerebral flow improved dominantly. The vital signs, blood gas values, and blood electrolytes did not change significantly. Decreased mortality and good recovery were also found in hypothermia group. CONCLUSIONS Mild hypothermia is safe and effective for preventing brain damage on patients with severe head injury, as well as reducing mortality and improving the prognosis. It is important to monitor PbtO2, BT, CBF, and SjvO2 in hypothermic therapy. (C) 2003 Elsevier Inc. All rights reserved.	Tianjin Huanbu Hosp, Tianjin 300060, Peoples R China		Zhi, DS (corresponding author), Tianjin Huanbu Hosp, Tianjin 300060, Peoples R China.						Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; JIANG J, 1997, CHIN J TRAUMATOL, V13, P13; Liu J, 1999, CHIN J TRAUMATOL, V15, P35; Maeda T, 1998, J NEUROTRAUM, V15, P655, DOI 10.1089/neu.1998.15.655; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; METZ C, 1996, J NEUROSURG, V85, P53; Schroder ML, 1998, NEUROSURGERY, V42, P1276, DOI 10.1097/00006123-199806000-00042; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; ZHANG S, 1999, TIANJIN MED, V27, P446; Zhi D, 2000, CHIN J NEUROSURG, V16, P239; Zhi DS, 1999, SURG NEUROL, V52, P393, DOI 10.1016/S0090-3019(99)00101-9	14	112	121	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	MAY	2003	59	5					381	385		10.1016/S0090-3019(03)00148-4			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	682JV	WOS:000183089200008	12765810				2022-02-06	
J	Monson, KL; Goldsmith, W; Barbaro, NM; Manley, GT				Monson, KL; Goldsmith, W; Barbaro, NM; Manley, GT			Axial mechanical properties of fresh human cerebral blood vessels	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							HUMAN AORTIC TISSUE; FAILURE PROPERTIES; TENSION TESTS; INJURY; VEINS	Human cerebral blood vessels are frequently damaged in head impact, whether accidental or deliberate, resulting in intracranial bleeding. Additionally, the vasculature constitutes the support structure for the brain and, hence, plays a key role in the cranial load response. Quantification of its mechanical behavior including limiting loads, is thus required for a proper understanding and modeling of traumatic brain injury-as well as providing substantial assistance in the development and application of preventive measures. It is believed that axial, stretching is the dominant loading mode for the blood vessels, regardless of the nature of the insult. Eighteen arteries and fourteen veins were obtained from the cortical surface of the cerebral temporal lobe of patients undergoing surgery. These vessels were stretched to failure in the longitudinal direction, either quasistatically or dynamically. The significance of specimen and experiment parameters was determined using multivariate analysis of variance (MANOVA) testing. Results demonstrate that the arteries were considerably stiffer than the veins, carrying approximately twice as much stress at failure but withstanding only half as much stretch. No significant rate dependence was measured over a strain rate range of more than four orders of magnitude (0.01 to 500 s(-1)).	Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA		Monson, KL (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.		Monson, Ken/L-4702-2019	Monson, Ken/0000-0002-8461-6034	ODCDC CDC HHS [R49/CCR919722-01, R49/CCR903697] Funding Source: Medline		Bandak F.A., 1994, P 38 STAPP CAR CRASH; BOOCK RJ, 1990, 1990 INT IRCOBI C BI, P169; Brossollet LJ, 1997, J BIOMECH ENG-T ASME, V119, P1, DOI 10.1115/1.2796059; BUSBY DE, 1965, CAN J PHYSIOL PHARM, V43, P185, DOI 10.1139/y65-018; CHALUPNIK JD, 1971, ME7111 U WASH; FUNG YCB, 1967, AM J PHYSIOL, V213, P1532, DOI 10.1152/ajplegacy.1967.213.6.1532; Gean AD, 1994, IMAGING HEAD TRAUMA; HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LEE MC, 1985, ADV BIOENG, P111; LOWENHIELM P, 1978, J BIOENG, V2, P509; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; MEANEY DF, 1991, THESIS U PENN PHILAD; Melvin J.W., 1993, ACCIDENTAL INJURY BI, P268; MOHAN D, 1983, J BIOMECH, V16, P31, DOI 10.1016/0021-9290(83)90044-1; MOHAN D, 1982, J BIOMECH, V15, P887, DOI 10.1016/0021-9290(82)90055-0; Monson K. L., 2001, THESIS U CALIFORNIA; OMORI K, 2000, CRASHWORTHINESS OCCU, V49, P167; STEHBENS WE, 1972, PAHTOLOGY CEREBRAL B; STEIGER H J, 1989, Heart and Vessels, V5, P41, DOI 10.1007/BF02058357; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vossoughi J., 1996, TRAUMATIC BRAIN INJU, P207; Yamada H., 1970, STRENGTH BIOL MAT	24	112	115	0	22	ASME-AMER SOC MECHANICAL ENG	NEW YORK	THREE PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731			J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	APR	2003	125	2					288	294		10.1115/1.1554412			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	675YV	WOS:000182725900016	12751292				2022-02-06	
J	Bogod, NM; Mateer, CA; MacDonald, SWS				Bogod, NM; Mateer, CA; MacDonald, SWS			Self-awareness after traumatic brain injury: A comparison of measures and their relationship to executive functions	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						self-awareness; executive function; frontal lobes; brain injury	WORKING-MEMORY TASKS; IMPAIRED AWARENESS; FRONTAL-CORTEX; STROOP INTERFERENCE; DEFICITS; REHABILITATION; IMPAIRMENTS; DISABILITY; ADULTS; LOBES	Poor awareness of deficit is common after brain injury. Recent literature has examined various tools for measurement of this phenomenon; the most widely used being self-other rating scales. Although self-other scale measures have face validity, their criterion-related validity has not been adequately demonstrated, and there is little information as to whether and how they relate to other neuropsychological measures. The present study compared measurement of awareness by the Dysexecutive (DEX) Questionnaire self-other rating scale with the Self-Awareness of Deficits Interview (SADI), a semistructured interview measure. Evaluation of awareness by these measures was compared to tests of executive functioning and IQ. Results indicated significant, albeit marginal relationships between the two measures, and better correlation of the SADI with measures of frontal lobe functioning. The SADI also predicted injury severity.	Univ Victoria, Dept Psychol, Victoria, BC V8W 3P5, Canada		Bogod, NM (corresponding author), Univ Victoria, Dept Psychol, POB 3050 STN CSC, Victoria, BC V8W 3P5, Canada.			MacDonald, Stuart/0000-0002-1042-4750			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Benson D.F., 1986, FRONTAL LOBES; Bergquist Thomas F., 1993, Brain Injury, V7, P275, DOI 10.3109/02699059309029680; Burgess P, 1996, BEHAV ASSESSMENT DYS; CAVELLO MM, 1992, BRAIN INJURY, V6, P327; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; deZubicaray GI, 1997, J NEUROL NEUROSUR PS, V63, P309, DOI 10.1136/jnnp.63.3.309; DIAMOND A, 1991, FRONTAL LOBE FUNCTIO, P189; Eslinger PJ, 1999, NEUROCASE, V5, P299, DOI 10.1093/neucas/5.4.299; EVANS JJ, 1997, PSYCHOL MED, V27, P1; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; GOLDMANRAKIC PS, 1996, PHILOS T ROY SOC B, V35, P1145; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; LAPIERRE D, 1995, NEUROPSYCHOLOGIA, V33, P139, DOI 10.1016/0028-3932(94)00110-B; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; PETRIDES M, 1995, J NEUROSCI, V15, P359; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P263; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; PRIGATANO GP, 1987, BARROW NEUROL I Q, V3, P18; Purdon SE, 1998, J PSYCHIATR NEUROSCI, V23, P163; REGARD M, 1991, STROOP TEST VICTORIA; Robbins TW, 1996, PHILOS T ROY SOC B, V351, P1463, DOI 10.1098/rstb.1996.0131; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Sattler JM, 1992, ASSESSMENT CHILDREN, Vthird; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Shimamura AP, 1995, ANN NY ACAD SCI, V769, P151, DOI 10.1111/j.1749-6632.1995.tb38136.x; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; STUSS DT, 1991, SELF : INTERDISCIPLINARY APPROACHES, P255; Toglia J, 2000, NEUROREHABILITATION, V15, P57; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, P125; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wechsler, 1997, WECHSLER ADULT INTEL; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; ZAJANO MJ, 1986, PERCEPT MOTOR SKILL, V63, P1087, DOI 10.2466/pms.1986.63.3.1087	49	112	113	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2003	9	3					450	458		10.1017/S1355617703930104			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	661HR	WOS:000181885600010	12666769				2022-02-06	
J	DeFord, SM; Wilson, MS; Rice, AC; Clausen, T; Rice, LK; Barabnova, A; Bullock, R; Hamm, RJ				DeFord, SM; Wilson, MS; Rice, AC; Clausen, T; Rice, LK; Barabnova, A; Bullock, R; Hamm, RJ			Repeated mild brain injuries result in cognitive impairment in B6C3F1 mice	JOURNAL OF NEUROTRAUMA			English	Article						cognitive performance; concussion; head injury; mild brain injury; repeated brain injury; traumatic brain injury	HEAD-INJURY; SOCCER PLAYERS; CELL-DEATH; RAT; REPERFUSION; TRAUMA; MODEL	Experimental investigations of single mild brain injury (SMI) show relatively little resultant cognitive impairment. However, repeated mild brain injuries (RMI), as those sustained by athletes (e.g., football, hockey, and soccer players) may have cumulative effects on cognitive performance and neuropathology. Numerous clinical studies show persistent, latent, and long-term consequences of RMI, unlike the episodic nature of SMI. The nature of repeated traumatic brain injury (TBI) introduces confounding factors in invasive and even semiinvasive animal models of brain injury (e.g., scar formation). Thus, the present study characterizes SMI and RMI in a noninvasive mouse weight drop model and the cumulative effects of RMI on cognitive performance. Investigation of drop masses and drop distances revealed masses of 50, 100, and 150 g dropped from 40 cm resulted in 0% mortality, no skull fracture, and no difference in acute neurological assessment following sham injury, SMI, or RMI. Cumulative effects of RMI were examined following four mild brain injuries 24 h apart induced by 50-, 100-, or 150-g masses dropped from 40 cm through histological measures, mean arterial pressure, and measures of complex/spatial learning. RMI produced no overt cell death within the cortex or hippocampus, no evidence of blood-brain barrier compromise, and no significant change in mean arterial pressure. Following testing in the Morris water maze (MWM) on days 7-11 after initial injury, mice in the RMI 100-g and RMI 150-g groups had significantly longer MWM goal latencies compared to sham, SMI 150-g, and RMI 50-groups. Additionally, the evident cognitive deficit manifested in the absence of observed cell death. This is the first study to show complex/spatial learning deficits following RMI, similar to the visual/spatial perception and planning deficits observed in clinical studies.	Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23284 USA		DeFord, SM (corresponding author), Univ Florida, Inst Brain, 100 Newell Dr,LI-126,POB 100244, Gainesville, FL 32610 USA.						Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BAKER SP, 1994, AM J PUBLIC HEALTH, V84, P649, DOI 10.2105/AJPH.84.4.649; Barancik M, 2000, J CARDIOVASC PHARM, V35, P474, DOI 10.1097/00005344-200003000-00019; Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOLL TJ, 1983, PSYCHIAT DEV, V1, P263; Chilian WM, 1999, AM J PHYSIOL-HEART C, V277, pH2416; Csonka C, 1999, CIRCULATION, V100, P2260, DOI 10.1161/01.CIR.100.22.2260; Dickson EW, 2000, ACAD EMERG MED, V7, P311, DOI 10.1111/j.1553-2712.2000.tb02228.x; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Ghosh S, 2000, CARDIOVASC RES, V45, P934, DOI 10.1016/S0008-6363(99)00407-1; GOVER GJ, 2000, J MOL CELL CARDIOL, V32, P677; GRONWALL D, 1975, LANCET, V2, P955; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hearse DJ, 1999, J MOL CELL CARDIOL, V31, P1961, DOI 10.1006/jmcc.1999.1027; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kawabata K, 2000, AM J PHYSIOL-HEART C, V278, pH1008, DOI 10.1152/ajpheart.2000.278.3.H1008; LOWELL MR, 1998, J HEAD TRAUMA REHAB, V13, P9; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; MARMAROU A, 1994, J NEUROSURG, V80, P281; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Perrault LP, 1999, ANN THORAC SURG, V68, P1988, DOI 10.1016/S0003-4975(99)01024-3; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Sturmi JE, 1998, SPORTS MED, V25, P351, DOI 10.2165/00007256-199825060-00001; Tang YP, 1997, BRIT J PHARMACOL, V122, P257, DOI 10.1038/sj.bjp.0701385; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109	34	112	114	0	19	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2002	19	4					427	438		10.1089/08977150252932389			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	542XP	WOS:000175071200004	11990349				2022-02-06	
J	Popovich, PG; Hickey, WE				Popovich, PG; Hickey, WE			Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						macrophage; microglia; neuroinflammation; secondary injury; spinal cord injury; wound repair	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEMATOGENOUS MACROPHAGES; INFLAMMATORY RESPONSE; MICROGLIAL CELLS; MESSENGER-RNA; INJURY; BRAIN; EXPRESSION; PHAGOCYTES; CYTOKINE	Brain and spinal cord inflammation that develops after traumatic injury is believed to differentially influence the structural and/or physiological integrity of surviving neurons and glia. It is possible that the functional dichotomy of CNS inflammation results from the activity of a heterogeneous macrophage population elicited by trauma. Indeed. unique functions have been attributed to macrophages derived from resident microglia versus those originating from infiltrating monocytes. Thus, whether progressive tissue injury or repair is favored could be explained by the disproportionate contributions of one macrophage subset relative to the other. Descriptive neuroanatomical studies are a reasonable first approach to revealing a relationship between microglia, recruited blood monocytes/macrophages, and regions of tissue degeneration and/or repair. Unfortunately, it is not possible to differentiate between CNS macrophage subsets using conventional immunohistochemical approaches. In the present study, we have used radiation bone marrow chimeric rats to definitively characterize the macrophage reaction elicited by experimental spinal contusion injury. In chimeric animals, antibodies raised against unique cell surface molecules expressed on bone marrow-derived cells (BMCs) were used to distinguish infiltrating BMCs from resident microglial-derived macrophages. Our findings indicate that the onset and plateau of macrophage activation (previously shown to be 3 and 7 days postinjury, respectively) is dominated initially by microglial-derived macrophages and then is supplanted by hematogenous cells. While resident macrophages are ubiquitously distributed throughout the injury site, leukocyte-derived monocytes exclusively infiltrate the gray matter and ro a lesser extent subpial white matter. Generally, monocyte foci in white matter remain associated with the lumen or abluminal surface of blood vessels. i.e. few cells actually infiltrate the parenchyma. If functional differences exist between CNS macrophage subsets, differences in the time-dependent accumulation and distribution of these cell types could differentially influence the survival of surrounding neurons and glia.	Ohio State Univ, Coll Med & Publ Hlth, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Dartmouth Med Sch, DHMC, Pathol Dept WFH, Lebanon, NH USA		Popovich, PG (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Mol Virol Immunol & Med Genet, 2078 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.		Popovich, Phillip/C-9187-2009	Popovich, Phillip/0000-0003-1329-7395	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037846] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37846] Funding Source: Medline		Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Bauer J, 1995, GLIA, V15, P437, DOI 10.1002/glia.440150407; Bethea JR, 1998, J NEUROSCI, V18, P3251; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LASSMANN H, 1993, CLIN NEUROPATHOL, V12, P284; LASSMANN H, 1993, GLIA, V7, P19, DOI 10.1002/glia.440070106; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Li H, 1996, NEUROPATH APPL NEURO, V22, P207; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; POPOVICH PG, 1993, J NEUROTRAUM, V10, P37, DOI 10.1089/neu.1993.10.37; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 1997, J NEUROPATH EXP NEUR, V56, P1323, DOI 10.1097/00005072-199712000-00007; RINNER WA, 1995, GLIA, V14, P257, DOI 10.1002/glia.440140403; Schroeter M, 1997, STROKE, V28, P382, DOI 10.1161/01.STR.28.2.382; STOKES BT, 1992, J NEUROTRAUM, V9, P187, DOI 10.1089/neu.1992.9.187; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Zhang ZY, 1997, EXP NEUROL, V143, P141, DOI 10.1006/exnr.1996.6355	25	112	113	0	3	AMER ASSN NEUROPATHOLOGISTS INC	LAWRENCE	1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUL	2001	60	7					676	685		10.1093/jnen/60.7.676			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	450PB	WOS:000169751400003	11444796	Bronze			2022-02-06	
J	Konrad, KN; Gauggel, S; Manz, A; Scholl, M				Konrad, KN; Gauggel, S; Manz, A; Scholl, M			Inhibitory control in children with traumatic brain injury (TBI) and children with attention deficit/hyperactivity disorder (ADHD)	BRAIN INJURY			English	Article							DEFICIT-HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; CHOICE REACTION-TIME; SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; ADOLESCENTS; PERFORMANCE; BEHAVIOR; TASK; METHYLPHENIDATE	The behavioural and cognitive sequelae of traumatic brain injury (TBI) have features in common with attention deficit/hyperactivity disorder (ADHD), best characterized by deficits in response inhibition. The performance was, therefore, examined of 27 children with TBI, 31 children with developmental ADHD, and 26 matched controls aged 8-12, on two inhibition tasks: the Stop-Signal Task and a Delayed-Response-Task. Children with TBI and children with ADHD showed a pervasive deficit in their inhibitory control processes with respect to inhibition of both pre-potent and on-going responses. In addition, children with TBI were found to suffer from a general slowing of their information processing, which was not correlated with the inhibition deficit. TBI children with and without a secondary ADHD differed only tendentially in their Mean Go-Reaction time in the stop-task. However, subdividing TBI children according to actigraph data into hypo-, hyper- and normokinetic subgroups revealed that the hyperactive TBI children had inhibitory deficit patterns that were similar to children with developmental ADHD. It is concluded that slowing of information processing speed seems to be a general consequence of TBI in childhood, whereas slowing of the stop-processes or inhibitory deficits, specifically, are associated with post-injury hypo- or hyperactivity.	Rhein Westfal TH Aachen, Clin Child & Adolescent Psychiat, D-52072 Aachen, Germany		Konrad, KN (corresponding author), Rhein Westfal TH Aachen, Clin Child & Adolescent Psychiat, Neuenhofer Weg 21, D-52072 Aachen, Germany.	Kerstin.Konrad@t-online.de	Konrad, Kerstin/H-7747-2013	Konrad, Kerstin/0000-0001-9039-2615; Gauggel, Siegfried/0000-0002-2742-4917			Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Barkley R.A., 1997, ADHD NATURE SELF CON; BARKLEY RA, 1993, PEDIATRICS, V92, P212; BARKLEY RA, 1992, J ABNORM CHILD PSYCH, V20, P163, DOI 10.1007/BF00916547; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; BIJUR PE, 1986, AM J DIS CHILD, V140, P487, DOI 10.1001/archpedi.1986.02140190097036; BLACK P, 1970, HEAD INJURIES, P131; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; COOLEY EL, 1990, DEV NEUROPSYCHOL, V6, P239, DOI 10.1080/87565649009540465; CORKUM PV, 1993, J CHILD PSYCHOL PSYC, V34, P1217, DOI 10.1111/j.1469-7610.1993.tb01784.x; DAUGHERTY TK, 1993, J GENET PSYCHOL, V154, P177, DOI 10.1080/00221325.1993.9914731; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Dopfner M., 1998, DIAGNOSTIK SYSTEM PS; DUPAUL GJ, 1992, J CLIN CHILD PSYCHOL, V21, P394, DOI 10.1207/s15374424jccp2104_10; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; HALPERIN JM, 1994, DEV NEUROPSYCHOLOGIC, P1; Harlow JM, 1848, BOSTON MED SURGICAL, V39, P389, DOI DOI 10.1056/NEJM184812130392001; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; IABONI F, 1995, J ABNORM PSYCHOL, V104, P232, DOI 10.1037/0021-843X.104.1.232; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; MCCLURE FD, 1984, J ABNORM CHILD PSYCH, V12, P561, DOI 10.1007/BF00916850; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; Milich R., 1994, DISRUPTIVE BEHAV DIS, P109, DOI 10.1007/978-1-4899-1501-6_5; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; SCHACHAR R, 1989, PARENT INTERVIEW CHI; SHUE KL, 1992, BRAIN COGNITION, V20, P104, DOI 10.1016/0278-2626(92)90064-S; SOLANTO MV, 1990, J CHILD PSYCHOL PSYC, V31, P803, DOI 10.1111/j.1469-7610.1990.tb00819.x; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P387, DOI 10.1111/j.1469-7610.1992.tb00874.x; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TANNOCK R, 1989, J ABNORM CHILD PSYCH, V17, P473, DOI 10.1007/BF00916508; TANNOCK R, 1995, J ABNORM CHILD PSYCH, V23, P235, DOI 10.1007/BF01447091; Tannock R, 1998, J CHILD PSYCHOL PSYC, V39, P65, DOI 10.1111/1469-7610.00304; UNNEWEHR S, 1995, DIAGNOSTISCHES INTER; WEYANDT LL, 1994, DEV NEUROPSYCHOL, V10, P27, DOI 10.1080/87565649409540564; YLVISAKER M, 1992, ED DIMENSIONS ACQUIR, P121; [No title captured]	51	112	114	0	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2000	14	10					859	875					17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	364QG	WOS:000089902900002	11076133				2022-02-06	
J	Paniak, C; Toller-Lobe, G; Reynolds, S; Melnyk, A; Nagy, J				Paniak, C; Toller-Lobe, G; Reynolds, S; Melnyk, A; Nagy, J			A randomized trial of two treatments for mild traumatic brain injury: 1 year follow-up	BRAIN INJURY			English	Article							HEAD-INJURY	The purpose of this study was to provide 1 year follow-up data to a previous paper that compared single-session (SS) treatment to treatment-as-needed (TAN) outcomes for mild traumatic brain injury (MTBI) survivors at 3 months post-injury. participants were 105 adults with MTBI who were recruited from consecutive admissions to two hospital emergency wards, and randomly assigned to either the SS or TAN modality. No group differences in outcome were evident at 12 months post-injury. As well, improvements seen in the groups after 3 months were maintained at 12 months. As improvements between 3 and 12 months were negligible, self-reported improvement after a treated MTBI typically occurred within the first 3 months. Brief educational intervention given soon after MTBI appears to be as helpful as more intensive treatment for most MTBI survivors for at least 12 months post-injury.	Glenrose Rehabil Hosp, Edmonton, AB T5G 0B7, Canada; Univ Alberta, Edmonton, AB, Canada		Paniak, C (corresponding author), Glenrose Rehabil Hosp, 10230-111 Ave, Edmonton, AB T5G 0B7, Canada.	cpaniak@cha.ab.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Glass GV., 1996, STAT METHODS ED PSYC, V3rd ed; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GRONWALL D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; PANIAK C, 1992, DISS ABSTR INT, V52, P6093; PANIAK CE, 1992, ARCH CLIN NEUROPSYCH, V7, P529, DOI 10.1016/0887-6177(92)90143-B; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; WARE JE, 1992, SF 36 HLTH SURVEY MA; Willer B., 1993, BRAIN INJURY REHABIL, P355	22	112	113	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2000	14	3					219	226					8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	294EE	WOS:000085897700002	10759039				2022-02-06	
J	Oyesiku, NM; Evans, CO; Houston, S; Darrell, RS; Smith, JS; Fulop, ZL; Dixon, CE; Stein, DG				Oyesiku, NM; Evans, CO; Houston, S; Darrell, RS; Smith, JS; Fulop, ZL; Dixon, CE; Stein, DG			Regional changes in the expression of neurotrophic factors and their receptors following acute traumatic brain injury in the adult rat brain	BRAIN RESEARCH			English	Article						neurotrophic factor; receptor; mRNA expression; traumatic brain injury	NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; CORTICAL IMPACT INJURY; DIFFERENTIAL REGULATION; HYPOGLYCEMIC DAMAGE; NEURONAL DEATH; CNTF RECEPTOR; TRKB; BDNF; NGF	We have analyzed the effect of severe traumatic brain injury (TBI) on the levels of mRNA expression of neurotrophic factors (NTFs): brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), ciliary neurotrophic factor (CNTF) and their respective receptors: trkB, trkA and CNTFR alpha. The expression was examined in the region of the lesion as well as a region remote from the lesion at 12, 24, and 36 h following the injury. Our data suggest that after the brain injury, the expression of NGF and BDNF mRNAs were early, transiently and significantly upregulated while that of CNTF was a slow and less amplified response in both areas of the brain. We also found that trkA mRNA expression was only upregulated significantly in the remote area; trkB mRNA showed no significant change in either area except an upregulation at 12 h in the remote area. CNTFR alpha was downregulated significantly by 24-36 h in the lesion area and by 24 h in the remote area. These changes suggest that TBI regulates the expression of NTFs and their receptors. These alterations in expression may be involved in modulating the neuronal response after brain injury. (C) 1999 Elsevier Science B.V. All rights reserved.	Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Psychol, Atlanta, GA 30322 USA; Wagner Coll, Dept Biol, Staten Isl, NY 10301 USA; Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA		Oyesiku, NM (corresponding author), Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.		Stein, Donald/AAJ-5139-2020	Smith, Jeffrey/0000-0001-5499-4475	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [CCR49/CCR412307] Funding Source: Medline		ASADA H, 1995, J NEUROSCI RES, V40, P22, DOI 10.1002/jnr.490400104; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CHENG B, 1991, NEURON, V7, P1031, DOI 10.1016/0896-6273(91)90347-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAVIES AM, 1988, TRENDS NEUROSCI, V11, P243, DOI 10.1016/0166-2236(88)90099-9; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; FINGER S, 1982, BRAIN DAMAGE RECOVER, P153; Finklestein S P, 1990, Restor Neurol Neurosci, V1, P387, DOI 10.3233/RNN-1990-1603; GAGE FH, 1986, NEUROSCIENCE, V17, P89, DOI 10.1016/0306-4522(86)90227-7; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; HUTTON LA, 1995, J NEUROSCI RES, V41, P185, DOI 10.1002/jnr.490410206; IKEDA K, 1995, ANN NEUROL, V37, P505, DOI 10.1002/ana.410370413; Ip Nancy Y., 1992, Progress in Growth Factor Research, V4, P139, DOI 10.1016/0955-2235(92)90028-G; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KELLY ME, 1994, BRAIN RES, V634, P245, DOI 10.1016/0006-8993(94)91927-5; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KOKAIA Z, 1994, NEUROREPORT, V5, P1241, DOI 10.1097/00001756-199406020-00021; KORSCHING S, 1993, J NEUROSCI, V13, P2739; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Lamballe F, 1991, Princess Takamatsu Symp, V22, P153; Lee MY, 1997, J NEUROSCI, V17, P1137; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; MAIESE K, 1993, J CEREB BLOOD FLOW S, V13, pS43; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Moore D.R., 1993, INTRO PRACTICE STAT; NANES MS, 1991, ENDOCRINOLOGY, V128, P2577, DOI 10.1210/endo-128-5-2577; NOONAN KE, 1988, NUCLEIC ACIDS RES, V16, P10366, DOI 10.1093/nar/16.21.10366; Oyesiku NM, 1997, J CLIN ENDOCR METAB, V82, P4184, DOI 10.1210/jc.82.12.4184; Oyesiku NM, 1996, J COMP NEUROL, V364, P68, DOI 10.1002/(SICI)1096-9861(19960101)364:1<68::AID-CNE6>3.0.CO;2-Q; POVLISHOCK J, 1985, NIH NINCDS CENTRAL N, P443; REGLI L, 1993, J CEREB BLOOD FLOW M, V13, P566; SAKAGUCHI J, 1993, J CEREB BLOOD FLOW S, V13, pS49; SIESJO BK, 1993, PROG BRAIN RES, V96, P1; Taga T, 1992, Nihon Rinsho, V50, P1802; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WANG AM, 1990, P NATL ACAD SCI USA, V87, P2865; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; Wong JYF, 1997, EXP NEUROL, V148, P83, DOI 10.1006/exnr.1997.6670; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; YANG K, 1995, J NEUROSCI RES, V42, P571, DOI 10.1002/jnr.490420415	52	112	125	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 3	1999	833	2					161	172		10.1016/S0006-8993(99)01501-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214HN	WOS:000081322700004	10375691				2022-02-06	
J	Lombardi, WJ; Andreason, PJ; Sirocco, KY; Rio, DE; Gross, RE; Umhau, JC; Hommer, DW				Lombardi, WJ; Andreason, PJ; Sirocco, KY; Rio, DE; Gross, RE; Umhau, JC; Hommer, DW			Wisconsin card sorting test performance following head injury: Dorsolateral fronto-striatal circuit activity predicts perseveration	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CEREBRAL BLOOD-FLOW; POSITRON EMISSION TOMOGRAPHY; PARKINSONS-DISEASE; PREFRONTAL CORTEX; LOBE LESIONS; MULTIPLE-SCLEROSIS; COGNITIVE DEFICITS; ALZHEIMERS-DISEASE; SCHIZOPHRENIA	The Wisconsin Card Sorting Test (WCST) has been argued to be a sensitive indicator of frontal lobe function. However, several recent studies have failed to find a consistent relationship between structural damage to this cortical area and perseveration on the test. In the present study, positron emission tomography (PET) imaging with F-18-fluorodeoxyglucose was used to examine the relationship of regional brain metabolism to perseverative responding on the WCST in patients with a history of closed-head injury. An inverse relationship was found between perseverative responses and metabolism in the right, but not the left, dorsolateral prefrontal cortex and caudate nucleus. Perseverative responding was not related to metabolism in several other regions of the frontal lobes and basal ganglia, including the putamen and the frontal poles bilaterally. These data suggest that the functional integrity of the right dorsolateral frontal-subcortical circuit is critical for WCST performance.	NIAAA, Clin Studies Lab, Bethesda, MD 20892 USA; Toronto Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada		Lombardi, WJ (corresponding author), Univ Utah, Dept Neurosci, 50 N Med Dr, Salt Lake City, UT 84132 USA.	wjl@suzy.med.utah.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [Z01AA000082] Funding Source: NIH RePORTER		ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; BORNSTEIN RA, 1986, INT J CLIN NEUROPSYC, V8, P18; BROOKS RA, 1982, J NUCL MED, V23, P538; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; CALTAGIRONE C, 1989, J NEUROL NEUROSUR PS, V52, P334, DOI 10.1136/jnnp.52.3.334; CANAVAN AGM, 1989, NEUROPSYCHOLOGIA, V27, P141, DOI 10.1016/0028-3932(89)90167-X; CICERONE KD, 1983, NEUROPSYCHOLOGIA, V21, P513, DOI 10.1016/0028-3932(83)90007-6; CLARK C, 1985, J CEREBR BLOOD F MET, V5, P142, DOI 10.1038/jcbfm.1985.18; Cohen J., 1983, APPL MULTIPLE REGRES; Cohen RM, 1988, NEUROPSY NEUROPSY BE, V1, P3; COOLS AR, 1984, J NEUROL NEUROSUR PS, V47, P443, DOI 10.1136/jnnp.47.5.443; Damasio H., 1989, LESION ANAL NEUROPSY; DREWE E A, 1974, Cortex, V10, P159; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FLOWERS KA, 1985, J NEUROL NEUROSUR PS, V48, P517, DOI 10.1136/jnnp.48.6.517; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; GRAFMAN J, 1990, ARCH NEUROL-CHICAGO, V47, P553, DOI 10.1001/archneur.1990.00530050077015; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.7.1120-1122; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Heaton R.K., 1981, WISCONSIN CARD SORTI; HECK ET, 1986, J CLIN EXP NEUROPSYC, V8, P313, DOI 10.1080/01688638608401321; HIETANEN M, 1986, ACTA NEUROL SCAND, V73, P151; JOSIASSEN RC, 1983, ARCH NEUROL-CHICAGO, V40, P791, DOI 10.1001/archneur.1983.04050120041005; LEES AJ, 1983, BRAIN, V106, P257, DOI 10.1093/brain/106.2.257; MARENCO S, 1993, PSYCHIAT RES-NEUROIM, V50, P177, DOI 10.1016/0165-1781(93)80012-T; MENDEZ MF, 1989, NEUROLOGY, V39, P349, DOI 10.1212/WNL.39.3.349; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; OWEN AM, 1993, BRAIN, V116, P1159, DOI 10.1093/brain/116.5.1159; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; PENDLETON MG, 1982, J CLIN PSYCHOL, V38, P392, DOI 10.1002/1097-4679(198204)38:2<392::AID-JCLP2270380232>3.0.CO;2-W; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; PILLON B, 1995, NEUROLOGY, V45, P1477, DOI 10.1212/WNL.45.8.1477; PILLON B, 1986, NEUROLOGY, V36, P1179, DOI 10.1212/WNL.36.9.1179; Pirozzolo F J, 1982, Brain Cogn, V1, P71, DOI 10.1016/0278-2626(82)90007-0; REITAN RM, 1971, J CONSULT CLIN PSYCH, V37, P364, DOI 10.1037/h0032005; REZAI K, 1993, ARCH NEUROL-CHICAGO, V50, P636, DOI 10.1001/archneur.1993.00540060066020; RICHARDS M, 1993, J CLIN EXP NEUROPSYC, V15, P266, DOI 10.1080/01688639308402562; Rio DE, 1996, COMPUT BIOMED RES, V29, P438, DOI 10.1006/cbmr.1996.0033; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; RUBIN P, 1991, ARCH GEN PSYCHIAT, V48, P987; SOKOLOFF L, 1982, ADV NEUROCHEM, V4, P1; SWIRSKYSACCHETTI T, 1992, NEUROLOGY, V42, P1291, DOI 10.1212/WNL.42.7.1291; TEUBER HL, 1951, J NERV MENT DIS, V114, P413, DOI 10.1097/00005053-195111450-00006; VanHorn JD, 1996, BIOL PSYCHIAT, V39, P389, DOI 10.1016/0006-3223(95)00249-9; Wechsler, 1997, WECHSLER ADULT INTEL; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; [No title captured]	57	112	116	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	1999	21	1					2	16		10.1076/jcen.21.1.2.940			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	214VN	WOS:000081348400002	10420997				2022-02-06	
J	Clark, RSB; Kochanek, PM; Marion, DW; Schiding, JK; White, M; Palmer, AM; DeKosky, ST				Clark, RSB; Kochanek, PM; Marion, DW; Schiding, JK; White, M; Palmer, AM; DeKosky, ST			Mild posttraumatic hypothermia reduces mortality after severe controlled cortical impact in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain injury; controlled cortical impact; electroencephalogram; hypothermia; rat	TRAUMATIC BRAIN INJURY; FLUID-PERCUSSION MODEL; SEVERE HEAD-INJURY; MODERATE HYPOTHERMIA; CARDIOPULMONARY BYPASS; CEREBRAL PROTECTION; CIRCULATORY ARREST; TEMPERATURE; SUPPRESSION; DISRUPTION	The effect of posttraumatic hypothermia (brain temperature controlled at 32 degrees C for 4 h) on mortality after severe controlled cortical impact (CCI) was studied in rats, Four posttraumatic brain temperatures were compared: 37 degrees C (n = 10), 36 degrees C (n = 4), 32 degrees C (n = 10), and uncontrolled (UC; n = 6). Rats were anesthetized and subjected to severe CCI (4.0-m/s velocity, 3.0-mm depth) to the exposed left parietal cortex. At 10 min posttrauma the rats were cooled or maintained at their target brain temperature, using external cooling or warming. Brain temperature in the UC group was recorded but not regulated, and rectal temperature was maintained at 37 +/- 0.5 degrees C. After 4 h, rats were rewarmed over a 1-h period to 37 degrees C, extubated, and observed for 24 h. In the 37 and 36 degrees C groups, 24-h mortality was 50% (37 degrees C = 5/10, 36 degrees C = 2/4). In the 32 degrees C group, 24-h mortality was 10% (1/10). In the UC group, brain temperature was 35.4 +/- 0.6 degrees C during the 4-h treatment period and 24-h mortality was 0% (0/6). Mortality was higher in groups with brain temperatures greater than or equal to 36 degrees C versus those with brain temperatures <36 degrees C (50 vs. 6%, respectively; p < 0.05). Additionally, electroencephalograms (EEG) were recorded in subsets of each temperature group and the percentage of time that the EEG was suppressed (isoelectric) was determined. Percentage of EEG suppression was greater in the hypothermic (32 degrees C, n = 6;UC, n = 4)groups than in the normothermic (36 degrees C, n = 3; 37 degrees C, n = 6) groups (23.3 +/- 14.3 vs. 1.2 +/- 3.1%, respectively; p < 0.05). Posttraumatic hypothermia suppressed EEG during treatment and reduced mortality after severe CCI. The threshold for this protective effect appears to be a brain temperature <36 degrees C. Thus, even mild hypothermia may be beneficial after severe brain trauma.	UNIV PITTSBURGH, SAFAR CTR RESUSCITAT RES, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT ANESTHESIOL & CRIT CARE MED, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT PEDIAT, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT NEUROL SURG, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT PSYCHIAT, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, BRAIN TRAUMA RES CTR, PITTSBURGH, PA 15260 USA				Marion, Donald/AAR-5749-2021; Kochanek, Patrick M/D-2371-2015; Palmer, Alan/AAP-8650-2020	Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P50NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30318] Funding Source: Medline		BERNTMAN L, 1981, ANESTHESIOLOGY, V55, P495, DOI 10.1097/00000542-198111000-00003; BOUZARTH WF, 1967, J AMER MED ASSOC, V199, P567; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; GILLINOV AM, 1993, ANN THORAC SURG, V55, P1432, DOI 10.1016/0003-4975(93)91084-Z; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Hickey P R, 1987, J Cardiothorac Anesth, V1, P137, DOI 10.1016/0888-6296(87)90010-X; HICKS RG, 1981, J THORAC CARDIOV SUR, V81, P781; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; LOOMIS CW, 1986, CLIN PHARMACOL THER, V40, P304, DOI 10.1038/clpt.1986.181; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; MAHER J, 1993, CEREBROVAS BRAIN MET, V5, P277; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; MIZRAHI EM, 1989, ELECTROEN CLIN NEURO, V72, P81, DOI 10.1016/0013-4694(89)90033-3; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; ROSOMOFF HL, 1965, ARCH NEUROL-CHICAGO, V13, P337, DOI 10.1001/archneur.1965.00470040003001; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WOODCOCK TE, 1987, ANESTHESIOLOGY, V67, P218, DOI 10.1097/00000542-198708000-00011	37	112	112	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	1996	16	2					253	261		10.1097/00004647-199603000-00010			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	TW393	WOS:A1996TW39300010	8594057	Bronze			2022-02-06	
J	GREIFFENSTEIN, MF; GOLA, T; BAKER, WJ				GREIFFENSTEIN, MF; GOLA, T; BAKER, WJ			MMPI-2 VALIDITY SCALES VERSUS DOMAIN-SPECIFIC MEASURES IN DETECTION OF FACTITIOUS TRAUMATIC BRAIN INJURY	CLINICAL NEUROPSYCHOLOGIST			English	Article							FAKING; PROSPECTS; SEQUELAE; DEFICITS	A known group methodology was used to compare the predictive accuracies of MMPI-2 validity scales and malingered amnesia measures in the detection of real versus feigned traumatic brain-injury. The domain specific compliance measures were consistently more accurate in the separation of factitious brain-injury patients (n = 68) from severe brain-injury patients (N = 56). Among MMPI-2 measures, only scale Sc improved on base-rate predictions of probable malingering. Anti-social traits, as measured by Pd, had no relationship to malingered amnesia. Factor analysis suggested independent psychiatric and neurological malingering factors. The implications for DSM-IV malingering criteria and models of feigned illness are discussed.	PSYCHOL SYST INC,ROYAL OAK,MI 48057; WAYNE STATE UNIV,DETROIT,MI 48202								BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; BINDER LM, 1993, CLIN NEUROPSYCHOL, V7, P104, DOI DOI 10.1080/13854049308401892; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BRANDT J, 1992, NEUROPSYCHOLOGY MEMO, P156; Butcher J.N., 1989, MMPI 2 MINNESOTA MUL; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CASEY VA, 1981, 9TH ANN M INT NEUR S; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; Dahlstrom W.G, 1972, MMPI HDB CLIN INTERP; DAHLSTROM WG, 1975, MMPI HDB, V1; DOER HO, 1991, FORENSIC NEUROPSYCHO; FAUST D, 1991, BRAIN DAMAGE CLAIMS; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; GOLA T, 1994, THESIS WAYNE STATE U; Gough H.G., 1950, J CONSULT PSYCHOL, V14, P408, DOI [10.1037/h0054506, DOI 10.1037/H0054506]; Graham J.R., 1990, MMPI 2 ASSESSING PER; GRANZEN MD, 1991, NEUROPSYCHOL REV, V1, P247; GREENE RL, 1991, MMPI MMPI 2 INTERPRE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1991, 11TH ANN C NAT AC NE; LAWTON MP, 1965, J CLIN PSYCHOL, V21, P269, DOI 10.1002/1097-4679(196507)21:3<269::AID-JCLP2270210311>3.0.CO;2-N; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041; MILLIS SR, 1992, CLIN NEUROPSYCHOLOGI, V7, P406; MITTENBERG W, 1994, ARCH CLIN NEUROPSYCH, V9; NOURSIS MJ, 1993, SPSS WINDOWS ADV STA; POPE KS, 1993, MMPI MMPI 2 MMPI A C; PRIGATANO G, 1994, J CLIN EXPT NEUROPSY, V15, P537; ROGERS R, 1990, PROF PSYCHOL-RES PR, V21, P182; RUTHERFORD WH, 1977, LANCET, V1, P1; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Strauss E. A, 1990, COMPENDIUM NEUROPSYC; Timbrook R. E., 1993, PSYCHOL ASSESSMENT, V5, P53, DOI [10.1037/1040-3590.5.1.53, DOI 10.1037/1040-3590.5.1.53]; WIENER DN, 1948, J CONSULT PSYCHOL, V12, P43; 1994, DIAGNOSTIC STATISTIC; [No title captured]	43	112	112	0	21	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL	1995	9	3					230	240		10.1080/13854049508400485			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	RJ646	WOS:A1995RJ64600005					2022-02-06	
J	OKIYAMA, K; SMITH, DH; GENNARELLI, TA; SIMON, RP; LEACH, M; MCINTOSH, TK				OKIYAMA, K; SMITH, DH; GENNARELLI, TA; SIMON, RP; LEACH, M; MCINTOSH, TK			THE SODIUM-CHANNEL BLOCKER AND GLUTAMATE RELEASE INHIBITOR BW1003C87 AND MAGNESIUM ATTENUATE REGIONAL CEREBRAL EDEMA FOLLOWING EXPERIMENTAL BRAIN INJURY IN THE RAT	JOURNAL OF NEUROCHEMISTRY			English	Article						CEREBRAL EDEMA; BRAIN INJURY; EXCITOTOXICITY; GLUTAMALE; MAGNESIUM; NMDA	EXCITATORY AMINO-ACIDS; D-ASPARTATE RECEPTORS; NMDA ANTAGONISTS; ISCHEMIC DAMAGE; LAMOTRIGINE; NEUROTOXICITY; NEURONS; ASTROCYTES; KETAMINE; INVITRO	Excitatory amino acid (EAA) neurotransmitters may play a role in the pathophysiology of traumatic injury to the CNS. Although NMDA receptor antagonists have been reported to have therapeutic efficacy in animal models of brain injury, these compounds may have unacceptable toxicity for clinical use. One alternative approach is to inhibit the release of EAAs following traumatic injury. The present study examined the effects of administration of a novel sodium channel blocker and EAA release inhibitor, BW1003C87, or the NMDA receptor-associated ion channel blocker magnesium chloride on cerebral edema formation following experimental brain injury in the rat. Animals (n = 33) were subjected to fluid percussion brain injury of moderate severity (2.3 atm) over the left parietal cortex. Fifteen minutes after injury, the animals received a constant infusion of BW1003C87(10 mg/kg, i.v.), magnesium chloride (300 mu mol/kg, i.v.), or saline over 15 min (2.75 ml/kg/15 min). In all animals, regional tissue water content in brain was assessed at 48 h after injury, using the wet weight/dry weight technique. In saline-treated control animals, fluid percussion brain injury produced significant regional brain edema in injured left parietal cortex (p < 0.001), the cortical area adjacent to the site of maximal injury (p < 0.001), left hippocampus (p < 0.001), and left thalamus (p = 0.02) at 48 h after brain injury. Administration of BW1003C87 15 min postinjury significantly reduced focal brain edema in the cortical area adjacent to the site of maximal injury (p < 0.02) and left hippocampus (p < 0.01), whereas magnesium chloride attenuated edema in left hippocampus (p = 0.02). These results suggest that excitatory neurotransmission may play an important role in the pathogenesis of posttraumatic brain edema and that pre- or postsynaptic blockade of glutamate receptor systems may attenuate part of the deleterious sequelae of traumatic brain injury.	UNIV PENN,DEPT SURG,DIV NEUROSURG,PHILADELPHIA,PA 19104; UNIV PITTSBURGH,DEPT NEUROL,PITTSBURGH,PA 15260; WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND				smith, douglas/A-1321-2007	Leach, Michael/0000-0002-9859-1325	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 26818, NS 08803] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R55NS026818, R01NS026818, P50NS008803, P01NS008803] Funding Source: NIH RePORTER		BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BENVENISTE H, 1989, J CEREBR BLOOD F MET, V9, P629, DOI 10.1038/jcbfm.1989.90; Bradbury M.W.B., 1979, CONCEPT BLOOD BRAIN; BUCHAN A, 1992, NEUROL CLIN, V10, P49, DOI 10.1016/S0733-8619(18)30233-0; BUCHAN AM, 1992, ARCH NEUROL-CHICAGO, V49, P420, DOI 10.1001/archneur.1992.00530280114032; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; BUTCHER SP, 1987, J NEUROCHEM, V48, P722, DOI 10.1111/j.1471-4159.1987.tb05576.x; CHAN PH, 1990, ACT NEUR S, V51, P7; CHEUNG H, 1992, EPILEPSY RES, V13, P107; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1987, J NEUROSCI, V7, P369; CLIFFORD DB, 1989, EXP NEUROL, V105, P272, DOI 10.1016/0014-4886(89)90130-1; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; FADEN AI, 1988, ANN NEUROL, V3, P623; FADEN AI, 1989, SCIENCE, V244, P789; GRAHAM SH, 1993, J CEREBR BLOOD F MET, V13, P88, DOI 10.1038/jcbfm.1993.11; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; IKEDA M, 1989, NEUROSCI LETT, V996, P202; ISHIGE N, 1987, J CEREB BLOOD FLOW M, V7, P750; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; JENSEN AM, 1990, J NEUROSCI, V10, P1165; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KIMELBERG HK, 1986, ASTROCYTES, V3, P129; KOENIG H, 1992, BRAIN RES, V588, P297, DOI 10.1016/0006-8993(92)91589-7; KOYAMA Y, 1991, NEUROSCI LETT, V122, P210, DOI 10.1016/0304-3940(91)90860-V; KUFFLER SW, 1984, NEURON BRAIN, P323; LANG DG, 1993, J PHARMACOL EXP THER, V266, P829; LEACH MJ, 1986, EPILEPSIA, V27, P490, DOI 10.1111/j.1528-1157.1986.tb03573.x; LEES G, 1993, BRAIN RES, V612, P190, DOI 10.1016/0006-8993(93)91660-K; LUSTIG HS, 1992, NEUROSCI LETT, V143, P229, DOI 10.1016/0304-3940(92)90271-8; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MCGEER EG, 1990, NEUROSCI LETT, V112, P348, DOI 10.1016/0304-3940(90)90229-3; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM B, 1985, CLIN SCI, V68, P113, DOI 10.1042/cs0680113; MELDRUM BS, 1992, BRAIN RES, V593, P1, DOI 10.1016/0006-8993(92)91254-C; MELDRUM BS, 1988, NEUROL NEUR, V46, P195; MEYER FB, 1990, J CEREBR BLOOD F MET, V10, P895, DOI 10.1038/jcbfm.1990.146; MILLER AA, 1986, NEW ANTICONVULSANT D, P165; MRSULJA BB, 1990, ACT NEUR S, V51, P180; Neuwelt EA., 1989, IMPLICATIONS BLOOD B; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PICOZZI P, 1985, J NEUROSURG, V62, P704, DOI 10.3171/jns.1985.62.5.0704; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SANCHEZPRIETO J, 1987, J NEUROCHEM, V49, P58, DOI 10.1111/j.1471-4159.1987.tb03394.x; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHARP FR, 1991, ANN NEUROL, V30, P801, DOI 10.1002/ana.410300609; SHIGENO T, 1982, J NEUROSURG, V57, P99, DOI 10.3171/jns.1982.57.1.0099; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIRVIO J, 1992, NEUROSCI LETT, V146, P215, DOI 10.1016/0304-3940(92)90081-H; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; STEINBERG GK, 1989, STROKE, V20, P1247, DOI 10.1161/01.STR.20.9.1247; STEINBERG GK, 1989, BRAIN RES, V497, P382, DOI 10.1016/0006-8993(89)90285-0; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	77	112	113	0	4	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-3042			J NEUROCHEM	J. Neurochem.	FEB	1995	64	2					802	809					8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	QD027	WOS:A1995QD02700040	7830074				2022-02-06	
J	VANZOMEREN, AH; DEELMAN, BG				VANZOMEREN, AH; DEELMAN, BG			LONG-TERM RECOVERY OF VISUAL REACTION-TIME AFTER CLOSED HEAD-INJURY	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									STATE UNIV GRONINGEN,DEPT NEUROPSYCHOL,GRONINGEN,NETHERLANDS								BENTON AL, 1957, J ABNORM SOC PSYCH, V54, P109, DOI 10.1037/h0047176; BENTON AL, 1958, CONFIN NEUROL, V19, P247; Bruhn P, 1971, Cortex, V7, P278; Conover W, 1971, PRACTICAL NONPARAMET, DOI 10.1002/bimj.19730150311; COSTA LD, 1962, PERCEPT MOTOR SKILL, V14, P391; DIMOND S, 1970, Q J EXP PSYCHOL, V22, P513, DOI 10.1080/14640747008401928; Fitts P. M., 1973, HUMAN PERFORMANCE; GRONWALL, 1974, LANCET, V2, P605; GRONWALL D, 1974, PSYCHOLOGICAL EFFECT; JENNETT B, 1975, LANCET, V1, P480; Kahneman D., 1973, ATTENTION EFFORT; KLENSCH H, 1973, FORTSCHR NEUROL PSYC, V41, P575; Miller E, 1970, Cortex, V6, P121; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; WINER BH, 1970, STATISTICAL PRINCIPL	18	112	113	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry		1978	41	5					452	457		10.1136/jnnp.41.5.452			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	EZ315	WOS:A1978EZ31500012	660209	Green Published, Bronze			2022-02-06	
J	Geisler, S; Doan, RA; Strickland, A; Huang, X; Milbrandt, J; DiAntonio, A				Geisler, Stefanie; Doan, Ryan A.; Strickland, Amy; Huang, Xin; Milbrandt, Jeffrey; DiAntonio, Aaron			Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice	BRAIN			English	Article						SARM1; axonal degeneration; chemotherapy-induced peripheral neuropathy; vincristine; CIPN	SPINAL DORSAL-HORN; QUALITY-OF-LIFE; WALLERIAN DEGENERATION; NEUROPROTECTIVE EFFICACY; LYMPHOBLASTIC-LEUKEMIA; AMINOPROPYL CARBAZOLES; AXONAL DEGENERATION; SELF-DESTRUCTION; MOUSE MODEL; CHEMOTHERAPY	Peripheral polyneuropathy is a common and dose-limiting side effect of many important chemotherapeutic agents. Most such neuropathies are characterized by early axonal degeneration, yet therapies that inhibit this axonal destruction process do not currently exist. Recently, we and others discovered that genetic deletion of SARM1 (sterile alpha and TIR motif containing protein 1) dramatically protects axons from degeneration after axotomy in mice. This finding fuels hope that inhibition of SARM1 or its downstream components can be used therapeutically in patients threatened by axonal loss. However, axon loss in most neuropathies, including chemotherapy-induced peripheral neuropathy, is the result of subacute/chronic processes that may be regulated differently than the acute, one time insult of axotomy. Here we evaluate if genetic deletion of SARM1 decreases axonal degeneration in a mouse model of neuropathy induced by the chemotherapeutic agent vincristine. In wild-type mice, 4 weeks of twice-weekly intraperitoneal injections of 1.5 mg/kg vincristine cause pronounced mechanical and heat hyperalgesia, a significant decrease in tail compound nerve action potential amplitude, loss of intraepidermal nerve fibres and significant degeneration of myelinated axons in both the distal sural nerve and nerves of the toe. Neither the proximal sural nerve nor the motor tibial nerve exhibit axon loss. These findings are consistent with the development of a distal, sensory predominant axonal polyneuropathy that mimics vincristine-induced peripheral polyneuropathy in humans. Using the same regimen of vincristine treatment in SARM1 knockout mice, the development of mechanical and heat hyperalgesia is blocked and the loss in tail compound nerve action potential amplitude is prevented. Moreover, SARM1 knockout mice do not lose unmyelinated fibres in the skin or myelinated axons in the sural nerve and toe after vincristine. Hence, genetic deletion of SARM1 blocks the development of vincristine-induced peripheral polyneuropathy in mice. Our results reveal that subacute/chronic axon loss induced by vincristine occurs via a SARM1 mediated axonal destruction pathway, and that blocking this pathway prevents the development of vincristine-induced peripheral polyneuropathy. These findings, in conjunction with previous studies with axotomy and traumatic brain injury, establish SARM1 as the central determinant of a fundamental axonal degeneration pathway that is activated by diverse insults. We suggest that targeting SARM1 or its downstream effectors may be a viable therapeutic option to prevent vincristine-induced peripheral polyneuropathy and possibly other peripheral polyneuropathies.	[Geisler, Stefanie; Doan, Ryan A.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Strickland, Amy; Huang, Xin; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Milbrandt, Jeffrey; DiAntonio, Aaron] Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63130 USA; [DiAntonio, Aaron] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA		Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.; Milbrandt, J (corresponding author), Washington Univ, Sch Med, Hope Ctr Neurol Dis, St Louis, MO 63130 USA.; DiAntonio, A (corresponding author), Washington Univ, Sch Med, 4523 Clayton Ave CB 8103, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu; diantonio@wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689; Doan, Ryan/0000-0002-6944-3921	American Brain Foundation; Foundation for Barnes Jewish Hospital Cancer Frontier Fund; Siteman Cancer Center; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087632]; Children's Discovery Institute;  [K08NS091448]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS091448, R01NS087632] Funding Source: NIH RePORTER	This study was funded by a Clinical Research Training Fellowship from the American Brain Foundation and K08NS091448 to S.G., a Foundation for Barnes Jewish Hospital Cancer Frontier Fund and Siteman Cancer Center grant to A.D. and J.M., the NIH NS087632 to J.M. and A.D and a microgrant from the Children's Discovery Institute to A.D.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Argyriou AA, 2014, CANCER MANAG RES, V6, P135, DOI 10.2147/CMAR.S44261; Authier N, 2003, NEUROTOXICOLOGY, V24, P797, DOI 10.1016/S0161-813X(03)00043-3; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Boehmerle W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06370; Boyette-Davis JA, 2013, CANCER CHEMOTH PHARM, V71, P619, DOI 10.1007/s00280-012-2047-z; BRADLEY WG, 1970, J NEUROL SCI, V10, P107, DOI 10.1016/0022-510X(70)90013-4; Bruna J, 2011, J PERIPHER NERV SYST, V16, P199, DOI 10.1111/j.1529-8027.2011.00346.x; Carozzi VA, 2015, NEUROSCI LETT, V596, P90, DOI 10.1016/j.neulet.2014.10.014; CASEY EB, 1973, BRAIN, V96, P69, DOI 10.1093/brain/96.1.69; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chaudhry V, 2003, NEUROLOGY, V60, P337, DOI 10.1212/01.WNL.0000043691.53710.53; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Costa TC, 2015, REV ESC ENFERM USP, V49, P332, DOI 10.1590/S0080-623420150000200020; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; DEANGELIS LM, 1991, CANCER-AM CANCER SOC, V67, P2241, DOI 10.1002/1097-0142(19910501)67:9<2241::AID-CNCR2820670905>3.0.CO;2-A; Diouf B, 2015, JAMA-J AM MED ASSOC, V313, P815, DOI 10.1001/jama.2015.0894; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Ebenezer GJ, 2007, BRAIN, V130, P2703, DOI 10.1093/brain/awm199; Ezendam NPM, 2014, GYNECOL ONCOL, V135, P510, DOI 10.1016/j.ygyno.2014.09.016; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; GOTTSCHALK PG, 1968, NEUROLOGY, V18, P875; GUIHENEUC P, 1980, J NEUROL SCI, V45, P355, DOI 10.1016/0022-510X(80)90179-3; HAIM N, 1994, CANCER, V73, P2515, DOI 10.1002/1097-0142(19940515)73:10<2515::AID-CNCR2820731011>3.0.CO;2-G; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; HIMES RH, 1976, CANCER RES, V36, P3798; Jongen JLM, 2015, J NEURO-ONCOL, V121, P229, DOI 10.1007/s11060-014-1632-x; Kamei J, 2005, PAIN, V117, P112, DOI 10.1016/j.pain.2005.05.026; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Smith EM, 2015, J PERIPHER NERV SYST, V20, P37, DOI 10.1111/jns.12114; Liew E, 2013, LEUKEMIA RES, V37, P1632, DOI 10.1016/j.leukres.2013.09.018; Lin CW, 2014, BRAIN BEHAV IMMUN, V37, P142, DOI 10.1016/j.bbi.2013.12.002; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Massoll C, 2013, INVEST OPHTH VIS SCI, V54, P2771, DOI 10.1167/iovs.12-10973; Milde S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001539; MORESS GR, 1967, ARCH NEUROL-CHICAGO, V16, P377, DOI 10.1001/archneur.1967.00470220041005; Ness KK, 2013, ARCH PHYS MED REHAB, V94, P1451, DOI 10.1016/j.apmr.2013.03.009; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; OWELLEN RJ, 1976, CANCER RES, V36, P1499; Reinders-Messelink H A, 2000, Eur J Paediatr Neurol, V4, P225, DOI 10.1053/ejpn.1999.0310; Saika F, 2009, BIOL PHARM BULL, V32, P1231, DOI 10.1248/bpb.32.1231; SANDLER SG, 1969, NEUROLOGY, V19, P367, DOI 10.1212/WNL.19.4.367; Shen Y, 2015, NEUROBIOL DIS, V79, P100, DOI 10.1016/j.nbd.2015.04.012; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Tanner KD, 2003, NEUROSCIENCE, V118, P809, DOI 10.1016/S0306-4522(03)00023-X; Tanner KD, 1998, J NEUROSCI, V18, P6480; Tanner KD, 1998, J COMP NEUROL, V424, P563; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Thibault K, 2013, J MOL NEUROSCI, V51, P880, DOI 10.1007/s12031-013-0095-4; Topp KS, 2000, J COMP NEUROL, V424, P563; Uceyler N, 2016, MUSCLE NERVE; Verstappen CCP, 2005, NEUROLOGY, V64, P1076, DOI 10.1212/01.WNL.0000154642.45474.28; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang MS, 2001, ANN NEUROL, V50, P773, DOI 10.1002/ana.10039; Wang MS, 2002, ANN NEUROL, V52, P442, DOI 10.1002/ana.10300; Weng HR, 2003, PAIN, V103, P131, DOI 10.1016/S0304-3959(02)00445-1; Wu G, 2002, J NEUROSCI, V22, P7746; Wu G, 2001, J NEUROSCI, V21; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030	69	111	113	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	DEC	2016	139		12				3092	3108		10.1093/brain/aww251			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI7US	WOS:000392709800013	27797810	Green Published, Bronze			2022-02-06	
J	Ager, RR; Davis, JL; Agazaryan, A; Benavente, F; Poon, WW; LaFerla, FM; Blurton-Jones, M				Ager, Rahasson R.; Davis, Joy L.; Agazaryan, Andy; Benavente, Francisca; Poon, Wayne W.; LaFerla, Frank M.; Blurton-Jones, Mathew			Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss	HIPPOCAMPUS			English	Article						Alzheimer's disease; neural stem cells; immune suppression; transplantation; therapeutic	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; A-BETA; MICROGLIAL ACTIVATION; AMYLOID HYPOTHESIS; MOUSE MODEL; MICE; DIFFERENTIATE; TRANSPLANTS	Alzheimer's disease (AD) is the most prevalent age-related neurodegenerative disorder, affecting over 35 million people worldwide. Pathologically, AD is characterized by the progressive accumulation of -amyloid (A) plaques and neurofibrillary tangles within the brain. Together, these pathologies lead to marked neuronal and synaptic loss and corresponding impairments in cognition. Current treatments, and recent clinical trials, have failed to modify the clinical course of AD; thus, the development of novel and innovative therapies is urgently needed. Over the last decade, the potential use of stem cells to treat cognitive impairment has received growing attention. Specifically, neural stem cell transplantation as a treatment for AD offers a novel approach with tremendous therapeutic potential. We previously reported that intrahippocampal transplantation of murine neural stem cells (mNSCs) can enhance synaptogenesis and improve cognition in 3xTg-AD mice and the CaM/Tet-DTA model of hippocampal neuronal loss. These promising findings prompted us to examine a human neural stem cell population, HuCNS-SC, which has already been clinically tested for other neurodegenerative disorders. In this study, we provide the first evidence that transplantation of research grade HuCNS-SCs can improve cognition in two complementary models of neurodegeneration. We also demonstrate that HuCNS-SC cells can migrate and differentiate into immature neurons and glia and significantly increase synaptic and growth-associated markers in both 3xTg-AD and CaM/Tet-DTA mice. Interestingly, improvements in aged 3xTg-AD mice were not associated with altered A or tau pathology. Rather, our findings suggest that human NSC transplantation improves cognition by enhancing endogenous synaptogenesis. Taken together, our data provide the first preclinical evidence that human NSC transplantation could be a safe and effective therapeutic approach for treating AD. (c) 2014 The Authors. Hippocampus Published by Wiley Periodicals, Inc.	[Ager, Rahasson R.; Davis, Joy L.; Agazaryan, Andy; Poon, Wayne W.; LaFerla, Frank M.; Blurton-Jones, Mathew] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Davis, Joy L.; Agazaryan, Andy; Benavente, Francisca; LaFerla, Frank M.; Blurton-Jones, Mathew] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Poon, Wayne W.; LaFerla, Frank M.; Blurton-Jones, Mathew] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA		Blurton-Jones, M (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	mblurton@uci.edu	Ager, Rahasson/I-6280-2019	Ager, Rahasson/0000-0003-1306-4321; Poon, Wayne/0000-0003-0625-3968; Blurton-Jones, Mathew/0000-0002-7770-7157; Benavente, Francisca/0000-0001-8245-2673	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG029378, AG16573]; California Institute for Regenerative Medicine (CIRM)California Institute for Regenerative Medicine [DR2A-05416, TG2-01152]; Alzheimer's AssociationAlzheimer's Association [NIRG 12-242-550]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG016573, K01AG029378] Funding Source: NIH RePORTER	Grant sponsor: National Institutes of Health (NIH); Grant numbers: AG029378 and AG16573; Grant sponsor: California Institute for Regenerative Medicine (CIRM) (to M.B.J.); Grant numbers: DR2A-05416 (to M.B.J. and F.M.L); TG2-01152 (to R.R.A.); Grant sponsor: Alzheimer's Association; Grant numbers: NIRG 12-242-550 (to M.B.J.).	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Bakondi B, 2009, MOL THER, V17, P1938, DOI 10.1038/mt.2009.185; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BENOWITZ LI, 1981, J NEUROSCI, V1, P300; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; DELAMONTE SM, 1989, DEV BRAIN RES, V46, P161, DOI 10.1016/0165-3806(89)90279-4; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Freeman TB, 2000, P NATL ACAD SCI USA, V97, P13877, DOI 10.1073/pnas.97.25.13877; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Helene J, 2003, BEHAV BRAIN RES, V143, P177, DOI 10.1016/S0166-4328(03)00032-9; Herber DL, 2007, J NEUROIMMUNE PHARM, V2, P222, DOI 10.1007/s11481-007-9069-z; Hong HS, 2010, J ALZHEIMERS DIS, V22, P97, DOI 10.3233/JAD-2010-100261; KALIL K, 1986, J NEUROSCI, V6, P2563; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Luo J, 2008, BRAIN RES BULL, V76, P464, DOI 10.1016/j.brainresbull.2007.12.005; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McGill TJ, 2012, EUR J NEUROSCI, V35, P468, DOI 10.1111/j.1460-9568.2011.07970.x; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Naimi S, 1996, EXP NEUROL, V137, P15, DOI 10.1006/exnr.1996.0002; NarisawaSaito M, 1996, NEUROREPORT, V7, P2925, DOI 10.1097/00001756-199611250-00024; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Qin S, 2004, ACTA NEUROPATHOL, V107, P209, DOI 10.1007/s00401-003-0800-4; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rosenkranz K, 2012, CELL TISSUE RES, V348, P429, DOI 10.1007/s00441-012-1401-0; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schubert D, 2012, FUTURE MED CHEM, V4, P1681, DOI [10.4155/FMC.12.109, 10.4155/fmc.12.109]; Selden NR, 2013, J NEUROSURG-PEDIATR, V11, P643, DOI 10.3171/2013.3.PEDS12397; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shimada IS, 2011, J CELL BIOCHEM, V112, P374, DOI 10.1002/jcb.22963; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tate CC, 2010, CELL TRANSPLANT, V19, P973, DOI 10.3727/096368910X494885; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wimo A, 2010, WORLD ALZHEIMER REPO; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yu DY, 2006, BIOL CHEM, V387, P977, DOI 10.1515/BC.2006.121; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004	64	111	114	1	47	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	JUL	2015	25	7					813	826		10.1002/hipo.22405			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL2YA	WOS:000356812700005	25530343	hybrid, Green Accepted, Green Published			2022-02-06	
J	Woods, DL; Wyma, JM; Yund, EW; Herron, TJ; Reed, B				Woods, David L.; Wyma, John M.; Yund, E. William; Herron, Timothy J.; Reed, Bruce			Factors influencing the latency of simple reaction time	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						gender; timing; processing speed; motor; foreperiod; handedness; hemisphere; replication	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; TRAUMATIC BRAIN-INJURY; VISUOSPATIAL ATTENTION; SEX-DIFFERENCES; INTRAINDIVIDUAL VARIABILITY; COMPUTERIZED MEASURES; AGE-DIFFERENCES; LIFE-STYLE; INTELLIGENCE; PERFORMANCE	Simple reaction time (SRI), the minimal time needed to respond to a stimulus, is a basic measure of processing speed. SRTs were first measured by Francis Galton in the 19th century, who reported visual SRI latencies below 190 ms in young subjects. However, recent large-scale studies have reported substantially increased SRI latencies that differ markedly in different laboratories, in part due to timing delays introduced by the computer hardware and software used for SRI measurement. We developed a calibrated and temporally precise SRI test to analyze the factors that influence SRI latencies in a paradigm where visual stimuli were presented to the left or right hemifield at varying stimulus onset asynchronies (SOAs). Experiment 1 examined a community sample of 1469 subjects ranging in age from 18 to 65. Mean SRI latencies were short (231, 213 ms when corrected for hardware delays) and increased significantly with age (0.55 ms/year), but were unaffected by sex or education. As in previous studies, SRTs were prolonged at shorter SOAs and were slightly faster for stimuli presented in the visual field contralateral to the responding hand. Stimulus detection time (SDI) was estimated by subtracting movement initiation time, measured in a speeded finger tapping test, from SRTs. SDI latencies averaged 131 ms and were unaffected by age. Experiment 2 tested 189 subjects ranging in age from 18 to 82 years in a different laboratory using a larger range of SOAs. Both SRTs and SDTs were slightly prolonged (by 7 ms). SRI latencies increased with age while SDI latencies remained stable. Precise computer based measurements of SRI latencies show that processing speed is as fast in contemporary populations as in the Victorian era, and that age-related increases in SRI latencies are due primarily to slowed motor output.	[Woods, David L.; Wyma, John M.; Yund, E. William; Herron, Timothy J.] Vet Affairs Northern Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA; [Woods, David L.; Reed, Bruce] Calif State Univ Sacramento, Dept Neurol, Davis, CA USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Reed, Bruce] Univ Calif Davis, Dept Neurol, Alzheimers Dis Ctr, Davis, CA 95616 USA		Woods, DL (corresponding author), Vet Affairs Northern Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052; Herron, Timothy/0000-0002-4297-014X	VA Research ServiceUS Department of Veterans Affairs [CX000583, CX001000]; National Institute of Environmental Health SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES014038]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES014038] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001000, I01CX000583] Funding Source: NIH RePORTER	This research was supported by a VA Research Service Grants CX000583 and CX001000 to DW and Award R01ES014038 from the National Institute of Environmental Health Sciences to Michael Bates. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. We would also like to thank Ben Edwards, Oran Poliva, Masood Younus, Nabeel Rahman, Kerry Hubel, Nerene Lynskey, Kataraina George, and John McKeogh, who helped to gather the data used in this report, and to Robert Hink, who developed the MySQL database.	ANNETT M, 1979, BRIT J PSYCHOL, V70, P393, DOI 10.1111/j.2044-8295.1979.tb01709.x; Anstey KJ, 2005, Q J EXP PSYCHOL-A, V58, P5, DOI 10.1080/02724980443000232; Benwell CSY, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00113; Berlingeri M, 2013, EXP BRAIN RES, V224, P393, DOI 10.1007/s00221-012-3319-x; Bherer L, 2004, J GERONTOL B-PSYCHOL, V59, pP66, DOI 10.1093/geronb/59.2.P66; Bielak AAM, 2014, DEV PSYCHOL, V50, P143, DOI 10.1037/a0032650; BISIACCHI P, 1994, BEHAV BRAIN RES, V64, P173, DOI 10.1016/0166-4328(94)90129-5; BRIZZOLARA D, 1994, BEHAV BRAIN RES, V64, P179, DOI 10.1016/0166-4328(94)90130-9; Bugg JM, 2006, BRAIN COGNITION, V62, P9, DOI 10.1016/j.bandc.2006.02.006; Caminiti R, 2009, P NATL ACAD SCI USA, V106, P19551, DOI 10.1073/pnas.0907655106; Chaumillon R, 2014, CORTEX, V58, P86, DOI 10.1016/j.cortex.2014.05.009; CLARKE JM, 1989, BRAIN, V112, P849, DOI 10.1093/brain/112.4.849; Commodari E, 2008, AGING CLIN EXP RES, V20, P578; Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1; Deary IJ, 2010, PSYCHOL AGING, V25, P219, DOI 10.1037/a0017750; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Dodonova YA, 2013, INTELLIGENCE, V41, P674, DOI 10.1016/j.intell.2013.09.001; Dykiert D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045759; Dykiert D, 2012, DEV PSYCHOL, V48, P1262, DOI 10.1037/a0027550; Eckner JT, 2011, J ATHL TRAINING, V46, P409; EMMERSONHANOVER R, 1994, ELECTROEN CLIN NEURO, V92, P93, DOI 10.1016/0168-5597(94)90049-3; Era P, 2011, AGING CLIN EXP RES, V23, P135, DOI 10.1007/BF03351077; FITTRO KP, 1992, J OCCUP ENVIRON MED, V34, P918; Forstmann BU, 2011, J NEUROSCI, V31, P17242, DOI 10.1523/JNEUROSCI.0309-11.2011; FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179; Godefroy O, 2010, EXP AGING RES, V36, P169, DOI 10.1080/03610731003613615; GOTTSDANKER R, 1982, J GERONTOL, V37, P342, DOI 10.1093/geronj/37.3.342; GREENWOOD PM, 1993, NEUROPSYCHOLOGIA, V31, P471, DOI 10.1016/0028-3932(93)90061-4; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Inui N, 1997, PERCEPT MOTOR SKILL, V84, P219, DOI 10.2466/pms.1997.84.1.219; Jensen AR, 2011, INTELLIGENCE, V39, P171, DOI 10.1016/j.intell.2011.03.004; JOHNSON RC, 1985, AM PSYCHOL, V40, P875, DOI 10.1037/0003-066X.40.8.875; Krieg EF, 2001, NEUROTOXICOL TERATOL, V23, P569, DOI 10.1016/S0892-0362(01)00177-5; Levin O, 2011, NEUROSCI LETT, V487, P53, DOI 10.1016/j.neulet.2010.09.072; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Miller J, 2003, COGNITIVE PSYCHOL, V46, P101, DOI 10.1016/S0010-0285(02)00517-0; Montare A, 2013, PERCEPT MOTOR SKILL, V116, P796, DOI 10.2466/27.24.PMS.116.3.796-805; Montare A, 2010, PERCEPT MOTOR SKILL, V111, P819, DOI 10.2466/03.15.25.PMS.111.6.819-828; Neath I, 2011, BEHAV RES METHODS, V43, P353, DOI 10.3758/s13428-011-0069-9; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Parker S, 2014, INTELLIGENCE, V47, P1, DOI 10.1016/j.intell.2014.08.002; Pins D, 1996, PERCEPT PSYCHOPHYS, V58, P390, DOI 10.3758/BF03206815; Plant RR, 2009, BEHAV RES METHODS, V41, P598, DOI 10.3758/BRM.41.3.598; Ratcliff R, 2001, PSYCHOL AGING, V16, P323, DOI 10.1037//0882-7974.16.2.323; Ratcliff R, 2011, P NATL ACAD SCI USA, V108, P11285, DOI 10.1073/pnas.1100483108; Reed BR, 2014, NEUROTOXICOL TERATOL, V42, P68, DOI 10.1016/j.ntt.2014.02.002; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Reimers S, 2006, AGING NEUROPSYCHOL C, V13, P479, DOI 10.1080/138255890969375; Ritchie SJ, 2013, PSYCHOL AGING, V28, P515, DOI 10.1037/a0030820; ROBINSON DL, 1990, NEUROPSYCHOLOGIA, V28, P291, DOI 10.1016/0028-3932(90)90022-G; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Silverman IW, 2010, AM J PSYCHOL, V123, P39, DOI 10.5406/amerjpsyc.123.1.0039; Silverman IW, 2006, SEX ROLES, V54, P57, DOI 10.1007/s11199-006-8869-6; Vallesi A, 2009, NEUROPSYCHOLOGIA, V47, P2876, DOI 10.1016/j.neuropsychologia.2009.06.013; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; WILKINSON RT, 1989, J GERONTOL, V44, pP29, DOI 10.1093/geronj/44.2.P29; Woodley MA, 2013, INTELLIGENCE, V41, P843, DOI 10.1016/j.intell.2013.04.006; Woods D. L., 2015, FRONT HUM N IN PRESS; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042	65	111	115	1	54	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAR 26	2015	9								131	10.3389/fnhum.2015.00131			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CF4AZ	WOS:000352492100001	25859198	gold, Green Published			2022-02-06	
J	Smith, C; Gentleman, SM; Leclercq, PD; Murray, LS; Griffin, WST; Graham, DI; Nicoll, JAR				Smith, C.; Gentleman, S. M.; Leclercq, P. D.; Murray, L. S.; Griffin, W. S. T.; Graham, D. I.; Nicoll, J. A. R.			The neuroinflammatory response in humans after traumatic brain injury	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						microglia; neuroinflammation; neurotrauma; traumatic axonal injury	GLIAL-NEURONAL INTERACTIONS; SITU DNA FRAGMENTATION; ALZHEIMERS-DISEASE; HEAD-INJURY; MICROGLIAL ACTIVATION; SYSTEMIC INFECTION; TDP-43 PROTEINOPATHY; WHITE-MATTER; RISK-FACTORS; INTERLEUKIN-1	Aims: Traumatic brain injury is a significant cause of morbidity and mortality worldwide. An epidemiological association between head injury and long-term cognitive decline has been described for many years and recent clinical studies have highlighted functional impairment within 12 months of a mild head injury. In addition chronic traumatic encephalopathy is a recently described condition in cases of repetitive head injury. There are shared mechanisms between traumatic brain injury and Alzheimer's disease, and it has been hypothesized that neuroinflammation, in the form of microglial activation, may be a mechanism underlying chronic neurodegenerative processes after traumatic brain injury. Methods: This study assessed the microglial reaction after head injury in a range of ages and survival periods, from < 24-h survival through to 47-year survival. Immunohistochemistry for reactive microglia (CD68 and CR3/43) was performed on human autopsy brain tissue and assessed ` blind' by quantitative image analysis. Head injury cases were compared with age matched controls, and within the traumatic brain injury group cases with diffuse traumatic axonal injury were compared with cases without diffuse traumatic axonal injury. Results: A major finding was a neuroinflammatory response that develops within the first week and persists for several months after traumatic brain injury, but has returned to control levels after several years. In cases with diffuse traumatic axonal injury the microglial reaction is particularly pronounced in the white matter. Conclusions: These results demonstrate that prolonged microglial activation is a feature of traumatic brain injury, but that the neuroinflammatory response returns to control levels after several years.	[Smith, C.] Univ Edinburgh, Acad Dept Neuropathol, Edinburgh EH8 9AG, Midlothian, Scotland; [Smith, C.; Murray, L. S.; Graham, D. I.] So Gen Hosp, Inst Neurol Sci, Univ Acad Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; [Gentleman, S. M.; Leclercq, P. D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Neuropathol Unit, London, England; [Nicoll, J. A. R.] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Griffin, W. S. T.] Univ Arkansas Med Sci, Donald W Reynolds Dept Geriatr, Little Rock, AR 72205 USA; [Griffin, W. S. T.] Cent Arkansas Vet Healthcare Syst, Geriatr Res Educ Clin Ctr, Little Rock, AR USA		Smith, C (corresponding author), Univ Edinburgh, Dept Acad Neuropathol, Wilkie Bldg,Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	col.smith@ed.ac.uk	Nicoll, James/I-9253-2017	Nicoll, James/0000-0002-9444-7246	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG12411]; Scottish Council for Postgraduate Medical and Dental Education; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG012411] Funding Source: NIH RePORTER	This work was funded by NIH Grant AG12411. Dr C. Smith was supported by a Clinical Research Fellow grant from the Scottish Council for Postgraduate Medical and Dental Education.	Armon C, 2011, J NEUROPATH EXP NEUR, V70, P97, DOI 10.1097/01.JNEN.0000392910.86750.32; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Bedlack RS, 2011, J NEUROPATH EXP NEUR, V70, P96, DOI 10.1097/NEN.0b013e318204782b; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Eyupoglu IY, 2003, FASEB J, V17, P1110, DOI 10.1096/fj.02-0825fje; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; HAGA S, 1989, ACTA NEUROPATHOL, V77, P569, DOI 10.1007/BF00687883; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; HOLNESS CL, 1993, BLOOD, V81, P1607; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; KALARIA RN, 1990, BRAIN RES, V516, P349, DOI 10.1016/0006-8993(90)90941-4; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mrak RE, 1996, J NEUROPATH EXP NEUR, V55, P273, DOI 10.1097/00005072-199603000-00002; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; NAGATA K, 1993, J NEUROSCI RES, V34, P357, DOI 10.1002/jnr.490340313; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.3.CO;2-7; Parmentier-Batteur S, 2002, J NEUROSCI, V22, P9771, DOI 10.1523/jneurosci.22-22-09771.2002; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rebola N, 2011, J NEUROCHEM, V117, P100, DOI 10.1111/j.1471-4159.2011.07178.x; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Sheng JG, 1997, J NEUROPATH EXP NEUR, V56, P285, DOI 10.1097/00005072-199703000-00007; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; STREIT WJ, 1989, J NEUROIMMUNOL, V21, P117, DOI 10.1016/0165-5728(89)90167-7; Sulaiman AM, 2011, J NEUROTRAUM, V28, P383, DOI 10.1089/neu.2010.1707; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; van Munster BC, 2011, REJUV RES, V14, P615, DOI 10.1089/rej.2011.1185; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031; Witting A, 2004, P NATL ACAD SCI USA, V101, P3214, DOI 10.1073/pnas.0306707101; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	63	111	115	0	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	OCT	2013	39	6					654	666		10.1111/nan.12008			13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	213ID	WOS:000324048500007	23231074	Green Accepted			2022-02-06	
J	Okonkwo, DO; Yue, JK; Puccio, AM; Panczykowski, DM; Inoue, T; McMahon, PJ; Sorani, MD; Yuh, EL; Lingsma, HF; Maas, AIR; Valadka, AB; Manley, GT; Casey, SS; Cheong, M; Cooper, SR; Dams-O'Connor, K; Gordon, WA; Hricik, AJ; Hochberger, K; Menon, DK; Mukherjee, P; Sinha, TK; Schnyer, DM; Vassar, MJ				Okonkwo, David O.; Yue, John K.; Puccio, Ava M.; Panczykowski, David M.; Inoue, Tomoo; McMahon, Paul J.; Sorani, Marco D.; Yuh, Esther L.; Lingsma, Hester F.; Maas, Andrew I. R.; Valadka, Alex B.; Manley, Geoffrey T.; Casey, Scott S.; Cheong, Maxwell; Cooper, Shelly R.; Dams-O'Connor, Kristen; Gordon, Wayne A.; Hricik, Allison J.; Hochberger, Kerri; Menon, David K.; Mukherjee, Pratik; Sinha, Tuhin K.; Schnyer, David M.; Vassar, Mary J.		Transforming Res Clinical Knowledg	GFAP-BDP as an Acute Diagnostic Marker in Traumatic Brain Injury: Results from the Prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; health-related quality of life; outcome; post-concussion syndrome; TBI	FIBRILLARY ACIDIC PROTEIN; COMMON DATA ELEMENTS; INTRACRANIAL LESIONS; CARDIAC TROPONIN; SERUM-LEVELS; MILD; BIOMARKERS; BLOOD; S100B	Reliable diagnosis of traumatic brain injury (TBI) is a major public health need. Glial fibrillary acidic protein (GFAP) is expressed in the central nervous system, and breakdown products (GFAP-BDP) are released following parenchymal brain injury. Here, we evaluate the diagnostic accuracy of elevated levels of plasma GFAP-BDP in TBI. Participants were identified as part of the prospective Transforming Research And Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Study. Acute plasma samples (<24 h post-injury) were collected from patients presenting with brain injury who had CT imaging. The ability of GFAP-BDP level to discriminate patients with demonstrable traumatic lesions on CT, and with failure to return to pre-injury baseline at 6 months, was evaluated by the area under the receiver operating characteristic curve (AUC). Of the 215 patients included for analysis, 83% had mild, 4% had moderate, and 13% had severe TBI; 54% had acute traumatic lesions on CT. The ability of GFAP-BDP level to discriminate patients with traumatic lesions on CT as evaluated by AUC was 0.88 (95% confidence interval [CI], 0.84-0.93). The optimal cutoff of 0.68 ng/mL for plasma GFAP-BDP level was associated with a 21.61 odds ratio for traumatic findings on head CT. Discriminatory ability of unfavorable 6 month outcome was lower, AUC 0.65 (95% CI, 0.55-0.74), with a 2.07 odds ratio. GFAP-BDP levels reliably distinguish the presence and severity of CT scan findings in TBI patients. Although these findings confirm and extend prior studies, a larger prospective trial is still needed to validate the use of GFAP-BDP as a routine diagnostic biomarker for patient care and clinical research. The term "mild'' continues to be a misnomer for this patient population, and underscores the need for evolving classification strategies for TBI targeted therapy. (ClinicalTrials.gov number NCT01565551; NIH Grant 1RC2 NS069409)	[Okonkwo, David O.; Puccio, Ava M.; Panczykowski, David M.; McMahon, Paul J.; Hricik, Allison J.; Hochberger, Kerri] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Yue, John K.; Inoue, Tomoo; Sorani, Marco D.; Manley, Geoffrey T.; Casey, Scott S.; Cooper, Shelly R.; Vassar, Mary J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Yuh, Esther L.; Cheong, Maxwell; Mukherjee, Pratik; Sinha, Tuhin K.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Lingsma, Hester F.] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Valadka, Alex B.] Seton Brain & Spine Inst, Austin, TX USA; [Dams-O'Connor, Kristen; Gordon, Wayne A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England; [Schnyer, David M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA		Okonkwo, DO (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurol Surg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	okonkwodo@upmc.edu	Schnyer, David/ABD-6372-2021; Yue, John K/P-1348-2015	Schnyer, David/0000-0002-7472-2853; Yue, John K/0000-0001-9694-7722; Mukherjee, Pratik/0000-0001-7473-7409; Cooper, Shelly/0000-0003-0026-6688	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2 NS069409] Funding Source: Medline; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC2NS069409] Funding Source: NIH RePORTER		Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Reinsfelt B, 2012, ANN THORAC SURG, V94, P549, DOI 10.1016/j.athoracsur.2012.04.044; Savage WJ, 2011, AM J HEMATOL, V86, P427, DOI 10.1002/ajh.21995; Seco M, 2012, ANN THORAC SURG, V94, P1026, DOI 10.1016/j.athoracsur.2012.04.142; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; Vissers JLM, 2006, CLIN CHIM ACTA, V366, P336, DOI 10.1016/j.cca.2005.11.017; Vos PE, 2006, EUR J NEUROL, V13, P632, DOI 10.1111/j.1468-1331.2006.01332.x; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue J.K., 2013, J NEUROTRAUMA; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	31	111	113	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1490	1497		10.1089/neu.2013.2883			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800004	23489259	Green Published, Green Submitted			2022-02-06	
J	Kleber, C; Giesecke, MT; Tsokos, M; Haas, NP; Buschmann, CT				Kleber, C.; Giesecke, M. T.; Tsokos, M.; Haas, N. P.; Buschmann, C. T.			Trauma-related Preventable Deaths in Berlin 2010: Need to Change Prehospital Management Strategies and Trauma Management Education	WORLD JOURNAL OF SURGERY			English	Article							ROAD TRAFFIC FATALITIES; SYSTEM; CARE; MORTALITY; QUALITY; AUDIT; INJURIES; VICTORIA	Fatal trauma is one of the leading causes of death in Western industrialized countries. The aim of the present study was to determine the preventability of traumatic deaths, analyze the medical measures related to preventable deaths, detect management failures, and reveal specific injury patterns in order to avoid traumatic deaths in Berlin. In this prospective observational study all autopsied, direct trauma fatalities in Berlin in 2010 were included with systematic data acquisition, including police files, medical records, death certificates, and autopsy records. An interdisciplinary expert board judged the preventability of traumatic death according to the classification of non-preventable (NP), potentially preventable (PP), and definitively preventable (DP) fatalities. Of the fatalities recorded, 84.9 % (n = 224) were classified as NP, 9.8 % (n = 26) as PP, and 5.3 % (n = 14) as DP. The incidence of severe traumatic brain injury (sTBI) was significantly lower in PP/DP than in NP, and the incidence of fatal exsanguinations was significantly higher. Most PP and NP deaths occurred in the prehospital setting. Notably, no PP or DP was recorded for fatalities treated by a HEMS crew. Causes of DP deaths consisted of tension pneumothorax, unrecognized trauma, exsanguinations, asphyxia, and occult bleeding with a false negative computed tomography scan. The trauma mortality in Berlin, compared to worldwide published data, is low. Nevertheless, 15.2 % (n = 40) of traumatic deaths were classified as preventable. Compulsory training in trauma management might further reduce trauma-related mortality. The main focus should remain on prevention programs, as the majority of the fatalities occurred as a result of non-survivable injuries.	[Kleber, C.; Giesecke, M. T.; Haas, N. P.] Charite, AG Polytrauma, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Kleber, C.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Tsokos, M.; Buschmann, C. T.] Charite, Inst Legal Med & Forens Sci, D-10559 Berlin, Germany		Kleber, C (corresponding author), Charite, AG Polytrauma, Ctr Musculoskeletal Surg, Augustenburger Pl 1, D-13353 Berlin, Germany.	christian.kleber@charite.de			Berlin-Brandenburg School for Regenerative Therapies [GSC 203]	Contributions were made possible by DFG funding through the Berlin-Brandenburg School for Regenerative Therapies GSC 203. The authors are grateful to Dr. Paul Bedford for his contribution to the manuscript.	ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; Arnold JL, 1999, ANN EMERG MED, V33, P97, DOI 10.1016/S0196-0644(99)70424-5; Ashour A, 2007, EMERG MED AUSTRALAS, V19, P163, DOI 10.1111/j.1742-6723.2007.00948.x; Bakke HK, 2011, WORLD J SURG, V35, P1615, DOI 10.1007/s00268-011-1102-y; Buschmann CT, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-55; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Davies GE, 2011, J TRAUMA, V70, pE75, DOI 10.1097/TA.0b013e3181f6f72f; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; Dick WF, 2003, PREHOSP DISASTER MED, V18, P35; Dick Wolfgang F, 2003, Prehosp Disaster Med, V18, P29; DRAAISMA JMT, 1989, J TRAUMA, V29, P1552; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Frink M, 2007, UNFALLCHIRURG, V110, P334, DOI 10.1007/s00113-006-1222-2; HAAS NP, 1995, CLIN ORTHOP RELAT R, P25; Jat Afzal Ali, 2004, Asian J Surg, V27, P58, DOI 10.1016/S1015-9584(09)60247-5; Kleber C, 2013, UNFALLCHIRURG, V116, P345, DOI 10.1007/s00113-011-2132-5; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Limb D, 1996, J ACCID EMERG MED, V13, P248; MACKENZIE EJ, 1992, J TRAUMA, V33, P292, DOI 10.1097/00005373-199208000-00021; Maio RF, 1996, J TRAUMA, V41, P83, DOI 10.1097/00005373-199607000-00013; McDermott FT, 2005, PREHOSP DISASTER MED, V20, P219, DOI 10.1017/S1049023X00002570; McDermott FT, 1996, J TRAUMA, V40, P520, DOI 10.1097/00005373-199604000-00003; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; OTTOSSON A, 1984, JAMA-J AM MED ASSOC, V251, P2668, DOI 10.1001/jama.251.20.2668; Papadopoulos IN, 1996, J TRAUMA, V41, P864, DOI 10.1097/00005373-199611000-00018; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Roy MS, 2004, BRAIN DEV-JPN, V26, P197, DOI 10.1016/S0387-7604(03)00147-5; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; STOCCHETTI N, 1994, J TRAUMA, V36, P401, DOI 10.1097/00005373-199403000-00022; VAN WAGONER F H, 1961, J Trauma, V1, P401; WEST JG, 1979, ARCH SURG-CHICAGO, V114, P455; ZOLLINGER RW, 1955, ARCH SURG-CHICAGO, V70, P694, DOI 10.1001/archsurg.1955.01270110066010	36	111	116	0	10	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	MAY	2013	37	5					1154	1161		10.1007/s00268-013-1964-2			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	123AU	WOS:000317361200033	23430005				2022-02-06	
J	Cao, T; Thomas, TC; Ziebell, JM; Pauly, JR; Lifshitz, J				Cao, T.; Thomas, T. C.; Ziebell, J. M.; Pauly, J. R.; Lifshitz, J.			MORPHOLOGICAL AND GENETIC ACTIVATION OF MICROGLIA AFTER DIFFUSE TRAUMATIC BRAIN INJURY IN THE RAT	NEUROSCIENCE			English	Article						classical activation; alternate activation; anti-inflammatory; neuroplasticity	CLOSED-HEAD INJURY; NEURONAL INJURY; NEUTROPHIL INFILTRATION; ALTERNATIVE ACTIVATION; AXON REGENERATION; MYELOID CELLS; SPINAL-CORD; LATE-ONSET; EXPRESSION; MACROPHAGES	Traumatic brain injury (TBI) survivors experience long-term post-traumatic morbidities. In diffuse brain-injured rats, a chronic sensory sensitivity to whisker stimulation models the agitation of TBI survivors and provides anatomical landmarks across the whisker-barrel circuit to evaluate post-traumatic neuropathology. As a consequence of TBI, acute and chronic microglial activation can contribute to degenerative and reparative events underlying post-traumatic morbidity. Here we hypothesize that a temporal sequence of microglial activation states contributes to the circuit pathology responsible for post-traumatic morbidity, and test the hypothesis by examining microglial morphological activation and neuroinflammatory markers for activation states through gene expression and receptor-binding affinity. Adult male, Sprague-Dawley rats were subjected to a single moderate midline fluid percussion injury (FPI) or sham injury. Microglial activation was determined by immunohistochemistry, quantitative real-time PCR and receptor autoradiography in the primary somatosensory barrel field (S1BF) and ventral posterior medial nucleus (VPM) of the thalamus at 7 and 28 days following FPI. Morphological changes indicative of microglial activation, including swollen cell body with thicker, shrunken processes, were evident in S1BF and VPM at 7 and 28 days post-injury. Principally at 7 days post-injury in VPM, general inflammatory gene expression (major histocompatibility complex I, major histocompatibility complex II, translocator protein 18 kDa [TSPO]) is increased above sham level and TSPO gene expression confirmed by receptor autoradiography. Further, CD45, a marker of classical activation, and TGF-beta I, an acquired deactivation marker, were elevated significantly above sham at 7 days post-injury. Daily administration of the anti-inflammatory ibuprofen (20 mg/kg, i.p.) significantly reduced the expression of these genes. Evidence for alternative activation (arginase 1) was not observed. Thus, these data demonstrate concomitant classical activation and acquired deactivation phenotypes of microglia in diffuse TBI in the absence of overt contusion or cavitation. Antiinflammatory treatment may further alleviate the neuropathological burden of post-traumatic inflammation. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Cao, T.] Univ Kentucky, Coll Art & Sci, Dept Biol, Lexington, KY USA; [Cao, T.; Thomas, T. C.; Ziebell, J. M.; Pauly, J. R.; Lifshitz, J.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Pauly, J. R.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Lifshitz, J.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA; [Lifshitz, J.] Univ Kentucky, Coll Med, Dept Phys Med & Rehabil, Lexington, KY USA		Lifshitz, J (corresponding author), Univ Arizona, Phoenix Childrens Hosp, Phoenix VA Hlth Care Syst, Barrow Neurol Inst,Dept Child Hlth,Coll Med Phoen, 3rd Floor,Ambulatory B Bldg,1919 E Thomas Rd, Phoenix, AZ 85016 USA.	JLifshitz@email.arizona.edu	Thomas, Theresa Currier/K-1979-2019; Ziebell, Jenna/Y-4496-2019	Thomas, Theresa Currier/0000-0002-9619-7666; Ziebell, Jenna/0000-0003-2497-4347	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS065052, P30 NS051220]; NIH NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061996]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [7-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052, P30NS051220] Funding Source: NIH RePORTER	With generous thanks to Amanda M. Lisembee for preparing the diffuse brain-injured rats; Deanne Hopkins for conducting the radioligand binding experiments; and Kelley D. Hall for assistance with the ibuprofen administration. Supported, in part, by NIH NINDS R01 NS065052, NIH NICHD R01 HD061996, Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) 7-11 and NIH NINDS P30 NS051220.	Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Boekhoff TMA, 2012, J NEUROTRAUM, V29, P1000, DOI 10.1089/neu.2011.1821; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Gao JJ, 2002, J LEUKOCYTE BIOL, V72, P1234; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Graham DI, 2002, GREENFIELDS NEUROP E, P823; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Ling ZD, 2006, EXP NEUROL, V199, P499, DOI 10.1016/j.expneurol.2006.01.010; Little KY, 1998, ARCH GEN PSYCHIAT, V55, P793, DOI 10.1001/archpsyc.55.9.793; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Park EM, 2005, NEUROSCIENCE, V132, P625, DOI 10.1016/j.neuroscience.2005.01.021; PATEL PM, 1993, BRAIN RES, V614, P315, DOI 10.1016/0006-8993(93)91050-3; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Ross SM, 2003, J ENG TECHNOL, V20, P38; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Soares HD, 1995, J NEUROSCI, V15, P8223; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wang XX, 2009, J NEUROTRAUM, V26, P81, DOI 10.1089/neu.2007.0464; Wei HH, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-19; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	72	111	114	0	27	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 6	2012	225						65	75		10.1016/j.neuroscience.2012.08.058			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	039SP	WOS:000311267100007	22960311	Green Accepted, Green Submitted			2022-02-06	
J	Fremont, RD; Koyama, T; Calfee, CS; Wu, W; Dossett, LA; Bossert, FR; Mitchell, D; Wickersham, N; Bernard, GR; Matthay, MA; May, AK; Ware, LB				Fremont, Richard D.; Koyama, Tatsuki; Calfee, Carolyn S.; Wu, William; Dossett, Lesly A.; Bossert, Fred R.; Mitchell, Daphne; Wickersham, Nancy; Bernard, Gordon R.; Matthay, Michael A.; May, Addison K.; Ware, Lorraine B.			Acute Lung Injury in Patients With Traumatic Injuries: Utility of a Panel of Biomarkers for Diagnosis and Pathogenesis	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	104th International Conference of the American-Thoracic-Society	MAY 16-21, 2008	Toronto, CANADA	Amer Thorac Soc		Acute respiratory distress syndrome; Acute pulmonary edema; Pulmonary contusion; Alveolar epithelium	RESPIRATORY-DISTRESS-SYNDROME; INTRAVASCULAR VOLUME STATUS; III PROCOLLAGEN PEPTIDE; GLYCATION END-PRODUCTS; CRITICALLY-ILL TRAUMA; PULMONARY-EDEMA FLUID; BRONCHOALVEOLAR LAVAGE; CLINICAL-OUTCOMES; VASCULAR PEDICLE; MORTALITY	Background: The diagnosis of acute lung injury (ALI) is based on a consensus clinical definition. Despite the simplicity of this definition, ALI remains underdiagnosed and undertreated. Severe trauma is a well-described cause of ALI that represents a relatively homogeneous subset of patients with ALI. The aims of this study were to develop a panel of plasma biomarkers to facilitate diagnosis of trauma-induced ALI and to enhance our understanding of the pathogenesis of human ALI. Methods: A retrospective nested case control of 192 patients admitted to the trauma intensive care unit at a university hospital between 2002 and 2006. We compared 107 patients with ALI to 85 patients without ALI. Plasma was collected within 72 hours of intensive care unit admission. Twenty-one plasma biomarkers were measured in duplicate in each plasma sample. Results: Patients with ALI had higher severity of illness scores, more days of mechanical ventilation, longer hospital stays, and higher mortality versus controls. Seven biomarkers (receptor for advanced glycation end products, procollagen peptide III, brain natriuretic peptide, angiopoietin-2, interleukin-10, tumor necrosis factor alpha, and interleukin-8) had a high diagnostic accuracy as reflected by the area under the receiver operating characteristic curve of 0.86 (95% confidence interval, 0.82-0.92) in differentiating ALI from controls. Conclusions: A model using seven plasma biomarkers had a high diagnostic accuracy in differentiating patients with trauma-induced ALI from trauma patients without ALI. In addition, use of a panel of biomarkers provides insight into the likely importance of alveolar epithelial injury in the pathogenesis of early ALI.	[Fremont, Richard D.; Bossert, Fred R.; Mitchell, Daphne; Wickersham, Nancy; Bernard, Gordon R.; Ware, Lorraine B.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Koyama, Tatsuki; Wu, William] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Dossett, Lesly A.; May, Addison K.] Vanderbilt Univ, Dept Surg, Div Trauma & Surg Crit Care, Nashville, TN 37232 USA; [Calfee, Carolyn S.; Matthay, Michael A.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Calfee, Carolyn S.; Matthay, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Calfee, Carolyn S.; Matthay, Michael A.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA		Ware, LB (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, T1218 MCN,1161 21st Ave St, Nashville, TN 37232 USA.	lorraine.ware@vanderbilt.edu	Ware, Lorraine/AAJ-9307-2021; Dossett, Lesly/I-8881-2019	Ware, Lorraine/0000-0002-9429-4702; Dossett, Lesly/0000-0001-8060-1073	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL 090833, U01 HL081332, HL51856, HL081332, K23 HL090833, K24 HL103836] Funding Source: Medline; NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [AI49989] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K24HL103836, R01HL051856, R37HL051856, U01HL081332, K23HL090833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI049989] Funding Source: NIH RePORTER		*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; BACHOFEN M, 1977, AM REV RESPIR DIS, V116, P589, DOI 10.1164/arrd.1977.116.4.589; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Calfee CS, 2007, CRIT CARE MED, V35, P2243, DOI 10.1097/01.CCM.0000280434.33451.87; Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124; CLARK JG, 1995, ANN INTERN MED, V122, P17, DOI 10.7326/0003-4819-122-1-199501010-00003; Cohn SM, 1997, J TRAUMA, V42, P973, DOI 10.1097/00005373-199705000-00033; Dicker RA, 2004, J TRAUMA, V57, P522, DOI 10.1097/01.TA.0000135749.64867.06; Dossett LA, 2008, CHEST, V134, P974, DOI 10.1378/chest.08-0079; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Dossett LA, 2008, SURG INFECT, V9, P41, DOI 10.1089/sur.2007.037; Effron B, 1993, INTRO BOOTSTRAP; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Ely EW, 2002, CHEST, V121, P942, DOI 10.1378/chest.121.3.942; Ely EW, 2001, CRIT CARE MED, V29, P1502; Estenssoro E, 2002, CRIT CARE MED, V30, P2450, DOI 10.1097/00003246-200211000-00008; Frank JA, 2002, AM J RESP CRIT CARE, V165, P242, DOI 10.1164/ajrccm.165.2.2108087; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Harrell FE Jr, 2017, REGRESSION MODELING; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Laffon M, 1999, AM J PHYSIOL-LUNG C, V277, pL760, DOI 10.1152/ajplung.1999.277.4.L760; LOW RB, 1983, LAB INVEST, V48, P755; LOW RB, 1992, AM REV RESPIR DIS, V146, P701, DOI 10.1164/ajrccm/146.3.701; Luchette FA, 2004, J TRAUMA, V57, P526; Marshall RP, 2000, AM J RESP CRIT CARE, V162, P1783, DOI 10.1164/ajrccm.162.5.2001061; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; May AK, 2008, CRIT CARE MED, V36, P62, DOI 10.1097/01.CCM.0000292015.16171.6D; McClintock D, 2008, CRIT CARE, V12, DOI 10.1186/cc6846; Meduri GU, 1998, AM J RESP CRIT CARE, V158, P1432; MILNE ENC, 1984, RADIOLOGY, V152, P1; Modelska K, 1999, AM J PHYSIOL-LUNG C, V276, pL844; MODELSKA K, 1998, AM J RESP CRIT CARE, V157, pA350; Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002; RAEDSCH R, 1983, GASTROENTEROLOGY, V85, P1265; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; RUBIN DB, 1990, J CLIN INVEST, V86, P474, DOI 10.1172/JCI114733; Salim A, 2008, INJURY, V39, P30, DOI 10.1016/j.injury.2007.06.015; Salim A, 2006, ARCH SURG-CHICAGO, V141, P655, DOI 10.1001/archsurg.141.7.655; Stapleton RD, 2005, CHEST, V128, P525, DOI 10.1378/chest.128.2.525; Treggiari MM, 2004, CRIT CARE MED, V32, P327, DOI 10.1097/01.CCM.0000108870.09693.42; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Ware LB, 2005, NEW ENGL J MED, V353, P2788, DOI 10.1056/NEJMcp052699; Ware LB, 2004, AM J RESP CRIT CARE, V170, P766, DOI 10.1164/rccm.200310-1434OC; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; WAYDHAS C, 1993, CRIT CARE MED, V21, P240, DOI 10.1097/00003246-199302000-00016; Weber KT, 1997, CIRCULATION, V96, P2488; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	58	111	124	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2010	68	5					1121	1127		10.1097/TA.0b013e3181c40728			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	595MQ	WOS:000277615200017	20038857	Green Accepted			2022-02-06	
J	Fay, TB; Yeates, KO; Taylor, HG; Bangert, B; Dietrich, A; Nuss, KE; Rusin, J; Wright, M				Fay, Taryn B.; Yeates, Keith Owen; Taylor, H. Gerry; Bangert, Barbara; Dietrich, Ann; Nuss, Kathryn E.; Rusin, Jerome; Wright, Martha			Cognitive reserve as a moderator of postconcussive symptoms in children with complicated and uncomplicated mild traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Nervous system trauma; Pediatric; Prospective studies; Head injury; Concussion; Head trauma; Cognitive ability	HEAD-INJURY	The Occurrence of postconcussive symptoms (PCS) following mild traumatic brain injury (TBI) in children may depend on cognitive reserve capacity. This prospective, longitudinal study examined whether the relationship between mild TBI and PCS is moderated by cognitive ability, which served as a proxy for cognitive reserve. Participants included 182 children with mild TBI and 99 children with orthopedic injuries (OI). ranging from 8 to 15 years of age when injured. Mild TBI were classified as complicated (n = 32) or uncomplicated (n = 150) depending oil whether they were associated with trauma-related intracranial abnormalities on magnetic resonance imaging. PCS were assessed initially within 3 weeks of injury, and again at 1, 3, and 12 months post injury. The initial assessment also included standardized tests of children's cognitive skills and retrospective parent ratings of pre-injury symptoms. Hierarchical linear modeling indicated that ratings of PCS were moderated jointly by cognitive ability and injury severity. Children of lower cognitive ability with a complicated mild TBI were especially prone to cognitive symptoms across time according to parents and to high acute levels of PCS according to children's self-ratings. Cognitive reserve is an important moderator of the outcomes of mild TBI in children and adolescents. (JINS, 2010, 16, 94-105.)	[Yeates, Keith Owen] Nationwide Childrens Hosp, Dept Psychol, Res Inst, Columbus, OH 43205 USA; [Fay, Taryn B.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Fay, Taryn B.; Yeates, Keith Owen; Dietrich, Ann; Nuss, Kathryn E.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Taylor, H. Gerry; Wright, Martha] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Wright, Martha] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Radiol, Cleveland, OH USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Neurosurg, Cleveland, OH USA; [Dietrich, Ann; Nuss, Kathryn E.] Nationwide Childrens Hosp, Dept Emergency Med, Columbus, OH 43205 USA; [Rusin, Jerome] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH 43205 USA		Yeates, KO (corresponding author), Nationwide Childrens Hosp, Dept Psychol, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	keith.yeates@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Fay-McClymont, Taryn/0000-0002-2706-6179; Nuss, Kathryn/0000-0003-2185-7364	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD39834, K02 HD44099]; National Center for Medical Rehabilitation Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD039834, K02HD044099] Funding Source: NIH RePORTER	The research reported here served as the basis for a dissertation submitted by the first author to The Ohio State University in partial fulfillment of the requirements for a doctoral degree. Portions of the research were presented at the annual meeting of the International Neuropsychological Society, Waikoloa, Hawaii, February, 2008. The larger study On which the research was based was supported by grants R01 HD39834 and K02 HD44099 from the National Institute of Child Health and Human Development and the National Center for Medical Rehabilitation Research to Keith Owen Yeates. The authors wish to acknowledge the contributions of Lauren Ayr, Anne Birnbaum, Amy Clemens, Kalaichelvi Ganesalingham, Christine Hajek, Amanda Lininger, Melissa Ginn. Katie Pestro, Elizabeth Roth, Elizabeth Shaver, and Heidi Walker in conducting the Study.	Alexander, 1997, Semin Clin Neuropsychiatry, V2, P177; *AM ASS ADV AUT ME, 1990, ABBR INJ SCAL; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beery K.E., 2004, BEERY BUKTENICA DEV; Bergman DA, 1999, PEDIATRICS, V104, P1407; BIJUR PE, 1990, PEDIATRICS, V86, P337; BURCHINAL MR, 1994, J EARLY INTERVENTION, V18, P403, DOI 10.1177/105381519401800409; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Delis D, 1994, MANUAL CALIFORNIA VE; Dennis M., 2006, COGNITIVE RESERVE TH, P53; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TAYLOR HG, NEUROPSYCHO IN PRESS; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; WECHSLER D, 1999, WECHSLER ABBREVIATEL; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	46	111	113	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2010	16	1					94	105		10.1017/S1355617709991007			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	543LR	WOS:000273579600011	19835663	Green Accepted			2022-02-06	
J	Yang, CY; Song, BB; Ao, Y; Nowak, AP; Abelowitz, RB; Korsak, RA; Havton, LA; Deming, TJ; Sofroniew, MV				Yang, Chu-Ya; Song, Bingbing; Ao, Yan; Nowak, Andrew P.; Abelowitz, Ryan B.; Korsak, Rose A.; Havton, Leif A.; Deming, Timothy J.; Sofroniew, Michael V.			Biocompatibility of amphiphilic diblock copolypeptide hydrogels in the central nervous system	BIOMATERIALS			English	Article						Scaffolds; Brain; Spinal cord; Biocompatibility; Drug delivery; Hydrogels	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; POLYPEPTIDE HYDROGELS; BLOCK COPOLYPEPTIDES; IN-VIVO; DELIVERY; REPAIR; CELLS; SCAFFOLDS; NEURONS	Amphiphilic diblock copolypeptide hydrogels (DCHs) are synthetic materials whose properties can be varied readily and predictably by altering copolymer chain length or composition and which are of potential interest for biomaterial applications. We tested the biocompatibility in the central nervous system (CNS) of DCH composed of lysine, homoarginine or glutamate in combination with leucine. A range of DCH formulations with theological properties similar to brain tissue were injected into mouse forebrain and examined after 1-8 weeks using light microscopy, immunohistochemistry and electron microscopy. DCH deposits elicited no more gliosis, inflammation, or toxicity to neurons, myelin or axons than did injections of physiological saline. The size, rigidity, and density of DCH deposits could be varied subtly by altering DCH composition and concentration. For any given DCH formulation, increased concentration correlated with increased gel strength in vitro and increased deposit size in vivo. DCHs of lysine and leucine (KmLn) were selected for detailed analyses because these formed deposits with desirable physical properties and since lysine is routinely used as a substrate for neural cell cultures. Deposits of unmodified K180L20 exhibited time-dependent in-growth of blood vessels and of certain glial cells, and limited in-growth of nerve fibers. These findings show that DCHs are injectable, re-assemble in vivo to form 3-dimensional deposits, exhibit little or no detectable toxicity in the CNS, integrate well with brain tissue and represent a new class of synthetic biomaterials with potential for applications as depots or scaffolds in the CNS. (C) 2009 Elsevier Ltd. All rights reserved.	[Song, Bingbing; Ao, Yan; Abelowitz, Ryan B.; Korsak, Rose A.; Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Yang, Chu-Ya; Nowak, Andrew P.; Deming, Timothy J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Havton, Leif A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Sofroniew, MV (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 10833 Conte Ave, Los Angeles, CA 90095 USA.	sofroniew@mednet.ucla.edu	Deming, Timothy/I-5411-2013; Sofroniew, Michael/ABE-8857-2020	Deming, Timothy/0000-0002-0594-5025	Adelson Medical Research Foundation	This study was supported by the Adelson Medical Research Foundation (Adelson Program in Neural Rehabilitation and Repair). We thank Dr. A. Katapodis, Novartis Insitute, Basel, Switzerland, for the anti-poly-lysine antibody, Prof. T.G. Mason and Dr. J.N. Wilking for rheology assistance, and Ms. B. Sjostrand for ultrastructural assistance.	Beardsley RL, 2002, ANAL CHEM, V74, P1884, DOI 10.1021/ac015613o; Bocchiaro CM, 2004, P NATL ACAD SCI USA, V101, P4292, DOI 10.1073/pnas.0305712101; Breedveld V, 2004, MACROMOLECULES, V37, P3943, DOI 10.1021/ma049885f; Deming TJ, 2005, SOFT MATTER, V1, P28, DOI 10.1039/b500307e; Deming TJ, 2002, ADV DRUG DELIVER REV, V54, P1145, DOI 10.1016/S0169-409X(02)00062-5; Deming TJ, 1999, MACROMOLECULES, V32, P4500, DOI 10.1021/ma9902899; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; Havton LA, 2005, J NEUROSCI METH, V149, P101, DOI 10.1016/j.jneumeth.2005.03.014; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Holowka EP, 2007, NAT MATER, V6, P52, DOI 10.1038/nmat1794; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; HUSEK P, 1991, J CHROMATOGR, V552, P289, DOI 10.1016/S0021-9673(01)95945-X; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Katopodis AG, 2002, J CLIN INVEST, V110, P1869, DOI 10.1172/JCI200216526; Kimmel J. R., 1967, METHOD ENZYMOL, V11, P584; KLEIN HF, 1975, CHEM BER-RECL, V108, P944, DOI 10.1002/cber.19751080327; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nowak AP, 2003, J AM CHEM SOC, V125, P15666, DOI 10.1021/ja0381050; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9; Peters A., 1991, FINE STRUCTURE NERVO, V3rd ed.; Pochan DJ, 2002, MACROMOLECULES, V35, P5358, DOI 10.1021/ma025526d; Sanjana NE, 2004, J NEUROSCI METH, V136, P151, DOI 10.1016/j.jneumeth.2004.01.011; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777; SVENDSEN CN, 1994, J NEUROSCI, V14, P75; Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540; Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071	43	111	112	1	44	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	MAY	2009	30	15					2881	2898		10.1016/j.biomaterials.2009.01.056			18	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	435FA	WOS:000265328100004	19251318				2022-02-06	
J	Nortje, J; Coles, JP; Timofeev, I; Fryer, TD; Aigbirhio, FI; Smielewski, P; Outtrim, JG; Chatfield, DA; Pickard, JD; Hutchinson, PJ; Gupta, AK; Menon, DK				Nortje, Jurgens; Coles, Jonathan P.; Timofeev, Ivan; Fryer, Tim D.; Aigbirhio, Franklin I.; Smielewski, Peter; Outtrim, Joanne G.; Chatfield, Doris A.; Pickard, John D.; Hutchinson, Peter J.; Gupta, Arun K.; Menon, David K.			Effect of hyperoxia on regional oxygenation and metabolism after severe traumatic brain injury: Preliminary findings	CRITICAL CARE MEDICINE			English	Article						brain injuries; brain ischemia; oxidative phosphorylation; positron-emission tomography; microdialysis; hyperoxia	SEVERE HEAD-INJURY; CEREBRAL-ISCHEMIA; TISSUE OXYGEN; NITRIC-OXIDE; DEPENDENT REGULATION; ENERGY-METABOLISM; DAMAGE; HYPOXIA; MICRODIALYSIS; CARE	Objective: To determine the effect of normobaric hyperoxia on cerebral metabolism in patients with severe traumatic brain injury. Design: Prospective clinical investigation. Setting: Neurosciences critical care unit of a university hospital. Patients: Eleven patients with severe traumatic brain injury. Interventions. Cerebral microdialysis, brain tissue oximetry (Pb0(2)), and oxygen-15 positron emission tomography ((15)0-PET) were undertaken at normoxia and repeated at hyperoxia (F10(2) increase of between 0.35 and 0.50). Measurements and Main Results. Established models were used to image cerebral blood flow, blood volume, oxygen metabolism, and oxygen extraction fraction. Physiology was characterized in a focal region of interest (surrounding the microdialysis catheter) and correlated with microdialysis and oximetry. Physiology was also characterized in a global region of interest (including the whole brain), and a physiologic region of interest (defined using a critical cerebral metabolic rate of oxygen threshold). Hyperoxia increased mean +/- SD Pb0(2) from 28 +/- 21 mm Hg to 57 +/- 47 mm Hg (p = .015). Microdialysate lactate and pyruvate were unchanged, but the lactate/pyruvate ratio showed a statistically significant reduction across the study population (34.1 +/- 9.5 vs. 32.5 +/- 9.0, p = .018). However, the magnitude of reduction was small, and its clinical significance doubtful. The focal region of interest and global (15)0-PET variables were unchanged. "Atrisk" tissue defined by the physiologic region of interest, however, showed a universal increase in cerebral metabolic rate of oxygen from a median (interquartile range) of 23 (22-25) mu mol(.)100 mL(-1)-min(-1) to 30 (28-36) mu mol(.)100 mL(-1.)min(-1) (p < .01). Conclusions: In severe traumatic brain injury, hyperoxia increases Pb0(2) with a variable effect on lactate and lactate/pyruvate ratio. Microdialysis does not, however, predict the universal increases in cerebral metabolic rate of oxygen in at-risk tissue, which imply preferential metabolic benefit with hyperoxia.	[Nortje, Jurgens; Coles, Jonathan P.; Outtrim, Joanne G.; Chatfield, Doris A.; Gupta, Arun K.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England; [Timofeev, Ivan; Smielewski, Peter; Pickard, John D.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Acad Neurosurg Unit, Cambridge CB2 2QQ, England; [Nortje, Jurgens; Coles, Jonathan P.; Timofeev, Ivan; Fryer, Tim D.; Aigbirhio, Franklin I.; Smielewski, Peter; Outtrim, Joanne G.; Chatfield, Doris A.; Pickard, John D.; Hutchinson, Peter J.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England		Menon, DK (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England.	dkm13@wbic.cam.ac.uk	Timofeev, Ivan/AAE-7019-2019	Timofeev, Ivan/0000-0002-1168-0393; Coles, Jonathan/0000-0003-4013-679X; Smielewski, Peter/0000-0001-5096-3938; Outtrim, Joanne/0000-0001-8118-6430	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0601025, G0600986, G0001237] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0600986, G0601025, G0001237] Funding Source: UKRI		Alessandri B, 1999, ACT NEUR S, V75, P25; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; BROWN GC, 1995, FEBS LETT, V369, P136, DOI 10.1016/0014-5793(95)00763-Y; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1975, LANCET, V1, P480; Kietzmann T, 2001, EUR ARCH PSY CLIN N, V251, P170, DOI 10.1007/s004060170037; Kim CH, 2002, CIRC RES, V90, pE25, DOI 10.1161/hh0202.104923; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li J, 2004, FREE RADICAL BIO MED, V36, P1460, DOI 10.1016/j.freeradbiomed.2004.03.005; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Magnusson L, 2003, BRIT J ANAESTH, V91, P61, DOI 10.1093/bja/aeg085; Mander P, 2005, J NEUROSCI RES, V79, P208, DOI 10.1002/jnr.20285; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARTIN WJ, 1981, J CLIN INVEST, V68, P1277, DOI 10.1172/JCI110374; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Menzaghi C, 1999, THYROID, V9, P1, DOI 10.1089/thy.1999.9.1; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reber A, 1996, ANAESTHESIA, V51, P733, DOI 10.1111/j.1365-2044.1996.tb07885.x; Reinert M, 2004, J NEUROSURG, V101, P323, DOI 10.3171/jns.2004.101.2.0323; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; ROTHEN HU, 1995, LANCET, V345, P1387, DOI 10.1016/S0140-6736(95)92595-3; Schwarzmaier S, 2006, J NEUROTRAUM, V23, P769; SCHWEIZER M, 1994, BIOCHEM BIOPH RES CO, V204, P169, DOI 10.1006/bbrc.1994.2441; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Smielewski Peter, 1800, J Clin Monit Comput, V17, P427, DOI 10.1023/A:1026293611455; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; TAKEHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V323, P27, DOI 10.1006/abbi.1995.0005; TEASDALE G, 1974, LANCET, V2, P81; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; WEISDORF DJ, 1982, INFLAMMATION, V6, P245, DOI 10.1007/BF00916406; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42	59	111	112	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2008	36	1					273	281		10.1097/01.CCM.0000292014.60835.15			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YA	WOS:000255232100039	18090356				2022-02-06	
J	Lloyd, V; Gatherer, A; Kalsy, S				Lloyd, Vicki; Gatherer, Amanda; Kalsy, Sunny			Conducting qualitative interview research with people with expressive language difficulties	QUALITATIVE HEALTH RESEARCH			English	Article						qualitative interviews; expressive language deficits; intellectual disability; dementia; stroke; traumatic brain injury	TRAUMATIC BRAIN INJURY; MENTALLY-RETARDED PERSONS; OF-LIFE ASSESSMENT; LEARNING-DISABILITIES; INTELLECTUAL DISABILITY; ALZHEIMERS-DISEASE; STROKE PATIENTS; COMMUNITY INTEGRATION; HEALTH RESEARCH; DEMENTIA	Despite the increasing application of qualitative interviewing and analysis approaches, individuals with expressive language difficulties are still frequently excluded from such research. In this article, the authors seek to clarify the role for and importance of conducting qualitative interviews with respondents with impaired expressive language. They review current research with reference to studies conducted with individuals with intellectual disabilities or dementia, or those who have experienced stroke or traumatic brain injury, and identify deficits within existing research. They consider the challenges and difficulties that contribute to the limited inclusion of individuals with impaired expressive communication in qualitative interviews and discuss the way forward with suggestions of possible means of overcoming these obstacles. They argue that a willingness to adapt methods appropriately and to modify expectations is an important factor in ensuring that researchers hear the voice of respondents with expressive language deficits.	Coventry Univ, Coventry, W Midlands, England				Parsons, Treena/B-7891-2009				Abbeduto L, 1997, MENT RETARD DEV D R, V3, P313, DOI 10.1002/(SICI)1098-2779(1997)3:4<313::AID-MRDD6>3.0.CO;2-O; Aggarwal N, 2003, J Psychiatr Ment Health Nurs, V10, P187; BAKRE C, 2002, RES METHODS CLIN PSY; BAMFORD C, 1998, CONSULTING OLDER PEO; Banister P., 1994, QUALITATIVE METHODS; Barnes C., 1992, DISABILITY HANDICAP, V7, P115, DOI [10.1080/02674649266780151, DOI 10.1080/02674649266780151]; Bays C L, 2001, Rehabil Nurs, V26, P18; Beard RL, 2004, J AGING STUD, V18, P415, DOI 10.1016/j.jaging.2004.06.005; Beattie A, 2004, HEALTH SOC CARE COMM, V12, P359, DOI 10.1111/j.1365-2524.2004.00505.x; BEDROSIAN JL, 1993, TOP LANG DISORD, V13, P36, DOI 10.1097/00011363-199305000-00006; BIKLEN SK, 1988, J ASSOC PERS SEVERE, V13, P155, DOI 10.1177/154079698801300305; Booth T, 1996, DISABIL SOC, V11, P55, DOI 10.1080/09687599650023326; BOURGEOIS MS, 1991, J SPEECH HEAR RES, V34, P831, DOI 10.1044/jshr.3404.831; BRINTON B, 1993, TOP LANG DISORD, V13, P9, DOI 10.1097/00011363-199305000-00004; BRINTON B, 1994, J SPEECH HEAR RES, V37, P369, DOI 10.1044/jshr.3702.369; BURTON A, 1997, DEMENTIA CHALLENGES, P194; Carnaby S, 1997, J INTELL DISABIL RES, V41, P225, DOI 10.1111/j.1365-2788.1997.tb00701.x; CHESTON R, 2000, J MENT HEALTH, V9, P471; Cinamon RG, 2004, CAREER DEV Q, V52, P212, DOI 10.1002/j.2161-0045.2004.tb00643.x; Clare L, 2003, SOC SCI MED, V57, P1017, DOI 10.1016/S0277-9536(02)00476-8; Clare L, 2002, AGING MENT HEALTH, V6, P139, DOI 10.1080/13607860220126826; Clare L., 2002, DEMENTIA, V1, P295, DOI DOI 10.1177/147130120200100303; Clarke P, 2003, J AGING STUD, V17, P171, DOI 10.1016/S0890-4065(03)00005-7; Cohen D., 1991, AM J ALZHEIMERS CARE, V6, P6, DOI DOI 10.1177/153331759100600303; COHEN D, 1986, LOSS SELF FAMILY RES; COHEN L, 1994, ANNU REV ANTHROPOL, V23, P137, DOI 10.1146/annurev.an.23.100194.001033; Conneeley AL., 2003, BRIT J OCCUP THER, V66, P440; Cox E. O., 1998, TOP STROKE REHABIL, V4, P76; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; Davies CA, 1997, DISABIL SOC, V12, P95, DOI 10.1080/09687599727498; DOCHERTY S, 1998, RES NURSING HLTH, V77, P177; Dowswell G, 2002, J EVAL CLIN PRACT, V8, P361, DOI 10.1046/j.1365-2753.2002.00302.x; Faircloth CA, 2004, J AGING STUD, V18, P399, DOI 10.1016/j.jaging.2004.06.006; Finlay WML, 2001, PSYCHOL ASSESSMENT, V13, P319, DOI 10.1037//1040-3590.13.3.319; FLYNN MC, 1986, J MENT DEFIC RES, V30, P369; GARRO L, 1994, SOC SCI MED, V38, P118; GILLEARD CJ, 1984, J EPIDEMIOL COMMUN H, V38, P319, DOI 10.1136/jech.38.4.319; Gillies BA, 2000, AGING MENT HEALTH, V4, P366, DOI 10.1080/713649961; Gillman M, 1997, DISABIL SOC, V12, P675, DOI 10.1080/09687599726985; good b, 1994, MED RATIONALITY EXPE; Goodley D, 1996, DISABIL SOC, V11, P333, DOI 10.1080/09687599627642; HAEGGSTROEM T, 1994, QUALITATIVE HLTH RES, V4, P321; Hagner D, 1996, MENT RETARD, V34, P159; Hagner D., 2002, J VOCATIONAL REHABIL, V17, P65; Hamill LB, 2003, MENT RETARD, V41, P340, DOI 10.1352/0047-6765(2003)41<340:GTCTEO>2.0.CO;2; Harker-Longton W., 2002, J LEARNING DISABILIT, V6, P137, DOI DOI 10.1177/146900470200600203; Harr?, 1992, AGEING SOC, V12, P443, DOI DOI 10.1017/S0144686X00005262; Harris PB, 1999, J AGING STUD, V13, P241, DOI 10.1016/S0890-4065(99)80096-6; HEAL LW, 1995, J INTELL DISABIL RES, V39, P331, DOI 10.1111/j.1365-2788.1995.tb00525.x; Higgins EL, 2002, LEARN DISABILITY Q, V25, P3, DOI 10.2307/1511187; Holst Goran, 2003, Am J Alzheimers Dis Other Demen, V18, P359, DOI 10.1177/153331750301800605; Howorth P, 2003, AGING MENT HEALTH, V7, P113, DOI 10.1080/1360786031000072286; Hubbard G, 2003, AGING MENT HEALTH, V7, P351, DOI 10.1080/1360786031000150685; KANE MN, 1998, AM J ALZHEIMERS DIS, V13, P179; Katsuno T., 2003, DEMENTIA, V2, P315, DOI [DOI 10.1177/14713012030023003, 10.1177/14713012030023003]; Keady J, 1996, J CLIN NURS, V5, P275, DOI 10.1111/jocn.1996.5.5.275; KEADY J, 1995, J DEMENTIA CARE, V13, P15; King C., 1997, CARE GIVING DEMENTIA, V2, P269; KITWOOD T, 1993, WORLDS ILLNESS BIOGR, P143; Kitwood T., 1990, AGEING SOC, V10, P177, DOI [10.1017/S0144686x00008060, DOI 10.1017/S0144686X00008060]; Kitwood Tom, 1992, Ageing Soc, V12, P269, DOI 10.1017/S0144686X0000502X; Kleinman Arthur, 1988, ILLNESS NARRATIVES S; Koch T, 2001, J CLIN NURS, V10, P352, DOI 10.1046/j.1365-2702.2001.00503.x; Kroese BS, 2002, J APPL RES INTELLECT, V15, P324; Kvigne K, 2003, QUAL HEALTH RES, V13, P1291, DOI 10.1177/1049732303257224; Levin E., 1989, FAMILIES SERVICES CO; Lilley SA, 2003, CLIN REHABIL, V17, P540, DOI 10.1191/0269215503cr647oa; Lofgren-Martenson L, 2004, SEX DISABIL, V22, P197, DOI 10.1023/B:SEDI.0000039062.73691.cb; Macdonald J, 2003, PSYCHOL PSYCHOTHER-T, V76, P433, DOI 10.1348/147608303770584764; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Mactavish JB, 2000, MENT RETARD, V38, P216, DOI 10.1352/0047-6765(2000)038<0216:ICSFMI>2.0.CO;2; McLean LK, 1996, AM J MENT RETARD, V100, P580; MCVILLY KR, 1996, BRIT J LEARN DISABIL, V23, P138; MEADAN H, 2004, LEARNING DISABILITIE, V19, P71, DOI DOI 10.1111/J.1540-5826.2004.00091.X; MENNE HL, 2002, INT J SOCIAL RES PRA, V1, P367; Miceli G, 2000, COGN NEUROPSYCHOL, V17, P489, DOI 10.1080/02643290050110629; Mishna F, 1996, INT J GROUP PSYCHOTH, V46, P265, DOI 10.1080/00207284.1996.11491498; Morningstar ME, 1996, EXCEPT CHILDREN, V62, P249; Morris J, 1992, DISABILITY HANDICAP, V7, P157, DOI [10.1080/02674649266780181, DOI 10.1080/02674649266780181]; Mozley CG, 1999, INT J GERIATR PSYCH, V14, P776, DOI 10.1002/(SICI)1099-1166(199909)14:9<776::AID-GPS13>3.0.CO;2-C; Murray CD, 2004, DISABIL REHABIL, V26, P808, DOI 10.1080/09638280410001696746; Myers F, 1998, DISABIL SOC, V13, P389, DOI 10.1080/09687599826704; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Nygard L, 1998, OCCUP THER J RES, V18, P109, DOI 10.1177/153944929801800203; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Oliver M., 1992, DISABILITY HANDICAP, V7, P101, DOI DOI 10.1080/02674649266780141; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pearce A., 2002, DEMENTIA, V1, P173, DOI [10.1177/147130120200100205, DOI 10.1177/147130120200100205]; Perry J, 2002, MENT RETARD, V40, P445, DOI 10.1352/0047-6765(2002)040<0445:SAOQOL>2.0.CO;2; Phinney A, 2003, J AGING STUD, V17, P283, DOI 10.1016/S0890-4065(03)00029-X; PHINNEY A, 2002, INT J SOCIAL RES PRA, V1, P329; Ping E, 2004, INT J REHABIL RES, V27, P241, DOI 10.1097/00004356-200409000-00011; Poston D, 2003, MENT RETARD, V41, P313, DOI 10.1352/0047-6765(2003)41<313:FQOLAQ>2.0.CO;2; Pottie C, 2004, MENT RETARD, V42, P55, DOI 10.1352/0047-6765(2004)42<55:FBPWAW>2.0.CO;2; Pound P, 1994, Qual Health Care, V3, P69, DOI 10.1136/qshc.3.2.69; POUND P, 1995, BMJ-BRIT MED J, V311, P18, DOI 10.1136/bmj.311.6996.18; Proctor G, 2001, DISABIL SOC, V16, P361, DOI 10.1080/09687590120045932; PROUT HT, 1994, COUNSELING PSYCHOTHE, P79; Quayhagen MP, 1996, WESTERN J NURS RES, V18, P120, DOI 10.1177/019394599601800202; Rapley M, 1996, J COMMUNITY APPL SOC, V6, P207, DOI 10.1002/(SICI)1099-1298(199608)6:3<207::AID-CASP370>3.0.CO;2-T; Reid D, 2001, DISABIL SOC, V16, P377, DOI 10.1080/09687590120045941; Rey GJ, 2001, CLIN NEUROPSYCHOL, V15, P13, DOI 10.1076/clin.15.1.13.1911; Robinson P, 1998, INT J AGING HUM DEV, V47, P143, DOI 10.2190/PJY4-WB9F-CN2D-1P2B; Rogers NB, 1998, J INTELL DISABIL RES, V42, P122, DOI 10.1046/j.1365-2788.1998.00103.x; Rogler LH, 1999, AM PSYCHOL, V54, P424, DOI 10.1037/0003-066X.54.6.424; Ross KB, 2001, J MED SPEECH-LANG PA, V9, P31; Ruef MB, 2002, RES PRACT PERS SEV D, V27, P125, DOI 10.2511/rpsd.27.2.125; Scior K, 2003, DISABIL SOC, V18, P779, DOI 10.1080/0968759032000119514; Shakespeare T, 1996, DISABIL SOC, V11, P115, DOI 10.1080/09687599650023380; SIGELMAN CK, 1981, MENT RETARD, V19, P53; SIGELMAN CK, 1980, AM J MENT DEF, V84, P479; SIGELMAN CK, 1981, APPL RES MENT RETARD, V2, P347, DOI 10.1016/0270-3092(81)90029-1; Sinason V, 1992, MENTAL HANDICAP HUMA; Smith J.A., 2003, QUALITATIVE PSYCHOL; Smith J.A., 2003, QUALITATIVE PSYCHOL, P51; Stalker K, 1999, INT J GERIATR PSYCH, V14, P120, DOI 10.1002/(SICI)1099-1166(199902)14:2<120::AID-GPS947>3.0.CO;2-9; Svanstrom R, 2004, WESTERN J NURS RES, V26, P671, DOI 10.1177/0193945904265920; Swain J, 1998, DISABIL SOC, V13, P21, DOI 10.1080/09687599826894; SZIVOSBACH SE, 1993, MENT HANDICAP RES, V0006, P00217, DOI [DOI 10.1111/J.1468-3148.1993.TB00054.X, DOI 10.1111/j.1468-3148.1993.tb00054.x]; Taylor SJ., 1998, INTRO QUALITATIVE RE, V3; Thorne S E, 2000, Annu Rev Nurs Res, V18, P3; TOMPSON D, 2002, J GERONTOLOGICAL SOC, V37, P7; Usher KJ, 1998, J ADV NURS, V27, P692, DOI 10.1046/j.1365-2648.1998.00589.x; Waldron, 1998, J MENTAL HLTH, V7, P95; Whitehouse PJ, 1997, ALZ DIS ASSOC DIS, V11, P56; Willig C., 2001, INTRO QUALITATIVE RE; WORTH A, 1993, J ADV NURS, V18, P1077, DOI 10.1046/j.1365-2648.1993.18071077.x; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302; Zigman W, 1997, J INTELL DISABIL RES, V41, P76, DOI 10.1111/j.1365-2788.1997.tb00679.x; [No title captured]	133	111	111	1	21	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	DEC	2006	16	10					1386	1404		10.1177/1049732306293846			19	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	104YO	WOS:000241996700006	17079800				2022-02-06	
J	Ouellet, MC; Morin, CM				Ouellet, Marie-Christine; Morin, Charles M.			Subjective and objective measures of insomnia in the context of traumatic brain injury: A preliminary study	SLEEP MEDICINE			English	Article						traumatic brain injury; insomnia; polysomnography; subjective; objective	MULTIDIMENSIONAL FATIGUE; PSYCHOMETRIC PROPERTIES; SLEEP DISTURBANCES; EEG SLEEP; LONG-TERM; INVENTORY; COMPLAINTS; PATTERNS; VALIDATION; DEPRESSION	Background and purpose: To compare subjective and objective measures of sleep in traumatic brain injury patients (TBI) suffering from insomnia and in controls. Patients and methods: Fourteen patients with mild to severe TBI were compared to 14 healthy good sleepers. Subjective measures of insomnia were obtained from a sleep diary (morning questionnaire), and objective measures from two nights of polysomnography (PSG). Results: All subjective measures of sleep revealed significant sleep disturbance in the TBI group. TBI patients with insomnia have a tendency to overestimate their sleep disturbance compared to PSG measures of sleep. With PSG, 10 out of 14 participants with TBI could be defined as having objective insomnia. Nonetheless, when groups were compared, no significant differences were found on sleep continuity variables, although large effect sizes were seen for several measures suggesting sleep fragmentation. In terms of sleep architecture, no significant differences were found in the percentage of stage 2, slow-wave (stages 3 and 4), and rapid eye movement (REM) sleep, but a higher proportion of stage I sleep was found in the TBI participants. When patients using psychotropic medication were excluded, TBI patients were found to have more awakenings lasting longer than 5 min and a shorter REM sleep latency. Conclusions: These results are similar to those found in patients with either primary insomnia or insomnia related to depression. (C) 2006 Elsevier B.V. All rights reserved.	Univ Laval, Ecole Psychol, Quebec City, PQ G1K 7P4, Canada		Ouellet, MC (corresponding author), Hop Enfants Jesus, CHA Pavillon Notre Dame,1401 18E Rue, Quebec City, PQ G1J 1Z4, Canada.	marie-christine.ouellet.1@ulaval.ca	Morin, Charles/G-1021-2011; Morin, Charles M./A-4700-2008	Morin, Charles M./0000-0002-8649-8895; Ouellet, Marie-Christine/0000-0003-3477-1893			*AM SLEEP DIS ASS, 1997, INT CLASS SLEEP DIS; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BERGAMASCO B, 1968, ELECTROEN CLIN NEURO, V24, P374, DOI 10.1016/0013-4694(68)90198-3; Blais FC, 1997, ENCEPHALE, V23, P447; BRICOLO A, 1968, ACTA NEUROL SCAND, V44, P512, DOI 10.1111/j.1600-0404.1968.tb05589.x; CARSKADON MA, 1976, AM J PSYCHIAT, V133, P1382; CHATRIAN GE, 1963, ELECTROEN CLIN NEURO, V15, P272, DOI 10.1016/0013-4694(63)90096-8; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; DEMENT WC, 1972, SLEEP MATURING NERVO, P319; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EDINGER JD, 1995, SLEEP, V18, P232, DOI 10.1093/sleep/18.4.232; Edinger JD, 1997, SLEEP, V20, P1119, DOI 10.1093/sleep/20.12.1119; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fillion L, 2003, CANCER NURS, V26, P143, DOI 10.1097/00002820-200304000-00008; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; FRANKEL BL, 1976, ARCH GEN PSYCHIAT, V33, P615; FREESTON MH, 1994, ENCEPHALE, V20, P47; GEORGE B, 1981, NEUROCHIRURGIE, V27, P35; GEORGE B, 1986, NEUROCHIRURGIA, V29, P45; Gervais M, 1999, ETUDE EXPLORATOIRE B; HUBAIN PP, 1990, J AFFECT DISORDERS, V18, P67, DOI 10.1016/0165-0327(90)90118-R; JOHNSON LC, 1983, MIL MED, V148, P727; JOHNSON LC, 1981, ELECTROEN CLIN NEURO, V52, P89, DOI 10.1016/0013-4694(81)90193-0; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kaynak H, 2004, SLEEP MED, V5, P15, DOI 10.1016/j.sleep.2003.06.006; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; KUPFER DJ, 1972, LANCET, V2, P684; LENARD HG, 1970, ACTA PAEDIATR SCAND, V59, P565, DOI 10.1111/j.1651-2227.1970.tb16809.x; Lustberg L, 2000, SLEEP MED REV, V4, P253, DOI 10.1053/smrv.1999.0075; Mahowald Mark W., 1996, P285; Mahowald MW, 2000, NEUROL DIS, V49, P365; MCCALL WV, 1993, J AMBULATORY MONITOR, V6, P135; MELLINGER GD, 1985, ARCH GEN PSYCHIAT, V42, P225, DOI 10.1001/archpsyc.1985.01790260019002; Morin CM, 1993, PSYCHOL ASSESSMENT M; MOURET J, 1988, PSYCHOPHARMACOLOGY, V95, pS37; Ott GE, 2004, INT J NEUROPSYCHOPH, V7, P275, DOI 10.1017/S1461145704004298; OUELLET MC, IN PRESS J HEAD TRAU; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Rechtschaffen A., 1968, MANUAL STANDARDIZED; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; ROTH T, 1976, COMPR PSYCHIAT, V17, P217, DOI 10.1016/0010-440X(76)90072-9; Saletu-Zyhlarz GM, 2002, PROG NEURO-PSYCHOPH, V26, P249, DOI 10.1016/S0278-5846(01)00262-7; SALINPASCUAL RJ, 1992, AM J PSYCHIAT, V149, P904; SEWITCH DE, 1984, SLEEP, V7, P147, DOI 10.1093/sleep/7.2.147; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; SPINWEBER CL, 1982, PSYCHOPHARMACOLOGY, V76, P5, DOI 10.1007/BF00430746; Wohlgemuth WK, 1999, PSYCHOPHYSIOLOGY, V36, P233, DOI 10.1017/S0048577299971214; Yamadera H, 1998, PSYCHIAT CLIN NEUROS, V52, P439, DOI 10.1046/j.1440-1819.1998.00403.x; [No title captured], DOI DOI 10.1037/H0081254	56	111	113	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	SEP	2006	7	6					486	497		10.1016/j.sleep.2006.03.017			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	094AW	WOS:000241212400004	16934524				2022-02-06	
J	Hiler, M; Czosnyka, M; Hutchinson, P; Balestreri, M; Smielewski, P; Matta, B; Pickard, JD				Hiler, M; Czosnyka, M; Hutchinson, P; Balestreri, M; Smielewski, P; Matta, B; Pickard, JD			Predictive value of initial computerized tomography scan, intracranial pressure, and state of autoregulation in patients with traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; intracranial pressure; computerized tomography; outcome	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; UNITED-KINGDOM; CARE; CLASSIFICATION; HYPERTENSION; THRESHOLDS; REACTIVITY; MANAGEMENT	Object. The authors explored the relationship between computerized tomography (CT) scan findings and intracranial pressure (ICP) measurements obtained in the first 24 hours of monitoring to identify parameters predicting outcome in patients with severe traumatic brain injury (TBI). Methods. Intracranial pressure, mean arterial blood pressure, cerebral perfusion pressure (CPP), and pressure reactivity index were measured continuously in 126 patients with severe TBI who were admitted to a neuroscience critical care unit. Mean values in the initial 24 hours of monitoring and in the total period of monitoring were compared with types of injury categorized on the basis of the initial CT scan according to the classification of Marshall, et al., and with Glasgow Outcome Scale scores. The initial CT scan classification correlated significantly but weakly with ICP measured during the first 24 hours of monitoring (p = 0.036) but not with mean ICP over the total time of intensive care. Both midline shift and the ratio of frontal horn diameter to internal diameter correlated with ICP in the first 24 hours (p < 0.007) and with ICP over the total monitoring period (p < 0.03). Outcome score correlated with initial CT scan findings (p = 0.018), ICP over the total monitoring period (p < 0.0023), pressure reactivity over the total monitoring period (p < 0.0002), and pressure reactivity in the first 24 hours (p < 0.0001) but not with ICP in the first 24 hours. Patients with disturbed pressure reactivity in the first 24 hours after injury had a significantly higher mortality rate than patients with intact pressure reactivity (28.6% compared with 9.5%; p < 0.001). Conclusions. Patients with severe TBI who have early loss of autoregulation have a worse prognosis. Mean ICP values in patients with diffuse TBI cannot be predicted by using the Marshall CT scan classification.	Univ Cambridge, Dept Clin Neurosci, Acad Neurosurg Unit, Cambridge, England; Addenbrookes NHS Trust, Dept Anaesthet, Cambridge CB2 2QQ, England		Czosnyka, M (corresponding author), Addenbrookes Hosp, Acad Neurosurg Unit, Box 167,Hills Rd, Cambridge CB2 2QQ, England.	mc141@medschl.cam.ac.uk		Smielewski, Peter/0000-0001-5096-3938	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0601025, G9439390] Funding Source: Medline		Al-Rawi PG, 2000, ZBL NEUROCHIR, V61, P74, DOI 10.1055/s-2000-8263; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; EDDY VA, 1995, AM SURGEON, V61, P24; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Lubillo S, 2000, ACT NEUR S, V76, P415; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Poca MA, 1998, ACT NEUR S, V71, P27; ROPPER AH, 2004, NEUROLOGICAL NEUROSU; Smielewski P, 1997, INT J CLIN MONIT COM, V14, P185, DOI 10.1023/A:1016901710584; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002	23	111	117	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2006	104	5					731	737		10.3171/jns.2006.104.5.731			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	041CD	WOS:000237429800007	16703877				2022-02-06	
J	Mendez, MF				Mendez, Mario F.			The accurate diagnosis of early-onset dementia	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article						dementia; Alzheimer's disease; vascular dementia; frontotemporal dementia; traumatic brain injury	ALZHEIMERS-DISEASE; PRESENILE-DEMENTIA; VASCULAR DEMENTIA; FRONTOTEMPORAL DEMENTIA; PREVALENCE; FEATURES; POPULATION; HEALTH; ASCERTAINMENT; IMPAIRMENT	Early-onset dementia (EOD, < 65 years at onset) is a relatively common and frequently misdiagnosed condition. One reason for misdiagnosis is that EOD has a more varied differential diagnosis than late-onset dementia (LOD). For example, Alzheimer's disease (AD), the preponderant LOD, makes up only about one-third of EODs; the rest are due to vascular dementias, frontotemporal lobar degenerations, traumatic head injury, alcohol-related dementia, and a great many other conditions. Another reason for misdiagnosis is that early-onset AD may have predominant cognitive deficits other than memory loss and a potential familial inheritance with spastic paraparesis, seizures, or myoclonus. A third reason is that EOD often presents with neuropsychiatric features out-of-proportion to any cognitive deficits. Despite these obstacles, it is important to accurately diagnose EODs, particularly because they differ in management and course. Clinicians can successfully diagnose most EODs with careful cognitive and family histories, mental status and neurological examinations, and neuroimaging.	VA Greater Los Angeles Healthcare Syst, Neurobiol Unit, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA		Mendez, MF (corresponding author), VA Greater Los Angeles Healthcare Syst, Neurobiol Unit, 116AF,Bldg 500,3S,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	mmendez@ucla.edu					BICKEL H, 2005, NERVENARZT      0615; Caine D, 2001, NEUROPSYCHOLOGY, V15, P155, DOI 10.1037/0894-4105.15.2.155; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J; DELANY N, 1995, INT J GERIATR PSYCH, V10, P597, DOI 10.1002/gps.930100710; Elberling TV, 2002, NEUROLOGY, V59, P1259, DOI 10.1212/WNL.59.8.1259; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Frisoni GB, 2005, J NEUROL NEUROSUR PS, V76, P112, DOI 10.1136/jnnp.2003.029876; Fujihara S, 2004, ARQ NEURO-PSIQUIAT, V62, P592, DOI 10.1590/S0004-282X2004000400005; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; Hodges JR, 2004, ANN NEUROL, V56, P399, DOI 10.1002/ana.20203; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; JACOBS D, 1994, NEUROLOGY, V44, P1215, DOI 10.1212/WNL.44.7.1215; Kemp PM, 2003, J NEUROL NEUROSUR PS, V74, P715, DOI 10.1136/jnnp.74.6.715; Knopman DS, 2003, ARCH NEUROL-CHICAGO, V60, P569, DOI 10.1001/archneur.60.4.569; KOKMEN E, 1989, NEUROLOGY, V39, P773, DOI 10.1212/WNL.39.6.773; Kono I, 2004, GERONTOLOGY, V50, P242, DOI 10.1159/000078353; KONO K, 1994, J GERIATR PSYCH NEUR, V7, P39, DOI 10.1177/089198879400700108; Lopez OL, 2005, NEUROLOGY, V64, P1539, DOI 10.1212/01.WNL.0000159860.19413.C4; LORING DW, 1985, NEUROPSYCHOLOGIA, V23, P351, DOI 10.1016/0028-3932(85)90021-1; MCGONIGAL G, 1993, BRIT MED J, V306, P680, DOI 10.1136/bmj.306.6879.680; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McMurtray A, 2006, DEMENT GERIATR COGN, V21, P59, DOI 10.1159/000089546; Mendez M. F., 2003, DEMENTIA CLIN APPROA; Mendez MF, 1997, BRAIN COGNITION, V34, P301, DOI 10.1006/brcg.1997.0923; Mendez MF, 2005, DEMENT GERIATR COGN, V20, P99, DOI 10.1159/000086474; Mendez MF, 1996, NEUROLOGY, V47, P1189, DOI 10.1212/WNL.47.5.1189; Mendez MF, 2002, J NEUROPSYCH CLIN N, V14, P424, DOI 10.1176/appi.neuropsych.14.4.424; Mendez MF, 1999, DEMENT GERIATR COGN, V10, P518, DOI 10.1159/000017199; MENDEZ MF, IN PRESS AM J GERIAT; MENDEZ MF, IN PRESS ALZHEIMER D; Mendible M, 2002, CRITIQUE-ST CONTEMP, V43, P289, DOI 10.1080/00111610209602186; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; NEWENS AJ, 1993, PSYCHOL MED, V23, P631, DOI 10.1017/S0033291700025411; Panegyres PK, 2000, MED J AUSTRALIA, V173, P279, DOI 10.5694/j.1326-5377.2000.tb125651.x; Passant U, 2005, ALZ DIS ASSOC DIS, V19, pS15, DOI 10.1097/01.wad.0000183084.22562.5a; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Raux G, 2000, NEUROLOGY, V55, P1577, DOI 10.1212/WNL.55.10.1577; Reed BR, 2004, CLIN NEUROPSYCHOL, V18, P63, DOI 10.1080/13854040490507163; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Sakamoto S, 2002, J NEUROL SCI, V200, P27, DOI 10.1016/S0022-510X(02)00114-4; Sampson EL, 2004, POSTGRAD MED J, V80, P125, DOI 10.1136/pgmj.2003.011171; SELTZER B, 1983, ARCH NEUROL-CHICAGO, V40, P143, DOI 10.1001/archneur.1983.04050030037006; Smith DM, 1995, INT J ADDICT, V30, P1843, DOI 10.3109/10826089509071058; TREVES T, 1986, ARCH NEUROL-CHICAGO, V43, P26, DOI 10.1001/archneur.1986.00520010022014; Wen HM, 2004, STROKE, V35, P1826, DOI 10.1161/01.STR.0000133686.29320.58; Woodburn K, 1999, INT J GERIATR PSYCH, V14, P362, DOI 10.1002/(SICI)1099-1166(199905)14:5<362::AID-GPS914>3.3.CO;2-L; World Health Organization, 1992, INT CLASS DIS; Yokota O, 2005, EUR J NEUROL, V12, P782, DOI 10.1111/j.1468-1331.2005.01072.x	50	111	113	0	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0091-2174	1541-3527		INT J PSYCHIAT MED	Int. J. Psychiatr. Med.		2006	36	4					401	412		10.2190/Q6J4-R143-P630-KW41			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	150VY	WOS:000245248900002	17407994	Green Submitted			2022-02-06	
J	McCarthy, ML; MacKenzie, EJ; Durbin, DR; Aitken, ME; Jaffe, KM; Paidas, CN; Slomine, BS; Dorsch, AM; Berk, RA; Christensen, JR; Ding, R				McCarthy, ML; MacKenzie, EJ; Durbin, DR; Aitken, ME; Jaffe, KM; Paidas, CN; Slomine, BS; Dorsch, AM; Berk, RA; Christensen, JR; Ding, R		CHAT Study Grp	The pediatric quality of life inventory: An evaluation of its reliability and validity for children with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	7th World Conference on Injury Prevention and Safety Promotion	JUN 06-09, 2004	Vienna, AUSTRIA			brain injuries; pediatrics; quality of life; rehabilitation	BEHAVIOR RATING INVENTORY; GENERIC CORE SCALES; EXECUTIVE FUNCTION; HEALTH-STATUS; INTELLECTUAL ABILITY; HEAD-INJURY; PEDSQL(TM)-4.0; ADOLESCENTS; SENSITIVITY; PREVALENCE	Objectives: To assess the reliability and validity of the Pediatric Quality of Life Inventory, version 4.0 (PedsQL), and to compare it with that of the Behavior Rating Inventory of Executive Function (BRIEF) among children with traumatic brain injury (TBI). Design: Prospective cohort study that documented the health-related quality of life of 391 children at 3 and 12 months postinjury. Setting: Four level I pediatric trauma centers. Participants: Children (age range, 5-15y) hospitalized with a TBI or an extremity fracture. Interventions: Not applicable. Main Outcome Measures: Parent-reported PedsQL and BRIEF scale scores. Results: Both the PedsQL and BRIEF scales showed good internal consistency (PedsQL a range,.74-.93; BRIEF alpha range,.82-98) and test-retest reliability (PedsQL r range, .75-90; BRIEF r range, .82-92), respectively. Factor analysis revealed that most PedsQL items loaded most highly on their conceptually derived scale. The PedsQL cognitive function scale detected the largest differences among groups of children with varying severities of TBI as well as parents' assessment of change in cognition postinjury. Conclusions: Although the reliability of the 2 instruments is comparable, the PedsQL discriminates better among children with TBI. The PedsQL is a promising instrument for measuring the health of children after TBI.	Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, John Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Arkansas Med Sci, Dept Pediat, Coll Med, Little Rock, AR 72205 USA; Childrens Hosp & Reg Med Ctr, Dept Rehabil Med, Seattle, WA USA; Childrens Hosp & Reg Med Ctr, Dept Pediat, Seattle, WA USA; Univ Washington, Sch Med, Seattle, WA 98195 USA; Univ S Florida, Dept Surg, Tampa, FL 33620 USA; Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Childrens Hosp & Reg Med Ctr, Div Rehabil Psychol, Seattle, WA USA; Johns Hopkins Sch Nursing, Baltimore, MD USA		McCarthy, ML (corresponding author), 1830 E Monument St,Ste 6-111, Baltimore, MD 21205 USA.	mmccarth@jhmi.edu	ding, ru/B-1615-2009; Durbin, Dennis/AAD-7829-2022; Aitken, Mary/ABG-6119-2021	Aitken, Mary/0000-0002-8318-9755	ODCDC CDC HHS [R49/CCR319701] Funding Source: Medline		Bastiaansen D, 2004, QUAL LIFE RES, V13, P489, DOI 10.1023/B:QURE.0000018483.01526.ab; Cohen J., 2013, STAT POWER ANAL BEHA; Committee on Injury Scaling, 1990, ABBR INJ SCAL 1990 R; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Daltroy LH, 1998, J PEDIATR ORTHOPED, V18, P561, DOI 10.1097/00004694-199809000-00001; Denckla MB, 1996, DEV NEUROPSYCHOL, V12, P5, DOI 10.1080/87565649609540637; Friefeld S, 2004, CNS SPECTRUMS, V9, P465; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA IP, 2000, BEHAV RATING INVENTO; Haley S, 1992, PEDIAT EVALUATION DI; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KAPLAN RM, 1976, HEALTH SERV RES, V11, P478; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; LANDGRAF JM, 1996, CHQ USERS MANUAL BOS; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LIANG MH, 1985, ARTHRITIS RHEUM, V28, P542, DOI 10.1002/art.1780280513; MACKENZIE EJ, 1984, AM J EMERG MED, V2, P537, DOI 10.1016/0735-6757(84)90081-0; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P52, DOI 10.1076/chin.8.1.52.8719; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Norman, 1995, HLTH MEASUREMENT SCA; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P29, DOI 10.1016/0001-4575(81)90040-3; Powers SW, 2004, CEPHALALGIA, V24, P120, DOI 10.1111/j.1468-2982.2004.00652.x; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; SPILKER B, 1998, QUALITY LIFE PHARMAC; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; STEIN REK, 1990, MED CARE, V28, P1041, DOI 10.1097/00005650-199011000-00006; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Varni JW, 2002, ARTHRITIS RHEUM, V46, P714, DOI 10.1002/art.10095; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2003, DIABETES CARE, V26, P631, DOI 10.2337/diacare.26.3.631; Varni JW, 2004, J BEHAV MED, V27, P297, DOI 10.1023/B:JOBM.0000028500.53608.2c	48	111	112	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2005	86	10					1901	1909		10.1016/j.apmr.2005.03.026			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	972KB	WOS:000232451600001	16213229				2022-02-06	
J	Babikian, T; Freier, MC; Tong, KA; Nickerson, JP; Wall, CJ; Holshouser, BA; Burley, T; Riggs, ML; Ashwal, S				Babikian, T; Freier, MC; Tong, KA; Nickerson, JP; Wall, CJ; Holshouser, BA; Burley, T; Riggs, ML; Ashwal, S			Susceptibility weighted imaging: Neuropsychologic outcome and pediatric head injury	PEDIATRIC NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; EXECUTIVE FUNCTION; FOCAL LESIONS; CHILDREN; ADOLESCENTS; SEVERITY; COHORT; MRI; COMPONENTS	Traumatic brain injury is among the most frequent pediatric neurologic disorders in the United States, affecting multiple aspects of neuropsychologic functioning. This study assessed the efficacy of susceptibility weighted imaging as a predictor of long-term neuropsychologic functioning after pediatric brain injury compared with magnetic resonance spectroscopic imaging. Susceptibility weighted imaging is a relatively new method that is considered superior to traditional magnetic resonance imaging sequences for detecting hemorrhagic diffuse axonal injury. In this study, imaging and spectroscopy were acquired 6 +/- 4 days after injury. Measures of neuropsychologic functioning were administered to 18 children and adolescents 1-4 years post injury. Negative correlations between lesion number and volume with neuropsychologic functioning were demonstrated. Lesion volume explained over 32% of the variance in cognitive performance, explaining at least an additional 20% beyond injury severity and age at injury alone and 19% beyond magnetic resonance spectroscopic metabolite variables. Exploratory analyses resulted in notable trends, with lesions in deeper brain regions more strongly associated with poorer neuropsychologic performance. Improved detection of the extent of diffuse axonal injury following a brain injury will allow for a better understanding of its association with long-term outcome, which in turn can improve prognostic efficacy for effective treatment planning. (c) 2005 by Elsevier Inc. All rights reserved.	Univ Calif Los Angeles, Inst Neuropsychiat, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Loma Linda Univ, Dept Psychol, Loma Linda, CA 92350 USA; Loma Linda Univ, Dept Pediat, Loma Linda, CA 92350 USA; Childrens Hosp, Loma Linda, CA USA; Loma Linda Univ, Dept Radiol, Med Ctr, Loma Linda, CA 92350 USA; Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA; Univ Saskatchewan, Royal Univ Hosp, Dept Med Imaging, Saskatoon, SK, Canada; Portland State Univ, Dept Psychol, Portland, OR 97207 USA; Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA		Babikian, T (corresponding author), Univ Calif Los Angeles, Inst Neuropsychiat, Dept Psychiat & Biobehav Sci, Room C8-746,760 Westwood Plaza, Los Angeles, CA 90024 USA.						Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; FRANZEN MD, 1998, SCREENING CHILDREN B; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; GILLES EE, 1999, PEDIAT NEUROLOGY PRI, P898; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Macmillan CSA, 2002, ACTA NEUROCHIR, V144, P853, DOI 10.1007/s00701-002-0966-x; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; ROSMAN NP, 1999, PEDIAT NEUROLOGY PRI; Signoretti S, 2002, ACT NEUR S, V81, P373; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Verger K, 2001, BRAIN INJURY, V15, P211; Vriezen ER, 2000, BRAIN COGNITION, V44, P67; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; WILSON J T L, 1990, Brain Injury, V4, P349	39	111	125	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	SEP	2005	33	3					184	194		10.1016/j.pediatrneurol.2005.03.015			11	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	967TN	WOS:000232114200006	16139733				2022-02-06	
J	Wong, EYH; Herbert, J				Wong, EYH; Herbert, J			Roles of mineralocorticoid and glucocorticoid receptors in the regulation of progenitor proliferation in the adult hippocampus	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						adrenal-derived corticoids; adrenalectomy; dentate gyrus; mifepristone; neurogenesis; spironolactone	RAT DENTATE GYRUS; TRAUMATIC BRAIN INJURY; CORTICOSTERONE TREATMENT; DEPENDENT MECHANISM; NEUROTROPHIC FACTOR; NEURAL PROGENITORS; CELL-PROLIFERATION; ADRENAL-STEROIDS; NEUROGENESIS; EXPRESSION	New neurons are produced continually in the dentate gyrus of the hippocampus. Numerous factors modulate the rate of neuron production. One of the most important is the adrenal-derived corticoids. Raised levels of corticoids suppress proliferation of progenitor cells, while removal of corticoids by adrenalectomy reverses this. The exact mechanisms by which corticoids mediate such regulation are unknown, but corticoids are believed to act through the receptors for mineralocorticoids (MR) and glucocorticoids (GR). Previous reports regarding the roles of these receptors in regulating cell proliferation came to contrasting conclusions. Here we use both agonists and antagonists to these receptors in adult male rats to investigate and clarify their roles. Blockade of MR with spironolactone in adrenalectomised male rats implanted with a corticosterone pellet to reproduce basal levels enhanced proliferation, whereas treatment with the GR antagonist mifepristone had no effect. However, mifepristone reversed the suppressive effect of additional corticosterone in intact rats. Both aldosterone and RU362, agonists of MR and GR, respectively, reduced proliferation in adrenalectomised rats, and combined treatment with both agonists had an additional suppressive action. These results clearly show that occupancies of both receptors act in the same direction on progenitor proliferation. The existence of two receptors with different affinities for corticoids may ensure that proliferation of progenitor cells in the adult dentate gyrus is regulated across the range of adrenal corticoid activity, including both basal and stressful contexts. Although a small proportion of newly formed cells may express GR and MR, corticosterone probably regulates proliferation indirectly through other local cells.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England		Herbert, J (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	jh24@cam.ac.uk	Herbert, Joe/K-5877-2013		Wellcome TrustWellcome TrustEuropean Commission [070288] Funding Source: Medline		Aberg MAI, 2000, J NEUROSCI, V20, P2896; Alonso G, 2000, GLIA, V31, P219, DOI 10.1002/1098-1136(200009)31:3<219::AID-GLIA30>3.0.CO;2-R; Ambrogini P, 2002, NEUROENDOCRINOLOGY, V76, P366, DOI 10.1159/000067581; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; CAMERON HA, 1993, BRAIN RES, V611, P342, DOI 10.1016/0006-8993(93)90524-Q; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Conrad CD, 1999, NEUROBIOL LEARN MEM, V72, P39, DOI 10.1006/nlme.1998.3898; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fischer AK, 2002, BRAIN RES, V947, P290, DOI 10.1016/S0006-8993(02)03042-1; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Goodyer IM, 2000, BRIT J PSYCHIAT, V176, P142, DOI 10.1192/bjp.176.2.142; Gould E, 1997, DEV BRAIN RES, V103, P91, DOI 10.1016/S0165-3806(97)00079-5; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gubba EM, 2004, MOL BRAIN RES, V127, P48, DOI 10.1016/j.molbrainres.2004.05.004; Harris TO, 2000, BRIT J PSYCHIAT, V177, P505, DOI 10.1192/bjp.177.6.505; Hastings NB, 2003, NAT MED, V9, P264, DOI 10.1038/nm0303-264; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Hellsten J, 2002, EUR J NEUROSCI, V16, P283, DOI 10.1046/j.1460-9568.2002.02093.x; Islam A, 1998, BRAIN RES, V797, P342, DOI 10.1016/S0006-8993(98)00389-8; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kulkarni VA, 2002, EUR J NEUROSCI, V16, P2008, DOI 10.1046/j.1460-9568.2002.02268.x; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Liu JL, 1998, J NEUROSCI, V18, P7768; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; Montaron MF, 2003, EUR J NEUROSCI, V18, P3105, DOI 10.1111/j.1460-9568.2003.03048.x; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Sapolsky RM, 2004, BIOL PSYCHIAT, V56, P137, DOI 10.1016/j.biopsych.2004.04.012; Schaaf M J, 2000, Stress, V3, P201, DOI 10.3109/10253890009001124; Seki Tatsunori, 2003, Anatomical Science International, V78, P69, DOI 10.1046/j.0022-7722.2003.00043.x; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Ueki T, 2003, J NEUROSCI, V23, P11732; VANEEKELEN JAM, 1988, J NEUROSCI RES, V21, P88, DOI 10.1002/jnr.490210113; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x	44	111	117	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2005	22	4					785	792		10.1111/j.1460-9568.2005.04277.x			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	957UB	WOS:000231397700001	16115202	Green Accepted			2022-02-06	
J	Agha, A; Sherlock, M; Phillips, J; Tormey, W; Thompson, CJ				Agha, A; Sherlock, M; Phillips, J; Tormey, W; Thompson, CJ			The natural history of post-traumatic neurohypophysial dysfunction	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ANTI-DIURETIC HORMONE; UNUSUAL DELAYED-ONSET; DIABETES-INSIPIDUS; HEAD-INJURY; INAPPROPRIATE SECRETION; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; VASOPRESSIN RELEASE; PRACTICAL SCALE	Background and objectives: Posterior pituitary function remains poorly investigated after traumatic brain injury (TBI). We report the results of a study designed to prospectively define the natural history of post-traumatic diabetes insipidus (DI) and syndrome of inappropriate antidiuretic hormone secretion (SIADH) using standard reliable methodology. Design and methods: 50 consecutive patients with severe or moderate TBI (initial Glasgow Coma Scale (GCS) score 3/15-13/15) were prospectively studied on three occasions: at the acute phase and at 6 months and at 12 months following TBI. In the acute phase, DI was diagnosed either by the presence of hypernatraemia in association with hypotonic polyuria or by the water-deprivation test (WDT) and. at 6 and 12 months by the WDT in all patients. Normative data on response to the WDT were obtained from healthy matched volunteers. Functional outcome was assessed using the Glasgow Outcome Scale (GOS). Results: 13 patients (26%) had DI in the acute post-TBI phase, of whom nine patients recovered by 6 months and one additional patient recovered by 12 months. Of the remaining three patients with permanent DI, two had partial vasopressin deficiency. Acute-phase peak plasma osmolality correlated negatively with the initial GCS scores (r = -0.39, P = 0.005) and with the GOS scores (r = -0.45, P = 0.001). Seven patients had SIADH in the acute phase of TBI but none did at 6 or 12 months. No new cases of DI or SIADH were noted after the acute phase. Conclusion: This prospective study shows that posterior pituitary dysfunction is common following TBI. Most cases recover completely but there is an appreciable frequency of long-term DI which can be subtle and should be recognized and managed appropriately.	Beaumont Hosp, Acad Dept Endocrinol, Dublin, Ireland; Beaumont Hosp, Dept Neurosurg, Dublin, Ireland; Beaumont Hosp, Dept Clin Chem, Dublin, Ireland		Thompson, CJ (corresponding author), Beaumont Hosp, Acad Dept Endocrinol, Dublin, Ireland.	christhompson@beaumont.ie					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Alaca R, 2002, AM J PHYS MED REHAB, V81, P788, DOI 10.1097/00002060-200210000-00013; ANDERSON RJ, 1986, KIDNEY INT, V29, P1237, DOI 10.1038/ki.1986.134; ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; Baylis P, 2001, PRINCIPLES PRACTICE; BECKER RM, 1973, J TRAUMA, V13, P112, DOI 10.1097/00005373-197302000-00003; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BOHNEN N, 1993, EUR NEUROL, V33, P77, DOI 10.1159/000116907; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Boughey JC, 2004, AM SURGEON, V70, P500; DASHE AM, 1963, JAMA-J AM MED ASSOC, V185, P699, DOI 10.1001/jama.1963.03060090031011; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; EDWARDS OM, 1986, MEDICINE, V65, P281; HADANI M, 1985, J NEUROSURG, V63, P456, DOI 10.3171/jns.1985.63.3.0456; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; SECKL J, 1989, BRIT MED J, V298, P2, DOI 10.1136/bmj.298.6665.2; Smith D, 2002, J CLIN ENDOCR METAB, V87, P4564, DOI 10.1210/jc.2002-020090; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; THOMPSON CJ, 1986, CLIN SCI, V71, P651, DOI 10.1042/cs0710651; THOMPSON CJ, 1991, AM J PHYSIOL, V260, pR533, DOI 10.1152/ajpregu.1991.260.3.R533; TRAINER PJ, 1995, BARTS ENDOCRINE PROT, P19; TWIJNSTRA A, 1980, CLIN NEUROL NEUROSUR, V82, P263, DOI 10.1016/0303-8467(80)90018-9; VERBALIS JG, 1989, BAILLIERE CLIN ENDOC, V3, P499, DOI 10.1016/S0950-351X(89)80013-8; VERBALIS JG, 2001, PRINCIPLES PRACTICE, P293; VIGERHOETS F, 1988, ACTA NEUROCHIR, V91, P50; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340; World Health Organization, 1980, INT CLASS IMP DIS HA; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	33	111	118	0	2	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	MAR	2005	152	3					371	377		10.1530/eje.1.01861			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	910CE	WOS:000227906200008	15757853	Bronze			2022-02-06	
J	Fork, M; Bartels, L; Ebert, AD; Grubich, C; Synowitz, H; Wallesch, CW				Fork, M; Bartels, L; Ebert, AD; Grubich, C; Synowitz, H; Wallesch, CW			Neuropsychological sequelae of diffuse traumatic brain injury	BRAIN INJURY			English	Article							BLUNT HEAD-INJURY; AXONAL INJURY; FOCAL LESIONS	Primary objectives: Description and analysis of neuropsychological deficits following brain trauma with diffuse lesion probably corresponding to diffuse axonal injury (DAI). Research design: A series of 111 patients suffering from traumatic brain injury could be investigated neuropsychologically within the first 4 weeks after injury and re-assessed after 5-8 months. They included 11 subjects with CT-evidence of diffuse axonal injury, but no C T-signs of focal contusions. Eleven patients with focal frontal contusions but no CT signs of DAI were matched to and compared with the DAI subjects. Seventeen TBI patients with normal CT scans served as controls. Results: When assessed within the first 4 weeks after TBI, both DAI and frontal contusion patients exhibited behavioural abnormalities and deficits in Wechsler Similarities. The DAI patients were also impaired in Digit Span backward and Stroop interference. When re-assessed, the DAI patients showed considerable deficits in the California Verbal Learning Test and in the Wisconsin Card Sorting Test. Conclusions: DAI leads to neuropsychological impairment dominated by executive and memory dysfunction.	Otto Von Guericke Univ, Dept Neurol, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Div Neuropsychol, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Dept Neurosurg, D-39120 Magdeburg, Germany; Univ Bremen, Dept Neuropsychol, Bremen, Germany		Wallesch, CW (corresponding author), Otto Von Guericke Univ, Dept Neurol, Leipziger Str 44, D-39120 Magdeburg, Germany.	wallesch@medizin.uni-magdeburg.de					DELIS C, 1987, CALIFORNIA VERBAL LE; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1994, HEAD INJURY, P137; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Harting C., 2000, WECHSLER GEDACHTNIST; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; OSWALD WD, 1995, NURNBERGER ALTERSINV; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schellig D., 1997, BLOCK TAPPING TEST; TEWES U, 1994, HDB TESTANWEISUNG, V2; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, WECHSLER MEMORY SCAL; WILCOX D, 1996, IMAGE TOOL 2 00; ZIMMERMANN P, 1993, NEUROPSYCHOLOGISCHE	23	111	113	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2005	19	2					101	108		10.1080/02699050410001726086			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	990JR	WOS:000233739600004	15841754				2022-02-06	
J	Chamelian, L; Reis, M; Feinstein, A				Chamelian, L; Reis, M; Feinstein, A			Six-month recovery from mild to moderate Traumatic Brain Injury: the role of APOE-epsilon 4 allele	BRAIN			English	Article						APOE-epsilon 4 allele; cognitive testing; mood; psychosocial outcome; head injury	APOLIPOPROTEIN-E POLYMORPHISM; ROUTINE FOLLOW-UP; HEAD-INJURY; ALZHEIMERS-DISEASE; RANDOMIZED-TRIAL; RISK-FACTORS; E EPSILON-4; APOE; ASSOCIATION; DEPRESSION	The possession of at least one APOE-epsilon4 allele may be linked to poor outcome in patients with predominantly severe traumatic brain injury (TBI). In mild TBI, which accounts for approximately 85% of all cases, the role of the APOE-epsilon4 allele is less clear. Studies completed to date have relied on brief cognitive assessments or coarse measures of global functioning, thereby limiting their conclusions. Our study investigated the influence of the APOE-epsilon4 allele in a prospective sample of 90 adults with mild to moderate TBI in whom neuropsychiatric outcome 6 months after injury was assessed as follows: (i) a detailed neuropsychological battery; (ii) an index of emotional distress (General Health Questionnaire); (iii) a diagnosis of major depression (Structured Clinical Interview for DSM-IV); (iv) a measure of global functioning (Glasgow Outcome Scale); (v) an index of psychosocial outcome (Rivermead Head Injury Follow-up Questionnaire); and (vi) symptoms of persistent post-concussion disorder (Rivermead Post-Concussion Symptoms Questionnaire). No association was found between the presence of the APOE-epsilon4 allele and poor outcome across all measures. Given the homogeneous nature of our sample (mild to moderate injury severity), the uniform follow-up period (6 months) and the comprehensive markers of recovery used, our data suggest that the APOE-epsilon4 allele does not adversely impact outcome in this group of TBI patients.	Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Traumat Brain Injury Clin, Toronto, ON M4N 3M5, Canada; Univ Toronto, Toronto, ON, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Clin Pathol, Toronto, ON, Canada		Feinstein, A (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Psychiat, Traumat Brain Injury Clin, FG08,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	loricham@yahoo.com; antfeinstein@aol.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bachman DL, 2003, NEUROLOGY, V60, P1372, DOI 10.1212/01.WNL.0000058751.43033.4D; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Benedict R., 1997, BRIEF VISUOSPATIAL M; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Delis D.C., 2000, CALIFORNIA VERBAL LE; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; FEINSTEIN A, 1992, BRAIN, V115, P1403, DOI 10.1093/brain/115.5.1403; First M.B., 1994, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; JENNETT B, 1975, LANCET, V1, P480; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Katzman R, 1996, NEUROLOGY, V46, P889; KEPPEL G, 1982, DESIGN ANAL RES HDB; Kerr ME, 1999, ADV EXP MED BIOL, V471, P117; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lopez-Figueroa AL, 2004, BIOL PSYCHIAT, V55, P225, DOI 10.1016/j.biopsych.2003.09.017; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Roth BL, 2004, PSYCHOPHARMACOLOGY, V174, P17, DOI 10.1007/s00213-003-1683-8; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Spreen O., 1969, NEUROSENSORY CTR COM; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wechsler D., 1999, WECHSLER ABBREVATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiner MF, 1999, BIOL PSYCHIAT, V45, P633, DOI 10.1016/S0006-3223(98)00222-4; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zekraoui L, 1997, HUM BIOL, V69, P575	62	111	113	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	DEC	2004	127		12				2621	2628		10.1093/brain/awh296			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874PE	WOS:000225361500008	15496436	Bronze			2022-02-06	
J	Dockree, PM; Kelly, SP; Roche, RAP; Hogan, MJ; Reilly, RB; Robertson, IH				Dockree, PM; Kelly, SP; Roche, RAP; Hogan, MJ; Reilly, RB; Robertson, IH			Behavioural and physiological impairments of sustained attention after traumatic brain injury	COGNITIVE BRAIN RESEARCH			English	Article						alpha power; no-go task; desynchronization; frontal lobes	CLOSED-HEAD-INJURY; EEG ALPHA; OSCILLATIONS; SYNCHRONIZATION; PERFORMANCE; FAILURES; DEFICITS; AROUSAL; MEMORY; DAMAGE	Sustaining attention under conditions of low external demand taxes our ability to stay on task and to avoid more appealing trains of thought or environmental distractions. By contrast, a stimulating, novel environment engages attention far more freely without the subjective feeling of having to override monotony. Our ability to maintain a goal-directed focus without support from the environment requires the endogenous control of behaviour. This control can be modulated by fronto-parietal circuits and this ability is compromised following traumatic brain injury (TBI) leading to increased lapses of attention. In this paper, we further explore a laboratory paradigm that we argue is particularly sensitive to sustained attention as opposed to other aspects of attentional control involving the selection and management of goals in working memory. The paradigm (fixed sequence Sustained Attention to Response Task-SART(fixed)) involves withholding a key press to an infrequent no-go target embedded within a predictable sequence of numbers. We demonstrate that TBI patients in this study make disproportionately more errors than controls on this task. An analysis of response times (RTs) and EEG alpha power across the task demonstrates group differences preceding the critical no-go trial. Controls demonstrate a lengthening of RTs accompanied by desynchronization of power within the alpha band (similar to 10 Hz) preceding the no-go trial. Conversely, the TBI group showed a shortening of RTs during this period with no evidence of alpha desynchronization. These findings suggest that TBI patients may have dysfunctional alpha generators as a consequence of their injury that impairs endogenous control during the task. (C) 2004 Elsevier B.V. All rights reserved.	Trinity Coll Dublin, Dept Psychol, Dublin, Ireland; Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; Univ Coll Dublin, Dept Elect & Elect Engn, Dublin 4, Ireland; Natl Univ Ireland, Dept Psychol, Galway, Ireland		Dockree, PM (corresponding author), Trinity Coll Dublin, Dept Psychol, Aras Phiarsaigh,D2, Dublin, Ireland.	dockreep@tcd.ie	Roche, Richard AP/C-4798-2009; Hogan, Michael/AAW-6943-2021; Reilly, Richard/N-1080-2019; Reilly, Richard B/F-7034-2011	Roche, Richard AP/0000-0001-6606-4187; Reilly, Richard/0000-0001-8578-1245; Reilly, Richard B/0000-0001-8578-1245; Kelly, Simon/0000-0003-4981-3099; Robertson, Ian H/0000-0001-8637-561X; Kelly, Simon/0000-0001-9983-3595			AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; FASSBENDER C, IN PRESS COGNITIVE B; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Klimesch W, 1998, EVOKED POTENTIAL, V108, P123, DOI 10.1016/S0168-5597(97)00078-6; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; LEVIN HS, 1989, COMPREHENSIVE NEUROL, V2, P53; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; MACKWORTH JF, 1968, PSYCHOL REV, V75, P308, DOI 10.1037/h0025896; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Portas CM, 1998, J NEUROSCI, V18, P8979; Posner MI, 2000, PSYCHOL BULL, V126, P873, DOI 10.1037/0033-2909.126.6.873; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shaw JC, 1996, INT J PSYCHOPHYSIOL, V24, P7, DOI 10.1016/S0167-8760(96)00052-9; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1987, NEUROBEHAVIORAL RECO; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	111	111	1	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6410			COGNITIVE BRAIN RES	Cognit. Brain Res.	AUG	2004	20	3					403	414		10.1016/j.cogbrainres.2004.03.019			12	Computer Science, Artificial Intelligence; Neurosciences; Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	850YP	WOS:000223650600007	15268918				2022-02-06	
J	Ashendorf, L; Constantinou, M; McCaffrey, RJ				Ashendorf, L; Constantinou, M; McCaffrey, RJ			The effect of depression and anxiety on the TOMM in community-dwelling older adults	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; neuropsychological; TOMM; depression; anxiety	MEMORY MALINGERING TOMM; SYMPTOMS; VALIDITY	Tests of possible malingering are in increasing demand among neuropsychologists. The Test of Memory Malingering (TOMM) is resistant to many neurological conditions, including traumatic brain injury, dementia, and aphasia. Less clear is the impact of psychological conditions on TOMM performance. This study examined a sample of community-based older adults (55-75) to determine whether scores on the TOMM are influenced by the presence of symptoms of depression or anxiety, as measured by the Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI), respectively. The results indicate that, regardless of BDI or STAI scores, all subjects scored above 45 correct out of 50 on TOMM Trial 2. These findings demonstrate that depression and anxiety levels in an older community-dwelling sample do not negatively affect performance on the TOMM. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd. All rights reserved.	SUNY Albany, Dept Psychol, Albany, NY 12222 USA		McCaffrey, RJ (corresponding author), SUNY Albany, Dept Psychol, 1400 Washington Ave, Albany, NY 12222 USA.		Ashendorf, Lee/R-7206-2019; Constantinou, Marios/AAL-2899-2020	CONSTANTINOU, MARIOS/0000-0002-6646-5877; Ashendorf, Lee/0000-0003-0479-4023			BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; HIMMELFARB S, 1983, J GERONTOL, V38, P333, DOI 10.1093/geronj/38.3.333; HIMMELFARB S, 1984, J PSYCHOL, V116, P159, DOI 10.1080/00223980.1984.9923632; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Pankratz L., 1997, CLIN ASSESSMENT MALI, P223; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Spielberger CD., 1983, STATE TRAIT ANXIETY; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260	13	111	111	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2004	19	1					125	130	PII S0887-6177(02)00218-4	10.1016/S0887-6177(02)00218-4			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	759MB	WOS:000187740500011	14670385				2022-02-06	
J	Emanuelson, I; Holmkvist, EA; Bjorklund, R; Stalhammar, D				Emanuelson, I; Holmkvist, EA; Bjorklund, R; Stalhammar, D			Quality of life and post-concussion symptoms in adults after mild traumatic brain injury: a population-based study in western Sweden	ACTA NEUROLOGICA SCANDINAVICA			English	Article						brain injury; mild; quality of life	ROUTINE FOLLOW-UP; HEAD-INJURY; SUBJECTIVE EXPERIENCE; SEQUELAE; MODERATE; INDIVIDUALS	Objectives - To study quality of life and subjective post-concussion symptoms in adults (16-60 years) with a mild traumatic brain injury (MTBI) 3 months and 1 year after injury. Methods - Of a total of 489 patients 173 responded to questionnaires at 3 months and at 1 year, including the SF-36 health-related quality of life survey, which is a standardized measure validated for Swedish conditions. Post-concussion symptoms were rated as either existing or non-existing in a 21-item checklist [a modified version of Comprehensive Psychopathological Rating Scale (CPRS)]. Results - SF-36 showed impaired scores in all dimensions. Existing post-concussion symptoms were reported by 15-45%. Significantly, more symptoms were present at 3 months than at 3 weeks after injury. Furthermore, a significant correlation between higher rates of post-concussion symptoms and lower SF-36 scores was found. Conclusions- The SF-36 results were significantly impaired compared with an age- and gender-matched normative control group and the rate of post-concussion symptoms was significantly higher at 3 months than at 3 weeks after injury. As a significant correlation between higher rates of symptoms and lowSF-36 scores was also found we assume SF-36 to be a sensitive enough measure of MTBI-related effects.	Univ Gothenburg, Dept Hlth Women & Children, Gothenburg, Sweden; Boras Hosp, Dept Rehabil Med, Boras, Sweden; Univ Gothenburg, Dept Neurosci, Gothenburg, Sweden		Emanuelson, I (corresponding author), Reg Rehabil Unit, PB 210 62, S-41804 Gothenburg, Sweden.	ingrid.emanuelson@vgregion.se					*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P704; ANDERSSON HE, 2002, 54 ANN C SCAND NEUR; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GANDEK B, 1998, J CLIN EPIDEMIOL, V0051, P00891, DOI DOI 10.1016/S0895-4356(98)00080-8; Gerard J M, 2000, Rev Med Brux, V21, P85; GOOD P, 2000, PERMUTATION TESTS PR, P36; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pSC2; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Paniak C, 2000, BRAIN INJURY, V14, P219; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177	35	111	112	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	NOV	2003	108	5					332	338		10.1034/j.1600-0404.2003.00155.x			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	731FV	WOS:000185874600005	14616303				2022-02-06	
J	Schreiber, MA; Aoki, N; Scott, BG; Beck, JR				Schreiber, MA; Aoki, N; Scott, BG; Beck, JR			Determinants of mortality in patients with severe blunt head injury	ARCHIVES OF SURGERY			English	Article; Proceedings Paper	14th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 10-13, 2001	TARPON SPRINGS, FLORIDA	Eastern Assoc Surg Trauma			OUTCOME PREDICTION; BRAIN INJURY; TRAUMA; EPIDEMIOLOGY; MANAGEMENT; POPULATION	Context: Head injury is the leading cause of traumatic death in the United States. Hypothesis: A set of clinical parameters available soon after injury can be used to accurately predict outcome in patients with severe blunt head trauma. Design: Validation cohort study. Setting: Urban level I trauma center. Patients and Methods: Data from patients with severe blunt head injury, as defined by inability to follow commands, were prospectively entered into a neurosurgical database and analyzed. The impact on survival of 23 potentially predictive parameters was studied using univariate analysis. Logistic regression models were used to control for confounding factors and to assess interactions between variables, whose significance was determined by univariate analysis, Goodness of fit was calculated with the Hosmer-Lemeshow c statistic. The predictability of the logistic model was evaluated by measuring the area under the receiver operating characteristic curve (AUC). Results: Logistic regression analysis revealed that 5 risk factors were independently associated with death. These variables included systemic hypotension in the emergency department, midline shift on computed tomographic scan, intracranial hypertension, and absence of pupillary light reflex. A low Glasgow Coma Scale score and advanced age were found to be highly correlated risk factors that, when combined, were independently associated with mortality, The model showed acceptable goodness of fit, and the AUC was 80.5%. Conclusions: Systemic hypotension and intracranial hypertension are the only independent risk factors for mortality that can be readily treated during the initial management of patients with severe head injuries. When used together, Glasgow Coma Scale score and age are significant predictors of mortality.	Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Ben Taub Gen Hosp, Houston, TX 77030 USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA		Schreiber, MA (corresponding author), 11 Garibaldi St, Lake Oswego, OR 97035 USA.						ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Baltas I, 1998, J Neurosurg Sci, V42, P85; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P561; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GIBSON RM, 1989, LANCET, V2, P369; Kotzan JA, 1999, CLIN THER, V21, P1988, DOI 10.1016/S0149-2918(00)86744-2; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nissen JJ, 1999, J NEUROL NEUROSUR PS, V67, P796, DOI 10.1136/jnnp.67.6.796; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Vollmer DG, 1991, J NEUROSURG S, V75, P37; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7	32	111	116	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0004-0010			ARCH SURG-CHICAGO	Arch. Surg.	MAR	2002	137	3					285	290		10.1001/archsurg.137.3.285			6	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	530YU	WOS:000174387800009	11888450	Bronze			2022-02-06	
J	Stahel, PF; Morganti-Kossmann, MC; Perez, D; Redaelli, C; Gloor, B; Trentz, O; Kossmann, T				Stahel, PF; Morganti-Kossmann, MC; Perez, D; Redaelli, C; Gloor, B; Trentz, O; Kossmann, T			Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; cerebrospinal fluid; complement; membrane attack complex; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; ACTIVATED TERMINAL COMPLEMENT; CEREBROSPINAL-FLUID; NEUROLOGICAL DISORDERS; MULTIPLE-SCLEROSIS; IGG ANALYSES; HEAD-INJURY; INTERLEUKIN-8; EXPRESSION; PRINCIPLES	It has become evident in recent years that intracranial inflammation after traumatic brain injury (TBI) is, at least in part, mediated by activation of the complement system. However, most conclusions have been drawn from experimental studies, and the intrathecal activation of the complement cascade after TBI has not yet been demonstrated in humans. In the present study, we analyzed the levels of the soluble terminal complement complex sC5b-9 by ELISA in ventricular cerebrospinal fluid (CSF) of patients with severe TBI (n = 11) for up to 10 days after trauma. The mean sC5b-9 levels in CSF were significantly elevated in 10 of 11 TBI patients compared to control CSF from subjects without trauma or inflammatory neurological disease (n = 12; p < 0.001). In some patients, the maximal sC5b-9 concentrations were up to 1,800-fold higher than in control CSF. The analysis of the extent of posttraumatic blood-brain barrier (BBB) dysfunction, as determined by CSF/serum albumin quotient (Q(A)), revealed that patients with a moderate to severe BBB impairment (mean Q(A) > 0.01) had significantly higher intrathecal sC5b-9 levels as compared to patients with normal BBB function (mean Q(A) < 0.007; p < 0.0001). In addition, a significant correlation between the individual daily Q(A) values and the corresponding sC5b-9 CSF levels was detected in 8 of 11 patients (r = 0.72-0.998; p < 0.05). These data demonstrate for the first time that terminal pathway complement activation occurs after head injury and suggest a possible pathophysiological role of complement with regard to posttraumatic BBB dysfunction.	Univ Zurich Hosp, Dept Surg, Div Trauma Surg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Surg, Div Res, CH-8091 Zurich, Switzerland; Univ Hosp Bern, Dept Visceral & Transplantat Surg, Bern, Switzerland		Stahel, PF (corresponding author), Univ Zurich Hosp, Dept Surg, Div Trauma Surg, CH-8091 Zurich, Switzerland.			Perez, Daniel/0000-0002-3154-7311; Morganti-Kossmann, Cristina/0000-0002-0807-2063			Barnum SR, 1999, MOL MED, V5, P569, DOI 10.1007/BF03402070; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Davoust N, 1999, J IMMUNOL, V163, P6551; FAUSTUMANN PM, 1995, ACTA NEUROPATHOL, V89, P239; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HOLLERHAGE HG, 1989, ACTA NEUROPATHOL, V77, P307, DOI 10.1007/BF00687583; JENNETT B, 1975, LANCET, V1, P480; Johnson SA, 1996, EXP NEUROL, V138, P198, DOI 10.1006/exnr.1996.0058; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Kilgore KS, 1997, AM J PATHOL, V150, P2019; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Lindsberg PJ, 1996, ANN NEUROL, V40, P587, DOI 10.1002/ana.410400408; LINK H, 1977, SCAND J CLIN LAB INV, V37, P391, DOI 10.3109/00365517709091497; Loeffler DA, 1997, NEUROCHEM RES, V22, P209, DOI 10.1023/A:1027323809229; Marshall LF, 1991, J NEUROSURG S, V75, P14; Matsumoto T, 1997, LAB INVEST, V77, P119; Morgan BP, 1999, CRIT REV IMMUNOL, V19, P173; Morgan BP, 1997, IMMUNOPHARMACOLOGY, V38, P43; MORGANTIKOSSMAN.MC, 2000, CURR OPIN CRIT CARE, V6, P98; Nataf S, 1999, TRENDS NEUROSCI, V22, P397, DOI 10.1016/S0166-2236(98)01390-3; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; SANDERS ME, 1987, J IMMUNOL, V138, P2095; SANDERS ME, 1986, J IMMUNOL, V136, P4456; Sellebjerg F, 1998, J NEUROL SCI, V157, P168, DOI 10.1016/S0022-510X(98)00086-0; Sherwood ER, 2000, CRIT CARE MED, V28, P1221, DOI 10.1097/00003246-200004000-00054; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; TEASDALE G, 1974, LANCET, V2, P81; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; VANGURI P, 1988, J BIOL CHEM, V263, P7228; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003	34	111	112	0	4	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2001	18	8					773	781		10.1089/089771501316919139			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	464AG	WOS:000170509600003	11526983				2022-02-06	
J	LaPlaca, MC; Zhang, J; Raghupathi, R; Li, JH; Smith, F; Bareyre, FM; Snyder, SH; Graham, DI; McIntosh, TK				LaPlaca, MC; Zhang, J; Raghupathi, R; Li, JH; Smith, F; Bareyre, FM; Snyder, SH; Graham, DI; McIntosh, TK			Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; DNA damage; DNA repair; experimental brain injury; NAD; PARP	FOCAL CEREBRAL-ISCHEMIA; DNA STRAND BREAKS; CELL-DEATH; FOREBRAIN ISCHEMIA; SUPPRESSOR GENE; APOPTOSIS; DAMAGE; MICE; FRAGMENTATION; ACTIVATION	The nuclear enzyme poly(ADP-ribose) polymerase (PARP), which has been shown to be activated following experimental traumatic brain injury (TBI), binds to DNA strand breaks and utilizes nicotinamide adenine dinucleotide (NAD) as a substrate. Since consumption of NAD may be deleterious to recovery in the setting of CNS injury, we examined the effect of a potent PARP inhibitor, GPI 6150, on histological outcome following TBI in the rat. Rats (n = 16) were anesthetized, received a preinjury dose of GPI 6150 (30 min; 15 mg/kg, i.p.), subjected to lateral fluid percussion (FP) brain injury of moderate severity (2.5-2.8 atm), and then received a second dose 3 h postinjury (15 mg/kg, i.p.). Lesion area was examined using Nissl staining, while DNA fragmentation and apoptosis-associated cell death was assessed with terminal deoxynucleotidyl-transferase-mediated biotin-dUTP nick end labeling (TUNEL) with stringent morphological evaluation. Twenty-four hours after brain injury, a significant cortical lesion and number of TUNEL-positive/nonapoptotic cells and TUNEL-positive/apoptotic cells in the injured cortex of vehicle-treated animals were observed as compared to uninjured rats. The size of the trauma-induced Lesion area was significantly attenuated in the GPI 6150-treated animals versus vehicle-treated animals (p < 0.05), Treatment of GPI 6150 did not significantly affect the number of TUNEL-positive apoptotic cells in the injured cortex. The observed neuroprotective effects on lesion size, however, offer a promising option for further evaluation of PARP inhibition as a means to reduce cellular damage associated with TBI.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Guilford Pharmaceut Inc, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; So Gen Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland		LaPlaca, MC (corresponding author), Georgia Inst Technol, Dept Biomed Engn, 315 Ferst Dr,Rm 1120, Atlanta, GA 30332 USA.		Raghupathi, Ramesh/AAX-5538-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, R01NS026818, P01NS008803] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS26818, 950-NS08803] Funding Source: Medline		BENJAMIN RC, 1980, J BIOL CHEM, V255, P502; Chen J, 1997, J NEUROCHEM, V69, P232; Clark RSB, 1997, J NEUROSCI, V17, P9172; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1998, EUR J PHARMACOL, V351, P377, DOI 10.1016/S0014-2999(98)00381-1; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; FUNG KM, 1995, AM J PATHOL, V146, P1376; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HELLER B, 1995, J BIOL CHEM, V270, P11176, DOI 10.1074/jbc.270.19.11176; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HUANG S, 2000, 30 ANN M SOC NEUR NE; KAUFMANN SH, 1993, CANCER RES, V53, P3976; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; LAUTAR S, 1998, 28 ANN M SOC NEUR LO, V24, P1226; LI Y, 1995, MOL BRAIN RES, V28, P164, DOI 10.1016/0169-328X(94)00220-9; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lindahl T, 1995, J CELL SCI, P73; Liu PK, 1996, J NEUROSCI, V16, P6795; Lo EH, 1998, STROKE, V29, P830, DOI 10.1161/01.STR.29.4.830; LU XCM, 2000, 30 ANN M SOC NEUR NE; MacManus JP, 1997, J CEREBR BLOOD F MET, V17, P815, DOI 10.1038/aj.jcbfm.9590266; MANEV H, 1994, NEUROREPORT, V5, P2661, DOI 10.1097/00001756-199412000-00064; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; RINK A, 1995, AM J PATHOL, V147, P1575; Rosenthal DS, 1997, EXP CELL RES, V232, P313, DOI 10.1006/excr.1997.3536; SchmidtKastner R, 1997, STROKE, V28, P163, DOI 10.1161/01.STR.28.1.163; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; States BA, 1996, J CEREBR BLOOD F MET, V16, P1165, DOI 10.1097/00004647-199611000-00011; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Takahashi K, 1997, J CEREBR BLOOD F MET, V17, P1137, DOI 10.1097/00004647-199711000-00001; Takahashi K, 1999, BRAIN RES, V829, P46, DOI 10.1016/S0006-8993(99)01335-9; Tokime T, 1998, J CEREBR BLOOD F MET, V18, P991, DOI 10.1097/00004647-199809000-00008; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; ZHANG J, 1999, 6 INT M BIOL NI S645, V167, P90; ZHANG J, 1998, 28 ANN M SOC NEUR LO, V24, P1226	49	111	112	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2001	18	4					369	376		10.1089/089771501750170912			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	425TP	WOS:000168308000001	11336438				2022-02-06	
J	Cordoba, J; Crespin, J; Gottstein, J; Blei, AT				Cordoba, J; Crespin, J; Gottstein, J; Blei, AT			Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis	GASTROENTEROLOGY			English	Article							FULMINANT HEPATIC-FAILURE; HYPERAMMONEMIA-INDUCED ENCEPHALOPATHY; CEREBRAL BLOOD-FLOW; LIVER-FAILURE; INTRACRANIAL HYPERTENSION; TOTAL HEPATECTOMY; BODY-TEMPERATURE; INJURY; GLUTAMINE; PRESSURE	Background & Aims: The pathogenesis of brain edema in fulminant hepatic failure is still unresolved. Mild hypothermia (33 degrees-35 degrees C) can ameliorate brain edema after traumatic brain injury. We evaluated mild hypothermia in a model of ammonia-induced brain edema in which accumulation of brain glutamine has been proposed as a key pathogenic factor, Methods: After portacaval anastomosis, anesthetized rats were infused with ammonium acetate at 33 degrees, 35 degrees, and 37 degrees C or vehicle at 37 degrees C. Water and glutamine levels in the brain, cardiac output, and regional and cerebral hemodynamics were measured when intracranial pressure increased 3-4-fold (ammonia infusion at 37 degrees) and matched times (other groups). Results: Mild hypothermia reduced ammonia-induced brain swelling and increased intracranial pressure. Brain glutamine level was not decreased by hypothermia, Brain edema was accompanied by a specific increase in cerebral blood flow and oxygen consumption, which were normal in both hypothermic groups. When the ammonia infusion was continued in hypothermic rats, plasma ammonia levels continued to increase and brain swelling eventually developed. Conclusions: Mild hypothermia delays ammonia-induced brain edema, In this moder, an increase in cerebral perfusion is required for brain edema to become manifest, Mild hypothermia could be tested for treatment of intracranial hypertension in fulminant hepatic failure.	Lakeside Vet Affairs Med Ctr, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Chicago, IL 60611 USA		Blei, AT (corresponding author), Lakeside Vet Affairs Med Ctr, Dept Med, Room 111 E,333 E Huron St, Chicago, IL 60611 USA.	andyblei@merle.acns.nwu.edu					BLEI AT, 1994, HEPATOLOGY, V19, P1437, DOI 10.1002/hep.1840190619; BRUSILOW SW, 1986, NEW ENGL J MED, V314, P786; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CARTHEUSER CF, 1993, COMP BIOCHEM PHYS A, V106, P775, DOI 10.1016/0300-9629(93)90396-L; CHODOBSKI A, 1986, J NEUROSURG, V65, P86, DOI 10.3171/jns.1986.65.1.0086; CLIFTON GL, 1995, J NEUROSURG ANESTH, V7, P152, DOI 10.1097/00008506-199504000-00023; Cordoba J, 1996, SEMIN LIVER DIS, V16, P271, DOI 10.1055/s-2007-1007240; Cordoba J, 1995, Liver Transpl Surg, V1, P187, DOI 10.1002/lt.500010310; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Donovan JP, 1998, LANCET, V351, P719, DOI 10.1016/S0140-6736(97)07373-X; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; FUNG HL, 1986, J PHARMACOL EXP THER, V239, P701; HEYMANN MA, 1977, PROG CARDIOVASC DIS, V20, P55, DOI 10.1016/S0033-0620(77)80005-4; Jalan R, 1998, HEPATOLOGY, V28, p492A; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KINDT GW, 1975, JAMA-J AM MED ASSOC, V231, P822, DOI 10.1001/jama.231.8.822; LANIER WL, 1995, J NEUROSURG ANESTH, V7, P216, DOI 10.1097/00008506-199507000-00021; Larsen FS, 1996, J HEPATOL, V25, P145, DOI 10.1016/S0168-8278(96)80066-3; Larsen FS, 1996, SEMIN LIVER DIS, V16, P281, DOI 10.1055/s-2007-1007241; LEE SH, 1961, SURGERY, V50, P668; Lichtenstein GR, 1997, GASTROENTEROLOGY, V112, P236, DOI 10.1016/S0016-5085(97)70240-3; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MADSEN PL, 1988, J CEREBR BLOOD FLOW, V18, P742; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mas A, 1997, LANCET, V349, P1081, DOI 10.1016/S0140-6736(96)08054-3; MITCHELL RB, 1988, AM J MED, V85, P662; MUNOZ SJ, 1993, SEMIN LIVER DIS, V13, P395; NORENBERG MD, 1994, ACTA NEUROCHIR, P24; OLAFSSON S, 1995, GASTROENTEROLOGY, V108, P1097, DOI 10.1016/0016-5085(95)90208-2; PEIGNOUX M, 1982, CLIN SCI, V62, P273, DOI 10.1042/cs0620273; ROZGA J, 1993, LANCET, V342, P898, DOI 10.1016/0140-6736(93)91947-K; SCHENKER S, 1962, J LAB CLIN MED, V60, P291; SHAH V, 1993, HEPATOLOGY, V17, P1117, DOI 10.1016/0270-9139(93)90131-6; TAKAHASHI H, 1991, AM J PHYSIOL, V261, pH825, DOI 10.1152/ajpheart.1991.261.3.H825; TAKAHASHI H, 1992, CIRC RES, V71, P1220, DOI 10.1161/01.RES.71.5.1220; TRABER P, 1989, GASTROENTEROLOGY, V96, P885; TRABER PG, 1986, GASTROENTEROLOGY, V91, P1347, DOI 10.1016/0016-5085(86)90186-1; Vogels BAPM, 1997, HEPATOLOGY, V25, P820, DOI 10.1002/hep.510250406; Vogels BAPM, 1997, J HEPATOL, V26, P387, DOI 10.1016/S0168-8278(97)80057-8; Walter, 1984, METHODS ENZYMATIC AN; WENDON JA, 1994, HEPATOLOGY, V19, P1407, DOI 10.1002/hep.1840190614	43	111	112	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	MAR	1999	116	3					686	693		10.1016/S0016-5085(99)70191-5			8	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	171ZG	WOS:000078894400026	10029628				2022-02-06	
J	Christiansen, C; Abreu, B; Ottenbacher, K; Huffman, K; Masel, B; Culpepper, R				Christiansen, C; Abreu, B; Ottenbacher, K; Huffman, K; Masel, B; Culpepper, R			Task performance in virtual environments used for cognitive rehabilitation after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Annual Conference of the American-Occupational-Therapy-Association	APR 13, 1997	ORLANDO, FL	Amer Occupat Therapy Assoc			REALITY	Objective: This report describes a reliability study using a prototype computer-simulated virtual environment to assess basic daily living skills in a sample of persons with traumatic brain injury (TBI). The benefits of using virtual reality in training for situations where safety is a factor have been established in defense and industry, but have not been demonstrated in rehabilitation. Subjects: Thirty subjects with TBI receiving comprehensive rehabilitation services at a residential facility. Methods: An immersive virtual kitchen was developed in which a meal preparation task involving multiple steps could be performed. The prototype was tested using subjects who completed the task twice within 7 days. Results: The stability of performance was estimated using intraclass correlation coefficients (ICCs). The ICC value for total performance based on all steps involved in the meal preparation task was .73, When three items with low variance were removed the ICC improved to .81. Little evidence of vestibular optical side-effects was noted in the subjects tested. Conclusion: Adequate initial reliability exists to continue development of the environment as an assessment and training prototype for persons with brain injury. (C) 1998 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Univ Texas, Med Branch, Sch Allied Hlth Sci, Off Dean, Galveston, TX 77555 USA; Transit Learning Community, Houston, TX USA; LinCom Corp, Houston, TX USA		Christiansen, C (corresponding author), Univ Texas, Med Branch, Sch Allied Hlth Sci, Off Dean, 301 Univ Blvd, Galveston, TX 77555 USA.		, Charles/V-6218-2019	Ottenbacher, Kenneth/0000-0001-5990-3982; Christiansen, Charles/0000-0003-0542-1042			Andreae MH, 1996, BMJ-BRIT MED J, V312, P4, DOI 10.1136/bmj.312.7022.4; BARFIELD W, 1995, VIRTUAL ENV ADV INTE, P503; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bricken M., 1991, Computer Graphics, V25, P178; Brown D., 1995, ABILITY, V15, P24; Byrne C.M., 1996, THESIS U WASHINGTON; Christiansen C, 1996, J MED VIRTUAL REALIT, V1, P6; Delis DC, 1987, CALIFORNIA VERBAL LE; ELLIS SR, 1995, VIRTUAL ENV ADV INTE, P14; Hettinger L. J., 1992, PRESENCE, V1, P306; INMAN D, 1994, VIRT REAL PERS DIS C; JENNETT B, 1975, LANCET, V1, P480; LOFTIN RB, 1995, IEEE COMPUT GRAPH, V15, P31, DOI 10.1109/38.403825; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; PROTHERO JD, 1997, INT WORKSH MOT SICKN; REGAN EC, 1994, AVIAT SPACE ENVIR MD, V65, P527; ROTHBAUM BO, 1995, AM J PSYCHIAT, V152, P626; SATAVA RM, 1992, MINIM INVASIV THER, V1, P357; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; TAUBES G, 1994, SCIENCE, V265, P884, DOI 10.1126/science.8052844; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; WANN JP, 1993, BAILLIERE CLIN NEUR, V2, P15; Wechsler D., 1939, MEASUREMENT ADULT IN; Whyte J, 1993, REHABILITATION MED P, P825; WILKINSON GS, 1984, WIDE RANGE ACHIEVEME; Winn W., 1993, DESIGNING ENV CONSTR, V105, P189, DOI DOI 10.1007/978-3-642-78069-1_10	26	111	117	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1998	79	8					888	892		10.1016/S0003-9993(98)90083-1			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	108MJ	WOS:000075269800002	9710158				2022-02-06	
J	Carbonell, WS; Maris, DO; McCall, T; Grady, MS				Carbonell, WS; Maris, DO; McCall, T; Grady, MS			Adaptation of the fluid percussion injury model to the mouse	JOURNAL OF NEUROTRAUMA			English	Article						axonal degeneration; C57B1/6; cell death; gliosis; mice; Morris water maze; traumatic brain injury	TRAUMATIC BRAIN INJURY; MORRIS WATER-MAZE; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; CELL-DEATH; RAT; MICE; PERFORMANCE; HIPPOCAMPUS; EXPRESSION	Fluid percussion injury (FPI) is a well-characterized experimental model of traumatic brain injury (TBI) in the rat. Many pathophysiologic consequences and mechanisms of recovery after TBI rely on neurochemical pathways that can be examined in genetically altered mice. Therefore, FPI applied to mice may be a useful experimental tool to investigate TBI at the molecular level. In the present study, we establish FPI as a viable model of TBI in the mouse by characterizing acute neurological, histopathological, and behavioral changes. Right-sided parasagittal FPI or sham treatment was administered in male C57BL/6 mice. Acute neurological evaluation revealed righting reflexes in the injured animals (p < 0.001). Deficits in spatial learning and memory were observed in the Morris water maze (MWM) 5 and 6 days after injury. A novel MWM data analysis protocol is described. The injured group (n = 18) demonstrated impaired performance in the MWM during acquisition (p < 0.05) and probe trials (p < 0.025) compared to sham animals (n = 16). At 7 days postinjury, glial fibrillary acidic protein immunohistochemistry revealed intense cortical, callosal, and hippocampal gliosis. The modified Gallyas silver degeneration stain consistently labeled cell bodies and terminals throughout the ipsilateral cortex, axons in the gray matter-white matter interface above the corpus callosum and within the corpus callosum bilaterally, and terminals and fibers in the thalamus bilaterally. Additionally, the mouse FPI model described is immediately employable in labs already using the FPI rat model with no modifications to a pre-existing PPI apparatus.	Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA		Grady, MS (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, 700 9th Ave,Box 359766, Seattle, WA 98104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033107, P50NS030305] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30305, NS33107] Funding Source: Medline		BERNASCONIGUASTALLA S, 1994, HIPPOCAMPUS, V4, P53, DOI 10.1002/hipo.450040107; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRAWLEY JN, 1996, TRENDS NEUROSCI, V19, P186; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; DAMBROSIO R, IN PRESS BRAIN RES; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ERREBOE I, 1995, PHARMACOL TOXICOL, V76, P376, DOI 10.1111/j.1600-0773.1995.tb00165.x; FRANCIS DD, 1995, PHYSIOL BEHAV, V58, P57, DOI 10.1016/0031-9384(95)00009-8; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GAVRIELI Y, 1992, JCELL BIOL, V119, P463; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GRADY MS, 1996, SOC NEUR ABS, V26, P93; GRANT SG, 1993, SCIENCE, V262, P760; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; INSEL TR, 1993, J NEUROENDOCRINOL, V5, P619, DOI 10.1111/j.1365-2826.1993.tb00531.x; Jursky F, 1996, J NEUROCHEM, V67, P336; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Lathe R, 1996, TRENDS NEUROSCI, V19, P183, DOI 10.1016/S0166-2236(96)20022-0; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; McNamara RK, 1996, MOL BRAIN RES, V40, P177, DOI 10.1016/0169-328X(96)00048-4; MIZUMORI SJY, 1982, BEHAV NEURAL BIOL, V35, P33, DOI 10.1016/S0163-1047(82)91253-5; Montkowski A, 1997, BRAIN RES, V762, P12, DOI 10.1016/S0006-8993(97)00370-3; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; MORRIS RGM, 1990, COLD SPRING HARB SYM, V55, P161; Morrison RS, 1996, J NEUROSCI, V16, P1337; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; NITATORI T, 1995, J NEUROSCI, V15, P1001; Owen EH, 1997, NEUROSCIENCE, V80, P1087, DOI 10.1016/S0306-4522(97)00165-6; REEVES TM, 1995, EXP BRAIN RES, V106, P248; REINSTEIN DK, 1983, BRAIN RES, V263, P172, DOI 10.1016/0006-8993(83)91217-9; RINK A, 1995, AM J PATHOL, V147, P1575; ROULLET P, 1995, PHYSIOL BEHAV, V58, P1189, DOI 10.1016/0031-9384(95)02066-7; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SCHWEGLER H, 1988, BEHAV GENET, V18, P153, DOI 10.1007/BF01067837; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SILVA AJ, 1993, SCIENCE, V262, P760; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SYMONDS H, 1994, COLD SPRING HARB SYM, V59, P247, DOI 10.1101/SQB.1994.059.01.029; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; UPCHURCH M, 1987, PHARMACOL BIOCHEM BE, V27, P143, DOI 10.1016/0091-3057(87)90488-6; UPCHURCH M, 1988, PHARMACOL BIOCHEM BE, V29, P325, DOI 10.1016/0091-3057(88)90164-5; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075	58	111	116	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	1998	15	3					217	229		10.1089/neu.1998.15.217			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZA547	WOS:000072375500006	9528921				2022-02-06	
J	Goss, JR; O'Malley, ME; Zou, LL; Styren, SD; Kochanek, PM; DeKosky, ST				Goss, JR; O'Malley, ME; Zou, LL; Styren, SD; Kochanek, PM; DeKosky, ST			Astrocytes are the major source of nerve growth factor upregulation following traumatic brain injury in the rat	EXPERIMENTAL NEUROLOGY			English	Article						astrocyte; hippocampus; hypothermia; in situ hybridization; nerve growth factor; traumatic brain injury	FACTOR MESSENGER-RNA; PHYSIOLOGICAL STOP PATHWAY; KAINIC ACID INJECTION; C-FOS; NEUROTROPHIC FACTOR; LIMBIC SEIZURES; FACTOR GENE; DIFFERENTIAL REGULATION; AXONAL REGENERATION; CORTICAL ASTROCYTES	Previous studies from our group have demonstrated an upregulation in nerve growth factor (NGF) RNA and protein in the cortex 24 h following traumatic brain injury (TBI) in a rat model. This increase in NGF is suppressed if rats are subjected to 4 h of whole-body hypothermia following TBI. In the present study we used in situ hybridization to extend our initial RNA gel-blot (Northern) hybridization findings by demonstrating that NGF RNA is increased in the cortex following TBI and that hypothermia diminishes this response. Further, by combining in situ hybridization with immunocytochemistry for glial fibrillary acidic protein we demonstrate that astrocytes are the major cellular source for the upregulation in NGF and that this upregulation can be observed in the hippocampus as early as 3 h posttrauma. The predominantly astrocytic origin suggests that the NGF upregulation is not related primarily to cholinotrophic activities. We hypothesize that its function is to stimulate upregulation of antioxidant enzymes, as part of an injury-induced cascade, and that supplementation of NGF or antioxidants may be warranted in hypothermic therapies for head injury. (C) 1998 Academic Press.	Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Neurobiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Anesthesiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Neurol, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA		Goss, JR (corresponding author), Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA.		Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P01NS030318, P20NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005133] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG05133] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318] Funding Source: Medline		ARENDT T, 1995, NEUROSCIENCE, V65, P647, DOI 10.1016/0306-4522(94)00523-8; AWATSUJI H, 1993, J NEUROSCI RES, V34, P539, DOI 10.1002/jnr.490340506; BAKHIT C, 1991, BRAIN RES, V560, P76, DOI 10.1016/0006-8993(91)91217-O; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; BRODIE C, 1995, NEUROSCI LETT, V186, P5, DOI 10.1016/0304-3940(95)11267-Z; BRUCE AJ, 1995, FREE RADICAL BIO MED, V18, P993, DOI 10.1016/0891-5849(94)00218-9; CARMANKRZAN M, 1993, J NEUROSCI RES, V34, P225, DOI 10.1002/jnr.490340210; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DEKOSKY ST, 1994, J NEUROTRAUMA, V11, P106; DREYFUS CF, 1989, TRENDS PHARMACOL SCI, V10, P145, DOI 10.1016/0165-6147(89)90166-1; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; FREDERICKSON RCA, 1991, BIOTECHNOLOGY, V9, P1; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GOMEZPINILLA F, 1992, J NEUROSCI, V12, P345; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; GOSS JR, 1995, J NEUROCHEM, V64, P1351; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GUTHRIE KM, 1995, J COMP NEUROL, V352, P147, DOI 10.1002/cne.903520111; HAHN M, 1994, GLIA, V10, P286, DOI 10.1002/glia.440100407; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HERRERA DG, 1993, BRAIN RES, V602, P99, DOI 10.1016/0006-8993(93)90247-K; HOFF SF, 1982, J COMP NEUROL, V205, P246, DOI 10.1002/cne.902050304; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; KESSLAK JP, 1986, EXP NEUROL, V92, P377, DOI 10.1016/0014-4886(86)90089-0; LANDFIELD PW, 1977, J GERONTOL, V32, P3, DOI 10.1093/geronj/32.1.3; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDSAY RM, 1982, BRAIN RES, V243, P329, DOI 10.1016/0006-8993(82)90257-8; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LIUZZI FJ, 1990, BRAIN RES, V512, P277, DOI 10.1016/0006-8993(90)90637-Q; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MOCCHETTI I, 1989, P NATL ACAD SCI USA, V86, P3891, DOI 10.1073/pnas.86.10.3891; NIETOSAMPEDRO M, 1987, J NEUROSCI RES, V17, P214, DOI 10.1002/jnr.490170303; NISHO T, 1994, NEUROSCIENCE, V1, P67; ODERFELDNOWAK B, 1992, NEUROCHEM INT, V21, P455, DOI 10.1016/0197-0186(92)90197-Y; PAN ZH, 1993, J NEUROCHEM, V61, P1713, DOI 10.1111/j.1471-4159.1993.tb09808.x; POLITIS MJ, 1985, BRAIN RES, V346, P186, DOI 10.1016/0006-8993(85)91114-X; PSHENICHKIN SP, 1995, J BIOL CHEM, V270, P5994, DOI 10.1074/jbc.270.11.5994; PSHENICHKIN SP, 1994, J NEUROCHEM, V63, P419; ROCAMORA N, 1992, MOL BRAIN RES, V13, P27, DOI 10.1016/0169-328X(92)90041-9; RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5; SCHWARTZ JP, 1994, BRAIN RES BULL, V35, P403, DOI 10.1016/0361-9230(94)90151-1; STRAUSS S, 1994, NEUROSCI LETT, V168, P193, DOI 10.1016/0304-3940(94)90448-0; TIMMUSK T, 1992, SOC NEUR ABSTR, V18; VIGE X, 1991, MOL PHARMACOL, V40, P186; VIGE X, 1992, BRAIN RES, V591, P345, DOI 10.1016/0006-8993(92)91718-T; WHITTEMORE SR, 1988, J NEUROSCI RES, V20, P403, DOI 10.1002/jnr.490200402; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P429; WHITTEMORE SR, 1987, J NEUROSCI, V7, P247; YANG K, 1995, J NEUROSCI RES, V42, P571, DOI 10.1002/jnr.490420415; ZHENG M, 1988, MOL BRAIN RES, V3, P133, DOI 10.1016/0169-328X(88)90058-7	56	111	113	0	5	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	FEB	1998	149	2					301	309		10.1006/exnr.1997.6712			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZA117	WOS:000072330600001	9500953				2022-02-06	
J	Teasdale, TW; Christensen, AL; Willmes, K; Deloche, G; Braga, L; Stachowiak, F; Vendrell, JM; CastroCaldas, A; Laaksonen, RK; Leclercq, M				Teasdale, TW; Christensen, AL; Willmes, K; Deloche, G; Braga, L; Stachowiak, F; Vendrell, JM; CastroCaldas, A; Laaksonen, RK; Leclercq, M			Subjective experience in brain-injured patients and their close relatives: A European brain injury questionnaire study	BRAIN INJURY			English	Article							KATZ ADJUSTMENT SCALE; REHABILITATION SAMPLE	Results are reported from an international project the aim of which has been to develop and validate a wide-ranging questionnaire suitable for administration to brain-injured patients and their relatives. A self-report questionnaire concerning subjective experience of cognitive, emotional and social difficulties (The European Brain Injury Questionnaire, EBIQ) was administered to a group of 905 brain injured patients, and close relatives to these competed a parallel version of the questionnaire concerning the brain-injured person. The sample was drawn from seven European countries together with Brazil. The same questionnaire was also administered to a group of 203 non-brain-injured controls, similarly in self-report and relative-report versions. Scales relating to eight specific areas of functioning, together with a global scale, are derived from the questionnaire and their internal reliability was estimated in the present data. Analyses of the 63 items of the questionnaire showed consistently greater levels of problems for the brain-injured group, especially as indicated by relatives. This pattern was substantially replicated among the nine scales. The scales discriminated well between stroke patients and those who had suffered a traumatic brain injury. There was also a tendency for reported problems to be greater for patients who were surveyed later post-injury (greater than or equal to 19 months) rather than earlier. Comparison of sets of controls derived from two countries (France and Brazil) showed small but important differences. It is concluded that the questionnaire has an acceptable reliability and validity, but that it will be necessary to obtain culturally relevant non-brain-injured control data when employing it in different countries.	UNIV COPENHAGEN, CTR REHABIL BRAIN INJURY, COPENHAGEN, DENMARK; RHEIN WESTFAL TH AACHEN, INST PSYCHOL, AACHEN, GERMANY; RHEIN WESTFAL TH AACHEN, NEUROL CLIN, AACHEN, GERMANY; UNIV STRASBOURG 1, DEPT PSYCHOL, STRASBOURG, FRANCE; HOSP SARAH KUBISTCHEK, BRASILIA, DF, BRAZIL; UNIV LEIPZIG, INST FORDERPADAG, D-7010 LEIPZIG, GERMANY; HOSP SANTA CRUZ & SAN PABLO, BARCELONA, SPAIN; HOSP SANTA MARIA, LISBON, PORTUGAL; KL INST, HELSINKI, FINLAND; CTR NEUROL WILLIAM LENNOX, OTTIGNIES, BELGIUM		Teasdale, TW (corresponding author), UNIV COPENHAGEN, DEPT PSYCHOL, COPENHAGEN, DENMARK.		Castro-Caldas, Alexandre/M-4156-2013; Willmes, Klaus F/A-1268-2014; Braga, Lucia/AAQ-1030-2020	Castro-Caldas, Alexandre/0000-0002-9148-3719; Willmes, Klaus F/0000-0002-9012-0553; 			Borg I., 1995, FACET THEORY FORM CO; BORG I, 1987, MULTIDIMENSIONAL SIM; BROOKS C, 1992, J AM STUD, V26, P126, DOI 10.1017/S002187580003053X; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Canter D., 1985, FACET THEORY APPROAC; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; DELOCHE G, 1996, ANN READAPTION MED P, V39, P21; DEROGATIS LR, 1983, SCL 90 R ADM SCONING; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; FABIANO RJ, 1992, REHABIL PSYCHOL, V37, P75, DOI 10.1037/h0079096; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; LEVY S, 1975, SOC INDIC RES, V2, P361, DOI 10.1007/BF00293253; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MCCLELLAND RJ, 1988, BRIT J PSYCHIAT, V153, P141, DOI 10.1192/bjp.153.2.141; MONGA TN, 1986, ARCH PHYS MED REHAB, V67, P19; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Prigatano G. P, 1988, BRAIN INJURY RECOVER, P335; Seron X., 1989, COGNITIVE APPROACHES; STACHOWIAK F, 1993, DEV ASSESSMENT REHAB; Teasdale T W, 1995, Appl Neuropsychol, V2, P116; TUOKKO H, 1991, Brain Injury, V5, P287, DOI 10.3109/02699059109008098; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004	29	111	112	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	1997	11	8					543	563		10.1080/026990597123250			21	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XL930	WOS:A1997XL93000001	9251864				2022-02-06	
